<SEC-DOCUMENT>0001193125-23-301741.txt : 20231222
<SEC-HEADER>0001193125-23-301741.hdr.sgml : 20231222
<ACCEPTANCE-DATETIME>20231222061648
ACCESSION NUMBER:		0001193125-23-301741
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		122
FILED AS OF DATE:		20231222
DATE AS OF CHANGE:		20231222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Interactive Strength, Inc.
		CENTRAL INDEX KEY:			0001785056
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				821432916
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276217
		FILM NUMBER:		231507113

	BUSINESS ADDRESS:	
		STREET 1:		1005 CONGRESS AVENUE
		STREET 2:		SUITE 925
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
		BUSINESS PHONE:		3106978655

	MAIL ADDRESS:	
		STREET 1:		1005 CONGRESS AVENUE
		STREET 2:		SUITE 925
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>d367939ds1.htm
<DESCRIPTION>S-1
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:trnr="http://formelife.com/20230930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>S-1</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;">
<h5><a href="#toc">Table of Contents</a></h5>
<div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2023To09_30_2023">0001785056</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2023To09_30_2023">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="trnr-20230930.xsd" /></ix:references><ix:resources><xbrli:context id="PAsOn12_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_23_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2017To12_31_2017" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2017-01-01</xbrli:startDate> <xbrli:endDate>2017-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P12_31_2022To12_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-31</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To03_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P11_01_2022To11_30_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-01</xbrli:startDate> <xbrli:endDate>2022-11-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_30_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-11-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P09_30_2019To09_30_2019" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-09-30</xbrli:startDate> <xbrli:endDate>2019-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_01_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-01-01</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_16_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-08-16</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P12_23_2022To12_23_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-23</xbrli:startDate> <xbrli:endDate>2022-12-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" >trnr:InternalUseSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:PreProductionToolingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MinimumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:PreProductionToolingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:CapitalizedContentCostsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:CapitalizedSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" >us-gaap:OtherAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_PromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FounderNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:FounderNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CapitalizedContentCostsAndContentLicensesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:CapitalizedContentCostsAndContentLicensesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:RightsOfferingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ScenarioPreviouslyReportedMembersrtRestatementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RestatementAxis" >srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:RightsOfferingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="trnr:AgreementAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ConvertibleDebtMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:DomesticCountryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ForeignCountryMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:ForeignCountryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesAStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesAOneMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesATwoMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesATwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedFourMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedFiveMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedSixMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedSevenMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedEightMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedNineMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedNineOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedTenMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis" >trnr:ContentLicensingAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CapitalizedStudioContentMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" >trnr:CapitalizedStudioContentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" >trnr:InternalUseSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_MinimumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:PreProductionToolingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:PreProductionToolingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:CapitalizedContentCostsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:CapitalizedSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_OtherAssetsMemberusgaapBalanceSheetLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" >us-gaap:OtherAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_PromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:RightsOfferingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >trnr:NoninterestBearingNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMemberusgaapDeferredRevenueArrangementTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis" >trnr:RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMemberusgaapDeferredRevenueArrangementTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis" >trnr:RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:PropertyAndEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" >trnr:IdentifiableIntangibleAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedNineConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedTenConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:WarrantsToPurchaseSeriesClassBCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:StockOptionsToPurchaseCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedOneConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedTwoConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedThreeConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedFourConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedFiveConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedSixConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedSevenConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedEightConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To09_30_2022_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:PropertyAndEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" >trnr:IdentifiableIntangibleAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2022To09_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-07-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeniorSecuredNotesStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:PropertyAndEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" >trnr:IdentifiableIntangibleAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedNineConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedTenConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:WarrantsToPurchaseSeriesClassBCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:StockOptionsToPurchaseCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedOneConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedTwoConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedThreeConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedFourConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedFiveConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedSixConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedSevenConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedEightConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >trnr:VendorThreeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_RestrictedStockMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:RestrictedStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_StockAppreciationRightsSARSMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >trnr:VendorThreeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:SeniorNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis" >dei:BusinessContactMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMemberusgaapDeferredRevenueArrangementTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis" >trnr:RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMemberusgaapDeferredRevenueArrangementTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis" >trnr:RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:PropertyAndEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" >trnr:IdentifiableIntangibleAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To09_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" >trnr:InternalUseSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_PromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_OtherAssetsMemberusgaapBalanceSheetLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" >us-gaap:OtherAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:CapitalizedSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CapitalizedContentCostsAndContentLicensesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >trnr:CapitalizedContentCostsAndContentLicensesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="trnr:AgreementAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ConvertibleDebtMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedSixMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedSevenMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedEightMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedNineMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedNineOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedTenMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedFourMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedFiveMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P05_01_2023To05_31_2023_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-01</xbrli:startDate> <xbrli:endDate>2023-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-01</xbrli:startDate> <xbrli:endDate>2023-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-01</xbrli:startDate> <xbrli:endDate>2023-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_01_2023To05_31_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-01</xbrli:startDate> <xbrli:endDate>2023-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_01_2023To05_31_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-01</xbrli:startDate> <xbrli:endDate>2023-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_01_2023To05_31_2023_BridgeNoteFinancingMemberusgaapCreditFacilityAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis" >trnr:BridgeNoteFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-01</xbrli:startDate> <xbrli:endDate>2023-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_31_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-31</xbrli:startDate> <xbrli:endDate>2023-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-05-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedOneConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedTwoConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedThreeConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedFourConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedFiveConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedSixConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedSevenConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedEightConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedNineConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedTenConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_WarrantsToPurchaseSeriesClassACommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:WarrantsToPurchaseSeriesClassACommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:WarrantsToPurchaseSeriesClassBCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:StockOptionsToPurchaseCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >trnr:VendorThreeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >trnr:VendorThreeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis" >trnr:TwoIndividualMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:ClassACommonWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ClassBCommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:ClassBCommonWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:ClassACommonWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:RightsOfferingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ConversionOfPreferredStockToClassACommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis" >trnr:ConversionOfPreferredStockToClassACommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ConversionOfPromissoryNotesToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis" >trnr:ConversionOfPromissoryNotesToConvertibleNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ConversionOfAccountsPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis" >trnr:ConversionOfAccountsPayableToConvertibleNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ConversionOfLoanPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis" >trnr:ConversionOfLoanPayableToConvertibleNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis" >trnr:ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMemberusgaapConversionOfStockByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis" >trnr:ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:DomesticCountryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ForeignCountryMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:ForeignCountryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis" >trnr:ContentLicensingAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis" >trnr:SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P11_01_2022To11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-01</xbrli:startDate> <xbrli:endDate>2022-11-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:November2022ConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-01</xbrli:startDate> <xbrli:endDate>2022-11-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P11_01_2022To11_30_2022_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-01</xbrli:startDate> <xbrli:endDate>2022-11-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P11_01_2022To11_30_2022_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-01</xbrli:startDate> <xbrli:endDate>2022-11-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:November2022ConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-11-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-11-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_30_2022_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-11-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:November2022ConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-11-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeniorSecuredNotesStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_LeadNoteholderMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:LeadNoteholderMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_OtherNoteholderMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:OtherNoteholderMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_SeniorNotesMemberusgaapLongtermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >us-gaap:SeniorNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:SeniorNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To03_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P06_01_2023To06_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_01_2023To06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_01_2023To06_30_2023_TenPercentageSeniorSecuredNotesDueMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:TenPercentageSeniorSecuredNotesDueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-11-13</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_13_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-11-13</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_13_2022_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-11-13</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeed9PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeed9PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeed9PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeed9PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_Seed10MemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:Seed10Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedNineMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedEightMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedSevenMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedSixMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedFiveMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedFourMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-03-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P03_01_2023To03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:SeniorNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-03-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-03-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2017To12_31_2017_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2017-01-01</xbrli:startDate> <xbrli:endDate>2017-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2017To12_31_2017_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2017-01-01</xbrli:startDate> <xbrli:endDate>2017-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:RightsOfferingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:RightsOfferingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-02-28</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:RightsOfferingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-02-28</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To01_31_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-01-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis" >trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-06</xbrli:startDate> <xbrli:endDate>2023-10-06</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_CommonStockMemberusgaapStatementEquityComponentsAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis" >trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-06</xbrli:startDate> <xbrli:endDate>2023-10-06</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_06_2023To10_06_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-06</xbrli:startDate> <xbrli:endDate>2023-10-06</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_06_2023To10_06_2023_CommonStockMemberusgaapStatementEquityComponentsAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-06</xbrli:startDate> <xbrli:endDate>2023-10-06</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis" >trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-06</xbrli:startDate> <xbrli:endDate>2023-10-06</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis" >trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-10-06</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P12_31_2024To12_31_2024_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_ScenarioForecastMembersrtStatementScenarioAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >srt:ScenarioForecastMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis" >trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-12-31</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-11-10</xbrli:startDate> <xbrli:endDate>2023-11-10</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P11_10_2023To11_10_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-11-10</xbrli:startDate> <xbrli:endDate>2023-11-10</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-11-10</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_IPOMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-05-17</xbrli:startDate> <xbrli:endDate>2019-05-17</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-05-17</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-08-28</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-08-28</xbrli:startDate> <xbrli:endDate>2019-08-28</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-11-28</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-11-28</xbrli:startDate> <xbrli:endDate>2019-11-28</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-03-20</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-03-20</xbrli:startDate> <xbrli:endDate>2020-03-20</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-02-12</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-12</xbrli:startDate> <xbrli:endDate>2021-02-12</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-09-30</xbrli:startDate> <xbrli:endDate>2019-09-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-10-21</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-10-21</xbrli:startDate> <xbrli:endDate>2019-10-21</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-02-18</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-02-18</xbrli:startDate> <xbrli:endDate>2020-02-18</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-09</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-06-09</xbrli:startDate> <xbrli:endDate>2020-06-09</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-15</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-06-15</xbrli:startDate> <xbrli:endDate>2020-06-15</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-11-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-11-02</xbrli:startDate> <xbrli:endDate>2020-11-02</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-12</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-12</xbrli:startDate> <xbrli:endDate>2021-01-12</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-02-22</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-22</xbrli:startDate> <xbrli:endDate>2021-02-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-10-27</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-10-27</xbrli:startDate> <xbrli:endDate>2022-10-27</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P08_01_2023To08_31_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >trnr:NoninterestBearingNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-08-01</xbrli:startDate> <xbrli:endDate>2023-08-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_27_2023To02_27_2023_ClassACommonStockToClassBCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis" >trnr:ClassACommonStockToClassBCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-27</xbrli:startDate> <xbrli:endDate>2023-02-27</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_13_2022To02_13_2022_ContractTerminationMemberusgaapRestructuringCostAndReserveAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis" >us-gaap:ContractTerminationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-02-13</xbrli:startDate> <xbrli:endDate>2022-02-13</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="trnr:AgreementAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-07-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_WarrantsToPurchaseSeriesClassACommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:WarrantsToPurchaseSeriesClassACommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedOneConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedTwoConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedThreeConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedFourConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedFiveConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedSixConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedSevenConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedEightConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedNineConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:SeriesSeedTenConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:WarrantsToPurchaseSeriesClassBCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >trnr:StockOptionsToPurchaseCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >trnr:VendorThreeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="trnr:AgreementAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorOneMembersrtMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >trnr:VendorOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:FuseprojectMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >trnr:ClassACommonWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ConversionOfPreferredStockToClassACommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis" >trnr:ConversionOfPreferredStockToClassACommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ConversionOfPromissoryNotesToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis" >trnr:ConversionOfPromissoryNotesToConvertibleNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ConversionOfAccountsPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis" >trnr:ConversionOfAccountsPayableToConvertibleNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ConversionOfLoanPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis" >trnr:ConversionOfLoanPayableToConvertibleNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis" >trnr:ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMemberusgaapConversionOfStockByUniqueDescriptionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis" >trnr:ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis" >trnr:SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis" >trnr:TwoIndividualMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_MinimumMembersrtRangeAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_MaximumMembersrtRangeAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis" >trnr:TwoIndividualMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2020To12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-07-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_02_2021To04_02_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-04-02</xbrli:startDate> <xbrli:endDate>2021-04-02</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P12_31_2020To12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-12-31</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandAndTwentySecuredConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedNineMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_SeriesSeedTwoTenMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedTwoTenMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:TwoThousandAndTwentySecuredConvertibleNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_SeriesSeedAndSeriesAAgreementMemberusgaapTypeOfArrangementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis" >trnr:SeriesSeedAndSeriesAAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_SeriesAConvertibleNotesMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >trnr:SeriesAConvertibleNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_23_2021To07_23_2021_SimpleAgreementsForFutureEquityMemberusgaapTypeOfArrangementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-23</xbrli:startDate> <xbrli:endDate>2021-07-23</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_25_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-25</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_25_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-25</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_25_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-25</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_25_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-25</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_25_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-25</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_25_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-25</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P08_25_2021To08_25_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAFinancingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-08-25</xbrli:startDate> <xbrli:endDate>2021-08-25</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P08_14_2018To12_31_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2018-08-14</xbrli:startDate> <xbrli:endDate>2018-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_14_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2018-08-14</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_14_2018_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2018-08-14</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_14_2018_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2018-08-14</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_13_2021_SeriesAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-13</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_24_2021_MinimumMembersrtRangeAxis_SeriesAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-11-24</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_24_2021_MaximumMembersrtRangeAxis_SeriesAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-11-24</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_24_2021_SeriesAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-11-24</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_23_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeniorSecuredNotesStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeniorSecuredNotesStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-09-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="trnr:AgreementAxis" >trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001785056</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD" > <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_shares" > <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Year" > <xbrli:measure>utr:Year</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Month" > <xbrli:measure>utr:Month</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure" > <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Day" > <xbrli:measure>utr:Day</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD_per_Share" > <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit><xbrli:unit id="Unit_Customer" > <xbrli:measure>trnr:Customer</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Vendor" > <xbrli:measure>trnr:Vendor</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Y" > <xbrli:measure>utr:Y</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top: 0pt; margin-bottom: 0pt; line-height: 0pt;;font-weight: bold;;font-size: .83em;"><br/></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;font-weight:bold;text-align:center">As filed with the Securities and Exchange Commission on December&#160;22, 2023 </div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: right;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Registration No.&#160;333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 4pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 4pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;; font-size: medium; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="font-family: &quot;Times New Roman&quot;; font-size: medium; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 16pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">UNITED ST<div style="display:inline;">AT</div>ES</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 16pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">SECURITIES AND EXCHANGE COMMISSION</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;">Washington, DC 20549</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;"><div style="line-height: 6pt; margin: 0pt auto 2pt; border-bottom: 1pt solid rgb(0, 0, 0); width: 171.359px; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 16pt; text-align: center;"><div style="font-weight:bold;display:inline;">FORM<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:DocumentType" contextRef="P01_01_2023To09_30_2023">S-1</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 16pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">REGISTRATION STATEMENT</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">UNDER</div></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">THE SECURITIES ACT OF 1933</div></div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;"><div style="line-height: 6pt; margin: 0pt auto 2pt; border-bottom: 1pt solid rgb(0, 0, 0); width: 171.359px; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 20pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 20pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2023To09_30_2023">INTERACTIVE STRENGTH INC.</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">(Exact name of registrant as specified in its charter)</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;"><div style="line-height: 6pt; margin: 0pt auto 2pt; border-bottom: 1pt solid rgb(0, 0, 0); width: 171.359px; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 8pt; width: 816px; border: 0px; margin: 0px auto; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 277.438px;"></td>
<td style="vertical-align: bottom;"></td>
<td style="width: 261.109px;"></td>
<td style="vertical-align: bottom; width: 8.15625px;"></td>
<td style="width: 261.109px;"></td></tr>
<tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 9pt;">
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="P01_01_2023To09_30_2023" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityPrimarySicNumber" contextRef="P01_01_2023To09_30_2023">3600</ix:nonNumeric></div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="P01_01_2023To09_30_2023">82-1432916</ix:nonNumeric></div></div></div></td></tr>
<tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;">
<td style="vertical-align: top;;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(State or Other Jurisdiction</div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">of Incorporation Organization)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(Primary Standard Industrial</div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Classification Code Number)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(I.R.S. Employer</div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Identification No.)</div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_01_2023To09_30_2023">1005 Congress Avenue</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="P01_01_2023To09_30_2023">Suite 925</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_01_2023To09_30_2023">Austin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P01_01_2023To09_30_2023" format="ixt-sec:stateprovnameen">Texas</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_01_2023To09_30_2023">78701</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_01_2023To09_30_2023">310</ix:nonNumeric>)<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_01_2023To09_30_2023">697-8655</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices)</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;"><div style="line-height: 6pt; margin: 0pt auto 2pt; border-bottom: 1pt solid rgb(0, 0, 0); width: 171.359px; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:ContactPersonnelName" contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Trent A. Ward</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Chief Executive Officer</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Interactive Strength Inc. d/b/a FORME</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">1005 Congress Avenue</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Suite 925</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Austin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" format="ixt-sec:stateprovnameen">Texas</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">78701</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">310</ix:nonNumeric>)<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">697-8655</ix:nonNumeric></div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;"><div style="line-height: 6pt; margin: 0pt auto 2pt; border-bottom: 1pt solid rgb(0, 0, 0); width: 171.359px; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Copies to:</div></div></div></div>
<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 9pt; width: 816px; border: 0px; margin: 0px auto; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 816px; font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 9pt;">
<td style="vertical-align: top;;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Davina K. Kaile, Esq.</div></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Pillsbury Winthrop Shaw Pittman LLP</div></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2550 Hanover Street</div></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Palo Alto, CA 94304</div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Telephone: (650) 233-4500</div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;"><div style="line-height: 6pt; margin: 0pt auto 2pt; border-bottom: 1pt solid rgb(0, 0, 0); width: 171.359px; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Approximate date of commencement of proposed sale to the public:</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">From time to time</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">after</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">this registration statement becomes</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">effective.</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box.&#160;&#160;&#9746;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accelerated</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12b-2</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>of the Exchange Act.</div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 9pt; width: 816px; border: 0px; margin: 0px auto; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 122.391px;"></td>
<td style="vertical-align: bottom; width: 8.15625px;"></td>
<td style="width: 505.922px;"></td>
<td style="vertical-align: bottom; width: 8.15625px;"></td>
<td style="width: 146.875px;"></td>
<td style="vertical-align: bottom; width: 8.15625px;"></td>
<td style="width: 16.3438px;"></td></tr>
<tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 9pt;">
<td style="vertical-align: bottom;">Large&#160;accelerated&#160;filer</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#9744;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">Accelerated&#160;filer</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#9744;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 9pt;">
<td style="vertical-align: bottom;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div><ix:nonNumeric name="dei:EntityFilerCategory" contextRef="P01_01_2023To09_30_2023" format="ixt-sec:entityfilercategoryen"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-accelerated</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>filer</ix:nonNumeric></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#9746;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">Smaller&#160;reporting&#160;company</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><ix:nonNumeric name="dei:EntitySmallBusiness" contextRef="P01_01_2023To09_30_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 9pt;">
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">Emerging growth company</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="P01_01_2023To09_30_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 3pt; margin-bottom: 0pt; font-size: 9pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section&#160;7(a)(2)(B) of the Securities Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="P01_01_2023To09_30_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;"><div style="line-height: 6pt; margin: 0pt auto 2pt; border-bottom: 1pt solid rgb(0, 0, 0); width: 171.359px; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;font-weight:bold">The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment, which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine. </div><div style="font-size: 4pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div><div style="line-height: 1pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><span style="color:#ff4338"><span style="font-weight:bold">The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted. </span></span></p> <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="color:#ff4338"><span style="font-weight:bold">SUBJECT TO COMPLETION, DATED DECEMBER&#160;22, 2023 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="color:#ff4338"><span style="font-weight:bold">PRELIMINARY PROSPECTUS </span></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g26d49.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Up to 12,480,480 Shares of Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">This prospectus relates to the resale, from time to time, of up to 12,480,480 shares of the common stock of Interactive Strength Inc. d/b/a Forme (the &#8220;Company,&#8221; &#8220;Forme,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;) by the selling stockholder, 3i, LP (&#8220;3i&#8221; or the &#8220;selling stockholder&#8221; or the &#8220;Note Investor&#8221;), or its permitted transferees or other <span style="white-space:nowrap"><span style="white-space:nowrap">successors-in-interest.</span></span> These 12,480,480 shares consist of: (a)&#160;up to 11,556,000 shares of common stock (the &#8220;Convertible Note Shares&#8221;) issuable upon the conversion of a senior unsecured convertible note in the aggregate principal amount of $2,160,000, which was issued with an eight percent (8.0%) original issue discount and which bears an interest rate of seven percent (7.0%) per annum, issued to the selling stockholder (the &#8220;Note&#8221;); and (b)&#160;up to 924,480 shares of common stock (the &#8220;Warrant Shares&#8221; and, together with the Convertible Note Shares, the &#8220;Shares&#8221;) issuable upon exercise of a common stock purchase warrant issued to the selling stockholder (the &#8220;Warrant&#8221; and, together with the Note, the &#8220;Securities&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">The Securities were issued pursuant to that certain purchase agreement between us and the selling stockholder, dated December&#160;7, 2023 (the &#8220;Purchase Agreement&#8221;). The number of shares of common stock issuable upon conversion of the Note or exercise of the Warrant, as applicable, are subject to certain beneficial ownership and share issuance caps as set forth in the Purchase Agreement. See <span style="font-style:italic">&#8220;The 3i Note Transaction&#8221;</span> for a description of the agreement and <span style="font-style:italic">&#8220;Selling Stockholder&#8221;</span> for additional information regarding the selling stockholder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">The selling stockholder, or its permitted transferees or other <span style="white-space:nowrap"><span style="white-space:nowrap">successors-in-interest,</span></span> may offer the Shares from time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. References to the &#8220;selling stockholder&#8221; in this prospectus shall also refer to any permitted transferees or other <span style="white-space:nowrap"><span style="white-space:nowrap">successors-in-interest</span></span> to the Note Investor. The prices at which the selling stockholder sells the Shares will be determined by the prevailing market price for the shares or in negotiated transactions. We provide additional information about how the selling stockholder may sell the Shares in <span style="font-style:italic">&#8220;Plan of Distribution&#8221;</span> on page&#160;181 of this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">We are not offering any shares of our common stock for sale under this prospectus. We are registering the offer and resale of the Shares to satisfy contractual obligations owed by us to the selling stockholder pursuant to the Purchase Agreement and documents ancillary thereto. Our registration of the Shares covered by this prospectus does not mean that the selling stockholder will offer or sell any of the Shares. Any of the Shares subject to resale hereunder will have been issued by us and acquired by the selling stockholder prior to any resale of such Shares pursuant to this prospectus. No underwriter or other person has been engaged to facilitate the sale of the Shares in this offering. The selling stockholder will pay or assume discounts, commissions, fees of underwriters, selling brokers, dealer managers or similar expenses, if any, incurred for the sale of the Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">We will not receive any proceeds from the resale of the Shares by the selling stockholder pursuant to this prospectus. However, we may receive up to $1.25 per share upon the cash exercise of the Warrant. The Warrant may be exercised at any time between December&#160;7, 2023 and June&#160;7, 2029. Upon the exercise of the Warrant for all 924,480 Warrant Shares by payment of cash, we will receive aggregate gross proceeds of approximately $1.2&#160;million. However, we cannot predict when and in what amounts or if the Warrant will be exercised, and it is possible that the Warrant may expire and never be exercised, in which case we would not receive any cash proceeds. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman">Our common stock is listed on the Nasdaq Stock Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;TRNR.&#8221; On December&#160;21, 2023, the last reported sale price of our common stock on Nasdaq was $0.93 per share. We are an &#8220;emerging growth company&#8221; as that term is used in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold">Investing in our common stock is speculative and involves a high degree of risk. See &#8220;<a href="#rom367939_5">Risk Factors</a>&#8221; beginning on page&#160;10 for a discussion of information that should be considered in connection with an investment in our common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman;font-weight:bold">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">The date of this prospectus is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 20&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc">TABLE OF CONTENTS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:95%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Page</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_1">ABOUT THIS PROSPECTUS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">ii</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_2">MARKET, INDUSTRY AND OTHER DATA</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">ii</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_3">PROSPECTUS SUMMARY</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_4">THE OFFERING</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_5">RISK FACTORS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_6">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_7">USE OF PROCEEDS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">82</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_8">DETERMINATION OF OFFERING PRICE</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">82</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_9">MARKET INFORMATION AND DIVIDEND POLICY</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">82</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_10">DILUTION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">84</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_11">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">86</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_12">BUSINESS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">121</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_13">MANAGEMENT</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">145</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_14">EXECUTIVE COMPENSATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">152</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_15">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">164</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_16">SELLING STOCKHOLDER</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_17">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">172</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_18">DESCRIPTION OF CAPITAL STOCK</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">174</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_19">PLAN OF DISTRIBUTION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">181</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_20">THE 3i NOTE TRANSACTION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">184</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_21">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES TO <span style="white-space:nowrap">NON-U.S.</span> HOLDERS OF OUR COMMON STOCK</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">186</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_22">LEGAL MATTERS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">190</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_23">EXPERTS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">190</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_24">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">190</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_25">WHERE YOU CAN FIND MORE INFORMATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">190</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#rom367939_26a">INDEX TO FINANCIAL STATEMENTS </a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">i </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_1">ABOUT THIS PROSPECTUS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on <span style="white-space:nowrap">Form&#160;S-1</span> that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221; or the &#8220;Commission&#8221;). The selling stockholder may offer, sell or distribute all or a portion of the shares of our common stock hereby registered publicly or through private transactions at prevailing market prices or at negotiated prices, from time to time in one or more offerings as described in this prospectus. We will not receive any of the proceeds from such sales of our common stock. We will bear all costs, expenses and fees in connection with the registration of these securities, including with regard to compliance with state securities or &#8220;blue sky&#8221; laws. The selling stockholder will bear all commissions and discounts, if any, attributable to its sale of our common stock hereby registered. See <span style="font-style:italic">&#8220;Plan of Distribution.&#8221;</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part that may contain material information relating to these offerings. The prospectus supplement or post-effective amendment may also add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. Before purchasing any securities, you should carefully read this prospectus, any post-effective amendment, and any applicable prospectus supplement, together with the additional information described in the <span style="font-style:italic">&#8220;Where You Can Find More Information&#8221;</span> section of this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither we nor the selling stockholder has authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any post-effective amendment, or any applicable prospectus supplement prepared by or on behalf of us or to which we have referred you. We and the selling stockholder take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We and the selling stockholder will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus, any post-effective amendment and any applicable prospectus supplement to this prospectus is accurate only as of the date on its respective cover. Our business, financial condition, results of operations and prospects may have changed since those dates. This prospectus contains, and any post-effective amendment or any prospectus supplement may contain, market data and industry statistics and forecasts that are based on independent industry publications and other publicly available information. Although we believe these sources are reliable, we do not guarantee the accuracy or completeness of this information and we have not independently verified this information. In addition, the market and industry data and forecasts that may be included in this prospectus, any post-effective amendment or any prospectus supplement may involve estimates, assumptions and other risks and uncertainties and are subject to change based on various factors, including those discussed in the <span style="font-style:italic">&#8220;Risk Factors&#8221;</span> section of this prospectus, any post-effective amendment and the applicable prospectus supplement. Accordingly, investors should not place undue reliance on this information. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_2">MARKET, INDUSTRY AND OTHER DATA </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including our general expectations, market position, market opportunity, and market size, is based on information from various sources, including our own estimates, as well as assumptions that we have made that are based on such data and other similar sources, and on our knowledge of the market for our products and services. This information involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we believe the market position, market opportunity, and market size information included in this prospectus is generally reliable, information of this sort is inherently imprecise. In addition, projections, assumptions, and estimates of our future performance and the future performance of the industry in which we operate is necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in <span style="font-style:italic">&#8220;Risk Factors&#8221;</span> and elsewhere in this prospectus. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">ii </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus contains statistical data, estimates, and forecasts that are based on industry publications or reports generated by third-party providers, or other publicly available information, as well as other information based on internal estimates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The sources of certain statistical data, estimates, and forecasts contained in this prospectus are provided below: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Global Wellness Institute,<span style="font-style:italic">&#160;Wellness Industry Statistics and Facts,</span>&#160;September 2020. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Bureau of Labor Statistics,<span style="font-style:italic">&#160;Sports and Exercise</span>, May 2017. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Fortune Business Insights,<span style="font-style:italic">&#160;US Home Fitness Equipment Market Size</span>, June 2022. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">MindBody Business,<span style="font-style:italic">&#160;Here&#8217;s How</span><span style="font-style:italic"></span><span style="font-style:italic"><span style="white-space:nowrap">&#160;COVID-19</span></span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Has Changed Fitness</span>. May 2020. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Personal Trainer Development Center,<span style="font-style:italic">&#160;Personal Trainer Salary 2022: Adaptable Personal Trainers Among Highest Paid</span>, December 2021. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Lessons.com,<span style="font-style:italic">&#160;How Much Does A Personal Trainer Cost?.</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The following reports from The International Health, Racquet&#160;&amp; Sportsclub Association:<span style="font-style:italic">&#160;2021 IHRSA Global Report, 2020 IHRSA Global Report, IHRSA Fitness Training Report.</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">McKinsey,<span style="font-style:italic">&#160;Still feeling good: The US wellness market continues to boom,</span><span style="font-style:italic"></span>&#160;September 2022. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statistics and estimates related to our total addressable market (&#8220;TAM&#8221;) are based on external research and internal estimates. To calculate our TAM, we estimated the number of households earning $100,000 (or the foreign equivalent) or more in annual household income in the United States using publicly available government censuses and sources. We then estimated a percentage of those households that had one or more fitness participants based on statistics published by the Bureau of Labor Statistics on fitness participation by educational attainment, which we used as a proxy for wealth, and therefore likelihood of spending on premium fitness offerings. We define a &#8220;fitness participant&#8221; as someone who engages in some form of fitness training at least once a week. To estimate our total TAM, we multiplied the total number of households earning $100,000 or more and had one or more fitness participants by our average expected revenue per user, which we expect, conservatively, to be $1,800 per year, assuming a&#160;30% to 40%&#160;penetration rate of our services offering in our member base. We believe this penetration rate is reasonable given internal research conducted on our member base. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">iii </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_3">PROSPECTUS SUMMARY </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">This summary highlights certain information contained elsewhere in this prospectus. This summary does not contain all of the information that you should consider before purchasing our common stock. The words &#8220;Forme,&#8221; &#8220;us,&#8221; &#8220;we,&#8221; the &#8220;Company&#8221; and any variants thereof used in this prospectus refer to Interactive Strength Inc. Investing in our common stock is speculative and involves a high degree of risk. You should carefully consider the risks and uncertainties described herein, including those discussed in the &#8220;Risk Factors&#8221; section of this prospectus, together with all of the other information in this prospectus, including our financial statements and related notes, before investing in our common stock. If any of the risks described herein materialize, our business, financial condition, operating results and prospects could be materially and adversely affected. In that event, the price of our common stock could decline, and you could lose part or all of your investment. Our expectations for our future performance may change after the date of this prospectus and there is no guarantee that such expectations will prove to be accurate. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a digital fitness platform that combines premium connected fitness hardware products with personal training and coaching (from real humans) to deliver an immersive experience and better outcomes for both consumers and trainers. We believe we are the pioneer brand in the emerging sector of virtual personal training and health coaching and that our products and services are accelerating a powerful shift towards outcome-driven fitness solutions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Forme platform delivers an immersive and dynamic <span style="white-space:nowrap">at-home</span> fitness experience through our VOD content, curated personalized fitness programming, Live 1:1 personal training, and other health coaching services, which are accessible via download or streaming through our connected fitness hardware products and via streaming through the Forme Studio app, which is available through iOS mobile devices and most iOS tablets and computers. The Forme Studio app is a standalone offering that members can use to access our training and health coaching services. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We offer two connected fitness hardware products, the Forme Studio (fitness mirror) and the Forme Studio Lift (fitness mirror and cable-based digital resistance). Both products are designed to provide a more integrated and immersive experience than similar connected fitness products currently on the market. The Forme Studio features a <span style="white-space:nowrap">43-inch</span> 4K ultra high definition (&#8220;UHD&#8221;) touchscreen display, which is among the largest and highest definition screens in the connected fitness equipment market, and two front-facing 12 megapixel (&#8220;MP&#8221;), wide angle cameras designed to facilitate seamless live interaction with a trainer. The Forme Studio Lift also features two cable-based resistance arms that can provide up to 100 pounds of resistance per arm. Sales of our connected fitness hardware products have accounted for the substantial portion of our revenue to date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to our connected fitness hardware products, we offer video <span style="white-space:nowrap">on-demand</span> (&#8220;VOD&#8221;) classes, personal training, and expert health coaching. Our health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. Personal training currently comprises the majority of our health coaching services. All members who purchase the Forme Studio and Forme Studio Lift are able to access our VOD content library by creating a Forme account and signing up for our monthly membership. Once on the platform, each member is matched with a Fitness Concierge who works to understand specific needs and goals and then curates weekly fitness plans, comprised of <span style="white-space:nowrap">On-Demand</span> classes from our VOD content library. Our VOD content library includes hundreds of <span style="white-space:nowrap">On-Demand</span> classes spanning a wide range of modalities, including strength, recovery, barre, mind, Pilates, yoga, and other specialty categories. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For members who desire additional personalization, we recently launched our Custom Training offering which connects members with our personal trainers and is an upgrade to the VOD membership. This offering is currently charged at $149 per month and includes full access to the VOD content library. Through Custom </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Training, members are able to work closely with one of our expert trainers who deliver custom, guided fitness programs that are specifically tailored to the members&#8217; health goals in a range of areas. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Live 1:1 personal training services are offered as an <span style="white-space:nowrap">add-on</span> to our memberships. Members who opt into Live 1:1 complete an onboarding process and are matched with one of our expert trainers based on the member&#8217;s preferences and criteria. Once matched, the trainer takes the member through a fitness assessment during the first session then builds a personalized program for the member based on specific needs and goals. Through our internally developed Live 1:1 software platform we strive to deliver a consistent and high quality user experience for both the member and the trainer that includes value added features like <span style="white-space:nowrap">on-screen</span> biometrics, an adjustable field of view for the trainer and other <span style="white-space:nowrap">on-screen</span> UI elements to provide context and motivation during a session. Coaches training members on the Studio Lift have the ability to adjust resistance for their members during a workout, providing an added level of personalization and service for the member. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We outsource the manufacturing of our products, which we believe allows us to focus our resources on the design, development, quality and reliability management, marketing, and sales of our products. In addition, we believe that outsourcing our manufacturing activities provides us with the flexibility needed to respond to new market opportunities, simplifies our operations, reduces risk, and significantly reduces our capital commitments. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our revenue is primarily generated from the sale of our connected fitness hardware products and associated recurring membership revenue. As we launched our first connected fitness hardware product in July 2021, we began generating revenue from sales of our products starting in the second half of 2021. In 2022, 2021, and the nine months ended September&#160;30, 2023, we generated total revenue of $0.7&#160;million, $0.3&#160;million, and $0.8&#160;million, respectively, and incurred net losses of $(58.2) million, $(32.8) million, and $(40.0) million, respectively. As of September&#160;30, 2023, we had an accumulated deficit of $155.5&#160;million. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Recent Developments </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2023, we received written notification from Nasdaq that our stockholders&#8217; equity as reported in our Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the period ended June&#160;30, 2023 did not satisfy the continued listing requirement under Nasdaq Listing Rule 5450(b)(1)(A) for the Nasdaq Global Market, which requires that a listed company&#8217;s stockholders&#8217; equity be at least $10.0&#160;million. In accordance with the Nasdaq Listing Rules, we submitted a plan to regain compliance and Nasdaq subsequently granted us an extension to evidence compliance on or before February&#160;19, 2024. Our common stock will continue to be listed on Nasdaq under the symbol &#8220;TRNR&#8221; during this period while we work to regain compliance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2023, we entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;) with CLMBR, Inc and CLMBR1, LLC (the &#8220;Sellers&#8221;) to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers (the &#8220;CLMBR Acquisition&#8221;). The purchase price enterprise value under the Asset Purchase Agreement is approximately $16.9&#160;million, consisting of $6.0&#160;million expected to be paid in the form of our equity, the assumption by us of $1.5&#160;million of subordinated debt, and the retirement of $9.4&#160;million of senior debt. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2023, we entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) with 3i, LP (&#8220;3i&#8221; or the &#8220;selling stockholder&#8221; or the &#8220;Note Investor&#8221;) pursuant to which we issued a senior unsecured convertible note in the aggregate principal amount of $2,160,000, with an eight percent (8.0%) original issue discount and an interest rate of seven percent (7.0%) per annum (the &#8220;Note&#8221;), and a warrant to purchase up to 924,480 shares of common stock (the &#8220;Warrant&#8221;) (the &#8220;3i Note Transaction&#8221;). The Note is convertible into a maximum of 11,556,000 shares of common stock. The conversion and exercise of the Note and the Warrant are subject to the terms of the Purchase Agreement, including the beneficial ownership limitations and share issuance caps specified therein. In connection with the 3i Note Transaction, we entered into a registration rights agreement with the selling stockholder, pursuant to which we agreed to file a resale registration statement covering the resale of the Shares. </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2023, we entered into a common stock purchase agreement (the &#8220;Equity Line Purchase Agreement&#8221;) with an accredited investor (the &#8220;Equity Line Investor&#8221;), pursuant to which we, in our sole discretion, may sell up to $20.0&#160;million in aggregate of newly issued common stock to the Equity Line Investor, subject to certain beneficial ownership limitations and limitations on the maximum number of shares we may issue and sell in accordance with Nasdaq listing requirements (the &#8220;Equity Line Financing&#8221;). In connection with the Equity Line Financing, we entered into a registration rights agreement with the Equity Line Investor, pursuant to which we will file a resale registration statement with respect to the shares we may sell to the Equity Line Investor under the Equity Line Purchase Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risk Factor Summary </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before you invest in our common stock, you should carefully consider all of the information in this prospectus, including matters set forth under <span style="font-style:italic">&#8220;Risk Factors.&#8221;</span> These risks include, but are not limited to, the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We have incurred operating losses in the past, expect to incur operating losses in the future, and may not achieve profitability, or, if we achieve profitability, be able to maintain it in the future. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our past financial results may not be a reliable indicator of our ability to successfully establish our product and service offerings in the marketplace, or of our future performance, and our revenue growth rate is likely to slow as our business matures. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We have a limited operating history with which to evaluate and predict the profitability of our subscription model, and any new revenue models we may introduce in the future may be unsuccessful. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our negative cash flows from operations, history of losses, and significant accumulated deficit raise substantial doubt about our ability to continue as a &#8220;going concern.&#8221; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we fail to compete successfully, we may fail to obtain a meaningful market share, which in turn would harm our business, financial condition, and results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our results of operations and other financial and <span style="white-space:nowrap">non-financial</span> business metrics may fluctuate from period to period due to a variety factors, and as a result, our results from any prior periods, or any historical trends reflected in such results, should not be viewed as indicative of our future financial or operating performance. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We derive a significant majority of our revenue from sales of our Forme Studio equipment and if sales of our Forme Studio equipment decline, it would materially and negatively affect our future revenue and results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our membership revenue is largely dependent on our ability to sell our Forme Studio equipment. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our results of operations could be adversely affected if we are unable to accurately forecast consumer demand for our products and services and adequately manage our inventory. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we are unable to sustain competitive pricing levels for our premium connected fitness hardware products and memberships to the Forme platform, our business could be adversely affected. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Changes in how we market our products and services could adversely affect our marketing expenses and membership levels. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The market for our products and services is still in the early stages of growth and if the market does not continue to grow, grows more slowly than we expect, or fails to grow as large as we expect, or if our products and services do not gain market acceptance, our business, financial condition, and results of operations may be adversely affected. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our revenue could decline if customers are no longer able to finance their purchases of our products due to changes in credit markets and decisions made by credit providers. </p></td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We may be unable to attract and retain members, which could have an adverse effect on our business and rate of growth. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we are unable to attract or otherwise retain health coaches and personal trainers, as well as fitness instructors, including to produce and provide fitness content on our platform, our business, financial condition, and results of operations could be harmed. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we fail to cost-effectively attract new members, provide high-quality member support, or increase utilization of the Forme platform by existing members, our business, financial condition, and results of operations could be harmed. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Changes to our pricing methodologies or business model could adversely affect our ability to attract or retain members as well as qualified personal trainers, health coaches, and fitness instructors. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we are unable to anticipate consumer preferences and successfully develop and introduce new, innovative, and updated products and services in a timely manner or effectively manage the introduction of new or enhanced products and services, our business may be adversely affected. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we fail to successfully expand our commercial and corporate wellness business, it could negatively impact our ability to grow our business and gain market share. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we are unable to manage our growth effectively, our brand, company culture, and financial performance may suffer. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we are unable to successfully expand our retail showroom footprint, it could adversely affect our ability to expand our business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If our marketing efforts are not effective, our ability to grow our business and maintain or expand our market share could suffer. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Design, manufacturing, and other defects in our products, or technical or performance issues related to our products or services, or similar events may result in claims against us and may cause us to incur significant additional expense to address these issues, and our liability insurance may not be adequate to cover any or all such costs. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The failure or inability of our contract manufacturers to comply with the specifications and requirements of our products could result in a product recall, which could adversely affect our reputation and subject us to significant liability should the use of any of our products cause or be claimed to cause physical harm. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we are unable to access or use production studios or if we are unable to attract and retain high-quality and innovative fitness instructors or other content production providers, we may not be able to generate interesting and attractive content for our platform. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we fail to establish and expand our strategic partnerships within the fitness and wellness industries or across the hospitality, fashion, sports and design industries, our ability to increase market share and grow our business may suffer. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We face risks, such as unforeseen costs and potential liability, in connection with content we acquire, produce, license, or distribute through our service. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We face certain risks related to the interaction of our members, trainers, and fitness instructors. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our directors and officers and certain holders beneficially own a significant percentage of our common stock, will be able to exert significant influence over matters subject to stockholder approval and may have interests that conflict with those of our other stockholders. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We rely on a limited number of suppliers, manufacturers, and logistics partners for our Forme Studio equipment and are subject to risks related to increases in component and equipment costs, long lead times, supply shortages, and supply changes. </p></td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our payments system depends on third-party providers and is subject to evolving laws and regulations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Any major disruption or failure of our information technology systems or websites, or our failure to successfully implement upgrades and new technologies effectively, could adversely affect our business and operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Any disruption of our use of these third-party services, including those we use for computing, storage, processing, and similar services, could have an adverse effect on our business, financial condition, and results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we experience any adverse change to, loss of, or claim that we do not hold necessary licenses to the music content included in our fitness content or otherwise accessible on our platform, it may have an adverse effect on our business, financial condition, and results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our member engagement on mobile devices depends upon effective operation with mobile operating systems, networks, and standards that we do not control. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We rely on third parties to drive traffic to our website, and these providers may change their algorithms or pricing in ways that could damage our business, operations, financial condition, and prospects. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We may not be able to accurately predict our future capital needs and may incur significant expenditures, and we may not be able to obtain additional financing to fund our operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we do not remediate the material weaknesses identified in our internal control over financial reporting, or if we fail to establish and maintain effective internal control, we may not be able to accurately report our financial results or file our periodic reports in a timely manner, which may cause investors to lose confidence in our reported financial information and may lead to a decline in the market price of our common stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We face risks related to intellectual property, privacy, cybersecurity, infrastructure, tax, and accounting matters, as well as risks related to our international operations and other regulatory matters, including contractor classification, export control, anti-corruption, environmental, ESG, and climate change. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Resale of the Shares may be at prices below the current market price for our common stock and the issuances of the Shares or any future issuances of our common stock or securities convertible into common stock will result in further dilution and could adversely affect the price of our common stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We may not use effectively the proceeds that we receive from the sale of the Note or the cash exercise of the Warrant, if any. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We face risks related to becoming a public company, our common stock, including delisting of our common stock from Nasdaq if we fail to meet continued listing requirements, as well as general risks, including those related to economic conditions, dependence on key personnel, acquisition-related matters, and litigation, among others. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Corporate Information </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were incorporated in Delaware on May&#160;8, 2017. Our principal executive offices are located at 1005 Congress Avenue, Suite 925, Austin, Texas 78701 and our phone number is (310) <span style="white-space:nowrap">697-8655.</span> Our principal website is www.formelife.com. The information contained on, or that can be accessed through, our website is not a part of this prospectus or the registration statement of which it forms a part. The inclusion of our website address in this prospectus is an inactive textual reference only. Investors should not rely on any such information in deciding whether to purchase our common stock. </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Implications of Being an Emerging Growth Company and a Smaller Reporting Company </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). As such, we are eligible for exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, including, but not limited to, presenting only two years of audited financial statements in addition to any required unaudited interim financial statements with correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; disclosure in this prospectus, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), reduced disclosure obligations regarding executive compensation and an exemption from the requirements to obtain a <span style="white-space:nowrap">non-binding</span> advisory vote on executive compensation or golden parachute arrangements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this provision of the JOBS Act. As a result, we will not be subject to new or revised accounting standards at the same time as other public companies that are not emerging growth companies. Therefore, our consolidated financial statements may not be comparable to those of companies that comply with new or revised accounting pronouncements as of their public company effective dates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will remain an emerging growth company until the earliest of: (i)&#160;the last day of the fiscal year following the fifth anniversary of the consummation of our initial public offering; (ii)&#160;the last day of the fiscal year in which we have total annual gross revenue of at least $1.235&#160;billion (as adjusted for inflation from time to time pursuant to SEC rules); (iii) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule <span style="white-space:nowrap">12b-2</span> under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which would occur if the market value of our common stock held by <span style="white-space:nowrap">non-affiliates</span> were at least $700.0&#160;million as of the last business day of the second fiscal quarter of such year; or (iv)&#160;the date on which we have issued more than $1.0&#160;billion in <span style="white-space:nowrap">non-convertible</span> debt securities during the prior three-year period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as our public float is less than $250.0&#160;million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0&#160;million during the most recently completed fiscal year and our public float is less than $700.0&#160;million measured on the last business day of our second fiscal quarter. Even after we no longer qualify as an emerging growth company, we may still qualify as a smaller reporting company, which would allow us to take advantage of many of the same exemptions from disclosure requirements, such as reduced disclosure regarding executive compensation, among others. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For certain risks related to our status as an emerging growth company, see <span style="font-style:italic">&#8220;Risk Factors</span><span style="font-style:italic"></span><span style="font-style:italic"> &#8211; Risks Related to Becoming a Public Company &#8211; We are an emerging growth company and a smaller reporting company, and any decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies and smaller reporting companies could make our common stock less attractive to investors.&#8221;</span> <span style="font-weight:bold"> </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Channels for Disclosure of Information </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We announce material information to the public through filings with the SEC, the investor relations page on our website (www.formelife.com), press releases, public conference calls, and public webcasts. We encourage investors, the media and others to follow the channels listed above and to review the information disclosed </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
through such channels. Any updates to the list of disclosure channels through which we will announce information will be posted on the investor relations page on our website. The inclusion of our website address in this prospectus is an inactive textual reference only. </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_4">THE OFFERING </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The following summary contains basic information about this offering and our common stock and is not intended to be complete. It does not contain all of the information that may be important to you. For a more complete understanding of our common stock, please refer to &#8220;Description of Capital Stock.&#8221; </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Common stock offered by the&#160;selling&#160;stockholder </p></td>
<td>Up to 12,480,480 shares of our common stock, consisting of (i)&#160;up to 11,556,000 shares of common stock (the &#8220;Convertible Note Shares&#8221;) issuable upon the conversion of a senior unsecured convertible note in the aggregate principal amount of $2,160,000 issued to the selling stockholder (the &#8220;Note&#8221;); and (ii)&#160;up to 924,480 shares of common stock (the &#8220;Warrant Shares&#8221; and, together with the Convertible Note Shares, the &#8220;Shares&#8221;) issuable upon exercise of a common stock purchase warrant issued to the selling stockholder (the &#8220;Warrant&#8221; and, together with the Note, the &#8220;Securities&#8221;). </td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; padding-bottom:3pt; margin-top:-2pt; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Common&#160;stock outstanding&#160;immediately after&#160;this&#160;offering<sup style="font-size:75%; vertical-align:top">(1</sup>)</p></td>
<td>26,793,665 shares, assuming the issuance of the 12,480,480 Shares upon the conversion of the Note and the exercise of the Warrant. </td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Use of proceeds</span> </p></td>
<td>We will not receive any proceeds from the resale of the Shares by the selling stockholder in this offering. We will receive proceeds in the event that the Warrant is exercised at the exercise price per share for cash, which will result in aggregate gross proceeds of up to approximately $1.2&#160;million and we received approximately $2.0&#160;million in proceeds from the issuance of the Note. We may use the proceeds from the Note and any proceeds that we receive from the exercise of the Warrant for the repayment of outstanding indebtedness and general corporate purposes. See <span style="font-style:italic">&#8220;Use of Proceeds.&#8221;</span> </td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Nasdaq Stock Market symbo</span>l </p></td>
<td>&#8220;TRNR&#8221; </td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Risk factors</span> </p></td>
<td>Investing in our common stock is speculative and involves a high degree of risk. See <span style="font-style:italic">&#8220;Risk Factors&#8221;</span> beginning on page&#160;10 and other information appearing elsewhere in this prospectus for a discussion of factors you should carefully consider before deciding whether to invest in our common stock. Additional risks and uncertainties not presently known to us or that we currently deem to be immaterial may also impair our business and operations. </td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The number of shares of our common stock outstanding after this offering is based on 14,313,185 shares outstanding as of September&#160;30, 2023, and excludes: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">3,108,111 shares of our common stock issuable upon the exercise of options to purchase shares of our common stock outstanding as of September&#160;30, 2023, with a weighted-average exercise price of $2.70 per share; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">325,227 shares of our common stock reserved for future issuance under our 2023 Stock Incentive Plan (the &#8220;2023 Plan&#8221;) as of September&#160;30, 2023, as well as automatic increases in the number of shares of our common stock reserved for future issuance pursuant to this plan, plus (x)&#160;any shares of our common stock underlying outstanding awards under the 2020 Equity Incentive Plan (the &#8220;2020 Plan&#8221;) that are subsequently forfeited or terminated before being exercised or becoming vested, not issued because an award is settled in cash, or withheld or reacquired to satisfy the applicable exercise, or purchase price, or a tax withholding obligation, and (y)&#160;the number of shares of our common stock </p></td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
which, but for the termination of the 2020 Plan immediately prior to the effective date of the 2023 Plan, were reserved and available for issuance under the 2020 Plan but not at such time issued or subject to outstanding awards under the 2020 Plan; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">324,045 shares of our common stock reserved for issuance under our Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), as well as any automatic increases in the number of shares of our common stock reserved for future issuance pursuant to this plan. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise noted, the information contained in this prospectus assumes or gives effect to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">no conversion of outstanding promissory notes, and no conversion of the Note; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">no exercise of outstanding options; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">no exercise of outstanding warrants, including the Warrant; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">no sales of shares under the Equity Line Financing. </p></td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_5">RISK FACTORS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Investing in our securities involves risks. Before you make a decision to buy our securities, in addition to the risks and uncertainties discussed below under &#8220;Special Note Regarding Forward-Looking Statements,&#8221; you should carefully consider the specific risks set forth herein. We have also identified a number of these factors under the heading &#8220;Risk Factors&#8221; in our periodic reports we file with the SEC, including our quarterly reports on Form <span style="white-space:nowrap">10-Q</span> for the quarters ended March&#160;31, 2023, June&#160;30, 2023, and September&#160;30, 2023, and will do so in our future filings. If any of these risks actually occur, it may materially harm our business, financial condition, liquidity, results of operations, and prospects. As a result, the market price of our securities could decline, and you could lose all or part of your investment. Additionally, the risks and uncertainties described in this prospectus or any prospectus supplement are not the only risks and uncertainties that we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may become material and adversely affect our business. If any of the following risks or other risks not specified below materialize, our business, financial condition and results of operations could be materially and adversely affected. In that case, the trading price of our shares of common stock could decline. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Our Business and Industry </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have incurred operating losses in the past, expect to incur operating losses in the future, and may not achieve profitability, or, if we achieve profitability, be able to maintain it in the future. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have incurred operating losses each year since our inception, including net losses of $40.0&#160;million and $39.4&#160;million for nine months ended September&#160;30, 2023 and 2022, respectively, and expect to continue to incur net losses for the foreseeable future. We had an accumulated deficit of $155.5&#160;million at September&#160;30, 2023. We expect our operating expenses to increase in the future as we increase our sales and marketing efforts, continue to invest in technology and engineering, expand our operating and retail infrastructure, add training and fitness programs, classes, content, and software features to our streaming platform, expand into new geographies, and invest in new or complementary products, equipment, accessories, content, and services for our immersive, customizable, and digital fitness platform, which include the Forme Studio, Forme Studio Lift, accompanying accessories, and our coaching services which we collectively refer to as the &#8220;Forme platform.&#8221; Further, as a public company, we have incurred, and will continue to incur substantial additional legal, accounting, and other expenses that we did not incur as a private company. These efforts and additional expenses may be more costly than we expect, and we may not be able to increase our revenue to offset any increase in our expenses. If our revenue does not grow at a greater rate than our operating expenses, we will not be able to achieve or maintain profitability. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have a limited operating history; and our past financial results may not be a reliable indicator of our ability to successfully establish our product and service offerings in the marketplace, or of our future performance, and our revenue growth rate is likely to slow as our business matures. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We commenced operations in May 2017, launched our first retail stores in late 2020, commenced delivery of our first Forme Studio in July 2021, commenced delivery our first Forme Studio Lift in August 2022, and conducted our first live personal training session in July 2022. We have a limited history of generating revenue. As a result of our brief operating history, we have limited financial data that can be used to evaluate our current business, including our ability to successfully establish our product and service offerings in the marketplace. Furthermore, while our business has grown and much of that growth has occurred in recent periods, the smart home gym and connected fitness industry, including the market for connected fitness hardware, may not develop or continue to develop in a manner that we expect or that otherwise would be favorable to our business. As a result of our limited operating history and ongoing changes in our new and evolving industry, our historical revenue growth should not be considered indicative of our future performance, and estimates of future revenue growth are subject to many risks and uncertainties and our future revenue may differ materially from our projections. In particular, we have experienced periods of higher revenue growth since we began selling our Forme Studio and Forme </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Studio Lift (collectively with any ancillary or related accessories and equipment, &#8220;Forme Studio equipment&#8221; or &#8220;our connected fitness hardware products&#8221;) that we do not expect to continue as our business matures. Our revenue growth, if any, may slow or our revenue may decline for a number of other reasons, including reduced demand for our products and services, the impacts to our business from inflation and rising interest rates, which in turn could, among other things, increase financing costs and thus reduce sales of our products, the <span style="white-space:nowrap">COVID-19</span> pandemic, a decrease in the growth or reduction in size of our overall market, a reduction in discretionary spending by consumers, or if we cannot capitalize on growth opportunities. We have encountered, and will continue to encounter, risks and difficulties frequently experienced by emerging companies in rapidly changing industries, including market acceptance of our products and services, attracting and retaining members, and increasing competition and expenses as we expand our business. We cannot be sure that we will be successful in addressing these and other challenges we may face in the future, and our business may be adversely affected if we do not manage these risks successfully. In addition, we may not achieve sufficient revenue to attain or maintain positive cash flows from operations or profitability in any given period, or at all. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our business, financial condition, and results of operations are subject to risks associated with rising interest rates, which could negatively impact our customers&#8217; ability to finance their purchases of our products or to make timely payments and our ability to obtain additional financing. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We face risks associated with rising interest rates, which could, among other things, negatively impact sales of, and demand for, our products, the ability of customers to make timely payments, and our ability to obtain debt financing on terms acceptable to us, if at all. Historically, a significant percentage of our members have financed their purchase of our Forme Studio equipment through third-party credit providers with whom we have existing relationships. If our third-party credit providers were to increase interest rates, it could negatively impact potential customers&#8217; ability to finance purchases of our products, which in turn would negatively impact our revenue. In addition, general reductions in consumer lending and the availability of consumer credit as a result of higher interest rates could limit the number of customers with the financial means to purchase our products and could reduce demand for our products and services. Higher interest rates could also increase our costs or the monthly payments for our products financed through other sources of consumer financing, or negatively impact the ability of our customers to make timely payments for our products and services. Third-party financing providers may not continue to provide consumers with access to credit or may reduce available credit limits. Restrictions or reductions in the availability of consumer credit, the loss or deterioration of our relationships with our current financing partners or changes in the terms such entities may provide to our potential customers could have an adverse effect on our business, financial condition, and results of operations. In addition, we will need to raise additional financing to support our operations, which could include equity or debt financing, in the immediate and near term. Rising interest rates would negatively impact our ability to obtain such financing on commercially reasonable terms or at all. Further, to the extent we are required to obtain financing at higher borrowing costs to support our operations, we may be unable to offset such costs through price increases, other cost control measures, or other means. Any attempts to offset cost increases with price increases may result in reduced sales, increased customer dissatisfaction, or otherwise harm our reputation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have a limited operating history with which to evaluate and predict the profitability of our recurring revenue model and any new revenue models we may introduce in the future may be unsuccessful. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We began selling memberships to our VOD platform in 2021 with the delivery of our first Forme Studio, and launched our Live 1:1 personal training service in July 2022. Accordingly, we have a limited operating history with which to evaluate our subscription model. For example, all of our members are on <span style="white-space:nowrap"><span style="white-space:nowrap">month-to-month</span></span> membership terms and may cancel their memberships at any time. We have limited historical data with respect to rates of membership renewals, so we may be unable to accurately predict member renewal or retention rates. We measure our membership retention rate by the number of members as of the beginning of the month who have a paid membership with a successful credit card billing of at least three months. Additionally, prior renewal rates may not accurately predict future member renewal rates for a variety of reasons, such as members&#8217; dissatisfaction with our offerings and the cost of our memberships, macroeconomic conditions, or new offering introductions by </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
us or our competitors. If our members do not renew their memberships, our revenue may decline and our business will suffer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the future, we may offer new membership products, services, or pricing models, implement promotions, or replace or modify current membership pricing models, any of which could result in additional costs. For example, we recently launched our Custom Training service, which is currently charged as a monthly membership for $149/month. We cannot predict member reaction to, or the success of, any new or modified products, services, or pricing models, or whether the costs or logistics of implementing these changes, including any new or updated pricing models, will adversely impact our business. If the adoption of new revenue models adversely impacts our member relationships, then member growth, member engagement, and our business, financial condition, and results of operations could be harmed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our negative cash flows from operations, history of losses, and significant accumulated deficit raise substantial doubt about our ability to continue as a &#8220;going concern.&#8221; </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our negative cash flows from operations and our history of losses, as well as our significant accumulated deficit, raise substantial doubt about our ability to continue as a &#8220;going concern.&#8221; Since inception, we have sustained recurring losses and have relied on funding from private investors and other third parties to finance our operations. We have historically generated losses from our operations as reflected in our accumulated deficit of $155.5&#160;million as of September&#160;30, 2023 and negative cash flows from operating activities. In addition, as of September&#160;30, 2023, we had loans outstanding with an aggregate principal and interest amount owed of approximately $6.3&#160;million. All of these loans matured prior to September&#160;30, 2023, but their repayment has been temporarily waived. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in March 2023, we issued approximately $2.0&#160;million in senior secured notes in connection with a bridge note financing, which senior secured notes were repaid in May 2023. In addition, we issued $1.0&#160;million in senior secured notes in connection with a note purchase agreement (the &#8220;June 2023 Notes&#8221;). The $1.0&#160;million is outstanding as of September&#160;30, 2023. Due to our history of losses from operations, negative cash flows from operations, and a significant accumulated deficit, our management concluded that there is substantial doubt about our ability to continue as a going concern. In our accompanying financial statements, our independent auditor included an emphasis of matter paragraph regarding the substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our becoming profitable in the future or obtaining the necessary capital to meet our obligations. Our determination of substantial doubt about our ability to continue as a going concern could materially limit our ability to raise additional funds through the issuance of equity securities, debt financing, or otherwise. There can be no assurance that any such issuance of equity securities, debt financing, or other means of financing will be available in the future, or the terms of any such financing will be acceptable to us. Further, there can be no assurance that we will ever become profitable or continue as a going concern. See <span style="font-style:italic">&#8220; &#8211; Risks Related to Financial, Accounting, and Tax Matters &#8211; We may not be able to accurately predict our future capital needs, and we may not be able to obtain additional financing to fund our operations.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we fail to compete successfully against existing and future competitors, we may fail to obtain a meaningful market share, which in turn would harm our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We operate in a highly competitive market. We face significant competition from multiple industries and exercise verticals, including <span style="white-space:nowrap">at-home</span> fitness equipment and content, fitness clubs, <span style="white-space:nowrap">in-studio</span> fitness classes, <span style="white-space:nowrap">in-person</span> personal training, and health and wellness apps. In addition, we compete with other virtual or smart home gym providers such as Curiouser Products Inc., dba MIRROR (acquired by Lululemon athletica, inc. and now sold as the lululemon Studio Mirror), Peloton Interactive, Inc., and Tonal Systems, Inc., among others. We expect the competition in our market to intensify in the future as new and existing competitors introduce new or enhanced products and services that compete with ours. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our competitors may develop, or have already developed, products, features, content, services, or technologies that are similar to ours or that achieve greater acceptance, may offer products at lower price points due to other revenue sources available within such competitors that are unavailable to us, may have better brand recognition, may undertake more successful product development efforts, create more compelling employment opportunities, or marketing campaigns, may be willing to offer products at price points with which we cannot compete, or may adopt more aggressive pricing policies. Our competitors may develop or acquire, or have already developed or acquired, intellectual property rights that significantly limit or prevent our ability to compete effectively. In addition, our competitors may have significantly greater resources than us, allowing them to identify and capitalize more efficiently upon opportunities in new markets and consumer preferences and trends, quickly transition and adapt their products and services, devote greater resources to marketing and advertising, or be better positioned to withstand substantial price competition. Current and future competitors have established or may establish financial and strategic relationships among themselves or with our existing or potential customers or other third parties in our industry, such as manufacturing and logistics providers. Additionally, any of the foregoing may enable our current and future competitors to better withstand adverse economic or market conditions, now or in the future, and significantly reduce their pricing so as to compete against us. If we are not able to compete effectively against our competitors, they may acquire and engage customers or generate revenue at the expense of our efforts, which could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our business may be affected by seasonality. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we do not have sufficient history with our product sales to assess the potential impact of seasonality, we expect that our business may be influenced by seasonal trends consistent with traditional retail selling periods. Accordingly, fluctuations in revenue during months of high demand could have a disproportionate effect on our results of operations for the entire year. In addition, we may experience quarterly fluctuations caused by seasonality and other factors, and thus comparisons of our results of operations across different fiscal quarters may not be accurate indicators of our future performance. Annual or quarterly comparisons of our results of operations may not be useful and our results in any particular period will not necessarily be indicative of the results to be expected for any future period. Seasonality in our business can also be affected by introductions of new or enhanced products and services, including the costs associated with such introductions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our results of operations and other financial and <span style="white-space:nowrap">non-financial</span> business metrics may fluctuate from period to period due to a variety factors, many of which are beyond our control, and as a result, our results from any prior periods, or any historical trends reflected in such results, should not be viewed as indicative of our future financial or operating performance. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our revenue and results of operations have fluctuated in the past and may fluctuate from period to period in the future due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations include the following factors, as well as other factors described elsewhere in this prospectus: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to raise additional capital sufficient to fund our operations, meet our obligations as they become due, and execute our growth strategy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to maintain and attract new members; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">membership cancellation and renewal rates; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">product returns; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in our recurring revenue model or pricing methodologies, or our adoption of any new membership, pricing, or revenue models; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the receipt, reduction or cancellation of, or changes in the forecasts or timing of, memberships by members; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in our mix of products and services, such as changes in demand for certain accessories or bundles or our Live 1:1 personal training and health coaching services, fitness programs and classes, or other streaming fitness content on our platform; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the diversification and growth of our revenue sources, including our ability to successfully expand our commercial and corporate wellness channels; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to maintain gross margins and operating margins; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">inaccurate forecasting of the demand for our products and services, which could lead to lower revenue or increased costs, or both; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the timing and amount of research, development, and new product expenditures, including resources allocated to the development of new equipment and accessories, programs, classes, and other content, and innovative features and technologies, as well as the continued development and upgrading of our proprietary technology platform; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increases in marketing, sales, and other operating expenses that we may incur to grow and expand our operations and to remain competitive; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in our relationship with our third-party financing partner who provides financing assistance to our members for the purchase of our Forme Studio equipment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">constraints on the availability of consumer financing or increased down payment requirements to finance purchases of our Forme Studio equipment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the continued maintenance and expansion of our delivery, installation, and maintenance services and network for our Forme Studio equipment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">supply chain disruptions, delays, shortages, and capacity limitations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increases or other changes in our product development and manufacturing costs, or the timing and extent thereof, and our ability to achieve cost reductions in a timely or predictable manner; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in market and customer acceptance of and demand for our products, content, and services, including cyclicality and seasonal fluctuations in memberships and usage of the Forme platform by our members, each of which may change as our products and services evolve or mature, or as our business grows; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the continued market acceptance of, and the growth of the smart home gym and connected fitness market; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the emergence of new industry expectations and product obsolescence; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the timing and success of new product, content, and service introductions by us or our competitors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the competitive landscape and pricing pressure as a result of competition or otherwise; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">costs and expenses associated with any potential acquisitions or strategic partnerships or initiatives; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the ability to maintain and open new retail locations and studio showrooms; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">successful expansion into international markets; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">significant warranty claims; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">loss of key personnel or the inability to attract qualified personnel, including personal trainers and fitness instructors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">geopolitical events, such as war, regional conflicts, other outbreaks of hostilities, or the escalation or expansion of the same (such as the Russian invasion of Ukraine and the Israel-Hamas war), threat of war or terrorist actions, or the occurrence of pandemics, epidemics, or other outbreaks of disease, or natural disasters, and the impact of these events on the factors set forth above; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in business or macroeconomic conditions, including inflation, interest rates, lower consumer confidence, recessionary conditions, increased unemployment rates, or stagnant or declining wages; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">system failures or breaches of security or privacy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">adverse litigation judgments, settlements, or other litigation-related costs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in the legislative or regulatory environment, including with respect to cybersecurity, climate change, privacy, consumer product safety, advertising, and employment matters, or enforcement by government regulators, including fines, orders, or consent decrees; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">fluctuations in currency exchange rates and changes in the proportion of our revenue and expenses denominated in foreign currencies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in our effective tax rate; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in accounting standards, policies, guidance, interpretations, or principles. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of these and other factors, our results of operations and revenue may vary significantly from period to period. Accordingly, you should not rely on the results of any prior quarterly or annual periods, or any historical trends reflected in such results, as indications of our future revenue or operating performance. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We derive a significant majority of our revenue from sales of our Forme Studio equipment and if sales of our Forme Studio equipment decline, it would materially and negatively affect our future revenue and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Forme Studio equipment is sold in highly competitive markets with limited barriers to entry. Introduction by competitors of comparable products at lower price points, a maturing product lifecycle, a decline in consumer spending, or other factors could result in a decline in our revenue derived from our Forme Studio equipment, which may have a material adverse effect on our business, financial condition, and results of operations. Sales of our Forme Studio equipment currently account for substantially all of our revenue, accounting for approximately 99% of revenue in 2021, 78% of revenue in 2022, and 65% of revenue for the nine months ended September&#160;30, 2023. As a result, any meaningful decline in sales of our Forme Studio equipment would materially and adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our membership revenue is largely dependent on our ability to sell our Forme Studio equipment. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our customer acquisition model is generally initiated upon the sale to customers and installation of our Forme Studio or Forme Studio Lift, with additional revenue generated from sales of memberships and health coaching services. While members are invited to gain access to our basic VOD membership upon purchase of the Forme Studio or Forme Studio Lift through an account creation process, they can cancel their membership at any time. As a result, our membership and health coaching revenue is largely dependent on our ability to sell our Forme Studio equipment and to engage and retain members to use our services on an ongoing basis thereafter. If we are unable to expand sales of our Forme Studio equipment or to engage new members or to maintain and expand our member base, our business, financial condition, and results of operations may suffer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our results of operations could be adversely affected if we are unable to accurately forecast consumer demand for our products and services and adequately manage our inventory. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To ensure adequate inventory supply, we must forecast inventory needs and expenses and place orders sufficiently in advance with our suppliers and manufacturers, based on our estimates of future demand for particular products and services. Failure to accurately forecast our needs, and any concomitant failure to place sufficient orders, may result in manufacturing delays or increased costs. Our ability to accurately forecast demand could be affected by many factors, including changes in consumer demand for our products and services, changes in demand for the products and services of our competitors, unanticipated changes in general market </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions, and the weakening of economic conditions or consumer confidence in future economic conditions. This risk may be exacerbated by the fact that we may not carry a significant amount of inventory and may not be able to satisfy short-term demand increases. If we fail to accurately forecast consumer demand, we may experience excess inventory levels or a shortage of products available for sale. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inventory levels in excess of consumer demand may result in inventory write-downs or write-offs and the sale of excess inventory at discounted prices, which would cause our gross margins to suffer and could impair the strength and premium nature of our brand. Further, lower than forecasted demand could also result in excess manufacturing capacity or reduced manufacturing efficiencies, which could result in lower margins. Conversely, if we underestimate consumer demand, our suppliers and manufacturers may not be able to deliver products to meet our requirements or we may be subject to higher costs in order to secure the necessary production capacity. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An inability to meet consumer demand and delays in the delivery of our products to our members could result in an increased rate of order cancellations, reputational harm and damaged member relationships and could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we are unable to sustain competitive pricing levels for our connected fitness hardware products and memberships to the Forme platform, our business could be adversely affected. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We compete with products and services that are generally sold at lower prices. If we are unable to sustain competitive pricing levels for our connected hardware products, including Forme Studio and Forme Studio Lift, and our membership and health coaching services, whether due to consumer sentiment and spending power, competitive pressure or otherwise, our financial results and cash flow could be significantly reduced. Further, our decisions around the development of new products and services are partly based on assumptions about pricing levels. If there is price compression in the market after these decisions are made, it could have a negative effect on our business. In addition, while we believe we offer high-quality, differentiated products and services, our pricing levels may be higher than those of our competitors. Our ability to maintain our pricing levels depends on several factors, including our brand recognition, product design and technology features and quality, innovative content, and public perception of our company. If we are unable to sustain our pricing levels due to these or other factors, our ability to attract new members and our business, financial condition, and results of operations could be harmed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Changes in how we market our products and services could adversely affect our marketing expenses and membership levels. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We use a broad mix of marketing and other brand-building measures to attract members. We use online advertising, including through native advertising and social media influencers, as well as third-party social media platforms, as marketing tools. As online and social media platforms continue to rapidly evolve or grow more competitive, we must continue to maintain a presence on these platforms and establish a presence on new or emerging popular social media and advertising and marketing platforms. Moreover, as we expand and as competition for customers increases in the industry, we may experience increased marketing expenses. If we cannot cost-effectively use these marketing tools or if we fail to promote our products and services efficiently and effectively, our ability to acquire new members, maintain or increase membership levels and our financial condition may suffer. In addition, an increase in the use of online, social media, or any other marketing channels for product promotion and marketing may increase the burden on us to monitor compliance of such materials and increase the risk that such materials could contain problematic product or marketing claims, or otherwise violate applicable laws or regulations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The market for our products and services is still in the early stages of growth and if the market does not continue to grow, grows more slowly than we expect, or fails to grow as large as we expect, or if our products and services do not gain market acceptance, our business, financial condition, and results of operations may be adversely affected. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The smart home gym and connected fitness market is relatively new, rapidly growing, largely unproven, and it is uncertain whether this market will achieve or sustain high levels of demand and achieve wide market acceptance. In addition, while we experienced some positive impact on demand for our product, as a result of the <span style="white-space:nowrap">COVID-19</span> pandemic, we cannot predict the potential impact on our business as the pandemic continues to evolve. Our success depends substantially on the willingness of consumers to widely adopt our products and services. To be successful, we will have to make significant investments in the education of consumers about our products and services and provide quality products, content, member experience that is superior to the products, content, and experiences provided by our competitors. Additionally, the fitness and wellness market is heavily saturated, and the demand for and market acceptance of new products and services in the market is uncertain. We cannot assure you that the connected fitness market will continue to develop, that the public&#8217;s interest in smart home gym and connected fitness will continue, or that our products and services will be widely adopted. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is difficult to predict the future growth rates, if any, and size of the smart home gym and connected fitness market, and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. Any forecasts in this prospectus relating to the expected growth in the smart home gym and connected fitness market, including internally developed estimates, may prove to be inaccurate. Even if the market experiences the forecasted growth described in this prospectus, we may not grow our business at a similar rate, or at all. Our growth is subject to many factors, including our success in implementing our </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">business strategy, which is subject to many risks and uncertainties. Accordingly, the forecasts of market growth included in this prospectus should not be taken as indicative of our future growth. If our market does not develop, develops more slowly than expected, or becomes saturated with competitors, or if our products and services do not achieve market acceptance, our business, financial condition, and results of operations could be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our revenue could decline if members are no longer able to finance their purchases of our products due to changes in credit markets and decisions made by credit providers. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Historically, a significant percentage of our members have financed their purchase of our Forme Studio equipment through third-party credit providers with whom we have existing relationships. If we are unable to maintain our relationships with our financing partners, there is no guarantee that we will be able to find replacement partners who will provide our members with financing on similar terms, and our ability to sell our Forme Studio equipment may be adversely affected. Further, reductions in consumer lending and the availability of consumer credit could limit the number of customers with the financial means to purchase our products. Higher interest rates could increase our costs or the monthly payments for our products financed through other sources of consumer financing. In the future, we cannot be assured that third-party financing providers will continue to provide consumers with access to credit or that available credit limits will not be reduced. Such restrictions or reductions in the availability of consumer credit, or the loss of our relationship with our current financing partners, could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may be unable to attract and retain members, which could have an adverse effect on our business and rate of growth. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business and revenue growth is dependent on our ability to continuously attract and retain members, and we cannot be sure that we will be successful in these efforts, or that member retention levels will not materially decline. There are a number of factors that could lead to a decline in member levels or that could prevent us from increasing our member levels, including: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our failure to introduce new products and services, including related equipment and accessories, programs, content, classes, features and technologies, that members find engaging and compelling; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our introduction of new products, content, or services, or changes to existing products, content, and services that are not favorably received; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">harm to our brand and reputation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">pricing and perceived value of our offerings; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our inability to deliver quality products, content, and services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our members engaging with the products and services of our competitors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">interruptions or disruptions preventing rapid and reliable access to our content and services or otherwise affecting the member experience; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">members being unsatisfied with the delivery, installation, or service of our Forme Studio equipment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a decline in the public&#8217;s interest in home fitness workouts, or other fitness disciplines we invest or decide to invest in; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">deteriorating general economic conditions or a change in consumer spending preferences or buying trends. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, further expansion into international markets such as Canada, the United Kingdom, and Europe will create new challenges in attracting and retaining members that we may not successfully address. As a result of these factors, we cannot be sure that our member levels will be adequate to maintain or permit the expansion of our operations. A decline in member levels could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we are unable to attract or otherwise access health coaches and personal trainers, and fitness instructors to produce and provide fitness content and services on our platform, our business, financial condition, and results of operations could be harmed. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business depends in part on our ability to attract and access qualified trainers and fitness instructors to produce and provide fitness content and services on our platform. For example, during the <span style="white-space:nowrap">COVID-19</span> pandemic, we experienced decreased access to fitness instructors due to social distancing and other restrictions imposed, which in turn impacted our ability to produce new fitness content in the volume we had originally anticipated. In addition, trainers and fitness instructors may become dissatisfied with our brand, products, services, programs, and/or benefits. If we are unable to access trainers and fitness instructors due to these or similar occurrences, or due to competition or other reasons, it would harm our ability to produce and provide fitness content on our platform, which in turn could materially and adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we fail to cost-effectively attract, recruit, and retain qualified health coaches, personal trainers, and fitness instructors, our business would be materially and adversely affected. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business depends in part on our ability to cost-effectively access, attract, recruit, and retain qualified trainers and fitness instructors. Competition for qualified trainers and fitness instructors is intense and may increase due to various factors beyond our control. For example, the easing of COVID restrictions resulted in more people returning to traditional gyms and <span style="white-space:nowrap">in-person</span> fitness, resulting in increased demand for trainers and fitness instructors. As a result, we experienced increased competition for such personnel in the past year. Our competitors may attempt to compete for trainers and fitness instructors on the basis of providing a more compelling platform or more lucrative earning opportunities. In addition, we may experience complaints, negative publicity, strikes, or other work stoppages that could dissuade potential candidates from joining our company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, most of the fitness instructors who are featured in our <span style="white-space:nowrap">On-Demand</span> content, as well as other content production providers with whom we work, are independent contractors and the classification of any of our </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
independent contractors may be subject to challenge. Our use of independent contractors for content production activities fluctuates depending on production volume and schedule. Further, certain jurisdictions may adopt laws and regulations seeking to limit the scope of individuals who may be appropriately classified as independent contractors and instead seek to classify them as employees. If we are required to classify our independent contractors as employees, we would need to adapt our employment model accordingly. We may face specific risks relating to our ability to onboard fitness instructors as employees, our ability to partner with third-party organizations to source trainers and fitness instructors, and our ability to effectively utilize employee trainers and fitness instructors to meet customer demand. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in certain laws and regulations, including immigration, labor and employment laws, occupational licensure regulations or background check requirements, may result in a change in the pool of qualified trainers and fitness instructors, which may result in increased competition for such personnel or higher costs of recruitment, operation and retention. Other factors outside of our control, such as the <span style="white-space:nowrap">COVID-19</span> pandemic, may also reduce the number of trainers and fitness instructors on the Forme platform or impact our ability to onboard new trainers and fitness instructors. If we fail to attract qualified trainers and fitness instructors on favorable terms, or lose qualified trainers and fitness instructors to our competitors, we may not be able to meet customer demand or maintain competitive pricing for our personal training, health coaching, and fitness programs and classes, and our business, financial condition, and results of operations could be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we fail to cost-effectively attract new members, or to increase utilization of the Forme platform from existing members, our business, financial condition, and results of operations could be harmed. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our success depends in part on our ability to cost-effectively attract new members, retain existing members and increase membership rates of the Forme platform. Members have a wide variety of fitness options, including <span style="white-space:nowrap">at-home</span> fitness equipment and content, fitness clubs, <span style="white-space:nowrap">in-studio</span> fitness classes, <span style="white-space:nowrap">in-person</span> personal training, and health and wellness apps. To expand our member base, we must have the ability to appeal to individuals who have historically used other methods of personal fitness and training or who have not previously used personal fitness and training or regularly exercised. Our reputation, brand, and ability to build trust with existing and new members may be adversely affected by complaints and negative publicity about us, our offerings, our pricing and policies, trainers and fitness instructors on the Forme platform, or our competitors, even if factually incorrect or based on isolated incidents. Further, if existing and new members do not perceive the services provided by trainers and fitness instructors on the Forme platform to be helpful, effective, engaging, or affordable, or if we fail to offer compelling offerings, services, content, and features on the Forme platform, we may not be able to attract or retain members or to increase their utilization of the Forme platform. If we fail to continue to grow our member base, retain existing members, or increase the overall utilization of the Forme platform by existing members, our business, financial condition, and results of operations could be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Changes to our pricing methodologies or business model could adversely affect our ability to attract or retain members as well as qualified trainers and fitness instructors. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many factors, including operating costs, legal, and regulatory requirements or constraints and our current and future competitors&#8217; pricing and marketing strategies, could significantly affect our pricing strategies. Certain of our competitors offer, or may in the future offer, lower-priced or a broader range of offerings. Similarly, certain competitors may use marketing strategies that enable them to attract or retain customers as well as qualified trainers and fitness instructors at a lower cost than us. We may reduce our membership and other pricing for members, increase the compensation we pay to trainers and fitness instructors, increase our marketing and other expenses, or otherwise modify our business model to attract and retain members, as well as qualified trainers and fitness instructors in response to competitive pressures. Furthermore, local regulations may affect our pricing in certain geographic locations, which could amplify these effects. For example, state and local laws and regulations may impose minimum earnings standards for trainers and fitness instructors, which in turn may cause us to revise our pricing methodology in certain markets. We have from time to time modified existing, or implemented new, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pricing methodologies and strategies, which may not prove effective. Any of the foregoing actions may not ultimately be successful, and in turn could cause our business, financial condition, and operating results to suffer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As many of the individuals who develop, provide, or produce content on our platform are independent contractors, any challenge to, or determination that, such individuals should be classified as employees versus independent contractors, could affect our business model and pricing methodologies. We have also launched, and may in the future launch, certain changes to the rates and fee structure for trainers and fitness instructors on the Forme platform, which may not ultimately be successful. Our assessments of the impact of any changes in our pricing methodologies or business model may not be accurate and we could be underpricing or overpricing our offerings. In addition, if the offerings on the Forme platform change, then we may need to revise our pricing methodologies. As we continue to develop and launch new product and service offerings, such as Forme Studio Lift, factors such as maintenance, customer financing, and supply chain efficiency may affect our pricing methodologies. Any such changes to our pricing methodologies or our ability to efficiently price our offerings could adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we are unable to anticipate consumer preferences and successfully develop and introduce new, innovative, and updated products and services in a timely manner or effectively manage the introduction of new or enhanced products and services, our business may be adversely affected. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our success in maintaining and increasing our member base depends on our ability to identify and originate trends as well as to anticipate and react to changing consumer demands in a timely manner. Our products and services are subject to changing consumer preferences that cannot be predicted with certainty. If we are unable to introduce new or enhanced offerings in a timely manner, our competitors may introduce similar offerings faster </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">than us, which could result in our new or enhanced offerings not being accepted by our members and negatively affect our rate of growth. Moreover, our new offerings may not receive consumer acceptance as preferences could shift rapidly to different types of fitness and wellness offerings or away from these types of offerings altogether, and our future success depends in part on our ability to anticipate and respond to these changes. Failure to anticipate and respond in a timely manner to changing consumer preferences could lead to, among other things, lower membership rates, lower sales, pricing pressure, lower gross margins, discounting of our existing Forme Studio equipment, and excess inventory levels. Even if we are successful in anticipating consumer preferences, our ability to adequately react to and address them will partially depend upon our continued ability to develop and introduce innovative, high-quality offerings. Development of new or enhanced </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">products and services may require significant time and financial investment, which could result in increased costs and a reduction in our profit margins. For example, we have historically incurred higher levels of sales and marketing expenses accompanying each product and service introduction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, we must successfully manage introductions of new or enhanced products and services, which could adversely impact the sales of our existing products and services. For instance, consumers may decide to purchase new or enhanced products and services instead of our existing products and services, which could lead to excess product inventory and discounting of our existing products and services. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our success depends on our ability to develop and maintain the value and reputation of the Forme brand. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that developing and maintaining our brand recognition and image is important to attracting and retaining members. Developing and maintaining our brand depends largely on the success of our marketing efforts, ability to provide consistent, high-quality products, services, features, content, and support to our members. We believe that the importance of our brand will increase as competition further intensifies and brand promotion activities may require substantial expenditures. Our brand could be harmed if we fail to achieve these objectives or if our public image were to be tarnished by negative publicity. Unfavorable publicity about us, including our products, services, technologies, customer service, content, personnel, and suppliers, or similar incidents involving our competitors in the smart home gym and smart home gym and connected fitness industry, could diminish confidence in, and the use of, our products and services. Such negative publicity also could have </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an adverse effect on the size, engagement and loyalty of our member base and result in decreased revenue, which could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We also sell the Forme platform to commercial and wellness customers, which exposes us to additional business and financial risks. In addition, if we fail to successfully expand our commercial and corporate wellness business, it could negatively impact our ability to grow our business and gain market share. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also sell the Forme platform to commercial and wellness customers. For example, we are actively installing Forme Studios in hotels, resorts, and other commercial environments such as boutique hotels, luxury apartments, and private condominiums, as well businesses with which we establish corporate wellness partnerships for the benefit of their employees. For commercial customers, we typically sell our connected hardware products with a three-year content membership paid up front, plus we offer an extended warranty program. In addition, many of the risks associated with our individual members are often exacerbated or heightened in the commercial or corporate environment. For example, the equipment we install at these locations may be used more frequently and by a larger group of users, which may increase the rate of wear and tear or the risk of product malfunction or injury in connection with the use of our equipment. This in turn could expose us to liability claims, warranty expense, and damage to our brand and reputation, among other risks, any of which could harm our reputation, business, financial condition, and results of operations. If we fail to successfully expand our commercial and corporate wellness business, it could harm our ability to grow our business, gain market share, and expand our brand. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have limited operating experience at our current scale of operations. If we are unable to manage our growth effectively, our brand, company culture, and financial performance may suffer. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have expanded our operations rapidly and have limited operating experience at our current scale of operations. For example, we commenced commercial delivery of the Forme Studio in July 2021, launched our Live 1:1 personal training service in July 2022, and delivered our Forme Studio Lift in August 2022. As we continue our transition from initial product development to mass production and commercial shipment of our products, we have experienced, and may in the future experience, adjustments in our business operations and headcount. For example, as a result of completing development and commencing mass production of the Forme Studio Lift and in response to economic headwinds, we reduced the size of our engineering team in 2022 and expect to continue to reallocate our personnel resources to support our ongoing product development efforts </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">while also increasing our focus on marketing and sales and building our brand. Our headcount reduction in July of 2022 comprised approximately 26% of our full-time employee base at the time of such reduction. We had a subsequent headcount reduction in December of 2022, comprising approximately 50% of our full-time employee base at the time of such reduction. We expect our headcount to fluctuate in the near term but to grow over the longer term as we continue to grow our business and expand our target markets. Further, we expect that our business and operations will become increasingly complex as we grow our business. To effectively manage and capitalize on our growth, we must continue to expand our sales and marketing, focus on innovative product and content development, and upgrade our management information systems and other processes. Our continued growth could strain our existing resources, and we could experience ongoing operating difficulties in managing our business, including difficulties in hiring, training, and managing a diffuse and growing employee base. Failure to scale and preserve our company culture with growth could harm our future success, including our ability to retain and recruit personnel and to effectively focus on and pursue our corporate objectives. Moreover, the vertically integrated nature of our business, where we design and develop our own Forme Studio equipment and accessories, and software, produce original fitness and wellness programming, recruit, train, and educate personal trainers, sell our products exclusively through our own sales teams, retail locations, and <span style="white-space:nowrap">e-commerce</span> site, and coordinate the delivery, installation, and service of our Forme Studio equipment with our third-party logistics providers, exposes us to risk and disruption at many points that are critical to successfully operating our business and may make it more difficult for us to scale our business. For example, we utilize both air and ocean shipment for our Forme Studio equipment and our limited history with commercial shipment of our products has in the past, and may in the future, result in delays in delivery and installation. If we do not adapt to meet these </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
evolving challenges, or if our management team does not effectively scale with our growth, we may experience erosion to our brand, the quality of our products and services may suffer, and our company culture may be harmed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because we have a limited history operating our business at its current scale, it is difficult to evaluate our current business and future prospects, including our ability to plan for and model future growth. Our limited operating experience at this scale, combined with the rapidly evolving nature of the market in which we sell our products and services, substantial uncertainty concerning how these markets may develop, and other economic factors beyond our control, reduces our ability to accurately forecast quarterly or annual revenue. Failure to manage our future growth effectively could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we are unable to successfully expand our retail showroom footprint, it could adversely affect our ability to expand our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our growth strategy contemplates a significant increase in our advertising and other marketing spending and expanding our retail locations and showroom presence. We currently have no retail locations. We cannot assure you that future retail locations or showrooms will generate revenue and cash flow. Further, we expect any future showrooms will be leased, pursuant to multi-year short-term leases, and our ability to negotiate favorable terms on an expiring lease or for a lease renewal option may depend on factors that are not within our control. Successful implementation of our growth strategy will require significant expenditures before any substantial associated revenue is generated and we cannot guarantee that these increased investments will result in corresponding and offsetting revenue growth. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If our marketing efforts are not effective, our ability to grow our business and maintain or expand our market share could suffer. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maintaining and promoting awareness of the Forme platform is important to our ability to retain existing, and to attract new, customers. To facilitate our future growth and profitability, we are investing in our advertising, </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">promotion, public relations, and marketing programs. These brand promotion activities may not yield increased revenue and the efficacy of these activities will depend on a number of factors, including our ability to do the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">select the right markets, media, and media vehicles in which to advertise; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">identify the most effective and efficient level of spending in each market, media, and media vehicle; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">effectively manage marketing costs, including creative and media expenses, to maintain acceptable customer acquisition costs. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may adjust or <span style="white-space:nowrap">re-allocate</span> our advertising spend across channels, product verticals, and geographic markets to optimize the effectiveness of these activities. We expect to increase advertising spend in future periods to continue driving our growth. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Implementing new marketing and advertising strategies also could increase the risk of devoting significant capital and other resources to endeavors that do not prove to be cost effective or provide a meaningful return on investment. We also may incur marketing and advertising expenses significantly in advance of recognizing revenue associated with such expenses and our marketing and advertising expenditures may not generate sufficient levels of brand awareness or result in increased revenue. Even if our marketing and advertising expenses result in increased sales, the increase might not offset our related expenditures. If we are unable to maintain our marketing and advertising channels on cost-effective terms or replace or supplement existing marketing and advertising channels with similarly or more effective channels, our marketing and advertising expenses could increase substantially, our brand, business, financial condition, and results of operations could suffer. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our products and services may be affected from time to time by design and manufacturing or other defects that could adversely affect our business and result in harm to our reputation. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We offer complex hardware and software products and services that can be affected by design and manufacturing or other defects, errors, and bugs. Sophisticated operating system software and applications, such as those included in our products, often have issues that can unexpectedly interfere with the intended operation of hardware or software products. Defects may also exist in components or parts that we source from third parties. Any such defects could make our products and services unsafe, create a risk of environmental or property damage and personal injury, and subject us to the hazards and uncertainties of product liability claims, regulatory investigations, and related litigation. We have in the past and may in the future experience these defects and similar issues in our products. If any of our products have reliability, quality, or safety problems, we may not be able to successfully correct these problems in a timely manner or at all. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There can be no assurance that we will be able to detect and fix all issues and defects in the products, software, and services we offer. Failure to do so could result in widespread technical and performance issues affecting our products and services, damage our reputation, result in customer warranty or return claims, and deter customers from purchasing our products. In addition, these defects, errors, or bugs could interrupt or delay sales and revenue. If any defects or issues are not discovered until after we have commenced commercial production of a new product, we may incur significant additional development costs and product recall, repair or replacement costs. In addition, from time to time we may experience outages, service slowdowns, or errors that affect our fitness and wellness programming. As a result, our services may not perform as anticipated and may not meet customer expectations. Further, quality problems could adversely affect the experience for users of our products and services, and result in harm to our reputation, loss of competitive advantage, poor market acceptance, reduced demand for our products and services, delay in new product and service introductions, and lost revenue. Any of the foregoing could harm our ability to retain existing members and attract new customers, and could adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Service interruptions, outages, technical or performance issues, or similar events, including those related to, or caused by, defects or similar issues in our products and services, may result in claims against us and may cause us to incur significant additional expense to address these issues, and our liability insurance may not be adequate to cover any or all such costs. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Service interruptions, outages, technical and performance issues, or similar events affecting our products and services, including those related to, or caused by, defects or similar issues in our products and services, may result in claims against us by our members or others. For example, we have received claims in the past, including in the past year, and while such claims have not had a significant impact on our results of operations, we may be subject to future claims, which could have a material and adverse impact on our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain general liability insurance; however, design and manufacturing defects, and claims related thereto, may subject us to judgments or settlements that result in damages materially in excess of the limits of our insurance coverage. In addition, we may be exposed to recalls, product replacements or modifications, write-offs of inventory, property, plant and equipment, or intangible assets, and significant warranty and other expenses such as litigation costs and regulatory fines. If we cannot successfully defend any large claim, maintain our general liability insurance on acceptable terms, or maintain adequate coverage against potential claims, our financial results could be adversely impacted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may be subject to warranty claims that could result in significant direct or indirect costs, or we could experience greater returns than expected, either of which could have an adverse effect on our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We generally provide a <span style="white-space:nowrap">12-month</span> limited warranty on our Forme Studio and Forme Studio Lift. The occurrence of any defects or other warranty claims for which we have a legal obligation could make us liable for damages </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and warranty claims in excess of our current reserves, which could result in an adverse effect on our business prospects, liquidity, financial condition, and cash flows if warranty claims were to materially exceed anticipated levels. In addition, we could incur significant costs to correct any defects, warranty claims, or other problems, including costs related to product recalls. Any negative publicity related to the perceived quality and safety of our products could affect our brand image, decrease consumer and member confidence and demand, and adversely affect our business, financial condition, and results of operations. Moreover, certain other companies within our industry have in the past, and may in the future, received reports of injuries related to the use of their products and services and issued product recalls. Such activity by other companies within our industry, and the associated negative publicity, may be seen as characteristic of participants in our industry and may therefore harm the reputation of all participants in our industry, including us. Also, warranty claims may result in litigation, the occurrence of which could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to warranties supplied by us, we also offer the option for members to purchase third-party extended warranty and services contracts and accidental protection coverage. Extended warranties are regulated in the United States on a state level and are treated differently by state. Outside the United States, regulations for extended warranties vary from country to country. In addition, changes in interpretation of the insurance regulations or other laws and regulations concerning warranties, whether limited, full, extended, or implied, on a federal, state, local, or international level may cause us to incur costs or have additional regulatory requirements to meet in the future. Our failure to comply with past, present, and future similar laws regarding warranties on our products, whether express or implied, could result in reduced sales of our products, reputational damage, litigation, penalties, and other sanctions, which could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The failure or inability of our contract manufacturers to comply with the specifications and requirements of our products could result in a product recall, which could adversely affect our reputation and subject us to significant liability should the use of any of our products cause or be claimed to cause physical harm. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our products are manufactured by independent third-party contract manufacturers. We do not have long-term contracts with our third-party contract manufacturers, and instead, order from these manufacturers on a purchase order basis. Under certain circumstances, we may be required to, or may voluntarily, recall or withdraw products. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A widespread recall or withdrawal of any of our products may negatively and significantly impact our sales and profitability for a period of time and could result in significant losses depending on the costs of the recall, destruction of product inventory, reduction in product availability, and reaction of competitors and consumers. We may also be subject to claims or lawsuits, including class actions lawsuits (which could significantly increase any adverse settlements or rulings), resulting in liability for actual or claimed injuries or death. Any of these events could adversely affect our business, financial condition and results of operations. Even if a product liability claim or lawsuit is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion that our products caused physical harm could adversely affect our reputation with existing and potential consumers and its corporate and brand image. Moreover, claims or liabilities of this sort might not be covered by insurance or by any rights of indemnity or contribution that we may have against others. A product liability judgment against us or a product recall could adversely affect our business, financial condition and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we fail to offer high-quality member support, our business and reputation will suffer. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently work with third-party logistics providers to handle shipment and delivery of our connected fitness hardware products, including the Forme Studio and Forme Studio Lift. Our third-party logistics providers also facilitate white glove installation services of our products. Our <span style="white-space:nowrap">in-house</span> field operations team is responsible for training our third-party logistics providers on how to safely and correctly install our products, coordinating shipment and delivery matters, and communicating with our members throughout the entire <span style="white-space:nowrap">pre-installation</span> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
process. We do not have any minimum or long-term binding commitments with our third-party logistics providers and are generally billed upon shipment of the freight and believe alternative third-party logistics services would be available if needed. Our members also rely on our member support services to resolve any issues related to the use of our Forme Studio equipment and platform. Providing a high-quality member experience is vital to our success in generating <span style="white-space:nowrap"><span style="white-space:nowrap">word-of-mouth</span></span> referrals to drive sales and for retaining existing members. The importance of high-quality support will increase as we expand our business and introduce new products and services. If we do not help our members quickly resolve issues and provide effective ongoing support, our reputation may suffer and our ability to retain and attract members, or to sell additional products and services to existing members, could be harmed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We rely on access to production studios, crews, and equipment and the creativity of our fitness instructors, third parties, and a network of independent contractors to generate and produce the content on our platform. If we are unable to access these resources or if we are unable to attract and retain high-quality and innovative fitness instructors or other content production providers, we may not be able to generate interesting and attractive content for our platform. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We offer fitness and wellness content on our platform that is produced by our <span style="white-space:nowrap">in-house</span> team located in Los Angeles, California, and by contracting seasoned content production and creative professionals. Due to our reliance on a limited number of studios in a concentrated location, any incident involving our studios, or affecting Southern California generally, could render our studios inaccessible or unusable and could inhibit our ability to produce and deliver new fitness and wellness content for our members. Production of the fitness and wellness content on our platform is further reliant on the creativity of our fitness instructors who, with the support of the content production team, plan and record our VOD content. Most of the fitness instructors who provide content for our <span style="white-space:nowrap">On-Demand</span> services are independent contractors. In addition, we also bid out our content production work, including lighting, direction, and sound, to a network of independent contractors. Once engaged, these contractors typically work on a day rate basis until the <span style="white-space:nowrap">contracted-for</span> content shoot is complete. If we are unable to attract or retain creative and experienced instructors or other content production providers, we may not be able to generate content on a scale or of a quality sufficient to grow our business. If we fail to produce and provide our members with interesting and attractive content led by instructors who they can relate to, then our business, financial condition, and results of operations may be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our growth will depend in part on our ability to develop and expand our strategic and commercial relationships with companies across the fitness, wellness, hospitality, fashion, sports and design industries. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have developed, and intend to continue to develop and expand, collaborations with companies across the fitness, wellness, hospitality, fashion, sports, and design industries. Our current and potential partners include international hotel chains, celebrity trainers, interior designers, celebrity stylists, and boutique fitness clubs. These strategic relationships tend to be focused on generating awareness of our brand by accessing audiences and followings and educating them regarding our products and services. If these arrangements do not continue to result in an increase in the number of customers and revenue, our business may be harmed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The loss of a partnership could harm our results of operations, damage our reputation, increase pricing and promotional pressures from other partners and distribution channels, or increase our marketing costs. If we are not successful in maintaining existing and creating new relationships with any of these third parties, or if we encounter technological, content licensing, or other impediments to our development of these relationships, our ability to grow our business could be adversely impacted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we fail to obtain and retain high-profile strategic relationships, or if the reputation of any of these parties is impaired, our business may suffer. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A principal component of our marketing program and employee retention and recruitment has been to develop relationships with highly qualified and high-profile persons to help us extend the reach of our brand. Although </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
we have relationships with well-known individuals in this manner, we may not be able to attract and build relationships with new persons in the future. In addition, if the actions of these parties were to damage their or our reputation, our relationships may be less attractive to our current or prospective customers. Any of these failures by us or these parties could materially and adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We face risks, such as unforeseen costs and potential liability in connection with content we acquire, produce, license and/or distribute through our service. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a creator and distributor of fitness and wellness content, we face potential liability for negligence, copyright and trademark infringement, or other claims based on the nature and content of materials that we acquire, produce, license and/or distribute. We also may face potential liability for content used in promoting our service, including marketing materials. We are devoting more resources toward the development, production, marketing and distribution of our fitness and wellness content. We believe that original content can help differentiate our service from other offerings, enhance our brand and otherwise attract and retain members. To the extent our fitness and wellness content does not meet our expectations, in particular, in terms of costs, usage, and popularity, our business, including our brand and results of operations may be adversely impacted. As we expand our fitness and wellness content, we continue to be responsible for production costs and other expenses. We also take on risks associated with production, such as completion and key talent risk with respect to our trainers and fitness instructors, which risks have been heightened during <span style="white-space:nowrap">COVID-19.</span> We also contract with third parties related to the development, production, marketing and distribution of our fitness and wellness content. We may face potential liability or may suffer significant losses in connection with such arrangements, including, but not limited to, if such third parties violate applicable law, become insolvent or engage in fraudulent behavior. To the extent we license rights of our fitness and wellness content to third parties, we could become subject to product liability, intellectual property or other claims related to such merchandise. We may decide to remove content from our service, not to place licensed or produced content on our service, or discontinue or alter production of our original content if we believe such content might not be well received by our members, or could be damaging to our brand or business. To the extent we, in the future, do not accurately anticipate costs or mitigate risks, including for content that we produce but ultimately does not appear on or is removed from our service, or if we incur liability for content we acquire, produce, license and/or distribute, our business may suffer. Litigation to defend these claims could be costly and the expenses and damages arising from any liability or unforeseen production risks could harm our results of operations. We may not be indemnified against claims or costs of these types and we may not have insurance coverage for these types of claims. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Beneficial owners of over 10% of our common stock collectively hold over 42% of our common stock as of September&#160;30, 2023. As a result, such holders will be able to exert significant influence over matters subject to stockholder approval and may have interests that conflict with those of our other stockholders. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial owners of over 10% of our common stock collectively held approximately 42% of our common stock as of September&#160;30, 2023. As such, each of such holders has the ability to substantially influence us through this ownership positions, and could discourage others from initiating any potential merger, takeover or other change of control transaction that may otherwise be beneficial to our stockholders. For example, if some or all of such 10% holders were to act together with a small number of our other large stockholders, they would be able to control elections of directors, amendments of our organizational documents or approval of any merger, amalgamation, sale of assets or other major corporate transaction. Any transferees or successors of all or a significant portion of such holder&#8217;s ownership in us will be able to exert a similar amount of influence over us through their ownership position. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The interests of our significant stockholders may not always coincide with our corporate interests or the interests of our other stockholders, and each may exercise its voting and other rights in a manner with which you may not agree or that may not be in the best interests of our other stockholders. So long as such holders continue to own a significant portion of our outstanding voting securities, they will continue to have considerable influence in all matters that are subject to approval by our stockholders and will be able to strongly influence our other decisions. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Suppliers, Manufacturers, and Other Ecosystem Partners </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We rely on a limited number of suppliers, manufacturers, and logistics partners for our Forme Studio equipment. A loss of any of these partners could negatively affect our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We rely on a limited number of suppliers to manufacture, transport, and install our Forme Studio equipment, which exposes us to supply chain and other risks. We have previously experienced, and may experience in the future, production, shipping, or logistical constraints that cause delays. Although we believe we have redundancy and alternatives for the manufacturers and suppliers for the key components of our products, our reliance on a limited number of manufacturers for the components and parts for our Forme Studio equipment and the geographic concentration among our suppliers increase our supply chain risk. In addition, we do not have long-term binding commitments with any of our manufacturers and suppliers and instead operate on a purchase order basis. Therefore, we have no guarantee that they will continue to manufacture or supply products or components for us on an ongoing basis. In the event of interruption from any of our manufacturers, we may not be able to replace or increase capacity from other sources or develop alternate or secondary sources without incurring material additional costs and substantial delays. Furthermore, our manufacturing partners&#8217; primary facilities are located in Taiwan. Thus, our business could be adversely affected if one or more of our suppliers is impacted by a natural disaster or other interruption at a particular location. Such suppliers also have experienced, and may continue to experience, residual production, shipping, or logistical constraints arising from the recent <span style="white-space:nowrap">COVID-19</span> pandemic. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our suppliers and partners have no obligation to continue to accept purchase orders from us, and we may be unable to get them to accept additional orders or engage an alternate manufacturer on terms that are acceptable to us, which may undermine our ability to deliver our products to members in a timely manner. For example, it may take a significant amount of time to identify a manufacturer that has the capability and resources to build our Forme Studio equipment to our specifications in sufficient volume. Identifying suitable suppliers, manufacturers, and logistics partners is an extensive process that requires us to become satisfied with their quality control, technical capabilities, responsiveness and service, financial stability, regulatory compliance, and labor and other ethical practices. Accordingly, a loss of any of our significant suppliers, manufacturers, or logistics partners could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have limited control over our suppliers, manufacturers, and logistics partners, which may subject us to significant risks, including the potential inability to produce or obtain quality products and services on a timely basis or in sufficient quantity. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have limited control over our suppliers, manufacturers, and logistics partners, which subjects us to risks, such as the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">inability to satisfy demand for our Forme Studio equipment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">limited control over delivery timing and product reliability; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">limited ability to monitor the manufacturing process and components or parts used in our Forme Studio equipment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">limited ability to develop comprehensive manufacturing specifications that take into account any materials shortages or substitutions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">variance in the manufacturing capability of our third-party manufacturers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">price increases; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">failure of a significant supplier, manufacturer, or logistics provider to perform its obligations to us for technical, market, or other reasons; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">variance in the quality of the delivery and installation services provided by our third-party logistics providers; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulties in establishing additional supplier, manufacturer, or logistics partner relationships if we experience difficulties with our existing suppliers, manufacturers, or logistics providers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">shortages of materials or components or parts included in our Forme Studio equipment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">misappropriation of our intellectual property; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">exposure to natural catastrophes, political unrest, terrorism, labor disputes, and economic instability; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in local economic conditions in the jurisdictions where our suppliers, manufacturers, and logistics providers are located; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the imposition of new laws and regulations, including those relating to labor conditions, quality and safety standards, imports, duties, tariffs, taxes, and other charges on imports, as well as trade restrictions and restrictions on currency exchange or the transfer of funds; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">insufficient warranties and indemnities on components and parts supplied to or by our manufacturers or in connection with performance by our providers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we do not have long-term binding commitments with any manufacturers and suppliers and instead operate on a purchase order basis. We also rely on our logistics partners, including our warehouse and delivery partners, to complete a substantial percentage of our deliveries to members, with the rest of the deliveries handled by our own white glove delivery and installation team. Our primary delivery and installation partner relies on a network of independent contractors to perform delivery and installation services for us in many markets. If any of these independent contractors, or the delivery and installation partner as a whole, do not perform their obligations or meet the expectations of us or our members, our reputation and business could suffer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The occurrence of any of these risks, especially during periods of peak demand, could cause us to experience a significant disruption in our ability to produce and deliver our products to our members. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Increases in component and equipment costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and negatively impact our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to maintain and expand our business depends on our ability to obtain timely and adequate delivery of components and parts for our Forme Studio equipment. The majority of the components and parts that go into the manufacturing of our Forme Studio equipment are sourced from a limited number of third-party suppliers, and some of these components or parts are provided by a single supplier based in Taiwan. In addition, the global semiconductor supply shortage is having wide-ranging effects across multiple industries. We have experienced, and may continue to experience, direct and indirect adverse impacts on our business, including delays in securing certain components, including semiconductors, of our Forme Studio equipment. Our manufacturers generally purchase these components or parts on our behalf, subject to certain approved supplier lists, and we do not have long-term arrangements with most of our component or parts suppliers. We are therefore subject to the risk of shortages and long lead times in the supply of these components or parts and the risk that our suppliers discontinue or modify components or parts used in our Forme Studio equipment. In addition, the lead times associated with certain components or parts are lengthy and preclude rapid changes in design, quantities, and delivery schedules. We may in the future experience component shortages, and the predictability of the availability of these components or parts may be limited. In the event of a component shortage or supply interruption from suppliers of these components or parts, we may not be able to develop alternate sources in a timely manner. While we believe we can obtain alternative sources of supply on commercially reasonable terms if needed, developing alternate sources of supply for these components or parts may be time-consuming, difficult, and costly and there can be no assurance that we will be able to source these components or parts on terms that are acceptable to us, or at all, which may undermine our ability to fill our orders in a timely manner. Any interruption or delay in the supply of any of these components or parts, or the inability to obtain these components or parts from alternate sources at acceptable prices and within a reasonable amount of time, would harm our ability to meet our scheduled deliveries to our members. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, volatile global economic conditions may make it more likely that our suppliers may be unable to timely deliver supplies, or at all, and there is no guarantee that we will be able to timely locate alternative suppliers of comparable quality at an acceptable price. Several of the components or parts that go into the manufacturing of our Forme Studio equipment are sourced internationally, including from China, where the United States has imposed tariffs on specified products imported therefrom following the U.S. Trade Representative Section&#160;301 Investigation. These tariffs have an impact on our component costs and have the potential to have an even greater impact depending on the outcome of the current trade negotiations, which have been protracted and recently resulted in increases in U.S. tariff rates on specified products from China. Increases in our component costs could have a material effect on our gross margins. The loss of a significant supplier, an increase in component costs, or delays or disruptions in the delivery of components or parts, could adversely impact our ability to generate future revenue and earnings and have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our ability to maintain a sufficient supply of components and raw materials for our products or to adequately control the costs thereof have been, and may be, negatively impacted by global supply chain constraints, which in turn may be impacted by geopolitical events or other factors beyond our control. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our products incorporate various components and raw materials, such as semiconductors, and our ability to maintain a sufficient supply of such components has been, and may continue to be, impacted by global supply chain issues. Further, the availability of such components and raw materials at reasonable cost, which is essential to the successful production and sale of our products, is subject to factors beyond our control, such as geopolitical unrest, global health crises, and global economic conditions, among others. For example, Russia&#8217;s invasion of Ukraine has resulted in sanctions levied by the United States and other countries against Russia, higher energy prices, and higher prices for certain raw materials and goods and services, which in turn is contributing to higher inflation in the United States and globally, and has caused significant disruption to financial markets. While we do not currently believe our business has been significantly impacted by the Ukraine crisis to date, we could potentially be adversely impacted by any significant disruption to the global economy as a result of the ongoing crisis or any escalation thereof. For example, the conflict between Ukraine and Russia has adversely impacted, and could continue to exacerbate, global supply chain constraints and disrupt our operations or negatively impact the demand for our products and services. Any such disruption could result in an adverse impact to our financial results. Further, military, social, and political instability in a number of countries around the world, including continued hostilities and civil unrest in Ukraine and civil unrest in the Middle East, may have a negative effect on our business, financial condition, and operations as a result of any impact on our customers and manufacturing partners, the global supply chain, the volatility in the prices of components, the global economy, and the financial markets. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, as our products incorporate semiconductor components, our manufacturing processes are subject to risks and trends within the semiconductor industry generally, including wafer foundry manufacturing capacity, wafer prices, and production yields, as well as timely delivery of semiconductors from foundries to our manufacturing partners and regulatory and geopolitical developments in various jurisdictions, including Russia, Ukraine, and Asia. If the cost of raw materials increases, or our manufacturing partners experience difficulties in obtaining sufficient components of sufficient quality for incorporation in our products, it could impact our ability to deliver products to our customers in a timely manner and adversely impact our business, financial condition, and results of operations, including our gross margins. For example, as Russia and Ukraine produce a significant portion of certain key raw materials used in semiconductor manufacturing such as neon and palladium, Russia&#8217;s invasion of Ukraine could exacerbate the ongoing semiconductor supply chain issues. Although we do not currently expect Russia&#8217;s invasion of Ukraine to materially impact us directly, we are unable at this time to predict the ultimate impact this conflict will have on our company, our supply chain, our customers, the global economy, or the financial markets. Further, future global pandemics similar to the <span style="white-space:nowrap">COVID-19</span> pandemic may cause manufacturing and supply constraints that affect our products, and increased tensions between the United States and other countries, such as Russia or China, may negatively impact the supply of certain components incorporated in our products, which in turn could harm our business, financial condition, and results of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We depend on sole source and limited source suppliers for certain components and parts used in the manufacture of our products. If we are unable to source these components on a timely basis, we will not be able to deliver our products to our customers. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We depend on sole source and limited source suppliers for certain components and parts used in the manufacture of our products. Any of the sole source and limited source suppliers upon whom we rely could stop producing our components or parts, cease operations or be acquired by, or enter into exclusive arrangements with, our competitors. We generally do not have long-term supply agreements with our suppliers, and our purchase volumes are currently too low for us to be considered a priority customer by most of our suppliers. As a result, most of these suppliers could stop selling to us at commercially reasonable prices, or at all. Any such interruption or delay may force us to seek similar components or products from alternative sources, which may not be available. Switching suppliers may require that we redesign our products to accommodate new components or parts, which would be costly and time-consuming. Any interruption in the supply of sole source or limited source components for our products would adversely affect our ability to meet scheduled product deliveries to our customers, could result in lost revenue or higher expenses and would harm our business. Although we have not experienced any significant disruption as a result of our reliance on limited or sole source suppliers, we have a limited operating history and cannot assure you that we will not experience disruptions in our supply chain in the future as a result of such reliance or otherwise. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our manufacturing partners and our sole supplier are located in Taiwan, which exposes us to various risks, including due to tensions between Taiwan and mainland China. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the primary facilities of our manufacturing partners and the sole supplier of certain components and parts used in the manufacture of our products are located in Taiwan, we face risks associated with geopolitical conditions, natural disasters, and other factors. For example, Taiwan is susceptible to regional natural disasters such as earthquakes, tsunamis, and typhoons, and has experienced an increasing frequency of extreme weather events, including heavier rains and atypical heat waves. In addition, we face risks associated to changes in governmental policies, taxation, inflation, or interest rates in Taiwan and by social instability and diplomatic and social developments in or affecting Taiwan which are outside of our control. For example, since 1949, Taiwan and the Chinese mainland have been separately governed. The government for the People&#8217;s Republic of China (the &#8220;PRC&#8221; which unless the context otherwise requires, refers to mainland China) claims that it is the only legitimate government in China and that Taiwan is part of China. Although significant economic and cultural relations have been established between Taiwan and mainland China in the past few years, relations between Taiwan and mainland China remain strained. For example, the PRC government has refused to renounce the use of military force to gain control over Taiwan and, in March 2005, passed an Anti-Secession Law that authorized <span style="white-space:nowrap">non-peaceful</span> means and other necessary measures should Taiwan move to gain independence from the PRC. The PRC government has indicated that it may use military force to gain control over Taiwan if Taiwan &#8220;declares independence.&#8221; Past developments in relations between Taiwan and mainland China have on occasion depressed the market prices of the securities of companies doing business in Taiwan. If political tensions between mainland China and Taiwan were to increase further, it could negatively impact our business, financial condition, and results of operations given our reliance on manufacturing partners and a sole source supplier in Taiwan. Given the current political and military situation in China and Taiwan, if the relationship between China and the United States worsens further, or if either China or the United States imposes significant new economic sanctions or restrictions on doing business, and we are restricted or precluded from continuing our manufacturing and supplier relationships with entities in Taiwan or the ability of such parties to maintain their relationships with us is disrupted, our costs could increase, and our ability to fulfill customer orders could be significantly harmed. Furthermore, relations between Taiwan and mainland China and other factors affecting military, political, or economic conditions in Taiwan could materially and adversely affect our business, financial condition, and results of operations, as well as the market price of our common stock. See <span style="font-style:italic">&#8220;&#8212; We depend on sole source and</span> <span style="font-style:italic">limited source suppliers for certain components and parts used in the manufacture of our products. If we are unable to source these components on a timely basis, we will not be able to deliver our products to our customers.&#8221;</span> </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our payments system depends on third-party providers and is subject to evolving laws and regulations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our members pay for our products and services, including their monthly membership fees, using a variety of different payment methods, including credit and debit cards, gift cards, and online wallets. We rely on internal systems as well as those of third parties to process payment. Acceptance and processing of these payment methods are subject to certain rules and regulations and require payment of interchange and other fees. To the extent there are disruptions in our payment processing systems, increases in payment processing fees, material changes in the payment ecosystem, such as large <span style="white-space:nowrap">re-issuances</span> of payment cards, delays in receiving payments from payment processors, or changes to rules or regulations concerning payment processing, our revenue, operating expenses and results of operation could be adversely impacted. We leverage our third-party payment processors to bill members on our behalf. If these third parties become unwilling or unable to continue processing payments on our behalf, we would have to find alternative methods of collecting payments, which could adversely impact member acquisition and retention. In addition, from time to time, we encounter fraudulent use of payment methods, which could impact our results of operation and if not adequately controlled and managed could create negative consumer perceptions of our services. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have engaged third-party service providers to perform underlying card processing, currency exchange, identity verification, and fraud analysis services. If these service providers do not perform adequately or if they terminate their relationships with us or refuse to renew their agreements with us on commercially reasonable terms, we will need to find an alternate payment processor and may not be able to secure similar terms or replace such payment processors in an acceptable timeframe. Further, the software and services provided by our third-party payment processors may not meet our expectations, contain errors or vulnerabilities, be compromised, or experience outages. Any of these risks could cause us to lose our ability to accept online payments, or conduct other payment transactions, any of which could make our platform less convenient and attractive and harm our ability to attract and retain customers. In addition, our ability to accept orders could be negatively impacted and our business would be harmed. In addition, if these providers increase the fees they charge us, our operating expenses could increase. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The laws and regulations related to payments are complex and vary across different jurisdictions in the United States and globally. As a result, we are required to spend significant time and effort to comply with those laws and regulations. Any failure or claim of our failure to comply, or any failure by our third-party service providers to comply, could cost us substantial resources, could result in liabilities, or could force us to stop offering certain third-party payment services. As we expand the availability of new payment methods in the future, we may become subject to additional regulations and compliance requirements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, through our agreement with our third-party credit card processor, we are subject to payment card association operating rules and certification requirements, including the Payment Card Industry Data Security Standard. We are also subject to rules governing electronic funds transfers. Any change in these rules and requirements could make it difficult or impossible for us to comply. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Any major disruption or failure of our information technology systems or websites, or our failure to successfully implement upgrades and new technologies effectively, could adversely affect our business and operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of our information technology systems are designed and maintained by us and are critical for the efficient functioning of our business, including the manufacture and distribution of our Forme Studio equipment, online sales of our Forme Studio equipment, and the ability of our members to access content on our platform. Our growth has, in certain instances, strained these systems. As we grow, we continue to implement modifications and upgrades to our systems, and these activities subject us to inherent costs and risks associated with replacing and upgrading these systems, including, but not limited to, impairment of our ability to fulfill customer orders and other disruptions in our business operations. Further, our system implementations may not result in productivity improvements at a level that outweighs the costs of implementation, or at all. If we fail to successfully implement modifications and upgrades or expand the functionality of our information technology systems, we could experience increased costs associated with diminished productivity and operating inefficiencies related to the flow of goods through our supply chain. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, any unexpected technological interruptions to our systems or websites would disrupt our operations, including our ability to timely deliver and track product orders, project inventory requirements, manage our supply chain, sell our Forme Studio equipment online, provide services to our members, and otherwise adequately serve our members. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Substantially all of our units have been sold through our commercial website in 2021. The operation of our <span style="white-space:nowrap"><span style="white-space:nowrap">direct-to-consumer</span></span> <span style="white-space:nowrap">e-commerce</span> business through our website depends on our ability to maintain the efficient and uninterrupted operation of online order-taking and fulfillment operations. Any system interruptions or delays could prevent potential customers from purchasing our Forme Studio equipment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, the ability of our members to access the content on our platform could be diminished by a number of factors, including members&#8217; inability to access the internet, the failure of our network or software systems, security breaches, or variability in member traffic for our platform. Platform failures would be most impactful if they occurred during peak platform use periods, which generally occur before and after standard work hours. During these peak periods, there are a significant number of members concurrently accessing our platform and if we are unable to provide uninterrupted access, our members&#8217; perception of our platform&#8217;s reliability may be damaged, our revenue could be reduced, our reputation could be harmed, and we may be required to issue credits or refunds, or risk losing members. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event we experience significant disruptions, we may be unable to repair our systems in an efficient and timely manner which could have a material adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We rely heavily on third parties for most of our computing, storage, processing, and similar services. Any disruption of or interference with our use of these third-party services could have an adverse effect on our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have outsourced our cloud infrastructure to third-party providers, and we currently use these providers to host and stream our services and content. We are therefore vulnerable to service interruptions experienced by these providers and we expect to experience interruptions, delays, or outages in service availability in the future due to a variety of factors, including infrastructure changes, human, hardware or software errors, hosting disruptions, and capacity constraints. Outages and capacity constraints could arise from a number of causes such as technical failures, natural disasters, fraud, or security attacks. The level of service provided by these providers, or regular or prolonged interruptions in that service, could also affect the use of, and our members&#8217; satisfaction with, our products and services and could harm our business and reputation. In addition, hosting costs will increase as membership engagement grows, which could harm our business if we are unable to grow our revenue faster than the cost of using these services or the services of similar providers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, our providers have broad discretion to change and interpret the terms of service and other policies with respect to us, and those actions may be unfavorable to our business operations. Our providers may also take actions beyond our control that could seriously harm our business, including discontinuing or limiting our access to one or more services, increasing pricing terms, terminating or seeking to terminate our contractual relationship altogether, or altering how we are able to process data in a way that is unfavorable or costly to us. Although we expect that we could obtain similar services from other third parties, if our arrangements with our current providers were terminated, we could experience interruptions on our platform and in our ability to make our content available to members, as well as delays and additional expenses in arranging for alternative cloud infrastructure services. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any of these factors could further reduce our revenue, subject us to liability, and cause our members to decline to renew their memberships, any of which could have an adverse effect on our business, financial condition, and results of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">32 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We face certain risks related to the interaction of our members, trainers, and fitness instructors. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The nature of our services is such that we cannot control all aspects of the interactions of our members, trainers, and fitness instructors. There is a possibility that one or more of our members, trainers, or fitness instructors could be subject to actual or perceived harm following interaction with another one of our members, trainers, or fitness instructors. For example, a verbal interaction between a member and a personal trainer may be perceived by one party as hostile, unwelcome, or causing emotional harm, unintentionally or otherwise. To the extent an unfortunate incident of this nature occurred, our reputation would be harmed and we could be exposed to liability, including through litigation. Litigation to defend these claims could be costly and the expenses and damages arising from any liability could harm our results of operations. We may not be indemnified against claims or costs of these types and we may not have insurance coverage for these types of claims. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we experience any adverse change to, loss of, or claim that we do not hold necessary licenses to the music content included in our fitness content or otherwise accessible on our platform, it may have an adverse effect on our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We include music in the fitness content, including our classes and <span style="white-space:nowrap">on-demand</span> and Live 1:1 personal training services, that we make available to our members. To secure the rights to use music in our content, we enter into license agreements with and pay royalties to rights holders such as record labels, music publishers, and performing rights organizations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The process of obtaining licenses involves identifying and negotiating with many rights holders, some of whom are unknown or difficult to identify, and implicates a myriad of complex legal issues. Rights holders also may attempt to take advantage of their market power to seek burdensome financial terms from us. Our relationship with certain rights holders may deteriorate. Artists and/or artist groups may object and may exert public or private pressure on rights holders to discontinue or to modify license terms. Additionally, there is a risk that aspiring rights holders, their agents, or legislative or regulatory bodies will create or attempt to create new rights that could require us to enter into new license agreements with, and pay royalties to, newly defined groups of rights holders, some of which may be difficult or impossible to identify. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we expend significant resources in an attempt to comply with our music licenses and to avoid using music for which we do not have all applicable licenses, the fragmented nature of music rights and the lack of reliable data on copyright ownership, particularly with respect to musical compositions, make it nearly impossible to do so with 100% accuracy, so we cannot guarantee that we are not infringing or violating any third-party intellectual property rights, or that we will not do so in the future. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Comprehensive and accurate ownership information for the musical compositions embodied in sound recordings is sometimes unavailable. In some cases, we obtain ownership information directly from music publishers, and in other cases we rely on the assistance of third parties to determine ownership information. If the information provided to us or obtained by such third parties does not comprehensively or accurately identify the ownership of musical compositions, or if we (or our third-party vendor) are unable to determine which musical compositions correspond to specific sound recordings, it becomes difficult or impossible to identify the appropriate rights holders to whom to pay royalties. This may make it difficult to comply with the obligations of any agreements with those rights holders or to secure the appropriate licenses with all necessary parties. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These challenges, and others concerning the licensing of music on our platform, may subject us to liability for copyright infringement, breach of contract, or other claims. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are a party to many music license agreements that are complex and impose numerous obligations upon us that may make it difficult to operate our business, and a breach of such agreements could adversely affect our business, financial condition, and results of operations. </span></p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">33 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our license agreements are complex and impose numerous obligations on us, including obligations to, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">calculate and make payments based on complex royalty structures, which requires tracking usage of content in our service that may have inaccurate or incomplete metadata necessary for such calculation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide periodic reports on the exploitation of the content in specified formats; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">represent that we will obtain all necessary publishing licenses and consents and pay all associated fees, royalties, and other amounts due for the licensing of musical compositions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">comply with strict technical and content security-related rules and restrictions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">comply with certain marketing and advertising restrictions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">grant the licensor the right to audit our compliance with the terms of such agreements; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">comply with certain security and technical specifications. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of our license agreements also contain minimum guarantees or require that we make minimum guarantee or advance payments, which are not always tied to our number of members or stream counts for music used in our services. Accordingly, our ability to achieve and sustain profitability and operating leverage in part depends on our ability to increase our revenue through increased sales of memberships on terms that maintain an adequate gross margin. Our license agreements that contain minimum guarantees typically have terms of between one and three years, but our members may cancel their memberships at any time. We rely on estimates to forecast whether such minimum guarantees and advances against royalties could be recouped against our actual content costs incurred over the term of the license agreement. To the extent that our estimates underperform relative to our expectations, and our content costs do not exceed such minimum guarantees and advance payments, our margins may be adversely affected. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some of our license agreements also include <span style="white-space:nowrap">so-called</span> &#8220;most-favored nations&#8221; provisions, which require that certain terms (including material financial terms) are no less favorable than those provided to any similarly situated licensor. If agreements are amended or new agreements are entered into on more favorable terms, these most-favored nations provisions could cause our payment or other obligations to escalate substantially. Additionally, some of our license agreements restrict our ability to undertake new business initiatives utilizing the licensed content (e.g., alternative distribution models), and without consent or negotiating additional licenses, our ability to undertake new business initiatives may be limited and our competitive position could be impacted. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The license agreements generally have a term of two years, with some arrangements including demonstration periods or <span style="white-space:nowrap">pre-launch</span> periods. The minimum guarantees or advances contained in the license agreements range from $20,000 to $150,000 and the royalty rates, after giving effect to &#8220;most-favored nations&#8221; provisions, are at the greater of 8.33% of gross service revenue or $3.25 per subscriber (or $6.50 per subscriber for an enterprise/commercial offering). In some arrangements, we may deduct a portion of payments (generally ranging from 2.5% to 25%) to performing rights organizations for performance rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we breach any obligations in any of our license agreements, or if we use content in ways that are found to exceed the scope of such agreements, we could be subject to monetary penalties or claims of infringement, and our rights under such agreements could be terminated. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our member engagement on mobile devices depends upon effective operation with mobile operating systems, networks, and standards that we do not control. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A significant and growing portion of our members access our platform through our Forme Studio app and there is no guarantee that popular mobile devices will continue to support our Forme Studio app or that mobile device users will use our Forme Studio app rather than competing products. We are dependent on the interoperability of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">34 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">our Forme Studio app with popular mobile operating systems that we do not control, such as Android and iOS devices. Additionally, in order to deliver high-quality mobile content, it is important that our digital offering is designed effectively and works well with a range of mobile technologies, systems, networks, and standards that we do not control. We may not be successful in developing relationships with key participants in the mobile industry or in developing products that operate effectively with these technologies, systems, networks, or standards. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The smaller screen size and reduced functionality associated with some mobile devices may make accessing our Live 1:1 personal training service, and our <span style="white-space:nowrap">On-Demand</span> programs, classes, and content more difficult or less appealing to customers. If we are not able to deliver a rewarding experience on mobile devices, our business may suffer. Further, although we strive to provide engaging mobile experiences for members who visit our mobile website using a browser on their mobile device, we depend on members downloading our mobile apps to provide them the optimal mobile experience. As new mobile devices and mobile platforms are released, we may encounter problems in developing or supporting apps for them. In addition, supporting new devices and mobile device operating systems may require substantial time and resources. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The success of our mobile apps could also be harmed by factors outside our control, such as: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">actions taken by providers of mobile operating systems or mobile app download stores; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">unfavorable treatment received by our mobile apps, especially as compared to competing apps, such as the placement of our mobile apps in a mobile app download store; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increased costs in the distribution and use our mobile apps; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in mobile operating systems, such as iOS and Android, which degrade the functionality of our mobile website or mobile apps or that give preferential treatment to competitive products. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that it is more difficult for our members to access and use our platform on their mobile devices or members find our mobile offerings do not effectively meet their needs, our competitors develop products and services that are perceived to operate more effectively on mobile devices, or if our members choose not to access or use our platform on their mobile devices or use mobile products that do not offer access to our platform, our member growth and member engagement could be adversely impacted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We rely on third parties to drive traffic to our website, and these providers may change their algorithms or pricing in ways that could damage our business, operations, financial condition, and prospects. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We rely in part on digital advertising, including search engine marketing, to promote awareness of our brand and business and attract new, and increase engagement with existing members. In particular, we rely on search engines, such as Google, and the major mobile app stores as important marketing channels. Search engine companies change their search algorithms periodically, and our ranking in searches may be adversely impacted by those changes. Search engine companies or app stores may also determine that we are not in compliance with their guidelines and penalize us as a result. If search engines change their algorithms, terms of service, display, or the featuring of search results, determine we are out of compliance with their terms of service, or if competition increases for advertisements, we may be unable to cost-effectively add content and services to our website and apps. Our relationships with our marketing vendors are not long-term in nature and do not require any specific performance commitments. In addition, many of our online advertising vendors provide advertising services to other companies, including companies with whom we may compete. As competition for online advertising has increased, the cost for some of these services has also increased. Our digital advertising initiatives may become increasingly expensive and generating a return on those initiatives may be difficult. Even if we successfully increase revenue as a result of our paid digital advertising efforts, such increase may not offset the additional digital advertising expenses we incur. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">35 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Our Intellectual Property </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have in the past, and may in the future, face claims of intellectual property infringement, misappropriation or other violations, which could be time-consuming or costly to defend or settle, result in the loss of significant rights or harm our relationships with our members or reputation in the industry. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our commercial success depends in part upon our ability, and the ability of our future collaborators, to develop, manufacture, market and sell our proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property of third parties. Companies in the fitness industry, including the smart home gym and connected fitness sector, may vigorously pursue, protect and enforce their intellectual property rights. Further, companies in the fitness industry are frequently subject to litigation based on allegations of infringement or other violations of intellectual property rights. Our competitors, as well as a number of other entities and individuals, including <span style="white-space:nowrap">so-called</span> <span style="white-space:nowrap">non-practicing</span> entities, may own or claim to own intellectual property relating to our product offering. We may be unaware of the intellectual property rights that others may claim cover some or all of our technologies. Because patent applications can take years to issue and are often afforded confidentiality for some period of time, there may currently be pending applications, unknown to us, that later result in issued patents that could cover one or more aspects of our technology and there is also a risk that we could adopt a technology without knowledge of a pending patent application, which technology would infringe a third-party patent once that patent is issued. From time to time, third parties have in the past and may in the future assert against us and our members their patent and other intellectual property rights to technologies that are important to our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have in the past, and may in the future, particularly as a public company with an increased profile and visibility, receive communications from others alleging our infringement, misappropriation or other violation of patents, trade secrets, or other intellectual property rights. In addition, in the event that we recruit employees from other technology companies, including certain potential competitors, and these employees are involved in the development of products that are similar to the products they assisted in developing for their former employers, we may become subject to claims that such employees have improperly used or disclosed trade secrets or other proprietary information. We may also in the future be subject to claims by our suppliers, employees, consultants, or contractors asserting an ownership right in our patents or patent applications, or other intellectual property as a result of the work they performed on our behalf. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Claims that our products or technologies infringe, misappropriate or otherwise violate third-party intellectual property rights, regardless of their merit or resolution, could be time-consuming or costly to defend or settle and could divert the efforts and attention of our management and technical personnel. Many potential litigants, including some of our competitors and patent holding companies, have the ability to dedicate substantial resources to enforcing their intellectual property rights. If such parties were to assert their intellectual property rights against us, even if we believe we would have defenses against any such assertion, there can be no assurance that any such defenses will be successful. For example, in a patent infringement claim against us, we may assert, as a defense, that we do not infringe the relevant patent claims, that the patent is invalid or both. The strength of our defenses will depend on the patents asserted, the interpretation of these patents, and our ability to invalidate the asserted patents. We may be unsuccessful in advancing <span style="white-space:nowrap">non-infringement</span> and/or invalidity arguments in our defense. In the United States, issued patents enjoy a presumption of validity, and the party challenging the validity of a patent claim must present clear and convincing evidence of invalidity, which is a high burden of proof. Conversely, the patent owner need only prove infringement by a preponderance of the evidence, which is a lower burden of proof. Further, any litigation may also involve <span style="white-space:nowrap">non-practicing</span> entities or other adverse patent owners that have no relevant solution revenue, and therefore, our patent portfolio may provide little or no deterrence as we would not be able to assert our patents against such entities or other adverse patent owners. Infringement claims could also harm our relationships with our members and might deter future customers from doing business with us. We do not know whether we will prevail in these proceedings given the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">36 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
complex technical issues and inherent uncertainties in intellectual property litigation. If any pending or future proceedings result in an adverse outcome, we could be required to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">cease the manufacture, use, sale, or importation of the infringing products, content, services, or technologies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">pay substantial damages for infringement, misappropriation or other violation, which could include treble damages and attorneys&#8217; fees if we are found to willfully infringe a third party&#8217;s intellectual property rights; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expend significant time, expense, and resources to develop, acquire, or license alternative <span style="white-space:nowrap">non-infringing</span> products, content, services, or technologies, which may not be successful; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">license technology from the third-party claiming infringement, which license may not be available on commercially reasonable terms, or at all; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">cross-license our intellectual property rights to a competitor to resolve an infringement claim, which could weaken our ability to compete with that competitor; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">pay substantial damages to our members or <span style="white-space:nowrap">end-users</span> to discontinue their use of or to replace infringing technology sold to them with <span style="white-space:nowrap">non-infringing</span> technology, if available. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, even if successful in such proceedings, our intellectual property rights in our products, services, content, or technologies may be invalidated or narrowed. Moreover, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Any of the foregoing results could have a material adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, certain contracts with our suppliers or customers may contain provisions whereby we indemnify, subject to certain limitations, the counterparty for damages suffered as a result of claims related to intellectual property infringement. Claims made under these provisions, even those without merit, could adversely affect our relationship with that third party as well as with new and existing customers, could be expensive to litigate and could result in significant payments. Even if we were to prevail in such a dispute, any litigation regarding our intellectual property could be costly and time-consuming and divert the attention of our management and key personnel from our business operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We use a significant amount of intellectual property in our business. Monitoring unauthorized use of our intellectual property can be difficult and costly and if we are unable to obtain, maintain, and protect our intellectual property, our business, financial condition, and results of operations could be adversely affected. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our success depends in part upon our ability to obtain and maintain intellectual property rights with respect to our products and the technologies we develop. To accomplish this, we rely on a combination of intellectual property rights, including patents, copyrights, trade areas, domain name, and trademarks in the United States and in selected foreign countries where we believe filing for such protection is appropriate. We also rely on trade secret laws, as well as confidentiality and <span style="white-space:nowrap">non-disclosure,</span> licensing, and other contractual protections, to protect our intellectual property rights. Some of our products and technologies are not covered by any patent or patent application, as we do not believe patent protection of these products and technologies is critical to our business strategy at this time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, our efforts to protect our intellectual property rights may not be sufficient or effective, and any of our intellectual property rights may be challenged, which could result in them being narrowed in scope or declared invalid or unenforceable. There can be no assurance that our intellectual property rights will be sufficient to protect against others offering products, services, or technologies that are substantially similar to ours and that compete with our business. Certain unauthorized use of our intellectual property may go undetected, or we may face legal or practical barriers to enforcing our legal rights even where unauthorized use is detected. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">37 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective protection of patents, trademarks, such as our rights to use the &#8220;Forme Life&#8221; mark, and domain names is expensive and difficult to maintain, both in terms of application and registration costs as well as the costs of defending and enforcing those rights. As we have grown, we have sought patent and trademark rights in a limited number of countries outside of the United States, a process that can be expensive and may not always be successful. For example, the U.S. Patent and Trademark Office and various foreign governmental patent agencies require compliance with a number of procedural requirements to complete the patent application process and to maintain issued patents, and noncompliance or <span style="white-space:nowrap">non-payment</span> could result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in a relevant jurisdiction. Further, intellectual property protection may not be available to us in every country in which our products and services are available. For example, some foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. In addition, many countries limit the enforceability of patents against certain third parties, including government agencies or government contractors. In these countries, patents may provide limited or no benefit. Further, the laws of some countries in which we operate or intend to operate do not protect proprietary rights and intellectual property to the same extent as the laws of the United States, and mechanisms for protection and enforcement of intellectual property rights in some foreign countries may be inadequate. To the extent we expand our international activities, our exposure to unauthorized copying and use of our products and technologies may increase. Further, competitors, foreign governments, foreign government-backed actors, criminals, or other third parties may gain unauthorized access to our proprietary information and technology. Accordingly, despite our efforts, we may be unable to prevent third parties from infringing upon or misappropriating our technology and intellectual property. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Patents and Other Registered Intellectual Property </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our patent and patent application portfolio primarily relates to various hardware and software inventions that may or may not be embodied in our current or future products. The United States patents in the portfolio and issued as of September&#160;30, 2023 are expected to expire between 2036 and 2040, without taking potential patent term extensions or adjustments into account. We cannot assure you that any patents from any pending or future patent applications will be issued, and even if our pending patent applications are granted, the scope of the rights granted to us may not be meaningful, may not provide us with a commercial advantage and may be subject to reinterpretation after issuance. The patent prosecution process is expensive, time-consuming, and complex, and we may not be able to file, prosecute, maintain, enforce, or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output in time to obtain patent protection. Failure to timely seek patent protection on products or technologies generally precludes us from seeking future patent protection on these products or technologies. Even if we do timely seek patent protection, the coverage claimed in a patent application can be significantly reduced before a patent is issued, and its scope can be reinterpreted after issuance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also rely on our trademarks to build name recognition and our brand in the markets in which we do business. Our registered or unregistered trademarks or trade names in the United States and in international jurisdictions may be challenged, infringed, circumvented, declared generic, lapsed, or determined to be infringing on or dilutive of other marks, and our current and future trademark applications may not be allowed or may subsequently be opposed. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with potential customers. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. As a means to enforce our trademark rights and prevent infringement, we may be required to file trademark claims against third parties or initiate trademark opposition proceedings. This can be expensive and time-consuming, and we may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">38 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot guarantee that: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any of our present or future patents or patent claims will not lapse or be invalidated, narrowed, circumvented, opposed or otherwise challenged, or abandoned; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our intellectual property rights will provide competitive advantages to us; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to assert our intellectual property rights against others (including potential competitors) or to settle current or future disputes will not be limited by our agreements with third parties; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any of our pending or future patent applications will be issued or have the coverage originally sought; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our intellectual property rights will be enforced in jurisdictions where competition may be intense or where legal protections may be weak; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">all inventors or contributors to intellectual property have executed appropriate and effective invention assignment agreements assigning their inventions and contributions to us; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any of the trademarks, copyrights, trade secrets, or other intellectual property rights that we presently employ in our business will not lapse or be invalidated, narrowed, circumvented, challenged, abandoned or otherwise diminished or eliminated; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">we will not lose the ability to assert our intellectual property rights against or to license our technologies to others and collect royalties or other payments. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our competitors or others may infringe on our trademarks or patents, independently develop similar offerings, duplicate our offerings, or design around our patents or other intellectual property rights. Further legal standards relating to the validity, enforceability, and scope of protection of intellectual property rights are constantly developing, uncertain, and may be applied or interpreted in ways that limit our ability to protect and enforce our rights. Effective intellectual property protection may be unavailable or more limited in foreign jurisdictions relative to those protections available in the United States. Further, intellectual property protection may not be applied for in one or more relevant jurisdictions. Even if foreign patents are granted, effective enforcement in foreign countries may not be available. The failure of our patents to adequately protect our technologies might make it easier for our competitors to offer similar products or technologies, and our business, financial condition, and results of operations could be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Trade Secrets and Other Unregistered Intellectual Property </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to patent protection, we also rely on other proprietary rights, including protection of trade secrets and other proprietary information that is not patentable or that we elect not to patent. We rely on contractual protections with our members, suppliers, employees, consultants, and contractors, and we implement security measures designed to protect our intellectual property, and proprietary technology. For example, all employees and consultants are generally required to execute confidentiality agreements in connection with their employment and consulting relationships with us. We also require them to agree to disclose and assign to us all inventions conceived or made in connection with the employment or consulting relationship. However, we cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technologies. Further, these agreements do not prevent our competitors or others from independently developing products or technologies that are substantially equivalent or superior to ours. The confidentiality agreements on which we rely to protect our intellectual property may be breached, may not be adequate to protect our confidential information, trade secrets, and proprietary technologies, and may not provide an adequate remedy in the event of unauthorized use or disclosure of our confidential information, trade secrets, or proprietary technologies. </p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">39 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our trade secrets, <span style="white-space:nowrap">know-how,</span> and other proprietary information may be stolen, disclosed to our competitors, used in an unauthorized manner, or compromised through a direct intrusion by private parties or foreign actors, including those affiliated with or controlled by state actors, through cyber intrusions into our computer systems, physical theft through corporate espionage, or other means, or through more indirect routes, including by licensees that do not honor the terms of the license or other parties reverse engineering our products or technologies. Others may independently develop substantially equivalent products or technologies or otherwise gain access to our trade secrets. Unauthorized copying or other misappropriation of our trade secrets and other intellectual property could enable third parties to benefit from our technologies without paying us for doing so, which could harm our business. We cannot assure you that our contractual protections and security measures have not been or will not be breached or that we will have adequate remedies for any such breach. Accordingly, we cannot guarantee that we have secured, or will be able to secure, effective protections for all of our trade secrets or other proprietary information that we use or claim rights to. We rely in part on the laws of the United States and international laws to protect our intellectual property. Intellectual property such as trade secrets are difficult to protect, and some courts inside and outside of the United States are less willing or unwilling to protect intellectual property, including trade secrets. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Monitoring Unauthorized Use of Intellectual Property </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Monitoring unauthorized use of our intellectual property is difficult and costly. Although we are not aware of any material misappropriation of our intellectual property to date, unauthorized use of our intellectual property may have occurred or may occur in the future. Although we have taken steps to minimize the risk of this occurring, any such failure to identify unauthorized use and otherwise adequately protect our intellectual property would adversely affect our business. When we become aware of companies infringing on our intellectual property rights, we seek to enforce our rights through appropriate actions. From time to time, we may need to commence litigation or other legal proceedings in order to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">assert claims of infringement of our intellectual property rights; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">defend our products from piracy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">protect our trade secrets or <span style="white-space:nowrap">know-how;</span> or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">determine the enforceability, scope, and validity of the propriety rights of others. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lawsuits or other proceedings that we initiate to protect or enforce our patents or other intellectual property rights could be expensive, time consuming, and unsuccessful. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their intellectual property or alleging that our intellectual property is invalid or unenforceable. Moreover, if we are required to commence litigation, whether as a plaintiff or defendant, we would also be forced to divert our attention and the efforts of our employees, which could, in turn, result in lower revenue and higher expenses. If we pursue litigation to assert our intellectual property rights, an adverse decision in any of these legal actions could limit our ability to assert our intellectual property rights, limit the value of our technologies or otherwise negatively impact our business, financial condition, and results of operations. Legal fees related to such litigation will increase our operating expenses and may reduce our net income. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Protection and pursuit of intellectual property rights and positions often results in protracted and expensive litigation for many companies. In the ordinary course of our business, we may become party to disputes involving intellectual property rights. We have in the past received, and we may in the future receive, communications alleging liability for damages or challenging the validity of our intellectual property or proprietary rights. We also have in the past, and may in the future receive claims of infringement or inquiries regarding possible infringement of the intellectual property rights of others, demands seeking royalty payments or other remedies, or cease and desist letters. Depending on the situations, we may defend our position, seek to negotiate a license, or engage in other acceptable resolution that is appropriate to our business. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">40 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we encounter disputes or other issues related to the intellectual property we license from or that we develop with third parties, it could narrow or restrict our ability to use such intellectual property and adversely impact our ability to develop and market our current or new products and services. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many of our products and services include intellectual property licensed from third parties, and we are party to a number of third-party intellectual property license agreements. Some of these license agreements require us to make <span style="white-space:nowrap">one-time</span> payments or ongoing royalty payments. We cannot guarantee that the technologies we license will not be licensed to our competitors or others in the fitness and wellness sector, including the smart home gym and connected fitness industry. As a result, we may not be able to prevent competitors from developing and commercializing competitive products in territories included in all of our licenses. In the future, we may need to obtain additional licenses, renew existing license agreements, or otherwise replace existing technologies. We are unable to predict whether these license agreements can be obtained or renewed or whether the technologies can be replaced on acceptable terms, or at all. In that event, we may be required to expend significant time and resources to redesign our technologies, products or the methods for manufacturing them or to develop or license replacement technologies, all of which may not be feasible on a technical or commercial basis. Any disputes with our licensing partners with respect to such agreements could narrow what we believe to be the scope of our rights to the relevant intellectual property, increase our obligations under such agreements, or restrict our ability to develop and market our current or new products and services. Any of these events could negatively impact our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, from time to time, we enter into agreements with select customers, such as our commercial customers, to customize and otherwise develop technologies and intellectual property, and we expect to enter into new, similar arrangements from time to time in the future. Some of these agreements contain terms that allocate ownership of, and rights to use and enforce, technologies and intellectual property rights. As a result of these agreements, we may be required to limit use of, refrain from using, or <span style="white-space:nowrap">co-own</span> certain of such related technologies and intellectual property rights in parts of our business. Determining inventorship and ownership of technologies and intellectual property rights resulting from development activities can be difficult and uncertain. Certain intellectual property rights to which we claim ownership are or may be subject to <span style="white-space:nowrap">co-ownership</span> disputes with certain inventors or third parties due to unexecuted assignment agreements. Disputes may arise with customers, vendors, and other third parties regarding ownership of and rights to use and enforce these technologies and intellectual property rights or regarding interpretation of our agreements with these third parties, and these disputes may result in claims against us or claims that intellectual property rights, which we believe we own, are not owned by us, are not enforceable, or are invalid. The cost and effort to resolve these types of disputes, or the loss of intellectual property rights if we lose these types of disputes, could harm our business, financial condition, and results of operations. Further, <span style="white-space:nowrap">co-ownership</span> of intellectual property rights may allow the other owners to freely use such intellectual property rights, or license or transfer such intellectual property rights to others including our competitors. Any of these could negatively impact our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may be involved in lawsuits to protect or enforce our patents or our other intellectual property rights, which could be expensive, time consuming and unsuccessful. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Competitors may infringe, misappropriate or otherwise violate our patents or our other intellectual property rights. To counter infringement, misappropriation, or other violations, we may be required to file legal claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or interpreted </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">narrowly and could put our patent applications at risk of not issuing. Litigation or other legal proceedings relating to intellectual property claims, with or without merit, are unpredictable and, even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our scientific and management personnel from their normal responsibilities. Any such litigation or proceedings also could substantially increase our operating losses and reduce the resources available for development activities or future sales, marketing, or distribution activities. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">41 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The initiation of a claim against a third party may also cause the third party to bring counter claims against us such as claims asserting that our patents are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, <span style="white-space:nowrap">non-enablement,</span> or lack of statutory subject matter. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant material information from the USPTO, or made a materially misleading statement, during prosecution. Third parties also may raise similar validity claims against our patents before the USPTO in post-grant proceedings such as ex parte reexaminations, inter partes review, or post-grant review, or oppositions or similar proceedings outside the United States, in parallel with litigation or even outside the context of litigation. The outcome following legal assertions of invalidity and unenforceability is unpredictable. We cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. For the patents and patent applications that we have licensed, we may have limited or no right to participate in the defense of any licensed patents against challenge by a third party. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of any future patent protection on our current or future proprietary technologies. Such a loss of patent protection could harm our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have an adverse effect on the price of our common stock. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors or other third parties may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our business, financial condition, results of operations, and prospects. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our use of third-party open source software may pose particular risks to our proprietary software, technologies, products, and services in a manner that could harm our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of our software, as well as that of our vendors, may use or be derived from &#8220;open source&#8221; software that is generally made available to the public by its authors and/or other third parties. Some open software is made available under license terms that may impose certain obligations on us in the event we were to distribute derivative works of the open source software. These obligations may require us to make source code for the derivative works available to the public and/or license such derivative works under a particular type of license, rather than the forms of license we customarily use to protect our intellectual property. Additionally, some open source software licenses also require those who distribute or make available across a network software and services that include open source software which may include valuable proprietary code. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we may take steps to monitor the use of all open source software in our products and technologies, and try to ensure that no open source software is used in such a way as to require us to disclose the source code to the related product or technology when we do not wish to do so, we have not conducted a complete open source license review and such use could inadvertently occur. Additionally, if a third-party software provider has incorporated certain types of open source software into software we license from such third party for our products and technologies, we could, under certain circumstances, be required to disclose the source code to our products and technologies. This could harm our intellectual property position and have a material adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, although some open source vendors provide warranty and support agreements, it is common for such software to be available <span style="white-space:nowrap">&#8220;as-is&#8221;</span> with no warranty, indemnity, or support. </p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">42 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, there is an increasing number of open-source software license types, almost none of which have been tested in a court of law, resulting in a dearth of guidance regarding the proper legal interpretation of such licenses. Additionally, we could face claims from third parties claiming ownership of, or demanding release of, the open source software or derivative works that we developed using such software, which could include our proprietary source code, or otherwise seeking to enforce the terms of the applicable open source license. These claims could result in litigation and could require us to make our software source code freely available, purchase a costly license, or cease offering the implicated products or services unless and until we can <span style="white-space:nowrap">re-engineer</span> them to avoid infringement. This <span style="white-space:nowrap">re-engineering</span> process could require us to expend significant additional research and development resources, and we cannot guarantee that we will be successful. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the use of certain open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally do not provide warranties or controls on the functionality or origins of software. There is typically no support available for open source software, and we cannot ensure that the authors of such open source software will implement or push updates to address security risks or will not abandon further development and maintenance. Many of the risks associated with the use of open source software, such as the lack of warranties or assurances of title or performance, cannot be eliminated, and could, if not properly addressed, negatively affect our business. Use of open source software may also present additional security risks because the public availability of such software may make it easier for hackers and other third parties to determine how to compromise our platform. We cannot be sure that all open source software is identified, reviewed, or submitted for approval prior to use in our products and services. Any of these risks could be difficult to eliminate or manage, and, if not addressed, could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Privacy, Cybersecurity, and Infrastructure </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We collect, store, process, and use personal information and other member data, which subjects us to legal obligations and laws and regulations related to security and privacy, and any actual or perceived failure to meet those obligations could harm our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the ordinary course of our business, we may collect, process, transmit, disclose, store, and use a wide variety of data from current and prospective members, including personal information or personal data, such as home addresses and geolocation. Federal, state, and international laws and regulations governing privacy, data protection, and <span style="white-space:nowrap">e-commerce</span> transactions require us to safeguard our members&#8217; personal information. Although we have established security procedures to protect member information, we may rely upon third-party service providers and technologies to operate critical business systems that process confidential and personal information in a variety of contexts, including, without limitation, third-party providers of cloud-based infrastructure, security technology, employee email, content delivery to members, and other functions. Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. We may share or receive sensitive data with or from third parties. Further, advances in computer capabilities, new discoveries in the field of cryptography, inadequate facility security, or other developments may result in a compromise or breach of the technology we use to protect member data. Any compromise of our security, the security of our third-party service providers, or any other breach of our members&#8217; privacy could harm our reputation or financial condition and, therefore, our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cyberattacks, malicious internet-based activity, and online and offline fraud are prevalent and continue to increase. These threats are becoming increasingly difficult to detect. These threats come from a variety of sources. In addition to traditional computer &#8220;hackers,&#8221; threat actors, personnel (such as through theft or misuse), sophisticated nation-states, and nation-state-supported actors now engage in attacks. We and the third parties upon which we rely may be subject to a variety of these evolving threats, including but not limited to social-engineering attacks (including through phishing attacks), malicious code (such as viruses and worms), malware (including as a result of advanced persistent threat intrusions), <span style="white-space:nowrap"><span style="white-space:nowrap">denial-of-service</span></span> attacks (such as credential stuffing), personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, server malfunctions, software or hardware failures, loss of data or other information technology assets, adware, telecommunications failures, earthquakes, fires, floods, and other similar threats. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">43 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any of the previously identified or similar threats could cause a security incident or other interruption. A security incident or other interruption could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to data. A security incident or other interruption could disrupt our ability (and that of third parties upon whom we rely) to provide our services. We may expend significant resources or modify our business activities in an effort to protect against security incidents. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depending on the nature of the information compromised, in the event of a data breach or other unauthorized access to our member data, we may also have obligations to notify members, along with administrative bodies, about the incident. We may also need to provide some form of remedy, such as a membership to a credit monitoring service, for the individuals affected by the incident. A growing number of legislative and regulatory bodies have adopted consumer notification requirements in the event of unauthorized access to or acquisition of certain types of personal data. Such breach notification laws continue to evolve and may be inconsistent from one jurisdiction to another. Complying with these obligations could cause us to incur substantial costs and could increase negative publicity surrounding any incident that compromises member data. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, we may be required to disclose personal data pursuant to demands from individuals, privacy advocates, regulators, government agencies, and law enforcement agencies in various jurisdictions with conflicting privacy and security laws. This disclosure or refusal to disclose personal data may result in a breach of privacy and data protection policies, notices, laws, rules, court orders, and regulations and could result in proceedings or actions against us in the same or other jurisdictions, damage to our reputation and brand, and inability to provide our products and services to consumers in certain jurisdictions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finally, we are subject to laws and regulations that govern our collection, use, and transfer of member data. In some jurisdictions, we are subject to affirmative requirements to meet certain data privacy rights afforded to the residents of that jurisdiction (e.g., access rights, data portability rights, sales <span style="white-space:nowrap">opt-out</span> rights). These laws are numerous and complex and if we, or our third-party service provider, are accused of noncompliance, we could face penalties. Moreover, these laws and rules are changing and could therefore impose additional requirements with respect to the retention and security of member data, raise our internal compliance costs, limit our marketing activities, and/or otherwise adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cybersecurity risks could adversely affect our business and disrupt our operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We face various cybersecurity threats, including threats to our information technology infrastructure, <span style="white-space:nowrap"><span style="white-space:nowrap">denial-of-service</span></span> attacks, zero day attacks, phishing and spoofing attempts, fraudulent requests for money transfers, attempts to compromise proprietary information, and ransomware attacks. In addition, we face cybersecurity threats from entities that may seek to target us by exploiting our relationships with our members, vendors, subcontractors, employees, independent contractors, and other third parties with whom we do business. While the cyber threat landscape is ever-changing, the current risks may be heightened by ongoing tensions with various nation state threat actors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Threats to our information technology assets, network, and data stored therein, are increasingly diverse and sophisticated. Despite our efforts and processes to prevent breaches, the commercial products we use, our servers, and other assets, along with those of our third party service providers, are vulnerable to cybersecurity threats, including zero day attacks, malware, phishing and spoofing exploits, <span style="white-space:nowrap"><span style="white-space:nowrap">denial-of-service</span></span> attacks, compromise of physical assets, insider theft or misuse or mistake, and similar disruptions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite our efforts to create security barriers to such threats, we may not be able to successfully guard against every threat or mitigate the resulting risks. A successful cyber-attack could lead to interruptions, delays, loss of critical data, unauthorized access to member data, and require large expenditure to investigate and remediate. This could, in turn, adversely affect consumer confidence, our business, our financial condition, and damage our reputation. </p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">44 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. Also, we cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">A breach of our information technology systems or physical security systems, or any actual or perceived violation of privacy or data protection laws, could harm our reputation, business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We rely on our information technology systems to process, transmit, and store electronic information (including sensitive data such as confidential business information, financial information, and personally identifiable information relating to employees, members, and other business partners), and to manage or support a variety of critical business processes and activities, as well as physical security systems to protect our facilities and employees. We can provide no assurance that our current information technology or physical security systems, or those of the third parties upon which we rely, are fully protected. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we have not experienced any known cyber or physical security events which have materially impacted our business, financial condition, operations, liquidity, or reputation to date, it is possible that we (and/or our members, vendors, partners, or others) have faced a cyber or physical security compromise that is not (yet) known. Further, future threats could, among other consequences: cause harm to our business and our reputation; disrupt our operations; cost significant resources to address; expose us to potential liability, regulatory actions, and the loss of business; and impact our results of operations materially. Due to the evolving nature of these security threats, we cannot predict the potential impact of any future incident. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Applicable data privacy and security obligations may require us to notify relevant stakeholders of security incidents. Such disclosures are costly, and the disclosures or the failure to comply with such requirements could lead to adverse consequences. If we (or a third party upon whom we rely) experience a security incident or are perceived to have experienced a security incident, we may experience adverse consequences. These consequences may include: government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional reporting requirements and/or oversight; restrictions on processing data (including personal data); litigation (including class claims); indemnification obligations; negative publicity; reputational harm; monetary fund diversions; interruptions in our operations (including availability of data); financial loss; and other similar harms. Security incidents and attendant consequences may negatively impact our ability to grow and operate our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we take measures to protect the security of, and prevent unauthorized access to, our systems, facilities, and personal and proprietary information, the security controls for our systems and facilities, as well as other security practices we follow, may not prevent unauthorized access or damage to our systems and facilities, or prevent the disablement or encryption of, use or misuse of, disclosure of, modification of, destruction of or loss of our data or the data of others (including personally identifiable information and proprietary information). Any actual or perceived security incident could harm our business and results of operations and could result in, among other things, unfavorable publicity, governmental inquiry, oversight, and sanction, difficulty in marketing our services, allegations by our members or partners that we have not performed our contractual obligations, litigation by affected parties including our members and possible financial obligations for damages related to the theft or misuse of such information or inventory, any of which could negatively impact our business, financial condition, and results of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">45 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Data privacy and security are subject to frequently changing rules and regulations, and failure to comply with these rules and regulations could materially and adversely harm our reputation, business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are, or could become, subject to a variety of local, state, national and international laws, directives, and regulations that apply to the collection, use, retention, protection, disclosure, transfer, and other processing of personal data in the different jurisdictions, and which sometimes conflict among the various jurisdictions and countries in which we operate. If and as we expand our business internationally, we expect to become subject to data privacy and security laws in additional jurisdictions. Data privacy laws and regulations, including, but not limited to, the California Consumer Privacy Act of 2018 (the &#8220;CCPA&#8221;) and the California Privacy Rights Act of 2020 (&#8220;CPRA&#8221;), as well as the European Union&#8217;s General Data Protection Regulation (&#8220;GDPR&#8221;) and its equivalent in the United Kingdom (to which we may become subject if we expand into those jurisdictions), pose increasingly complex compliance challenges, which may increase compliance costs. Any failure to comply with data privacy laws and regulations could result in significant penalties. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CCPA requires, among other things, that covered companies provide disclosures to California consumers and affords such consumers with certain rights, including the ability to opt out of certain sales of their personal information. The CCPA prohibits discrimination against individuals who exercise their privacy rights and provides for civil penalties for violations, as well as a private right of action in certain circumstances. Additionally, the CPRA, which became effective in most material respects starting on January&#160;1, 2023, further expands the CCPA with additional compliance requirements that may impact our business and establishes a regulatory agency dedicated to enforcing the CCPA and CPRA. Aspects of the interpretation and enforcement of the CCPA and CPRA remain uncertain and will impose additional compliance requirements that may impact our business. In addition, we may be subject to other new data privacy laws, such as the Virginia Consumer Data Protection Act, the Colorado Privacy Act, the Connecticut Data Privacy Act and the Utah Consumer Privacy Act in the United States (all of which go into effect in 2023) as well as the European Union Regulation on Privacy and Electronic Communications (or ePrivacy Regulation). Further, in the United States, emerging state data privacy laws may encourage other states and the federal government to pass comparable legislation, introducing the possibility of greater penalties and more rigorous compliance requirements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The GDPR regulates the collection, control, sharing, disclosure, use, and other processing of data that can directly or indirectly identify a living individual that is a resident of the European Union and imposes stringent data protection requirements with significant penalties and the risk of civil litigation, for noncompliance. Moreover, following the UK&#8217;s exit from the European Union, the GDPR was transposed into UK law (the &#8220;UK GDPR&#8221;). However, a risk of divergent parallel regimes (and related uncertainty) exist. We cannot predict how the GDPR, the UK GDPR, or other UK or international data protection laws or regulations may develop or impact our business if and when we become subject to such laws and regulations, nor can we predict the effects of divergent laws and related guidance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compliance with U.S. and international data protection laws and regulations could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business. Any inability to adequately address data privacy or data protection, or other information security-related concerns, even if unfounded, or to successfully negotiate privacy, data protection or information security-related contractual terms with members, or to comply with applicable laws, regulations and policies relating to privacy, data protection and information security, could result in additional cost and liability to us, harm our reputation and brand, and could negatively impact our business, financial condition, and results of operations</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Financial, Accounting, and Tax Matters </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may not be able to accurately predict our future capital needs, and we may not be able to obtain additional financing to fund our operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will need to raise additional funds in the future, including in the short term and long term, to fund our operations and meet our obligations. See &#8220;Note 1. Description of Business and Basis of Presentation &#8211; Liquidity and Going Concern&#8221; to the notes to our audited and unaudited condensed consolidated financial statements included elsewhere in this prospectus and <span style="font-style:italic">&#8220; &#8211; Risks Related to Our Business and Industry</span><span style="font-weight:bold"> &#8211; </span><span style="font-style:italic">Our negative cash</span> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">46 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">flows from operations, history of losses, and significant accumulated deficit raise substantial doubt about our ability to continue as a &#8216;going concern.&#8217;&#8221;</span> As we generated recurring net losses and negative operating cash flow during the research and development stage of the Forme Studio and Forme Studio Lift products, we have funded our operations primarily with gross proceeds from sales of our redeemable convertible preferred stock, the sale of SAFE notes, and the issuance of convertible notes, as well as from promissory notes. Certain of our outstanding promissory notes provides for a security interest on our assets. If we were to default on such promissory notes or any other secured debt instrument and such default is not waived, any secured collateral would become subject to liens or risk of forfeiture. In addition, any required additional financing may not be available on terms acceptable to us, or at all. If we raise additional funds by issuing equity securities or convertible debt, investors may experience significant dilution of their ownership interest, and the newly issued securities may have rights senior to those of the holders of our common stock. If we raise additional funds by obtaining loans from third parties, the terms of those financing arrangements may include security interests on our assets, negative covenants or other restrictions on our business that could impair our operational flexibility and would also require us to incur additional interest expense. If additional financing is not available when required or is not available on acceptable terms, we may have to scale back our operations, limit our production activities, or implement other cost reduction measures, including personnel costs. For example, partially as a result of economic headwinds, we reduced our headcount in July of 2022 by approximately 26% of our full-time employee base at the time and in December of 2022, we had a subsequent headcount reduction comprising approximately 50% of our full-time employee base at the time. Further, if we are unable to secure additional financing when needed, we may not be able to expand our business, develop or enhance our products, take advantage of business opportunities, or respond to competitive pressures, which could negatively impact our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2023 we entered into the Asset Purchase Agreement, pursuant to which we will assume additional indebtedness and issue additional equity consideration. Further, in December 2023, we entered into the 3i Note Transaction pursuant to which we may issue up to 14,313,185 shares of common stock upon the conversion and exercise in full of the Note and Warrant, as applicable, and the Equity Line Financing, pursuant to which we may sell up to $20.0&#160;million in aggregate of newly issued common stock, in each case subject to certain beneficial ownership limitations and share issuance caps and in accordance with their respective resale registration rights agreements. To the extent we issue additional equity for the CLMBR Acquisition and the selling stockholder or we sell any shares under the respective registration rights agreement, there will be further dilution. See <span style="font-style:italic">&#8220;&#8211;Risks Related to Our Common Stock &#8211; Substantial future sales of our common stock could cause the market price of our common stock to decline.&#8221;</span>&#160;If we were to default on the Note and such default is not waived, the Note shall bear interest at a rate of 14.0% per annum, and the Note Investor may require us to redeem all or any portion of the Note. The Note also imposes certain restrictions on us and our subsidiaries. These restrictions limit us and our subsidiaries&#8217; ability, among other things, to incur or guarantee certain additional indebtedness, engage in transactions with affiliates, sell certain assets, and create liens, and they place restrictions on the ability of us to make dividends and our subsidiaries to pay dividends. If we fail to maintain compliance with the restrictions and covenants under the Purchase Agreement and the Note, we would be subject to events of default which in turn would materially and adversely affect our business, financial condition, and results of operations and our liquidity. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have identified material weaknesses in our internal control over financial reporting, and in the future, we may identify additional material weaknesses or fail to maintain an effective system of controls. If we do not remediate the material weaknesses in our internal control over financial reporting, or if we fail to establish and maintain effective internal control, we may not be able to accurately report our financial results or file our periodic reports in a timely manner, which may cause investors to lose confidence in our reported financial information and may lead to a decline in the market price of our common stock. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective internal control over financial reporting is necessary for us to provide reliable financial reports in a timely manner. In connection with the preparation of our financial statements for the nine months ended September&#160;30, 2023 and September&#160;30, 2022, we concluded that there were material weaknesses in our internal </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">47 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
control over financial reporting. A material weakness is a significant deficiency, or a combination of significant deficiencies, in internal control over financial reporting such that it is reasonably possible that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses we identified related to (1)&#160;the lack of a sufficient number of trained professionals with the expertise to design, implement, and execute a formal risk assessment process and formal accounting policies, procedures, and controls over accounting and financial reporting to ensure the timely and accurate recording of financial transactions while maintaining a segregation of duties; and (2)&#160;the lack of a sufficient number of trained professionals with the appropriate U.S. GAAP technical expertise to identify, evaluate, and account for complex transactions and review valuation reports prepared by external specialists. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are planning on implementing measures designed to improve our internal control over financial reporting to remediate these material weaknesses, including formalizing our processes and internal control documentation and strengthening supervisory reviews by our financial management; hiring additional qualified accounting and finance personnel and engaging financial consultants to enable the implementation of internal control over financial reporting and segregating duties amongst accounting and finance personnel. In addition, we are planning on implementing an accounting software system with the design and functionality to segregate incompatible accounting duties, which we currently expect will be fully implemented in our 2024 fiscal year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we are implementing these measures, we cannot assure you that these efforts will remediate our material weaknesses and significant deficiencies in a timely manner, or at all, or prevent restatements of our financial statements in the future. In particular, our material weakness related to our accounting software was not fully remediated for the fiscal year ended December&#160;31, 2023 as we expect to implement new software in 2024. If we are unable to successfully remediate our material weaknesses, or identify any future significant deficiencies or material weaknesses, the accuracy and timing of our financial reporting may be adversely affected, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports, and the market price of our common stock may decline as a result. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be <span style="white-space:nowrap">re-evaluated</span> frequently. We expect to incur additional costs to remediate these control deficiencies, though there can be no assurance that our efforts will be successful or avoid potential future material weaknesses. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles. If we are unable to successfully remediate our existing or any future material weaknesses in our internal control over financial reporting, or if we identify any additional material weaknesses, the accuracy and timing of our financial reporting may be adversely affected, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting, and our stock price may decline as a result. We also could become subject to investigations by Nasdaq, the SEC, or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets. In addition, investors&#8217; perceptions that our internal controls are inadequate or that we are unable to produce accurate financial statements on a timely basis may harm our stock price and make it more difficult for us to effectively market and sell our products to new and existing customers. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may need to incur significant expenditures to address the additional operational and control requirements of our growth, either of which could harm our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To effectively manage our growth, we must continue to expand our operational, engineering and financial systems, procedures and controls and to improve our accounting and other internal management systems. This may require substantial managerial and financial resources, and our efforts in this regard may not be successful. Our current systems, procedures, and controls may not be adequate to support our future operations. In addition, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">48 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in connection with operating as a public company, we have incurred, and expect to continue to incur, additional significant legal, accounting, and other expenses that we did not incur as a private company. If our revenue does not increase to offset these increases in our expenses, we may not achieve or maintain profitability in future periods. Any failure to successfully implement systems enhancements and improvements will likely have a negative impact on our ability to manage our expected growth as well as our ability to ensure uninterrupted operation of key business systems and compliance with the rules and regulations applicable to public companies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our members&#8217; ability to obtain financing on commercially reasonable terms and our ability to receive timely payments from our members could adversely affect our results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many of our members seek third-party financing, including through Affirm Holdings, Inc. (&#8220;Affirm&#8221;), our financing partner, to purchase our Forme Studio equipment. Our members&#8217; ability to obtain such financing, the ability of Affirm or other consumer financing providers to provide financing to our members, and our ability to receive timely payments from our members could adversely impact our revenue and results of operations. We regularly review the collectability and creditworthiness of our members to determine an appropriate allowance for doubtful accounts. Based on our review of our members, we had no reserve for doubtful accounts as of September&#160;30, 2023 and December 2022. If our doubtful accounts were to exceed our current or future allowance for doubtful accounts, our business, financial condition, and results of operations would be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our ability to use our net operating loss to offset future taxable income may be subject to certain limitations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, we had U.S. federal net operating loss carryforwards (&#8220;NOLs&#8221;) and state NOLs of approximately $16.8&#160;million and $3.8&#160;million, respectively, due to prior period losses which if not utilized will begin to expire for federal and state tax purposes beginning in 2037 and 2038, respectively. Realization of these NOLs depends on future income, and there is a risk that our existing NOLs could expire unused and be unavailable to offset future income tax liabilities, which could adversely affect our results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, under Section&#160;382 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), a corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its NOLs to offset future taxable income. Our initial public offering, as well as future changes in our stock ownership, the causes of which may be outside of our control, could result in an additional ownership change under Section&#160;382 of the Code. Our NOLs may also be impaired under state laws. In addition, under 2017 legislation commonly referred to as the Tax Cuts and Jobs Act, NOLs generated in taxable years beginning after December&#160;31, 2017 may be utilized to offset no more than 80% of taxable income annually. This change may require us to pay federal income taxes in future years despite generating a cumulative loss for federal income tax purposes. There is also a risk that due to regulatory changes, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could expire or otherwise be unavailable to offset future income tax liabilities. For these reasons, we may not be able to realize a tax benefit from the use of our NOLs, whether or not we attain profitability. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Fluctuations in exchange rates between and among the currencies of the countries in which we do business could adversely affect our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our sales have been historically and primarily denominated in U.S. dollars. An increase in the value of the U.S. dollar relative to the currencies of the countries in which our members operate could impair the ability of our members to cost-effectively purchase or integrate our products into their product offerings, which may materially affect the demand for our products and cause these members to reduce their orders, which in turn would adversely affect our business, financial condition, and results of operations. If we increase operations in other currencies in the future, we may experience further foreign exchange gains or losses due to the volatility of other currencies compared to the U.S. dollar. Our results of operations are denominated in U.S. dollars, and the difference in exchange rates in one period compared to another may directly impact <span style="white-space:nowrap"><span style="white-space:nowrap">period-to-period</span></span> comparisons of our results of operations. Furthermore, currency exchange rates have been especially volatile in the recent past, and these currency fluctuations may make it difficult for us to predict our results of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">49 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not implemented any hedging strategies to mitigate risks related to the impact of fluctuations in currency exchange rates. Even if we were to implement hedging strategies, not every exposure can be hedged and, where hedges are put in place based on expected foreign exchange exposure, they are based on forecasts which may vary or which may later prove to have been inaccurate. Failure to hedge successfully or anticipate currency risks accurately could adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a public company, we are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act and the rules and regulations of the applicable listing standards of Nasdaq. We expect that the requirements of these rules and regulations will continue to increase our legal, accounting, and financial compliance costs, make some activities more difficult, time-consuming and costly and place significant strain on our personnel, systems and resources. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we will file with the SEC is recorded, processed, summarized, and reported within the applicable time periods specified in SEC rules and forms and that information required to be disclosed in reports under the Exchange Act is accumulated and communicated to our principal executive and financial officers. We are also continuing to improve our internal control over financial reporting. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight. Our current controls and any new controls that we develop may become inadequate because of changes in conditions in our business. In addition, changes in accounting principles or interpretations could also challenge our internal controls and require that we establish new business processes, systems and controls to accommodate such changes. We have limited experience with implementing the systems and controls necessary to operate as a public company, as well as adopting changes in accounting principles or interpretations mandated by the relevant regulatory bodies. Additionally, if these new systems, controls or standards and the associated process changes do not give rise to the benefits that we expect or do not operate as intended, it could adversely affect our financial reporting systems and processes, our ability to produce timely and accurate financial reports, or the effectiveness of internal control over financial reporting. Moreover, our business may be harmed if we experience problems with any new systems and controls that result in delays in their implementation or increased costs to correct any post-implementation issues that may arise. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, weaknesses in our disclosure controls and internal control over financial reporting may be discovered in the future. Any failure to develop or maintain effective controls or any difficulties encountered in their implementation or improvement could harm our business or cause us to fail to meet our reporting obligations and may result in a restatement of our financial statements for prior periods. Any failure to implement and maintain effective internal control over financial reporting also could adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that we will eventually be required to include in our periodic reports that will be filed with the SEC. Ineffective disclosure controls and procedures and internal control over financial reporting could also cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of our common stock. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on Nasdaq. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not currently required to comply with the SEC rules that implement Section&#160;404 of the Sarbanes-Oxley Act and are therefore not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. As a public company, we are required to provide an annual management </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">50 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
report on the effectiveness of our internal control over financial reporting commencing with our second annual report on Form <span style="white-space:nowrap">10-K.</span> Our independent registered public accounting firm is not required to formally attest to the effectiveness of our internal control over financial reporting until our first annual report filed with the SEC where we are an accelerated filer or a large accelerated filer, which will not occur until at least our second annual report on Form <span style="white-space:nowrap">10-K.</span> At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed or operating. Any failure to maintain effective disclosure controls and internal control over financial reporting could harm our business, financial condition, and results of operations and could cause a decline in the trading price of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">In preparing our consolidated financial statements, we make good faith estimates and judgments that may change or turn out to be erroneous, which could adversely affect our results of operations for the periods in which we revise our estimates or judgments. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In preparing our consolidated financial statements in conformity with GAAP, we must make estimates and judgments in applying our most critical accounting policies. Those estimates and judgments have a significant impact on the results we report in our consolidated financial statements. The most difficult estimates and subjective judgments that we make relate to revenue recognition, inventories, stock-based compensation, and income taxes. We base our estimates on historical experience, input from outside experts and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue, and expenses that are not readily apparent from other sources. We also have other key accounting policies that are not as subjective, and therefore, their application would not require us to make estimates or judgments that are as difficult, but which nevertheless could significantly affect our financial reporting. Actual results may differ materially from these estimates. If these estimates, judgments, or their related assumptions change, our results of operations for the periods in which we revise our estimates, judgments, or assumptions could be adversely and perhaps materially affected and may fall below the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Changes to financial accounting standards may affect our results of operations and could cause us to change our business practices. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We prepare our consolidated financial statements in accordance with GAAP. These accounting principles are subject to interpretation by the Financial Accounting Standards Board, the SEC, and various bodies formed to interpret and create accounting rules and regulations. Changes in accounting rules can have a significant effect on our reported financial results and may affect our reporting of transactions completed before a change is announced. Changes to those rules or the questioning of current practices may adversely affect our financial results or the way we conduct our business. The issuance of new accounting standards or future interpretations of existing accounting standards, or resulting changes in our business practices or estimates, could result in future changes in our revenue recognition or other accounting policies that could have a material adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We or our members may be subject to sales and other taxes, and taxing authorities may successfully assert that we should have collected or in the future should collect sales and use, gross receipts, value added or similar taxes and may successfully impose additional obligations on us, and any such assessments or obligations could adversely affect our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The application of indirect taxes, such as sales and use tax, value-added tax, goods and services tax, business tax, and gross receipts tax, to businesses like ours and to our members is a complex and evolving issue. Many of the fundamental statutes and regulations that impose these taxes were established before the adoption and growth of the Internet and <span style="white-space:nowrap">e-commerce.</span> Significant judgment is required on an ongoing basis to evaluate applicable tax obligations and as a result amounts recorded are estimates and are subject to adjustments. In many cases, the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">51 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ultimate tax determination is uncertain because it is not clear how new and existing statutes might apply to our business or to trainers and fitness instructors&#8217; businesses generally. In addition, local governments are increasingly looking for ways to increase revenue, which has resulted in discussions about tax reform and other legislative action to increase tax revenue, including through indirect taxes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to indirect taxes in the United States and various foreign jurisdictions, and we may face indirect tax audits in various U.S. and foreign jurisdictions. In certain jurisdictions, we collect and remit indirect taxes. However, tax authorities have raised and may continue to raise questions about or challenge or disagree with our calculation, reporting or collection of taxes and may require us to collect taxes in jurisdictions in which we do not currently do so or to remit additional taxes and interest, and could impose associated penalties and fees. A successful assertion by one or more tax authorities requiring us to collect taxes in jurisdictions in which we do not currently do so or to collect additional taxes in a jurisdiction in which we currently collect taxes, could result in substantial tax liabilities, including taxes on past sales, as well as penalties and interest, or could otherwise harm our business, financial condition, and results of operations. Although we have reserved for potential payments of possible past tax liabilities in our financial statements, if these liabilities exceed such reserves, our financial condition could be harmed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, one or more states, the federal government, other localities or other taxing jurisdictions may seek to impose additional reporting, record-keeping or indirect tax collection obligations on businesses like ours. For example, taxing authorities in the United States and other countries have identified <span style="white-space:nowrap">e-commerce</span> as a means to calculate, collect and remit indirect taxes for transactions taking place over the Internet, and are considering related legislation. After the U.S. Supreme Court decision in South Dakota v. Wayfair Inc., certain states have enacted laws that would require tax reporting, collection or tax remittance on items sold online. This new legislation could require us or trainers and fitness instructors to incur substantial costs in order to comply, including costs associated with tax calculation, collection, and remittance and audit requirements, which could make our offerings less attractive and could adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of these and other factors, the ultimate amount of tax obligations owed may differ from the amounts recorded in our financial statements and any such difference may adversely impact our results of operations in future periods in which we change our estimates of our tax obligations or in which the ultimate tax outcome is determined. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Changes in our tax rates or exposure to additional tax liabilities or assessments could affect our profitability, and audits by tax authorities could result in additional tax payments. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are affected by various taxes imposed in different jurisdictions, including direct and indirect taxes imposed on our global activities. Significant judgment is required in determining our provisions for taxes, and there are many transactions and calculations where the ultimate tax determination is uncertain. The amount of income tax we pay is subject to ongoing audits by tax authorities. If audits result in payments or assessments, our future results may include unfavorable adjustments to our tax liabilities, and we could be adversely affected. Any significant changes to the tax system in the jurisdictions where we operate could adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">New or future changes to U.S. and <span style="white-space:nowrap">non-U.S.</span> tax laws could materially adversely affect us. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New or future changes in tax laws, regulations, and treaties, or the interpretation thereof, in addition to tax regulations adopted but not in effect, tax policy initiatives and reforms under consideration in the United States or in international jurisdictions, and other initiatives could have an adverse effect on the taxation of international businesses. Furthermore, countries where we are subject to taxes, including the United States, are independently evaluating their tax policy and we may see significant changes in legislation and regulations concerning taxation. Certain countries may enact tax legislation which could affect international businesses, and other countries have </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">52 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
become more aggressive in their approach to audits and enforcement of their applicable tax laws. We are unable to predict what future tax changes may be proposed or enacted or the potential impact any such changes would have on our business, but any changes, to the extent they are brought into tax legislation, regulations, policies, or practices, could increase our effective tax rates in the United States, as well as in countries in the event we expand our international operations, and have an adverse effect on our overall tax rate, along with increasing the complexity, burden, and cost of tax compliance, all of which could impact our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Tax regulatory authorities may disagree with our positions and conclusions regarding certain tax positions resulting in unanticipated costs or <span style="white-space:nowrap">non-realization</span> of expected benefits. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A tax authority may disagree with tax positions that we have taken. For example, a tax authority may take the position that material income tax liabilities, interest, and penalties are payable by us, in which case, we expect that we might contest such assessment. Contesting such an assessment may be lengthy and costly and if we were unsuccessful in disputing the assessment, the implications could be materially adverse to us and affect our anticipated effective tax rate or operating income, and we could be required to pay substantial penalties and interest where applicable. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Our International Operations </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our business, financial condition, and results of operations could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which we conduct business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business, financial condition, and results of operations are impacted by worldwide economic conditions. Uncertainty about current global economic conditions may cause businesses to postpone spending in response&#160;to tighter credit, unemployment or negative financial news. This in turn could have a material adverse effect on the demand for our products or the systems into which our products are incorporated. Multiple factors relating to our international operations and to particular countries in which we operate, or plan to operate, could negatively impact our business, financial condition, and results of operations. These factors include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulty establishing and managing international operations and the increased operations, travel, infrastructure, including establishment of local delivery service and customer service operations, and legal compliance costs associated with locations in different countries or regions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the need to vary pricing and margins to effectively compete in international markets; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the need to adapt and localize products and services for specific countries, including obtaining rights to third-party intellectual property, including music, used in each country; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increased competition from local providers of similar products and services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the need to offer content and customer support in various languages; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">compliance with anti-bribery laws, such as the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), and&#160;the U.K. Bribery Act 2010 (&#8220;U.K. Bribery Act&#8221;), by us, our employees, and our business partners; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">complexity and other risks associated with current and future legal requirements in other countries, including legal requirements related to consumer protection, consumer product safety, and data privacy frameworks, such as the E.U. General Data Protection Regulation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">varying levels of internet technology adoption and infrastructure, and increased or varying network and hosting service provider costs; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">53 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">fluctuations in currency exchange rates and the requirements of currency control regulations, which might restrict or prohibit conversion of other currencies into U.S. dollars; and compliance with local laws and regulations, such as content rules, and unanticipated changes in local laws and regulations, including tax laws and regulations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reduced protection of intellectual property rights and heightened exposure to intellectual property theft; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">trade and foreign exchange restrictions and higher tariffs, including any trade tensions between the United States and foreign countries that may result in higher tariffs on our products or components or parts of our products; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">timing and availability of import and export licenses and other governmental approvals, permits and licenses, including export classification requirements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">restrictions imposed by the U.S. government or foreign governments on our ability to do business with certain companies or in certain countries as a result of international political conflicts or the <span style="white-space:nowrap">COVID-19</span> pandemic, and the complexity of complying with those restrictions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">transportation delays and other consequences of limited local infrastructure, and disruptions, such as large scale outages or interruptions of service from utilities or telecommunications providers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the effects of adverse economic conditions in the markets in which we sell our products, including inflationary pressures, which has or may result in increased interest rates, fuel prices, wages, and other costs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulties in staffing international operations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in immigration policies which may impact our ability to hire personnel; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">local business and cultural factors that differ from our normal standards and practices; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">differing employment practices and labor relations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">heightened risk of terrorist acts, civil disturbances or political instability; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">regional health issues and the impact of public health epidemics on employees and the global economy, such as the worldwide <span style="white-space:nowrap">COVID-19</span> pandemic; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">power outages and natural disasters; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in political, regulatory, legal, or economic conditions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">disruptions of capital and trading markets; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulty in obtaining distribution and support. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These risks could harm our international operations, delay new product releases, increase our operating costs and hinder our ability to grow our operations and business and, consequently, our business, financial condition, and results of operations could suffer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have limited experience with international regulatory environments and market practices and may not be able to penetrate or successfully operate in the markets we choose to enter. In addition, we may incur significant expenses as a result of our international expansion, and we may not be successful. We may face limited brand recognition in certain parts of the world that could lead to <span style="white-space:nowrap">non-acceptance</span> or delayed acceptance of our products and services by consumers in new markets. We may also face challenges to acceptance of our fitness and wellness content in new markets. Our failure to successfully manage these risks could harm our international operations and have an adverse effect on our business, financial condition, and results of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">54 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Expansion of our business internationally exposes us to numerous legal and regulatory requirements and failure to comply with such requirements, including unexpected changes to such requirements, could adversely affect our results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to expand our business internationally and as a result, we will be increasingly subject to numerous, and sometimes conflicting, legal regimes of the United States and foreign national, state and provincial authorities on matters as diverse as anti-corruption, trade restrictions, tariffs, taxation, sanctions, immigration, internal and disclosure control obligations, securities regulation, anti-competition, data security, privacy, labor relations, wages and severance, and health care requirements. For example, our operations in the United States are, and our operations outside of the United States may also be, subject to U.S. laws on these diverse matters. U.S. laws may be different in significant respects from the laws of jurisdictions where we seek to expand, such as Canada and the United Kingdom. We also may seek to expand operations in emerging market jurisdictions where legal systems are less developed or familiar to us. Our exposure for potential violations of international legal and regulatory requirements will increase to the extent we expand our international operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, there can be no assurance that the laws or administrative practices relating to taxation (including the current position as to income and withholding taxes), foreign exchange, export controls, economic sanctions, or otherwise in the jurisdictions where we have operations will not change. Changes in tax laws in some jurisdictions may also have a retroactive effect and we may be found to have paid less tax than required in such regions. Compliance with diverse legal requirements is costly, time consuming, and requires significant resources. Violations of one or more of these regulations in the conduct of our business could result in significant fines, criminal sanctions against us or our officers, prohibitions on doing business, and damage to our reputation. Violations of these regulations in connection with the performance of our obligations to our members also could result in liability for significant monetary damages, fines or criminal prosecution, unfavorable publicity and other reputational damage, and allegations by our members that we have not performed our contractual obligations. Due to the varying degrees of development of the legal systems of the countries in which we operate, local laws might be insufficient to protect our rights. New legislation or regulation, the application of laws from jurisdictions whose laws do not currently apply to our business, or the application of existing laws and regulations to the fitness and wellness industry generally could result in significant additional compliance costs and responsibilities for our business. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Regulatory Matters </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our business is subject to a wide range of laws and regulations, many of which are evolving, and failure to comply with such laws and regulations could harm our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to a wide variety of laws, regulations, and standards in the United States and other jurisdictions governing issues such as worker classification, labor and employment, anti-discrimination, automatically renewing subscription payments, gift cards, whistleblowing and worker confidentiality obligations, product liability, warranties, product defects, maintenance, and repairs, personal injury, membership services, intellectual property, consumer protection, taxation, privacy, data security, competition, terms of service, mobile application accessibility, insurance, payment processing, environmental, health. and safety, background checks, public health, anti-corruption, anti-bribery, import and export restrictions, trade and economic sanctions, foreign ownership and investment, foreign exchange controls, and delivery and installation of goods are often complex and subject to varying interpretations, in many cases due to their lack of specificity. As a result, their application in practice may change or develop over time through judicial decisions or as new guidance or interpretations are provided by regulatory and governing bodies, such as federal, state, and local administrative agencies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fitness equipment sold for home use, such as our Forme Studio and Forme Studio Lift, is regulated in the United States by the Consumer Product Safety Commission (&#8220;CPSC&#8221;) under the Consumer Product Safety Act (&#8220;CPSA&#8221;). Safety-related information that we learn about our Forme Studio and Forme Studio Lift from any </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">55 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
source&#8212;including, but not limited to, internal testing, third-party testing, our customer service channels, our social media accounts, customer reviews, investigative and news reports, and direct notices from the CPSC may trigger reporting obligations under the CPSA that could lead to product safety investigations, corrective actions including consumer-level recalls, enforcement actions, and civil or criminal penalties. The outcome of any such actions mandated by or entered into voluntarily with CPSC may have adverse business, financial, legal, reputational, and other consequences to our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The smart home gym and connected fitness industry and our business model are relatively nascent and rapidly evolving. New laws and regulations and changes to existing laws and regulations continue to be adopted, implemented and interpreted in response to our industry and related technologies. As we expand our business into new markets or introduce new offerings into existing markets, regulatory bodies or courts may claim that we or users on the Forme platform are subject to additional requirements, or that we are prohibited from conducting our business in certain jurisdictions, or that users on the Forme platform are prohibited from using the Forme platform, either generally or with respect to certain offerings. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recent financial, political, and other events have increased the level of regulatory scrutiny on larger companies, technology companies in general and companies engaged in dealings with independent contractors. Regulatory bodies may enact new laws or promulgate new regulations that are adverse to our business, or, due to changes in our operations and structure or partner relationships as a result of changes in the market or otherwise, they may view matters or interpret laws and regulations differently than they have in the past or in a manner adverse to our business. See <span style="font-style:italic">&#8220;&#8212; Challenges to independent contractor classification of certain personnel, including content production personnel, may have adverse business, financial, tax, legal, and other consequences to our business.&#8221;</span> Such regulatory scrutiny or action may create different or conflicting obligations from one jurisdiction to another, and may have a negative outcome that could adversely affect our business, operations, financial condition, and results of operations. Additionally, we have invested and from time to time we will continue to invest resources in an attempt to influence or challenge legislation and other regulatory matters pertinent to our operations. These activities may not be successful, and any negative outcomes could adversely affect our business, operations, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Challenges to independent contractor classification of certain personnel, including content production personnel, may have adverse business, financial, tax, legal, and other consequences to our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may become subject to claims, lawsuits, arbitration proceedings, administrative actions, government investigations, and other legal and regulatory proceedings at the federal, state and municipal levels challenging the classification of our fitness instructors or other content production providers with whom we work as independent contractors. Our use of independent contractors for content production activities fluctuates depending on production volume and schedule. The tests governing whether an individual is an independent contractor or an employee vary by governing law and are typically highly fact sensitive. Laws and regulations that govern the status and misclassification of independent contractors are subject to changes and divergent interpretations by various authorities which can create uncertainty and unpredictability for us. For example, Assembly Bill 5 (as codified in part at Cal. Labor Code sec. 2750.3) codified and extended an employment classification test in Dynamex Operations West, Inc. v. Superior Court, which established a new standard for determining employee or independent contractor status. A determination that classifies our independent contractors as &#8220;employees,&#8221; could harm our business, financial condition, and results of operations, including as a result of: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">monetary exposure arising from or relating to failure to withhold and remit taxes, unpaid wages and wage and hour laws and requirements (such as those pertaining to failure to pay minimum wage and overtime, or to provide required breaks and wage statements), expense reimbursement, statutory and punitive damages, penalties, including related to the California Private Attorneys General Act, and government fines; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">injunctions prohibiting continuance of existing business practices; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">56 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">claims for employee benefits, social security, workers&#8217; compensation, and unemployment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">claims of discrimination, harassment, and retaliation under civil rights laws; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">claims under new or existing laws pertaining to unionizing, collective bargaining, and other concerted activity; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">other claims, charges, or other proceedings under laws and regulations applicable to employers and employees, including risks relating to allegations of joint employer liability or agency liability; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">harm to our reputation and brand. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the harms listed above, a determination in, or settlement of, any legal proceeding that classifies an independent contractor as an employee may require us to alter our existing business model or operations, which may increase our costs and may negatively impact our ability to add qualified fitness instructors and other content production personnel and grow our business. This in turn would likely have a material adverse effect on our business, financial condition, and results of operations and our ability to achieve or maintain profitability in the future. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are subject to economic sanctions, export control, and similar laws. <span style="white-space:nowrap">Non-compliance</span> with such laws can subject us to criminal or civil liability and harm our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The United States and various foreign governments have imposed controls, export license requirements, restrictions on the import or export of certain technologies, and economic sanctions measures administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control (OFAC) and other agencies. Our products are subject to U.S. export controls, which may require submission of a product classification request and submission of periodic reports. Compliance with applicable regulatory requirements regarding the export of our products and services may create delays in the introduction of our products and services in international markets, prevent our international members from accessing our products and services, and, in some cases, prevent the export of our products and services to some countries altogether. As a U.S. company, we are subject to U.S. sanctions restrictions in our U.S. and foreign activities. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, U.S. export control laws and economic sanctions prohibit the provision of products and services to countries, governments, and persons targeted by U.S. sanctions. We are in the process of implementing policies and procedures to prevent transacting with or allowing our products to be provided to targets of U.S. sanctions, our products and services, including our firmware updates, could be inadvertently provided to those targets or to prohibited or blocked persons. Any such provision or prohibited transactions could have negative consequences for us, including government investigations, penalties, and reputational harm. Our failure to obtain required import or export approval for our products could harm our international and domestic sales and adversely affect our revenue. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we could be subject to future enforcement action with respect to compliance with governmental export and import controls and economic sanctions laws that result in penalties, costs, and restrictions on export privileges that could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, various countries regulate the import and export of certain encryption and other technology, including import and export permitting and licensing requirements. While we do not currently incorporate any encryption technology in our products and services and currently sell our products and services only the United States, if and when such laws become applicable to us, it could limit our ability to distribute our products or could limit our users&#8217; ability to access our products in those countries. Further, if changes in our products and services result in such laws becoming applicable to us (for example, if we were to incorporate encryption technology into our products and services), future changes in the export and import control regulations of the United States or other countries may prevent members from utilizing our products globally or, in some cases, prevent the export or import of our products to certain countries, governments, or persons altogether. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">57 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any future change in export or import regulations, economic sanctions, or related legislation, or change in the countries, governments, persons, or technologies targeted by such regulations, could also result in decreased use of our products by, or in our decreased ability to export or sell products to, existing or potential users. Any decreased use of our products or limitation on our ability to export or sell our products would likely adversely affect our business, financial condition, and results of operations. Additionally, supply chain and ethical sourcing rules in the United States, such as the Uyghur Forced Labor Prevention Act, and similar rules in other countries may impact outsourcing, manufacturing, sales, and ability to import or export our products and services. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot predict whether any material suits, claims, or investigations relating to these laws may arise in the future. Regardless of the outcome of any future actions, claims, or investigations, we may incur substantial defense costs and such actions may cause a diversion of management time and attention. Also, it is possible that we may be required to pay substantial damages or settlement costs which could have a material adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We could be adversely affected by violations of applicable anti-corruption laws or violations of our internal policies designed to ensure ethical business practices. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to the risk that we, our U.S. employees or our employees located in other jurisdictions or any third parties that we engage to do work on our behalf in foreign countries may take action determined to be in violation of anti-corruption laws in any jurisdiction in which we conduct business, including the FCPA and the U.K. Bribery Act, as well as other similar anti-bribery and anti-kickback laws and regulations. These laws prohibit companies and their employees and third-party intermediaries from corruptly promising, authorizing, offering, or providing, directly or indirectly, improper payments or anything of value to government officials, political parties, public international organizations, and private-sector recipients for the purpose of obtaining or retaining business, directing business to any person, or securing any improper advantage. In addition, U.S. public companies are required to maintain records that accurately and fairly represent their transactions and accounts and have an adequate system of internal accounting controls. In many foreign countries, including countries in which we may conduct business, it may be a local custom that businesses engage in practices that are prohibited by the FCPA or other applicable laws and regulations. We face significant risks if we or any of our directors, officers, employees, agents or other partners or representatives fail to comply with these laws. We have begun to implement an anti-corruption compliance program, including policies and procedures designed to foster compliance with these laws. However, despite such precautions, our employees, contractors, agents, and companies to which we outsource certain of our business operations may take actions in violation of our policies or applicable law. Any such violation could have an adverse effect on our reputation, business, financial condition, results of operations, and prospects. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any violation of the FCPA, other applicable anti-corruption laws, or anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, loss of export privileges, substantial fines, sanctions, civil penalties, criminal penalties, and curtailment of operations in certain jurisdictions and, in the case of the FCPA, suspension or debarment from U.S. government contracts, any of which could have a materially adverse effect on our reputation, business, financial condition, results of operations, and prospects. In addition, responding to any enforcement action may result in a significant diversion of management&#8217;s attention and resources and significant defense costs and other professional fees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Changes to U.S. or foreign trade policy, tariff, or similar regulations may have a material adverse effect on our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in U.S. or foreign international, social, political, regulatory, and economic conditions or in laws and policies governing foreign trade, supply chain sourcing and transparency, manufacturing, development, and investment in the territories or countries where we currently sell our products or conduct our business have in the past and could in the future adversely affect our business. Although we do not currently expect Russia&#8217;s invasion of Ukraine or the related current or future export and other business sanctions on Russia and Belarus to </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">58 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
materially impact us directly due to our limited sales to Russia, we are unable at this time to predict the ultimate impact this conflict will have on our company, the global economy or the stock markets. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Successive U.S. presidential administrations and Congress have instituted or proposed changes in trade policies that included the negotiation or termination of trade agreements, the imposition of higher tariffs on imports into the U.S., economic sanctions on individuals, corporations or countries, and other government regulations affecting trade between the U.S. and other countries where we conduct our business. Any new tariffs and other changes in U.S. trade policy could trigger retaliatory actions by affected countries, and certain foreign governments have instituted or are considering imposing trade sanctions on certain U.S. goods. U.S. presidential administrations and Congress also have focused on policy reforms that discouraged corporations from outsourcing manufacturing and production activities to foreign jurisdictions, including through tariffs or penalties on goods manufactured outside the United States, which have required us to change the way we conduct business. The current U.S. presidential administration has continued certain import tariffs and export restrictions against certain foreign manufacturers initiated by prior administrations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Political changes and trends such as populism, protectionism, economic nationalism, and sentiment toward multinational companies and resulting changes to trade, tax or other laws and policies may be disruptive to our businesses. These changes in U.S. and foreign laws and policies have the potential to adversely impact the U.S. economy or certain sectors thereof, our industry, and the global demand for our products, and as a result, could have a material adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Changes in legislation in U.S. and foreign taxation of international business activities or the adoption of other tax reform policies, as well as the application of such laws, could adversely impact our financial position and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recent or future changes to U.S., U.K. and other tax laws could impact the tax treatment of our foreign earnings. We generally conduct our international operations through wholly owned subsidiaries, branches, or representative offices and report our taxable income in various jurisdictions worldwide based upon our business operations in those jurisdictions. Further, we are in the process of implementing an international structure that aligns with our financial and operational objectives as evaluated based on our international markets, expansion plans, and operational needs for headcount and physical infrastructure outside the United States. The intercompany relationships between our legal entities are subject to complex transfer pricing regulations administered by taxing authorities in various jurisdictions. Although we believe we are compliant with applicable transfer pricing and other tax laws in the United States, the United Kingdom, and other relevant countries, due to changes in such laws and rules, we may have to modify our international structure in the future, which will incur costs, may increase our worldwide effective tax rate, and may adversely affect our financial position and results of operations. In addition, significant judgment is required in evaluating our tax positions and determining our provision for income taxes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the ordinary course of business, there are many transactions and calculations for which the ultimate tax determination is uncertain. For example, our effective tax rates could be adversely affected by earnings being lower than anticipated in countries where we have lower statutory rates and higher than anticipated in countries where we have higher statutory rates, by changes in foreign currency exchange rates, or by changes in the relevant tax, accounting, and other laws, regulations, principles, and interpretations. As we operate in numerous taxing jurisdictions, the application of tax laws can be subject to diverging and sometimes conflicting interpretations by tax authorities of these jurisdictions. It is not uncommon for taxing authorities in different countries to have conflicting views with respect to, among other things, the manner in which the <span style="white-space:nowrap">arm&#8217;s-length</span> standard is applied for transfer pricing purposes, or with respect to the valuation of intellectual property. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If U.S., U.K., or other tax laws further change, if our current or future structures and arrangements are challenged by a taxing authority, or if we are unable to appropriately adapt the manner in which we operate our business, we </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">59 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may have to undertake further costly modifications to our international structure and our tax liabilities and results of operations may be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We and our third-party manufacturers and suppliers are, or could become, subject to environmental, health, and safety laws, which could increase our costs, restrict our operations and require expenditures that could have a material adverse effect on our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our third-party manufacturers and suppliers are, and could become, subject to a wide range of international, federal, state, provincial, and local governmental regulations directed at preventing or mitigating environmental harm, as well as to the storage, discharge, handling, generation, disposal and labeling of toxic or other hazardous substances. Although we outsource our manufacturing, the manufacturing of our products by our third-party manufacturers and suppliers require the use of hazardous materials that similarly subject these third parties, and therefore our business, to such environmental laws and regulations. Our failure or the failure of these third parties to comply with these laws or regulations can result in regulatory, civil, or criminal penalties, fines, and legal liabilities, suspension of production, alteration of manufacturing processes, including for our products, reputational damage, and negative impact on our operations or sales of our products and services. Failure to comply with environmental regulations could also subject us or our third-party manufacturing partners to property damage or personal injury claims. Compliance with current or future environmental laws and regulations could restrict our ability to expand our business or require us or our third-party manufacturing partners to incur other substantial expenses, which could harm our business. Increased compliance costs by our third-party manufacturing partners may also result in increased costs to our business. Our business and operations are also subject to health and safety laws and regulations adopted by government agencies such as the Occupational Safety and Health Administration (&#8220;OSHA&#8221;). Although we believe we are in material compliance with applicable law concerning matters relating to health, safety, and the environment, the risk of liability relating to these matters cannot be eliminated completely. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Becoming a Public Company </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have incurred, and will continue to incur, increased costs and became subject to additional regulations and requirements as a result of becoming a public company, which could have a material adverse effect on our business, financial condition, and results of operations, and make it more difficult to run our business or divert management&#8217;s attention from our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a public company, we are required to commit significant resources and management time and attention to the requirements of being a public company, which has caused, and will continue to cause, us to incur significant legal, accounting and other expenses that we did not incur as a private company, including costs associated with public company reporting requirements. We also will incur costs associated with the Sarbanes-Oxley Act and related rules implemented by the SEC and Nasdaq, and compliance with these requirements will place significant demands on our legal, accounting and finance staff and on our accounting, financial and information systems. In addition, we might not be successful in implementing these requirements. The expenses incurred by public companies generally for reporting and corporate governance purposes have been increasing. We expect these rules and regulations to increase our legal and financial compliance costs and to make some activities more time consuming and costly, although we are currently unable to estimate these costs with any degree of certainty. These laws and regulations also could make it more difficult or costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. These laws and regulations could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees, or as our executive officers. Furthermore, if we are unable to satisfy our obligations as a public company, we could be subject to delisting of our common stock, fines, sanctions and other regulatory action and potentially civil litigation, any of which could have a material adverse effect on our business, financial condition, and results of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">60 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to hire additional accounting and finance personnel with system implementation experience and expertise regarding compliance with the Sarbanes-Oxley Act. We may be unable to locate and hire qualified professionals with requisite technical and public company experience when and as needed. In addition, new employees will require time and training to learn our business and operating processes and procedures. If we are unable to recruit and retain additional finance personnel or if our finance and accounting team is unable for any reason to respond adequately to the increased demands that will result from being a public company, the quality and timeliness of our financial reporting may suffer, which could result in the identification of material weaknesses in our internal controls. Any consequences resulting from inaccuracies or delays in our reported financial statements could cause our stock price to decline and could harm our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are an emerging growth company and a smaller reporting company, and any decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies and smaller reporting companies could make our common stock less attractive to investors. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and, for as long as we continue to be an emerging growth company, we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies but not to emerging growth companies, including: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section&#160;404 of the Sarbanes-Oxley Act; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reduced disclosure obligations regarding executive compensation in our periodic reports and annual report on Form <span style="white-space:nowrap">10-K;</span> and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">exemptions from the requirements of holding <span style="white-space:nowrap">non-binding</span> advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We could be an emerging growth company for up to five years following the completion of our initial public&#160;offering. Our status as an emerging growth company will end as soon as any of the following takes place: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the last day of the fiscal year in which we have more than $1.235&#160;billion in annual revenue (subject to adjustment for inflation from time to time, pursuant to SEC rules); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the date we qualify as a &#8220;large accelerated filer,&#8221; with at least $700.0&#160;million of equity securities held by <span style="white-space:nowrap">non-affiliates;</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the date on which we have issued, in any three-year period, more than $1.0&#160;billion in <span style="white-space:nowrap">non-convertible</span> debt securities; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the last day of the fiscal year ending after the fifth anniversary of the completion of our initial public offering. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently intend to take advantage of the available exemptions described above. We have taken advantage of reduced reporting burdens in this prospectus. In particular, we have not included all of the executive compensation information that would be required if we were not an emerging growth company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to avail ourselves of this provision of the JOBS Act. As a result, we will not be subject to new or revised accounting standards at the same time as other public companies that are not emerging growth companies. Therefore, our consolidated financial statements may not be comparable to those of companies that comply with new or revised accounting pronouncements as of public company effective dates. In addition, for as long as we are an &#8220;emerging growth company&#8221; under the JOBS Act, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section&#160;404 of the Sarbanes-Oxley </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">61 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Act. Even if our management concludes that our internal controls over financial reporting are effective, however, our independent registered public accounting firm may still issue a report that is qualified if it is not satisfied with our controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company,&#8221; which would allow us to take advantage of many of the same exemptions from disclosure requirements including exemption from compliance with the auditor attestation requirements of Section&#160;404 and reduced disclosure obligations regarding executive compensation in this prospectus and our periodic reports and proxy statements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot predict if investors will find our common stock less attractive if we choose to rely on any of the exemptions afforded emerging growth companies or smaller reporting companies. If some investors find our common stock less attractive because we rely on any of these exemptions, there may be a less active trading market for our common stock and the market price of our common stock may be more volatile. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our management team has limited experience managing a public company. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Most members of our management team have limited experience managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently manage our transition to being a public company subject to significant regulatory oversight and reporting obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents require significant attention from our senior management and could divert their attention away from the <span style="white-space:nowrap"><span style="white-space:nowrap">day-to-day</span></span> management of our business, which could adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Our Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">An active trading market for our common stock may not develop or be sustained and stockholders may not be able to sell their shares at or above the price paid for such shares, or at all. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There was no public market for our common stock prior to our initial public offering. Although our common stock is currently listed on Nasdaq, an active market in our common stock may not develop or, if it does develop, it may not be sustainable or liquid enough for stockholders to sell their shares at or above the purchase price paid for such shares, or at all. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our share price and trading volume have been, and are likely to continue to be, volatile and an active trading market for our common stock may not develop or be sustained and stockholders may not be able to sell their shares at or above the price paid for such shares, or at all. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although our common stock is currently listed on Nasdaq, an active market in our common stock may not develop or, if it does develop, it may not be sustainable or liquid enough for stockholders to sell their shares at or above the purchase price paid for such shares, or at all. Our common stock is currently trading well below the initial public offering price per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The trading price and volume of our common stock has been, and will likely continue to be, volatile and has fluctuated, and will likely continue to fluctuate, significantly in response to numerous factors, many of which are beyond our control, including but not limited to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">actual or anticipated fluctuations in our results of operations and financial and <span style="white-space:nowrap">non-financial</span> metrics due to, among other things, changes in customer demand, product life cycles, pricing, ordering patterns, and unforeseen operating costs; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">62 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the financial projections we may provide to the public, any changes in these projections, our practice of providing projections, if any, or our failure to meet these projections; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to raise additional capital sufficient to fund our operations and to execute our growth strategy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">failure of securities analysts to initiate or maintain coverage of us, changes in financial estimates or ratings by any securities analysts who follow us, or our failure to meet these estimates or the expectations of investors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">announcements related to key management, founders, key management, directors, or key investors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">announcements by us of changes to our product offerings, business plans, or strategies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">announcements by us or our competitors of significant technical innovations, acquisitions, strategic partnerships, joint ventures, or capital commitments; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in operating performance and stock market valuations of companies in our industry or our target markets; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">negative publicity related to problems in our manufacturing or the real or perceived quality of our products, as well as the failure to timely launch new products or services that gain market acceptance; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">rumors and market speculation involving us or other companies in our industry; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">developments or disputes concerning our or other parties&#8217; products, services, or intellectual property rights; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">timing and seasonality of the <span style="white-space:nowrap">end-market</span> demand; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">cyclical fluctuations, trends, and changes in the economic conditions in our industry or target markets; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">price and volume fluctuations in the overall stock market from time to time, including as a result of trends in the economy as a whole; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">actual or anticipated developments in our business or our competitors&#8217; businesses or the competitive landscape generally; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">new laws or regulations or new interpretations of existing laws, or regulations applicable to our business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in our management; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">lawsuits or investigations threatened, filed, or initiated against us; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the expiration of contractual <span style="white-space:nowrap">lock-up</span> or market standoff agreements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">sales of shares of our common stock by us or our stockholders, or the perception that such sales may occur; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">other events or factors, including those resulting from macroeconomic conditions, geopolitical crises, outbreak of hostilities or acts of war such as the Russian invasion of Ukraine, and the Israel-Hamas war, incidents of terrorism, global pandemics such as the <span style="white-space:nowrap">COVID-19</span> pandemic, and similar events, as well as responses to these or similar events. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stock markets in general have experienced extreme price and volume fluctuations. Stock prices of many companies, including companies in the fitness and wellness industry, have fluctuated in a manner unrelated or disproportionate to the operating performance of those companies. In the past, stockholders have instituted securities class action litigation following periods of market volatility. If we were to become involved in </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">63 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities litigation, it could subject us to substantial costs, divert resources and the attention of management from our business and adversely affect our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, because of these fluctuations, comparing our results of operations on a <span style="white-space:nowrap"><span style="white-space:nowrap">period-to-period</span></span> basis may not be meaningful. You should not rely on our past results as an indication of our future performance. This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our net revenue or results of operations fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a share price decline could occur even when we have met any previously publicly stated net revenue or earnings forecasts that we may provide. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Certain recent initial public offerings of companies, including those with relatively smaller public floats comparable to the anticipated public float of Forme, have experienced extreme, rapid, and substantial stock price volatility that was seemingly unrelated to the underlying performance of the respective company. We may experience similar volatility, which may make it difficult for prospective investors to assess the value of our common stock. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock has been, and may continue to be, subject to extreme, rapid, and substantial volatility that may or may not be related to the underlying performance of our business. Recently, companies with comparable public floats and initial public offering sizes have experienced instances of extreme stock price <span style="white-space:nowrap">run-ups</span> followed by rapid price declines, and such stock price volatility was seemingly unrelated to the respective company&#8217;s underlying performance. Although the specific cause of such volatility is unclear, our limited public float may amplify the impact of the actions taken by a few stockholders on the price of our common stock, which may cause our stock price to deviate, potentially significantly, from a price that more appropriately reflects the underlying performance of our business. In addition, our limited operating history and the ownership concentration among our directors, officers, and stockholders owning 5% or more of common stock may exacerbate the risk of stock price volatility with respect to our offering. Should our common stock experience <span style="white-space:nowrap">run-ups</span> and declines that are seemingly unrelated to our actual or expected operating performance and financial condition or prospects, prospective investors may have difficulty assessing the rapidly changing value of our common stock. In addition, our common stock is currently trading well below our initial public offering price per share. Investors in our common stock may experience losses, which may be material. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our focus on delivering a high-quality and engaging member experience may not maximize short-term financial results, which may yield results that conflict with the market&#8217;s expectations and could result in our stock price being negatively affected. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We focus on driving long-term member engagement through innovation, frictionless, cost-effective and immersive programs, classes and content, technologically advanced and customizable connected fitness hardware products, and community support, which may not necessarily maximize short-term financial results. We may make business decisions that may reduce our short-term financial results if we believe that the decisions are consistent with our goals to improve the member experience, which we believe will improve our financial results over the long term. For example, our decision to use real, human trainers to deliver our coaching offering may increase operating expenses, but we believe these decisions will drive higher member satisfaction, retention, profit, and ultimately lifetime value. These decisions may not be consistent with the short-term expectations of our stockholders and may not produce the long-term benefits that we expect, in which case our membership growth and member engagement, business, financial condition, and results of operations could be harmed. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">64 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we fail to meet the continued listing requirements of Nasdaq, it could result in a delisting of our common stock. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is currently listed on Nasdaq under the symbol &#8220;TRNR.&#8221; As previously disclosed, on August&#160;22, 2023, we received written notification from Nasdaq that our stockholders&#8217; equity as reported in our Form <span style="white-space:nowrap">10-Q</span> for the period ended June&#160;30, 2023 did not satisfy the continued listing requirement under Nasdaq Listing Rule 5450(b)(1)(A) for the Nasdaq Global Market. In accordance with the Nasdaq Listing Rules, we submitted a plan to regain compliance and subsequently received an extension from Nasdaq to evidence compliance on or before February&#160;19, 2024. Our common stock will continue to be listed on Nasdaq under the symbol &#8220;TRNR&#8221; during this period while we work to regain compliance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There can be no assurance that we will be able to satisfy Nasdaq&#8217;s continued listing requirements, regain compliance with the minimum stockholders&#8217; equity requirement, or maintain compliance with the other listing requirements. If we fail to regain compliance with, or if we otherwise fail to satisfy, the continued listing requirements of Nasdaq, such as the corporate governance requirements or the minimum closing bid price requirement, Nasdaq may take steps to <span style="white-space:nowrap">de-list</span> our common stock. Such a delisting would likely have a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a <span style="white-space:nowrap">de-listing,</span> we would take actions to restore our compliance with Nasdaq&#8217;s listing requirements, but we can provide no assurance that any such action taken by us would allow our common stock to become listed again, stabilize the market price or improve the liquidity of our common stock, prevent our common stock from dropping below the Nasdaq minimum bid price requirement or prevent future <span style="white-space:nowrap">non-compliance</span> with Nasdaq&#8217;s listing requirements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If our shares are delisted from Nasdaq and become subject to the penny stock rules, it would become more difficult to trade our shares. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. The price of our common stock has been volatile and has declined significantly since our initial public offering and has traded at prices as high as $8.50 per share to as low as $0.84 per share. If we do retain a listing on Nasdaq and if the price of our common stock is less than $5.00, our common stock will be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive (i)&#160;the purchaser&#8217;s written acknowledgment of the receipt of a risk disclosure statement; (ii)&#160;a written agreement to transactions involving penny stocks; and (iii)&#160;a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our common stock, and therefore stockholders may have difficulty selling their shares. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Substantial future sales of our common stock could cause the market price of our common stock to decline. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The market price of our common stock could decline as a result of substantial sales of our common stock, particularly sales by our directors, executive officers and significant stockholders, a large number of our common stock becoming available for sale, or the perception in the market that holders of a large number of shares intend to sell their shares. All of the common stock sold in our initial public offering, as well as the shares registered for resale under the registration statement filed in connection with our initial public offering, are freely transferable without restriction or additional registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), subject to restrictions applicable to shares held by affiliates. Subject to the restrictions under Rule 144 and 701 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">65 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the Securities Act, common stock outstanding after our initial public offering will be eligible for resale upon the expiration of <span style="white-space:nowrap">lock-up</span> agreements or other contractual restrictions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, all of our directors and executive officers, and the holders of a majority of our common stock and securities exercisable for or convertible into our common stock outstanding immediately prior to the closing of our initial public offering, including holders of ten percent (10%) or more of such securities, have agreed with the underwriter, subject to certain exceptions, not to offer for sale, sell, pledge, lend, or otherwise dispose of, or hedge, any common stock or securities convertible into or exchangeable for common stock during the period from the date of the prospectus related to our initial public offering continuing through 540 days after the date of the prospectus related to our initial public offering (the &#8220;Restricted Period&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of these contractual <span style="white-space:nowrap">lock-up</span> agreements and the provisions of Rules 144 and 701 under the Securities Act, these shares of common stock will be available for sale in the public market beginning 540 days after the date of the prospectus related to our initial public offering, subject in some cases to restrictions in award agreements and contractual obligations with us or the volume and other restrictions of Rule 144. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Aegis Capital Corp., the underwriter in our initial public offering, may in its sole discretion release some or all of the shares subject to the <span style="white-space:nowrap">lock-up</span> agreements prior to the expiration of the Restricted Period, subject to applicable notice requirements and in some cases without public notice. As these resale restrictions end, the market price of our common stock could decline if the holders of those shares sell them or are perceived by the market as intending to sell them. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, subject to the <span style="white-space:nowrap">lock-up</span> agreements described above, certain shares of our common stock are also entitled to demand and &#8220;piggyback&#8221; registration rights. We also intend to register shares of common stock that we may issue under our employee equity incentive plans. As a result, such shares, if and when registered (and subject to restrictions applicable to shares held by affiliates and existing market <span style="white-space:nowrap">stand-off</span> or <span style="white-space:nowrap">lock-up</span> agreements), will be able to be sold freely in the public market upon issuance, which in turn could negatively affect our stock price. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2023, we entered into the Asset Purchase Agreement, pursuant to which we will assume additional indebtedness and issue additional equity consideration. Further, in December 2023, we entered into the 3i Note Transaction pursuant to which we may issue up to 12,480,480 shares of common stock upon the conversion and exercise in full of the Note and Warrant, as applicable, and the Equity Line Financing, pursuant to which we may sell up to $20.0&#160;million in aggregate of newly issued common stock, in each case subject to certain beneficial ownership limitations and share issuance caps in compliance with Nasdaq listing rules and in accordance with their respective resale registration rights agreements. To the extent we issue additional equity for the CLMBR Acquisition or if we sell shares under the Equity Line Financing, there will be further dilution, including significant dilution, to existing stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If securities analysts or industry analysts downgrade our common stock, publish negative research or reports, or fail to publish reports about our business, our ordinary share price and trading volume could decline. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The market price and trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us, our business and our market. If one or more analysts adversely change their recommendation regarding our shares or change their recommendation about our competitors&#8217; shares, our share price would likely decline. If one or more analysts cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets which in turn could cause our share price or trading volume to decline. In addition, if our results of operations fail to meet the expectations created by securities analysts&#8217; reports, our share price could decline. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">66 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our actual results of operations may not meet our guidance and investor expectations, which would likely cause our share price to decline. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, we may release guidance in our earnings releases, earnings conference calls, or otherwise, regarding our future performance that represent our management&#8217;s estimates as of the date of release. If given, this guidance, which will include forward-looking statements, will be based on projections prepared by our management. Projections are based upon a number of assumptions and estimates that, while presented with numerical specificity, are inherently subject to significant business, economic, and competitive uncertainties and contingencies, many of which are beyond our control. The principal reason that we expect to release guidance is to provide a basis for our management to discuss our business outlook with analysts and investors. With or without our guidance, analysts and investors may publish expectations regarding our business, financial condition, and results of operations. We do not accept any responsibility for any projections or reports published by any such third parties. Guidance is necessarily speculative in nature, and it can be expected that some or all of the assumptions of the guidance furnished by us will not materialize or will vary significantly from actual results. If our actual performance does not meet or exceed our guidance or investor expectations, the trading price of our common stock is likely to decline. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We do not expect to declare or pay any dividends on our common stock for the foreseeable future. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not intend to pay cash dividends on our common stock for the foreseeable future. Consequently, investors must rely on sales of their shares after price appreciation, which may never occur, as the only way to realize any future gains on their investment. Investors seeking dividends should not purchase our common stock. If we issue shares of Series A convertible preferred stock, it is expected that such shares of Series A convertible preferred stock would be entitled to dividends which would be accrued as set forth in the certificate of designations for the Series A convertible preferred stock. See <span style="font-style:italic">&#8220;Description of Capital Stock</span>.&#8221; Any future determination to pay dividends will be at the discretion of our board of directors and subject to, among other things, our compliance with applicable law, and depending on, among other things, our business prospects, financial condition, results of operations, cash requirements and availability, capital expenditure needs, the terms of any preference equity securities we may issue in the future, covenants in the agreements governing any current or future indebtedness, other contractual restrictions, industry trends, and any other factors or considerations our board of directors may regard as relevant. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Certain provisions in our charter documents and under Delaware law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current management, and limit the market price of our common stock. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Provisions in our certificate of incorporation and bylaws may have the effect of delaying or preventing a change of control or changes in our management. Our amended and restated certificate of incorporation and bylaws include provisions that: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">authorize our board of directors to issue, without further action by the stockholders, shares of undesignated preferred stock with terms, rights, and preferences determined by our board of directors that may be senior to our common stock, which could be used by our board of directors to implement a stockholder rights plan; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">specify that special meetings of our stockholders can be called only by our board of directors, the Chairperson of our board of directors (&#8220;Chairperson&#8221;), or our Chief Executive Officer and eliminating the ability of our stockholders to call special meetings of stockholders; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">establish an advance notice procedure for stockholder proposals to be brought before an annual meeting, including proposed nominations of persons for election to our board of directors; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">67 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">establish that our board of directors is divided into three classes, with each class serving three-year staggered terms; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">prohibit cumulative voting in the election of directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that our directors may be removed &#8220;for cause&#8221; and only with the approval of at least 66 2/3% of our stockholders; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that vacancies on our board of directors may be filled by a majority of directors then in office, even if less than a quorum; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">permit our board of directors to establish the number of directors and fill any vacancies and newly created directorships; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that our board of directors is expressly authorized to make, alter, or repeal our bylaws; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">require the approval of our board of directors or the holders of at least 66 2/3% of our outstanding shares of capital stock to amend our bylaws and certain provisions of our certificate of incorporation. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&#160;203 of the Delaware General Corporation Law, which generally prohibits a Delaware corporation from engaging in a broad range of business combinations with any interested stockholder for a period of three years following the date on which such stockholder became an interested stockholder. See <span style="font-style:italic">&#8220;Description of Capital Stock &#8211; Certain Provisions of Our Certificate of Incorporation, Our Bylaws, and Delaware Law.&#8221;</span> Any delay or prevention of a change of control transaction or changes in our management could cause our stock price to decline or could prevent or deter a transaction that you might support. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our amended and restated certificate of incorporation and amended and restated bylaws designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, and provides that federal district courts will be the sole and exclusive forum for Securities Act claims, which could limit our stockholders&#8217; ability to obtain what they believe to be a favorable judicial forum for disputes with us or our directors, officers, or other employees. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the Court of Chancery of the State of Delaware (or, if that court lacks subject matter jurisdiction, another federal or state court situated in the State of Delaware) shall be the sole and exclusive forum for (a)&#160;any derivative action or proceeding brought on our behalf, (b)&#160;any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, or other employees to us or our stockholders, (c)&#160;any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation or our bylaws, or (d)&#160;any action asserting a claim against us governed by the internal affairs doctrine (collectively, the &#8220;Delaware Forum Provision&#8221;). Our amended and restated certificate of incorporation and our amended and restated bylaws further provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts are the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act (the &#8220;Federal Forum Provision&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. As a result, the enforceability of this provision is uncertain, and a court may determine that such provision will not apply to suits brought to enforce any duty or liability created by the Securities Act or any other claim for which the federal and state courts have concurrent jurisdiction. Further, compliance with the federal securities laws and the rules and regulations thereunder cannot be waived by investors in our common stock. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">68 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Accordingly, the Delaware Forum Provision does not designate the Court of Chancery as the exclusive forum for any derivative action arising under the Exchange Act, as there is exclusive federal jurisdiction in such instances. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or otherwise acquiring any interest in our capital stock shall be deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision of our bylaws described above. These choice of forum provisions may impose additional litigation costs on stockholders in pursuing any such claims. Additionally, these choice of forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage such lawsuits against us and our directors, officers, or other employees. Alternatively, if a court were to find these provisions of our bylaws inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business, financial condition, and results of operations and result in a diversion of the time and resources of our management and board of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court are &#8220;facially valid&#8221; under Delaware law, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. If the Federal Forum Provision is found to be unenforceable, we may incur additional costs associated with resolving such matters. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid. The Court of Chancery of the State of Delaware and the federal district courts of the United States may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to This Offering </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The selling stockholder may choose to sell the shares at prices below the current market price. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholder is not restricted as to the prices at which it may sell or otherwise dispose of the Shares covered by this prospectus. Sales or other dispositions of the Shares below the then-current market prices could adversely affect the market price of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Neither we nor the selling stockholder has authorized any other party to provide you with information concerning us or this offering. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should carefully evaluate all of the information in this prospectus. We may receive media coverage regarding us, including coverage that is not directly attributable to statements made by our officers, that incorrectly reports on statements made by our officers or employees, or that is misleading as a result of omitting information provided by us, our officers or employees. Neither we nor the selling stockholder has authorized any other party to provide you with information concerning us or this offering, and recipients should not rely on this information. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We will have broad discretion as to the proceeds that we received from the Note and that we may receive from the cash exercise of the Warrant, and we may not use the proceeds effectively. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will not receive any of the proceeds from the resale of the Shares by the selling stockholder pursuant to this prospectus. We received approximately $2.0&#160;million in connection with the issuance of the Note, and we may </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">69 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
receive up to approximately $1.2&#160;million in aggregate gross proceeds from cash exercises of the Warrant. To the extent that we receive such proceeds, subject to any obligation to pay a portion of such proceeds to repay any amounts outstanding under the Note, we intend to use the net proceeds from cash exercises of the Warrant, as well as the proceeds from the Note, for working capital and general corporate purposes. Our management will have broad discretion in the application of such proceeds, including for any of the purposes described in <span style="font-style:italic">&#8220;Use of Proceeds,&#8221;</span> and we could spend the proceeds from the sale of Warrant Shares in ways our stockholders may not agree with or that do not yield a favorable return, if at all. You will not have the opportunity, as part of your investment decision, to assess whether such proceeds are being used in a manner agreeable to you. You will be relying on the judgment of our management concerning these uses and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. The failure of our management to apply these funds effectively could result in unfavorable returns and uncertainty about our prospects, each of which could cause the price of our common stock to decline. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">You may experience future dilution as a result of issuance of the Shares, future equity offerings by us and other issuances of our common stock or other securities. In addition, the issuance of the Shares and future equity offerings and other issuances of our common stock or other securities may adversely affect our common stock price. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Shares sold in the offering will be freely tradable without restriction or further registration under the Securities Act. As a result, a substantial number of shares of our common stock may be sold in the public market following this offering. If there are significantly more shares of our common stock offered for sale than buyers are willing to purchase, then the market price of our common stock may decline to a market price at which buyers are willing to purchase the offered common stock and sellers remain willing to sell our common stock. The issuance of the Shares or any future sales of a substantial number of shares of our common stock in the public market, or the perception that such sales may occur, could also adversely affect the price of our common stock. We cannot predict the effect, if any, that market sales of those shares of common stock or the availability of those shares for sale will have on the market price of our common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in order to raise additional capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock at prices that may not be the same as the price per share as prior issuances of common stock. We may not be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price per share previously paid by investors, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional shares of our common stock or securities convertible into common stock in future transactions may be higher or lower than the prices per share per share. In addition, the exercise price of the Warrant for the Warrant Shares may be or greater than the price per share previously paid by certain investors. You will incur dilution upon exercise of any outstanding stock options, warrants or upon the issuance of shares of common stock under our stock incentive programs. In addition, the issuance of the Shares and any future sales of a substantial number of shares of our common stock in the public market, or the perception that such sales may occur, could adversely affect the price of our common stock. We cannot predict the effect, if any, that market sales of those shares of common stock or the availability of those shares for sale will have on the market price of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">General Risk Factors </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We face risks related to recession, inflation, weak growth, and other economic conditions. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Customer demand for our products may be impacted by weak economic conditions, inflation, weak growth, recession, equity market volatility, or other negative economic factors in the United States or other nations. For example, under these conditions, potential customers may delay or cancel purchases of our products. Further, in the event of a recession our manufacturing partners, suppliers, and other third-party partners, as well as our commercial and corporate wellness customers, may suffer their own financial and economic challenges and as a </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">70 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
result they may demand pricing accommodations, delay payment, or become insolvent, which could harm our ability to meet our customer demands or collect revenue or otherwise could harm our business, financial condition, and results of operations. Similarly, disruptions in financial and credit markets may impact our ability to manage normal commercial relationships with our customers, suppliers, and lenders and might cause us to not be able to access sources of liquidity, and our borrowing costs could increase. If general macroeconomic conditions deteriorate, our business, financial condition, and results of operations could be materially and adversely affected. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we are also subject to risk from inflation and increasing market prices of certain components, parts, supplies, and commodity raw materials, which are incorporated into our products or used by our suppliers to manufacture our products. These components, parts, supplies, and commodities may from time to time become restricted, or general market factors and conditions may affect pricing of such components, parts, supplies and commodities, such as inflation or supply chain constraints. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The ongoing inflationary pressures in the United States could increase our operating costs as well as our manufacturing and component costs, among others, which in turn could negatively affect our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The United States has recently experienced high levels of inflation. If the inflation rate continues to increase, it will likely affect our expenses, including, but not limited to, employee compensation expenses, increased manufacturing and supplier costs, and increasing market prices of certain components, parts, supplies, and commodity raw materials, which are incorporated into our products or used by our suppliers to manufacture our products. As a result of inflationary pressures, we have experienced general price increases in the cost of components and parts used in our products and in our manufacturing and logistical costs, which in turn has increased our overall operating costs. We have not taken any specific measures to mitigate inflationary pressures to date; however, we may in the future consider or implement such measures, including price increases for our products and services, changes to our pricing model, or reducing other operating and personnel costs. We cannot predict the impact of any actions we may take in response to such pressures on our business, financial condition, and results of operations. Any attempts to offset cost increases with price increases may result in reduced sales, increased customer dissatisfaction, or otherwise harm our reputation. Moreover, to the extent inflation results in rising interest rates, reduces discretionary spending, and has other adverse effects on the market, it may adversely affect our business, financial condition and results of operations. Given our limited operating history, we cannot predict how ongoing recessionary or inflationary pressures may impact our business, financial condition, and results of operations in the future, including with respect to our manufacturing and logistics costs, our pricing models, and our customers&#8217; ability to obtain financing for the purchase of our products. If our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition, and operating results. See <span style="font-style:italic">&#8220;&#8211; Risks Related to Suppliers, Manufacturers, and Other Ecosystem Partners &#8211; Our manufacturing partners and our sole supplier are located in Taiwan, which exposes us to various risks, including due to tensions between Taiwan and mainland China.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">An economic downturn or economic uncertainty may adversely affect consumer discretionary spending and demand for our products and services. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our products and services may be considered discretionary items for consumers. Factors affecting the level of consumer spending for such discretionary items include general economic conditions, including inflation, and other factors, such as consumer confidence in future economic conditions, fears of recession, the availability and cost of consumer credit, levels of unemployment, and tax rates. In recent years, the United States and other significant economic markets have experienced cyclical downturns and worldwide economic conditions remain uncertain. As global economic conditions continue to be volatile or economic uncertainty remains, including due to the <span style="white-space:nowrap">COVID-19</span> pandemic, trends in consumer discretionary spending also remain unpredictable and subject to reductions and fluctuations. Due in part to our limited operating history, we cannot predict the extent to which we </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">71 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may be affected by recessionary conditions. Unfavorable economic conditions may lead consumers to delay or reduce purchases of our products and services and consumer demand for our products and services may not grow as we expect. As we have a very limited history selling our connected fitness hardware products, we do not have sufficient basis with which to assess the impact of the current uncertain economic conditions on the sales of our products and services. However, we expect that ongoing economic uncertainty may result in reduced consumer demand for our connected fitness products and services in the future. Our sensitivity to economic cycles and any related fluctuation in consumer demand for our products and services could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or <span style="white-space:nowrap">non-performance</span> by financial institutions, could adversely affect our business, financial condition or results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Events involving limited liquidity, defaults, <span style="white-space:nowrap">non-performance</span> or other adverse developments that affect financial institutions or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, could adversely affect our liquidity. The failure of financial institutions may increase the possibility of a sustained deterioration of financial market liquidity, or illiquidity at clearing, cash management and/or custodial financial institutions. The distress or failure of one or more banks with which we have a commercial relationship could adversely affect, among other things, our ability to pursue key strategic initiatives, our ability to access funds, or our ability to borrow from financial institutions on favorable terms. In addition, our deposits will be at risk to the extent they exceed available FDIC insurance limits. If a bank with which we have a commercial relationship has failed or is otherwise distressed (including for example, as a result of large scale depositor withdrawals), or if market activity leads to threat of distress resulting in regulator control, the loss or restriction of access to our cash and liquidity resources could, among other things, adversely impact our ability to meet our operating expenses and financial obligations, or fulfill other obligations, and result in breaches of our contractual obligations or violations of federal or state wage and hour laws. Our ability to spread banking relationships among multiple institutions may be limited by practical considerations or our lender&#8217;s suitability requirements for deposit and custodial account institutions. Any of these effects could have a material adverse effect on our financial condition and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Increasing scrutiny and evolving expectations from customers, partners, regulators, investors, and other stakeholders with respect to our environmental, social and governance practices may impose additional costs on us, expose us to new or additional risks, or harm our reputation. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Companies are facing increasing scrutiny from customers, partners, regulators, investors, and other stakeholders related to their environmental, social, and governance (&#8220;ESG&#8221;) practices and disclosure. Investor advocacy groups, investment funds, and influential investors are also increasingly focused on these practices, especially as they relate to the environment, health and safety, diversity, labor conditions, and human rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For example, an increasing number of investors are also requiring companies to disclose corporate social and environmental policies, practices, and metrics. Legal and regulatory requirements, as well as investor expectations, on corporate social responsibility practices and disclosure, are subject to change, can be unpredictable, and may be difficult and expensive for us to comply with, given the complexity of our supply chain and our significant outsourced manufacturing. Increased ESG related compliance costs could result in increases to our overall operational costs. If we are unable to adapt to or comply, or are unable to cause our suppliers to comply, with such regulatory requirements, policies, or provisions or meet the expectations or standards of our customers, investors, and other stakeholders, a customer may stop purchasing products from us or an investor may sell their shares or take legal action against us, our reputation may suffer, and the price of our common stock may decline. Any of the foregoing could harm our reputation, revenue, business, financial condition, and results of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">72 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, our current ESG disclosures, and any standards we may set for ourselves or a failure to meet these standards, may influence our reputation and the value of our brand. For example, we have elected to share publicly certain information about our ESG initiatives and information, and our commitment to the recruitment, engagement, and retention of a diverse workforce. Our business may face increased scrutiny related to these activities, including from the investment community, and our failure to achieve progress in these areas on a timely basis, or at all, could adversely affect our reputation, business, and financial performance. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Climate change may have an adverse impact on our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Risks related to rapid climate change may have an increasingly adverse impact on our business in the longer term. Any of our primary locations and the locations of our members and third-party partners, such as our manufacturing partners, may be vulnerable to the adverse effects of climate change. For example, our California locations have historically experienced, and are projected to continue to experience, climate-related events at an increasing frequency, including drought, water scarcity, heat waves, wildfires and resultant air quality impacts, and power shutoffs associated with wildfire prevention. Furthermore, it is more difficult to mitigate the impact of these events on our employees while they work from home as a result of the <span style="white-space:nowrap">COVID-19</span> pandemic. In addition, some of our employees and our manufacturing partners are located in Taiwan, which is susceptible to regional natural disasters including, for example, earthquakes, tsunamis, and typhoons, and has experienced an increasing frequency of extreme weather events, including heavier rains and atypical heat waves. Changing market dynamics, global policy developments, and the increasing frequency and impact of extreme weather events on critical infrastructure in the U.S. and elsewhere have the potential to disrupt our business and the business of our members and third-party partners, and may cause us to experience higher attrition, losses and additional costs to maintain our operations. Further, the effects of climate change may negatively impact regional and local economic activity, which could lead to an adverse effect on our members and third-party partners and impact the communities in which we operate. Overall, climate change, its effects, and the resulting, unknown impact could have a material adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we acquire businesses, enter into licensing arrangements, or make investments in other companies or technologies, it may disrupt our business, create integration issues, impair our results of operations, dilute our stockholders&#8217; ownership, cause us to incur debt, divert management resources, or cause us to incur significant expense </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may pursue in the future acquisitions of businesses and assets, as well as technology licensing arrangements, that we believe will complement our products or technologies. For example, in October 2023, we entered into the Asset Purchase Agreement to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. See Note 20 to the notes to our unaudited condensed consolidated financial statements included elsewhere in this prospectus. We also may make investments in other companies or pursue strategic alliances that leverage our core technologies and industry experience to expand our product offerings or distribution. Any acquisition involves a number of risks, many of which could harm our business, or materially impact our stock price, including: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulty in integrating the operations, technologies, products, existing contracts, accounting and personnel of the acquired company or business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">not realizing the anticipated benefits of any acquisition; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulty in transitioning and supporting customers of the acquired company; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulty in transitioning and collaborating with suppliers of the acquired company; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">diversion of financial and management resources from existing operations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the risk that the price we pay, costs we incur, or other resources that we devote to the acquisition may exceed the value we realize, or the value we could have realized if we had allocated the purchase price or other resources to another opportunity; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">73 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">unanticipated costs and expenses or accounting impacts of an acquisition, licensing arrangement, or other strategic investments; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">potential loss of key employees, customers and strategic alliances from either our current business or the acquired company&#8217;s business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">inability to successfully bring newly acquired products to market or achieve design wins with such products; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">fluctuations in industry trends that change the demand or purchasing volume of newly acquired products; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">assumption of unanticipated problems or latent liabilities, such as problems with the quality of the acquired products or technology; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">inability to generate sufficient revenue to offset acquisition costs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">market or investor reaction to, or perception of, the anticipated benefits, costs, or other consequences of any proposed or consummated acquisition; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the incurrence of significant costs and diversion of management resources in connection with any potential acquisition, irrespective of whether an acquisition is successfully completed; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the dilutive effect on our common stock as a result of any acquisitions financed through the issuance of equity; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">inability to successfully complete transactions with a suitable acquisition candidate; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in the event of international acquisitions, risks associated with accounting and business practices or regulatory requirements that are different from applicable U.S. practices and requirements. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acquisitions also frequently result in the recording of goodwill and other intangible assets that are subject to potential impairments, which could harm our financial results. If we fail to properly evaluate acquisitions or investments, it may impair our ability to achieve the anticipated benefits of any such acquisitions or investments, and we may incur costs in excess of what we anticipate. The failure to successfully evaluate and execute acquisitions or investments or otherwise adequately address these risks could materially harm our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To finance any acquisitions or investments, we may choose to issue equity or equity-linked securities as consideration, which could dilute the ownership of our stockholders, including materially. If the price of our common stock is low or volatile, we may not be able to acquire other companies for equity or equity-linked consideration. In addition, newly issued securities may have rights, preferences or privileges senior to those of existing stockholders. If we raise additional funds by obtaining loans from third parties, the terms of those financing arrangements may include negative covenants or other restrictions on our business that could impair our operating flexibility, and would also require us to incur interest expense. Additional funds for acquisitions also may not be available on terms that are favorable to us, or at all. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We depend on our executive officers and other key employees, and the loss of one or more of these employees or an inability to attract or retain highly skilled employees could adversely affect our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our success depends largely upon the continued services of our executive officers and other officers and key personnel, including Trent A. Ward, our <span style="white-space:nowrap">co-founder</span> and Chief Executive Officer, who are critical to the development of our business, future vision, and strategic direction. Mr.&#160;Ward is our sole executive officer and is expected to continue to hold for the foreseeable future, primary and ultimate responsibility, authority, and operational decision-making functions over the principal operations, business units, and functions of the Company, including all significant policymaking authority. As a result, the loss of Mr.&#160;Ward&#8217;s services for any reason would likely materially and adversely affect or business. We also heavily rely on the continued service and performance of our senior management team, which provides leadership, contributes to the core areas of our </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">74 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business and helps us to efficiently execute our business. Also imperative to our success are our trainers and fitness instructors, who we rely on to bring new, engaging, and innovative fitness and wellness content to our platform, and who act as brand ambassadors. We also are dependent on the continued service of our existing software engineers because of the complexity of our products and platform capabilities. If the senior management team, including any new hires that we make, fails to work together effectively and to execute our plans and strategies on a timely basis then our business and future growth prospects could be harmed. From time to time, there may be changes in our executive management team or other key personnel, which could disrupt our business. We do not have employment agreements with our executive officers or other key personnel that require them to continue to work for us for any specified period and, therefore, they could terminate their employment with us at any time and with little or no notice. The loss of one or more of our executive officers or other key employees could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not entered into <span style="white-space:nowrap">non-competition</span> agreements with our executive officers and other officers and key personnel during the course of their employment with us. As a result, such personnel are not contractually prohibited from working with or for our competitors after leaving our employment or from engaging in other business endeavors which are, may be perceived as, or may become, competitive to our business. The loss of the services of our executive officers and other officers and key personnel to our competitors may harm our reputation, brand, our competitive position, and our business. Furthermore, members of our management team or other personnel may engage in other business endeavors in addition to and outside of their employment with us. As a result, although members of our management team are full-time employees of ours and have been, and are expected to be, fully committed and focused on our business, they are not obligated to commit their time and attention exclusively to our business. Accordingly, their attention to our business may be diverted from time to time or they may encounter conflicts of interest in allocating their time and resources between us and other business endeavors in which they are engaged. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, to execute our growth plan, we must attract and retain highly qualified personnel. Competition for these personnel in Southern California, where we have a retail store and where we produce much of our <span style="white-space:nowrap">On-Demand</span> content, and in other locations where we have a substantial presence, is intense, especially for qualified and highly skilled personnel, including senior management, engineers, producers, designers, product managers, logistics and supply chain personnel, retail managers, trainers, and fitness instructors. In addition, we have not historically conducted background checks on our employees or independent contractors. Although we conduct customary identity verification checks for employees and intend to implement additional background screening, and may conduct additional identify verification processes, for personnel generally as we deem necessary or appropriate, there can be no assurance that such processes will enable us to identify any potential risks or issues or otherwise be sufficient or accurate. The implementation of additional screening processes could make it more difficult for us to hire additional personnel. We have from time to time experienced, and we expect to continue to experience, difficulty in hiring and retaining employees with appropriate qualifications. Many of the companies with which we compete for experienced personnel have greater resources than we have. If we hire employees from competitors or other companies, their former employers may attempt to assert that these employees or we have breached legal obligations, resulting in a diversion of our time and resources. In addition, job candidates and existing employees often consider the value of the equity awards they receive in connection with their employment. If the perceived value of our equity awards declines, it may adversely affect our ability to recruit and retain highly skilled employees. In addition, we may periodically change our equity compensation practices, which may include reducing the number of employees eligible for equity awards or reducing the size of equity awards granted per employee. If we are unable to attract, integrate, or retain the qualified and highly skilled personnel required to fulfill our current or future needs, our business, financial condition, results of operations, and future growth prospects could be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our officers and directors may encounter conflicts of interest involving us and other entities with which they may be affiliated, including matters that involve corporate opportunities. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many of our directors are, and any future directors may be, affiliated with other entities, including venture capital or private equity funds or businesses that may be complementary, competitive, or potentially competitive to our </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">75 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
company. They may also in the future become affiliated with entities that are engaged in business or other activities similar to our business. Additionally, all of our officers and directors, in the course of their other business activities, may become aware of or involved in investments, business opportunities, or information which may be appropriate for presentation to us as well as to other entities to which they owe a fiduciary duty. As a result, directors and officers may encounter perceived or actual conflicts of interest involving us and other entities with which they are or become affiliated, including matters that involve corporate opportunities. For example, a portfolio company of a director-affiliated venture fund may become a competitor of ours or a potential strategic partner. In addition, in the event we consider potential acquisitions, it is possible an entity affiliated with one of our directors could be an acquisition target or a competitive acquiror. Further, to the extent we engage in transactions with any director-affiliated entity, it could create actual, or the perception of, additional conflicts of interest, including with respect to our ability to negotiate terms equivalent to those that could be obtained in an arms&#8217;-length negotiation with an unaffiliated third party. As a result of the foregoing, our directors and officers may have conflicts of interest in determining to which entity particular opportunities or information should be presented. If, as a result of such potential conflicts, we are deprived of investment, business, or information, the execution of our business plan and our ability to effectively compete may be adversely affected. Our directors are also not obligated to commit their time and attention exclusively to our business and accordingly, they may encounter conflicts of interest in allocating their time and resources between us and other entities with which they are affiliated. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce cash resources. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors and executive officers may be subject to litigation for a variety of claims or disputes. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for any breach of fiduciary duties as directors, except liability for: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any transaction from which the director derives an improper personal benefit; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any unlawful payment of dividends or redemption of shares; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any breach of a director&#8217;s duty of loyalty to the corporation or its stockholders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Such limitation of liability does not apply to liabilities arising under federal securities laws and does not affect the availability of equitable remedies such as injunctive relief or rescission. Our amended and restated bylaws will provide that we are required to indemnify our directors and officers to the fullest extent permitted by Delaware law and may indemnify our other employees and agents. Our amended and restated bylaws also provide that, on satisfaction of certain conditions, we will advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee, or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under the provisions of Delaware law. We have entered into, and intend to enter into, agreements to indemnify our directors and executive officers. With certain exceptions, these agreements provide for indemnification for related expenses, including attorneys&#8217; fees, judgments, fines, and settlement amounts incurred by any of these individuals in connection with any action, proceeding, or investigation. Such provisions in our amended and restated bylaws and our indemnification agreements may discourage stockholders from bringing a lawsuit against our directors and executive officers for breach of their fiduciary duties. Such provisions may also reduce the likelihood of derivative litigation against our directors and executive officers, even though an action, if successful, might benefit us and other stockholders. See <span style="font-style:italic">&#8220;Management &#8211; Indemnification and Insurance.&#8221;</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we maintain directors&#8217; and officers&#8217; liability insurance, such insurance may not be adequate to cover all liabilities that we may incur, which may reduce our available funds to satisfy third-party claims and could harm </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">76 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our business, results of operations, and financial condition. Further, a stockholder&#8217;s investment may be harmed to the extent that we pay the costs of settlement and damage awards against our directors and executive officers as required by these indemnification provisions.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Litigation and other legal proceedings may adversely affect our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time we may become involved in legal proceedings, claims, government investigations, and other proceedings relating to patent and other intellectual property matters, product liability, labor and employment, competition or antitrust, commercial, tort or contract, privacy, consumer protection, tax, federal regulatory investigations, securities (including class action litigation), and other legal proceedings or investigations, which could have an adverse impact on our business, financial condition, and results of operations and divert the attention of our management from the operation of our business. Litigation is inherently unpredictable and can result in excessive or unanticipated verdicts and/or injunctive relief that affect how we operate our business. We could incur judgments or enter into settlements of claims for monetary damages or for agreements to change the way we operate our business, or both. There may be an increase in the scope of these matters or there may be additional lawsuits, claims, proceedings or investigations in the future, which could have a material adverse effect on our business, financial condition, and results of operations. Adverse publicity about regulatory or legal action against us could damage our reputation and brand image, undermine our members&#8217; confidence and reduce long-term demand for our products, even if the regulatory or legal action is unfounded or not material to our operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The <span style="white-space:nowrap">COVID-19</span> pandemic has disrupted, and any future recurrence of the pandemic will likely disrupt, normal business activity and may adversely impact our business, financial condition, and results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The global spread of <span style="white-space:nowrap">COVID-19</span> and the efforts to control it disrupted, and reduced the efficiency of, normal business activities in much of the world. The pandemic has resulted in authorities around the world implementing numerous unprecedented measures such as travel restrictions, quarantines, shelter in place orders, and factory and office shutdowns. These measures have impacted, and will likely continue to impact, our workforce and operations, and those of our members, contract manufacturers, suppliers, and logistics providers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although transmission rates have declined generally, and the <span style="white-space:nowrap">roll-out</span> of vaccines and other therapeutic treatments have lessened the severity of the pandemic, uncertainty regarding the economic impact of any recurrence of the <span style="white-space:nowrap">COVID-19</span> pandemic could result in market turmoil and global economic disruption. In addition, although several vaccines have been introduced, distribution globally and within countries has been uneven and there remains uncertainty whether or how quickly they will impact the lifting or reimposition of governmental and social measures and the return of economic growth to <span style="white-space:nowrap">pre-pandemic</span> levels. We have experienced, and expect to continue to experience, some disruptions to parts of our supply chain, including procuring necessary components or parts, in a timely fashion, with suppliers increasing lead times or placing products on allocation and raising prices. In addition, disruptions to commercial transportation infrastructure have increased delivery times for materials and components or parts of our fitness equipment, and has impacted, and could in the future impact, our ability to timely deliver our products to customers. Further, if we were to elect to transition or add manufacturing or logistics providers or suppliers, it may result in temporary or additional delays in product delivery or risks related to consistent product quality or reliability. As a result of these supply chain disruptions, we may be required to increase customer order lead times and place some products on allocation. These factors may limit our ability to fulfill customer orders and we may be unable to satisfy all of the demand for our products. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in response to governmental directives and recommended safety measures, we modified our workplace practices globally, which has resulted in many of our employees working remotely for extended periods of time. Working remotely for extended periods may reduce our employees&#8217; efficiency and productivity, which may cause product development delays, hamper new product innovation and have other unforeseen adverse effects on our business. While we have implemented a <span style="white-space:nowrap">phased-in</span> return of employees to some of our </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">77 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
facilities, we may need to modify our business practices in a manner that may adversely impact our business. While we have implemented personal safety measures at all of our facilities where our employees are working onsite, any actions we take may not be sufficient to mitigate the risk of infection. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Continuation of governmental restrictions, continued spread of the virus (including the emergence of vaccine-resistant variants) or prolonged disruption in global markets may result in: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a global economic recession or depression that could significantly reduce demand and/or prices for our products; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reduced productivity in our product development, operations, marketing, sales, and other activities, and delays in the delivery of our products; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">disruptions to our supply chain; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increased costs resulting from individuals working from home or from our efforts to mitigate the impact of the <span style="white-space:nowrap">COVID-19</span> pandemic; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reduced access to financing to fund our operations due to a deterioration of credit and financial markets; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">higher rate of losses on our accounts receivables due to credit defaults. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The impact of the <span style="white-space:nowrap">COVID-19</span> pandemic continues to evolve and the duration of any recurrence of the pandemic and any resulting disruption to our business, the overall demand for our products and the related financial impact, as well as any similar disruptions that may result from any future pandemic, epidemic or other outbreak of infectious disease, will depend on future developments, which are highly uncertain and cannot be predicted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Catastrophic events may disrupt our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our manufacturing partners have operations located in areas that are in active earthquake zones or are subject to wildfires, floods, hurricanes, and other natural disasters. For example, we have a retail store and engage in content production activities in Southern California and our manufacturing partners are located in Taiwan. In addition, <span style="white-space:nowrap">man-made</span> actions or other events, such as power outages, acts of war, terrorism, or other outbreak of hostilities, malicious computer viruses, and pandemics or other widespread public health crises and disease outbreaks could cause disruptions in our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any such catastrophic event, we may be unable to continue our operations and may endure system interruptions, reputational harm, delays in our product development, breaches of data security or loss of critical data, any of which could have an adverse effect on our business, financial condition, and results of operations. For example, a significant natural disaster, such as an earthquake, fire, or flood, could have an adverse effect on our business, financial condition, and results of operations, and our insurance coverage may be insufficient to compensate us for losses that may occur. Acts of terrorism, which may be targeted at metropolitan areas that have higher population density than rural areas, could also cause disruptions in our or our suppliers&#8217; and manufacturers&#8217; businesses or the economy as a whole. We may not have sufficient protection or recovery plans in some circumstances, such as natural disasters affecting locations that store significant inventory of our products, which house our servers, or from which we generate content. As we rely heavily on our computer and communications systems, and the internet to conduct our business and provide high-quality customer service, these disruptions could negatively impact our ability to run our business and either directly or indirectly disrupt suppliers&#8217; and manufacturers&#8217; businesses, which could have an adverse effect on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Regulations related to conflict minerals may cause us to incur additional expenses and could limit the supply and increase the costs of certain metals used in the manufacturing of our products. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, which will require us to conduct due diligence on and disclose whether or not our products contain conflict </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">78 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
minerals. The implementation of these requirements could adversely affect the sourcing, availability, and pricing of the materials used in the manufacture of components or parts used in our products. In addition, we will incur additional costs to comply with the disclosure requirements, including costs related to conducting diligence procedures to determine the sources of minerals that may be used or necessary to the production of our products and, if applicable, potential changes to products, processes, or sources of supply as a consequence of such due diligence activities. It is also possible that we may face reputational harm if we determine that certain of our products contain minerals not determined to be conflict free or if we are unable to alter our products, processes, or sources of supply to avoid such materials. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">79 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_6">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and any prospectus supplement contain forward-looking statements that are subject to risks and uncertainties. All statements contained in this prospectus other than statements of historical fact, including statements regarding our future financial performance, our growth strategy, our objectives for future operations and industry trends, are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as &#8220;can,&#8221; &#8220;may,&#8221; &#8220;intend,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; the negative of these terms, and other comparable terminology that convey uncertainty of future events or outcomes. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business and in the industry in which we operate. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance, or achievements expressed or implied by the forward-looking statements, including those factors discussed under <span style="font-style:italic">&#8220;</span><span style="font-style:italic">Risk Factors.</span><span style="font-style:italic">&#8221;</span> Forward-looking statements include, but are not limited to, statements regarding: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our future financial performance, including our expectations regarding our revenue, cost of revenue, gross profit, operating expenses including changes in research and development, sales and marketing, and general and administrative expenses (including any components of the foregoing), and our ability to achieve and maintain future profitability; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our business plan and our ability to effectively manage our growth; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">anticipated trends, growth rates, and challenges in our business and in the markets in which we operate; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our market opportunity, including our potential or anticipated growth of the fitness and wellness industry, including the smart home gym and connected fitness sector of this industry; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our internal estimates as to our market opportunities, including our total addressable market; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">market acceptance of our connected fitness hardware and services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">beliefs and objectives for future operations, products, and services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to maintain and increase sales of our Forme Studio equipment, increase memberships to the Forme platform, and expand our product and service offerings; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to attract and retain qualified trainers, including personal trainers, and to contract with fitness instructors and other content production personnel; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our expectations regarding potential changes to our membership or pricing models or to our products and services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our plans to expand our commercial and corporate wellness customer base; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to develop new content, features, equipment, and other services to integrate with or complement the Forme platform and bring them to market in a timely manner; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our expectations regarding content costs included in our products and services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the effects of seasonal trends on our results of operations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our expectations concerning relationships with third-party manufacturers, suppliers, content providers, ecosystem partners, and other third parties, as well as current and potential strategic relationships; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our expectations regarding our manufacturing and supply chain, including any defects or warranty claims; our ability to maintain, protect, and enhance our intellectual property; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our international expansion plans and ability to continue to expand internationally; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">80 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the effects of increased competition in our markets and our ability to compete effectively; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to stay in compliance with laws and regulations that currently apply or become applicable to our business both in the United States and internationally; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">economic and industry trends, projected growth, or trend analysis; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the accuracy of our estimates regarding capital requirements and need for additional financing; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our expectations regarding the impact of general economic conditions, geopolitical events, and the <span style="white-space:nowrap">COVID-19</span> pandemic; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our expectations regarding the period during which we qualify as an emerging growth company under the JOBS Act and as a smaller reporting company. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We caution you that the foregoing list may not contain all of the forward-looking statements made in this prospectus and any prospectus supplement. These forward-looking statements reflect our management&#8217;s beliefs and views with respect to future events and are based on estimates and assumptions as of the date of this prospectus and any prospectus supplement, and are subject to risks and uncertainties. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in <span style="font-style:italic">&#8220;Risk Factors&#8221;</span> and under similar headings in our most recent Quarterly Reports on <span style="white-space:nowrap">Form&#160;10-Q</span> or Current Reports on <span style="white-space:nowrap">Form&#160;8-K.</span> Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward- looking events and circumstances discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied in our forward-looking statements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should refer to the <span style="font-style:italic">&#8220;Risk Factors&#8221;</span> section of this prospectus and any prospectus supplement for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. We cannot assure you that the forward-looking statements in this prospectus and any prospectus supplement will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified timeframe, or at all. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur. Given these uncertainties, you should not place undue reliance on these forward-looking statements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements made in this prospectus and any prospectus supplement relate only to events as of the date of hereof or thereof. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these statements to actual results or to changes in our expectations, except as required by law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read this prospectus and any prospectus supplement, and the documents that we reference in this prospectus and have filed as exhibits to the registration statement of which this prospectus forms a part completely and with the understanding that our actual future results, levels of activity, performance, and events and circumstances may be materially different from what we expect. We qualify all of the forward-looking statements in this prospectus by these cautionary statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">81 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_7">USE OF PROCEEDS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All shares of our common stock offered by this prospectus are being registered for the account of the selling stockholder and we will not receive any proceeds from the resale of the Shares by the selling stockholder. We received $2.0&#160;million in gross proceeds upon the issuance of the Note to the selling stockholder, and we may receive up to approximately $1.2&#160;million in aggregate gross proceeds from the cash exercise of the Warrant, based on the per share exercise price of the Warrant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may use the net proceeds from any cash exercises of the Warrant for the repayment of outstanding indebtedness and for general corporate purposes, which may include working capital and capital expenditures or the acquisition of complementary businesses, products, services, or technologies. However, we do not have agreements, commitments, or plans for any specific acquisitions, other than the CLMBR Acquisition, at this time. The Note bears interest at 7.0% per annum and has a maturity date of December&#160;7, 2024. The proceeds from the issuance of the Note may be used for the repayment of outstanding indebtedness and general corporate purposes as set forth above. See &#8220;<span style="font-style:italic">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span>&#8211; <span style="font-style:italic">Liquidity and Capital Resources</span>&#8221; and Note 22 to the notes to our consolidated financial statements included elsewhere in this prospectus, and Notes 10, 19, and 20 to the notes to our unaudited condensed consolidated financial statements included elsewhere in this prospectus for additional information regarding our outstanding indebtedness, including the interest rates and maturity dates of such indebtedness. The proceeds of such indebtedness were used for working capital and general corporate purposes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our expected use of proceeds from the sale of the Note and any cash exercises of the Warrant (if any) represents our intentions based on our present plans and business conditions, which could change as our plans and business conditions evolve. The amounts and timing of our actual expenditures will depend on numerous factors, including cash flows from operations, the extent and results of our research and development efforts, the anticipated growth of our business, and other factors described under <span style="font-style:italic">&#8220;Risk Factors.&#8221;</span> We may find it necessary or advisable to use such proceeds for other purposes, and, except as set forth above, we will have broad discretion in the application of such proceeds. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_8">DETERMINATION OF OFFERING PRICE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot currently determine the price or prices at which the shares of common stock may be sold by the selling stockholder under this prospectus. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_9">MARKET INFORMATION AND DIVIDEND POLICY </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Market Information </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock began trading on the Nasdaq Stock Market on April&#160;28, 2023 under the symbol &#8220;TRNR.&#8221; As of September&#160;30, 2023, there were approximately 386 registered holders of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Dividend Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have never declared or paid cash dividends on our common stock. We do not anticipate declaring or paying any cash dividends on our common stock in the foreseeable future. The preferred stock has dividends that may accrue. See <span style="font-style:italic">&#8220;Description of Capital Stock.&#8221;</span> We currently intend to retain all available funds and any future earnings to support our operations and finance the growth and development of our business. Any future determination related to our dividend policy will be made at the discretion of our board of directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions, business prospects, and other factors our board of directors may deem relevant. If we issue shares of Series A convertible preferred stock, it is expected that such shares of Series A convertible preferred stock would be entitled to dividends which would be accrued as set forth in the certificate of designations for the Series A </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">82 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
convertible preferred stock. See <span style="font-style:italic">&#8220;Description of Capital Stock.&#8221; </span>Further, the Note and any future debt facilities we may enter into may contain restrictions on our ability to pay dividends or make distributions, and any new credit facilities we may enter into may contain similar restrictions. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">83 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_10">DILUTION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuance of the Convertible Note Shares and the Warrant Shares pursuant to the Purchase Agreement will have a dilutive impact on our stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our net tangible book value represents total tangible assets less total liabilities divided by the number of shares of common stock outstanding on September&#160;30, 2023. As of September&#160;30, 2023, we had a historical net tangible book value of $(3.1) million, or $(0.22) per share of common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After giving effect to (i)&#160;the receipt of $1.7&#160;million in net proceeds from the issuance of the Note and the assumed exercise in full of the Warrant less $0.3&#160;million in estimated expenses, and (ii)&#160;the issuance of 12,480,480 Shares to the selling stockholder upon the assumed conversion and exercise in full of the Note and the Warrant, as applicable, our pro forma as adjusted net tangible book value as of September&#160;30, 2023, would have been approximately $(0.7) million, or ($0.03) per share. This represents an immediate increase in net tangible book value of $0.19 per share as a result of the 3i Note Transaction and an immediate dilution of $0.28 per share to our existing stockholders as a result of the 3i Note Transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table illustrates this dilution on a per share basis: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:86%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed offering price per Share<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical net tangible book value per share of common stock at September&#160;30, 2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.22</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Decrease in net tangible book value per share of common stock attributable to pro forma <br />adjustments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.03</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net tangible book value per share as of September&#160;30, 2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.25</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in pro forma as adjusted net tangible book value per share of common stock attributable to this offering</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.22</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma as adjusted net tangible book value per share of common stock after this offering</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.03</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share of common stock to existing stockholders attributable to pro forma adjustments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.28</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The assumed offering price per Share is based on gross proceeds of $2.0&#160;million from (i)&#160;the issuance of the Note in the principal amount of $2,160,000 and (ii)&#160;gross proceeds of approximately $1.2&#160;million upon the exercise of the Warrant for all of the Warrant Shares, divided by the number of Shares being registered by this registration statement. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The calculations above are based on 14,313,185 shares of our common stock outstanding as of September&#160;30, 2023 and exclude: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">3,108,111 shares of our common stock issuable upon the exercise of options to purchase shares of our common stock outstanding as of September&#160;30, 2023, with a weighted-average exercise price of $2.70 per share; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">325,227 shares of our common stock reserved for future issuance under the 2023 Plan as of September&#160;30, 2023, as well as automatic increases in the number of shares of our common stock reserved for future issuance pursuant to this plan, plus (x)&#160;any shares of our common stock underlying outstanding awards under the 2020 Plan that are subsequently forfeited or terminated before being exercised or becoming vested, not issued because an award is settled in cash, or withheld or reacquired to satisfy the applicable exercise, or purchase price, or a tax withholding obligation, and (y)&#160;the number of shares of our common stock which, but for the termination of the 2020 Plan immediately prior to the effective date of the 2023 Plan, were reserved and available for issuance under the 2020 Plan but not at such time issued or subject to outstanding awards under the 2020 Plan; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">324,045 shares of our common stock reserved for issuance under our ESPP, as well as any automatic increases in the number of shares of our common stock reserved for future issuance pursuant to this plan. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">84 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise noted, the information contained in this prospectus assumes or gives effect to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">no conversion of outstanding promissory notes, and no conversion of the Notes; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">no exercise of outstanding options; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">no exercise of outstanding warrants, including the Warrant; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">no sales of shares under the Equity Line Financing. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing discussion of dilution assumes no exercise of warrants, convertible notes or other potentially dilutive securities, other than the Warrant and the Note. The exercise of potentially dilutive securities having an exercise price less than the offering price would increase the dilutive effect to new investors. In addition, we will need to raise additional capital in the immediate and near future to fund our operations and execute our business strategy, and we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2023, we entered into the Asset Purchase Agreement. The purchase price enterprise value under the Asset Purchase Agreement is approximately $16.9&#160;million, of which $6.0&#160;million will be paid in the form of our equity, and we will assume $1.5&#160;million of subordinated debt and will retire $9.4&#160;million of senior debt. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2023, we entered into the Equity Line Purchase Agreement, pursuant to which we, in our sole discretion, may sell up to $20.0&#160;million in aggregate of newly issued common stock to the Equity Line Investor, subject to certain beneficial ownership limitations and limitations on the maximum number of shares we can sell in accordance with Nasdaq listing requirements. In connection with the Equity Line Financing, we entered into a registration rights agreement with the Equity Line Investor, pursuant to which we will file resale registration statements with respect to the shares we may sell to the Equity Line Investor under the Equity Line Purchase Agreement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">85 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_11">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the related notes and other information for the year ended December&#160;31, 2021 and 2022 and our unaudited condensed consolidated financial statements and the related notes and other financial information included elsewhere in this prospectus. Historic results are not necessarily indicative of future results. Some of the information contained in this discussion and analysis or set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business, includes forward-looking statements based upon current plans, expectations and beliefs that involve risks and uncertainties. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this prospectus, our actual results could differ materially from the results described in or implied by these forward-looking statements. You should carefully read the &#8220;Risk Factors&#8221; section to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see &#8220;Special Note Regarding Forward-Looking Statements.&#8221; </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forme is a digital fitness platform that combines premium connected fitness hardware products with expert customizable coaching deliver an immersive experience and better outcomes for both consumers and trainers. Our health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. Our coaching services are delivered primarily by our team of more than 38 trainers. All of our coaches can deliver personal training and 22 can deliver health coaching in other areas of wellness. We believe we are the pioneer brand in the emerging sector of virtual health coaching and that our products and services are accelerating a powerful shift towards outcome-driven fitness solutions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key milestones in our growth history include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">May 2017 &#8211; Forme founded </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">July 2021 &#8211; Commenced commercial delivery of Forme Studio (fitness mirror), our first connected fitness hardware product </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">July 2022 &#8211; Live 1:1 personal training service launched </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">August 2022 &#8211; Commenced commercial delivery of Forme Studio Lift (fitness mirror and cable-based digital resistance) </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our revenue is primarily generated from the sale of our connected fitness hardware products and associated recurring membership revenue. As we launched our first connected fitness hardware product in July 2021, we began generating revenue from sales of our products starting in the second half of 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the nine months ended September&#160;30, 2023 and 2022, we generated total revenue of $0.8&#160;million and $0.5&#160;million, respectively, and incurred net losses of $40.0&#160;million and $39.4&#160;million, respectively. As we generated recurring net losses and negative operating cash flow during the research and development stage of the Forme Studio and Forme Studio Lift products, we have funded our operations primarily with gross proceeds from the sales of our redeemable convertible preferred stock, the sale of our SAFE notes, the issuance of convertible notes, and the issuance of common stock. Through September&#160;30, 2023, we had received gross proceeds of $60.5&#160;million from sales of our redeemable convertible preferred stock, $12.0&#160;million from the sale of our SAFE notes, and $30.7&#160;million from the issuance of convertible notes, and $21.8&#160;million from the sale of our common stock. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">86 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Business Model and Growth Strategy </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Increase uptake of <span style="white-space:nowrap">add-on</span> services through compelling member experience </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to increase uptake of our <span style="white-space:nowrap">add-on</span> memberships and services by providing a compelling member experience focused on introducing our members to the variety of services available on our platform and specifically, the value-added benefits of our coaching and personal training offering. We believe our ability to provide service offerings at a number of price points will serve as a valuable lever for growth by increasing overall service revenues over time. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Reduce the cost of personal training and expand addressable market without sacrificing quality </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to continue to explore ways to leverage our products, technology, and proprietary trainer education platform to bring the cost of coaching down incrementally, while maintaining an unwavering focus on the quality of the coaching experience we deliver to our members. This strategy is key to our medium- to long-term objectives, as we believe we can expand the addressable market for coaching services by reducing the per session cost and increasing accessibility of expert coaching services through our hardware and mobile experiences. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Build out partnership ecosystem </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to continue to build our strategic partner ecosystem with a focus on relationships that enable us to extend our platform to new audiences. We are pursuing opportunities in a number of attractive verticals, including sports, physical therapy and rehabilitation, and telemedicine. We are continuously identifying and evaluating opportunities to apply our coaching <span style="white-space:nowrap">know-how</span> in new and innovative ways to expand our reach and impact. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Expand corporate wellness </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to expand our recently launched corporate wellness initiative. Historically, corporate wellness programs were generally <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">one-size-fits-all</span></span></span> solutions for employees, such as corporate gyms. The rise of the hybrid workforce has made robust corporate wellness both an imperative and a challenge for many companies. We believe our comprehensive product portfolio makes us a better fit for modern corporate wellness programs than many existing alternatives. Our solution enables corporations to provide all of their employees with a coaching platform regardless of whether they work from home, in the office, or both. Our multi-pronged service offering also provides a new level of customization that can be adapted to employees at virtually all levels of tenure. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Expand into new geographies </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to expand the international reach of our product and service offerings. With more than 180&#160;million people belonging to gyms globally in 2019, according to IHRSA, we believe there is significant opportunity to grow internationally. For example, we are currently evaluating potential international expansion in the United Kingdom and Canada, although we have not yet made any definitive plans regarding such expansion or the potential timing thereof. We plan to continue to pursue disciplined international expansion by targeting countries with high fitness penetration and spend, as well as the presence of boutique fitness, and where we believe Forme&#8217;s value proposition will resonate. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Factors Affecting Our Performance </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our financial condition and results of operations have been, and will continue to be, affected by a number of factors, including the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We have a limited operating history; and our past financial results may not be a reliable indicator of our ability to successfully establish our product and service offerings in the marketplace, or of our future performance, and our revenue growth rate is likely to slow as our business matures. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">87 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We derive a significant majority of our revenue from sales of our Forme Studio and Forme Lift equipment and if sales of our Forme Studio and Forme Lift equipment decline, it would materially and negatively affect our future revenue and results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our membership revenue is largely dependent on our ability to sell our Forme Studio equipment and if sales of our Forme Studio equipment decline, our membership revenue would decline, and it would materially and negatively affect our future revenue and results of operations. Similarly, we may be unable to attract and retain members, which could have an adverse effect on our business and rate of growth. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we fail to compete successfully against existing and future competitors, we may fail to obtain a meaningful market share, which in turn would harm our business, financial condition, and results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Increases in component and equipment costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and negatively impact our business, financial condition, and results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The sufficiency of our liquidity and capital resources, and our ability to obtain additional funding as needed for our operations and to execute on our strategy. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our ability to execute or realize the anticipated benefits of any strategic acquisition or transaction. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have experienced, and expect to continue to experience, some disruptions to parts of our supply chain, including procuring necessary components or parts in a timely fashion, with suppliers increasing lead times or placing products on allocation and raising prices. In addition, disruptions to commercial transportation infrastructure have increased delivery times for materials and components or parts of our fitness equipment, and has impacted, and could in the future impact, our ability to timely deliver our products to customers. These supply chain disruptions have not materially affected our business outlook and goals or our operating results, including our sales, revenue, or liquidity or capital resources, and we have not implemented any mitigation efforts to date as a result. However, we cannot predict the impact to us of any future or prolonged supply chain disruptions or any mitigation efforts we may take going forward. For example, as a result of these supply chain disruptions, we may be required to increase customer order lead times and place some products on allocation. In addition, we may consider additional or alternative third-party manufacturing and logistics providers or suppliers. Such mitigation efforts may result in cost increases and any attempts to offset such increases with price increases may result in reduced sales, increased customer dissatisfaction, or otherwise harm our reputation. Further, if we were to elect to transition or add manufacturing or logistics providers or suppliers, it may result in temporary or additional delays in product delivery or risks related to consistent product quality or reliability. This in turn may limit our ability to fulfill customer orders and we may be unable to satisfy all of the demand for our products. We may in the future also purchase components further in advance, which in return can result in less capital being allocated to other activities such as marketing and other business needs. We cannot quantify the impact of such disruptions at this time or predict the impact of any mitigation efforts we may take in response to supply chain disruptions on our business, financial condition, and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, customer demand for our products may be impacted by weak economic conditions, inflation, weak growth, recession, equity market volatility, or other negative economic factors in the United States or other nations. The United States has recently experienced historically high levels of inflation. If the inflation rate continues to increase, it will likely affect our expenses, including, but not limited to, employee compensation expenses, increased manufacturing and supplier costs, and increasing market prices of certain components, parts, supplies, and commodity raw materials, which are incorporated into our products or used by our suppliers to manufacture our products. These components, parts, supplies, and commodities may from time to time become restricted, or general market factors and conditions may affect pricing of such components, parts, supplies and commodities, such as inflation or supply chain constraints. Given our limited operating history, we cannot predict how ongoing or increasing recessionary or inflationary pressures may impact our business, financial condition, and results of operations in the future. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">88 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Recent Developments </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2023, we received written notification from Nasdaq that our stockholders&#8217; equity as reported in our Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the period ended June&#160;30, 2023 did not satisfy the continued listing requirement under Nasdaq Listing Rule 5450(b)(1)(A) for the Nasdaq Global Market, which requires that a listed company&#8217;s stockholders&#8217; equity be at least $10.0&#160;million. In accordance with the Nasdaq Listing Rules, we submitted a plan to regain compliance and Nasdaq subsequently granted us an extension to evidence compliance on or before February&#160;19, 2024. Our common stock will continue to be listed on Nasdaq under the symbol &#8220;TRNR&#8221; during this period while we work to regain compliance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2023, we entered into the Asset Purchase Agreement with the Sellers to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. The purchase price enterprise value under the Asset Purchase Agreement is approximately $16.9&#160;million, consisting of $6.0&#160;million expected to be paid in the form of our equity, the assumption by us of $1.5&#160;million of subordinated debt, and the retirement of $9.4&#160;million of senior debt. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2023, we entered into the Purchase Agreement with the selling stockholder pursuant to which we issued the Note in the aggregate principal amount of $2,160,000, with an eight percent (8.0%) original issue discount and an interest rate of seven percent (7.0%) per annum, and the Warrant to purchase up to 924,480 shares of common stock. The Note is convertible into a maximum of 11,556,000 shares of common stock. The conversion and exercise of the Note and the Warrant are subject to the terms of the Purchase Agreement, including the beneficial ownership limitations and share issuance caps specified therein. In connection with the 3i Note Transaction, we entered into a registration rights agreement with the selling stockholder, pursuant to which we agreed to file a resale registration statement covering the resale of the Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2023, we entered into the Equity Line Purchase Agreement with the Equity Line Investor, pursuant to which we, in our sole discretion, may sell up to $20.0&#160;million in aggregate of newly issued common stock to the Equity Line Investor, subject to certain beneficial ownership limitations and limitations on the maximum number of shares we may issue and sell in accordance with Nasdaq listing requirements. In connection with the Equity Line Financing, we entered into a registration rights agreement with the Equity Line Investor, pursuant to which we will file resale registration statements with respect to the shares we may sell to the Equity Line Investor under the Equity Line Purchase Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Key Operational and Business Metrics </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the measures presented in our consolidated financial statements, we use the following key operational and business metrics to evaluate our business, measure our performance, develop financial forecasts, and make strategic decisions. We may in the future elect to use additional metrics, discontinue the use of current metrics, or adjust our methodology or definitions of our operational and business metrics as our business evolves. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:65%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year Ended<br />December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Households (at end of period)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">184</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">226</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">173</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Members (at end of period)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">199</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">232</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">192</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Recurring Revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">291,129</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">464,425</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">223,547</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average Annualized Recurring Revenue per Household</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 1,020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 439</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,723</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Dollar Retention Rate</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">NM</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">NM</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">185</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">NM</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Loss (in thousands)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(58,225</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(32,840</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,408</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(14,754</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA (in thousands)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(41,803</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(33,791</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,373</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,160</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NM &#8211; Not meaningful. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">89 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Households </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe our ability to expand the number of households is an indicator of our market penetration and growth. Total households are defined as individuals or entities with an active paid membership and training. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Members </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our total member count is a key indicator of the size of our future revenue opportunity. We define a member as someone who has a unique profile on our platform, either as the primary membership owner or an associated user within the household. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">ARR </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the recurring nature of usage on our platform, we view annual recurring revenue as an important indicator of our progress towards growth targets and of the overall health of the member base. We calculate ARR at a point in time by multiplying the latest monthly period&#8217;s revenue by 12. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">ARPH </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that our average revenue per household, which we refer to as ARPH, is a strong indication of our ability to deliver value to our members and we use this metric to track expanding usage on our platform by our existing members. We calculate ARPH on a monthly basis as our total revenue in that period divided by the number of households determined as of the last day of that period. For a quarterly or annual period, ARPH is determined as the weighted average monthly ARPH over such three or <span style="white-space:nowrap">12-month</span> period. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Net Dollar Retention Rate </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to maintain long-term revenue growth and achieve profitability is dependent on our ability to retain and grow revenue from our existing members. To help us measure our performance in this area, we monitor our net dollar retention rate. We calculate net dollar retention rate monthly by starting with the revenue from the cohort of all members during the corresponding month 12 months prior, or the Prior Period Revenue. We then calculate the revenue from these same members as of the current month, or the Current Period Revenue, including any expansion and net of any contraction or attrition from these members over the last 12 months. The calculation also includes revenue from members that generated revenue before, but not in, the corresponding month 12 months prior, but subsequently generated revenue in the current month and are therefore reflected in the Current Period Revenue. We include this group of <span style="white-space:nowrap">re-engaged</span> members in this calculation because our members may use our platform for workouts that stop and start over time. We then divide the total Current Period Revenue by the total Prior Period Revenue to arrive at the net dollar retention rate for the relevant month. For a quarterly or annual period, the net dollar retention rate is determined as the average monthly net dollar retention rates over such three or <span style="white-space:nowrap">12-month</span> period. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Components of Our Operating Results </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We generate revenue from sales of our connected fitness products, membership revenue, and personal training revenue. We identify our reportable segment based on the information used by management to monitor performance and make operating decisions. See Note 2 of the notes to our consolidated financial statements included elsewhere in this prospectus for additional information regarding our reportable segment. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Connected Fitness Product </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Connected Fitness Product revenue consists of sales of our connected fitness products and related accessories, delivery and installation services, and extended warranty agreements offered through a third-party. Fitness </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">90 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Product revenue is recognized at the time of delivery, except for extended warranty revenue which is recognized over the warranty period. For the third-party extended warranty service sold along with the connected fitness products, we do not obtain control of the warranty before transferring it to the customers. Therefore, we account for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission we retain. Connected fitness product revenue represented 68% of total revenue for the three months ended September&#160;30, 2023, and 72% of total revenue for the three months ended September&#160;30, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Membership </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Membership revenue consists of revenue generated from our monthly Connected Fitness membership. Membership revenue represented 11% of total revenue for the year ended December&#160;31, 2022, and 1% of total revenue for the year ended December&#160;31, 2021. Membership revenue represented 12% of total revenue for the three months ended September&#160;30, 2023, and 12% of total revenue for the three months ended September&#160;30, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Training </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Training revenue consists of sales of our personal training services delivered through our connected fitness products and third-party mobile devices. Training revenue is recognized at the time of delivery. Training revenue represented 11% of total revenue for the year ended December&#160;31, 2022, and 0% of total revenue for the year ended December&#160;31, 2021. Training revenue represented 20% of total revenue for the three months ended September&#160;30, 2023, and 16% of total revenue for the three months ended September&#160;30, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cost of Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Connected Fitness Product </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Connected Fitness Product cost of revenue consists of Studio and Studio Lift and accessories product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management and facilities expenses associated with supply chain logistics. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Membership </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Membership cost of revenue includes costs associated with personnel related expenses, filming and production costs, hosting fees, music royalties, and amortization of capitalized software development costs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Training </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Training cost of revenue includes costs associated with personnel related expenses. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Research and Development </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expense primarily consists of personnel and facilities-related expenses, consulting and contractor expenses, tooling and prototype materials, and software platform expenses. We capitalize certain qualified costs incurred in connection with the development of <span style="white-space:nowrap">internal-use</span> software and software to be sold or marketed which may also cause research and development expenses to vary from period to period. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Sales and Marketing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales and marketing expense consists of performance marketing media spend, asset creation, and other brand creative, all showroom expenses and related lease payments, payment processing fees incurred in connection with the sale of our connected fitness products, and sales and marketing personnel-related expenses. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">91 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General and Administrative </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and administrative expense includes personnel-related expenses and facilities-related costs primarily for our executive, finance, accounting, legal, human resources, and IT functions. General and administrative expense also includes fees for professional services principally comprised of legal, audit, tax and accounting services, and insurance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect to incur additional general and administrative expenses as a result of operating as a public company, including expenses related to compliance and reporting obligations of public companies, and increased costs for insurance, investor relations expenses, and professional services. As a result, we expect that our general and administrative expenses will increase in absolute dollars in future periods and vary from period to period as a percentage of revenue, but we expect to leverage these expenses over time as we grow our revenue and member base. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other (Expense) Income, Net </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other (expense) income, net consists of unrealized currency gains and losses. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Interest Expense </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest expense consists of interest associated with the related party loans. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Change in Fair Value of Convertible Notes </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in fair value of convertible notes consists of the change in the fair value of the outstanding convertible notes since the previous reporting period. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Change in Fair Value of Warrants </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in fair value of warrants consists of the change in the fair value of the outstanding warrants notes since the previous reporting period. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Provision for Income Taxes </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The provision for income taxes consists primarily of income taxes related to foreign and state jurisdictions in which we conduct business. We maintain a full valuation allowance on our federal and state deferred tax assets as we have concluded that it is more likely than not that the deferred assets will not be utilized. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Results of Operations </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following tables set forth our consolidated results of operations in dollars and as a percentage of total revenue for the periods presented. The consolidated statement of operations data presented below for the years ended December&#160;31, 2022 and 2021 are derived from our audited consolidated financial statements included elsewhere in this prospectus. The consolidated statement of operations data for the nine months ended September&#160;30, 2023 and 2022 are derived from our unaudited condensed consolidated financial statements included elsewhere in this prospectus. We have prepared the unaudited condensed consolidated financial data on the same basis as the audited consolidated financial statements, and the unaudited condensed consolidated financial data include, in our opinion, all adjustments, consisting only of normal recurring adjustments, that we consider necessary for a fair presentation of the financial information set forth in those statements. Our historical results are not necessarily indicative of the results to be expected in the future and our operating results for the nine months ended September&#160;30, 2023 are not necessarily indicative of the results that may be expected for the entire year ending December&#160;31, 2023.The <span style="white-space:nowrap"><span style="white-space:nowrap">period-to-period</span></span> comparison of our historical results are not necessarily indicative of the results that may be expected in the future. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">92 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Results of Operations for the Three and Nine Months Ended September&#160;30, 2023 and 2022 (unaudited) </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:64%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Revenue:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fitness product revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">502</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">402</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Membership revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">94</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">53</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Training revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">62</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">183</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">306</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">201</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">779</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">487</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of fitness product revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(360</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(764</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,529</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,047</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of membership<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(960</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,545</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,861</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,537</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of training</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(109</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(387</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(300</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,077</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,429</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,696</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,690</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,661</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,123</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,495</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,911</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,174</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,357</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,854</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,796</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,284</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and marketing<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">282</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,193</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,473</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,194</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative<sup style="font-size:75%; vertical-align:top">(1)(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,313</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,131</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,043</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,774</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,952</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,178</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">39,312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,075</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(14,673</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(43,223</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(38,426</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(179</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(417</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(740</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(154</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(187</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,382</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(748</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain upon debt extinguishment</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">523</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,595</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">523</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of convertible notes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(252</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(24</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,266</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other (expense) income, net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(333</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(81</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(989</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,408</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(14,754</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(39,971</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(39,415</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax benefit (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,408</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(14,754</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(39,971</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(39,415</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes stock-based compensation expense as follows: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:59%"></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,347</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">383</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,803</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">478</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and marketing</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">87</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">34</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">407</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,402</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,356</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,563</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,421</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,773</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,773</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,951</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the three months ended September&#160;30, 2023 and 2022, $0.1&#160;million and $0.0&#160;million of stock-based compensation was capitalized as software costs, respectively. For the nine months ended September&#160;30, 2023 and 2022, $0.7&#160;million and $0.0&#160;million of stock-based compensation was capitalized as software costs, respectively. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">93 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2022, the Company enacted a restructuring cost savings initiative which resulted in employee terminations in both December 2022 and January 2023. In association with the January 2023 terminations, the Company accelerated the vesting of a number of individual option awards, resulting in the accelerated vesting of 5,938 shares on the date of modification. Also in January 2023, the Company repriced 301,537 option awards. Both the accelerated vesting and repricing were accounted for as an equity award modifications under ASC Topic 718 which resulted in adjustment of the award value to reflect the fair value at the modification date and acceleration of the recognition schedule in the case of awards which were modified to have accelerated vesting. The adjustment resulted in additional expense of $0.5&#160;million. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes depreciation and amortization expense as follows: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:64%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of membership</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">964</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,700</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,657</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">743</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">775</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,231</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,010</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total depreciation and amortization expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,696</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,740</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,931</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Comparison of the Three and Nine Months Ended September&#160;30, 2023 and 2022 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Revenue </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:53%"></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine&#160;Months&#160;Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td colspan="5" style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td colspan="5" style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fitness product</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">502</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">402</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Membership</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">94</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">53</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Training</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">62</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">94</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">183</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">472</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">306</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">201</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">779</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">487</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">60</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Percentage of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fitness product</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">72</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">65</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">82</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Membership</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Training</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fitness product revenue increased $0.1&#160;million or 43% and $0.1&#160;million or 25% for the three and nine months ended September&#160;30, 2023 compared to the three and nine months ended September&#160;30, 2022. This increase was primarily attributable to increase in Studio with Lift installations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Membership revenue increased $0.01&#160;million or 52% and $0.04&#160;million or 77% for the three and nine months ended September&#160;30, 2023 compared to the three and nine months ended September&#160;30, 2022. The increase was primarily attributable to the year-over-year growth in our memberships and price increase from $39 to $49 effective in August 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Training revenue increased $0.03&#160;million or 94% and $0.2&#160;million or 472% for the three and nine months ended September&#160;30, 2023 compared to the three and nine months ended September&#160;30, 2022. The increase was primarily attributable to launch of our Live 1:1 personal training services. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">94 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cost of Revenue and Gross Loss </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:52%"></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of Revenue:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td colspan="5" style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td colspan="5" style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fitness product</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">360</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">764</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(53</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,529</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,047</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(25</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Membership</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">960</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,545</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(38</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,861</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,537</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(19</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Training</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">109</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">387</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(72</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">300</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,077</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(72</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,429</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,696</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(47</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,690</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,661</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(30</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Loss:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fitness product</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(154</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(620</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(75</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,027</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,645</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(38</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Membership</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(922</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,520</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(39</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,767</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,484</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(21</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Training</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(47</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(355</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(87</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(117</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,045</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(89</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total gross loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,123</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,495</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(55</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,911</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,174</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(37</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Margin:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fitness product</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(75</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(431</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(205</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(409</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Membership</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,426</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,079</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,944</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,573</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Training</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(76</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,110</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(64</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,266</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(367</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,241</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(502</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,268</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Three Months Ended September&#160;30, 2023 and 2022 </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fitness product cost of revenue for the three months ended September&#160;30, 2023 decreased $0.4&#160;million, or 53%, compared to the three months ended September&#160;30, 2022. The decrease is primarily due to a decrease in the inventory valuation reserve expense in the three months ended September&#160;30, 2023 compared to the three months ended September&#160;30, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Membership cost of revenue for the three months ended September&#160;30, 2023 decreased $0.6&#160;million, or 38%, compared to the three months ended September&#160;30, 2022. The decrease is primarily related to the decrease in personnel-related expenses from a reduction in headcount. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Training cost of revenue for the three months ended September&#160;30, 2023 decreased $0.3&#160;million, or 72%, compared to the three months ended September&#160;30, 2022. The decrease is primarily related to the decrease in personnel-related expenses from a reduction in headcount. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our gross loss decreased by $1.4&#160;million for the three months ended September&#160;30, 2023 compared to the three months ended September&#160;30, 2022 due to the decrease in personnel-related expenses from reduction in headcount. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Nine Months Ended September&#160;30, 2023 and 2022 </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fitness product cost of revenue for the nine months ended September&#160;30, 2023 decreased $0.5&#160;million, or 25%, compared to the nine months ended September&#160;30, 2022. The decrease is primarily due to a decrease in the inventory valuation reserve expense in the nine months ended September&#160;30, 2023 compared to the nine months ended September&#160;30, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Membership cost of revenue for the nine months ended September&#160;30, 2023 decreased $0.7&#160;million, or 19%, compared to the nine months ended September&#160;30, 2022. The decrease is primarily related to the decrease in personnel-related expenses from a reduction in headcount. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">95 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Training cost of revenue for the nine months ended September&#160;30, 2023 decreased $0.8&#160;million, or 72%, compared to the nine months ended September&#160;30, 2022. The decrease is primarily related to the decrease in personnel-related expenses from a reduction in headcount. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our gross loss decreased by $2.3&#160;million for the nine months ended September&#160;30, 2023 compared to the nine months ended September&#160;30, 2022 due to the decrease in personnel-related expenses from reduction in headcount. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Expenses </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:52%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating Expenses:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td colspan="5" style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td colspan="5" style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,357</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,854</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(51</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,796</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,284</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(49</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and marketing</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">282</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,193</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(76</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,473</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,194</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(72</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,313</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,131</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,043</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,774</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">155</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,952</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,178</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(26</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">39,312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Three and Nine Months Ended September&#160;30, 2023 and 2022 </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Research and Development </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expense decreased $2.5&#160;million or 51% and $7.5&#160;million or 49% for the three and nine months ended September&#160;30, 2023, as compared to the three and nine months ended September&#160;30, 2022, respectively. The decrease was primarily due to a decrease in personnel-related expenses from a reduction in headcount of $2.8&#160;million and $8.2&#160;million, respectively, and a decrease in engineering of $0.7&#160;million and $3.7&#160;million, respectively, partially offset by an increase of $1.0&#160;million and $4.3&#160;million in stock-based compensation expenses, respectively. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Sales and Marketing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales and marketing expense decreased $0.9&#160;million or 76% and $3.7&#160;million or 72% for the three and nine months ended September&#160;30, 2023, as compared to the three and nine months ended September&#160;30, 2022, respectively. The decrease was primarily due to a decrease in personnel-related expenses from a reduction in headcount of $0.7&#160;million and $2.3&#160;million, respectively, a decrease of $0.2&#160;million and $1.4&#160;million in advertising and marketing, respectively, and a decrease of $0.1&#160;million and $0.3&#160;million in rent expense, respectively, due to the closure of retail locations, partially offset by an increase of $0.1&#160;million and $0.3&#160;million in stock-based compensation expenses, respectively. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General and Administrative </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and administrative expense increased $0.2&#160;million or 3% and $18.3&#160;million or 155% for the three and nine months ended September&#160;30, 2023, as compared to the three and nine months ended September&#160;30, 2022, respectively. The increase was due primarily to increases of $0.1&#160;million and $15.1&#160;million, respectively, in stock-based compensation expenses, $0.7&#160;million decrease and $0.7&#160;million increase in accounting and tax expenses, respectively, $0.2&#160;million and $0.4&#160;million increase in insurance, respectively, and $0.4&#160;million and $2.4&#160;million increase in digital marketing and advisory services, respectively, and $0.1&#160;million and $0.4&#160;million decrease in travel, respectively, with the remaining difference due to change in other miscellaneous expenses. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">96 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Other (Expense) Income, net </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:52%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine&#160;Months&#160;Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td colspan="5" style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td colspan="5" style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(179</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(417</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(57</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(740</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(103</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(154</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(187</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(18</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,382</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(748</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">85</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain upon debt extinguishment</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">523</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(100</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,595</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">523</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">396</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of convertible notes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(252</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(24</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">950</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,266</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other (expense) income, net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(333</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(81</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">311</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(989</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(429</td>
<td style="white-space:nowrap;vertical-align:bottom">%)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Three and Nine Months Ended September&#160;30, 2023 and 2022 </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other (Expense) Income, net </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The changes in other (expense) income was primarily attributable to changes in unrealized currency gains. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Interest Income (Expense) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest expense decreased $0.03&#160;million for the three months ended September&#160;30, 2023 and increased $0.6&#160;million for the nine months ended September&#160;30, 2023, as compared to the three and nine months ended September&#160;30, 2022, respectively. The increase in interest expense for the nine months ended September&#160;30, 2023 was due to $1.3&#160;million of amortization of debt discount on senior secured notes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Gain on debt extinguishment </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gain on debt extinguishment was a result of forgiveness of debt of $2.6&#160;million related to the third-party content provider for the nine months ended September&#160;30, 2023, and forgiveness of Paycheck Protection Program (&#8220;PPP&#8221;) loan of $0.5&#160;million for the nine months ended September&#160;30, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Change in Fair Value of Convertible Notes, and Change in Fair Value of Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Change in fair value of convertible notes and warrants for the three and nine months ended September&#160;30, 2023 and 2022 were due to change in fair value of these financial instruments. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">97 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Results of Operations for the Years Ended December&#160;31, 2022 and 2021 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:67%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year Ended<br />December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td rowspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="14" align="center"><span style="font-weight:bold">(in thousands, expect share and per share data)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fitness product revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">319</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">211</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">66</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Membership revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">74</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">70</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1750</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Training revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of fitness product revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,402</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,652</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-9</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of membership and training</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,147</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,513</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,634</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">184</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,868</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,842</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,026</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">83</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,960</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,300</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,660</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and marketing</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,219</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,566</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(347</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-5</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,298</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,438</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,860</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">104</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">45,477</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,304</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,173</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">41</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(54,345</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(37,146</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(17,199</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,036</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,339</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-1432</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(952</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(935</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(17</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain upon debt extinguishment</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">523</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">523</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of SAFEs</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(251</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">251</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of convertible notes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">107</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,193</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,086</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-98</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">478</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">478</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other (expense) income, net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,880</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,310</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,190</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-190</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(58,225</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(32,836</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(25,389</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax benefit (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$(58,225)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$(32,840)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$(25,385)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">77%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share&#8211;basic and diluted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(119.49</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(332.31</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average common stock outstanding &#8211; basic and diluted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">487,276</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">98,823</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:68%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year&#160;Ended&#160;December&#160;31</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;Amount&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#160;&#160;&#160;&#160;%&#160;&#160;&#160;&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="14" align="center"><span style="font-weight:bold">(in thousands, expect share and per share data)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net Loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(58,225</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(32,840</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(25,385</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive loss:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency translation gain</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">524</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">179</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">345</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-193</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$(57,701)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$(32,661)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$(25,040)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">77%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Comparison of the Years Ended December&#160;31, 2022 and 2021 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue for the year ended December&#160;31, 2022, increased $0.4&#160;million or 111%, compared to the year ended December&#160;31, 2021. The increase in revenue is due to a $0.2&#160;million increase in fitness product sales driven by growing volume of Forme Studio sales to new customers and launch of Forme Studio Lift and Forme Studio Lift upgrades in 2022, a $0.1&#160;million increase in membership activity and a $0.1&#160;million increase in training revenue, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">98 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including as a result of the launch of our Custom Training service, which was launched during the third quarter of 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cost of Revenue and Gross Loss </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cost of revenue for the year ended December&#160;31, 2022, increased $4.3 million, or 85%, compared to the year ended December&#160;31, 2021. The increase in cost of revenue is primarily due to the increase in expense related to the amortization of capitalized studio content and internal-use software in addition to a growing volume of fitness product sales, increased membership activity and launch of live training sessions in 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our gross loss increased by $4.0 million due to increased costs with connected fitness product sales, which in turn resulted in higher logistics costs, and the amortization of software. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Research and Development </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expense for the year ended December&#160;31, 2022, increased $3.7 million, or 22%, compared to the year ended December&#160;31, 2021. The increase was due primarily to an increase of $5.3 million in payroll and $1.6 million in stock-based compensation expenses, partially offset by a decrease of $3.2 million in engineering expense. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Sales and Marketing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales and marketing expense for the year ended December&#160;31, 2022, decreased $0.3 million, or -5%, compared to the year ended December&#160;31, 2021. The decrease was primarily due to a decrease of $1.4 million rent expense due to downsizing of office space in the current year, partially offset by increases of $0.5 million in advertising expenses and $0.6 million in payroll and stock-based compensation expenses. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General and Administrative </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and administrative expense for the year ended December&#160;31, 2022, increased $9.9 million, or 104%, compared to the year ended December&#160;31, 2021. The increase was due primarily to increases of $3.9 million in payroll and stock-based compensation expenses, $1.7 million in depreciation and amortization expense, $2.5 million in accounting and tax expenses, $0.2 million in business travel and entertainment, offset by a decrease of $0.8 million in business license and fees. In the year ended December&#160;31, 2022, the Company also recognized a $2.3 million impairment of capitalized content related to the third-party Content Provider. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other (Expense) Income, net </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other (expense) income, net for the year ended December&#160;31, 2022, was $(4) million compared to $0.3 million for the year ended December&#160;31, 2021. The decrease in other (expense) income was primarily due to amounts attributable to the issuance costs associated with the 2022 Convertible Notes, as well as changes in unrealized currency gains. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Interest Expense </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest expense was $1.0 million for the year ended December&#160;31, 2022, compared to $0.9 million for the year ended December&#160;31, 2021. The increase in interest expense was due to a greater outstanding balance of loan payables. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">99 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Gain Upon Debt Forgiveness </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gain upon debt forgiveness was $0.5 million for the year ended December&#160;31, 2022, compared to $0 for the year ended December&#160;31, 2021. The increase in gain upon debt forgiveness is due to loan forgiveness of the Company&#8217;s PPP loan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Change in Fair Value of Convertible Notes, Change in Fair Value of SAFEs, and Change in Fair Value of Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Change in fair value of convertible notes for the year ended December&#160;31, 2022, decreased $5.1 million compared to the year ended December&#160;31, 2021. Change in fair value of SAFEs and ASAs for the year ended December&#160;31, 2022, was $0 compared $0.3 million for the year ended December&#160;31, 2021. Change in fair value of warrants for the year ended December&#160;31, 2022, was $0.5 million compared to $0 for the year ended December&#160;31, 2021. The changes were due primarily to change in fair value of these financial instruments. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Non-GAAP Financial Measures </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to our results determined in accordance with accounting principles generally accepted in the United States, or GAAP, we believe the following non-GAAP financial measures are useful in evaluating our operating performance </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Adjusted EBITDA </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We calculate Adjusted EBITDA as net (loss) income adjusted to exclude: other expense (income), net; income tax expense (benefit); depreciation and amortization expense; stock-based compensation expense; impairment expense; reorganization, severance, exit, disposal and other costs associated with restructuring plans; vendor settlements; transaction related expenses; IPO related expenses; and other adjustment items that arise outside the ordinary course of our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We use Adjusted EBITDA as a measure of operating performance and the operating leverage in our business. We believe that these non-GAAP financial measures are useful to investors for period-to-period comparisons of our business and in understanding and evaluating our operating results for the following reasons: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA is widely used by investors and securities analysts to measure a company&#8217;s operating performance without regard to items such as stock-based compensation expense, depreciation and amortization expense, other expense (income), net, and provision for income taxes that can vary substantially from company to company depending upon their financing, capital structures, and the method by which assets were acquired; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our management uses Adjusted EBITDA in conjunction with financial measures prepared in accordance with GAAP for planning purposes, including the preparation of our annual operating budget, as a measure of our core operating results and the effectiveness of our business strategy, and in evaluating our financial performance; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA provides consistency and comparability with our past financial performance, facilitate period-to-period comparisons of our core operating results, and may also facilitate comparisons with other peer companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our use of Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as substitutes for analysis of our financial results as reported under GAAP. Some of these limitations are, or may in the future be, as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Although depreciation and amortization expense are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">100 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA excludes stock-based compensation expense, which has recently been, and will continue to be for the foreseeable future, a significant recurring expense for our business and an important part of our compensation strategy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA does not reflect: (1)&#160;changes in, or cash requirements for, our working capital needs; (2)&#160;interest expense, or the cash requirements necessary to service interest or principal payments on our debt, which reduces cash available to us; or (3)&#160;tax payments that may represent a reduction in cash available to us; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA does not reflect impairment charges for fixed assets, and gains (losses) on disposals for fixed assets; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA does not reflect gains associated with vendor settlements. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA does not reflect non-cash fair value gains (losses) on convertible notes, warrants and unrealized currency gains (losses). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA does not reflect IPO readiness costs and expenses that do not qualify as equity issuance costs. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA does not reflect reorganization, severance, exit, disposal and other costs associated with restructuring plans; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Adjusted EBITDA does not reflect expenses related to the Asset Purchase Agreement and potential acquisition; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The expenses and other items that we exclude in our calculation of Adjusted EBITDA may differ from the expenses and other items, if any, that other companies may exclude from Adjusted EBITDA when they report their operating results and we may, in the future, exclude other significant, unusual expenses or other items from these financial measures. Because companies in our industry may calculate such measures differently than we do, their usefulness as comparative measures can be limited. Because of these limitations, Adjusted EBITDA should be considered along with other operating and financial performance measures presented in accordance with GAAP. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because of these limitations, Adjusted EBITDA should be considered along with other operating and financial performance measures presented in accordance with GAAP. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents a reconciliation of Adjusted EBITDA to Net loss, the most directly comparable financial measure prepared in accordance with GAAP, for each of the periods indicated: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:64%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine Months Ended<br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,408</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(14,754</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(39,971</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(39,415</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted to exclude the following:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other expense (income), net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">604</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(657</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,512</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax benefit (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,696</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,740</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,931</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,667</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,773</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,773</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,951</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on extinguishment of debt<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(523</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(523</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vendor settlements<sup style="font-size:75%; vertical-align:top">(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,595</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPO related expenses<sup style="font-size:75%; vertical-align:top">(4)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">817</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction related expenses<sup style="font-size:75%; vertical-align:top">(5)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,373</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,160</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(13,532</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(29,808</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">101 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Stock-based compensation of $0.1 million and $0.0 million and $0.7 million and $0.0 million was capitalized as software costs for the three and nine months ended September&#160;30, 2023 and 2022. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Gain on forgiveness of debt from PPP loan. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Gain on forgiveness of debt of $2.6 million related to the third-party Content Provider. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Adjusts for IPO-readiness costs and expenses that do not qualify as equity issuance costs. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Transaction costs related to acquisition of CLMBR, Inc. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Liquidity and Capital Resources </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception, we have sustained recurring losses and have relied on equity and debt funding from private investors and other third-parties (collectively &#8220;outside capital&#8221;) for our business operations and to execute our growth strategy. As a result, we incurred a net loss of $58.2 million during the year ended December&#160;31, 2022 and had an accumulated deficit of $115.5 million as of December&#160;31, 2022, and a net loss of $40.0 million during the nine months ended September&#160;30, 2023 and had an accumulated deficit of $155.5 million as of September&#160;30, 2023. Our long-term success is dependent upon its ability to successfully develop, market, and deliver its revenue-generating products and services in a profitable manner. While management believes we can be successful in executing our growth strategy, no assurance can be provided we will be able to do so in a timely or profitable manner. As a result, we anticipate we will continue to rely on additional financing and outside capital, including in the near term, to fund our operations for the foreseeable future. For example, in December 2023, we entered into the 3i Note Transaction and the Equity Line Financing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date the accompanying consolidated financial statements were issued (the &#8220;issuance date&#8221;), our available liquidity was not sufficient to fund our operations over the next twelve months or meet our obligations as they become due, absent our ability to secure additional outside capital. While management plans to take action to address our liquidity needs, such as cost mitigation initiatives to reduce unnecessary costs, securing additional outside capital, and/or pursuing other strategic arrangements, no assurance can be provided that management&#8217;s actions will be sufficient to fund our operations, including over the next twelve months or meet our obligations as they become due. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, as of December&#160;31, 2022, we had loans outstanding from certain related parties (See Note 22 to the notes to our consolidated financial statements included elsewhere in this prospectus) with an aggregate principal and interest amount owed of approximately $6.7 million. Certain of these loans matured prior to December&#160;31, 2022, but their repayment has been temporarily waived, and the remaining loans are scheduled to mature over the next twelve months beyond issuance date. However, absent additional outside capital, we will be unable to repay these loans upon their maturity and, as such, the aggregate amounts owed have been classified as current debt in the accompanying consolidated balance sheet as of December&#160;31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&#160;30, 2023, we had $1.0 million of senior secured notes outstanding with THLWY, LLC (see Note 10 to the notes to our consolidated financial statements included elsewhere in this prospectus). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2023, we borrowed $0.2 million in a non-interest bearing note and repaid $0.1 million. As of September&#160;30, 2023, this loan remains outstanding in the amount of $0.1 million. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, as of September&#160;30, 2023, we had loans outstanding from certain related parties (See Note 19 to the notes to our condensed consolidated financial statements included elsewhere in this prospectus) with an aggregate principal and interest amount owed of approximately $6.3 million. All of these loans matured prior to September&#160;30, 2023, but their repayment has been temporarily waived. However, absent additional outside capital, we will be unable to repay these loans upon their maturity and, as such, the aggregate amounts owed have been classified as current debt in the accompanying consolidated balance sheet as of September&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that one or more of management&#8217;s planned actions are not sufficient to fund our operations over the next twelve months or meet its obligations as they become due, management will be required to seek other </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">102 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
strategic alternatives, which may include, among others, a significant curtailment in our operations, a sale of certain of the our assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy. These uncertainties raise substantial doubt about our ability to continue as a going concern. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements included elsewhere in this prospectus have been prepared on the basis that we will continue to operate as a going concern, which contemplates that we will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the consolidated financial statements included elsewhere in this prospectus do not include any adjustments that may result from the outcome of these uncertainties. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Debt and Preferred Equity </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">2020 Convertible Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2020, we issued convertible notes (the &#8220;2020 Convertible Notes&#8221;) with an aggregate principal amount of $6.2 million, pursuant to a private placement offering. The 2020 Convertible Notes bore interest at 6%&#160;per annum and had a scheduled maturity date of 12 to 24 months from issuance, at which time the principal and accrued interest would be due and payable. We elected the fair value option for the 2020 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Convertible Notes did not include any financial covenants and were subject to acceleration upon the occurrence of specified events of default. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Convertible Notes were subject to the following conversion features: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event we completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $3.0 million prior to the maturity date of the 2020 Convertible Notes, all principal and accrued interest will automatically convert into preferred stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event we did not complete a qualified financing prior to the maturity date of the 2020 Convertible Notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing. The conversion price with respect to an elective conversion at the time of maturity is equal to the fair market value of the Company divided by our fully diluted capitalization table at the time of conversion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Two individual 2020 Convertible Notes with an aggregate principal value of $1,250,000 were subject to the following conversion features: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event we completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0 million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event we did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) $50.0 million divided by the sum of our then-outstanding common stock, outstanding option, and promised options (the &#8220;Cap Price&#8221;). The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">103 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2021, we completed a qualified financing, and as a result the 2020 Convertible Notes were automatically converted into 13,373 shares of Series Seed-9 preferred stock and 3,279 shares of Series A-1 preferred stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">2021 Convertible Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From January through July 2021, we issued convertible notes (the &#8220;2021 Convertible Notes&#8221;) with an aggregate principal amount of $14.8 million, pursuant to a private placement offering. The 2021 Convertible Notes bore interest at 6%&#160;per annum and had a scheduled maturity date of 24 months from issuance, at which time the principal and accrued interest would be due and payable. We elected the fair value option for the 2021 Convertible Notes under ASC Topic 825, <span style="font-style:italic">Financial Instruments</span>, with changes in fair value recorded in earnings each reporting period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2021 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2021 Convertible Notes were subject to the following conversion features: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event we completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0 million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event we did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#8220;Cap Price&#8221;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2021, we completed a qualified financing, and as a result the 2021 Convertible Notes were automatically converted into 130 shares of Series Seed-9 preferred stock, 24,576 shares of Series A preferred stock, and 6,929 shares of Series A-1 preferred stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">2022 Convertible Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From January through March 2022, we issued convertible notes (the &#8220;2022 Convertible Notes&#8221;) with an aggregate principal amount of $5.9 million, pursuant to a private placement offering. The 2022 Convertible Notes bore interest at 6%&#160;per annum and had a scheduled maturity date of 24 months from issuance, at which time the principal and accrued interest would be due and payable. We elected the fair value option for the 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0 million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">104 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#8220;Cap Price&#8221;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2022, we completed a qualified financing, and as a result the 2022 Convertible Notes were automatically converted into 124,313 shares of Series A-2 Preferred Stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">November 2022 Convertible Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2022, we issued convertible notes (the &#8220;November 2022 Convertible Notes&#8221;) with an aggregate principal amount of $4.4 million, pursuant to a private placement offering. The November 2022 Convertible Notes bore interest at 6%&#160;per annum and had a scheduled maturing date of 12 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the November 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The November 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The November 2022 Convertible Notes were subject to the following conversion features: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0 million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) the price per share in the Next Financing round, or ii) the Original Issue Price of the Company&#8217;s Series A-2 Preferred Stock, which is $47.67. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognized losses equal to $0.3 million and $0.02 million for the nine months ended September&#160;30, 2023 and 2022, respectively, related to changes in fair value for the November 2022 Convertible Notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2023, upon closing of the Company&#8217;s IPO, the November 2022 Convertible notes were converted into an aggregate of 565,144 shares of common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Paycheck Protection Program Loan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;2, 2021, we received loan proceeds of approximately $0.5 million under the PPP. The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;), provided loans to qualifying businesses to help sustain our employee payroll costs, rent, and utilities due to the impact of the recent COVID-19 pandemic. Loans obtained through the PPP are eligible to be forgiven as long as the proceeds are used for qualifying purposes, which include the payment of payroll costs, interest on covered mortgage obligations, rent obligations and utility payments. The receipt of these funds, and the forgiveness of the loan is dependent on us having initially qualified for the loan and qualifying for the forgiveness of such loan based on our adherence to the forgiveness criteria. In June 2020, Congress passed the Payroll Protection Program Flexibility Act that made several significant changes to PPP loan provisions, including providing greater flexibility for loan forgiveness. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">105 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We used the proceeds from the PPP loan to fund payroll costs in accordance with the relevant terms and conditions of the CARES Act. We followed the government guidelines and tracking costs to ensure full forgiveness of the loan. To the extent it was not forgiven, we would have been required to repay that portion at an interest rate of 1% over a period of 5 years, beginning May 2022 with a final installment in April 2027. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the third quarter of 2022, the outstanding balance on the PPP loan including interest was forgiven by the U.S. Small Business Administration, which resulted in a $0.5 million gain upon debt forgiveness. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Warrant Transactions </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;23, 2021, we issued 6,632 common stock warrants in lieu of interest payments on our convertible notes and as compensation for services provided to us in relation to the agreements entered into with a third-party content provider. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 7 years, risk-free rate of 1.30%, and volatility of 65%. The fair value of the warrants of $0.4 million was recorded as a long-term liability. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;23, 2021, we issued 76,353 common stock warrants in connection with the issuance of preferred stock. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 10 years, risk-free rate of 1.30%, and volatility of 65%. The fair value of the warrants of $4.2 million was recorded as a reduction in the value of the Series A Financing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;25, 2021, we issued 49,629 common stock warrants in connection with the issuance of preferred stock. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 9.9 years, risk-free rate of 1.35%, and volatility of 65%. The fair value of the warrants of $2.8 million was recorded as a reduction in the value of the Series A Financing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&#160;13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. The fair value of the warrants was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the warrants as of each valuation date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded a change in fair value adjustment of $2.3 million and $0 million in the condensed consolidated statement of operations and comprehensive loss for the nine months ended September&#160;30, 2023 and 2022, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into shares of common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Class B Common Stock Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During July 2021 we issued an aggregate 6,632 warrants to purchase Class B Common Stock to various employees and non-employees. Each warrant has a strike price of $0.01 and has a contractual term of seven years. The warrants are classified as permanent equity within the consolidated balance sheets. Upon IPO, 4,000 of these warrants with an aggregate fair value of $0.2 million were issued as compensation for services provided to us and are recorded within operating expenses. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Preferred Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;23, 2022, all outstanding shares of redeemable convertible preferred stock were converted into shares of common stock on a one-to-one basis. Accordingly, no shares of preferred stock were outstanding as of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">106 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
December&#160;31, 2022. On December&#160;23, 2022, the Company amended and restated its certificate of incorporation to provide for, among other things, the Company&#8217;s authorized capital stock to consist of 369,950,000 shares of common stock, par value $0.0001 per share and 200,000,000 share of preferred stock, par value $0.0001 per share. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Series Seed Financing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2018, we entered into a Series Seed Preferred Stock Purchase Agreement (the &#8220;Series Seed Agreement&#8221;) for the issuance of 7,546 shares of Series Seed and 2,393 shares of Series Seed-1. We completed our initial Series Seed closing on August&#160;14, 2018, by issuing a total of 1,666 shares on this date at a purchase price of approximately $300.00 per share (the &#8220;Series Seed Share Price&#8221;). Between August 2018 and December 2018, we issued additional shares of Series Seed in a series of subsequent closings total of 5,880 shares and an additional 2,393 shares related from the conversion of our SAFE (combined the &#8220;Series Seed Financing&#8221;). The aggregate gross proceeds from the Series Seed Financing were approximately $2.3 million. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Series A Financing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2021 we amended our Certificate of Incorporation (&#8220;COI&#8221;) to authorize the issuance of 250,000 shares of Series Seed-2, 37,313 shares of Series Seed-3, 21,131 shares of Series Seed-4, 512,425 shares of Series Seed-5, 122,500 shares of Series Seed-6, 257,797 shares of Series Seed-7, 665,588 shares of Series Seed-8, 2,775,210 shares of Series Seed-9, 327,218 shares of Seed-10, 9,592,788 shares of Series A, and 1,531,734 shares of Series A-1. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;23, 2021, we executed a Series Seed and Series A Preferred Stock Purchase Agreement (the &#8220;Series Seed and Series A Agreement&#8221;) for the purposes of raising capital in the aggregate amount of up to $33.0 million by the means of issuance of Series A, Series A-1 and Series Seed-2, Series Seed-3, Series Seed-4, Series Seed-5, Series Seed-6, Series Seed-7, Series Seed-8, Series Seed-9, and Series Seed-10 (all Series Seed issuances noted herein are collectively referred to as &#8220;Series Seed 2-10&#8221;). On this date, we cancelled $5.3 million and $6.9 million (including principal and interest) of Series A Convertible Notes and SAFEs, respectively, which converted into a total of 13,503 shares of Series Seed-9 and a total of 19,519 of Series Seed-2-10, respectively. On the date of the Series Seed and Series A Agreement, we also cancelled our 2020 Secured Convertible Notes, of which $12.1 million (including principal and interest) converted into 24,576 shares of Series A and $4.0 million (including principal and interest) converted into 10,208 shares of Series A-1 (see Note 11 to the notes to our consolidated financial statements included elsewhere in this prospectus). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;23, 2021, we issued 14,182 shares of Series A at a purchase price of approximately $490.50 per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;13, 2021, we issued 25,189 shares of Series A at a purchase price of approximately $490.50 per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&#160;24, 2021, we amended our Amended and Restated Certificate of Incorporation to increase the number of Series A shares authorized from 9,592,788 to 18,165,136 total shares. As a result, on that date, we completed an additional closing of Series A and issued a total of 22,756 shares at a purchase price of approximately $490.50 per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;10, 2022, we amended our Amended and Restated Certificate of Incorporation to authorize 173,135,395 total shares of Series A-2. As a result, on that date, we completed a closing of Series A-2 and issued a total of 631,293 shares at a purchase price of approximately $47.67 per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate gross proceeds from the Series A Financing were approximately $58.1 million. Proceeds from the issuances associated with the cancellation of the convertible notes were equal to the fair value of the convertible notes upon conversion. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">107 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We classify preferred stock in accordance with ASC 480, Distinguishing Liabilities from Equity, which requires that contingently redeemable securities be classified outside of permanent stockholders&#8217; equity. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to the conversion of all outstanding preferred shares in the year ended December&#160;31, 2022, there were no contingently redeemable securities classified outside of permanent stockholders&#8217; equity as of September&#160;30, 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cash Flows </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Comparison of the Years Ended December&#160;31, 2022 and 2021 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:68%"></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year Ended<br />December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-style:italic">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(35,545</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(38,256</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,607</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(12,359</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">41,772</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52,452</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of exchange rate on cash</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(91</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(151</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Change In Cash and Cash Equivalents</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,471</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,686</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Comparison of the Nine Months Ended September&#160;30, 2023 and 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:68%"></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nine Months Ended <br />September&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-style:italic">(in thousands)</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(13,561</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(29,492</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,146</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,203</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,656</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">36,732</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of exchange rate on cash</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(145</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(74</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Change In Cash and Cash Equivalents</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(196</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,037</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities of $35.5 million for the year ended December&#160;31, 2022, was primarily due to a net loss of $58.2 million offset by an increase in depreciation and amortization, stock-based compensation, fair value of warrants issued with convertible notes, interest expense, foreign currency, and change in operating assets and liabilities, as well as an impairment write-off of $6.7 million, $6.3 million, $3.5 million, $1.0 million, $0.4 million, $2.5 million, and $2.3 million, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities of $38.3 million for the year ended December&#160;31, 2021, was primarily due to a net loss of $32.8 million and a decrease in net change in operating assets and liabilities of $6.1 million. The decrease in net operating assets and liabilities was primarily due to an increase in inventory of $3.4 million, a $3.2 million increase in vendor deposits and a $1.2 million decrease in accounts payable due to timing of payments, offset partially by a $1.2 million increase in accrued expenses and other current liabilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities of $13.6 million for the nine months ended September&#160;30, 2023, was primarily due to a net loss of $40.0 million offset by depreciation and amortization expense of $4.9 million, stock-based compensation of $23.8 million, amortization of debt discount $1.3 million, warrants issued to service providers $0.5 million, change in fair value of convertible notes of $0.3 million, and increase in operating assets and liabilities of $0.1 million, partially offset by gain on debt forgiveness of $2.6 million and change in the fair value of warrants of $2.3 million. The remaining difference of $0.5 million was related to foreign currency, inventory valuation loss and interest expense. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">108 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities of $29.5 million for the nine months ended September&#160;30, 2022, was primarily due to a net loss of $39.4 million, stock-based compensation expense of $4.0 million, inventory valuation loss of $1.1 million, interest expense of $0.7 million, foreign currency expense of $0.8 million, depreciation and amortization expense of $4.7 million, partially offset by decrease in operating assets and liabilities of $0.9 million primarily related to inventory purchases and gain on debt forgiveness of $0.5 million. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Investing Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities of $7.6 million for the year ended December, 2022 was primarily related to the development of internal-use software, software to be sold and markets and content, and purchases of property and equipment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash used in investing activities of $12.4 million for the year ended December&#160;31, 2021, was primarily related to the development of internal-use software, software to be sold and markets and content, and purchases of property and equipment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities of $1.1 million for the nine months ended September&#160;30, 2023 related to the acquisition of software and content and internal use software. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities of $8.2 million for the nine months ended September&#160;30, 2022, was primarily related to the development of internal-use software, software and content to be sold and marketed and, and purchases of property and equipment. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Financing Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities of $41.8 million for the year ended December&#160;31, 2022 was primarily related to proceeds from the issuance of preferred stock &#8211; Series A, convertible notes and common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities of $52.5 million for the year ended December&#160;31, 2021 was primarily related to proceeds from the issuance of preferred stock &#8211; Series A, convertible notes and common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities of $14.7 million for the nine months ended September&#160;30, 2023 was primarily related to $4.3 million of proceeds from the issuance of common stock in connection with the rights offering completed in February 2023 and $10.8 million net proceeds from issuance of common stock upon IPO, net proceeds from senior secured notes of $1.0 million and net payments of loans of $0.02 million, partially offset by payments of offering costs of $1.5 million. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities of $36.7 million for the nine months ended September&#160;30, 2022 was primarily related to proceeds from the issuance of preferred stock &#8211; Series A, convertible notes and common stock. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">109 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Contractual Obligations and Other Commitments </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Lease Obligations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following represents our minimum annual rental payments under operating leases for each of the next five years and thereafter as of December&#160;31, 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:80%"></td>

<td style="vertical-align:bottom;width:16%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Future <br />Minimum<br />Payments</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Year Ending December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">(in&#160;thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2026</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2027</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">169</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following represents our minimum annual rental payments under operating leases for each of the next five years and thereafter as of September&#160;30, 2023: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:80%"></td>

<td style="vertical-align:bottom;width:16%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Future<br />Minimum<br />Payments</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Fiscal Year Ending December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">(in&#160;thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023(remaining)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">78</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">78</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2026</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">78</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2027</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">78</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-style:italic">C</span><span style="font-weight:bold"><span style="font-style:italic">ommitments </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2021, we entered into two agreements with a third-party content provider (&#8220;Content Provider&#8221;), a service agreement and a collaboration agreement. Per the service agreement, Forme is to provide content creation services for the Content Provider in which we are to produce workout content using the Content Provider&#8217;s trainers and studios. Under the collaboration agreement, both we and the Content Provider agree to jointly market their partnership; in addition, the collaboration agreement provides us with a license to use the Content Provider&#8217;s content and marks on our Studio fitness ecosystem (i.e., the &#8220;License&#8221;). The license issued to us allows us to reproduce, modify, prepare derivative works based upon, distribute, publicly display, publicly perform the content and the modified content, to market, advertise or promote Forme, perform specified activities, and provide our customers access to and use of the Content Provider&#8217;s content, throughout the world on our Studio products and in any media, so long as such other media is associated or related to the use of our Studio products. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will recognize an asset and liability for the total minimum commitment (the license fee) on a quarterly basis. As of December&#160;31, 2022, approximately $2.3 million was recognized as a liability. We believe the estimated number of future showings or content produced by the Content Provider will remain consistent for each tranche over the initial term of the agreement and consistent with the content produced by us. The content produced by us and the content licensed from the Content Provider by us will be made available and marketed to the customer in </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">110 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the same way. As the content is ultimately being consumed by the customer in the same way we believe it will have the same estimated number of future showings and estimated useful life as we produced content. As such, each quarterly tranche will be amortized over three (3)&#160;years. The unamortized cost of content related to the Content Provider is approximately $0.0 million as of December&#160;31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The liability will be recorded and accreted at the gross amount for each tranche of content delivered to us for $0.5 million per quarter and will be decreased when the payments per the payment schedule above are made. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A liability for total minimum commitment (the license fee) on a quarterly basis was recognized as a liability of $2.3 million as of December&#160;31, 2022. In March 2023, both agreements with the Content Provider were terminated by mutual agreement and no payments remain due or payable thereunder and the liability was recognized as a gain on settlement for the nine months ended September&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Content Provider was committed to developing a minimum number of hours of content for our exclusive use over the five-year term, subject to extensions, of the collaboration agreement. In exchange, we were required to pay fixed fees, totaling $9.0 million, of which $1.2 million are due within the first year of the agreement, and the remaining fixed fees are paid systematically over the initial five-year terms. Additional payments could be required if our member membership amount from the licensed content exceed certain stipulated annual and cumulative thresholds during the contract term. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following represents our minimum annual guaranteed payments under license agreements for each of the next five years and thereafter as of December&#160;31, 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:76%"></td>

<td style="vertical-align:bottom;width:17%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Future&#160;Minimum<br />Payments</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Year Ending December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">(in&#160;thousands)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,025</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,950</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2026</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,200</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2027</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,425</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As noted above, we could be required to make additional payments in each of these years if our membership amount reaches certain thresholds. This may result in additional payments of up to $0.7 million, $0.4 million, $2.1 million and $2.8 million in 2024, 2025, 2026, and 2027, respectively. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Restructuring </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&#160;31, 2022, the Company announced a restructuring cost savings initiative designed to reallocate personnel resources to support their ongoing product development efforts while also increasing their focus on marketing and sales and building their brand. As a result of this action, the Company has incurred restructuring costs that include employee termination severance, as well as other incremental costs resulting from the restructuring actions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Employee termination severance is recorded based on statutory requirements and completed negotiations. Restructuring costs are recognized in the Company&#8217;s condensed consolidated financial statements in accordance with GAAP. Generally, charges are recorded when restructuring actions are approved, communicated and/or implemented. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">111 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Off-Balance Sheet Arrangements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with ASC 718, when a nonrecourse note is used to fund the exercise of a stock option, the stock option is not considered &#8220;exercised&#8221; for accounting purposes until the employee repays the loan. Prior to repayment of a nonrecourse loan, the outstanding shares received in exchange for the loan are excluded from the denominator of basic earnings per share. Additionally, the nonrecourse loan itself is not recorded on the Company&#8217;s balance sheet since the arrangement is, in substance, a stock option. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2022 and 2021, the sale of the shares of common stock to several employees was completed in the form of issuances of Secured Partial Recourse Promissory Notes (the &#8220;Note(s)&#8221;) by the respective employee to the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes were in the aggregate amount of $477,290 and $449,750 for 353,532 and 299,832 shares as of September&#160;30, 2023 and December&#160;31, 2022, respectively. The Notes are secured by a pledge of collateral, representing the shares of stock sold. Interest is charged at the mid-term Applicable Federal Rate as of the date of the Note and compounded annually. Per the terms of the Notes, 51% of the initial amounts of the outstanding principal balances plus any accrued and unpaid interest, represent a full recourse note, and 49% of the initial amounts represent a nonrecourse note. The Company analyzed the terms of the Notes and concluded that the recourse portion of the notes are nonrecourse in nature as the Company does not have intention to seek repayment beyond the shares issued despite the recourse legal terms, and thus will be treated the same as the nonrecourse portion of the Notes. All Notes were outstanding as of December&#160;31, 2022 and September&#160;30, 2023, and are not recorded on the balance sheet. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x)&#160;the price per share of the next equity financing with total proceeds of at least $10.0 million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In accordance with ASC 718, as the warrant contains a performance condition dependent on an initial public offering, there was no impact recorded prior to December&#160;31, 2022. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 28,124 shares of common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $400,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 49,996 shares of common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2023, we issued warrants to certain existing non-affiliate stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with the Bridge Note Financing. Such warrants are exercisable for a number of shares of our common stock that is determined by dividing: (A)&#160;(i)&#160;in the case of the warrants issued to the lead noteholder, 67% of the aggregate principal amount of notes issued to such lead noteholder and; (ii)&#160;in the case of all other noteholders in the Bridge Note Financing, 60% of the aggregate principal amount of notes issued to such other noteholders by (B)&#160;(i)&#160;the initial public offering price per share or (ii)&#160;if the initial public offering is not consummated, by either (x)&#160;the price per share offered in a change of control transaction or (y)&#160;if a change of control transaction does not occur, the fair market value of our common stock as determined by an independent appraiser. The warrants may also be net exercised </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">112 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 163,121 shares of common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Critical Accounting Policies and Estimates </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with GAAP. In preparing the consolidated financial statements, we make estimates and judgments that affect the reported amounts of assets, liabilities, stockholders&#8217; equity/deficit, revenue, expenses, and related disclosures. We re-evaluate our estimates on an ongoing basis. Our estimates are based on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Because of the uncertainty inherent in these matters, actual results may differ from these estimates and could differ based upon other assumptions or conditions. The critical accounting policies that reflect our more significant judgments and estimates used in the preparation of our consolidated financial statements include those noted below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Fair Value Measurements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Level 1 inputs are based on quoted prices in active markets for identical assets or liabilities. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Level 2 inputs are based on observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Level 3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our material financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these instruments. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Internal-use Software </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We capitalize certain eligible software development costs incurred in connection with our internal use software in accordance with ASC 350-40, Internal-use Software and ASC 985, Software. These capitalized costs also relate to our Studio software that is accessed by our customers on a membership basis as well as certain costs associated with our information systems. Capitalized software costs are amortized over the estimated useful life, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">113 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which is three years. Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is probable the project will be completed, and the software will be used to perform the function intended. Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for our intended use. We expense all costs incurred that relate to planning and post-implementation phases of development. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the years ended December&#160;31, 2022 and 2021, we capitalized $1.4 million and $1.3 million, respectively, of software costs. During the years ended December&#160;31, 2022 and 2021, we capitalized $2.7 million and $1.4 million, respectively, of internal-use software. As of December&#160;31, 2022 and 2021, we had $2.6 million and $2.3 million of unamortized software costs, respectively. As of December&#160;31, 2022 and 2021, we had $3.8 million and $2.7 million of unamortized internal-use software costs, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&#160;30, 2023 and December&#160;31, 2022, the Company capitalized $1.4 million and $1.4 million, respectively, of software costs. As of September&#160;30, 2023 and December&#160;31, 2022, the Company capitalized $0.5 million and $2.7 million, respectively, of internal-use software. As of September&#160;30, 2023 and December&#160;31, 2022, we had $2.8 million and $2.6 million of unamortized software costs, respectively. As of September&#160;30, 2023 and December&#160;31, 2022, we had $2.9 million and $3.8 million of unamortized internal-use software costs, respectively. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amortization is computed on a straight-line basis over the following estimated useful lives: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Internal-use Software&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3 years </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Capitalized Studio Content </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Capitalized Studio content costs include certain expenditures to develop video and live content for our customers. We capitalize production costs for recorded content in accordance with ASC 926-20, Entertainment-Films &#8211; Other Assets &#8211; Film Costs. We recognize capitalized content, net of accumulated amortization, within other non-current assets in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, we amortize individual titles within the Studio content library on a straight-line basis over a three-year useful life. We review factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#8220;obsolescence&#8221; of such content over such period given the nature of our videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of our member base which will contribute to substantial increases in viewership over time given the recent launch of our product and membership offerings. Based on these factors, we have determined that a three-year (3-year) amortization period is reasonable for the content. We will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">114 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
produced content is completed. To date, we have recognized one impairment with regards to the carrying value of our content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $2.9 million and $4.4 million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Convertible Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As permitted under ASC Topic 825, Financial Instruments, we have elected the fair value option to account for our convertible notes. In accordance with ASC Topic 825, we record these convertible notes at fair value with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive income (loss). As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. We concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. As of December&#160;31, 2022, there are $4.3 million of convertible notes outstanding. In May 2023, upon closing of the Company&#8217;s IPO, the convertible notes were converted into an aggregate of 565,144 shares of common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Simple Agreements for Future Equity (&#8220;SAFEs&#8221;) and Advance Subscription Agreements (&#8220;ASAs&#8221;) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have issued several SAFEs and ASAs in exchange for cash financing. The SAFEs were initially measured at fair value using a probability weighted expected return method (&#8220;PWERM&#8221;) and were subsequently remeasured at fair value at each reporting period, through the date of conversion. The ASAs were initially measured at fair value utilizing the fair value of our common stock according to the Section&#160;409A valuation performed by an independent appraiser closest to the date of grant and were subsequently remeasured at fair value at each reporting period, through date of conversion. Pursuant to the SAFE agreement provisions, all outstanding SAFE instruments were converted to preferred stock in 2021, in connection with a Series A financing. All ASAs were converted to common stock on the respective ASA Longstop Dates (6-month anniversary of issuance). There were no outstanding SAFEs or ASAs as of December&#160;31, 2022 or 2021. The remeasurements of the SAFEs and ASAs resulted in the recognition of a $0.3 million loss for the year ended December&#160;31, 2021 (see Note 4 to the notes to our consolidated financial statements included elsewhere in this prospectus for the accounting for any significant inputs to the valuation of the SAFE and ASA instruments). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Revenue Recognition </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our primary source of revenue is from sales of our Connected Fitness Products and related accessories and associated recurring membership revenue. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We determine revenue recognition through the following steps: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Identification of the contract, or contracts, with a customer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Identification of the performance obligations in the contract; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Determination of the transaction price; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Allocation of the transaction price to the performance obligations in the contract; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Recognition of revenue when, or as, we satisfy a performance obligation. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Our revenue is reported net of sales returns, discounts, incentives, and rebates to commercial distributors as a </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">115 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reduction of the transaction price. We estimate our liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We apply the practical expedient as per ASC 606-10-50-14 and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expense sales commissions on our connected fitness products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in our consolidated statements of operations and comprehensive (loss). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Connected Fitness Products </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Connected Fitness Products include our portfolio of connected fitness products and related accessories, delivery and installation services, and extended warranty agreements. We recognize Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period. We allow customers to return products within 30 days of purchase, as stated in our return policy. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We record payment processing fees for our credit card sales for connected fitness products within fitness product revenue in our consolidated statements of operations and comprehensive (loss). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Membership </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our memberships provide unlimited access to content in our library of on-demand fitness classes. Our memberships are offered on a month-to-month basis. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amounts paid for membership fees are included within deferred revenue on our consolidated balance sheets and recognized ratably over the membership term. We record payment processing fees for our monthly membership charges within cost of membership and training in our consolidated statements of operations and comprehensive (loss). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Training </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our training services are personal training services delivered through the Connected Fitness Products and third- party mobile devices. Training revenue is recognized at the time of delivery. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Stock-Based Compensation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2020, our board of directors adopted the 2020 Equity Incentive Plan (the &#8220;2020 Plan&#8221;) and in April 2023, our board of directors adopted the 2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;). Following the completion of our initial public offering, no additional awards and no additional shares of our common stock remained available for future issuance under the 2020 Plan. However, the 2020 Plan continues to govern the terms and conditions of the outstanding awards previously granted thereunder. Stock-based awards are measured at the grant date based on the fair value of the award and are recognized as expense, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. We estimate the fair value of stock options using the Black-Scholes option pricing model. The determination of the grant date fair value of stock awards issued is affected by a number of variables, including the fair value of our common stock, the expected common stock price volatility over the expected life of the awards, the expected term of the stock option, risk-free interest rates, and the expected dividend yield of our common stock. We derive </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">116 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our volatility from the average historical stock volatilities of several peer public companies over a period equivalent to the expected term of the awards. We estimate the expected term based on the simplified method for employee stock options considered to be &#8220;plain vanilla&#8221; options, as our historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant. Expected dividend yield is 0.0% as we have not paid and does not currently anticipate paying dividends on our common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense is classified in the accompanying consolidated statement of operations in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified. For the year ended December&#160;31, 2022, the Company recognized an additional stock-based compensation expense of $1.1 million as a result of a modification related to accelerated option vesting. There were no modifications during the year ended December&#160;31, 2021. For the nine months ended September&#160;30, 2023, the Company recognized an additional stock- based compensation expense of $0.5 million as a result of a modification related to accelerated option vesting and repricing of options. There were no modifications during the nine months ended September&#160;30, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Income Taxes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We utilize the asset and liability method for computing our income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes estimates, assumptions, and judgments to determine our provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. We assess the likelihood that our deferred tax assets will be recovered from future taxable income and, to the extent we believe that recovery is not likely, we establish a valuation allowance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We recognize the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within provision for income taxes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Common Stock Valuations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Historically, for all periods prior to our IPO, as there was no public market for our common stock prior to such date, the estimated fair value of our common stock has been determined by our board of directors, with input from management, as of the date of each award grant, considering our most recently available independent third- party valuations of common stock and any additional objective and subjective factors that we believed were relevant and which may have changed from the date of the most recent valuation through the date of each award grant. The independent third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, <span style="font-style:italic">Valuation of Privately-Held-Company Equity Securities Issued as Compensation</span>. We determined that based on our stage of development and other relevant factors, it was most appropriate to prepare our common stock valuations using the option-pricing method, or OPM, which used a market approach to estimate our enterprise value. The OPM treats common stock and preferred stock as call options on the total equity value of a company, with exercise prices based on the value thresholds at which the allocation among the various holders of a company&#8217;s securities changes. Under this method, the common stock has value only if the funds available for distribution to stockholders exceeded the value of the preferred stock liquidation preferences at the time of the liquidity event, such as a strategic sale or a merger. A discount for lack of marketability of the common stock is then applied to arrive at an indication of value for the common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The assumptions underlying these valuations were highly complex and subjective and represented management&#8217;s best estimates, which involved inherent uncertainties and the application of management&#8217;s judgment. As a result, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">117 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
if we had used significantly different assumptions or estimates, the fair value of our common stock and our stock-based compensation expense could be materially different. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the absence of a public trading market, our board of directors, with input from management, considered numerous objective and subjective factors to determine the fair value of common stock. The factors included, but were not limited to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">contemporaneous valuations performed by an independent third-party valuation firm; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our stage of development and material risks related to our business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the progress of our research and development programs, including the development of Studio Lift; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">sales of our preferred stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the rights, preferences and privileges of our preferred stock relative to those of our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">lack of marketability of our common and preferred stock as a private company; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our operating results and financial performance; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the likelihood of achieving a liquidity event, such as an initial public offering or sale of our company, in light of prevailing market conditions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the trends, developments and conditions in the fitness sectors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">analysis of initial public offerings and the market performance and stock price volatility of similar public companies in the health and fitness sectors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the economy in general. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a public market for our common stock has been established in connection with the completion of our IPO, it is no longer necessary for our board of directors to estimate the fair value of our common stock in connection with our accounting for granted stock options and other such awards we may grant, as the fair value of our common stock is based on the quoted market price of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Recent Accounting Pronouncements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See Note 2, Summary of Significant Accounting Policies, of the notes to our consolidated financial statements included elsewhere in this prospectus for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of the dates of the statement of financial position included in this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Emerging Growth Company and Smaller Reporting Company Status </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Section&#160;107(b) of the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, an &#8220;emerging growth company&#8221; can delay the adoption of new or revised accounting standards until such time as those standards would apply to private companies. We have elected this exemption to delay adopting new or revised accounting standards until such time as those standards apply to private companies. Where allowable we have early adopted certain standards as described in Note 2 of our audited condensed financial statements and the notes to our unaudited condensed consolidated financial statements included elsewhere in this prospectus. As a result, our consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. We will continue to remain an &#8220;emerging growth company&#8221; until the earliest of the following: (i)&#160;the last day of the fiscal year following the fifth anniversary of the date of the completion of our initial public offering; (ii)&#160;the last day of the fiscal year in which our total annual gross revenue is equal to or more than $1.235 billion; (iii)&#160;the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv)&#160;the date on which we </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">118 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
are deemed to be a large accelerated filer under the rules of the SEC. We are also a &#8220;smaller reporting company,&#8221; meaning that the market value of our stock held by non-affiliates is less than $700.0 million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i)&#160;the market value of our stock held by non-affiliates is less than $250.0 million or (ii)&#160;our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700.0 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Quantitative and Qualitative Disclosure About Market Risk </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Foreign Currency Risk </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To date, all of our inventory purchases have been denominated in U.S. dollars. A portion of our operating expenses are incurred outside the United States and are denominated in foreign currencies, which are also subject to fluctuations due to changes in foreign currency exchange rates. In addition, our suppliers incur many costs, including labor and supply costs, in other currencies. While we are not currently contractually obligated to pay increased costs due to changes in exchange rates, to the extent that exchange rates move unfavorably for our suppliers, they may seek to pass these additional costs on to us, which could have a material impact on our gross margins. Our operating results and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. However, we believe that the exposure to foreign currency fluctuation from operating expenses is relatively small at this time as the related costs do not constitute a significant portion of our total expenses. To date, we have not entered into derivatives or hedging transactions, as our exposure to foreign currency exchange rates has historically been partially hedged as our foreign currency denominated inflows have covered our foreign currency denominated expenses. However, we may enter into derivative or hedging transactions in the future if our exposure to foreign currency should become more significant. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Inflation Risk </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition, and operating results. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Internal Control Over Financial Reporting </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A company&#8217;s internal control over financial reporting is a process designed by, or under the supervision of, a company&#8217;s principal executive and principal financial officers, or persons performing similar functions, and effected by a company&#8217;s board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles. A material weakness is a significant deficiency, or a combination of significant deficiencies, in internal control over financial reporting such that it is reasonably possible that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In preparing our financial statements as of and for the years ended December&#160;31, 2022 and December&#160;31, 2021, and as of and for the nine months ended September&#160;30, 2023 and 2022, management identified material weaknesses in our internal control over financial reporting. The material weaknesses we identified related to (1)&#160;the lack of a sufficient number of trained professionals with the expertise to design, implement, and execute a </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">119 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
formal risk assessment process and formal accounting policies, procedures, and controls over accounting and financial reporting to ensure the timely and accurate recording of financial transactions while maintaining a segregation of duties; and (2)&#160;the lack of a sufficient number of trained professionals with the appropriate U.S. GAAP technical expertise to identify, evaluate, and account for complex transactions and review valuation reports prepared by external specialists. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are implementing measures designed to improve our internal control over financial reporting to remediate these material weaknesses, including formalizing our processes and internal control documentation and strengthening supervisory reviews by our financial management; hiring additional qualified accounting and finance personnel and engaging financial consultants to enable the implementation of internal control over financial reporting and segregating duties amongst accounting and finance personnel. In addition, we are planning on implementing an accounting software system with the design and functionality to segregate incompatible accounting duties, which we currently expect will be fully implemented in our 2024 fiscal year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we are implementing these measures, we cannot assure you that these efforts will remediate our material weaknesses and significant deficiencies in a timely manner, or at all, or prevent restatements of our financial statements in the future. In particular, our material weakness related to our accounting software was not fully remediated for the fiscal year ended December&#160;31, 2022 or the nine months ended September&#160;30, 2023, as we expect to implement new software in 2024. If we are unable to successfully remediate our material weaknesses, or identify any future significant deficiencies or material weaknesses, the accuracy and timing of our financial reporting may be adversely affected, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports, and the market price of our common stock may decline as a result. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of the JOBS Act, we and our independent registered public accounting firm were not required to, and did not, perform an evaluation of our internal control over financial reporting as of December&#160;31, 2022 or September&#160;30, 2023, nor any period subsequent in accordance with the provisions of the Sarbanes-Oxley Act. Accordingly, we cannot assure you that we have identified all, or that we will not in the future have additional, material weaknesses. Material weaknesses may still exist when we report on the effectiveness of our internal control over financial reporting as required under Section&#160;404 of the Sarbanes-Oxley Act after the completion of this offering. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Inherent Limitations on Effectiveness of Controls </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management, including our principal executive officer and principal financial officer, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Due to inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">120 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_12">BUSINESS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Purpose </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our mission is to reinvent how we take care of ourselves through the power of coaching, and to usher in a new era of health, happiness, and longevity. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe the most important commitment we make in our lifetime is the commitment we make to our health and wellbeing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe one of the best ways to protect, improve and even transform your health is to work with an expert who knows what you need and can coach you human-to-human, 1:1, to help you reach your goals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While technology cannot replace a real coach, we believe technology can make connecting with expert coaches more effective, convenient, and accessible than ever before. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our goal is to create a holistic platform designed to connect people with coaches in all areas of fitness and wellness, including personal training and specialized sport instruction, nutrition, sleep, mindfulness, and physical therapy. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who We Are </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are Forme, a digital fitness service that combines premium connected fitness hardware products with expert personal training and coaching (from real humans) to deliver an immersive experience and better outcomes for both consumers and trainers. Our health coaching services encompass guidance and coaching on fitness training, nutrition, recovery, sleep, and other health and lifestyle categories. Our health coaching services are delivered primarily by our team of more than 38 trainers, as of September&#160;30, 2023. All of our trainers can deliver personal training and 22 of whom can also deliver health coaching in other areas of wellness. We believe we are the pioneer brand in the emerging sector of virtual health coaching and that our products and services are accelerating a powerful shift towards outcome-driven fitness solutions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We offer two connected fitness hardware products, the Forme Studio (fitness mirror) and the Forme Studio Lift (fitness mirror and cable-based digital resistance), currently priced at $2,495 and $6,495, respectively. Both products are designed to provide a more integrated and immersive experience than similar connected fitness products currently on the market. The Forme Studio is our base product and features a 43-inch 4K ultra high definition (&#8220;UHD&#8221;) touchscreen display, which is among the largest and highest definition screens in the connected fitness equipment market, and two front-facing 12 megapixel (&#8220;MP&#8221;), wide angle cameras designed to facilitate seamless live interaction with a trainer. The Forme Studio Lift also features two cable-based resistance arms that can provide up to 100 pounds of resistance per arm. Our products ship with a set of premium accessories that are included with purchase. We also offer add-on accessories, including our barre, a unique accessory that attaches to the Forme Studio or Forme Studio Lift and enables members to incorporate a wooden ballet barre into their barre routines. Sales of our connected fitness hardware products have accounted for the substantial portion of our revenue to date. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">121 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g38t23.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to our connected fitness hardware products, we offer expert personal training and health coaching in different formats and price points so that our members can customize their training plans according to their unique needs. Personal training currently comprises the majority of our health coaching services. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Video On-Demand (&#8220;VOD&#8221; or &#8220;On-Demand&#8221;): All members who purchase the Forme Studio and Forme Studio Lift are able to access our VOD content library by creating a Forme account and signing up for our monthly membership at a cost of $49 per month. Our VOD content library includes hundreds of On-Demand classes featuring what we believe to be the top fitness instructors in the Los Angeles area. Upon joining the Forme platform, each member is matched with a Fitness Concierge who works to understand specific needs and goals and then curates weekly fitness plans, comprised of On-Demand classes from our VOD content library, that are designed to create a sense of accountability, structure, and motivation for the member. Members may cancel their monthly membership at any time, during which they would no longer have access to any of our VOD content or our health coaching services. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Custom Training: For members who desire additional personalization, our Custom Training provides members guidance from real personal trainers. Through Custom Training members work closely with one of our expert trainers who will deliver custom, guided programs that are specifically tailored to the members&#8217; health goals in a range of areas, including movement, fitness, nutrition, recovery, and mindfulness. These programs can include a mixture of On-Demand classes and custom workouts, designed by the coach, with demonstration videos that the member can follow on the Forme Studio, Forme Studio Lift, or on the Forme iOS app (the &#8220;Forme Studio app&#8221;) at a time that is convenient for them. Additionally, our Custom Training service includes live, regular check-ins on progress and will include two-way messaging through the Forme Studio app, enabling members to keep in regular contact with their trainer to review progress and celebrate successes. This service is charged as a monthly membership for $149/month (inclusive of VOD membership). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Live 1:1 personal training: Our highest touch coaching offering is Live 1:1 personal training, which introduces live training sessions in our members&#8217; training program. Members who opt into Live 1:1 complete an onboarding process and are matched with one of our expert trainers based on the member&#8217;s preferences and criteria. Once matched, the trainer takes the member through a fitness assessment during the first session then builds a personalized program for the member based on specific needs and goals. Through our internally developed Live 1:1 software platform we strive to deliver a consistent and high quality user experience for both the member and the trainer that includes value added features like on-screen biometrics (e.g., heart rate and calories burned), an adjustable field of view for the trainer and other on-screen UI elements to provide context and motivation during a session. Coaches training members on the Studio Lift have the ability to adjust resistance for their members during a workout, providing an added level of personalization and service for the member. We offer Live 1:1 personal training as a monthly membership starting at $399 per month, which includes four Live 1:1 training sessions per month, unlimited custom workouts (through our Custom </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">122 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Training offering), and access to our VOD library. We have additional plans available for members who want to train live more frequently and/or need more customization from a health coach. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g72h71.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our services are accessible via download or streaming through our connected fitness hardware products or via streaming through our standalone Forme Studio app, which is available through iOS mobile devices and most iOS tablets and computers. Members can access Custom Training and Live 1:1 personal training services through the Forme Studio app. We believe the combination of our proprietary software and immersive content combined with our premium connected fitness hardware products and expert coaching network creates a compelling value proposition for our member base and our trainers, and can generate attractive recurring membership revenue. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the beginning of every member&#8217;s journey, they are matched with a Fitness Concierge who works to understand specific needs and goals. Our Fitness Concierge team is currently comprised of personnel with training and expertise in hospitality and membership experience, and with our connected fitness hardware products and health coaching services. In addition to curating weekly fitness plans for members, the Fitness Concierge team assists members from initial onboarding through the entirety of the membership experience, including answering general questions, assisting members with matching and changing trainers depending on a member&#8217;s preferences, and addressing other member questions and concerns regarding their fitness goals and experience. Our Fitness Concierge team works with our health trainers to help ensure that each member is maximizing the value of their experience. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What Sets Us Apart </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Connected fitness hardware products with services to address a large and growing market </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our product offering is a combination of premium connected fitness hardware products and health coaching services, which we believe significantly differentiates us in our industry. We currently offer three coaching offerings, VOD membership Custom Training, and Live 1:1 personal training. We offer these three coaching services at different price points to enable accessibility and provide choice to our members. We believe the addition of premium connected fitness hardware products, including the Forme Studio (fitness mirror) and the Forme Studio Lift (fitness mirror with digital weight system), through which members can access our trainers, can drive increased customer lifetime values. Our service can also be accessed through our Forme Studio app, which is available through iOS mobile devices and most iOS tablets and computers, which increases the opportunity for consumer engagement and flexibility. We have designed our product portfolio to be modular and customizable so that our product and service offerings can be tailored to a broad range of fitness goals, budgets, and needs, thereby accessing a larger addressable market. We also view the fact that we in-source development and management of our trainers and the hardware and software through which they reach our members, as a key differentiator that allows us to deliver a high quality and consistent integrated experience across our offerings. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Services offer compelling unit economics </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By adding services on top of our connected fitness hardware products, we aim to achieve attractive unit economics relative to others in the smart home gym and connected fitness industry. For example, at a 20%-30% </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">123 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
member penetration rate, our health coaching service offerings increase our average revenue per device by three times relative to VOD content-only membership, and increase gross profit per device by nearly two times. We believe our service offerings also reduces our reliance on driving volume through brand awareness and product sales, and positions us to achieve attractive levels of annual recurring revenue and profitability. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g51z45.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Internal company analysis. See <span style="font-style:italic">&#8220;Market, Industry, and Other Data&#8221;</span> for a discussion of the methodology and assumptions underlying internal company estimates. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Premium hardware enables immersive training experiences </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our premium connected fitness hardware products were designed in-house. The Forme Studio and Forme Studio Lift have a 43-inch 4K display, which we believe is currently the largest and highest definition reflective screen in the connected fitness equipment industry, a built-in microphone, and two 12 MP cameras with body detection and tracking technology to enable high quality, two-way video communication between client and trainer and to maximize the field of vision for our trainers such that they can see their clients throughout the live coaching session. The Forme Studio Lift provides digital resistance up to 100 pounds per arm and is able to auto-adjust resistance based on the user&#8217;s profile and can be adjusted remotely by the trainer during a live session. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Engaging VOD content from leading instructors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our VOD content spans several modalities, including strength, recovery, barre, mindfulness and meditation, Pilates, yoga, and other specialty fitness categories. We produce our VOD content both through our highly skilled in-house team and by contracting seasoned content production and creative professionals. Our VOD content features what we believe to be the top fitness instructor talent in the Los Angeles area. Our Fitness Concierge team curates workout programming from our VOD content library for our members, which provides an enhanced experience for our members, an added sense of accountability, and tailored instruction on how to reach their goals. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Highly qualified trainers who continue to advance their skills and expertise through continuing education </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We strive to hire highly experienced trainers in the industry to deliver our services. In 2022, we hired approximately 4% of the 1,500 total applicants that we received to be a trainer on our platform. When recruiting our trainers, we seek to ensure that they have a nationally accredited personal training certification (&#8220;CPT&#8221;) through industry leading organizations, such as NSCA (National Strength and Conditioning Association), ACSM (The American College of Sports Medicine), ACE (American Council on Exercise), NCSF (National Council on Strength and Fitness), and NASM (National Academy of Sports Medicine). In addition to CPT, as of September&#160;30, 2023, we have 27 trainers on board with additional coaching certifications including Precision Nutrition (PN) certifications for nutritional coaching. Once onboard, our trainers go through a proprietary eight-week training curriculum, taught by our team of seasoned fitness industry professionals, prior to being matched with our members. After onboarding and to help retain top talent as our member base grows, we provide our trainers with ongoing education to ensure continued skill advancement in their careers. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">124 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Access to multiple, cost-effective customer acquisition channels </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe our business model positions us to access multiple, cost-effective customer acquisition channels, which in turn presents a compelling value proposition. Our customer acquisition strategy is based on the belief that our technology can be employed to digitize health coaching in other markets. While direct-to-consumer channels can provide the quickest path to initial growth, we have also invested early in developing channels that we believe may yield more cost-effective customer acquisition rates in the future. For example, we anticipate initiating strategic relationships in sport sectors, and expect to continue our expansion into the corporate wellness sector, which we believe can enable us to scale efficiently and reach new target audiences. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Seasoned leadership team of fitness industry professionals </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have assembled a seasoned leadership team that has experience building industry-leading connected fitness and coaching products. Members of our team have extensive expertise in the connected fitness and general health and wellness industries, including previous tenures at highly recognized names in the industry, such as Equinox, Peloton, and Exos. Our founding team believes deeply that health coaching is key to fitness outcomes, and we believe we have assembled talent with deep experience in both technology and personal training to bring the most advanced virtual health coaching platform to the market. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Industry and Opportunity </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Industry </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We participate in the large and steady growing health and wellness industry. According to the 2021 Global Wellness Institute, total global spending in the wellness industry in 2020 was $4.4 trillion, of which approximately $740 billion was spent on fitness and other categories of wellness, including yoga, barre, and Pilates. Additionally, according to the International Health, Racquet&#160;&amp; Sportsclub Association (&#8220;IHRSA&#8221;), the U.S. gym and health club industry had a total of approximately 64&#160;million gym memberships and generated $35 billion of revenue in 2019, representing compound annual growth rates (CAGR) of 4% and 6%, respectively, since 1997, which we believe signals consistent underlying growth in demand for fitness offerings. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our current product portfolio, which consists of our Forme Studio, Forme Studio Lift, and health coaching services, including our VOD membership, and Live 1:1 personal training, addresses a large consumer base. Leveraging data from the Bureau of Labor Statistics and IHRSA, we estimate that within the U.S. market, approximately 32&#160;million people participate in strength training and over 8&#160;million people participate in personal training services in a given year. Based on information from Fortune Business Insights, we estimate that over $5 billion of fitness equipment was purchased in the United States for in-home use in in 2021. For a discussion of the methodology used in estimating participation rates, see <span style="font-style:italic">&#8220;Market, Industry, and Other Data.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Opportunity </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We view our market opportunity in terms of a TAM, which we believe is the market we can reach over the long-term in our current markets with our current and future product and service offerings. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">According to our research, we believe our TAM includes nearly 10&#160;million households, representing total potential revenue of $18 billion, all of which is in the United States. Our TAM consists of households in our current market, the United States, that earn an annual income of $100,000 or greater and have one or more fitness participants in the home. We define a &#8220;fitness participant&#8221; as someone who engages in some form of fitness training at least once per week. The average annual revenue per household is based on our conservative internal estimates of average revenue per device of $1,800/year, which consists of membership and services revenue, assuming a penetration rate of 30-40% of services within our member base. For a discussion of the methodology used in determining our TAM, see <span style="font-style:italic">&#8220;Market, Industry, and Other Data.&#8221;</span> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">125 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compelling Industry and Market Trends </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The fitness industry has seen steady growth driven by increased participation in health and wellness activities. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe changing generational attitudes towards fitness and increased awareness of the connection between exercise and positive health outcomes are contributing to increased participation, as illustrated below. According to IHRSA, health club industry revenue in the United States grew by approximately 6% annually from 1997 through 2019 (prior to the COVID-19 pandemic), and has demonstrated resilience during times of economic recession, as illustrated below. Since 2019 and reflecting the impact of the COVID-19 pandemic, closures of gyms and health clubs significantly impacted the brick and mortar fitness industry, driving a 57% decrease in overall health club industry revenue from $35 billion in 2019 to $15 billion in 2020, according to IHRSA. Based on data compiled by Piper Sandler, we believe health club revenue has recovered to $28 billion in 2021 as gyms reopened, despite the challenges caused by the COVID-19 pandemic, which we believe indicates the underlying interest in participation in health and wellness remains strong. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g26m40.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Bureau of Labor Statistics, Sports and Exercise, May 2017 (left), 2021 IHRSA Global Report, compiled by Piper Sandler based on data from other third-parties, including IBISWorld, Morgan Stanley research, and LEK (2021 revenue) (right) </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Consumers are shifting consumption of fitness to digital </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2020 and 2021, the COVID-19 pandemic significantly impacted the gym and health club industry (see discussion above). During this time, consumers rapidly shifted consumption of brick and mortar fitness offerings to digital offerings. According to Mindbody Business, a business management platform for the wellness services industry, 80% of consumers accessed livestream fitness content in 2020 as compared to 7% in 2019. At the time, of those consumers, 46% said that they intend to include virtual workouts as a regular part of their routine even now that gyms and studios have reopened. The gym and health club industry began to recover in 2021, with domestic revenue reaching $28 billion. However, revenue has not yet reached pre-COVID levels, according to IHRSA data from 2021, which we believe signals a shift in consumer preferences to virtual offerings. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Strength training is the largest segment within the fitness industry. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Within the broader fitness industry, we believe the strength training category is large and well-positioned for growth. According to the Bureau of Labor Statistics, participation in strength training on average is larger than all of cardio equipment combined. Despite high overall participation rates relative to other forms of exercise, strength training under-indexes with two key demographics &#8211; women and adults over 55 &#8211; where participation rates are 30% and 19%, respectively. Accordingly, we believe there is a significant opportunity to increase participation among these groups by offering more compelling and more customized strength training equipment options for home use, paired with expert coaching and instruction. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">126 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt">


<img src="g367939g12q38.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Bureau of Labor Statistics, Sports and Exercise, 2015-2021 </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The need for health coaching has grown beyond fitness </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Traditional offerings in the fitness industry are often &#8220;self-serve&#8221; in that individuals utilize equipment and gym memberships but often without the guidance of expert health coaching, contributing to low satisfaction and high attrition. According to IHRSA, nearly 50% of new gym members quit within six months of joining a club. Furthermore, the COVID-19 pandemic has driven consumers to focus more on their overall well-being, and turn to physical exercise as a way to improve mental health and increase longevity. We believe health coaching is the most effective way to drive consistency, engagement, and positive outcomes among consumers and is well-aligned to expanding consumer wellness preferences and goals. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Premium offerings attract majority of revenue in the fitness industry </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe the premium end of the market is the most attractive sector to target with our products and health coaching services, as evidenced by data on consumer behavior and spending habits. For example, in the United States, according to IHRSA, fitness participation tends to be highly correlated with household income, suggesting that increased disposable income is associated with increased time and money spent on fitness, which we believe makes the premium end of the market the most compelling for our products and health coaching services. Further, this dynamic is also reflected in the distribution of consumer spend seen in the gym memberships. According to IHRSA, premium gyms, which are defined as those costing approximately $100 or more per month in membership fees, account for 32% of total gym memberships and generate 73% of overall gym revenue, indicating that most of the spend in the industry is at the premium end. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">127 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g86x61.jpg" alt="LOGO" />
 </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">IHRSA &#8211; membership mix across gym tiers assumed to be constant from 2016-2020 </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Bureau of Labor Statistics, Sports and Exercise, May 2017 (left), 2020 IHRSA Global Report (right) </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Wellness services are gaining share and coaching services are just starting to digitize </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In fitness, nearly 70% of spending has historically been weighted toward products rather than services, according to McKinsey. However, wellness services and apps are gaining ground. According to McKinsey, in 2022, approximately 45% of consumers intend to spend more on wellness services or app-based wellness services over the next year, while approximately 25% intend to spend more on fitness products. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Health coaching can often result in optimal fitness outcomes because coaches offer expert guidance, accountability, and motivation, but we believe that these services have historically been inaccessible to many due to cost and lack of convenience. We believe digitization can lower the cost of personal training and health coaching, primarily due to lower distribution costs relative to gyms. Further, digitization can increase peak capacity and utilization for service providers, and increase convenience for clients. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">128 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g56j56.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Internal company research informed by interviews with personal trainers (left), internal member usage data on most common times to work out by time zone (right) </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While the COVID-19 pandemic has accelerated the adoption of digital, on-demand fitness products and services, and while we expect that there may be some short- to medium-term fluctuations in demand if and to the extent the COVID-19 pandemic continues to ease, we believe live virtual health coaching services are still in the early phases of growth and have the potential to continue to grow over the longer-term. We believe the continued digitization of fitness services should contribute to growth of the overall market and benefit market participants that are positioned with digital platforms capable of connecting consumers to expert health coaching services in the United States and globally. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Demand for convenient fitness options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Household trends, work from home, and the rise of mobile technology make it challenging to balance time between family, work, and personal health and wellness, resulting in increasing demand for convenient fitness options. Digitization increases convenience of fitness options for consumers, enabling them to train from home and increasing flexibility to schedule with trainers from different time zones. Trainers are increasingly becoming attracted to digital platforms as well. Digital platforms reduce the time spent on traveling to clients, while value-added tech tools increase efficiency and effectiveness. According to the Personal Trainer Development Center, nearly 83% of trainers plan to offer virtual services compared to 40% of trainers prior to the COVID-19 pandemic. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Growth strategies </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Increase uptake of add-on services through compelling member experience </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to increase uptake of our add-on memberships and services by providing a compelling member experience focused on introducing our members to the variety of services available on our platform and specifically, the value-added benefits of our coaching and personal training offering. We believe our ability to provide service offerings at a number of price points will serve as a valuable lever for growth by increasing overall service revenues over time. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">129 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Reduce the cost of personal training and expand addressable market without sacrificing quality </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are exploring ways to leverage our products, technology, and proprietary trainer education platform to bring the cost of coaching down incrementally, while maintaining an unwavering focus on the quality of the coaching experience we deliver to our members. This strategy is key to our medium- to long-term objectives, as we believe we can expand the addressable market for coaching services by reducing the per session cost and increasing accessibility of expert coaching services through our hardware and mobile experiences. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Build out partnership ecosystem </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to continue to build our strategic partner ecosystem with a focus on relationships that enable us to extend our platform to new audiences. We are pursuing opportunities in a number of attractive verticals, including sports, physical therapy and rehabilitation, and telemedicine. We are continuously identifying and evaluating opportunities to apply our coaching know-how in new and innovative ways to expand our reach and impact. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Expand corporate wellness </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to continue expanding our recently launched corporate wellness initiative. Historically, corporate wellness programs were generally one-size-fits-all solutions for employees, such as corporate gyms. The rise of the hybrid workforce has made robust corporate wellness both an imperative and a challenge for many companies. We believe our comprehensive product portfolio makes us a better fit for modern corporate wellness programs than many existing alternatives. Our solution enables corporations to provide all of their employees with a coaching service regardless of whether they work from home, in the office, or both. Our multi-pronged service offering also provides a new level of customization that can be adapted to employees at virtually all levels of tenure. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Expand into new geographies </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to expand the international reach of our product and service offerings. With more than 180&#160;million people belonging to gyms globally in 2019, according to IHRSA, we believe there is significant opportunity to grow internationally. For example, we are currently evaluating potential international expansion with the United Kingdom and Canada, although we have not yet made any definitive plans regarding such expansion or the potential timing thereof. We plan to pursue disciplined international expansion by targeting countries with high fitness penetration and spend, as well as the presence of boutique fitness, and where we believe Forme&#8217;s value proposition will resonate. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Compelling Value Proposition </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">For Members </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">High-quality trainers</span> &#8211; Our trainer recruitment engine was built by seasoned industry veterans from well-known personal training brands. Our hiring criteria is extremely selective, and our interview process consists of multiple rounds and programming reviews. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Better match with trainer</span> &#8211; We employ a rigorous methodology to match our members with a trainer that is the best fit for their goals. Because of our virtual platform, we can match members across a larger pool of trainers to find the perfect fit without geographical limitations. Our matching algorithm considers factors such as fitness goals, motivation preferences, physical limitations, and more when presenting a match. In addition, our Fitness Concierge team works with members to pair them with a trainer based on the member&#8217;s unique needs, preferences, and goals. Members and trainers will then have a virtual &#8220;meet and greet&#8221; session and a mobility fitness screening, which our trainers use to determine how to achieve each member&#8217;s goals in an effective yet safe manner. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">130 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">More affordable</span> &#8211; We believe, based on industry data, that the pricing of our virtual coaching offerings are on average less expensive than a monthly gym membership or the monthly cost of in-person personal training. The average monthly cost of in-person personal training rates at premium gyms is estimated to be $400 per month, according to Lessons.com. Our Custom Training offering provides a full month of customized workouts created by a real personal trainer, and is currently priced at a fraction of the price of personal training. Our monthly VOD membership is currently $49 per month and is less expensive than most monthly gym memberships and monthly spend at boutique fitness classes, according to IHRSA </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We offer qualified customers in the United States 12-, 18-, and 36-month, 0% APR financing programs through Affirm, our third-party financing partner. Our financing programs have successfully broadened our base of members by attracting consumers from a wider spectrum of ages and income levels. In 2023, approximately 7% of all Forme Studio or Forme Studio Lift units sold were financed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">More convenient</span> &#8211; Our coaching offering can be accessed through multiple platforms and devices so customers can workout at home or on the go. Our VOD content, and Custom Training offering, can be accessed at any time, providing members the flexibility to fit workouts into their lifestyle and schedules. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Trainers </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">More convenient</span> &#8211; Our platform provides trainers the opportunity to work from home and eliminate time spent on the road traveling to gyms and clients&#8217; homes. Virtual training also eliminates the inefficiency of &#8220;dead times&#8221; during the afternoons, when trainers typically do not have clients. Our ability to match trainers across time zones means that coaches can choose to work only in the mornings or in the evenings. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Higher earning potential</span> &#8211; Our platform has created new opportunities for trainers to increase their earning potential, driven by increased capacity to take on clients during peak hours. The time saved from commuting can instead be spent with more clients. We believe many trainers also earn more per session with Forme than they typically would in the gym. According to ISSA, on average, gyms take a 40-70% margin on each session, while Forme&#8217;s platform is approximately 30% margin for training. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Continuing education</span> &#8211; Trainers on our platform also have the opportunity to continue their development through our proprietary education program. Upon joining, trainers must complete a mandatory eight-week program focused on honing their virtual training skillset. After onboarding, trainers are encouraged to participate in continuing education facilitated by our training team in order to advance their skillset on our platform, which in turn can increase the fees charged for their training services. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forme Platform Offerings </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Forme platform delivers an immersive and dynamic at-home fitness experience through our VOD content, curated personalized fitness programming, Live 1:1 personal training, and other health coaching services, which are accessible via download or streaming through our connected fitness hardware products and via streaming through the Forme Studio app, which is available through iOS mobile devices and most iOS tablets and computers. Our connected fitness hardware products include the Forme Studio and Forme Studio Lift, as well as accompanying equipment and accessories. The design and technology of the Forme platform enables our members to engage in a virtual yet truly immersive training experience, whether through On-Demand classes or through our Live 1:1 personal training services. Our VOD content library includes a variety of individual classes and multi-week programs spanning a range of modalities, including strength training, meditation, barre, yoga, and recovery, among others. Through our VOD membership, all of our members have access to a Fitness Concierge who can curate weekly personalized fitness programs free of charge to suit each member&#8217;s fitness level, needs, preferences, and goals, and help each member maximize the value of their Forme platform experience. In addition to providing a wide range of programs and On-Demand classes through our VOD content library, accessible via download or streaming through our connected fitness hardware products and via streaming </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">131 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
through the Forme Studio app, we offer Live 1:1 personal training and health coaching services that enable our members to workout with expert trainers from the convenience of their own homes or devices. All members who purchase the Forme Studio and Forme Studio Lift are able to access our VOD content library by creating a Forme account and signing up for our monthly membership at a cost of $49 per month, and can cancel their membership at any time. As of November 2022, we also offer memberships to the Forme platform without purchase of the Forme Studio or Forme Studio Lift. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forme Studio Connected Fitness Hardware Products </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our connected fitness hardware products include the Forme Studio, launched in 2021, the Forme Studio Lift, launched in 2022, and various accessories, including the Forme Barre attachment that can be used with both products. The Forme Studio and Forme Studio Lift were both designed to provide an immersive workout experience delivered through innovative hardware, software, and VOD content. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g38t23.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Forme Studio features: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a 43&#8221; fully mirrored touchscreen to facilitate app-free navigation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">4K UHD resolution and a life-size height to provide a virtual, immersive experience; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Two front-facing 12 MP full body cameras designed for two-way live interaction, enabling members to work with a live trainer in a virtual setting similar to an in-person experience; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Internet wired connectivity and 802.11ac wireless networking, which is IEEE 802.11a/b/g/n/ac compatible; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Bluetooth headphone and heart rate monitor syncing ability; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Sound system with microphone and rear-facing speakers. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Forme Studio ships with the following accessories and equipment: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Yoga mat; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Heart rate monitor; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Microfiber cleaning towel; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Camera covers; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Mounting hardware. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forme Studio Lift includes all the components of the Forme Studio as well as the additional following equipment: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Two Forme handles; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">One rope grip; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">132 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Two ankle straps; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">One short bar; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Storage cabinet. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently sell our Forme Studio for $2,495 and our Forme Studio Lift for $6,495. We offer qualified customers in the United States 12-, 18-, and 36-month, 0% APR financing programs through Affirm, our third-party financing partner. As of December&#160;31, 2022, we have sold 204 units of our Forme Studio and 194 units of our Forme Studio Lift. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Fitness Content, Instruction, and Personal Training and Health Coaching Services </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Forme platform delivers an immersive at-home fitness experience through accessing VOD content, Live 1:1 personal training, and other health coaching services. The design and technology of the Forme platform enables our members to engage in a virtual yet truly immersive training experience, whether through On-Demand classes or through our Live 1:1 personal training services. Our VOD content library and instruction and health coaching services are accessible via download or streaming through our connected fitness hardware products, as well as via streaming through the Forme Studio app, and are offered at difference price points depending on format and, in the case of our Live 1:1 personal training services, depending on the needs of the member and the experience level of the personal trainer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Fitness Content and Instruction </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our VOD content spans strength, recovery, barre, mind, Pilates, yoga, and other specialty categories. We produce our VOD content both through our highly skilled in-house team and by contracting seasoned content production and creative professionals, and we feature what we believe to be the top fitness instructor talent in the Los Angeles area. In addition, we intend to develop localized content for international regions in the future, such as Canada and the United Kingdom. Our team of qualified and experienced health coaching professionals curate workout programming for our members giving those members an enhanced experience, an added sense of accountability, and instruction on how to reach their goals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our systems allow us to collect anonymized performance data to understand how our members are engaging with the platform in order to optimize our content development around fitness disciplines, class type, length, music, and other factors. We have developed a diverse collection of fitness and wellness programs and On-Demand classes across a range of fitness disciplines, class types and lengths, fitness preferences, trends, and difficulty levels. Members can easily access our content through our touchscreen interface which features intuitive filtering and search capabilities. In 2021, our content production team developed hundreds of original On-Demand classes, across eight fitness and wellness disciplines. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Personal Training and Health Coaching </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our expert team of more than 38 trainers provide personal training and health coaching services to our members. Our trainers are highly experienced, undergo a thorough interview process, and are required to complete comprehensive internal education and development programing as well as continuing education once they are on our platform. Specifically, upon joining, trainers must complete a mandatory eight-week program focused on honing their virtual training skillset. While we have not historically conducted background checks on our personnel, we intend to implement additional background screening procedures. After onboarding, trainers can participate in continuing education facilitated by our training team to advance their skillset on our platform. Our Fitness Concierge service works with members to pair them with a trainer based on the member&#8217;s unique needs, preferences, and goals. Members and trainers will then have a virtual &#8220;meet and greet&#8221; session and a mobility fitness screening, which our trainers use to determine how to achieve each member&#8217;s goals in an effective yet safe manner. Trainers often provide services to their clients through a combination of live sessions, custom </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">133 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
workout programming, and curated fitness programs comprised of On-Demand classes from our VOD content library. Our Live 1:1 personal training service also provides members flexible scheduling with monthly rollover for unused sessions, customized workouts, and expert coaching in holistic areas such as movement, fitness, nutrition, recovery, and mindfulness. Members are also able to train with trainers certified in specialized areas such as pre-and post-natal workouts, post-surgical rehabilitation, and sports-specific performance. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Forme Platform Membership </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Access to our VOD content library and health coaching services on the Forme platform, whether via download or streaming through our connected fitness hardware products or via streaming through the Forme Studio app, is available by signing up as a member. All members who purchase the Forme Studio and Forme Studio Lift are able to access our VOD content library by creating a Forme account and signing up for our monthly membership. We offer Live 1:1 personal training as a monthly membership starting at $399 per month, which includes four Live 1:1 training sessions per month, unlimited custom workouts (through our Custom Training offering), and access to our VOD library. Our memberships are charged on a month-to-month basis, allow for multiple household users, and provide unlimited access to our VOD content library. A monthly membership also includes streaming access to our VOD content library through our Forme Studio app, which is available through iOS mobile devices and most iOS tablets and computers. Our memberships allow up to six members of a household to access our VOD content library. On average, we had 1.6 unique profiles per membership as of December&#160;31, 2022. Our On-Demand membership is currently offered on a $49 per month membership fee and our Live 1:1 personal training service is currently offered as an add-on service with sessions currently ranging from $70-$130 per 60-minute session, depending on the needs of the member and the experience level of the personal trainer. Our Live 1:1 personal training services have a personal trainer satisfaction guarantee and are billed monthly and cancelable at any time. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Forme Studio App </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently offer our Forme Studio app as a standalone mobile offering. Members can access our personal training services via our mobile app or through purchasing the Forme Studio or Studio Lift. The Forme Studio app currently includes full access to our VOD content library, as well as our coaching offerings. We define a Forme Studio app member as an individual or household that has a paid Forme Studio membership with a successful credit card billing of at least three months. In December 2022, 5% of our VOD content usage was consumed via the Forme Studio app. As of December&#160;31, 2022, there are nearly 11&#160;million households in our current and announced markets within our target demographic according to our TAM estimates (see <span style="font-style:italic">&#8220;&#8212; Our Industry and Opportunity&#8221;</span>). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Strategic Relationships </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A key component of our strategy is to establish and expand strategic partnerships within the fitness and wellness industry to help accelerate expansion of our business and build our brand recognition. To date, we focused on building strategic relationships in the fitness space, primarily through content collaborations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have developed, and intend to continue to develop and expand, collaborations with companies across the hospitality, fashion, sports, and design industries. Our current and potential partners include international hotel chains, celebrity trainers, interior designers, celebrity stylists and boutique fitness clubs. These strategic relationships tend to be focused on generating awareness of our brand by accessing audiences and followings and educating them regarding our products and services. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Product Design and Technology Development </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We view our product design and technology as a competitive advantage and devote substantial resources to the design, research and development of new products and features to complement and improve upon our platform. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">134 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
We believe that our future success depends on our ability to both improve our existing products and to develop new products for both existing and new markets. We design our own connected fitness hardware products. We invest substantial resources in research and development to enhance our platform, develop new products and features, and improve our platform infrastructure. We believe our content delivery and interactive software platform are critical to our member experience. We plan to continue to commit significant resources to technology and product design, innovation, and development. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our product design, engineering, and research and development organization consists of strong engineering, product, and design teams which collaborate across software, firmware, hardware, quality assurance, program management, product design and product management. Our teams are comprised of individuals with a diverse set of skills and industry experience, including expertise in complex mechanical and electrical/firmware design (with motor systems), scalable distributed systems, video and audio machine learning, artificial intelligence, and user-centric application engineering. Our engineering, product, and design teams work together to bring our products to fruition, from conception and validation to implementation. We improve our existing products through frequent software updates, which are downloaded automatically approximately every month, to deploy new and innovative interactive features. We generally provide a 12-month limited warranty for the Forme Studio and Forme Studio Lift. See <span style="font-style:italic">&#8220;Risk Factors &#8211; Risks Related to Our Business and Industry &#8211; We may be subject to warranty claims that could result in significant direct or indirect costs, or we could experience greater returns than expected, either of which could have an adverse effect on our business, financial condition, and results of operations.&#8221;</span> We are committed to leveraging data to continuously improve our member experience by studying and understanding points of interaction and how our members use our software features. As of September&#160;30, 2023, we had 14 employees across our engineering functions, including 2 employees in our product design and product management functions. Our engineering and product teams are located in the United States. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Video streaming and storage are provided by third-party cloud providers. By leveraging these third parties, we are able to focus our resources on enhancing our products and developing new software features. In addition, our technology platform is designed with redundancy and high utilization capacity in order to minimize member service disruption. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Sales and Marketing and Member Support </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our goal is to increase brand awareness and purchase intent for our products and services. We market our products through various paid channels including Facebook and Google, as well as through unpaid channels driven by referrals and public relations initiatives. We use a combination of brand and product-specific performance marketing to build brand awareness and generate sales of our products and services. Our marketing strategies have focused on product education and broadening our demographic reach. Our target demographic segments include members making greater than $100,000 in annual household income. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We promote our products and brand through various means, including digital marketing and online advertising, press releases, contributed articles, speaking opportunities, trade events, customer events, public relations, and industry analyst relations. We believe video has been the most effective medium to communicate the features of our offering. We primarily market through advertisements on social media to reach our target audience, focusing on incremental return on investment. Our direct-to-consumer model allows us to conduct frequent tests in our sales channels, including testing our brand creative and messages, allowing us to further optimize marketing spend. We also selectively test alternative marketing channels, such as podcasts, connected TV, and direct mailing. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">135 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Direct to Consumer, Multi-Channel Sales Model </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We sell our products directly to customers through a multi-channel sales platform that includes e-commerce and inside sales. Our sales associates use customer relationship management tools to deliver a personalized and educational purchase experience. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">E-Commerce and Inside Sales: Our desktop- and mobile-compatible website provides an elevated brand experience where visitors can learn about our products and services and access product reviews. Our inside sales team engages with customers by phone, email, and online chat on our websites, and offers one-on-one sales consultations seven days a week. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Commercial: We believe that the commercial and corporate wellness markets are important to driving trial and brand awareness. For example, we believe providing access to our platform through hospitality or workplace locations helps keep our members engaged during travel or at work, creating further member engagement, loyalty, and convenience. We believe the commercial channel provides us with a valuable opportunity to introduce our product to wider audiences and allow for physical, on-product experiences outside of a store or showroom. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Member Support Services </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our member support team encompasses our member engagement staff, our field operations team, and our Fitness Concierge team focuses on retention and customer satisfaction. Our member engagement staff identifies, evaluates, and implements new ways to promote engagement with our members and to help members reengage with our platform when activity has lapsed, such as monitoring member activity and reaching out via email in the absence of recent activity generally within the preceding three months. The member engagement staff also collects and responds to member feedback about our products and services. Our field operations team provides support regarding sales, scheduling, delivery, installation, account and billing inquiries, troubleshooting and repair, product education, returns and exchanges, and other member requests. This team primarily works remotely and is distributed across the United States. Our Fitness Concierge team is currently comprised of personnel with training and expertise in hospitality and membership experience, and with our connected fitness hardware products. The Fitness Concierge team assists members from initial onboarding through the entirety of the membership experience, including answering general questions, assisting members with matching and changing personal trainers depending on a member&#8217;s preferences, addressing other member questions and concerns regarding their fitness goals and experience, and curating weekly personalized fitness programs free of charge to suit each member&#8217;s fitness level, needs, preferences, and goals. Our Fitness Concierge team works with our trainers to help ensure that each member is maximizing the value of their experience. We also utilize additional third-party support services in areas such as web chat messaging and customer relationship management tools, and intend to increasingly do so as we grow in order to efficiently scale. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Manufacturing </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We outsource the manufacturing of our products to multiple manufacturing partners located primarily in Taiwan. We believe this outsourced manufacturing approach allows us to focus our resources on the design, development, quality and reliability management, marketing, and sales of our products. In addition, we believe that outsourcing our manufacturing activities provides us with the flexibility needed to respond to new market opportunities, simplifies our operations, reduces risk, and significantly reduces our capital commitments. The components and parts used in our products are sourced either directly by us or on our behalf by our manufacturing partners from a variety of component suppliers. We have strict qualification processes to qualify new suppliers, components, and parts. We have a supply chain team which coordinates the relationships between our manufacturing partners and component suppliers. This team is responsible for cost, quality, and efficiency in the manufacturing processes and for ensuring that timely delivery is made. We regularly audit our existing manufacturing partners, and component suppliers, and evaluate new partners and suppliers, to help ensure that we can scale our manufacturing base as we grow our business. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">136 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have long-term supply agreements with most of our third-party manufacturing partners, and we purchase from our primary manufacturers on a purchase order basis. Our product purchase orders outline the delivery terms of our agreement with these manufacturing partners. Our manufacturing partners must follow our product design specifications, quality assurance programs, and manufacturing standards. We have developed preferred relationships with our partners to maintain access to the resources needed to scale seasonally and ensure our manufacturing partners have the requisite experience to produce our Forme Studio System products and accessories. We pay for and own certain equipment specifically required to manufacture our products. We have purchase commitments based on our purchase orders for certain amounts of goods, work-in-progress and components. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We depend on these third parties to supply us with products of a requested quantity in a timely manner that meets our standards for cost and manufacturing quality. If our current third-party manufacturing partners cannot perform as agreed, we may be required to replace those manufacturers. We may be unable to establish any agreements with third-party manufacturing partners or to do so on acceptable terms, in particular with respect to the manufacture and supply of our Forme Studio System equipment. Although we believe that there are potential alternative suppliers, we may incur added costs and delays in identifying and qualifying any such replacement. In order to mitigate against the risks related to a single source of supply, we qualify alternative suppliers and manufacturers when possible, and develop contingency plans for responding to disruptions, including maintaining adequate inventory of any single source components and products. To date, we have not experienced material delays in obtaining any of our components or products. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We subject our third-party manufacturing partners to our standard qualification requirements to meet our quality and reliability standards. At each of our manufacturers&#8217; facilities, we have a quality team that is involved throughout the entire development process. To help ensure consistent quality, we routinely perform product audits on non-core suppliers and staff full-time supplier quality engineers at core product manufacturing sites. We believe our ability to work closely with our third-party partners to optimize the manufacturing and production processes for our products provides us with a meaningful competitive advantage. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to a stringent list of qualification tests that take place prior to releasing our designs to manufacturing, Manufacturing quality testing takes place in two stages: first, before the product leaves Taiwan, and second, at our warehouse facility in the United States, prior to installation at the customer&#8217;s location. For example, we conduct in process quality checks at various stages of production and &#8220;end of line&#8221; final tests which serve as quality controls at the end of the manufacturing line in Taiwan and must be completed before the product can be shipped to us in the United States. Once we receive the product, we again inspect units and validate the product again before installation at the user&#8217;s home, giving us a secondary degree of quality assurance before a user engages with the product. We provide various physical and user interface safety features to guide users on how to interact with the product safely and obtain all necessary product qualifications. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The technology embedded in our platform incorporates various components, including semiconductors, which are developed from silicon wafers, the most important raw material used in our products. As a result, our manufacturing processes are subject to risks and trends within the semiconductor industry generally, including wafer foundry manufacturing capacity, wafer prices, and production yields, as well as timely wafer delivery from foundries to our manufacturing partners and regulatory and geopolitical developments in various jurisdictions. If the cost of raw materials increases, or our manufacturing partners experience difficulties in obtaining sufficient components of sufficient quality for incorporation in our products, it could impact our ability to deliver products to our customers in a timely manner and adversely impact our business, financial condition, and results of operations, including our gross margins. For example, future global pandemics similar to the COVID-19 pandemic, may cause manufacturing and supply constraints that affect our products and increased tensions between the United States and its trading partners, particularly China, may negatively impact the supply of certain components incorporated in our products. See <span style="font-style:italic">&#8220;Risk Factors &#8211; Risks Related to Suppliers, Manufacturers, and Other Ecosystem Partners.&#8221;</span> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">137 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Logistics and Fulfillment </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have established a nationwide network of logistics and operations centers, leveraging third-party providers to support our internal logistics resources. We currently work with third-party logistics providers to handle warehousing, shipment and delivery, including middle-mile (warehouse to major city hub) and last mile (major city hub to member&#8217;s home) delivery of our connected fitness hardware products, including the Forme Studio and Forme Studio Lift. Our third-party logistics partners also provide white glove installation services of our products. Our in-house logistics and field support teams are responsible for training our third-party logistics providers on how to safely and correctly install our products, coordinating shipment and delivery matters, and communicating with our members throughout the entire pre-installation process. Our in-house team is also equipped to perform installations in all of our markets as needed. Our in-house logistics and field support teams offer product education, assistance with account set up, and tips and recommendations for product care. We currently expect to continue to outsource our shipment, delivery, and installation services. We do not have any minimum or long-term binding commitments with our third-party logistics providers and are generally billed upon shipment of the freight. We believe alternative third-party logistics services would be available if needed. As we grow our logistics network, we believe we will be able to efficiently service products and deploy and install replacement parts for our members. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to increase our logistics and field support coverage in locations we identify as cost-effective delivery markets throughout the United States and, in the future, in new international regions. To further scale our distribution system and maintain flexibility, we intend to expand our relationships with third-party providers that deliver our products from multiple locations in the United States. Third-party fulfillment partnerships allow us to reduce order fulfillment time, reduce shipping costs, and expand our geographical reach. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Intellectual Property </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our success depends in part upon our ability to obtain and maintain patent and other intellectual property protection with respect to our products and the technology we develop. We rely on a combination of patents, copyrights, trademarks, trade secrets, confidentiality procedures, and contractual commitments, to protect our intellectual property and proprietary know-how. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Patents </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&#160;30, 2023, we owned (i)&#160;more than 18 issued patents and/or pending applications in the United States and (ii)&#160;more than 74 issued patents and more than 6 pending patent applications in foreign jurisdictions. The inventions covered by our patent and patent application portfolio primarily relate to various hardware and software inventions that may or may not be embodied in our current or future products. The issued United States patents are expected to expire between 2036 and 2040. We periodically review our development efforts to assess the existence and patentability of new intellectual property. We expect to continue to file patent applications in the United States and abroad covering technologies and productions considered to be important to our business. We seek to protect proprietary technology related know-how that is not covered by our patent portfolio as trade secrets through contracts and policies to the extent that we believe it to be beneficial and cost-effective. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Trademarks </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&#160;30, 2023, we owned (i)&#160;two registered trademarks in the United States; (ii)&#160;five registered trademarks in various states; and (iii)&#160;two trademark grants of protection covering the United Kingdom and European Union via an International Registration. We expect to continue to file trademark applications in the United States and abroad covering trademarks considered to be important to our business. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Trade Secrets and Other Intellectual Property </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to patent protection, we also rely on other proprietary rights and contractual obligations, including protection of trade secrets and other proprietary information that is not patentable or that we elect not to patent </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">138 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(for example, where we may not believe patent protection of a specific product or technology is critical to our business strategy at the time). We rely on contractual protections with our customers, suppliers, employees, consultants, and contractors, and we implement security measures designed to protect our intellectual property, including trade secrets. For example, all employees and consultants are generally required to execute confidentiality and invention assignment agreements in connection with their employment and consulting relationships with us, except with respect to content produced pursuant to specific strategic partnerships. However, we cannot guarantee that we have entered into such agreements with every such party, and we may not have adequate remedies in case of a breach of any such agreements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Monitoring Unauthorized Use of Intellectual Property </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Monitoring unauthorized use of our intellectual property is difficult and costly. Despite our efforts to protect our intellectual property, unauthorized parties may still copy, misappropriate, or otherwise obtain and use our software, technology, or other information that we regard as our proprietary intellectual property. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the ordinary course of our business, we may become party to disputes involving intellectual property rights. Depending on the situation, we may defend our position, seek to negotiate a license or engage in other acceptable resolution that is appropriate to our business. See <span style="font-style:italic">&#8220;Risk Factors &#8211; Risks Related to Our Intellectual Property.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Competition </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fitness industry, including the smart home gym and connected fitness industry, is highly competitive. We face significant competition from multiple industries and exercise verticals, including at-home fitness equipment and content, fitness clubs, in-studio fitness classes, in-person personal training, and health and wellness apps. We expect the competition in our industry to intensify in the future as new and existing competitors introduce new or enhanced products and services that compete with ours. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our competitors may develop, or have already developed, products, features, content, services, or technologies that are similar to ours or that achieve greater acceptance, may undertake more successful product development efforts, create more compelling employment opportunities, or marketing campaigns, or may adopt more aggressive pricing policies. Our competitors may also develop or acquire, or have already developed or acquired, intellectual property rights that significantly limit or prevent our ability to compete effectively. In addition, our competitors may have significantly greater resources than us, allowing them to identify and capitalize more efficiently upon opportunities in new markets and consumer preferences and trends, quickly transition and adapt their products and services, devote greater resources to marketing and advertising, or be better positioned to withstand substantial price competition. Current and potential competitors have established or may establish financial and strategic relationships between themselves or with our existing or potential customers, manufacturing partners, or other third parties. Any of the foregoing may enable our current and future competitors to better withstand adverse economic or market conditions, such as those caused by the current COVID-19 pandemic. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that we provide a compelling, cutting-edge and engaging service to our customers, which we believe provides us with a competitive advantage versus traditional fitness and wellness products and services, and future entrants. We believe we are competitive with other industry participants principally as a result of the following factors: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Superior and compelling product offerings: We compete with producers of fitness products and strive to ensure that our platform provides innovative and engaging features, content, technologies, and user-friendly features. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Member engagement and support: We compete for customers to subscribe to the platform and to retain them through superior member support and engagement. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">139 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Talent: We compete for talent in technology, media, fitness, design, logistics, music, marketing, finance, legal, and retail. As our platform is highly dependent on technology and software, we require a significant base of engineers to continue innovating. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, other competitive factors in our industry include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">total cost; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">manufacturing efficiency; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">enhanced products and services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">content originality; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">product quality and safety; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">competitive pricing policies and practices; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">product innovation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">market vision; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">sales and marketing strategies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">technological advances; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">brand awareness and reputation. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe we compete favorably among competitors across all of these factors. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Human Capital Resources </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">General </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&#160;30, 2023, we had 27 full-time equivalent employees located in the United States across San Francisco, New York, Los Angeles, and other cities and 9 full-time equivalent employees located in Taiwan across manufacturing and supply chain functions. We consider relations with our employees to be good and have never experienced a work stoppage. None of our employees are either represented by a labor union or subject to a collective bargaining agreement. We also engage fitness instructors and fitness content production personnel on an independent contractor basis. Our utilization of independent contractors fluctuates significantly depending on several factors, including the growth of, and demand for new fitness content by, our member base. For example, from January&#160;1, 2021 through March&#160;31, 2022, we engaged more than 165 independent contractors to produce additional content due to increased demand for On-Demand classes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Employee Relations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our core philosophy is that our employees are our most important resource, dedicating their talents, time, and professional reputations to the Company. Our success has been built on attracting, motivating, and retaining a talented and driven workforce, particularly on our research and development teams, but also our senior management and support personnel. We have a diverse workforce that represents many cultures and we celebrate our diversity by fostering inclusion across our organization. Diversity is both a priority and strength of our company. Our employee base reflects diversity in backgrounds and experiences and each employee contributes different perspectives, ideas, strengths, and abilities to our business. Our training and development program focuses on a harassment-free workplace and diversity topics, as well as ethics and compliance. We consider our global employee relations to be good. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our objective is to attract and retain talented and experienced personnel, including personal trainers and fitness instructors, advisors, and consultants. To ensure a varied outreach approach for candidates, our team members </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">140 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
often leverage their professional networks, as well as online search tools, specialized recruiting firms, internships and university hires. In order to motivate our team to perform to the best of their abilities and achieve both our short-and long-term objectives, we offer a combination of competitive base salary, time-based equity incentives and discretionary bonuses, which have generally been linked to financial performance that are designed to motivate and reward personnel with annual grants of stock-based incentive compensation awards, some of which vest over a period of four years. We offer competitive benefits tailored to local markets and laws and that are designed to support employee health, welfare and retirement; examples of such benefits include paid time off; remote working/work from home flexibility, 401(k), pension or other retirement plans; basic and voluntary life, disability and supplemental insurance; medical, dental and vision insurance; and flexible spending accounts. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation structure is intended to align incentives with the success of our company as a whole. This includes our executives, whose incentives are generally the same as the rest of our employees. We believe that this fosters harmony within the Company, as all teams are working together towards the same goals. For more details regarding our executive compensation, see <span style="font-style:italic">&#8220;Executive Compensation.&#8221;</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ongoing focus on workplace safety and compliance to applicable regulations has enabled us to preserve business continuity while ensuring a safe work environment during the COVID-19 pandemic, including work-from-home arrangements for a substantial portion of our workforce and reduced capacity for those that have returned to the office, adhering to local health authority guidelines. We also comply with applicable laws and regulations regarding workplace safety and are subject to audits by entities such as OSHA in the United States. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We rely on third parties to manufacture our products and require our suppliers to maintain a safe work environment. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Government Regulation </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">General </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to many varying laws and regulations, including in the United States, the United Kingdom, and the European Union, including those related to privacy, data protection, content regulation, intellectual property, consumer protection, e-commerce, marketing, advertising, messaging, rights of publicity, health and safety, employment and labor, product liability, accessibility, competition, and taxation. These laws often require companies to implement specific information security controls to protect certain types of information, such as personal data, &#8220;special categories of personal data&#8221; or health data. These laws and regulations are constantly evolving and may be interpreted, applied, created, or amended in a manner that could harm our current or future business and operations. In addition, it is possible that certain governments may seek to block or limit our products and services or otherwise impose other restrictions that may affect the accessibility or usability of any or all of our products and services for an extended period of time or indefinitely. We have implemented compliance programs and processes, including with respect to export regulation, anti-bribery and anti-corruption, privacy, and cybersecurity. To date, our compliance with these regulations has not had a material impact on our results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Export Regulation and Anti-Corruption Compliance </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business activities are also subject to various restrictions under U.S. export control and similar laws and regulations, as well as various economic and trade sanctions administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control, which prohibit or restrict the provision of products and services to embargoed jurisdictions and sanctioned persons. Further, various countries regulate the import of certain technology and have enacted or could enact laws that could limit our ability to provide customers with our products in those countries. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are also subject to various domestic and international anti-corruption laws, such as the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the U.K. Bribery Act, as well as other similar anti-bribery and anti-</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">141 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
kickback laws and regulations. These laws and regulations generally prohibit companies, their employees, and their intermediaries from directly or indirectly authorizing, offering, providing, and/or accepting improper payments or other benefits for improper purposes. Although we take precautions to prevent violations of these laws, our exposure for violating these laws increases as our international presence expands and as we increase sales and expand operations into new jurisdictions. New legislation or regulations, the application of laws from jurisdictions whose laws do not currently apply to our business, or the application of existing laws and regulations to the fitness industry generally could result in significant additional compliance costs and responsibilities for our business. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Privacy </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are, and could become, subject to a variety of local, state, national and international laws, directives, and regulations that apply to the collection, use, retention, protection, disclosure, transfer, and other processing of personal data in the different jurisdictions, and which sometimes conflict among the various jurisdictions and countries in which we operate. As we expand our business internationally, we expect to become subject to data privacy and security laws in additional jurisdictions. Data privacy laws and regulations, including, but not limited to, the CPRA and the CCPA, as well as the GDPR and its equivalent in the United Kingdom (to which we may become subject if we expand into those jurisdictions), pose increasingly complex compliance challenges, which may increase compliance costs. Any failure to comply with data privacy laws and regulations could result in significant penalties. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CCPA requires, among other things, that covered companies provide disclosures to California consumers and affords such consumers with certain rights, including the ability to opt out of certain sales of their personal information. The CCPA prohibits discrimination against individuals who exercise their privacy rights and provides for civil penalties for violations, as well as a private right of action in certain circumstances. Additionally, the CPRA, which became effective in most material respects starting on January&#160;1, 2023, further expands the CCPA with additional compliance requirements that may impact our business and establishes a regulatory agency dedicated to enforcing the CCPA and CPRA. In addition, we may be subject to other new data privacy laws, such as the Virginia Consumer Data Protection Act, the Colorado Privacy Act, the Connecticut Data Privacy Act and the Utah Consumer Privacy Act in the United States (all of which go into effect in 2023) as well as the European Union Regulation on Privacy and Electronic Communications (or ePrivacy Regulation). Further, in the United States, emerging state data privacy laws may encourage other states and the federal government to pass comparable legislation, introducing the possibility of greater penalties and more rigorous compliance requirements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The GDPR regulates the collection, control, sharing, disclosure, use, and other processing of data that can directly or indirectly identify a living individual that is a resident of the European Union and imposes stringent data protection requirements with significant penalties and the risk of civil litigation, for noncompliance. Moreover, following the UK&#8217;s exit from the European Union, the GDPR was transposed into the UK GDPR. However, a risk of divergent parallel regimes (and related uncertainty) exist. We cannot predict how the GDPR, the UK GDPR, or other UK or international data protection laws or regulations may develop or impact our business if and when we become subject to such laws and regulations, nor can we predict the effects of divergent laws and related guidance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We strive to comply with all applicable laws and regulations relating to privacy, data security, and data protection. However, governments are continuing to focus on privacy and data security, and it is possible that new privacy or data security laws will be passed, or existing laws will be amended in a way that is material to our business. Any significant change to applicable laws, regulations, or industry practices could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business. Any inability to adequately address data privacy or data protection, or other information security-related concerns, even if unfounded, or to successfully negotiate privacy, data protection or information security-related contractual terms with customers, or to comply with applicable laws, regulations and policies relating to </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">142 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
privacy, data protection and information security, could result in additional cost and liability to us, harm our reputation and brand, and could negatively impact our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Product Safety </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are or may become subject to a variety of laws and regulations in the United States and abroad regarding the safety of our products. These laws and regulations are continuously evolving and developing. In particular, fitness equipment sold for home use is regulated in the United States by the Consumer Product Safety Commission. Safety-related information that we learn about our products from any source may trigger federal reporting obligations that could lead to product safety investigations, corrective actions, enforcement actions, and civil or criminal penalties. To protect the health and safety of our users and mitigate these risks, we obtain relevant safety testing on our products and maintain all necessary product qualifications. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cybersecurity </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are in the process of designing and implementing a security program consisting of policies, procedures, and technology intended to maintain the security and integrity of our information, systems and networks. Among other things, the program includes controls designed to limit access to systems, networks, and data, prevent unauthorized access or modification, and monitor for threats. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Environmental, Health, and Safety </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our third-party manufacturers and suppliers are, and could become, subject to a wide range of international, federal, state, provincial, and local governmental regulations directed at preventing or mitigating environmental harm, as well as to the storage, discharge, handling, generation, disposal and labeling of toxic or other hazardous substances. Although we outsource our manufacturing, the manufacturing of our products by our third-party manufacturers and suppliers require the use of hazardous materials that similarly subject these third parties, and therefore our business, to such environmental laws and regulations. Our failure or the failure of these third parties to comply with these laws or regulations can result in regulatory, civil, or criminal penalties, fines, and legal liabilities, suspension of production, alteration of manufacturing processes, including for our products, reputational damage, and negative impact on our operations or sales of our products and services. Increased compliance costs by our third-party manufacturing partners may also result in increased costs to our business. Our business and operations are also subject to health and safety laws and regulations adopted by government agencies such as OSHA. Although we believe we are in material compliance with applicable law concerning matters relating to health, safety, and the environment, the risk of liability relating to these matters cannot be eliminated completely. To date, we have not incurred significant expenditures relating to environmental compliance nor have we experienced any material issues relating to employee health and safety. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See <span style="font-style:italic">&#8220;Risk Factors &#8211; Risks Related to Privacy, Cybersecurity, and Infrastructure&#8221;</span> and <span style="font-style:italic">&#8220;Risks Related to Regulatory Matters &#8211; Our business is subject to a wide range of laws and regulations, many of which are evolving, and failure to comply with such laws and regulations could harm our business, financial condition, and results of operations&#8221;</span> and <span style="font-style:italic">&#8220;&#8211; We and our third-party manufacturers and suppliers are, or could become, subject to environmental, health, and safety laws, which could increase our costs, restrict our operations and require expenditures that could have a material adverse effect on our business, financial condition, and results of operations.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Facilities </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our corporate headquarters are located in Austin, Texas, where we hold a lease that has a monthly fee of $99 and variable cost based on usage. Our lease facilities in New York, New York expired in 2023. These facilities are and were primarily used for engineering, sales and marketing, and other general business purposes. We recently terminated a lease for approximately 7,500 square feet in San Francisco, California, which was used primarily for </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">143 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
engineering, information technology, operations and other general business purposes, which are now being conducted remotely. We also have a small office in Taiwan that is primarily used for supply chain and manufacturing purposes and another small office in London, UK that is used for general business purposes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that our existing facilities are sufficient for our current needs. We intend to add new facilities and expand our existing facilities as we continue to add employees and grow our business. We believe that new spaces will be available at reasonable terms in the future in order to meet our needs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Legal Proceedings </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, we may become involved in additional regulatory investigations or legal proceedings arising in the ordinary course of our business. We are not currently a party to any regulatory investigations or other legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition, and results of operations. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation could have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">144 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_13">MANAGEMENT </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Executive Officers and Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding our current directors, executive officer, non-executive and other officers: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:33%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:63%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Position</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Executive Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trent A. Ward</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Co-Founder, Chief Executive Officer, Chairperson and Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Non-Executive Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deepak M. Mulchandani</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Technology Officer and Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael J. Madigan</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Financial Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Non-Employee Directors</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aaron N. D. Weaver<sup style="font-size:75%; vertical-align:top">(1)(2)(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kirsten Bartok Touw<sup style="font-size:75%; vertical-align:top">(1)(2)(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Member of the audit committee. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Member of the compensation committee. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Member of the nominating and corporate governance committee. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Executive Officer </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Trent A. Ward</span></span> is our co-founder and has served as our Chief Executive Officer and as a member of our board of directors since our inception in May 2017. Prior to founding Interactive Strength Inc., Mr.&#160;Ward served as an associate, analyst, and portfolio manager at Citadel LLC, a financial services company, from July 2006 to February 2014. From February 2014 to May 2017, Mr.&#160;Ward left Citadel LLC to begin investing in start-ups and pursuing various entrepreneurial endeavors, including starting the research and development for the precursor entity to us in October 2015. Mr.&#160;Ward holds a Bachelor of Science degree in Economics and a Bachelor of Applied Science degree in Engineering from the University of Pennsylvania. We believe Mr.&#160;Ward&#8217;s position as one of our founders and as our Chief Executive Officer, and his industry and financial expertise, qualify him to serve on our board of directors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Non-Executive Officer </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Deepak M. Mulchandani</span></span> has served as our Chief Technology Officer and as a member of our board of directors since December 2021. Prior to joining Interactive Strength Inc., Mr.&#160;Mulchandani served as the Chief Product Officer and Executive Vice President of Engineering at Emerge Now Inc. (&#8220;Emerge&#8221;), a computer and electronic manufacturing company, from January 2020 to December 2021. Prior to joining Emerge, Mr.&#160;Mulchandani served as the Senior Vice President of Product Engineering at Peloton Interactive, Inc. (Nasdaq: PTON) from June 2017 to July 2019. Mr.&#160;Mulchandani holds a Bachelor of Science degree in Computer Science from Purdue University. We believe Mr.&#160;Mulchandani&#8217;s extensive background in the technology and product engineering space and his experience in the smart home gym industry qualify him to serve on our board of directors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Officer </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Michael J. Madigan</span></span> has served as our Chief Financial Officer since February 2023, and previously served as our Senior Director of Finance from September 2022 to February 2023. Prior to joining Interactive Strength Inc., Mr.&#160;Madigan served in various roles at XPO Last Mile, Inc. (&#8220;XPO Last Mile&#8221;), a third party logistics company, including (i)&#160;Senior Director of Financial Planning and Analysis from October 2019 to September 2022, (ii)&#160;Senior Vice President of Finance from November 2016 to October 2019, and (iii)&#160;Vice President of Finance from 2013 to 2016. Prior to joining XPO Last Mile, Mr.&#160;Madigan served as Vice President of Finance at 3PD, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">145 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Inc. and held various roles at PricewaterhouseCoopers. Mr.&#160;Madigan holds a Bachelor of Science degree in Accounting from Le Moyne College. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Non-Employee Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Aaron N. D. Weaver</span></span> has served as a member of our board of directors since March 2022. Mr.&#160;Weaver served as a Portfolio Manager at Apeiron from May 2020 to April 2023 with a focus on the life sciences and technology sectors. From May 2019 to May 2020, Mr.&#160;Weaver served as legal counsel and in a lead fundraising role at Atai Life Sciences, a pharmaceutical company. From October 2018 to March 2019, Mr.&#160;Weaver served as a legal contractor at Lloyds Banking Group, a financial services company. From August 2015 to July 2017, Mr.&#160;Weaver was an investment banker at Credit Suisse Group AG in London within the Capital Markets Solutions team, advising on capital structuring and issuances for a full spectrum of corporate issuers from pre-revenue companies to public listed companies. Mr.&#160;Weaver was a capital markets solicitor at Allen&#160;&amp; Overy LLP (London) from 2007 to 2013. Mr.&#160;Weaver currently serves on the boards of Bionomics Limited (Nasdaq: BNOX), MagForce AG, Endogena Therapeutics, Inc., and Rejuveron Life Sciences AG. Mr.&#160;Weaver holds a Masters in Law from the Queensland University of Technology, a Bachelor of Law from University of Queensland and a Bachelor of Business Management from University of Queensland. Mr.&#160;Weaver is a Chartered Financial Analyst and a registered solicitor in the United Kingdom. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Kirsten Bartok Touw</span></span> has served as a member of our board of directors since April 2023. Ms.&#160;Bartok Touw has been the Co-President and Chief Operating Officer and a member of the board of directors of New Vista Acquisition Corp., a special purpose acquisition company since December 2020. Ms.&#160;Bartok Touw is the co-founder and managing partner of AirFinance, which has financed more than $1.2 billion across a variety of structured products to aerospace companies, their suppliers, and their customers globally since 2008. Ms.&#160;Bartok Touw is also an active early-stage investor in emerging technologies. Prior to AirFinance, from 2009 to 2012, Ms.&#160;Bartok Touw was Vice President, Structured Finance&#160;&amp; Corporate Development at Hawker Beechcraft Corporation, where she helped lead the company&#8217;s expansion into Asia, joint ventures, mergers and acquisitions, and sales financing. Prior to Hawker, from 2005 to 2008, Ms.&#160;Bartok Touw co-founded XOJET, Inc., serving on its board of directors and as Chief Financial Officer. Before co-founding XOJET, Inc., Ms.&#160;Bartok Touw spent over 12 years in private equity and venture capital at Alpine Investors and JPMorgan Partners/Chase Capital Partners technology team. Ms.&#160;Bartok Touw began her career as an investment banker at Goldman Sachs. She received a bachelor&#8217;s degree from the University of Pennsylvania and a Masters in Business Administration from Stanford University&#8217;s Graduate School of Business. She also serves on the board of the French American Foundation and on the National Business Aviation Association&#8217;s Advisory Council. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Family Relationships </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our directors or executive officers. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Independence </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors consists of four (4)&#160;members. Our board of directors determined that Ms.&#160;Bartok Touw qualifies as an independent director under applicable SEC and Nasdaq rules. In addition, after the resignation of Mr.&#160;Weaver from Apeiron and based on a review of the applicable SEC and Nasdaq rules, our board of directors determined that Mr.&#160;Weaver qualifies as an independent director. Specifically, our board of directors undertook a review of the independence of each director. Based on information provided by each director concerning his or her background, employment, and affiliations, our board of directors determined that each of Ms.&#160;Bartok Touw and Mr.&#160;Weaver does not have relationships that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that Ms.&#160;Bartok Touw and Mr.&#160;Weaver are &#8220;independent&#8221; as that term is defined under applicable SEC and Nasdaq rules. In making these determinations, our board of directors considered the current and prior relationships that each non-employee director has with our company and all other facts and circumstances our board of directors deemed relevant in determining their independence, including the beneficial ownership of our shares by each non-employee director and the transactions described in </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">146 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<span style="font-style:italic">&#8220;Certain Relationships and Related Party Transactions.&#8221;</span> In making this determination with respect to Mr.&#160;Weaver, our board of directors also considered the nature of Apeiron&#8217;s investment in the Company, the prior advisory services rendered by Apeiron, the nature of Mr.&#160;Weaver&#8217;s employment position with Apeiron as a portfolio manager and not a director, partner, or executive or senior officer, his direct and indirect ownership of less than 10% in Apeiron, and his resignation from Apeiron. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Nasdaq rules (and SEC rules with respect to audit committees), newly public companies are allowed to phase-in compliance with certain board and committee composition requirements (the &#8220;Phase-in Compliance Rules&#8221;). Specifically, a newly public company is required to have: (a)&#160;upon initial listing, one independent director on each of the audit committee, compensation committee, and nominating and corporate governance committee, with such independent director otherwise meeting any other qualification requirements for such committees; (b)&#160;within 90 days after initial listing, a majority of independent directors on each committee; and (c)&#160;within one year of initial listing, a majority of independent directors on the board and full compliance with independence requirements for each of the audit committee, compensation committee, and nominating and corporate governance committee. We currently intend to avail ourselves of the Phase-in Compliance Rules. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Structure </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors are divided into three classes serving staggered three-year terms. Class I, Class II and Class III directors will serve until our annual meetings of stockholders in 2024, 2025, and 2026, respectively. At each annual meeting of stockholders, directors will be appointed to succeed the class of directors whose terms have expired. This classification of our board of directors could have the effect of increasing the length of time necessary to change the composition of a majority of our board of directors. In general, at least two annual meetings of stockholders will be necessary for stockholders to effect a change in a majority of the members of our board of directors. Our current directors are divided among the three classes as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Class I director is Mr.&#160;Mulchandani, and his term will expire at the annual meeting of stockholders to be held in 2024; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Class II director is Mr.&#160;Weaver, and his term will expire at the annual meeting of stockholders to be held in 2025; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Class III directors are Mr.&#160;Ward and Ms.&#160;Bartok Touw, and their terms will expire at the annual meeting of stockholders to be held in 2026. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Lead Independent Director </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors adopted corporate governance guidelines that provide that the board of directors shall appoint an independent director to serve as our lead independent director for so long as we have a non-independent Chairperson. Our board of directors appointed Ms.&#160;Bartok Touw to serve as our lead independent director. As lead independent director, Ms.&#160;Bartok Touw has primary responsibilities to preside over all meetings at which the Chairperson is not present and serve as a liaison between the Chairperson and the independent directors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Compensation </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">General </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the members of our current board of directors received compensation for their service in 2021 or 2022. Directors who are also full-time officers or employees of our company receive no additional compensation for serving as directors. All non-employee directors receive compensation in accordance with our non-employee director compensation policy, described below. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">147 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Non-Employee Director Compensation Policy </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not historically paid cash retainers or other compensation with respect to service on our board of directors. We have reimbursed and will continue to reimburse all of our non-employee directors for their reasonable expenses incurred in attending meetings of our board of directors and committees of our board of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We adopted a non-employee director compensation policy. This policy provides for the annual grant of stock options under the Interactive Strength Inc. 2023 Stock Incentive Plan (the &#8220;2023 Plan&#8221;) following the conclusion of each regular annual meeting of our stockholders, commencing with the 2024 annual meeting, to each non-employee director who will continue serving as a member of our board of directors. The annual option award will be with respect to a number of shares of common stock with an aggregate fair market value as determined under the 2023 Plan equal to $120,000 calculated on the date of grant. This number of shares underlying each such award will be equal to $120,000 divided by the estimated Black-Scholes value of such stock options as of the date of grant, rounded down to the nearest whole share. Each annual option award will be granted with an exercise price per share equal to the fair market value on the date of grant and will become fully vested, subject to continued service as a director, on the earliest of the 12-month anniversary of the date of grant, the next annual meeting of stockholders following the date of grant, or the consummation of a change in control (as defined in the 2023 Plan). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a non-employee director is elected to our board of directors after the 2024 annual meeting and other than at an annual meeting of our stockholders, such non-employee director will receive an award of stock options upon election to our board of directors that is consistent with the foregoing, provided that such grant will be prorated based on the number of calendar days remaining before (i)&#160;the next annual meeting of stockholders, if scheduled, or (ii)&#160;the date of the first anniversary of the last annual meeting of stockholders, if the next annual meeting is not yet scheduled. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each non-employee director who first joins the board of directors as a non-employee member after the completion of our initial public offering will receive a stock option award under the 2023 Plan with an aggregate fair value determined under the 2023 Plan with a grant date fair value as determined under the 2023 Plan equal to $240,000 calculated on the date of grant. The number of shares underlying each such award will be equal to $240,000 divided by the estimated Black-Scholes value of such stock options as of the date of grant, rounded down to the nearest whole share. This option award will be granted with an exercise price per share equal to the fair market value on the date of grant and will vest, subject to continued service as a director, in equal annual installments over three years or, if earlier, the consummation of a change in control (as defined in the 2023 Plan). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate value of all compensation granted or paid, as applicable, to any non-employee director for service as a non-employee director during any 12-month period, including awards granted and cash fees we pay to such non-employee director, will not exceed $500,000 in total value, and with respect to the 12-month period in which a non-employee director is first appointed or elected to the board of directors, will not exceed $750,000 in total value, in each case calculating the value of any awards based on the grant date fair value of such awards as determined for financial reporting purposes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Non-Employee Director Share Ownership Policy </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors adopted a share ownership policy for its non-employee directors to further align the personal interests of such directors with the interests of our stockholders. Under such policy, each non-employee director is expected to acquire, and continue to hold during the term of his or her service on our board of directors, ownership of shares of our common stock having a specified minimum value as determined by our board of directors. Such policy requires non-employee directors to hold a specified minimum percentage of the shares acquired through any of our equity incentive plans (net of the number applied to pay applicable taxes) until the share ownership policy is satisfied. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">148 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Committees </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors established an audit committee, a compensation committee, and a nominating and corporate governance committee. Our board of directors adopted a charter for each of these committees, which complies with the applicable requirements of current Nasdaq rules. We intend to comply with future requirements to the extent they are applicable to us. Copies of the charters for each committee are available on the investor relations page of our website (www.formelife.com). The inclusion of our website address in this prospectus is an inactive textual reference only. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently intend to avail ourselves of the Phase-in Compliance Rules with respect to the composition of our board committees. See <span style="font-style:italic">&#8220;&#8212; Director Independence.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Audit Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audit committee consists of Ms.&#160;Bartok Touw and Mr.&#160;Weaver. Ms.&#160;Bartok Touw is the chairperson of our audit committee. The composition of our audit committee meets the requirements for independence under the current Nasdaq listing standards and SEC rules and regulations. Each member of our audit committee can read and understand fundamental financial statements in accordance with Nasdaq audit committee requirements. In arriving at this determination, our board of directors examined each audit committee member&#8217;s scope of experience and the nature of their prior and/or current employment. In addition, our board of directors determined that each of Ms.&#160;Bartok Touw and Mr.&#160;Weaver is an &#8220;audit committee financial expert&#8221; as defined in Item&#160;407(d)(5)(ii) of Regulation S-K promulgated under the Securities Act. This designation does not impose any duties, obligations or liabilities that are greater than are generally imposed on members of our audit committee and our board of directors. Our audit committee is directly responsible for, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">selecting a firm to serve as the independent registered public accounting firm to audit our financial statements and determining its compensation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">ensuring the independence of the independent registered public accounting firm; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">discussing the scope and results of the audit with the independent registered public accounting firm and reviewing, with management and that firm, our interim and year-end operating results; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">establishing procedures for employees to anonymously submit concerns about questionable accounting or audit matters; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">considering the adequacy of our internal controls and internal audit function; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">discussing our major financial risk exposures and the steps we have taken to monitor and control such exposures, including our policies with respect to risk assessment and risk management; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing material related party transactions or those that require disclosure; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">approving or, as permitted, pre-approving all audit and non-audit services to be performed by the independent registered public accounting firm. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Compensation Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee consists of Ms.&#160;Bartok Touw and Mr.&#160;Weaver. Ms.&#160;Bartok Touw is the chairperson of our compensation committee. Each member of this committee is a non-employee director, as defined by Rule 16b-3 promulgated under the Exchange Act, and meets the requirements for independence under the current Nasdaq listing standards and SEC rules and regulations. Our compensation committee is directly responsible for, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">determining and approving, or recommending that our board of directors approve, the compensation of our executive officers; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">149 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and approving the terms of any employment agreements, severance arrangements, change in control protections, indemnification agreements and any other material agreements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and approving performance goals and objectives relevant to the compensation of our executive officers and assessing their performance against these goals and objectives; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and approving the compensation of our non-employee directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">administering our equity incentive plans; </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">overseeing the development and implementation of the Company&#8217;s human capital management strategies and policies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and approving, or making recommendations to our board of directors with respect to, incentive compensation and equity plans; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing our overall compensation philosophy. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Nominating and Corporate Governance Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our nominating and corporate governance committee consists of Ms.&#160;Bartok Touw and Mr.&#160;Weaver. Ms.&#160;Bartok Touw is the chairperson of our nominating and corporate governance committee. Ms.&#160;Bartok Touw and Mr.&#160;Weaver meet the requirements for independence under the current Nasdaq listing standards. Our nominating and corporate governance committee is directly responsible for, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">identifying and recommending candidates for membership on our board of directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and recommending our corporate governance guidelines and policies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and making recommendations to our board of directors regarding the type and amount of compensation to be paid or awarded to our non-employee board members; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing proposed waivers of the code of conduct for directors and executive officers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">evaluating the independence of directors and director nominees against the requirements for independence under the current Nasdaq listing standards and SEC rules and regulations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">overseeing the process of evaluating the performance of our board of directors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">assisting our board of directors on corporate governance matters. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Code of Ethics </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors adopted a code of ethics that applies to all of our employees, officers and directors, including our Chief Executive Officer and other executive and senior financial officers. The full text of our codes of business conduct and ethics is posted on the investor relations page of our website (www.formelife.com). The inclusion of our website address in this prospectus is an inactive textual reference only. We intend to disclose future amendments to our codes of business conduct and ethics, or any waivers of such code, on our website or in public filings. Information contained on, or that can be accessed through, our website is not incorporated by reference in this prospectus and does not form a part of this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation Committee Interlocks and Insider Participation </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the members of our compensation committee has ever been an executive officer or employee of ours. None of our executive officers currently serve, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more executive officers serving as a member of our board of directors or compensation committee. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">150 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Indemnification and Insurance </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certification of incorporation and our amended and restated bylaws provide that we shall indemnify our directors and officers against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such director or officer, other than such liability (if any) that he or she may incur by reason of his or her own actual fraud or willful default, in connection with the execution or discharge of his or her duties, powers, authorities or discretions as a director or officer of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have also entered into indemnification agreements with our directors, executive officers, and certain other employees under which we have agreed to indemnify each such person and hold them harmless against expenses, judgments, penalties, fines, and amounts payable under settlement agreements in connection with any threatened, pending or completed action, suit or proceeding to which they have been made a party or in which they became involved by reason of the fact that they are, or were, our director, officer, or employee. Except with respect to expenses to be reimbursed by us in the event that the indemnified person has been successful on the merits or otherwise in defense of the action, suit or proceeding, our obligations under the indemnification agreements are subject to certain customary restrictions and exceptions. The indemnification agreements are governed under Delaware law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we maintain standard policies of insurance under which coverage is provided to our directors and officers against loss rising from claims made by reason of breach of duty or other wrongful act, and to us with respect to payments which may be made by us to such directors and officers pursuant to the above indemnification provision or otherwise as a matter of law. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">151 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_14">EXECUTIVE COMPENSATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As an emerging growth company as defined in the JOBS Act, we are not required to include a Compensation Discussion and Analysis section and have elected to comply with the scaled disclosure requirements applicable to emerging growth companies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our named executive officer for the years ended December&#160;31, 2021 and December&#160;31, 2022 was Trent A. Ward, our Chief Executive Officer, who was our sole executive officer in 2021 and 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary Compensation Table </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:41%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name and Principal Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Salary<sup style="font-size:75%; vertical-align:top">(1)</sup><br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Bonus<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option<br />Awards<sup style="font-size:75%; vertical-align:top">(2)</sup><br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Nonequity<br />Incentive Plan<br />Compensation<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">All Other<br />Compensation<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trent A. Ward</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">229,920</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,320,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,549,920</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">232,300</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">766,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">998,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The amount in this column for 2021 includes $121,337.56 plus &#163;82,000, which was converted to $110,962.40 using the exchange rate on December&#160;31, 2021 of 1.3532. The amount in this column for 2022 includes $187,375.00 plus &#163;35,166.68, which was converted to $42,544.65 using the exchange rate on December&#160;31, 2022 of 1.2098. A portion of Mr.&#160;Ward&#8217;s salary in each of 2021 and 2022 was paid in British pounds as, prior to 2022, Mr.&#160;Ward was based part-time in the United States and part-time in the United Kingdom. Mr.&#160;Ward is currently based full-time in the United States. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The amounts in this column represent the aggregate grant-date fair value of awards granted to the named executive officer, computed in accordance with the Financial Accounting Standards Board&#8217;s Accounting Standards Codification Topic 718. See Note 17 to the notes to our audited consolidated financial statements included elsewhere in this prospectus for a discussion of the assumptions we made in determining the grant-date fair value of our equity awards. Each of the stock option awards granted to Mr.&#160;Ward in 2021 was cancelled on August&#160;31, 2022. In connection with the cancellation of these awards, Mr.&#160;Ward received two new stock option grants. The first grant, which was fully vested upon grant, was an option to purchase 80,000 shares of our common stock. The second grant was also an option to purchase 80,000 shares of our common stock, 40,000 of which vested on December&#160;1, 2022, 20,000 of which will vest of December&#160;1, 2023, and the remainder of which will vest ratably over the 12-month period between December&#160;1, 2023 and December&#160;1, 2024. On January&#160;24, 2023, our board of directors approved a common stock repricing whereby previously granted and unexercised options held by certain current employees, including Mr.&#160;Ward, with exercise prices above $0.51 per share were repriced on a one-for-one-basis to $0.51 per share. There was no modification to the other terms, including the vesting schedules, of the previously issued options. We will treat the repricing as a modification of the original awards and calculate additional compensation costs for the difference between the fair value of the modified award and the fair value of the original award on the modification date. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Narrative to Summary Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We review compensation annually for all employees, including our executives. In setting executive base salaries and bonuses and granting equity incentive awards, we consider compensation for comparable positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders, and a long-term commitment to our company. We do not target a specific competitive position or a specific mix of compensation among base salary, bonus or equity incentives. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In evaluating the roles, responsibilities, authority, titles, and functions of our management team, our board of directors has determined that Trent A. Ward, our co-founder and Chief Executive Officer, was the sole executive </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">152 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
officer of the Company in 2021 and 2022 and continues to serve as our sole executive officer in 2023. We based this determination on an analysis of several factors, including those articulated in the applicable rules and regulations of the SEC. Specifically, since our inception in 2017, Mr.&#160;Ward has held, and is expected to continue to hold for the foreseeable future, primary and ultimate responsibility, authority, and operational decision-making functions over the principal operations, business units, and functions of the Company, including all significant policymaking authority. In addition, we believe this determination is appropriate in light of the current size and scope of our business and operations and the relatively early growth stage of the Company, as reflected by the fact we did not commence commercial delivery of our first product until mid-2021 and only recently commenced shipment of our second product in August 2022. We intend to continue to evaluate the roles and responsibilities of our management team as our business and operations evolve, and to reassess the designation and composition of our executive officers as appropriate and in consideration of applicable rules and regulations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Base Salaries </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2022, base salary was set at a level that was commensurate with Mr.&#160;Ward&#8217;s duties and authorities, contributions, prior experience, and sustained performance. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Executive Annual Incentive Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted the Executive Annual Incentive Plan (the &#8220;Annual Incentive Plan&#8221;). The Annual Incentive Plan is administered by the compensation committee. Only key employees designated by the compensation committee as participants are eligible to participate in the Annual Incentive Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the first quarter of each fiscal year, the compensation committee will establish an individual target award opportunity for employees who participate in the Annual Incentive Plan (including any threshold or maximum award opportunities), the performance goals, the target performance goals (including any threshold or maximum), and the percentage weighting of each performance goal and/or formulas which will be utilized to measure the performance of the participants during the fiscal year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amount available to allocate for payment of bonuses under the Annual Incentive Plan in respect of a given fiscal year of the Company (the &#8220;Bonus Pool&#8221;) will be determined by the compensation committee. During the first quarter of a fiscal year, the compensation committee will establish target funding levels (including any threshold or maximum) for the Bonus Pool. No later than 30 days after the end of each fiscal year, the compensation committee will determine the actual achievement of the performance goals and the overall percentage of achievement based on the achievement of the various performance goals and certify the final Bonus Pool for the year based on the pre-established funding levels and the level of achievement relative to the pre-established performance goals after taking into account any adjustment of the individual target award opportunity (including any threshold or maximum award opportunities), the performance metrics, formulas and the targeted achievement levels (including any threshold or maximum achievement levels) relating to such performance goals and the formulas used in determining the Bonus Pool as deemed necessary or appropriate by the compensation committee in recognition of unusual or nonrecurring events affecting us or our consolidated financial statements or changes in applicable laws, regulations or accounting principles. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Individual bonus payouts are determined by applying the participant&#8217;s individual target award opportunity by the overall percentage of achievement of the performance goals, provided that the calculated payment may not exceed the maximum award opportunity (to the extent applicable) and no bonus payment will be made if the amount calculated falls below any applicable threshold. Bonuses are not guaranteed and are awarded and payable at our compensation committee&#8217;s discretion. Bonuses will be payable in cash or shares of our common stock issued under the 2023 Plan, in either case less applicable deductions and tax withholdings. An employee must be employed on the date of payment to earn any bonus under the Annual Incentive Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Either our board of directors or the compensation committee may amend, suspend or terminate the Annual Incentive Plan in writing at any time, for any and no reason. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">153 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent permitted by applicable law, any bonus payments under the Annual Incentive Plan will be subject to any clawback or recoupment policies we have in place from time to time. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Equity Incentive Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our equity incentive awards are designed to align our interests with those of our employees, including Mr.&#160;Ward. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have historically granted stock options to our employees, including Mr.&#160;Ward, under the 2020 Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options are granted at a price not less than the fair market value on the date of grant and generally become exercisable within four years after the date of grant, subject to continued service with us. Options generally expire ten years from the date of grant. The 2020 Plan provides for the grant of incentive stock options, which qualify for favorable tax treatment to recipients under Section&#160;422 of the Code and non-qualified stock options. Such awards may be granted to our employees, directors and consultants. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the completion of our initial public offering, equity awards were granted to our employees, including Mr.&#160;Ward, under the Interactive Strength, Inc. 2023 Stock Incentive Plan (as described below). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Health and Welfare Benefits and Perquisites </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Ward is eligible to participate in our employee benefit plans, including our medical, dental, vision, life and disability insurance plans, on the same basis as all of our other employees. We do not maintain any executive-specific benefit or perquisite programs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Retirement Benefits </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We sponsor a tax-qualified Section&#160;401(k) plan for our United States employees, including Mr.&#160;Ward. Participants may make pre-tax and certain after-tax (Roth) salary deferral contributions to the plan from their eligible earnings up to the statutorily prescribed annual limit under the Code. An employee&#8217;s interest in his or her salary deferral contributions is 100% vested when contributed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not provide employees, including Mr.&#160;Ward, any other retirement benefits, including but not limited to tax-qualified defined benefit plans, supplemental executive retirement plans or nonqualified defined contribution plans. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Offer Letter with Our Named Executive Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Below is a description of the material terms of our offer letter with Trent A. Ward, our Chief Executive Officer (principal executive officer) and our sole executive. The offer letter provides for at-will employment and sets forth the individual&#8217;s base salary and eligibility for employee benefits. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Employment Letter Agreement with Trent A. Ward </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2021, we entered into an employment letter agreement with Mr.&#160;Ward to memorialize the terms of his continued employment with us. On October&#160;27, 2022, we entered into a new offer letter with Mr.&#160;Ward which replaced and superseded his initial offer letter. The new offer letter provides for an annual base salary of $240,000 for the remainder of the 2022 calendar year and, effective January&#160;1, 2023, an annual base salary of $300,000. The new offer letter also provides that, beginning with the 2024 calendar year, Mr.&#160;Ward will have an annual bonus target of 75% of base salary. Lastly, the new offer letter provides that Mr.&#160;Ward is eligible to receive severance benefits under our Executive Severance Plan, as described in more detail under <span style="font-style:italic">&#8220;&#8212; Potential Payments upon Termination or Change in Control.&#8221;</span> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">154 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Mr.&#160;Ward&#8217;s June&#160;30, 2021 employment letter agreement, he received three separate stock option grants to purchase 5,333, 9,333, and 9,666 shares of our common stock, respectively, subject to vesting requirements as described in more detail under <span style="font-style:italic">&#8220;&#8212; Outstanding Equity Awards at 2021 Year End.&#8221;</span> Each of these three stock option grants was cancelled on August&#160;31, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proprietary Information and Inventions Assignment Agreement and Agreement to Arbitrate </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Ward, who is based in Texas, has executed our standard Proprietary Information and Inventions Assignment Agreement for employees based in Texas, which contains customary restrictions on the disclosure of confidential information and provisions regarding the assignment of intellectual property. Mr.&#160;Ward also executed our standard Agreement to Arbitrate for employees based in California, which provides that all employment-related disputes will be subject to arbitration. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Ward is not subject to restrictions on competition under his respective agreements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Outstanding Equity Awards at 2022 Year End </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents information regarding outstanding equity awards held by Mr.&#160;Ward, our sole named executive officer, as of December&#160;31, 2022. All of the option awards were granted under the 2020 Plan. The terms of the 2020 Plan are described below under <span style="font-style:italic">&#8220;Equity Incentive Plans.&#8221;</span> All of the option awards were granted with a per share exercise price equal to the fair market value of one share of our common stock on the date of grant. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:37%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Grant Date</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Vesting<br />Commencement<br />Date</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />Exercisable <br />(#)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />Unexercisable<br />(#)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option<br />Exercise<br />Price<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option<br />Expiration<br />Date<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trent A. Ward</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8/31/2022</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(1)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8/31/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8/30/2032</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8/31/2022</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(2)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12/1/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8/30/2032</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This option was fully vested upon the grant date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This option is subject to vesting over a 24-month period, with 50% vesting on December&#160;1, 2022, 25% vesting on December&#160;1, 2023, and the remaining 25% vesting in twelve (12)&#160;equal monthly installments thereafter. This option is subject to an early exercise provision and was immediately exercisable upon its grant date. On January&#160;24, 2023, our board of directors approved a common stock repricing whereby previously granted and unexercised options held by certain current employees, including Mr.&#160;Ward, with exercise prices above $0.51 per share were repriced on a one-for-one-basis to $0.51 per share. There was no modification to the other terms, including the vesting schedules, of the previously issued options. We treat the repricing as a modification of the original awards and calculate additional compensation costs for the difference between the fair value of the modified award and the fair value of the original award on the modification date. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Potential Payments upon Termination or Change in Control </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Executive Severance Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2022, we adopted an Executive Severance Plan (the &#8220;Executive Severance Plan&#8221;) applicable to our Chief Executive Officer and certain other key employees that became effective upon the completion of our initial public offering. Under the Executive Severance Plan, if a participant&#8217;s employment is terminated (i)&#160;by the participant with &#8220;good reason&#8221; (as defined in the Executive Severance Plan), (ii)&#160;by us without &#8220;cause&#8221; (as </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">155 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
defined in the Executive Severance Plan) or (iii)&#160;due to the named executive officer&#8217;s death or the named executive officer becoming &#8220;disabled&#8221; (as defined in the Executive Severance Plan&#8221;), and provided the named executive officer (or his or her estate or representative, as applicable) signs and does not revoke our standard release of claims and complies with all applicable restrictive covenants and contractual obligations, the participant will be entitled to receive: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">salary continuation payments for 18 months (for our Chief Executive Officer) or 12 months (for participants other than our Chief Executive Officer) (such period, the &#8220;Severance Period&#8221;) following the participant&#8217;s termination of employment; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">subsidized continued health insurance coverage under the Consolidated Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;), for the participant and his or her eligible dependents during the Severance Period. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any participant&#8217;s employment is terminated (i)(A) by the participant with good reason, (B)&#160;by us without cause or (C)&#160;due to the participant&#8217;s death or the participant becoming disabled, and (ii)&#160;such termination occurs within 12 months after a &#8220;change in control&#8221; (as defined in the Executive Severance Plan), and provided the participant (or his or her estate or representative, as applicable) signs and does not revoke our standard release of claims and complies with all applicable restrictive covenants and contractual obligations, the participant will be entitled to receive: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">continued payments of an amount equal to the sum of (A)&#160;the participant&#8217;s then current base salary plus (B)&#160;the participant&#8217;s then current target annual bonus, in equal installments during the Severance Period; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">full vesting acceleration with respect to all outstanding equity compensation awards, with post-termination exercisability as specified in the applicable equity award agreement; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">subsidized continued health insurance coverage under COBRA for the participant and his or her eligible dependents during the Severance Period. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in the event any of the payments or benefits provided for under the Executive Severance Plan or otherwise payable to a participant would constitute a &#8220;parachute payment&#8221; within the meaning of Section&#160;280G of the Code and could be subject to the related excise tax, the participant would be entitled to receive either full payment of such payments and benefits or such lesser amount which would result in no portion of the payments and benefits being subject to the excise tax, whichever results in the greater amount of after-tax benefits to the participant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Executive Severance Plan supersedes all prior or contemporaneous agreements or understandings, written or oral, relating to the participants&#8217; entitlement to receive severance pay or benefits from the Company (including, without limitation, the participants&#8217; offer letters). Accordingly, none of the participants is eligible to receive severance payments or benefits under any other plan or agreement with us. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Current and Potential Equity Grants </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We granted options to purchase shares of our common stock under the 2023 Plan to certain of our executive officers and other employees and to non-employee directors. Such option grants were approved and granted immediately prior to the completion of our initial public offering. The grant of options was, and any future grant of RSUs that may be made to directors and executive officers would be, subject to approval by the compensation committee or, in the case of director equity grants, issued pursuant to our non-employee director compensation policy approved by the compensation committee and our board of directors. However, we have not made any final determinations as to any future RSU awards or the timing thereof, and there can be no assurance that we will grant any RSU awards in the future, if at all, or as to the number of shares which may be subject to any such future equity awards. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">156 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Equity Incentive Plans </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">2020 Equity Incentive Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a description of the material terms of our 2020 Equity Incentive Plan (the &#8220;2020 Plan&#8221;). The summary below does not contain a complete description of all provisions of the 2020 Plan and is qualified in its entirety by reference to the 2020 Plan, a copy of which is included as an exhibit to this registration statement of which this prospectus forms a part. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General</span>. The 2020 Plan was adopted by our board of directors on December&#160;15, 2020 and subsequently approved by our stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, options to purchase a total of 446,841 shares of our common stock were outstanding under the 2020 Plan. The weighted-average exercise price of the options outstanding under the 2020 Plan is $2.30 per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the completion of our initial public offering, no additional awards and no additional shares of our common stock will remain available for future issuance under the 2020 Plan. However, the 2020 Plan will continue to govern the terms and conditions of the outstanding awards previously granted thereunder. Shares originally reserved for issuance under the 2020 Plan, but which are not subject to outstanding options on the effective date of the 2023 Plan (as defined below), and shares subject to outstanding options under the 2020 Plan on the effective date of the 2023 Plan that are subsequently forfeited or terminated for any reason before being exercised or becoming vested, not issued because an option is settled in cash, or withheld or reacquired to satisfy the applicable exercise, or a tax withholding obligation will again become available for issuance under our 2023 Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Plan provides for the grant of incentive stock options, or ISOs, to employees and the grant of nonstatutory stock options, NSOs, to employees, non-employee directors, advisors, and consultants. The 2020 Plan also provides for the grant of restricted stock awards, restricted stock unit awards, and stock appreciation rights to employees, non-employee directors, advisors and consultants. While we have granted ISOs and NSOs, we have not granted any restricted stock awards, restricted stock unit awards, or stock appreciation rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Administration</span>. The 2020 Plan has been administered by our board of directors, and may be amended, suspended, or terminated by our board of directors. To the extent required by applicable law or deemed necessary or advisable by our board of directors, any amendment to the 2020 Plan is subject to stockholder approval. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Authorized Shares</span>. We previously reserved 2,477,588 shares of our common stock for issuance under the 2020 Plan. In the event of a stock split, reverse stock split, stock dividend, recapitalization, subdivision, combination, reclassification of the shares, or other change in our capital structure affecting shares without consideration, the administrator of the 2020 Plan will proportionately adjust (i)&#160;the number and class of shares (or other securities) that thereafter may be made the subject of awards, (ii)&#160;the number, and class of shares (or other securities or property) subject to any outstanding awards, and/or (iii)&#160;the purchase or exercise price of any outstanding awards, in each case to the extent necessary to prevent diminution or enlargement of the level of incentives intended by the 2020 Plan and the then-outstanding awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stock Options</span>. The administrator of the 2020 Plan determines the exercise price for each stock option, provided that the exercise price of an option must equal at least 100% of the fair market value of our common stock subject to the option on the date of grant and the term of an option may not exceed ten years, provided further, that no ISO may be granted to any stockholder holding more than 10% of our voting shares unless the option exercise price is at least 110% of the fair market value of the common stock subject to the option on the date of grant, and the term of the ISO does not exceed five years from the date of grant. No option may be transferred by the option holder other than by will, or by the laws of descent or distribution and, in case of NSOs, to a trust or by gift to a &#8220;family member&#8221; as that term is defined in Rule 701 of the Securities Act. Each option may be </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">157 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exercised during the option holder&#8217;s lifetime solely by the option holder or his or her legal representative. Options granted under the 2020 Plan are early exercisable and generally vest over a 48-month period, with 25% vesting on the first anniversary of the vesting commencement date and the remaining portion vesting in 36 equal monthly installments thereafter. Unless otherwise provided in an applicable award agreement, upon the termination of an option holder&#8217;s service as an employee, non-employee director, or consultant due to death or disability (or death within three months after a termination other than for cause) or for any reason other than for cause, such option holder may exercise his or her vested options no later than seven years after the date service terminates. If the option holder&#8217;s service is terminated for cause, the shares that are vested under the option will be exercisable only on the option holder&#8217;s termination date unless otherwise determined by the administrator. Notwithstanding the foregoing, no option may be exercised after the expiration of its term. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Corporate Transactions</span>. The 2020 Plan provides that, in the event of a merger, consolidation, sale of more than 50% of our voting stock to a third party, or sale of all substantially all of our assets (each, a &#8220;Change in Control Event&#8221;), the outstanding options will be subject to the agreement evidencing the Change in Control Event which may provide for continuation, assumption, substitution, acceleration, settlement in cash, cash equivalents, or securities of the successor entity, or termination without any consideration of such outstanding options. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">2023 Stock Incentive Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;24, 2023, our board of directors approved and adopted, subject to stockholder approval, the Interactive Strength, Inc. 2023 Stock Incentive Plan, or the 2023 Plan, and our stockholders approved the 2023 Plan on January&#160;26, 2023. The 2023 Plan became effective upon the completion of our initial public offering. Once the 2023 Plan became effective, no further grants were made under our 2020 Plan. This summary is not a complete description of all provisions of the 2023 Plan and is qualified in its entirety by reference to the 2023 Plan, which is filed as an exhibit to the registration statement of which this prospectus is a part. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stock Awards</span>. The 2023 Plan provides for incentive stock options, or ISOs, non-qualified stock options, or NSOs, restricted share awards, stock unit awards, stock appreciation rights, other stock-based awards, performance-based stock awards, (collectively, &#8220;stock awards&#8221;) and cash-based awards (stock awards and cash-based awards are collectively referred to as &#8220;awards&#8221;). ISOs may be granted only to our employees, including officers, and the employees of our parent or subsidiaries. All other awards may be granted to our employees, officers, our non-employee directors, and consultants and the employees and consultants of our subsidiaries and affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Share Reserve</span>. The aggregate number of shares of our common stock that may be issued pursuant to stock awards under the 2023 Plan will be 1,602,451 shares (as adjusted for stock splits, stock dividends, combinations, and the like), plus (x)&#160;any shares underlying outstanding awards under the 2020 Plan that are subsequently forfeited or terminated for any reason before being exercised or becoming vested, not issued because an award is settled in cash, or withheld or reacquired to satisfy the applicable exercise, or purchase price, or a tax withholding obligation, plus (y)&#160;the number of shares which, but for the termination of the 2020 Plan immediately prior to the completion of our initial public offering, were reserved under the 2020 Plan but not at such time issued or subject to outstanding awards under the 2020 Plan, plus (z)&#160;an annual increase on the first day of each calendar year, for a period of not more than ten years, beginning on January&#160;1, 2024 and ending on (and including) January&#160;1, 2032, in an amount equal to the lesser of (i)&#160;5% of our outstanding shares on the last day of the immediately preceding calendar year or (ii)&#160;such lesser amount (including zero) that the compensation committee (as defined below) determines for purposes of the annual increase for that calendar year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If restricted shares or shares issued upon the exercise of options are forfeited, then such shares will again become available for awards under the 2023 Plan. If stock units, options, or stock appreciation rights are forfeited or terminate for any reason before being exercised or settled, or an award is settled in cash without the delivery of shares to the holder, then the corresponding shares will again become available for awards under the 2023 Plan. Any shares withheld to satisfy the exercise price or tax withholding obligation pursuant to any award of options </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">158 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or stock appreciation rights will again become available for awards under the 2023 Plan. If stock units or stock appreciation rights are settled, then only the number of shares (if any) actually issued in settlement of such stock units or stock appreciation rights will reduce the number of shares available under the 2023 Plan, and the balance (including any shares withheld to cover taxes) will again become available for awards under the 2023 Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares issued under the 2023 Plan will be authorized but unissued shares, treasury shares, or previously issued shares. As of September&#160;30, 2023, we have granted awards and issued 1,399,800 shares of common stock, in each case under the 2023 Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Incentive Stock Option Limit</span>. The maximum number of shares that may be issued upon the exercise of ISOs under the 2023 Plan is equal to five (5)&#160;times the number of shares specified in subpart (w)&#160;of the 2023 Plan&#8217;s share reserve formula as described above under the heading &#8220;<span style="font-style:italic">Share Reserve</span>&#8221;, plus, to the extent allowable under Section&#160;422 of the Code, any shares of common stock that become available for issuance under the 2023 Plan on account of (i)&#160;an award being forfeited before all underlying shares have been issued or settled, or (ii)&#160;a portion of the shares underlying an award being withheld to satisfy the exercise price or tax withholding of such award. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Grants to Outside Directors</span>. The sum of (i)&#160;the grant date fair value for financial reporting purposes of any awards granted during any calendar year under the 2023 Plan to an outside director as compensation for services as an outside director and (ii)&#160;any cash fees paid by us to such outside director during such calendar year for service on our board of directors, may not exceed five hundred thousand dollars ($500,000), or, in the calendar year in which the outside director is first appointed or elect to our board of directors, seven hundred and fifty thousand dollars ($750,000). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Administration</span>. The 2023 Plan is administered by the compensation committee appointed by our board of directors, or the compensation committee, or by the board of directors acting as the compensation committee. Subject to the limitations set forth in the 2023 Plan, the compensation committee has the authority to determine, among other things, to whom awards will be granted, the number of shares subject to awards, the term during which an option or stock appreciation right may be exercised and the rate at which the awards may vest or be earned, including any performance criteria to which they may be subject. The compensation committee also has the authority to determine the consideration and methodology of payment for awards. To the extent permitted by applicable law, the board of directors or compensation committee may also authorize one or more of our officers to designate employees, other than officers under Section&#160;16 of the Exchange Act, to receive awards and/or to determine the number of such awards to be received by such persons subject to a maximum total number of awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Repricing; Cancellation and Re-Grant of Stock Awards</span>. The compensation committee has the authority to modify outstanding awards under the 2023 Plan. Subject to the terms of the 2023 Plan, the compensation committee has the authority to cancel any outstanding stock award in exchange for new stock awards, including awards having the same or a different exercise price cash, or other consideration, without stockholder approval but with the consent of any adversely affected participant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stock Options</span>. A stock option is the right to purchase a certain number of shares of stock, at a certain exercise price, in the future. Under the 2023 Plan, ISOs and NSOs are granted pursuant to stock option agreements adopted by the compensation committee. The compensation committee determines the exercise price for a stock option, within the terms and conditions of the 2023 Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Options granted under the 2023 Plan vest at the rate specified by the compensation committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock options granted under the 2023 Plan generally must be exercised by the optionee before the earlier of the expiration of such option or the expiration of a specified period following the optionee&#8217;s termination of employment. The compensation committee determines the term of the stock options up to a maximum of ten years. Each stock option agreement will also set forth the extent to which the option recipient will have the right </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">159 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to exercise the option following the termination of the recipient&#8217;s service with us, and the right to exercise the option of any executors or administrators of the award recipient&#8217;s estate or any person who has acquired such options directly from the award recipient by bequest or inheritance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of the exercise price may be made in cash or, if provided for in the stock option agreement evidencing the award, (1)&#160;by surrendering, or attesting to the ownership of, shares which have already been owned by the optionee, (2)&#160;future services or services rendered to the company or its affiliates prior to the award, (3)&#160;by delivery of an irrevocable direction to a securities broker to sell shares and to deliver all or part of the sale proceeds to us in payment of the aggregate exercise price, (4)&#160;by delivery of an irrevocable direction to a securities broker or lender to pledge shares and to deliver all or part of the loan proceeds to us in payment of the aggregate exercise price, (5)&#160;by a &#8220;net exercise&#8221; arrangement, (6)&#160;by delivering a full-recourse promissory note, or (7)&#160;by any other form that is consistent with applicable laws, regulations, and rules. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Tax Limitations on Incentive Stock Options</span>. The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that are exercisable for the first time by an option holder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our affiliates unless (1)&#160;the option exercise price is at least one 110% of the fair market value of the stock subject to the option on the date of grant, and (2)&#160;the term of the ISO does not exceed five years from the date of grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Restricted Share Awards</span>. The terms of any awards of restricted shares under the 2023 Plan will be set forth in a restricted share agreement to be entered into between us and the recipient. The compensation committee will determine the terms and conditions of such restricted share agreements, which need not be identical. A restricted share award may be subject to vesting requirements or transfer restrictions or both. Restricted shares may be issued for such consideration as the compensation committee may determine, including cash, cash equivalents, full recourse promissory notes, past services and future services. Award recipients who are granted restricted shares generally have all of the rights of a stockholder with respect to those shares, provided that dividends and other distributions will not be paid in respect of unvested shares unless otherwise determined by the compensation committee and, in such case, only once such unvested shares vest. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stock Unit Awards</span>. Stock unit awards give recipients the right to acquire a specified number of shares of stock (or cash amount) at a future date upon the satisfaction of certain conditions, including any vesting arrangement, established by the compensation committee and as set forth in a stock unit award agreement. A stock unit award may be settled by cash, delivery of stock, a combination of cash and stock as deemed appropriate by the compensation committee. Recipients of stock unit awards generally will have no voting or dividend rights prior to the time the vesting conditions are satisfied and the award is settled. At the compensation committee&#8217;s discretion and as set forth in the stock unit award agreement, stock units may provide for the right to dividend equivalents. Dividend equivalents may not be distributed prior to settlement of the stock unit to which the dividend equivalents pertain and the value of any dividend equivalents payable or distributable with respect to any unvested stock units that do not vest will be forfeited. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stock Appreciation Rights</span>. Stock appreciation rights generally provide for payments to the recipient based upon increases in the price of our common stock over the exercise price of the stock appreciation right. The compensation committee determines the exercise price for a stock appreciation right, which generally cannot be less than 100% of the fair market value of our common stock on the date of grant. A stock appreciation right granted under the 2023 Plan vests at the rate specified in the stock appreciation right agreement as determined by the compensation committee. The compensation committee determines the term of stock appreciation rights granted under the 2023 Plan, up to a maximum of ten years. Upon the exercise of a stock appreciation right, we will pay the participant an amount in stock, cash, or a combination of stock and cash as determined by the compensation committee, equal to the product of (1)&#160;the excess of the per share fair market value of our common stock on the date of exercise over the exercise price, multiplied by (2)&#160;the number of shares of common stock with respect to which the stock appreciation right is exercised. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">160 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other Stock Awards</span>. The compensation committee may grant other awards based in whole or in part by reference to our common stock. The compensation committee will set the number of shares under the stock award and all other terms and conditions of such awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Cash-Based Awards</span>. A cash-based award is denominated in cash. The compensation committee may grant cash-based awards in such number and upon such terms as it will determine. Payment, if any, will be made in accordance with the terms of the award, and may be made in cash or in shares of common stock, as determined by the compensation committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Performance-Based Awards</span>. The number of shares or other benefits granted, issued, retainable and/or vested under a stock or stock unit award may be made subject to the attainment of performance goals. The compensation committee may utilize any performance criteria selected by it in its sole discretion to establish performance goals. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Changes to Capital Structure</span>. In the event of a recapitalization, stock split, or similar capital transaction, the compensation committee will make appropriate and equitable adjustments to the number of shares reserved for issuance under the 2023 Plan, the number of shares that can be issued as incentive stock options, the number of shares subject to outstanding awards and the exercise price under each outstanding option or stock appreciation right. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Transactions</span>. If we are involved in a merger or other reorganization, outstanding awards will be subject to the agreement or merger or reorganization. Subject to compliance with applicable tax laws, such agreement may provide, without limitation, for (1)&#160;the continuation of the outstanding awards by us, if we are a surviving corporation, (2)&#160;the assumption or substitution of the outstanding awards by the surviving corporation or its parent or subsidiary, (3)&#160;the immediate vesting, exercisability, and settlement of the outstanding awards followed by their cancellation, (4)&#160;cancellation of the award, to the extent not vested or not exercised prior to the effective time of the merger or reorganization, in exchange for such cash or equity consideration (including no consideration) as the compensation committee, in its sole discretion, may consider appropriate, or (5)&#160;the settlement of the intrinsic value of the outstanding awards (whether or not vested or exercisable) in cash, cash equivalents, or equity (including cash or equity subject to deferred vesting and delivery consistent with the vesting restrictions applicable to such award or the underlying shares) followed by cancellation of such awards, provided that any such amount may be delayed to the same extent that payment of consideration to the holders of shares in connection with the merger or reorganization is delayed as a result of escrows, earnouts, holdbacks or other contingencies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Change of Control</span>. The compensation committee may provide, in an individual award agreement or in any other written agreement between a participant and us, that the stock award will be subject to acceleration of vesting and exercisability in the event of a change of control. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Transferability</span>. Unless the compensation committee provides otherwise, no award granted under the 2023 Plan may be transferred in any manner (prior to the vesting and lapse of any and all restrictions applicable to shares issued under such award), except by will, the laws of descent and distribution, or pursuant to a domestic relations order, provided that all ISOs may only be transferred or assigned only to the extent consistent with Section&#160;422 of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amendment and Termination</span>. Our board of directors has the authority to amend, suspend, or terminate the 2023 Plan, provided that such action does not materially impair the existing rights of any participant without such participant&#8217;s written consent. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No ISOs may be granted more than ten years after years after the later of (i)&#160;the approval of the 2023 Plan by the board of directors (or if earlier, the stockholders) and (ii)&#160;the approval by the board of directors (or if earlier, the stockholders) of any amendment to the 2023 Plan that constitutes the adoption of a new plan for purposes of Section&#160;422 of the Code. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">161 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Recoupment</span>. To the extent permitted by applicable law, the compensation committee will have the authority to require that, in the event that we are required to prepare restated financial results owing to an executive officer&#8217;s intentional misconduct or grossly negligent conduct, such executive officer will reimburse or forfeit to us the amount of any bonus or incentive compensation (whether cash-based or equity-based) such executive officer received during a fixed period, as determined by the compensation committee, preceding the year the restatement is determined to be required. That executive officer will forfeit or reimburse to us any bonus or incentive compensation to the extent that such bonus or incentive compensation exceeds what the officer would have received in that period based on an applicable restated performance measure or target. We will recoup incentive-based compensation from executive officers to the extent required under the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules, regulations and listing standards that may be issued under that act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">2023 Employee Stock Purchase Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;24, 2023, our board of directors approved and adopted, subject to stockholder approval, the Interactive Strength, Inc. 2023 Employee Stock Purchase Plan, or the ESPP, and our stockholders approved the ESPP on January&#160;26, 2023. The ESPP became effective upon the completion of our initial public offering. This summary is not a complete description of all provisions of the ESPP and is qualified in its entirety by reference to the ESPP, which is filed as an exhibit to the registration statement of which this prospectus is a part. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General</span>. The ESPP is intended to qualify as an &#8220;employee stock purchase plan&#8221; under Code Section&#160;423, except as explained below under the heading &#8220;International Participation.&#8221; During regularly scheduled &#8220;offerings&#8221; under the ESPP, participants will be able to request payroll deductions and then expend the accumulated deduction to purchase a number of shares of our common stock at a discount and in an amount determined in accordance with the ESPP&#8217;s terms. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Shares Available for Issuance</span>. The ESPP has 320,491 authorized but unissued shares of our common stock (as adjusted for stock splits, stock dividends, combinations, and the like) reserved for issuance upon becoming effective, plus an additional number of shares of our common stock to be reserved annually on the first day of each calendar year for a period of not more than ten years, beginning on January&#160;1, 2024, in an amount equal to the least of (i)&#160;1% of the outstanding shares of our common stock on such date, (ii)&#160;33,333 shares (as adjusted for stock splits, stock dividends, combinations, and the like), or (iii)&#160;a lesser amount (including zero) that the compensation committee determines for purposes of the annual increase for that calendar year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Administration</span>. The ESPP is administered by the compensation committee, or by our board of directors acting as the compensation committee. The compensation committee has the authority to construe, interpret and apply the terms of the ESPP, to determine eligibility, to establish such limitations and procedures as it determines are consistent with the ESPP and to adjudicate any disputed claims under the ESPP. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Eligibility</span>. Each full-time and part-time employee, including officers, employee directors, and employees of participating subsidiaries, who is employed by us on the day preceding the start of any offering period will be eligible to participate in the ESPP. The ESPP requires that an employee customarily work more than twenty (20)&#160;hours per week and more than five months per calendar year in order to be eligible to participate in the ESPP. The ESPP permits an eligible employee to purchase our common stock through payroll deductions, which may not be less than 1% nor more than 15% of the employee&#8217;s compensation, or such lower limit as may be determined by the compensation committee from time to time. However, no employee is eligible to participate in the ESPP if, immediately after electing to participate, the employee would own stock (including stock such employee may purchase under this plan or other outstanding options) representing 5% or more of the total combined voting power or value of all classes of our common stock. Unless provided otherwise by the compensation committee prior to the commencement of an offering, in no event will a participant be eligible to purchase during any offering period that number of whole shares of our common stock determined by dividing $25,000 by the fair market value of a share of our common stock on the first date of such offering period (subject to any adjustment pursuant to the terms of the ESPP). In addition, under applicable tax rules, no employee is </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">162 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
permitted to accrue, under the ESPP and all of our or our subsidiaries&#8217; similar purchase plans, a right to purchase stock having a fair market value in excess of twenty-five thousand dollars ($25,000) (determined at the time the right is granted) for each calendar year. Employees will be able to withdraw their accumulated payroll deductions prior to the end of the offering period in accordance with the terms of the offering. Participation in the ESPP will end automatically on termination of employment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Offering Periods and Purchase Price</span>. The ESPP is implemented through a series of offerings of purchase rights to eligible employees. Under the ESPP, the compensation committee may specify offerings with a duration of not more than 27 months and may specify shorter purchase periods within each offering. During each purchase period, payroll deductions will accumulate, without interest. On the last day of the purchase period, accumulated payroll deductions will be used to purchase our common stock for employees participating in the offering. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price will be specified pursuant to the offering, but cannot, under the terms of the ESPP, be less than 85% of the fair market value per share of our common stock on either the offering date or on the purchase date, whichever is less. The fair market value of our common stock for this purpose will generally be the closing price on the Nasdaq Stock Market (or such other exchange as our common stock may be traded at the relevant time) for the date in question, or if such date is not a trading day, for the last trading day before the date in question. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Reset Feature</span>. The compensation committee may specify that, if the fair market value of a share of our common stock on any purchase date within a particular offering period is less than or equal to the fair market value on the start date of that offering period, then the offering period will automatically terminate and the employee in that offering period will automatically be transferred and enrolled in a new offering period which will begin on the next day following such purchase date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Changes to Capital Structure</span>. In the event that there is a specified type of change in our capital structure, such as a stock split, appropriate adjustments will be made to (1)&#160;the number of shares reserved under the ESPP, (2)&#160;the individual and aggregate participant share limitations described in the plan and (3)&#160;the price of shares that any participant has elected to purchase. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">International Participation</span>. To provide us with greater flexibility in structuring our equity compensation programs for our non-U.S. employees, the ESPP also permits us to grant employees of our non-U.S. subsidiary entities rights to purchase shares of our common stock pursuant to other offering rules or sub-plans adopted by the compensation committee in order to achieve tax, securities law or other compliance objectives. While the ESPP is intended to be a qualified &#8220;employee stock purchase plan&#8221; within the meaning of Code Section&#160;423, any such international sub-plans or offerings are not required to satisfy those U.S. tax code requirements and therefore may have terms that differ from the ESPP terms applicable in the U.S. However, the international sub-plans or offerings are subject to the ESPP terms limiting the overall shares available for issuance, the maximum payroll deduction rate, maximum purchase price discount and maximum offering period length. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Corporate Reorganization</span>. Immediately before a corporate reorganization, the offering period and purchase period then in progress will terminate and either our common stock will be purchased with the accumulated payroll deductions or the accumulated payroll deductions will be refunded without occurrence of any common stock purchase, unless the surviving corporation (or its parent corporation) assumes the ESPP under the plan of merger or consolidation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amendment and Termination</span>. Our board of directors and the compensation committee each have the right to amend, suspend or terminate the ESPP at any time. Any increase in the aggregate number of shares of stock to be issued under the ESPP is subject to stockholder approval. Any other amendment is subject to stockholder approval only to the extent required under applicable law or regulation, including Section&#160;423 of the Code. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">163 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_15">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We describe below transactions and series of similar transactions, during our last three fiscal years or currently proposed, to which we were a party or will be a party, in which: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the amounts involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any of our directors, executive officers or beneficial holders of more than 5% of any class of our voting securities had or will have a direct or indirect material interest. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than as described below, there have not been, nor are there any currently proposed, transactions or series of similar transactions meeting these criteria to which we have been or will be a party other than compensation arrangements, which are described where required under <span style="font-style:italic">&#8220;Management &#8211; Director Compensation&#8221;</span> and <span style="font-style:italic">&#8220;Executive Compensation.&#8221;</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following information reflects the 1-for-150 reverse stock split effected on December&#160;30, 2022. In addition, in December 2022, all outstanding shares of our redeemable convertible preferred stock were converted into shares of our Class&#160;A common stock on a 1:1 basis. The reverse stock split and conversion of preferred stock were effected in connection with an equity financing transaction, which also involved a rights offering completed in February 2023. In February 2023, all outstanding shares of our Class&#160;A common stock and Class B common stock were converted into shares of our common on a 1:1 basis. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Financings and Issuances </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Class&#160;A Common Stock and Class B Common Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From January&#160;1, 2019 to December&#160;31, 2022, we issued and sold an aggregate of 1,294,943 shares of our Class&#160;A common stock at a weighted-average purchase price of $5.18 per share, for aggregate gross proceeds of $6,713,132. From January&#160;1, 2019 to December&#160;31, 2022, we issued and sold an aggregate of 4.20 shares of our Class B common stock, at a weighted-average purchase price of $4.20 per share. The holders of Class&#160;A common stock are entitled to one vote for each share of Class&#160;A common stock held at all meetings of stockholders. The holders of Class B common stock do not have voting rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate number of shares of our Class&#160;A common stock acquired by certain of our directors, officers, and beneficial owners of more than 5% of our voting securities in the financing transactions described above and the aggregate consideration paid therefor. In February 2023, the Class&#160;A common stock converted into common stock on a 1:1 basis. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:36%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:43%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Investor<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares of<br />Class A<br />Common<br />Stock <br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Consideration&#160;Paid<br />for&#160;Class&#160;A<br />Common&#160;Stock<br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Basis of Relationship</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aaron N. D. Weaver</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">11,572</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">550,000</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">Director (originally appointed by Apeiron)<sup style="font-size:75%; vertical-align:top">(2)</sup></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Apeiron Investment Group Ltd.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">173,355</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">313,429</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley J. Wickens</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1,177,375</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1,550,000</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">See <span style="font-style:italic">&#8220;Security Ownership of Certain Beneficial Owners and Management&#8221;</span> for additional details regarding these participants and their equity holdings. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Apeiron relinquished its board designation rights prior to the completion of our initial public offering. However, while he will cease to be the board designee of Apeiron, Mr.&#160;Weaver continues to serve as a member of our board of directors. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate number of shares of our Class B common stock acquired by certain of our directors, executive officers, and beneficial owners of more than 5% of our voting securities in the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">164 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financing transactions described above and the aggregate consideration paid therefor. In February 2023, the Class B common stock converted into common stock on a 1:1 basis. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:37%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:43%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Investor<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares&#160;of<br />Class&#160;B<br />Common<br />Stock <br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Consideration&#160;Paid<br />for Class B<br />Common Stock<br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Basis of Relationship</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deepak M. Mulchandani</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">2,166</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">32,500</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">Director and non-executive officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trent A. Ward</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">553</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">8,613</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">Co-founder, Chief Executive Officer, director, and 5% or greater stockholder</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Additional details regarding these participants and their equity holdings are provided in <span style="font-style:italic">&#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221;</span> </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Series A and Series A-2 Redeemable Convertible Preferred Stock Financings </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From July&#160;23, 2021 to December&#160;23, 2021, and from March&#160;10, 2022 to March&#160;30, 2022, we issued and sold 86,703 and 755,606 shares of our Series A and Series A-2 redeemable convertible preferred stock at a weighted-average purchase price of at $490.50 and $47.67 per share, respectively, for aggregate gross proceeds of $42,529,715 and $36,020,056.72, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate number of our Series A and Series A-2 redeemable convertible preferred stock acquired by certain of our directors, officers, and beneficial owners of more than 5% of our voting securities in the financing transactions described above and the aggregate consideration paid therefor. Each of the Series A and Series A-2 redeemable convertible preferred stock were automatically converted into Class&#160;A common stock on a 1:1 basis, respectively, which in turn converted into common stock on a 1:1 basis in February 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:37%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:21%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Investor<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares of<br />Series A<br />Redeemable<br />Convertible<br />Preferred<br />Stock <br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Consideration<br />Paid for<br />Series A<br />Redeemable<br />Convertible<br />Preferred<br />Stock<br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares of<br />Series A-2<br />Redeemable<br />Convertible<br />Preferred<br />Stock <br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Consideration<br />Paid for Series<br />A-2 Redeemable<br />Convertible<br />Preferred Stock<br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Basis of Relationship</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Apeiron</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">9,925</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">4,868,418</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">203,976</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">9,723,613.66</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">block.one Investments 1</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">367,107</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">17,499,999</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley J. Wickens</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">21,029</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1,002,465</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deepak M. Mulchandani</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">611</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">300,000</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director and non-executive officer</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Additional details regarding these participants and their equity holdings are provided in <span style="font-style:italic">&#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221;</span> </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Convertible Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From April&#160;8, 2020 to March&#160;9, 2022, we issued an aggregate $26,857,011 in principal amount of convertible notes, which have been converted into an aggregate of 172,600 shares of our Series Seed-9, Series A, Series A-1 and Series A-2 redeemable convertible preferred stock, taking into account the principal amount of the convertible notes and any accrued and unpaid interest. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">165 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate principal amount of convertible notes acquired by our directors, officers, and beneficial owners of more than 5% of our voting securities in the financing transactions described above and the amount of shares that were issued thereunder upon conversion. Each of the Series Seed-9, Series A, Series A-1, and Series A-2 Series A and Series A-2 redeemable convertible preferred stock were automatically converted into Class A common stock on a 1:1 basis, respectively, which in turn converted into common stock on a 1:1 basis in February 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:40%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:21%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Investor<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Principal<br />Amount of<br />Convertible<br />Note <br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Accrued<br />Interest of<br />Convertible<br />Note<br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number of<br />Shares of Series<br />A Redeemable<br />Convertible<br />Preferred&#160;Stock<br />Issuable Upon<br />Conversion <br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number of<br />Shares of <br />Series A-2<br />Redeemable<br />Convertible<br />Preferred&#160;Stock<br />Issuable Upon<br />Conversion <br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Basis of Relationship</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Apeiron Investment Group Ltd.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">4,700,000</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">23,613</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">99,089</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5%&#160;or&#160;greater&#160;stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley J. Wickens</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1,002,465</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">21,029</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5%&#160;or&#160;greater&#160;stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deepak M. Mulchandani</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">181,818</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">370</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director and non-executive officer</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Additional details regarding these participants and their equity holdings are provided in <span style="font-style:italic">&#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221;</span> </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From November&#160;13, 2022 to November&#160;29, 2022, we issued an aggregate of $4.4 million in principal amount of convertible notes, which were converted into an aggregate of 567,908 shares of our common stock based on the aggregate principal amount outstanding under such convertible notes as of December&#160;31, 2022 (at the initial public offering price of $8.00 per share). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate principal amount of convertible notes acquired by our directors, officers, and beneficial owners of more than 5% of our voting securities in the financing transactions described above, and the amount of shares issuable thereunder upon conversion based on the aggregate amount outstanding under such convertible notes as of December&#160;31, 2022 (at the initial public offering price of $8.00 per share). </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:42%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:28%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Investor<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Principal<br />Amount of<br />Convertible<br />Note<br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of&#160;Shares<br />of Common Stock<br />Issuable Upon<br />Conversion<br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Basis of Relationship</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Apeiron</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,150,952</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">147,790</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">block.one Investments 1</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,146,276</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8147,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley J. Wickens</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">327,700</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">42,006</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5% or greater stockholder</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Additional details regarding these participants and their equity holdings are provided in <span style="font-style:italic">&#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221;</span> </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2022, all of our outstanding shares of redeemable convertible preferred stock were converted into shares of Class&#160;A common stock on a 1:1 basis in connection with an equity financing transaction, which included a 1-for-150 a reverse stock split and included a capital raise in the form of a rights offering as described further below. The rights offering transaction was completed in February 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From July&#160;23, 2021 to August&#160;25, 2021, we issued warrants to purchase an aggregate of 125,982 shares of our Class&#160;A common stock, with an exercise price of $0.01 per share. On July&#160;23, 2021, we issued warrants to purchase an aggregate of 6,632 shares of our Class B common stock, with an exercise price of $0.01 per share. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">166 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate number of shares of our common stock underlying the warrants acquired by our directors, officers, and beneficial owners of more than 5% of our voting securities in the financing transaction described above and the aggregate proceeds to us upon exercise at the exercise price of $0.01 per share. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:50%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:23%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Investor<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares<br />Underlying<br />Class A<br />Warrants <br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares<br />Underlying<br />Class B<br />Warrants<br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Proceeds<br />Upon<br />Exercise<br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Basis of Relationship</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Apeiron Investment Group Ltd.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">11,520</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">172</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deepak M. Mulchandani</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1,204</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">18</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">Director and non-executive officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trent A. Ward</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">266</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">40</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">Co-founder, Chief Executive Officer, director, and 5% or greater stockholder</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left"><span style="font-style:italic"></span>(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">See <span style="font-style:italic">&#8220;Security Ownership of Certain Beneficial Owners and Management&#8221;</span> for additional details regarding these participants and their equity holdings.<span style="font-style:italic"> </span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From November&#160;13, 2022 to November&#160;29, 2022, we issued warrants exercisable for up to 92,296 shares of our common stock at an exercise price of $0.01 per share, which were automatically deemed net exercised for 92,122 shares of our common stock upon the completion of our initial public offering (at the initial public offering price of $8.00 per share). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the aggregate number of shares of our common stock underlying the warrants acquired by our directors, officers, and beneficial owners of more than 5% of our voting securities in the financing transactions described above and the aggregate proceeds to us if such warrants were exercised at the exercise price of $0.01 per share. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:46%"></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:25%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Investor<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares<br />Underlying<br />Warrants <br />#</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Proceeds<br />Upon<br />Exercise<br />$</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Basis of Relationship</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Apeiron</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">24,143</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">362.17</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">block.one Investments 1</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">24,046</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">360.69</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley J. Wickens</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">6,874</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">103.12</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left"><span style="font-style:italic"></span>(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Additional details regarding these participants and their equity holdings are provided in <span style="font-style:italic">&#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221; </span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We completed an equity financing transaction involving: (a)&#160;the automatic conversion of all of our outstanding shares of redeemable convertible preferred stock into shares of Class&#160;A common stock on a 1:1 basis, which was effected in December 2022 as described above; (b)&#160;a 1-for-150 reverse stock split effected on December&#160;30, 2022; and (c)&#160;a rights offering completed in February 2023. The rights offering involved the sale of Class&#160;A common stock to all existing accredited investors as of December&#160;19, 2022 at a price equal to approximately $0.51 per share (which per share amount was adjusted to reflect the 1-for-150 reverse stock split effected on December&#160;30, 2022). Each accredited investor received the right to elect to purchase shares of Class&#160;A common stock in the rights offering up to their respective pro rata amount, which was equal to the product of (x)&#160;$5,000,000, multiplied by (y)&#160;the quotient obtained by dividing (a)&#160;the number of shares of our capital stock </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">167 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
held by the accredited investor as of December&#160;19, 2022 including any common stock issuable on the exercise of warrants or options held by such accredited investor as of December&#160;19, 2022, by (b)&#160;our fully-diluted capitalization as of December&#160;19, 2022. The rights offering was closed on January&#160;31, 2023. In connection with the rights offering, we issued a total of 9,749,439 shares of Class&#160;A common stock, of which 1,072,438 was issued in December 2022, and 8,677,001 was issued in January and February 2023. The following table sets forth the aggregate number of our Class&#160;A common stock acquired by certain of our directors, officers, and beneficial owners of more than 5% of our voting securities in the financing transactions described above and the aggregate consideration paid therefor. In February 2023, the Class B common stock converted into common stock on a 1:1 basis. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:42%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:25%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Investor<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares of<br />Class A<br />Common<br />Stock #</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Aggregate<br />Consideration<br />for Class A<br />Common<br />Stock $</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Basis of Relationship</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Apeiron</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">2,218,374</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1,137,693</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">block.one Investments<sup style="font-size:75%; vertical-align:top">1</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">2,650,884</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1,359,505</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley J. Wickens</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1,423,596</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top">$</td>
<td style="white-space:nowrap;vertical-align:top" align="right">730,090</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;white-space:nowrap">5% or greater stockholder</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">See <span style="font-style:italic">&#8220;Security Ownership of Certain Beneficial Owners and Management&#8221;</span> for additional details regarding these participants and their equity holdings. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Investors&#8217; Rights Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"></span>In connection with the sale of redeemable convertible preferred stock described above, we entered into an investors&#8217; rights agreement with the holders of our common stock and preferred stock, including each of the persons and entities listed in the tables above titled &#8220;Class A Common Stock and Class B Common Stock&#8221; and &#8220;Redeemable Convertible Series A and Series A-2 Preferred Stock Financings.&#8221; The investor rights agreement, among other things, grants our preferred stockholders and certain of our common stockholders specified registration rights with respect to shares of our common stock, including shares of our common stock issued or issuable upon conversion of the shares of redeemable convertible preferred stock held by them. For more information regarding the registration rights provided in the investor rights agreement, see <span style="font-style:italic">&#8220;Description of Capital Stock &#8211; Registration Rights.&#8221; </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Offer Letter </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into an offer letter with our Chief Executive Officer, Trent A. Ward. Mr.&#160;Ward is also a director and a 5% or greater stockholder. See <span style="font-style:italic">&#8220;Executive Compensation &#8211; Narrative to Summary Compensation Table &#8211; Offer Letter with Our Named Executive Officer.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Agreements with Related Parties </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Shareholder Loan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been partially funded to date by two secured promissory notes issued to Trent A. Ward, our Chief Executive Officer, a director, and a beneficial owner of more than 5% of our voting securities. One of the promissory notes had a principal amount of $82,500, an issuance date of August&#160;28, 2019, a late payment fee of 15.0%, a maturity date of February&#160;28, 2022 and was interest-free. We subsequently received a waiver for all defaults and associated remedies under this promissory note. The other promissory note had a principal amount of $353,672, an issuance date of September&#160;30, 2020, a maturity date of June&#160;30, 2021, and was interest-free and settled before June&#160;30, 2021. As of December&#160;31, 2021, and December&#160;31, 2022, the aggregate amount outstanding under these promissory notes was in each case $78,501. The largest amount outstanding under these promissory notes was $436,172. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">168 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Apeiron Advisory Services </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We paid an aggregate of $0.9 million to Apeiron Advisory Ltd. (&#8220;Apeiron Advisory&#8221;), an affiliate of Apeiron, which is a beneficial owner of more than 5% of our common stock, for various advisory services related to our business. This arrangement has been terminated and we are no longer receiving any advisory services from Apeiron Advisory. Aaron N. D. Weaver, one of our directors, was appointed to our board of directors by Apeiron pursuant to Apeiron&#8217;s board designation rights, which rights lapsed upon the completion of our initial public offering. Apeiron relinquished its board designation rights prior to the completion of our initial public offering. However, while he ceased to be the board designee of Apeiron, Mr.&#160;Weaver continues to serve as a member of our board of directors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Indemnification Agreements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have also entered into customary indemnification agreements with our directors, executive officers, and certain other employees under which we have agreed to indemnify each such person and hold them harmless against expenses, judgments, penalties, fines and amounts payable under settlement agreements in connection with any threatened, pending or completed action, suit or proceeding to which they have been made a party or in which they became involved by reason of the fact that they are, or were, our director or officer or employee. Except with respect to expenses to be reimbursed by us in the event that the indemnified person has been successful on the merits or otherwise in defense of the action, suit or proceeding, our obligations under the indemnification agreements are subject to certain customary restrictions and exceptions. The indemnification agreements are governed under Delaware law. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Policies and Procedures for Related Party Transactions </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors approved a policy, effective immediately prior to the completion of our initial public offering, that our executive officers, directors, nominees for election as a director, beneficial owners of more than 5% of any class of our voting securities (including our common stock), including any of their immediate family members and affiliates, including entities owned or controlled by such persons (collectively, &#8220;related persons&#8221;) are not permitted to enter into a related person transaction with us without the prior consent of our audit committee. Transactions involving compensation for services provided to us as an employee, consultant, or director are not considered related person transactions under this policy. Any request for us to enter into a transaction with any related person in which the amount involved exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years (to extent we are deemed a smaller reporting company), and such person would have a direct or indirect interest must first be presented to our audit committee for review, consideration and approval. To identify related person transactions in advance, we rely on information supplied by our executive officers, directors, and certain significant stockholders. In considering related person transactions, our audit committee takes into account the relevant available facts and circumstances, which may include, but are not limited to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the risks, costs, and benefits to us; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the extent of the related person&#8217;s interest in the transaction; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the impact on a director&#8217;s independence in the event the related person is a director, immediate family member of a director or an entity with which a director is affiliated; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the terms of the transaction; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the availability of other sources for comparable services or products; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the terms available whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We did not have a formal review and approval policy for related party transactions at the time of any of the transactions described above. However, all of the transactions described above were entered into after presentation, consideration and approval by our board of directors. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">169 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_16">SELLING STOCKHOLDER </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have prepared this prospectus to allow the selling stockholder to sell or otherwise dispose of, from time to time, up to 12,480,480 shares of our common stock, which are comprised of (i)&#160;up to 11,556,000 Convertible Note Shares issuable upon the conversion of the Note, and (ii)&#160;up to 924,480 Warrant Shares issuable upon exercise of the Warrant. See <span style="font-style:italic">&#8220;Prospectus Summary &#8211; The Offering&#8221;</span> and <span style="font-style:italic">&#8220;The 3i Note Transaction&#8221;</span> for a description of the private transactions in which we issued the Securities. Except for the transactions contemplated by the Purchase Agreement and the related registration rights agreement, and the beneficial ownership of our securities, neither the selling stockholder nor any persons who have control over the selling stockholder have had any material relationship with us within the past three years. We do not know how long the selling stockholder will hold the shares before selling them, and we are not currently aware of any existing agreements, arrangements or understandings between the selling stockholder and any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the shares of our common stock offered by this prospectus by the selling stockholder. Unless the context otherwise requires, as used in this prospectus, &#8220;selling stockholder&#8221; refers to the selling stockholder named in this prospectus, or certain transferees, assignees or other successors-in-interest that may receive our securities from the selling stockholder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides, as of December&#160;7, 2023, information regarding the selling stockholder and the shares of common stock that it may offer and sell from time to time under this prospectus. The percentage of ownership in the table below is based on 14,313,185 shares of common stock outstanding as of December&#160;7, 2023. The table is prepared based on information supplied to us by the selling stockholder, and reflects its holdings as of December&#160;7, 2023. The number of shares in the column &#8220;Maximum Number of Shares to be Offered&#8221; represents all of the shares of common stock that the selling stockholder may offer under this prospectus. The selling stockholder may sell some, all or none of its shares in this offering. Beneficial ownership is determined in accordance with Section&#160;13(d)&#160;of the Exchange Act and Rule&#160;13d-3 thereunder, and includes shares of common stock with respect to which the selling stockholder has voting and investment power, as well as shares issuable upon the exercise or conversion of securities exercisable or convertible into shares of common stock within 60 days of the measurement date held by the selling stockholder. Accordingly, the information in the columns regarding &#8220;Shares Beneficially Owned Prior to Offering&#8221; and &#8220;Shares Beneficially Owned After Offering&#8221; lists the number of shares of common stock owned by the selling stockholder, based on its ownership of the shares of common stock and securities convertible or exercisable into shares of common stock, as of December&#160;7, 2023 or within 60 days of such date, assuming exercise or conversion, as applicable, of the securities exercisable or convertible into shares of common stock held by the selling stockholder on that date, if applicable, without regard to any limitations on conversions or exercises. The fourth column assumes the sale of all of the shares offered by the selling stockholder pursuant to this prospectus. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:55%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares Beneficially<br />Owned Prior to<br />Offering<sup style="font-size:75%; vertical-align:top">(1)(2)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Maximum<br />Number of<br />Shares to be<br />Offered</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares Beneficially<br />Owned After<br />Offering<sup style="font-size:75%; vertical-align:top">(3)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name of Selling Stockholders</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Percentage</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Percentage</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3i, LP<sup style="font-size:75%; vertical-align:top">(4)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,480,480</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46.6</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,480,480</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The number and percentage reflect the maximum number of shares and percentage ownership assuming full conversion under the Note and full exercise of the Warrant before taking into account the Beneficial Ownership Limitation (as defined below) and the Share Cap (as defined below). The selling stockholder may not convert or exercise, as applicable, any portion of the 12,480,480 Shares to the extent such conversion or exercise would cause the selling stockholder, together with its affiliates, to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding common stock (the &#8220;Beneficial Ownership Limitation&#8221;). Due to the Beneficial Ownership Limitation, notwithstanding the maximum number of shares and percentage reflected above, the selling stockholder&#8217;s beneficial ownership of our shares of common stock at any time will not exceed 4.99% of our outstanding common stock, or 1,337,004 shares based on our common stock outstanding as of December&#160;7, 2023 plus the issuance of such </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">170 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td align="left" style="vertical-align:top">
1,337,004 shares. The Purchase Agreement also prohibits us from issuing or selling shares of our common stock under the Purchase Agreement in excess of 19.99% of the shares of our common stock outstanding as of immediately prior to the signing of the Purchase Agreement (the &#8220;Share Cap&#8221;) unless we obtain stockholder approval to do so under applicable Nasdaq rules. Neither the Beneficial Ownership Limitation nor the Share Cap (to the extent applicable under Nasdaq rules) may be amended or waived under the Securities Purchase Agreement. </td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Applicable percentage ownership is based on 14,313,185 shares of our common stock outstanding as of December&#160;7, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Assumes the sale of all shares being offered pursuant to this prospectus, although the selling stockholder is under no obligation to sell any Shares at this time. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The business address of 3i, LP is 2 Wooster Street, 2nd Floor, New York, New York 10013. 3i&#8217;s principal business is that of a private investor. Maier Joshua Tarlow is the manager of 3i Management, LLC, the general partner of 3i, LP, and has sole voting control and investment discretion over securities beneficially owned directly by 3i, LP and indirectly by 3i Management, LLC. The foregoing should not be construed in and of itself as an admission by Mr.&#160;Tarlow as to beneficial ownership of the securities beneficially owned directly by 3i, LP and indirectly by 3i Management, LLC. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">171 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_17">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information with respect to the beneficial ownership of our common stock, as of December&#160;7, 2023 by: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each person or group of affiliated persons known by us to beneficially own more than 5% of our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each of our named executive officers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each of our directors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">all of our executive officers and directors as a group. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares beneficially owned by each stockholder is determined under rules&#160;issued by the SEC. Under these rules, a person is deemed to be a &#8220;beneficial&#8221; owner of a security if that person has or shares voting power or investment power, which includes the power to dispose of or to direct the disposition of such security. Except as indicated in the footnotes below, we believe, based on the information furnished to us, that the individuals and entities named in the table below have sole voting and investment power with respect to all shares of common stock beneficially owned by them, subject to any applicable community property laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Percentage ownership of our common stock is based on 14,313,185 shares of our common stock outstanding on December&#160;7, 2023. Unless noted otherwise, the address of all listed stockholders is 1005 Congress Avenue, Suite 925, Austin, Texas 78701. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:80%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number of<br />Shares<br />Beneficially<br />Owned (#)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Percentage<br />of<br />Shares<br />Beneficially<br />Owned (%)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><span style="font-weight:bold">Name of Beneficial Owner</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">5% Stockholders</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">block.one Investments <sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,376,779</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23.6</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley J. Wickens</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,704,891</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11.9</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Apeiron<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,427,592</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alta-Gateway SICAV PLC Global Equities Impact Fund<sup style="font-size:75%; vertical-align:top">(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,300,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Directors and Executive Officers</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trent Ward <sup style="font-size:75%; vertical-align:top">(4)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">960,235</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6.6</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deepak M. Mulchandani <sup style="font-size:75%; vertical-align:top">(5)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">280,260</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1.9</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aaron N. D. Weaver<sup style="font-size:75%; vertical-align:top">(6)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,104</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kirsten Bartok Touw<sup style="font-size:75%; vertical-align:top">(7)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,276</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael J. Madigan <sup style="font-size:75%; vertical-align:top">(8)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,091</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">All executive officers and directors as a group (5 individuals)</span></span><sup style="font-size:75%; vertical-align:top">(9)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,290,966</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8.6</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Less than 1%. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The principal business address for block.one Investments 1 is c/o Maples Corporate Services Limited, PO Box 309 Ugland House, Grand Cayman KY1-1104, Cayman Islands. block.one Investments 1 is managed by a board of directors. There is no individual which may be deemed to have shared voting and dispositive power over the shares held by block.one Investments 1. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 728,675 shares of common stock held of record by Apeiron Investment Group Ltd. (&#8220;Apeiron Ltd.&#8221;) and 698,917 shares of common stock held of record by Apeiron Presight Capital Fund II, L.P. (&#8220;Apeiron Presight&#8221;). Apeiron Ltd. is a limited liability company managed by a board of directors. Julien Hoefer and Jefim Gewiet are the directors of Apeiron Ltd. There is no individual which may be deemed to have shared voting and dispositive power over the shares held by Apeiron Ltd. Apeiron Presight is managed by its general partners. Apeiron Ltd. and Fabian Hansen are the general partners of Apeiron Presight and </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">172 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td align="left" style="vertical-align:top">
may be deemed to have joint voting and investment power over shares held by Apeiron Presight. The principal business address for Apeiron Ltd. is 66&#160;&amp; 67, Beatrice, Amery Street, Sliema, SLM 1707, Malta. The principal business address for Apeiron Presight is 340 S. Lemon Ave. #3391, Walnut, California 91789. </td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The principal business address for Alta-Gateway SICAV PLC Global Equities Impact Fund is Cornerstone Complex, Suite A, Level 1, 16th&#160;September Square, Mosta, MT-32 MST 1180, Malta.&#160;Alta-Gateway PLC Global Equities Impact Fund is managed by a board of directors.&#160;There is no individual which may be deemed to have shared voting and dispositive power over the shares held by Alta-Gateway SICAV PLC Global Equities Impact Fund. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i)&#160;630,931 shares of common stock held by Mr.&#160;Ward individually; (ii)&#160;312,555 shares of common stock subject to stock options exercisable within 60 days of December&#160;7, 2023; and (iii)&#160;16,763 shares of common stock held of record by Trent Ward Investments LLC, for which Mr.&#160;Ward serves as manager and is deemed to hold voting and dispositive power. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 3,370 shares of common stock and 276,890 shares of common stock subject to stock options exercisable within 60 days of December&#160;7, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 13,104 shares of common stock subject to stock options exercisable within 60 days of December&#160;7, 2023 </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 12,172 shares of common stock and 13,104 shares of common stock subject to stock options exercisable within 60 days of December&#160;7, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 12,091 shares of common stock subject to stock options exercisable within 60 days of December&#160;7, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes 627,744 shares of common stock subject to stock options exercisable within 60 days of December&#160;7, 2023. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">173 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_18">DESCRIPTION OF CAPITAL STOCK </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the rights of our common and preferred stock and certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws, and of the Delaware General Corporation Law (&#8220;DGCL&#8221;). This summary is not complete. For more detailed information, please see our amended and restated certificate of incorporation and amended and restated bylaws, which are filed as exhibits to the registration statement of which this prospectus forms a part, as well as the relevant provisions of the DGCL. The information below gives effect to the 1-for-150 reverse stock split effected on December&#160;30, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">General </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of 900,000,000 shares of common stock, $0.0001 par value per share and 200,000,000 shares of preferred stock, $0.0001 par value per share. All of our outstanding shares of common stock are fully paid and nonassessable. The remaining unissued shares of our authorized preferred stock are undesignated. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"></span>As of September&#160;30, 2023, there were 14,313,185 shares of common stock issued and outstanding held by approximately 386 holders of record and no shares of preferred stock issued and outstanding. We may designate and issue Series A convertible preferred stock or other series of convertible preferred stock. See <span style="font-style:italic">&#8220; &#8211; Preferred Stock.&#8221; </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Voting </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, including the election of directors, and does not have cumulative voting rights. Accordingly, the holders of a majority of the shares of our common stock entitled to vote in any election of directors can elect all of the directors standing for election. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Dividends </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to preferences that may be applicable to any then outstanding preferred stock, the holders of common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Liquidation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of our liquidation, dissolution, or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Rights and Preferences </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no preemptive, redemption or sinking fund provisions applicable to our common stock. The rights, preferences, and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate and issue in the future. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Preferred Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock. The issuance of preferred </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">174 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, or preventing a change in our control that may otherwise benefit holders of our common stock and may adversely affect the market price of our common stock and the voting and other rights of the holders of common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not currently have any shares of preferred stock designated or issued and outstanding. In connection with the potential conversion of certain outstanding promissory notes, we may elect to convert such promissory notes into non-voting preferred stock, which may be designated as Series A convertible preferred stock. We have not made any final determination with respect to any such conversion. In addition, we may elect to designate additional series of preferred stock if deemed appropriate to facilitate potential future transactions, including strategic investments or acquisitions. If additional series of preferred stock are designated in the future, we currently anticipate that such shares would be non-voting preferred stock and will be subject to voluntary and mandatory conversion provisions, as well as beneficial ownership restrictions and share issuance caps, in each case as would be set forth in a certificate of designations for the series of preferred stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A convertible preferred stock, if and when designated and issued, will be subject to certain rights, preferences, privileges, and obligations, including voluntary and mandatory conversion provisions, as well as beneficial ownership restrictions and share issuance caps, as described below and as set forth in the Certificate of Designations for the Series A convertible preferred stock (the &#8220;Series A Certificate&#8221;) which would be subject to the approval by our board of directors. It is further anticipated the Series A convertible preferred stock can be issued at any time and any subsequent mandatory or voluntary conversion into common stock shall be at a conversion price at least equal to or above the closing price per share of our common stock as reported on the Nasdaq Stock Market on the last trading day immediately preceding the date that the conversion transaction, including the Series A Certificate, is approved by the Company&#8217;s board of directors and executed by the Company and the holders of the promissory notes, in each case subject to customary adjustments for stock splits and combinations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A convertible preferred stock is anticipated to include the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Subject to certain conversion restrictions to be specified in the Series A Certificate, and applicable legal and regulatory requirements, including without limitation, the listing requirements of the Nasdaq Stock Market, (i)&#160;each share of Series A convertible preferred stock is convertible, at the option of the holder, at any time, provided that such conversion occurs at least 12 months following the Original Issuance Date (as defined in the Series A Certificate), into such whole number of fully paid and non-assessable shares of common stock as is determined by dividing the Original Issue Price (as defined in the Series A Certificate) by the Conversion Price (as defined in the Series A Certificate) in effect at the time of conversion, and (ii)&#160;upon the earliest Mandatory Conversion Time (as defined in the Series A Certificate) all outstanding shares of Series A convertible preferred stock shall automatically be converted into shares of common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">In no event shall any share of Series A convertible preferred stock convert into shares of common stock if the total number of shares of common stock issued would exceed 19.99% of the total number of our shares of common stock outstanding as of immediately prior to the adoption of the Series A Certificate; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Dividends will accrue on each share of Series A convertible preferred stock at the rate per annum to be set forth in the Series A Certificate, plus the amount of previously accrued dividends, compounded annually, subject to certain restrictions and provisions as set forth in the Series A Certificate; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Series A convertible preferred stock will not have any voting rights, other than any vote required by law or our certificate of incorporation (which does not currently provide for any such voting rights). </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Potential Effects of Authorized but Unissued Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have shares of common stock and preferred stock available for future issuance without stockholder approval. We may utilize these additional shares for a variety of corporate purposes, including future public offerings to </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">175 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
raise additional capital, to facilitate corporate acquisitions or payment as a dividend on the capital stock. The existence of unissued and unreserved common stock and preferred stock may enable our board of directors to issue shares to persons friendly to current management or to issue preferred stock with terms that could render more difficult or discourage a third-party attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise, thereby protecting the continuity of our management. In addition, the board of directors has the discretion to determine designations, rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences of each series of preferred stock, all to the fullest extent permissible under the Delaware General Corporation Law and subject to any limitations set forth in our Certificate of Incorporation. The purpose of authorizing the board of directors to issue preferred stock and to determine the rights and preferences applicable to such preferred stock is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing desirable flexibility in connection with possible financings, acquisitions and other corporate purposes, could have the effect of making it more difficult for a third-party to acquire, or could discourage a third-party from acquiring, a majority of our outstanding voting stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Stock Options </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&#160;30, 2023, there were 3,108,111 shares of common stock subject to outstanding options. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Warrants and Convertible Notes </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of September&#160;30, 2023, there were no outstanding warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2023, we issued warrants to purchase shares of common stock to two accredited investors pursuant to an exemption from the registration requirements under Section&#160;4(a)(2) of the Securities Act, which warrants expire five years from the date of issuance. The warrants were issued in connection with the issuance by the Company of secured promissory notes to such investors in the aggregate principal amount of approximately $1.9 million, with an original issuance discount of 15%, due November&#160;9, 2024. Interest on the outstanding principal of the notes accrues initially at a rate of 3%&#160;per annum, with a step-up interest rate of 8%&#160;per annum after January&#160;31, 2024 until maturity. The warrants are not exercisable until May 2024, after which they will become exercisable for such number of shares of common stock equal to the then-outstanding principal amount under the promissory note divided by the Warrant Stock Fair Market Value as defined in the warrant. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Registration Rights </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain holders of our common stock and common stock subject to outstanding warrants, or their transferees, will be entitled to the registration rights set forth below with respect to registration of the resale of such shares under the Securities Act pursuant to the investors&#8217; rights agreement by and among us and certain of our stockholders. We will pay the registration expenses, other than underwriting discounts and commissions, of the shares registered pursuant to the demand, piggyback, and Form S-3 registrations described below, including the legal fees payable to one selling holders&#8217; counsel. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, in an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions, to limit the number of shares such holders may include. The demand, piggyback, and Form S-3 registration rights described below will expire upon the earlier of (1)&#160;the date that is five years after the completion of this offering and (2)&#160;the date that a holder may sell all of their shares in a three-month period under Rule 144 of the Exchange Act, this offering has been closed and such holder holds less than 1% of our outstanding common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Demand Registration Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of 11,171,619 shares of our common stock, common stock issuable upon conversion of outstanding redeemable convertible preferred stock, and common stock subject to outstanding warrants as of December&#160;31, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">176 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
2022, will be entitled to certain demand registration rights. At any time after March&#160;9, 2027, the holders of a majority of these shares may request that we register all or a portion of their shares, subject to certain specified exceptions. Such request for registration must cover securities with an aggregate offering price which exceeds $30 million. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Piggyback Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this offering, the holders of 11,171,619 shares of our common stock, common stock issuable upon conversion of outstanding redeemable convertible preferred stock, and common stock subject to outstanding warrants as of December&#160;31, 2022 are entitled to their rights to notice of this offering and to include their shares of registrable securities in this offering. In the event that we propose to register any of our securities under the Securities Act in another offering, either for our own account or for the account of other security holders, the holders of these shares will be entitled to certain &#8220;piggyback&#8221; registration rights allowing them to include their shares in such registration, subject to certain marketing and other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, including a registration statement on Form S-3, other than with respect to a demand registration, a registration statement relating to a business combination or exchange offer or a registration statement relating solely to employee benefit plans, the holders of these shares are entitled to notice of the registration and have the right, subject to limitations that the underwriter may impose on the number of shares included in the registration, to include their shares in the registration. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">S-3 Registration Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of 11,358,552 shares of our common stock, common stock issuable upon conversion of outstanding redeemable convertible preferred stock, and common stock subject to outstanding warrants as of December&#160;31, 2022, will be entitled to certain Form S-3 registration rights. Holders of at least 20% of these shares can make a request that we register their shares on Form S-3 if we are qualified to file a registration statement on Form S-3, subject to specified exceptions. Such request for registration on Form S-3 must cover securities with an aggregate offering price which equals or exceeds $3 million. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Convertible Note and Warrant </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2023, in the 3i Note Transaction, we issued a senior unsecured convertible note in the aggregate principal amount of $2,160,000, which is convertible into shares of our common stock, par value $0.0001 per share, and a warrant to purchase an aggregate of 924,480 shares of common stock at an exercise price of $1.25 per share. The senior unsecured convertible note carries an original issue discount of 8.0% and accrues interest at a rate of 7.0%&#160;per annum. In connection with the issuance of the senior unsecured convertible note and the warrant, we granted the selling stockholder certain registration rights. See <span style="font-style:italic">&#8220;3i Note Transaction.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain Provisions of Our Certificate of Incorporation, Our Bylaws, and Delaware Law </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Delaware Anti-Takeover Law </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to Section&#160;203 of the DGCL (&#8220;Section 203&#8221;). Section&#160;203 generally prohibits a public Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (but not the outstanding voting stock owned by the interested stockholder) shares owned </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">177 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
(a)&#160;by persons who are directors and also officers, and (b)&#160;by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon or subsequent to the consummation of the transaction, the business combination is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;203 defines a business combination to include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any merger or consolidation involving the corporation and the interested stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation to or with the interested stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation owned by the interested stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, Section&#160;203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the voting power of our shares of common stock outstanding will be able to elect all of our directors. Our amended and restated certificate of incorporation and amended and restated bylaws provide that all stockholder actions must be effected at a duly called meeting of stockholders and not by written consent. A special meeting of stockholders may be called by the majority of our board of directors, Chairperson of our board of directors or our Chief Executive Officer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described above in <span style="font-style:italic">&#8220;Management&#8212;Board Structure,&#8221;</span> in accordance with our amended and restated certificate of incorporation and our amended and restated bylaws, our board of directors is divided into three classes with staggered three-year terms. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our amended and restated certificate of incorporation and amended and restated bylaws provide that the number of directors constituting our board of directors will be permitted to be set only by a resolution adopted by a majority vote of the members of our board of directors then in office, and that our directors may be removed only for cause. Our amended and restated certificate of incorporation and amended and restated bylaws also provide that vacancies occurring on our board of directors and newly created directorships resulting from an increase in the authorized number of directors may be filled only by vote of a majority of the remaining members of our board of directors, even though less than a quorum. Our amended and restated certificate of incorporation and amended and restated bylaws provide that our board of directors is expressly authorized to adopt, amend, or repeal our bylaws, and require a 66 2/3% stockholder vote to amend our bylaws and certain provisions of our certificate of incorporation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">178 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
meeting of stockholders. Our amended and restated bylaws also specify certain requirements regarding the form and content of a stockholder notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed. We expect that these provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of us. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing provisions will make it more difficult for our existing stockholders to replace our board of directors as well as for another party to obtain control of us by replacing our board of directors. Since our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of us. These provisions are also designed to reduce our vulnerability to an unsolicited acquisition proposal and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of deterring hostile takeovers or delaying changes in our control or management. As a consequence, these provisions also may inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Choice of Forum </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the Court of Chancery of the State of Delaware (or, if that court lacks subject matter jurisdiction, another federal or state court situated in the State of Delaware) shall be the sole and exclusive forum for (a)&#160;any derivative action or proceeding brought on our behalf, (b)&#160;any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, or other employees to us or our stockholders, (c)&#160;any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation or our bylaws, or (d)&#160;any action asserting a claim against us governed by the internal affairs doctrine (collectively, the &#8220;Delaware Forum Provision&#8221;). In addition, our amended and restated certificate of incorporation and our amended and restated bylaws further provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts are the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act (the &#8220;Federal Forum Provision&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. As a result, the enforceability of this provision is uncertain, and a court may determine that such provision will not apply to suits brought to enforce any duty or liability created by the Securities Act or any other claim for which the federal and state courts have concurrent jurisdiction. Further, compliance with the federal securities laws and the rules and regulations thereunder cannot be waived by investors in our common stock. Section&#160;27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Accordingly, the Delaware Forum Provision does not designate the Court of Chancery as the exclusive forum for any derivative action arising under the Exchange Act, as there is exclusive federal jurisdiction in such instances. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or otherwise acquiring any interest in our capital stock shall be deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision described above. We </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">179 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have provided disclosure in our filings with the SEC regarding the exclusive forum provisions in our amended and restated certificate of incorporation and our amended and restated bylaws (including that they will not apply to actions brought under the Exchange Act). The enforceability of similar choice of forum provisions in other companies&#8217; certificates of incorporation has been challenged in legal proceedings, and it is possible that a court could find these types of provisions to be inapplicable or unenforceable. See <span style="font-style:italic">&#8220;Risk Factors &#8212;Our amended and restated certificate of incorporation and amended and restated bylaws designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, and provides that federal district courts will be the sole and exclusive forum for Securities Act claims, which could limit our stockholders&#8217; ability to obtain what they believe to be a favorable judicial forum for disputes with us or our directors, officers, or other employees.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Listing </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the Nasdaq Stock Market under the symbol &#8220;TRNR.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Transfer Agent and Registrar </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock is American Stock Transfer&#160;&amp; Trust Company, LLC. The transfer agent and registrar&#8217;s address is 6201 15th Avenue, Brooklyn, New York, 11219 and the telephone number is (800)&#160;937-5449. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">180 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_19">PLAN OF DISTRIBUTION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares of common stock offered by this prospectus are being offered by the selling stockholder. The shares may be sold or distributed from time to time by the selling stockholder, or its permitted transferees or other successors-in-interest, directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. The sale of the ordinary shares offered by this prospectus could be effected in one or more of the following methods: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">ordinary brokers&#8217; transactions;</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">transactions involving cross or block trades;</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">through brokers, dealers, or underwriters who may act solely as agents;</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">&#8220;at the market&#8221; into an existing market for the ordinary shares;</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;&#160;an exchange distribution in accordance with the rules&#160;of the applicable exchange; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in transactions through broker-dealers that agree with the selling stockholder to sell a specified number of such securities at a stipulated price per security; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in privately negotiated transactions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any combination of the foregoing; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any other method permitted pursuant to applicable law. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholder may also sell securities under Rule 144 under the Securities Act, if available, rather than under this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to comply with the securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from the state&#8217;s registration or qualification requirement is available and complied with. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholder has informed us that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our common stock that it has acquired and may in the future acquire from us pursuant to the Purchase Agreement. Such sales will be made at prices and at terms then prevailing or at prices related to the then current market price. Each such registered broker-dealer will be an underwriter within the meaning of Section&#160;2(a)(11) of the Securities Act. The selling stockholder has informed us that each such broker-dealer will receive commissions from 3i that will not exceed customary brokerage commissions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brokers, dealers, underwriters or agents participating in the distribution of the shares of our common stock offered by this prospectus may receive compensation in the form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by the selling stockholder through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of shares of our common stock sold by the selling stockholder may be less than or in excess of customary commissions but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule&#160;2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule&#160;2121. Neither we nor the selling stockholder can presently estimate the amount of compensation that any agent will receive from any purchasers of shares of our common stock sold by the selling stockholder. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">181 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholder and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. The selling stockholder has informed us that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities offered by this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may from time to time file with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to disclose certain information relating to a particular sale of shares offered by this prospectus by the selling stockholder, including the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by the selling stockholder, any compensation paid by the selling stockholder to any such brokers, dealers, underwriters or agents, and any other required information. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will pay the expenses incident to the registration under the Securities Act of the offer and sale of the shares of our common stock covered by this prospectus by the selling stockholder, and have agreed to reimburse 3i for the fees and disbursements of its counsel incurred in connection therewith. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also have agreed to indemnify the selling stockholder and certain other persons against certain liabilities in connection with the offering of shares of our common stock offered hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. The selling stockholder has agreed to indemnify us against liabilities under the Securities Act that may arise from certain written information furnished to us by the selling stockholder specifically for use in this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore, unenforceable. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that the total expenses for the offering will be approximately $250,000. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the sale of the securities covered hereby, the selling stockholder may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The selling stockholder may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The selling stockholder may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under applicable rules&#160;and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to our common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholder will be subject to applicable provisions of the Exchange Act and the rules&#160;and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of our common stock by the selling stockholder or any other person. We will make copies of this prospectus available to the selling stockholder and are informing the selling stockholder of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule&#160;172 under the Securities Act). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to keep this prospectus effective until the earlier of (i)&#160;the date on which the securities may be resold by the selling stockholder without registration and without regard to any volume or manner-of-sale limitations by </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">182 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reason of Rule&#160;144, without the requirement for us to be in compliance with the current public information requirement under Rule&#160;144 under the Securities Act or any other rule&#160;of similar effect or (ii)&#160;all of the securities have been sold pursuant to this prospectus or Rule&#160;144 under the Securities Act or any other rule&#160;of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is currently listed on The Nasdaq Stock Market under the symbol &#8220;TRNR.&#8221; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">183 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_20">THE 3i NOTE TRANSACTION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;7, 2023, we entered into the Purchase Agreement with 3i, LP (&#8220;3i&#8221; or the &#8220;selling stockholder&#8221; or the &#8220;Note Investor&#8221;) pursuant to which we sold, and the selling stockholder purchased, (a)&#160;a senior unsecured convertible note issued by the Company (the &#8220;Note&#8221;) with an aggregate principal amount of $2,160,000, which is convertible into shares of our common stock, par value $0.0001 per share, and (b)&#160;a warrant to purchase an aggregate of 924,480 shares of common stock (the &#8220;3i Note Transaction&#8221;). The 3i Note Transaction closed on December&#160;7, 2023. The gross proceeds to us from the 3i Note Transaction, prior to the payment of transaction expenses, was $2,000,000. The Purchase Agreement contains customary representations, warranties, and covenants of the Company and the Note Investor. Further, the Purchase Agreement contains a restriction whereby there cannot, under any circumstances, be more than 2,861,206 shares of our common stock issued under the Note and the Warrant combined without first receiving stockholder approval to issue more than 2,861,206 shares of our common stock thereunder in accordance with Nasdaq listing requirements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">The Note </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Note carries an original issue discount of 8.0% and accrues interest at a rate of 7.0%&#160;per annum. The maturity date of the Note is December&#160;7, 2024 (the &#8220;Maturity Date&#8221;). Interest payments are guaranteed through the Maturity Date regardless of whether the Note is earlier converted or redeemed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Note is convertible (in whole or in part) after December&#160;7, 2023 into the number of shares of common stock equal to (x)&#160;the sum of (i)&#160;the portion of the principal amount to be converted or redeemed, (ii)&#160;all accrued and unpaid interest with respect to such principal amount, and (iii)&#160;all accrued and unpaid Late Charges (as defined in the Purchase Agreement) with respect to such principal and interest amounts, if any, divided by (y)&#160;a conversion price of $1.25 per share (such shares, the &#8220;Note Conversion Shares&#8221;). In addition, the Investor may, at any time and at its option, convert the Note (in whole or in part) into shares of common stock pursuant to the formula included in the preceding sentence at an alternate conversion price equal to 92% of the lowest dollar volume-weighted average price (&#8220;VWAP&#8221;) during the ten trading days immediately preceding the date of conversion, subject to a conversion price floor, or, any time following an Event of Default (as defined below), equal to 80% of the lowest VWAP during the ten trading days immediately preceding the date of conversion, in each case subject to the additional terms and conditions set forth in the Note. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Note sets forth certain standard events of default (each such event, an &#8220;Event of Default&#8221;), upon the occurrence of which the Company is required to deliver written notice to the Note Investor within one business day (an &#8220;Event of Default Notice&#8221;). At any time after the earlier of (a)&#160;the Note Investor&#8217;s receipt of an Event of Default Notice, and (b)&#160;the Note Investor becoming aware of an Event of Default, the Note Investor may require the Company to redeem all or any portion of the Note. Upon an Event of Default, the Note shall bear interest at a rate of 14.0%&#160;per annum. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">The Warrant </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant is exercisable for shares of common stock at a price of $1.25 per share (the &#8220;Exercise Price&#8221;). The Warrant may be exercised during the period commencing December&#160;7, 2023 and ending June&#160;7, 2029. The Exercise Price is subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of common stock and the like. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Registration Rights Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the 3i Note Transaction, the Company entered into a registration rights agreement, dated December&#160;7, 2023, with the Note Investor (the &#8220;Registration Rights Agreement&#8221;). Under the Registration Rights Agreement, we agreed to file a resale registration statement covering the resale of the Shares within 30 calendar days after the date of the Registration Rights Agreement, and to use commercially reasonable efforts to cause </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">184 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such resale registration statement to be declared effective by the SEC as promptly as possible after the filing thereof, but in any event no later than February&#160;14, 2024 (the &#8220;Effectiveness Date&#8221;); provided, however, that in the event we are notified by the SEC that the resale registration statement will not be reviewed or is no longer subject to further review, the Effectiveness Date will be the fifth trading day following the date on which we are so notified if such date precedes the dates otherwise required above. Under certain circumstances, if we fail to meet our obligations under the Registration Rights Agreement, the Note Investor may require us to pay certain liquidated damages to the Note Investor and it would result in the occurrence of an Event of Default under the Note. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">185 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_21">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">TO NON-U.S. HOLDERS OF OUR COMMON STOCK </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the material U.S. federal income tax considerations relating to the acquisition, ownership, and disposition of our common stock by&#160;non-U.S.&#160;holders (as defined below). This summary deals only with common stock held as a capital asset (within the meaning of Section&#160;1221 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)) and does not discuss all of the U.S. federal income tax considerations applicable to a&#160;non-U.S.&#160;holder that is subject to special treatment under U.S. federal income tax laws, including, but not limited to: a dealer in securities or currencies; a broker-dealer; a financial institution; a qualified retirement plan, individual retirement plan, or other&#160;tax-deferred&#160;account; a regulated investment company; a real estate investment trust; a&#160;tax-exempt&#160;organization; an insurance company; a person holding common stock as part of a hedging, integrated, conversion, or straddle transaction or a person deemed to sell common stock under the constructive sale provisions of the Code; a trader in securities that has elected the&#160;mark-to-market&#160;method of tax accounting; an accrual method taxpayer subject to special tax accounting rules under Section&#160;451(b) of the Code; an entity that is treated as a partnership for U.S. federal income tax purposes (or an investor therein); a person that received such common stock in connection with services provided, including upon the exercise of an option; a corporation that accumulates earnings to avoid U.S. federal income tax; a corporation organized outside the United States, any state thereof or the District of Columbia that is nonetheless treated as a U.S. corporation for U.S. federal income tax purposes; a person that is not a&#160;non-U.S.&#160;holder; a &#8220;controlled foreign corporation;&#8221; a &#8220;passive foreign investment company;&#8221; or a U.S. expatriate. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary is based upon provisions of the Code, its legislative history, applicable U.S. Treasury regulations promulgated thereunder, published rulings, and judicial decisions, all as in effect as of the date hereof. We have not sought, and will not seek, any ruling from the Internal Revenue Service (the &#8220;IRS&#8221;) with respect to the tax consequences discussed herein, and there can be no assurance that the IRS will not take a position contrary to the tax consequences discussed below or that any position taken by the IRS would not be sustained. Those authorities may be repealed, revoked, or modified, perhaps retroactively, or may be subject to differing interpretations, which could result in U.S. federal income tax consequences different from those discussed below. This summary does not address all aspects of U.S. federal income tax, does not deal with all tax considerations that may be relevant to stockholders in light of their personal circumstances, and does not address the Medicare tax imposed on certain investment income or any state, local, foreign, gift, estate, or alternative minimum tax considerations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a &#8220;U.S. holder&#8221; is a beneficial holder of common stock that is for U.S. federal income tax purposes: an individual citizen or resident of the United States; a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia; an estate the income of which is subject to U.S. federal income taxation regardless of its source; or a trust if it (1)&#160;is subject to the primary supervision of a court within the United States and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (2)&#160;was in existence on August&#160;20, 1996 and has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a&#160;&#8220;non-U.S.&#160;holder&#8221; is a beneficial owner of common stock that is neither a U.S. holder nor a partnership (or any other entity or arrangement that is treated as a partnership) for U.S. federal income tax purposes regardless of its place of organization or formation. If a partnership (or an entity or arrangement that is treated as a partnership for U.S. federal income tax purposes) holds common stock, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. A partner of a partnership holding common stock is urged to consult its tax advisors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">PROSPECTIVE INVESTORS ARE URGED TO CONSULT THEIR TAX ADVISORS CONCERNING THE U.S. FEDERAL INCOME, ESTATE, AND OTHER TAX CONSEQUENCES OF ACQUIRING, OWNING, AND DISPOSING OF OUR COMMON STOCK IN LIGHT OF THEIR SPECIFIC </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">186 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">
SITUATIONS, AS WELL AS THE TAX CONSEQUENCES ARISING UNDER ANY STATE, LOCAL, OR&#160;NON-U.S.&#160;TAX LAWS AND ANY OTHER U.S. FEDERAL TAX LAWS (INCLUDING THE U.S. FEDERAL ESTATE AND GIFT TAX LAWS). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Distributions on Our Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Distributions with respect to common stock, if any, generally will constitute dividends for U.S. federal income tax purposes to the extent paid out of current or accumulated earnings and profits, as determined for U.S. federal income tax purposes. Any portion of a distribution in excess of current or accumulated earnings and profits will be treated as a return of capital and will first be applied to reduce the holder&#8217;s tax basis in its common stock, but not below zero. Any remaining amount will then be treated as gain from the sale or exchange of the common stock and will be treated as described under <span style="font-style:italic">&#8220; &#8211; Disposition of Our Common Stock&#8221;</span> below. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Distributions treated as dividends that are paid to a&#160;non-U.S.&#160;holder, if any, with respect to shares of our common stock will be subject to U.S. federal withholding tax at a rate of 30% (or such lower rate as may be specified in an applicable income tax treaty) of the gross amount of the dividends unless the dividends are effectively connected with the&#160;non-U.S.&#160;holder&#8217;s conduct of a trade or business in the United States, subject to the discussion below regarding foreign accounts. If a&#160;non-U.S.&#160;holder is engaged in a trade or business in the United States and dividends with respect to the common stock are effectively connected with the conduct of that trade or business and, if required by an applicable income tax treaty, are attributable to a U.S. permanent establishment, then although the&#160;non-U.S.&#160;holder will generally be exempt from the 30% U.S. federal withholding tax, provided certain certification requirements are satisfied, the&#160;non-U.S.&#160;holder will be subject to U.S. federal income tax on those dividends on a net income basis at regular U.S. federal income tax rates in the same manner as if such holder were a resident of the United States. Any such effectively connected income received by a foreign corporation may, under certain circumstances, be subject to an additional branch profits tax equal to 30% (or lower applicable income tax treaty rate) of its effectively connected earnings and profits for the taxable year, as adjusted under the Code. To claim the exemption from withholding with respect to any such effectively connected income, the&#160;non-U.S.&#160;holder must generally furnish to us or our paying agent a properly executed IRS Form&#160;W-8ECI&#160;(or applicable successor form). In the case of a&#160;non-U.S.&#160;holder that is an entity, Treasury Regulations and the relevant tax treaty provide rules to determine whether, for purposes of determining the applicability of a tax treaty, dividends will be treated as paid to the entity or to those holding an interest in that entity. If a&#160;non-U.S.&#160;holder holds stock through a financial institution or other agent acting on the holder&#8217;s behalf, the holder will be required to provide appropriate documentation to such agent. Such holder&#8217;s agent will then be required to provide certification to us or our paying agent. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A non-U.S. holder of shares of common stock who wishes to claim the benefit of a reduced rate of withholding tax under an applicable treaty must furnish to us or our paying agent a valid IRS Form&#160;W-8BEN&#160;or IRS Form <span style="white-space:nowrap">W-8BEN-E&#160;(or</span> applicable successor form) certifying such holder&#8217;s qualification for the exemption or reduced rate. If a&#160;non-U.S.&#160;holder is eligible for a reduced rate of U.S. withholding tax pursuant to an income tax treaty and does not timely file the required certification, it may obtain a refund or credit of any excess amounts withheld by timely filing a U.S. tax return with the IRS.&#160;Non-U.S.&#160;holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Disposition of Our Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion below regarding backup withholding, a&#160;non-U.S.&#160;holder generally will not be subject to U.S. federal income tax on any gain from a sale, exchange or other disposition of our stock unless: (a)&#160;that gain is effectively connected with the&#160;non-U.S.&#160;holder&#8217;s conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, is attributable to a U.S. permanent establishment maintained by the&#160;non-U.S.&#160;holder); (b)&#160;the&#160;non-U.S.&#160;holder is a nonresident alien individual who is present in the United States for 183 days or more in the taxable year of that disposition, and certain other conditions are met; or (c)&#160;we are or have been a &#8220;United States real property holding corporation&#8221; within the meaning of Code Section&#160;897(c)(2) for </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">187 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
U.S. federal income tax purposes at any time during the shorter of the five-year period preceding the date of disposition or the holder&#8217;s holding period for our common stock, and certain other requirements are met. Although there can be no assurance, we believe that we are not, and we do not anticipate becoming, a United States real property holding corporation for U.S. federal income tax purposes. Even if we are treated as a United </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">States real property holding corporation, gain realized by a&#160;non-U.S.&#160;holder on a disposition of our common stock will not be subject to U.S. federal income tax so long as: (1)&#160;the&#160;non-U.S.&#160;holder owned, directly, indirectly and constructively, no more than five percent of our common stock at all times within the shorter of (x)&#160;the five-year period preceding the disposition, or (y)&#160;the holder&#8217;s holding period, and (2)&#160;our common stock is regularly traded on an established securities market. Although Nasdaq qualifies as an established securities market, there can be no assurance that our common stock will continue to qualify as regularly traded on an established securities market. If any gain on your disposition is taxable because we are a United States real property holding corporation and your ownership of our common stock exceeds five percent, you will be taxed on such disposition generally in the manner applicable to U.S. persons and in addition, a purchaser of your common stock may be required to withhold tax with respect to that obligation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a&#160;non-U.S.&#160;holder is described in clause (a)&#160;of the preceding paragraph, the&#160;non-U.S.&#160;holder will generally be subject to tax on the net gain derived from the disposition at the regular U.S. federal income tax rates in the same manner as if such&#160;non-U.S.&#160;holder were a U.S. person, unless an applicable income tax treaty provides otherwise. In addition, a&#160;non-U.S.&#160;holder that is a corporation may be subject to the branch profits tax at a rate equal to 30% (or lower applicable income tax treaty rate) of its effectively connected earnings and profits for the taxable year, as adjusted under the Code. If the&#160;non-U.S.&#160;holder is an individual described in clause (b)&#160;of the preceding paragraph, the&#160;non-U.S.&#160;holder will generally be subject to a flat 30% tax on the gain derived from the disposition, which may be offset by U.S. source capital losses even though the&#160;non-U.S.&#160;holder is not considered a resident of the United States, provided that the&#160;non-U.S.&#160;holder has timely filed U.S. federal income tax returns with respect to such losses. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Information Reporting and Backup Withholding Tax </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We report to our&#160;non-U.S.&#160;holders and the IRS certain information with respect to any dividends we pay on our common stock, including the amount of dividends paid during each fiscal year, the name and address of the recipient, and the amount, if any, of tax withheld. All distributions to holders of common stock are subject to any applicable withholding. Information reporting requirements apply even if no withholding was required because the distributions were effectively connected with the&#160;non-U.S.&#160;holder&#8217;s conduct of a U.S. trade or business or withholding was reduced by an applicable income tax treaty. This information also may be made available under a specific treaty or agreement with the tax authorities in the country in which the&#160;non-U.S.&#160;holder resides or is established. Under U.S. federal income tax law, interest, dividends, and other reportable payments may, under certain circumstances, be subject to &#8220;backup withholding&#8221; at the then applicable rate (currently, 24%). Backup withholding, however, generally will not apply to distributions on our common stock to a&#160;non-U.S.&#160;holder, provided the&#160;non-U.S.&#160;holder furnishes to us or our paying agent the required certification as to its&#160;non-U.S.&#160;status, such as by providing a valid IRS Form&#160;W-8BEN,&#160;IRS Form&#160;W-8BEN-E&#160;or IRS Form&#160;W-8ECI,&#160;or certain other requirements are met. Notwithstanding the foregoing, backup withholding may apply if either we or our paying agent has actual knowledge, or reason to know, that the holder is a U.S. person that is not an exempt recipient. Backup withholding is not an additional tax but merely an advance payment, which may be credited against the tax liability of persons subject to backup withholding or refunded to the extent it results in an overpayment of tax and the appropriate information is timely supplied to the IRS. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Foreign Accounts </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain withholding taxes may apply to certain types of payments made to &#8220;foreign financial institutions&#8221; (as specially defined under these rules) and certain other&#160;non-U.S.&#160;entities if certification, information reporting and other specified requirements are not met. A 30% withholding tax may apply to &#8220;withholdable payments&#8221; if they are paid to a foreign financial institution or to a&#160;non-financial&#160;foreign entity, unless (a)&#160;the foreign financial </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">188 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
institution undertakes certain diligence and reporting obligations and other specified requirements are satisfied, or (b)&#160;the&#160;non-financial&#160;foreign entity either certifies it does not have any substantial U.S. owners or furnishes identifying information regarding each substantial U.S. owner and other specified requirements are satisfied. &#8220;Withholdable payment&#8221; generally means any payment of interest, dividends, rents, and certain other types of </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">generally passive income if such payment is from sources within the United States. Treasury regulations proposed in December 2018 (and upon which taxpayers and withholding agents are entitled to rely) eliminate possible withholding under these rules on the gross proceeds from any sale or other disposition of our common stock, previously scheduled to apply beginning January&#160;1, 2022. If the payee is a foreign financial institution, it must enter into an agreement with the U.S. Treasury requiring, among other things, that it undertake to identify accounts held by certain U.S. persons or U.S.-owned foreign entities, annually report certain information about such accounts and withhold 30% on payments to account holders whose actions prevent it from complying with these reporting and other requirements, or comply with comparable requirements under an applicable inter-governmental agreement between the United States and the foreign financial institution&#8217;s home jurisdiction. If an investor does not provide the information necessary to comply with these rules, it is possible that distributions to such investor that are attributable to withholdable payments, such as dividends, will be subject to the 30% withholding tax. Holders should consult their own tax advisers regarding the implications of these rules for their investment in our common stock. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">189 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_22">LEGAL MATTERS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of the common stock will be passed upon for us by Pillsbury Winthrop Shaw Pittman LLP, Palo Alto, California. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_23">EXPERTS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial statements of Interactive Strength Inc. dba FORME as of December&#160;31, 2022 and 2021, and for each of the two years in the period ended December&#160;31, 2022, included in this Prospectus, have been audited by Deloitte&#160;&amp; Touche LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are included in reliance upon the report of such firm given their authority as experts in accounting and auditing. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_24">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">LIABILITIES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us, we have been informed that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_25">WHERE YOU CAN FIND MORE INFORMATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have filed with the Commission a registration statement on Form&#160;S-1 under the Securities Act with respect to the shares of common stock being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not include all of the information contained in the registration statement or the exhibits, schedules and amendments to the registration statement. For further information with respect to us and our common stock, we refer you to the registration statement, any documents incorporated by reference into the registration statement and to the exhibits and schedules to the registration statement. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete. If a contract or other document has been filed as an exhibit to the registration statement, please see the copy of the contract or other document that has been filed. Each statement in this prospectus relating to a contract or other document filed as an exhibit is qualified in all respects by the filed exhibit. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the Commission. Our Commission filings are available to the public at the Commission&#8217;s website at www.sec.gov and on our website at www.Forme.com/investors. Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only. You may inspect a copy of the registration statement through the Commission&#8217;s website, as provided herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Commission&#8217;s rules allow us to &#8220;incorporate by reference&#8221; information into this prospectus provided we meet certain eligibility requirements, which means that if we become eligible, including if we have filed an annual report on Form 10-K, we can disclose important information to you by referring you to another document filed separately with the Commission. Any information incorporated by reference would be deemed to be part of this prospectus, and subsequent information that we file with the Commission would automatically update and supersede that information. Any statement contained in this prospectus or a previously filed document incorporated by reference would be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">190 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We refer you to the following documents which have previously been filed with the Commission: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our Quarterly Reports on Form 10-Q for the quarters ended <a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1785056/000095017023027147/trnr-20230331.htm">March&#160;31, 2023</a>,&#160;<a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1785056/000095017023042459/trnr-20230630.htm">June&#160;30, 2023</a> and <a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1785056/000095017023063841/trnr-20230930.htm">September&#160;30, 2023</a>; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our Current Reports on Form&#160;8-K filed with the Commission on&#160;<a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1785056/000119312523132663/d74645d8k.htm">May 2, 2023</a>,&#160;<a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1785056/000095017023044769/trnr-20230822.htm">August&#160;28, 2023</a>,&#160;<a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1785056/000095017023052952/trnr-20231006.htm">October&#160;11, 2023</a>, and <a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1785056/000095017023070073/trnr-20231207.htm">December&#160;13, 2023</a>; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The description of our common stock contained in Item&#160;1 of the&#160;Registration Statement on Form&#160;8-A (File No.&#160;001-41475), filed with the Commission on <a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523021855/d465077d8a12b.htm">August&#160;10, 2022</a>, including any amendment or report filed for the purpose of updating such description. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If and when we are eligible to incorporate by reference, all reports and other documents we subsequently file pursuant to Section&#160;13(a), 13(c), 14 or 15(d)&#160;of the Exchange Act prior to the termination of this offering shall be deemed to be incorporated by reference into this prospectus, and all such documents we may file with the Commission after the date hereof and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the Commission, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a free copy of any of the documents we refer to above, and any documents we incorporate by reference in this prospectus when we are eligible to do so, by writing or telephoning us at the following address: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Interactive Strength Inc. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Attn: Chief Financial Officer </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Interactive Strength Inc. d/b/a Forme </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">1005 Congress Avenue </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Suite 925 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Austin, Texas 78701 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(310) 697-8655 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus supplement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">191 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>
<div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" id="hidden95757149" contextRef="PAsOn12_31_2022">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" id="hidden95757150" contextRef="PAsOn09_30_2023">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" id="hidden95757447" contextRef="PAsOn12_31_2022_MinimumMembersrtRangeAxis">P2Y</ix:nonNumeric><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" id="hidden95758008" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3">179000</ix:nonFraction><ix:nonNumeric name="us-gaap:OperatingLossCarryforwardsExpirationDate" id="hidden95757939" contextRef="P01_01_2022To12_31_2022">2029-12-31</ix:nonNumeric><ix:nonNumeric name="us-gaap:TaxCreditCarryforwardExpirationDate" id="hidden95757488" contextRef="P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis">2040-12-31</ix:nonNumeric><ix:nonNumeric name="us-gaap:TaxCreditCarryforwardExpirationDate" id="hidden95757489" contextRef="P01_01_2022To12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">2035-12-31</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="trnr-20230930.xsd" /></ix:references></ix:header></div><div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="rom367939_26a">INTERACTIVE STRENGTH INC, AND SUBSIDIARIES INDEX </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">TO FINANCIAL STATEMENTS </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:96%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Audited Financial Statements</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="4" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_1">Report of Independent Registered Public Accounting Firm</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_2">Consolidated Balance Sheets as of December&#160;31, 2022 and 2021</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_3">Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December&#160;31, 2022 and 2021</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_4">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Deficit for the Years Ended December&#160;31, 2022 and 2021</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_5">Consolidated Statements of Cash Flows for the Years Ended December&#160;31, 2022 and 2021</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-7</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_6">Notes to Consolidated Financial Statements</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-8</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Unaudited Condensed Consolidated Financial Statements </div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:95%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_7">Condensed Consolidated Balance Sheets as of September&#160;30, 2023 (and December&#160;31, 2022)</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_8">Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September&#160;30, 2023 and 2022</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-39</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_9">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Deficit for the nine months ended September&#160;30, 2023 and 2022 (unaudited)</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-40</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_10">Condensed Consolidated Statements of Cash Flows for the nine months ended September&#160;30, 2023 and 2022 (unaudited)</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#fin367939_11">Notes to Condensed Consolidated Financial Statements (unaudited)</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">F-43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-1 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_1" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">REPORT OF INDEPENDENT REGISTERED <div style="display:inline;">PUBLIC</div> ACCOUNTING FIRM </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">To the shareholders and the Board of Directors of Interactive Strength Inc. dba FORME </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Opinion on the Financial Statements </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">We have audited the accompanying consolidated balance sheets of Interactive Strength Inc. and subsidiaries dba FORME (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, redeemable convertible preferred stock and stockholders&#8217; deficit, and cash flows, for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Going Concern </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying financial statements have been prepared assuming the Company will be able to continue as a going concern. As discussed in Note 1 to the financial statements, the Company is experiencing difficulty in generating sufficient cash flow to meet its obligations and sustain its operations and does not have sufficient capital to repay certain outstanding loans currently due, has suffered recurring losses from operations and recurring negative operating cash flows since inception which raises substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to this matter are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Basis for Opinion </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Morristown, NJ </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">/s/ Deloitte &amp; Touche LLP </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">March 29, 2023 </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">We have served as the Company&#8217;s auditor since 2022. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-2 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_2" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONSOLIDATED BALANCE SHEETS </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(In thousands, except share and per share amounts) </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:61%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">226</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,697</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,567</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,056</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax receivable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IncomeTaxesReceivables" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IncomeTaxesReceivables" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">7</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor deposit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DepositsAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,603</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DepositsAssetsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,944</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,426</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,165</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,822</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,855</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,326</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,190</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Right-of-use-assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">110</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,834</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,655</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,337</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredCosts" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,018</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,366</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">24,447</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,066</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities and stockholders&#8217; equity</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,743</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,114</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,304</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,420</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liability, current portion</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">106</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">29</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,708</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,927</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,270</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">24,167</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,476</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liability, net of current portion</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrant liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,004</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PPP loan payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">520</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">27,180</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,996</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commitments and contingencies (Note 15)</div></td>
<td style="vertical-align:bottom"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed convertible preferred stock, par value $<ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">6,462,258</ix:nonFraction></ix:nonFraction> shares authorized as of December&#160;31, 2022 and December&#160;31, 2021; and <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction> and <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">42,999</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2022 and December&#160;31, 2021, respectively; liquidation preference of $<ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">0</ix:nonFraction> as of December&#160;31, 2022.</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,594</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A convertible preferred stock, par value $<ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">187,673,157</ix:nonFraction> and <ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">19,696,870</ix:nonFraction> shares authorized as of December&#160;3<ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn09_30_2023_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction>1, 2022 and December&#160;31, 2021, respectively; <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction> and <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">96,911</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2022 and December&#160;31, 2021, respectively; liquidation preference of $<ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">0</ix:nonFraction> as of December&#160;31, 2022.</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,139</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Stockholders&#8217; equity (deficit)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">369,950,000</ix:nonFraction> and <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">86,000,000</ix:nonFraction> shares authorized as of December&#160;31, 2022 and December&#160;31, 2021, respectively; <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,450,922</ix:nonFraction></ix:nonFraction> and <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">213,065</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2022 and December&#160;31, 2021, respectively.</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Additional paid-in capital</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">112,436</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">37,806</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated other comprehensive income (loss)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">365</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">159</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated deficit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">115,538</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">57,313</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stockholders&#8217; equity (deficit)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,733</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">19,663</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities, preferred stock and stockholders&#8217; equity (deficit)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">24,447</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,066</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-3 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_3" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(In thousands, except share and per share amounts) </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:59%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fitness product revenue</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:FitnessProductRevenue1" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">530</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:FitnessProductRevenue1" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">319</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Membership revenue</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:MembershipRevenue1" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">74</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:MembershipRevenue1" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Training Revenue</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TrainingRevenue1" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">77</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TrainingRevenue1" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenue:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of fitness product revenue</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfFitnessProductRevenue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,402</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfFitnessProductRevenue" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,652</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of membership and training</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfMembershipAndTraining" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,147</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfMembershipAndTraining" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,513</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">8,868</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">4,842</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,960</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,300</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,219</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,566</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,298</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,438</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">45,477</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">32,304</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from operations</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">54,345</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">37,146</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other (expense) income, net:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other (expense) income, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">4,036</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">303</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">952</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">935</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain upon debt forgiveness</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainUponDebtForgiveness" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">523</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainUponDebtForgiveness" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">251</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">107</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,193</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">478</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other income, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3,880</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,310</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss before provision for income taxes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,836</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss attributable to common stockholders</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,840</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">119.49</ix:nonFraction></ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">332.31</ix:nonFraction></ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common stock outstanding&#8212;basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">487,276</ix:nonFraction></ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">98,823</ix:nonFraction></ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:58%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,840</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other comprehensive loss:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation gain (loss)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">524</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">179</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total comprehensive loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">57,701</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,661</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-4 </div></div></div></div><div></div></div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_4" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; DEFICIT </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(In thousands, except share amounts) </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:6.5pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:22%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series Seed<br/>0 - 10</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible<br/>Preferred<br/>Stock&#160;Series&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series A-1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series A-2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A<br/>Common<br/>Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B<br/>Common<br/>Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional<br/>Paid-In<br/>Capital</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Deficit</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/>Stockholders&#8217;<br/>Equity<br/>(Deficit)</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2020</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2020_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">9,939</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2020_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,986</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">40,474</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">14,973</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,041</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">20</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,473</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">16,411</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of promissory notes in exchange for stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">106</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">106</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">14,906</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,100</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,100</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon exercise of warrants</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">125,982</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,992</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,994</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class B common stock upon exercise of warrants</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">879</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">237</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">237</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class B common stock upon conversion of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">13,852</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,667</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,667</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class B common stock upon exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,999</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">35</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">35</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-2-10 preferred stock upon conversion of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">19,519</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,655</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-2 preferred stock upon conversion of SAFE</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,666</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-3 preferred stock upon conversion of SAFE</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">248</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-4 preferred stock upon conversion of SAFE</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">140</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-5 preferred stock upon conversion of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,414</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-6 preferred stock upon conversion of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">815</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-7 preferred stock upon conversion of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,716</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-8 preferred stock upon conversion of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">4,410</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-9 preferred stock upon conversion of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">4,939</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-10 preferred stock upon conversion of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,171</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-9 preferred stock upon conversion of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">13,405</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,933</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed-9 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">136</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">20</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">94</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">94</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A preferred stock net of issuance costs of $135</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">62,127</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,113</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,370</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,370</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A preferred stock upon conversion of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">24,576</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,422</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A-1 preferred stock upon conversion of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." contextRef="P01_01_2021To12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." contextRef="P01_01_2021To12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,164</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,164</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation gain</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2021To12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">179</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden95758008">(179</span>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,840</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,840</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2021</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">42,999</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,594</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">86,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,535</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">181,362</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">31,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">37,806</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">159</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">57,313</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">19,663</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,339,821</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,625</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,626</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A-2 preferred stock upon conversion of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">124,313</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,926</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A-2 preferred stock, net of issuance costs of $97</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">631,292</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">29,996</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">86,703</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">19,535</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">86,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">19,535</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">19,535</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series A-1 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,208</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,604</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series A-2 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">755,605</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">35,922</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">755,605</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">35,922</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">35,922</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-5 </div></div></div></div><div></div></div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:6.5pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:34%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series Seed<br/>0 - 10</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible<br/>Preferred<br/>Stock&#160;Series&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series A-1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series A-2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A<br/>Common<br/>Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B<br/>Common<br/>Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional<br/>Paid-In<br/>Capital</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Deficit</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/>Stockholders&#8217;<br/>Equity<br/>(Deficit)</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">7,546</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,267</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">7,546</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,267</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,267</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-1 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,393</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">719</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,393</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">719</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">719</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-2 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,666</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">160</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,666</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">160</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">160</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-3 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">248</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">25</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">248</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-4 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">140</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">15</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">140</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-5 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">3,414</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">425</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,414</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">425</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">425</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-6 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">815</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">104</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">815</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">104</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">104</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-7 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,716</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">235</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,716</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">235</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">235</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-8 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">4,410</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">659</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">4,410</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">659</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">659</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-9 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">18,481</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,664</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">18,481</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,664</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,664</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock upon conversion of Series Seed-10 preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,170</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">321</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,170</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">321</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">321</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class B common stock upon exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,521</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,347</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,347</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation gain</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">524</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">524</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,416,698</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">34,224</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">112,436</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">365</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">115,538</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,733</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-6 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_5" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONSOLIDATED STATEMENT OF CASH FLOWS </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(In thousands) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows From Operating Activities:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,840</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Adjustments to reconcile net loss to net cash used in operating activities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">422</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">54</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Depreciation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,143</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">747</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,999</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,444</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of operating lease assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">590</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory valuation loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">904</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,371</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,347</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,164</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of warrants issued with convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FairValueOfWarrantsIssuedWithConvertibleNotes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,482</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FairValueOfWarrantsIssuedWithConvertibleNotes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain upon debt forgiveness</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">523</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss on property and equipment disposal</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">181</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Non-cash interest expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NonCashInterestExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">952</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NonCashInterestExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">978</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment write-off</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,275</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">251</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">107</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,193</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">478</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Changes in operating assets and liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,435</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,410</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">261</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">163</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDepositOtherAssets" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">341</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDepositOtherAssets" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,228</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">292</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,926</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,181</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,490</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,225</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">585</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash used in operating activities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">35,545</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,256</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows From Investing Activities:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of property and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">577</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,623</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Acquisition of internal use software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireSoftware" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,743</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireSoftware" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,429</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Acquisition of software and content</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToDevelopSoftware" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,287</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToDevelopSoftware" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,307</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash used in investing activities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">7,607</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">12,359</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows From Financing Activities:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from PPP loan</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ProceedsFromPPPLoan" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ProceedsFromPPPLoan" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">520</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of loans</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">425</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,361</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments of loans</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,324</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,887</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of SAFEs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,479</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of Preferred Stock&#8212;Series A, net of issuance costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">29,996</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,475</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,106</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14,355</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from the issuance of common stock A</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,626</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,100</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from the exercise of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from the exercise of common stock options</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">12</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">47</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayment Bounce Back Loan</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:RepaymentOfBouncebackLoans" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">69</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:RepaymentOfBouncebackLoans" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash provided by financing activities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">41,772</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">52,452</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of exchange rate on cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">91</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">151</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net (Decrease) Increase In Cash and Cash Equivalents</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,471</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,686</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash at beginning of year</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,697</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash at end of year</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">226</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,697</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Supplemental Disclosure Of Cash Flow Information:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property &amp; equipment in AP</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PropertyAndEquipmentInAccountsPayable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PropertyAndEquipmentInAccountsPayable" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">135</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories in AP and accrued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:InventoriesInAccountsPayableAndAccrued" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,007</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:InventoriesInAccountsPayableAndAccrued" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">27</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software and content in AP</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:CapitalizedSoftwareAndContentInAccountsPayable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">75</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:CapitalizedSoftwareAndContentInAccountsPayable" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A preferred stock in connection with convertible notes payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,926</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NoncashActivityDeferredCostsIncurred" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,337</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NoncashActivityDeferredCostsIncurred" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Right-of-use assets obtained in exchange for new operating lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">411</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Right-of-use assets obtained in exchange for new operating lease liabilities upon ASC 842 adoption</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">289</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class A common stock through conversion of preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="P01_01_2022To12_31_2022_ConversionOfPreferredStockToClassACommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">65,655</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="P01_01_2021To12_31_2021_ConversionOfPreferredStockToClassACommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible note in conversion of outstanding loan payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="P01_01_2022To12_31_2022_ConversionOfLoanPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">161</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="P01_01_2021To12_31_2021_ConversionOfLoanPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible note in conversion of AP</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="P01_01_2022To12_31_2022_ConversionOfAccountsPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">36</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="P01_01_2021To12_31_2021_ConversionOfAccountsPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">400</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of promissory notes in exchange for stock options</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="P01_01_2022To12_31_2022_ConversionOfPromissoryNotesToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="P01_01_2021To12_31_2021_ConversionOfPromissoryNotesToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">105</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock in connection with exercise of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,605</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants in connection with Series A</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">388</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed preferred stock in connection with convertible notes payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesIssued1" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesIssued1" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,947</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series Seed in connection with convertible SAFEs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="P01_01_2022To12_31_2022_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="P01_01_2021To12_31_2021_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,665</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock in connection with convertible SAFEs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="P01_01_2022To12_31_2022_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="P01_01_2021To12_31_2021_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,667</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-7 </div></div></div></div><div></div></div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_6" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </div></div><ix:nonNumeric name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">1. Description of Business and Basis of Presentation </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Description and Organization </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Interactive Strength Inc., together with its consolidated subsidiaries doing business as &#8220;Forme&#8221; (&#8220;Forme&#8221; or the &#8220;Company&#8221;), is an interactive home fitness platform that offers an immersive smart home gym with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">life-size</div> touchscreen mirror and accessories. Our Members are defined as any individual who has a Forme account through a paid connected fitness membership. The Company&#8217;s interactive home fitness platform is known as the Studio, for which the Company continues to develop new accessories and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">add-ons</div> to further customize a Member&#8217;s experience (&#8220;Connected Fitness Products&#8221;). Through the Studio, Members can stream immersive, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">instructor-led</div> boutique classes anytime, anywhere. The Company enables Members to get the most out of their wellness journey from their home. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation and Consolidation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of Interactive Strength Inc. and its subsidiaries in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity and Going Concern </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Since its inception, the Company has sustained recurring losses and has relied on funding from private investors and other third-parties (collectively &#8220;outside capital&#8221;) to execute the Company&#8217;s growth strategy. As a result, the Company incurred a net loss of $<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">58.2</ix:nonFraction> million during the year ended December 31, 2022 and had an accumulated deficit of $<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">115.5</ix:nonFraction> million as of December 31, 2022. The Company&#8217;s long-term success is dependent upon its ability to successfully develop, market, and deliver its revenue-generating products and services in a profitable manner. While management believes the Company can be successful in executing its growth strategy, no assurance can be provided it will be able to do so in a timely or profitable manner. As a result, the Company anticipates it will continue to rely on outside capital to fund the Company&#8217;s operations for the foreseeable future. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of the date the accompanying consolidated financial statements were issued (the &#8220;issuance date&#8221;), the Company&#8217;s available liquidity was not sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due, absent the Company&#8217;s ability to secure additional outside capital. While management plans to take action to address the Company&#8217;s liquidity needs, such as cost mitigation initiatives to reduce unnecessary costs, securing additional outside capital, pursuing an initial public offering of the Company&#8217;s common stock, and/or pursuing other strategic arrangements, no assurance can be provided that management&#8217;s actions will be sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In addition, as of December 31, 2022, the Company had loans outstanding from certain related parties (See Note&#160;22) with an aggregate principal and interest amount owed of approximately $<ix:nonFraction name="us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.7</ix:nonFraction> million. Certain of these loans matured prior to December 31, 2022, but their repayment has been temporarily waived, and the remaining loans are scheduled to mature over the next twelve months beyond issuance date. However, absent additional outside capital, the Company will be unable to repay these loans upon their maturity and, as such, the aggregate amounts owed have been classified as current debt in the accompanying consolidated balance sheet as of December 31, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the event that one or more of management&#8217;s planned actions are not sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment in the Company&#8217;s operations, a sale of certain of the Company&#8217;s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy. These uncertainties raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-8 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95758007"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">2. Summary of Significant Accounting Policies </div></div><ix:nonNumeric name="us-gaap:UseOfEstimates" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, simple agreement for future equity (&#8220;SAFE&#8221;) liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#8220;CODM&#8221;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">at-home</div> fitness technology platform. The Company&#8217;s chief operating decision maker, its chief executive officer, manages the Company&#8217;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of December&#160;31, 2022 and 2021, substantially all of the Company&#8217;s long-lived assets are held in the United States. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cash consists of cash on deposit in banks. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Off-Balance</div> Sheet Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any credit losses on its cash or cash equivalents. The Company maintains its cash and cash equivalents at a high-quality financial institution. Management believes that such funds are not exposed to any significant credit or concentration risk. The Company has no financial instruments with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-balance-sheet</div> risk of loss and has not experienced any losses on such accounts. </div></ix:nonNumeric><ix:nonNumeric name="trnr:DeferredOfferingCostsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Offering Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of Offering&#8221;</div></div>. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. The Company has incurred and expensed offering costs amounting to $<ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction>&#160;million as of December&#160;31, 2022. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95758471"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-9</ix:exclude> </div></ix:nonNumeric></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95758471" continuedAt="TextSelectionAppend_95758471_1"><ix:continuation id="TextSelection_95758007" continuedAt="TextSelectionAppend_95758007_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_1" continuedAt="TextSelectionAppend_95758007_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_2" continuedAt="TextSelectionAppend_95758007_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758007_3" continuedAt="TextSelectionAppend_95758007_4"><ix:continuation id="TextSelectionAppend_95758471_1">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s material financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFEs and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these <div style="display:inline;">instruments</div>. </div></ix:continuation><ix:nonNumeric name="us-gaap:InventoryPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">written-off</div> against the reserve. </div></ix:nonNumeric><ix:nonNumeric name="trnr:VendorDepositPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Vendor Deposits </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#8217;s inventory. In general, the Company&#8217;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#8217;s consolidated balance sheet. </div></ix:nonNumeric><ix:nonNumeric name="trnr:CapitalizedStudioContentPolicytextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Capitalized Studio Content </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Capitalized&#160;Studio content costs include certain expenditures to develop video and live content for the Company&#8217;s customers. The Company capitalizes production costs for recorded&#160;content in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;926-20,&#160;Entertainment-Films</div> - Other&#160;Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">other&#160;non-current&#160;assets</div> in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized&#160;content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#8220;obsolescence&#8221; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="PAsOn12_31_2022_CapitalizedStudioContentMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" format="ixt-sec:duryear">3</ix:nonNumeric>-year)</div> amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $<ix:nonFraction name="us-gaap:CooperativeAdvertisingAmount" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.4</ix:nonFraction>&#160;million as of December&#160;31, 2022. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95758467"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Identifiable Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;350-40,&#160;Internal-use&#160;Software</div></div> and ASC 985, Software.&#160;These capitalized costs also relate to the Company&#8217;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems.&#160;Capitalized software costs are amortized over the estimated useful life is three years.&#160;Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-10</ix:exclude> </div></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_95758467" continuedAt="TextSelectionAppend_95758467_1"><ix:continuation id="TextSelectionAppend_95758007_4" continuedAt="TextSelectionAppend_95758007_5"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_5" continuedAt="TextSelectionAppend_95758007_6"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_6" continuedAt="TextSelectionAppend_95758007_7"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758007_7" continuedAt="TextSelectionAppend_95758007_8"><ix:continuation id="TextSelectionAppend_95758467_1"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">probable the project will be completed, and the software will be used to perform the function intended.&#160;Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use.&#160;The Company expenses all costs incurred that relate to planning and post-implementation phases of development. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the years ended December&#160;31, 2022 and 2021, the Company capitalized $<ix:nonFraction name="us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.7</ix:nonFraction>&#160;million, and $<ix:nonFraction name="us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" contextRef="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction>&#160;million, respectively, of internally developed software. </div><ix:nonNumeric name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;&#160;Internal-use software</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P01_01_2022To12_31_2022" format="ixt-sec:durwordsen">3 years</ix:nonNumeric></td></tr></table></ix:nonNumeric></ix:continuation><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-production</div> tooling which it owns under a supply arrangement. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling, including the related engineering costs the Company will not own or will not be used in producing products under long-term supply arrangements, are expensed as incurred. </div><ix:nonNumeric name="trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><div style="display:inline;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn12_31_2022_MinimumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis" format="ixt-sec:duryear">2</ix:nonNumeric> </div>&#8211; <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn12_31_2022_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis" format="ixt-sec:duryear">5</ix:nonNumeric> years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn12_31_2022_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis" format="ixt-sec:duryear">2</ix:nonNumeric> &#8211; <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn12_31_2022_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis" format="ixt-sec:duryear">10</ix:nonNumeric> years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis" format="ixt-sec:duryear">3</ix:nonNumeric> &#8211; <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis" format="ixt-sec:duryear">5</ix:nonNumeric> years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="-sec-ix-hidden:hidden95757149">Lesser of lease term or estimated useful life</span></td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="trnr:ContentLicensingAgreementPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Content Licensing Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company entered into two agreements with a third-party content provider (&#8220;Content Provider&#8221;), a service agreement and a collaboration agreement. Per the service agreement, Forme is to provide content creation services for the Content Provider in which the Company is to produce workout content using the Content Provider&#8217;s trainers and studios. Under the collaboration agreement, both the Company and the Content Provider agree to jointly market their partnership; in addition, the collaboration agreement provides the Company with a license to use the Content Provider&#8217;s content on its Studio fitness ecosystem (i.e., the &#8220;License&#8221;). The license issued to the Company allows the Company to reproduce, modify, prepare derivative works based upon, distribute, publicly display, publicly perform the content and the modified content, to market, advertise or promote the Company, perform specified activities, and provide the Company&#8217;s customers access to and use of the Content Provider&#8217;s content, throughout the world on the Company&#8217;s Studio devices and in any media, so long as such other media is associated or related to the use of the Company&#8217;s Studio devices. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, the company determined that the Content Provider&#8217;s content would no longer be used on Forme&#8217;s platform, leading to a triggering event. Upon further analysis, it was determined that this content was abandoned in December 2022 with no remaining fair value. As such, Forme recorded an impairment loss of $<ix:nonFraction name="us-gaap:OtherAssetImpairmentCharges" contextRef="P01_01_2022To12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction> million within general and administrative costs within the consolidated statement of operations and comprehensive loss as of December 31, 2022. As a result, there is <ix:nonFraction name="us-gaap:EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" contextRef="PAsOn12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction> related unamortized costs of content as of December 31, 2022. Refer to Note 14 for further information on future minimum payments as of December 31, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The liability will be recorded and accreted at the gross amount for each tranche of content delivered to the Company for $<ix:nonFraction name="trnr:LicenseFeePayablePerQuarter" contextRef="PAsOn12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction>&#160;million per quarter and will be decreased when the payments per the payment schedule above are made. The liability for the license fee is approximately $<ix:nonFraction name="us-gaap:EntertainmentLicenseAgreementForProgramMaterialLiability" contextRef="PAsOn12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction> million as of December 31, 2022. </div></ix:nonNumeric><ix:nonNumeric name="trnr:MusicRoyaltyFeesPolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Music&#160;Royalty Fees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes&#160;music&#160;royalty fees&#160;as these fees are incurred in accordance with the terms of the relevant license agreement with the&#160;music&#160;rights holder. The incurrence of such royalties is primarily driven by&#160;the number of paid subscribers each month&#160;and it is classified as cost of membership and training within the Company&#8217;s statement of operations. The Company&#8217;s license agreements with&#160;music&#160;rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of December 31, 2022 and 2021, there were music guarantee-related prepaids of $<ix:nonFraction name="trnr:MusicGuaranteesDeposits" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">0</ix:nonFraction> million and $<ix:nonFraction name="trnr:MusicGuaranteesDeposits" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million, respectively. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-11</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95758007_8" continuedAt="TextSelectionAppend_95758007_9"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_9" continuedAt="TextSelectionAppend_95758007_10"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_10" continuedAt="TextSelectionAppend_95758007_11"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758007_11" continuedAt="TextSelectionAppend_95758007_12"><ix:nonNumeric name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. There was a $2.3 million impairment loss related to the impairment of the Content Provider&#8217;s content for the year ended December 31, 2022. There was no charge to impairment for the year ended December&#160;31, 2021. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company adopted the Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases</div></div> (Topic 842) (&#8220;ASU 2016-02&#8221; or &#8220;ASC&#160;842&#8221;) as of January 1, 2022, using the modified retrospective method and utilized the effective date as its date of initial application, with prior periods presented in accordance with previous guidance under Accounting Standards Codification (&#8220;ASC&#8221;) 840, Leases. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease liabilities, as applicable. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Prospectively, the Company will adjust the right-of-use assets for straight-line rent expense and remeasure the lease liability at the net present value using the same incremental borrowing rate that was in effect as of the lease commencement or transition date. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date: i) the Company did not reassess whether any expired or existing contracts are or contain leases, ii) the Company did not reassess the lease classification for any expired or existing leases, and iii) the Company did not reassess initial direct costs for any existing leases. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In accordance with ASC 842, components of a lease should be split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Entities may elect not to separate lease and non-lease components. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only. As a result of the adoption of ASC 842, the Company recognized right-of-use assets and lease liabilities of $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn01_01_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="PAsOn01_01_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million, respectively, as of the January 1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. The Company recorded an immaterial amount of general and administrative expense in its consolidated statement of operations related to lease expense, including short-term lease expense during the year ended December 31, 2022. </div></ix:nonNumeric><ix:nonNumeric name="trnr:ConvertibleNotesPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. </div></ix:nonNumeric><ix:nonNumeric name="trnr:WarrantsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757169"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-12</ix:exclude> </div></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_95757169" continuedAt="TextSelectionAppend_95757169_1"><ix:continuation id="TextSelectionAppend_95758007_12" continuedAt="TextSelectionAppend_95758007_13"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_13" continuedAt="TextSelectionAppend_95758007_14"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_14" continuedAt="TextSelectionAppend_95758007_15"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758007_15" continuedAt="TextSelectionAppend_95758007_16"><ix:continuation id="TextSelectionAppend_95757169_1"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party (the &#8220;acqui-hire transaction&#8221;) that is exercisable for a number of shares of common stock that is determined by dividing $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="P11_01_2022To11_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">225,000</ix:nonFraction> by (x) the price per share of the next equity financing with total proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="P11_01_2022To11_30_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction> million or (y) the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn11_30_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In accordance with ASC 718, as the warrant contains a performance condition dependent on an initial public offering, there has been no impact recorded prior to December 31, 2022. </div></ix:continuation><ix:nonNumeric name="us-gaap:DerivativesPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Instruments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company measures derivative financial instruments at fair value and recognizes them as either assets or liabilities on the consolidated balance sheets. The Company evaluates its convertible instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives requiring separate recognition in the Company&#8217;s financial statements in accordance with the criteria under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15.</div> As of December&#160;31, 2022 and 2021, the Company did not have any material derivative contracts or contracts with material embedded derivative features requiring bifurcation. </div></ix:nonNumeric><ix:nonNumeric name="trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Simple Agreements for Future Equity (&#8220;SAFES&#8221;) and Advance Subscription Agreements (&#8220;ASAs&#8221;) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has issued several SAFEs and ASAs in exchange for cash financing. The SAFEs were initially measured at fair value using a probability weighted expected return method (PWERM) and were subsequently remeasured at fair value at each reporting period, through the date of conversion. The ASAs were initially measured at fair value utilizing the&#160;fair value of the Company&#8217;s common stock according to the ASC 718 valuation&#160;performed by an independent appraiser closest to the date of grant and were subsequently remeasured at fair value at each reporting period, through date of conversion. Pursuant to the SAFE agreement provisions, all outstanding SAFE instruments were converted to preferred stock in 2021, in connection with a Series A financing. All ASAs were converted to common stock on the respective ASA Longstop Dates <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(6-month</div> anniversary of issuance). There were are <ix:nonFraction name="us-gaap:ForwardContractIndexedToIssuersEquityShares" contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:ForwardContractIndexedToIssuersEquityShares" contextRef="P01_01_2022To12_31_2022_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> outstanding SAFEs or ASAs as of December&#160;31, 2022 or December 31, 2021. The remeasurements of the SAFEs and ASAs resulted in the recognition of a $<ix:nonFraction name="trnr:RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" contextRef="P01_01_2022To12_31_2022_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million loss for the year ended December&#160;31, 2021 (see Note 4 to the consolidated financial statements for the accounting for significant inputs to the valuation of the SAFE and ASA instruments). </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Commitments and Contingencies </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. If a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the possible loss or states that such an estimate cannot be made. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:RevenueRecognitionPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On January&#160;1, 2020, the Company adopted Accounting Standards Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;ASU&#8221;)&#160;2014-09,&#160;Revenue</div> from Contracts with Customers (Topic 606) (&#8220;ASC 606&#8221;)&#160;and all subsequent amendments. As the Company had not recognized any revenue prior to the adoption of the new standard, there was no impact on the measurement or timing of revenue recognition as a result of the adoption. Revenue is recognized when control of the promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Refer to Note 3 for additional information. </div></ix:nonNumeric><ix:nonNumeric name="trnr:CostOfFitnessProductRevenuePolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Fitness Product Revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cost of fitness product revenue relates to the Fitness Product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management, facilities, and personnel-related expenses associated with supply chain logistics. Cost of fitness product revenue also contains valuation losses related to the Company&#8217;s inventory lower of cost or market reserve. </div></ix:nonNumeric><ix:nonNumeric name="trnr:CostOfMembershipAndTrainingPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Membership and Training </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Membership costs include costs associated with the creation of content and training, including associated payroll, filming and production costs, other content specific costs, hosting fees, music royalties, amortization of capitalized software development costs, and warranty replacement and servicing costs associated with extended warranty contracts. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-13</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95758007_16" continuedAt="TextSelectionAppend_95758007_17"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_17" continuedAt="TextSelectionAppend_95758007_18"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_18" continuedAt="TextSelectionAppend_95758007_19"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758007_19" continuedAt="TextSelectionAppend_95758007_20"><ix:nonNumeric name="us-gaap:AdvertisingCostsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Advertising Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Advertising and other promotional costs to market the Company&#8217;s products are expensed as incurred. Advertising expenses were $2.5&#160;million and $2.0&#160;million for the years ended December&#160;31, 2022 and 2021, respectively, and are included within sales and marketing expenses in the consolidated statements of operations and comprehensive loss. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Research and Development Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Research and development expenses consist primarily of personnel- and facilities-related expenses, consulting and contractor expenses, tooling and prototype materials software platform expenses, and depreciation of property and equipment. Substantially all of the Company&#8217;s research and development expenses are related to developing new products and services and improving existing products and services. Research and development expenses are expensed as incurred. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:CompensationRelatedCostsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-Based Compensation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (&#8220;the 2020 Plan&#8221;). Stock-based awards are measured at the grant date based on the fair value of the award and are recognized as expense, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The determination of the grant date fair value of stock awards issued is affected by a number of variables, including the fair value of the Company&#8217;s common stock, the expected common stock price volatility over the expected life of the awards, the expected term of the stock option, risk-free interest rates, and the expected dividend yield of the Company&#8217;s common stock. The Company derives its volatility from the average historical stock volatilities of several peer public companies over a period equivalent to the expected term of the awards. The Company estimates the expected term based on the simplified method for employee stock options considered to be &#8220;plain vanilla&#8221; options, as the Company&#8217;s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant. Expected dividend yield is <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">0.0</ix:nonFraction>% as the Company has not paid and does not currently anticipate paying dividends on its common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Stock-based compensation expense is classified in the accompanying consolidated statement of operations in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Foreign Currency Transactions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The functional currency for the Company&#8217;s wholly-owned foreign subsidiaries, Interactive Strength UK and Interactive Strength Taiwan, is the United States dollar. All foreign currency transaction gains and losses are recognized in the consolidated statements of operations and comprehensive loss through other income (expense). The Company has <ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="P01_01_2022To12_31_2022_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="P01_01_2021To12_31_2021_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t recognized material currency transaction gains or losses during the years ended December&#160;31, 2022 and 2021. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive Loss </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Comprehensive loss includes net loss as well as other changes in stockholders&#8217; deficit that result from transactions and economic events other than those with stockholders. For the years ended December 31, 2022 and 2021, comprehensive loss included $<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2022To12_31_2022_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2021To12_31_2021_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million of foreign currency transaction gains, respectively. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Loss Per Share </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company computes loss per share using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method required for participating securities. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company&#8217;s redeemable convertible preferred stock and common stock issued upon early exercise of stock options are participating securities. The Company considers any shares issued upon early exercise of stock options, subject to repurchase, to be participating securities because holders of such shares have <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-forfeitable</div> dividend rights in the event a cash dividend is declared on common stock. These participating securities do not contractually require the holders of such shares to participate in the Company&#8217;s losses. As such, net losses for the periods presented were not allocated to the Company&#8217;s participating securities. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Basic loss per share is computed using the weighted-average number of outstanding shares of common stock during the period. Diluted earnings (loss) per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential shares of common stock outstanding during the period. Potential shares of common stock consist of incremental shares issuable upon the assumed exercise of stock options, employee stock purchase plan (&#8220;ESPP&#8221;) shares to be issued, and vesting of restricted stock awards. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-14</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95758007_20" continuedAt="TextSelectionAppend_95758007_21"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_21" continuedAt="TextSelectionAppend_95758007_22"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_22" continuedAt="TextSelectionAppend_95758007_23"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758007_23" continuedAt="TextSelectionAppend_95758007_24"><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than <ix:nonFraction name="trnr:PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" contextRef="PAsOn12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">50</ix:nonFraction>% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757167"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) and has elected not to &#8220;opt out&#8221; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time private companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Recently Adopted </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, Leases (&#8220;Topic 842&#8221;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize an ROU asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January 1, 2022. Financial positions for reporting periods beginning on or after January 1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2016-13 </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2016, the FASB issued ASU 2016-03, Measurement of Credit Losses on Financial Instruments (&#8220;CECL&#8221;), which amends ASC 326 &#8220;Financial Instruments - Credit Losses&#8221; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#8220;expected loss model&#8221; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January 1, 2022 and the guidance did not have a material impact on our consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>, which amends ASC Topic 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div>. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div>eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU 2019-12 effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#8217;s financial statements. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-15</ix:exclude> </div></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_95757167" continuedAt="TextSelectionAppend_95757167_1"><ix:continuation id="TextSelectionAppend_95758007_24" continuedAt="TextSelectionAppend_95758007_25"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_25" continuedAt="TextSelectionAppend_95758007_26"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758007_26" continuedAt="TextSelectionAppend_95758007_27"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758007_27"><ix:continuation id="TextSelectionAppend_95757167_1"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements Not Yet Adopted </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> and ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial</div></div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reporting</div></div>. This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div>ease entities&#8217; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848)</div></div>, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its consolidated financial statements. </div></ix:continuation></ix:continuation><ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95759025"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">3. Revenue Recognition </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s primary source of revenue is solely derived from the United States from sales of its Connected Fitness Products and related accessories and associated recurring Membership revenue, as well as from sales of personal training services recorded within Training revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company determines revenue recognition through the following steps: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Identification of the contract, or contracts, with a customer; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Identification of the performance obligations in the contract; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Determination of the transaction price; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Allocation of the transaction price to the performance obligations in the contract; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Recognition of revenue when, or as, the Company satisfies a performance obligation. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Revenue is recognized when control of the promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company&#8217;s revenue is reported net of sales returns, discounts and incentives as a reduction of the transaction price. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the practical expedient as per ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">606-10-50-14</div></div></div> and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company&#8217;s consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Connected Fitness Products </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Connected Fitness Products include the Company&#8217;s portfolio of Connected Fitness Products and related accessories, delivery and installation services, and extended warranty agreements. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period. The Company allows customers to return products within thirty days of purchase, as stated in its return policy. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amounts paid for payment processing fees for credit card sales for Connected Fitness Products are included as a reduction to fitness product revenue in the Company&#8217;s consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Membership </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s memberships provide unlimited access to content in its library of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on-demand</div> fitness classes. The Company&#8217;s memberships are offered on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">month-to-month</div></div> basis. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-16</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95759025" continuedAt="TextSelectionAppend_95759025_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759025_1" continuedAt="TextSelectionAppend_95759025_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759025_2" continuedAt="TextSelectionAppend_95759025_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95759025_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amounts paid for membership fees are included within deferred revenue on the Company&#8217;s consolidated balance sheets and recognized ratably over the membership term. The Company records payment processing fees for its monthly membership charges within cost of membership and training in the Company&#8217;s consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Training </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s training services are personal training services delivered through the Connected Fitness Products and third-party mobile devices. Training revenue is recognized at the time of delivery. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Standard Product Warranty </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company offers a standard product warranty that its Connected Fitness Products and related accessories will operate under normal, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-commercial</div> use for a period of one year which covers the touchscreen, frame and all incorporated elements, and related accessories from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company also offers the option for customers in some markets to purchase a third-party extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of <ix:nonNumeric name="trnr:ExtendedProductWarrantyPeriod" contextRef="P01_01_2022To12_31_2022_MinimumMembersrtRangeAxis" format="ixt-sec:durmonth">24</ix:nonNumeric> to <ix:nonNumeric name="trnr:ExtendedProductWarrantyPeriod" contextRef="P01_01_2022To12_31_2022_MaximumMembersrtRangeAxis" format="ixt-sec:durmonth">48</ix:nonNumeric> months. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For third-party extended warranty service sold along with the Company&#8217;s Connected Fitness Products, the Company does not obtain control of the warranty before transferring it to the customers. Therefore, the Company accounts for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission it retains. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it can establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product. </div></ix:continuation><ix:nonNumeric name="trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">4. Simple Agreements for Future Equity and Advance Subscription Agreements </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From 2017 to 2021, the Company issued Simple Agreements for Future Equity (&#8220;SAFE&#8221;) and Advance Subscription Agreements (&#8220;ASA&#8221;) to several investors. The SAFE and ASA agreements have no maturity date and bear no interest. The SAFE Agreements provide a right to the holder to (a)&#160;future equity in the Company in the form of SAFE Preferred Stock when it completes an Equity Financing (as defined in the SAFE agreements), or (b)&#160;future equity in the form of Common Stock or cash proceeds if there is a liquidity event or dissolution event. The ASA Agreements provide a right to the holder to future equity in the Company in the form of Common Stock when it completes an Equity Financing, in the event of a sale, on the date falling six months from the date of the Agreement, or at the option of the holder on the closing of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Qualifying</div> Financing Round (as defined in the ASA agreements) or at any time prior to the occurrence of any of the events listed above. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The SAFE and ASA agreements will expire and terminate upon either (i)&#160;the issuance of shares to the investor pursuant to an equity financing event or (ii)&#160;the payment, or setting aside for payment, of amounts due to the investor pursuant to a liquidity or dissolution event. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, in connection with a Series A financing, all outstanding SAFEs were converted through the issuance of <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn07_23_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_shares" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.02</ix:nonFraction>&#160;million shares of SAFE Preferred Stock. There were <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> outstanding SAFEs as of December&#160;31, 2022 or 2021. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:InventoryDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">5. Inventories, net </div></div><ix:nonNumeric name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories consist of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,567</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,056</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total inventories, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,567</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,056</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-17 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">6. Property and Equipment, net </div></div><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment consisted of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:PreProductionTooling" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,094</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:PreProductionTooling" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,775</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:MachineryAndEquipmentGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">125</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:MachineryAndEquipmentGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">243</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">113</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">113</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software and technology development asset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,370</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,156</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,044</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">966</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,326</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,190</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization expense amounted to $<ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million for the years ended December&#160;31, 2022 and 2021, respectively. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:IntangibleAssetsDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">7. Intangible Assets, net </div></div><ix:nonNumeric name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Identifiable intangible assets, net consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book<br/>Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book<br/>Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,827</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,993</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,834</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,083</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">428</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,655</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,827</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,993</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,834</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,083</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">428</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,655</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><ix:nonNumeric name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, estimated annual amortization expense for each of the next five fiscal years is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom;white-space:nowrap"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Years Ending December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,946</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,516</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">372</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">8. Prepaid Expenses and Other Current Assets </div></div><ix:nonNumeric name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Prepaid expenses and other current assets consisted of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security deposit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">146</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">607</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PrepaidLicenses" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">45</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PrepaidLicenses" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">202</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ResearchAndDevelopmentTaxCredit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">750</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ResearchAndDevelopmentTaxCredit" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:VendorDeposits" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">178</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:VendorDeposits" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other prepaid</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="PAsOn12_31_2022_ScenarioPreviouslyReportedMembersrtRestatementAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">307</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">356</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,426</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,165</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-18 </div></div></div></div><div></div></div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:OtherAssetsDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">9. Other Assets </div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><ix:nonNumeric name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized content costs and content licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2022_CapitalizedContentCostsAndContentLicensesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,404</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2021_CapitalizedContentCostsAndContentLicensesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,099</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,605</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2021_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,258</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2021_OtherAssetsMemberusgaapBalanceSheetLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,018</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,366</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">10. Accrued Expenses and Other Current Liabilities </div></div><ix:nonNumeric name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Accrued expenses consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued bonus</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">145</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">223</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued payroll</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">193</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued PTO</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PaidTimeOffAccrual" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">188</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PaidTimeOffAccrual" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedOfferingCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,490</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedOfferingCosts" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued advertising</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedAdvertisingCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedAdvertisingCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">195</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued professional fees</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">31</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued engineering</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedEngineeringCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedEngineeringCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">93</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedLicenses" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,250</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedLicenses" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,050</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales tax payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued royalties</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">195</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022_ScenarioPreviouslyReportedMembersrtRestatementAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">323</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">532</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,784</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,125</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">520</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">295</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,304</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,420</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95759132"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">11. Debt </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2020 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the year ended December&#160;31, 2020 the Company issued convertible notes (the &#8220;2020 Convertible Notes&#8221;) with an aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.2</ix:nonFraction>&#160;million, pursuant to a private placement offering. The 2020 Convertible Notes bore interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% per annum and had a scheduled maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P01_01_2020To12_31_2020_MinimumMembersrtRangeAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" format="ixt-sec:durmonth">12</ix:nonNumeric> to <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P01_01_2020To12_31_2020_MaximumMembersrtRangeAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" format="ixt-sec:durmonth">24</ix:nonNumeric> months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2020 Convertible Notes under ASC Topic 825, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial Instruments</div></div>, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2020 Convertible Notes did not include any financial covenants and were subject to acceleration upon the occurrence of specified events of default. The 2020 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<div style="display:inline;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2020To12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.0</ix:nonFraction></div>&#160;million prior to the maturity date of the 2020 Convertible Notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the 2020 Convertible Notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to <ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="P01_01_2020To12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">80</ix:nonFraction>% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing. The conversion price with respect to an elective conversion at the time of maturity is equal to the fair market value of the Company divided by the Company&#8217;s fully diluted capitalization table at the time of conversion. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Two individual 2020 Convertible Notes with an aggregate principal value of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,250,000</ix:nonFraction> were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<div style="display:inline;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2020To12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction></div>&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-19</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95759132" continuedAt="TextSelectionAppend_95759132_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759132_1" continuedAt="TextSelectionAppend_95759132_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759132_2" continuedAt="TextSelectionAppend_95759132_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95759132_3" continuedAt="TextSelectionAppend_95759132_4">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) <ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="P01_01_2022To12_31_2022_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">80</ix:nonFraction>% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) $<ix:nonFraction name="us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature" contextRef="P01_01_2020To12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">50.0</ix:nonFraction>&#160;million divided by the sum of the Company&#8217;s then-outstanding common stock, outstanding option, and promised options (the &#8220;Cap Price&#8221;). The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In July 2021, the Company completed a qualified financing, and as a result the 2020 Convertible Notes were automatically converted into <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn07_31_2021_SeriesSeed9PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">13,373</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div> preferred stock and <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn07_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,279</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> preferred stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From January through July 2021, the Company issued convertible notes (the &#8220;2021 Convertible Notes&#8221;) with an aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">14.8</ix:nonFraction>&#160;million, pursuant to a private placement offering. The 2021 Convertible Notes bore interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% per annum and had a scheduled maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P01_01_2021To07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" format="ixt-sec:durmonth">24</ix:nonNumeric> months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2021 Convertible Notes under ASC Topic 825, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial Instruments</div></div>, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2021 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2021 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2021To07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) <ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="P01_01_2021To07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">80</ix:nonFraction>% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#8220;Cap Price&#8221;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In July 2021, the Company completed a qualified financing, and as a result the 2021 Convertible Notes were automatically converted into <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn07_31_2021_SeriesSeed9PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">130</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div> preferred stock, <div style="display:inline;"><ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn07_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">24,576</ix:nonFraction> </div>shares of Series A preferred stock, and <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn07_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">6,929</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> preferred stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From January through March 2022, the Company issued convertible notes (the &#8220;2022 Convertible Notes&#8221;) with an aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.9</ix:nonFraction>&#160;million, pursuant to a private placement offering. The 2022 Convertible Notes bore interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% per annum and had a scheduled maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" format="ixt-sec:durmonth">24</ix:nonNumeric> months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) <ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">80</ix:nonFraction>% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#8220;Cap Price&#8221;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March&#160;2022, the Company completed a qualified financing, and as a result the 2022 Convertible Notes were automatically converted into <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">124,313</ix:nonFraction> shares of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;A-2.</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued convertible notes (the &#8220;November 2022 Convertible Notes&#8221;) with an aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.4</ix:nonFraction>&#160;million, pursuant to a private placement offering. The November 2022 Convertible Notes bore interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% per annum and had a schedule maturing date of <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" format="ixt-sec:durmonth">12</ix:nonNumeric> months from issuance, at which time the principal and </div><ix:exclude><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-20 </div></ix:exclude></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95759132_4" continuedAt="TextSelectionAppend_95759132_5"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759132_5" continuedAt="TextSelectionAppend_95759132_6"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759132_6" continuedAt="TextSelectionAppend_95759132_7"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95759132_7"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">accrued interest would be due and payable. The Company elected the fair value option for the November 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) the price per share in the Next Financing round, or ii) the Original Issue Price of the Company&#8217;s Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> Preferred Stock, which is $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">47.67</ix:nonFraction>. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognized gains equal to $<ix:nonFraction name="trnr:GainRecognizedOnFairValueChangesOfConvertibleNotes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction name="trnr:GainRecognizedOnFairValueChangesOfConvertibleNotes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.2</ix:nonFraction>&#160;million for the years ended December&#160;31, 2022 and 2021, respectively, related to changes in fair value for the 2022 Convertible Notes, 2021 Convertible Notes, and 2020 Convertible Notes. The outstanding balance of convertible notes as of December&#160;31, 2022 and 2021 was $<ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="PAsOn12_31_2022_ConvertibleDebtMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.3</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="PAsOn12_31_2021_ConvertibleDebtMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">0</ix:nonFraction>&#160;million, respectively. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Paycheck Protection Program Loan </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On April&#160;2, 2021, the Company received loan proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="P04_02_2021To04_02_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction>&#160;million under the Paycheck Protection Program (&#8220;PPP&#8221;). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;), provides for loans to qualifying businesses to help sustain its employee payroll costs, rent, and utilities due to the impact of the recent <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. Loans obtained through the PPP are eligible to be forgiven as long as the proceeds are used for qualifying purposes, which include the payment of payroll costs, interest on covered mortgage obligations, rent obligations and utility payments. The receipt of these funds, and the forgiveness of the loan is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on its adherence to the forgiveness criteria. In June 2020, Congress passed the Payroll Protection Program Flexibility Act that made several significant changes to PPP loan provisions, including providing greater flexibility for loan forgiveness. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company used the proceeds from the PPP loan to fund payroll costs in accordance with the relevant terms and conditions of the CARES Act. The Company followed the government guidelines and tracking costs to ensure full forgiveness of the loan. To the extent it was not forgiven, the Company would have been required to repay that portion at an interest rate of <ix:nonFraction name="trnr:PercentageOfInterestRateOfDebtForgiveness" contextRef="P04_02_2021To04_02_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">1</ix:nonFraction>% over a period of 5 years, beginning May 2022 with a final installment in April 2027. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The balance outstanding for the PPP loan was $<ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="PAsOn12_31_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction>&#160;million at December&#160;31, 2021 and was forgiven in 2022, which resulted in a $<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="P01_01_2022To12_31_2022_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million gain upon debt forgiveness. </div></ix:continuation><ix:nonNumeric name="trnr:WarrantsDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757041"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">12. Warrants </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;A Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During July 2021 and August 2021 the Company issued an aggregate <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn07_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">125,982</ix:nonFraction> warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with its Series A financing rounds at that time. Additionally, on November 13, 2022, the Company issued an aggregate <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction> warrants to purchase Class A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. Each warrant has a strike price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share and has a contractual term of <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>. The warrants are classified as other long-term liabilities within the consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The fair value of the warrants issued in 2021 at the time of issuance was recorded as a reduction to the carrying value of the related preferred stock that they were issued with. The fair value of the warrants issued in 2022 was recorded as a liability on the Balance Sheet and expensed to other (expense) income, net on the Statement of Operations and Comprehensive Loss, at the time of issuance. </div><ix:exclude><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-21 </div></ix:exclude></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757041" continuedAt="TextSelectionAppend_95757041_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757041_1" continuedAt="TextSelectionAppend_95757041_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757041_2" continuedAt="TextSelectionAppend_95757041_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757041_3"><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="P01_01_2022To12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" escape="true"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A&#160;Common<br/>Stock Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2020_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ClassOfWarrantsIssued" contextRef="P01_01_2021To12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">125,982</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:ClassOfWarrantsExercised" contextRef="P01_01_2021To12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">125,982</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ClassOfWarrantsIssued" contextRef="P01_01_2022To12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ClassOfWarrantsExercised" contextRef="P01_01_2022To12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;B Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During July 2021, the Company issued an aggregate <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">6,632</ix:nonFraction> warrants to purchase Class&#160;B Common Stock to various employees and nonemployees. Each warrant has a strike price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> and has a contractual term of <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" format="ixt-sec:durwordsen">seven years</ix:nonNumeric>. The warrants are classified as permanent equity within the consolidated balance sheets. <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">4,000</ix:nonFraction> of these warrants with an aggregate fair value of $<ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million were issued as compensation for services provided to the Company and are recorded within operating expenses, as described in Note 15. </div><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="P01_01_2022To12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B&#160;Common<br/>Stock Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2020_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ClassOfWarrantsIssued" contextRef="P01_01_2021To12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">6,632</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:ClassOfWarrantsExercised" contextRef="P01_01_2021To12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">879</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">5,753</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">5,753</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:continuation><ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95759144"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">13. Fair Value Measurements </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s financial instruments consist of its convertible notes, warrants, SAFEs, and ASAs. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">There were <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> assets measured at fair value on a recurring basis as of December 31, 2022 and 2021. <ix:nonNumeric name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95759143">Liabilities measured at fair value on a recurring basis as of December 31, 2022 were as follows:</ix:nonNumeric> </div><ix:continuation id="TextSelection_95759143"><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measurements as of<br/>December&#160;31, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,270</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,270</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,004</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,004</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,274</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,274</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:continuation><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">There were <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> liabilities measured at fair value on a recurring basis as of December 31, 2021. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the year ended December&#160;31, 2022, there were <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> transfers between Level&#160;1 and Level&#160;2, nor into and out of Level&#160;3. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-22</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95759144" continuedAt="TextSelectionAppend_95759144_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759144_1" continuedAt="TextSelectionAppend_95759144_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759144_2" continuedAt="TextSelectionAppend_95759144_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95759144_3" continuedAt="TextSelectionAppend_95759144_4"><ix:nonNumeric name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company&#8217;s Level&#160;3 liabilities measured at fair value on a recurring basis: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">SAFE&#160;Liability</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2020_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,655</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of SAFEs and ASAs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,416</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">251</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of ASAs into common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5,667</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of SAFEs into series seed preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,655</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2020_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,546</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14,620</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" contextRef="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,193</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series Seed preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" contextRef="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,947</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" contextRef="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,026</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,303</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" contextRef="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">107</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" contextRef="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5,926</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,270</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:13%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant&#160;Liability</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,482</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">478</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,004</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">SAFEs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 4, between 2017 and 2021, the Company entered into several SAFEs with certain investors. The Company recorded the liability related to the SAFEs at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the SAFEs was determined using a probability weighted expected return method (PWERM), in which the probability and timing of potential future events (such as a qualified equity financing or a dissolution) is considered in order to estimate the fair value of the SAFEs as of each valuation date. Management determined the fair value of the SAFEs using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;<ix:nonFraction name="trnr:EquityValuePercentage" contextRef="PAsOn12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% equity value of the business, (3)&#160;equity volatility, and (4)&#160;recovery rate. The Company recorded an unfavorable change in fair value adjustment of $<ix:nonFraction name="trnr:FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million in the consolidated statement of operations for the year ended December 31, 2021. Upon the occurrence of a Series&#160;A financing in 2021, all outstanding SAFEs were converted through the issuance of <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn07_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis" unitRef="Unit_shares" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.02</ix:nonFraction>&#160;million shares of SAFE Preferred Stock. There were <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> outstanding SAFEs as of December 31, 2022 or 2021. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 10, the Company entered into several convertible note arrangements with certain investors during 2020, 2021, and 2022. The Company recorded the liability related to the convertible notes at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the convertible notes was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the convertible notes as of each valuation date. For the outstanding notes as of December 31, 2022, management determined the fair value of the convertible notes using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;expected future equity value of the underlying shares at the time of conversion, and (3)&#160;a discount rate of <ix:nonFraction name="trnr:DebtInstrumentMeasurementDiscountRate" contextRef="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">20.36</ix:nonFraction>%. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-23</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95759144_4" continuedAt="TextSelectionAppend_95759144_5"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759144_5" continuedAt="TextSelectionAppend_95759144_6"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759144_6" continuedAt="TextSelectionAppend_95759144_7"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95759144_7"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recorded a change in fair value adjustment of $<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" contextRef="P01_01_2022To12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" contextRef="P01_01_2021To12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.2</ix:nonFraction>&#160;million in the consolidated statement of operations and comprehensive loss for the years ended December&#160;31, 2022 and 2021, respectively. Upon the occurrence of a Series Seed and Series A financing in 2021, $<ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="PAsOn12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.0</ix:nonFraction>&#160;million of convertible notes were converted through the issuance of <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_shares" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.05</ix:nonFraction>&#160;million shares of Preferred Stock. Upon the occurrence of a Series A financing in 2022, $<ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="PAsOn12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.9</ix:nonFraction> million of convertible notes were converted through the issuance of <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million shares of Preferred Stock. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrants </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 12, on November&#160;13, 2022, the Company issued an aggregate <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn11_13_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction> warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. The Company recorded the liability related to the warrants at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the warrants was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of December 31, 2022, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) a discount rate of <ix:nonFraction name="trnr:WarrantsMeasurementDiscountRate" contextRef="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">21.7</ix:nonFraction>%. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recorded a change in fair value adjustment of $<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">0</ix:nonFraction>&#160;million in the consolidated statement of operations and comprehensive loss for the years ended December&#160;31, 2022 and 2021, respectively. </div></ix:continuation><ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">14. Leases </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company adopted ASC 842 on January&#160;1, 2022, using the effective date transition method, which requires a cumulative-effect adjustment to the opening balance of retained earnings on the effective date. As a result of the adoption of ASC 842, the Company recognized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities of $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn01_01_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="PAsOn01_01_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million, respectively, as of the January&#160;1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has made certain assumptions and judgements when applying ASC 842 including the adoption of the package of practical expedients available for transition. The practical expedients allowed the Company to not reassess (i)&#160;whether expired or existing contracts contained leases, (ii)&#160;lease classification for expired or existing leases and (iii)&#160;previously capitalized initial direct costs. The Company also elected not to recognize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities for short-term leases (leases with a term of twelve months or less). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating lease arrangements primarily consist of office and warehouse leases expiring at various years through 2024. The facility leases have original lease terms of <span style="-sec-ix-hidden:hidden95757447">two</span> to <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="PAsOn12_31_2022_MaximumMembersrtRangeAxis" format="ixt-sec:durwordsen">seven years</ix:nonNumeric> and contain options to extend the lease up to <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="P01_01_2022To12_31_2022">5 years</ix:nonNumeric> or terminate the lease. Options to extend are included in leased <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities in the consolidated balance sheet when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of December&#160;31, 2022, the weighted average discount rate for operating leases was <ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="PAsOn12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">7.98</ix:nonFraction>% and the weighted average remaining lease term for operating leases was <ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="PAsOn12_31_2022" format="ixt-sec:duryear">0.8</ix:nonNumeric> years, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has entered into various short-term operating leases for office and warehouse space, with an initial term of twelve months or less. These short-term leases are not recorded on the Company&#8217;s consolidated balance sheet and the related lease expense for these short-term leases was $<ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">0</ix:nonFraction>&#160;million for the years ended December&#160;31, 2022 and 2021 respectively. Total operating lease cost was $<ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">0</ix:nonFraction>&#160;million for the years ended December&#160;31, 2022 and 2021, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets of $<ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction>&#160;million were obtained in exchange for lease liabilities during the year ended December&#160;31, 2022. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-24 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">15. Commitments and Contingencies </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lease Obligations </div></div></div></div><ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual rental payments under operating leases for each of the next five years and thereafter:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future Minimum Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">160</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">169</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Commitments </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company is subject to minimum payments on a content licensing agreement. </div><ix:nonNumeric name="us-gaap:OtherCommitmentsTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual guarantee payments under license agreements for each of the next five years and thereafter:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future Minimum Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherCommitmentDueInNextTwelveMonths" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,025</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherCommitmentDueInSecondYear" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,950</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherCommitmentDueInThirdYear" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,250</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherCommitmentDueInFourthYear" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,200</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherCommitmentDueInFifthYear" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherCommitmentDueAfterFifthYear" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherCommitment" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,425</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Legal Proceedings </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company is involved in legal proceedings in the normal course of business. The Company currently believes that any ultimate liability arising out of such proceedings will not have a material adverse effect on the Company&#8217;s financial position, results of operations or cash flows. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95758473"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">16. Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s authorized common stock consisted of <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">369,950,000</ix:nonFraction> shares and <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">86,000,000</ix:nonFraction> shares at $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction> par value, as of December&#160;31, 2022 and 2021, respectively. The issued and outstanding common stock was <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,450,922</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">213,065</ix:nonFraction></ix:nonFraction> shares as of December&#160;31, 2022 and 2021, respectively. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Transactions </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company issued <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" contextRef="P07_23_2021To07_23_2021_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">6,632</ix:nonFraction> common stock warrants in lieu of interest payments on the Company&#8217;s convertible notes and as compensation for services provided to the Company in relation to agreements entered into with a third-party content provider. Refer to Note 2 for additional information regarding these agreements. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share, price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:num-dot-decimal">55.50</ix:nonFraction> per share, expected term of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_Y" decimals="0" scale="0" format="ixt:num-dot-decimal">7</ix:nonFraction> years, risk-free rate of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">1.30</ix:nonFraction>%, and volatility of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:num-dot-decimal">65</ix:nonFraction>%. The fair value of the warrants of $<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn07_23_2021_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million was recorded as a long-term liability. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company issued <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" contextRef="P07_23_2021To07_23_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">76,353</ix:nonFraction> common stock warrants in connection with the issuance of preferred stock. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share, price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:num-dot-decimal">55.50</ix:nonFraction> per share, expected term of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_Y" decimals="0" scale="0" format="ixt:num-dot-decimal">10</ix:nonFraction> years, risk-free rate of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">1.30</ix:nonFraction>%, and volatility of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn07_23_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:num-dot-decimal">65</ix:nonFraction>%. The fair value of the warrants of $<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn07_23_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.2</ix:nonFraction>&#160;million was recorded as a reduction in the value of the Series A Financing. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-25</ix:exclude> </div></ix:nonNumeric></div></div></div><ix:continuation id="TextSelection_95758473" continuedAt="TextSelectionAppend_95758473_1"><div></div></ix:continuation></div><ix:continuation id="TextSelectionAppend_95758473_1" continuedAt="TextSelectionAppend_95758473_2"><div><div style="line-height:normal;background-color:white;display: inline;"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></div></div></ix:continuation></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758473_2" continuedAt="TextSelectionAppend_95758473_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On August&#160;25, 2021, the Company issued <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" contextRef="P08_25_2021To08_25_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">49,629</ix:nonFraction> common stock warrants in connection with the issuance of preferred stock. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn08_25_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share, price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn08_25_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:num-dot-decimal">55.50</ix:nonFraction> per share, expected term of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn08_25_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_Y" decimals="1" scale="0" format="ixt:num-dot-decimal">9.9</ix:nonFraction> years, risk-free rate of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn08_25_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">1.35</ix:nonFraction>%, and volatility of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn08_25_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:num-dot-decimal">65</ix:nonFraction>%. The fair value of the warrants of $<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn08_25_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.8</ix:nonFraction>&#160;million was recorded as a reduction in the value of the Series A Financing. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November 13, 2022, the Company issued <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn11_13_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction> common stock warrants in connection with the issuance of the November 2022 Convertible Notes. The fair value of the warrants was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of December&#160;31, 2022, management determined the fair value of the warrants using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;expected future equity value of the underlying shares at the time of conversion, and (3)&#160;a discount rate of <ix:nonFraction name="trnr:PercentageOfDiscountRateOnConvertibleNotes" contextRef="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">21.7</ix:nonFraction>%. The fair value of the warrants of $<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn11_13_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million was recorded as a long-term liability upon issuance. A change in the fair value of warrants of $<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million resulted in a long-term liability of $<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.0</ix:nonFraction> million as of December 31, 2022. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Stock </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On December 23, 2022, all outstanding shares of redeemable convertible preferred stock were converted into shares of common stock on a <ix:nonNumeric name="us-gaap:PreferredStockConversionBasis" contextRef="P12_23_2022To12_23_2022">one-to-one</ix:nonNumeric> basis. Accordingly, <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> shares of preferred stock were outstanding as of December 31, 2022. On December 23, 2022 the Company amended and restated its certificate of incorporation to provide for, among other things, the Company&#8217;s authorized capital stock to consist of <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_23_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">369,950,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_23_2022" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share and <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_23_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">200,000,000</ix:nonFraction> share of preferred stock, par value $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_23_2022" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Series Seed Financing </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In August 2018, the company entered into a Series Seed Preferred Stock Purchase Agreement (the &#8220;Series Seed Agreement&#8221;) for the issuance of <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn08_14_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">7,546</ix:nonFraction> shares of Series Seed and <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn08_14_2018_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,393</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-1.</div> The Company completed its initial Series Seed closing on August&#160;14, 2018, by issuing a total of <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn08_14_2018_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,666</ix:nonFraction> shares on this date at a purchase price of approximately $<ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn08_14_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">300.00</ix:nonFraction> per share (the &#8220;Series Seed Share Price&#8221;). Between August 2018 and December 2018, the Company issued additional shares of Series Seed in a series of subsequent closings total of <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P08_14_2018To12_31_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">5,880</ix:nonFraction> shares and an additional <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P08_14_2018To12_31_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,393</ix:nonFraction> shares related from the conversion of the Company&#8217;s SAFE (combined the &#8220;Series Seed Financing&#8221;). The aggregate gross proceeds from the Series Seed Financing were approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="P08_14_2018To12_31_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction>&#160;million. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Series A Financing </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In July 2021 the Company amended its Certificate of Incorporation (&#8220;COI&#8221;) to authorize the issuance of <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">37,313</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">21,131</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">512,425</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">122,500</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">257,797</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">665,588</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,775,210</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_Seed10MemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">327,218</ix:nonFraction> shares of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10,</div> <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">18,165,136</ix:nonFraction> shares of Series A, and <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn07_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,531,734</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1.</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company executed a Series Seed and Series A Preferred Stock Purchase Agreement (the &#8220;Series Seed and Series A Agreement&#8221;) for the purposes of raising capital in the aggregate amount of up to $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="P07_23_2021To07_23_2021_SeriesSeedAndSeriesAAgreementMemberusgaapTypeOfArrangementAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">33.0</ix:nonFraction>&#160;million by the means of issuance of Series A, Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9,</div> and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10</div> (all Series Seed issuances noted herein are collectively referred to as &#8220;Series Seed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2-10&#8221;).</div> On this date, the Company cancelled $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P07_23_2021To07_23_2021_SeriesAConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.3</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P07_23_2021To07_23_2021_SimpleAgreementsForFutureEquityMemberusgaapTypeOfArrangementAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.9</ix:nonFraction>&#160;million (including principal and interest) of Series A Convertible Notes and SAFEs, respectively, which converted into a total of <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P07_23_2021To07_23_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">13,503</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div> and a total of <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P07_23_2021To07_23_2021_SeriesSeedTwoTenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">19,519</ix:nonFraction> of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2-10,</div></div> respectively. On the date of the Series Seed and Series A Agreement, the Company also cancelled its 2020 Secured Convertible Notes, of which $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P07_23_2021To07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.1</ix:nonFraction>&#160;million (including principal and interest) converted into <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P07_23_2021To07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">24,576</ix:nonFraction> shares of Series A and $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P07_23_2021To07_23_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.0</ix:nonFraction>&#160;million (including principal and interest) converted into <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P07_23_2021To07_23_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1(see</div> Note 11). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company issued <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">14,182</ix:nonFraction> shares of Series A at a purchase price of approximately $<ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">490.50</ix:nonFraction> per share. On August&#160;13, 2021, the Company issued <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn08_13_2021_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">25,189</ix:nonFraction> shares of Series A at a purchase price of approximately $<ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn08_13_2021_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">490.50</ix:nonFraction> per share. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November&#160;24, 2021, the Company amended its Amended and Restated Certificate of Incorporation to increase the number of Series A shares authorized from <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn11_24_2021_MinimumMembersrtRangeAxis_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">9,592,788</ix:nonFraction> to <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn11_24_2021_MaximumMembersrtRangeAxis_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">18,165,136</ix:nonFraction> total shares. As a result, on that date, the Company completed an additional closing of Series A and issued a total of <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn11_24_2021_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">22,756</ix:nonFraction> shares at a purchase price of approximately $<ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn11_24_2021_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">490.50</ix:nonFraction> per share. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The aggregate gross proceeds from the Series A Financing were approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="P01_01_2022To12_31_2022_SeriesAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">30.5</ix:nonFraction>&#160;million. Proceeds from the issuances associated with the cancellation of the convertible notes were equal to the fair value of the convertible notes upon conversion. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-26</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95758473_3" continuedAt="TextSelectionAppend_95758473_4"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758473_4" continuedAt="TextSelectionAppend_95758473_5"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758473_5" continuedAt="TextSelectionAppend_95758473_6"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758473_6" continuedAt="TextSelectionAppend_95758473_7"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Dividends </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The holders of common stock are entitled to receive dividends upon declaration by the Board of Directors. Such dividends <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">are&#160;non-cumulative.</div> As of December&#160;31, 2022 and 2021, <ix:nonFraction name="us-gaap:DividendsPayableCurrentAndNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:DividendsPayableCurrentAndNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> dividends have been declared or distributed to any stockholders. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Liquidation Preferences </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the event of any voluntary or involuntary liquidation event, dissolution or winding up of the Company or deemed liquidation event, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to the stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Rights and Preferences </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">There are no preemptive, redemption or sinking fund provisions applicable to our common stock. The rights, preferences, and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate and issue in the future. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Voting </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The holder of each share of preferred stock is entitled to <ix:nonNumeric name="us-gaap:PreferredStockVotingRights" contextRef="P01_01_2022To12_31_2022">one vote</ix:nonNumeric> for each share of common stock into which such preferred stock is convertible at the time of the vote. With respect to such vote, such holder has full voting rights and powers equal to the voting rights of the holders of common stock. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Redemption </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has classified the preferred stock as temporary equity as the shares have certain&#160;redemption features&#160;that are not solely in the control of the Company. The preferred stock is not currently redeemable because the deemed liquidation provision is considered a substantive condition that is contingent on the event and it is not currently probable that it will become redeemable. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company classifies preferred stock in accordance with ASC 480,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Distinguishing Liabilities from Equity</div></div>, which requires that contingently redeemable securities be classified outside of permanent stockholders&#8217; equity. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Accordingly, the Company has classified all shares and classes of preferred stock as mezzanine equity in the accompanying financial statements as of December&#160;31, 2021. In 2022, the Company&#8217;s preferred stock was converted to common stock on a <ix:nonNumeric name="us-gaap:PreferredStockConversionBasis" contextRef="P01_01_2022To12_31_2022">one-to-one</ix:nonNumeric> share basis. As a result, there is <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> mezzanine equity as of December 31, 2022. </div><ix:nonNumeric name="us-gaap:TemporaryEquityTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757537"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Convertible redeemable preferred stock consisted of the following as of December&#160;31, 2022:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:28%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable<br/>Convertible&#160;Preferred<br/>Stock:</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Authorized</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Outstanding</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price&#160;per&#160;Share</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Carrying&#160;Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation<br/>Preference</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesAStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">13,006,028</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesAStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">490.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesAOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,531,734</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesAOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">393.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesATwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">173,135,395</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesATwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">47.67</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,133,701</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">300.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">359,375</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">210.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">60.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">37,313</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">100.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">21,131</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">177.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">512,425</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">283.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">122,500</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">300.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">257,797</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">355.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">665,588</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">417.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,754,796</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">393.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">20,414</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">393.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">327,218</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2022_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">490.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total redeemable convertible preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">194,135,415</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-27</ix:exclude> </div></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_95757537" continuedAt="TextSelectionAppend_95757537_1"><ix:continuation id="TextSelectionAppend_95758473_7" continuedAt="TextSelectionAppend_95758473_8"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758473_8" continuedAt="TextSelectionAppend_95758473_9"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758473_9" continuedAt="TextSelectionAppend_95758473_10"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758473_10"><ix:continuation id="TextSelectionAppend_95757537_1"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Convertible redeemable preferred stock consisted of the following as December&#160;31, 2021: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:26%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable<br/>Convertible Preferred<br/>Stock:</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Authorized</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Outstanding</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price&#160;per&#160;Share</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Carrying&#160;Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation<br/>Preference</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">18,165,136</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">86,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">490.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,535</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">53,162</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,531,734</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">393.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,013</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,133,701</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">7,546</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">300.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,267</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,267</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">359,375</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,393</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">210.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">719</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">503</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,666</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">60.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">160</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">100</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">37,313</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">248</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">100.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">21,131</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">140</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">177.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">512,425</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,414</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">283.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">425</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">968</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">122,500</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">815</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">300.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">104</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">245</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">257,797</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,716</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">355.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">235</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">611</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">665,588</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">4,410</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">417.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">659</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,850</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,754,796</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">18,344</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">393.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,644</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,218</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">20,414</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">136</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">393.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">20</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">53</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">327,218</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,171</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">490.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">321</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,070</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total redeemable convertible preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">26,159,128</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">139,910</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">29,733</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">72,110</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:continuation></ix:continuation><ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757121"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">17. Equity-Based Compensation </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">2020 Equity Incentive Plan </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2020, the Board of Directors approved the establishment of the 2020 Plan to provide stock award grants to employees, directors, and consultants of the Company. The Board of Directors, or at its sole discretion, a committee of the Board of Directors, is responsible for the administration of the 2020 Plan. As of December 2021, the Board of Directors has authorized the issuance of up to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,000,000</ix:nonFraction> shares of common stock for stock award grants, including incentive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and&#160;non-qualified&#160;stock</div> options; restricted stock; or stock appreciation rights. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2020 Plan requires that the per share exercise price of each stock option shall not be less than <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" contextRef="P12_31_2020To12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the fair market value of the common stock subject to the stock option on the grant date. Stock option grants shall not be exercisable after the expiration of <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="P12_31_2020To12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">10</ix:nonNumeric> years from the date of its grant or such shorter period as specified in a stock award agreement. The Board of Directors shall determine the terms of vesting. The 2020 Plan provides that the Board of Directors may, in its sole discretion, impose such limitations on transferability of stock options as the Board of Directors shall determine. In the absence of a determination by the Board of Directors to the contrary, stock options shall not be transferable except by will or by the laws of descent and distribution and domestic relations orders, unless specifically agreed to by the plan administrator. </div><ix:nonNumeric name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Presented below is a summary of the compensation cost recognized in the consolidated statements of operations for the years ended December 31, 2022 and 2021. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:56%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,765</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">112</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">286</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2021To12_31_2021_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">31</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,297</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2021To12_31_2021_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,021</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,348</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,164</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock Options </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2020 Plan allows for the early exercise of stock options. Stock options exercised prior to vesting will continue to vest according to the respective option agreement. Shares purchased pursuant to the early exercise of stock options are subject to repurchase until those shares vest; therefore, cash received in exchange for unvested shares exercised is recorded as a liability on the accompanying consolidated balance sheets and are reclassified to common stock and additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital as the shares vest. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-28</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757121" continuedAt="TextSelectionAppend_95757121_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757121_1" continuedAt="TextSelectionAppend_95757121_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757121_2" continuedAt="TextSelectionAppend_95757121_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757121_3" continuedAt="TextSelectionAppend_95757121_4"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the fiscal year ended December&#160;31, 2022 and 2021, the Company granted options to purchase <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">439,786</ix:nonFraction> and <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P01_01_2021To12_31_2021_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">45,394</ix:nonFraction> shares under the 2020 Plan, respectively. The Company has not granted any restricted stock or stock appreciation rights. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, the Company enacted a restructuring cost savings initiative which resulted in employee terminations. In association with the restructuring, the Company accelerated the vesting of a number of individual option awards, resulting in the accelerated vesting of <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" contextRef="P12_31_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">42,934</ix:nonFraction> shares on the date of modification. This was accounted for as an equity award modification under ASC Topic 718 which resulted in adjustment of the award value to reflect the fair value at the modification date and acceleration of the recognition schedule. </div><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following summary sets forth the stock option activity under the 2020 Plan:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:41%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/>options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>remaining<br/>contractual term<br/>(in years)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/>intrinsic&#160;value<br/>(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2021</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">51,149</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">20.34</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">9.7</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="PAsOn12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,953</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">439,786</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">1.66</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">7,784</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">2.75</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">271</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options cancelled</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">36,310</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">19.78</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">446,841</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">2.30</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">9.6</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,706</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">145,713</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">3.53</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">9.6</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,638</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">266,993</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">2.07</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="trnr:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">9.6</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,058</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The aggregate intrinsic value of options outstanding, exercisable and unvested were calculated as the difference between the exercise price of the options and the estimated fair market value of the Company&#8217;s common stock, as of December&#160;31, 2022 and 2021. </div><ix:nonNumeric name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:69%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Early Option Exercises</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/>Options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>Average<br/>Exercise<br/>Price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Repurchase</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liability</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock &#8212; December&#160;31, 2021</div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="PAsOn12_31_2021_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,134</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="PAsOn12_31_2021_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" contextRef="PAsOn12_31_2021_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">88</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issued</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">6,057</ix:nonFraction>&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">7.48</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">794</ix:nonFraction>)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">7.17</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repurchased</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">(<ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,574</ix:nonFraction>)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock &#8212; December&#160;31, 2022</div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,823</ix:nonFraction>&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">306</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the years ended December&#160;31, 2022 and 2021, the weighted-average grant date fair value per option was $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">27.17</ix:nonFraction> and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.21</ix:nonFraction>, respectively. <ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757125">The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: </ix:nonNumeric></div><ix:continuation id="TextSelection_95757125"><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:96%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">3.3</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">1.2</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected term (in years)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="P01_01_2022To12_31_2022" format="ixt-sec:duryear">5.35</ix:nonNumeric>&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:duryear">5.50</ix:nonNumeric>&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected volatility</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">54.6</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">43.1</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:fixed-zero">&#8212;</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:fixed-zero">&#8212;</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Based on U.S. Treasury&#160;seven-year&#160;constant maturity interest rate whose term is consistent with the expected term of the option. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#8217;s stage of development. </div></td></tr></table></ix:continuation><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-29</ix:exclude> </div></ix:continuation></div></div></div><ix:continuation id="TextSelectionAppend_95757121_4" continuedAt="TextSelectionAppend_95757121_5"><div></div></ix:continuation></div><ix:continuation id="TextSelectionAppend_95757121_5" continuedAt="TextSelectionAppend_95757121_6"><div><div style="line-height:normal;background-color:white;display: inline;"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></div></div></ix:continuation></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757121_6"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">With respect to the 2020 Plan, the Company recognized stock compensation expense of $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.3</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction> for the fiscal years ended December&#160;31, 2022 and 2021, respectively. As of December 31, 2022 and 2021, the Company had $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.9</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="PAsOn12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction> million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of <ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">1.6</ix:nonNumeric> years and <ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">1.7</ix:nonNumeric> years, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrants Issued to Nonemployees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company issued a total of <ix:nonFraction name="trnr:WarrantsIssuedDuringThePeriodShares" contextRef="P07_23_2021To07_23_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">4,000</ix:nonFraction> warrants to purchase Class&#160;B Common Stock to various nonemployees as compensation for services rendered. Each warrant has a strike price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn07_23_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share and has a seven-year term from the date of issuance. Each warrant had a grant date fair value of $<ix:nonFraction name="trnr:WarrantGrantDateFairValue" contextRef="PAsOn07_23_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">55.50</ix:nonFraction> for an aggregate fair value of $<ix:nonFraction name="trnr:FairValueOfWarrants" contextRef="P07_23_2021To07_23_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million, which was recorded as a general and administrative expense within the Statement of Operations. Each warrant was fully vested at issuance and are subject to the guidance under ASC 718, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Compensation-Stock Compensation</div></div>. The warrants meet the criteria for permanent equity classification. </div></ix:continuation><ix:nonNumeric name="us-gaap:ConcentrationRiskDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">18. Concentration of Credit Risk and Major Customers and Vendors </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company&#8217;s cash and cash equivalents are maintained with high-quality financial institutions, the compositions and maturities of which are regularly monitored by management. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the years ended December&#160;31, 2022 and 2021, there were <ix:nonFraction name="trnr:NumberOfCustomer" contextRef="P01_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_Customer" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="trnr:NumberOfCustomer" contextRef="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_Customer" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> customers representing greater than <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company had <ix:nonFraction name="trnr:NumberOfSignificantVendors" contextRef="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" unitRef="Unit_Vendor" decimals="0" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction> vendors and <ix:nonFraction name="trnr:NumberOfSignificantVendors" contextRef="P01_01_2021To12_31_2021_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorOneMembersrtMajorCustomersAxis" unitRef="Unit_Vendor" decimals="0" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> vendor representing greater than <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2021To12_31_2021_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction></ix:nonFraction>% of total finished goods purchases for the years ended December&#160;31, 2022 and 2021, respectively. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">19. Benefit Plans </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company established a defined contribution savings plan under Section&#160;401(k) of the Internal Revenue Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a&#160;pre-tax&#160;basis.</div> Matching contributions to the plan may be made at the discretion of the Company&#8217;s board of directors. During the years ended December&#160;31, 2022 and 2021, the Company made contributions of $<ix:nonFraction name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">0</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction>&#160;million, respectively, to the plan. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757349"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">20. Income Taxes </div></div><ix:nonNumeric name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The components of loss before income taxes are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">56,817</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">31,746</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,408</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,090</ix:nonFraction>)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from operations before income taxes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,836</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-30</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757349" continuedAt="TextSelectionAppend_95757349_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757349_1" continuedAt="TextSelectionAppend_95757349_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757349_2" continuedAt="TextSelectionAppend_95757349_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757349_3" continuedAt="TextSelectionAppend_95757349_4"><ix:nonNumeric name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The components of income tax (benefit) expense are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:67%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><ix:nonNumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:73%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="14" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal statutory rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">12,228</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">21.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">6,879</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">21.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nondeductible expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">78</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.13</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">192</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">0.60</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nontaxable changes in fair value of convertible notes and SAFEs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">123</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.21</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,038</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.22</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,670</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.59</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">674</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">2.06</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State taxes, net of federal benefit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,865</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.20</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,705</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">5.20</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign tax rate differential</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">28</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">0.05</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">0.03</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">190</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.33</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,567</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">26.73</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,093</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">30.81</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Disqualified debt</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IncometaxreconciliationDisqualifiedDebt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">731</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="trnr:EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">1.26</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IncometaxreconciliationDisqualifiedDebt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Return to provision adjustements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,060</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">1.82</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangibles</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IncometaxreconciliationIntangibles" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,281</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="trnr:EffectiveIncomeTaxRateReconciliationIntangiblesPercent" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">2.20</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IncometaxreconciliationIntangibles" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:EffectiveIncomeTaxRateReconciliationIntangiblesPercent" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock based compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">615</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">1.06</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal">0.01</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.04</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The primary differences from the U.S. statutory rate and the Company&#8217;s effective tax rate for the year ended December&#160;31, 2022 are due to the change in valuation allowance, federal net operating loss true ups, and State taxes, net of Federal benefit. The primary differences from the U.S. statutory rate and the Company&#8217;s effective tax rate for the year ended December&#160;31, 2021 were due to the change in valuation allowance, share based compensation including excess tax benefits, state and international taxes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On August&#160;16, 2022, the Inflation Reduction Act was signed into law in the United States. Among other provisions, the Inflation Reduction Act includes a <ix:nonFraction name="trnr:MinimumTaxOnBookIncomeInflationReductionActPercent" contextRef="PAsOn08_16_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">15</ix:nonFraction>% minimum tax rate applied to corporations with profits in excess of $<ix:nonFraction name="trnr:MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" contextRef="PAsOn08_16_2022" unitRef="Unit_USD" decimals="-9" scale="9" format="ixt:num-dot-decimal">1</ix:nonFraction>&#160;billion and also includes an excise tax on the repurchase of corporate stock. The Company has reviewed the provisions of the law and does not believe that any of the provisions will have a material impact on the business. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On March&#160;11, 2021, the American Rescue Plan was enacted, which extends the period companies can claim an Employee Retention Credit, expands the IRC Section 162(m) limit on deductions for publicly traded companies, and repeals the election that allows US affiliate groups to allocate interest expense on a worldwide basis, among other provisions. The Company reviewed the provisions of the law and determined it had no material impact for the year ended December&#160;31, 2021. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On December&#160;21, 2020, Congress passed the Consolidated Appropriations Act, 2021. The act includes the Taxpayer Certainty and Disaster Tax Relief Act of 2020 and the COVID-related Tax Relief Act of 2020, both of which extend many credits and other COVID-19 relief, among other extensions. The Company evaluated the provisions of the Consolidated Appropriations Act, including but not limited to the Employee Retention Credit extension, the extension for the IRC Section 45S credit for paid family and medical leave, and the provision allowing a full deduction for certain business meals, and determined that there was no material impact for the year ended December&#160;31, 2022. </div><ix:exclude><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-31 </div></ix:exclude></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95757349_4" continuedAt="TextSelectionAppend_95757349_5"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757349_5" continuedAt="TextSelectionAppend_95757349_6"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757349_6" continuedAt="TextSelectionAppend_95757349_7"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757349_7" continuedAt="TextSelectionAppend_95757349_8"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022 and December&#160;31, 2021, the Company&#8217;s deferred tax assets were primarily the result of U.S. federal and state net operating losses (&#8220;NOLs&#8221;). A valuation allowance was maintained and/or established in substantially all jurisdictions on the Company&#8217;s gross deferred tax asset balances as of December&#160;31, 2022 and 2021. As of each reporting date, the Company&#8217;s management considers new evidence, both positive and negative, that could impact management&#8217;s view with regard to future realization of deferred tax assets. The realization of deferred tax assets was based on the evaluation of current and estimated future profitability of the operations, reversal of deferred tax liabilities and the likelihood of utilizing tax credit and/or loss carryforwards. As of December&#160;31, 2022 and December&#160;31, 2021, the Company continued to maintain that it is not at the more likely than not standard, wherein deferred taxes will be realized due to the recent history of losses and management&#8217;s expectation of continued tax losses. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. <ix:nonNumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757345">Significant components of the Company&#8217;s deferred tax assets (liabilities) are as follows: </ix:nonNumeric></div><ix:continuation id="TextSelection_95757345"><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:65%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;(in thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - Federal</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,776</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,760</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:DeferredTaxAssetsCapitalizedResearchAndDevelopment" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,768</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:DeferredTaxAssetsCapitalizedResearchAndDevelopment" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,593</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">923</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - State</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,752</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,260</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - Foreign</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,894</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,846</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,219</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets and intangibles</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:DeferredTaxAssetsFixedAssetsAndIntangibles" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">868</ix:nonFraction>)&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:DeferredTaxAssetsFixedAssetsAndIntangibles" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax assets, gross:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,134</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14,789</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,134</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14,789</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets, net:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:continuation><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, the Company had federal NOLs of approximately $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">79.9</ix:nonFraction>&#160;million, substantially all of which will be carried forward indefinitely. As of December&#160;31, 2022, the Company had state NOLs of approximately $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">75.8</ix:nonFraction>&#160;million, which will begin to expire in <div style="display:inline;"><span style="-sec-ix-hidden:hidden95757939">2029</span></div>. As of December&#160;31, 2022, the Company had foreign NOLs of approximately $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="PAsOn12_31_2022_ForeignCountryMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million, generated primarily from its operations in the United Kingdom, which will be carried forward indefinitely. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, the Company also has federal and state tax credits of $<ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" contextRef="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.6</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" contextRef="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.5</ix:nonFraction>&#160;million, respectively, which being to expire in <div style="display:inline;"><span style="-sec-ix-hidden:hidden95757488">2040</span></div> for the federal tax credit and <div style="display:inline;"><span style="-sec-ix-hidden:hidden95757489">2035</span></div> for the state tax credits. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, the Company did not have material undistributed foreign earnings. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Tax Cuts and Jobs Act (TCJA) resulted in significant changes to the treatment of research and developmental (R&amp;D) expenditures under Section&#160;174. For tax years beginning after December&#160;31, 2021, taxpayers are required to capitalize and amortize all R&amp;D expenditures that are paid or incurred in connection with their trade or business. Specifically, costs for U.S.-based R&amp;D activities must be amortized over <ix:nonNumeric name="trnr:AmortisationOfResearchAndDevelopmentalCost" contextRef="P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" format="ixt-sec:durwordsen">five years</ix:nonNumeric> and costs for foreign R&amp;D activities must be amortized over <ix:nonNumeric name="trnr:AmortisationOfResearchAndDevelopmentalCost" contextRef="P01_01_2022To12_31_2022_ForeignCountryMemberusgaapIncomeTaxAuthorityAxis" format="ixt-sec:duryear">15</ix:nonNumeric> years&#8212;both using a midyear convention. During the year ended December&#160;31, 2022, the Company capitalized $<ix:nonFraction name="trnr:CapitalizedResearchAndDevelopmentExpenses" contextRef="P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">18.2</ix:nonFraction>&#160;million of domestic R&amp;D expenses. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"><ix:nonNumeric name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" contextRef="P01_01_2022To12_31_2022">Section&#160;382 of the Internal Revenue Code and similar provisions under state law limit the utilization of federal NOL carryforwards, state NOL carryforwards, and Research and Development (R&amp;D) credits following certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of <div style="display:inline;"><ix:nonFraction name="trnr:OperatingLossCarryForwardsPercentage" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">50</ix:nonFraction></div>%. Based on the Company&#8217;s analysis under Section&#160;382, the Company believes that its federal NOL carryforwards, its state NOL carryforwards, and R&amp;D credits are limited by Section&#160;382 and similar provisions under state law as of December&#160;31, 2022. The portion of federal NOL carryforwards, state NOL carryforwards, and R&amp;D credits that were determined to be limited have been written off as of December&#160;31, 2022. The remaining unused carryforwards and credits remain available for future periods. Due the Company&#8217;s full valuation allowance the write off of NOL carryforwards and R&amp;D did not have any impact to the statements of operation and comprehensive loss.</ix:nonNumeric> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-32</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95757349_8" continuedAt="TextSelectionAppend_95757349_9"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757349_9" continuedAt="TextSelectionAppend_95757349_10"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757349_10" continuedAt="TextSelectionAppend_95757349_11"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"><ix:continuation id="TextSelectionAppend_95757349_11">The Company is subject to taxation in the United States, various state and local jurisdictions, as well as foreign jurisdictions where the Company conducts business. Accordingly, on a continuing basis, the Company cooperates with taxing authorities for the various jurisdictions in which it conducts business to comply with audits and inquiries for tax periods that are open to examination. The tax years ended from December&#160;31, 2019 and 2018 and later remain open to examination by tax authorities in the United States and United Kingdom, respectively.</ix:continuation> </div><ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">21. Loss Per Share </div></div><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The computation of loss per share is as follows:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:58%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="trnr:NetLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction>)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="trnr:NetLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,840</ix:nonFraction>)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss attributable to common stockholders</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">58,225</ix:nonFraction>)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">32,840</ix:nonFraction>)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common stock outstanding - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">487,276</ix:nonFraction></ix:nonFraction>&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">98,823</ix:nonFraction></ix:nonFraction>&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share attributable to common stockholders - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">119.49</ix:nonFraction></ix:nonFraction>)&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">332.31</ix:nonFraction></ix:nonFraction>)&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:70%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">86,703</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">7,546</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 1 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,393</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 2 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,666</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 3 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">248</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 4 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">140</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 5 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,414</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 6 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">815</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 7 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,716</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 8 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">4,410</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 9 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">18,480</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 10 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,171</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;A common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_WarrantsToPurchaseSeriesClassACommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_WarrantsToPurchaseSeriesClassACommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;B common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">5,753</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">5,753</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options to purchase common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">446,841</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">51,149</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">544,890</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">196,812</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95757042"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">22. Related Party Transactions </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the ordinary course of business, we may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal stockholders (commonly referred to as &#8220;related parties&#8221;). </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Founder Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has noninterest bearing promissory notes, of which $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn12_31_2021_PromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn12_31_2022_PromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.08</ix:nonFraction></ix:nonFraction> million was outstanding as of December&#160;31, 2022 and December 31, 2021. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-33</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757042" continuedAt="TextSelectionAppend_95757042_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757042_1" continuedAt="TextSelectionAppend_95757042_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757042_2" continuedAt="TextSelectionAppend_95757042_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757042_3" continuedAt="TextSelectionAppend_95757042_4"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Principal Stockholder Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2019, 2020, and 2021 the Company entered into the following promissory notes with a principal stockholder of the Company: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On May&#160;17, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">2.5</ix:nonFraction>% per annum and maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">May 17, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">7.5</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On August&#160;28, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">August 28, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On November&#160;28, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">August 28, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On March 20, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">March 20, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;12, 2021, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 12, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, all principal stockholder promissory notes were outstanding and included within the loan payable on the Consolidated Balance Sheet for a total of $<ix:nonFraction name="us-gaap:NotesAndLoansPayable" contextRef="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.5</ix:nonFraction> million, including accrued interest and default interest of $<ix:nonFraction name="trnr:AccruedInterestAndDefaultInterest" contextRef="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction>&#160;million. As the 2019, 2020, and 2021 notes were not paid upon maturity, these loans were in default as of year end. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the consolidated statement of operations was $<ix:nonFraction name="trnr:InterestExpenseAndDefaultInterest" contextRef="P01_01_2022To12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction>&#160;million during the twelve months ended December&#160;31, 2022. On September&#160;30, 2022, the principal officer and certain related parties waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#8217;s assets. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Other Related Party Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2019, 2020, 2021, and 2022, the Company entered into the following promissory notes with other related parties: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On September 30, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">September 30, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million. This loan remains outstanding for interest in the amount of $<ix:nonFraction name="trnr:DefaultInterest" contextRef="P09_30_2019To09_30_2019" unitRef="Unit_USD" decimals="-4" scale="6">.08</ix:nonFraction> million. Upon default, on the September 30, 2019, loan the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#8217;s assets. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-34</ix:exclude> </div></ix:continuation></div></div></div><ix:continuation id="TextSelectionAppend_95757042_4" continuedAt="TextSelectionAppend_95757042_5"><div></div></ix:continuation></div><div><div style="line-height:normal;background-color:white;display: inline;"><ix:continuation id="TextSelectionAppend_95757042_5" continuedAt="TextSelectionAppend_95757042_6"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757042_6" continuedAt="TextSelectionAppend_95757042_7"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757042_7" continuedAt="TextSelectionAppend_95757042_8"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757042_8" continuedAt="TextSelectionAppend_95757042_9">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On October&#160;21, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">October 21, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;18, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">February 18, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On June&#160;9, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">75,000</ix:nonFraction> note was entered into by the Company from the president and co-founder of the Company. This note has interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 9, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. The principal of this loan has been paid as of December 31, 2022. However, the loan remains outstanding for interest accrued throughout the term. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On June&#160;15, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">7.5</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 15, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million. The principal of this loan was paid as of December&#160;31, 2022 and remains outstanding for interest in the amount of $<ix:nonFraction name="us-gaap:NotesAndLoansPayable" contextRef="PAsOn06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.01</ix:nonFraction>&#160;million. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.5</ix:nonFraction>%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#8217;s assets. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On November&#160;2, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">50,000</ix:nonFraction> note was entered into by the Company from to the president and co-founder of the Company. This note has interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 2, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. The principal of this loan has been paid as of December 31, 2022. However, the loan remains outstanding for interest accrued throughout the term. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On January&#160;12, 2021, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 12, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;22, 2021, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">40,000</ix:nonFraction> note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 22, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On October&#160;27, 2022, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">425,000</ix:nonFraction> note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">January 27, 2023</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#8217;s assets. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-35</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95757042_9" continuedAt="TextSelectionAppend_95757042_10"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757042_10" continuedAt="TextSelectionAppend_95757042_11"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757042_11" continuedAt="TextSelectionAppend_95757042_12"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757042_12"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, all other related party promissory notes were outstanding and included within the loan payable on the Consolidated Balance Sheet for a total of $<ix:nonFraction name="us-gaap:NotesAndLoansPayable" contextRef="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction> million, including accrued interest and default interest of $<ix:nonFraction name="trnr:AccruedInterestAndDefaultInterest" contextRef="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction>&#160;million. All notes, except the October&#160;27, 2022 note, were not paid upon maturity. These loans were in default as of period end due to outstanding interest. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the consolidated statement of operations was $<ix:nonFraction name="trnr:InterestExpenseAndDefaultInterest" contextRef="P01_01_2022To12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million during the twelve months ending December&#160;31, 2022. On September&#160;30, 2022, related parties waived their rights to remedy in the event of default, which in effect releases the Company from the obligation of the incremental interest and fees, as well as the lender from their lien on and security interest in the Company&#8217;s assets. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2022, multiple of the loans above with maturity dates in 2022 remained unpaid as of the maturity date. On September&#160;30, 2022, those lenders waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. Currently, the Company is renegotiating the terms of the loans. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the twelve months ending December&#160;31, 2022 and 2021, the Company repaid $<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="P01_01_2022To12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="P01_01_2021To12_31_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.9</ix:nonFraction>&#160;million of its related party loans. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2016, the Company entered into an agreement with Fuseproject, a design firm that designed the Company&#8217;s main product, its fitness mirror. As of December&#160;31, 2022 and 2021, the Company had incurred $<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn12_31_2021_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction>&#160;million, respectively, of expenses for design services provided by Fuseproject. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, the principal stockholder associated with Fuseproject referenced above owned <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">7,499</ix:nonFraction> of the Company&#8217;s Class&#160;A common shares and <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2022To12_31_2022_ClassBCommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,833</ix:nonFraction> of the Company&#8217;s Class&#160;B common warrants. As of December&#160;31, 2022, the principal stockholder also owned <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">28,666</ix:nonFraction> shares of the Company&#8217;s Class&#160;B common shares, with fully diluted ownership of <ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="P01_01_2022To12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">1.26</ix:nonFraction>% and <ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="P01_01_2021To12_31_2021_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">2.17</ix:nonFraction> % as of December&#160;31, 2022 and 2021, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2022, the Company entered into an agreement with Apeiron Advisory Ltd for promotion of the Company, participation in industry conferences, and ongoing structural advice and consulting. As of December&#160;31, 2022 and 2021, the Company has incurred $<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction>&#160;million and $ <ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.0</ix:nonFraction>&#160;million, respectively, of expenses for such services provided by Apeiron Advisory Ltd. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022 and 2021, Apeiron Investment Group Ltd owned <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">447,318</ix:nonFraction> and <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">11,520</ix:nonFraction> shares of the Company&#8217;s Class&#160;A common shares, <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction> and <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">9,925</ix:nonFraction> shares of the Company&#8217;s Series A preferred shares, and <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">24,143</ix:nonFraction> and <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction> of the Company&#8217;s Class&#160;A common warrants, respectively, with fully diluted ownership of <ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">15.60</ix:nonFraction>% and <ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">5.00</ix:nonFraction>%, respectively. </div></ix:continuation><ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_95759018"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">23. Subsequent Events </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has evaluated subsequent events through the financial statement issuance date, March&#160;29, 2023, pursuant to ASC 855-10 <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Subsequent Events.</div></div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, January 2023 and February 2023, the Company issued <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">9,749,439</ix:nonFraction> shares of Class&#160;A common stock (of which <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,072,438</ix:nonFraction> were issued in December 2022 and <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">8,677,001</ix:nonFraction> were issued in January and February&#160;2023) pursuant to a rights offering involving the sale of Class&#160;A common stock to all existing accredited investors as of December&#160;19, 2022 at a price equal to approximately $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.51</ix:nonFraction> per share. Each accredited investor received the right to elect to purchase shares of Class A common stock in the rights offering up to their respective pro rata amount, which was equal to the product of (x)&#160;$<ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction>, multiplied by (y)&#160;the quotient obtained by dividing (a) the number of shares of the Company&#8217;s capital stock held by the accredited investor as of December&#160;19, 2022 including any common stock issuable on the exercise of warrants or options held by such accredited investor as of December&#160;19, 2022, by (b) the Company&#8217;s fully-diluted capitalization as of December&#160;19, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, the Company issued warrants to four accredited investors in consideration for services rendered, which warrants are exercisable for a total number of shares of the Company&#8217;s common stock that is determined by dividing $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">400,000</ix:nonFraction> by (x)&#160;the price per share of the Company&#8217;s next bona fide equity financing with total proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction> or (y)&#160;the offering price per share in the Company&#8217;s contemplated initial public offering price, whichever event occurs first, for an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share, in whole or in part. The warrants may also be net exercised upon election. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On February&#160;27, 2023, the Company filed an Amended and Restated Certificate of Incorporation of Interactive Strength Inc., which converted all issued shares of Class A Common Stock and Class B Common Stock into shares of Common Stock on a <ix:nonNumeric name="us-gaap:CommonStockConversionBasis" contextRef="P02_27_2023To02_27_2023_ClassACommonStockToClassBCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">one to one basis</ix:nonNumeric>. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-36</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95759018" continuedAt="TextSelectionAppend_95759018_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759018_1" continuedAt="TextSelectionAppend_95759018_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95759018_2" continuedAt="TextSelectionAppend_95759018_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95759018_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On March&#160;6, 2023, the Company entered into a Termination Agreement with a third-party content provider (&#8220;Content Provider&#8221;) to terminate a service agreement and collaboration agreement previously entered into in 2021. The Company made a payment of $<ix:nonFraction name="us-gaap:PaymentsForRestructuring" contextRef="P02_13_2022To02_13_2022_ContractTerminationMemberusgaapRestructuringCostAndReserveAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million to the Content Provider on February&#160;13, 2022 and has no further obligations to the Content Provider. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, the Company issued an aggregate of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="P03_01_2023To03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction>&#160;million of senior secured notes to three investors, including one related party, with associated warrants to purchase the Company&#8217;s common stock at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction>, in lieu of future cash interest payments under the senior secured notes issued to such investors. </div></ix:continuation><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-37 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_7" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONDENSED CONSOLIDATED BALANCE SHEETS </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(unaudited) </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(In thousands, except share and per share amounts) </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:62%"></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">226</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable, net of allowances</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,443</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,567</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DepositsAssetsCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,280</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DepositsAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,603</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">962</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,426</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,722</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,822</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">583</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,326</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use-assets</div></div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">296</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">110</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,866</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,834</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term inventories, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryNoncurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,121</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredCosts" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,337</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,683</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,018</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,271</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">24,447</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities and stockholders&#8217; equity</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,921</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,743</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,951</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,304</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liability, current portion</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">53</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">106</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">66</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">29</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,266</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,708</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior secured notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,038</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,270</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,302</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">24,167</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liability, net of current portion</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">243</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrant liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,004</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,545</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">27,180</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commitments and contingencies (Note 13)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Stockholders&#8217; equity</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn09_30_2023" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn09_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">900,000,000</ix:nonFraction> and <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">369,950,000</ix:nonFraction> shares authorized as of September&#160;30, 2023 and December&#160;31, 2022, respectively; <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn09_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn09_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">14,178,514</ix:nonFraction></ix:nonFraction> and <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,450,922</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of September&#160;30, 2023 and December&#160;31, 2022, respectively.</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">154,942</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">112,436</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated other comprehensive income</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">286</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">365</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated deficit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">155,509</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">115,538</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stockholders&#8217; equity (deficit)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">274</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,733</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities and stockholders&#8217; equity (deficit)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,271</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">24,447</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-38 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_8" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(unaudited) </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(In thousands, except share and per share amounts) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:39%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fitness product revenue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FitnessProductRevenue1" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">206</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FitnessProductRevenue1" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">144</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FitnessProductRevenue1" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">502</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FitnessProductRevenue1" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">402</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Membership revenue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:MembershipRevenue1" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">38</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:MembershipRevenue1" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:MembershipRevenue1" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">94</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:MembershipRevenue1" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">53</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Training revenue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TrainingRevenue1" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">62</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TrainingRevenue1" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">32</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TrainingRevenue1" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">183</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TrainingRevenue1" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">32</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">306</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">201</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">779</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">487</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenue:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of fitness product revenue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfFitnessProductRevenue" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">360</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfFitnessProductRevenue" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">764</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfFitnessProductRevenue" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,529</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfFitnessProductRevenue" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,047</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of membership</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfMembership" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">960</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfMembership" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,545</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfMembership" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,861</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfMembership" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,537</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of training</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfTraining" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">109</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfTraining" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">387</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfTraining" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">300</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:CostOfTraining" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,077</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cost of revenue</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,429</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,696</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,690</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,661</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,123</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,495</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3,911</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">6,174</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,357</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,854</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,796</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,284</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">282</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,193</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,473</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,194</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,313</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,131</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,043</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,774</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,952</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,178</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">39,312</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">32,252</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from operations</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,075</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">14,673</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">43,223</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,426</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other income (expense), net:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other income (expense), net</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">179</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">417</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">740</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest (expense)</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">154</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">187</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,382</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">748</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain upon debt forgiveness</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainUponDebtForgiveness" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainUponDebtForgiveness" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">523</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainUponDebtForgiveness" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,595</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainUponDebtForgiveness" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">523</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">252</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.33em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of warrants</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,266</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.67em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other income (expense), net</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">333</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">81</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,252</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">989</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss before provision for income taxes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,408</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">14,754</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,971</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,415</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax expense</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss attributable to common stockholders</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,408</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">14,754</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,971</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,415</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">0.73</ix:nonFraction></ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">30.16</ix:nonFraction></ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">3.40</ix:nonFraction></ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">93.10</ix:nonFraction></ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common stock outstanding&#8212;basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">14,186,222</ix:nonFraction></ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">489,132</ix:nonFraction></ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">11,750,907</ix:nonFraction></ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">423,362</ix:nonFraction></ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:39%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,408</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">14,754</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,971</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,415</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other comprehensive loss:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation (loss) gain</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">172</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">441</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">79</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">931</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total comprehensive loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,236</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">14,313</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">40,050</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,484</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-39 </div></div></div></div><div></div></div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_9" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(unaudited) </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(In thousands, except share amounts) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:6.5pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:19%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series&#160;Seed</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0 - 10</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Series A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;A-2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common&#160;Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-In</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Comprehensive</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Income) Loss</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deficit</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stockholders&#8217;</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Deficit)</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2021</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;<ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">42,999</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,594</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">86,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,535</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">181,362</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">31,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">37,806</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">159</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;$&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">57,313</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">19,663</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P01_01_2022To03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">267,384</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2022To03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,060</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2022To03_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,063</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> preferred stock upon conversion of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">124,313</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,926</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> preferred stock, net of issuance costs of $<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">66</ix:nonFraction></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">631,292</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,028</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;B common stock upon exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P01_01_2022To03_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">501</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2022To03_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">97</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P01_01_2022To03_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">97</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation gain</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2022To03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">167</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2022To03_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">167</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">12,691</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To03_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">12,691</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at March&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn03_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">42,999</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn03_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,594</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn03_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">86,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn03_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,535</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn03_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn03_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">755,605</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">35,954</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">448,746</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn03_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">32,204</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">39,971</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">70,004</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">30,019</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> preferred stock, net of issuance costs of $<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P04_01_2022To06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">27</ix:nonFraction></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" contextRef="P04_01_2022To06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">27</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;B common stock upon exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P04_01_2022To06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P04_01_2022To06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">100</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">100</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation gain</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P04_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">323</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">323</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">11,970</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">11,970</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at June&#160;30, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn06_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">42,999</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn06_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,594</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn06_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">86,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn06_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,535</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn06_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn06_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">755,605</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">35,927</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">448,746</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn06_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">32,204</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">40,073</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">81,974</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">41,564</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;A common stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P07_01_2022To09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">8</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P07_01_2022To09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> preferred stock, net of issuance costs of $<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" contextRef="P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" contextRef="P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">4</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;B common stock upon exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P07_01_2022To09_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">57</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P07_01_2022To09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P07_01_2022To09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,754</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,754</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation gain</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P07_01_2022To09_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">441</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">441</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P07_01_2022To09_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">14,754</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">14,754</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at September&#160;30, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn09_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">42,999</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn09_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,594</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">86,703</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,535</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn09_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn09_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,604</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">755,606</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">35,923</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">448,754</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn09_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">32,261</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">43,830</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">772</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">96,728</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">52,122</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-40 </div></div></div></div><div></div></div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:6.5pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:24%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series&#160;Seed</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">0 - 10</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Series A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;A-2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common&#160;Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-In</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Comprehensive</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Income) Loss</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deficit</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stockholders&#8217;</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Deficit)</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="border-left: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,416,698</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">34,224</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">112,436</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">365</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">115,538</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,733</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Common stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">8,676,924</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,449</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,452</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Common stock upon conversion of Class&#160;A Common Stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,416,698</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="P01_01_2023To03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,416,698</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="P01_01_2023To03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">4</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Class&#160;B common stock upon exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P01_01_2023To03_31_2023_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">646,433</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Common stock upon conversion of Class&#160;B Common Stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">680,657</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="P01_01_2023To03_31_2023_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">680,657</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,057</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,057</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net exercise of options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NetExerciseOfOptions" contextRef="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">323</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NetExerciseOfOptions" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">323</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2023To03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">115</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">115</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2023To03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">15,961</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">15,961</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at March&#160;31, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">11,774,279</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">132,279</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">250</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">131,499</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,037</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial public offering, net of issuance cost of $<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P04_01_2023To06_30_2023_IPOMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction>&#160;million</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,500,000</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,820</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P04_01_2023To06_30_2023_IPOMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,820</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial public offering costs</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:InitialPublicOfferingCosts" contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">4,607</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:InitialPublicOfferingCosts" contextRef="P04_01_2023To06_30_2023_IPOMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">4,607</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Common stock upon conversion of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">565,144</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,521</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,521</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise of stock warrants</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">339,091</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,468</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,468</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,510</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,510</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P04_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">136</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">136</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">13,602</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">13,602</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at June&#160;30, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">14,178,514</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">149,991</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">114</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">145,101</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,011</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P07_01_2023To09_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,951</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,951</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P07_01_2023To09_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">172</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">172</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P07_01_2023To09_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,408</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,408</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 6.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at September&#160;30, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">14,178,514</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">154,942</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">286</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">155,509</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">274</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-41 </div></div></div></div><div></div></div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_10" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(unaudited) </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(In thousands) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows From Operating Activities:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,971</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,415</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Adjustments to reconcile net loss to net cash used in operating activities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">64</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">821</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Depreciation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">743</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">932</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,188</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,735</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-cash</div> lease expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NonCashLeaseExpense" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">66</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NonCashLeaseExpense" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory valuation loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">261</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,106</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">23,773</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,951</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain upon debt forgiveness</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,595</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">523</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">77</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">746</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,305</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">252</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:GainLossOnChangeInFairValueOfConvertibleNotes" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued to service providers</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FairValueAdjustmentOfWarrantsIssuedToServiceProviders" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">442</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FairValueAdjustmentOfWarrantsIssuedToServiceProviders" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,266</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Changes in operating assets and liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">442</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,806</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">464</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">721</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDepositOtherAssets" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">323</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDepositOtherAssets" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">316</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCharges" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCharges" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,123</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IncreaseDecreaseInLongTermInventory" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:IncreaseDecreaseInLongTermInventory" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">313</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">585</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,642</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">780</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,141</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">37</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">4</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">70</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash used in operating activities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">13,561</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">29,492</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows From Investing Activities:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of property and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">501</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Acquisition of internal use software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireSoftware" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">349</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireSoftware" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,744</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Acquisition of software and content</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToDevelopSoftware" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">797</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToDevelopSoftware" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,958</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash used in investing activities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,146</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">8,203</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows From Financing Activities:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of related party loans</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">465</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments of related party loans</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:RepaymentsOfRelatedPartyLoans" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">483</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:RepaymentsOfRelatedPartyLoans" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,178</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of common stock upon initial public offering, net of offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,820</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments of offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,453</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from senior secured notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,030</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments of senior secured notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:PaymentsOfSeniorSecuredNotes" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PaymentsOfSeniorSecuredNotes" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of Preferred Stock&#8212;Series A, net of issuance costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">29,997</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,902</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from the issuance of common stock A</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,247</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from the exercise of common stock options</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayment Bounce Back Loan</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:RepaymentOfBouncebackLoans" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:RepaymentOfBouncebackLoans" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">69</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash provided by financing activities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14,656</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">36,732</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of exchange rate on cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">145</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">74</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net Change In Cash and Cash Equivalents</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">196</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,037</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and restricted cash at beginning of year</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">226</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,697</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and restricted cash at end of year</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">660</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Supplemental Disclosure Of Cash Flow Information:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property&#160;&amp; equipment in AP</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PropertyAndEquipmentInAccountsPayable" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PropertyAndEquipmentInAccountsPayable" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">175</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories in AP and accrued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:InventoriesInAccountsPayableAndAccrued" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">815</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:InventoriesInAccountsPayableAndAccrued" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">783</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A preferred stock in connection with convertible notes payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,926</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs in AP and accrued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:RecognitionOfDeferredAndAccruedOfferingCosts" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,155</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:RecognitionOfDeferredAndAccruedOfferingCosts" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise of stock warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ProceedsFromPaycheckProtectionProgramLoan" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,468</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ProceedsFromPaycheckProtectionProgramLoan" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets obtained in exchange for new operating lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">313</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,521</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decrease in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and operating lease liabilities due to lease termination</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">61</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Common Stock from Rights Offering</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NonCashIssuanceOfCommonStockFromRightsOffering" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">202</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NonCashIssuanceOfCommonStockFromRightsOffering" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net exercise of options</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NonCashExerciseOfOptions" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">323</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:NonCashExerciseOfOptions" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation capitalized in software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:StockBasedCompensationCapitalizedInSoftware" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">745</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:StockBasedCompensationCapitalizedInSoftware" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-42 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin367939_11" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">INTERACTIVE STRENGTH INC. AND SUBSIDIARIES </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </div></div><ix:nonNumeric name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95758466"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">1. Description of Business and Basis of Presentation </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Description and Organization </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Interactive Strength Inc., together with its consolidated subsidiaries doing business as &#8220;Forme&#8221; (&#8220;Forme&#8221; or the &#8220;Company&#8221;), is an interactive home fitness platform that offers an immersive smart home gym with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">life-size</div> touchscreen mirror and accessories. Our Members are defined as any individual who has a Forme account through a paid connected fitness membership. The Company&#8217;s interactive home fitness platform is known as the Studio, for which the Company continues to develop new accessories and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">add-ons</div> to further customize a Member&#8217;s experience (&#8220;Connected Fitness Products&#8221;). Through the Studio, Members can stream immersive, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">instructor-led</div> boutique classes anytime, anywhere. The Company enables Members to get the most out of their wellness journey from their home. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Initial Public Offering </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, the Company closed its initial public offering (&#8220;IPO&#8221;) in which we issued and sold <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction>&#160;million shares of common stock at a public offering price of $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">8.00</ix:nonFraction> per share and excluding shares sold in the IPO by certain of our existing stockholders. Total proceeds, after deducting underwriting commissions of $<ix:nonFraction name="us-gaap:InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction>&#160;million and other offering expenses of $<ix:nonFraction name="us-gaap:DividendsCommonStockStock" contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.6</ix:nonFraction>&#160;million, was $<ix:nonFraction name="us-gaap:DividendsCommonStock" contextRef="P05_31_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.2</ix:nonFraction>&#160;million. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation and Consolidation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). The condensed consolidated financial statements include the accounts of Interactive Strength Inc. and its subsidiaries in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, cash flows, and the changes in equity for the interim period. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity and Going Concern </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Since its inception, the Company has sustained recurring losses and has relied on funding from private investors and other third-parties (collectively &#8220;outside capital&#8221;) to execute the Company&#8217;s growth strategy. As a result, the Company incurred a net loss of $<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">40.0</ix:nonFraction>&#160;million during the nine months ended September&#160;30, 2023 and had an accumulated deficit of $<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">155.5</ix:nonFraction>&#160;million as of September&#160;30, 2023. The Company&#8217;s long-term success is dependent upon its ability to successfully develop, market, and deliver its revenue-generating products and services in a profitable manner. While management believes the Company can be successful in executing its growth strategy, no assurance can be provided it will be able to do so in a timely or profitable manner. As a result, the Company anticipates it will continue to rely on outside capital to fund the Company&#8217;s operations for the foreseeable future. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of the date the accompanying condensed consolidated financial statements were issued (the &#8220;issuance date&#8221;), the Company&#8217;s available liquidity was not sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due, absent the Company&#8217;s ability to secure additional outside capital. While management plans to take action to address the Company&#8217;s liquidity needs, such as cost mitigation initiatives to reduce unnecessary costs, securing additional outside capital, and/or pursuing other strategic arrangements, no assurance can be provided that management&#8217;s actions will be sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, the Company had $<ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="PAsOn09_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction>&#160;million of senior secured notes outstanding with THLWY, LLC (see Note 10). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In addition, as of September&#160;30, 2023, the Company had loans outstanding from certain related parties (See Note 19) with an aggregate principal and interest amount owed of approximately $<ix:nonFraction name="us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.3</ix:nonFraction>&#160;million. All of these loans matured prior to September&#160;30, 2023, but their repayment has been temporarily waived. However, absent additional outside capital, the Company will be unable to repay these loans upon their maturity and, as such, the aggregate amounts owed have been classified as current debt in the accompanying condensed consolidated balance sheet as of September&#160;30, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the event that one or more of management&#8217;s planned actions are not sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due, management will be required to seek other strategic </div><ix:exclude><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-43 </div></ix:exclude></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95758466" continuedAt="TextSelectionAppend_95758466_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758466_1" continuedAt="TextSelectionAppend_95758466_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758466_2" continuedAt="TextSelectionAppend_95758466_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758466_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">alternatives, which may include, among others, a significant curtailment in the Company&#8217;s operations, a sale of certain of the Company&#8217;s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy. These uncertainties raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying condensed consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties. </div></ix:continuation><ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95758464"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">2. Summary of Significant Accounting Policies </div></div><ix:nonNumeric name="us-gaap:ComparabilityOfPriorYearFinancialData" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Interim Financial Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP, for interim financial reporting and as required by Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X,</div> Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-01.</div> The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated annual financial statements for the years ended December&#160;31, 2022 and 2021 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company&#8217;s condensed consolidated balance sheet as of September&#160;30, 2023, the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022, the condensed consolidated statement of redeemable convertible preferred stock and stockholders&#8217; equity (deficit) as of September&#160;30, 2023 and condensed consolidated statements of cash flows for the nine months ended September&#160;30, 2023 and 2022. The financial data and other information disclosed in these notes related to the nine months ended September&#160;30, 2023 and 2022 are unaudited. The results for the nine months ended September&#160;30, 2023, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2023, any other interim periods, or any future year or period. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:UseOfEstimates" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#8220;CODM&#8221;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">at-home</div> fitness technology platform. The Company&#8217;s chief operating decision maker, its chief executive officer, manages the Company&#8217;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of September&#160;30, 2023 and 2022, substantially all of the Company&#8217;s long-lived assets are held in the United States. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cash consists of cash on deposit in banks. </div></ix:nonNumeric><ix:nonNumeric name="trnr:DeferredOfferingCostsPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Offering Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company complies with the requirements of ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1</div></div></div> and SEC Staff Accounting Bulletin Topic 5A &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of Offering&#8221;</div></div>. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. As of September&#160;30, 2023, the Company incurred offering costs amounting to $<ix:nonFraction name="us-gaap:GeneralPartnersOfferingCosts" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.6</ix:nonFraction>&#160;million through the IPO and subsequently classified the costs to additional paid in capital. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-44</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95758464" continuedAt="TextSelectionAppend_95758464_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758464_1" continuedAt="TextSelectionAppend_95758464_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758464_2" continuedAt="TextSelectionAppend_95758464_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758464_3" continuedAt="TextSelectionAppend_95758464_4"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-production</div> tooling which it owns under a supply arrangement. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling, including the related engineering costs the Company will not own or will not use in producing products under long-term supply arrangements, are expensed as incurred. </div><ix:nonNumeric name="trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn09_30_2023_MinimumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis" format="ixt-sec:duryear">2</ix:nonNumeric> &#8211; <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn09_30_2023_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis" format="ixt-sec:duryear">5</ix:nonNumeric> years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn09_30_2023_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis" format="ixt-sec:duryear">2</ix:nonNumeric> &#8211; <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn09_30_2023_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis" format="ixt-sec:duryear">10</ix:nonNumeric> years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn09_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis" format="ixt-sec:duryear">3</ix:nonNumeric> &#8211; <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="PAsOn09_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis" format="ixt-sec:duryear">5</ix:nonNumeric> years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="-sec-ix-hidden:hidden95757150">Lesser of lease term or estimated useful life</span></td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:InventoryPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Inventories, net </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">written-off</div> against the reserve. Inventory not expected to be sold in the next twelve months is classified as long-term in the accompanying condensed, consolidated balance sheets. </div></ix:nonNumeric><ix:nonNumeric name="trnr:VendorDepositPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Vendor Deposits </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#8217;s inventory. In general, the Company&#8217;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#8217;s consolidated balance sheet. </div></ix:nonNumeric><ix:nonNumeric name="trnr:CapitalizedStudioContentPolicytextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Capitalized Studio Content </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Capitalized Studio content costs include certain expenditures to develop video and live content for the Company&#8217;s customers. The Company capitalizes production costs for recorded content in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">926-20,</div> Entertainment-Films - Other Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#8220;obsolescence&#8221; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(3-year)</div> amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $<ix:nonFraction name="us-gaap:CooperativeAdvertisingAmount" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.9</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:CooperativeAdvertisingAmount" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.4</ix:nonFraction>&#160;million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-45</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95758464_4" continuedAt="TextSelectionAppend_95758464_5"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758464_5" continuedAt="TextSelectionAppend_95758464_6"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758464_6" continuedAt="TextSelectionAppend_95758464_7"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758464_7" continuedAt="TextSelectionAppend_95758464_8"><ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Identifiable Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">350-40,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-use</div> Software and ASC 985, Software. These capitalized costs also relate to the Company&#8217;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems. Capitalized software costs are amortized over the estimated useful life is three years. Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is probable the project will be completed, and the software will be used to perform the function intended. Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. The Company expenses all costs incurred that relate to planning and post-implementation phases of development. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment, and <ix:nonFraction name="us-gaap:GoodwillAndIntangibleAssetImpairment" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen">none</ix:nonFraction> were identified in the quarter ended September&#160;30, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the nine months ended September&#160;30, 2023 and the year ended December&#160;31, 2022, the Company capitalized $<ix:nonFraction name="us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" contextRef="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.7</ix:nonFraction>&#160;million, respectively, of internal use software. </div><ix:nonNumeric name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:41%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="width:56%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Internal-use</div> software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;"><ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P01_01_2023To09_30_2023" format="ixt-sec:durwordsen">3 years</ix:nonNumeric></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="trnr:MusicRoyaltyFeesPolicyPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Music Royalty Fees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes music royalty fees as these fees are incurred in accordance with the terms of the relevant license agreement with the music rights holder. The incurrence of such royalties is primarily driven by the number of paid subscribers each month and it is classified as cost of membership and training within the Company&#8217;s statement of operations. The Company&#8217;s license agreements with music rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of September&#160;30, 2023 and December&#160;31, 2022 there were no music guarantee-related prepaids, respectively. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s material financial instruments consist primarily of cash and cash equivalents, accounts payable, accrued expenses, convertible notes, and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these instruments. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95759291"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the </div><ix:exclude><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-46 </div></ix:exclude></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_95759291" continuedAt="TextSelectionAppend_95759291_1"><ix:continuation id="TextSelectionAppend_95758464_8" continuedAt="TextSelectionAppend_95758464_9"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758464_9" continuedAt="TextSelectionAppend_95758464_10"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758464_10" continuedAt="TextSelectionAppend_95758464_11"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758464_11" continuedAt="TextSelectionAppend_95758464_12"><ix:continuation id="TextSelectionAppend_95759291_1"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. </div></ix:continuation><ix:nonNumeric name="trnr:ConvertibleNotesPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the convertible notes were converted into an aggregate of <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="P05_01_2023To05_31_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">565,144</ix:nonFraction> shares of common stock. </div></ix:nonNumeric><ix:nonNumeric name="trnr:WarrantsPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the condensed consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party (the &#8220;acqui-hire transaction&#8221;) that is exercisable for a number of shares of common stock that is determined by dividing $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="P11_01_2022To11_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">225,000</ix:nonFraction> by (x)&#160;the price per share of the next equity financing with total proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="P11_01_2022To11_30_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn11_30_2022" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of <ix:nonFraction name="trnr:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="P11_01_2022To11_30_2022_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">28,124</ix:nonFraction> shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">400,000</ix:nonFraction> by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction> or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn03_31_2023" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of <ix:nonFraction name="trnr:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">49,996</ix:nonFraction> shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to certain existing affiliate and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliate</div> stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with a note financing (the &#8220;Bridge Note Financing&#8221;). Such warrants are exercisable for a number of shares of our common stock that is determined by dividing: (A)&#160;(i) in the case of the warrants issued to the lead noteholder, <ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" contextRef="P01_01_2023To03_31_2023_LeadNoteholderMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">67</ix:nonFraction>% of the aggregate principal amount of notes issued to such lead noteholder and; (ii)&#160;in the case of all other noteholders in the Bridge Note Financing, <ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" contextRef="P01_01_2023To03_31_2023_OtherNoteholderMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">60</ix:nonFraction>% of the aggregate principal amount of notes issued to such other noteholders by (B)&#160;(i) the initial public offering price per share or (ii)&#160;if the initial public offering is not consummated, by either (x)&#160;the price per share offered in a change of control transaction or (y)&#160;if a change of control transaction does not occur, the fair market value of our common stock as determined by an independent appraiser. The warrants may also be net exercised upon election. The value of the warrants of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="PAsOn03_31_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.3</ix:nonFraction>&#160;million was recorded as debt discount on the senior notes of $<ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="P01_01_2023To03_31_2023_SeniorNotesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction>&#160;million. The debt discount was amortized into interest expense over life of the senior notes. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of <ix:nonFraction name="trnr:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="P05_01_2023To05_31_2023_BridgeNoteFinancingMemberusgaapCreditFacilityAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">163,121</ix:nonFraction> shares of common stock. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757628"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes </div><ix:exclude><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-47 </div></ix:exclude></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_95757628" continuedAt="TextSelectionAppend_95757628_1"><ix:continuation id="TextSelectionAppend_95758464_12" continuedAt="TextSelectionAppend_95758464_13"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758464_13" continuedAt="TextSelectionAppend_95758464_14"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758464_14" continuedAt="TextSelectionAppend_95758464_15"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758464_15" continuedAt="TextSelectionAppend_95758464_16"><ix:continuation id="TextSelectionAppend_95757628_1"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">estimates, assumptions, and judgments to determine the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. </div></ix:continuation><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757629"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s condensed consolidated financial statements upon adoption. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) and has elected not to &#8220;opt out&#8221; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time public companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Recently Adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02,</div> Leases (&#8220;Topic 842&#8221;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January&#160;1, 2022. Financial positions for reporting periods beginning on or after January&#160;1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-03,</div> Measurement of Credit Losses on Financial Instruments (&#8220;CECL&#8221;), which amends ASC 326 &#8220;Financial Instruments - Credit Losses&#8221; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#8220;expected loss model&#8221; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January&#160;1, 2022 and the guidance did not have a material impact on our condensed consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>, which amends ASC Topic 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div>. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances, eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#8217;s condensed consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Not Yet Adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> and ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</div></div>. This guidance provides temporary optional expedients and exceptions to accounting </div><ix:exclude><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-48 </div></ix:exclude></ix:nonNumeric></ix:continuation></div></div></div><ix:continuation id="TextSelection_95757629" continuedAt="TextSelectionAppend_95757629_1"><ix:continuation id="TextSelectionAppend_95758464_16" continuedAt="TextSelectionAppend_95758464_17"><div></div></ix:continuation></ix:continuation></div><ix:continuation id="TextSelectionAppend_95757629_1" continuedAt="TextSelectionAppend_95757629_2"><ix:continuation id="TextSelectionAppend_95758464_17" continuedAt="TextSelectionAppend_95758464_18"><div><div style="line-height:normal;background-color:white;display: inline;"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></div></div></ix:continuation></ix:continuation></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758464_18"><ix:continuation id="TextSelectionAppend_95757629_2"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">guidance on contract modifications and hedge accounting to ease entities&#8217; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848)</div></div>, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its condensed consolidated financial statements. </div></ix:continuation></ix:continuation><ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757646"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">3. Revenue Recognition </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s primary source of revenue is solely derived from the United States from sales of its Connected Fitness Products and related accessories and associated recurring Membership revenue, as well as from sales of personal training services recorded within Training revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company determines revenue recognition through the following steps: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Identification of the contract, or contracts, with a customer; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Identification of the performance obligations in the contract; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Determination of the transaction price; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Allocation of the transaction price to the performance obligations in the contract; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Recognition of revenue when, or as, the Company satisfies a performance obligation. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Revenue is recognized when control of the promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company&#8217;s revenue is reported net of sales returns, discounts and incentives as a reduction of the transaction price. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the practical expedient as per ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">606-10-50-14</div></div></div> and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company&#8217;s condensed consolidated statements of operations and comprehensive (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Connected Fitness Products </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Connected Fitness Products include the Company&#8217;s portfolio of Connected Fitness Products and related accessories, delivery and installation services, and extended warranty agreements. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period. The Company allows customers to return products within thirty days of purchase, as stated in its return policy. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amounts paid for payment processing fees for credit card sales for Connected Fitness Products are included as a reduction to fitness product revenue in the Company&#8217;s condensed consolidated statements of operations and comprehensive (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Membership </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s memberships provide unlimited access to content in its library of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on-demand</div> fitness classes. The Company&#8217;s memberships are offered on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">month-to-month</div></div> basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amounts paid for membership fees are included within deferred revenue on the Company&#8217;s condensed consolidated balance sheets and recognized ratably over the membership term. The Company records payment processing fees for its monthly membership charges within cost of membership and training in the Company&#8217;s condensed consolidated statements of operations and comprehensive (loss). </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-49</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757646" continuedAt="TextSelectionAppend_95757646_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757646_1" continuedAt="TextSelectionAppend_95757646_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757646_2" continuedAt="TextSelectionAppend_95757646_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757646_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Training </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s training services are personal training services delivered through the Connected Fitness Products and third-party mobile devices. Training revenue is recognized at the time of delivery. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Standard Product Warranty </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company offers a standard product warranty that its Connected Fitness Products and related accessories will operate under normal, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-commercial</div> use for a period of one year which covers the touchscreen, frame and all incorporated elements, and related accessories from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company also offers the option for customers in some markets to purchase a third-party extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of <ix:nonNumeric name="trnr:ExtendedProductWarrantyPeriod" contextRef="P01_01_2023To09_30_2023_MinimumMembersrtRangeAxis" format="ixt-sec:durmonth">24</ix:nonNumeric> to <ix:nonNumeric name="trnr:ExtendedProductWarrantyPeriod" contextRef="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis" format="ixt-sec:durmonth">48</ix:nonNumeric> months. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For third-party extended warranty service sold along with the Company&#8217;s Connected Fitness Products, the Company does not obtain control of the warranty before transferring it to the customers. Therefore, the Company accounts for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission it retains. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it can establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product. </div></ix:continuation><ix:nonNumeric name="us-gaap:InventoryDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">4. Inventories, net </div></div><ix:nonNumeric name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,443</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,567</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products - LT</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryNoncurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,121</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total inventories, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,564</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,567</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Finished products - LT represents inventory not expected to be sold in the next twelve months. </div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">5. Property and Equipment, net </div></div><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:PreProductionTooling" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,094</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:PreProductionTooling" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,094</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:MachineryAndEquipmentGross" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">125</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:MachineryAndEquipmentGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">125</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">113</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">113</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software and technology development asset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,370</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,370</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,787</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,044</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">583</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,326</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation expense amounted to $<ix:nonFraction name="us-gaap:Depreciation" contextRef="P07_01_2023To09_30_2023_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:Depreciation" contextRef="P07_01_2022To09_30_2022_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million for the three months ended September&#160;30, 2023 and 2022, respectively, and $<ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2023To09_30_2023_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2022To09_30_2022_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-50 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:IntangibleAssetsDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">6. Intangible Assets, net </div></div><ix:nonNumeric name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Identifiable intangible assets, net consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,346</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,480</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,866</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,827</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,993</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,834</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable intangible assets</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,346</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,480</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,866</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,827</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,993</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,834</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization expense amounted to $<ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="P07_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="P07_01_2022To09_30_2022_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction></ix:nonFraction>&#160;million for each of the three months ended September&#160;30, 2023 and 2022, and $<ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="P01_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="P01_01_2022To09_30_2022_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.1</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment. </div><ix:nonNumeric name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, estimated annual amortization expense for each of the next five fiscal years is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="4" style="vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Years Ending December&#160;31,</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="4" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 (remaining)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">530</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,689</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">554</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">93</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,866</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">7. Prepaid Expenses and Other Current Assets </div></div><ix:nonNumeric name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Prepaid expenses and other current assets consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:69%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,<br/> 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security deposit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">66</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">146</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PrepaidLicenses" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">133</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PrepaidLicenses" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">45</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ResearchAndDevelopmentTaxCredit" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">266</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ResearchAndDevelopmentTaxCredit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">750</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other receivables</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">178</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">178</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidInsurance" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">248</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidInsurance" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other prepaid</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">71</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">293</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">962</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,426</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:OtherAssetsDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">8. Other Assets, net </div></div><ix:nonNumeric name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Other assets consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:36%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized content costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsGross" contextRef="PAsOn09_30_2023_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,589</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:AccumulatedAmortizationOfOtherDeferredCosts" contextRef="PAsOn09_30_2023_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,721</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn09_30_2023_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,868</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsGross" contextRef="PAsOn12_31_2022_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,589</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(<ix:nonFraction name="us-gaap:AccumulatedAmortizationOfOtherDeferredCosts" contextRef="PAsOn12_31_2022_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,185</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2022_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,404</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsGross" contextRef="PAsOn09_30_2023_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,370</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedAmortizationOfOtherDeferredCosts" contextRef="PAsOn09_30_2023_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,555</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn09_30_2023_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,815</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsGross" contextRef="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,996</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedAmortizationOfOtherDeferredCosts" contextRef="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,391</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,605</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsGross" contextRef="PAsOn09_30_2023_OtherAssetsMemberusgaapBalanceSheetLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccumulatedAmortizationOfOtherDeferredCosts" contextRef="PAsOn09_30_2023_OtherAssetsMemberusgaapBalanceSheetLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn09_30_2023_OtherAssetsMemberusgaapBalanceSheetLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsGross" contextRef="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccumulatedAmortizationOfOtherDeferredCosts" contextRef="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherDeferredCostsGross" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,959</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedAmortizationOfOtherDeferredCosts" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,276</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,683</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:OtherDeferredCostsGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,594</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedAmortizationOfOtherDeferredCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,576</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,018</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization expense amounted to $<ix:nonFraction name="us-gaap:OtherAmortizationOfDeferredCharges" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:OtherAmortizationOfDeferredCharges" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction>&#160;million for the three months ended September&#160;30, 2023 and 2022, respectively, and $<ix:nonFraction name="us-gaap:OtherAmortizationOfDeferredCharges" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.7</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:OtherAmortizationOfDeferredCharges" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.7</ix:nonFraction>&#160;million for each of the nine months ended September&#160;30, 2023 and 2022. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-51 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">9. Accrued Expenses and Other Current Liabilities </div></div><ix:nonNumeric name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Accrued expenses consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,<br/> 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued bonus</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">145</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued payroll</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">58</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">193</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued PTO</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PaidTimeOffAccrual" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">21</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:PaidTimeOffAccrual" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">188</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedOfferingCosts" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">500</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedOfferingCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,490</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedLicenses" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:AccruedLicenses" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,250</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued royalties</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">204</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedRoyaltiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">195</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued professional fees</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">953</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:CustomerDeposits" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">52</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:CustomerDeposits" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">517</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued expenses and current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">138</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">326</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,951</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,304</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757668"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">10. Debt </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From January through March 2022, the Company issued convertible notes (the &#8220;2022 Convertible Notes&#8221;) with an aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.9</ix:nonFraction>&#160;million, pursuant to a private placement offering. The 2022 Convertible Notes bore interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% per annum and had a scheduled maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" format="ixt-sec:durmonth">24</ix:nonNumeric> months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) <ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">80</ix:nonFraction>% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#8220;Cap Price&#8221;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognized losses equal to $<ix:nonFraction name="trnr:LossDueToChangesInFairValueOfConvertibleNotes" contextRef="PAsOn09_30_2023_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023 related to changes in fair value for the November 2022 Convertible Notes, and $<ix:nonFraction name="trnr:LossDueToChangesInFairValueOfConvertibleNotes" contextRef="PAsOn09_30_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.02</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2022, related to changes in fair value for the 2022 Convertible Notes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2022, the Company completed a qualified financing, and as a result the 2022 Convertible Notes were automatically converted into <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">124,313</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2.</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">November 2022 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued convertible notes (the &#8220;November 2022 Convertible Notes&#8221;) with an aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.4</ix:nonFraction>&#160;million, pursuant to a private placement offering. The November 2022 Convertible Notes bore interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% per annum and had a schedule maturing date of <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" format="ixt-sec:durmonth">12</ix:nonNumeric> months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the November 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The November 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The November 2022 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-52</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757668" continuedAt="TextSelectionAppend_95757668_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757668_1" continuedAt="TextSelectionAppend_95757668_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757668_2" continuedAt="TextSelectionAppend_95757668_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757668_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) the price per share in the Next Financing round, or ii) the Original Issue Price of the Company&#8217;s Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> Preferred Stock, which is $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">47.67</ix:nonFraction>. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognized losses equal to $<ix:nonFraction name="trnr:LossDueToChangesInFairValueOfConvertibleNotes" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023 related to changes in fair value for the November 2022 Convertible Notes, and $<ix:nonFraction name="trnr:LossDueToChangesInFairValueOfConvertibleNotes" contextRef="PAsOn09_30_2022" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.02</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2022, related to changes in fair value for the 2022 Convertible Notes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the November 2022 Convertible notes were converted into an aggregate of <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="P05_01_2023To05_31_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">565,144</ix:nonFraction> shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Secured Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, the Company issued an aggregate of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="P03_01_2023To03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction>&#160;million of senior secured notes to three investors, including one related party, with associated warrants to purchase the Company&#8217;s common stock at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction>, in lieu of future cash interest payments under the senior secured notes issued to such investors. In May 2023, the Company repaid the $<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="P03_01_2023To03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction>&#160;million in senior secured notes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note Purchase Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2023, the Company entered into a note purchase agreement with THLWY, LLC (the &#8220;June 2023 Notes&#8221;) pursuant to which the Company agreed to issue up to $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="P06_01_2023To06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">15.8</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction>% senior secured notes due <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P06_01_2023To06_30_2023_TenPercentageSeniorSecuredNotesDueMemberusgaapShortTermDebtTypeAxis" format="ixt:date-monthname-day-year-en">June 25, 2025</ix:nonNumeric> at their sole discretion. The June 2023 Notes are the senior secured obligations of the Company, bear interest at a rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>% per annum, and contain customary events of default. The June 2023 Notes will mature on June&#160;25, 2025, subject to earlier repurchase by the Company. The Company may redeem the June 2023 Notes, in whole or in part, at a redemption price equal to <ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="P06_01_2023To06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the principal amount of the June 2023 Notes to be redeemed, plus any accrued and unpaid interest to (including any additional interest), but excluding, the redemption date. As of September&#160;30, 2023, $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="P01_01_2023To09_30_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction>&#160;million of the senior secured notes have been issued. Additional senior secured notes may become available at the sole discretion of THLWY, LLC. As of September&#160;30, 2023, the Company defaulted on the payment of interest due on the June 2023 Notes. On November&#160;3, 2023, THLWY, LLC waived their rights to seek remedies resulting from an event of default. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was less than $<ix:nonFraction name="trnr:InterestExpenseAndDefaultInterest" contextRef="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023. </div></ix:continuation><ix:nonNumeric name="trnr:WarrantsDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757670"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">11. Warrants </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;A Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November&#160;13, 2022, the Company issued an aggregate <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction> warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. Each warrant has a strike price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per share and has a contractual term of <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>. The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The fair value of the warrants issued in 2022 was recorded as a liability on the Balance Sheet and expensed to other (expense) income, net on the Statement of Operations and Comprehensive Loss, at the time of issuance. The Company recognized a gain equal to $<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023, related to changes in fair value for the warrants issued in November 2022. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into shares of common stock. </div><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A&#160;Common</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ClassOfWarrantsIssued" contextRef="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:ClassOfWarrantsExercised" contextRef="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">92,296</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;B Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company issued warrants in 2021 to purchase Class&#160;B Common Stock to various employees and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees.</div> Each warrant has a strike price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> and has a contractual term of <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis" format="ixt-sec:durwordsen">seven years</ix:nonNumeric>. The warrants are classified as permanent equity within the condensed consolidated balance sheets. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into shares of common stock. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-53</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757670" continuedAt="TextSelectionAppend_95757670_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757670_1" continuedAt="TextSelectionAppend_95757670_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757670_2" continuedAt="TextSelectionAppend_95757670_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757670_3"><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="P01_01_2023To09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" escape="true"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:84%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B&#160;Common</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">5,753</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ClassOfWarrantsIssued" contextRef="P01_01_2023To09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:ClassOfWarrantsExercised" contextRef="P01_01_2023To09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">5,753</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Service Providers Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party that is exercisable for a number of shares of common stock that is determined by dividing $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="P11_01_2022To11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">225,000</ix:nonFraction> by (x)&#160;the price per share of the next equity financing with total proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="P11_01_2022To11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of <ix:nonFraction name="trnr:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="P11_01_2022To11_30_2022_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">28,124</ix:nonFraction> shares of common stock </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">400,000</ix:nonFraction> by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction> or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of <ix:nonFraction name="trnr:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">49,996</ix:nonFraction> shares of common stock. </div><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="P01_01_2023To09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Service&#160;Providers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:ClassOfWarrantsIssued" contextRef="P01_01_2023To09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">78,120</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:ClassOfWarrantsExercised" contextRef="P01_01_2023To09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">78,120</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Secured Notes Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to certain existing affiliate and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliate</div> stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with a note financing. The fair value of the warrants of $<ix:nonFraction name="trnr:FairValueOfWarrants" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.3</ix:nonFraction>&#160;million was recorded as debt discount on the senior secured notes of $<ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="P01_01_2023To03_31_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction>&#160;million. The debt discount was amortized into interest expense over life of the senior secured notes. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of <ix:nonFraction name="trnr:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="P01_01_2023To03_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">163,121</ix:nonFraction> shares of common stock. </div><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="P01_01_2023To09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:81%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior&#160;Secured&#160;Notes</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn12_31_2022_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:ClassOfWarrantsIssued" contextRef="P01_01_2023To09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">163,121</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:ClassOfWarrantsExercised" contextRef="P01_01_2023To09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">163,121</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:WarrantOutstanding" contextRef="PAsOn09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:continuation><ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757681"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">12. Fair Value Measurements </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s financial instruments consist of its convertible notes and warrants. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-54</ix:exclude> </div></ix:nonNumeric></div></div></div><ix:continuation id="TextSelection_95757681" continuedAt="TextSelectionAppend_95757681_1"><div></div></ix:continuation></div><ix:continuation id="TextSelectionAppend_95757681_1" continuedAt="TextSelectionAppend_95757681_2"><div><div style="line-height:normal;background-color:white;display: inline;"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></div></div></ix:continuation></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757681_2" continuedAt="TextSelectionAppend_95757681_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">There were <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> assets or liabilities measured at fair value on a recurring basis as of September&#160;30, 2023, and <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> assets measured at fair value on a recurring basis as of December&#160;31, 2022. <ix:nonNumeric name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757998">Liabilities measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows: </ix:nonNumeric></div><ix:continuation id="TextSelection_95757998"><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value&#160;measurements&#160;as&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,270</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,270</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,004</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,004</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,274</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,274</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:continuation><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the nine months ended September&#160;30, 2023, there were <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> transfers between Level&#160;1 and Level&#160;2, nor into and out of Level&#160;3. </div><ix:nonNumeric name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,270</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2023To09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" contextRef="P01_01_2023To09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">252</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" contextRef="P01_01_2023To09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,521</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,004</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" contextRef="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,266</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise of stock warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" contextRef="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">738</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:16%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2022To09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,902</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" contextRef="P01_01_2022To09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" contextRef="P01_01_2022To09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,926</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 10, the Company entered into several convertible note arrangements with certain investors during 2022. The Company recorded the liability related to the convertible notes at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recorded a change in fair value adjustment of $<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" contextRef="P01_01_2023To09_30_2023_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023 related to the November 2022 Convertible Notes, and $<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" contextRef="P01_01_2022To09_30_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.02</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2022 related to the 2022 Convertible Notes in the condensed consolidated statement of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the November 2022 Convertible notes were converted into an aggregate of <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="P05_01_2023To05_31_2023_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">565,144</ix:nonFraction> shares of common stock. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-55</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95757681_3" continuedAt="TextSelectionAppend_95757681_4"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757681_4" continuedAt="TextSelectionAppend_95757681_5"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757681_5" continuedAt="TextSelectionAppend_95757681_6"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757681_6"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 11, on November&#160;13, 2022, the Company issued an aggregate <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn11_13_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">92,296</ix:nonFraction> warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. The Company recorded the liability related to the warrants at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recorded a change in fair value adjustment of $<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" contextRef="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" contextRef="P01_01_2022To09_30_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">0</ix:nonFraction>&#160;million in the condensed consolidated statement of operations and comprehensive loss for the nine months ended September&#160;30, 2023 and 2022, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into shares of common stock. </div></ix:continuation><ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">13. Commitments and Contingencies </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Lease Obligations </div></div></div><ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual rental payments under operating leases for each of the next five years and thereafter: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future&#160;Minimum&#160;Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in&#160;thousands)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 (remaining)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">20</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">78</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">78</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">78</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">78</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">33</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">365</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay <ix:nonFraction name="trnr:PercentageOfCumulativeNetSales" contextRef="P01_01_2017To12_31_2017_MaximumMembersrtRangeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">3</ix:nonFraction>% of cumulative net sales up to $<ix:nonFraction name="trnr:CumulativeNetSales" contextRef="P01_01_2017To12_31_2017_MaximumMembersrtRangeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million and <ix:nonFraction name="trnr:PercentageOfCumulativeNetSales" contextRef="P01_01_2017To12_31_2017_MinimumMembersrtRangeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">1</ix:nonFraction>% of cumulative net sales above $<ix:nonFraction name="trnr:CumulativeNetSales" contextRef="P01_01_2017To12_31_2017_MinimumMembersrtRangeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million, up to a maximum total royalty of $<ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="P01_01_2017To12_31_2017" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction>&#160;million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $<ix:nonFraction name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of September&#160;30, 2023. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Legal Proceedings </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company is involved in legal proceedings in the normal course of business. The Company currently believes that any ultimate liability arising out of such proceedings will not have a material adverse effect on the Company&#8217;s financial position, results of operations or cash flows. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">14. Stockholders&#8217; Deficit </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s authorized common stock consisted of <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">900,000,000</ix:nonFraction> and <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">369,950,000</ix:nonFraction> shares at $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction> par value, as of September&#160;30, 2023 and December&#160;31, 2022, respectively. The issued and outstanding common stock was <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">14,178,514</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,450,922</ix:nonFraction></ix:nonFraction> shares as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In February 2023, the Company completed a rights offering involving the sale of Class&#160;A common stock to all existing accredited investors as of December&#160;19, 2022, at a price equal to approximately $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.51</ix:nonFraction> per share. In connection with the rights offering, the Company issued a total of <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">9,749,439</ix:nonFraction> shares of Class&#160;A common stock, of which <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,072,515</ix:nonFraction> was issued in December 2022, and <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn01_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">8,676,924</ix:nonFraction></ix:nonFraction> was issued in January and February 2023. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-56 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95758000"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">15. Equity-Based Compensation </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">2023 and 2020 Equity Incentive Plan </div></div></div><ix:nonNumeric name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:43%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P07_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,347</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P07_01_2022To09_30_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">383</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,803</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To09_30_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">478</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P07_01_2023To09_30_2023_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">87</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P07_01_2022To09_30_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">34</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2023To09_30_2023_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">407</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To09_30_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">52</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P07_01_2023To09_30_2023_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,402</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P07_01_2022To09_30_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,356</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2023To09_30_2023_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,563</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To09_30_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,421</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stock-based compensation expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P07_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,836</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P07_01_2022To09_30_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,773</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">23,773</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To09_30_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,951</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the three months ended September&#160;30, 2023 and 2022, $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" contextRef="P07_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" contextRef="P07_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.0</ix:nonFraction>&#160;million of stock-based compensation was capitalized as software costs, respectively. For the nine months ended September&#160;30, 2023 and 2022 $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" contextRef="P01_01_2022To09_30_2022_MaximumMembersrtRangeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.0</ix:nonFraction>&#160;million of stock-based compensation was capitalized as software costs, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the nine months ended September&#160;30, 2023, the Company granted options to purchase <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P01_01_2023To09_30_2023_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">3,428,225</ix:nonFraction> shares under the 2023 and 2020 Plan. The Company has <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="P01_01_2023To09_30_2023_StockAppreciationRightsSARSMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="P01_01_2023To09_30_2023_RestrictedStockMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t granted any restricted stock or stock appreciation rights. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, the Company enacted a restructuring cost savings initiative which resulted in employee terminations in both December 2022 and January 2023. In association with January 2023 terminations, the Company accelerated the vesting of a number of individual option awards, resulting in the accelerated vesting of <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" contextRef="P01_01_2023To01_31_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">5,938</ix:nonFraction> shares on the date of modification. Also in January 2023, the Company repriced <ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" contextRef="P01_01_2023To01_31_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">301,537</ix:nonFraction> option awards. Both the accelerated vesting and repricing were accounted for as an equity award modification under ASC Topic 718 which resulted in adjustment of the award value to reflect the fair value at the modification date and acceleration of the recognition schedule in the case of awards which were modified to have accelerated vesting. The adjustment resulted in additional expense of $<ix:nonFraction name="trnr:AdditionalExpense" contextRef="P01_01_2023To01_31_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction>&#160;million. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2023, the Company granted <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P06_01_2023To06_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,294,998</ix:nonFraction> options to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> directors, selected executives and other key employees where vesting is contingent on the Company&#8217;s share price meeting certain targets. The fair value of each option granted was estimated on the date of grant using the Monte Carlo valuation model and assumes that share price targets are achieved. </div><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following summary sets forth the stock option activity under the 2023 and 2020 Plan: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;Number&#160;of&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">exercise</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">remaining</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">contractual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;term&#160;(in&#160;years)&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;intrinsic&#160;value&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Outstanding as of December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">446,839</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">2.30</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">9.6</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,706</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,428,225</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">2.38</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">677,350</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.53</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,690</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cancelled or forfeited</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">89,603</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.92</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Outstanding as of September&#160;30, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,108,111</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">2.70</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">9.5</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,341</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercisable as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">178,310</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">5.97</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">8.8</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options unvested as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,325,600</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">3.33</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="trnr:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">9.5</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">775</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-57</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95758000" continuedAt="TextSelectionAppend_95758000_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758000_1" continuedAt="TextSelectionAppend_95758000_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95758000_2" continuedAt="TextSelectionAppend_95758000_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95758000_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The aggregate intrinsic value of options outstanding, exercisable and unvested were calculated as the difference between the exercise price of the options and the estimated fair market value of the Company&#8217;s common stock, as of September&#160;30, 2023. </div><ix:nonNumeric name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:92%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Early Option Exercises</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;average&#160;exercise&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;Repurchase&#160;&#160;&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">liability&#160;(in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock as of December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">3,823</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">306</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">30,947</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">1.19</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">37</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repurchased</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,655</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD_per_Share" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock as of September&#160;30, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="PAsOn09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">32,078</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" contextRef="PAsOn09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">52</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table></ix:nonNumeric><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the nine months ended September&#160;30, 2023 and 2022 the weighted-average grant date fair value per option was $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">12.67</ix:nonFraction> and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.18</ix:nonFraction> respectively. <ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95759014">The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: </ix:nonNumeric></div><ix:continuation id="TextSelection_95759014"><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:96%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate (1)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">3.7</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">3.3</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected term (in years)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="P01_01_2023To09_30_2023" format="ixt-sec:duryear">5.93</ix:nonNumeric>&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="P01_01_2022To09_30_2022" format="ixt-sec:duryear">5.34</ix:nonNumeric>&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected volatility (2)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">62.27</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">54.6</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:fixed-zero">&#8212;</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:fixed-zero">&#8212;</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Based on U.S. Treasury seven-year constant maturity interest rate whose term is consistent with the expected term of the option. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#8217;s stage of development. </div></td></tr></table></ix:continuation><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">With respect to the 2023 and 2020 Plan, the Company recognized stock compensation expense of $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">24.5</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To09_30_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.0</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively, of which $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" contextRef="P01_01_2022To09_30_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.0</ix:nonFraction>&#160;million was capitalized as software costs for the nine months ended September&#160;30, 2023 and 2022, respectively. As of September&#160;30, 2023 and December&#160;31, 2022, the Company had $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="PAsOn09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">23.6</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.9</ix:nonFraction>&#160;million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of <ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">1.9</ix:nonNumeric> years and <ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">1.6</ix:nonNumeric> years, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For financial reporting purposes for the awards granted in January 2023, we applied a straight-line calculation between the $<ix:nonFraction name="trnr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">30.00</ix:nonFraction> per share determined in the contemporaneous third-party valuation as of December&#160;31, 2022 and the $<ix:nonFraction name="trnr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" contextRef="PAsOn03_31_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">6.08</ix:nonFraction> per share determined in the contemporaneous third-party valuation as of March&#160;31, 2023 to determine the fair value of our common stock on the grant date. Using the benefit of hindsight, we determined that the straight-line calculation would provide the most appropriate conclusion for the valuation of our common stock on the interim dates between valuations because we did not identify any single event or series of events that occurred during this interim period that would have caused a material change in fair value. Based on this calculation, we assessed the fair value of our common stock for awards granted in January 2023 to be $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="PAsOn01_31_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">19.27</ix:nonFraction> per share. </div></ix:continuation><ix:nonNumeric name="us-gaap:ConcentrationRiskDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">16. Concentration of Credit Risk and Major Customers and Vendors </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company&#8217;s cash and cash equivalents are maintained with high-quality financial institutions, the compositions and maturities of which are regularly monitored by management. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the nine months ended September&#160;30, 2023 and 2022, there were <ix:nonFraction name="trnr:NumberOfCustomer" contextRef="P01_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_Customer" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="trnr:NumberOfCustomer" contextRef="P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_Customer" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> customers representing greater than <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company had <ix:nonFraction name="trnr:NumberOfSignificantVendors" contextRef="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" unitRef="Unit_Vendor" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="trnr:NumberOfSignificantVendors" contextRef="P01_01_2023To09_30_2023_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" unitRef="Unit_Vendor" decimals="0" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></ix:nonFraction> vendors representing greater than <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To09_30_2023_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction></ix:nonFraction>% of total finished goods purchases for the nine months ended September&#160;30, 2023 and year ended December&#160;31, 2022, respectively. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757996"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">17. Benefit Plans </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company established a defined contribution savings plan under Section&#160;401(k) of the Internal Revenue Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-58</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757996" continuedAt="TextSelectionAppend_95757996_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757996_1" continuedAt="TextSelectionAppend_95757996_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757996_2" continuedAt="TextSelectionAppend_95757996_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757996_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">annual compensation on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-tax</div> basis. Matching contributions to the plan may be made at the discretion of the Company&#8217;s board of directors. During the nine months ended September&#160;30, 2023 and 2022, the Company did <ix:nonFraction name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="INF" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="INF" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>t make any contributions to the plan. </div></ix:continuation><ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">18. Loss Per Share </div></div><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The computation of loss per share is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:94%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;months&#160;ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in thousands, except share and per share amounts)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:NetLoss" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,971</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="trnr:NetLoss" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,415</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss attributable to common stockholders</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,971</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">39,415</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common stock outstanding - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">11,750,907</ix:nonFraction></ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">423,362</ix:nonFraction></ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share attributable to common stockholders - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">3.40</ix:nonFraction></ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">93.10</ix:nonFraction></ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">86,703</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">10,208</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">755,606</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">7,546</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 1 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,393</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 2 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,666</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 3 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">248</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 4 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">140</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 5 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">3,414</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 6 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">815</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 7 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,716</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 8 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">4,410</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 9 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">18,480</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 10 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,171</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;B common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">5,753</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options to purchase common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,108,111</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">452,549</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To09_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">3,108,111</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To09_30_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,353,818</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757676"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">19. Related Party Transactions </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the ordinary course of business, we may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal stockholders (commonly referred to as &#8220;related parties&#8221;). </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Founder Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company had <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing promissory notes, of which $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn09_30_2023_PromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.0</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn12_31_2022_PromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.08</ix:nonFraction>&#160;million was outstanding as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div><ix:exclude><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-59 </div></ix:exclude></ix:nonNumeric></div></div></div><ix:continuation id="TextSelection_95757676" continuedAt="TextSelectionAppend_95757676_1"><div></div></ix:continuation></div><div><div style="line-height:normal;background-color:white;display: inline;"><ix:continuation id="TextSelectionAppend_95757676_1" continuedAt="TextSelectionAppend_95757676_2"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757676_2" continuedAt="TextSelectionAppend_95757676_3"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757676_3" continuedAt="TextSelectionAppend_95757676_4"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757676_4" continuedAt="TextSelectionAppend_95757676_5"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Principal Stockholder Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2019, 2020, and 2021 the Company entered into the following promissory notes with a then-principal stockholder (the &#8221;former principal stockholder&#8221;) of the Company: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On May&#160;17, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">2.5</ix:nonFraction>% per annum and maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">May 17, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">7.5</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On August&#160;28, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">August 28, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On November&#160;28, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">August 28, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On March&#160;20, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">March 20, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;12, 2021, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 12, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, all outstanding promissory notes with respect to the former principal stockholder are included within the loan payable on the condensed consolidated balance sheet for a total of $<ix:nonFraction name="us-gaap:NotesAndLoansPayable" contextRef="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.4</ix:nonFraction>&#160;million, including accrued interest and default interest of $<ix:nonFraction name="trnr:AccruedInterestAndDefaultInterest" contextRef="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction>&#160;million. As the 2019, 2020, and 2021 notes were not paid upon maturity, these loans were in default as of September&#160;30, 2023, and on August&#160;4, 2023, the Company received a notice of default from the principal stockholder. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $<ix:nonFraction name="trnr:InterestExpenseAndDefaultInterest" contextRef="P01_01_2023To09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023. On September&#160;30, 2022, the former principal stockholder and certain related parties waived their rights to seek remedies resulting from an event of default due to a failure to make payments of principal or interest at the stated maturity or due date, respectively. On October&#160;30, 2023, the Company entered into an agreement with the former principal stockholder regarding a mutually agreed upon repayment schedule with respect to the outstanding promissory notes issued to such former principal stockholder. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Other Related Party Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2019, 2020, 2021, and 2022, the Company entered into the following promissory notes with other related parties: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On September&#160;30, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">September 30, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million. This loan remains outstanding for interest in the amount of $<ix:nonFraction name="trnr:DefaultInterest" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million. Upon default, on the September&#160;30, 2019, loan the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-60</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95757676_5" continuedAt="TextSelectionAppend_95757676_6"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757676_6" continuedAt="TextSelectionAppend_95757676_7"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757676_7" continuedAt="TextSelectionAppend_95757676_8"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757676_8" continuedAt="TextSelectionAppend_95757676_9">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:8%">&#160;</td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On October&#160;21, 2019, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">October 21, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. The principal and interest of this loan has been paid as of September&#160;30, 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;18, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">February 18, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On June&#160;9, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">75,000</ix:nonFraction> note was entered into by the Company from the president and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-founder</div> of the Company. This note has interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">J<div style="display:inline;">une 9, 2022</div></ix:nonNumeric><div style="display:inline;"></div>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. The principal and interest of this loan has been paid as of September&#160;30, 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On June&#160;15, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">7.5</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 15, 2021</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.5</ix:nonFraction>%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. The principal and interest of this loan has been paid as of September&#160;30, 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On November&#160;2, 2020, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">50,000</ix:nonFraction> note was entered into by the Company from to the president and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-founder</div> of the Company. This note has interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 2, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">10.0</ix:nonFraction>%. The principal and interest of this loan has been paid as of September&#160;30, 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On January&#160;12, 2021, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 12, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;22, 2021, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">40,000</ix:nonFraction> note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">June 22, 2022</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On October&#160;27, 2022, a $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction>&#160;million note with interest at the rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% per annum and a maturity date of <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">January 27, 2023</ix:nonNumeric>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of <ix:nonFraction name="trnr:DebtInstrumentFeePercentage" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of <ix:nonFraction name="trnr:DebtInstrumentInterestRateStatedPercentageAdditional" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">17.0</ix:nonFraction>%. The Company borrowed $<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million in April 2023 and repaid $<ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million in May 2023 upon closing of the Company&#8217;s IPO. This loan </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-61</ix:exclude> </div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_95757676_9" continuedAt="TextSelectionAppend_95757676_10"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757676_10" continuedAt="TextSelectionAppend_95757676_11"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757676_11" continuedAt="TextSelectionAppend_95757676_12"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757676_12">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:8%">&#160;</td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">remains outstanding in the amount of $<ix:nonFraction name="us-gaap:NotesAndLoansPayable" contextRef="PAsOn10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">0.01</ix:nonFraction>&#160;million. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In August 2023, the company borrowed $<ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="P08_01_2023To08_31_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million in a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing note and repaid $<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="P08_01_2023To08_31_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million. As of September&#160;30, 2023, this loan remains outstanding in the amount of $<ix:nonFraction name="us-gaap:NotesAndLoansPayable" contextRef="PAsOn09_30_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, all other related party promissory notes were outstanding and included within the loan payable on the condensed consolidated balance sheet for a total of $<ix:nonFraction name="us-gaap:NotesAndLoansPayable" contextRef="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction>&#160;million, including accrued interest and default interest of $<ix:nonFraction name="trnr:AccruedInterestAndDefaultInterest" contextRef="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction>&#160;million. All notes were not paid upon maturity. These loans were in default as of period end due to outstanding interest. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $<ix:nonFraction name="trnr:InterestExpenseAndDefaultInterest" contextRef="P01_01_2023To09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023. On September&#160;30, 2022, related parties waived their rights to remedy in the event of default, which in effect releases the Company from the obligation of the incremental interest and fees, as well as the lender from their lien on and security interest in the Company&#8217;s assets. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2022, multiple of the loans above with maturity dates in 2022 remained unpaid as of the maturity date. On September&#160;30, 2022, those lenders waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. Currently, the Company is renegotiating the terms of the loans. </div><ix:nonNumeric name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Loan payable consisted of the following as of September&#160;30, 2023 and December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:70%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in thousands)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Founder Notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="PAsOn12_31_2022_FounderNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">79</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal stockholder promissory notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,404</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,503</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other related party promissory notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">862</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,126</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Loan Payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:NotesPayable" contextRef="PAsOn09_30_2023" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,266</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:NotesPayable" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,708</ix:nonFraction>&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Other Related Party Transactions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2016, the Company entered into an agreement with Fuseproject, a design firm that designed the Company&#8217;s main product, its fitness mirror. As of September&#160;30, 2023 and 2022, the Company had incurred $<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn09_30_2023_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn09_30_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.0</ix:nonFraction>&#160;million, respectively, of expenses for design services provided by Fuseproject. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay <ix:nonFraction name="trnr:RoyaltyPaymentPercentage" contextRef="PAsOn09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMemberusgaapDeferredRevenueArrangementTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">3</ix:nonFraction>% of cumulative net sales up to $<ix:nonFraction name="us-gaap:RoyaltyIncomeNonoperating" contextRef="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMemberusgaapDeferredRevenueArrangementTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million and <ix:nonFraction name="trnr:RoyaltyPaymentPercentage" contextRef="PAsOn09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMemberusgaapDeferredRevenueArrangementTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">1</ix:nonFraction>% of cumulative net sales above $<ix:nonFraction name="us-gaap:RoyaltyIncomeNonoperating" contextRef="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMemberusgaapDeferredRevenueArrangementTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million, up to a maximum total royalty of $<ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction>&#160;million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $<ix:nonFraction name="trnr:GuaranteedRoyaltyPayment" contextRef="P01_01_2023To09_30_2023_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of September&#160;30, 2023. As of September&#160;30, 2023 the Company has accrued $<ix:nonFraction name="trnr:ContingentRoyaltyObligation" contextRef="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million in royalty payments. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, the principal stockholder associated with Fuseproject referenced above owned <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">226,217</ix:nonFraction> of the Company&#8217;s common stock., with fully diluted ownership of less than <ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="P01_01_2023To09_30_2023_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="P01_01_2022To12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction></ix:nonFraction>% as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2022, the Company entered into an agreement with Apeiron Advisory Ltd for promotion of the Company, participation in industry conferences, and ongoing structural advice and consulting. The agreement was terminated and the Company is no longer receiving any advisory services from Apeiron Advisory Ltd. As of the nine months ended September&#160;30, 2023 and 2022, the Company has incurred $<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.0</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn09_30_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction>&#160;million, respectively, of expenses for such services provided by Apeiron Advisory Ltd. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, Apeiron Investment Group Ltd and certain of its affiliates (&#8220;Apeiron&#8221;) owned <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2023To09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,490,524</ix:nonFraction> shares of common stock. As of December&#160;31, 2022 Apeiron owned <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">447,318</ix:nonFraction> shares of the Company&#8217;s Class&#160;A common shares, and <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">24,143</ix:nonFraction> of the Company&#8217;s Class&#160;A common warrants. As of September&#160;30, 2023 and December&#160;31, 2022, Apeiron had fully diluted ownership of more than <ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="P01_01_2023To09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction></ix:nonFraction>%, respectively. </div></ix:continuation><ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" contextRef="P01_01_2023To09_30_2023" escape="true" continuedAt="TextSelection_95757669"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">20. Subsequent Events </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has evaluated subsequent events through the financial statement issuance date, November&#160;14, 2023, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">855-10</div> Subsequent Events. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On October&#160;6, 2023, the Company entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;) with CLMBR, Inc and CLMBR1, LLC (the &#8220;Sellers&#8221;) to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-62</ix:exclude> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_95757669" continuedAt="TextSelectionAppend_95757669_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757669_1" continuedAt="TextSelectionAppend_95757669_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_95757669_2" continuedAt="TextSelectionAppend_95757669_3"><ix:exclude><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_95757669_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The purchase price enterprise value under the Asset Purchase Agreement is approximately $<ix:nonFraction name="us-gaap:AssetAcquisitionPriceOfAcquisitionExpected" contextRef="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">16.9</ix:nonFraction>&#160;million, of which $<ix:nonFraction name="us-gaap:AssetAcquisitionPriceOfAcquisitionExpected" contextRef="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_CommonStockMemberusgaapStatementEquityComponentsAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.0</ix:nonFraction>&#160;million will be paid in the form of the Company&#8217;s common stock, and the Company will assume $<ix:nonFraction name="us-gaap:SubordinatedDebt" contextRef="PAsOn10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction>&#160;million of subordinated debt and will retire $<ix:nonFraction name="trnr:RetirementOfSeniorDebt" contextRef="PAsOn10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">9.4</ix:nonFraction>&#160;million of senior debt. <ix:nonNumeric name="trnr:AssetPurchaseAgreementTerms" contextRef="P10_06_2023To10_06_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">The number of shares to be issued will be based on the volume weighted average price (&#8220;VWAP&#8221;) of the Company&#8217;s common stock based on the 10 consecutive trading days ending on (and including) the closing date of the Acquisition, on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;); provided, however, that such VWAP shall not exceed or be less than an amount equal to twenty-five percent (25%) of the VWAP for the common stock based on the <ix:nonNumeric name="trnr:WeightedAverageThresholdConsecutiveTradingDays1" contextRef="P10_06_2023To10_06_2023_CommonStockMemberusgaapStatementEquityComponentsAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" format="ixt-sec:durday">10</ix:nonNumeric> consecutive trading days ending on (and including) the date the Asset Purchase Agreement was executed (the &#8220;VWAP Collar&#8221;).</ix:nonNumeric> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Sellers shall also be entitled to receive a contingent payment in the form of the Company&#8217;s common stock (collectively, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Earn-Out</div> Shares&#8221;) calculated in the manner set forth in the Asset Purchase Agreement based on the 2024 Unit Sales (as defined in the Asset Purchase Agreement) and the VWAP for the Company&#8217;s common stock based on the <ix:nonNumeric name="trnr:WeightedAverageThresholdConsecutiveTradingDays1" contextRef="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" format="ixt-sec:durday">10</ix:nonNumeric> consecutive trading days ending on (and including) December&#160;31, 2024, subject to the VWAP collar. In addition, in the event the 2024 Unit Sales include at least <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="P12_31_2024To12_31_2024_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_ScenarioForecastMembersrtStatementScenarioAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,400</ix:nonFraction> Units sold in the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">business-to-business</div></div> channel, the Sellers shall be entitled to an additional number of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares calculated in the manner set forth in the Asset Purchase Agreement subject to total maximum number of <ix:nonFraction name="trnr:MaximumNumberOfEarnOutShares" contextRef="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">22,665,681</ix:nonFraction> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Asset Purchase Agreement contains customary representations and warranties and covenants for a transaction of this nature and customary indemnification provisions with respect to certain matters, including breaches of the Company&#8217;s and Sellers&#8217; representations and warranties. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On October&#160;30, 2023, the Company entered into an agreement with the former principal stockholder regarding a mutually agreed upon repayment schedule with respect to outstanding promissory notes previously issued to such former principal stockholder. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November&#160;3, 2023, THLWY, LLC waived their rights to seek remedies resulting from an event of default on the June 2023 Notes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November&#160;10, 2023, the Company issued secured promissory notes in the aggregate principal amount of approximately $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.9</ix:nonFraction>&#160;million, of which approximately $<ix:nonFraction name="us-gaap:ProceedsFromLongTermLinesOfCredit" contextRef="P11_10_2023To11_10_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction>&#160;million was with a related party, with an original issuance discount of <ix:nonFraction name="trnr:PercentageOfOriginalIssuanceDiscount" contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">15</ix:nonFraction>%, due <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" format="ixt:date-monthname-day-year-en">November 9, 2024</ix:nonNumeric>. Interest on the outstanding principal of the notes accrues initially at a rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">3</ix:nonFraction>% per annum, with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">step-up</div> interest rate of <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">8</ix:nonFraction>% per annum after January&#160;31, 2024 until maturity. In addition, the Company issued warrants to purchase shares of common stock of the Company to the noteholders, which warrants expire <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" format="ixt-sec:durwordsen">five years</ix:nonNumeric> from the date of issuance. </div></ix:continuation><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-63 </div></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g367939g61d94.jpg" alt="LOGO" />
 </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman;font-weight:bold;text-align:center">Up to 12,480,480 Shares of Common Stock </p> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROSPECTUS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">The date of this prospectus is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 20&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </p> <p style="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PART&#160;II </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INFORMATION NOT REQUIRED IN PROSPECTUS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ITEM&#160;13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the various expenses to be incurred in connection with the sale and distribution of our common stock being registered hereby, all of which will be borne by us (except any underwriting discounts and commissions and expenses incurred for brokerage, accounting, tax or legal services or any other expenses incurred in disposing of the shares). All amounts shown are estimates except the Commission registration fee. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:83%"></td>

<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC Filing Fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,639</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Fees and Expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">150,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Fees and Expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">58,361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ITEM&#160;14. INDEMNIFICATION OF DIRECTORS AND OFFICERS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant is incorporated under the laws of the State of Delaware. Section&#160;145 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;), provides that a Delaware corporation may indemnify any persons who were, are, or are threatened to be made, parties to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person is or was an officer, director, employee, or agent of such corporation, or is or was serving at the request of such corporation as an officer, director, employee, or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#8217; fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit, or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation&#8217;s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was illegal. The indemnity may include expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit provided such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation&#8217;s best interests, except that no indemnification is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses (including attorneys&#8217; fees) actually and reasonably incurred. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant&#8217;s amended and restated bylaws provide for the indemnification of its directors and officers to the fullest extent permitted under the DGCL. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for liability for any: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">transaction from which the director derives an improper personal benefit; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">unlawful payment of dividends or redemption or repurchase of shares; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">breach of a director&#8217;s duty of loyalty to the corporation or its stockholders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant&#8217;s amended and restated certificate of incorporation includes such a provision. Under the Registrant&#8217;s amended and restated bylaws, expenses incurred by any director or officers in defending any such </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
action, suit, or proceeding in advance of its final disposition shall be paid by the Registrant upon delivery to it of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified by the Registrant, as long as such undertaking remains required by the DGCL. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;174 of the DGCL provides, among other things, that a director who willfully or negligently approves of an unlawful payment of dividends or an unlawful stock repurchase or redemption may be held liable for such actions. A director who was either absent when the unlawful actions were approved or dissented at the time may avoid liability by causing his or her dissent to such actions to be entered in the books containing minutes of the meetings of the board of directors at the time such action occurred or immediately after such absent director receives notice of the unlawful acts. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As permitted by the DGCL, the Registrant has entered into indemnification agreements with each of its directors and officers that require the Registrant, among other things, to indemnify its directors and officers against certain liabilities which may arise by reason of their status or service as directors or officers to the fullest extent not prohibited by law. These indemnification agreements may be sufficiently broad to permit indemnification of the Registrant&#8217;s officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act. Under these agreements, the Registrant is not required to provide indemnification for certain matters. The indemnification agreements also set forth certain procedures that will apply in the event of a claim for indemnification thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is at present no pending litigation or proceeding involving any of the Registrant&#8217;s directors or executive officers as to which indemnification is required or permitted, and the Registrant is not aware of any threatened litigation or proceeding that may result in a claim for indemnification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant has entered into an insurance policy that covers its officers and directors with respect to certain liabilities, including liabilities arising under the Securities Act or otherwise. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ITEM&#160;15. RECENT SALES OF UNREGISTERED SECURITIES </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following sets forth information regarding all unregistered securities sold by the Registrant since January&#160;1, 2019. The following information reflects the <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-150</span></span> reverse stock split effected on December&#160;30, 2022. In addition, in December 2022, all then-outstanding shares of our redeemable convertible preferred stock were converted into shares of our Class&#160;A common stock on a 1:1 basis, which conversion is not reflected below. The reverse stock split and conversion of preferred stock were effected in connection with an equity financing transaction, which also involved a rights offering completed in February 2023. Upon the completion of our initial public offering, all then-outstanding shares of redeemable convertible preferred stock were converted into shares of common stock on a 1:1 basis. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">From December&#160;15, 2020 to February&#160;28, 2023, we granted stock options to purchase an aggregate of 2,524,456 shares of our Class&#160;B common stock at exercise prices ranging from $0.51 to $22.50 per share to a total of 218 employees, consultants and directors under the 2020 Plan. Of these options, through February&#160;28, 2023, options to purchase 785,034 shares of our Class&#160;B Common Stock have been exercised for cash consideration in the aggregate amount of $622,041, options to purchase 46,868 shares have been forfeited, cancelled, or expired without being exercised, and options to purchase 1,692,554 shares remain outstanding; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">From January&#160;31, 2020 to July&#160;11, 2021, we issued and sold an aggregate of 28,833 shares of our Class&#160;B common stock to 100 accredited investors in connection with the conversion of approximately $11.4&#160;million of subscription agreements at a weighted-average conversion price of $396.57 per share; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">From July&#160;21, 2021 to August&#160;12, 2021, we issued and sold an aggregate of 14,906 shares of our Class&#160;A common stock to seven accredited investors at a weighted-average purchase price of $274.93 per share, for aggregate cash consideration of approximately $4.1&#160;million; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">From July&#160;23, 2021 to December&#160;23, 2021, we issued and sold an aggregate of (i) 62,127 shares of our Series A redeemable convertible preferred stock for aggregate cash consideration of approximately $30.5&#160;million at a purchase price of $490.50 per share, (ii) 24,576 shares of our Series A redeemable convertible preferred stock in connection with the conversion of $12.1&#160;million principal amount of convertible notes at a conversion price of $490.50 per share, (iii) 10,208 shares of our Series <span style="white-space:nowrap">A-1</span> redeemable convertible preferred stock to eight accredited investors in connection with the conversion of $3.9&#160;million principal amount of convertible notes at a conversion price of $393.00 per share, (iv)&#160;1,666 shares of our Series <span style="white-space:nowrap">Seed-2</span> redeemable convertible preferred stock to one accredited investor in connection with the conversion of $100,000 of simple agreements for future equity at a conversion price of $60.00 per share, (v) 248 shares of our Series <span style="white-space:nowrap">Seed-3</span> redeemable convertible preferred stock to one accredited investor in connection with the conversion of $25,000 of simple agreements for future equity at a conversion price of $100.50 per share, (vi) 140 shares of our Series <span style="white-space:nowrap">Seed-4</span> redeemable convertible preferred stock to one accredited investor in connection with the conversion of $25,000 of simple agreements for future equity at a conversion price of $177.00 per share, (vii) 3,414 shares of our Series <span style="white-space:nowrap">Seed-5</span> redeemable convertible preferred stock to 12 accredited investors in connection with the conversion of $970,000 of simple agreements for future equity at a conversion price of $283.50 per share, (viii) 815 shares of our Series <span style="white-space:nowrap">Seed-6</span> redeemable convertible preferred stock to three accredited investors in connection with the conversion of $245,000 of simple agreements for future equity at a conversion price of $300.00 per share, (ix) 1,716 shares of our Series <span style="white-space:nowrap">Seed-7</span> redeemable convertible preferred stock to five accredited investors in connection with the conversion of $610,000 of simple agreements for future equity at a conversion price of $355.50 per share, (x) 4,410 shares of our Series <span style="white-space:nowrap">Seed-8</span> redeemable convertible preferred stock to 30 accredited investors in connection with the conversion of approximately $1.9&#160;million of simple agreements for future equity at a conversion price of $417.00 per share, (xi) 4,977 shares of our Series <span style="white-space:nowrap">Seed-9</span> redeemable convertible preferred stock to 11 accredited investors in connection with the conversion of approximately $2&#160;million of simple agreements for future equity at a conversion price of $393.00 per share, (xii) 13,503 shares of our Series <span style="white-space:nowrap">Seed-9</span> redeemable convertible preferred stock to 38 accredited investors in connection with the conversion of approximately $5&#160;million principal amount of convertible notes at a conversion price of $393.00 per share, and (xiii) 2,171 shares of our Series <span style="white-space:nowrap">Seed-10</span> redeemable convertible preferred stock to 15 accredited investors in connection with the conversion of approximately $1.1&#160;million of simple agreements for future equity at a conversion price of $490.50 per share; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">From July&#160;23, 2021 to August&#160;25, 2021, we issued warrants to purchase an aggregate of 132,614 shares of our Class&#160;A common stock and Class&#160;B common stock for cash consideration of $1,883.14. On July&#160;23, 2021, we issued and sold an aggregate of 879 shares of our Class&#160;B common stock to five accredited investors in connection with the exercises of warrants at an exercise price of $0.01 per share for aggregate cash consideration of $8.79. From September&#160;11, 2021 to November&#160;16, 2021, we issued and sold an aggregate of 125,982 shares of our Class&#160;A common stock to six accredited investors in connection with the exercises of warrants at an exercise price of $0.01 per share for aggregate cash consideration of $1,889.78. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">From March&#160;10, 2022 to March&#160;30, 2022, we issued and sold to 41 accredited investors an aggregate of (i) 267,392 shares of our Class&#160;A common stock at a weighted-average purchase price of $6.96 per share for aggregate cash consideration of approximately $2.1&#160;million, (ii) 631,293 shares of our Series <span style="white-space:nowrap">A-2</span> redeemable convertible preferred stock at a purchase price of $47.67 per share for aggregate cash consideration of approximately $30.1&#160;million, and (iii) 124,313 shares of our Series <span style="white-space:nowrap">A-2</span> redeemable convertible preferred stock to three accredited investors in connection with the conversion of approximately $5.9&#160;million principal amount of convertible notes at a conversion price of $47.67 per share. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">From November&#160;13, 2022 to November&#160;29, 2022, we issued convertible notes to 28 accredited investors in the aggregate principal amount of approximately $4.4&#160;million with a maturity date of November&#160;13, 2023, and warrants exercisable for up to 92,296 shares of our common stock at an </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td align="left" style="vertical-align:top">
exercise price of $0.01 per share. In connection with the initial public offering and based on the initial public offering price of $8.00 per share, the convertible notes were automatically converted into 567,908 shares of common stock and the warrants were automatically deemed net exercised for 92,122 shares of common stock. </td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">In November 2022, we issued to one accredited investor in connection with an acqui-hire transaction a warrant that is exercisable for a number of shares of our Class&#160;A common stock that is determined by dividing $225,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the offering price of our initial public offering, whichever event occurs first, for an exercise price of $0.01 per share, in whole or in part. In connection with the initial public offering and based on the initial public offering price of $8.00 per share, the warrants were automatically deemed net exercised for 32,081 shares of common stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">In December 2022, January 2023 and February 2023, we issued 9,749,439 shares of Class&#160;A common stock (of which 1,072,438 were issued in December 2022 and 8,677,001 were issued in January and February 2023) to accredited investors pursuant to a rights offering involving the sale of Class&#160;A common stock to all existing accredited investors as of December&#160;19, 2022 at a price equal to approximately $0.51 per share (which per share amount was adjusted to reflect the <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-150</span></span> reverse stock split effected on December&#160;30, 2022). Each accredited investor received the right to elect to purchase shares of Class&#160;A common stock in the rights offering up to their respective pro rata amount, which was equal to the product of (x) $5,000,000, multiplied by (y)&#160;the quotient obtained by dividing (a)&#160;the number of shares of our capital stock held by the accredited investor as of December&#160;19, 2022 including any common stock issuable on the exercise of warrants or options held by such accredited investor as of December&#160;19, 2022, by (b)&#160;our fully-diluted capitalization as of December&#160;19, 2022. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(10)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">In March 2023, we issued warrants to four accredited investors in consideration for services rendered, which warrants are exercisable for a number of shares of our common stock that is determined by dividing $400,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the offering price per share in our initial public offering price, whichever event occurs first, for an exercise price of $0.01 per share, in whole or in part. In connection with the initial public offering and based on the initial public offering price of $8.00 per share, the warrants were automatically deemed net exercised for 57,034 shares of common stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(11)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">In March 2023, we issued warrants to purchase a total of 186,425 shares of our common stock at an exercise price of $0.0001 per share to three accredited investors in lieu of future cash interest payments under our senior secured notes issued to such investors. In connection with the initial public offering and based on the initial public offering price of $8.00 per share, the warrants were automatically deemed net exercised for 163,125 shares of common stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(12)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">In November 2023, we issued warrants to two accredited investors to purchase shares of common stock, which warrants expire five years from the date of issuance. The warrants were issued in connection with the issuance by the registrant of secured promissory notes to such investors in the aggregate principal amount of approximately $1.9&#160;million with an original issuance discount of 15%, due November&#160;9, 2024. The warrants are not exercisable until May 2024, after which they will become exercisable for such number of shares of common stock equal to the then-outstanding principal amount under the promissory note divided by the Warrant Stock Fair Market Value as defined in the warrant, with the number of shares issuable upon exercise of the Warrant and the Warrant Price are subject to adjustment as set forth in the Warrant. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(13)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">In December 2023, we issued a senior unsecured convertible note to an accredited investor in the aggregate principal amount of $2,160,000, with an eight percent (8.0%) original issue discount and an interest rate of seven percent (7.0%) per annum, and a warrant to purchase up to 924,480 shares of common stock. The convertible notes are convertible into a maximum of 11,556,000 shares of common stock. The conversion and exercise of the convertible note and the warrant are subject to the terms of the Purchase Agreement, including the beneficial ownership limitations and share issuance caps specified therein. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offers, sales and issuances of the securities described in paragraph (1)&#160;above were deemed to be exempt from registration under the Securities Act in reliance on Rule 701 in that the transactions were under compensatory benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of such securities were employees, directors or bona fide consultants of the Registrant and received the securities under the Registrant&#8217;s equity incentive plans. Appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions had adequate access, through employment, business or other relationships, to information about the Registrant. The offers, sales and issuances of the securities described in paragraphs (2)&#160;through (13) above were deemed to be exempt from registration under the Securities Act in reliance on Section&#160;4(a)(2) of the Securities Act and Rule 506 promulgated under Regulation D promulgated thereunder as transactions by an issuer not involving a public offering. The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions was an accredited investor or institutional accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act and had adequate access, through employment, business or other relationships, to information about the Registrant. No underwriter was involved in these transactions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ITEM&#160;16. EXHIBITS </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Exhibits. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See the Exhibit Index immediately preceding the signature page hereto for a list of exhibits filed as part of this registration statement on <span style="white-space:nowrap">Form&#160;S-1,&#160;which</span> Exhibit Index is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Financial Statement Schedules. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All other schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the consolidated financial statements or related notes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ITEM&#160;17. UNDERTAKINGS </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To include any prospectus required by Section&#160;10(a)(3)&#160;of the Securities Act; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b)&#160;if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Filing Fee&#8221; table in the effective registration statement; and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">provided, however, </span>that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act, each such post- effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) That, for the purpose of determining liability under the Securities Act to any purchaser </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each prospectus filed pursuant to Rule&#160;424(b)(3)&#160;shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5)&#160;or (b)(7)&#160;as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii)&#160;or (x)&#160;for the purpose of providing the information required by Section&#160;10(a)&#160;of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. <span style="font-style:italic">Provided, however</span>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXHIBIT INDEX </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:90%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;2.1&#8224;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000095017023052952/trnr-ex2_1.htm">Asset Purchase Agreement, dated October&#160;6, 2023, by and among CLMBR, INC, CLMBR1, LLC and Interactive Strength Inc. (incorporated by reference from Exhibit 2.1 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed October&#160;11, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523132663/d74645dex31.htm">Amended and Restated Certificate of Incorporation of Interactive Strength Inc. (incorporated by reference from Exhibit 3.1 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed May&#160;2, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;3.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523132663/d74645dex32.htm">Amended and Restated Bylaws of Interactive Strength Inc. (incorporated by reference from Exhibit 3.2 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed May&#160;2, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523021672/d379507dex41.htm">Form of Specimen Common Stock Certificate (incorporated by reference from Exhibit 4.1 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;4.2&#8224;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000119312523008845/d379507dex42.htm">Amended and Restated Investors&#8217; Rights Agreement, dated March&#160;10, 2022, by and among the Registrant and the investor signatories thereto, as amended by the Amendment Agreement dated December&#160;19, 2022 (incorporated by reference from Exhibit 4.2 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523021672/d379507dex43.htm">Form of Underwriter Warrant (incorporated by reference from Exhibit 4.3 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;4.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000095017023070073/trnr-ex4_1.htm">Common Stock Purchase Warrant (incorporated by reference from Exhibit 4.1 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed December&#160;13, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;4.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000095017023070073/trnr-ex4_2.htm">Convertible Note (incorporated by reference from Exhibit 4.2 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed December&#160;13, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;4.6*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d367939dex46.htm">Form of Warrant to Purchase Common Stock. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;5.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d367939dex51.htm">Opinion of Pillsbury Winthrop Shaw Pittman LLP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.1#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523021672/d379507dex101.htm">Form of Indemnification Agreement entered into with each of the Registrant&#8217;s officers and directors (incorporated by reference from Exhibit 10.1 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.2#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523008845/d379507dex102.htm">2020 Equity Incentive Plan and Forms of Stock Option Agreement, Notice of Exercise, and Stock Option Grant Notice thereunder (incorporated by reference from Exhibit 10.2 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023).</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.3#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000119312523008845/d379507dex103.htm">2023 Stock Incentive Plan and Forms of Notice of Stock Option Grant, Stock Option Agreement, Notice of Restricted Stock Unit Award, Restricted Stock Unit Agreement, Notice of Restricted Stock Award, and Restricted Stock Agreement thereunder (incorporated by reference from Exhibit 10.3 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.4#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000119312523008845/d379507dex104.htm">2023 Employee Stock Purchase Plan (incorporated by reference from Exhibit 10.4 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.5#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000119312523008845/d379507dex105.htm">Executive Severance Plan (incorporated by reference from Exhibit 10.5 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on </a><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000119312523008845/d379507dex105.htm">April&#160;27, 2023). </a></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">viii </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:88%"></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.6#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000119312523008845/d379507dex106.htm">Executive Annual Incentive Plan (incorporated by reference from Exhibit 10.6 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.7#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523021672/d379507dex107.htm"><span style="white-space:nowrap">Non-Employee&#160;Director</span> Compensation Policy (incorporated by reference from Exhibit 10.7 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.8#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000119312523008845/d379507dex108.htm">Offer Letter from the registrant to Trent A. Ward, dated October&#160;27, 2022 (incorporated by reference from Exhibit 10.8 to the registrant&#8217;s registration statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.9&#8224;#*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d367939dex109.htm">Offer Letter from the registrant to Michael J. Madigan, dated September&#160;27, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.10&#8224;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000095017023027147/trnr-ex10_10.htm">Note Purchase Agreement and Form of Note, dated June&#160;6, 2023 by and among Interactive Strength Inc, THLWY LLC, a Wyoming limited liability company) and the additional lender parties listed therein (incorporated by reference from Exhibit 10.10 to the registrant&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarter ended March&#160;31, 2023, filed with the SEC on June&#160;9, 2023). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.11&#8224;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000095017023070073/trnr-ex10_1.htm">Securities Purchase Agreement, dated December<span style="text-decoration:underline"></span>&#160;7, 2023, by and between Interactive Strength Inc. and 3i, LP (incorporated by reference from Exhibit 10.1 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed December<span style="text-decoration:underline"></span>&#160;13, 2023).<span style="font-style:italic"> </span><span style="font-style:italic"></span></a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.12</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000095017023070073/trnr-ex10_2.htm">Registration Rights Agreement, dated December<span style="text-decoration:underline"></span>&#160;7, 2023, by and between Interactive Strength Inc. and 3i, LP (incorporated by reference from Exhibit 10.2 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed December<span style="text-decoration:underline"></span>&#160;13, 2023).<span style="font-style:italic"> </span></a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.13&#8224;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000095017023070073/trnr-ex10_3.htm">Form of Equity Line Purchase Agreement (incorporated by reference from Exhibit 10.3 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed December<span style="text-decoration:underline"></span>&#160;13, 2023).<span style="font-style:italic"> </span></a><span style="font-style:italic"></span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;10.14</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1785056/000095017023070073/trnr-ex10_4.htm">Form of Equity Line Registration Rights Agreement (incorporated by reference from Exhibit 10.4 to the registrant&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> filed December<span style="text-decoration:underline"></span>&#160;13, 2023).<span style="font-style:italic"> </span></a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;21.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001785056/000119312523008845/d379507dex211.htm">Subsidiaries of the Registrant (incorporated by reference from Exhibit 21.1 to the registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-269246),</span> as declared effective by the SEC on April&#160;27, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;23.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d367939dex231.htm">Consent of Independent Registered Public Accounting Firm. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;23.2*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d367939dex51.htm">Consent of Pillsbury Winthrop Shaw Pittman LLP (included in Exhibit 5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;24.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="#sig">Power of Attorney (included on signature page). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">101.INS*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">101.SCH*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Schema Document.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">101.CAL*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">101.DEF*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Definition Linkbase Document.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">101.LAB*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Label Linkbase Document.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">101.PRE*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File embedded within the Inline XBRL document).</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">107*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d367939dexfilingfees.htm">Filing fee table. </a></td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed herewith. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">#</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Indicates management contract or compensatory plan or arrangement. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">&#8224;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of <span style="white-space:nowrap">Regulation&#160;S-K.&#160;A</span> copy of any omitted schedule or exhibit will be furnished to the SEC upon request. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Austin, Texas, on this 22nd day of December, 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:100%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-weight:bold">INTERACTIVE STRENGTH INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Trent A. Ward</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Trent A. Ward</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Chief Executive Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(Principal Executive Officer)</td></tr>
</table></div> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="sig">POWER OF ATTORNEY </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Trent A. Ward and Michael J. Madigan, and each of them, as their true and lawful <span style="white-space:nowrap"><span style="white-space:nowrap">attorneys-in-fact</span></span> and agents, with full power of substitution and resubstitution, for them and in their name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and sign any registration statement for the same offering covered by the registration statement that is to be effective upon filing pursuant to Rule&#160;462 promulgated under the Securities Act of 1933, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said <span style="white-space:nowrap"><span style="white-space:nowrap">attorneys-in-fact</span></span> and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said <span style="white-space:nowrap"><span style="white-space:nowrap">attorneys-in-fact</span></span> and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement on <span style="white-space:nowrap">Form&#160;S-1</span> has been signed by the following persons in the capacities and on the dates indicated. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:43%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:37%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:18%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signature</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Trent A. Ward</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">Chief Executive Officer and Chair</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">December&#160;22,&#160;2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">Trent A. Ward</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">(<span style="font-style:italic">Principal Executive Officer</span>)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Michael J. Madigan</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">Chief Financial Officer</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">December&#160;22,&#160;2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">Michael J. Madigan</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"><span style="font-style:italic">(Principal&#160;Financial&#160;and&#160;Accounting&#160;Officer)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Kirsten Bartok Touw</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">December&#160;22,&#160;2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">Kirsten Bartok Touw</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Aaron N. D. Weaver</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">December&#160;22,&#160;2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">Aaron N. D. Weaver</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Deepak M. Mulchandani</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">December&#160;22,&#160;2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center">Deepak M. Mulchandani</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-10 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>2
<FILENAME>d367939dex46.htm
<DESCRIPTION>EX-4.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.6 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&#147;ACT&#148;), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES
LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF
COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE THEREOF HAVE BEEN AND WILL BE ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH,
THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE ISSUER THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE
ACT. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE HOLDER OF THIS WARRANT AGREES THAT IT WILL COMPLY WITH THE RESALE RESTRICTIONS SET FORTH IN THE ACT, UNLESS SUCH TRANSACTION IS EXEMPT
FROM THE REGISTRATION REQUIREMENTS OF THE ACT. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE SALE OF SECURITIES WHICH ARE NOT REGISTERED UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS
CAN RESULT IN CIVIL LIABILITY UNDER FEDERAL AND STATE SECURITIES LAWS. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE ISSUER OF THIS WARRANT HAS CLAIMED AN EXEMPTION UNDER THE ACT AND THE
APPLICABLE STATE SECURITIES LAWS FOR THE OFFER AND SALE OF THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE THEREOF. NEITHER THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS CONFIRMED THE ACCURACY OR
DETERMINED THE ADEQUACY OF THIS DOCUMENT OR THE OFFERING HEREUNDER. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERACTIVE STRENGTH INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT TO PURCHASE COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Issued on [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This certifies that, for value received, [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] (together with its
permitted assigns and transferees, &#147;<B><I>Holder</I></B>&#148;) is entitled, subject to the terms and conditions of this Warrant, to purchase from Interactive Strength Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;) at a
price per share equal to the Warrant Price at any time before the Expiration Date up to the Exercise Amount shares of Warrant Stock upon surrender of this Warrant, together with a duly executed subscription form in the form attached hereto as
<U>Exhibit 1</U> and simultaneous payment of an amount equal to the product obtained by multiplying the Warrant Price by the number of shares of Warrant Stock so purchased in lawful money of the United States, or if permitted, by an election to net
exercise as set forth in Section&nbsp;2.6. The Warrant Price and the number and character of shares of Warrant Stock purchasable under this Warrant are subject to adjustment as provided </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Warrant is being issued to Holder in connection with, and as partial consideration for, Holder&#146;s purchase of the Company&#146;s
Secured Promissory Note on or about the date hereof (the &#147;<B><I>Note</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><U>DEFINITIONS</U></B><B>.</B> The
following definitions shall apply for purposes of this Warrant: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Adjusted</I></B> <B><I>Warrant</I></B>
<B><I>Price</I></B>&#148; means, if at any time after the date hereof and before the Expiration Date, the Company issues shares of Common Stock at a purchase price per share of less than
$[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] (subject to adjustment as provided herein), the lowest price per share at which the Company issues Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Affiliate</I></B>&#148; means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is
controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more
general partners or managing members of, or shares the same management company with, such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Business</I></B>
<B><I>Day</I></B>&#148; means a weekday on which banks are open for general banking business in New York, New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Certificate</I></B>&#148; means the Company&#146;s Amended and Restated Certificate of Incorporation, as amended from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Change</I></B> <B><I>of</I></B> <B><I>Control</I></B>&#148; means a Deemed Liquidation Event (as defined in the
Certificate). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Company</I></B>&#148; shall include, in addition to the Company identified in the opening paragraph of this
Warrant, any corporation or other entity that succeeds to the Company&#146;s obligations under this Warrant, whether by permitted assignment, by merger or consolidation or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Exercise</I></B> <B><I>Amount</I></B>&#148; means an amount equal to
$[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] divided by the Warrant Stock Fair Market Value pursuant to Section&nbsp;2.6.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Expiration</I></B> <B><I>Date</I></B>&#148; means 5:00 p.m. New York City time on
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] or such earlier date and time on which the Warrant ceases to be exercisable as provided in Section&nbsp;4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Initial</I></B> <B><I>Exercise</I></B> <B><I>Date</I></B>&#148; means the date that is
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Person</I></B>&#148; means
an individual, corporation, limited liability company, partnership, association, joint-stock company, trust, unincorporated organization, joint venture or other entity or any governmental authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Securities</I></B> <B><I>Act</I></B>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Warrant</I></B>&#148; means this Warrant and any warrant(s) delivered in substitution or exchange therefor, as provided herein.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Warrant</I></B> <B><I>Price</I></B>&#148; means the <U>greater</U> of (a)&nbsp;the Warrant Price Floor and (b)&nbsp;the
<U>lesser</U> of (x) $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] and (y) the Adjusted Warrant Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Warrant</I></B> <B><I>Price</I></B> <B><I>Floor</I></B>&#148; means an amount that, after giving effect to the issuance of Warrant
Stock upon full or partial exercise of this Warrant in accordance with the terms hereof, would result in Holder beneficially owning [&nbsp;&nbsp;&nbsp;&nbsp;]% of the Company&#146;s then-outstanding Common Stock, including, for the avoidance of
doubt, Common Stock otherwise beneficially owned by Holder, regardless of whether such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Common Stock was obtained upon exercise of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Warrant</I></B> <B><I>Stock</I></B>&#148; means the Common Stock of the Company, $0.0001 par value per share
(&#147;<B><I>Common</I></B> <B><I>Stock</I></B>&#148;). The number and character of shares of Warrant Stock are subject to adjustment as provided herein and the term &#147;<B><I>Warrant</I></B> <B><I>Stock</I></B>&#148; shall include stock and other
securities and property at any time receivable or issuable upon exercise of this Warrant taking into account all such adjustments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.
<B><U>EXERCISE</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Method</U></B><U> </U><B><U>of</U></B><U> </U><B><U>Exercise</U></B>. Subject to
the terms and conditions of this Warrant, Holder may exercise this Warrant in whole or in part, at any time or from time to time, on any Business Day after the Initial Exercise Date but before the Expiration Date. This Warrant shall be exercised by
surrendering this Warrant, with the subscription form attached hereto duly executed by Holder, and by payment in a form specified in Section&nbsp;2.2 of an amount equal to the product obtained by multiplying (i)&nbsp;the number of shares of Warrant
Stock to be purchased by Holder by (ii)&nbsp;the Warrant Price as determined in accordance with the terms hereof or, if applicable, an election to net exercise the Warrant as provided in Section&nbsp;2.6 for the number of shares to be acquired in
connection with such exercise. Holder may deliver the subscription form attached hereto duly executed by Holder in order to exercise this Warrant in connection with a Change of Control, with the exercise and payment to be contingent upon
consummation of the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Form</U></B><U> </U><B><U>of</U></B><U> </U><B><U>Payment</U></B>.
Subject to the provisions of Section&nbsp;4, payment for the Warrant Stock upon exercise may be made by (a)&nbsp;a check payable to the Company&#146;s order, (b)&nbsp;wire transfer of funds to the Company, (c)&nbsp;cancellation of indebtedness of
the Company to Holder, (d)&nbsp;by net exercise as provided in Section&nbsp;2.6, or (e)&nbsp;any combination of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.3&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Partial</U></B><U> </U><B><U>Exercise</U></B><B>.</B> Upon a partial exercise of this Warrant, this Warrant
shall be cancelled and replaced with a new Warrant of like tenor in which the total number of shares of Warrant Stock issuable hereunder as set forth in the first paragraph hereof is reduced by the number of shares of Warrant Stock purchased
pursuant to such exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No</U></B><U> </U><B><U>Fractional</U></B><U> </U><B><U>Shares</U></B>. No
fractional shares may be issued upon any exercise of this Warrant. If upon exercise of this Warrant in whole or in part, a fraction of a share would otherwise result, then in lieu of such fractional share, the Company shall pay to Holder an amount
in cash equal to such fraction of a share multiplied by the applicable Warrant Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.5&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Restrictions</U></B><U> </U><B><U>on</U></B><U> </U><B><U>Exercise</U></B>. This Warrant may not be exercised
if the issuance of the Warrant Stock upon such exercise would constitute a violation of any applicable federal or state securities laws or other laws or regulations, including regulations of the stock exchange on which the Company is listed at the
time of such exercise. As a condition to the exercise of this Warrant, Holder shall execute the subscription form attached hereto as <U>Exhibit 1</U>, confirming and acknowledging that the representations and warranties of the original Holder set
forth in herein are true and complete as of the date of exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.6&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Net</U></B><U>
</U><B><U>Exercise</U></B><U> </U><B><U>Election;</U></B><U> </U><B><U>Exercise</U></B><U> </U><B><U>Generally</U></B><B>.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.6.1&nbsp;&nbsp;&nbsp;&nbsp;Holder may elect to convert all or any portion of this Warrant at any time after the Initial Exercise Date but
before the Expiration Date, without the payment by Holder of any additional consideration, by the surrender of this Warrant to the Company, with the net exercise election selected in the subscription form attached hereto, duly executed by Holder,
into up to the number of shares of Warrant Stock that is obtained under the following formula: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"><B>X =&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><B><FONT STYLE="white-space:nowrap">Y&nbsp;(A-B)</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">where</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">X</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Warrant Stock to be issued to Holder pursuant to a net exercise of this Warrant effected pursuant to this Section 2.6.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Y</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the number of shares of Warrant Stock as to which this Warrant is then being net exercised.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the fair market value of one share of Warrant Stock, determined at the time of such net exercise as set forth in the last paragraph of this Section&nbsp;2.6.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">B</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">the Warrant Price.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will promptly respond in writing to an inquiry by Holder as to the then current fair market value of one share of
Warrant Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.6.2&nbsp;&nbsp;&nbsp;&nbsp;The fair market value of one share of Warrant Stock (the &#147;<B><I>Warrant</I></B>
<B><I>Stock</I></B> <B><I>Fair</I></B> <B><I>Market</I></B> <B><I>Value</I></B>&#148;) shall mean: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;if the Company is at such time subject to a Change of Control, the fair market value of Warrant
Stock shall be deemed to be the value received by the holders of such stock pursuant to such Change of Control; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;if on the relevant exercise date for which such value must be determined, a public market for the
Company&#146;s Common Stock, then the fair market value per share of the Warrant Stock shall be determined by reference to the market price of the Common Stock as follows: the fair market value shall be the average of (i)&nbsp;the closing bid and
asked prices of the Common Stock quoted in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Over-The-Counter</FONT></FONT> Market Summary or (ii)&nbsp;the last reported sale price of the Common Stock or the closing price quoted
on the Nasdaq Stock Market or on any exchange on which the Common Stock is listed, whichever is applicable, as published in the Western Edition of <I>The</I> <I>Wall</I> <I>Street</I> <I>Journal</I> for the five (5)&nbsp;trading days prior to the
date as of which the value of the fair market value is to be determined; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;if neither
(i)&nbsp;nor (ii) is applicable, then the Company&#146;s Board of Directors shall consider the relevant facts and circumstances at such time when determining the fair market value of Warrant Stock in good faith, including the highest price per share
which the Company could obtain on the date of calculation from a willing buyer (not a current employee or director) for shares of Warrant Stock sold by the Company, from authorized but unissued shares, as determined by a reputable independent
appraiser the identity of which shall be determined by the Company and the Holder and whose fees and expenses shall be borne by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>ISSUANCE</U></B><U> </U><B><U>OF</U></B><U> </U><B><U>STOCK</U></B><B>.</B> Except as set forth in
Section&nbsp;4, this Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender for exercise as provided above, and the person entitled to receive the shares of Warrant Stock issuable upon
such exercise shall be treated for all purposes as the holder of record of such shares as of the close of business on such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>EXERCISES</U></B><U> </U><B><U>IN</U></B><U> </U><B><U>CONNECTION</U></B><U> </U><B><U>WITH</U></B><U>
</U><B><U>CERTAIN</U></B><U> </U><B><U>TRANSACTIONS</U></B><U> </U><B><U>OR</U></B> <B><U>EXPIRATION</U></B><U> </U><B><U>DATE.</U></B><U> </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1&nbsp;&nbsp;&nbsp;&nbsp;If the Company proposes at any time to effect a Change of Control, the Company shall give Holder at least ten
(10)&nbsp;Business Days advance written notice (a &#147;<B><I>Transaction</I></B> <B><I>Notice</I></B>&#148;) of the anticipated consummation of such Change of Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2&nbsp;&nbsp;&nbsp;&nbsp;If Holder has not elected to exercise this Warrant (a)&nbsp;under Section&nbsp;2.1 in connection with (i)&nbsp;a
Change of Control pursuant to a Transaction Notice or (b)&nbsp;prior to the Expiration Date, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then upon the effective date of the Change of Control or Expiration Date, as applicable, this Warrant shall
automatically be deemed net exercised in full pursuant to Section&nbsp;2.6 above without any further action on the part of Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>ADJUSTMENT</U></B><U> </U><B><U>PROVISIONS</U></B><B>.</B> The number and character of shares of Warrant Stock
issuable upon exercise of this Warrant and the Warrant Price therefor, are subject to adjustment upon each event in Sections 5.1 through 5.4 occurring between the date this Warrant is issued and earlier of the time that it is exercised in full or
the Expiration Date: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.1&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Adjustment</U></B><U> </U><B><U>for</U></B><U> </U><B><U>Stock</U></B><U>
</U><B><U>Splits</U></B><U> </U><B><U>and</U></B><U> </U><B><U>Stock</U></B><U> </U><B><U>Dividends</U></B>. The Warrant Price and the number of shares of Warrant Stock for which this Warrant remains exercisable shall each be proportionally adjusted
to reflect any stock dividend, stock split, reverse stock split or other similar event affecting the number of outstanding shares of Warrant Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Adjustment</U></B><U> </U><B><U>for</U></B><U> </U><B><U>Other</U></B><U> </U><B><U>Dividends</U></B><U>
</U><B><U>and</U></B><U> </U><B><U>Distributions</U></B>. In case the Company shall make or issue, or shall fix a record date for the determination of eligible holders entitled to receive a dividend or other distribution payable with respect to the
Warrant Stock that is payable in (a)&nbsp;securities of the Company (other than issuances with respect to which adjustment is made under Section&nbsp;5.1 or Section&nbsp;5.3) or (b)&nbsp;assets (other than cash) which dividend or distribution is
actually made (each a &#147;<B><I>Dividend</I></B> <B><I>Event</I></B>&#148;), then, and in each such case, Holder, upon exercise of this Warrant at any time after such Dividend Event, shall receive, in addition to the shares of Warrant Stock, the
securities or such other assets of the Company that would have been payable to Holder if Holder had completed such exercise of this Warrant, immediately prior to such Dividend Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.3&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Adjustment</U></B><U> </U><B><U>for</U></B><U> </U><B><U>Reorganization,</U></B><U>
</U><B><U>Consolidation,</U></B><U> </U><B><U>Merger</U></B>. (a)&nbsp;In case of any recapitalization or reorganization of the Company or (b)&nbsp;in case the Company shall consolidate with or merge into one or more other corporations or entities
which results in a change of the Warrant Stock (each, a &#147;<B><I>Reorganization</I></B> <B><I>Event</I></B>&#148;), then, and in each such case, Holder, upon the exercise of this Warrant after such Reorganization Event shall be entitled to
receive, in lieu of the stock or other securities and property that Holder would have been entitled to receive upon such exercise prior to such Reorganization Event, the stock or other securities or property which Holder would have been entitled to
receive upon such Reorganization Event if, immediately prior to such Reorganization Event, Holder had completed such exercise of this Warrant, all subject to further adjustment as provided in this Warrant. If after such Reorganization Event, the
Warrant is exercisable for securities of a corporation or entity other than the Company, then such corporation or entity shall duly execute and deliver to Holder a supplement hereto acknowledging such corporation&#146;s or other entity&#146;s
obligations under this Warrant; and in each such case, the terms of this Warrant shall be applicable to the shares of stock or other securities or property receivable upon the exercise of this Warrant after the consummation of such Reorganization
Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Conversion</U></B><U> </U><B><U>of</U></B><U> </U><B><U>Stock</U></B>. In case the Warrant Stock
ceases to exist or to be authorized by the Certificate (a &#147;<B><I>Stock</I></B> <B><I>Event</I></B>&#148;), then Holder, upon exercise of this Warrant at any time after such Stock Event, shall receive, in lieu of the number of shares of Warrant
Stock that would have been issuable upon exercise of this Warrant immediately prior to such Stock Event, the stock and other securities and property that Holder would have been entitled to receive upon the Stock Event, if, immediately prior to such
Stock Event, Holder had completed such exercise of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.5&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Notice</U></B><U>
</U><B><U>of</U></B><U> </U><B><U>Adjustments</U></B>. The Company shall promptly give written notice of each adjustment under Section&nbsp;5 of the Warrant Price or the number of shares of Warrant Stock or other securities that remain issuable upon
exercise of this Warrant. The notice shall describe the adjustment and show in reasonable detail the facts on which the adjustment or readjustment is based. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.6&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No</U></B><U> </U><B><U>Change</U></B><U> </U><B><U>Necessary</U></B>. The form of this Warrant need not be
changed because of any adjustment in the Warrant Price or in the number of shares of Warrant Stock issuable upon its exercise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.7&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Reservation</U></B><U> </U><B><U>of</U></B><U>
</U><B><U>Stock</U></B>. The Company will at all times reserve and keep available, solely for the issuance and delivery upon the exercise of this Warrant, such shares of Warrant Stock and other stock, securities and property, as from time to time
shall be issuable upon the exercise of this Warrant. If the number of shares of Warrant Stock or other securities issuable upon exercise of this Warrant that are authorized and unissued under the Certificate shall not be sufficient to effect the
exercise of this Warrant in full, the Company will promptly take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Warrant Stock or other securities issuable upon exercise of
this Warrant as shall be sufficient for such purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><U>NO</U></B><U> </U><B><U>IMPAIRMENT</U></B><B>.</B> The Company will not,
by amendment of its Certificate or bylaws, or through reorganization, consolidation, merger, dissolution, issue or sale of securities, sale of assets or any other action, avoid or seek to avoid the observance or performance of any of the terms of
this Warrant, or impair the economic interest of the Holder, and the Company shall at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect
the rights and economic interest of Holder against such impairment. Without limiting the generality of the foregoing, the Company will take all such action as may be necessary or appropriate in order that the Company may duly and validly issue fully
paid and nonassessable shares of Warrant Stock upon the exercise of this Warrant, and ensure and take any necessary action to ensure, that the Warrant Stock, at the time of their issuance, will be free and clear from all preemptive rights,
anti-dilution rights, rights of first refusal, rights of first offer, <FONT STYLE="white-space:nowrap">co-sale</FONT> rights, or any similar rights and free and clear of all debts, taxes, liens, encumbrances, charges, equities, claims, any rights of
third parties and any other liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><U>PROVISIONS</U></B><U> </U><B><U>RELATING</U></B><U> </U><B><U>TO</U></B><U>
</U><B><U>STOCKHOLDER</U></B><U> </U><B><U>RIGHTS</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.1&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No</U></B><U> </U><B><U>Voting</U></B><U>
</U><B><U>or</U></B><U> </U><B><U>Other</U></B><U> </U><B><U>Rights</U></B>. This Warrant does not entitle Holder to any voting rights or other rights as a stockholder of the Company, unless and until (and only to the extent that) this Warrant is
actually validly exercised for shares of the Company&#146;s capital stock in accordance with its terms. In the absence of valid exercise of this Warrant, no provisions of this Warrant, and no enumeration herein of the rights or privileges of Holder,
shall cause Holder to be a stockholder of the Company for any purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><U>REPRESENTATIONS</U></B><U> </U><B><U>AND</U></B><U>
</U><B><U>WARRANTIES</U></B><U> </U><B><U>OF</U></B><U> </U><B><U>HOLDER.</U></B> In order to induce the Company to issue this Warrant to the original Holder, the original Holder has made representations and warranties to the Company as set forth in
the Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><U>GENERAL</U></B><U> </U><B><U>PROVISIONS.</U></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Attorneys&#146;</U></B><U> </U><B><U>Fees</U></B><B>.</B> In the event any party is required to engage the
services of any attorneys for the purpose of enforcing this Warrant, or any provision thereof, the substantially prevailing party shall be entitled to recover its reasonable expenses and costs in enforcing this Warrant, including attorneys&#146;
fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Transfer</U></B><B>.</B> Neither this Warrant nor any rights hereunder may be assigned, conveyed
or transferred, in whole or in part, by a party without the prior written consent of the other party, which other party may withhold in its sole discretion; <I><U>provided,</U></I><U> </U><I><U>however</U></I>, that this Warrant may be assigned,
conveyed or transferred without the prior written consent of the Company to any Affiliate of Holder who executes and delivers an acknowledgement that such transferee agrees to be subject to, and bound by, all the terms and conditions of this
Warrant. Subject to the foregoing, the rights and obligations of the Company and Holder under this Warrant shall be binding upon and benefit their respective permitted successors, assigns, heirs, administrators and transferees. For the avoidance of
doubt, any such transfer contemplated by this Section&nbsp;9.2 shall comply with applicable state and federal securities laws, and the Company shall bear no liability in the event a transfer is not made in accordance therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.3&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Governing</U></B><U> </U><B><U>Law</U></B><B>.</B> This
Warrant shall be governed by and construed under the internal laws of the State of Delaware as applied to agreements entered into and to be performed entirely within the State of Delaware, without reference to principles of conflict of laws or
choice of laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.4&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Headings</U></B><B>.</B> The headings and captions used in this Warrant are used only
for convenience and are not to be considered in construing or interpreting this Warrant. All references in this Warrant to sections and exhibits shall, unless otherwise provided, refer to sections hereof and exhibits attached hereto, all of which
exhibits are incorporated herein by this reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.5&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Notices</U></B><B>.</B> Unless otherwise provided
herein, any notice required or permitted under this Warrant shall be given in writing and shall be deemed effectively given (a)&nbsp;at the time of personal delivery, if delivery is in person; (b)&nbsp;one (1) Business Day after deposit with an
express overnight courier for United States deliveries, or three (3)&nbsp;Business Days after deposit with an international express overnight air courier for deliveries outside of the United States, in each case with proof of delivery from the
courier requested; or (c)&nbsp;when sent, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the next Business Day, in each case when addressed to the party to be notified
at the address indicated for such party on the signature pages hereto, or at such other address as any party hereto may designate by giving ten (10)&nbsp;days&#146; advance written notice to all other parties in accordance with the provisions of
this Section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.6&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Amendment;</U></B><U> </U><B><U>Waiver</U></B><B>.</B> This Warrant may be amended and
provisions may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.7&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Severability</U></B><B>.</B> If one or more provisions of this Warrant are held to be unenforceable under
applicable law, then such provision(s) shall be excluded from this Warrant to the extent they are unenforceable and the remainder of the Warrant shall be interpreted as if such provision(s) were so excluded and shall be enforceable in accordance
with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.8&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Rights</U></B><U> </U><B><U>of</U></B><U> </U><B><U>the</U></B><U>
</U><B><U>Holder</U></B>. Without limiting the foregoing or any remedies available to the Holder, the Holder will be entitled to seek specific performance of the obligations hereunder and injunctive relief against actual or threatened violations of
the obligations of any person subject to this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.9&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Survival</U></B><U> </U><B><U>of</U></B><U>
</U><B><U>Representations</U></B>. Unless otherwise provided herein, the representations, warranties and covenants contained in or made pursuant to this Warrant shall survive the exercise of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN</B> <B>WITNESS</B> <B>WHEREOF,</B> the parties hereto have executed this Warrant to
Purchase Common Stock as of the date first written above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>THE COMPANY: </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INTERACTIVE STRENGTH INC. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B><U>HOLDER:</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:550pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Common Stock Warrant] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT 1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FORM OF SUBSCRIPTION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(To be completed and signed only upon exercise of Warrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To: Interactive Strength Inc. (the <B>&#147;</B><B><I>Company</I></B><B>&#148;</B>) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We refer to that certain Warrant to Purchase Common Stock of the Company issued on
[<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>] (the &#147;<B><I>Warrant</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Select one of the following two alternatives: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#9744; <B><U>Cash</U></B><U> </U><B><U>Exercise</U></B><B>.</B> On the terms and conditions set forth in the
Warrant, the undersigned Holder hereby elects to purchase <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares of Common Stock of the Company (the &#147;<B><I>Warrant</I></B> <B><I>Stock</I></B>&#148;), pursuant to
the terms of the attached Warrant, and tenders herewith payment of the purchase price for such shares in full. This exercise &#9744; IS &#9744; IS NOT conditioned upon the completion of the Change in Control that has been described in a Transaction
Notice, dated <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, delivered by the Company to Holder pursuant to Section&nbsp;4 of the Warrant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#9744; <B><U>Net</U></B><U> </U><B><U>Exercise</U></B><U> </U><B><U>Election</U></B><B>.</B> On the terms and
conditions set forth in the Warrant, the undersigned Holder elects to convert the Warrant into shares of Warrant Stock by net exercise election pursuant to Section&nbsp;2.6 of the Warrant. This conversion is exercised with respect to
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares of Common Stock of the Company (the <B>&#147;</B><B><I>Warrant</I></B> <B><I>Stock</I></B>&#148;) covered by the Warrant. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In exercising the Warrant, the undersigned Holder hereby confirms and acknowledges that the representations and warranties set forth in the
Note as they apply to the undersigned Holder continue to be true and complete as of this date. Please issue a certificate or certificates representing such shares of Warrant Stock in Holder&#146;s name and deliver such certificate(s) to Holder at
the address set forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">(Address)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">(City, State, Zip Code)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000">(Federal Tax Identification Number)</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREFORE, the undersigned Holder has executed and delivered the Warrant and this Subscription Form as
of the date set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>[INSERT HOLDER&#146;S NAME]</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[Its:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">]</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d367939dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PILLSBURY WINTHROP SHAW PITTMAN LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2550 Hanover Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Palo Alto, CA
94304-1115 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">December 22, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interactive
Strength Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1005 Congress Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Suite 925 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Austin, Texas 78701 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Re:&nbsp;&nbsp;&nbsp;&nbsp; Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are acting as
counsel for Interactive Strength Inc., a Delaware corporation (the &#147;Company&#148;), in connection with the Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (the &#147;Registration Statement&#148;) filed by the
Company with the Securities and Exchange Commission&nbsp;under the Securities Act of 1933 (the &#147;Act&#148;) relating to the registration of an aggregate of 12,480,480 shares of common stock, $0.0001 par value per share (the &#147;Common
Stock&#148;) of the Company, consisting of (i)&nbsp;11,556,000 shares of Common Stock (the &#147;Conversion Shares&#148;) issuable upon the conversion of the Company&#146;s senior unsecured convertible note due December&nbsp;7, 2024 (the
&#147;Note&#148;) and (ii)&nbsp;924,480 shares of Common Stock (the &#147;Warrant Shares&#148; and together with the Conversion Shares, the &#147;Shares&#148;) issuable upon the exercise of the warrant (the &#147;Warrant&#148;) issued in connection
with the Note. The Shares are to be offered and sold from time to time by the selling stockholder listed in the Registration Statement under &#147;Selling Stockholder&#148; (the &#147;Selling Stockholder&#148;). The Note and Warrant were issued
pursuant to a securities purchase agreement dated December&nbsp;7, 2023 by and between the Company and the Selling Stockholder (the &#147;Securities Purchase Agreement&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have reviewed the Registration Statement, the Securities Purchase Agreement, the Note, the Warrant, and such other agreements, documents, records,
certificates and other materials, and have reviewed and are familiar with such corporate proceedings and satisfied ourselves as to such other matters, as we have considered relevant or necessary as a basis for our opinions set forth in this letter.
In such review, we have assumed the accuracy and completeness of all agreements, documents, records, certificates and other materials submitted to us, the conformity with the originals of all such materials submitted to us as copies (whether or not
certified and including facsimiles), the authenticity of the originals of such materials and all materials submitted to us as originals, the genuineness of all signatures and the legal capacity of all natural persons, and that each of the Securities
Purchase Agreement, Note, and Warrant has been duly authorized, executed and delivered by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the basis of the foregoing and subject to the
other qualifications and limitations set forth herein, we are of the opinion that (a)&nbsp;the Conversion Shares have been duly authorized and, when issued by the Company upon conversion of the Note in accordance with the Securities Purchase
Agreement and the Note, will be validly issued, fully paid and nonassessable and (b)&nbsp;the Warrant Shares have been duly authorized and, when issued by the Company upon the exercise of the Warrant in accordance with the Securities Purchase
Agreement and the Note, will be validly issued, fully paid and nonassessable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our opinions set forth above, we have assumed that
(i)&nbsp;at or prior to the time of the delivery of any of the Conversion Shares, the Board of Directors of the Company shall not have rescinded or otherwise modified the authorization of such Conversion Shares, (ii)&nbsp;at or prior to the time of
the delivery of any of the Warrant Shares, the Board of Directors of the Company shall not have rescinded or otherwise modified the authorization of the Warrant Shares, and (iii)&nbsp;at or prior to the time of the delivery of any of the Shares
(x)&nbsp;the Company shall remain validly existing as a corporation in good standing under the General Corporation Law of the State of Delaware, (y)&nbsp;the Company will have a sufficient number of authorized but unissued shares thereof under the
Certificate of Incorporation of the Company at the time of such issuance, and (z)&nbsp;there shall not have occurred any change in law affecting the validity or enforceability of the Securities Purchase Agreement, the Note, or the Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinions set forth in this letter are limited to the General Corporation Law of the State of Delaware, as in effect on the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion letter as Exhibit&nbsp;5.1 to the Registration Statement and to the use of our name under the caption
&#147;Legal Matters&#148; in the Registration Statement and in the Prospectus included therein. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Act or
the rules and regulations of the Securities and Exchange Commission promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Pillsbury Winthrop Shaw Pittman LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>4
<FILENAME>d367939dex109.htm
<DESCRIPTION>EX-10.9
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.9 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g367939dsp216.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interactive Strength, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">dba FORME Life</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>9/27/2022</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">204 West Spear Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Suite 3697</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Mike Madigan</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Carson City, NV 89703</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Contact Information</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">370 Hourglass Lane</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">Baldwinsville, NY 13027</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Delivered via DocuSign </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: Offer Letter - Senior Director, Finance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear
<B>Mike:</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interactive Strength, Inc. (the &#147;Company&#148;) is pleased to offer you employment on the terms described herein. Your official start
date will be mutually agreed upon, with a target start date of <B>September</B><B></B><B>&nbsp;29, 2022.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <B>Position</B>. You are being hired in a
full-time position, exempt role as the <B>Senior Director, Finance. In this role, you will be responsible for </B>planning, forecasting, budgeting, and analytical activities that support the company&#146;s major business decisions and overall
financial health.. Please keep in mind that the Company&#146;s business needs require that all employees are highly flexible in their ability to perform multiple tasks and accept changes in their duties when necessary. By accepting this offer of
employment, you agree that your job title is subject to change and that your job duties may change from time to time in accordance with the Company&#146;s business needs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <B>Duties</B>. You will be responsible for duties normally associated with such a position. You will report to <B>Ben Bartlett</B>. Longer-term reporting
structures may shift per the business needs of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <B>Location. </B>Remote </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <B>Compensation. </B>You will be paid a starting annual base salary at the rate of <B>$227,000 </B>USD, payable semi-monthly on the Company&#146;s regular
payroll dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <B>Benefits</B>. As a regular employee of the Company, you will be eligible to participate in a number of Company-sponsored benefits,
which are described in the employee benefits summary attached hereto as Exhibit A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <B>Stock Options</B>. Subject to the approval of the Company&#146;s
Board of Directors, you will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
granted an option to purchase <B>220,000 </B>shares of the Company&#146;s common stock. The option will be subject to the terms and conditions applicable to options granted under the
Company&#146;s 2020 Stock Option Plan, as described in that plan and the applicable stock option agreement, which you will be required to sign. <FONT STYLE="white-space:nowrap">One-fourth</FONT> (25%) of the options will vest on the <FONT
STYLE="white-space:nowrap">12-month</FONT> anniversary of your vesting commencement date and thereafter 1/48th of the total options will vest in monthly installments during continuous service, as described in the applicable stock option agreement.
The exercise price per share will be equal to the fair market value per share on the date the option is granted, as determined by the Company&#146;s Board of Directors in good faith compliance with applicable guidance in order to avoid having the
option be treated as deferred compensation under Section&nbsp;409A of the Internal Revenue Code of 1986, as amended. There is no guarantee that the Internal Revenue Service will agree with this value. You should consult with your own tax advisor
concerning the tax risks associated with accepting an option to purchase the Company&#146;s common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, you will be eligible to receive a
retention bonus of <B>$25,000 </B>which will be payable on or around the anniversary of your start date. This performance bonus is taxable, and all regular payroll taxes will be withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <B>Confidential Information and Invention Assignment Agreement. </B>As a condition of employment, you will be required to sign and comply with a
Confidentiality (Exhibit B) and Invention Assignment Agreement (Exhibit C), which among other things, prohibits unauthorized use or disclosure of Company proprietary information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <B>Company Policies</B>. As a Company employee, you will be expected to abide by the Company&#146;s rules and standards. A handbook will be provided for
your review upon your start date. You will be required to sign an acknowledgment that you have read and that you understand the Company&#146;s rules of conduct which are included in the Company Handbook. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. <B><FONT STYLE="white-space:nowrap">I-9</FONT> Condition to Employment. </B>As a condition of employment, you will be required to sign and return a
satisfactory <FONT STYLE="white-space:nowrap">I-9</FONT> Immigration form providing sufficient documentation establishing your employment eligibility in the United States, and provide satisfactory proof of your identity as required by United States
law. This documentation must be provided prior to your Start Date as a condition of this offer and of your employment. Failure to provide this documentation will result in immediate termination of this relationship. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. <B>Background Check</B>. Your employment may be further subject to the satisfactory completion of a background check. We will notify you in writing in the
case that a background check will be conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. <B>Representation</B>. By signing below, you represent that your performance of services to the
Company will not violate any duty which you may have to any other person or entity (such as a present or former employer), including obligations concerning providing services (whether or not competitive) to others, confidentiality of proprietary
information and assignment of inventions, ideas, patents or copyrights, and you agree that you will not do anything in the performance of services hereunder that would violate any such duty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. <B>Employment Relationship. </B>Notwithstanding any of the above, your employment with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Confidential | Page 2
</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company is <FONT STYLE="white-space:nowrap">&#147;at-will&#148;.</FONT> This means you may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying
the Company. Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice. Although your job duties, title, compensation and benefits, as well as the Company&#146;s personnel
policies and procedures, may change from time to time, the <FONT STYLE="white-space:nowrap">&#147;at-will&#148;</FONT> nature of your employment may only be changed in an express written agreement signed by you and the Company&#146;s Chief Executive
Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. <B>Dispute Resolution</B>. In the event of any dispute or claim relating to or arising out of our employment relationship, you and the
Company agree that (i)&nbsp;any and all disputes between you and the Company shall be fully and finally resolved by binding arbitration as outlined in Exhibit B. Please note that we must receive your signed Agreement before your first day of
employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. <B>Outside Activities. </B>While you render services to the Company, you agree that you will not engage in any other employment,
consulting, or other business activity without the written consent of the Company. In addition, while you render services to the company, you will not assist any person or entity in competing with the Company, in preparing to compete with the
Company or in hiring any employees or consultants of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. <B>Withholding Taxes. </B>All forms of compensation referred to in this letter are
subject to applicable withholding and payroll taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. <B>Entire Agreement</B>. If you accept this offer, this letter and the Confidential Information
and Invention Assignment Agreement shall constitute the complete agreement between you and Company with respect to the terms and conditions of your employment. Any prior or contemporaneous representations (whether oral or written) not contained in
this letter or the Confidential Information and Invention Assignment Agreement or contrary to those contained in this letter or the Confidential Information and Invention Assignment Agreement, that may have been made to you are expressly canceled
and superseded by this offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>[Signature Page Follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Confidential | Page 3
</P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you wish to accept this offer, please sign and date this letter, and the attached Confidentiality and
Invention Assignment Agreement and return it to the Company by <B>September</B><B></B><B>&nbsp;28, 2022.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We look forward to having you join the FORME
team! </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>INTERACTIVE STRENGTH, INC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>


<IMG SRC="g367939dsp219a.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marybeth Weiss</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">VP, People&nbsp;&amp; Culture</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">9/27/2022</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"><B>ACCEPTED AND AGREED:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Signature:


<IMG SRC="g367939dsp219b.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Name: Mike Madigan</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date: 9/27/2022</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Confidential | Page 4
</P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>d367939dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the use in this Registration Statement <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;S-1&nbsp;of</FONT> our report dated March&nbsp;29,
2023, relating to the financial statements of Interactive Strength Inc. dba FORME. We also consent to the reference to us under the heading &#147;Experts&#148; in such Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Deloitte&nbsp;&amp; Touche LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morristown, NJ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December 22, 2023 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>d367939dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML><HEAD>
<TITLE>EX-FILING FEES</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 107 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calculation of Filing Fee Tables </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERACTIVE
STRENGTH INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table 1: Newly Registered and Carry Forward Securities </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Security<BR>Type</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Security</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Class&nbsp;Title</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Fee<BR>Calculation<BR>or Carry<BR>Forward<BR>Rule</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Amount<BR>Registered&nbsp;(1)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Proposed<BR>Maximum<BR>Offering<BR>Price Per<BR>Unit (2)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Maximum<BR>Aggregate<BR>Offering<BR>Price (2)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Fee Rate</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><B>Amount of<BR>Registration<BR>Fee (2)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" COLSPAN="23" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="23" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt; padding-right:2pt"><B>Securities to Be Registered</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">Fees&nbsp;to &nbsp;&nbsp;Be&nbsp;Paid&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Equity</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000">Shares of&nbsp;Common Stock, $0.0001&nbsp;par&nbsp;value per share</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Other</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12,480,480&nbsp;(3)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.89</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,107,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0001476</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">$1,639</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="right" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Total&nbsp;Offering Amounts</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000" ALIGN="right">11,107,627</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">$1,639</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Total Fees Previously Paid</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Total Fee Offsets</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000"><B>Net Fee Due</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">$1,639</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this
Registration Statement shall also cover any additional shares of common stock, par value $0.0001 per share (&#147;Common Stock&#148;), of the registrant that become issuable by reason of any stock dividend, stock split, recapitalization or other
similar transaction effected without receipt of consideration. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In accordance with Rule 457(c), based on the average of the high ($0.92) and low ($0.85) prices of the Common
Stock on the Nasdaq Stock Market on December&nbsp;19, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents (a) 11,556,000 shares of Common Stock that may be sold by the selling stockholder named herein upon
the conversion of the Note (as defined herein); and (b) 924,480 shares of Common Stock that may be sold by the selling stockholder named herein upon the exercise of the Warrant (as defined herein). </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>trnr-20230930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 22-December-2023 [11:38:22] {AM}-->
<schema targetNamespace="http://formelife.com/20230930" elementFormDefault="qualified" xmlns:trnr="http://formelife.com/20230930" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
<annotation>
<appinfo>
<link:roleType roleURI="http://formelife.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document - Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
<link:definition>1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
<link:definition>1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" id="CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
<link:definition>1004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited" id="CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited">
<link:definition>1005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2 (UNAUDITED)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited" id="CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited">
<link:definition>1006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" id="CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical">
<link:definition>1007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited" id="CondensedConsolidatedStatementOfCashFlowsUnaudited">
<link:definition>1008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
<link:definition>1009 - Disclosure - Description of Business and Basis of Presentation</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1010 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/RevenueRecognition" id="RevenueRecognition">
<link:definition>1011 - Disclosure - Revenue Recognition</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" id="SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements">
<link:definition>1012 - Disclosure - Simple Agreements for Future Equity and Advance Subscription Agreements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/InventoriesNet" id="InventoriesNet">
<link:definition>1013 - Disclosure - Inventories, Net</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
<link:definition>1014 - Disclosure - Property and Equipment, Net</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
<link:definition>1015 - Disclosure - Intangible Assets, Net</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssets" id="PrepaidExpensesAndOtherCurrentAssets">
<link:definition>1016 - Disclosure - Prepaid Expenses and Other Current Assets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/OtherAssetsNet" id="OtherAssetsNet">
<link:definition>1017 - Disclosure - Other Assets, Net</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilities" id="AccruedExpensesAndOtherCurrentLiabilities">
<link:definition>1018 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/Debt" id="Debt">
<link:definition>1019 - Disclosure - Debt</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/Warrants" id="Warrants">
<link:definition>1020 - Disclosure - Warrants</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/FairValueMeasurements" id="FairValueMeasurements">
<link:definition>1021 - Disclosure - Fair Value Measurements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>1022 - Disclosure - Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/Leases" id="Leases">
<link:definition>1023 - Disclosure - Leases</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/StockholdersDeficit" id="StockholdersDeficit">
<link:definition>1024 - Disclosure - Stockholders' Deficit</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/EquityBasedCompensation" id="EquityBasedCompensation">
<link:definition>1025 - Disclosure - Equity-Based Compensation</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendors" id="ConcentrationOfCreditRiskAndMajorCustomersAndVendors">
<link:definition>1026 - Disclosure - Concentration of Credit Risk and Major Customers and Vendors</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/BenefitPlans" id="BenefitPlans">
<link:definition>1027 - Disclosure - Benefit Plans</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition>1028 - Disclosure - Income Taxes</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/LossPerShare" id="LossPerShare">
<link:definition>1029 - Disclosure - Loss Per Share</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition>1030 - Disclosure - Related Party Transactions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>1031 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1032 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition>1033 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/InventoriesNetTables" id="InventoriesNetTables">
<link:definition>1034 - Disclosure - Inventories, Net (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
<link:definition>1035 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
<link:definition>1036 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" id="PrepaidExpensesAndOtherCurrentAssetsTables">
<link:definition>1037 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/OtherAssetsNetTables" id="OtherAssetsNetTables">
<link:definition>1038 - Disclosure - Other Assets, Net (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" id="AccruedExpensesAndOtherCurrentLiabilitiesTables">
<link:definition>1039 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/StockholdersDeficitTables" id="StockholdersDeficitTables">
<link:definition>1040 - Disclosure - Stockholders' Deficit (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/EquityBasedCompensationTables" id="EquityBasedCompensationTables">
<link:definition>1041 - Disclosure - Equity-Based Compensation (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/WarrantsTables" id="WarrantsTables">
<link:definition>1042 - Disclosure - Warrants (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
<link:definition>1043 - Disclosure - Fair Value Measurements (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
<link:definition>1044 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition>1045 - Disclosure - Income Taxes (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/LossPerShareTables" id="LossPerShareTables">
<link:definition>1046 - Disclosure - Loss Per Share (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
<link:definition>1047 - Disclosure - Related Party Transactions (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails" id="DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails">
<link:definition>1048 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" id="SummaryOfSignificantAccountingPoliciesNarrativeDetails">
<link:definition>1049 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails" id="SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails">
<link:definition>1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Plant and Equipment (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails" id="SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails">
<link:definition>1051 - Disclosure - Summary of Significant Accounting Policies - Schedule of Amortization Computed on a Straight-line Basis (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails" id="RevenueRecognitionAdditionalInformationDetails">
<link:definition>1052 - Disclosure - Revenue Recognition - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails" id="SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails">
<link:definition>1053 - Disclosure - Simple Agreements for Future Equity and Advance Subscription Agreements - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails" id="InventoriesNetScheduleOfInventoriesDetails">
<link:definition>1054 - Disclosure - Inventories, Net - Schedule of Inventories (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails" id="PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails">
<link:definition>1055 - Disclosure - Property and Equipment, Net - Schedule of Property, Plant and Equipment (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails" id="PropertyAndEquipmentNetAdditionalInformationDetails">
<link:definition>1056 - Disclosure - Property and Equipment, Net - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails" id="IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails">
<link:definition>1057 - Disclosure - Intangible Assets, Net - Schedule of Identifiable Intangible Assets, Net (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails" id="IntangibleAssetsNetAdditionalInformationDetails">
<link:definition>1058 - Disclosure - Intangible Assets, Net - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails" id="IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails">
<link:definition>1059 - Disclosure - Intangible Assets, Net - Schedule of Estimated Annual Amortization Expense (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" id="PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails">
<link:definition>1060 - Disclosure - Prepaid Expenses and Other Current Assets- Schedule of Prepaid Expenses and Other Current Assets (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails" id="OtherAssetsNetScheduleOfOtherAssetsDetails">
<link:definition>1061 - Disclosure - Other Assets, Net - Schedule of Other Assets (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/OtherAssetsNetAdditionalInformationDetails" id="OtherAssetsNetAdditionalInformationDetails">
<link:definition>1062 - Disclosure - Other Assets, Net - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
<link:definition>1063 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/DebtAdditionalInformationDetails" id="DebtAdditionalInformationDetails">
<link:definition>1064 - Disclosure - Debt - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/WarrantsAdditionalInformationDetails" id="WarrantsAdditionalInformationDetails">
<link:definition>1065 - Disclosure - Warrants - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails" id="WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails">
<link:definition>1066 - Disclosure - Warrants - Schedule of Changes in Warrants Issued and Outstanding (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails" id="FairValueMeasurementsAdditionalInformationDetails">
<link:definition>1067 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails" id="FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails">
<link:definition>1068 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails" id="FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails">
<link:definition>1069 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/LeasesAdditionalInformationDetails" id="LeasesAdditionalInformationDetails">
<link:definition>1070 - Disclosure - Leases - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails" id="CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails">
<link:definition>1071 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments under Operating Leases (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails" id="CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails">
<link:definition>1072 - Disclosure - Commitments and Contingencies - Schedule of Schedule of Other Commitments (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" id="CommitmentsAndContingenciesAdditionalInformationDetails">
<link:definition>1073 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails" id="StockholdersDeficitAdditionalInformationDetails">
<link:definition>1074 - Disclosure - Stockholders' Deficit - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails" id="StockholdersDeficitDisclosureOfTemporaryEquityDetails">
<link:definition>1075 - Disclosure - Stockholders' Deficit - Disclosure of Temporary Equity (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails" id="EquityBasedCompensationAdditionalInformationDetails">
<link:definition>1076 - Disclosure - Equity-Based Compensation - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails" id="EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails">
<link:definition>1077 - Disclosure - Equity-Based Compensation - Summary of Compensation Cost Recognized (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails" id="EquityBasedCompensationSummaryOfStockOptionActivityDetails">
<link:definition>1078 - Disclosure - Equity-Based Compensation - Summary of Stock option activity (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails" id="EquityBasedCompensationSummaryOfUnvestedCommonStockDetails">
<link:definition>1079 - Disclosure - Equity-Based Compensation - Summary of Unvested Common Stock (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails" id="EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails">
<link:definition>1080 - Disclosure - Equity-Based Compensation - Summary of Stock Option Valuation Assumptions (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails" id="ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails">
<link:definition>1081 - Disclosure - Concentration of Credit Risk and Major Customers and Vendors - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/BenefitPlansAdditionalInformationDetails" id="BenefitPlansAdditionalInformationDetails">
<link:definition>1082 - Disclosure - Benefit Plans - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" id="IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails">
<link:definition>1083 - Disclosure - Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" id="IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails">
<link:definition>1084 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" id="IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
<link:definition>1085 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails" id="IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails">
<link:definition>1086 - Disclosure - Income Taxes - Disclosure of the components of deferred tax assets (liabilities) (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/IncomeTaxesAdditionalInformationDetails" id="IncomeTaxesAdditionalInformationDetails">
<link:definition>1087 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails" id="LossPerShareScheduleOfLossPerShareDetails">
<link:definition>1088 - Disclosure - Loss Per Share - Schedule of Loss Per Share (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails" id="LossPerShareScheduleOfPotentiallyDilutiveSharesDetails">
<link:definition>1089 - Disclosure - Loss Per Share - Schedule of Potentially Dilutive Shares (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails" id="RelatedPartyTransactionsAdditionalInformationDetails">
<link:definition>1090 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails" id="RelatedPartyTransactionsScheduleOfLoanPayableDetails">
<link:definition>1091 - Disclosure - Related Party Transactions - Schedule of Loan Payable (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://formelife.com/role/SubsequentEventsAdditionalInformationDetails" id="SubsequentEventsAdditionalInformationDetails">
<link:definition>1092 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="trnr-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="trnr-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="trnr-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="trnr-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
<import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
<import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
<import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
<import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<element name="IncomeTaxesReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_IncomeTaxesReceivables" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="SeriesSeedConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="FitnessProductRevenue1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FitnessProductRevenue1" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="MembershipRevenue1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_MembershipRevenue1" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TrainingRevenue1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TrainingRevenue1" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CostOfFitnessProductRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CostOfFitnessProductRevenue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CostOfMembership" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CostOfMembership" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CostOfTraining" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CostOfTraining" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CostOfMembershipAndTraining" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CostOfMembershipAndTraining" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="GainUponDebtForgiveness" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_GainUponDebtForgiveness" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="GainLossOnChangeInFairValueOfConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_GainLossOnChangeInFairValueOfConvertibleNotes" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ChangeInFairValuesOfSimpleAgreementsForFutureEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="SeriesA1PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesA1PreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesA2PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesA2PreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedZeroToTenPreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedZeroToTenPreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesAConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesAConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="InitialPublicOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_InitialPublicOfferingCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="StockIssuedDuringPeriodSharesWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_StockIssuedDuringPeriodSharesWarrantsExercised" substitutionGroup="xbrli:item" />
<element name="StockIssuedDuringPeriodValueWarrantsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_StockIssuedDuringPeriodValueWarrantsExercised" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NetExerciseOfOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NetExerciseOfOptions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." substitutionGroup="xbrli:item" />
<element name="TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" substitutionGroup="xbrli:item" />
<element name="ConversionOfLoanPayableToConvertibleNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ConversionOfLoanPayableToConvertibleNoteMember" substitutionGroup="xbrli:item" />
<element name="ConversionOfAccountsPayableToConvertibleNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ConversionOfAccountsPayableToConvertibleNoteMember" substitutionGroup="xbrli:item" />
<element name="ConversionOfPromissoryNotesToConvertibleNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" substitutionGroup="xbrli:item" />
<element name="NonCashLeaseExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NonCashLeaseExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="FairValueAdjustmentOfWarrantsIssuedToServiceProviders" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncreaseDecreaseInLongTermInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IncreaseDecreaseInLongTermInventory" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueOfWarrantsIssuedWithConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NonCashInterestExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NonCashInterestExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="RepaymentsOfRelatedPartyLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_RepaymentsOfRelatedPartyLoans" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PaymentsOfSeniorSecuredNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_PaymentsOfSeniorSecuredNotes" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ProceedsFromPPPLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ProceedsFromPPPLoan" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="RepaymentOfBouncebackLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_RepaymentOfBouncebackLoans" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="InventoriesInAccountsPayableAndAccrued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_InventoriesInAccountsPayableAndAccrued" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PropertyAndEquipmentInAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_PropertyAndEquipmentInAccountsPayable" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="RecognitionOfDeferredAndAccruedOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_RecognitionOfDeferredAndAccruedOfferingCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ProceedsFromPaycheckProtectionProgramLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ProceedsFromPaycheckProtectionProgramLoan" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NonCashExerciseOfOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NonCashExerciseOfOptions" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NonCashIssuanceOfCommonStockFromRightsOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NonCashIssuanceOfCommonStockFromRightsOffering" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="StockBasedCompensationCapitalizedInSoftware" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_StockBasedCompensationCapitalizedInSoftware" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NoncashActivityDeferredCostsIncurred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NoncashActivityDeferredCostsIncurred" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CapitalizedSoftwareAndContentInAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CapitalizedSoftwareAndContentInAccountsPayable" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" substitutionGroup="xbrli:item" />
<element name="ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" substitutionGroup="xbrli:item" />
<element name="ConversionOfPreferredStockToClassACommonStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ConversionOfPreferredStockToClassACommonStockMember" substitutionGroup="xbrli:item" />
<element name="SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" substitutionGroup="xbrli:item" />
<element name="PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" substitutionGroup="xbrli:item" />
<element name="PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" substitutionGroup="xbrli:item" />
<element name="WarrantsDisclosureTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_WarrantsDisclosureTextBlock" substitutionGroup="xbrli:item" />
<element name="DeferredOfferingCostsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_DeferredOfferingCostsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="VendorDepositPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_VendorDepositPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="CostOfFitnessProductRevenuePolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CostOfFitnessProductRevenuePolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="CostOfMembershipAndTrainingPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CostOfMembershipAndTrainingPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="ContentLicensingAgreementPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ContentLicensingAgreementPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="CapitalizedStudioContentPolicytextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CapitalizedStudioContentPolicytextBlock" substitutionGroup="xbrli:item" />
<element name="MusicRoyaltyFeesPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="ConvertibleNotesPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ConvertibleNotesPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="WarrantsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_WarrantsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" substitutionGroup="xbrli:item" />
<element name="ClassBCommonStockWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ClassBCommonStockWarrantsMember" substitutionGroup="xbrli:item" />
<element name="ServiceProvidersStockWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ServiceProvidersStockWarrantsMember" substitutionGroup="xbrli:item" />
<element name="SeniorSecuredNotesStockWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeniorSecuredNotesStockWarrantsMember" substitutionGroup="xbrli:item" />
<element name="ClassACommonStockWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ClassACommonStockWarrantsMember" substitutionGroup="xbrli:item" />
<element name="NotePurchaseAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_NotePurchaseAgreementMember" substitutionGroup="xbrli:item" />
<element name="OtherNoteholderMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_OtherNoteholderMember" substitutionGroup="xbrli:item" />
<element name="LeadNoteholderMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_LeadNoteholderMember" substitutionGroup="xbrli:item" />
<element name="BridgeNoteFinancingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_BridgeNoteFinancingMember" substitutionGroup="xbrli:item" />
<element name="CapitalizedStudioContentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_CapitalizedStudioContentMember" substitutionGroup="xbrli:item" />
<element name="InternalUseSoftwareMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_InternalUseSoftwareMember" substitutionGroup="xbrli:item" />
<element name="LicenseFeePayablePerQuarter" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_LicenseFeePayablePerQuarter" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="MusicGuaranteesDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_MusicGuaranteesDeposits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" substitutionGroup="xbrli:item" />
<element name="ContentLicensingAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ContentLicensingAgreementMember" substitutionGroup="xbrli:item" />
<element name="SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" substitutionGroup="xbrli:item" />
<element name="PreProductionToolingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_PreProductionToolingMember" substitutionGroup="xbrli:item" />
<element name="ExtendedProductWarrantyPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ExtendedProductWarrantyPeriod" substitutionGroup="xbrli:item" />
<element name="SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" substitutionGroup="xbrli:item" />
<element name="AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_AgreementAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="AgreementDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_AgreementDomain" substitutionGroup="xbrli:item" />
<element name="SimpleAgreementsForFutureEquityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SimpleAgreementsForFutureEquityMember" substitutionGroup="xbrli:item" />
<element name="PreProductionTooling" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_PreProductionTooling" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PropertyAndEquipmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_PropertyAndEquipmentMember" substitutionGroup="xbrli:item" />
<element name="IdentifiableIntangibleAssetsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_IdentifiableIntangibleAssetsMember" substitutionGroup="xbrli:item" />
<element name="PrepaidLicenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_PrepaidLicenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ResearchAndDevelopmentTaxCredit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_ResearchAndDevelopmentTaxCredit" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="VendorDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_VendorDeposits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CapitalizedSoftwareMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_CapitalizedSoftwareMember" substitutionGroup="xbrli:item" />
<element name="CapitalizedContentCostsAndContentLicensesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_CapitalizedContentCostsAndContentLicensesMember" substitutionGroup="xbrli:item" />
<element name="CapitalizedContentCostsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_CapitalizedContentCostsMember" substitutionGroup="xbrli:item" />
<element name="PaidTimeOffAccrual" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_PaidTimeOffAccrual" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AccruedOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_AccruedOfferingCosts" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AccruedLicenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_AccruedLicenses" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CustomerDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_CustomerDeposits" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AccruedEngineeringCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_AccruedEngineeringCurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TwoThousandTwentyTwoConvertibleNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TwoThousandTwentyTwoConvertibleNotesMember" substitutionGroup="xbrli:item" />
<element name="November2022ConvertibleNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_November2022ConvertibleNotesMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyConvertibleNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TwoThousandTwentyConvertibleNotesMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyOneConvertibleNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TwoThousandTwentyOneConvertibleNotesMember" substitutionGroup="xbrli:item" />
<element name="PaycheckProtectionProgramLoanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_PaycheckProtectionProgramLoanMember" substitutionGroup="xbrli:item" />
<element name="TenPercentageSeniorSecuredNotesDueMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TenPercentageSeniorSecuredNotesDueMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeed9PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeed9PreferredStockMember" substitutionGroup="xbrli:item" />
<element name="LossDueToChangesInFairValueOfConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_LossDueToChangesInFairValueOfConvertibleNotes" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="GainRecognizedOnFairValueChangesOfConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="InterestExpenseAndDefaultInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_InterestExpenseAndDefaultInterest" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PercentageOfInterestRateOfDebtForgiveness" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_PercentageOfInterestRateOfDebtForgiveness" substitutionGroup="xbrli:item" />
<element name="TwoIndividualMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TwoIndividualMember" substitutionGroup="xbrli:item" />
<element name="NovemberTwoThousandTwentyTwoConvertibleNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" substitutionGroup="xbrli:item" />
<element name="FairValueOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueOfWarrants" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="WarrantOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_WarrantOutstanding" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ClassOfWarrantsIssued" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ClassOfWarrantsExercised" substitutionGroup="xbrli:item" />
<element name="FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="EquityValuePercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_EquityValuePercentage" substitutionGroup="xbrli:item" />
<element name="WarrantsMeasurementDiscountRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_WarrantsMeasurementDiscountRate" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentMeasurementDiscountRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_DebtInstrumentMeasurementDiscountRate" substitutionGroup="xbrli:item" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PercentageOfCumulativeNetSales" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_PercentageOfCumulativeNetSales" substitutionGroup="xbrli:item" />
<element name="CumulativeNetSales" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CumulativeNetSales" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SeriesAFinancingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesAFinancingMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedFourMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedFourMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedFiveMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedFiveMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedSixMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedSixMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedSevenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedSevenMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedEightMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedEightMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedNineMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedNineMember" substitutionGroup="xbrli:item" />
<element name="SeriesAOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesAOneMember" substitutionGroup="xbrli:item" />
<element name="Seed10Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_Seed10Member" substitutionGroup="xbrli:item" />
<element name="SeriesSeedTwoTenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedTwoTenMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedOneMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedTwoMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedThreeMember" substitutionGroup="xbrli:item" />
<element name="RightsOfferingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_RightsOfferingMember" substitutionGroup="xbrli:item" />
<element name="PercentageOfDiscountRateOnConvertibleNotes" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_PercentageOfDiscountRateOnConvertibleNotes" substitutionGroup="xbrli:item" />
<element name="SeriesSeedAndSeriesAAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedAndSeriesAAgreementMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandAndTwentySecuredConvertibleNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" substitutionGroup="xbrli:item" />
<element name="SeriesAConvertibleNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesAConvertibleNotesMember" substitutionGroup="xbrli:item" />
<element name="SeriesAStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesAStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesATwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesATwoMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedNineOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedNineOneMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedTenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedTenMember" substitutionGroup="xbrli:item" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" substitutionGroup="xbrli:item" />
<element name="AdditionalExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_AdditionalExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" substitutionGroup="xbrli:item" />
<element name="WarrantsIssuedDuringThePeriodShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_WarrantsIssuedDuringThePeriodShares" substitutionGroup="xbrli:item" />
<element name="WarrantGrantDateFairValue" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_WarrantGrantDateFairValue" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyEquityIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TwoThousandTwentyEquityIncentivePlanMember" substitutionGroup="xbrli:item" />
<element name="SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" substitutionGroup="xbrli:item" />
<element name="Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" substitutionGroup="xbrli:item" />
<element name="SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" substitutionGroup="xbrli:item" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" substitutionGroup="xbrli:item" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyPlanEarlyExerciseMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_TwoThousandTwentyPlanEarlyExerciseMember" substitutionGroup="xbrli:item" />
<element name="VendorThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_VendorThreeMember" substitutionGroup="xbrli:item" />
<element name="VendorOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_VendorOneMember" substitutionGroup="xbrli:item" />
<element name="NumberOfCustomer" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NumberOfCustomer" substitutionGroup="xbrli:item" />
<element name="NumberOfSignificantVendors" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NumberOfSignificantVendors" substitutionGroup="xbrli:item" />
<element name="IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" substitutionGroup="xbrli:item" />
<element name="EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" substitutionGroup="xbrli:item" />
<element name="EffectiveIncomeTaxRateReconciliationIntangiblesPercent" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" substitutionGroup="xbrli:item" />
<element name="IncometaxreconciliationDisqualifiedDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IncometaxreconciliationDisqualifiedDebt" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncometaxreconciliationIntangibles" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_IncometaxreconciliationIntangibles" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetsCapitalizedResearchAndDevelopment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetsFixedAssetsAndIntangibles" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_IncomeTaxDisclosureTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_IncomeTaxDisclosureLineItems" substitutionGroup="xbrli:item" />
<element name="AmortisationOfResearchAndDevelopmentalCost" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_AmortisationOfResearchAndDevelopmentalCost" substitutionGroup="xbrli:item" />
<element name="CapitalizedResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_CapitalizedResearchAndDevelopmentExpenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="OperatingLossCarryForwardsPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_OperatingLossCarryForwardsPercentage" substitutionGroup="xbrli:item" />
<element name="MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="MinimumTaxOnBookIncomeInflationReductionActPercent" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" substitutionGroup="xbrli:item" />
<element name="NumeratorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_NumeratorAbstract" substitutionGroup="xbrli:item" />
<element name="NetLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_NetLoss" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DenominatorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_DenominatorAbstract" substitutionGroup="xbrli:item" />
<element name="SeriesAOneConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesAOneConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesATwoConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesATwoConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedOneConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedOneConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedTwoConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedTwoConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedThreeConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedThreeConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedFourConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedFourConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedFiveConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedFiveConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedSixConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedSixConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedSevenConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedSevenConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedEightConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedEightConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedNineConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedNineConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesSeedTenConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_SeriesSeedTenConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="WarrantsToPurchaseSeriesClassACommonStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_WarrantsToPurchaseSeriesClassACommonStockMember" substitutionGroup="xbrli:item" />
<element name="WarrantsToPurchaseSeriesClassBCommonStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" substitutionGroup="xbrli:item" />
<element name="StockOptionsToPurchaseCommonStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_StockOptionsToPurchaseCommonStockMember" substitutionGroup="xbrli:item" />
<element name="ClassACommonWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ClassACommonWarrantsMember" substitutionGroup="xbrli:item" />
<element name="ClassBCommonWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ClassBCommonWarrantsMember" substitutionGroup="xbrli:item" />
<element name="PromissoryNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_PromissoryNotesMember" substitutionGroup="xbrli:item" />
<element name="OtherRelatedPartyPromissoryNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_OtherRelatedPartyPromissoryNotesMember" substitutionGroup="xbrli:item" />
<element name="PrincipalStockholderPromissoryNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_PrincipalStockholderPromissoryNotesMember" substitutionGroup="xbrli:item" />
<element name="OtherRelatedPartyTransactionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_OtherRelatedPartyTransactionsMember" substitutionGroup="xbrli:item" />
<element name="NoninterestBearingNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_NoninterestBearingNoteMember" substitutionGroup="xbrli:item" />
<element name="FuseprojectMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_FuseprojectMember" substitutionGroup="xbrli:item" />
<element name="ApeironAdvisoryLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ApeironAdvisoryLtdMember" substitutionGroup="xbrli:item" />
<element name="RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" substitutionGroup="xbrli:item" />
<element name="RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" substitutionGroup="xbrli:item" />
<element name="DefaultInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_DefaultInterest" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="RoyaltyPaymentPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_RoyaltyPaymentPercentage" substitutionGroup="xbrli:item" />
<element name="GuaranteedRoyaltyPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_GuaranteedRoyaltyPayment" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ContingentRoyaltyObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_ContingentRoyaltyObligation" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DebtInstrumentFeePercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_DebtInstrumentFeePercentage" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentInterestRateStatedPercentageAdditional" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_DebtInstrumentInterestRateStatedPercentageAdditional" substitutionGroup="xbrli:item" />
<element name="AccruedInterestAndDefaultInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_AccruedInterestAndDefaultInterest" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FounderNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_FounderNotesMember" substitutionGroup="xbrli:item" />
<element name="ClassACommonStockToClassBCommonStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_ClassACommonStockToClassBCommonStockMember" substitutionGroup="xbrli:item" />
<element name="AssetPurchaseAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="trnr_AssetPurchaseAgreementMember" substitutionGroup="xbrli:item" />
<element name="AssetPurchaseAgreementTerms" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_AssetPurchaseAgreementTerms" substitutionGroup="xbrli:item" />
<element name="WeightedAverageThresholdConsecutiveTradingDays1" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_WeightedAverageThresholdConsecutiveTradingDays1" substitutionGroup="xbrli:item" />
<element name="PercentageOfOriginalIssuanceDiscount" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_PercentageOfOriginalIssuanceDiscount" substitutionGroup="xbrli:item" />
<element name="MaximumNumberOfEarnOutShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="trnr_MaximumNumberOfEarnOutShares" substitutionGroup="xbrli:item" />
<element name="RetirementOfSeniorDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="trnr_RetirementOfSeniorDebt" substitutionGroup="xbrli:item" xbrli:balance="credit" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>trnr-20230930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 22-December-2023 [11:38:22] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://formelife.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementOfCashFlowsUnaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#InventoriesNetScheduleOfInventoriesDetails" roleURI="http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails" roleURI="http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails" roleURI="http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNetScheduleOfOtherAssetsDetails" roleURI="http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" />
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaap_AccruedBonusesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedBonusesCurrent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaidTimeOffAccrual" xlink:label="loc_TRNR_PaidTimeOffAccrual" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_TRNR_PaidTimeOffAccrual" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedOfferingCosts" xlink:label="loc_TRNR_AccruedOfferingCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_TRNR_AccruedOfferingCosts" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedLicenses" xlink:label="loc_TRNR_AccruedLicenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_TRNR_AccruedLicenses" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CustomerDeposits" xlink:label="loc_TRNR_CustomerDeposits" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_TRNR_CustomerDeposits" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaap_AccruedAdvertisingCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedAdvertisingCurrent" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedEngineeringCurrent" xlink:label="loc_TRNR_AccruedEngineeringCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_TRNR_AccruedEngineeringCurrent" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent" use="optional" order="14" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_InventoryFinishedGoods" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_DepositsAssetsCurrent" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxesReceivables" xlink:label="loc_TRNR_IncomeTaxesReceivables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_TRNR_IncomeTaxesReceivables" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNoncurrent" xlink:label="loc_us-gaap_InventoryNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_InventoryNoncurrent" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_DeferredCosts" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OtherAssets" use="optional" order="13" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapital" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaap_LoansPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_LoansPayableCurrent" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaap_SecuredDebtCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_SecuredDebtCurrent" use="optional" order="26" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" use="optional" order="27" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent" use="optional" order="28" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" order="29" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_DerivativeLiabilities" use="optional" order="30" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LongTermDebtNoncurrent" use="optional" order="31" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_CommitmentsAndContingencies" use="optional" order="32" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" use="optional" order="33" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" order="2" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" use="optional" order="3" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_Depreciation" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" order="7" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets" use="optional" order="9" weight="-1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashLeaseExpense" xlink:label="loc_TRNR_NonCashLeaseExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRNR_NonCashLeaseExpense" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCharges" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCharges" use="optional" order="11" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_InventoryWriteDown" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncreaseDecreaseInLongTermInventory" xlink:label="loc_TRNR_IncreaseDecreaseInLongTermInventory" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRNR_IncreaseDecreaseInLongTermInventory" use="optional" order="13" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ShareBasedCompensation" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" use="optional" order="15" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" use="optional" order="16" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_InterestIncomeExpenseNet" use="optional" order="18" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xlink:label="loc_TRNR_GainLossOnChangeInFairValueOfConvertibleNotes" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRNR_GainLossOnChangeInFairValueOfConvertibleNotes" use="optional" order="22" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" xlink:label="loc_TRNR_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRNR_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" use="optional" order="26" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" xlink:label="loc_TRNR_FairValueOfWarrantsIssuedWithConvertibleNotes" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRNR_FairValueOfWarrantsIssuedWithConvertibleNotes" use="optional" order="27" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" use="optional" order="28" weight="-1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashInterestExpense" xlink:label="loc_TRNR_NonCashInterestExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRNR_NonCashInterestExpense" use="optional" order="29" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AssetImpairmentCharges" use="optional" order="30" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xlink:label="loc_TRNR_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRNR_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" use="optional" order="31" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" order="32" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="33" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireSoftware" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware" use="optional" order="34" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopSoftware" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware" use="optional" order="35" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" use="optional" order="36" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" order="37" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt" use="optional" order="38" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RepaymentsOfRelatedPartyLoans" xlink:label="loc_TRNR_RepaymentsOfRelatedPartyLoans" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_TRNR_RepaymentsOfRelatedPartyLoans" use="optional" order="39" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" use="optional" order="40" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts" use="optional" order="41" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" use="optional" order="42" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaymentsOfSeniorSecuredNotes" xlink:label="loc_TRNR_PaymentsOfSeniorSecuredNotes" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_TRNR_PaymentsOfSeniorSecuredNotes" use="optional" order="43" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" use="optional" order="44" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt" use="optional" order="45" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" order="46" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised" use="optional" order="47" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RepaymentOfBouncebackLoans" xlink:label="loc_TRNR_RepaymentOfBouncebackLoans" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_TRNR_RepaymentOfBouncebackLoans" use="optional" order="48" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromPPPLoan" xlink:label="loc_TRNR_ProceedsFromPPPLoan" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_TRNR_ProceedsFromPPPLoan" use="optional" order="49" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" xlink:label="loc_TRNR_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_TRNR_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" use="optional" order="50" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises" use="optional" order="51" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" use="optional" order="52" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" use="optional" order="53" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_OperatingIncomeLoss" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" use="optional" order="3" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_SellingAndMarketingExpense" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_GrossProfit" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_Revenues" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FitnessProductRevenue1" xlink:label="loc_TRNR_FitnessProductRevenue1" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues" xlink:to="loc_TRNR_FitnessProductRevenue1" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MembershipRevenue1" xlink:label="loc_TRNR_MembershipRevenue1" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues" xlink:to="loc_TRNR_MembershipRevenue1" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TrainingRevenue1" xlink:label="loc_TRNR_TrainingRevenue1" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues" xlink:to="loc_TRNR_TrainingRevenue1" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_CostOfRevenue" use="optional" order="12" weight="-1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfFitnessProductRevenue" xlink:label="loc_TRNR_CostOfFitnessProductRevenue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="loc_TRNR_CostOfFitnessProductRevenue" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfMembership" xlink:label="loc_TRNR_CostOfMembership" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="loc_TRNR_CostOfMembership" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfTraining" xlink:label="loc_TRNR_CostOfTraining" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="loc_TRNR_CostOfTraining" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfMembershipAndTraining" xlink:label="loc_TRNR_CostOfMembershipAndTraining" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="loc_TRNR_CostOfMembershipAndTraining" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_NonoperatingIncomeExpense" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRevenueExpenseNet" xlink:label="loc_us-gaap_InterestRevenueExpenseNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InterestRevenueExpenseNet" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainUponDebtForgiveness" xlink:label="loc_TRNR_GainUponDebtForgiveness" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_TRNR_GainUponDebtForgiveness" use="optional" order="20" weight="-1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xlink:label="loc_TRNR_GainLossOnChangeInFairValueOfConvertibleNotes" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_TRNR_GainLossOnChangeInFairValueOfConvertibleNotes" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" use="optional" order="22" weight="-1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xlink:label="loc_TRNR_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_TRNR_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" use="optional" order="23" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit" use="optional" order="24" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" use="optional" order="2" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet" xlink:to="loc_us-gaap_InventoryFinishedGoods" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNoncurrent" xlink:label="loc_us-gaap_InventoryNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet" xlink:to="loc_us-gaap_InventoryNoncurrent" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="loc_us-gaap_OtherDeferredCostsNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsGross" xlink:label="loc_us-gaap_OtherDeferredCostsGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherDeferredCostsNet" xlink:to="loc_us-gaap_OtherDeferredCostsGross" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" xlink:label="loc_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherDeferredCostsNet" xlink:to="loc_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" use="optional" order="2" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaap_SecurityDeposit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaap_SecurityDeposit" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidLicenses" xlink:label="loc_TRNR_PrepaidLicenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_TRNR_PrepaidLicenses" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ResearchAndDevelopmentTaxCredit" xlink:label="loc_TRNR_ResearchAndDevelopmentTaxCredit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_TRNR_ResearchAndDevelopmentTaxCredit" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaap_OtherReceivables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaap_OtherReceivables" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaap_PrepaidInsurance" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaap_PrepaidInsurance" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent" use="optional" order="6" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PreProductionTooling" xlink:label="loc_TRNR_PreProductionTooling" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="loc_TRNR_PreProductionTooling" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="loc_us-gaap_MachineryAndEquipmentGross" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="loc_us-gaap_LeaseholdImprovementsGross" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="loc_us-gaap_FurnitureAndFixturesGross" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" order="7" weight="-1" />
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>trnr-20230930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 22-December-2023 [11:38:22] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CoverPage" roleURI="http://formelife.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://formelife.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementOfCashFlowsUnaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#WarrantsTables" roleURI="http://formelife.com/role/WarrantsTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails" roleURI="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RevenueRecognitionAdditionalInformationDetails" roleURI="http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails" roleURI="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNetAdditionalInformationDetails" roleURI="http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails" roleURI="http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetAdditionalInformationDetails" roleURI="http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNetScheduleOfOtherAssetsDetails" roleURI="http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#DebtAdditionalInformationDetails" roleURI="http://formelife.com/role/DebtAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#WarrantsAdditionalInformationDetails" roleURI="http://formelife.com/role/WarrantsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails" roleURI="http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurementsAdditionalInformationDetails" roleURI="http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails" roleURI="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails" roleURI="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LeasesAdditionalInformationDetails" roleURI="http://formelife.com/role/LeasesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingenciesAdditionalInformationDetails" roleURI="http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#StockholdersDeficitAdditionalInformationDetails" roleURI="http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#StockholdersDeficitDisclosureOfTemporaryEquityDetails" roleURI="http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationAdditionalInformationDetails" roleURI="http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails" roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationSummaryOfStockOptionActivityDetails" roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationSummaryOfUnvestedCommonStockDetails" roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails" roleURI="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesAdditionalInformationDetails" roleURI="http://formelife.com/role/IncomeTaxesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LossPerShareScheduleOfPotentiallyDilutiveSharesDetails" roleURI="http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RelatedPartyTransactionsScheduleOfLoanPayableDetails" roleURI="http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SubsequentEventsAdditionalInformationDetails" roleURI="http://formelife.com/role/SubsequentEventsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentation" roleURI="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentation" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RevenueRecognition" roleURI="http://formelife.com/role/RevenueRecognition" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#InventoriesNet" roleURI="http://formelife.com/role/InventoriesNet" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNet" roleURI="http://formelife.com/role/PropertyAndEquipmentNet" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNet" roleURI="http://formelife.com/role/IntangibleAssetsNet" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PrepaidExpensesAndOtherCurrentAssets" roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssets" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNet" roleURI="http://formelife.com/role/OtherAssetsNet" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilities" roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilities" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#Debt" roleURI="http://formelife.com/role/Debt" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#Warrants" roleURI="http://formelife.com/role/Warrants" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurements" roleURI="http://formelife.com/role/FairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingencies" roleURI="http://formelife.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#StockholdersDeficit" roleURI="http://formelife.com/role/StockholdersDeficit" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensation" roleURI="http://formelife.com/role/EquityBasedCompensation" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#ConcentrationOfCreditRiskAndMajorCustomersAndVendors" roleURI="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendors" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#BenefitPlans" roleURI="http://formelife.com/role/BenefitPlans" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LossPerShare" roleURI="http://formelife.com/role/LossPerShare" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RelatedPartyTransactions" roleURI="http://formelife.com/role/RelatedPartyTransactions" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SubsequentEvents" roleURI="http://formelife.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNetTables" roleURI="http://formelife.com/role/PropertyAndEquipmentNetTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PrepaidExpensesAndOtherCurrentAssetsTables" roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNetTables" roleURI="http://formelife.com/role/OtherAssetsNetTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationTables" roleURI="http://formelife.com/role/EquityBasedCompensationTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#InventoriesNetTables" roleURI="http://formelife.com/role/InventoriesNetTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetTables" roleURI="http://formelife.com/role/IntangibleAssetsNetTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LossPerShareTables" roleURI="http://formelife.com/role/LossPerShareTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurementsTables" roleURI="http://formelife.com/role/FairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingenciesTables" roleURI="http://formelife.com/role/CommitmentsAndContingenciesTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RelatedPartyTransactionsTables" roleURI="http://formelife.com/role/RelatedPartyTransactionsTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#InventoriesNetScheduleOfInventoriesDetails" roleURI="http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails" roleURI="http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNetAdditionalInformationDetails" roleURI="http://formelife.com/role/OtherAssetsNetAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails" roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#BenefitPlansAdditionalInformationDetails" roleURI="http://formelife.com/role/BenefitPlansAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LossPerShareScheduleOfLossPerShareDetails" roleURI="http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails" roleURI="http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails" roleURI="http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" roleURI="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#Leases" roleURI="http://formelife.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxes" roleURI="http://formelife.com/role/IncomeTaxes" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesTables" roleURI="http://formelife.com/role/IncomeTaxesTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" roleURI="http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" roleURI="http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails" roleURI="http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#StockholdersDeficitTables" roleURI="http://formelife.com/role/StockholdersDeficitTables" />
<roleRef xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm" roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_1139" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_121" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_LocalPhoneNumber_121" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityFilerCategory_127" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityExTransitionPeriod_128" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityEmergingGrowthCompany_129" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntitySmallBusiness_130" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_102" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_DocumentType_102" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_107" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityRegistrantName_107" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_108" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityCentralIndexKey_108" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_112" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_AmendmentFlag_112" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityIncorporationStateCountryCode_113" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityTaxIdentificationNumber_114" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressAddressLine1_115" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressAddressLine2_116" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_117" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressCityOrTown_117" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_118" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressStateOrProvince_118" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_119" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressPostalZipCode_119" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_CityAreaCode_120" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_DocumentInformationTable_1135" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_1135" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1136" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1136" xlink:to="loc_dei_AddressTypeDomain_1137" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1137_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1136" xlink:to="loc_dei_AddressTypeDomain_1137_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_1137" xlink:to="loc_dei_BusinessContactMember_1138" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber_1140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityPrimarySicNumber_1140" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_1141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_ContactPersonnelName_1141" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_150" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_151" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_151" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_156" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_156" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_160" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_160" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNoncurrent" xlink:label="loc_us-gaap_InventoryNoncurrent_164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_InventoryNoncurrent_164" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts_167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_DeferredCosts_167" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets_169" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_OtherAssets_169" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_171" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_Assets_171" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_173" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_173" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_173" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_142" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_152" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_152" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_157" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_157" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaap_LoansPayableCurrent_161" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_LoansPayableCurrent_161" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaap_SecuredDebtCurrent_165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_SecuredDebtCurrent_165" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_168" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_168" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_170" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_170" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_172" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_LiabilitiesCurrent_172" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_146" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_146" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_AccountsPayableCurrent_137" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_174" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_175" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_DerivativeLiabilities_175" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_Liabilities_176" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_CommitmentsAndContingencies_177" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_178" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_StockholdersEquityAbstract_178" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_149" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_AdditionalPaidInCapital_149" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_155" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_159" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_159" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_163" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_StockholdersEquity_163" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_CommonStockValue_141" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_144" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_AssetsAbstract_144" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_144" xlink:to="loc_us-gaap_AssetsCurrentAbstract_140" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_147" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_147" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_InventoryFinishedGoods_153" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_DepositsAssetsCurrent_158" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_162" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_AssetsCurrent_166" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_138" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxesReceivables" xlink:label="loc_trnr_IncomeTaxesReceivables_1222" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_trnr_IncomeTaxesReceivables_1222" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_145" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_StatementTable_145" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_145" xlink:to="loc_us-gaap_StatementClassOfStockAxis_143" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_154" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_143" xlink:to="loc_us-gaap_ClassOfStockDomain_154" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_154_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_143" xlink:to="loc_us-gaap_ClassOfStockDomain_154_default" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_148" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_154" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_148" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedConvertiblePreferredStockMember_139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_154" xlink:to="loc_trnr_SeriesSeedConvertiblePreferredStockMember_139" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_179" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_179" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1223" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1223" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_1224" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_1224" use="optional" order="46" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_183" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1238" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_1239" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_1239" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_182" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_184" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_CommonStockSharesIssued_185" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_186" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_186" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1109" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_StatementTable_1109" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1241" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1109" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1241" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1241" xlink:to="loc_us-gaap_ClassOfStockDomain_1242" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1242_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1241" xlink:to="loc_us-gaap_ClassOfStockDomain_1242_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedConvertiblePreferredStockMember_1243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1242" xlink:to="loc_trnr_SeriesSeedConvertiblePreferredStockMember_1243" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_1244" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1242" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_1244" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_1235" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_1235" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_1236" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_1236" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_1237" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_1237" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_239" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_235" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_235" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_240" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockholdersEquity_240" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_SharesOutstanding_243" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_245" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InitialPublicOfferingCosts" xlink:label="loc_trnr_InitialPublicOfferingCosts_247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_InitialPublicOfferingCosts_247" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_249" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_249" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_250" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_251" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1_252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_ConversionOfStockAmountIssued1_252" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_253" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_253" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_254" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_254" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_255" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_255" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues_256" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues_256" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_257" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_257" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_258" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_258" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_259" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_259" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_260" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_260" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_261" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_261" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_262" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_262" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodValueWarrantsExercised_263" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_StockIssuedDuringPeriodValueWarrantsExercised_263" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_264" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_264" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NetExerciseOfOptions" xlink:label="loc_trnr_NetExerciseOfOptions_265" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_NetExerciseOfOptions_265" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_266" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_266" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_267" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_NetIncomeLoss_267" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_231" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_231" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions_1281" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions_1281" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue_1283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue_1283" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares_1284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares_1284" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue_1285" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue_1285" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares_1286" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares_1286" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue_1287" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue_1287" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares_1288" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares_1288" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues_1291" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues_1291" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1292" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1292" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1294" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1294" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1296" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1298" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1298" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1300" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1302" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1304" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1306" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1308" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1310" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1310" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock_1363" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock_1363" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock_1369" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock_1369" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock_1370" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock_1370" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock_1371" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock_1371" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock_1372" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock_1372" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock_1373" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock_1373" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock._1374" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock._1374" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock._1375" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock._1375" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock_1376" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock_1376" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock_1377" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock_1377" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue_1379" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue_1379" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares_1380" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares_1380" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue_1383" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue_1383" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares_1386" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares_1386" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue_1391" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue_1391" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares_1392" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares_1392" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue_1394" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue_1394" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares_1395" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares_1395" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue_1396" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue_1396" use="optional" order="62" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares_1398" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares_1398" use="optional" order="63" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue_1402" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue_1402" use="optional" order="64" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares_1403" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares_1403" use="optional" order="65" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue_1404" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue_1404" use="optional" order="66" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares_1405" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares_1405" use="optional" order="67" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue_1406" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue_1406" use="optional" order="68" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares_1407" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares_1407" use="optional" order="69" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue_1409" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue_1409" use="optional" order="70" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares_1413" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares_1413" use="optional" order="71" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue_1415" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue_1415" use="optional" order="72" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares_1416" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares_1416" use="optional" order="73" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue_1417" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue_1417" use="optional" order="74" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares_1418" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares_1418" use="optional" order="75" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue_1419" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue_1419" use="optional" order="76" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares_1420" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares_1420" use="optional" order="77" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue_1421" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue_1421" use="optional" order="78" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares_1422" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares_1422" use="optional" order="79" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue_1423" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue_1423" use="optional" order="80" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares_1424" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares_1424" use="optional" order="81" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_226" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StatementTable_226" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="82" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_226" xlink:to="loc_us-gaap_StatementClassOfStockAxis_234" use="optional" order="83" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_237" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_234" xlink:to="loc_us-gaap_ClassOfStockDomain_237" use="optional" order="84" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_237_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_234" xlink:to="loc_us-gaap_ClassOfStockDomain_237_default" use="optional" order="85" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA1PreferredStockMember" xlink:label="loc_trnr_SeriesA1PreferredStockMember_236" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_trnr_SeriesA1PreferredStockMember_236" use="optional" order="86" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA2PreferredStockMember" xlink:label="loc_trnr_SeriesA2PreferredStockMember_241" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_trnr_SeriesA2PreferredStockMember_241" use="optional" order="87" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_244" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_us-gaap_CommonClassAMember_244" use="optional" order="88" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_us-gaap_CommonClassBMember_246" use="optional" order="89" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_us-gaap_IPOMember_248" use="optional" order="90" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedZeroToTenPreferredStockMember" xlink:label="loc_trnr_SeriesSeedZeroToTenPreferredStockMember_227" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_trnr_SeriesSeedZeroToTenPreferredStockMember_227" use="optional" order="91" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesAConvertiblePreferredStockMember_232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_trnr_SeriesAConvertiblePreferredStockMember_232" use="optional" order="92" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_226" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_230" use="optional" order="93" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_229" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_230" xlink:to="loc_us-gaap_EquityComponentDomain_229" use="optional" order="94" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_229_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_230" xlink:to="loc_us-gaap_EquityComponentDomain_229_default" use="optional" order="95" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_233" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_229" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_233" use="optional" order="96" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_229" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_238" use="optional" order="97" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_229" xlink:to="loc_us-gaap_RetainedEarningsMember_242" use="optional" order="98" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_228" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_229" xlink:to="loc_us-gaap_CommonStockMember_228" use="optional" order="99" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_279" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_274" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_279" xlink:to="loc_us-gaap_StatementTable_274" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_274" xlink:to="loc_us-gaap_StatementClassOfStockAxis_276" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_276" xlink:to="loc_us-gaap_ClassOfStockDomain_280" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_280_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_276" xlink:to="loc_us-gaap_ClassOfStockDomain_280_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA2PreferredStockMember" xlink:label="loc_trnr_SeriesA2PreferredStockMember_275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_280" xlink:to="loc_trnr_SeriesA2PreferredStockMember_275" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_278" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_280" xlink:to="loc_us-gaap_IPOMember_278" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_279" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_277" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1266" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireSoftware" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_296" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_289" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_289" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopSoftware" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_303" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_309" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_309" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_292" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_Depreciation_292" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_299" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_299" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_285" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_285" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_317" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_ShareBasedCompensation_317" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashLeaseExpense" xlink:label="loc_trnr_NonCashLeaseExpense_306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_NonCashLeaseExpense_306" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_312" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_InventoryWriteDown_312" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_322" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_322" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_327" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_327" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_332" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_332" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xlink:label="loc_trnr_GainLossOnChangeInFairValueOfConvertibleNotes_336" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_GainLossOnChangeInFairValueOfConvertibleNotes_336" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" xlink:label="loc_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders_340" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders_340" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_342" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_342" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_297" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_297" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_290" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_290" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_283" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncreaseDecreaseInLongTermInventory" xlink:label="loc_trnr_IncreaseDecreaseInLongTermInventory_315" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_trnr_IncreaseDecreaseInLongTermInventory_315" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_304" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCharges_310" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCharges_310" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_334" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_334" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_320" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_320" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_325" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_325" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_330" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_330" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_338" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_338" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1248" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" xlink:label="loc_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes_1249" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes_1249" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1250" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashInterestExpense" xlink:label="loc_trnr_NonCashInterestExpense_1251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_NonCashInterestExpense_1251" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_1252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_AssetImpairmentCharges_1252" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity_1253" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity_1253" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_287" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" xlink:to="loc_us-gaap_ProfitLoss_287" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_301" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RepaymentsOfRelatedPartyLoans" xlink:label="loc_trnr_RepaymentsOfRelatedPartyLoans_295" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_RepaymentsOfRelatedPartyLoans_295" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_288" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_288" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_302" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_308" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_314" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_314" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_333" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_333" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaymentsOfSeniorSecuredNotes" xlink:label="loc_trnr_PaymentsOfSeniorSecuredNotes_319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_PaymentsOfSeniorSecuredNotes_319" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_324" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_324" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_329" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_329" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromPPPLoan" xlink:label="loc_trnr_ProceedsFromPPPLoan_1254" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_ProceedsFromPPPLoan_1254" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_337" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_337" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RepaymentOfBouncebackLoans" xlink:label="loc_trnr_RepaymentOfBouncebackLoans_341" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_RepaymentOfBouncebackLoans_341" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_343" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_343" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity_1255" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity_1255" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_1278" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_1278" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_1280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_1280" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1256" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_1256" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_307" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_307" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_313" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_313" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_318" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_318" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" xlink:label="loc_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable_298" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable_298" use="optional" order="62" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InventoriesInAccountsPayableAndAccrued" xlink:label="loc_trnr_InventoriesInAccountsPayableAndAccrued_291" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_InventoriesInAccountsPayableAndAccrued_291" use="optional" order="63" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PropertyAndEquipmentInAccountsPayable" xlink:label="loc_trnr_PropertyAndEquipmentInAccountsPayable_284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_PropertyAndEquipmentInAccountsPayable_284" use="optional" order="64" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_316" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_316" use="optional" order="65" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RecognitionOfDeferredAndAccruedOfferingCosts" xlink:label="loc_trnr_RecognitionOfDeferredAndAccruedOfferingCosts_305" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_RecognitionOfDeferredAndAccruedOfferingCosts_305" use="optional" order="66" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromPaycheckProtectionProgramLoan" xlink:label="loc_trnr_ProceedsFromPaycheckProtectionProgramLoan_311" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_ProceedsFromPaycheckProtectionProgramLoan_311" use="optional" order="67" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashExerciseOfOptions" xlink:label="loc_trnr_NonCashExerciseOfOptions_335" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NonCashExerciseOfOptions_335" use="optional" order="68" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_321" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_321" use="optional" order="69" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" xlink:label="loc_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination_326" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination_326" use="optional" order="70" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashIssuanceOfCommonStockFromRightsOffering" xlink:label="loc_trnr_NonCashIssuanceOfCommonStockFromRightsOffering_331" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NonCashIssuanceOfCommonStockFromRightsOffering_331" use="optional" order="71" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockBasedCompensationCapitalizedInSoftware" xlink:label="loc_trnr_StockBasedCompensationCapitalizedInSoftware_339" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_StockBasedCompensationCapitalizedInSoftware_339" use="optional" order="72" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashActivityDeferredCostsIncurred" xlink:label="loc_trnr_NoncashActivityDeferredCostsIncurred_1279" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NoncashActivityDeferredCostsIncurred_1279" use="optional" order="73" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedSoftwareAndContentInAccountsPayable" xlink:label="loc_trnr_CapitalizedSoftwareAndContentInAccountsPayable_1257" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_CapitalizedSoftwareAndContentInAccountsPayable_1257" use="optional" order="74" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" xlink:label="loc_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption_1258" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption_1258" use="optional" order="75" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_1259" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_1259" use="optional" order="76" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_1260" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_1260" use="optional" order="77" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" xlink:label="loc_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants_1261" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants_1261" use="optional" order="78" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" xlink:label="loc_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA_1262" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA_1262" use="optional" order="79" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesIssued1" xlink:label="loc_us-gaap_NotesIssued1_1263" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_NotesIssued1_1263" use="optional" order="80" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaap_StockIssued1_1264" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_StockIssued1_1264" use="optional" order="81" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1265" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_StatementTable_1265" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="82" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="loc_us-gaap_DebtConversionByUniqueDescriptionAxis_1270" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1265" xlink:to="loc_us-gaap_DebtConversionByUniqueDescriptionAxis_1270" use="optional" order="83" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionNameDomain" xlink:label="loc_us-gaap_DebtConversionNameDomain_1271" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtConversionByUniqueDescriptionAxis_1270" xlink:to="loc_us-gaap_DebtConversionNameDomain_1271" use="optional" order="84" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionNameDomain" xlink:label="loc_us-gaap_DebtConversionNameDomain_1271_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtConversionByUniqueDescriptionAxis_1270" xlink:to="loc_us-gaap_DebtConversionNameDomain_1271_default" use="optional" order="85" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfLoanPayableToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfLoanPayableToConvertibleNoteMember_1272" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionNameDomain_1271" xlink:to="loc_trnr_ConversionOfLoanPayableToConvertibleNoteMember_1272" use="optional" order="86" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfAccountsPayableToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfAccountsPayableToConvertibleNoteMember_1273" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionNameDomain_1271" xlink:to="loc_trnr_ConversionOfAccountsPayableToConvertibleNoteMember_1273" use="optional" order="87" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember_1274" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionNameDomain_1271" xlink:to="loc_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember_1274" use="optional" order="88" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1267" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1265" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1267" use="optional" order="89" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_1268" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1267" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_1268" use="optional" order="90" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_1268_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1267" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_1268_default" use="optional" order="91" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" xlink:label="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember_1275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_1268" xlink:to="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember_1275" use="optional" order="92" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" xlink:label="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember_1276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_1268" xlink:to="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember_1276" use="optional" order="93" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfPreferredStockToClassACommonStockMember" xlink:label="loc_trnr_ConversionOfPreferredStockToClassACommonStockMember_1269" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_1268" xlink:to="loc_trnr_ConversionOfPreferredStockToClassACommonStockMember_1269" use="optional" order="94" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/WarrantsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_464" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_461" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_464" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_461" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_462" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_461" xlink:to="loc_us-gaap_StatementClassOfStockAxis_462" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_466" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_462" xlink:to="loc_us-gaap_ClassOfStockDomain_466" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_466_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_462" xlink:to="loc_us-gaap_ClassOfStockDomain_466_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonStockWarrantsMember" xlink:label="loc_trnr_ClassBCommonStockWarrantsMember_463" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_466" xlink:to="loc_trnr_ClassBCommonStockWarrantsMember_463" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember_465" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_466" xlink:to="loc_trnr_ServiceProvidersStockWarrantsMember_465" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeniorSecuredNotesStockWarrantsMember" xlink:label="loc_trnr_SeniorSecuredNotesStockWarrantsMember_467" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_466" xlink:to="loc_trnr_SeniorSecuredNotesStockWarrantsMember_467" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockWarrantsMember" xlink:label="loc_trnr_ClassACommonStockWarrantsMember_459" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_466" xlink:to="loc_trnr_ClassACommonStockWarrantsMember_459" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_460" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_464" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_460" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_482" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_482" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_481" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_481" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_483" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_481" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_483" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_483_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_481" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_483_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_486" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_483" xlink:to="loc_us-gaap_IPOMember_486" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_487" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_487" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_480" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_487" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_480" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_480_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_487" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_480_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NotePurchaseAgreementMember" xlink:label="loc_trnr_NotePurchaseAgreementMember_485" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_480" xlink:to="loc_trnr_NotePurchaseAgreementMember_485" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_491" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_491" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_492" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_CommonStockSharesIssued_492" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_493" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_493" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" xlink:label="loc_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions_494" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions_494" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockStock" xlink:label="loc_us-gaap_DividendsCommonStockStock_495" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_DividendsCommonStockStock_495" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock" xlink:label="loc_us-gaap_DividendsCommonStock_497" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_DividendsCommonStock_497" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_488" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_488" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaap_SecuredDebtCurrent_490" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_SecuredDebtCurrent_490" use="optional" order="18" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_526" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_526" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CooperativeAdvertisingAmount" xlink:label="loc_us-gaap_CooperativeAdvertisingAmount_520" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_CooperativeAdvertisingAmount_520" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:label="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_522" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_522" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_524" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_524" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralPartnersOfferingCosts" xlink:label="loc_us-gaap_GeneralPartnersOfferingCosts_517" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_GeneralPartnersOfferingCosts_517" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_528" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_528" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" xlink:label="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost_1564" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost_1564" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_530" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_530" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_532" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_532" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_533" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_533" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_534" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_534" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_535" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_535" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_536" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_536" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts_1559" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_DeferredOfferingCosts_1559" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1576" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1576" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1581" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1581" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_519" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_519" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_507" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_519" xlink:to="loc_us-gaap_RelatedPartyDomain_507" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_507_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_519" xlink:to="loc_us-gaap_RelatedPartyDomain_507_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherNoteholderMember" xlink:label="loc_trnr_OtherNoteholderMember_518" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_507" xlink:to="loc_trnr_OtherNoteholderMember_518" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LeadNoteholderMember" xlink:label="loc_trnr_LeadNoteholderMember_503" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_507" xlink:to="loc_trnr_LeadNoteholderMember_503" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_525" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_CreditFacilityAxis_525" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_515" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_525" xlink:to="loc_us-gaap_CreditFacilityDomain_515" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_515_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_525" xlink:to="loc_us-gaap_CreditFacilityDomain_515_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_BridgeNoteFinancingMember" xlink:label="loc_trnr_BridgeNoteFinancingMember_509" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_515" xlink:to="loc_trnr_BridgeNoteFinancingMember_509" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_527" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_527" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_514" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_527" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_514" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_514_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_527" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_514_default" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_504" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_514" xlink:to="loc_us-gaap_SeniorNotesMember_504" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_521" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_521" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_510" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_521" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_510" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_510_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_521" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_510_default" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_512" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_510" xlink:to="loc_us-gaap_IPOMember_512" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_523" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_523" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_500" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_523" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_500" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_500_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_523" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_500_default" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_511" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_500" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_511" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_513" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_513" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_513" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_513" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516_default" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedStudioContentMember" xlink:label="loc_trnr_CapitalizedStudioContentMember_1577" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516" xlink:to="loc_trnr_CapitalizedStudioContentMember_1577" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InternalUseSoftwareMember" xlink:label="loc_trnr_InternalUseSoftwareMember_508" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516" xlink:to="loc_trnr_InternalUseSoftwareMember_508" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_529" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_srt_StatementScenarioAxis_529" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_506" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_529" xlink:to="loc_srt_ScenarioUnspecifiedDomain_506" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_506_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_529" xlink:to="loc_srt_ScenarioUnspecifiedDomain_506_default" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1560" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1560" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1561" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1560" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1561" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1561_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1560" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1561_default" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ContentLicensingAgreementMember" xlink:label="loc_trnr_ContentLicensingAgreementMember_1562" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1561" xlink:to="loc_trnr_ContentLicensingAgreementMember_1562" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis_1578" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis_1578" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain_1579" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis_1578" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain_1579" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain_1579_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis_1578" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain_1579_default" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember_1580" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain_1579" xlink:to="loc_trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember_1580" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1582" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1582" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1583" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1582" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1583" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1583_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1582" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1583_default" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyGainLossMember" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_1584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1583" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_1584" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1589" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1589" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1590" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1589" xlink:to="loc_us-gaap_EquityComponentDomain_1590" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1590_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1589" xlink:to="loc_us-gaap_EquityComponentDomain_1590_default" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1591" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1590" xlink:to="loc_us-gaap_WarrantMember_1591" use="optional" order="62" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetImpairmentCharges" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_1563" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_1563" use="optional" order="63" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LicenseFeePayablePerQuarter" xlink:label="loc_trnr_LicenseFeePayablePerQuarter_1565" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_LicenseFeePayablePerQuarter_1565" use="optional" order="64" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability" xlink:label="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability_1566" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability_1566" use="optional" order="65" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MusicGuaranteesDeposits" xlink:label="loc_trnr_MusicGuaranteesDeposits_1567" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_MusicGuaranteesDeposits_1567" use="optional" order="66" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1568" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1568" use="optional" order="67" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1569" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_OperatingLeaseLiability_1569" use="optional" order="68" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_1570" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_1570" use="optional" order="69" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" xlink:label="loc_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements_1571" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements_1571" use="optional" order="70" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1573" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1573" use="optional" order="71" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1574" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1574" use="optional" order="72" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" xlink:label="loc_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions_1575" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions_1575" use="optional" order="73" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_551" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_551" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_545" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_545" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_545" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_545" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PreProductionToolingMember" xlink:label="loc_trnr_PreProductionToolingMember_544" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" xlink:to="loc_trnr_PreProductionToolingMember_544" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_548" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_550" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_550" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_549" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" xlink:to="loc_srt_RangeAxis_549" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_541" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_549" xlink:to="loc_srt_RangeMember_541" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_541_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_549" xlink:to="loc_srt_RangeMember_541_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_540" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_541" xlink:to="loc_srt_MaximumMember_540" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_546" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_541" xlink:to="loc_srt_MinimumMember_546" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_542" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_551" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_542" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_551" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_547" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_563" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_561" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_563" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_561" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_558" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_561" xlink:to="loc_srt_RangeAxis_558" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_560" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_558" xlink:to="loc_srt_RangeMember_560" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_560_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_558" xlink:to="loc_srt_RangeMember_560_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_559" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_560" xlink:to="loc_srt_MaximumMember_559" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_564" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_560" xlink:to="loc_srt_MinimumMember_564" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ExtendedProductWarrantyPeriod" xlink:label="loc_trnr_ExtendedProductWarrantyPeriod_562" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_563" xlink:to="loc_trnr_ExtendedProductWarrantyPeriod_562" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems_1164" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable_1162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems_1164" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable_1162" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementAxis" xlink:label="loc_trnr_AgreementAxis_1167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable_1162" xlink:to="loc_trnr_AgreementAxis_1167" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementDomain" xlink:label="loc_trnr_AgreementDomain_1173" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_trnr_AgreementAxis_1167" xlink:to="loc_trnr_AgreementDomain_1173" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementDomain" xlink:label="loc_trnr_AgreementDomain_1173_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_trnr_AgreementAxis_1167" xlink:to="loc_trnr_AgreementDomain_1173_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember_1174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_AgreementDomain_1173" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityMember_1174" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1171" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems_1164" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1171" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1172" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems_1164" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1172" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1607" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_582" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1607" xlink:to="loc_us-gaap_Depreciation_582" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_1186" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1607" xlink:to="loc_us-gaap_DepreciationAndAmortization_1186" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1606" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1607" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1606" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1608" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1606" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1608" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1609" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1608" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1609" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1609_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1608" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1609_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PropertyAndEquipmentMember" xlink:label="loc_trnr_PropertyAndEquipmentMember_1610" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1609" xlink:to="loc_trnr_PropertyAndEquipmentMember_1610" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_588" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_591" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_591" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_592" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_592" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_587" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_587" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_587" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InternalUseSoftwareMember" xlink:label="loc_trnr_InternalUseSoftwareMember_585" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589" xlink:to="loc_trnr_InternalUseSoftwareMember_585" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_600" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_597" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_600" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_597" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_596" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_597" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_596" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_599" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_596" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_599" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_599_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_596" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_599_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IdentifiableIntangibleAssetsMember" xlink:label="loc_trnr_IdentifiableIntangibleAssetsMember_595" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_599" xlink:to="loc_trnr_IdentifiableIntangibleAssetsMember_595" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_598" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_600" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_598" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1600" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1599" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_StatementTable_1599" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1601" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1599" xlink:to="loc_srt_RestatementAxis_1601" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1602" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_1601" xlink:to="loc_srt_RestatementDomain_1602" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1602_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_1601" xlink:to="loc_srt_RestatementDomain_1602_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1603" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_1602" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1603" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaap_SecurityDeposit_611" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_SecurityDeposit_611" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidLicenses" xlink:label="loc_trnr_PrepaidLicenses_612" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_trnr_PrepaidLicenses_612" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ResearchAndDevelopmentTaxCredit" xlink:label="loc_trnr_ResearchAndDevelopmentTaxCredit_613" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_trnr_ResearchAndDevelopmentTaxCredit_613" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaap_OtherReceivables_614" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_OtherReceivables_614" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaap_PrepaidInsurance_615" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_PrepaidInsurance_615" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_616" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_616" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_617" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_617" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorDeposits" xlink:label="loc_trnr_VendorDeposits_1187" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_trnr_VendorDeposits_1187" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_630" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" xlink:label="loc_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts_628" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_630" xlink:to="loc_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts_628" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="loc_us-gaap_OtherDeferredCostsNet_631" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_630" xlink:to="loc_us-gaap_OtherDeferredCostsNet_631" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsGross" xlink:label="loc_us-gaap_OtherDeferredCostsGross_624" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_630" xlink:to="loc_us-gaap_OtherDeferredCostsGross_624" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_621" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_630" xlink:to="loc_us-gaap_StatementTable_621" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_627" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_621" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_627" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_620" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_627" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_620" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_620_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_627" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_620_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_626" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_620" xlink:to="loc_us-gaap_OtherAssetsMember_626" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_623" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_621" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_623" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_623" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_623" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedSoftwareMember" xlink:label="loc_trnr_CapitalizedSoftwareMember_629" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" xlink:to="loc_trnr_CapitalizedSoftwareMember_629" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedContentCostsAndContentLicensesMember" xlink:label="loc_trnr_CapitalizedContentCostsAndContentLicensesMember_1189" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" xlink:to="loc_trnr_CapitalizedContentCostsAndContentLicensesMember_1189" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedContentCostsMember" xlink:label="loc_trnr_CapitalizedContentCostsMember_625" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" xlink:to="loc_trnr_CapitalizedContentCostsMember_625" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1595" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaap_AccruedBonusesCurrent_637" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedBonusesCurrent_637" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_638" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_638" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaidTimeOffAccrual" xlink:label="loc_trnr_PaidTimeOffAccrual_639" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_PaidTimeOffAccrual_639" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedOfferingCosts" xlink:label="loc_trnr_AccruedOfferingCosts_640" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_AccruedOfferingCosts_640" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedLicenses" xlink:label="loc_trnr_AccruedLicenses_641" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_AccruedLicenses_641" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_642" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_642" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_643" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_643" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CustomerDeposits" xlink:label="loc_trnr_CustomerDeposits_644" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_CustomerDeposits_644" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_645" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_645" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_646" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_646" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaap_AccruedAdvertisingCurrent_1190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedAdvertisingCurrent_1190" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedEngineeringCurrent" xlink:label="loc_trnr_AccruedEngineeringCurrent_1191" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_AccruedEngineeringCurrent_1191" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_1192" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_1192" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1194" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1195" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1594" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_StatementTable_1594" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1596" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1594" xlink:to="loc_srt_RestatementAxis_1596" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1597" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_1596" xlink:to="loc_srt_RestatementDomain_1597" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1597_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_1596" xlink:to="loc_srt_RestatementDomain_1597_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1598" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_1597" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1598" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/DebtAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_670" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_652" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentTable_652" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_650" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_us-gaap_DebtInstrumentAxis_650" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_666" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_650" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_666" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_666_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_650" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_666_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyTwoConvertibleNotesMember_655" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_TwoThousandTwentyTwoConvertibleNotesMember_655" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_November2022ConvertibleNotesMember" xlink:label="loc_trnr_November2022ConvertibleNotesMember_659" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_November2022ConvertibleNotesMember_659" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_1233" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_us-gaap_ConvertibleDebtMember_1233" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyConvertibleNotesMember_1199" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_TwoThousandTwentyConvertibleNotesMember_1199" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyOneConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyOneConvertibleNotesMember_1200" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_TwoThousandTwentyOneConvertibleNotesMember_1200" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaycheckProtectionProgramLoanMember" xlink:label="loc_trnr_PaycheckProtectionProgramLoanMember_1218" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_PaycheckProtectionProgramLoanMember_1218" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_667" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_srt_RangeAxis_667" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_654" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_667" xlink:to="loc_srt_RangeMember_654" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_654_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_667" xlink:to="loc_srt_RangeMember_654_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_653" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_654" xlink:to="loc_srt_MaximumMember_653" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1206" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_654" xlink:to="loc_srt_MinimumMember_1206" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_658" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_658" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_649" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_658" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_649" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_649_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_658" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_649_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NotePurchaseAgreementMember" xlink:label="loc_trnr_NotePurchaseAgreementMember_664" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_649" xlink:to="loc_trnr_NotePurchaseAgreementMember_664" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TenPercentageSeniorSecuredNotesDueMember" xlink:label="loc_trnr_TenPercentageSeniorSecuredNotesDueMember_668" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_649" xlink:to="loc_trnr_TenPercentageSeniorSecuredNotesDueMember_668" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_656" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_649" xlink:to="loc_us-gaap_SeniorNotesMember_656" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_660" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_649" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_660" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_662" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_us-gaap_StatementClassOfStockAxis_662" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_663" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_662" xlink:to="loc_us-gaap_ClassOfStockDomain_663" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_663_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_662" xlink:to="loc_us-gaap_ClassOfStockDomain_663_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA2PreferredStockMember" xlink:label="loc_trnr_SeriesA2PreferredStockMember_651" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_663" xlink:to="loc_trnr_SeriesA2PreferredStockMember_651" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA1PreferredStockMember" xlink:label="loc_trnr_SeriesA1PreferredStockMember_1230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_663" xlink:to="loc_trnr_SeriesA1PreferredStockMember_1230" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_1232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_663" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_1232" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeed9PreferredStockMember" xlink:label="loc_trnr_SeriesSeed9PreferredStockMember_1229" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_663" xlink:to="loc_trnr_SeriesSeed9PreferredStockMember_1229" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_1225" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_srt_TitleOfIndividualAxis_1225" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1226" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_1225" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1226" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1226_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_1225" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1226_default" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoIndividualMember" xlink:label="loc_trnr_TwoIndividualMember_1227" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1226" xlink:to="loc_trnr_TwoIndividualMember_1227" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_671" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentTerm_671" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_672" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_672" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_673" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_673" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_674" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_674" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_675" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_675" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LossDueToChangesInFairValueOfConvertibleNotes" xlink:label="loc_trnr_LossDueToChangesInFairValueOfConvertibleNotes_676" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_trnr_LossDueToChangesInFairValueOfConvertibleNotes_676" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_677" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_677" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_678" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_678" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_665" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_665" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_669" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_669" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_657" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_657" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_661" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_661" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_679" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_679" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1234" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" xlink:label="loc_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes_1240" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes_1240" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_680" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_680" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InterestExpenseAndDefaultInterest" xlink:label="loc_trnr_InterestExpenseAndDefaultInterest_681" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_trnr_InterestExpenseAndDefaultInterest_681" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1215" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1215" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1216" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1216" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfInterestRateOfDebtForgiveness" xlink:label="loc_trnr_PercentageOfInterestRateOfDebtForgiveness_1219" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_trnr_PercentageOfInterestRateOfDebtForgiveness_1219" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_1228" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_1228" use="optional" order="54" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/WarrantsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_698" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_702" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_702" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_686" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_686" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_688" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_688" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_700" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_700" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_684" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_700" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_684" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_684_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_700" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_684_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_691" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_684" xlink:to="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_691" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_693" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_693" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_689" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_693" xlink:to="loc_us-gaap_EquityComponentDomain_689" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_689_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_693" xlink:to="loc_us-gaap_EquityComponentDomain_689_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_687" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_689" xlink:to="loc_us-gaap_WarrantMember_687" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_696" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_StatementClassOfStockAxis_696" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_699" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_696" xlink:to="loc_us-gaap_ClassOfStockDomain_699" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_699_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_696" xlink:to="loc_us-gaap_ClassOfStockDomain_699_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeniorSecuredNotesStockWarrantsMember" xlink:label="loc_trnr_SeniorSecuredNotesStockWarrantsMember_701" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_699" xlink:to="loc_trnr_SeniorSecuredNotesStockWarrantsMember_701" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonStockWarrantsMember" xlink:label="loc_trnr_ClassBCommonStockWarrantsMember_694" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_699" xlink:to="loc_trnr_ClassBCommonStockWarrantsMember_694" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockWarrantsMember" xlink:label="loc_trnr_ClassACommonStockWarrantsMember_685" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_699" xlink:to="loc_trnr_ClassACommonStockWarrantsMember_685" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember_697" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_699" xlink:to="loc_trnr_ServiceProvidersStockWarrantsMember_697" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_703" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_703" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_690" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_703" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_690" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_690_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_703" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_690_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_692" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_690" xlink:to="loc_us-gaap_IPOMember_692" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_1245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_1245" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_695" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_695" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_704" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_704" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_706" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_706" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrants" xlink:label="loc_trnr_FairValueOfWarrants_707" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_trnr_FairValueOfWarrants_707" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_708" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_708" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_709" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_709" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_710" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_710" use="optional" order="31" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantOutstanding" xlink:label="loc_trnr_WarrantOutstanding_714" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" xlink:to="loc_trnr_WarrantOutstanding_714" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_715" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_715" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_716" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_715" xlink:to="loc_us-gaap_StatementClassOfStockAxis_716" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_722" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_716" xlink:to="loc_us-gaap_ClassOfStockDomain_722" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_722_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_716" xlink:to="loc_us-gaap_ClassOfStockDomain_722_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonStockWarrantsMember" xlink:label="loc_trnr_ClassBCommonStockWarrantsMember_717" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_722" xlink:to="loc_trnr_ClassBCommonStockWarrantsMember_717" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember_720" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_722" xlink:to="loc_trnr_ServiceProvidersStockWarrantsMember_720" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeniorSecuredNotesStockWarrantsMember" xlink:label="loc_trnr_SeniorSecuredNotesStockWarrantsMember_723" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_722" xlink:to="loc_trnr_SeniorSecuredNotesStockWarrantsMember_723" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockWarrantsMember" xlink:label="loc_trnr_ClassACommonStockWarrantsMember_713" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_722" xlink:to="loc_trnr_ClassACommonStockWarrantsMember_713" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassOfWarrantsIssued" xlink:label="loc_trnr_ClassOfWarrantsIssued_718" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" xlink:to="loc_trnr_ClassOfWarrantsIssued_718" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassOfWarrantsExercised" xlink:label="loc_trnr_ClassOfWarrantsExercised_721" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" xlink:to="loc_trnr_ClassOfWarrantsExercised_721" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaap_ConvertibleDebt_1212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_ConvertibleDebt_1212" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_741" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_741" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_743" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_743" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_745" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_745" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_747" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_747" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity_1203" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity_1203" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1204" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1204" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1205" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1205" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EquityValuePercentage" xlink:label="loc_trnr_EquityValuePercentage_1585" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_trnr_EquityValuePercentage_1585" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsMeasurementDiscountRate" xlink:label="loc_trnr_WarrantsMeasurementDiscountRate_1586" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_trnr_WarrantsMeasurementDiscountRate_1586" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentMeasurementDiscountRate" xlink:label="loc_trnr_DebtInstrumentMeasurementDiscountRate_1587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_trnr_DebtInstrumentMeasurementDiscountRate_1587" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1208" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1208" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1209" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1208" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1209" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1209_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1208" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1209_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_1210" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1209" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_1210" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_739" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_739" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_731" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_739" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_731" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_731_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_739" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_731_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember_735" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_731" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityMember_735" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_742" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_742" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_727" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_742" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_727" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_727_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_742" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_727_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_740" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_727" xlink:to="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_740" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_744" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_744" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_732" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_744" xlink:to="loc_us-gaap_EquityComponentDomain_732" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_732_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_744" xlink:to="loc_us-gaap_EquityComponentDomain_732_default" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_728" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_732" xlink:to="loc_us-gaap_WarrantMember_728" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_733" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_733" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_729" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_733" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_729" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_729_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_733" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_729_default" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_737" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_729" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_737" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_738" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_738" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_730" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_730" use="optional" order="34" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_766" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_753" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_766" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_753" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_766" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_756" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_756" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_752" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_756" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_752" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_752_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_756" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_752_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_760" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_752" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_760" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_762" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_762" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_755" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_762" xlink:to="loc_us-gaap_EquityComponentDomain_755" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_755_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_762" xlink:to="loc_us-gaap_EquityComponentDomain_755_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_751" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_755" xlink:to="loc_us-gaap_WarrantMember_751" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_764" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_764" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_750" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_764" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_750" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_750_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_764" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_750_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_757" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_750" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_757" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_765" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_765" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_765" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_765" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_754" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_754" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_761" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_761" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_763" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_763" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock_780" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock_780" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock_782" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock_782" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_774" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_774" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants_781" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants_781" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementAxis" xlink:label="loc_trnr_AgreementAxis_1196" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" xlink:to="loc_trnr_AgreementAxis_1196" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementDomain" xlink:label="loc_trnr_AgreementDomain_1197" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_trnr_AgreementAxis_1196" xlink:to="loc_trnr_AgreementDomain_1197" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementDomain" xlink:label="loc_trnr_AgreementDomain_1197_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_trnr_AgreementAxis_1196" xlink:to="loc_trnr_AgreementDomain_1197_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember_1198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_AgreementDomain_1197" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityMember_1198" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_772" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_772" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_771" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_772" xlink:to="loc_us-gaap_EquityComponentDomain_771" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_771_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_772" xlink:to="loc_us-gaap_EquityComponentDomain_771_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_770" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_771" xlink:to="loc_us-gaap_WarrantMember_770" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_776" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_776" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_769" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_776" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_769" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_769_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_776" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_769_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_773" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_769" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_773" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_777" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_777" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments_779" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments_779" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock_1214" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock_1214" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock_1217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock_1217" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock_1221" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock_1221" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/LeasesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1176" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1181" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1182" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_1183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_ShortTermLeaseCost_1183" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_1184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseCost_1184" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1185" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1175" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_StatementTable_1175" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1397" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1175" xlink:to="loc_srt_RangeAxis_1397" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1399" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1397" xlink:to="loc_srt_RangeMember_1399" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1399_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1397" xlink:to="loc_srt_RangeMember_1399_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1400" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1399" xlink:to="loc_srt_MaximumMember_1400" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1401" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1399" xlink:to="loc_srt_MinimumMember_1401" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1177" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1178" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseLiability_1178" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1179" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1179" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_1180" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_1180" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_800" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_795" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_us-gaap_LossContingenciesTable_795" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_796" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_795" xlink:to="loc_srt_RangeAxis_796" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_799" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_796" xlink:to="loc_srt_RangeMember_799" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_799_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_796" xlink:to="loc_srt_RangeMember_799_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_797" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_799" xlink:to="loc_srt_MaximumMember_797" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_801" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_799" xlink:to="loc_srt_MinimumMember_801" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfCumulativeNetSales" xlink:label="loc_trnr_PercentageOfCumulativeNetSales_798" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_trnr_PercentageOfCumulativeNetSales_798" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CumulativeNetSales" xlink:label="loc_trnr_CumulativeNetSales_802" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_trnr_CumulativeNetSales_802" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_803" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_us-gaap_RoyaltyExpense_803" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="loc_us-gaap_RoyaltyGuaranteesCommitmentsAmount_804" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_us-gaap_RoyaltyGuaranteesCommitmentsAmount_804" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_809" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_809" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_813" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_813" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_816" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_816" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_814" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_816" xlink:to="loc_us-gaap_EquityComponentDomain_814" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_814_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_816" xlink:to="loc_us-gaap_EquityComponentDomain_814_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_810" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_814" xlink:to="loc_us-gaap_CommonStockMember_810" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1509" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_814" xlink:to="loc_us-gaap_WarrantMember_1509" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_821" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_821" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_807" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_821" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_807" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_807_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_821" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_807_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_815" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_807" xlink:to="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_815" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_1516" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_807" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_1516" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_824" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_StatementClassOfStockAxis_824" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_823" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_824" xlink:to="loc_us-gaap_ClassOfStockDomain_823" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_823_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_824" xlink:to="loc_us-gaap_ClassOfStockDomain_823_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_808" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_823" xlink:to="loc_us-gaap_CommonClassAMember_808" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAFinancingMember" xlink:label="loc_trnr_SeriesAFinancingMember_1514" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesAFinancingMember_1514" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFourMember" xlink:label="loc_trnr_SeriesSeedFourMember_1529" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedFourMember_1529" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFiveMember" xlink:label="loc_trnr_SeriesSeedFiveMember_1530" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedFiveMember_1530" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSixMember" xlink:label="loc_trnr_SeriesSeedSixMember_1531" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedSixMember_1531" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSevenMember" xlink:label="loc_trnr_SeriesSeedSevenMember_1532" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedSevenMember_1532" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedEightMember" xlink:label="loc_trnr_SeriesSeedEightMember_1533" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedEightMember_1533" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineMember" xlink:label="loc_trnr_SeriesSeedNineMember_1534" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedNineMember_1534" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAOneMember" xlink:label="loc_trnr_SeriesAOneMember_1536" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesAOneMember_1536" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAMember" xlink:label="loc_us-gaap_SeriesAMember_1538" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_us-gaap_SeriesAMember_1538" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_Seed10Member" xlink:label="loc_trnr_Seed10Member_1539" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_Seed10Member_1539" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoTenMember" xlink:label="loc_trnr_SeriesSeedTwoTenMember_1546" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedTwoTenMember_1546" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedMember" xlink:label="loc_trnr_SeriesSeedMember_1525" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedMember_1525" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedOneMember" xlink:label="loc_trnr_SeriesSeedOneMember_1526" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedOneMember_1526" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoMember" xlink:label="loc_trnr_SeriesSeedTwoMember_1527" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedTwoMember_1527" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedThreeMember" xlink:label="loc_trnr_SeriesSeedThreeMember_1528" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedThreeMember_1528" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_826" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_826" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_818" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_826" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_818" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_818_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_826" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_818_default" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RightsOfferingMember" xlink:label="loc_trnr_RightsOfferingMember_817" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_818" xlink:to="loc_trnr_RightsOfferingMember_817" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_828" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_828" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_812" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_828" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_812" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_812_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_828" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_812_default" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_811" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_811" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_820" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_820" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1510" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1510" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1511" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1511" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1512" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1512" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1541" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1541" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1541" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1541" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542_default" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedAndSeriesAAgreementMember" xlink:label="loc_trnr_SeriesSeedAndSeriesAAgreementMember_1543" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542" xlink:to="loc_trnr_SeriesSeedAndSeriesAAgreementMember_1543" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember_1544" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityMember_1544" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_DebtInstrumentAxis_1547" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1547" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1548" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1548_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1547" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1548_default" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember_1549" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1548" xlink:to="loc_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember_1549" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAConvertibleNotesMember" xlink:label="loc_trnr_SeriesAConvertibleNotesMember_1550" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1548" xlink:to="loc_trnr_SeriesAConvertibleNotesMember_1550" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1551" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_srt_RangeAxis_1551" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1552" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1551" xlink:to="loc_srt_RangeMember_1552" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1552_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1551" xlink:to="loc_srt_RangeMember_1552_default" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1553" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1552" xlink:to="loc_srt_MaximumMember_1553" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1554" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1552" xlink:to="loc_srt_MinimumMember_1554" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_819" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_819" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_822" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_CommonStockSharesIssued_822" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_825" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_825" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_827" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_827" use="optional" order="62" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_829" use="optional" order="63" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_1515" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_1515" use="optional" order="64" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_832" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_832" use="optional" order="65" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_834" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_834" use="optional" order="66" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_835" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_835" use="optional" order="67" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_836" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_836" use="optional" order="68" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfDiscountRateOnConvertibleNotes" xlink:label="loc_trnr_PercentageOfDiscountRateOnConvertibleNotes_837" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_trnr_PercentageOfDiscountRateOnConvertibleNotes_837" use="optional" order="69" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_1506" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_1506" use="optional" order="70" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_1508" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_DerivativeLiabilities_1508" use="optional" order="71" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1540" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1540" use="optional" order="72" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_1555" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_1555" use="optional" order="73" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaap_PaymentsOfDividends_1556" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PaymentsOfDividends_1556" use="optional" order="74" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaap_PreferredStockVotingRights_1557" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockVotingRights_1557" use="optional" order="75" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1558" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1558" use="optional" order="76" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="loc_us-gaap_PreferredStockConversionBasis_1517" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockConversionBasis_1517" use="optional" order="77" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_1519" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_1519" use="optional" order="78" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1520" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1520" use="optional" order="79" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1521" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1521" use="optional" order="80" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1522" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1522" use="optional" order="81" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1523" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1523" use="optional" order="82" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1493" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1469" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1469" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1470" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1469" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1470" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1472" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1470" xlink:to="loc_us-gaap_ClassOfStockDomain_1472" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1472_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1470" xlink:to="loc_us-gaap_ClassOfStockDomain_1472_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAStockMember" xlink:label="loc_trnr_SeriesAStockMember_1474" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesAStockMember_1474" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAOneMember" xlink:label="loc_trnr_SeriesAOneMember_1476" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesAOneMember_1476" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesATwoMember" xlink:label="loc_trnr_SeriesATwoMember_1478" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesATwoMember_1478" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedMember" xlink:label="loc_trnr_SeriesSeedMember_1479" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedMember_1479" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoMember" xlink:label="loc_trnr_SeriesSeedTwoMember_1481" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedTwoMember_1481" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedThreeMember" xlink:label="loc_trnr_SeriesSeedThreeMember_1482" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedThreeMember_1482" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFourMember" xlink:label="loc_trnr_SeriesSeedFourMember_1483" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedFourMember_1483" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFiveMember" xlink:label="loc_trnr_SeriesSeedFiveMember_1484" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedFiveMember_1484" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedOneMember" xlink:label="loc_trnr_SeriesSeedOneMember_1486" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedOneMember_1486" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSixMember" xlink:label="loc_trnr_SeriesSeedSixMember_1487" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedSixMember_1487" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSevenMember" xlink:label="loc_trnr_SeriesSeedSevenMember_1488" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedSevenMember_1488" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedEightMember" xlink:label="loc_trnr_SeriesSeedEightMember_1489" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedEightMember_1489" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineMember" xlink:label="loc_trnr_SeriesSeedNineMember_1490" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedNineMember_1490" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineOneMember" xlink:label="loc_trnr_SeriesSeedNineOneMember_1491" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedNineOneMember_1491" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTenMember" xlink:label="loc_trnr_SeriesSeedTenMember_1492" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedTenMember_1492" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_1494" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_1494" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="loc_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_1497" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_1497" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1495" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1495" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_1496" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_1496" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_1498" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_1498" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_849" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_849" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_852" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_852" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_854" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_854" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber_856" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber_856" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_858" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_858" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_860" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_860" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_862" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_862" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdditionalExpense" xlink:label="loc_trnr_AdditionalExpense_863" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_AdditionalExpense_863" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_864" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_864" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" xlink:label="loc_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue_865" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue_865" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_866" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_866" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1466" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1466" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1471" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1471" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1473" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1473" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsIssuedDuringThePeriodShares" xlink:label="loc_trnr_WarrantsIssuedDuringThePeriodShares_1499" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_WarrantsIssuedDuringThePeriodShares_1499" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1500" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1500" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantGrantDateFairValue" xlink:label="loc_trnr_WarrantGrantDateFairValue_1501" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_WarrantGrantDateFairValue_1501" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrants" xlink:label="loc_trnr_FairValueOfWarrants_1502" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_FairValueOfWarrants_1502" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_843" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_843" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_850" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" xlink:to="loc_us-gaap_AwardTypeAxis_850" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_850" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_850" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_857" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" xlink:to="loc_us-gaap_EmployeeStockOptionMember_857" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_859" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" xlink:to="loc_us-gaap_RestrictedStockMember_859" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_861" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_861" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_853" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" xlink:to="loc_srt_RangeAxis_853" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_845" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_853" xlink:to="loc_srt_RangeMember_845" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_845_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_853" xlink:to="loc_srt_RangeMember_845_default" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_844" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_845" xlink:to="loc_srt_MaximumMember_844" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_846" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" xlink:to="loc_us-gaap_PlanNameAxis_846" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_842" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_846" xlink:to="loc_us-gaap_PlanNameDomain_842" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_842_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_846" xlink:to="loc_us-gaap_PlanNameDomain_842_default" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_848" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_842" xlink:to="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_848" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_841" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_842" xlink:to="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_841" use="optional" order="35" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_878" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_871" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_878" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_871" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_878" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_872" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" xlink:to="loc_us-gaap_PlanNameAxis_872" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_870" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_872" xlink:to="loc_us-gaap_PlanNameDomain_870" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_870_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_872" xlink:to="loc_us-gaap_PlanNameDomain_870_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_869" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_870" xlink:to="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_869" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_1445" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_870" xlink:to="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_1445" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_876" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_876" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_874" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_876" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_874" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_874_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_876" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_874_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_875" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_874" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_875" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_877" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_874" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_877" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_879" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_874" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_879" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_886" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_886" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_909" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_909" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_911" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_911" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_893" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_893" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_899" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_904" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_904" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_889" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_889" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_888" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_889" xlink:to="loc_us-gaap_PlanNameAxis_888" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_883" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_888" xlink:to="loc_us-gaap_PlanNameDomain_883" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_883_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_888" xlink:to="loc_us-gaap_PlanNameDomain_883_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_882" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_883" xlink:to="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_882" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_1447" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_883" xlink:to="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_1447" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_884" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_884" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_897" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_908" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_908" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_910" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_910" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_891" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_891" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_902" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_902" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" xlink:label="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_887" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_887" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_894" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_894" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" xlink:label="loc_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm_900" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" xlink:to="loc_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm_900" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" xlink:label="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_896" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_896" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_890" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_890" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_901" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_901" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_905" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_905" use="optional" order="29" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_918" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_918" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_917" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_918" xlink:to="loc_us-gaap_PlanNameAxis_917" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_915" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_917" xlink:to="loc_us-gaap_PlanNameDomain_915" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_915_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_917" xlink:to="loc_us-gaap_PlanNameDomain_915_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyPlanEarlyExerciseMember" xlink:label="loc_trnr_TwoThousandTwentyPlanEarlyExerciseMember_914" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_915" xlink:to="loc_trnr_TwoThousandTwentyPlanEarlyExerciseMember_914" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue_927" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue_927" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_924" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_924" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability_929" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability_929" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability_930" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability_930" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability_931" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability_931" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability_932" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability_932" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_919" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_919" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_921" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_921" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased_922" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased_922" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_916" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_916" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_925" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_925" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_926" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_926" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaap_ProductInformationLineItems_963" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_943" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_963" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_943" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_960" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_960" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_942" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_960" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_942" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_942_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_960" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_942_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_954" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_942" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_954" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_958" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_942" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_958" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_961" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_srt_MajorCustomersAxis_961" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_950" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_961" xlink:to="loc_srt_NameOfMajorCustomerDomain_950" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_950_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_961" xlink:to="loc_srt_NameOfMajorCustomerDomain_950_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorThreeMember" xlink:label="loc_trnr_VendorThreeMember_949" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_950" xlink:to="loc_trnr_VendorThreeMember_949" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorOneMember" xlink:label="loc_trnr_VendorOneMember_1277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_950" xlink:to="loc_trnr_VendorOneMember_1277" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_962" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_srt_RangeAxis_962" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_946" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_962" xlink:to="loc_srt_RangeMember_946" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_946_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_962" xlink:to="loc_srt_RangeMember_946_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_945" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_946" xlink:to="loc_srt_MinimumMember_945" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_953" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_953" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_953" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_953" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_947" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948" xlink:to="loc_us-gaap_SalesRevenueNetMember_947" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="loc_us-gaap_CostOfGoodsTotalMember_956" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948" xlink:to="loc_us-gaap_CostOfGoodsTotalMember_956" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_957" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_us-gaap_InvestmentTypeAxis_957" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_951" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_957" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_951" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_951_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_957" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_951_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_944" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_963" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_944" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NumberOfCustomer" xlink:label="loc_trnr_NumberOfCustomer_955" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_963" xlink:to="loc_trnr_NumberOfCustomer_955" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NumberOfSignificantVendors" xlink:label="loc_trnr_NumberOfSignificantVendors_959" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_963" xlink:to="loc_trnr_NumberOfSignificantVendors_959" use="optional" order="26" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/IncomeTaxesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxDisclosureLineItems" xlink:label="loc_trnr_IncomeTaxDisclosureLineItems_1434" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_1438" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_1438" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1439" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_1439" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardExpirationDate" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_1440" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_1440" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AmortisationOfResearchAndDevelopmentalCost" xlink:label="loc_trnr_AmortisationOfResearchAndDevelopmentalCost_1441" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_AmortisationOfResearchAndDevelopmentalCost_1441" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedResearchAndDevelopmentExpenses" xlink:label="loc_trnr_CapitalizedResearchAndDevelopmentExpenses_1442" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_CapitalizedResearchAndDevelopmentExpenses_1442" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OperatingLossCarryForwardsPercentage" xlink:label="loc_trnr_OperatingLossCarryForwardsPercentage_1443" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_OperatingLossCarryForwardsPercentage_1443" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_1444" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_1444" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_1437" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_OperatingLossCarryforwards_1437" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" xlink:label="loc_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax_1436" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax_1436" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" xlink:label="loc_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent_1435" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent_1435" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxDisclosureTable" xlink:label="loc_trnr_IncomeTaxDisclosureTable_1428" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_IncomeTaxDisclosureTable_1428" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1429" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trnr_IncomeTaxDisclosureTable_1428" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1429" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1430" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1429" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1430" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1430_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1429" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1430_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1433" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1430" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_1433" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_1432" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1430" xlink:to="loc_us-gaap_ForeignCountryMember_1432" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_1431" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1430" xlink:to="loc_us-gaap_DomesticCountryMember_1431" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_984" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_983" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_984" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_983" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_980" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_984" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_980" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_979" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_980" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_979" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_979" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_979" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesAConvertiblePreferredStockMember_981" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesAConvertiblePreferredStockMember_981" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAOneConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesAOneConvertiblePreferredStockMember_985" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesAOneConvertiblePreferredStockMember_985" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesATwoConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesATwoConvertiblePreferredStockMember_986" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesATwoConvertiblePreferredStockMember_986" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedConvertiblePreferredStockMember_987" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedConvertiblePreferredStockMember_987" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedOneConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedOneConvertiblePreferredStockMember_988" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedOneConvertiblePreferredStockMember_988" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedTwoConvertiblePreferredStockMember_989" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedTwoConvertiblePreferredStockMember_989" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedThreeConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedThreeConvertiblePreferredStockMember_990" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedThreeConvertiblePreferredStockMember_990" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFourConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedFourConvertiblePreferredStockMember_991" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedFourConvertiblePreferredStockMember_991" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFiveConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedFiveConvertiblePreferredStockMember_992" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedFiveConvertiblePreferredStockMember_992" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSixConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedSixConvertiblePreferredStockMember_993" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedSixConvertiblePreferredStockMember_993" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSevenConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedSevenConvertiblePreferredStockMember_994" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedSevenConvertiblePreferredStockMember_994" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedEightConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedEightConvertiblePreferredStockMember_995" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedEightConvertiblePreferredStockMember_995" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedNineConvertiblePreferredStockMember_996" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedNineConvertiblePreferredStockMember_996" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTenConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedTenConvertiblePreferredStockMember_997" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedTenConvertiblePreferredStockMember_997" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsToPurchaseSeriesClassACommonStockMember" xlink:label="loc_trnr_WarrantsToPurchaseSeriesClassACommonStockMember_998" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_WarrantsToPurchaseSeriesClassACommonStockMember_998" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" xlink:label="loc_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember_999" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember_999" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockOptionsToPurchaseCommonStockMember" xlink:label="loc_trnr_StockOptionsToPurchaseCommonStockMember_1000" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_StockOptionsToPurchaseCommonStockMember_1000" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1049" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1035" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1035" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1019" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1035" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1019" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1019_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1035" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1019_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonWarrantsMember" xlink:label="loc_trnr_ClassACommonWarrantsMember_1028" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1019" xlink:to="loc_trnr_ClassACommonWarrantsMember_1028" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonWarrantsMember" xlink:label="loc_trnr_ClassBCommonWarrantsMember_1017" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1019" xlink:to="loc_trnr_ClassBCommonWarrantsMember_1017" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1027" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1027" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1032" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1027" xlink:to="loc_us-gaap_ClassOfStockDomain_1032" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1032_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1027" xlink:to="loc_us-gaap_ClassOfStockDomain_1032_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1006" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1032" xlink:to="loc_us-gaap_CommonClassAMember_1006" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1021" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1032" xlink:to="loc_us-gaap_CommonClassBMember_1021" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_1030" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1032" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_1030" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1016" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_DebtInstrumentAxis_1016" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1036" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1016" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1036" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1036_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1016" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1036_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PromissoryNotesMember" xlink:label="loc_trnr_PromissoryNotesMember_1014" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1036" xlink:to="loc_trnr_PromissoryNotesMember_1014" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherRelatedPartyPromissoryNotesMember" xlink:label="loc_trnr_OtherRelatedPartyPromissoryNotesMember_1034" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1036" xlink:to="loc_trnr_OtherRelatedPartyPromissoryNotesMember_1034" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrincipalStockholderPromissoryNotesMember" xlink:label="loc_trnr_PrincipalStockholderPromissoryNotesMember_1025" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1036" xlink:to="loc_trnr_PrincipalStockholderPromissoryNotesMember_1025" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherRelatedPartyTransactionsMember" xlink:label="loc_trnr_OtherRelatedPartyTransactionsMember_1038" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1036" xlink:to="loc_trnr_OtherRelatedPartyTransactionsMember_1038" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1039" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1039" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1018" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1039" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1018" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1018_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1039" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1018_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoninterestBearingNoteMember" xlink:label="loc_trnr_NoninterestBearingNoteMember_1033" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1018" xlink:to="loc_trnr_NoninterestBearingNoteMember_1033" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1041" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1041" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1011" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1041" xlink:to="loc_us-gaap_RelatedPartyDomain_1011" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1011_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1041" xlink:to="loc_us-gaap_RelatedPartyDomain_1011_default" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FuseprojectMember" xlink:label="loc_trnr_FuseprojectMember_1008" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1011" xlink:to="loc_trnr_FuseprojectMember_1008" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ApeironAdvisoryLtdMember" xlink:label="loc_trnr_ApeironAdvisoryLtdMember_1022" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1011" xlink:to="loc_trnr_ApeironAdvisoryLtdMember_1022" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaap_DeferredRevenueArrangementTypeAxis_1043" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_DeferredRevenueArrangementTypeAxis_1043" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeAxis_1043" xlink:to="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeAxis_1043" xlink:to="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003_default" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" xlink:label="loc_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember_1026" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003" xlink:to="loc_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember_1026" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" xlink:label="loc_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember_1015" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003" xlink:to="loc_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember_1015" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1045" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_srt_RangeAxis_1045" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1013" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1045" xlink:to="loc_srt_RangeMember_1013" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1013_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1045" xlink:to="loc_srt_RangeMember_1013_default" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1012" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1013" xlink:to="loc_srt_MaximumMember_1012" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1024" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1013" xlink:to="loc_srt_MinimumMember_1024" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1047" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_srt_StatementScenarioAxis_1047" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1010" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1047" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1010" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1010_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1047" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1010_default" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1005" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1005" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1029" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1029" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1020" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1020" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DefaultInterest" xlink:label="loc_trnr_DefaultInterest_1051" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_DefaultInterest_1051" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InterestExpenseAndDefaultInterest" xlink:label="loc_trnr_InterestExpenseAndDefaultInterest_1052" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_InterestExpenseAndDefaultInterest_1052" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaap_OtherLiabilities_1053" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_OtherLiabilities_1053" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyPaymentPercentage" xlink:label="loc_trnr_RoyaltyPaymentPercentage_1054" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_RoyaltyPaymentPercentage_1054" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyIncomeNonoperating" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_1055" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_1055" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_1056" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_RoyaltyExpense_1056" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GuaranteedRoyaltyPayment" xlink:label="loc_trnr_GuaranteedRoyaltyPayment_1057" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_GuaranteedRoyaltyPayment_1057" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ContingentRoyaltyObligation" xlink:label="loc_trnr_ContingentRoyaltyObligation_1058" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_ContingentRoyaltyObligation_1058" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1059" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1059" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1060" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1060" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1037" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1037" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_1040" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_1040" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_1042" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_1042" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentFeePercentage" xlink:label="loc_trnr_DebtInstrumentFeePercentage_1044" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_DebtInstrumentFeePercentage_1044" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentInterestRateStatedPercentageAdditional" xlink:label="loc_trnr_DebtInstrumentInterestRateStatedPercentageAdditional_1046" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_DebtInstrumentInterestRateStatedPercentageAdditional_1046" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansPayable" xlink:label="loc_us-gaap_NotesAndLoansPayable_1048" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_NotesAndLoansPayable_1048" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedInterestAndDefaultInterest" xlink:label="loc_trnr_AccruedInterestAndDefaultInterest_1050" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_AccruedInterestAndDefaultInterest_1050" use="optional" order="61" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1072" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1072" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1070" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1070" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1066" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1070" xlink:to="loc_us-gaap_RelatedPartyDomain_1066" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1066_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1070" xlink:to="loc_us-gaap_RelatedPartyDomain_1066_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_1065" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1066" xlink:to="loc_us-gaap_RelatedPartyMember_1065" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1068" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" xlink:to="loc_us-gaap_DebtInstrumentAxis_1068" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1073" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1068" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1073" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1073_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1068" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1073_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrincipalStockholderPromissoryNotesMember" xlink:label="loc_trnr_PrincipalStockholderPromissoryNotesMember_1069" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1073" xlink:to="loc_trnr_PrincipalStockholderPromissoryNotesMember_1069" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherRelatedPartyPromissoryNotesMember" xlink:label="loc_trnr_OtherRelatedPartyPromissoryNotesMember_1071" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1073" xlink:to="loc_trnr_OtherRelatedPartyPromissoryNotesMember_1071" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FounderNotesMember" xlink:label="loc_trnr_FounderNotesMember_1067" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1073" xlink:to="loc_trnr_FounderNotesMember_1067" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_1064" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1072" xlink:to="loc_us-gaap_NotesPayable_1064" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://formelife.com/role/SubsequentEventsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1102" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1119" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1119" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1120" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1121" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1121" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockConversionBasis" xlink:label="loc_us-gaap_CommonStockConversionBasis_1123" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_CommonStockConversionBasis_1123" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_1127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_PaymentsForRestructuring_1127" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AssetPurchaseAgreementTerms" xlink:label="loc_trnr_AssetPurchaseAgreementTerms_1095" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_AssetPurchaseAgreementTerms_1095" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WeightedAverageThresholdConsecutiveTradingDays1" xlink:label="loc_trnr_WeightedAverageThresholdConsecutiveTradingDays1_1097" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_WeightedAverageThresholdConsecutiveTradingDays1_1097" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfOriginalIssuanceDiscount" xlink:label="loc_trnr_PercentageOfOriginalIssuanceDiscount_1108" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_PercentageOfOriginalIssuanceDiscount_1108" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1080" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_SubsequentEventTable_1080" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1124" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1124" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_1125" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1124" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_1125" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_1125_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1124" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_1125_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockToClassBCommonStockMember" xlink:label="loc_trnr_ClassACommonStockToClassBCommonStockMember_1126" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_1125" xlink:to="loc_trnr_ClassACommonStockToClassBCommonStockMember_1126" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1128" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1128" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1129" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1129_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1128" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1129_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractTerminationMember" xlink:label="loc_us-gaap_ContractTerminationMember_1130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1129" xlink:to="loc_us-gaap_ContractTerminationMember_1130" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaap_AssetAcquisitionAxis_1096" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_AssetAcquisitionAxis_1096" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaap_AssetAcquisitionDomain_1083" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1096" xlink:to="loc_us-gaap_AssetAcquisitionDomain_1083" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaap_AssetAcquisitionDomain_1083_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1096" xlink:to="loc_us-gaap_AssetAcquisitionDomain_1083_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AssetPurchaseAgreementMember" xlink:label="loc_trnr_AssetPurchaseAgreementMember_1090" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_1083" xlink:to="loc_trnr_AssetPurchaseAgreementMember_1090" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1094" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1094" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1082" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1094" xlink:to="loc_us-gaap_RelatedPartyDomain_1082" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1082_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1094" xlink:to="loc_us-gaap_RelatedPartyDomain_1082_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_1078" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1082" xlink:to="loc_us-gaap_RelatedPartyMember_1078" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1098" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_srt_StatementScenarioAxis_1098" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1081" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1098" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1081" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1081_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1098" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1081_default" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_1077" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1081" xlink:to="loc_srt_ScenarioForecastMember_1077" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_1100" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_srt_OwnershipAxis_1100" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1089" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_1100" xlink:to="loc_srt_OwnershipDomain_1089" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1089_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_1100" xlink:to="loc_srt_OwnershipDomain_1089_default" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1115" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1115" xlink:to="loc_us-gaap_ClassOfStockDomain_1116" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1116_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1115" xlink:to="loc_us-gaap_ClassOfStockDomain_1116_default" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember_1122" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1116" xlink:to="loc_trnr_ServiceProvidersStockWarrantsMember_1122" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1117" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1116" xlink:to="loc_us-gaap_CommonClassAMember_1117" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1088" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1088" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1084" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1088" xlink:to="loc_us-gaap_EquityComponentDomain_1084" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1084_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1088" xlink:to="loc_us-gaap_EquityComponentDomain_1084_default" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1079" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1084" xlink:to="loc_us-gaap_CommonStockMember_1079" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1092" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1092" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1076" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1092" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1076" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1076_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1092" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1076_default" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1087" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1076" xlink:to="loc_us-gaap_SubsequentEventMember_1087" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1112" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1112" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1112" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1113" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1113_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1112" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1113_default" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RightsOfferingMember" xlink:label="loc_trnr_RightsOfferingMember_1114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1113" xlink:to="loc_trnr_RightsOfferingMember_1114" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1132" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1132" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1132" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1133" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1133_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1132" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1133_default" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_1134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1133" xlink:to="loc_us-gaap_SeniorNotesMember_1134" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xlink:label="loc_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected_1086" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected_1086" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1099" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1099" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MaximumNumberOfEarnOutShares" xlink:label="loc_trnr_MaximumNumberOfEarnOutShares_1101" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_MaximumNumberOfEarnOutShares_1101" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1103" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1103" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1104" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1104" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1105" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1105" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1106" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1106" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1107" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_DebtInstrumentTerm_1107" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebt" xlink:label="loc_us-gaap_SubordinatedDebt_1091" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_SubordinatedDebt_1091" use="optional" order="62" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RetirementOfSeniorDebt" xlink:label="loc_trnr_RetirementOfSeniorDebt_1093" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_RetirementOfSeniorDebt_1093" use="optional" order="63" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_1110" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_1110" use="optional" order="64" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_1111" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_CommonStockSharesIssued_1111" use="optional" order="65" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1_1118" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ConversionOfStockAmountIssued1_1118" use="optional" order="66" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1131" use="optional" order="67" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:label="loc_us-gaap_UsefulLifeDescriptionOfTermDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" order="1.0" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>trnr-20230930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 22-December-2023 [11:38:22] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract" xml:lang="en-US">Cover [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AddressTypeDomain" xml:lang="en-US">Address Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_BusinessContactMember" xml:lang="en-US">Business Contact [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_BusinessContactMember" xml:lang="en-US">Business Contact</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber" xml:lang="en-US">Local Phone Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_LocalPhoneNumber" xml:lang="en-US">Local Phone Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod" xml:lang="en-US">Entity Ex Transition Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityExTransitionPeriod" xml:lang="en-US">Entity Ex Transition Period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany" xml:lang="en-US">Entity Emerging Growth Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityEmergingGrowthCompany" xml:lang="en-US">Entity Emerging Growth Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness" xml:lang="en-US">Entity Small Business</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntitySmallBusiness" xml:lang="en-US">Entity Small Business</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber" xml:lang="en-US">Entity Tax Identification Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityTaxIdentificationNumber" xml:lang="en-US">Entity Tax Identification Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2" xml:lang="en-US">Entity Address, Address Line Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressAddressLine2" xml:lang="en-US">Entity Address, Address Line Two</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressStateOrProvince" xml:lang="en-US">Entity Address, State or Province</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressStateOrProvince" xml:lang="en-US">Entity Address, State or Province</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode" xml:lang="en-US">City Area Code</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_CityAreaCode" xml:lang="en-US">City Area Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityPrimarySicNumber" xml:lang="en-US">Entity Primary SIC Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPrimarySicNumber" xlink:to="lab_dei_EntityPrimarySicNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelName" xml:lang="en-US">Contact Personnel Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Total property and equipment, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Right-of-use-assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating lease, right-of-use asset</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Right of use assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US">Intangible assets, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNoncurrent" xlink:label="loc_us-gaap_InventoryNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryNoncurrent" xml:lang="en-US">Inventory, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InventoryNoncurrent" xml:lang="en-US">Long-term inventories, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InventoryNoncurrent" xml:lang="en-US">Finished products - LT</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCosts" xml:lang="en-US">Deferred Costs, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredCosts" xml:lang="en-US">Deferred offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCosts" xlink:to="lab_us-gaap_DeferredCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssets" xml:lang="en-US">Other Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssets" xml:lang="en-US">Other assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Total Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating Lease, Liability, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating lease liability, current portion</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xml:lang="en-US">Contract with Customer, Liability, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xml:lang="en-US">Deferred revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaap_LoansPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LoansPayableCurrent" xml:lang="en-US">Loans Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LoansPayableCurrent" xml:lang="en-US">Loan payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableCurrent" xlink:to="lab_us-gaap_LoansPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaap_SecuredDebtCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SecuredDebtCurrent" xml:lang="en-US">Secured Debt, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SecuredDebtCurrent" xml:lang="en-US">Senior secured notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SecuredDebtCurrent" xml:lang="en-US">Senior secured notes outstanding balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtCurrent" xlink:to="lab_us-gaap_SecuredDebtCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xml:lang="en-US">Taxes Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xml:lang="en-US">Income tax payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xml:lang="en-US">Convertible Notes Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xml:lang="en-US">Convertible note payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="lab_us-gaap_ConvertibleNotesPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xml:lang="en-US">Accrued expenses and other current liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xml:lang="en-US">Total accrued expenses and other current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Operating lease liability, net of current portion</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeLiabilities" xml:lang="en-US">Derivative Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeLiabilities" xml:lang="en-US">Warrant liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DerivativeLiabilities" xml:lang="en-US">Fair value of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Total liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and contingencies (Note 13)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' equity (deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional Paid in Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional paid-in capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Accumulated other comprehensive income (loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Equity, Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Total stockholders' equity (deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Ending balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts receivable, net of allowances</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryFinishedGoods" xml:lang="en-US">Inventory, Finished Goods, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InventoryFinishedGoods" xml:lang="en-US">Inventories, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InventoryFinishedGoods" xml:lang="en-US">Finished goods</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xml:lang="en-US">Deposits Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xml:lang="en-US">Vendor deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent" xlink:to="lab_us-gaap_DepositsAssetsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid expenses and other current assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Total prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxesReceivables" xlink:label="loc_trnr_IncomeTaxesReceivables" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IncomeTaxesReceivables" xml:lang="en-US">Income Taxes Receivables</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IncomeTaxesReceivables" xml:lang="en-US">Income tax receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IncomeTaxesReceivables" xlink:to="lab_trnr_IncomeTaxesReceivables" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IncomeTaxesReceivables" xml:lang="en-US">Income taxes receivables.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total liabilities and stockholders' equity (deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xml:lang="en-US">PPP loan payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xml:lang="en-US">Convertible preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A convertible preferred stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A Preferred Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trnr_SeriesSeedConvertiblePreferredStockMember" xml:lang="en-US">Series Seed convertible preferred stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedConvertiblePreferredStockMember" xml:lang="en-US">Series Seed convertible preferred stock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xml:lang="en-US">Temporary Equity, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xml:lang="en-US">Temporary equity, shares outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xml:lang="en-US">Ending balance, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xml:lang="en-US">Beginning balance, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xml:lang="en-US">Shares&#160;Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xml:lang="en-US">Temporary Equity, Liquidation Preference</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xml:lang="en-US">Temporary equity, liquidation preference</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xml:lang="en-US">Liquidation Preference</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:to="lab_us-gaap_TemporaryEquityLiquidationPreference" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock, par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock shares authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, shares Issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xml:lang="en-US">Temporary equity, par or stated value per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xml:lang="en-US">Temporary Equity, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xml:lang="en-US">Temporary equity, shares authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xml:lang="en-US">Shares&#160;Authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xml:lang="en-US">Temporary Equity, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xml:lang="en-US">Temporary equity, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenuesAbstract" xml:lang="en-US">Revenues [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenuesAbstract" xml:lang="en-US">Revenue:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FitnessProductRevenue1" xlink:label="loc_trnr_FitnessProductRevenue1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FitnessProductRevenue1" xml:lang="en-US">Fitness Product Revenue1</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FitnessProductRevenue1" xml:lang="en-US">Fitness product revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FitnessProductRevenue1" xlink:to="lab_trnr_FitnessProductRevenue1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FitnessProductRevenue1" xml:lang="en-US">Fitness product revenue.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MembershipRevenue1" xlink:label="loc_trnr_MembershipRevenue1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_MembershipRevenue1" xml:lang="en-US">Membership revenue1</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_MembershipRevenue1" xml:lang="en-US">Membership revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_MembershipRevenue1" xlink:to="lab_trnr_MembershipRevenue1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_MembershipRevenue1" xml:lang="en-US">Membership revenue.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TrainingRevenue1" xlink:label="loc_trnr_TrainingRevenue1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TrainingRevenue1" xml:lang="en-US">Training Revenue1</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TrainingRevenue1" xml:lang="en-US">Training revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TrainingRevenue1" xlink:to="lab_trnr_TrainingRevenue1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TrainingRevenue1" xml:lang="en-US">Training revenue.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Revenues" xml:lang="en-US">Revenues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Revenues" xml:lang="en-US">Total revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfFitnessProductRevenue" xlink:label="loc_trnr_CostOfFitnessProductRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CostOfFitnessProductRevenue" xml:lang="en-US">Cost Of Fitness Product Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_CostOfFitnessProductRevenue" xml:lang="en-US">Cost of fitness product revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CostOfFitnessProductRevenue" xlink:to="lab_trnr_CostOfFitnessProductRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CostOfFitnessProductRevenue" xml:lang="en-US">Cost of fitness product revenue.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfMembership" xlink:label="loc_trnr_CostOfMembership" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CostOfMembership" xml:lang="en-US">Cost Of Membership</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_CostOfMembership" xml:lang="en-US">Cost of membership</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CostOfMembership" xlink:to="lab_trnr_CostOfMembership" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CostOfMembership" xml:lang="en-US">Cost of membership.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfTraining" xlink:label="loc_trnr_CostOfTraining" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CostOfTraining" xml:lang="en-US">Cost Of Training</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_CostOfTraining" xml:lang="en-US">Cost of training</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CostOfTraining" xlink:to="lab_trnr_CostOfTraining" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CostOfTraining" xml:lang="en-US">Cost of training.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfRevenue" xml:lang="en-US">Cost of Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_CostOfRevenue" xml:lang="en-US">Total cost of revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">Gross Profit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">Gross loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfMembershipAndTraining" xlink:label="loc_trnr_CostOfMembershipAndTraining" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CostOfMembershipAndTraining" xml:lang="en-US">Cost Of Membership And Training</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_CostOfMembershipAndTraining" xml:lang="en-US">Cost of membership and training</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CostOfMembershipAndTraining" xlink:to="lab_trnr_CostOfMembershipAndTraining" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CostOfMembershipAndTraining" xml:lang="en-US">Cost of membership&#160;and training.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating Expenses [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating expenses:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and Development Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xml:lang="en-US">Selling and Marketing Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xml:lang="en-US">Sales and marketing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Loss from operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other income (expense), net:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other income (expense), net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRevenueExpenseNet" xlink:label="loc_us-gaap_InterestRevenueExpenseNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestRevenueExpenseNet" xml:lang="en-US">Interest Revenue (Expense), Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InterestRevenueExpenseNet" xml:lang="en-US">Interest (expense)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRevenueExpenseNet" xlink:to="lab_us-gaap_InterestRevenueExpenseNet" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainUponDebtForgiveness" xlink:label="loc_trnr_GainUponDebtForgiveness" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_GainUponDebtForgiveness" xml:lang="en-US">Gain Upon Debt Forgiveness</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_GainUponDebtForgiveness" xml:lang="en-US">Gain upon debt forgiveness</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_GainUponDebtForgiveness" xlink:to="lab_trnr_GainUponDebtForgiveness" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_GainUponDebtForgiveness" xml:lang="en-US">Gain upon debt forgiveness</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xlink:label="loc_trnr_GainLossOnChangeInFairValueOfConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xml:lang="en-US">Gain Loss On Change In Fair Value Of Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xml:lang="en-US">Change in fair value of convertible notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xml:lang="en-US">Change in fair value of convertible notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xlink:to="lab_trnr_GainLossOnChangeInFairValueOfConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xml:lang="en-US">Gain loss on change in fair value of convertible notes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Change in fair value of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Change in fair value of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair value of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair value adjustment of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Nonoperating Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Total other income (expense), net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Change in Fair Values of Simple Agreements for Future Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Change in fair value of SAFEs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Change in fair value of SAFEs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xlink:to="lab_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Change in fair values of simple agreements for future equity.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Loss before provision for income taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income tax expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US">Net loss attributable to common stockholders</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Earnings Per Share, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Net loss per share - basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Net loss per share attributable to common stockholders - basic</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Earnings Per Share, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Net loss per share - diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Net loss per share attributable to common stockholders - diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted average common stock outstanding - basic</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted average common stock outstanding - diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xml:lang="en-US">Foreign currency translation (loss) gain</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US">Total comprehensive loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA1PreferredStockMember" xlink:label="loc_trnr_SeriesA1PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesA1PreferredStockMember" xml:lang="en-US">Series A-1 preferred stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesA1PreferredStockMember" xml:lang="en-US">Series A-1 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesA1PreferredStockMember" xlink:to="lab_trnr_SeriesA1PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesA1PreferredStockMember" xml:lang="en-US">Series A-1 Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA2PreferredStockMember" xlink:label="loc_trnr_SeriesA2PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesA2PreferredStockMember" xml:lang="en-US">Series A-2 Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesA2PreferredStockMember" xml:lang="en-US">Series A-2 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesA2PreferredStockMember" xlink:to="lab_trnr_SeriesA2PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesA2PreferredStockMember" xml:lang="en-US">Series A-2 preferred stock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Common Class A [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Class A Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Class A Common Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonClassBMember" xml:lang="en-US">Common Class B [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonClassBMember" xml:lang="en-US">Class B Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonClassBMember" xml:lang="en-US">Class B Common Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IPOMember" xml:lang="en-US">IPO [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IPOMember" xml:lang="en-US">IPO [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedZeroToTenPreferredStockMember" xlink:label="loc_trnr_SeriesSeedZeroToTenPreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedZeroToTenPreferredStockMember" xml:lang="en-US">Series Seed Zero To Ten Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedZeroToTenPreferredStockMember" xml:lang="en-US">Series Seed 0 - 10 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedZeroToTenPreferredStockMember" xlink:to="lab_trnr_SeriesSeedZeroToTenPreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedZeroToTenPreferredStockMember" xml:lang="en-US">Series seed zero to ten preferred stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesAConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesAConvertiblePreferredStockMember" xml:lang="en-US">Series A Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesAConvertiblePreferredStockMember" xml:lang="en-US">Series A Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesAConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesAConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesAConvertiblePreferredStockMember" xml:lang="en-US">Series A convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Endng balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Temporary equity, carrying amount, attributable to parent</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Beginning balance, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Ending balance, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InitialPublicOfferingCosts" xlink:label="loc_trnr_InitialPublicOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_InitialPublicOfferingCosts" xml:lang="en-US">Initial Public Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_InitialPublicOfferingCosts" xml:lang="en-US">Initial public offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_InitialPublicOfferingCosts" xlink:to="lab_trnr_InitialPublicOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_InitialPublicOfferingCosts" xml:lang="en-US">Initial public offering costs.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Issuance of stock, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock issued during period, shares, new issues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares Conversion of Convertible Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Issuance of Series A-2 preferred stock upon conversion of convertible notes, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Temporary equity stock issued during period shares conversion of convertible securities.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US">Temporary Equity Stock Issued During Period Value Conversion of Convertible Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US">Issuance of Series A-2 preferred stock upon conversion of convertible notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US">Temporary equity stock issued during period value conversion of convertible Securities.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockAmountIssued1" xml:lang="en-US">Conversion of Stock, Amount Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConversionOfStockAmountIssued1" xml:lang="en-US">Issuance of Common stock upon conversion of Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConversionOfStockAmountIssued1" xml:lang="en-US">Conversion of stock, amount issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountIssued1" xlink:to="lab_us-gaap_ConversionOfStockAmountIssued1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xml:lang="en-US">Conversion of Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xml:lang="en-US">Issuance of Common stock upon conversion of Common Stock, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xml:lang="en-US">Issuance of Class A common stock through conversion of preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Issuance of Series A-2 preferred stock, net of issuance costs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Temporary equity stock issued during period shares new issues.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of Series A-2 preferred stock, net of issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Temporary Equity Additional Stock Issued During Period Value New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of Series A-2 preferred stock, net of issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Temporary equity additional stock issued during period value new issues.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Issuance of Class B common stock upon exercise of stock options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Issuance of Class B common stock upon exercise of stock options, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Number of options, Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xml:lang="en-US">Conversion of Stock, Shares Converted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xml:lang="en-US">Common stock converted, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xml:lang="en-US">Conversion of Common Stock, Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:to="lab_us-gaap_ConversionOfStockSharesConverted1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Issuance of common stock upon conversion of convertible notes, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Issuance of common stock upon conversion, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Stock issued during period, shares, conversion of convertible securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US">Issuance of Common stock upon conversion of convertible notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US">Stock issued during period, value, conversion of convertible securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xml:lang="en-US">Stock Issued During Period Shares Warrants Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xml:lang="en-US">Exercise of stock warrants (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xml:lang="en-US">Stock issued upon exercise of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="lab_trnr_StockIssuedDuringPeriodSharesWarrantsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xml:lang="en-US">Stock issued during period shares warrants exercised.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodValueWarrantsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_StockIssuedDuringPeriodValueWarrantsExercised" xml:lang="en-US">Stock Issued During Period Value Warrants Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_StockIssuedDuringPeriodValueWarrantsExercised" xml:lang="en-US">Exercise of stock warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="lab_trnr_StockIssuedDuringPeriodValueWarrantsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_StockIssuedDuringPeriodValueWarrantsExercised" xml:lang="en-US">Stock issued during period value warrants exercised.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xml:lang="en-US">Stock-based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NetExerciseOfOptions" xlink:label="loc_trnr_NetExerciseOfOptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NetExerciseOfOptions" xml:lang="en-US">Net Exercise of Options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NetExerciseOfOptions" xml:lang="en-US">Net exercise of options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NetExerciseOfOptions" xlink:to="lab_trnr_NetExerciseOfOptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NetExerciseOfOptions" xml:lang="en-US">Net exercise of options</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" xml:lang="en-US">Adjustments to Additional Paid in Capital Issuance of Promissory Notes in Exchange for Stock Options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" xml:lang="en-US">Issuance of promissory notes in exchange for stock options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" xlink:to="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" xml:lang="en-US">Adjustments to Additional Paid in Capital Issuance of Promissory Notes in Exchange for Stock Options.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" xml:lang="en-US">Issuance of Class A Common Stock Upon Exercise of Warrants Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon exercise of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" xml:lang="en-US">Issuance of Class A Common Stock Upon Exercise of Warrants Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" xml:lang="en-US">Issuance of Class A Common Stock Upon Exercise of Warrants Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon exercise of warrants, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" xml:lang="en-US">Issuance of Class A Common Stock Upon Exercise of Warrants Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" xml:lang="en-US">Issuance of Class B Common Stock Upon Exercise of Warrants Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" xml:lang="en-US">Issuance of Class B common stock upon exercise of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" xlink:to="lab_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" xml:lang="en-US">Issuance of Class B Common Stock Upon Exercise of Warrants Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" xml:lang="en-US">Issuance of Class B Common Stock Upon Exercise of Warrants Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" xml:lang="en-US">Issuance of Class B common stock upon exercise of warrants, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" xlink:to="lab_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" xml:lang="en-US">Issuance of Class B Common Stock Upon Exercise of Warrants Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" xml:lang="en-US">Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" xml:lang="en-US">Issuance of Class B common stock upon conversion of SAFEs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" xlink:to="lab_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" xml:lang="en-US">Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" xml:lang="en-US">Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" xml:lang="en-US">Issuance of Class B common stock upon conversion of SAFEs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" xlink:to="lab_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" xml:lang="en-US">Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" xml:lang="en-US">Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" xml:lang="en-US">Issuance of Series Seed-2-10 preferred stock upon conversion of SAFEs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" xlink:to="lab_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" xml:lang="en-US">Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-2-10 preferred stock upon conversion of SAFEs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Two preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-2 preferred stock upon conversion of SAFE, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Two preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Three preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-3 preferred stock upon conversion of SAFE, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Three preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Four preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-4 preferred stock upon conversion of SAFE, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Four preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Five preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-5 preferred stock upon conversion of SAFEs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Five preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Six preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-6 preferred stock upon conversion of SAFEs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Six preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Seven preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-7 preferred stock upon conversion of SAFEs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Seven preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Eight preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-8 preferred stock upon conversion of SAFEs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Eight preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Nine preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-9 preferred stock upon conversion of SAFEs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Nine preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed-10 preferred stock upon conversion of SAFEs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:to="lab_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xml:lang="en-US">Issuance of Series Seed Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares New Issues Series Seed Nine Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" xml:lang="en-US">Issuance of Series Seed-9 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares New Issues Series Seed Nine Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Value New Issues Series Seed Nine Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" xml:lang="en-US">Issuance of Series Seed-9 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Value New Issues Series Seed Nine Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Value New Issues Issuance of Series A Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Issuance of Series A preferred stock net of issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Value New Issues Issuance of Series A Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares New Issues Issuance of Series A Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Issuance of Series A preferred stock net of issuance costs, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares New Issues Issuance of Series A Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Issuance of Series A preferred stock upon conversion of convertible notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Issuance of Series A preferred stock upon conversion of convertible notes, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xml:lang="en-US">Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A One Preferred Stock.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xml:lang="en-US">Issuance of Series A-1 preferred stock upon conversion of convertible notes, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xml:lang="en-US">Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A One Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xml:lang="en-US">Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A One Preferred Stock.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xml:lang="en-US">Issuance of Series A-1 preferred stock upon conversion of convertible notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xlink:to="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xml:lang="en-US">Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A One Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" xml:lang="en-US">Adjustments to Additional Paid in Capital Issuance of Series Seed Nine Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" xml:lang="en-US">Issuance of Series Seed-9 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" xlink:to="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" xml:lang="en-US">Adjustments to Additional Paid in Capital Issuance of Series Seed Nine Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Adjustments to Additional Paid in Capital Issuance of Series A Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Issuance of Series A preferred stock net of issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" xlink:to="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" xml:lang="en-US">Adjustments to Additional Paid in Capital Issuance of Series A Preferred Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" xml:lang="en-US">Issuance Of Class A Common Stock Upon Conversion Of Series A Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series A preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series A preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" xml:lang="en-US">Issuance Of Class A Common Stock Upon Conversion Of Series A1 Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series A-1 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A1 Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A1 Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series A-1 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A1 Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series A-2 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series A-2 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" xml:lang="en-US">Issuance Of Class A Common Stock Upon Conversion Of Series Seed Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-2 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-2 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-1 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-1 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-3 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-3 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-4 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-4 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-5 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-5 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-6 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-6 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-7 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-7 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-8 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-8 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-9 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-9 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-10 preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" xml:lang="en-US">Issuance of Class&#160;A common stock upon conversion of Series Seed-10 preferred stock, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" xlink:to="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" xml:lang="en-US">Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Shares.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid In Capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Accumulated Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Payments of Stock Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Issuance costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Payments of offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="loc_us-gaap_DebtConversionByUniqueDescriptionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtConversionByUniqueDescriptionAxis" xml:lang="en-US">Debt Conversion Description [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="lab_us-gaap_DebtConversionByUniqueDescriptionAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionNameDomain" xlink:label="loc_us-gaap_DebtConversionNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtConversionNameDomain" xml:lang="en-US">Debt Conversion, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionNameDomain" xlink:to="lab_us-gaap_DebtConversionNameDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfLoanPayableToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfLoanPayableToConvertibleNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ConversionOfLoanPayableToConvertibleNoteMember" xml:lang="en-US">Conversion of Loan Payable to Convertible Note [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ConversionOfLoanPayableToConvertibleNoteMember" xlink:to="lab_trnr_ConversionOfLoanPayableToConvertibleNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ConversionOfLoanPayableToConvertibleNoteMember" xml:lang="en-US">Conversion of Loan Payable to Convertible Note.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfAccountsPayableToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfAccountsPayableToConvertibleNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ConversionOfAccountsPayableToConvertibleNoteMember" xml:lang="en-US">Conversion of Accounts Payable to Convertible Note [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ConversionOfAccountsPayableToConvertibleNoteMember" xlink:to="lab_trnr_ConversionOfAccountsPayableToConvertibleNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ConversionOfAccountsPayableToConvertibleNoteMember" xml:lang="en-US">Conversion of Accounts Payable to Convertible Note.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" xml:lang="en-US">Conversion of Promissory Notes to Convertible Note [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" xlink:to="lab_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" xml:lang="en-US">Conversion of Promissory Notes to Convertible Note.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Cash Flows From Investing Activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireSoftware" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xml:lang="en-US">Payments to Acquire Software</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xml:lang="en-US">Acquisition of internal use software</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchase of property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopSoftware" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xml:lang="en-US">Payments to Develop Software</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xml:lang="en-US">Acquisition of software and content</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopSoftware" xlink:to="lab_us-gaap_PaymentsToDevelopSoftware" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net cash used in investing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash Flows From Operating Activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xml:lang="en-US">Amortization of Intangible Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xml:lang="en-US">Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xml:lang="en-US">Amortization expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xml:lang="en-US">Foreign currency</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xml:lang="en-US">Foreign currency transaction gains or losses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock-based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashLeaseExpense" xlink:label="loc_trnr_NonCashLeaseExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NonCashLeaseExpense" xml:lang="en-US">Non-cash lease expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NonCashLeaseExpense" xlink:to="lab_trnr_NonCashLeaseExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NonCashLeaseExpense" xml:lang="en-US">Non-cash lease expense</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryWriteDown" xml:lang="en-US">Inventory Write-down</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InventoryWriteDown" xml:lang="en-US">Inventory valuation loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Gain upon debt forgiveness</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xml:lang="en-US">Interest Income (Expense), Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xml:lang="en-US">Interest expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xml:lang="en-US">Amortization of debt discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" xlink:label="loc_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" xml:lang="en-US">Fair Value Adjustment Of Warrants Issued To Service Providers</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" xml:lang="en-US">Warrants issued to service providers</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" xlink:to="lab_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" xml:lang="en-US">Fair value adjustment of warrants issued to service providers.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Changes in operating assets and liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xml:lang="en-US">Increase (Decrease) in Inventories</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xml:lang="en-US">Inventories</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncreaseDecreaseInLongTermInventory" xlink:label="loc_trnr_IncreaseDecreaseInLongTermInventory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IncreaseDecreaseInLongTermInventory" xml:lang="en-US">Increase (Decrease) In Long-term Inventory</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_IncreaseDecreaseInLongTermInventory" xml:lang="en-US">Long-term inventories</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IncreaseDecreaseInLongTermInventory" xlink:to="lab_trnr_IncreaseDecreaseInLongTermInventory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IncreaseDecreaseInLongTermInventory" xml:lang="en-US">Increase (decrease) in long-term inventory.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets" xml:lang="en-US">Increase (Decrease) in Deposit Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets" xml:lang="en-US">Vendor deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInDepositOtherAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCharges" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCharges" xml:lang="en-US">Increase (Decrease) in Deferred Charges</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCharges" xml:lang="en-US">Deferred offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCharges" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCharges" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xml:lang="en-US">Deferred revenues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xml:lang="en-US">Other assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xml:lang="en-US">Accrued expenses and other current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xml:lang="en-US">Operating lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xml:lang="en-US">Amortization of operating lease assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" xlink:label="loc_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Fair Value Of Warrants Issued With Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Fair value of warrants issued with convertible notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" xlink:to="lab_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Fair value of Warrants Issued with Convertible Notes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xml:lang="en-US">Loss on property and equipment disposal</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashInterestExpense" xlink:label="loc_trnr_NonCashInterestExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NonCashInterestExpense" xml:lang="en-US">Non Cash Interest Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NonCashInterestExpense" xml:lang="en-US">Non-cash interest expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NonCashInterestExpense" xlink:to="lab_trnr_NonCashInterestExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NonCashInterestExpense" xml:lang="en-US">Non Cash Interest Expense.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetImpairmentCharges" xml:lang="en-US">Asset Impairment Charges</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetImpairmentCharges" xml:lang="en-US">Impairment write-off</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash Flows From Financing Activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RepaymentsOfRelatedPartyLoans" xlink:label="loc_trnr_RepaymentsOfRelatedPartyLoans" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RepaymentsOfRelatedPartyLoans" xml:lang="en-US">Repayments Of Related Party Loans</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_RepaymentsOfRelatedPartyLoans" xml:lang="en-US">Payments of related party loans</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RepaymentsOfRelatedPartyLoans" xlink:to="lab_trnr_RepaymentsOfRelatedPartyLoans" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RepaymentsOfRelatedPartyLoans" xml:lang="en-US">Repayments of related party loans.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xml:lang="en-US">Proceeds from Related Party Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xml:lang="en-US">Proceeds from issuance of related party loans</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRelatedPartyDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xml:lang="en-US">Proceeds from issuance of common stock upon initial public offering, net of offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xml:lang="en-US">Proceeds from Issuance of Secured Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xml:lang="en-US">Proceeds from senior secured notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xml:lang="en-US">Senior secured notes issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from the issuance of common stock A</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaymentsOfSeniorSecuredNotes" xlink:label="loc_trnr_PaymentsOfSeniorSecuredNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PaymentsOfSeniorSecuredNotes" xml:lang="en-US">Payments Of Senior Secured Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_PaymentsOfSeniorSecuredNotes" xml:lang="en-US">Payments of senior secured notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PaymentsOfSeniorSecuredNotes" xlink:to="lab_trnr_PaymentsOfSeniorSecuredNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PaymentsOfSeniorSecuredNotes" xml:lang="en-US">Payments of senior secured notes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xml:lang="en-US">Proceeds from Issuance of Preferred Stock and Preference Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xml:lang="en-US">Proceeds from issuance of Preferred Stock - Series A, net of issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xml:lang="en-US">Proceeds from Convertible Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xml:lang="en-US">Proceeds from issuance of convertible notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromPPPLoan" xlink:label="loc_trnr_ProceedsFromPPPLoan" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ProceedsFromPPPLoan" xml:lang="en-US">Proceeds From PPP Loan</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ProceedsFromPPPLoan" xml:lang="en-US">Proceeds from PPP loan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ProceedsFromPPPLoan" xlink:to="lab_trnr_ProceedsFromPPPLoan" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ProceedsFromPPPLoan" xml:lang="en-US">Proceeds from PPP loan.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xml:lang="en-US">Proceeds from the exercise of common stock options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RepaymentOfBouncebackLoans" xlink:label="loc_trnr_RepaymentOfBouncebackLoans" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RepaymentOfBouncebackLoans" xml:lang="en-US">Repayment of Bounceback Loans</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_RepaymentOfBouncebackLoans" xml:lang="en-US">Repayment Bounce Back Loan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RepaymentOfBouncebackLoans" xlink:to="lab_trnr_RepaymentOfBouncebackLoans" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RepaymentOfBouncebackLoans" xml:lang="en-US">Repayment of Bounceback Loans</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Proceeds from Issuance of Simple Agreements for Future Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Proceeds from issuance of SAFEs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" xlink:to="lab_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Proceeds from Issuance of Simple Agreements for Future Equity.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xml:lang="en-US">Proceeds from Issuance of Other Long-Term Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xml:lang="en-US">Proceeds from issuance of loans</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xml:lang="en-US">Proceeds from (Repayments of) Other Long-Term Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xml:lang="en-US">Payments of loans</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US">Proceeds from Warrant Exercises</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US">Proceeds from the exercise of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xml:lang="en-US">Effect of exchange rate on cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Net Change In Cash and Cash Equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xml:lang="en-US">Cash and restricted cash at beginning of year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xml:lang="en-US">Cash and restricted cash at end of year</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Disclosure Of Cash Flow Information:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" xlink:label="loc_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" xml:lang="en-US">Issuance of Series A preferred stock in connection with convertible notes payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" xml:lang="en-US">Issuance of Series A preferred stock in connection with convertible notes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" xlink:to="lab_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" xml:lang="en-US">Issuance of Series A preferred stock in connection with convertible notes payable</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InventoriesInAccountsPayableAndAccrued" xlink:label="loc_trnr_InventoriesInAccountsPayableAndAccrued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_InventoriesInAccountsPayableAndAccrued" xml:lang="en-US">Inventories in Accounts Payable and accrued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_InventoriesInAccountsPayableAndAccrued" xml:lang="en-US">Inventories in AP and accrued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_InventoriesInAccountsPayableAndAccrued" xlink:to="lab_trnr_InventoriesInAccountsPayableAndAccrued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_InventoriesInAccountsPayableAndAccrued" xml:lang="en-US">Inventories in Accounts Payable and accrued</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PropertyAndEquipmentInAccountsPayable" xlink:label="loc_trnr_PropertyAndEquipmentInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PropertyAndEquipmentInAccountsPayable" xml:lang="en-US">Property and Equipment in Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PropertyAndEquipmentInAccountsPayable" xml:lang="en-US">Property &amp; equipment in AP</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PropertyAndEquipmentInAccountsPayable" xlink:to="lab_trnr_PropertyAndEquipmentInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PropertyAndEquipmentInAccountsPayable" xml:lang="en-US">Property and equipment in accounts payable.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RecognitionOfDeferredAndAccruedOfferingCosts" xlink:label="loc_trnr_RecognitionOfDeferredAndAccruedOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RecognitionOfDeferredAndAccruedOfferingCosts" xml:lang="en-US">Recognition Of Deferred And Accrued Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_RecognitionOfDeferredAndAccruedOfferingCosts" xml:lang="en-US">Offering costs in AP and accrued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RecognitionOfDeferredAndAccruedOfferingCosts" xlink:to="lab_trnr_RecognitionOfDeferredAndAccruedOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RecognitionOfDeferredAndAccruedOfferingCosts" xml:lang="en-US">Recognition of deferred and accrued offering costs.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromPaycheckProtectionProgramLoan" xlink:label="loc_trnr_ProceedsFromPaycheckProtectionProgramLoan" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ProceedsFromPaycheckProtectionProgramLoan" xml:lang="en-US">Proceeds From Paycheck Protection Program Loan</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ProceedsFromPaycheckProtectionProgramLoan" xml:lang="en-US">Exercise of stock warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ProceedsFromPaycheckProtectionProgramLoan" xlink:to="lab_trnr_ProceedsFromPaycheckProtectionProgramLoan" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ProceedsFromPaycheckProtectionProgramLoan" xml:lang="en-US">Proceeds from paycheck protection program loan.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashExerciseOfOptions" xlink:label="loc_trnr_NonCashExerciseOfOptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NonCashExerciseOfOptions" xml:lang="en-US">Non cash Exercise of Options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NonCashExerciseOfOptions" xml:lang="en-US">Net exercise of options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NonCashExerciseOfOptions" xlink:to="lab_trnr_NonCashExerciseOfOptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NonCashExerciseOfOptions" xml:lang="en-US">Non cash Exercise of Options</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xml:lang="en-US">Conversion of Stock, Amount Converted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xml:lang="en-US">Conversion of convertible notes into common stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" xlink:label="loc_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" xml:lang="en-US">Decrease in right-of-use asset and operating lease liabilities due to lease termination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" xml:lang="en-US">Decrease in right-of-use asset and operating lease liabilities due to lease termination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" xlink:to="lab_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" xml:lang="en-US">Decrease in right-of-use asset and operating lease liabilities due to lease termination</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashIssuanceOfCommonStockFromRightsOffering" xlink:label="loc_trnr_NonCashIssuanceOfCommonStockFromRightsOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NonCashIssuanceOfCommonStockFromRightsOffering" xml:lang="en-US">Non Cash Issuance of Common Stock from Rights Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NonCashIssuanceOfCommonStockFromRightsOffering" xml:lang="en-US">Issuance of Common Stock from Rights Offering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NonCashIssuanceOfCommonStockFromRightsOffering" xlink:to="lab_trnr_NonCashIssuanceOfCommonStockFromRightsOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NonCashIssuanceOfCommonStockFromRightsOffering" xml:lang="en-US">Non cash issuance of common stock from rights offering.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockBasedCompensationCapitalizedInSoftware" xlink:label="loc_trnr_StockBasedCompensationCapitalizedInSoftware" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_StockBasedCompensationCapitalizedInSoftware" xml:lang="en-US">Stock Based Compensation Capitalized in Software</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_StockBasedCompensationCapitalizedInSoftware" xml:lang="en-US">Stock-based compensation capitalized in software</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_StockBasedCompensationCapitalizedInSoftware" xlink:to="lab_trnr_StockBasedCompensationCapitalizedInSoftware" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_StockBasedCompensationCapitalizedInSoftware" xml:lang="en-US">Stock based compensation capitalized in software.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashActivityDeferredCostsIncurred" xlink:label="loc_trnr_NoncashActivityDeferredCostsIncurred" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NoncashActivityDeferredCostsIncurred" xml:lang="en-US">Noncash Activity Deferred Costs Incurred</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NoncashActivityDeferredCostsIncurred" xml:lang="en-US">Deferred offering&#160;costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NoncashActivityDeferredCostsIncurred" xlink:to="lab_trnr_NoncashActivityDeferredCostsIncurred" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NoncashActivityDeferredCostsIncurred" xml:lang="en-US">Noncash Activity Deferred Costs Incurred.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedSoftwareAndContentInAccountsPayable" xlink:label="loc_trnr_CapitalizedSoftwareAndContentInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CapitalizedSoftwareAndContentInAccountsPayable" xml:lang="en-US">Capitalized Software and Content in Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CapitalizedSoftwareAndContentInAccountsPayable" xml:lang="en-US">Capitalized software and content in AP</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CapitalizedSoftwareAndContentInAccountsPayable" xlink:to="lab_trnr_CapitalizedSoftwareAndContentInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CapitalizedSoftwareAndContentInAccountsPayable" xml:lang="en-US">Capitalized Software and Content in Accounts Payable.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" xlink:label="loc_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Operating Lease Liability Upon Accounting Standard Adoption 842 Adoption</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities upon ASC 842 adoption</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" xlink:to="lab_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Operating Lease Liability Upon Accounting Standard Adoption 842 Adoption.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xml:lang="en-US">Issuance of convertible note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" xlink:label="loc_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" xml:lang="en-US">Noncash Transaction Issuance of Common Stock in Connection with Exercise of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" xml:lang="en-US">Issuance of common stock in connection with exercise of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" xlink:to="lab_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" xml:lang="en-US">Noncash Transaction Issuance of Common Stock in Connection with Exercise of Warrants.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" xlink:label="loc_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" xml:lang="en-US">Noncash Transaction Issuance of Warrants in Connection with Series A</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" xml:lang="en-US">Issuance of warrants in connection with Series A</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" xlink:to="lab_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" xml:lang="en-US">Noncash Transaction Issuance of Warrants in Connection with Series A.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesIssued1" xlink:label="loc_us-gaap_NotesIssued1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesIssued1" xml:lang="en-US">Notes Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NotesIssued1" xml:lang="en-US">Issuance of Series Seed preferred stock in connection with convertible notes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesIssued1" xlink:to="lab_us-gaap_NotesIssued1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaap_StockIssued1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssued1" xml:lang="en-US">Stock Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssued1" xml:lang="en-US">Issuance of connection with convertible SAFEs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xml:lang="en-US">Stock Conversion Description [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xml:lang="en-US">Conversion of Stock, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" xlink:label="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" xml:lang="en-US">Conversion of Convertible Simple Agreements for Future Equity to Series Seed Shares [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" xlink:to="lab_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" xml:lang="en-US">Conversion of Convertible Simple Agreements for Future Equity to Series Seed Shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" xlink:label="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" xml:lang="en-US">Conversion of Convertible Simple Agreements for Future Equity to Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" xlink:to="lab_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" xml:lang="en-US">Conversion of Convertible Simple Agreements for Future Equity to Common Stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfPreferredStockToClassACommonStockMember" xlink:label="loc_trnr_ConversionOfPreferredStockToClassACommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ConversionOfPreferredStockToClassACommonStockMember" xml:lang="en-US">Conversion of Preferred Stock to Class A Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ConversionOfPreferredStockToClassACommonStockMember" xlink:to="lab_trnr_ConversionOfPreferredStockToClassACommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ConversionOfPreferredStockToClassACommonStockMember" xml:lang="en-US">Conversion of Preferred Stock to Class A Common Stock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xml:lang="en-US">Description of Business and Basis of Presentation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Summary of Significant Accounting Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xml:lang="en-US">Revenue Recognition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityAbstract" xml:lang="en-US">Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" xml:lang="en-US">Simple Agreements for Future Equity and Advance Subscription Agreements [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" xml:lang="en-US">Simple Agreements for Future Equity and Advance Subscription Agreements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" xlink:to="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" xml:lang="en-US">Simple agreements for future equity and advance subscription agreements.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xml:lang="en-US">Inventory Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xml:lang="en-US">Inventory Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xml:lang="en-US">Inventories, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">Property and Equipment, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xml:lang="en-US">Intangible Assets, Net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" xlink:label="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" xml:lang="en-US">Prepaid Expenses and Other Current Assets Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" xlink:to="lab_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" xml:lang="en-US">Prepaid expenses and other current assets disclosure abstract.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" xlink:label="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" xml:lang="en-US">Prepaid Expenses and Other Current Assets Disclosure [TextBlock]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" xml:lang="en-US">Prepaid Expenses and Other Current Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" xlink:to="lab_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" xml:lang="en-US">Prepaid expenses and other current assets disclosure textBlock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xml:lang="en-US">Other Assets Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xml:lang="en-US">Other Assets, Net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_OtherAssetsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xml:lang="en-US">Payables and Accruals [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xml:lang="en-US">Debt Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US">Debt Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US">Debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsDisclosureTextBlock" xlink:label="loc_trnr_WarrantsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WarrantsDisclosureTextBlock" xml:lang="en-US">Warrants Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_WarrantsDisclosureTextBlock" xml:lang="en-US">Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WarrantsDisclosureTextBlock" xlink:to="lab_trnr_WarrantsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WarrantsDisclosureTextBlock" xml:lang="en-US">Disclosure of warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">Fair Value Measurements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesAbstract" xml:lang="en-US">Leases [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xml:lang="en-US">Leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Equity [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders' Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Equity-Based Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xml:lang="en-US">Risks and Uncertainties [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xml:lang="en-US">Concentration of Credit Risk and Major Customers and Vendors</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xml:lang="en-US">Retirement Benefits [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xml:lang="en-US">Retirement Benefits [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xml:lang="en-US">Benefit Plans</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Earnings Per Share [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Loss Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DeferredOfferingCostsPolicyTextBlock" xlink:label="loc_trnr_DeferredOfferingCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DeferredOfferingCostsPolicyTextBlock" xml:lang="en-US">Deferred Offering Costs [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DeferredOfferingCostsPolicyTextBlock" xml:lang="en-US">Deferred Offering Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DeferredOfferingCostsPolicyTextBlock" xlink:to="lab_trnr_DeferredOfferingCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DeferredOfferingCostsPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for deferred offering costs.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property and Equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xml:lang="en-US">Inventories, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorDepositPolicyTextBlock" xlink:label="loc_trnr_VendorDepositPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_VendorDepositPolicyTextBlock" xml:lang="en-US">Vendor Deposit [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_VendorDepositPolicyTextBlock" xml:lang="en-US">Vendor Deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_VendorDepositPolicyTextBlock" xlink:to="lab_trnr_VendorDepositPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_VendorDepositPolicyTextBlock" xml:lang="en-US">Vendor Deposit policy .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xml:lang="en-US">Segment Information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComparabilityOfPriorYearFinancialData" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xml:lang="en-US">Comparability of Prior Year Financial Data, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xml:lang="en-US">Unaudited Interim Financial Information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:to="lab_us-gaap_ComparabilityOfPriorYearFinancialData" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration of Credit Risk and&#160;Off-Balance&#160;Sheet Risk</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xml:lang="en-US">Commitments and Contingencies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfFitnessProductRevenuePolicyTextBlock" xlink:label="loc_trnr_CostOfFitnessProductRevenuePolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CostOfFitnessProductRevenuePolicyTextBlock" xml:lang="en-US">Cost of Fitness Product Revenue [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CostOfFitnessProductRevenuePolicyTextBlock" xml:lang="en-US">Cost of Fitness Product Revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CostOfFitnessProductRevenuePolicyTextBlock" xlink:to="lab_trnr_CostOfFitnessProductRevenuePolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CostOfFitnessProductRevenuePolicyTextBlock" xml:lang="en-US">Cost of Fitness Product Revenue.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfMembershipAndTrainingPolicyTextBlock" xlink:label="loc_trnr_CostOfMembershipAndTrainingPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CostOfMembershipAndTrainingPolicyTextBlock" xml:lang="en-US">Cost of Membership and Training [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CostOfMembershipAndTrainingPolicyTextBlock" xml:lang="en-US">Cost of Membership and Training</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CostOfMembershipAndTrainingPolicyTextBlock" xlink:to="lab_trnr_CostOfMembershipAndTrainingPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CostOfMembershipAndTrainingPolicyTextBlock" xml:lang="en-US">Cost of Membership and Training.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xml:lang="en-US">Advertising Cost [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xml:lang="en-US">Advertising Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xml:lang="en-US">Stock-Based Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xml:lang="en-US">Foreign Currency Transactions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xml:lang="en-US">Comprehensive Loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Loss Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ContentLicensingAgreementPolicyTextBlock" xlink:label="loc_trnr_ContentLicensingAgreementPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ContentLicensingAgreementPolicyTextBlock" xml:lang="en-US">Content Licensing Agreement [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ContentLicensingAgreementPolicyTextBlock" xml:lang="en-US">Content Licensing Agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ContentLicensingAgreementPolicyTextBlock" xlink:to="lab_trnr_ContentLicensingAgreementPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ContentLicensingAgreementPolicyTextBlock" xml:lang="en-US">Content Licensing Agreement.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xml:lang="en-US">Leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedStudioContentPolicytextBlock" xlink:label="loc_trnr_CapitalizedStudioContentPolicytextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CapitalizedStudioContentPolicytextBlock" xml:lang="en-US">Capitalized Studio Content [PolicyText Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CapitalizedStudioContentPolicytextBlock" xml:lang="en-US">Capitalized Studio Content</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CapitalizedStudioContentPolicytextBlock" xlink:to="lab_trnr_CapitalizedStudioContentPolicytextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CapitalizedStudioContentPolicytextBlock" xml:lang="en-US">Capitalized studio content policy.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xml:lang="en-US">Identifiable Intangible Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" xlink:label="loc_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" xml:lang="en-US">Music Royalty Fees Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" xml:lang="en-US">Music Royalty Fees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" xlink:to="lab_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" xml:lang="en-US">Music royalty fees policy.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US">Fair Value Measurements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xml:lang="en-US">Impairment of Long-Lived Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConvertibleNotesPolicyTextBlock" xlink:label="loc_trnr_ConvertibleNotesPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ConvertibleNotesPolicyTextBlock" xml:lang="en-US">Convertible Notes [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ConvertibleNotesPolicyTextBlock" xml:lang="en-US">Convertible Notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ConvertibleNotesPolicyTextBlock" xlink:to="lab_trnr_ConvertibleNotesPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ConvertibleNotesPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for convertible notes.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsPolicyTextBlock" xlink:label="loc_trnr_WarrantsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WarrantsPolicyTextBlock" xml:lang="en-US">Warrants [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_WarrantsPolicyTextBlock" xml:lang="en-US">Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WarrantsPolicyTextBlock" xlink:to="lab_trnr_WarrantsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WarrantsPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recently Issued Accounting Pronouncements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xml:lang="en-US">Derivative Instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" xml:lang="en-US">Simple Agreements for Future Equity and Advance Subscription Agreements [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" xml:lang="en-US">Simple Agreements for Future Equity ("SAFES") and Advance Subscription Agreements ("ASAs")</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" xlink:to="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" xml:lang="en-US">Simple Agreements for Future Equity and Advance Subscription Agreements.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" xlink:label="loc_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" xml:lang="en-US">Property Plant And Equipment Estimated Useful Lives Of Assets [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" xml:lang="en-US">Schedule of Property, Plant and Equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" xlink:to="lab_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" xml:lang="en-US">Property Plant And Equipment Estimated Useful Lives Of Assets [Table Text Block]</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xml:lang="en-US">Schedule of Amotization Computed on a Straight-line Basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xml:lang="en-US">Schedule of Inventories</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Schedule of Property, Plant and Equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xml:lang="en-US">Schedule of Identifiable Intangible Assets, Net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xml:lang="en-US">Schedule of Estimated Annual Amortization Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xml:lang="en-US">Schedule of Other Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of Accrued Expenses and Other Current Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xml:lang="en-US">Temporary Equity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xml:lang="en-US">Disclosure of Temporary Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xml:lang="en-US">Summary of Compensation Cost Recognized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Summary of Stock Option Activity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xml:lang="en-US">Summary of Unvested Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Summary of Stock Option Valuation Assumptions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class of Warrant or Right [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonStockWarrantsMember" xlink:label="loc_trnr_ClassBCommonStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ClassBCommonStockWarrantsMember" xml:lang="en-US">Class B Common Stock Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ClassBCommonStockWarrantsMember" xml:lang="en-US">Class B Common Stock Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ClassBCommonStockWarrantsMember" xlink:to="lab_trnr_ClassBCommonStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ClassBCommonStockWarrantsMember" xml:lang="en-US">Class B common stock warrants.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ServiceProvidersStockWarrantsMember" xml:lang="en-US">Service Providers Stock Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ServiceProvidersStockWarrantsMember" xml:lang="en-US">Service Providers Stock Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ServiceProvidersStockWarrantsMember" xlink:to="lab_trnr_ServiceProvidersStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ServiceProvidersStockWarrantsMember" xml:lang="en-US">Service providers stock warrants.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeniorSecuredNotesStockWarrantsMember" xlink:label="loc_trnr_SeniorSecuredNotesStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeniorSecuredNotesStockWarrantsMember" xml:lang="en-US">Senior Secured Notes Stock Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeniorSecuredNotesStockWarrantsMember" xml:lang="en-US">Senior Secured Notes Stock Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeniorSecuredNotesStockWarrantsMember" xlink:to="lab_trnr_SeniorSecuredNotesStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeniorSecuredNotesStockWarrantsMember" xml:lang="en-US">Senior secured notes stock warrants.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockWarrantsMember" xlink:label="loc_trnr_ClassACommonStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ClassACommonStockWarrantsMember" xml:lang="en-US">Class A Common Stock Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ClassACommonStockWarrantsMember" xml:lang="en-US">Class A Common Stock Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ClassACommonStockWarrantsMember" xlink:to="lab_trnr_ClassACommonStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ClassACommonStockWarrantsMember" xml:lang="en-US">Class A common stock warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xml:lang="en-US">Schedule of Changes in Warrants Issued and Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xml:lang="en-US">Schedule of Fair Value of Liabilities Measured on Recurring Basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xml:lang="en-US">Schedule of Future Minimum Rental Payments under Operating Leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTableTextBlock" xlink:label="loc_us-gaap_OtherCommitmentsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsTableTextBlock" xml:lang="en-US">Other Commitments [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentsTableTextBlock" xml:lang="en-US">Schedule of Other Commitments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTableTextBlock" xlink:to="lab_us-gaap_OtherCommitmentsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Disclosure of the components of deferred tax assets (liabilities)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Loss Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US">Schedule of Potentially Dilutive Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xml:lang="en-US">Schedule of Loan Payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xml:lang="en-US">Short-Term Debt, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xml:lang="en-US">Short-Term Debt, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NotePurchaseAgreementMember" xlink:label="loc_trnr_NotePurchaseAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NotePurchaseAgreementMember" xml:lang="en-US">Note Purchase Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NotePurchaseAgreementMember" xml:lang="en-US">June 2023 Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NotePurchaseAgreementMember" xlink:to="lab_trnr_NotePurchaseAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NotePurchaseAgreementMember" xml:lang="en-US">Note purchase agreement.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xml:lang="en-US">Loans and Leases Receivable, Related Parties, Additions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xml:lang="en-US">Loans outstanding from relate parties</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:to="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" xlink:label="loc_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" xml:lang="en-US">Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" xml:lang="en-US">Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions, Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" xlink:to="lab_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockStock" xlink:label="loc_us-gaap_DividendsCommonStockStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DividendsCommonStockStock" xml:lang="en-US">Dividends, Common Stock, Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockStock" xlink:to="lab_us-gaap_DividendsCommonStockStock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock" xlink:label="loc_us-gaap_DividendsCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DividendsCommonStock" xml:lang="en-US">Dividends, Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DividendsCommonStock" xml:lang="en-US">Dividends, Common Stock, Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherNoteholderMember" xlink:label="loc_trnr_OtherNoteholderMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_OtherNoteholderMember" xml:lang="en-US">60 Other Noteholder [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_OtherNoteholderMember" xlink:to="lab_trnr_OtherNoteholderMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_OtherNoteholderMember" xml:lang="en-US">60 Other noteholder.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LeadNoteholderMember" xlink:label="loc_trnr_LeadNoteholderMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_LeadNoteholderMember" xml:lang="en-US">67 Lead Noteholder [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_LeadNoteholderMember" xlink:to="lab_trnr_LeadNoteholderMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_LeadNoteholderMember" xml:lang="en-US">67 Lead Noteholder .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditFacilityAxis" xml:lang="en-US">Credit Facility [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditFacilityDomain" xml:lang="en-US">Credit Facility [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_BridgeNoteFinancingMember" xlink:label="loc_trnr_BridgeNoteFinancingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_BridgeNoteFinancingMember" xml:lang="en-US">Bridge Note Financing [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_BridgeNoteFinancingMember" xlink:to="lab_trnr_BridgeNoteFinancingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_BridgeNoteFinancingMember" xml:lang="en-US">Bridge Note Financing.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xml:lang="en-US">Long-Term Debt, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xml:lang="en-US">Long-Term Debt, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeniorNotesMember" xml:lang="en-US">Senior Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SeniorNotesMember" xml:lang="en-US">Senior Secured Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xml:lang="en-US">Convertible Notes Payable [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xml:lang="en-US">Convertible Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedStudioContentMember" xlink:label="loc_trnr_CapitalizedStudioContentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CapitalizedStudioContentMember" xml:lang="en-US">Capitalized Studio Content [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CapitalizedStudioContentMember" xlink:to="lab_trnr_CapitalizedStudioContentMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InternalUseSoftwareMember" xlink:label="loc_trnr_InternalUseSoftwareMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_InternalUseSoftwareMember" xml:lang="en-US">Internal Use Software [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_InternalUseSoftwareMember" xml:lang="en-US">Internal-Use Software</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_InternalUseSoftwareMember" xlink:to="lab_trnr_InternalUseSoftwareMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_InternalUseSoftwareMember" xml:lang="en-US">Internal use software member.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementScenarioAxis" xml:lang="en-US">Scenario [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xml:lang="en-US">Scenario [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds from issuance of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CooperativeAdvertisingAmount" xlink:label="loc_us-gaap_CooperativeAdvertisingAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CooperativeAdvertisingAmount" xml:lang="en-US">Cooperative Advertising Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CooperativeAdvertisingAmount" xml:lang="en-US">unamortized cost of content</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CooperativeAdvertisingAmount" xlink:to="lab_us-gaap_CooperativeAdvertisingAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:label="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xml:lang="en-US">Capitalized Software Development Costs for Software Sold to Customers</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xml:lang="en-US">Capitalized software</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:to="lab_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xml:lang="en-US">Goodwill and Intangible Asset Impairment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xml:lang="en-US">Intangible assets impairment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralPartnersOfferingCosts" xlink:label="loc_us-gaap_GeneralPartnersOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralPartnersOfferingCosts" xml:lang="en-US">General Partners' Offering Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralPartnersOfferingCosts" xlink:to="lab_us-gaap_GeneralPartnersOfferingCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US">Proceeds from issuance or sale of equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" xlink:label="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" xml:lang="en-US">Entertainment, License Agreement for Program Material, Capitalized Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" xml:lang="en-US">Content unamortized costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" xlink:to="lab_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Warrant exercise price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Warrant strike price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise price per share or per unit of warrants or rights outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">Warrants and Rights Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">Value of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xml:lang="en-US">Amortization of Debt Discount (Premium)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xml:lang="en-US">Debt discount on senior notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredOfferingCosts" xml:lang="en-US">Deferred Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredOfferingCosts" xml:lang="en-US">Deferred offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xml:lang="en-US">Amortization period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetImpairmentCharges" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xml:lang="en-US">Other Asset Impairment Charges</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xml:lang="en-US">Impairment loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LicenseFeePayablePerQuarter" xlink:label="loc_trnr_LicenseFeePayablePerQuarter" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_LicenseFeePayablePerQuarter" xml:lang="en-US">License Fee Payable Per Quarter</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_LicenseFeePayablePerQuarter" xml:lang="en-US">Licence fee payable per quarter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_LicenseFeePayablePerQuarter" xlink:to="lab_trnr_LicenseFeePayablePerQuarter" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_LicenseFeePayablePerQuarter" xml:lang="en-US">License fee payable per quarter.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability" xlink:label="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability" xml:lang="en-US">Entertainment, License Agreement for Program Material, Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability" xml:lang="en-US">License fee liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability" xlink:to="lab_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MusicGuaranteesDeposits" xlink:label="loc_trnr_MusicGuaranteesDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_MusicGuaranteesDeposits" xml:lang="en-US">Music Guarantees Deposits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_MusicGuaranteesDeposits" xml:lang="en-US">Music guarantees deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_MusicGuaranteesDeposits" xlink:to="lab_trnr_MusicGuaranteesDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_MusicGuaranteesDeposits" xml:lang="en-US">Music guarantees deposits.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Operating Lease, Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Operating lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" xml:lang="en-US">Maximum number of shares that could be issued to net share settle a contract</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:to="lab_us-gaap_ForwardContractIndexedToIssuersEquityShares" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" xlink:label="loc_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" xml:lang="en-US">Remeasurement Loss of Simple Agreements for Future Equity and Advance Subscription Agreements</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" xml:lang="en-US">Remeasurement loss of simple agreements for future equity and advance subscription agreements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" xlink:to="lab_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" xml:lang="en-US">Remeasurement loss of simple agreements for future equity and advance subscription agreements.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Expected dividend rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Expected dividend yield</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" xlink:label="loc_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" xml:lang="en-US">Percentage of Recognition of Tax Benefits During Income Tax Examination for Uncertain Tax Positions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" xml:lang="en-US">Percentage of recognition of tax benefits during income tax examination for uncertain tax positions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" xlink:to="lab_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" xml:lang="en-US">Percentage of recognition of tax benefits during income tax examination for uncertain tax positions.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ContentLicensingAgreementMember" xlink:label="loc_trnr_ContentLicensingAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ContentLicensingAgreementMember" xml:lang="en-US">Content Licensing Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ContentLicensingAgreementMember" xlink:to="lab_trnr_ContentLicensingAgreementMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis" xlink:to="lab_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain" xml:lang="en-US">Forward Contract Indexed to Issuer's Equity, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" xml:lang="en-US">Simple Agreements For Future Equity SAFES And Advance Subscription Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" xlink:to="lab_trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xml:lang="en-US">Income Statement Location [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xml:lang="en-US">Income Statement Location [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyGainLossMember" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xml:lang="en-US">Foreign Currency Gain (Loss) [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:to="lab_us-gaap_ForeignCurrencyGainLossMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PreProductionToolingMember" xlink:label="loc_trnr_PreProductionToolingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PreProductionToolingMember" xml:lang="en-US">Pre Production Tooling [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PreProductionToolingMember" xml:lang="en-US">Pre - Production Tooling [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PreProductionToolingMember" xlink:to="lab_trnr_PreProductionToolingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PreProductionToolingMember" xml:lang="en-US">Pre Production Tooling.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xml:lang="en-US">Machinery and Equipment [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and Fixtures [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember" xml:lang="en-US">Statistical Measurement [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US">Property, plant and equipment, estimated useful lives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xml:lang="en-US">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xml:lang="en-US">Internal-use software</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xml:lang="en-US">Disaggregation of Revenue [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xml:lang="en-US">Disaggregation of Revenue [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ExtendedProductWarrantyPeriod" xlink:label="loc_trnr_ExtendedProductWarrantyPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ExtendedProductWarrantyPeriod" xml:lang="en-US">Extended Product Warranty Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ExtendedProductWarrantyPeriod" xml:lang="en-US">Extended product warranty period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ExtendedProductWarrantyPeriod" xlink:to="lab_trnr_ExtendedProductWarrantyPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ExtendedProductWarrantyPeriod" xml:lang="en-US">Extended product warranty period.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" xml:lang="en-US">Simple Agreements for Future Equity and Advance Subscription Agreements [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" xlink:to="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" xml:lang="en-US">Simple agreements for future equity and advance subscription agreements.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" xml:lang="en-US">Simple Agreements for Future Equity and Advance Subscription Agreements [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" xlink:to="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" xml:lang="en-US">Simple agreements for future equity and advance subscription agreements.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xml:lang="en-US">Convertible Preferred Stock Shares Issued Upon Conversion</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xml:lang="en-US">Convertible notes converted into preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock, shares outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementAxis" xlink:label="loc_trnr_AgreementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AgreementAxis" xml:lang="en-US">Agreement [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AgreementAxis" xlink:to="lab_trnr_AgreementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AgreementAxis" xml:lang="en-US">Agreement.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementDomain" xlink:label="loc_trnr_AgreementDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AgreementDomain" xml:lang="en-US">Agreement [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AgreementDomain" xlink:to="lab_trnr_AgreementDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AgreementDomain" xml:lang="en-US">Agreement.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityMember" xml:lang="en-US">Simple Agreements for Future Equity [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityMember" xml:lang="en-US">Simple Agreements for Future Equity [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityMember" xml:lang="en-US">SAFE Liability [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityMember" xlink:to="lab_trnr_SimpleAgreementsForFutureEquityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SimpleAgreementsForFutureEquityMember" xml:lang="en-US">Simple agreements for future equity.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryNet" xml:lang="en-US">Inventory, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_InventoryNet" xml:lang="en-US">Total inventories, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PreProductionTooling" xlink:label="loc_trnr_PreProductionTooling" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PreProductionTooling" xml:lang="en-US">Pre-Production Tooling</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PreProductionTooling" xml:lang="en-US">Pre-production tooling</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PreProductionTooling" xlink:to="lab_trnr_PreProductionTooling" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PreProductionTooling" xml:lang="en-US">Pre-Production Tooling</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xml:lang="en-US">Machinery and Equipment, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xml:lang="en-US">Machinery and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xml:lang="en-US">Leasehold Improvements, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xml:lang="en-US">Leasehold improvements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xml:lang="en-US">Furniture and Fixtures, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xml:lang="en-US">Furniture and fixtures</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xml:lang="en-US">Capitalized Computer Software, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xml:lang="en-US">Software and technology development asset</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property, Plant and Equipment, Gross, Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Less: Accumulated depreciation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation and amortization expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PropertyAndEquipmentMember" xlink:label="loc_trnr_PropertyAndEquipmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PropertyAndEquipmentMember" xml:lang="en-US">Property and Equipment [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PropertyAndEquipmentMember" xlink:to="lab_trnr_PropertyAndEquipmentMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xml:lang="en-US">Cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US">Accumulated Amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IdentifiableIntangibleAssetsMember" xlink:label="loc_trnr_IdentifiableIntangibleAssetsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IdentifiableIntangibleAssetsMember" xml:lang="en-US">Identifiable Intangible Assets [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IdentifiableIntangibleAssetsMember" xml:lang="en-US">Identifiable Intangible Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IdentifiableIntangibleAssetsMember" xlink:to="lab_trnr_IdentifiableIntangibleAssetsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IdentifiableIntangibleAssetsMember" xml:lang="en-US">Identifiable intangible assets.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xml:lang="en-US">2023 (remaining)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xml:lang="en-US">2024 / 2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xml:lang="en-US">2025 / 2024</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xml:lang="en-US">2026 / 2025</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xml:lang="en-US">2027 / 2026</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xml:lang="en-US">2027</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaap_SecurityDeposit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SecurityDeposit" xml:lang="en-US">Security Deposit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SecurityDeposit" xml:lang="en-US">Security deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecurityDeposit" xlink:to="lab_us-gaap_SecurityDeposit" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidLicenses" xlink:label="loc_trnr_PrepaidLicenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PrepaidLicenses" xml:lang="en-US">Prepaid Licenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PrepaidLicenses" xml:lang="en-US">Prepaid licenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PrepaidLicenses" xlink:to="lab_trnr_PrepaidLicenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PrepaidLicenses" xml:lang="en-US">Prepaid licenses.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ResearchAndDevelopmentTaxCredit" xlink:label="loc_trnr_ResearchAndDevelopmentTaxCredit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ResearchAndDevelopmentTaxCredit" xml:lang="en-US">Research and Development Tax Credit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ResearchAndDevelopmentTaxCredit" xml:lang="en-US">Research and development tax credit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ResearchAndDevelopmentTaxCredit" xlink:to="lab_trnr_ResearchAndDevelopmentTaxCredit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ResearchAndDevelopmentTaxCredit" xml:lang="en-US">Research and development tax credit.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaap_OtherReceivables" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherReceivables" xml:lang="en-US">Other Receivables</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherReceivables" xml:lang="en-US">Other receivables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaap_PrepaidInsurance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidInsurance" xml:lang="en-US">Prepaid Insurance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PrepaidInsurance" xml:lang="en-US">Insurance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xml:lang="en-US">Other Prepaid Expense, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xml:lang="en-US">Other prepaid</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorDeposits" xlink:label="loc_trnr_VendorDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_VendorDeposits" xml:lang="en-US">Vendor Deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_VendorDeposits" xlink:to="lab_trnr_VendorDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_VendorDeposits" xml:lang="en-US">Vendor deposits.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RestatementAxis" xml:lang="en-US">Revision of Prior Period [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RestatementDomain" xml:lang="en-US">Revision of Prior Period [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xml:lang="en-US">Previously Reported [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xml:lang="en-US">Balance Sheet Location [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xml:lang="en-US">Balance Sheet Location [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsMember" xml:lang="en-US">Other Assets [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssetsMember" xml:lang="en-US">Other Member</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" xlink:label="loc_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" xml:lang="en-US">Accumulated Amortization of Other Deferred Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" xml:lang="en-US">Accumulated Amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" xlink:to="lab_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="loc_us-gaap_OtherDeferredCostsNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherDeferredCostsNet" xml:lang="en-US">Other Deferred Costs, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OtherDeferredCostsNet" xml:lang="en-US">Net Book Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDeferredCostsNet" xlink:to="lab_us-gaap_OtherDeferredCostsNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsGross" xlink:label="loc_us-gaap_OtherDeferredCostsGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherDeferredCostsGross" xml:lang="en-US">Other Deferred Costs, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherDeferredCostsGross" xml:lang="en-US">Cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDeferredCostsGross" xlink:to="lab_us-gaap_OtherDeferredCostsGross" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedSoftwareMember" xlink:label="loc_trnr_CapitalizedSoftwareMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CapitalizedSoftwareMember" xml:lang="en-US">Capitalized Software [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CapitalizedSoftwareMember" xml:lang="en-US">Capitalized Software Member</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CapitalizedSoftwareMember" xlink:to="lab_trnr_CapitalizedSoftwareMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CapitalizedSoftwareMember" xml:lang="en-US">Capitalized software.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedContentCostsAndContentLicensesMember" xlink:label="loc_trnr_CapitalizedContentCostsAndContentLicensesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CapitalizedContentCostsAndContentLicensesMember" xml:lang="en-US">Capitalized Content Costs And Content Licenses [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CapitalizedContentCostsAndContentLicensesMember" xlink:to="lab_trnr_CapitalizedContentCostsAndContentLicensesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CapitalizedContentCostsAndContentLicensesMember" xml:lang="en-US">Capitalized content costs and content licenses.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedContentCostsMember" xlink:label="loc_trnr_CapitalizedContentCostsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CapitalizedContentCostsMember" xml:lang="en-US">Capitalized Content Costs [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CapitalizedContentCostsMember" xml:lang="en-US">Capitalized Content Costs Member</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CapitalizedContentCostsMember" xlink:to="lab_trnr_CapitalizedContentCostsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CapitalizedContentCostsMember" xml:lang="en-US">Capitalized content costs.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAmortizationOfDeferredCharges" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xml:lang="en-US">Amortization of Other Deferred Charges</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xml:lang="en-US">Amortization expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaap_AccruedBonusesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xml:lang="en-US">Accrued Bonuses, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xml:lang="en-US">Accrued bonus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xml:lang="en-US">Accrued Payroll Taxes, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xml:lang="en-US">Accrued payroll</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedPayrollTaxesCurrent" xlink:to="lab_us-gaap_AccruedPayrollTaxesCurrent" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaidTimeOffAccrual" xlink:label="loc_trnr_PaidTimeOffAccrual" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PaidTimeOffAccrual" xml:lang="en-US">Paid Time Off Accrual</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PaidTimeOffAccrual" xml:lang="en-US">Accrued PTO</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PaidTimeOffAccrual" xlink:to="lab_trnr_PaidTimeOffAccrual" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PaidTimeOffAccrual" xml:lang="en-US">Paid time off accrual.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedOfferingCosts" xlink:label="loc_trnr_AccruedOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AccruedOfferingCosts" xml:lang="en-US">Accrued Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AccruedOfferingCosts" xml:lang="en-US">Accrued offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AccruedOfferingCosts" xlink:to="lab_trnr_AccruedOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AccruedOfferingCosts" xml:lang="en-US">Accrued offering costs.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedLicenses" xlink:label="loc_trnr_AccruedLicenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AccruedLicenses" xml:lang="en-US">Accrued Licenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AccruedLicenses" xml:lang="en-US">Accrued licenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AccruedLicenses" xlink:to="lab_trnr_AccruedLicenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AccruedLicenses" xml:lang="en-US">Accrued licenses.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xml:lang="en-US">Accrued Royalties, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xml:lang="en-US">Accrued royalties</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US">Accrued Professional Fees, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US">Accrued professional fees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CustomerDeposits" xlink:label="loc_trnr_CustomerDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CustomerDeposits" xml:lang="en-US">Customer Deposits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CustomerDeposits" xml:lang="en-US">Customer deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CustomerDeposits" xlink:to="lab_trnr_CustomerDeposits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CustomerDeposits" xml:lang="en-US">Customer deposits</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xml:lang="en-US">Other Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xml:lang="en-US">Other accrued expenses and current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaap_AccruedAdvertisingCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedAdvertisingCurrent" xml:lang="en-US">Accrued Advertising, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedAdvertisingCurrent" xml:lang="en-US">Accrued advertising</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedAdvertisingCurrent" xlink:to="lab_us-gaap_AccruedAdvertisingCurrent" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedEngineeringCurrent" xlink:label="loc_trnr_AccruedEngineeringCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AccruedEngineeringCurrent" xml:lang="en-US">Accrued Engineering Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AccruedEngineeringCurrent" xml:lang="en-US">Accrued engineering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AccruedEngineeringCurrent" xlink:to="lab_trnr_AccruedEngineeringCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AccruedEngineeringCurrent" xml:lang="en-US">Accrued engineering current.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xml:lang="en-US">Sales and Excise Tax Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xml:lang="en-US">Sales tax payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Total accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US">Other Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US">Other current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentTable" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentAxis" xml:lang="en-US">Debt Instrument [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyTwoConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TwoThousandTwentyTwoConvertibleNotesMember" xml:lang="en-US">Two Thousand Twenty-Two Convertible Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TwoThousandTwentyTwoConvertibleNotesMember" xml:lang="en-US">2022 Convertible Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TwoThousandTwentyTwoConvertibleNotesMember" xlink:to="lab_trnr_TwoThousandTwentyTwoConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TwoThousandTwentyTwoConvertibleNotesMember" xml:lang="en-US">Two thousand twenty-two convertible notes.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_November2022ConvertibleNotesMember" xlink:label="loc_trnr_November2022ConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_November2022ConvertibleNotesMember" xml:lang="en-US">November 2022 Convertible Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_November2022ConvertibleNotesMember" xlink:to="lab_trnr_November2022ConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_November2022ConvertibleNotesMember" xml:lang="en-US">November 2022 Convertible Notes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConvertibleDebtMember" xml:lang="en-US">Convertible Debt [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TwoThousandTwentyConvertibleNotesMember" xml:lang="en-US">Two Thousand Twenty Convertible Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TwoThousandTwentyConvertibleNotesMember" xml:lang="en-US">2020 Convertible Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TwoThousandTwentyConvertibleNotesMember" xlink:to="lab_trnr_TwoThousandTwentyConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TwoThousandTwentyConvertibleNotesMember" xml:lang="en-US">Two thousand twenty convertible notes.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyOneConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyOneConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TwoThousandTwentyOneConvertibleNotesMember" xml:lang="en-US">Two Thousand Twenty One Convertible Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TwoThousandTwentyOneConvertibleNotesMember" xml:lang="en-US">2021 Convertible Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TwoThousandTwentyOneConvertibleNotesMember" xlink:to="lab_trnr_TwoThousandTwentyOneConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TwoThousandTwentyOneConvertibleNotesMember" xml:lang="en-US">Two thousand twenty one convertible notes.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaycheckProtectionProgramLoanMember" xlink:label="loc_trnr_PaycheckProtectionProgramLoanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PaycheckProtectionProgramLoanMember" xml:lang="en-US">Paycheck Protection Program Loan [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PaycheckProtectionProgramLoanMember" xlink:to="lab_trnr_PaycheckProtectionProgramLoanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PaycheckProtectionProgramLoanMember" xml:lang="en-US">Paycheck protection program loan.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TenPercentageSeniorSecuredNotesDueMember" xlink:label="loc_trnr_TenPercentageSeniorSecuredNotesDueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TenPercentageSeniorSecuredNotesDueMember" xml:lang="en-US">Ten Percentage Senior secured Notes Due [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TenPercentageSeniorSecuredNotesDueMember" xml:lang="en-US">10% senior secured notes due [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TenPercentageSeniorSecuredNotesDueMember" xlink:to="lab_trnr_TenPercentageSeniorSecuredNotesDueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TenPercentageSeniorSecuredNotesDueMember" xml:lang="en-US">10% senior secured notes.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeed9PreferredStockMember" xlink:label="loc_trnr_SeriesSeed9PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeed9PreferredStockMember" xml:lang="en-US">Series Seed 9 Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeed9PreferredStockMember" xlink:to="lab_trnr_SeriesSeed9PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeed9PreferredStockMember" xml:lang="en-US">Series seed 9 preferred stock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xml:lang="en-US">Debt Instrument [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Debt Instrument, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Scheduled maturity date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Debt instrument term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xml:lang="en-US">Conversion price as a percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares Issued, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Stock price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LossDueToChangesInFairValueOfConvertibleNotes" xlink:label="loc_trnr_LossDueToChangesInFairValueOfConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_LossDueToChangesInFairValueOfConvertibleNotes" xml:lang="en-US">Loss Due to Changes in Fair Value of Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_LossDueToChangesInFairValueOfConvertibleNotes" xml:lang="en-US">Convertible Notes losses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_LossDueToChangesInFairValueOfConvertibleNotes" xlink:to="lab_trnr_LossDueToChangesInFairValueOfConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_LossDueToChangesInFairValueOfConvertibleNotes" xml:lang="en-US">Loss due to changes in fair value of convertible notes</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xml:lang="en-US">Debt Instrument, Maturity Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xml:lang="en-US">Maturity Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Debt Instrument, Face Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Debt Instrument, Face Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Interest rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" xlink:label="loc_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" xml:lang="en-US">Gain Recognized on Fair Value Changes of Convertible Notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" xlink:to="lab_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" xml:lang="en-US">Gain recognized on fair value changes of convertible notes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xml:lang="en-US">Repayments of Lines of Credit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xml:lang="en-US">Repayments of senior secured notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InterestExpenseAndDefaultInterest" xlink:label="loc_trnr_InterestExpenseAndDefaultInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_InterestExpenseAndDefaultInterest" xml:lang="en-US">Interest Expense And Default Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_InterestExpenseAndDefaultInterest" xml:lang="en-US">Interest expense including default interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_InterestExpenseAndDefaultInterest" xlink:to="lab_trnr_InterestExpenseAndDefaultInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_InterestExpenseAndDefaultInterest" xml:lang="en-US">Interest expense including default interest.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xml:lang="en-US">Long-Term Debt, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xml:lang="en-US">Debt Instrument Carrying Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfInterestRateOfDebtForgiveness" xlink:label="loc_trnr_PercentageOfInterestRateOfDebtForgiveness" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PercentageOfInterestRateOfDebtForgiveness" xml:lang="en-US">Percentage Of Interest Rate Of Debt Forgiveness</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PercentageOfInterestRateOfDebtForgiveness" xml:lang="en-US">Percentage Of Interest Rate Of Debt Forgiveness</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PercentageOfInterestRateOfDebtForgiveness" xlink:to="lab_trnr_PercentageOfInterestRateOfDebtForgiveness" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PercentageOfInterestRateOfDebtForgiveness" xml:lang="en-US">Percentage of interest rate of debt forgiveness.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xml:lang="en-US">Debt Instrument, Convertible, Beneficial Conversion Feature</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xml:lang="en-US">Debt Instrument, Convertible, Beneficial Conversion Feature</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="lab_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Title of Individual [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoIndividualMember" xlink:label="loc_trnr_TwoIndividualMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TwoIndividualMember" xml:lang="en-US">Two Individual [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TwoIndividualMember" xlink:to="lab_trnr_TwoIndividualMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TwoIndividualMember" xml:lang="en-US">Two individual.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xml:lang="en-US">November Two Thousand Twenty Two Convertible Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xml:lang="en-US">November 2022 Convertible Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xlink:to="lab_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xml:lang="en-US">November two thousand twenty two convertible notes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Warrants contractual term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Common stock, warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xml:lang="en-US">Warrants Not Settleable in Cash, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xml:lang="en-US">Warrants not settleable in cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrants" xlink:label="loc_trnr_FairValueOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueOfWarrants" xml:lang="en-US">Fair Value Of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FairValueOfWarrants" xml:lang="en-US">Fair value of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueOfWarrants" xlink:to="lab_trnr_FairValueOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueOfWarrants" xml:lang="en-US">Fair value of warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Warrants issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantOutstanding" xlink:label="loc_trnr_WarrantOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WarrantOutstanding" xml:lang="en-US">Warrant Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trnr_WarrantOutstanding" xml:lang="en-US">Outstanding warrant, Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trnr_WarrantOutstanding" xml:lang="en-US">Outstanding warrant, Ending balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WarrantOutstanding" xlink:to="lab_trnr_WarrantOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WarrantOutstanding" xml:lang="en-US">Warrant outstanding.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassOfWarrantsIssued" xlink:label="loc_trnr_ClassOfWarrantsIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ClassOfWarrantsIssued" xml:lang="en-US">Class of Warrants Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ClassOfWarrantsIssued" xml:lang="en-US">Warrants issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ClassOfWarrantsIssued" xlink:to="lab_trnr_ClassOfWarrantsIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ClassOfWarrantsIssued" xml:lang="en-US">Class of warrants issued.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassOfWarrantsExercised" xlink:label="loc_trnr_ClassOfWarrantsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ClassOfWarrantsExercised" xml:lang="en-US">Class of Warrants Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ClassOfWarrantsExercised" xml:lang="en-US">Warrants exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ClassOfWarrantsExercised" xlink:to="lab_trnr_ClassOfWarrantsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ClassOfWarrantsExercised" xml:lang="en-US">Class of warrants exercised.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xml:lang="en-US">Measurement Input Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xml:lang="en-US">Measurement Input Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xml:lang="en-US">Measurement Input, Discount Rate [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xml:lang="en-US">Liability Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xml:lang="en-US">Fair Value by Liability Class [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaap_ConvertibleDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConvertibleDebt" xml:lang="en-US">Convertible Debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xml:lang="en-US">Fair value liabilities, measurements transfers between levels</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xml:lang="en-US">Liabilities, Fair Value Adjustment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xml:lang="en-US">Change in fair value adjustment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:to="lab_us-gaap_LiabilitiesFairValueAdjustment" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Fair Value Adjustments Of Simple Agreements for Future Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Fair value adjustments of simple agreements for future equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" xlink:to="lab_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" xml:lang="en-US">Fair value adjustments of simple agreements for future equity.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EquityValuePercentage" xlink:label="loc_trnr_EquityValuePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_EquityValuePercentage" xml:lang="en-US">Equity Value Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_EquityValuePercentage" xml:lang="en-US">Equity value, FV-NI</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_EquityValuePercentage" xlink:to="lab_trnr_EquityValuePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_EquityValuePercentage" xml:lang="en-US">Equity value percentage.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsMeasurementDiscountRate" xlink:label="loc_trnr_WarrantsMeasurementDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WarrantsMeasurementDiscountRate" xml:lang="en-US">Warrants Measurement Discount Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_WarrantsMeasurementDiscountRate" xml:lang="en-US">Warrants measurement discount rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WarrantsMeasurementDiscountRate" xlink:to="lab_trnr_WarrantsMeasurementDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WarrantsMeasurementDiscountRate" xml:lang="en-US">Warrants measurement discount rate.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentMeasurementDiscountRate" xlink:label="loc_trnr_DebtInstrumentMeasurementDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DebtInstrumentMeasurementDiscountRate" xml:lang="en-US">Debt Instrument Measurement Discount Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DebtInstrumentMeasurementDiscountRate" xml:lang="en-US">Debt instrument measurement discount rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DebtInstrumentMeasurementDiscountRate" xlink:to="lab_trnr_DebtInstrumentMeasurementDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DebtInstrumentMeasurementDiscountRate" xml:lang="en-US">Debt instrument measurement discount rate.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US">Liabilities, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US">Liabilities, fair value disclosure</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xml:lang="en-US">Assets, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xml:lang="en-US">Assets, fair value disclosure</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xml:lang="en-US">Measurement Frequency [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xml:lang="en-US">Measurement Frequency [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xml:lang="en-US">Fair Value, Recurring [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xml:lang="en-US">Fair Value, Recurring [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Level 1 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Level 2 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Level 3 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xml:lang="en-US">Financial liabilities fair value disclosure</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" xml:lang="en-US">Fair Value Measurement with Unobservable Inputs Reconciliations Recurring Basis Liability Conversion of Convertible Notes in to Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" xml:lang="en-US">Conversion of convertible notes into common stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" xlink:to="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" xml:lang="en-US">Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of convertible notes into common stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Conversion of Convertible Notes in to Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" xml:lang="en-US">Conversion of convertible notes into Series A preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" xlink:to="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" xml:lang="en-US">Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, conversion of convertible notes in to preferred stock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair value, ending balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair value, beginning balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" xml:lang="en-US">Fair Value Measurement with Unobservable Inputs Reconciliations Recurring Basis Liability Exercise of Stock Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" xml:lang="en-US">Exercise of stock warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" xlink:to="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" xml:lang="en-US">Fair value measurement with unobservable inputs reconciliations recurring basis liability exercise of stock warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xml:lang="en-US">Issuance of convertible notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Changes in Estimated Fair Value of Financial Instruments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" xml:lang="en-US">Change in estimated fair value of financial instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" xlink:to="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" xml:lang="en-US">Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, changes in estimated fair value of financial instruments.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Conversion Of ASAs Into Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" xml:lang="en-US">Conversion of ASAs into common stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" xlink:to="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" xml:lang="en-US">Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of asas into common stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Conversion Of SAFEs Into Series Seed Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" xml:lang="en-US">Conversion of SAFEs into series seed preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" xlink:to="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" xml:lang="en-US">Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of safes into series seed preferred stock.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Conversion Of Convertible Notes Into Series A Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" xml:lang="en-US">Conversion of convertible notes into Series A preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" xlink:to="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" xml:lang="en-US">Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of convertible notes into series a preferred stock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xml:lang="en-US">weighted average discount rate for operating leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xml:lang="en-US">weighted average remaining lease term for operating leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermLeaseCost" xml:lang="en-US">Short-Term Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShortTermLeaseCost" xml:lang="en-US">Short term lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseCost" xml:lang="en-US">Operating Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseCost" xml:lang="en-US">Operating lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xml:lang="en-US">Lessee, operating lease, term of contract</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" xml:lang="en-US">lessee, Operating Lease, option to extend</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="lab_us-gaap_LesseeOperatingLeaseOptionToExtend" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xml:lang="en-US">2023 (remaining)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xml:lang="en-US">2024/2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US">2025/2024</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US">2026/2025</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US">2027/2026</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:label="loc_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xml:lang="en-US">Lessee Operating Lease Liability To Be Paid After Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xml:lang="en-US">Lessee operating lease liability to be paid after year four.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xml:lang="en-US">2027</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAbstract" xlink:label="loc_us-gaap_OtherCommitmentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsAbstract" xml:lang="en-US">Other Commitments [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAbstract" xlink:to="lab_us-gaap_OtherCommitmentsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" xml:lang="en-US">Other Commitment, to be Paid, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" xml:lang="en-US">2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:to="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentDueInSecondYear" xml:lang="en-US">Other Commitment, to be Paid, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentDueInSecondYear" xml:lang="en-US">2024</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInSecondYear" xlink:to="lab_us-gaap_OtherCommitmentDueInSecondYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentDueInThirdYear" xml:lang="en-US">Other Commitment, to be Paid, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentDueInThirdYear" xml:lang="en-US">2025</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInThirdYear" xlink:to="lab_us-gaap_OtherCommitmentDueInThirdYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentDueInFourthYear" xml:lang="en-US">Other Commitment, to be Paid, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentDueInFourthYear" xml:lang="en-US">2026</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInFourthYear" xlink:to="lab_us-gaap_OtherCommitmentDueInFourthYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFifthYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentDueInFifthYear" xml:lang="en-US">Other Commitment, to be Paid, Year Five</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentDueInFifthYear" xml:lang="en-US">2027</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInFifthYear" xlink:to="lab_us-gaap_OtherCommitmentDueInFifthYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueAfterFifthYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentDueAfterFifthYear" xml:lang="en-US">Other Commitment, to be Paid, after Year Five</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentDueAfterFifthYear" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueAfterFifthYear" xlink:to="lab_us-gaap_OtherCommitmentDueAfterFifthYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitment" xml:lang="en-US">Other Commitment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OtherCommitment" xml:lang="en-US">Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LossContingenciesTable" xml:lang="en-US">Loss Contingencies [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LossContingenciesLineItems" xml:lang="en-US">Loss Contingencies [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfCumulativeNetSales" xlink:label="loc_trnr_PercentageOfCumulativeNetSales" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PercentageOfCumulativeNetSales" xml:lang="en-US">Percentage of Cumulative Net Sales</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PercentageOfCumulativeNetSales" xml:lang="en-US">Percentage of cumulative net sales</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PercentageOfCumulativeNetSales" xlink:to="lab_trnr_PercentageOfCumulativeNetSales" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PercentageOfCumulativeNetSales" xml:lang="en-US">Percentage of cumulative net sales.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CumulativeNetSales" xlink:label="loc_trnr_CumulativeNetSales" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CumulativeNetSales" xml:lang="en-US">Cumulative Net Sales</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CumulativeNetSales" xml:lang="en-US">Cumulative net sales</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CumulativeNetSales" xlink:to="lab_trnr_CumulativeNetSales" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CumulativeNetSales" xml:lang="en-US">Cumulative Net Sales</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RoyaltyExpense" xml:lang="en-US">Royalty Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RoyaltyExpense" xml:lang="en-US">Maximum total royalty payments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RoyaltyExpense" xml:lang="en-US">Royalty Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="loc_us-gaap_RoyaltyGuaranteesCommitmentsAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RoyaltyGuaranteesCommitmentsAmount" xml:lang="en-US">Royalty Guarantees, Commitments, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RoyaltyGuaranteesCommitmentsAmount" xml:lang="en-US">Guaranteed minimum payment of royalty</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:to="lab_us-gaap_RoyaltyGuaranteesCommitmentsAmount" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAFinancingMember" xlink:label="loc_trnr_SeriesAFinancingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesAFinancingMember" xml:lang="en-US">Series A Financing [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesAFinancingMember" xlink:to="lab_trnr_SeriesAFinancingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesAFinancingMember" xml:lang="en-US">Series A financing.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFourMember" xlink:label="loc_trnr_SeriesSeedFourMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedFourMember" xml:lang="en-US">Series Seed Four [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedFourMember" xml:lang="en-US">Series&#160;Seed-4 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedFourMember" xlink:to="lab_trnr_SeriesSeedFourMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedFourMember" xml:lang="en-US">Series seed 4</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFiveMember" xlink:label="loc_trnr_SeriesSeedFiveMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedFiveMember" xml:lang="en-US">Series Seed Five [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedFiveMember" xml:lang="en-US">Series&#160;Seed-5 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedFiveMember" xlink:to="lab_trnr_SeriesSeedFiveMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedFiveMember" xml:lang="en-US">Series&#160;seed-5.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSixMember" xlink:label="loc_trnr_SeriesSeedSixMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedSixMember" xml:lang="en-US">Series Seed Six [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedSixMember" xml:lang="en-US">Series&#160;Seed-6 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedSixMember" xlink:to="lab_trnr_SeriesSeedSixMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedSixMember" xml:lang="en-US">Series&#160;seed-6.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSevenMember" xlink:label="loc_trnr_SeriesSeedSevenMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedSevenMember" xml:lang="en-US">Series Seed Seven [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedSevenMember" xml:lang="en-US">Series&#160;Seed-7 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedSevenMember" xlink:to="lab_trnr_SeriesSeedSevenMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedSevenMember" xml:lang="en-US">Series&#160;seed-7.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedEightMember" xlink:label="loc_trnr_SeriesSeedEightMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedEightMember" xml:lang="en-US">Series Seed Eight [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedEightMember" xml:lang="en-US">Series&#160;Seed-8 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedEightMember" xlink:to="lab_trnr_SeriesSeedEightMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedEightMember" xml:lang="en-US">Series&#160;seed-8.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineMember" xlink:label="loc_trnr_SeriesSeedNineMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedNineMember" xml:lang="en-US">Series Seed Nine [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedNineMember" xml:lang="en-US">Series&#160;Seed-9 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedNineMember" xlink:to="lab_trnr_SeriesSeedNineMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedNineMember" xml:lang="en-US">Series&#160;seed-9.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAOneMember" xlink:label="loc_trnr_SeriesAOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesAOneMember" xml:lang="en-US">Series A One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesAOneMember" xml:lang="en-US">Series&#160;A-1 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesAOneMember" xlink:to="lab_trnr_SeriesAOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesAOneMember" xml:lang="en-US">Series&#160;A-1.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAMember" xlink:label="loc_us-gaap_SeriesAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeriesAMember" xml:lang="en-US">Series A [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAMember" xlink:to="lab_us-gaap_SeriesAMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_Seed10Member" xlink:label="loc_trnr_Seed10Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_Seed10Member" xml:lang="en-US">Seed 10 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_Seed10Member" xml:lang="en-US">Seed 10 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_Seed10Member" xlink:to="lab_trnr_Seed10Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_Seed10Member" xml:lang="en-US">Seed-10.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoTenMember" xlink:label="loc_trnr_SeriesSeedTwoTenMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedTwoTenMember" xml:lang="en-US">Series Seed Two Ten [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedTwoTenMember" xml:lang="en-US">Series&#160;Seed-2-10 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedTwoTenMember" xlink:to="lab_trnr_SeriesSeedTwoTenMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedMember" xlink:label="loc_trnr_SeriesSeedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedMember" xml:lang="en-US">Series Seed [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedMember" xml:lang="en-US">Series Seed [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedMember" xlink:to="lab_trnr_SeriesSeedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedMember" xml:lang="en-US">Series seed.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedOneMember" xlink:label="loc_trnr_SeriesSeedOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedOneMember" xml:lang="en-US">Series Seed One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedOneMember" xml:lang="en-US">Series&#160;Seed-1 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedOneMember" xlink:to="lab_trnr_SeriesSeedOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedOneMember" xml:lang="en-US">Series&#160;seed-1.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoMember" xlink:label="loc_trnr_SeriesSeedTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedTwoMember" xml:lang="en-US">Series Seed Two [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedTwoMember" xml:lang="en-US">Series&#160;Seed-2 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedTwoMember" xlink:to="lab_trnr_SeriesSeedTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedTwoMember" xml:lang="en-US">Series&#160;seed-2.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedThreeMember" xlink:label="loc_trnr_SeriesSeedThreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedThreeMember" xml:lang="en-US">Series Seed Three [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedThreeMember" xml:lang="en-US">Series&#160;Seed-3 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedThreeMember" xlink:to="lab_trnr_SeriesSeedThreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedThreeMember" xml:lang="en-US">Series&#160;seed-3.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RightsOfferingMember" xlink:label="loc_trnr_RightsOfferingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RightsOfferingMember" xml:lang="en-US">Rights Offering [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_RightsOfferingMember" xml:lang="en-US">Rights Offering [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RightsOfferingMember" xlink:to="lab_trnr_RightsOfferingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RightsOfferingMember" xml:lang="en-US">Rights offering member.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Risk free [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US">Measurement Input, Price Volatility [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US">Volatility [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember" xml:lang="en-US">Measurement Input, Exercise Price [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExercisePriceMember" xlink:to="lab_us-gaap_MeasurementInputExercisePriceMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US">Measurement Input, Share Price [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xml:lang="en-US">Measurement Input, Expected Term [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of Stock, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Price per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xml:lang="en-US">Warrants measurement input</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfDiscountRateOnConvertibleNotes" xlink:label="loc_trnr_PercentageOfDiscountRateOnConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PercentageOfDiscountRateOnConvertibleNotes" xml:lang="en-US">Percentage Of Discount Rate On Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PercentageOfDiscountRateOnConvertibleNotes" xml:lang="en-US">Discount rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PercentageOfDiscountRateOnConvertibleNotes" xlink:to="lab_trnr_PercentageOfDiscountRateOnConvertibleNotes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PercentageOfDiscountRateOnConvertibleNotes" xml:lang="en-US">Percentage of discount rate on convertible notes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xml:lang="en-US">Debt Conversion, Converted Instrument, Warrants or Options Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xml:lang="en-US">Warrant issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xml:lang="en-US">Dividends Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xml:lang="en-US">Dividends payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaap_PaymentsOfDividends" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfDividends" xml:lang="en-US">Payments of Dividends</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PaymentsOfDividends" xml:lang="en-US">Payments of dividends</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaap_PreferredStockVotingRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockVotingRights" xml:lang="en-US">Preferred Stock, Voting Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockVotingRights" xml:lang="en-US">Preferred stock, voting rights</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockVotingRights" xlink:to="lab_us-gaap_PreferredStockVotingRights" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="loc_us-gaap_PreferredStockConversionBasis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockConversionBasis" xml:lang="en-US">Preferred Stock, Conversion Basis</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockConversionBasis" xml:lang="en-US">Preferred stock, conversion basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConversionBasis" xlink:to="lab_us-gaap_PreferredStockConversionBasis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xml:lang="en-US">Temporary Equity, Redemption Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xml:lang="en-US">Temporary equity, redemption price per share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" xml:lang="en-US">Price&#160;per&#160;Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="lab_us-gaap_TemporaryEquityRedemptionPricePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xml:lang="en-US">Proceeds from issuance of convertible preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedAndSeriesAAgreementMember" xlink:label="loc_trnr_SeriesSeedAndSeriesAAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedAndSeriesAAgreementMember" xml:lang="en-US">Series Seed and Series A Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedAndSeriesAAgreementMember" xlink:to="lab_trnr_SeriesSeedAndSeriesAAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedAndSeriesAAgreementMember" xml:lang="en-US">Series seed and series A agreement.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" xml:lang="en-US">Two Thousand and Twenty Secured Convertible Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" xml:lang="en-US">2020 Secured Convertible Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" xlink:to="lab_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAConvertibleNotesMember" xlink:label="loc_trnr_SeriesAConvertibleNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesAConvertibleNotesMember" xml:lang="en-US">Series A Convertible Notes [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesAConvertibleNotesMember" xlink:to="lab_trnr_SeriesAConvertibleNotesMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAStockMember" xlink:label="loc_trnr_SeriesAStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesAStockMember" xml:lang="en-US">Series A Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_trnr_SeriesAStockMember" xml:lang="en-US">Series A [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesAStockMember" xlink:to="lab_trnr_SeriesAStockMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesATwoMember" xlink:label="loc_trnr_SeriesATwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesATwoMember" xml:lang="en-US">Series A Two [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesATwoMember" xml:lang="en-US">Series&#160;A-2 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesATwoMember" xlink:to="lab_trnr_SeriesATwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesATwoMember" xml:lang="en-US">Series&#160;A-2.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineOneMember" xlink:label="loc_trnr_SeriesSeedNineOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedNineOneMember" xml:lang="en-US">Series Seed Nine One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedNineOneMember" xml:lang="en-US">Series&#160;Seed-9 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedNineOneMember" xlink:to="lab_trnr_SeriesSeedNineOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedNineOneMember" xml:lang="en-US">Series seed nine one.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTenMember" xlink:label="loc_trnr_SeriesSeedTenMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedTenMember" xml:lang="en-US">Series Seed Ten [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedTenMember" xml:lang="en-US">Series&#160;Seed-10 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedTenMember" xlink:to="lab_trnr_SeriesSeedTenMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedTenMember" xml:lang="en-US">Series&#160;seed-10.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xml:lang="en-US">Temporary Equity [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="loc_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xml:lang="en-US">Temporary Equity, Aggregate Amount of Redemption Requirement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xml:lang="en-US">Net&#160;Carrying&#160;Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="lab_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">All Award Types</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Employee Stock Option [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Stock Option</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedStockMember" xml:lang="en-US">Restricted Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RestrictedStockMember" xml:lang="en-US">Restricted Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xml:lang="en-US">Stock Appreciation Rights (SARs)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Number of options, Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US">Grants in period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xml:lang="en-US">Number of accelerated vested shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options Re-priced Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" xml:lang="en-US">Number of repriced option awards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" xlink:to="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" xml:lang="en-US">Number of options repriced.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted-average grant date fair value per option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted average exercise price, Issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Share-Based Payment Arrangement, Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Recognized stock compensation expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Compensation cost recognized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US">Unrecognized stock-based compensation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdditionalExpense" xlink:label="loc_trnr_AdditionalExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AdditionalExpense" xml:lang="en-US">Additional Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AdditionalExpense" xlink:to="lab_trnr_AdditionalExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AdditionalExpense" xml:lang="en-US">Additional expense</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Weighted-average period expected to be recognized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" xlink:label="loc_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" xml:lang="en-US">Share Based Compensation Arrangements by Share Based Payment Award, Grants in Period, Straight-line Calculation using Third-Party Valuation, Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" xml:lang="en-US">Awards granted, straight-line using third-party valuation (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" xlink:to="lab_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" xml:lang="en-US">The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing by straight-line calculation using the contemporaneous third-party valuations methodology.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xml:lang="en-US">Fair value of common stock for awards granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US">Number of shares authorized for issuance under share-based payment arrangement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xml:lang="en-US">Purchase price of common stock expressed as a percentage of its fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xml:lang="en-US">Expiration Period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsIssuedDuringThePeriodShares" xlink:label="loc_trnr_WarrantsIssuedDuringThePeriodShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WarrantsIssuedDuringThePeriodShares" xml:lang="en-US">Warrants Issued During The Period Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_WarrantsIssuedDuringThePeriodShares" xml:lang="en-US">Warrants issued during the period shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WarrantsIssuedDuringThePeriodShares" xlink:to="lab_trnr_WarrantsIssuedDuringThePeriodShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WarrantsIssuedDuringThePeriodShares" xml:lang="en-US">Warrants issued during the period shares.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantGrantDateFairValue" xlink:label="loc_trnr_WarrantGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WarrantGrantDateFairValue" xml:lang="en-US">Warrant Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_WarrantGrantDateFairValue" xml:lang="en-US">Warrant Grant Date Fair Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WarrantGrantDateFairValue" xlink:to="lab_trnr_WarrantGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WarrantGrantDateFairValue" xml:lang="en-US">Warrant grant date fair value.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xml:lang="en-US">Share-Based Payment Arrangement, Amount Capitalized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xml:lang="en-US">Capitalized amount of stock based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xml:lang="en-US">Two Thousand Twenty Three And Two Thousand Twenty Equity Incentive Plan Member</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xml:lang="en-US">2023 and 2020 Equity Incentive Plan [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xlink:to="lab_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xml:lang="en-US">Two thousand twenty three and two thousand twenty equity incentive plan.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TwoThousandTwentyEquityIncentivePlanMember" xml:lang="en-US">Two Thousand Twenty Equity Incentive Plan [ Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TwoThousandTwentyEquityIncentivePlanMember" xml:lang="en-US">2020 Equity Incentive Plan [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="lab_trnr_TwoThousandTwentyEquityIncentivePlanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TwoThousandTwentyEquityIncentivePlanMember" xml:lang="en-US">Two Thousand Twenty Equity Incentive Plan [ Member]</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US">Research and Development Expense [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US">Research and development</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xml:lang="en-US">Sales and marketing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xml:lang="en-US">General and Administrative Expense [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xml:lang="en-US">General and administrative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Number of options, Outstanding as of December 31, 2022</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Number of options, Outstanding as of September 30, 2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US">Options exercisable as of September 30, 2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Number of options, unvested as of September 30, 2023</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Ending balance of September 30, 2023</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Beginning as of December 31, 2022</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Number of options, Cancelled or forfeited</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding as of December 31, 2022</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding as of September 30, 2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US">Options exercisable as of September 30, 2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Ending balance of September 30, 2023</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Beginning as of December 31, 2022</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Cancelled or forfeited</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" xlink:label="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTerm [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" xlink:to="lab_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" xml:lang="en-US">Share based compensation arrangement by share based payment award options weighted average remaining contractual term [Abstract]</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US">Options exercisable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" xlink:label="loc_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" xml:lang="en-US">Options unvested</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" xlink:to="lab_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" xml:lang="en-US">Share based compensation arrangement by share based payment award options non vested weighted average remaining contractual term.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" xlink:label="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValue [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" xlink:to="lab_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" xml:lang="en-US">Share based compensation arrangement by share based payment award options aggregate intrinsic value.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Outstanding, aggregate intrinsic value, outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xml:lang="en-US">Options exercisable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xml:lang="en-US">Unvested, aggregate intrinsic value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Repurchased Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted average exercise price, Repurchased</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" xlink:to="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share based compensation arrangement by share based payment award options repurchased weighted average grant date fair value.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Repurchase Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xml:lang="en-US">Beginning Balance, Repurchase liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xml:lang="en-US">Ending Balance, Repurchase liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xlink:to="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xml:lang="en-US">Share based compensation arrangement by share based payment award options repurchase liability.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Grants in Period Repurchase Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" xml:lang="en-US">Repurchase liability, Issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" xlink:to="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" xml:lang="en-US">Share based compensation arrangement by share based payment award options grants in period repurchase liability.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Vested Repurchase Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" xml:lang="en-US">Repurchase liability, Vested</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" xlink:to="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" xml:lang="en-US">Share based compensation arrangement by share based payment award options vested repurchase liability.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Repurchased Repurchase Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" xml:lang="en-US">Repurchase liability, Repurchased</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" xlink:to="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" xml:lang="en-US">Share based compensation arrangement by share based payment award options repurchased repurchase liability.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Vested</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Non Vested Number of Shares Repurchased</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" xml:lang="en-US">Repurchased</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" xlink:to="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" xml:lang="en-US">Share based compensation arrangement by share based payment award options non vested number of shares repurchased.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted average exercise price, Vested</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyPlanEarlyExerciseMember" xlink:label="loc_trnr_TwoThousandTwentyPlanEarlyExerciseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_TwoThousandTwentyPlanEarlyExerciseMember" xml:lang="en-US">Two Thousand Twenty Plan Early Exercise [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_TwoThousandTwentyPlanEarlyExerciseMember" xml:lang="en-US">2020 Plan Early Exercise</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_TwoThousandTwentyPlanEarlyExerciseMember" xlink:to="lab_trnr_TwoThousandTwentyPlanEarlyExerciseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_TwoThousandTwentyPlanEarlyExerciseMember" xml:lang="en-US">Two thousand twenty plan early exercise.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Weighted-average risk-free interest rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Weighted-average expected term (in years)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Weighted-average expected volatility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xml:lang="en-US">Schedule of Product Information [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xml:lang="en-US">Concentration Risk Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xml:lang="en-US">Concentration Risk Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US">Customer Concentration Risk [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US">Customer Concentration Risk [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xml:lang="en-US">Supplier Concentration Risk [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xml:lang="en-US">Supplier Concentration Risk [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MajorCustomersAxis" xml:lang="en-US">Customer [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_NameOfMajorCustomerDomain" xml:lang="en-US">Customer [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorThreeMember" xlink:label="loc_trnr_VendorThreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_VendorThreeMember" xml:lang="en-US">Vendor Three [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_VendorThreeMember" xml:lang="en-US">Vendor Three [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_VendorThreeMember" xlink:to="lab_trnr_VendorThreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_VendorThreeMember" xml:lang="en-US">Vendor three.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorOneMember" xlink:label="loc_trnr_VendorOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_VendorOneMember" xml:lang="en-US">Vendor One [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_VendorOneMember" xlink:to="lab_trnr_VendorOneMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaap_ProductInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProductInformationLineItems" xml:lang="en-US">Product Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Concentration Risk, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Percentage of total revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NumberOfCustomer" xlink:label="loc_trnr_NumberOfCustomer" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NumberOfCustomer" xml:lang="en-US">Number Of Customer</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NumberOfCustomer" xml:lang="en-US">Number of customer</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NumberOfCustomer" xlink:to="lab_trnr_NumberOfCustomer" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NumberOfCustomer" xml:lang="en-US">Number of customer.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NumberOfSignificantVendors" xlink:label="loc_trnr_NumberOfSignificantVendors" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NumberOfSignificantVendors" xml:lang="en-US">Number Of Significant Vendors</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NumberOfSignificantVendors" xml:lang="en-US">Number of vendors</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NumberOfSignificantVendors" xlink:to="lab_trnr_NumberOfSignificantVendors" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NumberOfSignificantVendors" xml:lang="en-US">Number of significant vendors.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesRevenueNetMember" xml:lang="en-US">Revenue Benchmark [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SalesRevenueNetMember" xml:lang="en-US">Sales Revenue [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="loc_us-gaap_CostOfGoodsTotalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfGoodsTotalMember" xml:lang="en-US">Cost of Goods and Service Benchmark [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CostOfGoodsTotalMember" xml:lang="en-US">Finished Goods Purchased [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsTotalMember" xlink:to="lab_us-gaap_CostOfGoodsTotalMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentTypeAxis" xml:lang="en-US">Investment Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xml:lang="en-US">Investments [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xml:lang="en-US">Benefit plans cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xml:lang="en-US">United States</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xml:lang="en-US">Foreign</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US">Current:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xml:lang="en-US">Current Federal Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xml:lang="en-US">Federal</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xml:lang="en-US">State</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xml:lang="en-US">Foreign</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xml:lang="en-US">Current Income Tax Expense (Benefit), Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xml:lang="en-US">Total current expense:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US">Deferred expense:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xml:lang="en-US">Federal</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xml:lang="en-US">State</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xml:lang="en-US">Foreign</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xml:lang="en-US">Total deferred expense:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Federal statutory rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xml:lang="en-US">Nondeductible expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" xlink:label="loc_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" xml:lang="en-US">IncomeTaxReconciliation Nontaxable changes in fair value of convertible notes and SAFEs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" xml:lang="en-US">Nontaxable changes in fair value of convertible notes and SAFEs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" xlink:to="lab_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" xml:lang="en-US">IncomeTaxReconciliation nontaxable changes in fair value of convertible notes and safes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xml:lang="en-US">Research and development tax credits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US">State taxes, net of federal benefit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xml:lang="en-US">Foreign tax rate differential</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Federal statutory rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Change in valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xml:lang="en-US">Nondeductible expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" xlink:label="loc_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nontaxable changes in fair value of convertible notes and SAFEs, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" xml:lang="en-US">Nontaxable changes in fair value of convertible notes and SAFEs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" xlink:to="lab_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" xml:lang="en-US">Effective income tax rate reconciliation, nontaxable changes in fair value of convertible notes and safes, percent.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xml:lang="en-US">Research and development tax credits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US">State taxes, net of federal benefit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xml:lang="en-US">Foreign tax rate differential</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xml:lang="en-US">Other</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" xlink:label="loc_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disqualified debt, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" xml:lang="en-US">Disqualified debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" xlink:to="lab_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" xml:lang="en-US">Effective income tax rate reconciliation, disqualified debt, percent.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xml:lang="en-US">Return to provision adjustements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" xlink:label="loc_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intangibles, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" xml:lang="en-US">Intangibles</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" xlink:to="lab_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" xml:lang="en-US">Effective income tax rate reconciliation, intangibles, percent.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xml:lang="en-US">Stock based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xml:lang="en-US">Other</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Change in valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncometaxreconciliationDisqualifiedDebt" xlink:label="loc_trnr_IncometaxreconciliationDisqualifiedDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IncometaxreconciliationDisqualifiedDebt" xml:lang="en-US">IncomeTaxReconciliation Disqualified debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IncometaxreconciliationDisqualifiedDebt" xml:lang="en-US">Disqualified debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IncometaxreconciliationDisqualifiedDebt" xlink:to="lab_trnr_IncometaxreconciliationDisqualifiedDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IncometaxreconciliationDisqualifiedDebt" xml:lang="en-US">IncomeTaxReconciliation disqualified debt.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xml:lang="en-US">Return to provision adjustements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncometaxreconciliationIntangibles" xlink:label="loc_trnr_IncometaxreconciliationIntangibles" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IncometaxreconciliationIntangibles" xml:lang="en-US">IncomeTaxReconciliation Intangibles</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_IncometaxreconciliationIntangibles" xml:lang="en-US">Intangibles</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IncometaxreconciliationIntangibles" xlink:to="lab_trnr_IncometaxreconciliationIntangibles" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_IncometaxreconciliationIntangibles" xml:lang="en-US">IncomeTaxReconciliation intangibles.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xml:lang="en-US">Stock based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Deferred tax assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xml:lang="en-US">Net operating loss carryforwards - Federal</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:label="loc_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xml:lang="en-US">Deferred Tax Assets, Capitalized research and development</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xml:lang="en-US">Capitalized research and development</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:to="lab_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xml:lang="en-US">Deferred tax assets, capitalized research and development.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xml:lang="en-US">Research and development tax credits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xml:lang="en-US">Net operating loss carryforwards - State</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xml:lang="en-US">Net operating loss carryforwards - Foreign</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xml:lang="en-US">Deferred Tax Assets, Other</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xml:lang="en-US">Other</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:label="loc_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" xml:lang="en-US">Deferred Tax Assets, Fixed Assets and Intangibles</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" xml:lang="en-US">Fixed assets and intangibles</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:to="lab_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" xml:lang="en-US">Deferred tax assets, fixed assets and intangibles.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xml:lang="en-US">Deferred Tax Assets, Gross, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xml:lang="en-US">Total deferred tax assets, gross:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xml:lang="en-US">Deferred Tax Liabilities, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xml:lang="en-US">Total deferred tax liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xml:lang="en-US">Deferred Tax Assets, Net, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xml:lang="en-US">Deferred tax assets, net:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxDisclosureTable" xlink:label="loc_trnr_IncomeTaxDisclosureTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IncomeTaxDisclosureTable" xml:lang="en-US">Income Tax Disclosure [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IncomeTaxDisclosureTable" xlink:to="lab_trnr_IncomeTaxDisclosureTable" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxDisclosureLineItems" xlink:label="loc_trnr_IncomeTaxDisclosureLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_IncomeTaxDisclosureLineItems" xml:lang="en-US">Income Tax Disclosure [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems" xlink:to="lab_trnr_IncomeTaxDisclosureLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" xml:lang="en-US">Operating Loss Carryforwards, Expiration Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" xml:lang="en-US">Operating Loss Carryforwards, Expiration Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="lab_us-gaap_OperatingLossCarryforwardsExpirationDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US">Tax Credit Carryforward, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US">Tax Credit Carryforward, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardExpirationDate" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xml:lang="en-US">Tax Credit Carryforward, Expiration Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TaxCreditCarryforwardExpirationDate" xml:lang="en-US">Tax Credit Carryforward, Expiration Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardExpirationDate" xlink:to="lab_us-gaap_TaxCreditCarryforwardExpirationDate" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AmortisationOfResearchAndDevelopmentalCost" xlink:label="loc_trnr_AmortisationOfResearchAndDevelopmentalCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AmortisationOfResearchAndDevelopmentalCost" xml:lang="en-US">Amortisation Of Research And Developmental Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AmortisationOfResearchAndDevelopmentalCost" xml:lang="en-US">Amortisation Of Research And Developmental Cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AmortisationOfResearchAndDevelopmentalCost" xlink:to="lab_trnr_AmortisationOfResearchAndDevelopmentalCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AmortisationOfResearchAndDevelopmentalCost" xml:lang="en-US">Amortisation of research and developmental cost.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedResearchAndDevelopmentExpenses" xlink:label="loc_trnr_CapitalizedResearchAndDevelopmentExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_CapitalizedResearchAndDevelopmentExpenses" xml:lang="en-US">Capitalized Research And Development Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_CapitalizedResearchAndDevelopmentExpenses" xml:lang="en-US">Capitalized Research And Development Expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_CapitalizedResearchAndDevelopmentExpenses" xlink:to="lab_trnr_CapitalizedResearchAndDevelopmentExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_CapitalizedResearchAndDevelopmentExpenses" xml:lang="en-US">Capitalized research and development expenses.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OperatingLossCarryForwardsPercentage" xlink:label="loc_trnr_OperatingLossCarryForwardsPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_OperatingLossCarryForwardsPercentage" xml:lang="en-US">Operating Loss Carry forwards Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_OperatingLossCarryForwardsPercentage" xml:lang="en-US">Operating Loss Carry forwards Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_OperatingLossCarryForwardsPercentage" xlink:to="lab_trnr_OperatingLossCarryForwardsPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_OperatingLossCarryForwardsPercentage" xml:lang="en-US">Operating loss carry forwards percentage.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xml:lang="en-US">Operating Loss Carryforwards, Limitations on Use</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xml:lang="en-US">Operating Loss Carryforwards, Limitations on Use</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xml:lang="en-US">Operating Loss Carryforwards</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xml:lang="en-US">Operating Loss Carryforwards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" xlink:label="loc_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" xml:lang="en-US">Minimum Adjusted Financial Statement Income Subject to Inflation Reduction Act Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" xml:lang="en-US">Minimum Adjusted Financial Statement Income Subject to Inflation Reduction Act Tax</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" xlink:to="lab_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" xml:lang="en-US">Minimum adjusted financial statement income subject to inflation reduction act tax.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" xlink:label="loc_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" xml:lang="en-US">Minimum Tax on Book Income, Inflation Reduction Act, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" xml:lang="en-US">Minimum Tax on Book Income, Inflation Reduction Act, Percent</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" xlink:to="lab_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" xml:lang="en-US">Minimum tax on book income, inflation reduction act, percent.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xml:lang="en-US">Income Tax Authority [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xml:lang="en-US">Income Tax Authority [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCountryMember" xml:lang="en-US">Foreign Tax Authority [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DomesticCountryMember" xml:lang="en-US">Domestic Tax Authority [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NumeratorAbstract" xlink:label="loc_trnr_NumeratorAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NumeratorAbstract" xml:lang="en-US">Numerator [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NumeratorAbstract" xml:lang="en-US">Numerator:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NumeratorAbstract" xlink:to="lab_trnr_NumeratorAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NumeratorAbstract" xml:lang="en-US">Numerator abstract</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NetLoss" xlink:label="loc_trnr_NetLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NetLoss" xml:lang="en-US">Net Loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NetLoss" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NetLoss" xlink:to="lab_trnr_NetLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NetLoss" xml:lang="en-US">Net loss.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DenominatorAbstract" xlink:label="loc_trnr_DenominatorAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DenominatorAbstract" xml:lang="en-US">Denominator [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DenominatorAbstract" xml:lang="en-US">Denominator:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DenominatorAbstract" xlink:to="lab_trnr_DenominatorAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DenominatorAbstract" xml:lang="en-US">Denominator abstract</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US">Antidilutive Securities [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAOneConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesAOneConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesAOneConvertiblePreferredStockMember" xml:lang="en-US">Series A One Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesAOneConvertiblePreferredStockMember" xml:lang="en-US">Series A-1 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesAOneConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesAOneConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesAOneConvertiblePreferredStockMember" xml:lang="en-US">Series A one convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesATwoConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesATwoConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesATwoConvertiblePreferredStockMember" xml:lang="en-US">Series A Two Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesATwoConvertiblePreferredStockMember" xml:lang="en-US">Series A-2 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesATwoConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesATwoConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesATwoConvertiblePreferredStockMember" xml:lang="en-US">Series A two convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedOneConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedOneConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedOneConvertiblePreferredStockMember" xml:lang="en-US">Series Seed One Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedOneConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 1 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedOneConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedOneConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedOneConvertiblePreferredStockMember" xml:lang="en-US">Series seed one convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedTwoConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedTwoConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Two Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedTwoConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 2 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedTwoConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedTwoConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedTwoConvertiblePreferredStockMember" xml:lang="en-US">Series seed two convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedThreeConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedThreeConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedThreeConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Three Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedThreeConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 3 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedThreeConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedThreeConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedThreeConvertiblePreferredStockMember" xml:lang="en-US">Series seed three convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFourConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedFourConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedFourConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Four Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedFourConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 4 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedFourConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedFourConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedFourConvertiblePreferredStockMember" xml:lang="en-US">Series seed four convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFiveConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedFiveConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedFiveConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Five Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedFiveConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 5 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedFiveConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedFiveConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedFiveConvertiblePreferredStockMember" xml:lang="en-US">Series seed five convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSixConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedSixConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedSixConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Six Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedSixConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 6 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedSixConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedSixConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedSixConvertiblePreferredStockMember" xml:lang="en-US">Series seed six convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSevenConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedSevenConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedSevenConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Seven Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedSevenConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 7 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedSevenConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedSevenConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedSevenConvertiblePreferredStockMember" xml:lang="en-US">Series seed seven convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedEightConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedEightConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedEightConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Eight Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedEightConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 8 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedEightConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedEightConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedEightConvertiblePreferredStockMember" xml:lang="en-US">Series seed eight convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedNineConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedNineConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Nine Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedNineConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 9 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedNineConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedNineConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedNineConvertiblePreferredStockMember" xml:lang="en-US">Series seed nine convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTenConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedTenConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_SeriesSeedTenConvertiblePreferredStockMember" xml:lang="en-US">Series Seed Ten Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_SeriesSeedTenConvertiblePreferredStockMember" xml:lang="en-US">Series Seed 10 Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_SeriesSeedTenConvertiblePreferredStockMember" xlink:to="lab_trnr_SeriesSeedTenConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_SeriesSeedTenConvertiblePreferredStockMember" xml:lang="en-US">Series seed ten convertible preferred stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsToPurchaseSeriesClassACommonStockMember" xlink:label="loc_trnr_WarrantsToPurchaseSeriesClassACommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WarrantsToPurchaseSeriesClassACommonStockMember" xml:lang="en-US">Warrants to Purchase Series Class A Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_WarrantsToPurchaseSeriesClassACommonStockMember" xml:lang="en-US">Warrants to Purchase Series Class A Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WarrantsToPurchaseSeriesClassACommonStockMember" xlink:to="lab_trnr_WarrantsToPurchaseSeriesClassACommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WarrantsToPurchaseSeriesClassACommonStockMember" xml:lang="en-US">Warrants to purchase series class A common stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" xlink:label="loc_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" xml:lang="en-US">Warrants to Purchase Series Class B Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" xml:lang="en-US">Warrants to Purchase Series Class B Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" xlink:to="lab_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" xml:lang="en-US">Warrants to purchase series class B common stock member.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockOptionsToPurchaseCommonStockMember" xlink:label="loc_trnr_StockOptionsToPurchaseCommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_StockOptionsToPurchaseCommonStockMember" xml:lang="en-US">Stock Options to Purchase Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_StockOptionsToPurchaseCommonStockMember" xml:lang="en-US">Stock Options to Purchase Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_StockOptionsToPurchaseCommonStockMember" xlink:to="lab_trnr_StockOptionsToPurchaseCommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_StockOptionsToPurchaseCommonStockMember" xml:lang="en-US">Stock options to purchase common stock member.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonWarrantsMember" xlink:label="loc_trnr_ClassACommonWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ClassACommonWarrantsMember" xml:lang="en-US">Class A Common Warrants [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ClassACommonWarrantsMember" xml:lang="en-US">Class A Common Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ClassACommonWarrantsMember" xlink:to="lab_trnr_ClassACommonWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ClassACommonWarrantsMember" xml:lang="en-US">Class A Common Warrants [member]</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonWarrantsMember" xlink:label="loc_trnr_ClassBCommonWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ClassBCommonWarrantsMember" xml:lang="en-US">Class B Common Warrants [member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ClassBCommonWarrantsMember" xml:lang="en-US">Class B Common Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ClassBCommonWarrantsMember" xlink:to="lab_trnr_ClassBCommonWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ClassBCommonWarrantsMember" xml:lang="en-US">Class B Common Warrants [member]</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PromissoryNotesMember" xlink:label="loc_trnr_PromissoryNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PromissoryNotesMember" xml:lang="en-US">Promissory Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PromissoryNotesMember" xml:lang="en-US">Promissory Notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PromissoryNotesMember" xlink:to="lab_trnr_PromissoryNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PromissoryNotesMember" xml:lang="en-US">Promissory Notes [Member]</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherRelatedPartyPromissoryNotesMember" xlink:label="loc_trnr_OtherRelatedPartyPromissoryNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_OtherRelatedPartyPromissoryNotesMember" xml:lang="en-US">Other Related Party Promissory Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_OtherRelatedPartyPromissoryNotesMember" xml:lang="en-US">Other Related Party Promissory Notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_OtherRelatedPartyPromissoryNotesMember" xlink:to="lab_trnr_OtherRelatedPartyPromissoryNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_OtherRelatedPartyPromissoryNotesMember" xml:lang="en-US">Other related party promissory notes.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrincipalStockholderPromissoryNotesMember" xlink:label="loc_trnr_PrincipalStockholderPromissoryNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PrincipalStockholderPromissoryNotesMember" xml:lang="en-US">Principal Stockholder Promissory Notes[Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PrincipalStockholderPromissoryNotesMember" xml:lang="en-US">Principal Stockholder Promissory Notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PrincipalStockholderPromissoryNotesMember" xlink:to="lab_trnr_PrincipalStockholderPromissoryNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PrincipalStockholderPromissoryNotesMember" xml:lang="en-US">Principal Stockholder Promissory Notes[Member]</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherRelatedPartyTransactionsMember" xlink:label="loc_trnr_OtherRelatedPartyTransactionsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_OtherRelatedPartyTransactionsMember" xml:lang="en-US">Other Related Party Transactions [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_OtherRelatedPartyTransactionsMember" xml:lang="en-US">Other Related Party Transactions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_OtherRelatedPartyTransactionsMember" xlink:to="lab_trnr_OtherRelatedPartyTransactionsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_OtherRelatedPartyTransactionsMember" xml:lang="en-US">Other related party transactions.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoninterestBearingNoteMember" xlink:label="loc_trnr_NoninterestBearingNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_NoninterestBearingNoteMember" xml:lang="en-US">Noninterest Bearing Note [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_NoninterestBearingNoteMember" xml:lang="en-US">Noninterest bearing note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_NoninterestBearingNoteMember" xlink:to="lab_trnr_NoninterestBearingNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_NoninterestBearingNoteMember" xml:lang="en-US">Noninterest bearing note.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FuseprojectMember" xlink:label="loc_trnr_FuseprojectMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FuseprojectMember" xml:lang="en-US">Fuseproject [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FuseprojectMember" xml:lang="en-US">Fuseproject</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FuseprojectMember" xlink:to="lab_trnr_FuseprojectMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FuseprojectMember" xml:lang="en-US">Fuseproject [Member]</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ApeironAdvisoryLtdMember" xlink:label="loc_trnr_ApeironAdvisoryLtdMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ApeironAdvisoryLtdMember" xml:lang="en-US">Apeiron Advisory Ltd [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ApeironAdvisoryLtdMember" xml:lang="en-US">Apeiron Advisory Ltd</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ApeironAdvisoryLtdMember" xlink:to="lab_trnr_ApeironAdvisoryLtdMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ApeironAdvisoryLtdMember" xml:lang="en-US">Apeiron Advisory Ltd [Member]</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaap_DeferredRevenueArrangementTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredRevenueArrangementTypeAxis" xml:lang="en-US">Deferred Revenue Arrangement Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="lab_us-gaap_DeferredRevenueArrangementTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaap_DeferredRevenueArrangementTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredRevenueArrangementTypeDomain" xml:lang="en-US">Deferred Revenue [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="lab_us-gaap_DeferredRevenueArrangementTypeDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" xlink:label="loc_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" xml:lang="en-US">Royalty Arrangement, three Percentage of Cumulative Net Sales up to 5 Million [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" xlink:to="lab_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" xml:lang="en-US">Royalty Arrangement, three Percentage of cumulative net sales up to 5 million.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" xlink:label="loc_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" xml:lang="en-US">Royalty Arrangement, One Percentage of Cumulative Net Sales above 5 Million [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" xml:lang="en-US">Royalty Arrangement, One Percentage of Cumulative Net Sales above 5 Million</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" xlink:to="lab_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" xml:lang="en-US">Royalty arrangement, one percentage of cumulative net sales above 5 Million.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xml:lang="en-US">Proceeds from Long-Term Lines of Credit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xml:lang="en-US">Proceeds from long-term lines of credit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DefaultInterest" xlink:label="loc_trnr_DefaultInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DefaultInterest" xml:lang="en-US">Default Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DefaultInterest" xml:lang="en-US">Default interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DefaultInterest" xlink:to="lab_trnr_DefaultInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DefaultInterest" xml:lang="en-US">Default interest</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaap_OtherLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilities" xml:lang="en-US">Other Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherLiabilities" xml:lang="en-US">Due to Related Parties</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyPaymentPercentage" xlink:label="loc_trnr_RoyaltyPaymentPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RoyaltyPaymentPercentage" xml:lang="en-US">Royalty Payment Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_RoyaltyPaymentPercentage" xml:lang="en-US">Royalty Payment Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RoyaltyPaymentPercentage" xlink:to="lab_trnr_RoyaltyPaymentPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RoyaltyPaymentPercentage" xml:lang="en-US">Royalty payment percentage.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyIncomeNonoperating" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xml:lang="en-US">Royalty Income, Nonoperating</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xml:lang="en-US">Licensing and royalty income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:to="lab_us-gaap_RoyaltyIncomeNonoperating" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GuaranteedRoyaltyPayment" xlink:label="loc_trnr_GuaranteedRoyaltyPayment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_GuaranteedRoyaltyPayment" xml:lang="en-US">Guaranteed Royalty Payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_GuaranteedRoyaltyPayment" xml:lang="en-US">Guaranteed Royalty payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_GuaranteedRoyaltyPayment" xlink:to="lab_trnr_GuaranteedRoyaltyPayment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_GuaranteedRoyaltyPayment" xml:lang="en-US">Guaranteed royalty payment.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ContingentRoyaltyObligation" xlink:label="loc_trnr_ContingentRoyaltyObligation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ContingentRoyaltyObligation" xml:lang="en-US">Contingent Royalty Obligation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_ContingentRoyaltyObligation" xml:lang="en-US">Contingent Royalty Obligation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ContingentRoyaltyObligation" xlink:to="lab_trnr_ContingentRoyaltyObligation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ContingentRoyaltyObligation" xml:lang="en-US">Contingent royalty obligation</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xml:lang="en-US">Sale of stock, percentage of ownership after transaction</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xml:lang="en-US">Sale of stock, number of shares issued in transaction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xml:lang="en-US">Sale of stock number of shares issued in transaction</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xml:lang="en-US">Repayments of Related Party Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xml:lang="en-US">Payment made to related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_RepaymentsOfRelatedPartyDebt" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentFeePercentage" xlink:label="loc_trnr_DebtInstrumentFeePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DebtInstrumentFeePercentage" xml:lang="en-US">Debt Instrument Fee Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DebtInstrumentFeePercentage" xml:lang="en-US">Fee Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DebtInstrumentFeePercentage" xlink:to="lab_trnr_DebtInstrumentFeePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DebtInstrumentFeePercentage" xml:lang="en-US">Debt Instrument Fee Percentage</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentInterestRateStatedPercentageAdditional" xlink:label="loc_trnr_DebtInstrumentInterestRateStatedPercentageAdditional" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_DebtInstrumentInterestRateStatedPercentageAdditional" xml:lang="en-US">Debt Instrument Interest Rate Stated Percentage, Additional Accrued Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_DebtInstrumentInterestRateStatedPercentageAdditional" xml:lang="en-US">Additional Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_DebtInstrumentInterestRateStatedPercentageAdditional" xlink:to="lab_trnr_DebtInstrumentInterestRateStatedPercentageAdditional" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_DebtInstrumentInterestRateStatedPercentageAdditional" xml:lang="en-US">Debt Instrument Interest Rate Stated Percentage, Additional Accrued Rate</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansPayable" xlink:label="loc_us-gaap_NotesAndLoansPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesAndLoansPayable" xml:lang="en-US">Notes and Loans Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NotesAndLoansPayable" xml:lang="en-US">Loan Payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansPayable" xlink:to="lab_us-gaap_NotesAndLoansPayable" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedInterestAndDefaultInterest" xlink:label="loc_trnr_AccruedInterestAndDefaultInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AccruedInterestAndDefaultInterest" xml:lang="en-US">Accrued Interest And Default Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AccruedInterestAndDefaultInterest" xml:lang="en-US">Accrued interest and default interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AccruedInterestAndDefaultInterest" xlink:to="lab_trnr_AccruedInterestAndDefaultInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AccruedInterestAndDefaultInterest" xml:lang="en-US">Accrued interest and default interest.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyMember" xml:lang="en-US">Related Party [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyMember" xml:lang="en-US">Related Party [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesPayable" xml:lang="en-US">Notes Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NotesPayable" xml:lang="en-US">Notes Payable, Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FounderNotesMember" xlink:label="loc_trnr_FounderNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_FounderNotesMember" xml:lang="en-US">Founder Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_FounderNotesMember" xml:lang="en-US">Founder Notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_FounderNotesMember" xlink:to="lab_trnr_FounderNotesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_FounderNotesMember" xml:lang="en-US">Founder notes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable" xml:lang="en-US">Subsequent Event [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockToClassBCommonStockMember" xlink:label="loc_trnr_ClassACommonStockToClassBCommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_ClassACommonStockToClassBCommonStockMember" xml:lang="en-US">Class A Common Stock to Class B Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_ClassACommonStockToClassBCommonStockMember" xlink:to="lab_trnr_ClassACommonStockToClassBCommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_ClassACommonStockToClassBCommonStockMember" xml:lang="en-US">Class A common stock to class B common stock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xml:lang="en-US">Restructuring Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xml:lang="en-US">Type of Restructuring [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractTerminationMember" xlink:label="loc_us-gaap_ContractTerminationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractTerminationMember" xml:lang="en-US">Contract Termination [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractTerminationMember" xlink:to="lab_us-gaap_ContractTerminationMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaap_AssetAcquisitionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xml:lang="en-US">Asset Acquisition [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaap_AssetAcquisitionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xml:lang="en-US">Asset Acquisition [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AssetPurchaseAgreementMember" xlink:label="loc_trnr_AssetPurchaseAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AssetPurchaseAgreementMember" xml:lang="en-US">Asset Purchase Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AssetPurchaseAgreementMember" xml:lang="en-US">Asset Purchase Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AssetPurchaseAgreementMember" xlink:to="lab_trnr_AssetPurchaseAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AssetPurchaseAgreementMember" xml:lang="en-US">Asset Purchase Agreement Member</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioForecastMember" xml:lang="en-US">Forecast [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_ScenarioForecastMember" xml:lang="en-US">Forecast [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_OwnershipAxis" xml:lang="en-US">Ownership [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_OwnershipDomain" xml:lang="en-US">Ownership [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems" xml:lang="en-US">Subsequent Event [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockConversionBasis" xlink:label="loc_us-gaap_CommonStockConversionBasis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockConversionBasis" xml:lang="en-US">Common Stock, Conversion Basis</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockConversionBasis" xml:lang="en-US">Common stock, conversion basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockConversionBasis" xlink:to="lab_us-gaap_CommonStockConversionBasis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsForRestructuring" xml:lang="en-US">Payments for Restructuring</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PaymentsForRestructuring" xml:lang="en-US">Payments for restructuring</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AssetPurchaseAgreementTerms" xlink:label="loc_trnr_AssetPurchaseAgreementTerms" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_AssetPurchaseAgreementTerms" xml:lang="en-US">Asset Purchase Agreement Terms</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_AssetPurchaseAgreementTerms" xml:lang="en-US">Asset purchase agreement terms</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_AssetPurchaseAgreementTerms" xlink:to="lab_trnr_AssetPurchaseAgreementTerms" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_AssetPurchaseAgreementTerms" xml:lang="en-US">Asset purchase agreement terms.</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WeightedAverageThresholdConsecutiveTradingDays1" xlink:label="loc_trnr_WeightedAverageThresholdConsecutiveTradingDays1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_WeightedAverageThresholdConsecutiveTradingDays1" xml:lang="en-US">Weighted Average Threshold Consecutive Trading Days1</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_WeightedAverageThresholdConsecutiveTradingDays1" xml:lang="en-US">Weighted Average Threshold Consecutive Trading Days</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_WeightedAverageThresholdConsecutiveTradingDays1" xlink:to="lab_trnr_WeightedAverageThresholdConsecutiveTradingDays1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_WeightedAverageThresholdConsecutiveTradingDays1" xml:lang="en-US">Weighted Average Threshold Consecutive Trading Days1</label>
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfOriginalIssuanceDiscount" xlink:label="loc_trnr_PercentageOfOriginalIssuanceDiscount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_PercentageOfOriginalIssuanceDiscount" xml:lang="en-US">Percentage of Original Issuance Discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_PercentageOfOriginalIssuanceDiscount" xml:lang="en-US">Percentage of original issuance discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_PercentageOfOriginalIssuanceDiscount" xlink:to="lab_trnr_PercentageOfOriginalIssuanceDiscount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_PercentageOfOriginalIssuanceDiscount" xml:lang="en-US">Percentage of original issuance discount.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xlink:label="loc_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xml:lang="en-US">Asset Acquisition, Price of Acquisition, Expected</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xml:lang="en-US">Purchase price under the Asset Purchase Agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xlink:to="lab_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MaximumNumberOfEarnOutShares" xlink:label="loc_trnr_MaximumNumberOfEarnOutShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_MaximumNumberOfEarnOutShares" xml:lang="en-US">Maximum Number of Earn-Out Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_MaximumNumberOfEarnOutShares" xml:lang="en-US">Maximum number of earn-out shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_MaximumNumberOfEarnOutShares" xlink:to="lab_trnr_MaximumNumberOfEarnOutShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_MaximumNumberOfEarnOutShares" xml:lang="en-US">Maximum number of earn-Out shares</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US">Step-up interest rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebt" xlink:label="loc_us-gaap_SubordinatedDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubordinatedDebt" xml:lang="en-US">Subordinated Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubordinatedDebt" xml:lang="en-US">Subordinated debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubordinatedDebt" xlink:to="lab_us-gaap_SubordinatedDebt" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RetirementOfSeniorDebt" xlink:label="loc_trnr_RetirementOfSeniorDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trnr_RetirementOfSeniorDebt" xml:lang="en-US">Retirement Of Senior Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trnr_RetirementOfSeniorDebt" xml:lang="en-US">Retirement of senior debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trnr_RetirementOfSeniorDebt" xlink:to="lab_trnr_RetirementOfSeniorDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trnr_RetirementOfSeniorDebt" xml:lang="en-US">Retirement of senior debt.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" />
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>trnr-20230930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 22-December-2023 [11:38:22] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CoverPage" roleURI="http://formelife.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://formelife.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" roleURI="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CondensedConsolidatedStatementOfCashFlowsUnaudited" roleURI="http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentation" roleURI="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentation" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RevenueRecognition" roleURI="http://formelife.com/role/RevenueRecognition" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" roleURI="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#InventoriesNet" roleURI="http://formelife.com/role/InventoriesNet" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNet" roleURI="http://formelife.com/role/PropertyAndEquipmentNet" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNet" roleURI="http://formelife.com/role/IntangibleAssetsNet" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PrepaidExpensesAndOtherCurrentAssets" roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssets" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNet" roleURI="http://formelife.com/role/OtherAssetsNet" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilities" roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilities" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#Debt" roleURI="http://formelife.com/role/Debt" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#Warrants" roleURI="http://formelife.com/role/Warrants" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurements" roleURI="http://formelife.com/role/FairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingencies" roleURI="http://formelife.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#Leases" roleURI="http://formelife.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#StockholdersDeficit" roleURI="http://formelife.com/role/StockholdersDeficit" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensation" roleURI="http://formelife.com/role/EquityBasedCompensation" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#ConcentrationOfCreditRiskAndMajorCustomersAndVendors" roleURI="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendors" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#BenefitPlans" roleURI="http://formelife.com/role/BenefitPlans" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxes" roleURI="http://formelife.com/role/IncomeTaxes" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LossPerShare" roleURI="http://formelife.com/role/LossPerShare" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RelatedPartyTransactions" roleURI="http://formelife.com/role/RelatedPartyTransactions" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SubsequentEvents" roleURI="http://formelife.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#InventoriesNetTables" roleURI="http://formelife.com/role/InventoriesNetTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNetTables" roleURI="http://formelife.com/role/PropertyAndEquipmentNetTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetTables" roleURI="http://formelife.com/role/IntangibleAssetsNetTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PrepaidExpensesAndOtherCurrentAssetsTables" roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNetTables" roleURI="http://formelife.com/role/OtherAssetsNetTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#StockholdersDeficitTables" roleURI="http://formelife.com/role/StockholdersDeficitTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationTables" roleURI="http://formelife.com/role/EquityBasedCompensationTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#WarrantsTables" roleURI="http://formelife.com/role/WarrantsTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurementsTables" roleURI="http://formelife.com/role/FairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingenciesTables" roleURI="http://formelife.com/role/CommitmentsAndContingenciesTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesTables" roleURI="http://formelife.com/role/IncomeTaxesTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LossPerShareTables" roleURI="http://formelife.com/role/LossPerShareTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RelatedPartyTransactionsTables" roleURI="http://formelife.com/role/RelatedPartyTransactionsTables" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails" roleURI="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails" roleURI="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RevenueRecognitionAdditionalInformationDetails" roleURI="http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails" roleURI="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#InventoriesNetScheduleOfInventoriesDetails" roleURI="http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails" roleURI="http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PropertyAndEquipmentNetAdditionalInformationDetails" roleURI="http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails" roleURI="http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetAdditionalInformationDetails" roleURI="http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails" roleURI="http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNetScheduleOfOtherAssetsDetails" roleURI="http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#OtherAssetsNetAdditionalInformationDetails" roleURI="http://formelife.com/role/OtherAssetsNetAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" roleURI="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#DebtAdditionalInformationDetails" roleURI="http://formelife.com/role/DebtAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#WarrantsAdditionalInformationDetails" roleURI="http://formelife.com/role/WarrantsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails" roleURI="http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurementsAdditionalInformationDetails" roleURI="http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails" roleURI="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails" roleURI="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LeasesAdditionalInformationDetails" roleURI="http://formelife.com/role/LeasesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails" roleURI="http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails" roleURI="http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#CommitmentsAndContingenciesAdditionalInformationDetails" roleURI="http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#StockholdersDeficitAdditionalInformationDetails" roleURI="http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#StockholdersDeficitDisclosureOfTemporaryEquityDetails" roleURI="http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationAdditionalInformationDetails" roleURI="http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails" roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationSummaryOfStockOptionActivityDetails" roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationSummaryOfUnvestedCommonStockDetails" roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails" roleURI="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails" roleURI="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#BenefitPlansAdditionalInformationDetails" roleURI="http://formelife.com/role/BenefitPlansAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" roleURI="http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" roleURI="http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails" roleURI="http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#IncomeTaxesAdditionalInformationDetails" roleURI="http://formelife.com/role/IncomeTaxesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LossPerShareScheduleOfLossPerShareDetails" roleURI="http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#LossPerShareScheduleOfPotentiallyDilutiveSharesDetails" roleURI="http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#RelatedPartyTransactionsScheduleOfLoanPayableDetails" roleURI="http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails" />
<roleRef xlink:type="simple" xlink:href="trnr-20230930.xsd#SubsequentEventsAdditionalInformationDetails" roleURI="http://formelife.com/role/SubsequentEventsAdditionalInformationDetails" />
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_101" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_101" xlink:to="loc_dei_DocumentInformationTable_1135" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1135" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1136" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1136" xlink:to="loc_dei_AddressTypeDomain_1137" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_1137" xlink:to="loc_dei_BusinessContactMember_1138" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_1139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1135" xlink:to="loc_dei_DocumentInformationLineItems_1139" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_102" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_DocumentType_102" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityRegistrantName_107" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityCentralIndexKey_108" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_AmendmentFlag_112" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityIncorporationStateCountryCode_113" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityTaxIdentificationNumber_114" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressAddressLine1_115" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressAddressLine2_116" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_117" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressCityOrTown_117" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_118" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressStateOrProvince_118" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_119" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityAddressPostalZipCode_119" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_CityAreaCode_120" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_LocalPhoneNumber_121" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityFilerCategory_127" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityExTransitionPeriod_128" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityEmergingGrowthCompany_129" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntitySmallBusiness_130" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber_1140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_EntityPrimarySicNumber_1140" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_1141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1139" xlink:to="loc_dei_ContactPersonnelName_1141" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_136" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_136" xlink:to="loc_us-gaap_StatementTable_145" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_145" xlink:to="loc_us-gaap_StatementClassOfStockAxis_143" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_143" xlink:to="loc_us-gaap_ClassOfStockDomain_154" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedConvertiblePreferredStockMember_139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_154" xlink:to="loc_trnr_SeriesSeedConvertiblePreferredStockMember_139" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_154" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_148" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_145" xlink:to="loc_us-gaap_StatementLineItems_150" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_AssetsAbstract_144" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_144" xlink:to="loc_us-gaap_AssetsCurrentAbstract_140" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_138" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_147" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_147" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_InventoryFinishedGoods_153" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxesReceivables" xlink:label="loc_trnr_IncomeTaxesReceivables_1222" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_trnr_IncomeTaxesReceivables_1222" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_DepositsAssetsCurrent_158" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_162" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_140" xlink:to="loc_us-gaap_AssetsCurrent_166" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_151" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_156" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_160" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_160" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNoncurrent" xlink:label="loc_us-gaap_InventoryNoncurrent_164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_InventoryNoncurrent_164" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts_167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_DeferredCosts_167" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets_169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_OtherAssets_169" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_171" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_Assets_171" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_173" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_173" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_173" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_142" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_AccountsPayableCurrent_137" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_146" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_152" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_152" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_157" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_157" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaap_LoansPayableCurrent_161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_LoansPayableCurrent_161" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaap_SecuredDebtCurrent_165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_SecuredDebtCurrent_165" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_168" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_170" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_170" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_172" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_142" xlink:to="loc_us-gaap_LiabilitiesCurrent_172" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_174" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_175" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_DerivativeLiabilities_175" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1223" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1223" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_Liabilities_176" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_CommitmentsAndContingencies_177" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_1224" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_1224" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_StockholdersEquityAbstract_178" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_CommonStockValue_141" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_149" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_AdditionalPaidInCapital_149" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_155" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_159" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_178" xlink:to="loc_us-gaap_StockholdersEquity_163" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_179" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_181" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_181" xlink:to="loc_us-gaap_StatementTable_1109" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1109" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1241" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1241" xlink:to="loc_us-gaap_ClassOfStockDomain_1242" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedConvertiblePreferredStockMember_1243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1242" xlink:to="loc_trnr_SeriesSeedConvertiblePreferredStockMember_1243" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_1244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1242" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_1244" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_181" xlink:to="loc_us-gaap_StatementLineItems_183" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_182" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_184" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_CommonStockSharesIssued_185" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_186" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_186" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_1235" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_1235" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_1236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_1236" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_1237" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_1237" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1238" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_1239" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_183" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_1239" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_188" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_RevenuesAbstract_190" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FitnessProductRevenue1" xlink:label="loc_trnr_FitnessProductRevenue1_191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_trnr_FitnessProductRevenue1_191" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MembershipRevenue1" xlink:label="loc_trnr_MembershipRevenue1_195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_trnr_MembershipRevenue1_195" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TrainingRevenue1" xlink:label="loc_trnr_TrainingRevenue1_199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_trnr_TrainingRevenue1_199" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_203" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_us-gaap_Revenues_203" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfFitnessProductRevenue" xlink:label="loc_trnr_CostOfFitnessProductRevenue_206" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_trnr_CostOfFitnessProductRevenue_206" use="optional" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfMembership" xlink:label="loc_trnr_CostOfMembership_209" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_trnr_CostOfMembership_209" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfMembershipAndTraining" xlink:label="loc_trnr_CostOfMembershipAndTraining_1246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_trnr_CostOfMembershipAndTraining_1246" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfTraining" xlink:label="loc_trnr_CostOfTraining_212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_trnr_CostOfTraining_212" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_us-gaap_CostOfRevenue_214" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_216" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_190" xlink:to="loc_us-gaap_GrossProfit_216" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_OperatingExpensesAbstract_194" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_189" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_194" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_189" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_193" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_194" xlink:to="loc_us-gaap_SellingAndMarketingExpense_193" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_197" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_194" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_197" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_201" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_194" xlink:to="loc_us-gaap_OperatingExpenses_201" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_OperatingIncomeLoss_198" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_192" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRevenueExpenseNet" xlink:label="loc_us-gaap_InterestRevenueExpenseNet_196" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" xlink:to="loc_us-gaap_InterestRevenueExpenseNet_196" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainUponDebtForgiveness" xlink:label="loc_trnr_GainUponDebtForgiveness_200" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" xlink:to="loc_trnr_GainUponDebtForgiveness_200" use="optional" order="21" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity_1247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" xlink:to="loc_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity_1247" use="optional" order="22" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xlink:label="loc_trnr_GainLossOnChangeInFairValueOfConvertibleNotes_204" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" xlink:to="loc_trnr_GainLossOnChangeInFairValueOfConvertibleNotes_204" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_207" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_207" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_210" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_202" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_210" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_205" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_208" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_208" use="optional" order="27" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_211" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_211" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_EarningsPerShareBasic_213" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_215" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_EarningsPerShareDiluted_215" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_217" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_188" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_218" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_220" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_220" xlink:to="loc_us-gaap_ProfitLoss_221" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_222" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_220" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_222" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_223" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_220" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_223" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_225" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_225" xlink:to="loc_us-gaap_StatementTable_226" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_226" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_230" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_229" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_230" xlink:to="loc_us-gaap_EquityComponentDomain_229" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_228" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_229" xlink:to="loc_us-gaap_CommonStockMember_228" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_233" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_229" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_233" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_229" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_238" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_229" xlink:to="loc_us-gaap_RetainedEarningsMember_242" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_226" xlink:to="loc_us-gaap_StatementClassOfStockAxis_234" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_237" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_234" xlink:to="loc_us-gaap_ClassOfStockDomain_237" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedZeroToTenPreferredStockMember" xlink:label="loc_trnr_SeriesSeedZeroToTenPreferredStockMember_227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_trnr_SeriesSeedZeroToTenPreferredStockMember_227" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesAConvertiblePreferredStockMember_232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_trnr_SeriesAConvertiblePreferredStockMember_232" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA1PreferredStockMember" xlink:label="loc_trnr_SeriesA1PreferredStockMember_236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_trnr_SeriesA1PreferredStockMember_236" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA2PreferredStockMember" xlink:label="loc_trnr_SeriesA2PreferredStockMember_241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_trnr_SeriesA2PreferredStockMember_241" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_us-gaap_CommonClassAMember_244" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_us-gaap_CommonClassBMember_246" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_237" xlink:to="loc_us-gaap_IPOMember_248" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_239" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_226" xlink:to="loc_us-gaap_StatementLineItems_239" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_231" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_231" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_235" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_235" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockholdersEquity_240" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_SharesOutstanding_243" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_245" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InitialPublicOfferingCosts" xlink:label="loc_trnr_InitialPublicOfferingCosts_247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_InitialPublicOfferingCosts_247" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_249" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_249" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_250" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_251" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1_252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_ConversionOfStockAmountIssued1_252" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_253" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_253" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_254" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_254" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_255" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_255" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues_256" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues_256" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_257" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_257" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_258" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_258" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_259" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_259" use="optional" order="34" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_260" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_260" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_261" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_261" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_262" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodValueWarrantsExercised_263" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_StockIssuedDuringPeriodValueWarrantsExercised_263" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NetExerciseOfOptions" xlink:label="loc_trnr_NetExerciseOfOptions_265" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_NetExerciseOfOptions_265" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions_1281" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions_1281" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue_1283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue_1283" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares_1284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares_1284" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue_1285" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue_1285" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares_1286" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares_1286" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue_1287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue_1287" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares" xlink:label="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares_1288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares_1288" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues_1291" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues_1291" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1292" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1294" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1294" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1296" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1298" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1298" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1300" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1302" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1304" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1306" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1308" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares" xlink:label="loc_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares_1310" use="optional" order="57" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock_1363" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock_1363" use="optional" order="58" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock_1369" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock_1369" use="optional" order="59" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock_1370" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock_1370" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock_1371" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock_1371" use="optional" order="61" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock_1372" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock_1372" use="optional" order="62" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock_1373" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock_1373" use="optional" order="63" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock._1374" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock._1374" use="optional" order="64" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock." xlink:label="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock._1375" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock._1375" use="optional" order="65" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock_1376" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock_1376" use="optional" order="66" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock" xlink:label="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock_1377" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock_1377" use="optional" order="67" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue_1379" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue_1379" use="optional" order="68" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares_1380" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares_1380" use="optional" order="69" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue_1383" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue_1383" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares_1386" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares_1386" use="optional" order="71" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue_1391" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue_1391" use="optional" order="72" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares_1392" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares_1392" use="optional" order="73" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue_1394" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue_1394" use="optional" order="74" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares_1395" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares_1395" use="optional" order="75" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue_1396" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue_1396" use="optional" order="76" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares_1398" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares_1398" use="optional" order="77" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue_1402" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue_1402" use="optional" order="78" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares_1403" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares_1403" use="optional" order="79" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue_1404" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue_1404" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares_1405" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares_1405" use="optional" order="81" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue_1406" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue_1406" use="optional" order="82" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares_1407" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares_1407" use="optional" order="83" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue_1409" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue_1409" use="optional" order="84" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares_1413" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares_1413" use="optional" order="85" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue_1415" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue_1415" use="optional" order="86" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares_1416" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares_1416" use="optional" order="87" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue_1417" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue_1417" use="optional" order="88" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares_1418" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares_1418" use="optional" order="89" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue_1419" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue_1419" use="optional" order="90" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares_1420" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares_1420" use="optional" order="91" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue_1421" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue_1421" use="optional" order="92" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares_1422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares_1422" use="optional" order="93" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue_1423" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue_1423" use="optional" order="94" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares" xlink:label="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares_1424" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares_1424" use="optional" order="95" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_264" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_264" use="optional" order="96" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_266" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_266" use="optional" order="97" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_267" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_NetIncomeLoss_267" use="optional" order="98" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_268" use="optional" order="99" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_269" use="optional" order="100" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_StockholdersEquity_270" use="optional" order="101" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_239" xlink:to="loc_us-gaap_SharesOutstanding_271" use="optional" order="102" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_273" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_273" xlink:to="loc_us-gaap_StatementTable_274" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_274" xlink:to="loc_us-gaap_StatementClassOfStockAxis_276" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_276" xlink:to="loc_us-gaap_ClassOfStockDomain_280" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA2PreferredStockMember" xlink:label="loc_trnr_SeriesA2PreferredStockMember_275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_280" xlink:to="loc_trnr_SeriesA2PreferredStockMember_275" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_278" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_280" xlink:to="loc_us-gaap_IPOMember_278" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_274" xlink:to="loc_us-gaap_StatementLineItems_279" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_279" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_277" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_282" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1265" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_282" xlink:to="loc_us-gaap_StatementTable_1265" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1267" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1265" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1267" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_1268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1267" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_1268" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfPreferredStockToClassACommonStockMember" xlink:label="loc_trnr_ConversionOfPreferredStockToClassACommonStockMember_1269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_1268" xlink:to="loc_trnr_ConversionOfPreferredStockToClassACommonStockMember_1269" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember" xlink:label="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember_1275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_1268" xlink:to="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember_1275" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember" xlink:label="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember_1276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_1268" xlink:to="loc_trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember_1276" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="loc_us-gaap_DebtConversionByUniqueDescriptionAxis_1270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1265" xlink:to="loc_us-gaap_DebtConversionByUniqueDescriptionAxis_1270" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionNameDomain" xlink:label="loc_us-gaap_DebtConversionNameDomain_1271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionByUniqueDescriptionAxis_1270" xlink:to="loc_us-gaap_DebtConversionNameDomain_1271" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfLoanPayableToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfLoanPayableToConvertibleNoteMember_1272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionNameDomain_1271" xlink:to="loc_trnr_ConversionOfLoanPayableToConvertibleNoteMember_1272" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfAccountsPayableToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfAccountsPayableToConvertibleNoteMember_1273" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionNameDomain_1271" xlink:to="loc_trnr_ConversionOfAccountsPayableToConvertibleNoteMember_1273" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConversionOfPromissoryNotesToConvertibleNoteMember" xlink:label="loc_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember_1274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionNameDomain_1271" xlink:to="loc_trnr_ConversionOfPromissoryNotesToConvertibleNoteMember_1274" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1266" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1265" xlink:to="loc_us-gaap_StatementLineItems_1266" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" xlink:to="loc_us-gaap_ProfitLoss_287" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_285" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_285" use="optional" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_Depreciation_292" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_299" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_299" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1248" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashLeaseExpense" xlink:label="loc_trnr_NonCashLeaseExpense_306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_NonCashLeaseExpense_306" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_312" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_InventoryWriteDown_312" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_317" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_ShareBasedCompensation_317" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrantsIssuedWithConvertibleNotes" xlink:label="loc_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes_1249" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes_1249" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_322" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_322" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_327" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_327" use="optional" order="25" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_332" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_332" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders" xlink:label="loc_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders_340" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders_340" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_1250" use="optional" order="28" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashInterestExpense" xlink:label="loc_trnr_NonCashInterestExpense_1251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_NonCashInterestExpense_1251" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_1252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_AssetImpairmentCharges_1252" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity_1253" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity_1253" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainLossOnChangeInFairValueOfConvertibleNotes" xlink:label="loc_trnr_GainLossOnChangeInFairValueOfConvertibleNotes_336" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_trnr_GainLossOnChangeInFairValueOfConvertibleNotes_336" use="optional" order="32" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_342" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_342" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_294" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_283" use="optional" order="35" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_290" use="optional" order="36" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_297" use="optional" order="37" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInDepositOtherAssets_304" use="optional" order="38" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCharges_310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCharges_310" use="optional" order="39" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncreaseDecreaseInLongTermInventory" xlink:label="loc_trnr_IncreaseDecreaseInLongTermInventory_315" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_trnr_IncreaseDecreaseInLongTermInventory_315" use="optional" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_320" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_320" use="optional" order="41" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_325" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_325" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_330" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_334" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_334" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_338" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_344" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_338" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_286" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_301" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_289" use="optional" order="48" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireSoftware" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_296" use="optional" order="49" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopSoftware" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_303" use="optional" order="50" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_309" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_293" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_309" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromPPPLoan" xlink:label="loc_trnr_ProceedsFromPPPLoan_1254" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_ProceedsFromPPPLoan_1254" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_1278" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_1278" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_288" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_1280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_1280" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RepaymentsOfRelatedPartyLoans" xlink:label="loc_trnr_RepaymentsOfRelatedPartyLoans_295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_RepaymentsOfRelatedPartyLoans_295" use="optional" order="57" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity_1255" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity_1255" use="optional" order="58" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_302" use="optional" order="59" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_308" use="optional" order="60" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_314" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_314" use="optional" order="61" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaymentsOfSeniorSecuredNotes" xlink:label="loc_trnr_PaymentsOfSeniorSecuredNotes_319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_PaymentsOfSeniorSecuredNotes_319" use="optional" order="62" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_324" use="optional" order="63" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_329" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_329" use="optional" order="64" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_333" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_333" use="optional" order="65" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1256" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_1256" use="optional" order="66" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_337" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_337" use="optional" order="67" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RepaymentOfBouncebackLoans" xlink:label="loc_trnr_RepaymentOfBouncebackLoans_341" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_trnr_RepaymentOfBouncebackLoans_341" use="optional" order="68" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_300" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_343" use="optional" order="69" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_307" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_313" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_313" use="optional" order="71" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_318" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_318" use="optional" order="72" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_323" use="optional" order="73" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1266" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" use="optional" order="74" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PropertyAndEquipmentInAccountsPayable" xlink:label="loc_trnr_PropertyAndEquipmentInAccountsPayable_284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_PropertyAndEquipmentInAccountsPayable_284" use="optional" order="75" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InventoriesInAccountsPayableAndAccrued" xlink:label="loc_trnr_InventoriesInAccountsPayableAndAccrued_291" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_InventoriesInAccountsPayableAndAccrued_291" use="optional" order="76" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedSoftwareAndContentInAccountsPayable" xlink:label="loc_trnr_CapitalizedSoftwareAndContentInAccountsPayable_1257" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_CapitalizedSoftwareAndContentInAccountsPayable_1257" use="optional" order="77" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable" xlink:label="loc_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable_298" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable_298" use="optional" order="78" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashActivityDeferredCostsIncurred" xlink:label="loc_trnr_NoncashActivityDeferredCostsIncurred_1279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NoncashActivityDeferredCostsIncurred_1279" use="optional" order="79" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RecognitionOfDeferredAndAccruedOfferingCosts" xlink:label="loc_trnr_RecognitionOfDeferredAndAccruedOfferingCosts_305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_RecognitionOfDeferredAndAccruedOfferingCosts_305" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ProceedsFromPaycheckProtectionProgramLoan" xlink:label="loc_trnr_ProceedsFromPaycheckProtectionProgramLoan_311" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_ProceedsFromPaycheckProtectionProgramLoan_311" use="optional" order="81" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_316" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_316" use="optional" order="82" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption" xlink:label="loc_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption_1258" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption_1258" use="optional" order="83" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_321" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_321" use="optional" order="84" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination" xlink:label="loc_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination_326" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination_326" use="optional" order="85" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashIssuanceOfCommonStockFromRightsOffering" xlink:label="loc_trnr_NonCashIssuanceOfCommonStockFromRightsOffering_331" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NonCashIssuanceOfCommonStockFromRightsOffering_331" use="optional" order="86" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NonCashExerciseOfOptions" xlink:label="loc_trnr_NonCashExerciseOfOptions_335" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NonCashExerciseOfOptions_335" use="optional" order="87" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockBasedCompensationCapitalizedInSoftware" xlink:label="loc_trnr_StockBasedCompensationCapitalizedInSoftware_339" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_StockBasedCompensationCapitalizedInSoftware_339" use="optional" order="88" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_1259" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_1259" use="optional" order="89" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_1260" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_1260" use="optional" order="90" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants" xlink:label="loc_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants_1261" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants_1261" use="optional" order="91" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA" xlink:label="loc_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA_1262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA_1262" use="optional" order="92" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesIssued1" xlink:label="loc_us-gaap_NotesIssued1_1263" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_NotesIssued1_1263" use="optional" order="93" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaap_StockIssued1_1264" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_328" xlink:to="loc_us-gaap_StockIssued1_1264" use="optional" order="94" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentation">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_346" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_347" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_346" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_347" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_349" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_350" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_349" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_350" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/RevenueRecognition">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_352" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_353" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_352" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_353" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1158" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock_1159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1158" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock_1159" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/InventoriesNet">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_355" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_356" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_355" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_356" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/PropertyAndEquipmentNet">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_358" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_359" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_358" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_359" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNet">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_361" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_362" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_361" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_362" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssets">
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" xlink:label="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract_364" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock" xlink:label="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock_365" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract_364" xlink:to="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock_365" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/OtherAssetsNet">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_367" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_368" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_367" xlink:to="loc_us-gaap_OtherAssetsDisclosureTextBlock_368" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilities">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_370" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_371" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_370" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_371" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/Debt">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_373" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_374" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_373" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_374" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/Warrants">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_376" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsDisclosureTextBlock" xlink:label="loc_trnr_WarrantsDisclosureTextBlock_377" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_376" xlink:to="loc_trnr_WarrantsDisclosureTextBlock_377" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/FairValueMeasurements">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_379" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_380" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_379" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_380" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_382" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_383" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_382" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_383" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/Leases">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1165" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1165" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1166" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/StockholdersDeficit">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_385" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_386" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_385" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_386" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensation">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_388" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_389" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_388" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_389" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendors">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_391" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_392" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_391" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_392" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/BenefitPlans">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_394" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_395" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_394" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_395" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IncomeTaxes">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1313" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1314" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1313" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1314" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/LossPerShare">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_397" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_398" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_397" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_398" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/RelatedPartyTransactions">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_400" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_401" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_400" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_401" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SubsequentEvents">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_403" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_404" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_403" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_404" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_406" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComparabilityOfPriorYearFinancialData" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData_407" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_ComparabilityOfPriorYearFinancialData_407" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_408" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_UseOfEstimates_408" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_409" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_409" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_410" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_410" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DeferredOfferingCostsPolicyTextBlock" xlink:label="loc_trnr_DeferredOfferingCostsPolicyTextBlock_411" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_DeferredOfferingCostsPolicyTextBlock_411" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_412" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_412" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_413" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_413" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorDepositPolicyTextBlock" xlink:label="loc_trnr_VendorDepositPolicyTextBlock_414" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_VendorDepositPolicyTextBlock_414" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedStudioContentPolicytextBlock" xlink:label="loc_trnr_CapitalizedStudioContentPolicytextBlock_415" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_CapitalizedStudioContentPolicytextBlock_415" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_416" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_416" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MusicRoyaltyFeesPolicyPolicyTextBlock" xlink:label="loc_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock_417" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock_417" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_418" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_418" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_419" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_419" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ConvertibleNotesPolicyTextBlock" xlink:label="loc_trnr_ConvertibleNotesPolicyTextBlock_420" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_ConvertibleNotesPolicyTextBlock_420" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsPolicyTextBlock" xlink:label="loc_trnr_WarrantsPolicyTextBlock_421" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_WarrantsPolicyTextBlock_421" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_422" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_423" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_423" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_1446" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_1446" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ContentLicensingAgreementPolicyTextBlock" xlink:label="loc_trnr_ContentLicensingAgreementPolicyTextBlock_1448" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_ContentLicensingAgreementPolicyTextBlock_1448" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_1449" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_1449" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_1450" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_1450" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock_1451" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock_1451" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_1452" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_1452" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_1455" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_1455" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfFitnessProductRevenuePolicyTextBlock" xlink:label="loc_trnr_CostOfFitnessProductRevenuePolicyTextBlock_1457" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_CostOfFitnessProductRevenuePolicyTextBlock_1457" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CostOfMembershipAndTrainingPolicyTextBlock" xlink:label="loc_trnr_CostOfMembershipAndTrainingPolicyTextBlock_1458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_trnr_CostOfMembershipAndTrainingPolicyTextBlock_1458" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_1459" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_1459" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1460" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1460" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_1461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_1461" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1462" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1462" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1475" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1475" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_1477" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_406" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_1477" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_425" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock" xlink:label="loc_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock_426" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_425" xlink:to="loc_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock_426" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_427" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_425" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_427" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/InventoriesNetTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_429" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_430" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_429" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_430" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/PropertyAndEquipmentNetTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_436" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_436" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_437" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNetTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_432" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_433" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_432" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_433" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_434" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_432" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_434" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsTables">
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract" xlink:label="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract_439" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_440" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract_439" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_440" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/OtherAssetsNetTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_442" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_443" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_442" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_443" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_445" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_446" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_445" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_446" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/StockholdersDeficitTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1464" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_1465" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1464" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_1465" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_448" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_449" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_448" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_449" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_450" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_448" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_450" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_451" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_448" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_451" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_452" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_448" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_452" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/WarrantsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_458" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_458" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_461" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_462" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_461" xlink:to="loc_us-gaap_StatementClassOfStockAxis_462" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_466" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_462" xlink:to="loc_us-gaap_ClassOfStockDomain_466" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockWarrantsMember" xlink:label="loc_trnr_ClassACommonStockWarrantsMember_459" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_466" xlink:to="loc_trnr_ClassACommonStockWarrantsMember_459" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonStockWarrantsMember" xlink:label="loc_trnr_ClassBCommonStockWarrantsMember_463" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_466" xlink:to="loc_trnr_ClassBCommonStockWarrantsMember_463" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember_465" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_466" xlink:to="loc_trnr_ServiceProvidersStockWarrantsMember_465" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeniorSecuredNotesStockWarrantsMember" xlink:label="loc_trnr_SeniorSecuredNotesStockWarrantsMember_467" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_466" xlink:to="loc_trnr_SeniorSecuredNotesStockWarrantsMember_467" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_464" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_461" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_464" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_460" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_464" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_460" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/FairValueMeasurementsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_469" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_470" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_469" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_470" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_471" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_469" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_471" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CommitmentsAndContingenciesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_473" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_474" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_473" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_474" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTableTextBlock" xlink:label="loc_us-gaap_OtherCommitmentsTableTextBlock_1142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_473" xlink:to="loc_us-gaap_OtherCommitmentsTableTextBlock_1142" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IncomeTaxesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1316" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1317" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1316" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1317" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1318" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1316" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1318" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1316" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1319" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1320" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1316" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1320" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/LossPerShareTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_454" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_455" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_454" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_455" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_456" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_454" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_456" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/RelatedPartyTransactionsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_476" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_477" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_476" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_477" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_479" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_479" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_481" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_481" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_483" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_481" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_483" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_486" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_483" xlink:to="loc_us-gaap_IPOMember_486" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_487" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_487" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_480" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_487" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_480" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NotePurchaseAgreementMember" xlink:label="loc_trnr_NotePurchaseAgreementMember_485" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_480" xlink:to="loc_trnr_NotePurchaseAgreementMember_485" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_484" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_482" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_482" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_488" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_488" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaap_SecuredDebtCurrent_490" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_SecuredDebtCurrent_490" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_491" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_491" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_492" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_CommonStockSharesIssued_492" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_493" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_493" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions" xlink:label="loc_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions_494" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions_494" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockStock" xlink:label="loc_us-gaap_DividendsCommonStockStock_495" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_DividendsCommonStockStock_495" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock" xlink:label="loc_us-gaap_DividendsCommonStock_497" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_489" xlink:to="loc_us-gaap_DividendsCommonStock_497" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_499" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_499" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_513" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_513" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_513" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InternalUseSoftwareMember" xlink:label="loc_trnr_InternalUseSoftwareMember_508" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516" xlink:to="loc_trnr_InternalUseSoftwareMember_508" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedStudioContentMember" xlink:label="loc_trnr_CapitalizedStudioContentMember_1577" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_516" xlink:to="loc_trnr_CapitalizedStudioContentMember_1577" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_519" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_519" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_507" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_519" xlink:to="loc_us-gaap_RelatedPartyDomain_507" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LeadNoteholderMember" xlink:label="loc_trnr_LeadNoteholderMember_503" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_507" xlink:to="loc_trnr_LeadNoteholderMember_503" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherNoteholderMember" xlink:label="loc_trnr_OtherNoteholderMember_518" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_507" xlink:to="loc_trnr_OtherNoteholderMember_518" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_521" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_521" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_510" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_521" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_510" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_512" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_510" xlink:to="loc_us-gaap_IPOMember_512" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_523" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_523" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_500" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_523" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_500" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_511" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_500" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_511" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_525" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_CreditFacilityAxis_525" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_515" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_525" xlink:to="loc_us-gaap_CreditFacilityDomain_515" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_BridgeNoteFinancingMember" xlink:label="loc_trnr_BridgeNoteFinancingMember_509" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_515" xlink:to="loc_trnr_BridgeNoteFinancingMember_509" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_527" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_527" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_514" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_527" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_514" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_504" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_514" xlink:to="loc_us-gaap_SeniorNotesMember_504" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_529" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_srt_StatementScenarioAxis_529" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_506" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_529" xlink:to="loc_srt_ScenarioUnspecifiedDomain_506" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1560" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1560" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1561" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1560" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1561" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ContentLicensingAgreementMember" xlink:label="loc_trnr_ContentLicensingAgreementMember_1562" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1561" xlink:to="loc_trnr_ContentLicensingAgreementMember_1562" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis_1578" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis_1578" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain_1579" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis_1578" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain_1579" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember_1580" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain_1579" xlink:to="loc_trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember_1580" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1582" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1583" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1582" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1583" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyGainLossMember" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_1584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1583" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_1584" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1589" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1589" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1590" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1589" xlink:to="loc_us-gaap_EquityComponentDomain_1590" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1590" xlink:to="loc_us-gaap_WarrantMember_1591" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_505" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralPartnersOfferingCosts" xlink:label="loc_us-gaap_GeneralPartnersOfferingCosts_517" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_GeneralPartnersOfferingCosts_517" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CooperativeAdvertisingAmount" xlink:label="loc_us-gaap_CooperativeAdvertisingAmount_520" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_CooperativeAdvertisingAmount_520" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:label="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_522" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_522" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_524" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_524" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_526" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_526" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_528" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_528" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_530" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_530" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_532" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_532" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_533" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_533" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_534" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_534" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_535" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_535" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_536" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_536" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts_1559" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_DeferredOfferingCosts_1559" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetImpairmentCharges" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_1563" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_1563" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost" xlink:label="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost_1564" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost_1564" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LicenseFeePayablePerQuarter" xlink:label="loc_trnr_LicenseFeePayablePerQuarter_1565" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_LicenseFeePayablePerQuarter_1565" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability" xlink:label="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability_1566" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability_1566" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MusicGuaranteesDeposits" xlink:label="loc_trnr_MusicGuaranteesDeposits_1567" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_MusicGuaranteesDeposits_1567" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1568" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1568" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_OperatingLeaseLiability_1569" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForwardContractIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_1570" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ForwardContractIndexedToIssuersEquityShares_1570" use="optional" order="57" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements" xlink:label="loc_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements_1571" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements_1571" use="optional" order="58" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1573" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1573" use="optional" order="59" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1574" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1574" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions" xlink:label="loc_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions_1575" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions_1575" use="optional" order="61" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1576" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1576" use="optional" order="62" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1581" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_531" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1581" use="optional" order="63" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_538" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_538" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_545" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_545" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_545" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PreProductionToolingMember" xlink:label="loc_trnr_PreProductionToolingMember_544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" xlink:to="loc_trnr_PreProductionToolingMember_544" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_548" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_550" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_543" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_550" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_549" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" xlink:to="loc_srt_RangeAxis_549" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_549" xlink:to="loc_srt_RangeMember_541" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_541" xlink:to="loc_srt_MaximumMember_540" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_546" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_541" xlink:to="loc_srt_MinimumMember_546" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_551" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_539" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_551" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_551" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_542" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_551" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_547" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_554" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_554" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_555" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_557" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_561" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_557" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_561" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_558" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_561" xlink:to="loc_srt_RangeAxis_558" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_560" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_558" xlink:to="loc_srt_RangeMember_560" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_559" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_560" xlink:to="loc_srt_MaximumMember_559" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_564" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_560" xlink:to="loc_srt_MinimumMember_564" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_563" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_561" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_563" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ExtendedProductWarrantyPeriod" xlink:label="loc_trnr_ExtendedProductWarrantyPeriod_562" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_563" xlink:to="loc_trnr_ExtendedProductWarrantyPeriod_562" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1161" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable_1162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1161" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable_1162" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementAxis" xlink:label="loc_trnr_AgreementAxis_1167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable_1162" xlink:to="loc_trnr_AgreementAxis_1167" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementDomain" xlink:label="loc_trnr_AgreementDomain_1173" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_AgreementAxis_1167" xlink:to="loc_trnr_AgreementDomain_1173" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember_1174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_AgreementDomain_1173" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityMember_1174" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems_1164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable_1162" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems_1164" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1171" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems_1164" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1171" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1172" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems_1164" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1172" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_566" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_567" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_566" xlink:to="loc_us-gaap_InventoryFinishedGoods_567" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNoncurrent" xlink:label="loc_us-gaap_InventoryNoncurrent_568" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_566" xlink:to="loc_us-gaap_InventoryNoncurrent_568" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_566" xlink:to="loc_us-gaap_InventoryNet_569" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PreProductionTooling" xlink:label="loc_trnr_PreProductionTooling_572" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" xlink:to="loc_trnr_PreProductionTooling_572" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_573" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_573" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_574" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_574" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_575" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_575" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_576" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_576" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_577" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_577" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_578" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_578" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_579" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_571" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_579" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_581" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1606" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_581" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1606" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1608" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1606" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1608" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1609" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1608" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1609" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PropertyAndEquipmentMember" xlink:label="loc_trnr_PropertyAndEquipmentMember_1610" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1609" xlink:to="loc_trnr_PropertyAndEquipmentMember_1610" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1607" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1606" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1607" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1607" xlink:to="loc_us-gaap_Depreciation_582" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_1186" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1607" xlink:to="loc_us-gaap_DepreciationAndAmortization_1186" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_584" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_584" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_587" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_587" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InternalUseSoftwareMember" xlink:label="loc_trnr_InternalUseSoftwareMember_585" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_589" xlink:to="loc_trnr_InternalUseSoftwareMember_585" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_588" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_591" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_592" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_590" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_592" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_594" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_597" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_594" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_597" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_596" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_597" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_596" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_599" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_596" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_599" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IdentifiableIntangibleAssetsMember" xlink:label="loc_trnr_IdentifiableIntangibleAssetsMember_595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_599" xlink:to="loc_trnr_IdentifiableIntangibleAssetsMember_595" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_600" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_597" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_600" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_598" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_600" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_598" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_602" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_603" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_602" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_603" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_604" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_602" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_604" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_605" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_602" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_605" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_606" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_602" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_606" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_607" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_602" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_607" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1188" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_602" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1188" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_608" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_602" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_608" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_610" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1599" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_610" xlink:to="loc_us-gaap_StatementTable_1599" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1601" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1599" xlink:to="loc_srt_RestatementAxis_1601" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1602" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_1601" xlink:to="loc_srt_RestatementDomain_1602" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1603" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_1602" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1603" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1600" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1599" xlink:to="loc_us-gaap_StatementLineItems_1600" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaap_SecurityDeposit_611" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_SecurityDeposit_611" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrepaidLicenses" xlink:label="loc_trnr_PrepaidLicenses_612" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_trnr_PrepaidLicenses_612" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ResearchAndDevelopmentTaxCredit" xlink:label="loc_trnr_ResearchAndDevelopmentTaxCredit_613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_trnr_ResearchAndDevelopmentTaxCredit_613" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorDeposits" xlink:label="loc_trnr_VendorDeposits_1187" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_trnr_VendorDeposits_1187" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaap_OtherReceivables_614" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_OtherReceivables_614" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaap_PrepaidInsurance_615" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_PrepaidInsurance_615" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_616" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_616" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_617" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1600" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_617" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_619" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_621" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_619" xlink:to="loc_us-gaap_StatementTable_621" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_623" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_621" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_623" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_623" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedContentCostsAndContentLicensesMember" xlink:label="loc_trnr_CapitalizedContentCostsAndContentLicensesMember_1189" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" xlink:to="loc_trnr_CapitalizedContentCostsAndContentLicensesMember_1189" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedContentCostsMember" xlink:label="loc_trnr_CapitalizedContentCostsMember_625" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" xlink:to="loc_trnr_CapitalizedContentCostsMember_625" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedSoftwareMember" xlink:label="loc_trnr_CapitalizedSoftwareMember_629" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_622" xlink:to="loc_trnr_CapitalizedSoftwareMember_629" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_627" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_621" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_627" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_620" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_627" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_620" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_626" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_620" xlink:to="loc_us-gaap_OtherAssetsMember_626" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_630" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_621" xlink:to="loc_us-gaap_StatementLineItems_630" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsGross" xlink:label="loc_us-gaap_OtherDeferredCostsGross_624" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_630" xlink:to="loc_us-gaap_OtherDeferredCostsGross_624" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedAmortizationOfOtherDeferredCosts" xlink:label="loc_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts_628" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_630" xlink:to="loc_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts_628" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="loc_us-gaap_OtherDeferredCostsNet_631" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_630" xlink:to="loc_us-gaap_OtherDeferredCostsNet_631" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/OtherAssetsNetAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_633" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAmortizationOfDeferredCharges" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_633" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_634" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_636" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_636" xlink:to="loc_us-gaap_StatementTable_1594" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1596" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1594" xlink:to="loc_srt_RestatementAxis_1596" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1597" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_1596" xlink:to="loc_srt_RestatementDomain_1597" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1598" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_1597" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1598" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1594" xlink:to="loc_us-gaap_StatementLineItems_1595" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaap_AccruedBonusesCurrent_637" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedBonusesCurrent_637" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_638" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_638" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaidTimeOffAccrual" xlink:label="loc_trnr_PaidTimeOffAccrual_639" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_PaidTimeOffAccrual_639" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedOfferingCosts" xlink:label="loc_trnr_AccruedOfferingCosts_640" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_AccruedOfferingCosts_640" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedLicenses" xlink:label="loc_trnr_AccruedLicenses_641" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_AccruedLicenses_641" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_642" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_642" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedAdvertisingCurrent" xlink:label="loc_us-gaap_AccruedAdvertisingCurrent_1190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedAdvertisingCurrent_1190" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_643" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_643" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedEngineeringCurrent" xlink:label="loc_trnr_AccruedEngineeringCurrent_1191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_AccruedEngineeringCurrent_1191" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_1192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_1192" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CustomerDeposits" xlink:label="loc_trnr_CustomerDeposits_644" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_trnr_CustomerDeposits_644" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_645" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_645" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1194" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1195" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_646" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1595" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_646" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/DebtAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_648" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_652" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_648" xlink:to="loc_us-gaap_DebtInstrumentTable_652" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_650" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_us-gaap_DebtInstrumentAxis_650" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_666" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_650" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_666" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyTwoConvertibleNotesMember_655" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_TwoThousandTwentyTwoConvertibleNotesMember_655" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_November2022ConvertibleNotesMember" xlink:label="loc_trnr_November2022ConvertibleNotesMember_659" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_November2022ConvertibleNotesMember_659" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyConvertibleNotesMember_1199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_TwoThousandTwentyConvertibleNotesMember_1199" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyOneConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandTwentyOneConvertibleNotesMember_1200" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_TwoThousandTwentyOneConvertibleNotesMember_1200" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PaycheckProtectionProgramLoanMember" xlink:label="loc_trnr_PaycheckProtectionProgramLoanMember_1218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_trnr_PaycheckProtectionProgramLoanMember_1218" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_1233" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_666" xlink:to="loc_us-gaap_ConvertibleDebtMember_1233" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_658" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_658" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_649" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_658" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_649" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_656" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_649" xlink:to="loc_us-gaap_SeniorNotesMember_656" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_660" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_649" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_660" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NotePurchaseAgreementMember" xlink:label="loc_trnr_NotePurchaseAgreementMember_664" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_649" xlink:to="loc_trnr_NotePurchaseAgreementMember_664" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TenPercentageSeniorSecuredNotesDueMember" xlink:label="loc_trnr_TenPercentageSeniorSecuredNotesDueMember_668" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_649" xlink:to="loc_trnr_TenPercentageSeniorSecuredNotesDueMember_668" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_662" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_us-gaap_StatementClassOfStockAxis_662" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_663" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_662" xlink:to="loc_us-gaap_ClassOfStockDomain_663" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA2PreferredStockMember" xlink:label="loc_trnr_SeriesA2PreferredStockMember_651" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_663" xlink:to="loc_trnr_SeriesA2PreferredStockMember_651" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesA1PreferredStockMember" xlink:label="loc_trnr_SeriesA1PreferredStockMember_1230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_663" xlink:to="loc_trnr_SeriesA1PreferredStockMember_1230" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeed9PreferredStockMember" xlink:label="loc_trnr_SeriesSeed9PreferredStockMember_1229" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_663" xlink:to="loc_trnr_SeriesSeed9PreferredStockMember_1229" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_1232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_663" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_1232" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_667" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_srt_RangeAxis_667" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_654" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_667" xlink:to="loc_srt_RangeMember_654" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_653" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_654" xlink:to="loc_srt_MaximumMember_653" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1206" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_654" xlink:to="loc_srt_MinimumMember_1206" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_1225" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_srt_TitleOfIndividualAxis_1225" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_1225" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1226" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoIndividualMember" xlink:label="loc_trnr_TwoIndividualMember_1227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1226" xlink:to="loc_trnr_TwoIndividualMember_1227" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_670" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_652" xlink:to="loc_us-gaap_DebtInstrumentLineItems_670" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_657" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_657" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_661" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_661" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_665" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_665" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_669" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_669" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_671" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentTerm_671" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_672" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_672" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_673" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_673" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_674" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_674" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_675" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_675" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LossDueToChangesInFairValueOfConvertibleNotes" xlink:label="loc_trnr_LossDueToChangesInFairValueOfConvertibleNotes_676" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_trnr_LossDueToChangesInFairValueOfConvertibleNotes_676" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_677" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_677" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_678" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_679" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_680" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InterestExpenseAndDefaultInterest" xlink:label="loc_trnr_InterestExpenseAndDefaultInterest_681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_trnr_InterestExpenseAndDefaultInterest_681" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1215" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1215" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1216" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1216" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfInterestRateOfDebtForgiveness" xlink:label="loc_trnr_PercentageOfInterestRateOfDebtForgiveness_1219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_trnr_PercentageOfInterestRateOfDebtForgiveness_1219" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_1228" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_1228" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1234" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes" xlink:label="loc_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes_1240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_670" xlink:to="loc_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes_1240" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/WarrantsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_683" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_688" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_683" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_688" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_693" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_693" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_689" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_693" xlink:to="loc_us-gaap_EquityComponentDomain_689" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_687" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_689" xlink:to="loc_us-gaap_WarrantMember_687" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_StatementClassOfStockAxis_696" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_696" xlink:to="loc_us-gaap_ClassOfStockDomain_699" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockWarrantsMember" xlink:label="loc_trnr_ClassACommonStockWarrantsMember_685" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_699" xlink:to="loc_trnr_ClassACommonStockWarrantsMember_685" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonStockWarrantsMember" xlink:label="loc_trnr_ClassBCommonStockWarrantsMember_694" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_699" xlink:to="loc_trnr_ClassBCommonStockWarrantsMember_694" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember_697" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_699" xlink:to="loc_trnr_ServiceProvidersStockWarrantsMember_697" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeniorSecuredNotesStockWarrantsMember" xlink:label="loc_trnr_SeniorSecuredNotesStockWarrantsMember_701" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_699" xlink:to="loc_trnr_SeniorSecuredNotesStockWarrantsMember_701" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_700" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_700" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_684" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_700" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_684" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_691" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_684" xlink:to="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_691" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_703" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_690" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_703" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_690" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_692" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_690" xlink:to="loc_us-gaap_IPOMember_692" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_688" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_686" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_686" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_695" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_695" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_698" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_702" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_704" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_706" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_trnr_StockIssuedDuringPeriodSharesWarrantsExercised_706" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrants" xlink:label="loc_trnr_FairValueOfWarrants_707" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_trnr_FairValueOfWarrants_707" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_708" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_708" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_709" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_709" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_710" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_1245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_705" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_1245" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_712" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_715" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_712" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_715" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_716" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_715" xlink:to="loc_us-gaap_StatementClassOfStockAxis_716" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_722" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_716" xlink:to="loc_us-gaap_ClassOfStockDomain_722" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockWarrantsMember" xlink:label="loc_trnr_ClassACommonStockWarrantsMember_713" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_722" xlink:to="loc_trnr_ClassACommonStockWarrantsMember_713" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonStockWarrantsMember" xlink:label="loc_trnr_ClassBCommonStockWarrantsMember_717" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_722" xlink:to="loc_trnr_ClassBCommonStockWarrantsMember_717" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember_720" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_722" xlink:to="loc_trnr_ServiceProvidersStockWarrantsMember_720" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeniorSecuredNotesStockWarrantsMember" xlink:label="loc_trnr_SeniorSecuredNotesStockWarrantsMember_723" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_722" xlink:to="loc_trnr_SeniorSecuredNotesStockWarrantsMember_723" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_715" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantOutstanding" xlink:label="loc_trnr_WarrantOutstanding_714" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" xlink:to="loc_trnr_WarrantOutstanding_714" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassOfWarrantsIssued" xlink:label="loc_trnr_ClassOfWarrantsIssued_718" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" xlink:to="loc_trnr_ClassOfWarrantsIssued_718" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassOfWarrantsExercised" xlink:label="loc_trnr_ClassOfWarrantsExercised_721" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" xlink:to="loc_trnr_ClassOfWarrantsExercised_721" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantOutstanding" xlink:label="loc_trnr_WarrantOutstanding_724" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_719" xlink:to="loc_trnr_WarrantOutstanding_724" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_726" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_726" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_733" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_733" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_729" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_733" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_729" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_737" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_729" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_737" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_739" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_739" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_731" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_739" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_731" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember_735" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_731" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityMember_735" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_742" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_742" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_727" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_742" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_727" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_740" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_727" xlink:to="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_740" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_744" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_744" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_732" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_744" xlink:to="loc_us-gaap_EquityComponentDomain_732" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_728" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_732" xlink:to="loc_us-gaap_WarrantMember_728" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1208" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1208" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1209" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1208" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1209" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_1210" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1209" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_1210" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_736" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_730" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_730" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_738" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_738" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_741" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_741" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_743" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_743" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_745" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_745" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_747" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_747" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EquityValuePercentage" xlink:label="loc_trnr_EquityValuePercentage_1585" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_trnr_EquityValuePercentage_1585" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity" xlink:label="loc_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity_1203" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity_1203" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1204" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_1204" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1205" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaap_ConvertibleDebt_1212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_us-gaap_ConvertibleDebt_1212" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentMeasurementDiscountRate" xlink:label="loc_trnr_DebtInstrumentMeasurementDiscountRate_1587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_trnr_DebtInstrumentMeasurementDiscountRate_1587" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsMeasurementDiscountRate" xlink:label="loc_trnr_WarrantsMeasurementDiscountRate_1586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_746" xlink:to="loc_trnr_WarrantsMeasurementDiscountRate_1586" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_749" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_749" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_756" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_756" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_752" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_756" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_752" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_760" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_752" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_760" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_762" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_762" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_755" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_762" xlink:to="loc_us-gaap_EquityComponentDomain_755" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_751" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_755" xlink:to="loc_us-gaap_WarrantMember_751" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_764" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_764" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_750" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_764" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_750" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_757" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_750" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_757" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_765" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_765" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_765" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_754" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_754" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_761" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_761" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_763" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_759" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_763" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_766" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_758" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_766" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_753" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_766" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_753" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_768" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_768" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_772" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_772" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_771" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_772" xlink:to="loc_us-gaap_EquityComponentDomain_771" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_770" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_771" xlink:to="loc_us-gaap_WarrantMember_770" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_776" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_776" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_769" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_776" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_769" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_773" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_769" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_773" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementAxis" xlink:label="loc_trnr_AgreementAxis_1196" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" xlink:to="loc_trnr_AgreementAxis_1196" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AgreementDomain" xlink:label="loc_trnr_AgreementDomain_1197" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_AgreementAxis_1196" xlink:to="loc_trnr_AgreementDomain_1197" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember_1198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_AgreementDomain_1197" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityMember_1198" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_774" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_774" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_777" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_777" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments_779" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments_779" use="optional" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock_1214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock_1214" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock_1221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock_1221" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock_780" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock_780" use="optional" order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants_781" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants_781" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock_1217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock_1217" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock" xlink:label="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock_782" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock_782" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_783" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_778" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_783" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/LeasesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1170" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1175" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1170" xlink:to="loc_us-gaap_StatementTable_1175" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1397" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1175" xlink:to="loc_srt_RangeAxis_1397" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1399" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1397" xlink:to="loc_srt_RangeMember_1399" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1400" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1399" xlink:to="loc_srt_MaximumMember_1400" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1401" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1399" xlink:to="loc_srt_MinimumMember_1401" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1175" xlink:to="loc_us-gaap_StatementLineItems_1176" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1177" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseLiability_1178" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1179" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_1180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_1180" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1181" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1182" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_1183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_ShortTermLeaseCost_1183" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_1184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_OperatingLeaseCost_1184" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1176" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1185" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_786" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_786" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_787" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_787" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_788" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_788" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_789" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_789" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_790" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_790" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1144" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1145" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:label="loc_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_791" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_791" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_792" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_785" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_792" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAbstract" xlink:label="loc_us-gaap_OtherCommitmentsAbstract_1147" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_1150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAbstract_1147" xlink:to="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_1150" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear_1151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAbstract_1147" xlink:to="loc_us-gaap_OtherCommitmentDueInSecondYear_1151" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear_1152" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAbstract_1147" xlink:to="loc_us-gaap_OtherCommitmentDueInThirdYear_1152" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear_1153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAbstract_1147" xlink:to="loc_us-gaap_OtherCommitmentDueInFourthYear_1153" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFifthYear_1154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAbstract_1147" xlink:to="loc_us-gaap_OtherCommitmentDueInFifthYear_1154" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueAfterFifthYear_1155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAbstract_1147" xlink:to="loc_us-gaap_OtherCommitmentDueAfterFifthYear_1155" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment_1156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAbstract_1147" xlink:to="loc_us-gaap_OtherCommitment_1156" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_794" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_795" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_794" xlink:to="loc_us-gaap_LossContingenciesTable_795" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_796" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_795" xlink:to="loc_srt_RangeAxis_796" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_799" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_796" xlink:to="loc_srt_RangeMember_799" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_797" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_799" xlink:to="loc_srt_MaximumMember_797" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_801" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_799" xlink:to="loc_srt_MinimumMember_801" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_800" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_795" xlink:to="loc_us-gaap_LossContingenciesLineItems_800" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfCumulativeNetSales" xlink:label="loc_trnr_PercentageOfCumulativeNetSales_798" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_trnr_PercentageOfCumulativeNetSales_798" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CumulativeNetSales" xlink:label="loc_trnr_CumulativeNetSales_802" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_trnr_CumulativeNetSales_802" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_803" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_us-gaap_RoyaltyExpense_803" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="loc_us-gaap_RoyaltyGuaranteesCommitmentsAmount_804" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_800" xlink:to="loc_us-gaap_RoyaltyGuaranteesCommitmentsAmount_804" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_806" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_813" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_806" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_813" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_816" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_816" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_814" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_816" xlink:to="loc_us-gaap_EquityComponentDomain_814" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_810" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_814" xlink:to="loc_us-gaap_CommonStockMember_810" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1509" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_814" xlink:to="loc_us-gaap_WarrantMember_1509" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_821" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_807" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_821" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_807" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember" xlink:label="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_815" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_807" xlink:to="loc_trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember_815" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_1516" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_807" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_1516" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_824" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_StatementClassOfStockAxis_824" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_824" xlink:to="loc_us-gaap_ClassOfStockDomain_823" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_808" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_823" xlink:to="loc_us-gaap_CommonClassAMember_808" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAFinancingMember" xlink:label="loc_trnr_SeriesAFinancingMember_1514" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesAFinancingMember_1514" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedMember" xlink:label="loc_trnr_SeriesSeedMember_1525" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedMember_1525" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedOneMember" xlink:label="loc_trnr_SeriesSeedOneMember_1526" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedOneMember_1526" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoMember" xlink:label="loc_trnr_SeriesSeedTwoMember_1527" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedTwoMember_1527" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedThreeMember" xlink:label="loc_trnr_SeriesSeedThreeMember_1528" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedThreeMember_1528" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFourMember" xlink:label="loc_trnr_SeriesSeedFourMember_1529" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedFourMember_1529" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFiveMember" xlink:label="loc_trnr_SeriesSeedFiveMember_1530" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedFiveMember_1530" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSixMember" xlink:label="loc_trnr_SeriesSeedSixMember_1531" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedSixMember_1531" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSevenMember" xlink:label="loc_trnr_SeriesSeedSevenMember_1532" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedSevenMember_1532" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedEightMember" xlink:label="loc_trnr_SeriesSeedEightMember_1533" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedEightMember_1533" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineMember" xlink:label="loc_trnr_SeriesSeedNineMember_1534" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedNineMember_1534" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_Seed10Member" xlink:label="loc_trnr_Seed10Member_1539" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_Seed10Member_1539" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAMember" xlink:label="loc_us-gaap_SeriesAMember_1538" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_us-gaap_SeriesAMember_1538" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAOneMember" xlink:label="loc_trnr_SeriesAOneMember_1536" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesAOneMember_1536" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoTenMember" xlink:label="loc_trnr_SeriesSeedTwoTenMember_1546" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonClassAMember_808" xlink:to="loc_trnr_SeriesSeedTwoTenMember_1546" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_826" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_818" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_826" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_818" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RightsOfferingMember" xlink:label="loc_trnr_RightsOfferingMember_817" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_818" xlink:to="loc_trnr_RightsOfferingMember_817" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_828" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_828" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_812" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_828" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_812" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_811" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_811" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_820" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1510" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1510" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1511" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1511" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1512" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_812" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1512" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1541" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1541" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedAndSeriesAAgreementMember" xlink:label="loc_trnr_SeriesSeedAndSeriesAAgreementMember_1543" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542" xlink:to="loc_trnr_SeriesSeedAndSeriesAAgreementMember_1543" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SimpleAgreementsForFutureEquityMember" xlink:label="loc_trnr_SimpleAgreementsForFutureEquityMember_1544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1542" xlink:to="loc_trnr_SimpleAgreementsForFutureEquityMember_1544" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_DebtInstrumentAxis_1547" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1547" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1548" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandAndTwentySecuredConvertibleNotesMember" xlink:label="loc_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember_1549" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1548" xlink:to="loc_trnr_TwoThousandAndTwentySecuredConvertibleNotesMember_1549" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAConvertibleNotesMember" xlink:label="loc_trnr_SeriesAConvertibleNotesMember_1550" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1548" xlink:to="loc_trnr_SeriesAConvertibleNotesMember_1550" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1551" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_srt_RangeAxis_1551" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1552" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1551" xlink:to="loc_srt_RangeMember_1552" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1553" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1552" xlink:to="loc_srt_MaximumMember_1553" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1554" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1552" xlink:to="loc_srt_MinimumMember_1554" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_813" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_809" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_809" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_819" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_819" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_CommonStockSharesIssued_822" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_825" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_825" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_827" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_829" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_832" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_832" use="optional" order="57" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_834" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_834" use="optional" order="58" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_835" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_835" use="optional" order="59" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_836" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_836" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfDiscountRateOnConvertibleNotes" xlink:label="loc_trnr_PercentageOfDiscountRateOnConvertibleNotes_837" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_trnr_PercentageOfDiscountRateOnConvertibleNotes_837" use="optional" order="61" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_1506" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_1506" use="optional" order="62" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_1508" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_DerivativeLiabilities_1508" use="optional" order="63" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_1515" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_1515" use="optional" order="64" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="loc_us-gaap_PreferredStockConversionBasis_1517" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockConversionBasis_1517" use="optional" order="65" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1520" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1520" use="optional" order="66" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_1519" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_1519" use="optional" order="67" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1521" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1521" use="optional" order="68" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1522" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1522" use="optional" order="69" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1523" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1523" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1540" use="optional" order="71" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_1555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_1555" use="optional" order="72" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaap_PaymentsOfDividends_1556" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PaymentsOfDividends_1556" use="optional" order="73" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaap_PreferredStockVotingRights_1557" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_PreferredStockVotingRights_1557" use="optional" order="74" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1558" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_830" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1558" use="optional" order="75" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1468" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1469" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1468" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1469" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1470" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1469" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1470" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1472" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1470" xlink:to="loc_us-gaap_ClassOfStockDomain_1472" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAStockMember" xlink:label="loc_trnr_SeriesAStockMember_1474" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesAStockMember_1474" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAOneMember" xlink:label="loc_trnr_SeriesAOneMember_1476" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesAOneMember_1476" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesATwoMember" xlink:label="loc_trnr_SeriesATwoMember_1478" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesATwoMember_1478" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedMember" xlink:label="loc_trnr_SeriesSeedMember_1479" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedMember_1479" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedOneMember" xlink:label="loc_trnr_SeriesSeedOneMember_1486" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedOneMember_1486" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoMember" xlink:label="loc_trnr_SeriesSeedTwoMember_1481" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedTwoMember_1481" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedThreeMember" xlink:label="loc_trnr_SeriesSeedThreeMember_1482" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedThreeMember_1482" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFourMember" xlink:label="loc_trnr_SeriesSeedFourMember_1483" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedFourMember_1483" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFiveMember" xlink:label="loc_trnr_SeriesSeedFiveMember_1484" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedFiveMember_1484" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSixMember" xlink:label="loc_trnr_SeriesSeedSixMember_1487" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedSixMember_1487" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSevenMember" xlink:label="loc_trnr_SeriesSeedSevenMember_1488" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedSevenMember_1488" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedEightMember" xlink:label="loc_trnr_SeriesSeedEightMember_1489" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedEightMember_1489" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineMember" xlink:label="loc_trnr_SeriesSeedNineMember_1490" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedNineMember_1490" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineOneMember" xlink:label="loc_trnr_SeriesSeedNineOneMember_1491" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedNineOneMember_1491" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTenMember" xlink:label="loc_trnr_SeriesSeedTenMember_1492" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1472" xlink:to="loc_trnr_SeriesSeedTenMember_1492" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1493" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1469" xlink:to="loc_us-gaap_TemporaryEquityLineItems_1493" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_1494" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_1494" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1495" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1495" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_1496" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquityRedemptionPricePerShare_1496" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="loc_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_1497" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_1497" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_1498" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1493" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_1498" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_840" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_840" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_846" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" xlink:to="loc_us-gaap_PlanNameAxis_846" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_842" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_846" xlink:to="loc_us-gaap_PlanNameDomain_842" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_841" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_842" xlink:to="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_841" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_848" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_842" xlink:to="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_848" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_850" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" xlink:to="loc_us-gaap_AwardTypeAxis_850" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_850" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_857" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" xlink:to="loc_us-gaap_EmployeeStockOptionMember_857" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_859" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" xlink:to="loc_us-gaap_RestrictedStockMember_859" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_861" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_851" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_861" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_853" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" xlink:to="loc_srt_RangeAxis_853" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_845" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_853" xlink:to="loc_srt_RangeMember_845" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_844" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_845" xlink:to="loc_srt_MaximumMember_844" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_847" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_843" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_843" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_849" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_849" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_852" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_852" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_854" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_854" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber_856" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber_856" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_858" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_858" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_860" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_860" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_862" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AdditionalExpense" xlink:label="loc_trnr_AdditionalExpense_863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_AdditionalExpense_863" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_864" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_864" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue" xlink:label="loc_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue_865" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue_865" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_866" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_866" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1466" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1466" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1471" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1471" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1473" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1473" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsIssuedDuringThePeriodShares" xlink:label="loc_trnr_WarrantsIssuedDuringThePeriodShares_1499" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_WarrantsIssuedDuringThePeriodShares_1499" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1500" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1500" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantGrantDateFairValue" xlink:label="loc_trnr_WarrantGrantDateFairValue_1501" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_WarrantGrantDateFairValue_1501" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FairValueOfWarrants" xlink:label="loc_trnr_FairValueOfWarrants_1502" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_855" xlink:to="loc_trnr_FairValueOfWarrants_1502" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_868" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_868" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_872" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" xlink:to="loc_us-gaap_PlanNameAxis_872" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_870" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_872" xlink:to="loc_us-gaap_PlanNameDomain_870" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_869" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_870" xlink:to="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_869" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_1445" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_870" xlink:to="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_1445" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_876" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_876" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_874" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_876" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_874" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_875" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_874" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_875" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_877" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_874" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_877" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_879" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_874" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_879" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_878" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_873" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_878" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_871" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_878" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_871" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_881" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_889" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_881" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_889" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_888" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_889" xlink:to="loc_us-gaap_PlanNameAxis_888" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_883" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_888" xlink:to="loc_us-gaap_PlanNameDomain_883" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_882" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_883" xlink:to="loc_trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember_882" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_1447" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_883" xlink:to="loc_trnr_TwoThousandTwentyEquityIncentivePlanMember_1447" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_886" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_886" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_893" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_893" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_899" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_904" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_904" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_907" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_907" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_909" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_911" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_885" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_911" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_884" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_884" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_891" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_891" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_897" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_902" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_902" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_906" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_906" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_908" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_908" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_892" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_910" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract" xlink:label="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_887" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_887" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_894" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_894" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm" xlink:label="loc_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm_900" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract_898" xlink:to="loc_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm_900" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract" xlink:label="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_895" xlink:to="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_890" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_890" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_896" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_896" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_901" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_901" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_905" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract_903" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_905" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_913" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_918" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_913" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_918" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_917" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_918" xlink:to="loc_us-gaap_PlanNameAxis_917" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_915" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_917" xlink:to="loc_us-gaap_PlanNameDomain_915" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_TwoThousandTwentyPlanEarlyExerciseMember" xlink:label="loc_trnr_TwoThousandTwentyPlanEarlyExerciseMember_914" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_915" xlink:to="loc_trnr_TwoThousandTwentyPlanEarlyExerciseMember_914" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_918" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_916" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_916" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_919" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_919" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_921" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_921" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased_922" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased_922" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_923" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_923" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_924" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_924" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_925" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_925" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_926" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_926" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue_927" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue_927" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability_929" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability_929" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability_930" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability_930" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability_931" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability_931" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability_932" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability_932" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability" xlink:label="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability_933" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_920" xlink:to="loc_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability_933" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_936" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_936" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_937" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_937" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_938" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_938" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_939" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_939" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_941" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_943" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_941" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_943" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_953" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_953" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_953" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_947" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948" xlink:to="loc_us-gaap_SalesRevenueNetMember_947" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsTotalMember" xlink:label="loc_us-gaap_CostOfGoodsTotalMember_956" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_948" xlink:to="loc_us-gaap_CostOfGoodsTotalMember_956" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_957" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_us-gaap_InvestmentTypeAxis_957" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_951" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_957" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_951" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_960" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_960" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_942" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_960" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_942" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_954" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_942" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_954" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_958" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_942" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_958" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_961" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_srt_MajorCustomersAxis_961" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_950" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_961" xlink:to="loc_srt_NameOfMajorCustomerDomain_950" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorThreeMember" xlink:label="loc_trnr_VendorThreeMember_949" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_950" xlink:to="loc_trnr_VendorThreeMember_949" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_VendorOneMember" xlink:label="loc_trnr_VendorOneMember_1277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_950" xlink:to="loc_trnr_VendorOneMember_1277" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_962" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_srt_RangeAxis_962" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_946" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_962" xlink:to="loc_srt_RangeMember_946" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_945" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_946" xlink:to="loc_srt_MinimumMember_945" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaap_ProductInformationLineItems_963" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_943" xlink:to="loc_us-gaap_ProductInformationLineItems_963" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_944" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_963" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_944" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NumberOfCustomer" xlink:label="loc_trnr_NumberOfCustomer_955" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_963" xlink:to="loc_trnr_NumberOfCustomer_955" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NumberOfSignificantVendors" xlink:label="loc_trnr_NumberOfSignificantVendors_959" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_963" xlink:to="loc_trnr_NumberOfSignificantVendors_959" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/BenefitPlansAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_965" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_966" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_965" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_966" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1322" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1322" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1323" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1322" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1324" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1325" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1322" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1325" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_1327" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1328" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_1327" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1328" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1329" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1328" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1329" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1328" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1330" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_1331" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1328" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_1331" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1332" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1328" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1332" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1333" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1328" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1333" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1334" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1333" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1334" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1335" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1333" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1335" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1336" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1333" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1336" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1337" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1333" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1337" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1338" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1333" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1338" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1341" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1341" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1342" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1342" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes" xlink:label="loc_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes_1343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes_1343" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1344" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1344" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1345" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1345" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1346" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1346" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_1347" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_1347" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1348" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1348" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncometaxreconciliationDisqualifiedDebt" xlink:label="loc_trnr_IncometaxreconciliationDisqualifiedDebt_1349" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_trnr_IncometaxreconciliationDisqualifiedDebt_1349" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_1350" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_1350" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncometaxreconciliationIntangibles" xlink:label="loc_trnr_IncometaxreconciliationIntangibles_1351" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_trnr_IncometaxreconciliationIntangibles_1351" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_1352" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_1352" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1353" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1353" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1340" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1355" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1355" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1356" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_1356" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent" xlink:label="loc_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent_1357" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent_1357" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1358" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1358" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1359" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1359" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1360" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1360" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1361" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1361" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1362" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1362" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent" xlink:label="loc_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent_1364" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent_1364" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1365" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1365" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent" xlink:label="loc_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent_1366" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent_1366" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_1367" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_1367" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1368" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1354" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1368" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1382" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1382" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1385" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1385" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:label="loc_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment_1387" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment_1387" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1388" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1388" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_1389" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_1389" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_1390" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_1390" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_1393" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_1393" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DeferredTaxAssetsFixedAssetsAndIntangibles" xlink:label="loc_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles_1408" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles_1408" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1410" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1410" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1411" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1411" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1412" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1412" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1414" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1384" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1414" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/IncomeTaxesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1427" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxDisclosureTable" xlink:label="loc_trnr_IncomeTaxDisclosureTable_1428" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1427" xlink:to="loc_trnr_IncomeTaxDisclosureTable_1428" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1429" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureTable_1428" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1429" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1430" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1429" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1430" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_1431" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1430" xlink:to="loc_us-gaap_DomesticCountryMember_1431" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_1432" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1430" xlink:to="loc_us-gaap_ForeignCountryMember_1432" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1433" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1430" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_1433" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_IncomeTaxDisclosureLineItems" xlink:label="loc_trnr_IncomeTaxDisclosureLineItems_1434" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureTable_1428" xlink:to="loc_trnr_IncomeTaxDisclosureLineItems_1434" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MinimumTaxOnBookIncomeInflationReductionActPercent" xlink:label="loc_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent_1435" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent_1435" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax" xlink:label="loc_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax_1436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax_1436" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_1437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_OperatingLossCarryforwards_1437" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_1438" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_1438" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1439" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_1439" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardExpirationDate" xlink:label="loc_us-gaap_TaxCreditCarryforwardExpirationDate_1440" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_TaxCreditCarryforwardExpirationDate_1440" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AmortisationOfResearchAndDevelopmentalCost" xlink:label="loc_trnr_AmortisationOfResearchAndDevelopmentalCost_1441" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_AmortisationOfResearchAndDevelopmentalCost_1441" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_CapitalizedResearchAndDevelopmentExpenses" xlink:label="loc_trnr_CapitalizedResearchAndDevelopmentExpenses_1442" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_CapitalizedResearchAndDevelopmentExpenses_1442" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OperatingLossCarryForwardsPercentage" xlink:label="loc_trnr_OperatingLossCarryForwardsPercentage_1443" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_trnr_OperatingLossCarryForwardsPercentage_1443" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_1444" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_IncomeTaxDisclosureLineItems_1434" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_1444" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_968" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NumeratorAbstract" xlink:label="loc_trnr_NumeratorAbstract_969" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_968" xlink:to="loc_trnr_NumeratorAbstract_969" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NetLoss" xlink:label="loc_trnr_NetLoss_971" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_NumeratorAbstract_969" xlink:to="loc_trnr_NetLoss_971" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_974" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_NumeratorAbstract_969" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_974" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DenominatorAbstract" xlink:label="loc_trnr_DenominatorAbstract_972" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_968" xlink:to="loc_trnr_DenominatorAbstract_972" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_970" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_DenominatorAbstract_972" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_970" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_973" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_DenominatorAbstract_972" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_973" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_975" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_DenominatorAbstract_972" xlink:to="loc_us-gaap_EarningsPerShareBasic_975" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_976" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trnr_DenominatorAbstract_972" xlink:to="loc_us-gaap_EarningsPerShareDiluted_976" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_978" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_980" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_978" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_980" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_979" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_980" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_979" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_979" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesAConvertiblePreferredStockMember_981" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesAConvertiblePreferredStockMember_981" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesAOneConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesAOneConvertiblePreferredStockMember_985" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesAOneConvertiblePreferredStockMember_985" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesATwoConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesATwoConvertiblePreferredStockMember_986" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesATwoConvertiblePreferredStockMember_986" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedConvertiblePreferredStockMember_987" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedConvertiblePreferredStockMember_987" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedOneConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedOneConvertiblePreferredStockMember_988" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedOneConvertiblePreferredStockMember_988" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTwoConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedTwoConvertiblePreferredStockMember_989" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedTwoConvertiblePreferredStockMember_989" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedThreeConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedThreeConvertiblePreferredStockMember_990" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedThreeConvertiblePreferredStockMember_990" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFourConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedFourConvertiblePreferredStockMember_991" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedFourConvertiblePreferredStockMember_991" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedFiveConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedFiveConvertiblePreferredStockMember_992" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedFiveConvertiblePreferredStockMember_992" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSixConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedSixConvertiblePreferredStockMember_993" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedSixConvertiblePreferredStockMember_993" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedSevenConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedSevenConvertiblePreferredStockMember_994" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedSevenConvertiblePreferredStockMember_994" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedEightConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedEightConvertiblePreferredStockMember_995" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedEightConvertiblePreferredStockMember_995" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedNineConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedNineConvertiblePreferredStockMember_996" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedNineConvertiblePreferredStockMember_996" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_SeriesSeedTenConvertiblePreferredStockMember" xlink:label="loc_trnr_SeriesSeedTenConvertiblePreferredStockMember_997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_SeriesSeedTenConvertiblePreferredStockMember_997" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsToPurchaseSeriesClassACommonStockMember" xlink:label="loc_trnr_WarrantsToPurchaseSeriesClassACommonStockMember_998" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_WarrantsToPurchaseSeriesClassACommonStockMember_998" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WarrantsToPurchaseSeriesClassBCommonStockMember" xlink:label="loc_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember_999" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_WarrantsToPurchaseSeriesClassBCommonStockMember_999" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_StockOptionsToPurchaseCommonStockMember" xlink:label="loc_trnr_StockOptionsToPurchaseCommonStockMember_1000" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_982" xlink:to="loc_trnr_StockOptionsToPurchaseCommonStockMember_1000" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_984" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_980" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_984" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_983" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_984" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_983" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1002" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1002" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1016" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_DebtInstrumentAxis_1016" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1036" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1016" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1036" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PromissoryNotesMember" xlink:label="loc_trnr_PromissoryNotesMember_1014" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1036" xlink:to="loc_trnr_PromissoryNotesMember_1014" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrincipalStockholderPromissoryNotesMember" xlink:label="loc_trnr_PrincipalStockholderPromissoryNotesMember_1025" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1036" xlink:to="loc_trnr_PrincipalStockholderPromissoryNotesMember_1025" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherRelatedPartyPromissoryNotesMember" xlink:label="loc_trnr_OtherRelatedPartyPromissoryNotesMember_1034" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1036" xlink:to="loc_trnr_OtherRelatedPartyPromissoryNotesMember_1034" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherRelatedPartyTransactionsMember" xlink:label="loc_trnr_OtherRelatedPartyTransactionsMember_1038" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1036" xlink:to="loc_trnr_OtherRelatedPartyTransactionsMember_1038" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1027" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1027" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1027" xlink:to="loc_us-gaap_ClassOfStockDomain_1032" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1006" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1032" xlink:to="loc_us-gaap_CommonClassAMember_1006" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1021" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1032" xlink:to="loc_us-gaap_CommonClassBMember_1021" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_1030" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1032" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_1030" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1035" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1035" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1019" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1035" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1019" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassBCommonWarrantsMember" xlink:label="loc_trnr_ClassBCommonWarrantsMember_1017" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1019" xlink:to="loc_trnr_ClassBCommonWarrantsMember_1017" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonWarrantsMember" xlink:label="loc_trnr_ClassACommonWarrantsMember_1028" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1019" xlink:to="loc_trnr_ClassACommonWarrantsMember_1028" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1039" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1039" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1018" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1039" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1018" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_NoninterestBearingNoteMember" xlink:label="loc_trnr_NoninterestBearingNoteMember_1033" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1018" xlink:to="loc_trnr_NoninterestBearingNoteMember_1033" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1041" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1041" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1011" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1041" xlink:to="loc_us-gaap_RelatedPartyDomain_1011" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FuseprojectMember" xlink:label="loc_trnr_FuseprojectMember_1008" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1011" xlink:to="loc_trnr_FuseprojectMember_1008" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ApeironAdvisoryLtdMember" xlink:label="loc_trnr_ApeironAdvisoryLtdMember_1022" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1011" xlink:to="loc_trnr_ApeironAdvisoryLtdMember_1022" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaap_DeferredRevenueArrangementTypeAxis_1043" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_DeferredRevenueArrangementTypeAxis_1043" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeAxis_1043" xlink:to="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember" xlink:label="loc_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember_1015" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003" xlink:to="loc_trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember_1015" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember" xlink:label="loc_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember_1026" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementTypeDomain_1003" xlink:to="loc_trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember_1026" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1045" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_srt_RangeAxis_1045" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1013" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1045" xlink:to="loc_srt_RangeMember_1013" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1012" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1013" xlink:to="loc_srt_MaximumMember_1012" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1024" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1013" xlink:to="loc_srt_MinimumMember_1024" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1047" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_srt_StatementScenarioAxis_1047" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1010" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1047" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1010" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1049" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1004" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_1049" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1005" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1005" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1020" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1020" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1029" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1029" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1037" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1037" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_1040" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_1040" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_1042" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_1042" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentFeePercentage" xlink:label="loc_trnr_DebtInstrumentFeePercentage_1044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_DebtInstrumentFeePercentage_1044" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DebtInstrumentInterestRateStatedPercentageAdditional" xlink:label="loc_trnr_DebtInstrumentInterestRateStatedPercentageAdditional_1046" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_DebtInstrumentInterestRateStatedPercentageAdditional_1046" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansPayable" xlink:label="loc_us-gaap_NotesAndLoansPayable_1048" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_NotesAndLoansPayable_1048" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AccruedInterestAndDefaultInterest" xlink:label="loc_trnr_AccruedInterestAndDefaultInterest_1050" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_AccruedInterestAndDefaultInterest_1050" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_DefaultInterest" xlink:label="loc_trnr_DefaultInterest_1051" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_DefaultInterest_1051" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_InterestExpenseAndDefaultInterest" xlink:label="loc_trnr_InterestExpenseAndDefaultInterest_1052" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_InterestExpenseAndDefaultInterest_1052" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaap_OtherLiabilities_1053" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_OtherLiabilities_1053" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RoyaltyPaymentPercentage" xlink:label="loc_trnr_RoyaltyPaymentPercentage_1054" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_RoyaltyPaymentPercentage_1054" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyIncomeNonoperating" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_1055" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_1055" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_1056" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_RoyaltyExpense_1056" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_GuaranteedRoyaltyPayment" xlink:label="loc_trnr_GuaranteedRoyaltyPayment_1057" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_GuaranteedRoyaltyPayment_1057" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ContingentRoyaltyObligation" xlink:label="loc_trnr_ContingentRoyaltyObligation_1058" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_trnr_ContingentRoyaltyObligation_1058" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1059" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1059" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1060" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1049" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1060" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1062" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1062" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1068" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" xlink:to="loc_us-gaap_DebtInstrumentAxis_1068" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1073" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1068" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1073" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_FounderNotesMember" xlink:label="loc_trnr_FounderNotesMember_1067" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1073" xlink:to="loc_trnr_FounderNotesMember_1067" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PrincipalStockholderPromissoryNotesMember" xlink:label="loc_trnr_PrincipalStockholderPromissoryNotesMember_1069" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1073" xlink:to="loc_trnr_PrincipalStockholderPromissoryNotesMember_1069" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_OtherRelatedPartyPromissoryNotesMember" xlink:label="loc_trnr_OtherRelatedPartyPromissoryNotesMember_1071" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1073" xlink:to="loc_trnr_OtherRelatedPartyPromissoryNotesMember_1071" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1070" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1070" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1066" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1070" xlink:to="loc_us-gaap_RelatedPartyDomain_1066" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_1065" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1066" xlink:to="loc_us-gaap_RelatedPartyMember_1065" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1072" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1063" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_1072" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_1064" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1072" xlink:to="loc_us-gaap_NotesPayable_1064" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://formelife.com/role/SubsequentEventsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1075" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1080" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1075" xlink:to="loc_us-gaap_SubsequentEventTable_1080" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1088" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1088" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1084" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1088" xlink:to="loc_us-gaap_EquityComponentDomain_1084" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1079" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1084" xlink:to="loc_us-gaap_CommonStockMember_1079" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1092" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1092" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1076" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1092" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1076" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1087" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1076" xlink:to="loc_us-gaap_SubsequentEventMember_1087" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1094" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1094" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1082" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1094" xlink:to="loc_us-gaap_RelatedPartyDomain_1082" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_1078" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1082" xlink:to="loc_us-gaap_RelatedPartyMember_1078" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaap_AssetAcquisitionAxis_1096" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_AssetAcquisitionAxis_1096" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaap_AssetAcquisitionDomain_1083" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1096" xlink:to="loc_us-gaap_AssetAcquisitionDomain_1083" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AssetPurchaseAgreementMember" xlink:label="loc_trnr_AssetPurchaseAgreementMember_1090" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_1083" xlink:to="loc_trnr_AssetPurchaseAgreementMember_1090" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1098" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_srt_StatementScenarioAxis_1098" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1081" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1098" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1081" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_1077" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1081" xlink:to="loc_srt_ScenarioForecastMember_1077" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_1100" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_srt_OwnershipAxis_1100" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1089" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_1100" xlink:to="loc_srt_OwnershipDomain_1089" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1112" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1112" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1113" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RightsOfferingMember" xlink:label="loc_trnr_RightsOfferingMember_1114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1113" xlink:to="loc_trnr_RightsOfferingMember_1114" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1115" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1115" xlink:to="loc_us-gaap_ClassOfStockDomain_1116" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1117" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1116" xlink:to="loc_us-gaap_CommonClassAMember_1117" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ServiceProvidersStockWarrantsMember" xlink:label="loc_trnr_ServiceProvidersStockWarrantsMember_1122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1116" xlink:to="loc_trnr_ServiceProvidersStockWarrantsMember_1122" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1124" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1124" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_1125" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1124" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_1125" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_ClassACommonStockToClassBCommonStockMember" xlink:label="loc_trnr_ClassACommonStockToClassBCommonStockMember_1126" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_1125" xlink:to="loc_trnr_ClassACommonStockToClassBCommonStockMember_1126" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1128" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1128" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1129" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractTerminationMember" xlink:label="loc_us-gaap_ContractTerminationMember_1130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1129" xlink:to="loc_us-gaap_ContractTerminationMember_1130" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1132" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1132" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1133" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_1134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1133" xlink:to="loc_us-gaap_SeniorNotesMember_1134" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1102" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1080" xlink:to="loc_us-gaap_SubsequentEventLineItems_1102" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xlink:label="loc_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected_1086" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected_1086" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebt" xlink:label="loc_us-gaap_SubordinatedDebt_1091" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_SubordinatedDebt_1091" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_RetirementOfSeniorDebt" xlink:label="loc_trnr_RetirementOfSeniorDebt_1093" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_RetirementOfSeniorDebt_1093" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_AssetPurchaseAgreementTerms" xlink:label="loc_trnr_AssetPurchaseAgreementTerms_1095" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_AssetPurchaseAgreementTerms_1095" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_WeightedAverageThresholdConsecutiveTradingDays1" xlink:label="loc_trnr_WeightedAverageThresholdConsecutiveTradingDays1_1097" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_WeightedAverageThresholdConsecutiveTradingDays1_1097" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1099" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1099" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_MaximumNumberOfEarnOutShares" xlink:label="loc_trnr_MaximumNumberOfEarnOutShares_1101" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_MaximumNumberOfEarnOutShares_1101" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1103" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1103" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1104" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1104" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1105" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1105" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1106" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1106" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_DebtInstrumentTerm_1107" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="trnr-20230930.xsd#trnr_PercentageOfOriginalIssuanceDiscount" xlink:label="loc_trnr_PercentageOfOriginalIssuanceDiscount_1108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_trnr_PercentageOfOriginalIssuanceDiscount_1108" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_1110" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_1110" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_1111" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_CommonStockSharesIssued_1111" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaap_ConversionOfStockAmountIssued1_1118" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ConversionOfStockAmountIssued1_1118" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1119" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1119" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1120" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1121" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockConversionBasis" xlink:label="loc_us-gaap_CommonStockConversionBasis_1123" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_CommonStockConversionBasis_1123" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_1127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_PaymentsForRestructuring_1127" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1102" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1131" use="optional" order="57" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g367939dsp216.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939dsp216.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ )0"N P$1  (1 0,1 ?_$ 'X
M  ,!  (# 0            @*"PD#!@0%!P(! 0                     0
M   % P($! 4!! @' 0    $" P0%$08'$@@ (1,),146"D%1(A08%V%Q,K:!
MD:%"(R9W.'(S-"<H>"DY$0$                     _]H # ,!  (1 Q$
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MOT)RR.H YU]#SIJU\?XAK^_@)_\ [1@/_I'E4!#F7;->YOV@(W[911$?B%0
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MEUS!S7,>16Z13B->FB7@.T^SX_V8[FO_ &0;_P AP7 ,V[LO]K.Y+_0C+/\
M(LYP$UCVZNWW(.X[>QD.QL:;E<K;6+@:8/O"X%L@8C2@E[F?LD;KMEJ>WG(3
MK)^T"#<.%4USU+UNLD32(!P#L)NTYN^$AP'O.;XZ&(8M2Q^-"F#440J4?(AH
M8*U#]O :.!@')(;5S[??R+R?^HIL>A:0;F 3A@RF$^ @8UYJ)F:>2C-Z@ "Z
M4.GIK4/#@,E_=!J%+VC\MU'FGD?$YS (E#Z?4"A@&IA /JT#3GX\ "GL[ER_
MA]NH5TF,G^0\.0IB:#@<0L"/.(ET&,(EYT_:/ .#<!XSI,%4NF8I3E.8H'(I
M_P M1,:]0AR_WRF)4*?.G 3:-]V!,B=DGO0V)N^A;<F%-MMUYJ/E:T;CC6BW
ME7IJ^G;E+)^-'+Q.B*4K#-)MZ*")A**K31I$1+3@*)F',S8USSC2T,NXFNV(
MO?']^0S.?MFXX-X@^9OH]ZB55,JBJ"B@(/&U="R1Q Z:A1*(5#@ E[JF^_'.
MP+:)E3+MW7%',;RD;6E[8Q%:RJY$IN[L@3C!PRAVL0S,<KEP6.5.#EPK0$FZ
M2>HYB\J@K/[5WM\9#N/+UZ=R/,MN2,=;H1MPV]A)W.M5T7=WW5=[Q8+UOF,!
MT5-PM&1;)5=HBXT 58[DXEJ 5$'4]S]/QJW#5&G_ &.RQ_;8<\ ?V\!/)]IT
MB<>Y[>):!_MXR86IBC01+/6ZB;0)BZ1,!SA^P2UX!GWOF]D^UNXKC-[ES$\;
M$6YO Q]!'"VY<J:39KER!CB]=2P;H5*4AP=."AICG9Q,*"ANB8>D?Z0QY[#?
M>GO#!UZH=LWN#24S:;ZTI\V/\1WK?PK,I:Q[ACEP:DP]?K]\8'*<4JZ)TXIV
MH<Q$P$B8J&1T&X!Z9BH51LF8@E.4X&4*J04S$6*<PF*L0R0B0Q5BF P"7D(#
M4. 6?W6J$'W,';9 #EK^,6<0$!&@@(VU>PE ?VG X4^? %+W]]@*>^;8!D-M
M;L1YGF/!:3S,&*%4$B*2+EU -%EKFMAH8$A5!*X+?(J0J51 5DD_B' *J>U_
MV<7QN@W(L\OY,<3$KM]V1/Y>Z<?VA*&54MAKGZ_6B#5L:+16UH$>P\=&?>./
MI^E9)(1 !I4&1O<_HKE[1>4TU* <^3,2%  $3@90]T" GJ!:T.)^0?W2A3X<
M &OL^ ,&R_<R82& IMQ[<2&$HE _^1((*%K01-7EP#->[(W_ (L[D: 8PC@K
M*Y*%#4;6:QYLNB@<]0"8*\ @#[1P:]R3*0A7EMBO<1 >1@I?ED\A*/U5$3>
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0T?47VZR1"PGW&O4GJJ'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g367939dsp219a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939dsp219a.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ ,0!L P$1  (1 0,1 ?_$ ),
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M\7-0<PZAWJD-/D@Y-K)I1,^S*0LC$.S-E5#-7K-8VQD50(J3<.10$= =_?\
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M3<>S\QGM;%-BM#RIX"I.&9]Q:R6>0R=4ZJJDRC:3"FEF1(\7AU73M9H*#0I
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MH_A7<*<GCX).EVRYE0.!A-L+8YP**8@ " [#ZZ [.@#0!H T : - &@#0!H
,T : - &@#0!H#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g367939dsp219b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939dsp219b.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ -0!\ P$1  (1 0,1 ?_$ )D
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MP*(< Y/D^U.>XWSVX1OEP72H^.9UU!UR:Z^P\R@M&#9J_/3CN.86N?D'JPL
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M0% +P"Y+1TW?-6[UHJ1=J[13<-ETQ\D606("B2A!$ $2G(8!#_;@&1P X <
;. ' #@!P X < . ' #@!P X < . ' #@'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g367939g12q38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g12q38.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1*Z4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $IZ^1V8X0DE-! 0      !4< @   @  ' )0  E0:6QL<V)U<GD .$))
M300E       0E2X!;]V>.+Q<!VA;\)B>%CA"24T$.@      Y0   !     !
M       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU
M;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +
M<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,
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M      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M     %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6)
M;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M             $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X
M;$!N6+1         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !0
M9U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N
M=$8C4FQT                4V-L(%5N=$8C4')C0%D            08W)O
M<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M   ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M        "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "
M  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M   $    6CA"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #0P    8              FX   .Y    !P!D ',
M<  Q #( -P!B     0                         !              .Y
M   ";@                     !                         !     !
M        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M   ";@    !29VAT;&]N9P   [D    &<VQI8V5S5FQ,<P    %/8FIC
M 0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)
M1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U
M=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   FX     4F=H=&QO
M;F<   .Y     W5R;%1%6%0    !        ;G5L;%1%6%0    !
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M300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
M  0    #.$))300,      A9     0   )\   !H   !X   PP    @] !@
M ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,
M"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,
M# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,
M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !H )\# 2(
M A$!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M,4%1\&%Q@9&AL<'1X?$"$B(R0E*"_]H # ,!  (1 Q$ /P#^_B $ ( 0 @!
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MTOQ$"SIN2)I26$TI/0$$P)/.9\$_W_O_ 'SR@40 @! " $ ( 0 @! " $ (
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M " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $
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M]LVAB<W.@<D8_*TB&Q@2Y ;9]FP7B?[#F;G5U46Y!MJD^9+^K+]0C07Y^3*
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MW_Z^L"?N\\^9(.1AAL&R_/;?+[N,# =\HQEVW%+6F\1K"W;K*'.>Q[;AD?\
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M?6DF< X^!&X.\7:,*MJE;[K9W592J^GZPXK[T-I$;(( 0 @! " $ ( 0 @!
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MF]?OQW)VY],'(<OR//ETQCDY7OM_TJ3AYSKNG+O!"#EB<;YW+ L0-B[C/7D
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M9\.N6S%4364U:[8;C92U23A9L=[)'BPVV<D@[^3#XCJ#$S<3WU65.)FEJO\
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MI3;[MIQ>33JEON=+.DLO5JU$J(<Q'/HVA0*( 0 @! %5^U/^8-*C_;=26_\
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M=16UWQ^Z4@^_,!@68Y;G!_?^8F7JNV]K*W::BK+[/;9^*Z>#:3&R" $ ( 0
M@! " $ ( 0 @! " $ ( 0 @! %4^V?<[S3=GSB1:K'1:A]=O.D=0 7VS2T?J
M.GT[5037:=2_*5.I]*+RVZ[R4D]G]'1W6FGJ9ZPTRU70HJS5,HCP_P"_%E2_
ML>*?%I;5/%*KKM.Z/X=</9*VQTEPX<6S3U;IU2T:B0T_3KIW*PVRFXA:XMU$
M;XA64MPOTU;+;JFMEFMZB*2Q"M74A?S+USYQ/;2%*C; -L[\_P"[#ZAY0*(
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MN&H;;56ZK%MM]+-85)Z:HN%LK%TZZ9*GB_&,*,K3'OTA";CFGY-FL4H@! "
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M !E#^O #VC;_ -.H_P",H?UX JWVHZJD6L&E_155.IW+U4S3]Q=*=A[.78S
M3E@"P[Q^Y<]UQ,0#'IW]L.]*=1?B1KSSZUZ%+N](" %$6;_ITMPV_P!WC. Q
M&.?>VSHVXB7&D[7,1&NJFHRSC+G3TBL]U3]G>3(PJ@^S^F1YMU4ZL^7RV,"#
M6E0VJ>B4MQU?EZSLYSGY)[Z>751&=PLCCQPH[/CD ?B+;V>V,^9T<TGWC(CO
MIY^^H9._ID<EAS[Y<;N<9.[ 1(>WC,9F$JM/>]4K8'>3_P"D1\3Z9(')8.\_
M@VVV_*$SK<X33G+K9M3+IXQ(??GMS4GOR#'I4'SCTR(&Q#?/P!+\.@>$-*5&
M-EC-1":64JM3.C9>KOUYY(,R;Y51?;\H2;&,_=?7TY%S!+$:6I4[/UO1Z,/?
M?\G9V51,7FTF==  7*@,Q-0D!*!5)=XN9^3'O8((9FYV[:B*A5$:OHM5KOHA
MRL\>NQM@DN-O,DI%?1D=T9]91Z?KQHB_.V_0R]HV_P#3J/\ C*']>!1[1M_Z
M=1_QE#^O #VC;_TZC_C*']> *>]J.HIEZK292J:90!"XB8R5")8]]!I7$Y$I
M(R =V+>$?M%R].V!OU>W3?QT7G-33,F<!5$'<@K)8&-R9\#H_CEXRUCI4S$3
M&DRJ<;8E1$7G,;6\][([R?)5#.X"R3^#??"6())RX/3G;BWB=4EJDG"4Q4XS
MX)UOG3<"9,D_?$2#_P"F2.>1?O@8.<XR_.$[M)W3<:];\Q#OHT\/$_G3V)$Z
M;EE4/_O)D.>3S3[='Z,QYQMSHKUREEQXB8>DY;@1WDQ@JHE\?X]'F'_?YW&[
M#=N1@TW41><RE7C+J+O=C ])('99$]&63=\])RYY8?GNXBM*M$JM+%K+OIUF
MM6.=M>WVFM-9$Z8R%D>60LC]/W8V."[X8] 4=L-2U<3O.7+ETW.*8[]?UI\=
MCVG#99)/B'HHS+("0:AMTQG],F0)9:E.<F8]]@  7.QR1S E;8:B(O:UX=NW
MT4@V@>T;?^G4?\90_KQL#VC;_P!.H_XRA_7@![1M_P"G4?\ &4/Z\ /:-O\
MTZC_ (RA_7@#G2717E,R*J:LH+=Y*>525PQ(>0D.'#AX#G/0Y8 0 @! " $
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MX;?R&TQ_9< /M-\(?X*N&_\ (;3']EQ(6R] 1-P<X0 $S<*^&S2AR3H?2[
M;N;6P8<RS0A;('CM(479GU=7WJU:%MW!2_W*P+BFU#;]+46A[A66>I<RR(7>
MEM":JM&M-W)A))5223?<32XFEFE%)G=5U6_'_#W_ -K+AI_J#HG/_9FR<_\
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MC8[70VFC].J)0HMZK0(4Z'I5!)()U.YWYQ)*)B1*& [F $ ( 0 @! " $ (
M0 @! " $ ( 0 @! " $ ( 0!37MO:.XIW_A=8-5\#],3ZQXM\,==6C5VC].)
M7&U6I2["MH+MI"^THK[S76VWHII634U9<5 O6T_I!;Q(D5%IDT5'.?'DFO\
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ME+(G++* 6_U%;7>3].@40 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! "
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M\/$_$]3 #NR_O9>7(<F;ER8-T80!EMM " $ ( 0 @! " $ ( 0 @! " $ (
M0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @!
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MT\H(2MSZ9JFGDE[\]0C)+WI).],JG++WU)PFG*YF [T\\TLDDKO-/,)0"2!
M">IITR!/4(R&:4SRB=5.4S2!GF ,P>4.'F& X<Y$ <:5;1+B<H5=*L$YI))R
ME4)*"2=1)&HDEG,D\PEFG0J$%I)2QF2714 ,BLDTP')/4TZ0E*BZ*8G432D,
MZLD@G55(E23E,TP[RBDQ$J<@>:<D"4$D0!A/64B<DZBE532)IAU)YUTI9)!W
M1.\\TTPEE'=FEF^Z(^YF!V(,!*WX\'*%D2Q"J9!V(GE+Y;#'.<8YXW@#CFJZ
M64SRS5-/+,FEZ903+)@R(O,/33@S/*D\LP]),TCRS9P8"5OSC1GZ='_IDLD
M??)-R[#?<L6&^# 'R*W>U(H252USMZ5,H.\G4*UM,F@I*9)E!-(M.J$Y@9)9
MIWEF([DLTVP)@#Z354TJ4R\U0A*A+*9YEBLF$I9)1WIIYE#-W!++*"3,9@
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M^230>AT^[W-&Z5D,LDB<IDT]:)9I4TI)4TY)9A2 B5-.2620 M)++++*P
MQFT#H69$4\VC-*3(2CNRHS:>M!2$HI_5&"9I.X!ZI^"MW6]7 0_Q0[L >J33
M313312DD222DE3333E$DB:<@$LDDDDH$LLLLH$LLH     : ,X 0 @! " $
M( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g367939g26d49.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g26d49.jpg
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M 0$! 0$! 0'_P  1"  D *T# 1$  A$! Q$!_\0 '0   @(# 0$!
M    "0H("P &!P0#!?_$ #T0   & @$!!@0#! @'      (#! 4&!P$("0 *
M$1(3%!46.7BW%R$X&!DQMAHD.EEYF)G6(E=8=[33U__$ !@! 0 # 0
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M(W5F:R]H6JB.NDQISDVH_:E^8DISDFJ>T-1*AI,N7A2 $?EE;)%#D;H$AW<
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M!"E6)Q /(+&$N@P01D95?WV5+8J15)R*R37-<N4D1;9*KI>SK8Z88(!'XC5
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..(BRBYSG;1F. '0!?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g367939g26m40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g26m40.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1*<4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $H"^1S8X0DE-! 0      !T< 5H  QLE1QP"   "   < E  "5!I;&QS
M8G5R>0 X0DE-!"4      ! 81B*I0:".H>X0B 2:K.3Y.$))300Z      #E
M    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
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M;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B
M:F,    !        4D="0P    ,     4F0@(&1O=6) ;^            !'
M<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N
M=$8C4FQT                0FQD(%5N=$8C4FQT                4G-L
M=%5N=$8C4'AL0&]>SN         *=F5C=&]R1&%T86)O;VP!     %!G4'-E
M;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M  !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M     !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL
M;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I
M9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M ! #O_XU  (  0.__C4  @ !.$))300F       .             #^    X
M0DE-! T       0   !:.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         !.$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      -#    !@             !\   !=0
M   ' &0 <P!P #$ ,@ W &$    !                          $
M        !=0   'P                      $
M    $     $       !N=6QL     @    9B;W5N9'-/8FIC     0
M %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M0G1O;6QO;F<   'P     %)G:'1L;VYG   %U     9S;&EC97-6;$QS
M 4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M  =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG
M:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !\
M  !29VAT;&]N9P  !=0    #=7)L5$585     $       !N=6QL5$585
M  $       !-<V=E5$585     $       9A;'1486=415A4     0
M#F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0
M"6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0
M   )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L
M=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4
M3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M       ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M       X0DE-!"@       P    "/_         X0DE-!!$       $! #A"
M24T$%       !     ,X0DE-! P     "#0    !    GP   #4   '@  !C
M8   "!@ &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$
M  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,
M# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@ O@([ P$1  (1 0,1 ?_$ !X  0  !P$! 0             ! @0%!@<(
M PD*_\0 <1   00! P$$ P8+#A '#@8# P$"! 4&  <1(0@2$S$405$)%2)A
M<8$6%Q@X55:1E*'1\",D,C0V4E-4DI>QP=36)28H-3="161U=G>TM=+3\2<S
M1&5T@N%#1F)C9G.#A(>3E:2RLRE'5W*&HJ6WQO_$ !D! 0$! 0$!
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M;N]BKL<;P7-G991N%10<IW"S2[R<5Q695@H+^XN<VI:FKKJB$6;'EOO:N/\
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M#0#0#0#0#0#0#0#0#0#0#02M1H)6N. T)*U0T$K5#0HT$K7>TQH!H!H"ALX
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M, E .)A1,B!2V%-8+\V(L<2!<<KU62H.<OOY1N-.J)H4: : : : : : : :
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M2S.<62<Q7.>H&4: : : : : : : : : : : : : : : : : : : : : : :
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M10Q>1=YS1S(Y6B?C+=_;36W;F9.?,-A17\FME5$F;E^V:2:V6"1'/!.#=W$
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MU22K:S"EZ.^JG%3X3<XC]S[1$R?<A/\ F6B^7]/V*)ZU]2)[/7\B#1]1= -
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M#8UK&HB(FA2IT T T T T T T T T T T T T T T T T T T T T T T T
MT T T T T T T!IW>?=V-LYCT7))E*>]BDFLCR84&6$%D@'*U'FKHI6$=92!
M*Y'NB,0*(!I3/D":/AXF]V_LOVW6X,?/\2A94VO)7,E2I\-T4!EMA(:OG2(+
MR1IT0+62XQ71U>,S0C[JJ\3T[S%50G7F\'@K]<,>=L;&;>^,?];*]OZ1F_R?
M\'G^#D)Y/3![\</6'OC'_6ROO&;_ "?E?F303AC?D_4>^,;];*]7_(9O\4?U
M>O\ !SH)Y//+[UR]8'OC'_6ROO&;\?\ XCXOGZ<:">OD^7WX7D)8QU_M97SP
M9O\ )_R]>@GKY/ZWT'OC'_6ROO&;[.?/T?CXOET$\GY/5+#'/R3'OC'Z_!E<
MI_>,W^3\?-H)PQORW8>^$?V2O7_R&;T_^7_@YT#?)^3'OC'_ %LK[QF_P^!Q
MH)Z^3]HD>^,?K\&5T_O&;_L.OS:">M^3^K>(]\8_ZV5]XS4_A G302N?DW[3
M<>^,?];*]G'H,WX_[W^+\*:">NLQT^_1CWPC\^4KY?09O'K_ +W_ "]>@FV#
MZ0YW^8'OC'_6ROO&;_$#03U\G\CWPC]/@RNOK]!F\?YOZN?Q:1N4_82N?2'/
MMR(>^,?];+^\9O\ L-"SN&1]\8WZV5]X3OB_O?X_P+H2>3W/UZH+8QT151LI
M?D@S5Z]>/^3^OC0=Y<\&[J,.IK6FW9J[C)!XVVKGA*1)_$UKA2X:K"(9B,:2
M+XK7D)Z-(&037]\,D!0,:?PCO"'7T3]K^<EN@;D;27<NYH<6O*";D4&MNFEK
MJJ*WTZ.,:D)8M[H8J/:STO@DM$7AQD0A45Z=]7]?UJ(QG3PSMDVE?'6W+YV=
MC8S0Y+NRI._P_ +5J<#>]45TKX/+1M>J)W53ESD:C4ZJJ+HIOA^->6T'ECCE
M.CT,O[ <H8,GW%[Z$5'TM(B>$$IEY;.L57E L>J<\^:IU]2KZF]^8;B.;@^D
M.3Y$ZGHK*RAC<^3%CJ\#),"Q41"N>,8QJT06D<Y[G]UB(YC>]PI2A$CBM9"9
MR?C*U\_BQ8L#S"[R1]P.]I1U+H4Y(\%T994@,H7YNUSWF>%HVJY8_CBZHU\6
M1&(WEA!O(&]VZ8O7)&R="C0#0#0&+YCDX,/Q^9?R(I9S(CXS$A@-&#)E/DR1
M1V BK**$191'%1L:/XC'',K!(YO>5S0>]W]C3ANT71LJX5C'QG()KYCYR,@Q
MG5KIB"C, ^,1K231B>^6DN.B@0GBQ7)+22UB0SJUO>[$OR]OLHMT\NK<YV*'
MDU4THX5EE^V#@BD(ULD7A[M8>%1G8QSD$=JL12#1ST&Y59WGHWO*(\'/.^BA
MJ>;Z1C@CIA/)/X_/Y]#2P7QAX%NLZBJNH9:^XK8%K .G=-!L8@)L0S>%3@L:
M2,H2)PJ_HV+YZ$C'>_"#19.SCBE/*-8;8Y#F.STPY7&+#P*Y06)F>Y$[RDP*
M^C7>&1WD<BO/(JJ2KFR7N[QY9.ZFA?'V^BK^E_O9#:OO=OV^:J+\!N1;<8M,
M9Q[".J'TA7+T3JT@_->GDNA+R],BE)2=J*.QPX^X6R=@UR.8TT_;',X4D2.1
M4:570=SGQC$:Y>]X?HH1NX1O+>>\@/RW\>*=TT9-@.T5;B5G-RV^M)><[BVX
MFAM<XOQB6<R(G5E+CT 2>@8MCD=RJX-/3B"PY5?,LSV-@4LMX1Z89&W41$1$
M1.$1$1$3R1$Z(GS:%(Z : : : : : : : : : : : : : : : : : : : :
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M#MDY7RX5>G3IQRB:!*%&,>&'@_"S^3RV!3CMEY=UYYO]SU__ ,E-Z=?9H\7
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M/0GB_3Z(>]%5]CH/K7CT2/ZTX_8_R^30OC[?7A^;D?>BJ^QL'[T![./V/V:
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MU6HJ+QRKE7IQQUX]B-Z]/9^+0B49)=/?<]2?0HT T T T T T T T T T T
MT T T T T T T T T T T!R#VL]P-P<"@[?.P"RMZX]]D1J^U2GQ:!DLB3%
MZMDH-'69&1('AQVS2G<]KB'KFV*P^+$,-'"9^']_'SE/7$95='"Y555<-BN5
M6JQ5<J(KO@.ZMZ\_!55X\N51.5!8+[GUY;@]M"C0#0#0#0#0%OM+2#30C6-E
M(;%A@4:%,]KW-8IBL /E!M>_X12,;RC51.]RO"(JZ Q2TRB3/J#S,,0=I,K<
MFJ*BUBD"5A1QO?>N#>C8AGQFBD1ZJ666.05ZQAC;Z0[Q&-[JB3:U[2O*5.F\
MRTUT+)LQQ> 7)89\6OXF16$ET7Q6+W(,"YLHU<URUUC(%(9)J4BD>Y9*AD&7
MTEHA-<%!!?)^:>=[8=(RMI>F%-Q;:/#*B+GV25<*OCR'0H<VVD'?'0Q%D%!%
M%(L"29D@HXRD'X\DA)!6(3Q2+WE1P6PB;SE;GN^,''7;.S1B8;M7:;>Y"6+0
MVLO(B1Y6-S2P84T4<->P:M6$\+2,"5\AJ-5.&%4G1'\Z#&97Y-4=J.5*G[8]
MG29-D&E2I&&E-(D'>XIC%?$JN\0A'JKWO<O5SE557U\ZFF/UUW/J4Y+]U&Y2
M'V6^.O&U*K]Q:KS]OK7G5"LY2P<]8WZ&'^Z1)S;=ESGS787$$5?7_P D]>J[
MSAB]]-#42[YU--:8;70[5[27]FC;/A53^EG;OK_UQ<<=>.5]?7Y>FH9=I_K^
MC(^T3]=YB/\ TG;U%3V_G_GGCXO+GS]7EYB:];>2': ^O Q/_#.W'R?USC?A
M]GSZ!X/QYZ]?++ \MR_KXH"<?]]>#=./+^@-'ZT]G"<>?L3VZ!*W6==<L]S+
MQ(4'U]*_X[W/J_\ )J9Z_7Y_=Y^8OOT92;;#Z]_(/7SF>XG_ -NTT(\,?'>^
M1#8)>>V5ER\?W=W.]O3BRFI^7GY^W3?4I1=FKIVB\]5%_N5N%Z_/\\F7KY=/
MP:;G=R/!]'ACX'EV,_U2[N>I?I?V_P#G2\+T]O5= \L_FSP_.4F6]@8*R+[=
M #7/$IL?IA-*)ZC*-Q)MFSQ!D3X3'L5>\U[>J.1%1?@IP#P^I\<.6',WAVGL
M=R"F[,G:*D6]J^PCR-G;.-W2RGRB.G0Z80"21*2-'?'"_P )?%$0LPD@Y'24
M*%7O81O>_P ,T^=I764^JG3(X^]QN_4'O/\ XW8]\?\ <4O'X./XNFAO_C_^
MS]E^#[.Z&1H!H!H"BGV,&KCK+L9<>%&0L<'CR2L +QY9QQHP?$(YK/$D2"B
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M0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0%HO\
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M>L1#K0R+"P]&KX\J4)L6*,YP62.:]1,&U*YCB&2?("-H$>&/35-[PSG'(O\
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MN]!ARG2(*UHV0Y5;WY+PQY@5(.0\1585R-1&@G._?1\M'Y;#T*- - - - -
M- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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-QQQQTT!-H!H!H#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g367939g38t23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g38t23.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[14\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %2"^5 @X0DE-! 0      !4< @   @  ' )0  E0:6QL<V)U<GD .$))
M300E       0E2X!;]V>.+Q<!VA;\)B>%CA"24T$.@      Y0   !     !
M       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU
M;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +
M<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,
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M      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M     %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6)
M;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M             $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X
M;$!HA*V         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !0
M9U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N
M=$8C4FQT                4V-L(%5N=$8C4')C0%D            08W)O
M<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M   ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M        "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "
M  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M   $    6CA"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #00    8              74   +X    !@!D ',
M<  Q #( ,@    $                          0             "^
M 74                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M 74     4F=H=&QO;F<   +X    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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MML;6YO8G-T=7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                 /_A/GQH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY4
M8WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B
M('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#8N,"UC,# R(#<Y+C$V-#0X."P@
M,C R,"\P-R\Q,"TR,CHP-CHU,R @(" @(" @(CX*(" @/')D9CI21$8@>&UL
M;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT
M87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B
M92YC;VTO<&1F+S$N,R\B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O
M<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(*(" @(" @(" @(" @>&UL;G,Z
M>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @
M(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T
M4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R
M8V52968C(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N
M<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @(" @(" \>&UP.D-R
M96%T941A=&4^,C R,RTQ,BTR,50Q,#HT-SHS-2LP-3HS,#PO>&UP.D-R96%T
M941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^36EC<F]S;V9TPJX@
M5V]R9" R,#$V/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z36]D
M:69Y1&%T93XR,#(S+3$R+3(Q5#$P.C4V.C(P*S U.C,P/"]X;7 Z36]D:69Y
M1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,RTQ,BTR,50Q
M,#HU-CHR,"LP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'!D
M9CI0<F]D=6-E<CY-:6-R;W-O9G3"KB!7;W)D(#(P,38\+W!D9CI0<F]D=6-E
M<CX*(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @(" @(" @(#QR9&8Z4V5Q
M/@H@(" @(" @(" @(" @(" \<F1F.FQI/E!I;&QS8G5R>3PO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E871O<CX*
M(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M870^"B @
M(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z9&4U.3DS,F8M.30W
M92UD8C0W+6(V.&8M-S R.60P93)D,V0S/"]X;7!-33I);G-T86YC94E$/@H@
M(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YA9&]B93ID;V-I9#IP:&]T;W-H
M;W Z8S5E-SDQ,#,M-V$Y,BUD-#0Y+3DQ-6$M.38W-&0T-6$P-65E/"]X;7!-
M33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N
M=$E$/GAM<"YD:60Z8F0Q,#9A,&,M-S9A,"UF9#0R+6(W,3(M96,S86-F-&$Y
M-60W/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-
M33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#IB
M9#$P-F$P8RTW-F$P+69D-#(M8C<Q,BUE8S-A8V8T83DU9#<\+W-T179T.FEN
M<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C,M
M,3(M,C%4,3 Z-38Z,#(K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<" R
M,BXP("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @
M(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-6%D.&1E,CDM9&4R
M9BTW,S0S+6(X938M-CDP-6-C8F4P-V0V/"]S=$5V=#II;G-T86YC94E$/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3$R+3(Q5#$P.C4V
M.C(P*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @,C(N," H5VEN9&]W
M<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO
M;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N
M<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P
M<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO
M<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V
M=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$
M/GAM<"YI:60Z9&4U.3DS,F8M.30W92UD8C0W+6(V.&8M-S R.60P93)D,V0S
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#(S+3$R+3(Q5#$P.C4V.C(P*S U.C,P/"]S=$5V=#IW:&5N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0
M:&]T;W-H;W @,C(N," H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H
M86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \
M+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @
M/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#HU860X9&4R
M.2UD93)F+3<S-#,M8CAE-BTV.3 U8V-B93 W9#8\+W-T4F5F.FEN<W1A;F-E
M240^"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z8F0Q
M,#9A,&,M-S9A,"UF9#0R+6(W,3(M96,S86-F-&$Y-60W/"]S=%)E9CID;V-U
M;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$
M/GAM<"YD:60Z8F0Q,#9A,&,M-S9A,"UF9#0R+6(W,3(M96,S86-F-&$Y-60W
M/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#PO>&UP34TZ
M1&5R:79E9$9R;VT^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-;V1E/C0\
M+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M!$P1,$3!$P1,$5)=9Y+L;)4Y;9Y3O<B]_P *K="+;CK?K86WQ#OL=T'K-[7
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MAH*!3Y_O3C4A):793*7%\[G@V0$K<)3S(6#AX'B[;AX7_P!Z7 L.Z"]I8'4
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MW5N^.MIV@8K-AV?"PL$?4'XL8<XIG?\ N(%]WC6F2Y1GP+@[.["_S<?&?CP
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M(CO-/L/-%2'F7FB%M.)6G="T.!*@0+_""/+' >,[0UKG_,<  #,FS2?J<?\
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MXJ_:$<7^OE*E:.:SYMH\G+,?4"E1ZYE^DY<R] 8^\:93HN9Z<PFH0*=%G>)
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M%.!H><<%G\4.'SW01/X =^;?RK6:FJSZU"Q/Q'O;J">_3H/KUN#?Z5LAG"'
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MT.+#+L/#>3,3$ &=*BDS4F84F<)?+^G%5;=*$JF99S53XZ.A>DS\IUV''8;
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MT&)<<)VZXS:. 4CZ[9"?U#R%F?++B#)=FT]]V#S)!\.?#;5*AJ1V"E/)#2B
M2EMQ9 ^$$V_"WBW_ "O;\%S'AK3/S#-F$#?<<@&Q)M % :1?\4>#,\<\.VC
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M2YL@F13/7V]I6] /YG^)QDJ5S@B8(F")@B8(F")@B8(F"+&5QW\/F>-<-<^
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MG9(_A\Q>_7S^OD+8@-+IB))N3D"1:DQI6<Y5-O('+.#Z=DR5R3T^?<_P]?\
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MHA_[/GJ$U8KU9R:L;#^RE5 'K_YRQVWMS #<WVMB"QV@Z3^>?D/,,1LW)_\
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..3TXD>R 6P4I@B8(O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g367939g51z45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g51z45.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1,X4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $QR^2)(X0DE-! 0      !4< @   @  ' )0  E0:6QL<V)U<GD .$))
M300E       0E2X!;]V>.+Q<!VA;\)B>%CA"24T$.@      Y0   !     !
M       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU
M;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +
M<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,
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M      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M     %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6)
M;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M             $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X
M;$!O4)N@        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !0
M9U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N
M=$8C4FQT                4V-L(%5N=$8C4')C0%D            08W)O
M<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M   ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M        "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "
M  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M   $    6CA"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #00    8              @0   38    !@!D ',
M<  Q #( -     $                          0             $V
M @0                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M @0     4F=H=&QO;F<   38    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
M 04! 0$! 0$          0 " P0%
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M-D95E-'6)S4W4E-F=M/4X?$H0T1'6&)C9,75,SA%2'-T=7>#A*:UML3&_\0
M&@$! 0$! 0$!              $" P0%!O_$ #H1 0 ! @,' P,# @0& P$
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M5;(UJ\/8QWDA5O3LJ]HOGSZ/[IQ\/[6M5/)>?^%1?+T]/AZKY8!.RKVB^/\
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MHYS62[,YRA6 S55RPT\3$(KI'2E3.<PV)&DK>G7+YKX27"F P& P& P& P&
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M/?4<,& ")9'=Z181X&CL5[T1%5ZL8BN=PBJ[E>$],#6POL@]'+ R:Q. NY[
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MJZW/6RA5'JHY(-1X*MAJ@HHE-5G+77-+TQOOIK6]Z']G'IN]@K$AN6>P%-+
M?';3-D"D9;:]=Q-&>C>8XH;+5:*:"-/HQ- BA8B1(C$%-3U]JV^]7;%T*UM
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MMT.[3O0GM(0;!/T2ZBTW4"'590(=@?3LL&MJY;-I3P(YU.#$Y4A@9"L\/O\
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MB#CQI[X8<K.Y[3(2ON]\'@(+^[L)PF?"FOM3C7)>L*8# 8# 8# 8# 8# 8#
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MB051*AVDSK0%L5<6CNXHITKITC%([_T/!G<QZN^BC><)7[<>3UK>TR10S.M
M&1$#*;!(XP9(Y@T9XBEQ/\7N2#-C5'K.URQ(Q4>KNZO.%>X4L8V!A(D\)(\J
M.6.<>6.:&1&N5CNY+$Y['=U[7,=W7+W7-5J\*F!Z,!@,!@,".0-;\ZK!_AP(
M]:6O:LR4)<)#FH6:J1OV5SO8C8FJYSF4T3$( <YQ<KEC-C1!K7;5$CP& P&
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MN!3NMYYX3GZ_NX\_K3CX+Y?'UP*+'&JJJL8JKW>55J<KW%5S.5XY^BJJK?\
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#@?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g367939g56j56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g56j56.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X?DE:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC
M871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET
M;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/F1S<#$R.3PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @
M(" @(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D9CI!;'0^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M<F5P86ER(CY&:6QE
M($YA;64Z(" @(" @(" @(" @(" @9'-P,3(Y+F%I)B-X03M5<V5R;F%M93H@
M(" @(" @(" @(" @($1E;'1A)B-X03M,;V-A;"!4:6UE.B @(" @(" @(" @
M(" R,2U$96,M,C R,R Q,3HQ,CHU,"8C>$$[15-4(%1I;64Z(" @(" @(" @
M(" @(" R,2U$96,M,C R,R P,3HT,CHU,"8C>$$[4V-R:7!T(%9E<G-I;VXZ
M(" @(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @(" Q-BXP
M+C F(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @0F%R($-H87)T)B-X03LF
M(WA!.^* HB Q,SD@8FQA8VL@=&5X="!C:&%R86-T97)S(&-H86YG960@=&\@
M;W9E<G!R:6YT+B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P
M<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!(96QV971I
M8V$M0F]L9"8C>$$[(" @(" @(" @($AE;'9E=&EC828C>$$[)B-X03M4:&4@
M9F]L;&]W:6YG(&-O;&]R<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z
M)B-X03L@(" @(" @(" @0FQA8VLF(WA!.R @(" @(" @("!#35E+)B-X03LF
M(WA!.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+28C>$$[1FEL92!.86UE.B @(" @(" @(" @(" @(&1S<#$R.2YA
M:28C>$$[57-E<FYA;64Z(" @(" @(" @(" @("!$96QT828C>$$[3&]C86P@
M5&EM93H@(" @(" @(" @(" @,C$M1&5C+3(P,C,@,3$Z,CDZ-3<F(WA!.T53
M5"!4:6UE.B @(" @(" @(" @(" @,C$M1&5C+3(P,C,@,#$Z-3DZ-3<F(WA!
M.U-C<FEP="!697)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@
M5F5R<VEO;CH@(" @,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @
M($)A<B!#:&%R="8C>$$[)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES
M(&-O;7!L971E+B!0;&5A<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O
M;7!L971E9"!P97(@<')O8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN
M9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z)B-X03L@(" @
M(" @(" @2&5L=F5T:6-A+4)O;&0F(WA!.R @(" @(" @("!(96QV971I8V$F
M(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@87)E('!R97-E;G0@:6X@
M=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($)L86-K)B-X03L@(" @(" @
M(" @0TU92R8C>$$[)B-X03LM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TF(WA!.T9I;&4@3F%M93H@(" @(" @(" @
M(" @("!G-39J-38N86DF(WA!.U5S97)N86UE.B @(" @(" @(" @(" @1&5L
M=&$F(WA!.TQO8V%L(%1I;64Z(" @(" @(" @(" @(#(Q+41E8RTR,#(S(#$Q
M.C,T.C4V)B-X03M%4U0@5&EM93H@(" @(" @(" @(" @(#(Q+41E8RTR,#(S
M(# R.C T.C4V)B-X03M38W)I<'0@5F5R<VEO;CH@(" @(" @(" R+C8F(WA!
M.TEL;'5S=')A=&]R(%9E<G-I;VXZ(" @(#$V+C N,"8C>$$[1W)A<&AI8R!T
M>7!E.B @(" @(" @("!"87(@0VAA<G0F(WA!.R8C>$$[*BHJ5&AE('!R969L
M:6=H="!C:&5C:R!I<R!C;VUP;&5T92X@4&QE87-E(&5N<W5R92!M86YU86P@
M8VAE8VMS(&%R92!C;VUP;&5T960@<&5R('!R;V-E<W,N*BHJ)B-X03LF(WA!
M.U1H92!F;VQL;W=I;F<@9F]N=',@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M
M96YT.B8C>$$[(" @(" @(" @($AE;'9E=&EC82U";VQD)B-X03L@(" @(" @
M(" @2&5L=F5T:6-A)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@8V]L;W)S(&%R
M92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!";&%C
M:R8C>$$[(" @(" @(" @($--64LF(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03L\+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.F1E<V-R
M:7!T:6]N/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X
M;6QN<SIX;7!'26UG/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I
M;6<O(CX*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,RTQ,BTR,50Q
M,3HS-3HP,BLP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM
M<#I-;V1I9GE$871E/C(P,C,M,3(M,C%4,3$Z,S4Z,#(K,#4Z,S \+WAM<#I-
M;V1I9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R,RTQ,BTR
M,50Q,3HS-3HP,BLP-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX
M;7 Z0W)E871O<E1O;VP^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S
M*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^
M"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z=VED=&@^,C T/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @
M(" @(" @(" \>&UP1TEM9SIH96EG:'0^,C4V/"]X;7!'26UG.FAE:6=H=#X*
M(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=)
M;6<Z9F]R;6%T/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO
M.6HO-$%!45-K6DI29T%"06=%0U=!2EE!040O-U%!<U5':'9D1SEZ84<Y=TE$
M375-04$T46ML3D$K,$%!04%!04)!0U=!04%!045!)B-X03M!44I904%!04%1
M04(O*S1!1&M&:V(R2FQ!1U1!04%!04%F+V)!25%!0F=114)!545"9U5&0F=K
M1T)164I#=V='0F=G3$1!;TM#=V]+)B-X03M$0D%-1$%W341!=U%$031014$X
M3T1"351&0E%417AW8D=X<V-(>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%9
M1VA54D92;V9(>#AF)B-X03M(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&8O.$%!15%G0D%!1$U!
M=T52)B-X03M!04E205%-4D%F+T5!84E!04%!2$%114)!445!04%!04%!04%!
M05%&07=)1T%104A#06M+0W=%04%G241!445"05%%04%!04%!04%!)B-X03M!
M44%#07=11D)G8TE#46],14%!0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!
M049)4DEX459%1T4R16EC645537!':$)X5WA1:5!")B-X03M5=$AH37A::3A#
M4GEG=D5L47I25&MQ2WE9,U!#3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG
M6FA*4D92<5,P5G1.5DM"<GDT+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:
M,FAP86UT<V)7-799,U(Q9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO
M*T-K-5-6;'!E66U:)B-X03MQ8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]2
M04%)0T%1241"455%0E%914-!341B445!06A%1$)#15--545&55).:$EG6GAG
M6D5Y)B-X03MO8DAW1DU(4C133D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-"
M,U!33F5*16=X9%5K=V=*0VAG6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP
M*U!Z:$I3:W1-5%4U4%)L9%E75G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q
M9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:
M;7!U8VY:-F9K<4]K<&%A;G%+;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X
M03E5-'$W1EA9<3=&6%EQ-T9867$W)B-X03M&6%EQ-T9867$W1EA9<3=&6%EQ
M=S-Z4F18565R3W-C>F]V0F9H5FE",#EJ;4AM:V5*>3A-4G=P.35::VMK,&E*
M-4=,<U=E<DU35#EO)B-X03LY>FPK12ML;WEJ,4I/,G4V;TY4.#1W;65K5VQ7
M,$5T9W9&4#-B4&)027AR5#1Q=71F:7)L>E=X6%%V>D4X,3-.<F%R<5554W)Z
M,&5*)B-X03MB=3)K0WI3=F8R475*1%!&2F)T2'A,1W1)*TI(44AV:7)8;&XX
M>69-,&YL94Q52DEO9%-V17-T3&MU4F0S4#%14WHS='%*071T2&$R)B-X03M5
M-TY*2DEA8T0S-E5',DMP<&1F;6YQ.79R03!O95=R:31U<E@V;VUS>#)V,7DU
M3G9,9&]K:%-+4T-Z:W0U0D5K9UIJ2DQ&6'1807)7)B-X03MM*V9034]R*UIV
M3%IH<S!S=DQE<G1F;4-55$Q.3F-2,C!B96U:;VI%<&=02F5A:$I',BLQ5'!I
M<6YQ4#5H82]A82]Q9'!D5VM35T]N)B-X03MA>$)95W)7<SE*2E5L,'<S>$9W
M2F]*0E$W9C-:56<W5F]T6$MQ55 U=6$X64)C,TAL=4=',UA48DQ7<F=J54,W
M<EI8-W1';D9F<7=$)B-X03M42S!B17!53%%F8G)T9U9-9DPO-6XS5W1E66\W
M0S,P0S<O4D4X.7IB4F%U27)Z9W!T4S8K<$M8=%5T5FIK84EQ<%,U8S%O0T%A
M,%9:)B-X03LU:7)S5F1I<G-64TQZ=')T-6]E9U-A:%IR1S V>7=X9U-O.&DP
M;&Q60V5#36I-44<R04]+<&)C95I.970Y3DYY<%<U3%A%54QZ3G!D)B-X03LY
M87)B4DU'36LW=WEY3DI+<3!(,E-T3S5W<6AR<GIF<G<X<V%L<3EP3EE34'!4
M>4LW0TXU175&055O46EZ<DIB=#A2-4Q*>5!C8EEQ)B-X03MY>E-',48W0T]7
M+VQH;6YL06-.0D4P2T)7545,>&5366MJ>#5F4F=61UEQ-T9867$W1EA9<3=&
M6%EQ-T952&1A4'!T,4M:<FE!4$E1)B-X03M!5TI98D0U2$E3>'A03FU*:V-L
M93)T64Q715%W2G=J5W!#:7 V-SDX;$=)1W=9:VLX,&PQ>GE*-5@Q=3=E-S%'
M,6MA96%)5SEY,$9Z)B-X03MC,GEZ=W%35FIU170U26QN46-J4EI!=S-0:FA1
M<51E4W9,370K8C4W46ED;6=K25-76DEU9'%P4T9H0W)I249&4$=V2'!S8U93
M-"]L)B-X03M:-4I!=$)$85A&<V)&230W5C=7+W9R9#!71T@V=D@X8TTV35-S
M6'<Q2G)1;GA/2V]Q6#AV=DMK,3%$9%0R,# P,$EG1$=3-W4S5UDR)B-X03MP
M<D$Q,&I3;&)L;WHY;'!G-4AJ:7)T4"]!0RLX<&%F<3A7<E=L;3AD-T$P>C)X
M3GAC=D9#8FUV<F5J03AJ47AI4W9X0D5!>%96=E!))B-X03LO;&DX,4-F54QI
M,%HW<35M:G5*>C8X-F\P,$U$5WE396MR:4U-25A+5D,W:6QE9V]Q-79),VQ:
M<F0W8S)665I,1S,P<#$Y5V)E>G1')B-X03M:-$EQ.#8O03!J9D8Y;SEY8U9D
M62M34$Q&:'$U,6$Q=$=J=D1*3$UG33 W45)Y,T@Y.4I$8G,U9VEE4W U<VE!
M;7!R,4]+<#=I<G-6)B-X03MD:7)S5E-N>E)O4#9D,&\V96)G,F]A4T]8,6Q5
M3W=-5$(Q;T=.4'1+3W5+<&)C*U5T6G9,9C!B-UAN=6YJ;&IU3%-D-V%&2DQE
M84MT)B-X03M(:CE,,#%*4$MH-6AH-UE653,X:EA%=6UA<%EZ-FPV-S9W46(K
M.&5':WI%2T97;D8Q:EAI<3!&17A6:VQH0E!B,GE1>E-,2UEW1E)K)B-X03M1
M<#A+9T%60EHY.$-O:D9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867%G3F$Q,U,Y1G15=612)B-X03ML84]/5U)9655J
M:FMN;&ML97!73TM+1EI*2D=)0BM&5DIX5E1S+TUM:UAU:$183$]34S4P-6Q:
M,6%'0V5352MM>%(Q1G5Q1V9M<DM6)B-X03M+8T]127!41E9$479/1V@V-658
M5FQ91S9&,UER1SDQ1&175C5:<V=L<C9D4F1242]A-&UL359D1#5Z.'-46$]T
M,C!6.')Z*UA&1&%Z)B-X03M'1FM*9T12;55%+T0X9G=+9G-6-E4V-UEQ<'DK
M92]+8U=K-E1Q.&PK;S O6$IO3&)3-794;$IM;'5F-W!/05AM<%!F:T)X-S!X
M5E!S)B-X03M654QU-DU!56AE6$MV96Y41E5.*VQ7+S,R4'8O04Q-5F0K;%<O
M=T(Y:C<O-TU69"ML5R\S,E!V+T%,359D*VQ7+W=".6HW+S=-5F0K)B-X03ML
M5R\S,E!V+T%,359D*VQ7+W=".6HW+S=-5F0K;%<O,S)0=B]!3$U69"ML5R]W
M0CEJ-R\W359253EW66]"3'AR5VTS>GA60R]P5G8Y)B-X03LY:C<O04]Z1EAF
M<%9V.3EJ-R\W359D*VQ7+S,R4'8X03=-5F0K;%<O,S)0=B]S>%8S-E9B+V99
M*R]W1'-X5C,V5F(O9EDK+RMZ1EAF)B-X03MP5G8Y.6HW+T%/>D989G!6=CDY
M:C<O-TU64E Q:R]64%@T-S!R>'(W,'A66'A6:"\U:"M88C-62DY$=F)A0S9V
M23E*=DI*-VUY<TQK)B-X03M79#%*2$QB4W=6:&Y-;'9X6E1)2R]V57%T9FDW
M1E96.&\V3C5P=$Y-<W)N5TY5=EAU645N1#91>E=K>4UJ4WE.8G).8TY%6FYM
M:FE:)B-X03M%6FQN0VQL<G9U4W%R954Y33%44W9,16PQ93(S<2M9-R]W0E15
M9%-T,61#5W9*4GE%06MQ17!%07-+;71+2TU6964R;C5C+VU$<&MA)B-X03LS
M<D<R,4<V,6Y43E)S.6-T-V%-45-*4&9,2F1O.&LX.7DV>BMN9$]99U562TLQ
M854V1E568V9L-S5R84<R=%)B0G)(4S=V5&)R5$E2)B-X03M,2%=S,3EB6%=P
M1G%S05!183-K2R]W07=C:&%N<7$Y9'=+;UAD<5IW;T1C94YE,65U2V]B.49.
M+W9W9F0O8FER=C!5,RLO0CDS.75+)B-X03MU+U)49C<X2#-F,C1Q-SE&3B]V
M=V9D+V)I<G8P53,K+T(Y,SEU2W4O4E1F-SA(,V8R-'$W.49.+W9W9F0O8FER
M=C!5,RLO0CDS.75+)B-X03MO<64S37-!:355<%1F-5EQ:&8P53,K+T(Y,SEU
M2W4O4E1F-SA(,V8R-'$W.49.+W9W9F0O8FER=C!5,RLO0CDS.75+=2]25&8W
M.$@S)B-X03MF,C1Q-SE&3B]V=V9D+V)I<G8P53,K+T(Y,SEU2W4O4E1F-SA(
M,V8R-'%I9G%X*W%E:'DS<%1L5#-R:7%V:7%1*V1:;G1.0G5.4B]3)B-X03MT
M-7!59&ER5%-.64IA>5-Z8E5724QD45A3,5II079&46$T<7@V-CAX-C<U8SAJ
M,TU/<C,P.3$U<U14<#=X8C97=VQA>E-C;S=24790)B-X03MA5SAD=#A$04I4
M6FU/+T@T9TU65G9Y-C%V>D9C-FAR3VUA+TID0V5X4S!N9V@Q2DQ.3'=2,T5B
M8VY9,D%&<S!2:VI92E0T:%$X=3)+)B-X03MS4S!,.#-B-U5T5#@Q2DAQ,7)0
M0DYP.3=F*U=O241!.'1O3E!A4T5R344U171-06QW;VLW5DA41E9E-B]-2'I5
M3D(X=5<P5C1&,75+)B-X03LO<S1V359X-DU2.5,S93=T-UE$9U8T4FTV:G9%
M;$A%0V="-#!W<3EF=TMX;GIT+V0R;GIF.5,U:F%N;S5';C9S5GI&8VPR2W5X
M5C)+)B-X03MU>%8R2W5X5C)+<W@X=R\X;S=&+WIY+U9M6&PK:'AC6#%S3WI%
M8W R2W5X5C)+=7A6,DMU>%8R2W-T+S99=CA!,D@O33--<B]!0U1J)B-X03MF
M-5)K95I,:G!2-6]0;&QD35-4>DIC5SET<'-.>$)/2F)U8U<X26YG;%=71&LW
M36EM:VE!:%-A1VY41E529')O=7(V3$U,;&],>E)R)B-X03MY0G968W-R=U-1
M374W8W=E4$AJ=E5(1E5N.'(V5C5(;C!U.5!L*S9453=/+T@Q93EV63<K5R]D
M=VE&4D=B<#5P<$)W5GIX55 X3F1Q)B-X03M9<38W,$AY0F4R:V5M>2]6:D(U
M66E-2F=J=41'8DM'5S%A17!,-F)Q>4LQ<W@R9EEJ9G181E9K,FDO;#$Y5FAV
M-5=T1G1D5FLP,%<Q)B-X03LU.5HT<&-Y5V)#5%1H2$HV9T5H1$M#9U4O2#-R
M:7)+<U93=EAD56=S1FA-='5,:C%#=T%.3G%5.%%F2$MS<WA(;S)9-$=85DM0
M.%97)B-X03M(+U9T6#<Q+S5P>6YX>#-.=F=N=F0O:7%W+S9T<2]E=B].3U!J
M:G58=U0S=2]W05972"]6=%@W,2]W0V%C9DA(8W9G;G9D+VEQ=R\V)B-X03MT
M<2]E=B].3U!J:G58=U0S=2]X5EEF.$%6=%@W,2\U<'@X8V1Y*T-E.3,K2W)$
M+W$R<CDV+W=$3D]0:FIU6'=4,W4O>%999CE7,69V)B-X03M8+VUN2'AX,TPT
M2C<S9C1Q<U X07$R<CDV+SA!3D]0:FIU6'=4,W S<5=O43(R;7!D4$%*56)H
M4TDP;T]1<C-"-EIF3V12='%H1WI3)B-X03M39C1Q<U X07$R<CDV+SA!3D]5
M94]/-70X13DW=CA65T@O5G18-S$O-7!X.&-D>2M#93DS*TMR1"]Q,G(Y-B\X
M,#0K3T\U9D)093<O)B-X03M!0E999CE7,69V6"]!2G!X.&-D>2M#93DS*TMR
M1"]Q,G(Y-B\X,#0K3T\U9D)093<O1E9H+W="5S%F=E@O;6Y(>'@S3#1*-S-F
M-'%S)B-X03M0*W)A=C-R+T%-,#0K3T\U9D)093<O1E9H+S%B5BLY9BMA8V9(
M2&-V9VYV5&HY2G=F;U V+W=$5G@V6$=V,69A;C(K4&A4.$UU-'AW)B-X03LS
M5%9W2&EP33AT83)%+VU:85AC>BM8<#1X95)7,6IQ0G5,:E5.3G1Z95AD<V9Q
M,'-A3DAB:4\T-6AZ2G=9;48V03%P,T-Q4C9:-6$X)B-X03MX="M6-S9894%P
M<$IS<C)/6%1)<D9M,5=93DQ-,%5W36QX2$-K:W%&2&5";W5V2F%I=$965$1Y
M1"MN:W9F36YM1%5L;&UT6EEB4TLP)B-X03M23D]N,#)353)557!K361L33!S
M-$HY4E5(22]%5BM%8V%9<7=V5"],+VYZ5$=V3E9V.4<K4'IH<&5O4C9S3$XU
M<G5C6&-Q4S-D<#E:)B-X03MH5S-I15!P2S=7=V]Z:79%5CA3<4EU+TLO;4YT
M4#!V4VIP='=D3SAU,S)L6&5N,&E9.&IE6#%T3DE604)++U5O>&-2=B]+:D1T
M,%9E)B-X03LS6493;GI";S@K<$I!26Y64%-,13@V+W15.$%F1$MS=4UY8F-5
M>$9*9CA'6"]W1'8K3"]H=C9:4BM83&(T-&0O9WDO+T%.+WAF.$XO)B-X03M4
M2#AU5CAC3R]W04=8+SA!=BM,+T%)8BMM4#5C<C0T9"]G>2\O=T(O>&8X041F
M,'@O3&QF2$1V.$=8+RLO=T-,+VAV-EDO;'EV:F@S)B-X03LK1$PO05 S+T%"
M9CA.+U1(.'56.&-/+W=:9CA!*R\T=BM'+W!J*UA+*T](9C1-=B]!4&8X6"]$
M9C!X+TQL9DA#9F%P<&,Q,W!A5V%/)B-X03MQ=79#<DY7;G=I;EE:9D]"36%A
M651Q5G!$+V=Y+W=$.2]W05@O1&8P>6HX=5<W>'<W+T)L+W=$-R]I+S1B*VU0
M-6-R-#1D+V=Y+SA!)B-X03LY+WAF.$XO5$@X=58X8T\O=UIF+T%/+S1V*T<O
M<&HK6$LK3TAF-$UV+W=$9CA8+T1F,'@O3&QF2$1V.$%";"\O04PO:2]W0T<O
M<&HK)B-X03M82RM/2&8T378O.$%F.%@O04$S.4UF>358>'<W+T)L+R]V.$%I
M+S1B*VU0-6-R-#14=CA!4D4O-D$O4G9.9E8T,#4W.&9T.'9#=5@K)B-X03M'
M941H875-8U9T96)D675T1SAT-FAQ;'!#<SEX85%M4T].*UA#=E1K+T%&=4-6
M-4Y496=Y,7%9,357+TTS4C=L-S8R,6I8=$AM3G1.)B-X03M$1F$V<F%Y0S)T
M3&LS15I94GA#86%A<VE-<DM1<W)F461S5F$Q1#AW.5IS<G)Z:W,K:T<S:3AU
M,DYR8S9:1DTX6FMU-4QL<FU-3WI2)B-X03M34W%K5'9B<49";S1&4W<S04-Q
M8F573F$Q-E17=%0P2%AM=%IT43 K0S!U,75R1TM30T8T<G8Q5C0K;DQ*3W=:
M2DQD>%AN=4M'9WA6)B-X03MJ96XO04IO-G!D6'9M6DAT64DW3S%S<G$O=T1+
M,#E(<F12864X;'9C;5E&:%@Y*VES=D-N=TU0;FEQ;&,O;6YR8658+T%#,5!(
M8E=P)B-X03LQ;2]V64QB5S1716AI:6A.,T9:>G9#02])1FYU63)I-4UF:$\Y
M8TMV5#A#<V,X-7E32DAA.$=+,4PQ;U-/=SA->'11951K64)Z678Y)B-X03M:
M=68Y*W8X03A%8WAR3&M52&978FXO9G(O=T1"2$=Y=$(S,6TU+S,V+W=$=U)X
M<W)19#E:=68X069R+SA%8V)+,$AF5V)N+V9R+SA!)B-X03M"2$=Y=$(S,6TU
M+S,V+SA!=U)X<W)19#E:=68Y*W8X03A%8V)+,$AF5V)N+T%(-B\O0DA'>71"
M;#-M0U-29DPX5$MX1$@P<7-$43E-)B-X03MY.' Y1&DT:#9M22]78FXO04@V
M+R]"2$U3>3560C,Q;34O,S8O=T1W4GAS<E%D.5IU9CA!9G(O.$5C8DLP2&97
M8FXO9G(O.$%"2$=Y)B-X03MT0C,Q;34O,S8O.$%W4GAS<E%D.5IU9CDK=CA!
M.$5C8DLP2&978FXO04@V+R]"2$=Y=$(S,6TU+S,V+R]!05)X<W)16E8V:VXK
M1'5F)B-X03M)."M(,G%M=CDW-#5L6"LW8V%V,VE:-G!&85@Y=F-A4S$V.7)C
M5%%L:3%R3C9.,4=H3D)+:$AX3%)U.4MD<WE':$M02DU8;'-*<4TK)B-X03MK
M-C1V;4LW=4QG3G%E;VUE,W5*5$EQ0D5J9C9Q<V-565)&059&4F9(<5-C5E9.
M4SAS95AT43%$5TER>55Y6$=V861&6C-D;C9I<69Q)B-X03LQ<3 S1U-*44))
M<$18:'$Y9&IX<%$Y5E9M9V578D,R=#E494A73')5-S=50CE5=DY8;&MG8358
M-G-R47!'1$)&2$5R46QM-G!8:U-7)B-X03MQ8U930F9Y>B]+*TM,-G9P<E<K
M;5A/9S(X;')Q;#%:3F)2,TIH=4Q2;VY';T]5671Y:F(Q87E54$EC<U9212]K
M+W=!9RMH2'%4-F]))B-X03LW9E9P=$I.<&0O5UE21DY,65!(2F%,07I$9WAU
M4%)14'<S8T%5<%1&5V0T<6AB.%=D12MS=TQ-3BM)6E9A;FHY<D%99S@P:5)(
M2D(P)B-X03LP8B]L:&DO-49X+S!W94A(=51X>3<S53!B+VQH:2\U1G@O,'@X
M3U!C=DA,=F144G8K5T=,+VM82"]42'<T.7DX8W4Y,4Y'+S59678K)B-X03M2
M8V8Y369$:C-,>'DW,U4P8B]L:&DO-49X+S!X.$]08W9(3'9D5%)V*U='3"]K
M6$@O5$AW-#EY.&-U.3%.1R\U65EV*U)C9CE-9D1J)B-X03LS3'AY-S-5,&(O
M;&AI+S5&>"\P>#A/4&-V2$QV5CE6=7)+,G-"3&-10V%#<6=28U9),S9B2&)B
M0FM)03-4045N6DDO,"]W0UAF*W)9)B-X03MV+TEU3$M01F@S3C-H>C<S9G O
M>3<O,6)&+S5&>%DK3$1U6'<U.3=V,"\U9"]W0W)9=CA!>4QI>#A72&-V:'HW
M,V9P+WDW+S%B1B\U)B-X03M&>%DK3$1U6'<U.3=V,"\U9"\V=&DO.$%)=4Q(
M>%ED>2M(4'9D*VXO04,W+T%.5WAF*U)C5U!I=S=L.$]F93<Y4"M89BMR678O
M275,)B-X03M(>%ED>2M(4'9D*VXO3'8O049B1B]W0U)C5U!I=S=L.$]F96Y(
M,39W+U%F,78V=5!Q9D=V,69I=$MC-F9:*WHQ,WDS:4A$9&).6$-E)B-X03M+
M<C-9:'(S;$LW8E@O3D5U:U(S0S-M<RM8<&])-W574V%725AB3DES4V]:5UI)
M*U!)2&=L0C-P;'I7:"],9'1R3CER1%@R9U=J84%L)B-X03MT;SEL<#!S;7)A
M9F-"2&UI:VMC>$Q!6DQ*-5!25G%E;T@T9D9T>3=+<'-N;&A9+WI&;79Z2&-S
M=6\V3DQ"9EAI>EA1:CE4,31W16A9)B-X03MY3CE84$AK>7)%>6MD974K0E94
M>4)P;SAU95=.4W1L=$QI3S-S.5$Q3U<R=#)%<W-Z=R]7<$AJ2V5P>6ML36DP
M2VUP3%8W-'$X-3 O)B-X03MY+S4X,'AR>E9B+U)V:C@T85AQ165R0WIE83=N
M1C-+:W0S8697659T-&A$-E-U,7-+331R>$9F17%I3'9Y=C5J8E0Y3#!O-F)C
M2%1V)B-X03M,=#EP5C-P.4EM4$DS;#EB5%-&44%3=C%+35A%8B]Y;W<W9$98
M=#)"54YE,C!K-%%*5#1A,7)I<44O4G1X-'(Y+W=$6FA6,S9.=5!&)B-X03MF
M=CA!-TU69"MJ8FIX6#<O04]Z1EAF;S(T.%8K+W=$<WA6,S9.=5!&9G8X03=-
M5F0K:F)J>%@W+T%/>D989F\R-#A6*R]W1'-X5C,V)B-X03M.=5!&9G8X03=-
M5EAA,W Y>&4V84QE2&HV;DI4.%)O3G-Q>7A-:%%B36-G1%I9-2]H1%9V1TPO
M9VHO5$UB=TI.+VIX9"]H1%9V1TPO)B-X03M!24DO,'@X0U,K4$8S*T5.5SA9
M=BM#4#E-9D%K=FIX9"]H1%9V1TPO04E)+S!X.$-3*U!&,RM%3E<X678K0U Y
M369!:W9J>&0O:$16)B-X03MV1TPO04E)+S!X.$-3*U!&,RM%3E<X678K0U Y
M369!:W9J>&0O:$16=D=,+T%)22\P>#A#4RM01E!V,%9D9C1D+U(O=R]73TY/
M=G<O)B-X03MB-61A94=8.$(T2V%E36-D<%):96-.96XX>&5:=$YB43522&\Q
M=%IZ861B0U,R*W,S:'58=55A44XV+V]O:F96>'=$<W)$8W0Q0VDU)B-X03MQ
M5G9,;FYE>'5F3'5I,S)V,U9N<%=O-G=#<T9N3$Y(15AM1#A04VA$=51)=TI5
M9D-4=69F1E5$6F5B=D]';W=E6DDW8E)%=&13,'DY)B-X03MG=$Q#,'5P66E2
M1DY&1$DQ>&-V1DLP6D-,2S!N0TXV.%)X*S%I<4TX;65:.5(Q97HQ:')Q5S%V
M4G!L,#%V8C9P65)Y4E=L,'%W<$E7)B-X03MJ4C5*>BLW9'I',T=2:%9D:C)#
M<D-.12].,UA,>E,Y4'92<5=I871C,S)M6$XY9#9:<#A5:51A9DI"6G1C<CE:
M4#%Y-$I4,49%5$%O)B-X03MH<5)I<5I84#5P-C)N;"]Y,5!(8E=P,6TO=EE,
M8E<T5T5H:6EH3C-&6GIV0T$O249N=5DR:35-9FA/.6-+=E0X0V]057!*15=0
M9WA7)B-X03MP3F%';4MO1#9X8V8W.68O04E)-%5/*W-82"LO6"\T231Q-S9X
M8V8W.68X031)-'$W-GAC9C<Y9B]G:FER=G)&>"]V,2]W1&=J:7)V)B-X03MR
M1G@O=C$O*T-/2W4K<UA(*R]8+T%/0T]+=2MS6$@K+U@O-$DT<78X>51Z=S9/
M2DEP1VIK-4HX845Q9"]C6E1M2D5D;3=#3&MX2#E+)B-X03LV<"]Y,E0O.&I(
M+W)M2'AY-S-+-$DY>G8P<G%N+TQ:4"]W06I(+W)J>'DW,31).7IV,')Q;B],
M6E O>4UF*W502$QV6&=J,T\O4W5Q)B-X03MF.'1K+W=$>4UF.$%R:GAY-S$T
M23EZ=C!R<6XO04,R5"]W1$EX+S8T.&-U.65#4&,W.4LV<"]Y,E0O.$%)>"\V
M-#AC=3EE0U!C-SE+)B-X03LV<"]Y,E0O.&I(+W)J>'DW,31).7IV,')Q;B],
M6E X03AJ2"]!2S0X8W4Y94-08WEF-GIC+W=#1798.58O6#16.5AK968Y-50W
M6%A-)B-X03MN:5!H,C0Y1'A+4CEV;VQR0G)T.7)34$EB<2]T-V$Q;5%K96U%
M=$=M94UQ2U9Q5&-T>7%F1' S>4=H9&]M:U<R:C980G!T<WIV0F)G)B-X03MH
M1VQ)3&YK>&)C<49(5G9$1E5O,79Y2'!M<C)7=#)K=#%C=TIR.'-%,38X2FA*
M2#%:26M#27-S57%&2%=!0C%D5S5!:V1$:7%9-DYO)B-X03MK*VY73#)C*W S
M3W!2<T]-5%A+5VM::5%,>$-2<F%15W%C9FUP>%93<W9+=6Y7;FQ#3'ER2$I-
M9$]I<V8P87-R37!M.45296IY3$)1)B-X03MV4&HS-#!R,GA62S50>7DX=79*
M3DQZ=49K;F946DA93VXR=$ME3C1E24M%1#%045%3,"LP04]L359:8FEQ:&1V
M8G%&.5IE44YE3TMO)B-X03MB,3E.+W=".4@W=C=C5F0V*VTO-S90,V8R-'$W
M,3E.+S,P9G4O='A6,W(V8B]V;R]D+V)I<G98,#,O9E(K-RLS1EAE=G!V.$%V
M;R]D)B-X03LO8FER=E@P,R]F4BLW*S-&6&5V<'8K*VHY,SEU2W0V=$YP.%9H
M>G9)>DIB,5@T04LW;G S1U%Y14%B<S1!:S=*2"MK9DM0.$%Y>'0O)B-X03MW
M4#A!>F1M4'@T*S5U-$HY-W8P:C52+S59,B\T2"]M-TAJ>#EY.$4K.3,V4CAO
M+SAS8F8X1"]Z9&IX-"LU94-F93<Y22M59BM73G8K)B-X03M"+S5U>#0X9F-V
M0E!V9"MK9DM0+T%#>'0O=T%$+W=!,UDX95!U6&=N,W4O4U!L2"]!2EDR+W=#
M0B]W0V)S95!(,TQW5#<S9G!(>6HO)B-X03M!37-B9CA$+T%-,UDX95!U6&=N
M,W4O4U!L2"]L:F(O9V8K8G-E4$@S3'=4-S T*W-A6"MG+U<Y22]O+VHO9%4S
M<'IP,'(O3C<U9&-E)B-X03M'*VI6575,>E)E;S)K=#-9>E<P5C%.67E3<597
M-W0O5#E73W8W4V5Q:W%6*V%N3%=T-#ED6$AL5WHX:65525!-0F@Q0U%R9$Q9
M,D]R)B-X03M83G9B-F9.2W!+=%!E>51Q5B]D2V9H-'%4>6):5#)+<S(X<%=7
M=5 U671.2FDQ0S)L,&M74W@R=FU85&)Z,7)H;D9!9E-H;70U;U%I)B-X03LO
M16EU6FY.04YQ.4%Q="M88UIJ+T%#-3 V374P<%,S;%5Y>4=R=%(S2$II04YZ
M,W=Q.'DX<BM43'8O;%AE;&$W1'!/;&%00F)E6')M)B-X03M3-79R1U)M=F11
M5V94;5)6=6Q&<F)Q4&E94W175B]I02ME0E-T=E5U,C!044Y!9%A&<#56,4A2
M<FA*1'E!8UAT.6)#>%94*S!)-V57)B-X03ME32LV:C)/1EAV;4)53&97.&MW
M44I4-&$Q<FEQ12]2,7HT1#<X2W4O4C%Z-$0W.%9D*VIR;G=(,S1Q-SE(6%!G
M4'9X5C,V3W5F069F)B-X03MI<G8P9&,K02LO1EAF;S8U.$(Y*TMU+U(Q>C1$
M-SA66&$U65A&-7!G=#1!1$IY53!*;TYU=59:66U1;TYM3U%"<W-B+T%-2C9X
M+TEN)B-X03LO0FI-8G=*3U(T,%AF-%0Q:BM24"M$1U!G4UAX;W4O=VYR2#AI
M9CA!0FI(=TI,-#!89C14,6HK4E K1$=09U-8>&]U+W=N<D@X:68X)B-X03M'
M369!:W9J4F0O:%!74#5%+W=#1$=09U-8>&]U+W=!2C9X+TEN+T)J2'=*3#0P
M6&8T5#%J*U)0*T1'4&=36'AO<"\X06]U-R]!34XO)B-X03M52T0V>'AP4W4Q
M969,<CAS=C1$=U8Q84]-8V1P>&QZ56M(;EAZ9$0U5S!6.5-K<S=I*UE%2DA$
M8GA33W1344MY>4EK:7=O2S=U*S,P)B-X03LT<6IV34=Q6%=M859,9#)L:DQQ
M5C!':FIG<V]1951V3$ES83AM06)G:6QU5'52.$MG;G1I<4$X="M:-W)61C%E
M1RMS-#=4561&=41B)B-X03M88U9V4#EA9UIJ0VLV;4]9>'=-9F=L05E.1T-P
M-V0X5EEZ6B]M;G)0-DDP<E8Y4C!/,G0W3%<W0V4K,#17,2]*8U,Q9W,R=F94
M;E(W)B-X03M305)H;S!)-7%Z56%G-S1Q:4QJ.#$T-'9,+VQZ53$P=W9D-C5E
M43)D>EEE<T%B5&YC2F%Z>48K0CE14E13;W8R4GDU03=9<7HW1E5*)B-X03MQ
M37-K87!W67)5;71-5E%0,74U+S,T8TM(9E<W;B]F:'A6,S%U-2\S-&-69#EB
M=68Y*TA&6&97-VXO9FAX5C,Q=34O,S1C5F0Y8G5F)B-X03LY*TA&6&97-VXO
M9FAX5DU,=5(P=$$V=%)T=#A#578X07)D>B]!3#A/1D1V<F1Z+W9W-'$W-C-C
M+S<X3TMU*W0S4"LO1&ER=G)D>B]V)B-X03MW-'$W-C-C+S<X3TMU*W0S4"LO
M1&ER=G)D>B]V=S1Q:G96:R]2+W%C:GIP.7(V8T-56&EQ5BM:.44O5&UG6'5K
M*W0Y6"MU4BMN-B]()B-X03MN>#-"<GAQ=&5N:FEQ6"MA4$ID='%L=&94855B
M9E(O34XX:V--=792,G=A-DU#=6AE27EX4&)Z.%A34&AT2T-/;S-!>%98.'(K
M6')V)B-X03M2.4EK,#):-T0P="]26%1B2C=+3E%W;WAD2DQI-TQU5'57-4%N
M=C0T<6Q':"]L5C5A,&)Y;BMH<D\P<S1T56945S R-#%Y1WII:75*)B-X03M3
M.%!P=DLO2#1Z>5!X1E1*.4]+;V%8.'%)2&MK:UA55T)A6%1*;U5-44MX1W=M
M9VUU3T$U:B]E=')74&PO2U)89F9&5V4T<6]84G1G)B-X03M&.6-61R](<B]$
M1E50>C!V=R]"<U9D>C!V=R]"<U9D>C!V=R]"<U9D>C!V=R]"<U9D>C!V=R]"
M<U9D>C!V=R]"<U9D>C!V=R]"<U9D)B-X03MZ,'9W+T)S5E)5-6=%24UG+V0W
M538O4FEQ1C4V6#1F9S)+=34V6#1F9S)+=34V6#1F9S)+=34V6#1F9S)+=34V
M6#1F9S)+=34V6#1F)B-X03MG,DMU-398-&9G,DMU-398-&9G,DMO;71T.59R
M5#EX5'!V,')I<71I<GHO.#)B>GEN8FY2,#$Y3&4W958W9U=';39L8U%7=6U3
M4T)&)B-X03M$5%AB>FAH4T97*T1I1V%R8DME;U919TU6<#5!=&)46%5T3F0X
M;E%W5W%3879:6&-T=TI0,S!9-7DR-%9&87IH879Q9C93.5DQ*TI4)B-X03M5
M9TMQ,S553&)284PU:G1R2U,Q=61.:C%'6G)/.3 R4#!.3VM74S-I6FA:=SAP
M1FIJ4C9Q47-J<5@U2&QU44971F56+TIL,R]!37$W)B-X03LP<EA99$HP<E(T
M3&)Y.6-Y6$XY67E-,3=Q0WHV8WE+=#!O=&)D4CA40U9Q>78X44AZ>%5R8C%,
M='1$,$112%9X86569%(P831343AG)B-X03M(1C=F5W=S5E4O=$-/,VQN:E!U
M;SEJ:%8W-6=60U@X17-O5# Q-55R6&-$.65+;U V:&0O>69I4#8T5F0Y474O
M-5!X2#EC5F0Y474O)B-X03LU4'A(.6-69#E1=2\U4'A(.6-69#E1=2\U4'A(
M.6-69#E1=2\U4'A(.6-69#E1=2\U4'A(.6-69#E1=2\U4'A(.6-64CDQ1$DY
M<455)B-X03M6654R,C=91E%(,4,W+VLO168Q=W$W-FAD+WEF:5 V-'$W-FAD
M+WEF:5 V-'$W-FAD+WEF:5 V-'$W-FAD+WEF:5 V-'$W-FAD+WEF)B-X03MI
M4#8T<3<V:&0O>69I4#8T<3<V:&0O>69I4#8T<6IF4FPK;V5L>"]E53962&I8
M07%+>%9J+VY(>DIQ3V=74UAL=F%7:VQM;V1R,BLQ)B-X03M'*UA4-U<S04MR
M1TAK36,W;'!89FEG0U5R,4DR<7%I3DTX>C)6,354=&9-=#1P,#9Z;G,T-S9:
M3&I:;U5E35-%3E1U2R]4:7%'.&]E)B-X03MB6#AX84IC-FTY:$IP-U<Y>F,R
M>'1*;4)K+S!:>6Q8;T)X6G%B<G9X-E9/2W-A<R]Z5#%N.45A5G$K;S9(8E<Y
M;')D:%!F86-,82]K)B-X03MU2F%W5V)8=G!Z;SEP04EW,&%%8S%:<4Y19#A6
M4D9X*V$X8UAL+WDU<6$V65AU.6-V26)/-7-05T%.<'IU171:-4,O02MO27!P
M55@W)B-X03M)-6-G9'-66CEI<45V-3599VYP='AR5W5W4#8X5E%F,2LW+VXO
M068P=W$W-B]D+WHO9U V67$W-B]D+WHO9U V67$W-B]D+WHO9U V)B-X03M9
M<3<V+V0O>B]G4#99<3<V+V0O>B]G4#99<3<V+V0O>B]G4#99<3<V+V0O>B]G
M4#99<6HW<6%23%5/<&]X<'9T,W=+9U!R.3,O4#A!)B-X03MG4#995F0Y9G4O
M-2]W2#E-5F0Y9G4O-2]W2#E-5F0Y9G4O-2]W2#E-5F0Y9G4O-2]W2#E-5F0Y
M9G4O-2]W2#E-5F0Y9G4O-2]W2#E-)B-X03M69#EF=2\U+W=(.4U64G9R4R]5
M4%8U9G9+9&%$>'!G5D99<6MN;4Q2=&%V<#=3-C!J5E)P,7IA<DY'.&,X5#-6
M<$UK-%5(,6)D6G)F)B-X03MK-D9!56)L.$\O6FII<54R9C54*U,T=$=T.5!U
M8D9*-VU+3TM/8E99:#E5=DI4039Y<%<T=%1$2T974TY75E$Q0GA8=T=+;S=Y
M;#5,)B-X03MT+TQE;C9J6G=88SEY=6]89'ID.#=I5V5::T9W>%E*5V5766MQ
M1#A45D)C-VYF1E5U,% X<79,5VIE52\P3EHR;&Y&<6HV83)M,T=U)B-X03M1
M,F-55GA+6&@Y3C58-"]'95(K27%:4'!X5D13+VQ203AK:VDV:7=,4S9:3D-H
M:4)723)%,$4Q>'=(368W,71A>#AV-5-+-S<T<7HS)B-X03M&5D,W1G)29EA.
M0G9X-B]W>%9$53!R>% O1%EQ-FUL94HO-&)&6%4P<GA0+T%!,DMU<'!8:68X
M06AS5F144W9%+W=$1%EQ-FUL94HO)B-X03LT8D9853!R>% O1%EQ-FUL94HO
M-&)&5590.5@Y065R+T%(5S%/=C!D3591=$Y+.%0O=T%.:7)Q858T;B]!26)&
M6%4P<GA0.$%W,DMU)B-X03MP<%AI9BM'>%8Q3DLX5"]W,DMU<'!8:68K1WA6
M,4Y+.%0O=S)+=7!P6&EF*T=X5D4P='9Q;E@Y>%1R=C!R.2M+<2M+<T4O3C$O
M36-N)B-X03ML*U-X,#)W=7)J5$QI,W57,6DV<S5,84]626\T<7!%4%AM=#(T
M>7-F:EI+:TE#04MS0T95<#%G86AQ9C5945=M<RMJ-68X='DR1VXK)B-X03MV
M<6IU,3-D249E1&MS='!(13!#4G919WE'9&Q65'ED86-G1E5Z+TQ)5V-/:F$Y
M6C97,71C-DAA,VIR<&UP,FQV8E=Y6%-.8E)02357)B-X03LP:FAT-4-K:DY(
M-FMA04YX.7-664@U6#AM6&8O04-R=E-T9&@P;E-T2&=T=DPQ>DIC,S%J27I8
M=6],4'!Z27$S4VDQ=#%(>$U*5W)+)B-X03LO=T%12'IX57)B,4QT=$0P1%%(
M5GAA959D4C!A-%-1.&=(1C=F5W=S5E4O=$-/,VQN:E!U;SEJ:%8W-6=60V%J
M1DI)<6-&3%5*<E1&)B-X03M51#E5=68X069:=V]D.55U9CDY;D989E9,;B]F
M6GA6,S%3-2\S,F-69#E5=68Y.6Y&6&963&XO9EIX5C,Q4S4O,S)C5F0Y575F
M.3EN)B-X03M&57=U-#-E,$-+=%<R,G=*4R\V<&,O-S=/1D1V<6QZ+T%,-T]+
M=2MQ6% X079S-'$W-G!C+W=#*WII<G9Q;'HO04PW3TMU*W%84#A!)B-X03MV
M<S1Q-S9P8R]W0RMZ:7)V<6QZ+T%,-T]+;S<P<% P9C9F13@V9EHK;D%L1C1Q
M>')Z<C4K,&9Y:6QI9%)J95)T46ME3T%,3&%12U!4)B-X03M4;7I03&5Z,G-+
M:G0Y=7!*;TU64CDY-6QS=% X=69P-CEI;&AT+U-J:RMR:C U6G55>%99-&PY
M1C5),V1N9%9(1GEP2C8P,WA69&\R)B-X03MU=G%.<F-Z5#9:93983&%U635B
M5RM21F,P44]':F5*-6]:1DEB-U-32&5O3D-#3599-5IF;79P<SEH6F%J8S9.
M<5=N,D=P5VMT-W!L)B-X03MZ8T-Z6F)H26)D<G!K4EE,;5HQ8W=O>D%32W94
M<FEQ2FXO33=Y.41O5VAA>5ER<&]0349Z0EHR<T-X<#8P57,X;G!(,3$U.%5%
M56YW)B-X03M314UA2%E6>%9L,DMP2C5N,4\X<T5T>F)/14UH64Y503E+538O
M4$M-,'I'<6)S34)+-U-$+T9/=&8W*T@O04PO045Y:G@U3C-G>&0O)B-X03MI
M;E=V.2]$+T%)0F8V62M02F9":3<O1D]T9C<K2"]!3"]42'@U3#1-6&8T<#%R
M+V9W+S1"9C99*U!*9D)I-R]&3W1F-RM(+T%,+U1()B-X03MX-4PT35AF-' Q
M<B]!2#A0*T%8*VU0:GE8=UEU+W=!538Q+W8T9CA!04PO5$AX-4PT35AF-' Q
M<B]F=R\T0F8V62M02F9":7E45TY1)B-X03MU<F)2;S=M1F=S>F-+=%%(-U$S
M,D]:3U-:16)$4D-)37%9,R]!27 Q<B]F=R]W0T%8*VU9,VIY8B]":3<O1D]T
M9C<K2"]!3"]!17@X)B-X03ME4RM$1C,K2V1A+S,X4#A!9T8O<&HT.&PX1TQV
M.%4V,2]V-&8X078Y369(:W9G>&0O:6Y7=CDO1"]G1B]P:C0X;#A'3'8X538Q
M+W8T)B-X03MF.$%V.4UF2&MV9WAD+VEN5W8X069W+S1"9C99*U!*9D)I-R]!
M0E1R6"LO:"]W04%V.4UF2&MV9WA:1"MK<GHO04%Z.64U:C9Z>')Z)B-X03MO
M2U8U.&5N5'!M4GAN9W9Q,#A!-#94;DQM;$EF33%H<DUS.6QE851P*VPS.3%B
M0V1+86U8:61&;E%+5$1C4GA80E%(:E-29E0K361X)B-X03M41E=->2]L2F)T
M-4IH,%DS1'IA:$9&84)K:W5,;V%C-S)K.%9X-F$R6FMK:&E2>D1W-4I(>D-K
M*SE653,X:V55-S-1-T16;W!O3%!4)B-X03LP,4<U864Q,&I4;F0W3S!1=W!(
M>&I:-#10='-H:V)J16]Q9&@S2W%684HK53ER<"]K<3,P*U9N;CAW46%42G V
M5'I8=#=C5VM5.'1T)B-X03LV16I14E1U>5))96YW4DME3S%/,DMO4V8X<DY9
M8V=,9%<U:'0U.4YN<TE#6D%):D9D5S%Z<5<O03$Y6C=-3DAT,4IR461#<C S
M07%6)B-X03LV-V(V5$US4#91;4U1570V9$13=&%6-TA+<V]I96)::DUH>5-J
M.4AE568X06QS8B]!24PO04IT>6YG>#DW8GAZ-VYF;S=Y:B]!371J)B-X03MF
M.$8O>F)J=UDK.65/9F,W.4AE568K5WAV*T,O-71X-$UF979(4'5D*VIV2U O
M3%DS+T)F.#(T.$=0=EAJ;C-/+U(S;$@O;'-B+V=V)B-X03LK8F-E1$@S<GAZ
M-VYF;S=Y:B]Y,DXO=U@O3G500FHW,30U.7IV,&0U4B\U8D<O-$PO;3-(9W@Y
M-CAC*S4S-D\X;R\X04Q9,R]!05@O)B-X03M!1&)J=UDK.65/9F-N97!186)*
M<'%2,U5P4S%(1&DT3D1S4&@S;V-V;4DX3R]*<6=493-.2E P9#52+S5B1R\T
M3"]M,TM/1$@S='9()B-X03M0=60K:G9+4"],63,O0F8X,C0X1U!V6&IN,T\O
M4C-L2"]L<V(O9W8K8F-E1$@S<GAZ-VYF;S=Y:B]W071J9CA!0F8X04YU4$)J
M-S$T)B-X03LU.7IV,&0U4B]W0U=X=CA!9W8X06TS2&=X.38X8RLU,S9/.&\O
M=T1,63,O0F8X,C0X1U!V6&IN,T\O4C-L2"]L<V(O9W8K8F-E1$@S)B-X03MR
M>'HW;F9O-WEJ+WDR3B]W6"].=5!":C<Q-#4Y>6-F5CE,+U%F;RMQ9C!F>"]V
M83<P-3$V,"]M.7-U<5!$6%)Q=5A&-7!N;')7=U0X)B-X03MY2G1D;3%B>2]O
M*VUH>D)F1S=M=6M3+VTP<U-',FE6:VIA-W0P;&U19D=Z8U5(>&-D+VAR:7)V
M3"MT5S)S951B8U@Y='$X3VI*64QD)B-X03M3-CE,97A2<W=H05IL*W,R3GA&
M9$UW-&UR*VUQ=4%A:S$S5E)8-68V6F57;FQI8E5B:31V5VLQ8FQE=U=T-V0S
M1C(Q<$$V+W5)5F4T)B-X03MK;6--16]Z+T%"9F)*-T%9<3@K.'0O-'-L.&PV
M6G)L<VUT,F]':#-.>G)'<6%H<6I854XP>C)$1THW844S;'DX5"]73TUI=#95
M9$%#)B-X03M/.4U62RLW.'DK66TP5'DO;S8V:F1,9F%*<4=M3G)&-'-R:5=E
M0S9V3&%+,&IN8TAL24QI,G576C9N-&U1,3=J0W(R+T%R2'9..7)C)B-X03MZ
M>#)O9VAE57%8-6-&3%5Q0C%P;5!Q26LQ5&9G248R>'(Y1F%P+WEX>B\X04ET
M+S9::F-%=35Y3T]093<Y1F%P+W=!<V,O.$%Y3&8K)B-X03MM4$),=5AJ:C-U
M+U)7<68X<V,O+T%#3&8K;5!"3'58:FHS=2]25W%F.'-C+R])="\V63A%=35E
M3U!E-SE&87 O>7AZ+T%0270O=T-M)B-X03M00DQU6&IJ,W4O4E=Q9CA!3$A0
M+T%-:3,O<&IW4S=L-#0Y-W8P5G%N+TQ(4"]W06DS+W!J=U,W;#0T.3=V,%9Q
M;B],2% O>4QF*VU0)B-X03M"3'58:FHS<W(Q,C-U2F1":6EJ:60U0C9D5593
M5S)'*W=Z2WEG;41J67E/2FEN-DLQ5"]L:FXO-49V.$$P>D8T2F1Z:SAC93DS
M-DLQ)B-X03M4+VQJ;B\U1G8O5$AG;#-,>'@W,V9O<E90*U=/9B]K5R]W1%1(
M9VPS3'AX-S-F;W)64#A!;&IN+T%/4F(O=T)-94-88W9(2'9D*VET)B-X03M5
M+S59-2\X06M7+SE-94-88W9(2'9D*VET52\U634O*U)B+S!X-$ID>3AC93DS
M-DLQ5"]L:FXO-49V.$$P>#1*9'DX8V4Y,S9+,50O)B-X03M!2EDU+W=$:U<O
M.$%42&=L,TQX>#<R5"]!1F$U+W=!2F5H-E0K=G=P-EA%."]W0SAR.6YR;51W
M;G<V8V5X-&QP+VU1,$UE.#=.<"\V)B-X03M-0V%N-6)B>DAP-CAP<#1I=&<X
M55!P0W9Q4TQF>C(V9$-A1F$P,S99<6@U4$UU:'8K6#8V,64V5%!$;S%Z8F]N
M-D=U24EF5F%+9&A")B-X03M&0S!03F]A4V,Q059M-#!0>%4S>%9'*UAF33%L
M<F1J9E!(6GHR5#9:4$I:6#%J8W)&>FIL:5)82U9H96%&:'=K56IG-4<O:FER
M1SE/)B-X03LO35AY-C)G5TEL.'58;6UE6#E1<TI:9$MJ;6IS4'$X.79$871C
M1T))8F4T;316=#!9<6MI2TM#;4MQ='HU>CAI<&]/:#9X2G!2:W0O)B-X03M-
M5C%:5VQT8FDR:$TP8WE3:$E$8TM7-'%,5V%I,41(9S%/3RM+<S=X5DIV365R
M6%=N2D%B9FI747-'-4-V4VYU4$A+8S)1>'%M,T9!)B-X03M3-7!(+VDO5G9#
M3"]!244O,7EJ>#5.,V=29"]I+U9V0TPO9U0O6$AX-4PT15AF-'8Q8G=I+W=#
M0E Y8V9(:W9G4F0O:2]6=D-,+V=4)B-X03LO6$AX-4PT15AF-'8Q8G=I+W=#
M0E Y8V9(:W9G4F0O:2]6=D-,+V=4+UA(>#5,-$589C1V,6)W:2]W0T)0.6-F
M2&MV9U)D+VDO5G9#)B-X03M,+V=4+UA(>#5,-$57439T<59X8391;#-&>#E6
M=49A:6\K25909DUJ2DUI3G1%24%Y<&HS*TPY5SA)=BM"4#A!6$UF>#5.+V=2
M9"]I)B-X03LO5G9#3"]G5"]82'@U3#1%6&8T=C%B=VDO=T-"4#EC9DAK=F=2
M9"]I+U9V0TPO9U0O6$AX-4PT15AF-'8Q8G=I+W=#0E Y8V9(:W9G)B-X03M2
M9"]I+U9V0TPO9U0O6$AX-4PT15AF-'8Q8G=I+W=#0E Y8V9(:W9G4F0O:2]6
M=D-,+V=4+UA(>#5,-$55*R]3=#$O:#,Y269$.5DT)B-X03LQ-F9$.79J,'(T
M6F9X;F=T<#1">#!M*UA.4U-E8G1%=3EC,'E,5$EN4DQ/935G3W%+-4E-;&Y'
M+T]72F%+,696-&A'0G X2D\K2W!B)B-X03LU,CAJ9G!V5#=S,E4P9W9R:S(T
M:W1B;3=U>G X,$U%,&-K;'9*8D(S:&I76DEV5%HP:3552C8Q24MR=DI(;$\X
M,$]W,6%+5T,P,"M0)B-X03M58FQR:3$P:E0S9#=/,%5W<$=6:5HT-$0X8DE:
M1S1X<6]*,DAC<7!6;VXU5#)U;BM3<F94-5=E9GI"0G!-;6YP4$YE,W1X85)4
M>3(S)B-X03MO4TY"1D\W2D5H-F9"17 T-U4W67%H2B]Y<S%H>4%T,6)M1S-N
M,#)E=V=*:T%I358Q8EA/<&(X1%@Q;G-W,&4S56UT0C!+=E1C0W!D)B-X03MR
M3VQ7="MS475*5$5)>5-T0T)7=%!(-5I8:WAI5$]'5&A3>B]!07!P4"],63,O
M0DHO5$LO>31B4$A,=CA+850O04UT:F8X16XY369Y)B-X03LT6'AY-R]#;6LO
M.$%,63,O04%39C!X+TQH9DA,=CA+850O>3).+W=39C!X+TQH9DA,=CA!0VUK
M+SAT:F8X16XY369Y-%AX>3<O0VUK)B-X03LO=T1,63,O0DHO5$@X=48X8W4O
M=W!P4"]!0S).+W=!16XY369Y-%AX>3<O0VUK+SAT:F8X16XY369Y-%AX>6UM
M<#)6;DYP>3(Y>% V)B-X03M-0SAA4VMQ=C)2='5D<W-N14555W5%:4194U0Y
M06589BMR;78O27E,2V9#:#-T,VE4-VYF;T1Y-R]W0EA.9CA!:UI&:C153SEF
M16XS)B-X03M/+U%(;#,O<35R+WE-:7@X2TAE=FE4-VYF;T1Y-R\Q8S$O-4=2
M62M&1'98>$HY>G8P0C5D+W=#<FUV.$%Y36EX.$M(979I5#=N9F]$)B-X03MY
M-R\Q8S$O-4=262M&1'98>$HY>G8P0C5D+S9U82\X04EY3$AW;V0V*TI0=60K
M9U!,=CA!,6,Q+S5'4EDK1D1V6'A*.7EC9E5B1#E")B-X03LO5E!R02MP.&%F
M5T]3,'!Z<CER-U!88DQE16-.6',Q8U(T<G)D33AT83)"+VU82G$Y>'%E9S90
M<&-J*W1E9EA:-6)96#%X<&%34C(P)B-X03M),V$X=%$X>7-J>7%Y>&=58F5T
M075+<%!&-6HX>3,S-5DR0W%T-FQW,719:30X=U181FI:<F1-6C1O-VE#0U@V
M>C9K8SAW3'AX3WE!)B-X03M&<45.=4-653<O3'95=%1U3%!Z3$)01F1W5VUN
M86<Y=G!Y6#EW3'4U:E%7<TQY4G9C0U-F,4-K>G9V-FIC9G,X=FAX5F<S;'8O
M1FMV)B-X03MK=E1.8W1K,74Q03!/-75D63%454Y5839H=6UE=UEX4&)1;3AU
M6&EF-GAX:U9V4VIO05(S<&EP6#-F;5AZ13)I95@Y2%A58G!B-U).)B-X03M1
M,'AT679&;&-3>G=85C5B4E=K8S=G.'!"8U<Q>7I052]%>4=V8UE693,T1E%7
M<'%X5T]G2C-05$95=CE/5"M5+V-C2TAE;DHO2V9U)B-X03M/2W4Y3U0K52]C
M8U9D-F-N.' K-#1Q-S U4#54.7AX5C-P>69Y;C=J:7)V5&LO;% S2$9896Y*
M+TMF=4]+<B]--D\K:6A657,S2DYG)B-X03M+;DM-+W="3&1H*W!H,S%A-2\S
M,"]W1'=*>D1O=5A99#E7=68Y.5 O04U#8V%+,DAF5G)N+V94+T%006Y':71H
M,S%A-2]W0CE0+W=*)B-X03MX;W)99#E7=68Y.5 O=T%#8V%+,DAF5G)N+V94
M+W=$06Y':71H,S%A-2\S,"]W1'=*>&]R660Y5W5F.$%F5"\X0V-A2S)'5F5N
M2B]G)B-X03LW:'A04&@Y;6AR+V4K1UI69G4S1W8Y-&UU<C9V<#)J-F9,<4]O
M>D-#>F=P-FMH1$UA<W=65E951$UZ37I"5E914U1S37E':$PP+W=L)B-X03LU
M>3 P+U=,3T163$]'57!*839H84AL1DUG0DMY5SDQ1W)X=4%W3D=51V@Y.%95
M-R]!1G)Y53)K-G1A6&HR,#)L85)W=$Y6=%=I.5=#)B-X03M-<VE-:T)I-'-R
M;FDV04EO3R]W,')T:7%T-5EV=DLY>&]Z2F]-561T<&QM-S(X;&MT<SEN-D1R
M.%1X=F)/:U1X;6HX=4I19&$Y.%93)B-X03MF5%!0;C5E6$]L4E=L<4AG,&53
M>6MK=%EP=$YV3%<P;',T665B<D(V,$5557%#2&9H2%@T93%-5E8W:GI"*UA3
M-E)P5W)49E94<#)V)B-X03M4,E5';5-M,DQE=$U'-5=3.%!43'%9,D96-6=E
M;68U8U9:6&EQ2'9,;#1!<%5!.'$Q<C=9<6AF,'!.+TEV-#1Q-SE+5&9Y3"M/
M2W4O)B-X03M3:S,X:2]J:7)V,'!.+TEV-#1Q-SE+5&9Y3"M/2W4O4VLS.&DO
M:FER=C!P3B])=C0T<3<Y2U1F>4PK3TMR=%HQ2U=X,#A836%Q>C%5)B-X03MC
M5W)4-'9L;&539D-,6C0T.%)P:B]W1&I/+SA!.3A29CA.+UA-9CA!349V.$%/
M+WAN9CA!*RM)=BM'+W)J*UE+*T%(9C1Z=B]!4&9%)B-X03M8+T1F,7@O349F
M041V.%HS+W=$=FE,+VAV-C0O;4-V9T(S*TTW+SA!,WA&+W<S.6-F>D)8=T$W
M+T%";F8O=T,K278X06AV-C0O;4-V)B-X03MG0C,K33<O+T%(>$8O=T%.+UA(
M.'=6.$%/+WAN9B\W-&DO-&(K=5 U9W(T051V.$%3."\V02]36$)F5C0Q-&(X
M9G0X9D=U6"M)941I)B-X03MA=4%C5DEB>GIP:RMO*U=R:3-T<E-7.'55:W0U
M-V5',VYJ='!X2D)/:W%Y47EY<3A1:VI+8S!$:FEX1D-11%A,5W!)9DIF;$1Z
M2&)M)B-X03LO=T)3,416=%-S8FY59%,K=7DR<V@P-E=A5T=/1T<S4T\W6DE*
M;U%75S-R4S)+,$15<G181E5&9F518GDR='9-55=I-EI"8E<W87AP)B-X03ME
M<F%B65%#1T-'-5=X1G),3DAX57%Q1U-30G@X64AX8FYB9D974656=$PQ551E
M63E6=G).=%!M,7DV5V%$5#-A2C5)-#1B4TLR57ET)B-X03M#.'-8<4]9:51X
M8V=#;2M+<U@P8CAS=%=J.&=A9$)Q;#=E6&US-F1O,'1T639233%K3&4R=35R
M2G):;%(T25DR86EU,&%T2DUW;V5V)B-X03MF1E5(8V9L-S5R84<R=%)B0G)(
M4S=V5&)R5$E23$A7<S$Y8EA7<$9Q<T%046$S:TLO=T%W8VAA;G%6974T1E5,
M=3-364M'9FA3=$U6)B-X03M1,S90:"\S.%!W+W)I<G8P9D0O=C1F:"]81EAF
M;RM(+T%(.%!W+W)I<G8P9D0O=C1F:"]81EAF;RM(+V9W+T0K=4MU+U(X4"LO
M:"M()B-X03LY8U9D*VHT9CDO1#A0-C1Q-SE(=R]W0R]H*T@Y8U9B,6%W:74W
M1#9V2DU)57%P.5$P-V9-:DE:23)+6G=L4G1)+W=$0W1H+S%C;"LU)B-X03MF
M*V%S>"]!2&4S94UE-3,K1F)$+T%+=5,O8W8O0416:C1!-S$X63EZ=CA+,D@O
M5GE8-VPO-7%X.$%D-BM-934S*T9B1"]Q-4PY>2\X)B-X03LQ62M!3SEF1U!C
M-R]!07)99CE82F9U6"]!2G%X.$%D-BM-934S*T9B1"]Q-4PY>2\X,5DK04\Y
M9D=08S<O0W1H+W="6$IF=5@O;7)()B-X03MW0C-R-'@W;F8T5G-0*W)K=C-,
M+T%-,5DK04\Y9D=08VY(-DUG+U%F,40V=U!3-# K<V)5*S-Y.&%F:FPS04]'
M<F%U33A6<TPQ:GIJ)B-X03LU=S R-C@Y1S5&<$5U:V%B6EA/:%%X<S!Y2V)L
M-W50,7)H;6IH8FMZ47%8459644M!;F-M,7)2,FQE6DPO43EE,5A1.6-V8C-7
M-#=3)B-X03M'=VYT-S9+>&%E8TYE0V18:FQJ,#)#:7%$83AL67!S1V]73S%6
M5F5,5V9/>F5C=&4P,S!B1F]B9E0W934P4S%-,&=2>DI04$=:3&UB)B-X03LP
M0S9-,W!$-$56=TMD5'5C5E(O:W969%8Q2'E4639J<55I=G%5<T1V8U!'044Y
M4E=99D-!1C)&3G1S5F5C*U@O041L-7IU9DQE;39T)B-X03MB-G!Q=6]45#90
M8S-M<W1F85I(8E=6=DET:3!S56QR3TQ+,5-8+U-!<7%O:VM$2U-E,6-62TMU
M=GI".#%$469,;'1&94)D8FEV-T],)B-X03MZ1F-E:D5F570S=3=E,D$T1F5%
M6G5O-WA*4GA!;T%E3DU+=E@X0V](5F9S>"]-+W=X5DQS2TA9<3=&6%EQ-T98
M67$W1EA9<7%E868K)B-X03M/25 Y6DUO>B]3,UEF<5E6;44U:G-69&ER<U9D
M:7)S5F1I<G-66F(O04Y-6"]S4"M:=5I8*U-C8B]+2FQC*UAD1G5:=%)M=4Q6
M6FXQ)B-X03MA,FIS9%)$;&U75S-I.5AH1WE%.&%$-GA*,$946&9T;5,T-GI1
M4$Q':F%$1DQ(<'-5:65U5F%A5V5E839L9F=O4D$P='<X<VA61D9&)B-X03M8
M;%%D<U924S9:67)Q:VUQ3$93*VQG4S%K;35.=D1%-W5I.&$X9&UL63%P6&9&
M6%=';#)';C9E;6Y7:UAP5V-A;%5I-4TQ07A*4'A-)B-X03M3,U4K3TMQ1G8U
M93!I,CAV<#5F:'0K1VM2,G8Q1DQB;35P8CA05#1C>7AF-T<Q959F9D9522]K
M9GES-U-S,6=V3UIR2G!71'E";4]M)B-X03M/2',V:TY8.3!Y:C4O=%9X5E!-
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D)B-X03MI<G-69&ER<U9D:7%H<49W.7996$YW9T)E1THU
M1D1D2W%P27)3;FAI<GDW5&9Z-S V2'DO<#DQ<F5N6%5U;U-A4$1R96]T<#!C
M9C%E)B-X03M+,VQU1&)C9TIP,6LK1U-L44]2;V4K.4978RMA9D]E;2M89$MS
M.5-N9W5,,DQ53&TS<S=32S!61VME5S=.271P2&E&0V9F1E=06"\U)B-X03LR
M955R0S,O,#)+-'1D448Q4%EY-EAC4U=6=DUK,7%I4U,X<%HW;4\Q;T9M46=I
M63AQ+T181E9+4#@Y+TIC<VHK:D)Q371R1EE,<6,Y)B-X03LY2&)&-$ER9&]P
M2E S<DMX2TAL1C9E-#-C:6Q256A62%<S-71A3%!::6-A9&9#95<T9W1,1S!8
M-G!+,3%.9$DP:V$R.#!.>$QA=#A#)B-X03M%=%=98V8R<59'2V]A."]/<GDU
M86TR:"]2,F]Z6#@W86A(3' X8V1V-C!%=6Q2<DQD4GDX-3!J-4-.=S8X2%E-
M3V@V67%Z2%%.8G-D)B-X03MD,%-X,6UW3$=Z,4-&3&E$;4],8TI&-4%-3WA(
M9D959FER<U9D:7)Y-U5V>E X>E=E<&$O;T@Q5S!/=C(K<U=&:&]31DI"1DQA
M86PX)B-X03MC8W-O.5=R3DA&2$QY2TUO<4]G>%9%868K8RMM=&-7.6A*6E@K
M<#9J9EAD-V(R:V1H6DMU,6YC<D$S3E1C>E5#."M2:UIL6&E#4T8K)B-X03MZ
M:7%J-64O3VQ(,%!3-W9Z1G!L>&)8=7$S1W%W,C8R>7=M27!P6FMD;4YB:5)H
M.$-C4&1W869">%EQ;W4Y+U!,>7!:,BMM6%4Q;'%#)B-X03LR=7%15VQX1$UY
M5SA95F(T.%EL<$I-:E1-=E9X8FE49T]U2W W-4,X>C,O;4<Q,6EA.6II:F)4
M.5EV.$%465)#1U5'1S!L.4].;35-)B-X03LO=T%:2#)I2T0R1TMS;GA6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W%D>F)P8U<P='4U25-:1VI9<C%O=V]A5G(T
M-'$X.68X:69+3%=,)B-X03M76G4Y43E*=$94>2M4-FM03#9Q;'HY840O=T)Z
M5#%E67!8-TY0,F4K2V]N>FXK5C%N<61J65)A1D1A-F)F>#9L<#DU9C9M:4I$
M9%-W)B-X03LR5#%*.59);DQY9V)P>D9+-'%I52]+=E-9;5,W=#E4,4,S,7AB
M:35U-4YD:F$S*W1Y4UAI2DA/2%9O1W0K3$I#9T-I24)E230P3TMO)B-X03MQ
M,"],<E-,8CE,34PS54I*9%IS<F94-WDT:W5N869H87))<5-*4%%3:5)V5UES
M4WA(9T%.<U93=7HO2FYY,V$K=D]L-65(5DIB:3)U)B-X03LT.5555VM-,%4Q
M;7)P0S92=U<X5G54>&QC35AI6718-'$W67%V+S55-35:3C%A6&ML,V936'1U
M9%1K;757:V@U,T5U<G=I0S5L;7!%)B-X03M&-4)&2$%)1E55-DA&5U4K5W1!
M<R],,F=71V@R5'E35VUN47!B=U!-5F%1<6=O0S5655=V>4%X5DUS5F1I<G-6
M67IE+VPW-69V4%!.)B-X03MJ-7IL16\Q87=G3G9(1W!145!S-G)*26A5<S!I
M3$UW5G57=T]+;V)Y+W=$;&9O1VAA>D)Q,7!C6&(S34)V:6E3=D=54#93;5=E
M86]7)B-X03M.5#A,24]'+U1R6$95='50>58X=E0V9EHR2C%,56MJ,"LU=G)Q
M>6M2-UE01W5P0FAC=T$K:'9',W%-45=Q-')S,U-I<4AU=GE&.'!4)B-X03LR
M,$YU3#=5655I=$Q+>DI2-UES-C9C,TLS8W1*8G5664@W451I<F0Q-EEQ>DQY
M,359<U!,,$XO1%I34WE,<48Y8S9L35II<D546&(K)B-X03MP27$X5E0T069S
M9S%0=6-65&9&6%EQ+R\R43T]/"]X;7!'26UG.FEM86=E/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @
M(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M
M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @(" @(" @("!X
M;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E
M+U)E<V]U<F-E179E;G0C(CX*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^
M>&UP+FEI9#HQ.4%&13A".$,S.49%13$Q03)#03E%04-$130V03=#-3PO>&UP
M34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP
M+F1I9#HQ.4%&13A".$,S.49%13$Q03)#03E%04-$130V03=#-3PO>&UP34TZ
M1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]X;7!-
M33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I296YD:71I
M;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*(" @(" @
M(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#HQ.$%&
M13A".$,S.49%13$Q03)#03E%04-$130V03=#-3PO<W12968Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#HQ.$%&
M13A".$,S.49%13$Q03)#03E%04-$130V03=#-3PO<W12968Z9&]C=6UE;G1)
M1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED
M.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]S=%)E9CIO<FEG
M:6YA;$1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I;VY#
M;&%S<SYD969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @(" @(" @
M/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^
M"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C$Q049%.$(X0S,Y
M1D5%,3%!,D-!.45!0T1%-#9!-T,U/"]S=$5V=#II;G-T86YC94E$/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3$R+3(Q5#$Q.C$R.C(V
M*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I
M/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.FEN<W1A;F-E240^>&UP+FEI9#HQ.4%&13A".$,S.49%13$Q03)#03E%04-$
M130V03=#-3PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.G=H96X^,C R,RTQ,BTR,50Q,3HS-3HP,BLP-3HS,#PO<W1%=G0Z
M=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^
M061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A
M<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO
M<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@
M(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO
M;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z:6QL=7-T<F%T;W(]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP+R(^"B @(" @
M(" @(#QI;&QU<W1R871O<CI3=&%R='5P4')O9FEL93Y0<FEN=#PO:6QL=7-T
M<F%T;W(Z4W1A<G1U<%!R;V9I;&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @
M(" @("!X;6QN<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]T+W!G+R(*(" @(" @(" @(" @>&UL;G,Z<W1$:6T](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*(" @(" @(" @
M(" @>&UL;G,Z<W1&;G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S
M5'EP92]&;VYT(R(*(" @(" @(" @(" @>&UL;G,Z>&UP1STB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @(" @/'AM<%109SI(87-6
M:7-I8FQE3W9E<G!R:6YT/E1R=64\+WAM<%109SI(87-6:7-I8FQE3W9E<G!R
M:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^
M1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/@H@(" @(" @
M(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z3E!A9V5S/@H@(" @(" @(" \
M>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @/'-T1&EM.G<^-S(N.# Y.#4T/"]S=$1I;3IW/@H@(" @
M(" @(" @(" \<W1$:6TZ:#XY,2XV,S P-C8\+W-T1&EM.F@^"B @(" @(" @
M(" @(#QS=$1I;3IU;FET/DUI;&QI;65T97)S/"]S=$1I;3IU;FET/@H@(" @
M(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @(" @(" @/'AM<%109SI&
M;VYT<SX*(" @(" @(" @(" @/')D9CI"86<^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1&;G0Z9F]N=$YA;64^2&5L=F5T:6-A+4)O;&0\+W-T1FYT.F9O
M;G1.86UE/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y(
M96QV971I8V$\+W-T1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IF;VYT1F%C93Y";VQD/"]S=$9N=#IF;VYT1F%C93X*(" @(" @
M(" @(" @(" @(" @/'-T1FYT.F9O;G14>7!E/E1Y<&4@,3PO<W1&;G0Z9F]N
M=%1Y<&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG
M/C P,2XP,# \+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @
M(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93Y(5D)?7U]?
M+E!&0CL@2%9"7U]?7RY01DT\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=$YA;64^2&5L=F5T:6-A/"]S=$9N=#IF;VYT3F%M93X*(" @(" @
M(" @(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^2&5L=F5T:6-A/"]S=$9N
M=#IF;VYT1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A
M8V4^365D:75M/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @
M/'-T1FYT.F9O;G14>7!E/E1Y<&4@,3PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @
M(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/C P,2XP,# \+W-T
M1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC
M;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @
M(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93Y(5E]?7U]?+E!&0CL@2%9?7U]?
M7RY01DT\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D)A9SX*(" @(" @(" @/"]X;7!4
M4&<Z1F]N=',^"B @(" @(" @(#QX;7!44&<Z4&QA=&5.86UE<SX*(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0WEA;CPO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI/DUA9V5N=&$\+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y996QL;W<\+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:3Y";&%C:SPO<F1F.FQI/@H@(" @(" @(" @
M(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G.E!L871E3F%M97,^"B @
M(" @(" @(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" @(" @(" \<F1F
M.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P3F%M93Y$
M969A=6QT(%-W871C:"!'<F]U<#PO>&UP1SIG<F]U<$YA;64^"B @(" @(" @
M(" @(" @(" @(#QX;7!'.F=R;W5P5'EP93XP/"]X;7!'.F=R;W5P5'EP93X*
M(" @(" @(" @(" @(" @(" @/'AM<$<Z0V]L;W)A;G1S/@H@(" @(" @(" @
M(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^5VAI=&4\+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y";&%C:SPO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E
M;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^
M,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXQ,# N,# P,# P/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0TU9
M2R!2960\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P
M,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0TU92R!996QL;W<\+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D--64L@1W)E96X\+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0TU92R!#>6%N/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXQ,# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+
M($)L=64\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C$P,"XP
M,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0TU92R!-86=E;G1A/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO
M=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP
M,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3$U($T],3 P(%D].3 @2STQ,#PO>&UP
M1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,30N.3DY.3DX/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^.3 N,# P,# P/"]X;7!'.GEE;&QO
M=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3 N
M,# P,# R/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STP($T].3 @63TX-2!+/3 \+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M.3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.GEE;&QO=SXX-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P
M,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIS=V%T8VA.86UE/D,],"!-/3@P(%D].34@2STP/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C@P+C P
M,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^.34N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM
M<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M<W=A=&-H3F%M93Y#/3 @33TU,"!9/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-3 N,# P,# P
M/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3 @33TS-2!9/3@U($L],#PO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP
M93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XS-2XP,# P,#0\+WAM
M<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M>65L;&]W/C@U+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STU($T],"!9/3DP($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^-2XP,# P,#$\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E
M;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^
M.3 N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3(P
M($T],"!9/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C$Y+CDY.3DY.#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N
M,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/34P($T]
M,"!9/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP
M1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N
M/C4P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3<U($T],"!9
M/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT
M>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C<U
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3@U($T],3 @63TQ
M,# @2STQ,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y
M<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^.#4N
M,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUA9V5N=&$^,3 N,# P,# R/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^,3 N,# P,# R/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STY,"!-/3,P(%D]
M.34@2STS,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y
M<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^.3 N
M,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUA9V5N=&$^,S N,# P,# R/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXY-2XP,# P,# \
M+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIB;&%C:SXS,"XP,# P,#(\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3<U($T],"!9/3<U
M($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-S4N,# P
M,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C<U+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STX,"!-/3$P(%D]-#4@2STP
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXX,"XP,# P,# \
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XQ,"XP,# P,#(\+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C0U+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STW,"!-/3$U(%D],"!+/3 \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C<P+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C$T+CDY.3DY.#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,].#4@33TU,"!9/3 @2STP/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXX-2XP,# P,# \+WAM<$<Z8WEA
M;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XU
M,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y#/3$P,"!-/3DU(%D]-2!+/3 \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XY-2XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C4N,# P,# Q/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM
M<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M<W=A=&-H3F%M93Y#/3$P,"!-/3$P,"!9/3(U($L],C4\+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N
M,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.GEE;&QO=SXR-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXR-2XP,# P,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y#/3<U($T],3 P(%D],"!+/3 \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C<U+C P,# P,#PO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM
M<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M<W=A=&-H3F%M93Y#/34P($T],3 P(%D],"!+/3 \+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C4P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P
M,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3,U($T],3 P(%D],S4@2STQ,#PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^,S4N,# P,# T/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,S4N,# P,# T/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3 N,# P,# R/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0STQ,"!-/3$P,"!9/34P($L],#PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^,3 N,# P,# R/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^-3 N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3 @33TY-2!9/3(P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP
M93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XY-2XP,# P,# \+WAM
M<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M>65L;&]W/C$Y+CDY.3DY.#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STR-2!-/3(U(%D]-# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM
M;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!2
M3T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8WEA;CXR-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XR-2XP,# P,# \+WAM<$<Z
M;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L
M;&]W/C,Y+CDY.3DY-CPO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STT,"!-/30U(%D]-3 @2STU/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXS.2XY.3DY.38\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XT-2XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C4P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C4N,# P,# Q/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STU
M,"!-/34P(%D]-C @2STR-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^-3 N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-3 N,# P,# P/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXV
M,"XP,# P,#0\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXR-2XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/34U
M($T]-C @63TV-2!+/30P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXU-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XV,"XP,# P,#0\+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C8U
M+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F)L86-K/C,Y+CDY.3DY-CPO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],C4@
M33TT,"!9/38U($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^,C4N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^,SDN.3DY.3DV/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXV-2XP
M,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],S @33TU
M,"!9/3<U($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP
M1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N
M/C,P+C P,# P,CPO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/C4P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^-S4N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,3 N,# P,# R/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STS-2!-/38P
M(%D].# @2STR-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'
M.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^
M,S4N,# P,# T/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUA9V5N=&$^-C N,# P,# T/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXX,"XP,# P
M,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIB;&%C:SXR-2XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/30P($T]-C4@
M63TY,"!+/3,U/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXS
M.2XY.3DY.38\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XV-2XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/CDP+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C,U+C P,# P-#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-# @33TW,"!9
M/3$P,"!+/34P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXS
M.2XY.3DY.38\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XW,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P
M,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIB;&%C:SXU,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/34P($T]-S @
M63TX,"!+/3<P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXU
M,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XW,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C@P+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C<P+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(#PO
M<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X;7!'.D-O;&]R86YT<SX*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \>&UP1SIG<F]U<$YA;64^1W)A>7,\+WAM<$<Z9W)O=7!.86UE/@H@(" @
M(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^,3PO>&UP1SIG<F]U<%1Y
M<&4^"B @(" @(" @(" @(" @(" @(#QX;7!'.D-O;&]R86YT<SX*(" @(" @
M(" @(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @
M63TP($L],3 P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C$P,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+
M/3DP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P
M,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C@Y+CDY.30P-3PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L].# \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^-SDN.3DX
M-SDU/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STW,#PO>&UP1SIS=V%T
M8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E
M/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P
M,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXV.2XY.3DW,#(\+WAM
M<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/38P/"]X;7!'.G-W871C:$YA;64^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO
M>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT
M>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X
M;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F)L86-K/C4Y+CDY.3$P-#PO>&UP1SIB;&%C
M:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.
M86UE/D,],"!-/3 @63TP($L]-3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO
M9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/
M0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^-3 N,# P,# P/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP
M($T],"!9/3 @2STT,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P
M,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIB;&%C:SXS.2XY.3DT,#$\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D]
M,"!+/3,P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C(Y+CDY.#@P,CPO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L],C \
M+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X
M;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA
M9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO
M=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3DN
M.3DY-S Q/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STQ,#PO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA
M;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP
M+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXY+CDY.3$P,SPO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L]-3PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXT+CDY.#@P,SPO>&UP1SIB;&%C
M:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X
M;7!'.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<$YA;64^0G)I9VAT<SPO>&UP
M1SIG<F]U<$YA;64^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P5'EP
M93XQ/"]X;7!'.F=R;W5P5'EP93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z
M0V]L;W)A;G1S/@H@(" @(" @(" @(" @(" @(" @(" \<F1F.E-E<3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0STP($T],3 P(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P
M/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3 @33TW-2!9/3$P,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-S4N,# P,# P/"]X
M;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3 @33TQ,"!9/3DU($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,"XP,# P,#(\+WAM<$<Z
M;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L
M;&]W/CDU+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STX-2!-/3$P(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^.#4N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 N,# P,# R/"]X;7!'.FUA
M9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO
M=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @
M(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#
M/3$P,"!-/3DP(%D],"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T53
M4SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIC>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XY,"XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/38P
M($T].3 @63TP($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^-C N,# P,# T/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^.3 N,# P,# P/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P
M,S Y.3PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C N,# S,#DY/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" \+WAM<$<Z0V]L;W)A;G1S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+WAM<%109SI3=V%T8VA'<F]U<',^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B
M92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%D;V)E
M(%!$1B!L:6)R87)Y(#$P+C Q/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1
M" %/ 0@# 1$  A$! Q$!_\0 '@ !  (" P$! 0            <(!@D$!0H#
M @'_Q  S$   !0," P@# 0$!  (#   " P0%!@ !!PC355:4"1$5%A<8EM02
M$Y(4,2$*(CAWMO_$ !L! 0 " P$!               ! @,&!P4$_\0 /!$
M 0(#! <'! (" @$% 0   0 $ @,1(5%4TA(4%C&1DJ$306&3E-'A!7&!L<'P
M(D(R4G(&,V*"\;+_V@ , P$  A$#$0 _ /?Q1$HB41*(E$2B)1$HB41*(E$2
MB)1$HB41*(E$2B)1$HBU!R_*>2TLLE"5-/YDG3)I$]D)R"9([EDD$$N2DLHD
MHL"NP"RRRPA   ;6" (;!#:UK6M7('GU7ZG [=00_4'D,,+F?##"'$T"&&&;
M$  !%0    =P74FOTSZ=$V;Q1,6L444B5%%$9$LDDRX2228:DDVDG>5L TU/
M;S(<5MKD^NK@\N)CJ]%&+G18H7*QEDK1 *+$H4F&&B 6"WX@#<5[!#_X&UK5
MT#_TU/G./I4J:XFS)TPS9P,R;'%'&0(R #%$2: 6"VQ:1_Z@DRI'U*9+D2X)
M4L2Y)$$N&&"$$P DTA %2;25!FN/-62<-.FB1-CJ0 82<PZ[\,X5R& ;0R.W
MCV-I=#\INK_'P">FYP&TC6KXVS'A=V83>]I?\=RDCB02H5%G>^O%'?9W6<1:
MH[UBZF,S82U6:6X-CA&YRV)SK3QKPR-+<6LB" >,Y!EF#H]@ARQJG;I#.W&,
M)F,UK4S22W&3:<1-H=0.%P/:I19&WW3%( (/=2EOW-+=_2U4?6]I%G64Z+$^
M:SEDVPWJ D'8N9WUKL\.\B84>\4G3Z$LF-CF/-C*[@EV2I0B(6/4L2NF.\7R
M8*MM50*1*1969&:;LI+ $K: TJ;QIB&MM:5M[A^3>++%>V&:LYR&1ZDT4:QY
MG[5))<5S/3W&73%D$9M-,'M!2\D:9X-E1P>(;)\B98Q*DF$46*WHIUDI\Q?2
M)6SRR2FL,385T,:BEZ0JT!IN%AM-;;3OH#T'W6*XX[5>!96Q-%<AP[3AJ/5R
M_)^<IS@'!^&C2<(GS+-LFQHS+7J?3: R]DS2]88489B!#-)B'K+#ED]!%+JH
MRYI6=4[JED?(>R&&AI4&P$D5LK]P#6T64[_O3+Q=I9CP<2;BT&%LZ.6H5QST
M[:8P:14K?C<.;TN:8_!"LJ/[0M=%.22,.D0EHQ4I19/4Y3ME$R C@[DUKD[T
M<[KT[&(FB;P!2M;:4K3N!.^RE.XW+L]".I;).I";:XA3^/S:"M^(]4##BZ$8
MOR*P0IEF>,F=-IBT]RZ419Y605>_,LH";DN63B0-<J3RZ9-SVS/;<KC<C61,
M3$602( :-.\5)'?_ )1"O "[Q%:JL^*^T!RWD9]=6W*D'R=@,EF[4<&D6%'L
MT>P++DF0HX.)R]W)QO.A)\O3Y='C&6S$4Y9!R#%DS:K$:[0U%CR[^4.<@8B&
M&E*&O^()W]YI<%E;;VOD1?D6+I#'='NL!]A&=,B37"6$I@C8\'IT>3<Z0=5-
M2'#&[0TN.<43\QHU96/)DI2Y*F3;&\9%DQQY4K94E;VY2O 4Z&^V&RA.^P&E
MNZG>+!4^"E1I[2V$OD(8#FG!.<U^H"19VR'IK0Z4$Q>+!Y:)R[B=E,E.1$B^
M3CR:7A9'!HK#KHIBXY'-R?Y7$Q/#&G1J54E>&Z.J"C1MWBE*UMH0:;K*[S3=
MTM5H--VH^-:D8Q,'1LB<UQQ,<89#>\2Y;Q9D9*PIYMC7)$?:V-^61UY/B<@E
MD1>4JZ-RB,RJ/2.)2A_CL@C4B:'- Y"$>>F3%!%/&MH(W$=#W7*P]%"41*(E
M$722:1LT.C<@ETC6^&QZ+,CM(WYQNG5*[(&9C0*'-T6W2H2%*U3_ )4*4\__
M #HTRA4=^O\ 6G(-.$ L3>FY4LA?:8Z)<ARJ+0J'9F/>9+-7]FC$9;PXPS$A
M*<WQ_<$[4TH_$G+'R-K1@5KU1!%UB]:E0I[#N<J4D$ ,-#8PQ"M1NW[E410F
MRO[78S7M%M(>/YV]8^DV4C$[K%WT,7EKR@ALW>(7$I((^R6[)(YLTQY9&6U>
M0J%9*O"8Y"*:U5C4[H:B.3*0$A!$14#?NM%3]A6IX(8@#0_H_P!NXK^9)[1W
M1CB.8NL"R!F8#+*64;:!>B38_P I2!'WO#4B>VP2)\C<(=V%T+6M3BC6$&M;
MFL*$ ^P+CL: PL 0Q&T"O!#$ :$]"K'X?S-C?/<'0Y(Q1(1RB&.2QQ0(G@QD
MD,>$<K:59B%P*NV2AI9'@JQ"HL95C#F\LH[\?V$#-+O8=X((-"I!!M"D^H4I
M1$HB41*(E$2B)1$HB41*(J O^D&6.[Z].Q4KCI13H[N3B4480Y7,*+6K#E("
MS+A(N&XP!-L$5PWN&XK7[KWMW5H#C_T>[G.)\X.VX$V=-F &&;4"..*( TAI
M4 T-%N\G_P!5-94F3*+6>3+E2Y9(BET)@@$)(K%6A(L5J\-P%?C2#HXJXKDC
MBJ3+G%4)4B"<!.("U1<X 0A/  S\@6O^(N\/=>__ "][5M7T;Z?'],8P-)DR
M"9'#',C,4 (A(CBT@!I4-@WK6OJSV#Z@\C<RX(I<,4$N$0QD&(&"'1)_Q)%O
M<H1UK:;I3J2QI"$F-YDRP',.%,U8SU$89DLJ95<CA9>1,7N:D](QSED;5S8[
M+8?+X\ZR.(/QK*XHWAL2/MWEL$H5MQ2)3ZJ\X$ VBH((X]_X-MMR@:&:7=4F
M6]0C7J)UAR/ S"MQE@S+F%,*8VT\WG\F96E9GA5"C,EY,F4TR*U1!T='@YLQ
MY&F&.1)LC"1K:D)SNJ5O;BM4DC**212@K:0:FG<#9U/?=994U<;.RVSXY:>&
M+$,RR1B!/(XOV2&<>S):W:,D30]D7+YD9C-HQWD]P+=6TA>F1E1K')*J:,Z<
M!YR9\<S$S&->@("I&4Z=M:?[Z>_\D;NO19KG3L^M5TB8-5C!@[,V,(>DU9Y+
MTY*LAW?!SYE=E6#\3Z<8)AO).-FV41)*8[Q=XRD[P<")1)64 US;CY[>DK<I
M;)(H2." H!H0:5H+*WU)KUW+]Y@[//,.<H!IN%/\;Z&'"3:0I@^$8FP):/9"
M5:79?AJ4XU3X^=(%*2GF/N\BA$A8%"-FD4'E$=BTH;V11%F] KCCBF=UXTA
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MH9'CM*L3I6 MLBS,/2^IQ'CI-*2Q+AW;T&.Q3V\I\S^*W7J4Q!3I=G_WGG"
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MG9G>T]D;D%H>7:/KCTG[2S3DH75C6('(E.K"7=*N()5%E+D)RE K"<C4GDF
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M#4IC&0O>4\%83QJZY*B,)9<8:CYU,M24'B49QJUOK+ELUP'B+,!Z/RUDA[D
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M-(O:-8G4*UL?P+V>\/UJ)?\ %<9JU;@239^AT.U!M"T"7\^]0V:=<L9*>%*
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M4$J36VM;2K?44+HY.^D1>./LD4D&J4["T.#N>G(N )QY3>E-5&%%",O8%C#
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MH8::40EP&(@5H*FE!6Q9F\F)Q/DMX2(8I\V7*ABBK2$S(Q ":6T!-32U5/\
M>A$.3Y)U+7OUJ>VC/!N>:5F6S;).\4WY9F5/>A$.3Y)U+7OTVT9X-SS2LR;)
M.\4WY9F5/>A$.3Y)U+7OTVT9X-SS2LR;).\4WY9F5/>A$.3Y)U+7OTVT9X-S
MS2LR;).\4WY9F5/>A$.3Y)U+7OTVT9X-SS2LR;).\4WY9F5/>A$.3Y)U+7OT
MVT9X-SS2LR;).\4WY9F5/>A$.3Y)U+7OTVT9X-SS2LR;).\4WY9F5/>A$.3Y
M)U+7OTVT9X-SS2LR;).\4WY9F5/>A$.3Y)U+7OTVT9X-SS2LR;).\4WY9F5/
M>A$.3Y)U+7OTVT9X-SS2LR;).\4WY9F5/>A$.3Y)U+7OTVT9X-SS2LR;).\4
MWY9F56MDD@(C49>I.H(.4IF1F6O)R8FX GG$H4ABL9)0AWL78P8"[@#<=[!L
M*]KWOW5M;EQ"V:SG44)BADR8Y\4,--**&" QF$$V5(%!6RJUJ1(B<.93:&*&
M&*=.@DB(UT08XA#4T%: FM@JJI>]"(<GR3J6O?K5-M&>#<\TK,MEV2=XIORS
M,J>]"(<GR3J6O?IMHSP;GFE9DV2=XIORS,J>]"(<GR3J6O?IMHSP;GFE9DV2
M=XIORS,J>]"(<GR3J6O?IMHSP;GFE9DV2=XIORS,J>]"(<GR3J6O?IMHSP;G
MFE9DV2=XIORS,J>]"(<GR3J6O?IMHSP;GFE9DV2=XIORS,J>]"(<GR3J6O?I
MMHSP;GFE9DV2=XIORS,J>]"(<GR3J6O?IMHSP;GFE9DV2=XIORS,J>]"(<GR
M3J6O?IMHSP;GFE9DV2=XIORS,J>]"(<GR3J6O?IMHSP;GFE9DV2=XIORS,J>
M]"(<GR3J6O?IMHSP;GFE9DV2=XIORS,JN96YK4UY*Y_#)#A:#XU?4NDIS>-9
M:;M08)(!]HE'UF&WA@RNU93UN!C!21ARPSSU9ER5)9?B25D8-D^!%D63((.R
M-DG;WMJ;V"#I'!3&[\G_ //X"R BN^PP&L-"*?XUW&RP@&M;=^\T7H<8,DO&
MIQ'F7$RO%>KC3 !@$4QH\L/[9!($LDY8WEP2C><-29EEV15!H?U,H5!JY\C;
M,I+9WUO-(3@6J#0H)5"*4M!K=W?=:-H>V*H[V0$4Q ?)I:O@60NU1D>G',TR
MD$C<%LN>,)9"[6F68\R:=,9C^Q.O5JY_&UBF,35]4FE&.Y$K=[JA!NX#HK_[
M_P#T!'W$L$<#:MB^ \9P#3QVHV:L.Z?H/$\58;F.AO"N7)SC+&\?:8EC]JRR
MWYJROCR-S)'$H^E0L+#(YE FM4RO2MN0HSI&A@#,>XV5GM)1X2J36$5M.D;2
M:G</'^+[5K-[46>27/.IW,[KC+&.H/(DL[-R 8Y<-,4@Q%AZ>9'@3?K;.FF/
M-2V1D\QD\10J61F,1X@A&(L4+4SP8K$W-&7LAA5ID@;C'>/[NNM_M/VK0TH!
M4#2)TC7_ %I06=]I)W;P-RY.L/+K'D/69I%[1K$ZA6MC^!>SWA^M1+_BN,U:
MMP))L_0Z':@VA:!+^?>H;-.N6,E/"E :298B315O >24H1_D3*D"D$4)_P"^
MC^:$C>+Q3NL)4F0%SMFSMH\+ZM25P72(RY7K<TNX47$*/]C8MQ/I(@V.(_)7
M]F5%#$B4)9)J1GN?0!6H;&$.+/'XX>%4I 65^LHM$!A^T1%EA)X[@*@G\!>D
M>BQK LJ)U"O&D_2I"#E2E1#Y$2G3)RAG'GG&M2H!9)))81&&FF#O8("P!$,8
MKV"&U[WM:O/^JPQ1_3/J$,$)BBB9N(88808HHHC*B   J22;  *D[E]OTV*&
M'Z@QBBB$,,+MN8HHB!#"!-@)))H  +238%J&\BS?DZ5?'G?Z=<AU%[@W7IYN
M1=2UUGBVWGRLZ>19OR=*OCSO].FHO<&Z]/-R)KK/%MO/E9T\BS?DZ5?'G?Z=
M-1>X-UZ>;D376>+;>?*SIY%F_)TJ^/._TZ:B]P;KT\W(FNL\6V\^5G3R+-^3
MI5\>=_ITU%[@W7IYN1-=9XMMY\K.GD6;\G2KX\[_ $Z:B]P;KT\W(FNL\6V\
M^5G3R+-^3I5\>=_ITU%[@W7IYN1-=9XMMY\K.GD6;\G2KX\[_3IJ+W!NO3S<
MB:ZSQ;;SY6=/(LWY.E7QYW^G347N#=>GFY$UUGBVWGRLZ>19OR=*OCSO].FH
MO<&Z]/-R)KK/%MO/E9T\BS?DZ5?'G?Z=-1>X-UZ>;D376>+;>?*SK;EDU,H5
M8LG"1*G.4JE$*?""$Q!1AR@X\QH4 +)*)+"(PPT8[V  L 1#$*]@AM>][6KK
MOU.&*+Z4^@AABBCB8SX1!""8C$9,0$(A )))LH!6JY?]/BAA^ILXXHH88 \E
M1&*(@0B'M0:F(F@%+:DT6HWR+-^3I5\>=_IUR+47N#=>GFY%U#76>+;>?*SI
MY%F_)TJ^/._TZ:B]P;KT\W(FNL\6V\^5G3R+-^3I5\>=_ITU%[@W7IYN1-=9
MXMMY\K.GD6;\G2KX\[_3IJ+W!NO3S<B:ZSQ;;SY6=/(LWY.E7QYW^G347N#=
M>GFY$UUGBVWGRLZ>19OR=*OCSO\ 3IJ+W!NO3S<B:ZSQ;;SY6=/(LWY.E7QY
MW^G347N#=>GFY$UUGBVWGRLZ>19OR=*OCSO].FHO<&Z]/-R)KK/%MO/E9T\B
MS?DZ5?'G?Z=-1>X-UZ>;D376>+;>?*SIY%F_)TJ^/._TZ:B]P;KT\W(FNL\6
MV\^5G3R+-^3I5\>=_ITU%[@W7IYN1-=9XMMY\K.MUIZU&F-1D*5:9.>XJ!I&
M\D\\HHU<J+2*5YB9&68,(U2@M"B6+1DD!&8%(D4J!!L20:,';ER!4I9-$&CZ
M 9J9,E(8^M;9P=/9CE:#8^><S9-7XL9<K2T+H?.<G8XT\OL\5XBCL_=KOSVN
M=)3$H"B=4BU\>W=,>B<7MV6K2MI&E.ZP5H*T[@32NX;J]RN_155:RM*^FI9A
M7(.F7T[8'3#4U?9Z\S_'BMY?'<A3),KS)TRS,')2O6/2J1L;NZ363K)LT*&Y
MT;5<:<%3<OB0F4I T?Y"FIK6MHIT%!TL7\TZZ7\%Z<RYNKQ$CD;C()ZZMWJ)
M/\@94R-F[),J60Y*H96!EDN2<KR^<316VPI$>L:X_&#GP#1&@JG*R!M2*G%R
M-5$))WTLN  X  +*83"<&Z>!.4=B]XWC]9F[+4WR&K0O4L4FO.2,NS]4=))B
MX(#)8]+G=\>G"R>YQ3(U&FI65C;DK8RMC:PM2-&E*%!T,TCZ'L2/;'C"+0R$
M1V1.&"\DX6CF.G'(4B<W=QP#/YTOR)D6(M$.DDP<5:Z'*9@O6K#%21M.M&T-
MP1QF7-$<2)F@DI,41WDVD'\@4K]Z;SO[RN_@6F[1WA9_TV8W@L;A4+E>G2"Y
M#9M-\&+G3OYEC,%G9;:DR0I:8ZZ2E2[3)(\"94(GJ121))%B9<2>L"YIERM<
M>H)4FMM:VE6^HH7$<%@&]"L7& $8!&F.4C #NL,822Q&""&XKVM^0K![K=][
M6[_^T%I O4$T!-PJHY]4VOAB_P#M/N5?0-XZ^RIVGAU^$]4VOAB_^T^Y30-X
MZ^R=IX=?A/5-KX8O_M/N4T#>.OLG:>'7X3U3:^&+_P"T^Y30-XZ^R=IX=?A/
M5-KX8O\ [3[E- WCK[)VGAU^$]4VOAB_^T^Y30-XZ^R=IX=?A/5-KX8O_M/N
M4T#>.OLG:>'7X3U3:^&+_P"T^Y30-XZ^R=IX=?A/5-KX8O\ [3[E- WCK[)V
MGAU^$]4VOAB_^T^Y30-XZ^R=IX=?A/5-KX8O_M/N4T#>.OLG:>'7X69R9^(C
M$;?)*I(-4IV)H7NYZ8BX G'E($IBH9)0C+V+L88$NX07'>P;"O:][VM7RNI\
M+5M/<Q0F*&1)F3HH8:"*(2X3$0*V5(%!6RJ^IM(B<N)+>$B&*=-@E"**M(3'
M$(032IH*U-%5'WH1#D^2=2U[]:GMHSP;GFE9ELVR3O%-^69E3WH1#D^2=2U[
M]-M&>#<\TK,FR3O%-^69E3WH1#D^2=2U[]-M&>#<\TK,FR3O%-^69E3WH1#D
M^2=2U[]-M&>#<\TK,FR3O%-^69E3WH1#D^2=2U[]-M&>#<\TK,FR3O%-^69E
M3WH1#D^2=2U[]-M&>#<\TK,FR3O%-^69E3WH1#D^2=2U[]-M&>#<\TK,FR3O
M%-^69E3WH1#D^2=2U[]-M&>#<\TK,FR3O%-^69E3WH1#D^2=2U[]-M&>#<\T
MK,FR3O%-^69E3WH1#D^2=2U[]-M&>#<\TK,FR3O%-^69E3WH1#D^2=2U[]-M
M&>#<\TK,FR3O%-^69E52-6>,!MG:>=E=E<>2,J.89'FK4;&BL9.<N"=B*-@0
MZ"]0A@WR.0I.VI0)I.N,07NL?7%P=%@2W!T3(KHT:XY/6YK5H?\ A'NW0_?_
M )#O_C=^52O-F)<3YHQ'V[FHW-4:CKIJ!P!/,NQO"64'M$C'D'3S&M/&D?%.
M5-/ZK#\B5 $^8X,%/GYRR997#U;..62*1+!N(W$8K@LO_O\ ?Q^U(/\ [8%:
M'>-]28B#996H '2M5M_PQJ#G65%#1AZ9X%U+0%_68;CKQ(=0"R*0=DQ"KE#S
M!HVO>2(3)"9L[20$B1NT@6DMQ+GCM&C3NK&Y%G!NG2$?["I2RMF_=6W\[E3C
M0#A4UEG7:TX7+S#G%Q-,U@1-!ZOOD[)><VE#?='VFA\-<"9LX,IR0I<V"<1M
M3!^#%9&R,25N:6]&2G0)K *T1L@W?\;KHHOZ;U(_8^1JT,TVYGAP7^42H$1U
MYZ]HL7)YN]J)+,Y"5'M4V2F<I[EDB5! I?9(Z%HP+7MX4  <Y.1RE88  CKA
ML41[_P#ZP?\ \A:N^U%GDESSJ=S.ZXRQCJ#R)+.S<@&.7#3%(,18>GF1X$WZ
MVSIICS4MD9/,9/$4*ED9C$>((1B+%"U,\&*Q-S1E[(85:9(&XQWC^[KK?[3]
MJT-* 5 TB=(U_P!:4%G?:2=V\#<N3K#RZQY#UF:1>T:Q.H5K8_@7L]X?K42_
MXKC-6K<"2;/T.AVH-H6@2_GWJ&S3KEC)3PI0&DF6(DT5;P'DE*$?Y$RI I!%
M"?\ OH_FA(WB\4[K"5)D!<[9L[:/"^K4E<%TB,N5ZW-+N%%Q"C_8V+<3Z2(-
MCB/R5_9E10Q(E"62:D9[GT 5J&QA#BSQ^.'A5*0%E?K*+1 8?M$1982>.X"H
M)_ 7I'HL:Z:1 &:PO)98!&&#;%H   &XQC&).98(0A#:XA"%>]K6#:U[WO?N
MM;OJ1O'W'[4'<?L56GP=VX6X]$IVJS5%XXA8:&X\"G@[MPMQZ)3M4J+QQ"4-
MQX%/!W;A;CT2G:I47CB$H;CP*>#NW"W'HE.U2HO'$)0W'@4\'=N%N/1*=JE1
M>.(2AN/ IX.[<+<>B4[5*B\<0E#<>!3P=VX6X]$IVJ5%XXA*&X\"G@[MPMQZ
M)3M4J+QQ"4-QX%/!W;A;CT2G:I47CB$H;CP*>#NW"W'HE.U2HO'$)0W'@4\'
M=N%N/1*=JE1>.(2AN/ J;\I)U"O&,\2I2#E*I1#G\A.F3E#.//.,:E("R222
MPB,--,'>P %@"(8Q7L$-KWO:U>1]5ABC^F?4(((8HHHF;@0PP@Q11$RH@  *
MDDG< *E>K],BA@^H,8HXA##"ZD&**(B&&$"9#4DF@ '>2:+43Y%F_)TJ^/._
MTZY#J+W!NO3S<BZCKK/%MO/E9T\BS?DZ5?'G?Z=-1>X-UZ>;D376>+;>?*SI
MY%F_)TJ^/._TZ:B]P;KT\W(FNL\6V\^5G3R+-^3I5\>=_ITU%[@W7IYN1-=9
MXMMY\K.GD6;\G2KX\[_3IJ+W!NO3S<B:ZSQ;;SY6=/(LWY.E7QYW^G347N#=
M>GFY$UUGBVWGRLZ>19OR=*OCSO\ 3IJ+W!NO3S<B:ZSQ;;SY6=/(LWY.E7QY
MW^G347N#=>GFY$UUGBVWGRLZ>19OR=*OCSO].FHO<&Z]/-R)KK/%MO/E9T\B
MS?DZ5?'G?Z=-1>X-UZ>;D376>+;>?*SIY%F_)TJ^/._TZ:B]P;KT\W(FNL\6
MV\^5G6V29XNQ?.,@X>F\Q9D3GD'##Y+IGB!<<\NB%;'7F1P9[QE+W=$U(7-&
MB?"U$*G#NPJRWE [H6^SV2M3DI'0+>M)[<N0U(!'<=_XM5>LKZ"=(^;LMN.2
M\APAQ=9L^IX2OR'&FC*N3HK!,MIH KOZ=K<WX=B<V9<<YB(B:E#9)'E.2XA)
M2P)6\AE-&J:VY,WIB"(@4'Z%1]C2H_!"NO10HEA&.<28Y<\KY/A:!J95>:I.
MBR=E.5@D"]:VR>0LD'C, 224\YR=5C.T)T4)A,<:1EL@&MIN2T_[U"<;@H7+
M5)*[O"P<2?V2OSA?'>(L=1=Z)PJA:$D3G60<B99=5+'(5TF;7R>Y2F#O-<@R
M,AS7.SR$(GZ7N[LY'(&Y42SMIQXT+4@;T1!*0HA-=_@. H.BB6*2_1;IJ=Y_
M &7*^$L9R>8Y/EN4LBQB29F8 2YTR?DY:3()&^OJ.92]7(B'!\&I0C0-@[)V
M]N9@-+4P-Z!C2-J(DF_]!8K"-)>AK%+NP8UB,0@K$^NN",CX:C&/EN1) [.;
MII]R%.5^1LA11DB,BF+DI<(6LES@L6W6(FX\,=0"+CK*N:8VE3-!)28HCO)M
M(/Y I7[TWG?WE9% M-VCO"S_ *;,;P6-PJ%RO3I!<ALVF^#%SIW\RQF"SLMM
M29(4M,==)2I=IDD>!,J$3U(I(DDBQ,N)/6!<TRY6N/4$J36VM;2K?44+B."P
M#>A6+C ", C3'*1@!W6&,))8C!!#<5[6_(5@]UN^]K=__:"T@7J": FX54<^
MJ;7PQ?\ VGW*OH&\=?94[3PZ_">J;7PQ?_:?<IH&\=?9.T\.OPGJFU\,7_VG
MW*:!O'7V3M/#K\)ZIM?#%_\ :?<IH&\=?9.T\.OPGJFU\,7_ -I]RF@;QU]D
M[3PZ_">J;7PQ?_:?<IH&\=?9.T\.OPGJFU\,7_VGW*:!O'7V3M/#K\)ZIM?#
M%_\ :?<IH&\=?9.T\.OPGJFU\,7_ -I]RF@;QU]D[3PZ_">J;7PQ?_:?<IH&
M\=?9.T\.OPGJFU\,7_VGW*:!O'7V3M/#K\+,Y,_$1B-ODE4D&J4[$T+W<],1
M< 3CRD"4Q4,DH1E[%V,,"7<(+CO8-A7M>][6KY74^%JVGN8H3%#(DS)T4,-!
M%$)<)B(%;*D"@K95?4VD1.7$EO"1#%.FP2A%%6D)CB$()I4T%:FBJC[T(AR?
M).I:]^M3VT9X-SS2LRV;9)WBF_+,RI[T(AR?).I:]^FVC/!N>:5F39)WBF_+
M,RI[T(AR?).I:]^FVC/!N>:5F39)WBF_+,RI[T(AR?).I:]^FVC/!N>:5F39
M)WBF_+,RI[T(AR?).I:]^FVC/!N>:5F39)WBF_+,RI[T(AR?).I:]^FVC/!N
M>:5F39)WBF_+,RI[T(AR?).I:]^FVC/!N>:5F39)WBF_+,RI[T(AR?).I:]^
MFVC/!N>:5F39)WBF_+,RI[T(AR?).I:]^FVC/!N>:5F39)WBF_+,RI[T(AR?
M).I:]^FVC/!N>:5F39)WBF_+,RI[T(AR?).I:]^FVC/!N>:5F39)WBF_+,RJ
MI$AQ@.%]M!IZF1F2,J3&^2=&^LU<&*S:6A>81CXIERAI)"4W8SC2=M;DD61.
M'BP[O9@AN#B\7;V>R]P."UI0@W-:K_H?_*&WOW1>R^&GS&QF)>UMU@)Q9"RU
ME,R3:'=,4^&?DZ6%RYT937/.^JQ!Y0A19:!E;X_#T)+$08S1M&F*3DN2YT7J
M%)ZMS5*!$/\ PA_\HOU K6I9(ZZV,+S^/.D(UHZ+;IUY3>)R?#(9A_+#LE"W
MB6G*8@^P^591"E8S_P!MT#@N+4-#P!24("(9'X!4B*-Q[CU"UB8+8-/+_P!B
M?V;JS5/(I#Z11F+Z:Y4Y8K8H^HG9^I>5H&MP3P'3^XXU0,[^]941S&<+V)^!
M &EK5'/[M$VT3L'RVE?+T5XR1,BI8:FW=2RVA[K%=CLZ-/TLQ9*=5.6S,)-F
MDW$FHJ<X\E.(=)C6.,)CL:HH?!0Q>2Y$EL9@!ZK'$#R%FA99M>)1"(6N=DS(
MGCC*-_>E\L6/H$I5B-:6U(%"=];;*> '?_ "U^P^'9#F&K7M7&V(=GUIPU?(
M''55%VI5+\ZY*A$-+8E:O2%IU*O$E+3(<,Y->E\8 2<2[*U+6K)"8)T7)D[7
M_J*&H4%8TI!6(C_$[A7_ &BMWBV[^%5/)V!9[HASIH2DK]*Q3G(/9F]G1&LN
M3Q]81.ZA [8L8]2<>QCJ5CS"8Y6\75Q*+Z>,GY)%$0.R4*HY/!XJH6HD2HG]
M:8IJ##%=%'0"S?0D=UX LI83;WJT\!<[9L[:/"^K4E<%TB,N5ZW-+N%%Q"C_
M &-BW$^DB#8XC\E?V944,2)0EDFI&>Y] %:AL80XL\?CAX52D!97ZRBT0&'[
M1$66$GCN J"?P%Z1Z+&NFD0!FL+R66 1A@VQ:   !N,8QB3F6"$(0VN(0A7O
M:U@VM>][W[K6[ZD;Q]Q^U!W'[%5I\'=N%N/1*=JLU1>.(6&AN/ IX.[<+<>B
M4[5*B\<0E#<>!3P=VX6X]$IVJ5%XXA*&X\"G@[MPMQZ)3M4J+QQ"4-QX%/!W
M;A;CT2G:I47CB$H;CP*>#NW"W'HE.U2HO'$)0W'@4\'=N%N/1*=JE1>.(2AN
M/ IX.[<+<>B4[5*B\<0E#<>!3P=VX6X]$IVJ5%XXA*&X\"G@[MPMQZ)3M4J+
MQQ"4-QX%/!W;A;CT2G:I47CB$H;CP*F_*2=0KQC/$J4@Y2J40Y_(3IDY0SCS
MSC&I2 LDDDL(C#33!WL !8 B&,5[!#:][VM7D?588H_IGU"""&***)FX$,,(
M,441,J(  "I))W "I7J_3(H8/J#&*.(0PPNI!BBB(AAA F0U))H !WDFBU$^
M19OR=*OCSO\ 3KD.HO<&Z]/-R+J.NL\6V\^5G3R+-^3I5\>=_ITU%[@W7IYN
M1-=9XMMY\K.GD6;\G2KX\[_3IJ+W!NO3S<B:ZSQ;;SY6=/(LWY.E7QYW^G34
M7N#=>GFY$UUGBVWGRLZ>19OR=*OCSO\ 3IJ+W!NO3S<B:ZSQ;;SY6=/(LWY.
ME7QYW^G347N#=>GFY$UUGBVWGRLZ>19OR=*OCSO].FHO<&Z]/-R)KK/%MO/E
M9T\BS?DZ5?'G?Z=-1>X-UZ>;D376>+;>?*SIY%F_)TJ^/._TZ:B]P;KT\W(F
MNL\6V\^5G3R+-^3I5\>=_ITU%[@W7IYN1-=9XMMY\K.GD6;\G2KX\[_3IJ+W
M!NO3S<B:ZSQ;;SY6=;;77$..GO*\-S@YQLM5E+'\,F^/8A*KN3P4:SP_(SI#
MWF:,P&HAQ*8E@'MS@,15#6.+6K<45V<!3:L1$K' M7VY<@K93NW\*T_97&0X
MNQ<@S1)<SH69$5F>3XTA^-Y(_A>7,QQ6XUALFFDDB#2;'S',;.E1-\EFLS5$
M.Z5G3N*X]Q4(UCBK3H$29&2ME.ZT\:5_06:%R*,.3NY14A_9%C^@2A.=H\F=
MD)SV@1J@@"6>N:R5%W!&0>$XO]1YQ)0!V-+N =_S#>Y%5.6]G_I-FN$<+:=7
MO&KPGQ#IW<61WPO&XSE?,<(<H$YQR-/T/95[9-87D"/SM6J01J3O[06<[R9Q
M&8G=50C[FG"":$IJ:DUJ3OK;7BL^T\Z:L):>&^1BPJ7-/#IL<UJ'A3+LXYFS
M84I,8/$TR*[2MR]D3((F,!0G%>6M*CIS:4X&V)\3 J,0([IB$UNX ?I8LT3'
M1=@/)&8@ILKX2QSE'+L];)WF%HD&98^BDKW/00B)0IJ<7&-2>7&'L"HR$Q>)
M-Z9L:6UH0J4R5,XV0FK5ZE:K)::"ZP<:_LK)YAC33/,,P"=9HGA#MF3(.!99
MA@#.Z2\P+]+L R%Y)?IA'T<'\>*3.\<6.R4I0Y2!&PG+TX #26>"$9AJ<9*F
MG?2M?R/YM6'P+3=H[PL_Z;,;P6-PJ%RO3I!<ALVF^#%SIW\RQF"SLMM29(4M
M,==)2I=IDD>!,J$3U(I(DDBQ,N)/6!<TRY6N/4$J36VM;2K?44+B."P#>A6+
MC ", C3'*1@!W6&,))8C!!#<5[6_(5@]UN^]K=__ &@M(%Z@F@)N%5'/JFU\
M,7_VGW*OH&\=?94[3PZ_">J;7PQ?_:?<IH&\=?9.T\.OPGJFU\,7_P!I]RF@
M;QU]D[3PZ_">J;7PQ?\ VGW*:!O'7V3M/#K\)ZIM?#%_]I]RF@;QU]D[3PZ_
M">J;7PQ?_:?<IH&\=?9.T\.OPGJFU\,7_P!I]RF@;QU]D[3PZ_">J;7PQ?\
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MF 'JL<0/(6:%EFUXE$(A:YV3,B>.,HW]Z7RQ8^@2DB-:6U(%"=];;*> '?\
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M, C3'*1@!W6&,))8C!!#<5[6_(5@]UN^]K=__:"T@7J": FX54<^J;7PQ?\
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M^@"M0V,(<6>/QP\*I2 LK]91:(##]HB++"3QW 5!/X"](]%C732( S6%Y++
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MY7+I<H?,F3249#F>7LDS><($*-C.6Y#R=D>33&>21Z:6Y D:$R-_D*D# B(
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MQ3\"8GTRY_[+">84Q;CZ^G5WS,TM;7K_ (1-HU.M4VJF7ZB<&9)(86S/IC3
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MXL\?CAX52D!97ZRBT0&'[1$66$GCN J"?P%Z1Z+&NFD0!FL+R66 1A@VQ:
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M[K=][6[_ /M!:0+U!- 3<*J.?5-KX8O_ +3[E7T#>.OLJ=IX=?A/5-KX8O\
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MQW-I6FUHJ<Y:CV6>HE.1<O2[RPVM61\69 >'%T997A(Q^.1X^AJR(@"H?K0
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M^&+_ .T^Y30-XZ^R=IX=?A/5-KX8O_M/N4T#>.OLG:>'7X3U3:^&+_[3[E-
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M#8XC\E?V944,2)0EDFI&>Y] %:AL80XL\?CAX52D!97ZRBT0&'[1$66$GCN
MJ"?P%Z1Z+&NFD0!FL+R66 1A@VQ:   !N,8QB3F6"$(0VN(0A7O:U@VM>][W
M[K6[ZD;Q]Q^U!W'[%5I\'=N%N/1*=JLU1>.(6&AN/ IX.[<+<>B4[5*B\<0E
M#<>!3P=VX6X]$IVJ5%XXA*&X\"G@[MPMQZ)3M4J+QQ"4-QX%/!W;A;CT2G:I
M47CB$H;CP*>#NW"W'HE.U2HO'$)0W'@4\'=N%N/1*=JE1>.(2AN/ IX.[<+<
M>B4[5*B\<0E#<>!3P=VX6X]$IVJ5%XXA*&X\"G@[MPMQZ)3M4J+QQ"4-QX%/
M!W;A;CT2G:I47CB$H;CP*F_*2=0KQC/$J4@Y2J40Y_(3IDY0SCSSC&I2 LDD
MDL(C#33!WL !8 B&,5[!#:][VM7D?588H_IGU"""&***)FX$,,(,441,J(
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MFQMD]S2['B+N:$FXP_MN4$5@",L7W_G<L(A6#<=@_C85[!O?OO:U$7Z$, 1
M"(80B,O<)81"M80Q!#<8K M>_>*]@!$*]@VO>P;7%?\ \M>]$7S)4$*+&73G
MDGV*-&0;<DP!MBCRKVL829< A?@:7>]K#+%W#!>]K"M:B+\DJTJ@:@I.I3GF
M)3/TJBR3BS1ICKAL.Q2@ !"$29< @B_698(OQO87=W7M>B+Z7-*L:$FYA=CA
M $8$JXPV-$6 00C,"7W_ )W $0P!$.UKA"(0;7O:XK=Y%]*(E$2B)1$HBH#!
MNTITTSG ^K#4*2JFL:AVBN;9?QYGUDET<3-$VC<MPHTIW>6-2!@*>%I;J8O
MJ)01<92\H#Z["$W$W*4%&A 5M$@PCOB (_.Y2'ITUD0S4P[($$.Q9GZ*-3QA
M;&6=F*:9)Q>JBD#?XEEAL(>8TSLLL"YN36XS5$UJTJV2Q9.:):P%*"P+1A._
M,H!013O&\B@-39W_ &\5(N5M2V%,(S7"N/,FS2T<F&H>>G8QQ"T C\H>[RN<
M)VF[X:QFKH\R.K;'+A:K?Z[.$I6,C6, @  M$:,!=R4)!/<-_P"33]J=J*%\
MAG$EF%$C.* :?^=B"AF "8=<L/YF6*!>]A&?K#_]A_A:_P"(?_1=UO\ VB*M
MT'U78JR#J<SEI*8/,OJQI[B>-9GD#_<SE)HSX-E9N4.<5\#>0KS37)7_ )4Q
MGB9!B!(%&9^( &'VO<5BFE@/<21^13W"LM10E$2B)1$HB41*(E$2B)1$HB41
M*(M)?_R+TYZKL;M8A"8@Y0>,O OX$D%C.-'^.IS# Q?@66$0Q?B (AB[K7[@
MAN*_=:U[T625_P"Y#^?_ .2M0>H'2GB34AJ:[>.19EB#S,E&"NS]TRY'PTC-
MD<O:V.-Y/:]%TF>V6<(F5D=VYI>)5&W.-)"F14ZI7,+<F=) W 3W2R!T(5-_
M]_H5JTAETI4F*NZO_+<?P5M0T+*^TQE^FS07,VS(FF)PTJ.&C[ RG*B/)++E
MMUU3OC@7B=*5+%C?*4R_R6:XK5X$)J%8^DGK#;!6'.IIRLZQERI%HUBL-=(T
MH1HTK993]%>8#1??3>MT^=DXOTO.^65O:[G:PHPGE'^-PS(H<2=-I66LF@FA
M+BF=#1XO+T[E0HIC,?#8\&Z$U>*:A>AW-]1B2H_'#[_;QKQ\2LL5=*8#30T3
M=0&EE/\ Y5X6E<UVC\XD>9\MFY1S!CS$G:E!UW/(H.^ND$UES+6\A5IIV09C
MUJQ:R0E[.PX]:=G>'E"0,B=/%SXJ3#5:C\E5B0,1E3_?[_2EEE 3 (?#1W5)
M._\ R!/?;6P+:1A73! 9@R=O;JCE3OG./9FQIK"U]XQQ3D'%JG($M?,-Q>=Q
M1G1SZ9XTPZS2V,,TE?GEJ=R021QN*TC%&8DU C+PQ.+2G67@?S%^RL9-#!N_
MXPDBP5H382?"]4#T122>Q-#JSQKH<CN(,CY==NS"G*N.9[T$2;/[&VB<&0]O
M$TVU#X=R60>U-^L!]2B=P1:0P]4WR5ODWZ&YD2.7C#F<AE7-/\=(D0Z0.C$1
M6G_QIO%]E@HK1:#0Z1P:Q^R?OV6QDO'ELW$>1+]J+9"9E,Q'>.^ES+=V%J0M
M,KWCH)U;,=Y5Y:LTV"G\W>%V26\/O#.\HBTM&+3I:08.(KH^&CX4W&RMM==*
M6G2#XVT+]@KK.B3/+6C5!D3M6L>8<G&2[RR;GNYN&'S4+J#C+YC@#.J>36-G
M@SHTP]M&XM*)I2)%:EWDZQ5<TR5O@EY6)&E,ALT= D"RFE2&T>/_ .+WW47S
MI1$HB41*(O&_VC6$,G1WM%LO:",<,+X##7;:RS2;D26OS* TEO@%L$3%S4:J
M5"$TK\3"W:00F)MTTDEP7N%Q*>RDQR@HD0B@O[_/\?T++"?\1%45@,0 [[0-
M'[T)_HM7,[1MJ/8L^=N@R1Q"J;&-F[+O2^U1IM:RE!"!O3MTA;$B9"T$)[6*
M)LD2$E$ *2VL(LDL .ZP;6M13#2DNM*Z45:[Z>/@L0U;:'M$VEZ,=B[E"90I
MR2P?)>HB)S+5CEG(LRRE-%4KD.1,)Q-:[O<W?'%^=C&0Z1O\<:S2&V.D,3:2
M:V& :VU*0%<$;<D,41TZ;Q"*  "@$0J-P%E3O\56;6!J#AF+=(O_ ,@31Y,G
M>6M&IC*?:623,F.,;%Q.;JW9PPS(<X8/EK1D4#NB9CF-GA"J/1M>>0ZKW9$D
M-,<&%"1^Q3)&8E:_O]^RD"L4J*@T=$ DTI45K58MVNDF@F0<[=H<Y'L,-AN?
M\)Q?3HWXN7Y4>-04[U-/*)@BD7?+S32!$8&OB&-L(8P0$B/=)I,7ZTZ3'%!<
M).Y>'.DA 442"P0UMA)MI00C?9%4'2-@IN(K0'<M^O9TN;E(NUFUYRMQ5J78
MZ2Z*^SB>#WXX8E 7I:Y8A$N6.%EW_P!BEAJLY0-2:<68/]@C;F7O?\N^BQ'_
M (CN_P HK/Q#[=%Z$**J41*(E$2B)1$HB41*(E$2B)1$HB41*(N*M2%KT2M"
M=<825J50D-$7<(3 EJ2ADCN7<01AL.P1WN"X@"#87=>X16[[7(JS:,])&,]#
M>F_&6E_$KG,'^!XH22E%''W(:]B=YLK3R^<R/(#F6\.L<CD3:% 2GN3KR484
M3 W +;R$1:@"E64<L4%,1,1).\W*S=TB42H"T29/=:62).6KN27=4!.,5AC(
M HN']H21C#88BK#L 0K6%<-[VM>BA<BB+C)D2-%^[_&D3)/])XU*C_,041^]
M29W?L4'?J #]IYG=;\S1_D8/NM^0K]U$7](1I$QB@U,E3IS59MCE9A!!11BH
MZP; L<H&6$(CC; M8-C#+B'^-K![^ZUK41<BB)1$HB41*(E$2B)1$HB_/X _
M.YGX!_9<-@7'^-OSN -Q"""XN[\KA"(0KV#>_=:XA7M;OO>B+\?YR/W_ .K]
M)7^G]7^?_1^L'[_T6'<RQ/[OQ_9^JQE[C_7^7X?G>XOQ_+_VB+ZT1*(E$7__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g367939g61d94.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g61d94.jpg
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MR,'<I4KA IVV98D=#'2C1["3D;)BVGT&TL8\7#+1QVJ@OLXPG5---;F[UO\
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M_GS[(_9.D_O@Q5T.6^$=7R-"WH9A3'Q?'S'-;/<'SKF'O[!W#_9#E'W /\(
M/Y0 >P]@[]^P=A=8=-]5\T5)\&U_Q?(E^CZG_P#Z;(="5O\ @_-^T>$Z&<G0
M$Z &5S-_16[W_9VO'ZNCT)V?3CJ9N'#OLY3-..177W8W(%4R/=JCCU/+ 2U9
MQ+6V=NO\E\;,*9&I+$8&OOYFOM'X,Y*R,W\H*LLT]EAVL@\)ZZC<C9;CRX/R
M:\S3:Q<HT5,5BZ(>._=-6FW]5?D6_P#'*H?MCZZ9_A2WQ_4BQFIG.EK/N'L#
M0-<L?X W2I5NR*:S%B;-EC"M<J5 C!JM.L-V?#/V!ADJ?=QX/(ZMO&$8*40[
M]JF'4>S/Z";@[E$<<'%-MQNW.K\ U70@8W6^]QD,@[Q[C7>4647>VC:'/,R<
MRAA,*23S*%H4:M2>81$B#)H*#-LD'R46Z"21  I  !NA="-/Z5R-@C%5784C
M%^-Z7%)IHQ=0H5/J\:BD!2I),("O1T2S33*3L4J:;=HF4@% "@4  /=VZ&'$
M][T!.@,>WDXJ*-!Y&MZ:LR3(V8Q6VN?E(M!'L0C6+D,GV65B4$P)V H-X]ZU
M2*!>WE\G;L AVZ&V%\(]5+R-9O5J\2.3M8]<\DS"JBTMD+!&(;Q*+*B)E59&
MV8^KT\^54,/O,HHY?JG.(^\3"(C[^F)C=S>K%>/&#?-:U&^OZU?=V^Z%MATW
MU7S1R/P<'\DN0'^T6M/^&9RZYF]%SD=M\8Z/F.7W6]T?&M;DKED6Y56@U"&1
M,XE[5=+#$5:N1;<A3'.O(S<X[8QC)(I"F,91RY3(!2F$1[ /72@SB?$>\J6,
M=_<V8RPSKE-#;<%:YA:53W]JBX0BLF9.MQHIE,25<2<IIN'U2JD5!-8:NS9D
M&Q9R0E;0^8)O(%2"E'PU64'&KDJ-W*N2S[_(:K\./HW>-+>/M@\RS!/:QE?8
MR[/<V6&KRS=1G.5&KOH.%KV/JS.,U2D68ROP!#FMC^-=)IR,.\MSB%DT6\A&
MN&R IM9*4KG5)47F'VZ%8H%RC_SEKB2^K;&7WP; =<S>BYR+8_*M-8\T+F>(
M(T(_$;W_ +NZJ4+\&81V/^$,W8H]E;^C%1#F<DE?PCT-GZ92-D/BA<UG3B.B
MVQ0)&4ZQ4Y(?E*]=+K*6U&F<;GY/R[!R_P .1OQ^.9H/7<?W&:"1S7J>,/AR
M\ Z<>K*35'0CU1Q!='(',HNH62JL<XJ+UZZ55=R=BHL_*.1+[>EYA1:QV9.B
MHG>MW%=CRR5#]KQ$>]2^G&@=GI5)DU6V<-KUY#!>-F\>H?X:CZ]+L2ERK;V"
M*(E=^>(J+T*S'O&*A'L9:[O57S<#"B8 ,6<=J5^"O>X#MO3HDAQ]^&>C,13,
M6DQRU<,J83RWG5;TR%=CE"\62+</8!TH7N"@4*!:0- 3,F<6[@]96DD@ \@L
M)Q.,MJV3RO2T47_)4+P@_P ^?9'[)TG]\&*NA*WPCJ^1H6]#,*6>+Z,(:1:T
M%[_)':EL80_.)<1Y* H_G]P'-_W]_P"3H76'3?5?- ,O#N<F^%^.1?;H^7L7
M[#Y)#,".""5\,"8[AK\:&&@GS$,J-J"7N52^"@D/CG'!""W%_P"W"REO5]E]
MD3]H%EK%RV:4NKBZ8T&9/W3GI=_5>Y$/_':F_MDZ%/PI;X_J01;C^Y0\)\C+
MO*C/$.+-C,;J8B;TQS/GSUCF%H24P2\*VA*,+5SQ-TMHRBC U3?C,%7*P!F5
MW&"F9S[4H" C*+C2M+]SK@$FZ$097,W]%;O?]G:\?JZ/0G9]..H@)X;SZ974
M;]%V _RS9BZ&BVZ#U1J8=#(3H"= 8^_*'BB4PER+;K8XE6JC,T3LGE>7B4E2
M&(HI5+G;)&[TMX)3  ]I"H6*#?E$.Y#$<E,0QB&*81N@ZPB^"7=<:S6L^0V&
M7-<< Y5BG)'D;DK"V+KZQ<IG Y%FUNI$'/(G Q1$!$2/P\P=^Y3 8I@ P" #
M"[FUN.W= 3H#'7W?M;G8OD%VKME(15L*F8-M,PNJ(T8=G"TPTMF5YYO3&3+R
M")5U7C)W%-FPE'RJF.3RCV,'0W1NA&N457N-=K">/4\289Q'BE)5-=+&6,:%
MCU)=+N"2R=+JL36R*I]P*/IJ%C0.3N4!\HAW !]W0PXBI_C!OFM:C?7]:ON[
M?="ZPZ;ZKYHJEX4O$-2SWK_R<8@O*MA:UF]K:XPK^2J-BE:C;(90\=F]=C.5
M>SPCAK*05@A7Z+:3B9%JM^\O&J0.$734R[5;F;T7.1VW=)1?!XI//<[@$/,%
MH;M?H9L6K1<_WW(6:<<V123E<$9PMT[8+$QO=3063*JR<.)J0DRP5YK:;ADR
MN=7!SYV3A5G*,#/*],0LD\Z6V<HR3:23_$DJ7[^-1D+PU>F7%#FC'D5GZ(A)
MK*FZ>)',<KD:D9OEH>;CL2V/UC#"7O%E#C8N)@Y*J3"S4CZL7&S-;58:O/M7
M+!"1AI9@@X="JVE.M'='*E:-<7OWK^1T?H4$Z 3_ .4<HAXEWB5-YODCC/%Y
M0+[^P"7,6P@B;\WR@,4/X._R0[_D[,Z:>-?0MC\JTUCS033Q!>A'X\>@%U>U
M&%^$\W:W?"&;<5>RM_6E9=E"1JGX2:(S\A3.%_C;34'+N.BVQ3*2EQK=/1[=
MB=#EG+9DMSN?;Z,1EX*M]QT&W\QQ:K1,C&83S(9'"V;@<KBE%QU9MDBS"OWA
MX!S>@A^#ZWI0U@?2'I*NT:J6U1S/R#+*^8:+6.U%TQ5Z].T8RH(%YJ^?^=R,
M<0LNEO&,FS95@X=GE7MU\J]@>EKKA(Q158/37[+\=.7-L[%)9G8\8XIBHQX/
M9=OYA5\NS_RGCO2]]S;",^*%^B5R1];N$O\ W%/H0LOF1[?^6+V^$'^?/LC]
MDZ3^^#%70MM\(ZOD:%O0S"E?B^OF1ZS_ &J&_P!TF2.A=8=-]5\T5)\&U_&7
M(C^@ZI?K&QO0E;_@_-^T>*Z&<G0$Z &5S-_16[W_ &=KQ^KH]"=GTXZB GAO
M/IE=1OT78#_+-F+H:+;H/5&IAT,A.@)T D]XIGBVN%PD8SD>P=5WEA+"56.I
M^T,!!LSNI1C"UI,[>GYE%H@11R^C8F&,G3KTY3\WP#"0U0F#-@B&EEE(X7V,
MZ5B\[UKN\^\MEX7_ ))Z9FO6"+T6R':&4=G;79&62QQ&RSU)%[DC"3I\YF8Y
M2 ]<Y!D9;&CE\]K4O#M4Q684]O4Y-('203*L<(VL'&3EE)^.:\QJ_H5 <>;7
MDEI?'EIO?7K&SL4-C,P5J>H&OU2;/$QL(6":9'BI+))F29Q=-:[C5D]4L"TH
MLD#!U84:_6A6(ZG$1()V<'.5,E>WPW:O+Z"A7AKN+RX;/;1U7<C)-8>,M;]:
M;*C:*Y*2K-1)ED[.$$H1U3H*OF7(4LC'8^EP:76TR;85FS24BJ]75B*J33P8
M\7VTU&.RL7X+ZX:5-(/H910'Q@WS6M1OK^M7W=ONA=8=-]5\T<C\'!_)+D!_
MM%K3_AF<NN9O1<Y';?&.CYC5.ZNE^#=]L 6[7C/E="7JUB2]M@YYD5NC:L?7
M!H@X3@KW2I1=%?X+L<(HY6!,QDU6,K'.)" FVDC!2LG'.NE,9.+JG1^[GP,S
MW+>*=W^ +?V&E(6:6A[54W;F9QED9FR>_@SV"Q([>D0?QTK&"Y*G(0<TV21B
M;Y273X9:ISJ:#AC((O6=7M2PUIQM8-/M6:>3]-YHO\9_))A+DRU[C,PXO<)0
M-TA 80N9,2/GZ3JR8NNJS8RAV+D0(@I*U::]!T^I=L2:H,[!&)+I*HQT_%3\
M'$#+*+@Z/L>3013H1% N4?\ G+7$E]6V,OO@V ZYF]%SD6Q^5::QYH;]$ $!
M 0[@/N$!_@$/S#UTJ,J#G<T('0G?[(U;JT*,9A/-1E\UX4]F;BE%QM?M<D[&
MRT9GZ910;_$"XI3$&PC055=(5,U3?N_*,JEYALLY[4;\5<V^8^-P0Z&?B&<?
MV-ZY:88(S-6:2HYMS3[2AZ4I&V"VQS,U:I#SU"^T-S4&FHPL%(1HJJ-6]L^-
M;]H! E5?,,UI+:DWE@M%ZX]I7WQ0OT2N2/K=PE_[BGT.V7S(]O\ RQ>WP@_S
MY]D?LG2?WP8JZ%MOA'5\C0MZ&84L\7T41TBUH-V^2&U+8HC^838CR4)0_/[P
M(;_M[_R="ZPZ;ZKYHJ1X-K^,N1']!U2_6-C>A*W_  ?F_:/%=#.3H"= 5WVT
MUXAML]:LTZUV&Q2=1A,T4.9H<G9H9HU?2L(TF4R)J/V+-\8C1PX1 @"1)P8J
M1A'Y0]#L6XM-8K>! T!\-WA;0+;+%VV-1V4RCD&P8N2O";"I6.H5.+AI4+QC
MRUX\="[?1CA1ZB+%G:W$BW!$H^JY:(I*=DCG'H3E:RFJ-*G"OFV,C]"LG0$Z
M _DN@@Z06;.44G#9PDH@X;KID60706(*:J*R2@&35253,8BB9RF(<AA*8!*(
MAT O-M/X;;2K,V129PUQM62M&,VM9D++'67 #Y)K2V%G*L+A*Q1M#46C5ZE)
M-EP34:)XUME!C&Y@45+'&<K&< +%:R2H_M)XJ5_CCS/V8WC]YOZ["$H\+S>1
M<C5T$08MK-9M)\4S.0TF %],16FYB6G)A\_,G\HTC(VIY* K^^)R2:@ < VH
M?V^S;:7+#/'PN.4X^\-'@JUY9-G??_:/8'?S*"ZS99^:]R3B@4V73:*&5:QT
MK&Q]@MEX-"1YS"G%U^(R/"U]FT%1B,2JQ.#8@[\5I4BE'BL?'GCQ&,*-1*5C
M&H5['^.:G7:+1JE%MH6KU"I0["OUNOQ+0OE;1T1#1:#9@P:) (B5%L@F03F.
MH8!.<QA%1ZOH 5G*MQ847E2QMBW&]ZRO;,3L\77B2N[&3J4%#SSJ5=24"M G
M8NT9APW200226%P55$QE#*% @AY1[]"<)N#;2K=2_5>AY?B>XB,?<447G*+H
M>8KEELF<'^/7\FK;J]"0!X(^/6]R;M$V!89RX!T61"Y.3.1<>0419( EY@44
M[,ZZ>%?43FYM-JE O?0@49Y!>/K 7(_@24P9G2*70,BX--X]R+!HLRW;%]P(
MEZ2%BJ[QVBJD=%TC_J%A@G93Q=AB3G:.R).D8Z0CQ*,G%IKNWK<P2^A_AW6W
M'GL#6]@<$;U9?0DX\ BKE3)3'%4-3\F4IRX16EJ7<&#>?3,YCWGHIN8]^B)9
M& F&[&;B5D'[)(PB<[7;5'%<'FO>8R=T*@5NR/%A1=C^0K5[D'F<KVRM6W6"
MOUVOP>.XR!AWM<M*-=M=YM2+B5EW3A.38J.5[PZ:*$:(J%(DP04*(G54 &==
M/"OJ24J1E&G2:==*>@5+H1*$;M<=V"-[[#J]8LR1P.7>K^<8K,,"!&3=V%GB
MFC4RDWC.;]H,!/B=;YR+IDK9&X)JG>IU)HP I47;DPB2DXUIFFGH_,OOT(E#
M^1_1.L\C6KU@U@MU_G<:0L_:J?:5;57(B/FY1NO3Y8LLW:)L)-PU:'2>J%]%
M90RH'2(/F(4QO=T)1ELR4DJTKXIHHGQ6\%>,^++,^0<RTG/EZRQ(7_&#C&+J
M$M-2K]?91S)Q:ZS:AE6[J)D':ZSHJ]:1: W4(5(4G2J@G\Z9 $2G:.:2:2HZ
MW!W.A6##Y3N,:C<IF&\?8<OF4+7BJ-Q_DQ#)C.9J,-#S;Z1?(5:QU8(QRWF5
M4FZ30S>QKNQ62$5O6;)$ /(<X]"4)N#JJ84O[-S6X$SAKPQHZYFL1]?>47=7
M!9[>6)+;#X>DR8T-9RP(R0P9;":F6>%&9+##,RXQ02(N0CQE)$6@)"]<^H)N
MU;QC!TPJF\=7P.Y?Z"K93_GC\H7_ -SW;]HG0Y\3_"S_ $_4]CCOA3V'HV0*
M+=I+F?Y)KO'4^XUBTOZ79\O7%Y6K>RK\VQEG57L+->^N$7<'/H-%(F6;+-UT
<EV#MPDHBJ0XD,#G5-;%FJJE5&]:7XA_^A6?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g367939g72h71.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g72h71.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1A"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &":^88(X0DE-! 0      !T< 5H  QLE1QP"   "   < E  "5!I;&QS
M8G5R>0 X0DE-!"4      ! 81B*I0:".H>X0B 2:K.3Y.$))300Z      #E
M    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
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M;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
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M;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M  !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M     !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL
M;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I
M9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M ! #O_XU  (  0.__C4  @ !.$))300F       .             #^    X
M0DE-! T       0   !:.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         !.$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      -!    !@             !L    LH
M   & &0 <P!P #$ ,@ S     0                         !
M      +*   !L                      !
M !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG   !L     !29VAT;&]N9P   LH    &<VQI8V5S5FQ,<P    %/
M8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '
M9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90
M  !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P
M(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ;
M4F=H=&QO;F<   +*     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M        37-G951%6%0    !       &86QT5&%G5$585     $       YC
M96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH
M;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M"79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0
M   +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO
M;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M    #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M    .$))300H       ,     C_P        .$))3001       ! 0 X0DE-
M!!0       0    #.$))300,      W;     0   *    !A   !X   M>
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MGY*TP_P2/XLZ'VN'N>X^QAU)Y(.Y$)=^\?O*'C_]\K_ZDHA1
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M,O54:[(%53*+R 3HSAR'?FQ+XO"GES72#3)44)!#740 3L'>WT.#-&M-;?\
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M:LS_ +4:C\"/V]=)F/$U?GTF2?7HP2PY<W[QUOB(I+F"SEF[_7ARQX_?#5?
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MVNSN-'+X9K;"E 8, $& <R/RD Y&?'0^NO/#:Z0(B03MW-#:XC*A$'Q$8$3
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MA!M?N%/H#9*G?<J7\9%@_P"6HZ@]]M//H^N*Z23<_P M'WLPT.^-C*#N2D0
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MAW<D;SX'&@4R\SVXI3'AR ()/[DIJ?$"_P"W<_:#?3F+[K!SB:NW"!@0FB,
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MJ?."/E/CGQ&3_7/0@/:##LY;G \C'?"T\/MZY88+,%0&1P./K_,\Y&8SCIP
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M_CIC8K2(@(P%&<J(_$"#SP!!Q\S!^M?$Z0&$6M&S6^GV@1*HR#\LGZ8'3*+
MGU?!X']4R*73B2"0K6MC!(B />I5D<G"O'!C(\TZZB54>2RP&I9.M]VVT<O@
MT'YNX=\X=TRU)[@:KP-J=-6@;B# ,5A/D<!S\^ >I  ,S45<^Y1RU/>,*LHM
M33#!9/-V!TY.?!L"K:E(T7V_0/C)U%;R8',5M6<?J!SD3!P2*M0DIIS/ZA+"
M6^??8.['E.)*1X:ZU/:F2W0$_0#H9AV;0C_I!'M&Z^[8:)T[VGT-=;I8J?NS
M6559K*XVJKJ*2I?T]IBBH66+&ZZPZTK[E=*Z]%VJ:)*'D4*6E MK6DWNSJ-.
MIFJPJ)X@I*DJ2;$$Q<?60,%7"D4: IO[M*S7_P!P6HB26L\,VHN03CC$NEP?
M+Y*UK5*AM*UJ*E'C,F9'GY\".M,1PE(2R0E":82  GA2"T2Y:7<7=H;%!)(!
M!)4ZUK=4GB6Q/6 R0?''3;_HU_M+ZOH.\G<[V8[E=:NLT3JG1E?W&L-NJ7G7
MJ>S:ETY66NAN511(6ZH4XNUMN3+=6VRB*A=%3K6 IH*5S,VA%-)*$)23)X1!
M-Y@"?5SB02AB[3!+M:T1;:8LV.RAT$$2<$XXGP0!'.?7@?G'.)< V/>SM8B\
MBQ'BTDO4ZXCG"4R1R29G,B8_*?&?6..@#:N0Q9OQW'O9XPG]=<,EE<R!N&(D
MC$<X/S/,?F!RBXT,_63!U+C2-VUPO5_7C.&3JCO/PD$),J5@1/J8!,QZCZ],
M2"T-$^MFPSAYAM3 GSMAE5*_"1!!E*A!F>1_@/\ (Z=(<\I\CAB2+68OX%IM
MIZ<-"O#<E)(Y5Q!&8,$8](_+ \]&4 <^I;F6M+<VPY + ]P_&(X_%NGR8Q]!
M_.<SZ],T"(N;V:VC27G=W(!.$FP\MO5]>N/D'<.0$P00>2(Y]?/CI_B&@8-%
MSXQY,).@=7=QR[F'G]L>5N;B5*1YD02)D <><G'1^OKZ[KP^ 4D $AW'YUC"
M?O$>GZ@3^?P=.QV/@<13N/ _G&*5K(3=:<)*@2TM(!5("?=R0)B!(!Q@8\@1
MYVDG_O/-!)/"K*TA\/RJ/O4L((!N;ZCOQZ7F0D^QF59(<9M9( L.$WB!L[/;
M!O0G_6VV(EM2H)DR6&U2)SGX8 Q@&#U)3!'MI68?O1.H^*;#Q?<XJ*)/LE5!
M)(35 2\\(8PES"7AAR+8(F7%_M4(!,*:$B3,A"#GQY\ 0=WJ9KT:II^V5<$%
MRA,ZD>\JAG8$,TN3>,#6XC[$J^8M424 NICPT^(H$D*X0"HAB0P,, GIX('=
M&J,; ;#4),Q!/O+21C'_ (?0&<];S+A)SJR& ))86L)(YF9'/GC$GB_3+$\/
M$&>S<,-+,YT[VP9:8 1W4O\   "[(?!!@5=*"D#)(^.8X3)F9Z>FWZJH($&+
M ND,=KCQP%1_=4&O!>Y,L;7NSF&#XGM&.$ZXUXE$ %FV'\)^$^_NWG (X$>F
M,]349K+?4>$?;$U1@$@MPL!LDD1T<N#WX;Z+62WW&!_BO"U9,?BME,DB//X>
M#F"1Q,K*EAF'.J] 29&MX[XLT'$50'^B"\%Q!L\;PX]7Q5%X7':_5@2K:$5=
MX CSN>WY P!*R%<X(GR>H5?^J*_YB&YO<G^0(,,TM8-60/\ ]L$,[0D$QO8N
MUR26TR0]E-2E=J=?I400-/E&XC&+'[N0>!.Z1X$1F>K>34105)+:R?N.K0T8
MJYCA_4T2& -,E1'^HBY9OB^NC!L M-3H0225$9*0HXR<CTGU]>1$=#/$IR[M
M]'$/_&G+%U/"P?AD<L+N(!0O; F8,2<<QQ(,Q$^GIT^(U,Y9FAFM;UWX#[TA
M26E@^6T_D861,&)DB."#C,1TB?A5+023X:W'.6Q"YXH);B&O.,8JVEY#/<S4
M[9E2EZ897$<E-S0"?/&]/J9GF .I*?Q4Q +&'FS2Q^S<[@X%V6HIA^)VU<@7
M%RVNP[L#O=)RY*TGJL6)]QF\'3M[%H<:25NM73]FU0H'&D>7&ZLM*0()*TB
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M:?6$]SKDD@#WMA?DD@;2FIM<$B,R5F,C(/Y3 MF:AV %H+B)Y7T>,':@2/\
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M85 \S&1P,@]%2(XLPQ#%YY[=;V@>4=5BG+/9AM,P^A'VYXJVZO3H/6C8F?\
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MZVV]66BJ6;=77%:[FX]:JUNG#%$R\Z"XS35+A<4E+2?=["O>I*3=R"QPKO\
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M 4M.5_W4-J2I#JVUB#9<DAI0$ "0_$&VTZ^6.;[JHM'$6XU**KD"09(UT.K
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M[-2O-9;/)IM5I?TP@E;J,E2Y( "@KA@M\,!W)@1VJ:62KY"G7=%4\-4 ( (
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MTU?OE0"%+9"0=RB*>9S% C@00HE+\0#$!S#0G39W+/;$Z)'?TVVQTHMU;*!
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MXE5LRFG36P']/@!4" W[GD@$G6S:;V6HFEV@/<A* J&OKKQ<3?RS8ZB'*(0
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M <?/J[V=R6)DOJV)>-._KU?;7#M';372OQV^@:P" JMIR23!@^[<7M_\WTS
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M4 \%200T!Q# : V?:#B,HU55?4)?>*5D8$@Y5Q.TX$<B "#!!SA"L:TJ' T
M'X7:S ?>/,V/=J"2P+!)#BS,TEFL.K,6C%EVQMFG:^\N_#LX42)!&" 3$G,@
M'(P!Z="JJ*0XBH"6DZ^>EAXX=*6+D%@'Y:2#Y-^,25+=J$UH54U#+++9 +K[
MS3*1)*LK60%*)(3M$J@D $P.HZG:.3I4ZB\XI)I)23\S3);2_3G)Q8IY.MFU
MTZ>70OC6IDJ"21PD]-"Y?33'9-]B][/.G--^S@UWN;6FX:B[KU=<EJK+*0FV
M:<L->[14EOI5K"G"*VKIWZZJ=*6_>;J=M*$A@K<\N[<[=I]L>[1DZ:OTM,J2
MAIX&)!)+D.5<1&IZACM^S^PZG8RZHJJXJJ@A7_+B0E8X07(NQ>S-OC;Q76Q2
M%J24;4@GXA(!]),8,\CB,R<SP2DL2S >/KPWQU4J 4'-VM8?7<0+[BV(E5O2
M@E0!6(GX03'SQP)C/KP#,=,$DF/YW%]/S<:S\:=Q]0.?3[80-$4D ^.5<$2,
M0,"?.<SYQ'0D%Y<#4'\-8ZRUXE\+C3OYX173[3 .9.%)VB(P.#P8GCGI'ON]
M^=N_;^,.""'%CAN:91D[1)E1 /Y\3Z?RSQTXCU?KAN)-W'J,>?=CP,>,#_$@
M_KTS#GXG\X=QS\#^,3]%IRE:^(T^0D;9YB09*0$C^9R8])LXYO&.?KOP5TML
M:8VGW+0"R"!L3C!C)!@\\@\8XZ< FV%QC1]R")Z7$Z\F+XF6F$ ?$E060  #
M'F9B08\8'Y&#TB"#/C]-6VC! O;UZ]1B00SMA*C,DQ( @9C,$_R,SB")*YP7
M?>&OMN-[;1A_7YPZ2VI2S!PD"0."!@$X$^L?* .A*A%Y9@V[Q>)\[WP[0_KT
MT^AAPEF3(4$^3ZX)QG!R" ,Q^70J/$'DS($F=]1XS;5PX!!+ZAG)(V##?Z@7
ML,.VVY@!1DR,B> ?(Q)&>)GI@C9K$:WD$]VFX\<&)D!B_P!+@&"+<X+<@%DM
M<A0X.#Q,\P><1.1^G3$[&9>Y&A8/NWH8<)N"(AG:8(T^G=KBE^]OM%]E/9NT
M_2ZF[U=P+)H:U5KCS5L_:3KKM=='J="%/LVVVTC3]=7+;2XV72Q3J0T%)+BD
M!0ET!S< M^XLXEV-WL(F^D8>S0;PVG6>O+&OJ[_;@^P1:5OM4VKM=7D-+4D.
MVW0=W]T\4DB6UUJZ;<DP0E1"4D\$9'4O 7<E,:.[;-#S?\Z.ER"P,:D[Z%[,
M;SOMBMKE]OQ[&=*%IH--]X[L4SM]UIJR4B%>AW5NHF5IW3@%(C/PXGJ,LE1<
MRUV@NYTOS@%Q@N%1L (L_/1^[76\@&L;[_I$7LXT"5BU]E>[MP,'8JKJ-)4#
M3F(^):+U6.(Y )#2C&8D1T:$&I(4(N6 ^T6Y.]P,(H+&UK$_6-+]SXI2^_Z2
M3H>E+G[#]F74]6E*1M5<M=VFEDCG>BFL=4K)V[87D$D@?">IA22#,7#QIX6A
M^C# "DHP\,-6$G[S)^C-BI[Q_I*U]V+39/9DLM.X4DH-VU]6U"0HD%!6FDL3
M"-H (*4K!,@[P1'3+HI41PDAAI/EYZQ+,<&FB1J)ZE^5A-H;5[,]677_ $D[
MOY42FU=@NTU ).S[Y<M6UJT#^$DIN=/O,9_"@&<3B'". ,+C4DF'UWV?=Q:[
MBDS.06C4$1S#MIJ6$RS@%Q_TA[VP[FE0MNC>SMFW)4$JI[!>JTH),I)-=?G^
M!XA4^21P?"6<E,7 ![[]1/TPZJ"2#PLYM<!XBSZ_FV*IO/VY_M^W@%-/K#15
MB97_ !VK0]I]Z@3,(55&HV^A5M)/GIF=W;ER+L^KP;<GY8$4B@_$ 3_M<RUI
M 8;G<Z!CBKKK]KK]H)J#>E[VA+W;D+0N46NR:;MRD[B3#;C-H"T@!12G:J9&
M59/0*IHX@+N+L&+/ROZV)(4^(_"PO=[WF#H="^\XK^Y?:$>VOJ(*3<_:7[M*
M2X%;TT>JZVV)G).T6Y5+L.8A.T 8SU 6^)*7402.'A42.1+ =[^+82T)0 I5
M2F' >5.&W^$@=7,N=6Q6%?[0_?S6%2U27;O'W<U+65;J6&Z>JUYJRX.//.0T
MEM+;ET=*U*W !(3F?(QU76M%)"UUEIHA =7O" 1M8D%S%YZ8EH4:E90%"DNN
M5.$^[227(_W-:YV8M=A<]J[1U+;:*_N?JRXUM4H(J;A25FH:ERVVY&TK4S55
MCE0IRKJFDELOH8=2TE<H2I:DJZQ/:/M-57QT<DD*"5*3Q(;B&Q)#:['0\\>G
M=@>PM!="EG.T2Q4>)=-1)=-P$A0 *AJY3HP4'Q':J]H73.@+"_H_MXQ3TS+C
MBG*RY4K2&15NE!27$O&:E[<$1+BB5!()7XZRJJ.;[04*V<J55@+/"A940&(8
ML21+Z GD((VZ*O9W8H-+(Y:DCX0#4X4A7"; E+R"(YG5YP_N_=)V\U3BZ^H?
M<<<<4O>IPC*E3(3N@@X,R20.)ZO4LO1ILR0DEN,%]?FD"QV,>6.=5SU6L>-2
MP0_&EB0&=TPU@X?1K:C G>_V%J"D6X\^JEK&TCW%2D\#D(<!(*FS$*3*8!*@
MJ<'O=B>TF?\ 9[.)J9:J5T 651<\!084P;AXDCY;![D/&6]HO9[)>T.7:M24
MG,LR:Z0EN-W *N(*X27!^$EK@N,5*TH,O.4Q?0E]E8'NVU I=W;?B0@D[D*,
M$Q/S@B.OHKLWVAR/;F3H9JC6ITU%+*HK9-5*CNE)4D FWQFQ#",?/?;/L_FN
MQ:ZZ-:C4(0H@UF)IJ#AN!2N%19R5<20Q4+EP56G:=NI"/>4RGUJ!V%Y+*BHC
M*"'TH@GD! SXD9ZLUL[EZ 7[U81P $@L[$ @R0)!W\"1CF4\I5KD)I\*@SW7
M%_\ ;<:P6<W &+<U!I"ETMVXL>OD:GL597W^K+"=+T3=X=N%K!J54R%W>I51
MT]"R75)"T"GJ*E!;=:*G$J44IX2_:KLHU:F63G4HKA"N +!2"ICPI!3Q&3 #
M<+L7;'6'LWVR4)J)R-55(@ K04E(2=94( N6=A8X[G/93^R^]CO379GMI<]1
M]C-+:LU;?=#:5N^H[CK1E_4KK]YK[/25EP4S3W%UVBHVOO;SJ4MTU.VE"0E,
MD@=9S.=J9O,U"D5S[KY@JFHN2/"&)\!$XZ>7[*ITJ134II]ZD E*@P;70EW:
M_.2P..8?[?3V1]*]CO;@[*W+M5I.TZ0T%W,[7T5>C3>FK<Q:[!;M1Z5O]TME
MX<IK;1-MT;2JB@7:*FH<#?O':AU2W%$F3C_:&OFC03PYZJ@$L4J6H)4'EV)>
M[6$:WQZ%[+TLLL +R-!1IH(2M"!QA6A+@!@9)$CQ?K/^RBHOV=[!?8-A#:6]
MEBN7PI"=I4N]W%2E2!)W'F0#).)'5CLEOT)9R&=S<NI1,/=YOKICF]N CM%8
M5<$6D ! 8%Q=@'%K[8V!OL)?G>F3,Q"1,"#($9SC(CR>.NF0X.]O%\<(0>A<
MCIU\OOB'7;TJ4=B%1"@0, >8W)/ ] KGH0D@Z,VP!YV%H.N)$D'?G)(\_P '
M;7$0_:7M^X "2 !,&<Y V$1'.23&),=,I)4;@!N]Y\XZ3@OXWW/KG:TXC3;W
M-RO> Q,<#!^7@R?4\< ]#[L[CN?\#$@4 EF+L=FGQPV^Y $B,I)D P9&2).)
MC,3D0!G!1IF+:7WY1O;$0,V-^;-IRZL?K&$?N8/#>/'P>/\ Y.EP'<?7\8=^
M1/A^<&Z&H'PHA4@R,R,>JN.3^DB>I=O6I]3BA;E_;R;$I3-#*C\0W2 <0?4R
MKCU]?4B>G!9VO_;1K]<&A(4[N+>)/-FC?Z:/\ # "3 'YJ@YCGGY1R>G)UN0
M.[PT >.YPYQ( $CZ^F'EARV@<G!DY$<&(_E]/K,PW76>^6)\?N19WP]0I.T
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M(-=<$DI"B3"@?7G$@1CC\O' Z10.9,$"([[.6^FLN?>SW Y6UD];6>"T55W
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MN5\"02F3 B2,\21XYY/CU(0W/;8<]SM]=L(*)(#">\QY2+?><1A0W)_M"/D
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/.2?F<]-QJW^@_&(,?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g367939g86x61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g367939g86x61.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2%>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (4*^A10X0DE-! 0      !T< 5H  QLE1QP"   "   < E  "5!I;&QS
M8G5R>0 X0DE-!"4      ! 81B*I0:".H>X0B 2:K.3Y.$))300Z      #E
M    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
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M;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B
M:F,    !        4D="0P    ,     4F0@(&1O=6) ;^            !'
M<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N
M=$8C4FQT                0FQD(%5N=$8C4FQT                4G-L
M=%5N=$8C4'AL0&O=;F         *=F5C=&]R1&%T86)O;VP!     %!G4'-E
M;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M  !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M     !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL
M;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I
M9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M ! #O_XU  (  @.__C4  @ ".$))300F       .             #^    X
M0DE-! T       0   !X.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         ".$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      ,U    !@             !\   !-,
M         0                         !              33   !\
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !\
M  !29VAT;&]N9P  !-,    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3001       ! 0 X0DE-!!0       0    .
M.$))300,     !<&     0   *    !    !X   >    !;J !@  ?_8_^(,
M6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )
M  8 ,0  86-S<$U31E0     245#('-21T(               $  /;6  $
M    TRU(4" @
M               18W!R=    5     S9&5S8P   80   !L=W1P=    ?
M   48FMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@
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M14,V,3DV-BTR+C$
M                     %A96B        #S40 !     1;,6%E:(
M              !865H@        ;Z(  #CU   #D%A96B        !BF0
MMX4  !C:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T
M<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N
M8V@
M    9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO
M=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A
M=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M     &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I
M;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#
M;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M      !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M      !,"58 4    %<?YVUE87,          0
M  */     G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 >
M ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L
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M*P(K-BMI*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_  !$( -8"% ,!$0 "$0$#$0'_Q  >   ! P4! 0
M        !@<( 0($!0D#"O_$ &00   % @0"!00'$0D.!@$%  $" P0%!A$
M!R$Q$D$($Q118146<8$B-E61E:'P"2,D)3(T-59T=7:QL[7!T=07&"8S4I*T
MQ.$W.$)#1$539&6$A92D\2=&5(*3TG-B8Z.RT__$ !H! 0$! 0$! 0
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MB %&U[]P@/H$._ 54DBD5 DFH .')I;B %SPN'T</<*!V<AAJ?1]V;->XJ$
M;"<@#W"8 '0+CI?NU]&-/?8.>6J.(W+#<D$^P*IUJ=Q#K"7 +B'&6X!WB%]
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M&'<EJ)9./2;/TS"JJ5J1(^S6^!3A_":H"6(@OL;LV9S=9,XV)4+5$,=1+/H
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MY2&AE:YSV>Y>Y;9@M:90D6RU/PL.8M0L9-D1T,:C4L<Z%K-1XB[5:2D<NH5
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MC-F#F)44EFU0&:$E&S]5Y659%PKBH8:/",CY-";I>&J($P9E45(BO'NI%VQ
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MJ\UY,,NJ&B6[9G%4E344T8O#R3!M&046P18R*I3)K/VB;5JD5%VLF<R2K@@
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MES4C@SRHZ(I*H'9SIJ&=3E-PLJN91(I$TU#*/62QA.1(@)%./LBI@4A3%*4
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M]+T^P";4!::!E#1S0)AP4_6$=2O4-B#(N2'$3E6=BL<#B8]^(>(-4CAI% D
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M81  OOWX(7'3J3T#,?1;&'K5!V^+$3;!W3<V<@BE'2/5G3>\-Q$T8_;B=J_
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MU"G)&1?H)OU)1O("H@Z)U3AJJR9ICUC<JA56&317QL][PS@@PT\Q&?+H*P
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MB8C$9$GD')S?H+ZPF&\_JQ +>7'07"]@*A8 ]/57N(_&-N=@^?\ S./47^*
M_P#BQT8FS->'DB,W]].!@<)/PWEG=G/GDS6UAF*J&8%8:7G7?C[% ?3_ (D
MUL%K;:X'Q'B/_,7-F!,:APW322SKK\'P[ _#L[V]1DYLR S K  "\X\TT$1*
MA_\ XZCI?PV\<:J\1XFD$G%@!R=HF'S/>4&'X8D#X4D/EZ?:?9T>?]7V^SSS
M7?V*'O?Q-@OX"(AM;33 \7C&!C.<@U0@YVY>:T<#PX#G";DUYZ;O.C*@U_6&
MOT]=^&B%[AIR2]?,!MWZXO\ ,X\CXTC6.]]#"@P?#EVP?;;/S[$W!7]86UGG
M?=]2WN/C_$W#\8[A@?%8X_\ U]_</]D^#X8'YL)MH+[[-SF8@/:-?5APC]/G
ME@L.A40&VG^$5(!OW@',?38/$XY,8Q]=;MT'V9W/EQ/#T&LFBDBF(!86:SZW
M-K[$.AE94T]-3$BUE)!9VBC'D63*KP"!5!<%3XKE*41-P\7,+C>X!CV>!Q<7
M$-?Q'8&KA)_R J@LY(@NS"\KEXG IPJ:#22>( D9B'O9WW;*R?;'T5Y48(M9
M-+*-X>471.9-9&.>*I'+;B(H1NH8ABW 0N!@ 0N ZXS46IJ.@+<\O54!R!N/
M?9E$DE?U@81O.O $+C_B[7#6VI! =M0'0;B%M<?%'B/$U'$X:C32*FIF^^;3
MSW8!U],>'P*11Q4FOBIXG<P#D=B6CJ^8]/W0*POK.O T_DH6Y:VZG:U_5L-[
M6'Q&/22#BLP?-YG7[_9;IPO#,'PP^KN\ZYY^2//^K_=UWI;_  4 N%PU_BK;
M".X^.V \3CF1BEN1]LU?A>&O\+IK:;?='[H%7^[KSPN5OZ1N/5!?N"_K'4<3
M^:Q__-S@\O)R)]-'P_#?^+V]_LW5 9@5A[NN[CH'L4-+CS#J1#T<]-K6Q1XG
MQ!,8L2<W8;0V6?)/A^%N<+].?Z3DV9/W0*P]W7>P:\*  '<(_.?'T;:CI8<?
MQ-,U8K/;.UQ'76<C9/A^%RPG^W/?4>3JOG]6&WEUX(\[%;\@Y_.;AZ+@(B'*
M^'\SC_\ E)Z'4C+*+]F_"\-_XO;[MOI9*&C:TJ=_5<,S>3#IPT7= FLD?J^%
M0@IJZ& A Y@ Z %AUOCIX;Q.-7X@4UGBI(^I]6#-<,^CY+S^)\/ATTG$H^5H
MX9R?I+:LQ'-2C#Q\?QZ?%C["^<L20U8/0_U1S^1/@B1F5P &7]+@&WD[^L+X
M@L.2+%H?[/YE?A<E^8XO%[[[*)R,$1@B:S,S**E\UT(MG5)I,[",575%@RD5
MV;-^"_4FZN0;I>P<%16;H.$#W(JDJD %4X%%"FRS54U"]-0(RL0<MP3.K*O%
M0MQ4D.+APSIOG_17RMDJ.:40\:2Z\4S?R4J5RI,.32:TC+.^V/'KEYP *ZYC
M@"9!$A2D1,<@%N-QZ5U<9-50!.NEK>6]^JXC"X2*A421K:8EIL;:RLG,UBWB
MZNZ.4<U()&T?7BS!N03&4,1!M1<T@@43F]D82IID QCCQ&L)AN(B.,KJI%X(
MC!$8(C!$8(C!$8(C!$8(C!$8(C!$8(C!$8(C!$8(C!$8(C!$8(C!$8(L5Z^9
MQK59Z_<H,V;<@J+N7*I$4$2!N=550Q2$(',QC  =^"+4>=E-"L5N$[$BN<Y4
MRI%D&AE!.=$[@@< +"8!.@F=8H" "9,., $H@(E6.A\DSF=N:%1Y?C1;FFTX
M5^WFIL&T@Q="Y7DY",2;F>2 PB+0PAUK.-2<R(N5"+E.+=%FDB=5XD(.^_W_
M %P[DAV@-:#GK:W8*BO1_35K1TTIVL*XI2-@,NI]_(,!FFB$B[<-%HN6?(NT
M :B8CU=XDR38I.D 8)I-72_6F5.BJ"297K,D<MQF/(]5T@CWB$BQ9R#53KFK
MYLB\;*VX>M;N4RK(J 4;" '3.4P ( ( (7 !N&"O?=UF8(C!$8(D! ^WVO/N
M.D^?^KRW+W_D(W*9^?V_1+_!5&"(P1-EE-[6'GX4U7^?'F")S<$1@B:+.;VL
MM1[I-&P7_P#VE?Q!?T:CXX^=_$F^ '_Y#(^7[D6S7I\(6QG_ /6KT"C.-K^(
M &@^CP#T6VUORQ\L&&?+(%@07<M([)<,OH4?326AS+ARY(:2>\\UC.E^S-G#
MDQ>,&R*JYB7L8X(IG4X $= $W#PW-?AT&PVMBAR07D-F,V:PAV8O(%R1"T:@
M' $6@;FT[@C*]G=0H?=,A6+38*R&54PU;2<(>=C'*TX=,LDT!PV;D(S,X@&R
M/$1158CERY4;LC&;'3CUWRRB90]@PS6U(JI:HE^*HQM])@-H3LN XO\ $L;Y
MEB'%@T[,! 9Y:^<Z93*G6Z8O: ?.WBK6FGZ2$=/H+-U&<[)K,GAS/%(Q/JCP
MS<J#AP19N47"K@B"'")>N'SC#IKIQ*J!2#17\,N "27FEA(A@[/>! HJK)^8
M@AG8/E9@?-W.@=B5M'?2_A&L53DF>CI!4TU)*-'S)O-,U'<$U2DHQF9^[13:
MF.N51H]5?MVW5MU'1&YTT5#F.4R:CPXQ7XR1P@,Q,@Z68,(ZG0+!QGJ---Z;
MN T\C<:6R?20&4^8*>:-$1E;(Q2\,A+.YINC'NG!'*Z9(J8?Q15CK)II)CVH
M&?:BDX;I$6*F8QC%$V)7@TX/RTDD,#F3=F%KM!@RMT5&H.9F^OMWJ[EQQN("
M%[@ ;7M<-M T_1[^.0N-VL^H=WY%VAUM/+DP A/RU_<I/U_10> 6MR#7?<0#
M3ZO@2_%&3[SPQZ?MGYO&/PX<Z1TY>DJ26/HKP(P1:>H/L'+AWQKT!"U[AV96
M_P O?TQBOZ*O]3K]OVUA6FXYCW4' $;F$!L&M][[!W^OER$!Y#CX0K JK^IW
M!< &#<$N T7!?-]?KL].&1=OWU=^C9:*H"<! 1$1*%POPW*&FFOCI8 O<1 !
MTOC-;5%P#(SEF%KN/:;6:#D ,I-WF&M?3[*^]P   >^W";4!_P +4 '_ +[
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MI(@A&NS]8LT7D44^%NJ)C*L&ITW+X@%"_9$#D67T23.4QKA3%GL#!#<Q[%@
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M ! )#><@WT70AH=][7">/)?[/RU]_)28>\Z#:U@MMRWOL("&/I^!_P ]"_\
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MY@*"2SO.OJWD=R++08GB#@B-^MSI<Y I9&U#AN-K:!Z-]@'F/=>PXR:C!S+
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MBJ1XAAE$^PS?7HGMR/F8M[44FDTD&3M;R441(W=MUS@4%R@)Q*FH8>'BX0N
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MW'^%*0Z^+ NH?B]',<?%_B'T-N/8=/?DO9X+^Z8_Q[]G4R4]Q_6.VOCW\]+
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M_A1_KIOF?L+/O%WJY<[^-OB"P#IX6M?%!#,8#L+R<SDUP9ME:* 6C=]A^LN
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MM%N\Y!O7?1Y$+" YG.1N&M[T?4(A;OO^+&E'&MK]]#]U(7!5&"(P1>9U4T[
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M3X+2T]0?8.6UM:.>Z_[LKC-?T5?ZF_+HK3<<Q[J#Y!&YM _PKVVVO8>=^\?
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MG6--1-1R\E(O(EH(4J[DFDQ',SO"&>29!AW#.3<-VR1+KM&;I%5<AOXPI2B
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M,MMI?[M;1O3%R]J^HXVG/(U1T^I(]44LC/\ DUC&H.!.[;.6ZKDSXP&%L^;
MPXT@43<NU2$:F6 IC!::^(B"'U_"Q2'XVC@,ONP+"6DYL;M#A+?.,>.MNCZ8
M M_XHJ#8;7OYHU"8+:V$+:7 ;:AC:%AY'R'X_;-2#P56FJ*/C):!F8N:!,T/
M(QKQC*%64ZE(8]T@H@\!5;B("28H'/QJ"8H$+<PF  QDAW!8TD6;OOUH)I(J
M%Q.JC8QR^Z-\<WJEJVG:6['6:44VGVJM7HK-W#:%ZWL#1%,\@8C=J4ZRZSA!
MOU:;A94ZBH&,/%C(PZ:0>$<+M;9OQV(6JL0X@D!Y--332"\ ,+$Q?=W63&S-
M&954]$TGEAY(EX)!6074X)GRR9!T\>*/'/7NT5USF5=*N%5 ZY0QP2!,H !2
MACEXSQ&+@$&*B6$NX=R-]6MS,*X&'\<F6 !)AR6(!:1'370K91>;DDXD&: P
MT:F5T[;H*F*=?CX5E2IW ;@ F #<0 -PN6PX\M'C\2JNFFJD&DD L9'66G4:
MW73$\+31357202/_ $ >0+N^]M!%U) H      !O8-@OK^,<?3S\_M^5YA$:
M1Z#7]57!5&")"YFU,ZHR@*NJUDW1=NZ<@I"7;M7!E"(.56;<ZI$5C)"50$E!
M#A,)1 P -P]D 8*'WY:'N/9UR&#YIYF9[$H9<4,%[V^C)RX &HC_ !HW$?JM
M.??OA:3871M@^6;0-AIWDZN5'2XK/I R$O#S=.PE-(TZU;R""\$\DS*.E'*Q
MFIDE@<J\($3*/6%L6XFM?0!Q\SQV)7AF@TF*^*"[TLQ$@L0;:=6*]/A\,5EZ
MVJ:" X%KLY(',WS3Y"^?B)2]N>W'4?HE8+"&NW&.@=XW';OQX*J\>IFQ&;YG
M#L1I#.]VG.++V##P:;T7+01#\Q:'9U*K*]556CH\RJAU#]8ZN8YC'-HX4"PF
M,(FTMH CH&/M>&-1P:34[D>T=M&UU\_%I%.)6 S/! 8MD^_=W3A8]"YHP1&"
M+YD>E/<>D)FV&GMVE;6\3$#7QOO^N^")I*/MYUTY^$,'I:P6\I-+7U#7E;NM
MIR&$L"=CZ2K3]0YA=T0$144[KVL-QL-Q#0-1 ;["&H\\?GL4-C8A>X.1AS-B
MS9B(LOK8+\ >XFX%B;D^O4Y)X\F+>7I+>_DP0T^Z6]]N7Q:\]\>WP$UU?Z9N
M]Z1,F\G1B%P\8?E U(@!@))T&08O+@J2N/J#/F?<KYZ,5$8(H0?-"K_O9ZFM
M[O4E^>D?'Q'NOIW8+)<D#)YZ!^@MH5\^8@(B.E[@'J&UM^8:B.E[;V#!:72S
MH5>T"IM_;4GS$?\ -Y>6X>KNTTUQ\3^(G^F3GQ#-I)$[Y[7)=>WP7]RK_0^[
M9<\^7.91-QWVVOH(6&]P]?O7OMCQ8O\ <P/^KO=V'W\K+KA@\>/:*3EJ^F;&
M7CR)4W*=^P,/][FGY FOKWQ^FH^BG_4>R^:MSC2(P1&") P/M\KW[CI+^CR^
M"F?0_9+[!5&"(P1-EE-[6'GX4U7\<Z\P0?GW3FX(C!%SH^:7_P!Q"!VUK>._
MH,AR[O38,%,_/[=,OQ8KA8.HVL W$!VML!?#ESOO>P"."JH&F@W"U@WO?3;0
M-AN//3E;3!0V/)>Z+A=N55-%9=$%R"FMU2JJ15DC!\\15 ABE53. :E4 Q?
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M9.CLCHNW48^B3+@HD%^,C60<"ER(MU:H!Q)AC)HH/^(&C !MUJBNK#^@\-G
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M<_'!$T='>VNG MIYPP8[=TFUMR 1MMMJ(<\2JQY'V5IN.8]UW1"_&<-KB/\
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MGO\ &R<W!5&"*,G2GR^IO,2A(Z(J=!TY8(3S9X5)J\49#UR2#DI#&42#B,
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M(-]U)[&U%AR#5-ZR<-51.4BZ9DQ,FH9)0HC]28BA!!0ARFL)3IB!RB &()3
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MI$JDZ(#AV,?'UQ-S+DCP[$S>'K&NI-4ITG#EHNYLQ?J 9FW6:+E7=E,+<A0
MW'<Y##W%0JH!'TU5XM(>":L"NG#Q!K\M5368R02'6114Y!N/]7MRBXS+L-$N
M:"ICHQYG/W<;0]3S-1/V$<WEG[1A7M8G48LW+YY&HG=E\K@*!SO6+I$$5>%4
M.I$XEX!*<<BH5&H!WI(>XN[,;$1[9%"*@SYO,.+-^+= G4_>W97?^FJG7?\
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M8" 2G)FH7*74A!(*OSRJTLBU7DF;63,P(,(Z:%4<SK@[ [BXJ) 3GP4"L55
MQ2WRG<M<_=<\2H44BHEW/"P9P#SRD.=K:J5]TELM:TJ]=&7Z/$%(O5YY&C&D
MW43P&[63@Q++M4W[PDDP;JN%.S12A&)RHN^$C@S,D@5<%FQE&& (,.2'<D.2
M9Y$M?2X$XQ@0?#$%Q62V0'S ,07<9N[1,NIU]$K,>'S.RM3J" H^,H2'"7E$
MFE-Q;Q-TBT,H[5<.%EDTT$"-'3I=4[A=L4@$*943D#A.43=@& \O)E:P1B5@
MRU50<9L2#ZR.>RE .PVUT'!8)8/HN<_2OS*\TZ]2)^X[1>9SB(I4CN/;2\$Z
ME*L=*23A^V7-!JA%OF9(N!*W)*SQ5%D5 8&,*8@N+=-?R8F)52:\,8=51Q*Z
M !2W_(.[D.PEY@1#KMP<)PCQ C$%=HX6I>>=@Q>\0F%>9^&29M)Y3H_9:R,^
MO2KB58$9T<^>N9^9=P3E4?)1X^,?E)'1)(Y"#F7+IT9PFZX&Q2-RF1,IO&Q*
ML$&BK#)%-%-9J9@>.JFE@^8?BT9Y<K50X "[N2'&0OJS0T,&ZI-*]):5G@F9
M.?Z,V7",RQA:=;J%FZ952?NAJ=^K$32[LCYLW=HQD>U9H)OFJI5"HF K5R[3
M%,N-X9J/B/@P&H%9J+<+$?*'UU<L&+DNIB _# XGI)FF_P S9Y"/6 &#AZ,S
MLXX;+27BF]+='*!JD5,O(=](5#&T@J2,:U8_:DE*7IM"2:1C]$8_JH]=117K
MU%6:QXP"E6 YC$T*G)JPQPU"HT/5+\)()#&'R$+!IJJ9ZHX:6R@2!89._*[%
MS7++I R-89Q1,0YR$IVE#TX]8TE!(KT\_:5VQC7SV=8O)2#54C$HYM3U/A%W
MDP(Y1(9O(D49JB"I45 IJKP\7&J(?#)#2*JB#]0?>_$7^V#!(DMF;DNT]6G-
MUU.+]2&EM &WCC8D ZH%7!$8(D! >WRO?N2DOZ-+8*9]#]DO\%48(C!$V64W
MM8>?A35?Y\>8*#[GW*<W!5&")FL[K>:S36WTU0_)J\O[!TP+L6U'W&HU/ODI
MF.1]QMWH5%KA$Q]MKZZ<K &M[:B-PN'KY8X. ,C;[GKIDQ8W8KH7+R1N0P+
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MR]_/5/U4C+B&NHR[*:]G3G2DD19NE*IER-I!@@(H**PC-W U&<6J:R[E#LH
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M(AUHW/8QO9:XI^;ZIYS[J-Y];;S/VR5P0\4FF5$L>R(F4YCE*#5O8%#@4#'
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M/)CBR )B()4D:/Z0"E3YLR&6QJ>[$S3"<)%S)7Z:ZCIS3B,$M*I.F)&Y :I
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MK5RH>I6JKR2(U=O&QZ;I:+239ODR*-FD^\[20#.3@.@Y$Z3O'./WA*13Q $
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M;,T7!49 6E132L5*+&2;LF+DJ9[)$1$F*,#X>'3A8=7!A4@TTX=,4BDUC%8
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M@ +;6  W]&#9Z?=%3@)80X0L(6$.5MA]_G@GVF[*@)IEV(4+C<= WN W]-P
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MMRT[*4$!2L#3*:J<-'IM#.#]8Z<"8ZSMVI8 ZQTZ6,HNN8   +UB@@4-"@
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>-DB(HI)D"Q2)ID I2E .0 &HB.XC@C?CR67@B__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674792848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTERACTIVE STRENGTH INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001785056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-1432916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1005 Congress Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">697-8655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPrimarySicNumber', window );">Entity Primary SIC Number</a></td>
<td class="text">3600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1005 Congress Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">697-8655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Trent A. Ward<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPrimarySicNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Primary Standard Industrial Classification (SIC) Number for the Entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPrimarySicNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sicNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674282192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">$ 1,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Inventories, net</a></td>
<td class="nump">1,443<span></span>
</td>
<td class="nump">4,567<span></span>
</td>
<td class="nump">2,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncomeTaxesReceivables', window );">Income tax receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Vendor deposits</a></td>
<td class="nump">3,280<span></span>
</td>
<td class="nump">3,603<span></span>
</td>
<td class="nump">3,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">962<span></span>
</td>
<td class="nump">1,426<span></span>
</td>
<td class="nump">1,165<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,722<span></span>
</td>
<td class="nump">9,822<span></span>
</td>
<td class="nump">8,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">2,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use-assets</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,866<span></span>
</td>
<td class="nump">3,834<span></span>
</td>
<td class="nump">2,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Long-term inventories, net</a></td>
<td class="nump">3,121<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">5,683<span></span>
</td>
<td class="nump">7,018<span></span>
</td>
<td class="nump">8,366<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">18,271<span></span>
</td>
<td class="nump">24,447<span></span>
</td>
<td class="nump">22,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,921<span></span>
</td>
<td class="nump">7,743<span></span>
</td>
<td class="nump">2,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">1,951<span></span>
</td>
<td class="nump">5,304<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current portion</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loan payable</a></td>
<td class="nump">6,266<span></span>
</td>
<td class="nump">6,708<span></span>
</td>
<td class="nump">6,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Senior secured notes</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Income tax payable</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible note payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,270<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">18,302<span></span>
</td>
<td class="nump">24,167<span></span>
</td>
<td class="nump">11,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,004<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">PPP loan payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">18,545<span></span>
</td>
<td class="nump">27,180<span></span>
</td>
<td class="nump">11,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">154,942<span></span>
</td>
<td class="nump">112,436<span></span>
</td>
<td class="nump">37,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(155,509)<span></span>
</td>
<td class="num">(115,538)<span></span>
</td>
<td class="num">(57,313)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="num">(274)<span></span>
</td>
<td class="num">(2,733)<span></span>
</td>
<td class="num">(19,663)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity (deficit)</a></td>
<td class="nump">$ 18,271<span></span>
</td>
<td class="nump">24,447<span></span>
</td>
<td class="nump">22,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedConvertiblePreferredStockMember', window );">Series Seed convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount', window );">Convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount', window );">Convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IncomeTaxesReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income taxes receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IncomeTaxesReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (12)(c)<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 14<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph 15<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (16)(c)<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047675415296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">900,000,000<span></span>
</td>
<td class="nump">369,950,000<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="nump">14,178,514<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">14,178,514<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194,135,415<span></span>
</td>
<td class="nump">26,159,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">139,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 72,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedConvertiblePreferredStockMember', window );">Series Seed convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,462,258<span></span>
</td>
<td class="nump">6,462,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,673,157<span></span>
</td>
<td class="nump">19,696,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">96,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">96,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671416464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FitnessProductRevenue1', window );">Fitness product revenue</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">$ 402<span></span>
</td>
<td class="nump">$ 530<span></span>
</td>
<td class="nump">$ 319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_MembershipRevenue1', window );">Membership revenue</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TrainingRevenue1', window );">Training revenue</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">779<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CostOfFitnessProductRevenue', window );">Cost of fitness product revenue</a></td>
<td class="num">(360)<span></span>
</td>
<td class="num">(764)<span></span>
</td>
<td class="num">(1,529)<span></span>
</td>
<td class="num">(2,047)<span></span>
</td>
<td class="num">(2,402)<span></span>
</td>
<td class="num">(2,652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CostOfMembership', window );">Cost of membership</a></td>
<td class="num">(960)<span></span>
</td>
<td class="num">(1,545)<span></span>
</td>
<td class="num">(2,861)<span></span>
</td>
<td class="num">(3,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CostOfMembershipAndTraining', window );">Cost of membership and training</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,147)<span></span>
</td>
<td class="num">(2,513)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CostOfTraining', window );">Cost of training</a></td>
<td class="num">(109)<span></span>
</td>
<td class="num">(387)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="num">(1,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="num">(1,429)<span></span>
</td>
<td class="num">(2,696)<span></span>
</td>
<td class="num">(4,690)<span></span>
</td>
<td class="num">(6,661)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross loss</a></td>
<td class="num">(1,123)<span></span>
</td>
<td class="num">(2,495)<span></span>
</td>
<td class="num">(3,911)<span></span>
</td>
<td class="num">(6,174)<span></span>
</td>
<td class="num">(8,868)<span></span>
</td>
<td class="num">(4,842)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,357<span></span>
</td>
<td class="nump">4,854<span></span>
</td>
<td class="nump">7,796<span></span>
</td>
<td class="nump">15,284<span></span>
</td>
<td class="nump">19,960<span></span>
</td>
<td class="nump">16,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">1,473<span></span>
</td>
<td class="nump">5,194<span></span>
</td>
<td class="nump">6,219<span></span>
</td>
<td class="nump">6,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">6,131<span></span>
</td>
<td class="nump">30,043<span></span>
</td>
<td class="nump">11,774<span></span>
</td>
<td class="nump">19,298<span></span>
</td>
<td class="nump">9,438<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">8,952<span></span>
</td>
<td class="nump">12,178<span></span>
</td>
<td class="nump">39,312<span></span>
</td>
<td class="nump">32,252<span></span>
</td>
<td class="nump">45,477<span></span>
</td>
<td class="nump">32,304<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(10,075)<span></span>
</td>
<td class="num">(14,673)<span></span>
</td>
<td class="num">(43,223)<span></span>
</td>
<td class="num">(38,426)<span></span>
</td>
<td class="num">(54,345)<span></span>
</td>
<td class="num">(37,146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(179)<span></span>
</td>
<td class="num">(417)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(740)<span></span>
</td>
<td class="num">(4,036)<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRevenueExpenseNet', window );">Interest (expense)</a></td>
<td class="num">(154)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="num">(1,382)<span></span>
</td>
<td class="num">(748)<span></span>
</td>
<td class="num">(952)<span></span>
</td>
<td class="num">(935)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_GainUponDebtForgiveness', window );">Gain upon debt forgiveness</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">2,595<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity', window );">Change in fair value of SAFEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_GainLossOnChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(252)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">5,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,266<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="num">(333)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="nump">3,252<span></span>
</td>
<td class="num">(989)<span></span>
</td>
<td class="num">(3,880)<span></span>
</td>
<td class="nump">4,310<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">(10,408)<span></span>
</td>
<td class="num">(14,754)<span></span>
</td>
<td class="num">(39,971)<span></span>
</td>
<td class="num">(39,415)<span></span>
</td>
<td class="num">(58,225)<span></span>
</td>
<td class="num">(32,836)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (10,408)<span></span>
</td>
<td class="num">$ (14,754)<span></span>
</td>
<td class="num">$ (39,971)<span></span>
</td>
<td class="num">$ (39,415)<span></span>
</td>
<td class="num">$ (58,225)<span></span>
</td>
<td class="num">$ (32,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic</a></td>
<td class="num">$ (0.73)<span></span>
</td>
<td class="num">$ (30.16)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="num">$ (93.1)<span></span>
</td>
<td class="num">$ (119.49)<span></span>
</td>
<td class="num">$ (332.31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted</a></td>
<td class="num">$ (0.73)<span></span>
</td>
<td class="num">$ (30.16)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="num">$ (93.1)<span></span>
</td>
<td class="num">$ (119.49)<span></span>
</td>
<td class="num">$ (332.31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common stock outstanding - basic</a></td>
<td class="nump">14,186,222<span></span>
</td>
<td class="nump">489,132<span></span>
</td>
<td class="nump">11,750,907<span></span>
</td>
<td class="nump">423,362<span></span>
</td>
<td class="nump">487,276<span></span>
</td>
<td class="nump">98,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common stock outstanding - diluted</a></td>
<td class="nump">14,186,222<span></span>
</td>
<td class="nump">489,132<span></span>
</td>
<td class="nump">11,750,907<span></span>
</td>
<td class="nump">423,362<span></span>
</td>
<td class="nump">487,276<span></span>
</td>
<td class="nump">98,823<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair values of simple agreements for future equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CostOfFitnessProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of fitness product revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CostOfFitnessProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CostOfMembership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of membership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CostOfMembership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CostOfMembershipAndTraining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of membership&#160;and training.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CostOfMembershipAndTraining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CostOfTraining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of training.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CostOfTraining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FitnessProductRevenue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fitness product revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FitnessProductRevenue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_GainLossOnChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain loss on change in fair value of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_GainLossOnChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_GainUponDebtForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain upon debt forgiveness</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_GainUponDebtForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_MembershipRevenue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Membership revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_MembershipRevenue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TrainingRevenue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Training revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TrainingRevenue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRevenueExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest revenue (income derived from investments in debt securities and on cash and cash equivalents) net of interest expense (cost of borrowed funds accounted for as interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRevenueExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671407232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2 (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (10,408)<span></span>
</td>
<td class="num">$ (14,754)<span></span>
</td>
<td class="num">$ (39,971)<span></span>
</td>
<td class="num">$ (39,415)<span></span>
</td>
<td class="num">$ (58,225)<span></span>
</td>
<td class="num">$ (32,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (10,236)<span></span>
</td>
<td class="num">$ (14,313)<span></span>
</td>
<td class="num">$ (40,050)<span></span>
</td>
<td class="num">$ (38,484)<span></span>
</td>
<td class="num">$ (57,701)<span></span>
</td>
<td class="num">$ (32,661)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047658022352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series Seed 0 - 10 [Member]</div></th>
<th class="th"><div>Series A Convertible Preferred Stock</div></th>
<th class="th"><div>Series A-1 [Member]</div></th>
<th class="th"><div>Series A-2 [Member]</div></th>
<th class="th"><div>IPO [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Class A Common Stock [Member]</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Class B Common Stock</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>IPO [Member]</div>
</th>
<th class="th"><div>Additional Paid In Capital</div></th>
<th class="th">
<div>Additional Paid In Capital </div>
<div>IPO [Member]</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive (Income) Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,986,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="num">$ (16,411,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,041,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="num">$ (24,473,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,474<span></span>
</td>
<td class="nump">14,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Series A-2 preferred stock upon conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of Series A-2 preferred stock upon conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,933,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions', window );">Issuance of promissory notes in exchange for stock options</a></td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue', window );">Issuance of Class&#160;A common stock upon exercise of warrants</a></td>
<td class="nump">6,994,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares', window );">Issuance of Class&#160;A common stock upon exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue', window );">Issuance of Class B common stock upon exercise of warrants</a></td>
<td class="nump">237,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares', window );">Issuance of Class B common stock upon exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue', window );">Issuance of Class B common stock upon conversion of SAFEs</a></td>
<td class="nump">5,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares', window );">Issuance of Class B common stock upon conversion of SAFEs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues', window );">Issuance of Series Seed-2-10 preferred stock upon conversion of SAFEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,655,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-2-10 preferred stock upon conversion of SAFEs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-2 preferred stock upon conversion of SAFE, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-3 preferred stock upon conversion of SAFE, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-4 preferred stock upon conversion of SAFE, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-5 preferred stock upon conversion of SAFEs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-6 preferred stock upon conversion of SAFEs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-7 preferred stock upon conversion of SAFEs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-8 preferred stock upon conversion of SAFEs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-9 preferred stock upon conversion of SAFEs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares', window );">Issuance of Series Seed-10 preferred stock upon conversion of SAFEs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock', window );">Issuance of Series Seed-9 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock', window );">Issuance of Series Seed-9 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock', window );">Issuance of Series A preferred stock net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock', window );">Issuance of Series A preferred stock net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock', window );">Issuance of Series A preferred stock upon conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,422,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock', window );">Issuance of Series A preferred stock upon conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.', window );">Issuance of Series A-1 preferred stock upon conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.', window );">Issuance of Series A-1 preferred stock upon conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock', window );">Issuance of Series Seed-9 preferred stock</a></td>
<td class="nump">94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock', window );">Issuance of Series A preferred stock net of issuance costs</a></td>
<td class="nump">11,370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,164,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,164,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="nump">179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (32,840,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,840,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="nump">139,910<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Endng balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,594,000<span></span>
</td>
<td class="nump">$ 19,535,000<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="num">$ (19,663,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,806,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,000)<span></span>
</td>
<td class="num">(57,313,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,362<span></span>
</td>
<td class="nump">31,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="nump">2,063,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Series A-2 preferred stock upon conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of Series A-2 preferred stock upon conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,926,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 preferred stock, net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,028,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">97,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="nump">167,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,691,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,691,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="nump">755,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Endng balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,594,000<span></span>
</td>
<td class="nump">$ 19,535,000<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="nump">$ 35,954,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="num">$ (30,019,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="num">(70,004,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,746<span></span>
</td>
<td class="nump">32,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="nump">139,910<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,594,000<span></span>
</td>
<td class="nump">$ 19,535,000<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="num">$ (19,663,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,806,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,000)<span></span>
</td>
<td class="num">(57,313,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,362<span></span>
</td>
<td class="nump">31,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="nump">931,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="nump">755,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Endng balance at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,594,000<span></span>
</td>
<td class="nump">$ 19,535,000<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="nump">$ 35,923,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="num">$ (52,122,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,830,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">772,000<span></span>
</td>
<td class="num">(96,728,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,754<span></span>
</td>
<td class="nump">32,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="nump">139,910<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,594,000<span></span>
</td>
<td class="nump">$ 19,535,000<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="num">$ (19,663,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,806,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,000)<span></span>
</td>
<td class="num">(57,313,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,362<span></span>
</td>
<td class="nump">31,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="nump">2,626,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,339,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Series A-2 preferred stock upon conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of Series A-2 preferred stock upon conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,926,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 preferred stock, net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,996,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series A preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (86,703,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,703,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series A preferred stock, shares</a></td>
<td class="nump">19,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series A-1 preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,208,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,208,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series A-1 preferred stock, shares</a></td>
<td class="nump">2,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,604)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series A-2 preferred stock</a></td>
<td class="nump">$ 35,922,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (35,922,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,922,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series A-2 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(755,605)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed preferred stock</a></td>
<td class="nump">2,267,000<span></span>
</td>
<td class="num">$ (2,267,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,267,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,546)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-2 preferred stock</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="num">$ (160,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-2 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-1 preferred stock</a></td>
<td class="nump">719,000<span></span>
</td>
<td class="num">$ (719,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-1 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,393)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-3 preferred stock</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="num">$ (25,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-3 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-4 preferred stock</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="num">$ (15,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-4 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-5 preferred stock</a></td>
<td class="nump">425,000<span></span>
</td>
<td class="num">$ (425,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-5 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,414)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-6 preferred stock</a></td>
<td class="nump">104,000<span></span>
</td>
<td class="num">$ (104,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-6 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(815)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-7 preferred stock</a></td>
<td class="nump">235,000<span></span>
</td>
<td class="num">$ (235,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-7 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-8 preferred stock</a></td>
<td class="nump">659,000<span></span>
</td>
<td class="num">$ (659,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">659,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-8 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-9 preferred stock</a></td>
<td class="nump">2,664,000<span></span>
</td>
<td class="num">$ (2,664,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-9 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,481)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-10 preferred stock</a></td>
<td class="nump">321,000<span></span>
</td>
<td class="num">$ (321,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares', window );">Issuance of Class&#160;A common stock upon conversion of Series Seed-10 preferred stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,347,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,347,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="nump">524,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (58,225,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58,225,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Endng balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="num">(2,733,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,436,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,000<span></span>
</td>
<td class="num">(115,538,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,416,698<span></span>
</td>
<td class="nump">34,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="nump">755,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,594,000<span></span>
</td>
<td class="nump">$ 19,535,000<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="nump">$ 35,954,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="num">(30,019,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="num">(70,004,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,746<span></span>
</td>
<td class="nump">32,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (27,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="nump">323,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,970,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,970,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="nump">755,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Endng balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,594,000<span></span>
</td>
<td class="nump">$ 19,535,000<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="nump">$ 35,927,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="num">(41,564,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,073,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,000<span></span>
</td>
<td class="num">(81,974,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,746<span></span>
</td>
<td class="nump">32,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 preferred stock, net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="nump">441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(14,754,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,754,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="nump">755,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Endng balance at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,594,000<span></span>
</td>
<td class="nump">$ 19,535,000<span></span>
</td>
<td class="nump">$ 2,604,000<span></span>
</td>
<td class="nump">$ 35,923,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="num">$ (52,122,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,830,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">772,000<span></span>
</td>
<td class="num">(96,728,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,754<span></span>
</td>
<td class="nump">32,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="num">(2,733,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,436,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,000<span></span>
</td>
<td class="num">(115,538,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,416,698<span></span>
</td>
<td class="nump">34,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="nump">4,452,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,449,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,676,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Issuance of Common stock upon conversion of Common Stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Issuance of Common stock upon conversion of Common Stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,416,698<span></span>
</td>
<td class="num">(2,416,698)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of Class B common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Common stock converted, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(680,657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NetExerciseOfOptions', window );">Net exercise of options</a></td>
<td class="nump">323,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">15,057,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,057,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="num">(115,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(15,961,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,961,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 1,037,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,279,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="num">(131,499,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,774,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="num">(2,733,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,436,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,000<span></span>
</td>
<td class="num">(115,538,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,416,698<span></span>
</td>
<td class="nump">34,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="num">(79,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="num">(274,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,942,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,000<span></span>
</td>
<td class="num">(155,509,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">1,037,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,279,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="num">(131,499,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,774,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_InitialPublicOfferingCosts', window );">Initial public offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,607,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,607,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of Common stock upon conversion of convertible notes</a></td>
<td class="nump">4,521,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,521,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of stock warrants</a></td>
<td class="nump">2,468,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,468,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="num">(136,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(13,602,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,602,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">5,011,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,991,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,000<span></span>
</td>
<td class="num">(145,101,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,951,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,951,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(10,408,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,408,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="num">$ (274,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,942,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 286,000<span></span>
</td>
<td class="num">$ (155,509,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital Issuance of Promissory Notes in Exchange for Stock Options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital Issuance of Series A Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital Issuance of Series Seed Nine Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_InitialPublicOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial public offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_InitialPublicOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series A1 Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series A1 Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series A Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series A Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock Upon Exercise of Warrants Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class A Common Stock Upon Exercise of Warrants Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class B Common Stock Upon Exercise of Warrants Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Class B Common Stock Upon Exercise of Warrants Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Eight preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Five preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Four preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Nine preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Seven preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Six preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Three preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Two preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NetExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net exercise of options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NetExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity additional stock issued during period value new issues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A One Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Issued During Period Shares New Issues Issuance of Series A Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Issued During Period Shares New Issues Series Seed Nine Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period value conversion of convertible Securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A One Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Issued During Period Value New Issues Issuance of Series A Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Stock Issued During Period Value New Issues Series Seed Nine Preferred Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678875600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesA2PreferredStockMember', window );">Series A-2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesA2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesA2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047586601568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (39,971)<span></span>
</td>
<td class="num">$ (39,415)<span></span>
</td>
<td class="num">$ (58,225)<span></span>
</td>
<td class="num">$ (32,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">821<span></span>
</td>
<td class="nump">422<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">932<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="nump">4,188<span></span>
</td>
<td class="nump">3,735<span></span>
</td>
<td class="nump">4,999<span></span>
</td>
<td class="nump">1,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NonCashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory valuation loss</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">904<span></span>
</td>
<td class="nump">1,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">23,773<span></span>
</td>
<td class="nump">3,951<span></span>
</td>
<td class="nump">6,347<span></span>
</td>
<td class="nump">1,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes', window );">Fair value of warrants issued with convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,482<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain upon debt forgiveness</a></td>
<td class="num">(2,595)<span></span>
</td>
<td class="num">(523)<span></span>
</td>
<td class="num">(523)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders', window );">Warrants issued to service providers</a></td>
<td class="nump">442<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on property and equipment disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NonCashInterestExpense', window );">Non-cash interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">952<span></span>
</td>
<td class="nump">978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,275<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity', window );">Change in fair value of SAFEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_GainLossOnChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="num">(5,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrants</a></td>
<td class="num">(2,266)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(478)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(442)<span></span>
</td>
<td class="num">(2,806)<span></span>
</td>
<td class="num">(2,435)<span></span>
</td>
<td class="num">(3,410)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">464<span></span>
</td>
<td class="num">(721)<span></span>
</td>
<td class="num">(261)<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Vendor deposits</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="num">(3,228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCharges', window );">Deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncreaseDecreaseInLongTermInventory', window );">Long-term inventories</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">585<span></span>
</td>
<td class="nump">1,642<span></span>
</td>
<td class="nump">3,926<span></span>
</td>
<td class="num">(1,181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(780)<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">1,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenues</a></td>
<td class="nump">37<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(585)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(13,561)<span></span>
</td>
<td class="num">(29,492)<span></span>
</td>
<td class="num">(35,545)<span></span>
</td>
<td class="num">(38,256)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(501)<span></span>
</td>
<td class="num">(577)<span></span>
</td>
<td class="num">(2,623)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Acquisition of internal use software</a></td>
<td class="num">(349)<span></span>
</td>
<td class="num">(2,744)<span></span>
</td>
<td class="num">(2,743)<span></span>
</td>
<td class="num">(1,429)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Acquisition of software and content</a></td>
<td class="num">(797)<span></span>
</td>
<td class="num">(4,958)<span></span>
</td>
<td class="num">(4,287)<span></span>
</td>
<td class="num">(8,307)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,146)<span></span>
</td>
<td class="num">(8,203)<span></span>
</td>
<td class="num">(7,607)<span></span>
</td>
<td class="num">(12,359)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ProceedsFromPPPLoan', window );">Proceeds from PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Proceeds from issuance of loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="nump">1,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from issuance of related party loans</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt', window );">Payments of loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,324)<span></span>
</td>
<td class="num">(1,887)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_RepaymentsOfRelatedPartyLoans', window );">Payments of related party loans</a></td>
<td class="num">(483)<span></span>
</td>
<td class="num">(1,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity', window );">Proceeds from issuance of SAFEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock upon initial public offering, net of offering costs</a></td>
<td class="nump">10,820<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of offering costs</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from senior secured notes</a></td>
<td class="nump">3,030<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PaymentsOfSeniorSecuredNotes', window );">Payments of senior secured notes</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Preferred Stock - Series A, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29,997<span></span>
</td>
<td class="nump">29,996<span></span>
</td>
<td class="nump">30,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,902<span></span>
</td>
<td class="nump">10,106<span></span>
</td>
<td class="nump">14,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock A</a></td>
<td class="nump">4,247<span></span>
</td>
<td class="nump">2,060<span></span>
</td>
<td class="nump">2,626<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from the exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of common stock options</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_RepaymentOfBouncebackLoans', window );">Repayment Bounce Back Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">14,656<span></span>
</td>
<td class="nump">36,732<span></span>
</td>
<td class="nump">41,772<span></span>
</td>
<td class="nump">52,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate on cash</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change In Cash and Cash Equivalents</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(1,037)<span></span>
</td>
<td class="num">(1,471)<span></span>
</td>
<td class="nump">1,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and restricted cash at beginning of year</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and restricted cash at end of year</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">660<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure Of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PropertyAndEquipmentInAccountsPayable', window );">Property &amp; equipment in AP</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_InventoriesInAccountsPayableAndAccrued', window );">Inventories in AP and accrued</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="nump">1,007<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CapitalizedSoftwareAndContentInAccountsPayable', window );">Capitalized software and content in AP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable', window );">Issuance of Series A preferred stock in connection with convertible notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,926<span></span>
</td>
<td class="nump">5,926<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NoncashActivityDeferredCostsIncurred', window );">Deferred offering&#160;costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_RecognitionOfDeferredAndAccruedOfferingCosts', window );">Offering costs in AP and accrued</a></td>
<td class="nump">3,155<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ProceedsFromPaycheckProtectionProgramLoan', window );">Exercise of stock warrants</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption', window );">Right-of-use assets obtained in exchange for new operating lease liabilities upon ASC 842 adoption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of convertible notes into common stock</a></td>
<td class="nump">4,521<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination', window );">Decrease in right-of-use asset and operating lease liabilities due to lease termination</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NonCashIssuanceOfCommonStockFromRightsOffering', window );">Issuance of Common Stock from Rights Offering</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NonCashExerciseOfOptions', window );">Net exercise of options</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_StockBasedCompensationCapitalizedInSoftware', window );">Stock-based compensation capitalized in software</a></td>
<td class="nump">$ 745<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants', window );">Issuance of common stock in connection with exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA', window );">Issuance of warrants in connection with Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesIssued1', window );">Issuance of Series Seed preferred stock in connection with convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,947<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfLoanPayableToConvertibleNoteMember', window );">Conversion of Loan Payable to Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure Of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Issuance of convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfAccountsPayableToConvertibleNoteMember', window );">Conversion of Accounts Payable to Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure Of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Issuance of convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfPromissoryNotesToConvertibleNoteMember', window );">Conversion of Promissory Notes to Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure Of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Issuance of convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfPreferredStockToClassACommonStockMember', window );">Conversion of Preferred Stock to Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure Of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Issuance of Class A common stock through conversion of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,655<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember', window );">Conversion of Convertible Simple Agreements for Future Equity to Series Seed Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure Of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of connection with convertible SAFEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember', window );">Conversion of Convertible Simple Agreements for Future Equity to Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure Of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of connection with convertible SAFEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,667<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CapitalizedSoftwareAndContentInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Software and Content in Accounts Payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CapitalizedSoftwareAndContentInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair values of simple agreements for future equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in right-of-use asset and operating lease liabilities due to lease termination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of warrants issued to service providers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueOfWarrantsIssuedWithConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of Warrants Issued with Convertible Notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueOfWarrantsIssuedWithConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_GainLossOnChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain loss on change in fair value of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_GainLossOnChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IncreaseDecreaseInLongTermInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in long-term inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IncreaseDecreaseInLongTermInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_InventoriesInAccountsPayableAndAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories in Accounts Payable and accrued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_InventoriesInAccountsPayableAndAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series A preferred stock in connection with convertible notes payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NonCashExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash Exercise of Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NonCashExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NonCashInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non Cash Interest Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NonCashInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NonCashIssuanceOfCommonStockFromRightsOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash issuance of common stock from rights offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NonCashIssuanceOfCommonStockFromRightsOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash lease expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NoncashActivityDeferredCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Activity Deferred Costs Incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NoncashActivityDeferredCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Transaction Issuance of Common Stock in Connection with Exercise of Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Transaction Issuance of Warrants in Connection with Series A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PaymentsOfSeniorSecuredNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of senior secured notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PaymentsOfSeniorSecuredNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Issuance of Simple Agreements for Future Equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ProceedsFromPPPLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from PPP loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ProceedsFromPPPLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ProceedsFromPaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from paycheck protection program loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ProceedsFromPaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PropertyAndEquipmentInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property and equipment in accounts payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PropertyAndEquipmentInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_RecognitionOfDeferredAndAccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition of deferred and accrued offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_RecognitionOfDeferredAndAccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_RepaymentOfBouncebackLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayment of Bounceback Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_RepaymentOfBouncebackLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_RepaymentsOfRelatedPartyLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments of related party loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_RepaymentsOfRelatedPartyLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Operating Lease Liability Upon Accounting Standard Adoption 842 Adoption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_StockBasedCompensationCapitalizedInSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock based compensation capitalized in software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_StockBasedCompensationCapitalizedInSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of notes issued in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from other long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfLoanPayableToConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfLoanPayableToConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfAccountsPayableToConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfAccountsPayableToConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfPromissoryNotesToConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=trnr_ConversionOfPromissoryNotesToConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfPreferredStockToClassACommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfPreferredStockToClassACommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047679016528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business and Basis of Presentation</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">1. Description of Business and Basis of Presentation </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Description and Organization </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Interactive Strength Inc., together with its consolidated subsidiaries doing business as &#8220;Forme&#8221; (&#8220;Forme&#8221; or the &#8220;Company&#8221;), is an interactive home fitness platform that offers an immersive smart home gym with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">life-size</div> touchscreen mirror and accessories. Our Members are defined as any individual who has a Forme account through a paid connected fitness membership. The Company&#8217;s interactive home fitness platform is known as the Studio, for which the Company continues to develop new accessories and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">add-ons</div> to further customize a Member&#8217;s experience (&#8220;Connected Fitness Products&#8221;). Through the Studio, Members can stream immersive, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">instructor-led</div> boutique classes anytime, anywhere. The Company enables Members to get the most out of their wellness journey from their home. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Initial Public Offering </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, the Company closed its initial public offering (&#8220;IPO&#8221;) in which we issued and sold 1.5&#160;million shares of common stock at a public offering price of $8.00 per share and excluding shares sold in the IPO by certain of our existing stockholders. Total proceeds, after deducting underwriting commissions of $1.2&#160;million and other offering expenses of $4.6&#160;million, was $6.2&#160;million. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation and Consolidation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). The condensed consolidated financial statements include the accounts of Interactive Strength Inc. and its subsidiaries in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, cash flows, and the changes in equity for the interim period. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity and Going Concern </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Since its inception, the Company has sustained recurring losses and has relied on funding from private investors and other third-parties (collectively &#8220;outside capital&#8221;) to execute the Company&#8217;s growth strategy. As a result, the Company incurred a net loss of $40.0&#160;million during the nine months ended September&#160;30, 2023 and had an accumulated deficit of $155.5&#160;million as of September&#160;30, 2023. The Company&#8217;s long-term success is dependent upon its ability to successfully develop, market, and deliver its revenue-generating products and services in a profitable manner. While management believes the Company can be successful in executing its growth strategy, no assurance can be provided it will be able to do so in a timely or profitable manner. As a result, the Company anticipates it will continue to rely on outside capital to fund the Company&#8217;s operations for the foreseeable future. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of the date the accompanying condensed consolidated financial statements were issued (the &#8220;issuance date&#8221;), the Company&#8217;s available liquidity was not sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due, absent the Company&#8217;s ability to secure additional outside capital. While management plans to take action to address the Company&#8217;s liquidity needs, such as cost mitigation initiatives to reduce unnecessary costs, securing additional outside capital, and/or pursuing other strategic arrangements, no assurance can be provided that management&#8217;s actions will be sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, the Company had $1.0&#160;million of senior secured notes outstanding with THLWY, LLC (see Note 10). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In addition, as of September&#160;30, 2023, the Company had loans outstanding from certain related parties (See Note 19) with an aggregate principal and interest amount owed of approximately $6.3&#160;million. All of these loans matured prior to September&#160;30, 2023, but their repayment has been temporarily waived. However, absent additional outside capital, the Company will be unable to repay these loans upon their maturity and, as such, the aggregate amounts owed have been classified as current debt in the accompanying condensed consolidated balance sheet as of September&#160;30, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the event that one or more of management&#8217;s planned actions are not sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due, management will be required to seek other strategic </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">alternatives, which may include, among others, a significant curtailment in the Company&#8217;s operations, a sale of certain of the Company&#8217;s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy. These uncertainties raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying condensed consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">1. Description of Business and Basis of Presentation </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Description and Organization </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Interactive Strength Inc., together with its consolidated subsidiaries doing business as &#8220;Forme&#8221; (&#8220;Forme&#8221; or the &#8220;Company&#8221;), is an interactive home fitness platform that offers an immersive smart home gym with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">life-size</div> touchscreen mirror and accessories. Our Members are defined as any individual who has a Forme account through a paid connected fitness membership. The Company&#8217;s interactive home fitness platform is known as the Studio, for which the Company continues to develop new accessories and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">add-ons</div> to further customize a Member&#8217;s experience (&#8220;Connected Fitness Products&#8221;). Through the Studio, Members can stream immersive, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">instructor-led</div> boutique classes anytime, anywhere. The Company enables Members to get the most out of their wellness journey from their home. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation and Consolidation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of Interactive Strength Inc. and its subsidiaries in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity and Going Concern </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Since its inception, the Company has sustained recurring losses and has relied on funding from private investors and other third-parties (collectively &#8220;outside capital&#8221;) to execute the Company&#8217;s growth strategy. As a result, the Company incurred a net loss of $58.2 million during the year ended December 31, 2022 and had an accumulated deficit of $115.5 million as of December 31, 2022. The Company&#8217;s long-term success is dependent upon its ability to successfully develop, market, and deliver its revenue-generating products and services in a profitable manner. While management believes the Company can be successful in executing its growth strategy, no assurance can be provided it will be able to do so in a timely or profitable manner. As a result, the Company anticipates it will continue to rely on outside capital to fund the Company&#8217;s operations for the foreseeable future. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of the date the accompanying consolidated financial statements were issued (the &#8220;issuance date&#8221;), the Company&#8217;s available liquidity was not sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due, absent the Company&#8217;s ability to secure additional outside capital. While management plans to take action to address the Company&#8217;s liquidity needs, such as cost mitigation initiatives to reduce unnecessary costs, securing additional outside capital, pursuing an initial public offering of the Company&#8217;s common stock, and/or pursuing other strategic arrangements, no assurance can be provided that management&#8217;s actions will be sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In addition, as of December 31, 2022, the Company had loans outstanding from certain related parties (See Note&#160;22) with an aggregate principal and interest amount owed of approximately $6.7 million. Certain of these loans matured prior to December 31, 2022, but their repayment has been temporarily waived, and the remaining loans are scheduled to mature over the next twelve months beyond issuance date. However, absent additional outside capital, the Company will be unable to repay these loans upon their maturity and, as such, the aggregate amounts owed have been classified as current debt in the accompanying consolidated balance sheet as of December 31, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the event that one or more of management&#8217;s planned actions are not sufficient to fund the Company&#8217;s operations over the next twelve months or meet its obligations as they become due, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment in the Company&#8217;s operations, a sale of certain of the Company&#8217;s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy. These uncertainties raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678950144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">2. Summary of Significant Accounting Policies </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Interim Financial Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP, for interim financial reporting and as required by Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X,</div> Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-01.</div> The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated annual financial statements for the years ended December&#160;31, 2022 and 2021 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company&#8217;s condensed consolidated balance sheet as of September&#160;30, 2023, the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022, the condensed consolidated statement of redeemable convertible preferred stock and stockholders&#8217; equity (deficit) as of September&#160;30, 2023 and condensed consolidated statements of cash flows for the nine months ended September&#160;30, 2023 and 2022. The financial data and other information disclosed in these notes related to the nine months ended September&#160;30, 2023 and 2022 are unaudited. The results for the nine months ended September&#160;30, 2023, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2023, any other interim periods, or any future year or period. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#8220;CODM&#8221;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">at-home</div> fitness technology platform. The Company&#8217;s chief operating decision maker, its chief executive officer, manages the Company&#8217;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of September&#160;30, 2023 and 2022, substantially all of the Company&#8217;s long-lived assets are held in the United States. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cash consists of cash on deposit in banks. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Offering Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company complies with the requirements of ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1</div></div></div> and SEC Staff Accounting Bulletin Topic 5A &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of Offering&#8221;</div></div>. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. As of September&#160;30, 2023, the Company incurred offering costs amounting to $4.6&#160;million through the IPO and subsequently classified the costs to additional paid in capital. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-production</div> tooling which it owns under a supply arrangement. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling, including the related engineering costs the Company will not own or will not use in producing products under long-term supply arrangements, are expensed as incurred. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 10 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">3 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="-sec-ix-hidden:hidden95757150">Lesser of lease term or estimated useful life</span></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Inventories, net </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">written-off</div> against the reserve. Inventory not expected to be sold in the next twelve months is classified as long-term in the accompanying condensed, consolidated balance sheets. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Vendor Deposits </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#8217;s inventory. In general, the Company&#8217;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#8217;s consolidated balance sheet. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Capitalized Studio Content </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Capitalized Studio content costs include certain expenditures to develop video and live content for the Company&#8217;s customers. The Company capitalizes production costs for recorded content in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">926-20,</div> Entertainment-Films - Other Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#8220;obsolescence&#8221; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(3-year)</div> amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $2.9&#160;million and $4.4&#160;million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Identifiable Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">350-40,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-use</div> Software and ASC 985, Software. These capitalized costs also relate to the Company&#8217;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems. Capitalized software costs are amortized over the estimated useful life is three years. Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is probable the project will be completed, and the software will be used to perform the function intended. Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. The Company expenses all costs incurred that relate to planning and post-implementation phases of development. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment, and none were identified in the quarter ended September&#160;30, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the nine months ended September&#160;30, 2023 and the year ended December&#160;31, 2022, the Company capitalized $0.5&#160;million and $2.7&#160;million, respectively, of internal use software. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:41%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="width:56%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Internal-use</div> software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">3 years</div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Music Royalty Fees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes music royalty fees as these fees are incurred in accordance with the terms of the relevant license agreement with the music rights holder. The incurrence of such royalties is primarily driven by the number of paid subscribers each month and it is classified as cost of membership and training within the Company&#8217;s statement of operations. The Company&#8217;s license agreements with music rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of September&#160;30, 2023 and December&#160;31, 2022 there were no music guarantee-related prepaids, respectively. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s material financial instruments consist primarily of cash and cash equivalents, accounts payable, accrued expenses, convertible notes, and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these instruments. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the convertible notes were converted into an aggregate of 565,144 shares of common stock. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the condensed consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party (the &#8220;acqui-hire transaction&#8221;) that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x)&#160;the price per share of the next equity financing with total proceeds of at least $10.0&#160;million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 28,124 shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $400,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 49,996 shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to certain existing affiliate and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliate</div> stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with a note financing (the &#8220;Bridge Note Financing&#8221;). Such warrants are exercisable for a number of shares of our common stock that is determined by dividing: (A)&#160;(i) in the case of the warrants issued to the lead noteholder, 67% of the aggregate principal amount of notes issued to such lead noteholder and; (ii)&#160;in the case of all other noteholders in the Bridge Note Financing, 60% of the aggregate principal amount of notes issued to such other noteholders by (B)&#160;(i) the initial public offering price per share or (ii)&#160;if the initial public offering is not consummated, by either (x)&#160;the price per share offered in a change of control transaction or (y)&#160;if a change of control transaction does not occur, the fair market value of our common stock as determined by an independent appraiser. The warrants may also be net exercised upon election. The value of the warrants of $1.3&#160;million was recorded as debt discount on the senior notes of $2.0&#160;million. The debt discount was amortized into interest expense over life of the senior notes. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 163,121 shares of common stock. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">estimates, assumptions, and judgments to determine the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s condensed consolidated financial statements upon adoption. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) and has elected not to &#8220;opt out&#8221; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time public companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Recently Adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02,</div> Leases (&#8220;Topic 842&#8221;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January&#160;1, 2022. Financial positions for reporting periods beginning on or after January&#160;1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-03,</div> Measurement of Credit Losses on Financial Instruments (&#8220;CECL&#8221;), which amends ASC 326 &#8220;Financial Instruments - Credit Losses&#8221; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#8220;expected loss model&#8221; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January&#160;1, 2022 and the guidance did not have a material impact on our condensed consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>, which amends ASC Topic 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div>. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances, eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#8217;s condensed consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Not Yet Adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> and ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</div></div>. This guidance provides temporary optional expedients and exceptions to accounting </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">guidance on contract modifications and hedge accounting to ease entities&#8217; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848)</div></div>, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its condensed consolidated financial statements. </div><span></span>
</td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">2. Summary of Significant Accounting Policies </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, simple agreement for future equity (&#8220;SAFE&#8221;) liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#8220;CODM&#8221;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">at-home</div> fitness technology platform. The Company&#8217;s chief operating decision maker, its chief executive officer, manages the Company&#8217;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of December&#160;31, 2022 and 2021, substantially all of the Company&#8217;s long-lived assets are held in the United States. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cash consists of cash on deposit in banks. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Off-Balance</div> Sheet Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any credit losses on its cash or cash equivalents. The Company maintains its cash and cash equivalents at a high-quality financial institution. Management believes that such funds are not exposed to any significant credit or concentration risk. The Company has no financial instruments with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-balance-sheet</div> risk of loss and has not experienced any losses on such accounts. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Offering Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of Offering&#8221;</div></div>. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. The Company has incurred and expensed offering costs amounting to $2.3&#160;million as of December&#160;31, 2022. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s material financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFEs and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these <div style="display:inline;">instruments</div>. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">written-off</div> against the reserve. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Vendor Deposits </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#8217;s inventory. In general, the Company&#8217;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#8217;s consolidated balance sheet. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Capitalized Studio Content </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Capitalized&#160;Studio content costs include certain expenditures to develop video and live content for the Company&#8217;s customers. The Company capitalizes production costs for recorded&#160;content in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;926-20,&#160;Entertainment-Films</div> - Other&#160;Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">other&#160;non-current&#160;assets</div> in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized&#160;content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#8220;obsolescence&#8221; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(3-year)</div> amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $4.4&#160;million as of December&#160;31, 2022. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Identifiable Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;350-40,&#160;Internal-use&#160;Software</div></div> and ASC 985, Software.&#160;These capitalized costs also relate to the Company&#8217;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems.&#160;Capitalized software costs are amortized over the estimated useful life is three years.&#160;Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">probable the project will be completed, and the software will be used to perform the function intended.&#160;Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use.&#160;The Company expenses all costs incurred that relate to planning and post-implementation phases of development. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the years ended December&#160;31, 2022 and 2021, the Company capitalized $2.7&#160;million, and $1.4&#160;million, respectively, of internally developed software. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;&#160;Internal-use software</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">3 years</td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-production</div> tooling which it owns under a supply arrangement. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling, including the related engineering costs the Company will not own or will not be used in producing products under long-term supply arrangements, are expensed as incurred. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><div style="display:inline;">2 </div>&#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 10 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">3 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="-sec-ix-hidden:hidden95757149">Lesser of lease term or estimated useful life</span></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Content Licensing Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company entered into two agreements with a third-party content provider (&#8220;Content Provider&#8221;), a service agreement and a collaboration agreement. Per the service agreement, Forme is to provide content creation services for the Content Provider in which the Company is to produce workout content using the Content Provider&#8217;s trainers and studios. Under the collaboration agreement, both the Company and the Content Provider agree to jointly market their partnership; in addition, the collaboration agreement provides the Company with a license to use the Content Provider&#8217;s content on its Studio fitness ecosystem (i.e., the &#8220;License&#8221;). The license issued to the Company allows the Company to reproduce, modify, prepare derivative works based upon, distribute, publicly display, publicly perform the content and the modified content, to market, advertise or promote the Company, perform specified activities, and provide the Company&#8217;s customers access to and use of the Content Provider&#8217;s content, throughout the world on the Company&#8217;s Studio devices and in any media, so long as such other media is associated or related to the use of the Company&#8217;s Studio devices. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, the company determined that the Content Provider&#8217;s content would no longer be used on Forme&#8217;s platform, leading to a triggering event. Upon further analysis, it was determined that this content was abandoned in December 2022 with no remaining fair value. As such, Forme recorded an impairment loss of $2.3 million within general and administrative costs within the consolidated statement of operations and comprehensive loss as of December 31, 2022. As a result, there is no related unamortized costs of content as of December 31, 2022. Refer to Note 14 for further information on future minimum payments as of December 31, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The liability will be recorded and accreted at the gross amount for each tranche of content delivered to the Company for $0.5&#160;million per quarter and will be decreased when the payments per the payment schedule above are made. The liability for the license fee is approximately $2.3 million as of December 31, 2022. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Music&#160;Royalty Fees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes&#160;music&#160;royalty fees&#160;as these fees are incurred in accordance with the terms of the relevant license agreement with the&#160;music&#160;rights holder. The incurrence of such royalties is primarily driven by&#160;the number of paid subscribers each month&#160;and it is classified as cost of membership and training within the Company&#8217;s statement of operations. The Company&#8217;s license agreements with&#160;music&#160;rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of December 31, 2022 and 2021, there were music guarantee-related prepaids of $0 million and $0.1 million, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. There was a $2.3 million impairment loss related to the impairment of the Content Provider&#8217;s content for the year ended December 31, 2022. There was no charge to impairment for the year ended December&#160;31, 2021. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company adopted the Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases</div></div> (Topic 842) (&#8220;ASU 2016-02&#8221; or &#8220;ASC&#160;842&#8221;) as of January 1, 2022, using the modified retrospective method and utilized the effective date as its date of initial application, with prior periods presented in accordance with previous guidance under Accounting Standards Codification (&#8220;ASC&#8221;) 840, Leases. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease liabilities, as applicable. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Prospectively, the Company will adjust the right-of-use assets for straight-line rent expense and remeasure the lease liability at the net present value using the same incremental borrowing rate that was in effect as of the lease commencement or transition date. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date: i) the Company did not reassess whether any expired or existing contracts are or contain leases, ii) the Company did not reassess the lease classification for any expired or existing leases, and iii) the Company did not reassess initial direct costs for any existing leases. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In accordance with ASC 842, components of a lease should be split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Entities may elect not to separate lease and non-lease components. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only. As a result of the adoption of ASC 842, the Company recognized right-of-use assets and lease liabilities of $0.3 million and $0.3 million, respectively, as of the January 1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. The Company recorded an immaterial amount of general and administrative expense in its consolidated statement of operations related to lease expense, including short-term lease expense during the year ended December 31, 2022. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party (the &#8220;acqui-hire transaction&#8221;) that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x) the price per share of the next equity financing with total proceeds of at least $10.0 million or (y) the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.01 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In accordance with ASC 718, as the warrant contains a performance condition dependent on an initial public offering, there has been no impact recorded prior to December 31, 2022. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Instruments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company measures derivative financial instruments at fair value and recognizes them as either assets or liabilities on the consolidated balance sheets. The Company evaluates its convertible instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives requiring separate recognition in the Company&#8217;s financial statements in accordance with the criteria under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15.</div> As of December&#160;31, 2022 and 2021, the Company did not have any material derivative contracts or contracts with material embedded derivative features requiring bifurcation. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Simple Agreements for Future Equity (&#8220;SAFES&#8221;) and Advance Subscription Agreements (&#8220;ASAs&#8221;) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has issued several SAFEs and ASAs in exchange for cash financing. The SAFEs were initially measured at fair value using a probability weighted expected return method (PWERM) and were subsequently remeasured at fair value at each reporting period, through the date of conversion. The ASAs were initially measured at fair value utilizing the&#160;fair value of the Company&#8217;s common stock according to the ASC 718 valuation&#160;performed by an independent appraiser closest to the date of grant and were subsequently remeasured at fair value at each reporting period, through date of conversion. Pursuant to the SAFE agreement provisions, all outstanding SAFE instruments were converted to preferred stock in 2021, in connection with a Series A financing. All ASAs were converted to common stock on the respective ASA Longstop Dates <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(6-month</div> anniversary of issuance). There were are no outstanding SAFEs or ASAs as of December&#160;31, 2022 or December 31, 2021. The remeasurements of the SAFEs and ASAs resulted in the recognition of a $0.3 million loss for the year ended December&#160;31, 2021 (see Note 4 to the consolidated financial statements for the accounting for significant inputs to the valuation of the SAFE and ASA instruments). </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Commitments and Contingencies </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. If a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the possible loss or states that such an estimate cannot be made. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On January&#160;1, 2020, the Company adopted Accounting Standards Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;ASU&#8221;)&#160;2014-09,&#160;Revenue</div> from Contracts with Customers (Topic 606) (&#8220;ASC 606&#8221;)&#160;and all subsequent amendments. As the Company had not recognized any revenue prior to the adoption of the new standard, there was no impact on the measurement or timing of revenue recognition as a result of the adoption. Revenue is recognized when control of the promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Refer to Note 3 for additional information. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Fitness Product Revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cost of fitness product revenue relates to the Fitness Product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management, facilities, and personnel-related expenses associated with supply chain logistics. Cost of fitness product revenue also contains valuation losses related to the Company&#8217;s inventory lower of cost or market reserve. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Membership and Training </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Membership costs include costs associated with the creation of content and training, including associated payroll, filming and production costs, other content specific costs, hosting fees, music royalties, amortization of capitalized software development costs, and warranty replacement and servicing costs associated with extended warranty contracts. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Advertising Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Advertising and other promotional costs to market the Company&#8217;s products are expensed as incurred. Advertising expenses were $2.5&#160;million and $2.0&#160;million for the years ended December&#160;31, 2022 and 2021, respectively, and are included within sales and marketing expenses in the consolidated statements of operations and comprehensive loss. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Research and Development Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Research and development expenses consist primarily of personnel- and facilities-related expenses, consulting and contractor expenses, tooling and prototype materials software platform expenses, and depreciation of property and equipment. Substantially all of the Company&#8217;s research and development expenses are related to developing new products and services and improving existing products and services. Research and development expenses are expensed as incurred. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-Based Compensation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (&#8220;the 2020 Plan&#8221;). Stock-based awards are measured at the grant date based on the fair value of the award and are recognized as expense, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The determination of the grant date fair value of stock awards issued is affected by a number of variables, including the fair value of the Company&#8217;s common stock, the expected common stock price volatility over the expected life of the awards, the expected term of the stock option, risk-free interest rates, and the expected dividend yield of the Company&#8217;s common stock. The Company derives its volatility from the average historical stock volatilities of several peer public companies over a period equivalent to the expected term of the awards. The Company estimates the expected term based on the simplified method for employee stock options considered to be &#8220;plain vanilla&#8221; options, as the Company&#8217;s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant. Expected dividend yield is 0.0% as the Company has not paid and does not currently anticipate paying dividends on its common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Stock-based compensation expense is classified in the accompanying consolidated statement of operations in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Foreign Currency Transactions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The functional currency for the Company&#8217;s wholly-owned foreign subsidiaries, Interactive Strength UK and Interactive Strength Taiwan, is the United States dollar. All foreign currency transaction gains and losses are recognized in the consolidated statements of operations and comprehensive loss through other income (expense). The Company has not recognized material currency transaction gains or losses during the years ended December&#160;31, 2022 and 2021. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive Loss </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Comprehensive loss includes net loss as well as other changes in stockholders&#8217; deficit that result from transactions and economic events other than those with stockholders. For the years ended December 31, 2022 and 2021, comprehensive loss included $0.5 million and $0.2 million of foreign currency transaction gains, respectively. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Loss Per Share </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company computes loss per share using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method required for participating securities. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company&#8217;s redeemable convertible preferred stock and common stock issued upon early exercise of stock options are participating securities. The Company considers any shares issued upon early exercise of stock options, subject to repurchase, to be participating securities because holders of such shares have <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-forfeitable</div> dividend rights in the event a cash dividend is declared on common stock. These participating securities do not contractually require the holders of such shares to participate in the Company&#8217;s losses. As such, net losses for the periods presented were not allocated to the Company&#8217;s participating securities. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Basic loss per share is computed using the weighted-average number of outstanding shares of common stock during the period. Diluted earnings (loss) per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential shares of common stock outstanding during the period. Potential shares of common stock consist of incremental shares issuable upon the assumed exercise of stock options, employee stock purchase plan (&#8220;ESPP&#8221;) shares to be issued, and vesting of restricted stock awards. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) and has elected not to &#8220;opt out&#8221; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time private companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Recently Adopted </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, Leases (&#8220;Topic 842&#8221;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize an ROU asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January 1, 2022. Financial positions for reporting periods beginning on or after January 1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2016-13 </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2016, the FASB issued ASU 2016-03, Measurement of Credit Losses on Financial Instruments (&#8220;CECL&#8221;), which amends ASC 326 &#8220;Financial Instruments - Credit Losses&#8221; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#8220;expected loss model&#8221; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January 1, 2022 and the guidance did not have a material impact on our consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>, which amends ASC Topic 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div>. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div>eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU 2019-12 effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#8217;s financial statements. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements Not Yet Adopted </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> and ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial</div></div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reporting</div></div>. This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div>ease entities&#8217; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848)</div></div>, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its consolidated financial statements. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678764976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">3. Revenue Recognition </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s primary source of revenue is solely derived from the United States from sales of its Connected Fitness Products and related accessories and associated recurring Membership revenue, as well as from sales of personal training services recorded within Training revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company determines revenue recognition through the following steps: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Identification of the contract, or contracts, with a customer; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Identification of the performance obligations in the contract; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Determination of the transaction price; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Allocation of the transaction price to the performance obligations in the contract; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Recognition of revenue when, or as, the Company satisfies a performance obligation. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Revenue is recognized when control of the promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company&#8217;s revenue is reported net of sales returns, discounts and incentives as a reduction of the transaction price. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the practical expedient as per ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">606-10-50-14</div></div></div> and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company&#8217;s condensed consolidated statements of operations and comprehensive (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Connected Fitness Products </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Connected Fitness Products include the Company&#8217;s portfolio of Connected Fitness Products and related accessories, delivery and installation services, and extended warranty agreements. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period. The Company allows customers to return products within thirty days of purchase, as stated in its return policy. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amounts paid for payment processing fees for credit card sales for Connected Fitness Products are included as a reduction to fitness product revenue in the Company&#8217;s condensed consolidated statements of operations and comprehensive (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Membership </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s memberships provide unlimited access to content in its library of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on-demand</div> fitness classes. The Company&#8217;s memberships are offered on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">month-to-month</div></div> basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amounts paid for membership fees are included within deferred revenue on the Company&#8217;s condensed consolidated balance sheets and recognized ratably over the membership term. The Company records payment processing fees for its monthly membership charges within cost of membership and training in the Company&#8217;s condensed consolidated statements of operations and comprehensive (loss). </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Training </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s training services are personal training services delivered through the Connected Fitness Products and third-party mobile devices. Training revenue is recognized at the time of delivery. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Standard Product Warranty </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company offers a standard product warranty that its Connected Fitness Products and related accessories will operate under normal, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-commercial</div> use for a period of one year which covers the touchscreen, frame and all incorporated elements, and related accessories from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company also offers the option for customers in some markets to purchase a third-party extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of 24 to 48 months. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For third-party extended warranty service sold along with the Company&#8217;s Connected Fitness Products, the Company does not obtain control of the warranty before transferring it to the customers. Therefore, the Company accounts for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission it retains. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it can establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product. </div><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">3. Revenue Recognition </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s primary source of revenue is solely derived from the United States from sales of its Connected Fitness Products and related accessories and associated recurring Membership revenue, as well as from sales of personal training services recorded within Training revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company determines revenue recognition through the following steps: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Identification of the contract, or contracts, with a customer; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Identification of the performance obligations in the contract; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Determination of the transaction price; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Allocation of the transaction price to the performance obligations in the contract; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Recognition of revenue when, or as, the Company satisfies a performance obligation. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Revenue is recognized when control of the promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company&#8217;s revenue is reported net of sales returns, discounts and incentives as a reduction of the transaction price. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the practical expedient as per ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">606-10-50-14</div></div></div> and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company&#8217;s consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Connected Fitness Products </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Connected Fitness Products include the Company&#8217;s portfolio of Connected Fitness Products and related accessories, delivery and installation services, and extended warranty agreements. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period. The Company allows customers to return products within thirty days of purchase, as stated in its return policy. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amounts paid for payment processing fees for credit card sales for Connected Fitness Products are included as a reduction to fitness product revenue in the Company&#8217;s consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Membership </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s memberships provide unlimited access to content in its library of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on-demand</div> fitness classes. The Company&#8217;s memberships are offered on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">month-to-month</div></div> basis. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amounts paid for membership fees are included within deferred revenue on the Company&#8217;s consolidated balance sheets and recognized ratably over the membership term. The Company records payment processing fees for its monthly membership charges within cost of membership and training in the Company&#8217;s consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Training </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s training services are personal training services delivered through the Connected Fitness Products and third-party mobile devices. Training revenue is recognized at the time of delivery. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Standard Product Warranty </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company offers a standard product warranty that its Connected Fitness Products and related accessories will operate under normal, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-commercial</div> use for a period of one year which covers the touchscreen, frame and all incorporated elements, and related accessories from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company also offers the option for customers in some markets to purchase a third-party extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of 24 to 48 months. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For third-party extended warranty service sold along with the Company&#8217;s Connected Fitness Products, the Company does not obtain control of the warranty before transferring it to the customers. Therefore, the Company accounts for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission it retains. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it can establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047769482864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Simple Agreements for Future Equity and Advance Subscription Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock', window );">Simple Agreements for Future Equity and Advance Subscription Agreements</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">4. Simple Agreements for Future Equity and Advance Subscription Agreements </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From 2017 to 2021, the Company issued Simple Agreements for Future Equity (&#8220;SAFE&#8221;) and Advance Subscription Agreements (&#8220;ASA&#8221;) to several investors. The SAFE and ASA agreements have no maturity date and bear no interest. The SAFE Agreements provide a right to the holder to (a)&#160;future equity in the Company in the form of SAFE Preferred Stock when it completes an Equity Financing (as defined in the SAFE agreements), or (b)&#160;future equity in the form of Common Stock or cash proceeds if there is a liquidity event or dissolution event. The ASA Agreements provide a right to the holder to future equity in the Company in the form of Common Stock when it completes an Equity Financing, in the event of a sale, on the date falling six months from the date of the Agreement, or at the option of the holder on the closing of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Qualifying</div> Financing Round (as defined in the ASA agreements) or at any time prior to the occurrence of any of the events listed above. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The SAFE and ASA agreements will expire and terminate upon either (i)&#160;the issuance of shares to the investor pursuant to an equity financing event or (ii)&#160;the payment, or setting aside for payment, of amounts due to the investor pursuant to a liquidity or dissolution event. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, in connection with a Series A financing, all outstanding SAFEs were converted through the issuance of 0.02&#160;million shares of SAFE Preferred Stock. There were no outstanding SAFEs as of December&#160;31, 2022 or 2021. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple agreements for future equity and advance subscription agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674675696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories, net</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">4. Inventories, net </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,443&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,567&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products - LT</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,121&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total inventories, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,564&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,567&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Finished products - LT represents inventory not expected to be sold in the next twelve months. </div><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">5. Inventories, net </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories consist of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,567&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,056&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total inventories, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,567&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,056&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678625072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, net</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">5. Property and Equipment, net </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software and technology development asset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,370&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,370&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,787)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,044)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">583&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,326&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation expense amounted to $0.2&#160;million and $0.3&#160;million for the three months ended September&#160;30, 2023 and 2022, respectively, and $0.7&#160;million and $1.0&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively. </div><span></span>
</td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">6. Property and Equipment, net </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment consisted of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,775&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">243&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software and technology development asset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,370&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,156&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,044)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(966)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,326&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,190&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization expense amounted to $1.2&#160;million and $0.7&#160;million for the years ended December&#160;31, 2022 and 2021, respectively. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673483200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">6. Intangible Assets, net </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Identifiable intangible assets, net consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;6,346&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(3,480)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;2,866&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;5,827&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(1,993)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;3,834&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable intangible assets</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,346&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,480)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,866&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,827&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,993)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,834&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization expense amounted to $0.5&#160;million for each of the three months ended September&#160;30, 2023 and 2022, and $1.5&#160;million and $1.1&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, estimated annual amortization expense for each of the next five fiscal years is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="4" style="vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Years Ending December&#160;31,</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="4" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 (remaining)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">530&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,689&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">554&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">93&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,866&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">7. Intangible Assets, net </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Identifiable intangible assets, net consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book<br/>Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book<br/>Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;5,827&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(1,993)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;3,834&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;3,083&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(428)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;2,655&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,827&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,993)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,834&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,083&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(428)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,655&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, estimated annual amortization expense for each of the next five fiscal years is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom;white-space:nowrap"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Years Ending December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,946&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,516&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">372&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671347056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract', window );"><strong>Prepaid Expenses and Other Current Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">7. Prepaid Expenses and Other Current Assets </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Prepaid expenses and other current assets consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:69%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,<br/> 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security deposit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">146&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">133&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">750&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other receivables</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other prepaid</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">293&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;962&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,426&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">8. Prepaid Expenses and Other Current Assets </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Prepaid expenses and other current assets consisted of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security deposit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">146&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">607&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">202&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">750&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other prepaid</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">307&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">356&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,426&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,165&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other current assets disclosure abstract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other current assets disclosure textBlock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673593120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Other Assets, Net</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">8. Other Assets, net </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Other assets consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:36%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized content costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,589&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(3,721)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;2,868&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,589&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(2,185)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;4,404&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,370&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,555)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,815&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,996&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,391)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,605&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;11,959&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,276)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,683&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;10,594&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,576)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,018&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization expense amounted to $0.9&#160;million and $0.9&#160;million for the three months ended September&#160;30, 2023 and 2022, respectively, and $2.7&#160;million and $2.7&#160;million for each of the nine months ended September&#160;30, 2023 and 2022. </div><span></span>
</td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">9. Other Assets </div></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized content costs and content licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,404&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,099&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,605&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,258&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,018&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,366&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674564416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">9. Accrued Expenses and Other Current Liabilities </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Accrued expenses consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,<br/> 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued bonus</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued payroll</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued PTO</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">188&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,490&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,250&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued royalties</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">204&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued professional fees</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">953&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">517&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued expenses and current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">138&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">326&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,951&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,304&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">10. Accrued Expenses and Other Current Liabilities </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Accrued expenses consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued bonus</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;145&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;223&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued payroll</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued PTO</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">188&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,490&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued advertising</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued professional fees</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued engineering</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">93&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,250&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,050&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales tax payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued royalties</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">323&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">532&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,784&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,125&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">520&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,304&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,420&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673439280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">10. Debt </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From January through March 2022, the Company issued convertible notes (the &#8220;2022 Convertible Notes&#8221;) with an aggregate principal amount of $5.9&#160;million, pursuant to a private placement offering. The 2022 Convertible Notes bore interest at 6% per annum and had a scheduled maturity date of 24 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#8220;Cap Price&#8221;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognized losses equal to $0.3&#160;million for the nine months ended September&#160;30, 2023 related to changes in fair value for the November 2022 Convertible Notes, and $0.02&#160;million for the nine months ended September&#160;30, 2022, related to changes in fair value for the 2022 Convertible Notes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2022, the Company completed a qualified financing, and as a result the 2022 Convertible Notes were automatically converted into 124,313 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2.</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">November 2022 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued convertible notes (the &#8220;November 2022 Convertible Notes&#8221;) with an aggregate principal amount of $4.4&#160;million, pursuant to a private placement offering. The November 2022 Convertible Notes bore interest at 6% per annum and had a schedule maturing date of 12 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the November 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The November 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The November 2022 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) the price per share in the Next Financing round, or ii) the Original Issue Price of the Company&#8217;s Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> Preferred Stock, which is $47.67. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognized losses equal to $0.3&#160;million for the nine months ended September&#160;30, 2023 related to changes in fair value for the November 2022 Convertible Notes, and $0.02&#160;million for the nine months ended September&#160;30, 2022, related to changes in fair value for the 2022 Convertible Notes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the November 2022 Convertible notes were converted into an aggregate of 565,144 shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Secured Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, the Company issued an aggregate of $2.0&#160;million of senior secured notes to three investors, including one related party, with associated warrants to purchase the Company&#8217;s common stock at an exercise price of $0.0001, in lieu of future cash interest payments under the senior secured notes issued to such investors. In May 2023, the Company repaid the $2.0&#160;million in senior secured notes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Note Purchase Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2023, the Company entered into a note purchase agreement with THLWY, LLC (the &#8220;June 2023 Notes&#8221;) pursuant to which the Company agreed to issue up to $15.8&#160;million in aggregate principal amount of 10% senior secured notes due June 25, 2025 at their sole discretion. The June 2023 Notes are the senior secured obligations of the Company, bear interest at a rate of 10.0% per annum, and contain customary events of default. The June 2023 Notes will mature on June&#160;25, 2025, subject to earlier repurchase by the Company. The Company may redeem the June 2023 Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the June 2023 Notes to be redeemed, plus any accrued and unpaid interest to (including any additional interest), but excluding, the redemption date. As of September&#160;30, 2023, $1.0&#160;million of the senior secured notes have been issued. Additional senior secured notes may become available at the sole discretion of THLWY, LLC. As of September&#160;30, 2023, the Company defaulted on the payment of interest due on the June 2023 Notes. On November&#160;3, 2023, THLWY, LLC waived their rights to seek remedies resulting from an event of default. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was less than $0.1&#160;million for the nine months ended September&#160;30, 2023. </div><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">11. Debt </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2020 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the year ended December&#160;31, 2020 the Company issued convertible notes (the &#8220;2020 Convertible Notes&#8221;) with an aggregate principal amount of $6.2&#160;million, pursuant to a private placement offering. The 2020 Convertible Notes bore interest at 6% per annum and had a scheduled maturity date of 12 to 24 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2020 Convertible Notes under ASC Topic 825, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial Instruments</div></div>, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2020 Convertible Notes did not include any financial covenants and were subject to acceleration upon the occurrence of specified events of default. The 2020 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<div style="display:inline;">3.0</div>&#160;million prior to the maturity date of the 2020 Convertible Notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the 2020 Convertible Notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing. The conversion price with respect to an elective conversion at the time of maturity is equal to the fair market value of the Company divided by the Company&#8217;s fully diluted capitalization table at the time of conversion. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Two individual 2020 Convertible Notes with an aggregate principal value of $1,250,000 were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $<div style="display:inline;">10.0</div>&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) $50.0&#160;million divided by the sum of the Company&#8217;s then-outstanding common stock, outstanding option, and promised options (the &#8220;Cap Price&#8221;). The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In July 2021, the Company completed a qualified financing, and as a result the 2020 Convertible Notes were automatically converted into 13,373 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div> preferred stock and 3,279 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> preferred stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From January through July 2021, the Company issued convertible notes (the &#8220;2021 Convertible Notes&#8221;) with an aggregate principal amount of $14.8&#160;million, pursuant to a private placement offering. The 2021 Convertible Notes bore interest at 6% per annum and had a scheduled maturity date of 24 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2021 Convertible Notes under ASC Topic 825, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial Instruments</div></div>, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2021 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2021 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#8220;Cap Price&#8221;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In July 2021, the Company completed a qualified financing, and as a result the 2021 Convertible Notes were automatically converted into 130 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div> preferred stock, <div style="display:inline;">24,576 </div>shares of Series A preferred stock, and 6,929 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> preferred stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From January through March 2022, the Company issued convertible notes (the &#8220;2022 Convertible Notes&#8221;) with an aggregate principal amount of $5.9&#160;million, pursuant to a private placement offering. The 2022 Convertible Notes bore interest at 6% per annum and had a scheduled maturity date of 24 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#8220;Cap Price&#8221;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March&#160;2022, the Company completed a qualified financing, and as a result the 2022 Convertible Notes were automatically converted into 124,313 shares of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;A-2.</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued convertible notes (the &#8220;November 2022 Convertible Notes&#8221;) with an aggregate principal amount of $4.4&#160;million, pursuant to a private placement offering. The November 2022 Convertible Notes bore interest at 6% per annum and had a schedule maturing date of 12 months from issuance, at which time the principal and </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">accrued interest would be due and payable. The Company elected the fair value option for the November 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) the price per share in the Next Financing round, or ii) the Original Issue Price of the Company&#8217;s Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> Preferred Stock, which is $47.67. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognized gains equal to $0.1&#160;million and $5.2&#160;million for the years ended December&#160;31, 2022 and 2021, respectively, related to changes in fair value for the 2022 Convertible Notes, 2021 Convertible Notes, and 2020 Convertible Notes. The outstanding balance of convertible notes as of December&#160;31, 2022 and 2021 was $4.3&#160;million and $0&#160;million, respectively. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Paycheck Protection Program Loan </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On April&#160;2, 2021, the Company received loan proceeds of approximately $0.5&#160;million under the Paycheck Protection Program (&#8220;PPP&#8221;). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;), provides for loans to qualifying businesses to help sustain its employee payroll costs, rent, and utilities due to the impact of the recent <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. Loans obtained through the PPP are eligible to be forgiven as long as the proceeds are used for qualifying purposes, which include the payment of payroll costs, interest on covered mortgage obligations, rent obligations and utility payments. The receipt of these funds, and the forgiveness of the loan is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on its adherence to the forgiveness criteria. In June 2020, Congress passed the Payroll Protection Program Flexibility Act that made several significant changes to PPP loan provisions, including providing greater flexibility for loan forgiveness. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company used the proceeds from the PPP loan to fund payroll costs in accordance with the relevant terms and conditions of the CARES Act. The Company followed the government guidelines and tracking costs to ensure full forgiveness of the loan. To the extent it was not forgiven, the Company would have been required to repay that portion at an interest rate of 1% over a period of 5 years, beginning May 2022 with a final installment in April 2027. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The balance outstanding for the PPP loan was $0.5&#160;million at December&#160;31, 2021 and was forgiven in 2022, which resulted in a $0.5 million gain upon debt forgiveness. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673334432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantsDisclosureTextBlock', window );">Warrants</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">11. Warrants </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;A Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November&#160;13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. Each warrant has a strike price of $0.01 per share and has a contractual term of ten years. The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The fair value of the warrants issued in 2022 was recorded as a liability on the Balance Sheet and expensed to other (expense) income, net on the Statement of Operations and Comprehensive Loss, at the time of issuance. The Company recognized a gain equal to $2.3&#160;million for the nine months ended September&#160;30, 2023, related to changes in fair value for the warrants issued in November 2022. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A&#160;Common</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(92,296)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;B Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company issued warrants in 2021 to purchase Class&#160;B Common Stock to various employees and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees.</div> Each warrant has a strike price of $0.01 and has a contractual term of seven years. The warrants are classified as permanent equity within the condensed consolidated balance sheets. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into shares of common stock. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:84%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B&#160;Common</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,753&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,753)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Service Providers Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x)&#160;the price per share of the next equity financing with total proceeds of at least $10.0&#160;million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 28,124 shares of common stock </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $400,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 49,996 shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Service&#160;Providers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;78,120&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(78,120)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Secured Notes Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to certain existing affiliate and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliate</div> stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with a note financing. The fair value of the warrants of $1.3&#160;million was recorded as debt discount on the senior secured notes of $2.0&#160;million. The debt discount was amortized into interest expense over life of the senior secured notes. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 163,121 shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:81%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior&#160;Secured&#160;Notes</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;163,121&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(163,121)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">12. Warrants </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;A Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During July 2021 and August 2021 the Company issued an aggregate 125,982 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with its Series A financing rounds at that time. Additionally, on November 13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. Each warrant has a strike price of $0.01 per share and has a contractual term of ten years. The warrants are classified as other long-term liabilities within the consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The fair value of the warrants issued in 2021 at the time of issuance was recorded as a reduction to the carrying value of the related preferred stock that they were issued with. The fair value of the warrants issued in 2022 was recorded as a liability on the Balance Sheet and expensed to other (expense) income, net on the Statement of Operations and Comprehensive Loss, at the time of issuance. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A&#160;Common<br/>Stock Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,982&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(125,982)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">92,296&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;B Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During July 2021, the Company issued an aggregate 6,632 warrants to purchase Class&#160;B Common Stock to various employees and nonemployees. Each warrant has a strike price of $0.01 and has a contractual term of seven years. The warrants are classified as permanent equity within the consolidated balance sheets. 4,000 of these warrants with an aggregate fair value of $0.2&#160;million were issued as compensation for services provided to the Company and are recorded within operating expenses, as described in Note 15. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B&#160;Common<br/>Stock Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,632&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(879)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,753&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,753</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673328576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">12. Fair Value Measurements </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s financial instruments consist of its convertible notes and warrants. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">There were no assets or liabilities measured at fair value on a recurring basis as of September&#160;30, 2023, and no assets measured at fair value on a recurring basis as of December&#160;31, 2022. Liabilities measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value&#160;measurements&#160;as&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,274&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,274&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the nine months ended September&#160;30, 2023, there were no transfers between Level&#160;1 and Level&#160;2, nor into and out of Level&#160;3. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">252&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,521)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,266)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise of stock warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(738)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:16%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,902&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,926)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 10, the Company entered into several convertible note arrangements with certain investors during 2022. The Company recorded the liability related to the convertible notes at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recorded a change in fair value adjustment of $0.3&#160;million for the nine months ended September&#160;30, 2023 related to the November 2022 Convertible Notes, and $0.02&#160;million for the nine months ended September&#160;30, 2022 related to the 2022 Convertible Notes in the condensed consolidated statement of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the November 2022 Convertible notes were converted into an aggregate of 565,144 shares of common stock. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 11, on November&#160;13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. The Company recorded the liability related to the warrants at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recorded a change in fair value adjustment of $2.3&#160;million and $0&#160;million in the condensed consolidated statement of operations and comprehensive loss for the nine months ended September&#160;30, 2023 and 2022, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into shares of common stock. </div><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">13. Fair Value Measurements </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s financial instruments consist of its convertible notes, warrants, SAFEs, and ASAs. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">There were no assets measured at fair value on a recurring basis as of December 31, 2022 and 2021. Liabilities measured at fair value on a recurring basis as of December 31, 2022 were as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measurements as of<br/>December&#160;31, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,274&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,274&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">There were no liabilities measured at fair value on a recurring basis as of December 31, 2021. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the year ended December&#160;31, 2022, there were no transfers between Level&#160;1 and Level&#160;2, nor into and out of Level&#160;3. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company&#8217;s Level&#160;3 liabilities measured at fair value on a recurring basis: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">SAFE&#160;Liability</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,655</td>
<td style="white-space:nowrap;vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of SAFEs and ASAs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,416&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">251&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of ASAs into common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,667)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of SAFEs into series seed preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,655)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,546&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,620&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,193</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series Seed preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,947)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,026)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,303&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">107&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,926)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:13%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant&#160;Liability</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,482&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(478)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">SAFEs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 4, between 2017 and 2021, the Company entered into several SAFEs with certain investors. The Company recorded the liability related to the SAFEs at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the SAFEs was determined using a probability weighted expected return method (PWERM), in which the probability and timing of potential future events (such as a qualified equity financing or a dissolution) is considered in order to estimate the fair value of the SAFEs as of each valuation date. Management determined the fair value of the SAFEs using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;100% equity value of the business, (3)&#160;equity volatility, and (4)&#160;recovery rate. The Company recorded an unfavorable change in fair value adjustment of $0.3 million in the consolidated statement of operations for the year ended December 31, 2021. Upon the occurrence of a Series&#160;A financing in 2021, all outstanding SAFEs were converted through the issuance of 0.02&#160;million shares of SAFE Preferred Stock. There were no outstanding SAFEs as of December 31, 2022 or 2021. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 10, the Company entered into several convertible note arrangements with certain investors during 2020, 2021, and 2022. The Company recorded the liability related to the convertible notes at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the convertible notes was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the convertible notes as of each valuation date. For the outstanding notes as of December 31, 2022, management determined the fair value of the convertible notes using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;expected future equity value of the underlying shares at the time of conversion, and (3)&#160;a discount rate of 20.36%. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recorded a change in fair value adjustment of $0.1&#160;million and $5.2&#160;million in the consolidated statement of operations and comprehensive loss for the years ended December&#160;31, 2022 and 2021, respectively. Upon the occurrence of a Series Seed and Series A financing in 2021, $12.0&#160;million of convertible notes were converted through the issuance of 0.05&#160;million shares of Preferred Stock. Upon the occurrence of a Series A financing in 2022, $5.9 million of convertible notes were converted through the issuance of 0.1&#160;million shares of Preferred Stock. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrants </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As further described in Note 12, on November&#160;13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. The Company recorded the liability related to the warrants at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the warrants was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of December 31, 2022, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) a discount rate of 21.7%. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recorded a change in fair value adjustment of $0.5&#160;million and $0&#160;million in the consolidated statement of operations and comprehensive loss for the years ended December&#160;31, 2022 and 2021, respectively. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047675469248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">13. Commitments and Contingencies </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Lease Obligations </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual rental payments under operating leases for each of the next five years and thereafter: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future&#160;Minimum&#160;Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in&#160;thousands)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 (remaining)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;365&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay 3% of cumulative net sales up to $5.0&#160;million and 1% of cumulative net sales above $5.0&#160;million, up to a maximum total royalty of $1.0&#160;million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $0.2&#160;million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of September&#160;30, 2023. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Legal Proceedings </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company is involved in legal proceedings in the normal course of business. The Company currently believes that any ultimate liability arising out of such proceedings will not have a material adverse effect on the Company&#8217;s financial position, results of operations or cash flows. </div><span></span>
</td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">15. Commitments and Contingencies </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lease Obligations </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual rental payments under operating leases for each of the next five years and thereafter:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future Minimum Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;169&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Commitments </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company is subject to minimum payments on a content licensing agreement. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual guarantee payments under license agreements for each of the next five years and thereafter:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future Minimum Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,025&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,950&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,250&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,200&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,425&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Legal Proceedings </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company is involved in legal proceedings in the normal course of business. The Company currently believes that any ultimate liability arising out of such proceedings will not have a material adverse effect on the Company&#8217;s financial position, results of operations or cash flows. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673243424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">14. Leases </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company adopted ASC 842 on January&#160;1, 2022, using the effective date transition method, which requires a cumulative-effect adjustment to the opening balance of retained earnings on the effective date. As a result of the adoption of ASC 842, the Company recognized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities of $0.3&#160;million and $0.3&#160;million, respectively, as of the January&#160;1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has made certain assumptions and judgements when applying ASC 842 including the adoption of the package of practical expedients available for transition. The practical expedients allowed the Company to not reassess (i)&#160;whether expired or existing contracts contained leases, (ii)&#160;lease classification for expired or existing leases and (iii)&#160;previously capitalized initial direct costs. The Company also elected not to recognize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities for short-term leases (leases with a term of twelve months or less). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating lease arrangements primarily consist of office and warehouse leases expiring at various years through 2024. The facility leases have original lease terms of <span style="-sec-ix-hidden:hidden95757447">two</span> to seven years and contain options to extend the lease up to 5 years or terminate the lease. Options to extend are included in leased <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities in the consolidated balance sheet when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of December&#160;31, 2022, the weighted average discount rate for operating leases was 7.98% and the weighted average remaining lease term for operating leases was 0.8 years, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has entered into various short-term operating leases for office and warehouse space, with an initial term of twelve months or less. These short-term leases are not recorded on the Company&#8217;s consolidated balance sheet and the related lease expense for these short-term leases was $0.1&#160;million and $0&#160;million for the years ended December&#160;31, 2022 and 2021 respectively. Total operating lease cost was $0.6&#160;million and $0&#160;million for the years ended December&#160;31, 2022 and 2021, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets of $0.4&#160;million were obtained in exchange for lease liabilities during the year ended December&#160;31, 2022. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674758080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Deficit</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">14. Stockholders&#8217; Deficit </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s authorized common stock consisted of 900,000,000 and 369,950,000 shares at $0.0001 par value, as of September&#160;30, 2023 and December&#160;31, 2022, respectively. The issued and outstanding common stock was 14,178,514 shares and 2,450,922 shares as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In February 2023, the Company completed a rights offering involving the sale of Class&#160;A common stock to all existing accredited investors as of December&#160;19, 2022, at a price equal to approximately $0.51 per share. In connection with the rights offering, the Company issued a total of 9,749,439 shares of Class&#160;A common stock, of which 1,072,515 was issued in December 2022, and 8,676,924 was issued in January and February 2023. </div><span></span>
</td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">16. Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s authorized common stock consisted of 369,950,000 shares and 86,000,000 shares at $0.0001 par value, as of December&#160;31, 2022 and 2021, respectively. The issued and outstanding common stock was 2,450,922 shares and 213,065 shares as of December&#160;31, 2022 and 2021, respectively. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Transactions </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company issued 6,632 common stock warrants in lieu of interest payments on the Company&#8217;s convertible notes and as compensation for services provided to the Company in relation to agreements entered into with a third-party content provider. Refer to Note 2 for additional information regarding these agreements. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 7 years, risk-free rate of 1.30%, and volatility of 65%. The fair value of the warrants of $0.4 million was recorded as a long-term liability. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company issued 76,353 common stock warrants in connection with the issuance of preferred stock. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 10 years, risk-free rate of 1.30%, and volatility of 65%. The fair value of the warrants of $4.2&#160;million was recorded as a reduction in the value of the Series A Financing. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On August&#160;25, 2021, the Company issued 49,629 common stock warrants in connection with the issuance of preferred stock. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 9.9 years, risk-free rate of 1.35%, and volatility of 65%. The fair value of the warrants of $2.8&#160;million was recorded as a reduction in the value of the Series A Financing. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November 13, 2022, the Company issued 92,296 common stock warrants in connection with the issuance of the November 2022 Convertible Notes. The fair value of the warrants was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of December&#160;31, 2022, management determined the fair value of the warrants using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;expected future equity value of the underlying shares at the time of conversion, and (3)&#160;a discount rate of 21.7%. The fair value of the warrants of $3.5 million was recorded as a long-term liability upon issuance. A change in the fair value of warrants of $0.5 million resulted in a long-term liability of $3.0 million as of December 31, 2022. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Stock </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On December 23, 2022, all outstanding shares of redeemable convertible preferred stock were converted into shares of common stock on a one-to-one basis. Accordingly, no shares of preferred stock were outstanding as of December 31, 2022. On December 23, 2022 the Company amended and restated its certificate of incorporation to provide for, among other things, the Company&#8217;s authorized capital stock to consist of 369,950,000 shares of common stock, par value $0.0001 per share and 200,000,000 share of preferred stock, par value $0.0001 per share. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Series Seed Financing </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In August 2018, the company entered into a Series Seed Preferred Stock Purchase Agreement (the &#8220;Series Seed Agreement&#8221;) for the issuance of 7,546 shares of Series Seed and 2,393 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-1.</div> The Company completed its initial Series Seed closing on August&#160;14, 2018, by issuing a total of 1,666 shares on this date at a purchase price of approximately $300.00 per share (the &#8220;Series Seed Share Price&#8221;). Between August 2018 and December 2018, the Company issued additional shares of Series Seed in a series of subsequent closings total of 5,880 shares and an additional 2,393 shares related from the conversion of the Company&#8217;s SAFE (combined the &#8220;Series Seed Financing&#8221;). The aggregate gross proceeds from the Series Seed Financing were approximately $2.3&#160;million. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Series A Financing </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In July 2021 the Company amended its Certificate of Incorporation (&#8220;COI&#8221;) to authorize the issuance of 250,000 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2,</div> 37,313 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3,</div> 21,131 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4,</div> 512,425 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5,</div> 122,500 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6,</div> 257,797 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7,</div> 665,588 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8,</div> 2,775,210 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9,</div> 327,218 shares of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10,</div> 18,165,136 shares of Series A, and 1,531,734 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1.</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company executed a Series Seed and Series A Preferred Stock Purchase Agreement (the &#8220;Series Seed and Series A Agreement&#8221;) for the purposes of raising capital in the aggregate amount of up to $33.0&#160;million by the means of issuance of Series A, Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9,</div> and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10</div> (all Series Seed issuances noted herein are collectively referred to as &#8220;Series Seed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2-10&#8221;).</div> On this date, the Company cancelled $5.3&#160;million and $6.9&#160;million (including principal and interest) of Series A Convertible Notes and SAFEs, respectively, which converted into a total of 13,503 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div> and a total of 19,519 of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2-10,</div></div> respectively. On the date of the Series Seed and Series A Agreement, the Company also cancelled its 2020 Secured Convertible Notes, of which $12.1&#160;million (including principal and interest) converted into 24,576 shares of Series A and $4.0&#160;million (including principal and interest) converted into 10,208 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1(see</div> Note 11). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company issued 14,182 shares of Series A at a purchase price of approximately $490.50 per share. On August&#160;13, 2021, the Company issued 25,189 shares of Series A at a purchase price of approximately $490.50 per share. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November&#160;24, 2021, the Company amended its Amended and Restated Certificate of Incorporation to increase the number of Series A shares authorized from 9,592,788 to 18,165,136 total shares. As a result, on that date, the Company completed an additional closing of Series A and issued a total of 22,756 shares at a purchase price of approximately $490.50 per share. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The aggregate gross proceeds from the Series A Financing were approximately $30.5&#160;million. Proceeds from the issuances associated with the cancellation of the convertible notes were equal to the fair value of the convertible notes upon conversion. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Dividends </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The holders of common stock are entitled to receive dividends upon declaration by the Board of Directors. Such dividends <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">are&#160;non-cumulative.</div> As of December&#160;31, 2022 and 2021, no dividends have been declared or distributed to any stockholders. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Liquidation Preferences </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the event of any voluntary or involuntary liquidation event, dissolution or winding up of the Company or deemed liquidation event, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to the stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Rights and Preferences </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">There are no preemptive, redemption or sinking fund provisions applicable to our common stock. The rights, preferences, and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate and issue in the future. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Voting </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The holder of each share of preferred stock is entitled to one vote for each share of common stock into which such preferred stock is convertible at the time of the vote. With respect to such vote, such holder has full voting rights and powers equal to the voting rights of the holders of common stock. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Redemption </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has classified the preferred stock as temporary equity as the shares have certain&#160;redemption features&#160;that are not solely in the control of the Company. The preferred stock is not currently redeemable because the deemed liquidation provision is considered a substantive condition that is contingent on the event and it is not currently probable that it will become redeemable. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company classifies preferred stock in accordance with ASC 480,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Distinguishing Liabilities from Equity</div></div>, which requires that contingently redeemable securities be classified outside of permanent stockholders&#8217; equity. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Accordingly, the Company has classified all shares and classes of preferred stock as mezzanine equity in the accompanying financial statements as of December&#160;31, 2021. In 2022, the Company&#8217;s preferred stock was converted to common stock on a one-to-one share basis. As a result, there is no mezzanine equity as of December 31, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Convertible redeemable preferred stock consisted of the following as of December&#160;31, 2022:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:28%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable<br/>Convertible&#160;Preferred<br/>Stock:</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Authorized</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Outstanding</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price&#160;per&#160;Share</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Carrying&#160;Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation<br/>Preference</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;13,006,028&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;490.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,531,734&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">173,135,395&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47.67</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,133,701&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">359,375&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">210.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250,000&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,313&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,131&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">512,425&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">283.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122,500&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257,797&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">355.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">665,588&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">417.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,754,796&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,414&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327,218&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">490.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total redeemable convertible preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">194,135,415&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Convertible redeemable preferred stock consisted of the following as December&#160;31, 2021: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:26%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable<br/>Convertible Preferred<br/>Stock:</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Authorized</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Outstanding</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price&#160;per&#160;Share</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Carrying&#160;Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation<br/>Preference</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18,165,136&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;86,703&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;490.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19,535&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;53,162&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,531,734&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,208&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,604&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,013&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,133,701&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,546&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,267&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,267&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">359,375&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,393&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">210.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">719&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">503&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250,000&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,666&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,313&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,131&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">140&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">512,425&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,414&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">283.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">425&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">968&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122,500&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">815&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">104&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">245&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257,797&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,716&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">355.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">235&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">611&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">665,588&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,410&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">417.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">659&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,850&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,754,796&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,344&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,644&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,218&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,414&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">136&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327,218&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,171&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">490.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">321&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,070&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total redeemable convertible preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,159,128&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">139,910&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,733&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72,110&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673328448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity-Based Compensation</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">15. Equity-Based Compensation </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">2023 and 2020 Equity Incentive Plan </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:43%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,347&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">383&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,803&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">478&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">87&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">407&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,402&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,356&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,563&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,421&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stock-based compensation expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,836&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,773&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;23,773&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,951&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the three months ended September&#160;30, 2023 and 2022, $0.1&#160;million and $0.0&#160;million of stock-based compensation was capitalized as software costs, respectively. For the nine months ended September&#160;30, 2023 and 2022 $0.7&#160;million and $0.0&#160;million of stock-based compensation was capitalized as software costs, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the nine months ended September&#160;30, 2023, the Company granted options to purchase 3,428,225 shares under the 2023 and 2020 Plan. The Company has not granted any restricted stock or stock appreciation rights. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, the Company enacted a restructuring cost savings initiative which resulted in employee terminations in both December 2022 and January 2023. In association with January 2023 terminations, the Company accelerated the vesting of a number of individual option awards, resulting in the accelerated vesting of 5,938 shares on the date of modification. Also in January 2023, the Company repriced 301,537 option awards. Both the accelerated vesting and repricing were accounted for as an equity award modification under ASC Topic 718 which resulted in adjustment of the award value to reflect the fair value at the modification date and acceleration of the recognition schedule in the case of awards which were modified to have accelerated vesting. The adjustment resulted in additional expense of $0.5&#160;million. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2023, the Company granted 1,294,998 options to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> directors, selected executives and other key employees where vesting is contingent on the Company&#8217;s share price meeting certain targets. The fair value of each option granted was estimated on the date of grant using the Monte Carlo valuation model and assumes that share price targets are achieved. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following summary sets forth the stock option activity under the 2023 and 2020 Plan: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;Number&#160;of&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">exercise</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">remaining</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">contractual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;term&#160;(in&#160;years)&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;intrinsic&#160;value&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Outstanding as of December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">446,839&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,706</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;3,428,225&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(677,350)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.53</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,690</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cancelled or forfeited</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(89,603)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;0.92</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Outstanding as of September&#160;30, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,108,111&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.70</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,341</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercisable as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178,310&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.97</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.8</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options unvested as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,325,600&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.33</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">775</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The aggregate intrinsic value of options outstanding, exercisable and unvested were calculated as the difference between the exercise price of the options and the estimated fair market value of the Company&#8217;s common stock, as of September&#160;30, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:92%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Early Option Exercises</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;average&#160;exercise&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;Repurchase&#160;&#160;&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">liability&#160;(in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock as of December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,823&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">306</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,947&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.19</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(37)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repurchased</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,655)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock as of September&#160;30, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;32,078&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the nine months ended September&#160;30, 2023 and 2022 the weighted-average grant date fair value per option was $12.67 and $0.18 respectively. The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:96%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate (1)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.7%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.3%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected term (in years)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.93&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.34&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected volatility (2)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;62.27%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;54.6%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Based on U.S. Treasury seven-year constant maturity interest rate whose term is consistent with the expected term of the option. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#8217;s stage of development. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">With respect to the 2023 and 2020 Plan, the Company recognized stock compensation expense of $24.5&#160;million and $4.0&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively, of which $0.7&#160;million and $0.0&#160;million was capitalized as software costs for the nine months ended September&#160;30, 2023 and 2022, respectively. As of September&#160;30, 2023 and December&#160;31, 2022, the Company had $23.6&#160;million and $5.9&#160;million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of 1.9 years and 1.6 years, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For financial reporting purposes for the awards granted in January 2023, we applied a straight-line calculation between the $30.00 per share determined in the contemporaneous third-party valuation as of December&#160;31, 2022 and the $6.08 per share determined in the contemporaneous third-party valuation as of March&#160;31, 2023 to determine the fair value of our common stock on the grant date. Using the benefit of hindsight, we determined that the straight-line calculation would provide the most appropriate conclusion for the valuation of our common stock on the interim dates between valuations because we did not identify any single event or series of events that occurred during this interim period that would have caused a material change in fair value. Based on this calculation, we assessed the fair value of our common stock for awards granted in January 2023 to be $19.27 per share. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">17. Equity-Based Compensation </div></div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">2020 Equity Incentive Plan </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2020, the Board of Directors approved the establishment of the 2020 Plan to provide stock award grants to employees, directors, and consultants of the Company. The Board of Directors, or at its sole discretion, a committee of the Board of Directors, is responsible for the administration of the 2020 Plan. As of December 2021, the Board of Directors has authorized the issuance of up to 3,000,000 shares of common stock for stock award grants, including incentive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and&#160;non-qualified&#160;stock</div> options; restricted stock; or stock appreciation rights. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2020 Plan requires that the per share exercise price of each stock option shall not be less than 100% of the fair market value of the common stock subject to the stock option on the grant date. Stock option grants shall not be exercisable after the expiration of 10 years from the date of its grant or such shorter period as specified in a stock award agreement. The Board of Directors shall determine the terms of vesting. The 2020 Plan provides that the Board of Directors may, in its sole discretion, impose such limitations on transferability of stock options as the Board of Directors shall determine. In the absence of a determination by the Board of Directors to the contrary, stock options shall not be transferable except by will or by the laws of descent and distribution and domestic relations orders, unless specifically agreed to by the plan administrator. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Presented below is a summary of the compensation cost recognized in the consolidated statements of operations for the years ended December 31, 2022 and 2021. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:56%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,765&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">286&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,297&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,021&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,348&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,164&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock Options </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The 2020 Plan allows for the early exercise of stock options. Stock options exercised prior to vesting will continue to vest according to the respective option agreement. Shares purchased pursuant to the early exercise of stock options are subject to repurchase until those shares vest; therefore, cash received in exchange for unvested shares exercised is recorded as a liability on the accompanying consolidated balance sheets and are reclassified to common stock and additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital as the shares vest. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the fiscal year ended December&#160;31, 2022 and 2021, the Company granted options to purchase 439,786 and 45,394 shares under the 2020 Plan, respectively. The Company has not granted any restricted stock or stock appreciation rights. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, the Company enacted a restructuring cost savings initiative which resulted in employee terminations. In association with the restructuring, the Company accelerated the vesting of a number of individual option awards, resulting in the accelerated vesting of 42,934 shares on the date of modification. This was accounted for as an equity award modification under ASC Topic 718 which resulted in adjustment of the award value to reflect the fair value at the modification date and acceleration of the recognition schedule. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following summary sets forth the stock option activity under the 2020 Plan:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:41%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/>options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>remaining<br/>contractual term<br/>(in years)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/>intrinsic&#160;value<br/>(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2021</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;51,149&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.34</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.7</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,786&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1.66</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,784)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;271</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options cancelled</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,310)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.78</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">446,841&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,706</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145,713&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.53</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,638</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266,993&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.07</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,058</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The aggregate intrinsic value of options outstanding, exercisable and unvested were calculated as the difference between the exercise price of the options and the estimated fair market value of the Company&#8217;s common stock, as of December&#160;31, 2022 and 2021. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:69%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Early Option Exercises</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/>Options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>Average<br/>Exercise<br/>Price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Repurchase</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liability</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock &#8212; December&#160;31, 2021</div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,134&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;88</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issued</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">6,057&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.48</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">(794)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">7.17</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repurchased</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">(2,574)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock &#8212; December&#160;31, 2022</div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">3,823&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">306</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the years ended December&#160;31, 2022 and 2021, the weighted-average grant date fair value per option was $27.17 and $0.21, respectively. The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:96%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.3%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.2%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected term (in years)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.35&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.50&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected volatility</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54.6%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43.1%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Based on U.S. Treasury&#160;seven-year&#160;constant maturity interest rate whose term is consistent with the expected term of the option. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#8217;s stage of development. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">With respect to the 2020 Plan, the Company recognized stock compensation expense of $6.3 million and $1.2 for the fiscal years ended December&#160;31, 2022 and 2021, respectively. As of December 31, 2022 and 2021, the Company had $5.9 million and $0.9 million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of 1.6 years and 1.7 years, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrants Issued to Nonemployees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On July&#160;23, 2021, the Company issued a total of 4,000 warrants to purchase Class&#160;B Common Stock to various nonemployees as compensation for services rendered. Each warrant has a strike price of $0.01 per share and has a seven-year term from the date of issuance. Each warrant had a grant date fair value of $55.50 for an aggregate fair value of $0.2&#160;million, which was recorded as a general and administrative expense within the Statement of Operations. Each warrant was fully vested at issuance and are subject to the guidance under ASC 718, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Compensation-Stock Compensation</div></div>. The warrants meet the criteria for permanent equity classification. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047675469248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk and Major Customers and Vendors<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Credit Risk and Major Customers and Vendors</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">16. Concentration of Credit Risk and Major Customers and Vendors </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company&#8217;s cash and cash equivalents are maintained with high-quality financial institutions, the compositions and maturities of which are regularly monitored by management. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the nine months ended September&#160;30, 2023 and 2022, there were no customers representing greater than 10% of the Company&#8217;s total revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company had three vendors representing greater than 10% of total finished goods purchases for the nine months ended September&#160;30, 2023 and year ended December&#160;31, 2022, respectively. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">18. Concentration of Credit Risk and Major Customers and Vendors </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company&#8217;s cash and cash equivalents are maintained with high-quality financial institutions, the compositions and maturities of which are regularly monitored by management. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">For the years ended December&#160;31, 2022 and 2021, there were no customers representing greater than 10% of the Company&#8217;s total revenue. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company had three vendors and one vendor representing greater than 10% of total finished goods purchases for the years ended December&#160;31, 2022 and 2021, respectively. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673320288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">17. Benefit Plans </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company established a defined contribution savings plan under Section&#160;401(k) of the Internal Revenue Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">annual compensation on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-tax</div> basis. Matching contributions to the plan may be made at the discretion of the Company&#8217;s board of directors. During the nine months ended September&#160;30, 2023 and 2022, the Company did not make any contributions to the plan. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">19. Benefit Plans </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company established a defined contribution savings plan under Section&#160;401(k) of the Internal Revenue Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a&#160;pre-tax&#160;basis.</div> Matching contributions to the plan may be made at the discretion of the Company&#8217;s board of directors. During the years ended December&#160;31, 2022 and 2021, the Company made contributions of $0&#160;million and $0.6&#160;million, respectively, to the plan. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673357984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">20. Income Taxes </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The components of loss before income taxes are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$(56,817)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31,746)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,408)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">(1,090)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from operations before income taxes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(58,225)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(32,836)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The components of income tax (benefit) expense are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:67%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:73%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="14" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal statutory rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,228</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,879</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nondeductible expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(78</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.13</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">192</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-0.60</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nontaxable changes in fair value of convertible notes and SAFEs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(123</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,038</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.22</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,670</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.59</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(674</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.06</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State taxes, net of federal benefit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,865</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.20</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,705</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.20</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign tax rate differential</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-0.05</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-0.03</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(190</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.33</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,567</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-26.73</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,093</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-30.81</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Disqualified debt</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">731</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-1.26</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Return to provision adjustements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,060</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.82</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangibles</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,281</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-2.20</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock based compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">615</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-1.06</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-0.01</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The primary differences from the U.S. statutory rate and the Company&#8217;s effective tax rate for the year ended December&#160;31, 2022 are due to the change in valuation allowance, federal net operating loss true ups, and State taxes, net of Federal benefit. The primary differences from the U.S. statutory rate and the Company&#8217;s effective tax rate for the year ended December&#160;31, 2021 were due to the change in valuation allowance, share based compensation including excess tax benefits, state and international taxes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On August&#160;16, 2022, the Inflation Reduction Act was signed into law in the United States. Among other provisions, the Inflation Reduction Act includes a 15% minimum tax rate applied to corporations with profits in excess of $1&#160;billion and also includes an excise tax on the repurchase of corporate stock. The Company has reviewed the provisions of the law and does not believe that any of the provisions will have a material impact on the business. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On March&#160;11, 2021, the American Rescue Plan was enacted, which extends the period companies can claim an Employee Retention Credit, expands the IRC Section 162(m) limit on deductions for publicly traded companies, and repeals the election that allows US affiliate groups to allocate interest expense on a worldwide basis, among other provisions. The Company reviewed the provisions of the law and determined it had no material impact for the year ended December&#160;31, 2021. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On December&#160;21, 2020, Congress passed the Consolidated Appropriations Act, 2021. The act includes the Taxpayer Certainty and Disaster Tax Relief Act of 2020 and the COVID-related Tax Relief Act of 2020, both of which extend many credits and other COVID-19 relief, among other extensions. The Company evaluated the provisions of the Consolidated Appropriations Act, including but not limited to the Employee Retention Credit extension, the extension for the IRC Section 45S credit for paid family and medical leave, and the provision allowing a full deduction for certain business meals, and determined that there was no material impact for the year ended December&#160;31, 2022. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022 and December&#160;31, 2021, the Company&#8217;s deferred tax assets were primarily the result of U.S. federal and state net operating losses (&#8220;NOLs&#8221;). A valuation allowance was maintained and/or established in substantially all jurisdictions on the Company&#8217;s gross deferred tax asset balances as of December&#160;31, 2022 and 2021. As of each reporting date, the Company&#8217;s management considers new evidence, both positive and negative, that could impact management&#8217;s view with regard to future realization of deferred tax assets. The realization of deferred tax assets was based on the evaluation of current and estimated future profitability of the operations, reversal of deferred tax liabilities and the likelihood of utilizing tax credit and/or loss carryforwards. As of December&#160;31, 2022 and December&#160;31, 2021, the Company continued to maintain that it is not at the more likely than not standard, wherein deferred taxes will be realized due to the recent history of losses and management&#8217;s expectation of continued tax losses. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets (liabilities) are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:65%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;(in thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - Federal</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;16,776&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,760&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,768&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,593&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">923&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - State</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,752&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,260&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - Foreign</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,894&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,846&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,219&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets and intangibles</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(868)&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax assets, gross:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,134&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,789&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(30,134)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,789)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets, net:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, the Company had federal NOLs of approximately $79.9&#160;million, substantially all of which will be carried forward indefinitely. As of December&#160;31, 2022, the Company had state NOLs of approximately $75.8&#160;million, which will begin to expire in <div style="display:inline;"><span style="-sec-ix-hidden:hidden95757939">2029</span></div>. As of December&#160;31, 2022, the Company had foreign NOLs of approximately $10.0&#160;million, generated primarily from its operations in the United Kingdom, which will be carried forward indefinitely. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, the Company also has federal and state tax credits of $1.6&#160;million and $2.5&#160;million, respectively, which being to expire in <div style="display:inline;"><span style="-sec-ix-hidden:hidden95757488">2040</span></div> for the federal tax credit and <div style="display:inline;"><span style="-sec-ix-hidden:hidden95757489">2035</span></div> for the state tax credits. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, the Company did not have material undistributed foreign earnings. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Tax Cuts and Jobs Act (TCJA) resulted in significant changes to the treatment of research and developmental (R&amp;D) expenditures under Section&#160;174. For tax years beginning after December&#160;31, 2021, taxpayers are required to capitalize and amortize all R&amp;D expenditures that are paid or incurred in connection with their trade or business. Specifically, costs for U.S.-based R&amp;D activities must be amortized over five years and costs for foreign R&amp;D activities must be amortized over 15 years&#8212;both using a midyear convention. During the year ended December&#160;31, 2022, the Company capitalized $18.2&#160;million of domestic R&amp;D expenses. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Section&#160;382 of the Internal Revenue Code and similar provisions under state law limit the utilization of federal NOL carryforwards, state NOL carryforwards, and Research and Development (R&amp;D) credits following certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of <div style="display:inline;">50</div>%. Based on the Company&#8217;s analysis under Section&#160;382, the Company believes that its federal NOL carryforwards, its state NOL carryforwards, and R&amp;D credits are limited by Section&#160;382 and similar provisions under state law as of December&#160;31, 2022. The portion of federal NOL carryforwards, state NOL carryforwards, and R&amp;D credits that were determined to be limited have been written off as of December&#160;31, 2022. The remaining unused carryforwards and credits remain available for future periods. Due the Company&#8217;s full valuation allowance the write off of NOL carryforwards and R&amp;D did not have any impact to the statements of operation and comprehensive loss. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div>The Company is subject to taxation in the United States, various state and local jurisdictions, as well as foreign jurisdictions where the Company conducts business. Accordingly, on a continuing basis, the Company cooperates with taxing authorities for the various jurisdictions in which it conducts business to comply with audits and inquiries for tax periods that are open to examination. The tax years ended from December&#160;31, 2019 and 2018 and later remain open to examination by tax authorities in the United States and United Kingdom, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673409376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss Per Share</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">18. Loss Per Share </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The computation of loss per share is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:94%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;months&#160;ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in thousands, except share and per share amounts)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(39,971)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(39,415)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss attributable to common stockholders</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(39,971)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(39,415)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common stock outstanding - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;11,750,907&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;423,362&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share attributable to common stockholders - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.40)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(93.10)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,703</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,208</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">755,606</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,546</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 1 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,393</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 2 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,666</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 3 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 4 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">140</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 5 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,414</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 6 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">815</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 7 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,716</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 8 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,410</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 9 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,480</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 10 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;B common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,753</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options to purchase common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,108,111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">452,549</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,108,111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,353,818</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">21. Loss Per Share </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The computation of loss per share is as follows:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:58%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(58,225)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(32,840)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss attributable to common stockholders</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(58,225)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(32,840)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common stock outstanding - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">487,276&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,823&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share attributable to common stockholders - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(119.49)&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(332.31)&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:70%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,703&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,208&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,546&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 1 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,393&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 2 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,666&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 3 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 4 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">140&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 5 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,414&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 6 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">815&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 7 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,716&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 8 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,410&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 9 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18,480&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 10 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,171&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;A common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;B common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,753&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,753&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options to purchase common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">446,841&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51,149&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">544,890&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">196,812&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673554480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">19. Related Party Transactions </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the ordinary course of business, we may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal stockholders (commonly referred to as &#8220;related parties&#8221;). </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Founder Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company had <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing promissory notes, of which $0.0&#160;million and $0.08&#160;million was outstanding as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div><div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Principal Stockholder Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2019, 2020, and 2021 the Company entered into the following promissory notes with a then-principal stockholder (the &#8221;former principal stockholder&#8221;) of the Company: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On May&#160;17, 2019, a $2.0&#160;million note with interest at the rate of 2.5% per annum and maturity date of May 17, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 7.5%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On August&#160;28, 2019, a $1.0&#160;million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5.0% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On November&#160;28, 2019, a $0.3&#160;million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On March&#160;20, 2020, a $0.3&#160;million note with interest at the rate of 5.0% per annum and a maturity date of March 20, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;12, 2021, a $0.6&#160;million note with interest at the rate of 5.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, all outstanding promissory notes with respect to the former principal stockholder are included within the loan payable on the condensed consolidated balance sheet for a total of $5.4&#160;million, including accrued interest and default interest of $1.4&#160;million. As the 2019, 2020, and 2021 notes were not paid upon maturity, these loans were in default as of September&#160;30, 2023, and on August&#160;4, 2023, the Company received a notice of default from the principal stockholder. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $0.3&#160;million for the nine months ended September&#160;30, 2023. On September&#160;30, 2022, the former principal stockholder and certain related parties waived their rights to seek remedies resulting from an event of default due to a failure to make payments of principal or interest at the stated maturity or due date, respectively. On October&#160;30, 2023, the Company entered into an agreement with the former principal stockholder regarding a mutually agreed upon repayment schedule with respect to the outstanding promissory notes issued to such former principal stockholder. </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Other Related Party Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2019, 2020, 2021, and 2022, the Company entered into the following promissory notes with other related parties: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On September&#160;30, 2019, a $0.2&#160;million note with interest at the rate of 12.0% per annum and a maturity date of September 30, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $0.2&#160;million. This loan remains outstanding for interest in the amount of $0.1&#160;million. Upon default, on the September&#160;30, 2019, loan the Company shall pay a fee of 5% of the outstanding principal balance and accrued </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:8%">&#160;</td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">interest and from that point further interest shall accrue at an additional rate of 17.0%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On October&#160;21, 2019, a $0.2&#160;million note with interest at the rate of 12.0% per annum and maturity date of October 21, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. The principal and interest of this loan has been paid as of September&#160;30, 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;18, 2020, a $0.1&#160;million note with interest at the rate of 12.0% per annum and a maturity date of February 18, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On June&#160;9, 2020, a $75,000 note was entered into by the Company from the president and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-founder</div> of the Company. This note has interest at the rate of 5.0% per annum and a maturity date of J<div style="display:inline;">une 9, 2022</div><div style="display:inline;"></div>. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. The principal and interest of this loan has been paid as of September&#160;30, 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On June&#160;15, 2020, a $0.1&#160;million note with interest at the rate of 7.5% per annum and a maturity date of June 15, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 12.5%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. The principal and interest of this loan has been paid as of September&#160;30, 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On November&#160;2, 2020, a $50,000 note was entered into by the Company from to the president and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-founder</div> of the Company. This note has interest at the rate of 5.0% per annum and a maturity date of June 2, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. The principal and interest of this loan has been paid as of September&#160;30, 2023. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On January&#160;12, 2021, a $0.3&#160;million note with interest at the rate of 12.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;22, 2021, a $40,000 note with interest at the rate of 12.0% per annum and a maturity date of June 22, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On October&#160;27, 2022, a $0.4&#160;million note with interest at the rate of 12.0% per annum and a maturity date of January 27, 2023. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. The Company borrowed $0.3&#160;million in April 2023 and repaid $0.3&#160;million in May 2023 upon closing of the Company&#8217;s IPO. This loan </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:8%">&#160;</td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">remains outstanding in the amount of $0.01&#160;million. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">In August 2023, the company borrowed $0.2&#160;million in a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing note and repaid $0.1&#160;million. As of September&#160;30, 2023, this loan remains outstanding in the amount of $0.1&#160;million. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, all other related party promissory notes were outstanding and included within the loan payable on the condensed consolidated balance sheet for a total of $0.8&#160;million, including accrued interest and default interest of $0.4&#160;million. All notes were not paid upon maturity. These loans were in default as of period end due to outstanding interest. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $0.1&#160;million for the nine months ended September&#160;30, 2023. On September&#160;30, 2022, related parties waived their rights to remedy in the event of default, which in effect releases the Company from the obligation of the incremental interest and fees, as well as the lender from their lien on and security interest in the Company&#8217;s assets. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2022, multiple of the loans above with maturity dates in 2022 remained unpaid as of the maturity date. On September&#160;30, 2022, those lenders waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. Currently, the Company is renegotiating the terms of the loans. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Loan payable consisted of the following as of September&#160;30, 2023 and December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:70%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in thousands)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Founder Notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal stockholder promissory notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,404&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,503&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other related party promissory notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">862&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,126&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Loan Payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,266&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,708&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Other Related Party Transactions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2016, the Company entered into an agreement with Fuseproject, a design firm that designed the Company&#8217;s main product, its fitness mirror. As of September&#160;30, 2023 and 2022, the Company had incurred $0.1&#160;million and $0.0&#160;million, respectively, of expenses for design services provided by Fuseproject. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay 3% of cumulative net sales up to $5.0&#160;million and 1% of cumulative net sales above $5.0&#160;million, up to a maximum total royalty of $1.0&#160;million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $0.2&#160;million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of September&#160;30, 2023. As of September&#160;30, 2023 the Company has accrued $0.2&#160;million in royalty payments. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, the principal stockholder associated with Fuseproject referenced above owned 226,217 of the Company&#8217;s common stock., with fully diluted ownership of less than 5% as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2022, the Company entered into an agreement with Apeiron Advisory Ltd for promotion of the Company, participation in industry conferences, and ongoing structural advice and consulting. The agreement was terminated and the Company is no longer receiving any advisory services from Apeiron Advisory Ltd. As of the nine months ended September&#160;30, 2023 and 2022, the Company has incurred $0.0&#160;million and $0.9&#160;million, respectively, of expenses for such services provided by Apeiron Advisory Ltd. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, Apeiron Investment Group Ltd and certain of its affiliates (&#8220;Apeiron&#8221;) owned 1,490,524 shares of common stock. As of December&#160;31, 2022 Apeiron owned 447,318 shares of the Company&#8217;s Class&#160;A common shares, and 24,143 of the Company&#8217;s Class&#160;A common warrants. As of September&#160;30, 2023 and December&#160;31, 2022, Apeiron had fully diluted ownership of more than 5%, respectively. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">22. Related Party Transactions </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In the ordinary course of business, we may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal stockholders (commonly referred to as &#8220;related parties&#8221;). </div><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Founder Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has noninterest bearing promissory notes, of which $0.08 million was outstanding as of December&#160;31, 2022 and December 31, 2021. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Principal Stockholder Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2019, 2020, and 2021 the Company entered into the following promissory notes with a principal stockholder of the Company: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On May&#160;17, 2019, a $2.0&#160;million note with interest at the rate of 2.5% per annum and maturity date of May 17, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 7.5%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On August&#160;28, 2019, a $1.0&#160;million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5.0% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On November&#160;28, 2019, a $0.3 million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On March 20, 2020, a $0.3 million note with interest at the rate of 5.0% per annum and a maturity date of March 20, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;12, 2021, a $0.6 million note with interest at the rate of 5.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, all principal stockholder promissory notes were outstanding and included within the loan payable on the Consolidated Balance Sheet for a total of $5.5 million, including accrued interest and default interest of $1.4&#160;million. As the 2019, 2020, and 2021 notes were not paid upon maturity, these loans were in default as of year end. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the consolidated statement of operations was $0.8&#160;million during the twelve months ended December&#160;31, 2022. On September&#160;30, 2022, the principal officer and certain related parties waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#8217;s assets. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Other Related Party Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2019, 2020, 2021, and 2022, the Company entered into the following promissory notes with other related parties: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On September 30, 2019, a $0.2 million note with interest at the rate of 12.0% per annum and a maturity date of September 30, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $0.2 million. This loan remains outstanding for interest in the amount of $.08 million. Upon default, on the September 30, 2019, loan the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#8217;s assets. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On October&#160;21, 2019, a $0.2 million note with interest at the rate of 12.0% per annum and maturity date of October 21, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;18, 2020, a $0.1 million note with interest at the rate of 12.0% per annum and a maturity date of February 18, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On June&#160;9, 2020, a $75,000 note was entered into by the Company from the president and co-founder of the Company. This note has interest at the rate of 5.0% per annum and a maturity date of June 9, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. The principal of this loan has been paid as of December 31, 2022. However, the loan remains outstanding for interest accrued throughout the term. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On June&#160;15, 2020, a $0.1&#160;million note with interest at the rate of 7.5% per annum and a maturity date of June 15, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $0.1&#160;million. The principal of this loan was paid as of December&#160;31, 2022 and remains outstanding for interest in the amount of $0.01&#160;million. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 12.5%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#8217;s assets. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On November&#160;2, 2020, a $50,000 note was entered into by the Company from to the president and co-founder of the Company. This note has interest at the rate of 5.0% per annum and a maturity date of June 2, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. The principal of this loan has been paid as of December 31, 2022. However, the loan remains outstanding for interest accrued throughout the term. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On January&#160;12, 2021, a $0.3 million note with interest at the rate of 12.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On February&#160;22, 2021, a $40,000 note with interest at the rate of 12.0% per annum and a maturity date of June 22, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#8217;s assets. The security interest will continue until all obligations under the note are satisfied. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">On October&#160;27, 2022, a $425,000 note with interest at the rate of 12.0% per annum and a maturity date of January 27, 2023. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#8217;s assets. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, all other related party promissory notes were outstanding and included within the loan payable on the Consolidated Balance Sheet for a total of $1.2 million, including accrued interest and default interest of $0.4&#160;million. All notes, except the October&#160;27, 2022 note, were not paid upon maturity. These loans were in default as of period end due to outstanding interest. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the consolidated statement of operations was $0.2&#160;million during the twelve months ending December&#160;31, 2022. On September&#160;30, 2022, related parties waived their rights to remedy in the event of default, which in effect releases the Company from the obligation of the incremental interest and fees, as well as the lender from their lien on and security interest in the Company&#8217;s assets. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During 2022, multiple of the loans above with maturity dates in 2022 remained unpaid as of the maturity date. On September&#160;30, 2022, those lenders waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#8217;s assets. Currently, the Company is renegotiating the terms of the loans. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the twelve months ending December&#160;31, 2022 and 2021, the Company repaid $0.7&#160;million and $1.9&#160;million of its related party loans. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2016, the Company entered into an agreement with Fuseproject, a design firm that designed the Company&#8217;s main product, its fitness mirror. As of December&#160;31, 2022 and 2021, the Company had incurred $0.2&#160;million and $0.8&#160;million, respectively, of expenses for design services provided by Fuseproject. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, the principal stockholder associated with Fuseproject referenced above owned 7,499 of the Company&#8217;s Class&#160;A common shares and 1,833 of the Company&#8217;s Class&#160;B common warrants. As of December&#160;31, 2022, the principal stockholder also owned 28,666 shares of the Company&#8217;s Class&#160;B common shares, with fully diluted ownership of 1.26% and 2.17 % as of December&#160;31, 2022 and 2021, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In 2022, the Company entered into an agreement with Apeiron Advisory Ltd for promotion of the Company, participation in industry conferences, and ongoing structural advice and consulting. As of December&#160;31, 2022 and 2021, the Company has incurred $0.9&#160;million and $ 0.0&#160;million, respectively, of expenses for such services provided by Apeiron Advisory Ltd. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022 and 2021, Apeiron Investment Group Ltd owned 447,318 and 11,520 shares of the Company&#8217;s Class&#160;A common shares, 0 and 9,925 shares of the Company&#8217;s Series A preferred shares, and 24,143 and 0 of the Company&#8217;s Class&#160;A common warrants, respectively, with fully diluted ownership of 15.60% and 5.00%, respectively. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673328576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">20. Subsequent Events </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has evaluated subsequent events through the financial statement issuance date, November&#160;14, 2023, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">855-10</div> Subsequent Events. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On October&#160;6, 2023, the Company entered into an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;) with CLMBR, Inc and CLMBR1, LLC (the &#8220;Sellers&#8221;) to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The purchase price enterprise value under the Asset Purchase Agreement is approximately $16.9&#160;million, of which $6.0&#160;million will be paid in the form of the Company&#8217;s common stock, and the Company will assume $1.5&#160;million of subordinated debt and will retire $9.4&#160;million of senior debt. The number of shares to be issued will be based on the volume weighted average price (&#8220;VWAP&#8221;) of the Company&#8217;s common stock based on the 10 consecutive trading days ending on (and including) the closing date of the Acquisition, on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;); provided, however, that such VWAP shall not exceed or be less than an amount equal to twenty-five percent (25%) of the VWAP for the common stock based on the 10 consecutive trading days ending on (and including) the date the Asset Purchase Agreement was executed (the &#8220;VWAP Collar&#8221;). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Sellers shall also be entitled to receive a contingent payment in the form of the Company&#8217;s common stock (collectively, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Earn-Out</div> Shares&#8221;) calculated in the manner set forth in the Asset Purchase Agreement based on the 2024 Unit Sales (as defined in the Asset Purchase Agreement) and the VWAP for the Company&#8217;s common stock based on the 10 consecutive trading days ending on (and including) December&#160;31, 2024, subject to the VWAP collar. In addition, in the event the 2024 Unit Sales include at least 2,400 Units sold in the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">business-to-business</div></div> channel, the Sellers shall be entitled to an additional number of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares calculated in the manner set forth in the Asset Purchase Agreement subject to total maximum number of 22,665,681 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Asset Purchase Agreement contains customary representations and warranties and covenants for a transaction of this nature and customary indemnification provisions with respect to certain matters, including breaches of the Company&#8217;s and Sellers&#8217; representations and warranties. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On October&#160;30, 2023, the Company entered into an agreement with the former principal stockholder regarding a mutually agreed upon repayment schedule with respect to outstanding promissory notes previously issued to such former principal stockholder. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November&#160;3, 2023, THLWY, LLC waived their rights to seek remedies resulting from an event of default on the June 2023 Notes. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On November&#160;10, 2023, the Company issued secured promissory notes in the aggregate principal amount of approximately $1.9&#160;million, of which approximately $0.8&#160;million was with a related party, with an original issuance discount of 15%, due November 9, 2024. Interest on the outstanding principal of the notes accrues initially at a rate of 3% per annum, with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">step-up</div> interest rate of 8% per annum after January&#160;31, 2024 until maturity. In addition, the Company issued warrants to purchase shares of common stock of the Company to the noteholders, which warrants expire five years from the date of issuance. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">23. Subsequent Events </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has evaluated subsequent events through the financial statement issuance date, March&#160;29, 2023, pursuant to ASC 855-10 <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Subsequent Events.</div></div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, January 2023 and February 2023, the Company issued 9,749,439 shares of Class&#160;A common stock (of which 1,072,438 were issued in December 2022 and 8,677,001 were issued in January and February&#160;2023) pursuant to a rights offering involving the sale of Class&#160;A common stock to all existing accredited investors as of December&#160;19, 2022 at a price equal to approximately $0.51 per share. Each accredited investor received the right to elect to purchase shares of Class A common stock in the rights offering up to their respective pro rata amount, which was equal to the product of (x)&#160;$5,000,000, multiplied by (y)&#160;the quotient obtained by dividing (a) the number of shares of the Company&#8217;s capital stock held by the accredited investor as of December&#160;19, 2022 including any common stock issuable on the exercise of warrants or options held by such accredited investor as of December&#160;19, 2022, by (b) the Company&#8217;s fully-diluted capitalization as of December&#160;19, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, the Company issued warrants to four accredited investors in consideration for services rendered, which warrants are exercisable for a total number of shares of the Company&#8217;s common stock that is determined by dividing $400,000 by (x)&#160;the price per share of the Company&#8217;s next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the offering price per share in the Company&#8217;s contemplated initial public offering price, whichever event occurs first, for an exercise price of $0.01 per share, in whole or in part. The warrants may also be net exercised upon election. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On February&#160;27, 2023, the Company filed an Amended and Restated Certificate of Incorporation of Interactive Strength Inc., which converted all issued shares of Class A Common Stock and Class B Common Stock into shares of Common Stock on a one to one basis. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On March&#160;6, 2023, the Company entered into a Termination Agreement with a third-party content provider (&#8220;Content Provider&#8221;) to terminate a service agreement and collaboration agreement previously entered into in 2021. The Company made a payment of $0.1&#160;million to the Content Provider on February&#160;13, 2022 and has no further obligations to the Content Provider. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, the Company issued an aggregate of $2.0&#160;million of senior secured notes to three investors, including one related party, with associated warrants to purchase the Company&#8217;s common stock at an exercise price of $0.0001, in lieu of future cash interest payments under the senior secured notes issued to such investors. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047655937360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComparabilityOfPriorYearFinancialData', window );">Unaudited Interim Financial Information</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Interim Financial Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP, for interim financial reporting and as required by Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X,</div> Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-01.</div> The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated annual financial statements for the years ended December&#160;31, 2022 and 2021 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company&#8217;s condensed consolidated balance sheet as of September&#160;30, 2023, the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022, the condensed consolidated statement of redeemable convertible preferred stock and stockholders&#8217; equity (deficit) as of September&#160;30, 2023 and condensed consolidated statements of cash flows for the nine months ended September&#160;30, 2023 and 2022. The financial data and other information disclosed in these notes related to the nine months ended September&#160;30, 2023 and 2022 are unaudited. The results for the nine months ended September&#160;30, 2023, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2023, any other interim periods, or any future year or period. </div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, simple agreement for future equity (&#8220;SAFE&#8221;) liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#8220;CODM&#8221;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">at-home</div> fitness technology platform. The Company&#8217;s chief operating decision maker, its chief executive officer, manages the Company&#8217;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of September&#160;30, 2023 and 2022, substantially all of the Company&#8217;s long-lived assets are held in the United States. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#8220;CODM&#8221;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">at-home</div> fitness technology platform. The Company&#8217;s chief operating decision maker, its chief executive officer, manages the Company&#8217;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of December&#160;31, 2022 and 2021, substantially all of the Company&#8217;s long-lived assets are held in the United States. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cash consists of cash on deposit in banks. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cash consists of cash on deposit in banks. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DeferredOfferingCostsPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Offering Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company complies with the requirements of ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-10-S99-1</div></div></div> and SEC Staff Accounting Bulletin Topic 5A &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of Offering&#8221;</div></div>. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. As of September&#160;30, 2023, the Company incurred offering costs amounting to $4.6&#160;million through the IPO and subsequently classified the costs to additional paid in capital. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Offering Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expenses of Offering&#8221;</div></div>. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. The Company has incurred and expensed offering costs amounting to $2.3&#160;million as of December&#160;31, 2022. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-production</div> tooling which it owns under a supply arrangement. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling, including the related engineering costs the Company will not own or will not use in producing products under long-term supply arrangements, are expensed as incurred. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 10 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">3 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="-sec-ix-hidden:hidden95757150">Lesser of lease term or estimated useful life</span></td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-production</div> tooling which it owns under a supply arrangement. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling, including the related engineering costs the Company will not own or will not be used in producing products under long-term supply arrangements, are expensed as incurred. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><div style="display:inline;">2 </div>&#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 10 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">3 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="-sec-ix-hidden:hidden95757149">Lesser of lease term or estimated useful life</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories, net</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Inventories, net </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">written-off</div> against the reserve. Inventory not expected to be sold in the next twelve months is classified as long-term in the accompanying condensed, consolidated balance sheets. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">written-off</div> against the reserve. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_VendorDepositPolicyTextBlock', window );">Vendor Deposits</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Vendor Deposits </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#8217;s inventory. In general, the Company&#8217;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#8217;s consolidated balance sheet. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Vendor Deposits </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#8217;s inventory. In general, the Company&#8217;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#8217;s consolidated balance sheet. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CapitalizedStudioContentPolicytextBlock', window );">Capitalized Studio Content</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Capitalized Studio Content </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Capitalized Studio content costs include certain expenditures to develop video and live content for the Company&#8217;s customers. The Company capitalizes production costs for recorded content in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">926-20,</div> Entertainment-Films - Other Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#8220;obsolescence&#8221; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(3-year)</div> amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $2.9&#160;million and $4.4&#160;million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Capitalized Studio Content </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Capitalized&#160;Studio content costs include certain expenditures to develop video and live content for the Company&#8217;s customers. The Company capitalizes production costs for recorded&#160;content in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;926-20,&#160;Entertainment-Films</div> - Other&#160;Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">other&#160;non-current&#160;assets</div> in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized&#160;content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#8220;obsolescence&#8221; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(3-year)</div> amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $4.4&#160;million as of December&#160;31, 2022. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Identifiable Intangible Assets</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Identifiable Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">350-40,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-use</div> Software and ASC 985, Software. These capitalized costs also relate to the Company&#8217;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems. Capitalized software costs are amortized over the estimated useful life is three years. Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is probable the project will be completed, and the software will be used to perform the function intended. Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. The Company expenses all costs incurred that relate to planning and post-implementation phases of development. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment, and none were identified in the quarter ended September&#160;30, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the nine months ended September&#160;30, 2023 and the year ended December&#160;31, 2022, the Company capitalized $0.5&#160;million and $2.7&#160;million, respectively, of internal use software. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:41%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="width:56%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Internal-use</div> software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">3 years</div></td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Identifiable Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;350-40,&#160;Internal-use&#160;Software</div></div> and ASC 985, Software.&#160;These capitalized costs also relate to the Company&#8217;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems.&#160;Capitalized software costs are amortized over the estimated useful life is three years.&#160;Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">probable the project will be completed, and the software will be used to perform the function intended.&#160;Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use.&#160;The Company expenses all costs incurred that relate to planning and post-implementation phases of development. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">During the years ended December&#160;31, 2022 and 2021, the Company capitalized $2.7&#160;million, and $1.4&#160;million, respectively, of internally developed software. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;&#160;Internal-use software</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">3 years</td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock', window );">Music Royalty Fees</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Music Royalty Fees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes music royalty fees as these fees are incurred in accordance with the terms of the relevant license agreement with the music rights holder. The incurrence of such royalties is primarily driven by the number of paid subscribers each month and it is classified as cost of membership and training within the Company&#8217;s statement of operations. The Company&#8217;s license agreements with music rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of September&#160;30, 2023 and December&#160;31, 2022 there were no music guarantee-related prepaids, respectively. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Music&#160;Royalty Fees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes&#160;music&#160;royalty fees&#160;as these fees are incurred in accordance with the terms of the relevant license agreement with the&#160;music&#160;rights holder. The incurrence of such royalties is primarily driven by&#160;the number of paid subscribers each month&#160;and it is classified as cost of membership and training within the Company&#8217;s statement of operations. The Company&#8217;s license agreements with&#160;music&#160;rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of December 31, 2022 and 2021, there were music guarantee-related prepaids of $0 million and $0.1 million, respectively. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s material financial instruments consist primarily of cash and cash equivalents, accounts payable, accrued expenses, convertible notes, and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these instruments. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company&#8217;s material financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFEs and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these <div style="display:inline;">instruments</div>. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. </div><span></span>
</td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. There was a $2.3 million impairment loss related to the impairment of the Content Provider&#8217;s content for the year ended December 31, 2022. There was no charge to impairment for the year ended December&#160;31, 2021. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ConvertibleNotesPolicyTextBlock', window );">Convertible Notes</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In May 2023, upon closing of the Company&#8217;s IPO, the convertible notes were converted into an aggregate of 565,144 shares of common stock. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the condensed consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party (the &#8220;acqui-hire transaction&#8221;) that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x)&#160;the price per share of the next equity financing with total proceeds of at least $10.0&#160;million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 28,124 shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $400,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 49,996 shares of common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2023, we issued warrants to certain existing affiliate and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliate</div> stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with a note financing (the &#8220;Bridge Note Financing&#8221;). Such warrants are exercisable for a number of shares of our common stock that is determined by dividing: (A)&#160;(i) in the case of the warrants issued to the lead noteholder, 67% of the aggregate principal amount of notes issued to such lead noteholder and; (ii)&#160;in the case of all other noteholders in the Bridge Note Financing, 60% of the aggregate principal amount of notes issued to such other noteholders by (B)&#160;(i) the initial public offering price per share or (ii)&#160;if the initial public offering is not consummated, by either (x)&#160;the price per share offered in a change of control transaction or (y)&#160;if a change of control transaction does not occur, the fair market value of our common stock as determined by an independent appraiser. The warrants may also be net exercised upon election. The value of the warrants of $1.3&#160;million was recorded as debt discount on the senior notes of $2.0&#160;million. The debt discount was amortized into interest expense over life of the senior notes. In May 2023, upon closing of the Company&#8217;s IPO, the warrants were exercised and converted into an aggregate of 163,121 shares of common stock. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#8217; deficit. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#8217;s hiring of certain employees from the third party (the &#8220;acqui-hire transaction&#8221;) that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x) the price per share of the next equity financing with total proceeds of at least $10.0 million or (y) the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.01 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In accordance with ASC 718, as the warrant contains a performance condition dependent on an initial public offering, there has been no impact recorded prior to December 31, 2022. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">estimates, assumptions, and judgments to determine the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. </div><span></span>
</td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s condensed consolidated financial statements upon adoption. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) and has elected not to &#8220;opt out&#8221; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time public companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Recently Adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02,</div> Leases (&#8220;Topic 842&#8221;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January&#160;1, 2022. Financial positions for reporting periods beginning on or after January&#160;1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-03,</div> Measurement of Credit Losses on Financial Instruments (&#8220;CECL&#8221;), which amends ASC 326 &#8220;Financial Instruments - Credit Losses&#8221; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#8220;expected loss model&#8221; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January&#160;1, 2022 and the guidance did not have a material impact on our condensed consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>, which amends ASC Topic 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div>. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances, eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#8217;s condensed consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Not Yet Adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> and ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</div></div>. This guidance provides temporary optional expedients and exceptions to accounting </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">guidance on contract modifications and hedge accounting to ease entities&#8217; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848)</div></div>, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its condensed consolidated financial statements. </div><span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) and has elected not to &#8220;opt out&#8221; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time private companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Recently Adopted </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02, Leases (&#8220;Topic 842&#8221;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize an ROU asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January 1, 2022. Financial positions for reporting periods beginning on or after January 1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU 2016-13 </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In June 2016, the FASB issued ASU 2016-03, Measurement of Credit Losses on Financial Instruments (&#8220;CECL&#8221;), which amends ASC 326 &#8220;Financial Instruments - Credit Losses&#8221; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#8220;expected loss model&#8221; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January 1, 2022 and the guidance did not have a material impact on our consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>, which amends ASC Topic 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div>. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div>eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU 2019-12 effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#8217;s financial statements. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements Not Yet Adopted </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> and ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In March 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial</div></div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reporting</div></div>. This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div>ease entities&#8217; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reference Rate Reform (Topic 848)</div></div>, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-01</div> are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its consolidated financial statements. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and&#160;Off-Balance&#160;Sheet Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Off-Balance</div> Sheet Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any credit losses on its cash or cash equivalents. The Company maintains its cash and cash equivalents at a high-quality financial institution. Management believes that such funds are not exposed to any significant credit or concentration risk. The Company has no financial instruments with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-balance-sheet</div> risk of loss and has not experienced any losses on such accounts. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ContentLicensingAgreementPolicyTextBlock', window );">Content Licensing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Content Licensing Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company entered into two agreements with a third-party content provider (&#8220;Content Provider&#8221;), a service agreement and a collaboration agreement. Per the service agreement, Forme is to provide content creation services for the Content Provider in which the Company is to produce workout content using the Content Provider&#8217;s trainers and studios. Under the collaboration agreement, both the Company and the Content Provider agree to jointly market their partnership; in addition, the collaboration agreement provides the Company with a license to use the Content Provider&#8217;s content on its Studio fitness ecosystem (i.e., the &#8220;License&#8221;). The license issued to the Company allows the Company to reproduce, modify, prepare derivative works based upon, distribute, publicly display, publicly perform the content and the modified content, to market, advertise or promote the Company, perform specified activities, and provide the Company&#8217;s customers access to and use of the Content Provider&#8217;s content, throughout the world on the Company&#8217;s Studio devices and in any media, so long as such other media is associated or related to the use of the Company&#8217;s Studio devices. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2022, the company determined that the Content Provider&#8217;s content would no longer be used on Forme&#8217;s platform, leading to a triggering event. Upon further analysis, it was determined that this content was abandoned in December 2022 with no remaining fair value. As such, Forme recorded an impairment loss of $2.3 million within general and administrative costs within the consolidated statement of operations and comprehensive loss as of December 31, 2022. As a result, there is no related unamortized costs of content as of December 31, 2022. Refer to Note 14 for further information on future minimum payments as of December 31, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The liability will be recorded and accreted at the gross amount for each tranche of content delivered to the Company for $0.5&#160;million per quarter and will be decreased when the payments per the payment schedule above are made. The liability for the license fee is approximately $2.3 million as of December 31, 2022. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company adopted the Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases</div></div> (Topic 842) (&#8220;ASU 2016-02&#8221; or &#8220;ASC&#160;842&#8221;) as of January 1, 2022, using the modified retrospective method and utilized the effective date as its date of initial application, with prior periods presented in accordance with previous guidance under Accounting Standards Codification (&#8220;ASC&#8221;) 840, Leases. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease liabilities, as applicable. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Prospectively, the Company will adjust the right-of-use assets for straight-line rent expense and remeasure the lease liability at the net present value using the same incremental borrowing rate that was in effect as of the lease commencement or transition date. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date: i) the Company did not reassess whether any expired or existing contracts are or contain leases, ii) the Company did not reassess the lease classification for any expired or existing leases, and iii) the Company did not reassess initial direct costs for any existing leases. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In accordance with ASC 842, components of a lease should be split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Entities may elect not to separate lease and non-lease components. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only. As a result of the adoption of ASC 842, the Company recognized right-of-use assets and lease liabilities of $0.3 million and $0.3 million, respectively, as of the January 1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. The Company recorded an immaterial amount of general and administrative expense in its consolidated statement of operations related to lease expense, including short-term lease expense during the year ended December 31, 2022. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Instruments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company measures derivative financial instruments at fair value and recognizes them as either assets or liabilities on the consolidated balance sheets. The Company evaluates its convertible instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives requiring separate recognition in the Company&#8217;s financial statements in accordance with the criteria under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15.</div> As of December&#160;31, 2022 and 2021, the Company did not have any material derivative contracts or contracts with material embedded derivative features requiring bifurcation. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock', window );">Simple Agreements for Future Equity ("SAFES") and Advance Subscription Agreements ("ASAs")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Simple Agreements for Future Equity (&#8220;SAFES&#8221;) and Advance Subscription Agreements (&#8220;ASAs&#8221;) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company has issued several SAFEs and ASAs in exchange for cash financing. The SAFEs were initially measured at fair value using a probability weighted expected return method (PWERM) and were subsequently remeasured at fair value at each reporting period, through the date of conversion. The ASAs were initially measured at fair value utilizing the&#160;fair value of the Company&#8217;s common stock according to the ASC 718 valuation&#160;performed by an independent appraiser closest to the date of grant and were subsequently remeasured at fair value at each reporting period, through date of conversion. Pursuant to the SAFE agreement provisions, all outstanding SAFE instruments were converted to preferred stock in 2021, in connection with a Series A financing. All ASAs were converted to common stock on the respective ASA Longstop Dates <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(6-month</div> anniversary of issuance). There were are no outstanding SAFEs or ASAs as of December&#160;31, 2022 or December 31, 2021. The remeasurements of the SAFEs and ASAs resulted in the recognition of a $0.3 million loss for the year ended December&#160;31, 2021 (see Note 4 to the consolidated financial statements for the accounting for significant inputs to the valuation of the SAFE and ASA instruments). </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Commitments and Contingencies </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. If a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the possible loss or states that such an estimate cannot be made. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">On January&#160;1, 2020, the Company adopted Accounting Standards Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;ASU&#8221;)&#160;2014-09,&#160;Revenue</div> from Contracts with Customers (Topic 606) (&#8220;ASC 606&#8221;)&#160;and all subsequent amendments. As the Company had not recognized any revenue prior to the adoption of the new standard, there was no impact on the measurement or timing of revenue recognition as a result of the adoption. Revenue is recognized when control of the promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Refer to Note 3 for additional information. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CostOfFitnessProductRevenuePolicyTextBlock', window );">Cost of Fitness Product Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Fitness Product Revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Cost of fitness product revenue relates to the Fitness Product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management, facilities, and personnel-related expenses associated with supply chain logistics. Cost of fitness product revenue also contains valuation losses related to the Company&#8217;s inventory lower of cost or market reserve. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CostOfMembershipAndTrainingPolicyTextBlock', window );">Cost of Membership and Training</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Membership and Training </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Membership costs include costs associated with the creation of content and training, including associated payroll, filming and production costs, other content specific costs, hosting fees, music royalties, amortization of capitalized software development costs, and warranty replacement and servicing costs associated with extended warranty contracts. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Advertising Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Advertising and other promotional costs to market the Company&#8217;s products are expensed as incurred. Advertising expenses were $2.5&#160;million and $2.0&#160;million for the years ended December&#160;31, 2022 and 2021, respectively, and are included within sales and marketing expenses in the consolidated statements of operations and comprehensive loss. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Research and Development Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Research and development expenses consist primarily of personnel- and facilities-related expenses, consulting and contractor expenses, tooling and prototype materials software platform expenses, and depreciation of property and equipment. Substantially all of the Company&#8217;s research and development expenses are related to developing new products and services and improving existing products and services. Research and development expenses are expensed as incurred. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-Based Compensation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">In December 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (&#8220;the 2020 Plan&#8221;). Stock-based awards are measured at the grant date based on the fair value of the award and are recognized as expense, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The determination of the grant date fair value of stock awards issued is affected by a number of variables, including the fair value of the Company&#8217;s common stock, the expected common stock price volatility over the expected life of the awards, the expected term of the stock option, risk-free interest rates, and the expected dividend yield of the Company&#8217;s common stock. The Company derives its volatility from the average historical stock volatilities of several peer public companies over a period equivalent to the expected term of the awards. The Company estimates the expected term based on the simplified method for employee stock options considered to be &#8220;plain vanilla&#8221; options, as the Company&#8217;s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant. Expected dividend yield is 0.0% as the Company has not paid and does not currently anticipate paying dividends on its common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Stock-based compensation expense is classified in the accompanying consolidated statement of operations in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Foreign Currency Transactions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The functional currency for the Company&#8217;s wholly-owned foreign subsidiaries, Interactive Strength UK and Interactive Strength Taiwan, is the United States dollar. All foreign currency transaction gains and losses are recognized in the consolidated statements of operations and comprehensive loss through other income (expense). The Company has not recognized material currency transaction gains or losses during the years ended December&#160;31, 2022 and 2021. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive Loss </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Comprehensive loss includes net loss as well as other changes in stockholders&#8217; deficit that result from transactions and economic events other than those with stockholders. For the years ended December 31, 2022 and 2021, comprehensive loss included $0.5 million and $0.2 million of foreign currency transaction gains, respectively. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Loss Per Share </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The Company computes loss per share using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method required for participating securities. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company&#8217;s redeemable convertible preferred stock and common stock issued upon early exercise of stock options are participating securities. The Company considers any shares issued upon early exercise of stock options, subject to repurchase, to be participating securities because holders of such shares have <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-forfeitable</div> dividend rights in the event a cash dividend is declared on common stock. These participating securities do not contractually require the holders of such shares to participate in the Company&#8217;s losses. As such, net losses for the periods presented were not allocated to the Company&#8217;s participating securities. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Basic loss per share is computed using the weighted-average number of outstanding shares of common stock during the period. Diluted earnings (loss) per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential shares of common stock outstanding during the period. Potential shares of common stock consist of incremental shares issuable upon the assumed exercise of stock options, employee stock purchase plan (&#8220;ESPP&#8221;) shares to be issued, and vesting of restricted stock awards. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CapitalizedStudioContentPolicytextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized studio content policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CapitalizedStudioContentPolicytextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ContentLicensingAgreementPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Content Licensing Agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ContentLicensingAgreementPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ConvertibleNotesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ConvertibleNotesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CostOfFitnessProductRevenuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of Fitness Product Revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CostOfFitnessProductRevenuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CostOfMembershipAndTrainingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of Membership and Training.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CostOfMembershipAndTrainingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DeferredOfferingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DeferredOfferingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_MusicRoyaltyFeesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Music royalty fees policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_MusicRoyaltyFeesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple Agreements for Future Equity and Advance Subscription Agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_VendorDepositPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vendor Deposit policy .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_VendorDepositPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComparabilityOfPriorYearFinancialData">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting any exceptions to the comparability of prior year financial data with data shown for the most recent accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483478/205-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComparabilityOfPriorYearFinancialData</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674603776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 10 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">3 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="-sec-ix-hidden:hidden95757150">Lesser of lease term or estimated useful life</span></td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><div style="display:inline;">2 </div>&#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">2 &#8211; 10 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">3 &#8211; 5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;&#160;Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="-sec-ix-hidden:hidden95757149">Lesser of lease term or estimated useful life</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Amotization Computed on a Straight-line Basis</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:41%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="width:56%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;Internal-use</div> software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 9pt; text-align: justify; line-height: normal;">3 years</div></td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Amortization is computed on a straight-line basis over the following estimated useful lives: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="width:47%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;&#160;Internal-use software</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">3 years</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property Plant And Equipment Estimated Useful Lives Of Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678900448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,443&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,567&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products - LT</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,121&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total inventories, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,564&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,567&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Finished products - LT represents inventory not expected to be sold in the next twelve months. </div><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Inventories consist of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Finished products</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,567&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,056&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total inventories, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,567&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,056&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674654848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software and technology development asset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,370&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,370&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,787)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,044)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">583&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,326&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Property and equipment consisted of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-production</div> tooling</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,775&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Machinery and equipment</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">243&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and fixtures</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software and technology development asset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,370&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,156&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,044)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(966)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,326&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,190&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047677563568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Identifiable Intangible Assets, Net</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Identifiable intangible assets, net consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;6,346&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(3,480)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;2,866&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;5,827&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(1,993)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;3,834&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable intangible assets</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,346&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,480)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,866&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,827&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,993)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,834&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Identifiable intangible assets, net consist of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:38%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book<br/>Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book<br/>Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;5,827&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(1,993)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;3,834&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;3,083&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(428)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;2,655&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,827&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,993)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,834&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,083&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(428)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,655&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Annual Amortization Expense</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of September&#160;30, 2023, estimated annual amortization expense for each of the next five fiscal years is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="4" style="vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Years Ending December&#160;31,</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="4" style="height:6pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 (remaining)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">530&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,689&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">554&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">93&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,866&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">As of December&#160;31, 2022, estimated annual amortization expense for each of the next five fiscal years is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom;white-space:nowrap"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Years Ending December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,946&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,516&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">372&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674551312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract', window );"><strong>Prepaid Expenses and Other Current Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Prepaid expenses and other current assets consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:69%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,<br/> 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security deposit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">146&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">133&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">750&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other receivables</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other prepaid</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">293&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;962&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,426&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Prepaid expenses and other current assets consisted of the following:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security deposit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">146&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">607&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">202&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">750&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vendor deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other prepaid</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">307&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">356&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,426&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,165&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other current assets disclosure abstract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047677655456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Other assets consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:36%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortization</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Book</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized content costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,589&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(3,721)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;2,868&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,589&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;(2,185)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;4,404&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,370&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,555)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,815&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,996&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,391)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,605&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;11,959&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,276)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,683&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;10,594&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,576)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,018&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized content costs and content licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,404&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,099&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,605&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,258&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,018&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,366&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678579680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Accrued expenses consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,<br/> 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued bonus</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued payroll</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued PTO</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">188&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,490&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,250&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued royalties</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">204&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued professional fees</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">953&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer deposits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">517&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued expenses and current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">138&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">326&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,951&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,304&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Accrued expenses consisted of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued bonus</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;145&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;223&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued payroll</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued PTO</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">188&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued offering costs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,490&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued advertising</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued professional fees</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued engineering</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">93&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued licenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,250&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,050&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales tax payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued royalties</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">323&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">532&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,784&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,125&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">520&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,304&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,420&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673423136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Disclosure of Temporary Equity</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Convertible redeemable preferred stock consisted of the following as of December&#160;31, 2022:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:28%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable<br/>Convertible&#160;Preferred<br/>Stock:</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Authorized</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Outstanding</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price&#160;per&#160;Share</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Carrying&#160;Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation<br/>Preference</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;13,006,028&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;490.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,531,734&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">173,135,395&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47.67</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,133,701&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">359,375&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">210.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250,000&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,313&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,131&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">512,425&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">283.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122,500&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257,797&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">355.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">665,588&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">417.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,754,796&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,414&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327,218&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">490.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total redeemable convertible preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">194,135,415&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Convertible redeemable preferred stock consisted of the following as December&#160;31, 2021: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:26%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable<br/>Convertible Preferred<br/>Stock:</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Authorized</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares&#160;Outstanding</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price&#160;per&#160;Share</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net&#160;Carrying&#160;Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidation<br/>Preference</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18,165,136&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;86,703&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;490.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19,535&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;53,162&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,531,734&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,208&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,604&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,013&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,133,701&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,546&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,267&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,267&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-1</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">359,375&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,393&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">210.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">719&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">503&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-2</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250,000&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,666&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-3</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,313&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-4</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,131&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">140&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">177.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-5</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">512,425&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,414&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">283.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">425&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">968&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-6</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122,500&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">815&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">300.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">104&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">245&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-7</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257,797&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,716&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">355.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">235&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">611&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-8</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">665,588&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,410&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">417.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">659&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,850&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,754,796&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,344&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,644&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,218&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-9</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,414&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">136&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Seed-10</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327,218&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,171&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">490.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">321&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,070&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total redeemable convertible preferred stock</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,159,128&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">139,910&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,733&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72,110&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047677658016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Compensation Cost Recognized</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:43%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;Months&#160;Ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,347&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">383&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,803&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">478&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">87&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">407&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,402&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,356&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,563&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,421&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stock-based compensation expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,836&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,773&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;23,773&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,951&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Presented below is a summary of the compensation cost recognized in the consolidated statements of operations for the years ended December 31, 2022 and 2021. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:56%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,765&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">286&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,297&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,021&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,348&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,164&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following summary sets forth the stock option activity under the 2023 and 2020 Plan: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:51%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;Number&#160;of&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">exercise</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">remaining</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">contractual</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;term&#160;(in&#160;years)&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;intrinsic&#160;value&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Outstanding as of December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">446,839&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,706</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;3,428,225&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(677,350)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.53</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,690</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cancelled or forfeited</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(89,603)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;0.92</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Outstanding as of September&#160;30, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,108,111&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.70</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,341</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercisable as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178,310&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.97</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.8</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options unvested as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,325,600&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.33</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">775</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following summary sets forth the stock option activity under the 2020 Plan:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:41%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/>options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>remaining<br/>contractual term<br/>(in years)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/>intrinsic&#160;value<br/>(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2021</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;51,149&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.34</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.7</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,786&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1.66</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,784)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;271</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options cancelled</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,310)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.78</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balances at December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">446,841&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,706</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145,713&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.53</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,638</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266,993&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.07</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,058</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Unvested Common Stock</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:92%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Early Option Exercises</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;average&#160;exercise&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;Repurchase&#160;&#160;&#160;&#160;</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">liability&#160;(in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock as of December&#160;31, 2022</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,823&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">306</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,947&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.19</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(37)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repurchased</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,655)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock as of September&#160;30, 2023</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;32,078&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:69%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Early Option Exercises</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/>Options</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>Average<br/>Exercise<br/>Price</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Repurchase</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liability</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock &#8212; December&#160;31, 2021</div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,134&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;88</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issued</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">6,057&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.48</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">(794)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">7.17</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repurchased</div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">(2,574)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Unvested common stock &#8212; December&#160;31, 2022</div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">3,823&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">306</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Stock Option Valuation Assumptions</a></td>
<td class="text">The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:96%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate (1)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.7%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.3%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected term (in years)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.93&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.34&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected volatility (2)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;62.27%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;54.6%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Based on U.S. Treasury seven-year constant maturity interest rate whose term is consistent with the expected term of the option. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#8217;s stage of development. </div></td></tr></table><span></span>
</td>
<td class="text">The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:96%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.3%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.2%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected term (in years)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.35&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.50&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average expected volatility</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54.6%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43.1%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Based on U.S. Treasury&#160;seven-year&#160;constant maturity interest rate whose term is consistent with the expected term of the option. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#8217;s stage of development. </div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047655896464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ClassACommonStockWarrantsMember', window );">Class A Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Changes in Warrants Issued and Outstanding</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A&#160;Common</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(92,296)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A&#160;Common<br/>Stock Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,982&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(125,982)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">92,296&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ClassBCommonStockWarrantsMember', window );">Class B Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Changes in Warrants Issued and Outstanding</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:84%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B&#160;Common</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,753&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,753)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B&#160;Common<br/>Stock Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,632&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(879)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,753&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,753</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember', window );">Service Providers Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Changes in Warrants Issued and Outstanding</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Service&#160;Providers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;78,120&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(78,120)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember', window );">Senior Secured Notes Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Changes in Warrants Issued and Outstanding</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:81%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior&#160;Secured&#160;Notes</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock&#160;Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants issued</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;163,121&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants exercised</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(163,121)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding as of September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ClassACommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ClassACommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ClassBCommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ClassBCommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673496304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of Fair Value of Liabilities Measured on Recurring Basis</a></td>
<td class="text">Liabilities measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows: <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value&#160;measurements&#160;as&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,274&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,274&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text">Liabilities measured at fair value on a recurring basis as of December 31, 2022 were as follows:<div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measurements as of<br/>December&#160;31, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,274&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,274&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2023: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">252&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,521)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,266)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercise of stock warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(738)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:16%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,902&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,926)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at September&#160;30, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following tables summarize the activity for the Company&#8217;s Level&#160;3 liabilities measured at fair value on a recurring basis: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">SAFE&#160;Liability</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,655</td>
<td style="white-space:nowrap;vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of SAFEs and ASAs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,416&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">251&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of ASAs into common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,667)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of SAFEs into series seed preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,655)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible&#160;Notes</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,546&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,620&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,193</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series Seed preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,947)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,026)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of convertible notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,303&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">107&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of convertible notes into Series A preferred stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,926)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,270&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:13%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands) </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant&#160;Liability</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2021</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,482&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in estimated fair value of financial instruments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(478)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;3,004&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673328576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Rental Payments under Operating Leases</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual rental payments under operating leases for each of the next five years and thereafter: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fiscal Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future&#160;Minimum&#160;Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in&#160;thousands)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 (remaining)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;365&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual rental payments under operating leases for each of the next five years and thereafter:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future Minimum Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;169&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsTableTextBlock', window );">Schedule of Other Commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following represents the Company&#8217;s minimum annual guarantee payments under license agreements for each of the next five years and thereafter:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0">
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ending December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Future Minimum Payments</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">(in thousands)</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,025&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,950&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,250&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,200&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,425&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about obligations resulting from other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673760848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The components of loss before income taxes are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$(56,817)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31,746)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,408)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">(1,090)</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from operations before income taxes</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(58,225)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(32,836)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The components of income tax (benefit) expense are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:67%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred expense:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:73%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="14" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal statutory rate</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,228</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,879</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nondeductible expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(78</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.13</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">192</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-0.60</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nontaxable changes in fair value of convertible notes and SAFEs</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(123</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,038</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.22</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,670</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.59</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(674</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.06</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State taxes, net of federal benefit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,865</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.20</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,705</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.20</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign tax rate differential</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-0.05</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-0.03</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(190</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.33</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,567</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-26.73</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,093</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-30.81</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Disqualified debt</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">731</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-1.26</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Return to provision adjustements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,060</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.82</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangibles</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,281</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-2.20</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock based compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">615</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-1.06</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-0.01</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Disclosure of the components of deferred tax assets (liabilities)</a></td>
<td class="text">Significant components of the Company&#8217;s deferred tax assets (liabilities) are as follows: <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:65%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;(in thousands)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div><div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - Federal</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;16,776&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,760&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,768&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development tax credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,593&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">923&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - State</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,752&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,260&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards - Foreign</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,894&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,846&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,219&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets and intangibles</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(868)&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax assets, gross:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,134&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,789&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(30,134)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,789)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets, net:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673322320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Loss Per Share</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The computation of loss per share is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:94%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine&#160;months&#160;ended&#160;September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in thousands, except share and per share amounts)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(39,971)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(39,415)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss attributable to common stockholders</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(39,971)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(39,415)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common stock outstanding - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;11,750,907&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;423,362&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share attributable to common stockholders - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.40)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(93.10)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The computation of loss per share is as follows:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:58%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(58,225)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(32,840)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss attributable to common stockholders</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(58,225)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(32,840)&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common stock outstanding - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">487,276&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,823&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share attributable to common stockholders - basic and diluted</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(119.49)&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;&#160;$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(332.31)&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potentially Dilutive Shares</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,703</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,208</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">755,606</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,546</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 1 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,393</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 2 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,666</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 3 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 4 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">140</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 5 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,414</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 6 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">815</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 7 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,716</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 8 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,410</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 9 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,480</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 10 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;B common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,753</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options to purchase common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,108,111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">452,549</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,108,111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,353,818</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:</div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:70%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,703&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,208&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,546&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 1 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,393&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 2 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,666&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 3 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 4 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">140&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 5 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,414&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 6 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">815&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 7 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,716&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 8 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,410&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 9 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18,480&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series Seed 10 convertible preferred stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,171&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;A common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants to purchase series Class&#160;B common stock (as converted to common stock)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,753&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,753&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options to purchase common stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">446,841&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51,149&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">544,890&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">196,812&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047658009456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Loan Payable</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify">Loan payable consisted of the following as of September&#160;30, 2023 and December&#160;31, 2022: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:70%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September&#160;30,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(in thousands)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Founder Notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal stockholder promissory notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,404&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,503&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other related party promissory notes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">862&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,126&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Loan Payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,266&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,708&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047666748400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,408)<span></span>
</td>
<td class="num">$ (14,754)<span></span>
</td>
<td class="num">$ (39,971)<span></span>
</td>
<td class="num">$ (39,415)<span></span>
</td>
<td class="num">$ (58,225)<span></span>
</td>
<td class="num">$ (32,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155,509)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155,509)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115,538)<span></span>
</td>
<td class="num">$ (57,313)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Senior secured notes outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions', window );">Loans outstanding from relate parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=trnr_NotePurchaseAgreementMember', window );">June 2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Senior secured notes outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions', window );">Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockStock', window );">Dividends, Common Stock, Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends, Common Stock, Total</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fees and commissions from banking, advisory, brokerage, and securities underwriting activities. Activities include, but are not limited to, underwriting securities, private placements of securities, investment advisory and management services, merger and acquisition services, sale and servicing of mutual funds, and other related consulting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount of new advances made to related parties in the form of loan and lease receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.7(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=trnr_NotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=trnr_NotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047669906016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralPartnersOfferingCosts', window );">General Partners' Offering Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CooperativeAdvertisingAmount', window );">unamortized cost of content</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Intangible assets impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from Issuance of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance or Sale of Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt discount on senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_MusicGuaranteesDeposits', window );">Music guarantees deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 296,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
<td class="num">$ (136,000)<span></span>
</td>
<td class="num">(115,000)<span></span>
</td>
<td class="nump">$ 441,000<span></span>
</td>
<td class="nump">$ 323,000<span></span>
</td>
<td class="nump">$ 167,000<span></span>
</td>
<td class="num">$ (79,000)<span></span>
</td>
<td class="nump">$ 931,000<span></span>
</td>
<td class="nump">$ 524,000<span></span>
</td>
<td class="nump">$ 179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions', window );">Percentage of recognition of tax benefits during income tax examination for uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains or losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,000)<span></span>
</td>
<td class="num">$ (821,000)<span></span>
</td>
<td class="num">$ (422,000)<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Foreign Currency Gain (Loss) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains or losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis=trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember', window );">Simple Agreements For Future Equity SAFES And Advance Subscription Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForwardContractIndexedToIssuersEquityShares', window );">Maximum number of shares that could be issued to net share settle a contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements', window );">Remeasurement loss of simple agreements for future equity and advance subscription agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=trnr_ContentLicensingAgreementMember', window );">Content Licensing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost', window );">Content unamortized costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_LicenseFeePayablePerQuarter', window );">Licence fee payable per quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability', window );">License fee liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt discount on senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Stock issued upon exercise of warrants</a></td>
<td class="nump">49,996<span></span>
</td>
<td class="nump">28,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Bridge Note Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Stock issued upon exercise of warrants</a></td>
<td class="nump">163,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock upon conversion, shares</a></td>
<td class="nump">565,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_LeadNoteholderMember', window );">67 Lead Noteholder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_OtherNoteholderMember', window );">60 Other Noteholder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_InternalUseSoftwareMember', window );">Internal-Use Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers', window );">Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_CapitalizedStudioContentMember', window );">Capitalized Studio Content [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_LicenseFeePayablePerQuarter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License fee payable per quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_LicenseFeePayablePerQuarter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_MusicGuaranteesDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Music guarantees deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_MusicGuaranteesDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of recognition of tax benefits during income tax examination for uncertain tax positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement loss of simple agreements for future equity and advance subscription agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CooperativeAdvertisingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount received by an entity from a vendor under a cooperative advertising arrangement that has been offset against advertising expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CooperativeAdvertisingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480341/340-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized cost for right acquired by broadcaster under license agreement for program material.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483282/920-350-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation incurred for right acquired by broadcaster under license agreement for program material.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483227/920-405-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForwardContractIndexedToIssuersEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForwardContractIndexedToIssuersEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralPartnersOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of offering costs allocated to the general partner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralPartnersOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-6<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 80: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 81: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 82: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 83: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 84: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 85: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 86: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 87: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 88: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 89: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 90: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 91: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 92: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis=trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis=trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=trnr_ContentLicensingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=trnr_ContentLicensingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=trnr_BridgeNoteFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=trnr_BridgeNoteFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_LeadNoteholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_LeadNoteholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_OtherNoteholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_OtherNoteholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_InternalUseSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_InternalUseSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_CapitalizedStudioContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_CapitalizedStudioContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047657983520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Property, Plant and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration', window );">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</a></td>
<td class="text">Property, Plant and Equipment, Net<span></span>
</td>
<td class="text">Property, Plant and Equipment, Net<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_PreProductionToolingMember', window );">Pre - Production Tooling [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_PreProductionToolingMember', window );">Pre - Production Tooling [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482190/360-10-35-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_PreProductionToolingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_PreProductionToolingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678608992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Amortization Computed on a Straight-line Basis (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Internal-use software</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671891296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ExtendedProductWarrantyPeriod', window );">Extended product warranty period</a></td>
<td class="text">48 months<span></span>
</td>
<td class="text">48 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ExtendedProductWarrantyPeriod', window );">Extended product warranty period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">24 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ExtendedProductWarrantyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extended product warranty period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ExtendedProductWarrantyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678900576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Simple Agreements for Future Equity and Advance Subscription Agreements - Additional Information (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems', window );"><strong>Simple Agreements for Future Equity and Advance Subscription Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AgreementAxis=trnr_SimpleAgreementsForFutureEquityMember', window );">Simple Agreements for Future Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems', window );"><strong>Simple Agreements for Future Equity and Advance Subscription Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible Preferred Stock Shares Issued Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simple agreements for future equity and advance subscription agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AgreementAxis=trnr_SimpleAgreementsForFutureEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AgreementAxis=trnr_SimpleAgreementsForFutureEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673767216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, Net - Schedule of Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 1,443<span></span>
</td>
<td class="nump">$ 4,567<span></span>
</td>
<td class="nump">$ 2,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Finished products - LT</a></td>
<td class="nump">3,121<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories, net</a></td>
<td class="nump">$ 4,564<span></span>
</td>
<td class="nump">$ 4,567<span></span>
</td>
<td class="nump">$ 2,056<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674185712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PreProductionTooling', window );">Pre-production tooling</a></td>
<td class="nump">$ 3,094<span></span>
</td>
<td class="nump">$ 3,094<span></span>
</td>
<td class="nump">$ 2,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Software and technology development asset</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross, Total</a></td>
<td class="nump">3,370<span></span>
</td>
<td class="nump">3,370<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(2,787)<span></span>
</td>
<td class="num">(2,044)<span></span>
</td>
<td class="num">(966)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 1,326<span></span>
</td>
<td class="nump">$ 2,190<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PreProductionTooling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-Production Tooling</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PreProductionTooling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671569856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 743<span></span>
</td>
<td class="nump">$ 932<span></span>
</td>
<td class="nump">$ 1,143<span></span>
</td>
<td class="nump">$ 747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_PropertyAndEquipmentMember', window );">Property and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_PropertyAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_PropertyAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047655866768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Identifiable Intangible Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 6,346<span></span>
</td>
<td class="nump">$ 5,827<span></span>
</td>
<td class="nump">$ 3,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,480)<span></span>
</td>
<td class="num">(1,993)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">2,866<span></span>
</td>
<td class="nump">3,834<span></span>
</td>
<td class="nump">2,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_InternalUseSoftwareMember', window );">Internal-Use Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">6,346<span></span>
</td>
<td class="nump">5,827<span></span>
</td>
<td class="nump">3,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,480)<span></span>
</td>
<td class="num">(1,993)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 2,866<span></span>
</td>
<td class="nump">$ 3,834<span></span>
</td>
<td class="nump">$ 2,655<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_InternalUseSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_InternalUseSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047655893632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,188<span></span>
</td>
<td class="nump">$ 3,735<span></span>
</td>
<td class="nump">$ 4,999<span></span>
</td>
<td class="nump">$ 1,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_IdentifiableIntangibleAssetsMember', window );">Identifiable Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_IdentifiableIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=trnr_IdentifiableIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047669969056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Estimated Annual Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2023 (remaining)</a></td>
<td class="nump">$ 530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024 / 2023</a></td>
<td class="nump">1,689<span></span>
</td>
<td class="nump">$ 1,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025 / 2024</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026 / 2025</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027 / 2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 2,866<span></span>
</td>
<td class="nump">$ 3,834<span></span>
</td>
<td class="nump">$ 2,655<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674227952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets- Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposits</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PrepaidLicenses', window );">Prepaid licenses</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ResearchAndDevelopmentTaxCredit', window );">Research and development tax credit</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_VendorDeposits', window );">Vendor Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Insurance</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other prepaid</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 962<span></span>
</td>
<td class="nump">1,426<span></span>
</td>
<td class="nump">$ 1,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other prepaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PrepaidLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid licenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PrepaidLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ResearchAndDevelopmentTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ResearchAndDevelopmentTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_VendorDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vendor deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_VendorDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047669626640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets, Net - Schedule of Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsGross', window );">Cost</a></td>
<td class="nump">$ 11,959<span></span>
</td>
<td class="nump">$ 10,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts', window );">Accumulated Amortization</a></td>
<td class="num">(6,276)<span></span>
</td>
<td class="num">(3,576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net Book Value</a></td>
<td class="nump">5,683<span></span>
</td>
<td class="nump">7,018<span></span>
</td>
<td class="nump">$ 8,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsGross', window );">Cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net Book Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedContentCostsAndContentLicensesMember', window );">Capitalized Content Costs And Content Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net Book Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,404<span></span>
</td>
<td class="nump">6,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedContentCostsMember', window );">Capitalized Content Costs Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsGross', window );">Cost</a></td>
<td class="nump">6,589<span></span>
</td>
<td class="nump">6,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts', window );">Accumulated Amortization</a></td>
<td class="num">(3,721)<span></span>
</td>
<td class="num">(2,185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net Book Value</a></td>
<td class="nump">2,868<span></span>
</td>
<td class="nump">4,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedSoftwareMember', window );">Capitalized Software Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsGross', window );">Cost</a></td>
<td class="nump">5,370<span></span>
</td>
<td class="nump">3,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts', window );">Accumulated Amortization</a></td>
<td class="num">(2,555)<span></span>
</td>
<td class="num">(1,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net Book Value</a></td>
<td class="nump">$ 2,815<span></span>
</td>
<td class="nump">$ 2,605<span></span>
</td>
<td class="nump">$ 2,258<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedAmortizationOfOtherDeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amortization of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs, deferred acquisition costs of insurance companies, or deferred leasing costs for real estate operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedAmortizationOfOtherDeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedContentCostsAndContentLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedContentCostsAndContentLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedContentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedContentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=trnr_CapitalizedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047673448240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets, Net - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization expense</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671783312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued bonus</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Accrued payroll</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PaidTimeOffAccrual', window );">Accrued PTO</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AccruedOfferingCosts', window );">Accrued offering costs</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AccruedLicenses', window );">Accrued licenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued royalties</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedAdvertisingCurrent', window );">Accrued advertising</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AccruedEngineeringCurrent', window );">Accrued engineering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses and current liabilities</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,784<span></span>
</td>
<td class="nump">2,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 1,951<span></span>
</td>
<td class="nump">5,304<span></span>
</td>
<td class="nump">$ 2,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses and current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AccruedEngineeringCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued engineering current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AccruedEngineeringCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AccruedLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued licenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AccruedLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PaidTimeOffAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Paid time off accrual.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PaidTimeOffAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedAdvertisingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedAdvertisingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047670305104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 02, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Preferred Stock - Series A, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29,997,000<span></span>
</td>
<td class="nump">$ 29,996,000<span></span>
</td>
<td class="nump">$ 30,475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_LossDueToChangesInFairValueOfConvertibleNotes', window );">Convertible Notes losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">20,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Senior secured notes issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,030,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,595,000<span></span>
</td>
<td class="nump">523,000<span></span>
</td>
<td class="nump">523,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes', window );">Gain Recognized on Fair Value Changes of Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Secured Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Senior secured notes issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of senior secured notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Common Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=trnr_NotePurchaseAgreementMember', window );">June 2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Senior secured notes issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=trnr_NotePurchaseAgreementMember', window );">June 2023 Notes [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_InterestExpenseAndDefaultInterest', window );">Interest expense including default interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=trnr_TenPercentageSeniorSecuredNotesDueMember', window );">10% senior secured notes due [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 25,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyTwoConvertibleNotesMember', window );">2022 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Scheduled maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Preferred Stock - Series A, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion price as a percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_LossDueToChangesInFairValueOfConvertibleNotes', window );">Convertible Notes losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyTwoConvertibleNotesMember', window );">2022 Convertible Notes [Member] | Series A-2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible notes converted into preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_November2022ConvertibleNotesMember', window );">November 2022 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Scheduled maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Preferred Stock - Series A, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_November2022ConvertibleNotesMember', window );">November 2022 Convertible Notes [Member] | Series A-2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyConvertibleNotesMember', window );">2020 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Preferred Stock - Series A, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion price as a percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyConvertibleNotesMember', window );">2020 Convertible Notes [Member] | Two Individual [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Preferred Stock - Series A, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion price as a percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Debt Instrument, Convertible, Beneficial Conversion Feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyConvertibleNotesMember', window );">2020 Convertible Notes [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Scheduled maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyConvertibleNotesMember', window );">2020 Convertible Notes [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Scheduled maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyConvertibleNotesMember', window );">2020 Convertible Notes [Member] | Series A-1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible notes converted into preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyConvertibleNotesMember', window );">2020 Convertible Notes [Member] | Series Seed 9 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible notes converted into preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyOneConvertibleNotesMember', window );">2021 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Scheduled maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Preferred Stock - Series A, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion price as a percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyOneConvertibleNotesMember', window );">2021 Convertible Notes [Member] | Series A-1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible notes converted into preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyOneConvertibleNotesMember', window );">2021 Convertible Notes [Member] | Series Seed 9 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible notes converted into preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyOneConvertibleNotesMember', window );">2021 Convertible Notes [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible notes converted into preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_PaycheckProtectionProgramLoanMember', window );">Paycheck Protection Program Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt Instrument Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PercentageOfInterestRateOfDebtForgiveness', window );">Percentage Of Interest Rate Of Debt Forgiveness</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from Issuance of Long-Term Debt</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt Instrument Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain recognized on fair value changes of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_InterestExpenseAndDefaultInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense including default interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_InterestExpenseAndDefaultInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_LossDueToChangesInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss due to changes in fair value of convertible notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_LossDueToChangesInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PercentageOfInterestRateOfDebtForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of interest rate of debt forgiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PercentageOfInterestRateOfDebtForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -SubTopic 470<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=trnr_NotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=trnr_NotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=trnr_TenPercentageSeniorSecuredNotesDueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=trnr_TenPercentageSeniorSecuredNotesDueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyTwoConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyTwoConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesA2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesA2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_November2022ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_November2022ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=trnr_TwoIndividualMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=trnr_TwoIndividualMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeed9PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeed9PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyOneConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_TwoThousandTwentyOneConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047661920064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 13, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from Issuance of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance or Sale of Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueOfWarrants', window );">Fair value of warrants</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt discount on senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2,266,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (478,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember', window );">Service Providers Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from Issuance of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance or Sale of Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember', window );">Service Providers Stock Warrants [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember', window );">Senior Secured Notes Stock Warrants [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member] | November 2022 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock, warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member] | Class A Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member] | Class A Common Stock Warrants [Member] | November 2022 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock, warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,296<span></span>
</td>
<td class="nump">125,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member] | Class B Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member] | Class B Common Stock Warrants [Member] | November 2022 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock, warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrants not settleable in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ClassACommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ClassACommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ClassBCommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ClassBCommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047672643456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Changes in Warrants Issued and Outstanding (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ClassACommonStockWarrantsMember', window );">Class A Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantOutstanding', window );">Outstanding warrant, Beginning balance</a></td>
<td class="nump">92,296<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ClassOfWarrantsIssued', window );">Warrants issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">92,296<span></span>
</td>
<td class="nump">125,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ClassOfWarrantsExercised', window );">Warrants exercised</a></td>
<td class="num">(92,296)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(125,982)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantOutstanding', window );">Outstanding warrant, Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">92,296<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ClassBCommonStockWarrantsMember', window );">Class B Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantOutstanding', window );">Outstanding warrant, Beginning balance</a></td>
<td class="nump">5,753<span></span>
</td>
<td class="nump">5,753<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ClassOfWarrantsIssued', window );">Warrants issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ClassOfWarrantsExercised', window );">Warrants exercised</a></td>
<td class="num">(5,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(879)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantOutstanding', window );">Outstanding warrant, Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,753<span></span>
</td>
<td class="nump">5,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember', window );">Service Providers Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantOutstanding', window );">Outstanding warrant, Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ClassOfWarrantsIssued', window );">Warrants issued</a></td>
<td class="nump">78,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ClassOfWarrantsExercised', window );">Warrants exercised</a></td>
<td class="num">(78,120)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantOutstanding', window );">Outstanding warrant, Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember', window );">Senior Secured Notes Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantOutstanding', window );">Outstanding warrant, Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ClassOfWarrantsIssued', window );">Warrants issued</a></td>
<td class="nump">163,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ClassOfWarrantsExercised', window );">Warrants exercised</a></td>
<td class="num">(163,121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantOutstanding', window );">Outstanding warrant, Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ClassOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ClassOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ClassOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ClassOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_WarrantOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_WarrantOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ClassACommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ClassACommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ClassBCommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ClassBCommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeniorSecuredNotesStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047670175984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 13, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Fair value liabilities, measurements transfers between levels</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_EquityValuePercentage', window );">Equity value, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantsMeasurementDiscountRate', window );">Warrants measurement discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember', window );">November 2022 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">$ 20,000.00<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Common Stock, Shares</a></td>
<td class="nump">565,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible notes converted into preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">50,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember', window );">November 2022 Convertible Notes [Member] | Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DebtInstrumentMeasurementDiscountRate', window );">Debt instrument measurement discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember', window );">November 2022 Convertible Notes [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock, warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=trnr_SimpleAgreementsForFutureEquityMember', window );">Simple Agreements for Future Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity', window );">Fair value adjustments of simple agreements for future equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible notes converted into preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DebtInstrumentMeasurementDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument measurement discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DebtInstrumentMeasurementDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_EquityValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity value percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_EquityValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustments of simple agreements for future equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_WarrantsMeasurementDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants measurement discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_WarrantsMeasurementDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=trnr_SimpleAgreementsForFutureEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=trnr_SimpleAgreementsForFutureEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671442304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring [Member]<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">$ 7,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">7,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">4,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Convertible Notes [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Convertible Notes [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Convertible Notes [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">4,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">3,004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Warrants [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Warrants [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Warrants [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value disclosure</a></td>
<td class="nump">$ 3,004<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047669613088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AgreementAxis=trnr_SimpleAgreementsForFutureEquityMember', window );">SAFE Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments', window );">Change in estimated fair value of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock', window );">Conversion of ASAs into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,667)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock', window );">Conversion of SAFEs into series seed preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">4,270<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,902<span></span>
</td>
<td class="nump">10,303<span></span>
</td>
<td class="nump">14,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments', window );">Change in estimated fair value of financial instruments</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="num">(5,193)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock', window );">Conversion of convertible notes into Series A preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,926)<span></span>
</td>
<td class="num">(10,026)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock', window );">Conversion of convertible notes into common stock</a></td>
<td class="num">(4,521)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock', window );">Conversion of SAFEs into series seed preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,947)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock', window );">Conversion of convertible notes into Series A preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,926)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,270<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning balance</a></td>
<td class="nump">3,004<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments', window );">Change in estimated fair value of financial instruments</a></td>
<td class="num">(2,266)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(478)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants', window );">Exercise of stock warrants</a></td>
<td class="num">(738)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,004<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, changes in estimated fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, conversion of convertible notes in to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of asas into common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of convertible notes into common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of convertible notes into series a preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of safes into series seed preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement with unobservable inputs reconciliations recurring basis liability exercise of stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AgreementAxis=trnr_SimpleAgreementsForFutureEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AgreementAxis=trnr_SimpleAgreementsForFutureEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678391712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">$ 296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">lessee, Operating Lease, option to extend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">weighted average discount rate for operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">weighted average remaining lease term for operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short term lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 411<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, operating lease, term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, operating lease, term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674809456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Rental Payments under Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (remaining)</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024/2023</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025/2024</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026/2025</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027/2026</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease liability to be paid after year four.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671572688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Schedule of Other Commitments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAbstract', window );"><strong>Other Commitments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInSecondYear', window );">2024</a></td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInThirdYear', window );">2025</a></td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFourthYear', window );">2026</a></td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFifthYear', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Total</a></td>
<td class="nump">$ 7,425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678370896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Maximum total royalty payments</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Guaranteed minimum payment of royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PercentageOfCumulativeNetSales', window );">Percentage of cumulative net sales</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CumulativeNetSales', window );">Cumulative net sales</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PercentageOfCumulativeNetSales', window );">Percentage of cumulative net sales</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CumulativeNetSales', window );">Cumulative net sales</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CumulativeNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Net Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CumulativeNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PercentageOfCumulativeNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of cumulative net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PercentageOfCumulativeNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the entity has committed to make for future royalty guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483119/928-440-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyGuaranteesCommitmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047653412320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 23, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 25, 2021 </div>
<div>USD ($) </div>
<div>shares </div>
<div>yr</div>
</th>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>USD ($) </div>
<div>shares </div>
<div>yr </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 13, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 24, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 13, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 14, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369,950,000<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,004,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,266,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (478,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConversionBasis', window );">Preferred stock, conversion basis</a></td>
<td class="text">one-to-one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one-to-one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock issued during period, value, conversion of convertible securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,521,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of dividends | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockVotingRights', window );">Preferred stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one vote<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary equity, carrying amount, attributable to parent | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_SeriesAConvertibleNotesMember', window );">Series A Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock issued during period, value, conversion of convertible securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=trnr_SeriesSeedAndSeriesAAgreementMember', window );">Series Seed and Series A Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=trnr_SimpleAgreementsForFutureEquityMember', window );">Simple Agreements for Future Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock issued during period, value, conversion of convertible securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,072,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | Rights Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,749,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,749,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,072,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,676,924<span></span>
</td>
<td class="nump">8,676,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedMember', window );">Series Seed [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period, shares, conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedOneMember', window );">Series&#160;Seed-1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoMember', window );">Series&#160;Seed-2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedThreeMember', window );">Series&#160;Seed-3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.5<span></span>
</td>
<td class="nump">100.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFourMember', window );">Series&#160;Seed-4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFiveMember', window );">Series&#160;Seed-5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">512,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283.5<span></span>
</td>
<td class="nump">283.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSixMember', window );">Series&#160;Seed-6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSevenMember', window );">Series&#160;Seed-7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355.5<span></span>
</td>
<td class="nump">355.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedEightMember', window );">Series&#160;Seed-8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineMember', window );">Series&#160;Seed-9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,775,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period, shares, conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_Seed10Member', window );">Seed 10 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember', window );">Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,165,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,756<span></span>
</td>
<td class="nump">25,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 490.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 490.5<span></span>
</td>
<td class="nump">$ 490.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember', window );">Series A [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,165,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember', window );">Series A [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,592,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember', window );">Series A [Member] | 2020 Secured Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period, shares, conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock issued during period, value, conversion of convertible securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesAOneMember', window );">Series&#160;A-1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,531,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesAOneMember', window );">Series&#160;A-1 [Member] | 2020 Secured Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period, shares, conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock issued during period, value, conversion of convertible securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoTenMember', window );">Series&#160;Seed-2-10 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period, shares, conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PercentageOfDiscountRateOnConvertibleNotes', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">369,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369,950,000<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,676,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period, shares, conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">267,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,339,821<span></span>
</td>
<td class="nump">14,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1', window );">Warrant issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Risk free [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input | yr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Series A Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1', window );">Warrant issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,629<span></span>
</td>
<td class="nump">76,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Series A Financing [Member] | Risk free [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.35<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Series A Financing [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Series A Financing [Member] | Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Series A Financing [Member] | Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Series A Financing [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input | yr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | November 2022 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock, warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PercentageOfDiscountRateOnConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of discount rate on convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PercentageOfDiscountRateOnConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480191/946-405-45-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConversionBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConversionBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_SeriesAConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_SeriesAConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=trnr_SeriesSeedAndSeriesAAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=trnr_SeriesSeedAndSeriesAAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=trnr_SimpleAgreementsForFutureEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=trnr_SimpleAgreementsForFutureEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=trnr_RightsOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=trnr_RightsOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_Seed10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_Seed10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_TwoThousandAndTwentySecuredConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_TwoThousandAndTwentySecuredConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesAOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesAOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesAFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesAFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047676071808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Deficit - Disclosure of Temporary Equity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 14, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">194,135,415<span></span>
</td>
<td class="nump">26,159,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">139,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 72,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesAStockMember', window );">Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">13,006,028<span></span>
</td>
<td class="nump">18,165,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 490.5<span></span>
</td>
<td class="nump">$ 490.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesAOneMember', window );">Series&#160;A-1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">1,531,734<span></span>
</td>
<td class="nump">1,531,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesATwoMember', window );">Series&#160;A-2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">173,135,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 47.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedMember', window );">Series Seed [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">1,133,701<span></span>
</td>
<td class="nump">1,133,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedOneMember', window );">Series&#160;Seed-1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">359,375<span></span>
</td>
<td class="nump">359,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoMember', window );">Series&#160;Seed-2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedThreeMember', window );">Series&#160;Seed-3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">37,313<span></span>
</td>
<td class="nump">37,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 100.5<span></span>
</td>
<td class="nump">$ 100.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFourMember', window );">Series&#160;Seed-4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">21,131<span></span>
</td>
<td class="nump">21,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFiveMember', window );">Series&#160;Seed-5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">512,425<span></span>
</td>
<td class="nump">512,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 283.5<span></span>
</td>
<td class="nump">$ 283.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSixMember', window );">Series&#160;Seed-6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">122,500<span></span>
</td>
<td class="nump">122,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSevenMember', window );">Series&#160;Seed-7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">257,797<span></span>
</td>
<td class="nump">257,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 355.5<span></span>
</td>
<td class="nump">$ 355.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedEightMember', window );">Series&#160;Seed-8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">665,588<span></span>
</td>
<td class="nump">665,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 417<span></span>
</td>
<td class="nump">$ 417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineMember', window );">Series&#160;Seed-9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">2,754,796<span></span>
</td>
<td class="nump">2,754,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineOneMember', window );">Series&#160;Seed-9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">20,414<span></span>
</td>
<td class="nump">20,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTenMember', window );">Series&#160;Seed-10 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares&#160;Authorized</a></td>
<td class="nump">327,218<span></span>
</td>
<td class="nump">327,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares&#160;Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Price&#160;per&#160;Share</a></td>
<td class="nump">$ 490.5<span></span>
</td>
<td class="nump">$ 490.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Net&#160;Carrying&#160;Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesAStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesAStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesAOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesAOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesATwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesATwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedNineOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_SeriesSeedTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047669711472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized amount of stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vested shares</a></td>
<td class="nump">42,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.67<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="nump">$ 27.17<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue', window );">Awards granted, straight-line using third-party valuation (in dollars per share)</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Fair value of common stock for awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantsIssuedDuringThePeriodShares', window );">Warrants issued during the period shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share or per unit of warrants or rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WarrantGrantDateFairValue', window );">Warrant Grant Date Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_FairValueOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized amount of stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized amount of stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Recognized stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,500<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">$ 6,348<span></span>
</td>
<td class="nump">$ 1,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance under share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock expressed as a percentage of its fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member] | Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439,786<span></span>
</td>
<td class="nump">45,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember', window );">2023 and 2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,294,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,428,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vested shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber', window );">Number of repriced option awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">301,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Recognized stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,773<span></span>
</td>
<td class="nump">$ 23,773<span></span>
</td>
<td class="nump">$ 3,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AdditionalExpense', window );">Additional Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember', window );">2023 and 2020 Equity Incentive Plan [Member] | Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,428,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AdditionalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AdditionalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_FairValueOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_FairValueOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options repriced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing by straight-line calculation using the contemporaneous third-party valuations methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_WarrantGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_WarrantGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_WarrantsIssuedDuringThePeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants issued during the period shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_WarrantsIssuedDuringThePeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047676024032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Compensation Cost Recognized (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember', window );">2023 and 2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="nump">$ 4,836<span></span>
</td>
<td class="nump">$ 3,773<span></span>
</td>
<td class="nump">$ 23,773<span></span>
</td>
<td class="nump">$ 3,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember', window );">2023 and 2020 Equity Incentive Plan [Member] | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">4,803<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember', window );">2023 and 2020 Equity Incentive Plan [Member] | Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember', window );">2023 and 2020 Equity Incentive Plan [Member] | General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="nump">$ 3,402<span></span>
</td>
<td class="nump">$ 3,356<span></span>
</td>
<td class="nump">18,563<span></span>
</td>
<td class="nump">3,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,500<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 6,348<span></span>
</td>
<td class="nump">$ 1,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member] | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member] | Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member] | General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation cost recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,297<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047670198752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Stock option activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember', window );">2023 and 2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, Outstanding as of December 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, Granted</a></td>
<td class="nump">1,294,998<span></span>
</td>
<td class="nump">3,428,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(677,350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, Cancelled or forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,603)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, Outstanding as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,108,111<span></span>
</td>
<td class="nump">446,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of options, unvested as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,325,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding as of December 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled or forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract', window );"><strong>ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTerm [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 6 months<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm', window );">Options unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract', window );"><strong>ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, aggregate intrinsic value, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,341<span></span>
</td>
<td class="nump">$ 11,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Unvested, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, Outstanding as of December 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,784)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, Cancelled or forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, Outstanding as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of options, unvested as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding as of December 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled or forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable as of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance of September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract', window );"><strong>ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTerm [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm', window );">Options unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract', window );"><strong>ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, aggregate intrinsic value, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,706<span></span>
</td>
<td class="nump">$ 1,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Unvested, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non vested weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options weighted average remaining contractual term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=trnr_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047666802736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Unvested Common Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, Issued</a></td>
<td class="nump">$ 12.67<span></span>
</td>
<td class="nump">$ 0.18<span></span>
</td>
<td class="nump">$ 27.17<span></span>
</td>
<td class="nump">$ 0.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyPlanEarlyExerciseMember', window );">2020 Plan Early Exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Beginning as of December 31, 2022</a></td>
<td class="nump">3,823<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issued</a></td>
<td class="nump">30,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested</a></td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(794)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased', window );">Repurchased</a></td>
<td class="num">(2,655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Ending balance of September 30, 2023</a></td>
<td class="nump">32,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,823<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning as of December 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, Issued</a></td>
<td class="nump">1.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, Vested</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, Repurchased</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability', window );">Beginning Balance, Repurchase liability</a></td>
<td class="nump">$ 306<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability', window );">Repurchase liability, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability', window );">Repurchase liability, Vested</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability', window );">Repurchase liability, Repurchased</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability', window );">Ending Balance, Repurchase liability</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options grants in period repurchase liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non vested number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options repurchase liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options repurchased repurchase liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options repurchased weighted average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options vested repurchase liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=trnr_TwoThousandTwentyPlanEarlyExerciseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=trnr_TwoThousandTwentyPlanEarlyExerciseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678315504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Stock Option Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected term (in years)</a></td>
<td class="text">5 years 11 months 4 days<span></span>
</td>
<td class="text">5 years 4 months 2 days<span></span>
</td>
<td class="text">5 years 4 months 6 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted-average expected volatility</a></td>
<td class="nump">62.27%<span></span>
</td>
<td class="nump">54.60%<span></span>
</td>
<td class="nump">54.60%<span></span>
</td>
<td class="nump">43.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047666722592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk and Major Customers and Vendors - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>Customer </div>
<div>Vendor</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Vendor </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Vendor </div>
<div>Customer</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue [Member] | Customer Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NumberOfCustomer', window );">Number of customer | Customer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue [Member] | Customer Concentration Risk [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total revenue</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember', window );">Finished Goods Purchased [Member] | Supplier Concentration Risk [Member] | Vendor Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NumberOfSignificantVendors', window );">Number of vendors</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember', window );">Finished Goods Purchased [Member] | Supplier Concentration Risk [Member] | Vendor Three [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total revenue</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember', window );">Finished Goods Purchased [Member] | Supplier Concentration Risk [Member] | Vendor One [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NumberOfSignificantVendors', window );">Number of vendors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NumberOfCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NumberOfCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NumberOfSignificantVendors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of significant vendors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NumberOfSignificantVendors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=trnr_VendorThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=trnr_VendorThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=trnr_VendorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=trnr_VendorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671827456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Benefit plans cost</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678801616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56,817)<span></span>
</td>
<td class="num">$ (31,746)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,408)<span></span>
</td>
<td class="num">(1,090)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">$ (10,408)<span></span>
</td>
<td class="num">$ (14,754)<span></span>
</td>
<td class="num">$ (39,971)<span></span>
</td>
<td class="num">$ (39,415)<span></span>
</td>
<td class="num">$ (58,225)<span></span>
</td>
<td class="num">$ (32,836)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047671840112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current expense:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred expense:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047661817744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,228)<span></span>
</td>
<td class="num">$ (6,879)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Nondeductible expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes', window );">Nontaxable changes in fair value of convertible notes and SAFEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,670)<span></span>
</td>
<td class="num">(674)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,865)<span></span>
</td>
<td class="nump">1,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,567<span></span>
</td>
<td class="nump">10,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncometaxreconciliationDisqualifiedDebt', window );">Disqualified debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Return to provision adjustements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,060)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncometaxreconciliationIntangibles', window );">Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.13%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent', window );">Nontaxable changes in fair value of convertible notes and SAFEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.21%<span></span>
</td>
<td class="nump">3.22%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.59%<span></span>
</td>
<td class="nump">2.06%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.05%)<span></span>
</td>
<td class="num">(0.03%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.33%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26.73%)<span></span>
</td>
<td class="num">(30.81%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent', window );">Disqualified debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.26%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Return to provision adjustements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.82%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent', window );">Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.06%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.01%)<span></span>
</td>
<td class="nump">0.04%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation, disqualified debt, percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation, intangibles, percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation, nontaxable changes in fair value of convertible notes and safes, percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IncometaxreconciliationDisqualifiedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IncomeTaxReconciliation disqualified debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IncometaxreconciliationDisqualifiedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IncometaxreconciliationIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IncomeTaxReconciliation intangibles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IncometaxreconciliationIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IncomeTaxReconciliation nontaxable changes in fair value of convertible notes and safes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480887/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480887/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047678840160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Disclosure of the components of deferred tax assets (liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Net operating loss carryforwards - Federal</a></td>
<td class="nump">$ 16,776<span></span>
</td>
<td class="nump">$ 9,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment', window );">Capitalized research and development</a></td>
<td class="nump">3,768<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credits</a></td>
<td class="nump">3,593<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Net operating loss carryforwards - State</a></td>
<td class="nump">3,752<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Net operating loss carryforwards - Foreign</a></td>
<td class="nump">1,894<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles', window );">Fixed assets and intangibles</a></td>
<td class="num">(868)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets, gross:</a></td>
<td class="nump">30,134<span></span>
</td>
<td class="nump">14,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(30,134)<span></span>
</td>
<td class="num">(14,789)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets, net:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, capitalized research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DeferredTaxAssetsFixedAssetsAndIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, fixed assets and intangibles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DeferredTaxAssetsFixedAssetsAndIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047657926800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent', window );">Minimum Tax on Book Income, Inflation Reduction Act, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax', window );">Minimum Adjusted Financial Statement Income Subject to Inflation Reduction Act Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating Loss Carryforwards, Expiration Date</a></td>
<td class="text">Dec. 31,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_OperatingLossCarryForwardsPercentage', window );">Operating Loss Carry forwards Percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating Loss Carryforwards, Limitations on Use</a></td>
<td class="text">Section&#160;382 of the Internal Revenue Code and similar provisions under state law limit the utilization of federal NOL carryforwards, state NOL carryforwards, and Research and Development (R&D) credits following certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50%. Based on the Company&#8217;s analysis under Section&#160;382, the Company believes that its federal NOL carryforwards, its state NOL carryforwards, and R&D credits are limited by Section&#160;382 and similar provisions under state law as of December&#160;31, 2022. The portion of federal NOL carryforwards, state NOL carryforwards, and R&D credits that were determined to be limited have been written off as of December&#160;31, 2022. The remaining unused carryforwards and credits remain available for future periods. Due the Company&#8217;s full valuation allowance the write off of NOL carryforwards and R&D did not have any impact to the statements of operation and comprehensive loss.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 79.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Dec. 31,  2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AmortisationOfResearchAndDevelopmentalCost', window );">Amortisation Of Research And Developmental Cost</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_CapitalizedResearchAndDevelopmentExpenses', window );">Capitalized Research And Development Expenses</a></td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AmortisationOfResearchAndDevelopmentalCost', window );">Amortisation Of Research And Developmental Cost</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 75.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax Credit Carryforward, Amount</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax Credit Carryforward, Expiration Date</a></td>
<td class="text">Dec. 31,  2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AmortisationOfResearchAndDevelopmentalCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortisation of research and developmental cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AmortisationOfResearchAndDevelopmentalCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_CapitalizedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_CapitalizedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum adjusted financial statement income subject to inflation reduction act tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_MinimumTaxOnBookIncomeInflationReductionActPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum tax on book income, inflation reduction act, percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_MinimumTaxOnBookIncomeInflationReductionActPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_OperatingLossCarryForwardsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carry forwards percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_OperatingLossCarryForwardsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the tax credit carryforward, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047674014304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share - Schedule of Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_NetLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,971)<span></span>
</td>
<td class="num">$ (39,415)<span></span>
</td>
<td class="num">$ (58,225)<span></span>
</td>
<td class="num">$ (32,840)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (10,408)<span></span>
</td>
<td class="num">$ (14,754)<span></span>
</td>
<td class="num">$ (39,971)<span></span>
</td>
<td class="num">$ (39,415)<span></span>
</td>
<td class="num">$ (58,225)<span></span>
</td>
<td class="num">$ (32,840)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common stock outstanding - basic</a></td>
<td class="nump">14,186,222<span></span>
</td>
<td class="nump">489,132<span></span>
</td>
<td class="nump">11,750,907<span></span>
</td>
<td class="nump">423,362<span></span>
</td>
<td class="nump">487,276<span></span>
</td>
<td class="nump">98,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common stock outstanding - diluted</a></td>
<td class="nump">14,186,222<span></span>
</td>
<td class="nump">489,132<span></span>
</td>
<td class="nump">11,750,907<span></span>
</td>
<td class="nump">423,362<span></span>
</td>
<td class="nump">487,276<span></span>
</td>
<td class="nump">98,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders - basic</a></td>
<td class="num">$ (0.73)<span></span>
</td>
<td class="num">$ (30.16)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="num">$ (93.1)<span></span>
</td>
<td class="num">$ (119.49)<span></span>
</td>
<td class="num">$ (332.31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders - diluted</a></td>
<td class="num">$ (0.73)<span></span>
</td>
<td class="num">$ (30.16)<span></span>
</td>
<td class="num">$ (3.4)<span></span>
</td>
<td class="num">$ (93.1)<span></span>
</td>
<td class="num">$ (119.49)<span></span>
</td>
<td class="num">$ (332.31)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Denominator abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Numerator abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047657877920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share - Schedule of Potentially Dilutive Shares (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">3,108,111<span></span>
</td>
<td class="nump">1,353,818<span></span>
</td>
<td class="nump">544,890<span></span>
</td>
<td class="nump">196,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">86,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesAOneConvertiblePreferredStockMember', window );">Series A-1 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesATwoConvertiblePreferredStockMember', window );">Series A-2 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">755,606<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedConvertiblePreferredStockMember', window );">Series Seed Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,546<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,546<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedOneConvertiblePreferredStockMember', window );">Series Seed 1 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedTwoConvertiblePreferredStockMember', window );">Series Seed 2 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,666<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedThreeConvertiblePreferredStockMember', window );">Series Seed 3 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedFourConvertiblePreferredStockMember', window );">Series Seed 4 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedFiveConvertiblePreferredStockMember', window );">Series Seed 5 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedSixConvertiblePreferredStockMember', window );">Series Seed 6 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">815<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedSevenConvertiblePreferredStockMember', window );">Series Seed 7 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedEightConvertiblePreferredStockMember', window );">Series Seed 8 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,410<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedNineConvertiblePreferredStockMember', window );">Series Seed 9 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,480<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedTenConvertiblePreferredStockMember', window );">Series Seed 10 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,171<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_WarrantsToPurchaseSeriesClassACommonStockMember', window );">Warrants to Purchase Series Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,296<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_WarrantsToPurchaseSeriesClassBCommonStockMember', window );">Warrants to Purchase Series Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,753<span></span>
</td>
<td class="nump">5,753<span></span>
</td>
<td class="nump">5,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_StockOptionsToPurchaseCommonStockMember', window );">Stock Options to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">3,108,111<span></span>
</td>
<td class="nump">452,549<span></span>
</td>
<td class="nump">446,841<span></span>
</td>
<td class="nump">51,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesAOneConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesAOneConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesATwoConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesATwoConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedOneConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedOneConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedTwoConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedTwoConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedThreeConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedThreeConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedFourConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedFourConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedFiveConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedFiveConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedSixConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedSixConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedSevenConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedSevenConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedEightConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedEightConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedNineConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedNineConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedTenConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_SeriesSeedTenConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_WarrantsToPurchaseSeriesClassACommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_WarrantsToPurchaseSeriesClassACommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_WarrantsToPurchaseSeriesClassBCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_WarrantsToPurchaseSeriesClassBCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_StockOptionsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=trnr_StockOptionsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047651739072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 27, 2022</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Feb. 12, 2021</div></th>
<th class="th"><div>Jan. 12, 2021</div></th>
<th class="th"><div>Nov. 02, 2020</div></th>
<th class="th"><div>Jun. 15, 2020</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Mar. 20, 2020</div></th>
<th class="th"><div>Feb. 18, 2020</div></th>
<th class="th"><div>Nov. 28, 2019</div></th>
<th class="th"><div>Oct. 21, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Aug. 28, 2019</div></th>
<th class="th"><div>May 17, 2019</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from issuance of related party loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465,000<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DefaultInterest', window );">Default interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_PromissoryNotesMember', window );">Promissory Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000.00<span></span>
</td>
<td class="nump">$ 80,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_PrincipalStockholderPromissoryNotesMember', window );">Principal Stockholder Promissory Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from long-term lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 12,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 20,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 28,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 28,  2021<span></span>
</td>
<td class="text">May 17,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DebtInstrumentFeePercentage', window );">Fee Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DebtInstrumentInterestRateStatedPercentageAdditional', window );">Additional Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayable', window );">Loan Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AccruedInterestAndDefaultInterest', window );">Accrued interest and default interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_InterestExpenseAndDefaultInterest', window );">Interest expense including default interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from long-term lines of credit</a></td>
<td class="nump">$ 425,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity Date</a></td>
<td class="text">Jan. 27,  2023<span></span>
</td>
<td class="text">Jun. 22,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 12,  2022<span></span>
</td>
<td class="text">Jun.  02,  2022<span></span>
</td>
<td class="text">Jun. 15,  2021<span></span>
</td>
<td class="text">Jun.  09,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 18,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 21,  2021<span></span>
</td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from issuance of related party loans</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payment made to related party</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DebtInstrumentFeePercentage', window );">Fee Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DebtInstrumentInterestRateStatedPercentageAdditional', window );">Additional Percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayable', window );">Loan Payable</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AccruedInterestAndDefaultInterest', window );">Accrued interest and default interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_DefaultInterest', window );">Default interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_InterestExpenseAndDefaultInterest', window );">Interest expense including default interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Fuseproject</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Fuseproject | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Sale of stock, percentage of ownership after transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.26%<span></span>
</td>
<td class="nump">2.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Apeiron Advisory Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Apeiron Advisory Ltd | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Sale of stock, percentage of ownership after transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.60%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Noninterest bearing note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from issuance of related party loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payment made to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayable', window );">Loan Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Class B Common Warrants | Fuseproject</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Class A Common Warrants | Apeiron Advisory Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,143<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Class A Common Shares | Fuseproject</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Class A Common Shares | Apeiron Advisory Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447,318<span></span>
</td>
<td class="nump">11,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Class B Common Shares | Fuseproject</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Series A Preferred Shares | Apeiron Advisory Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_ContingentRoyaltyObligation', window );">Contingent Royalty Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_GuaranteedRoyaltyPayment', window );">Guaranteed Royalty payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Royalty Arrangement, One Percentage of Cumulative Net Sales above 5 Million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_RoyaltyPaymentPercentage', window );">Royalty Payment Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Licensing and royalty income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Royalty Arrangement, three Percentage of Cumulative Net Sales up to 5 Million [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_RoyaltyPaymentPercentage', window );">Royalty Payment Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Licensing and royalty income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Fuseproject</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Fuseproject | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Sale of stock, percentage of ownership after transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Apeiron Advisory Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Apeiron Advisory Ltd | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Sale of stock, percentage of ownership after transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Class A Common Warrants | Apeiron Advisory Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Class A Common Shares | Fuseproject</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember', window );">Other Related Party Transactions | Class A Common Shares | Apeiron Advisory Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,490,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AccruedInterestAndDefaultInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued interest and default interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AccruedInterestAndDefaultInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_ContingentRoyaltyObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent royalty obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_ContingentRoyaltyObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DebtInstrumentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DebtInstrumentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DebtInstrumentInterestRateStatedPercentageAdditional">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Interest Rate Stated Percentage, Additional Accrued Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DebtInstrumentInterestRateStatedPercentageAdditional</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_DefaultInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Default interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_DefaultInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_GuaranteedRoyaltyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guaranteed royalty payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_GuaranteedRoyaltyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_InterestExpenseAndDefaultInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense including default interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_InterestExpenseAndDefaultInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_RoyaltyPaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty payment percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_RoyaltyPaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_PrincipalStockholderPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_PrincipalStockholderPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_FuseprojectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_FuseprojectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_ApeironAdvisoryLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=trnr_ApeironAdvisoryLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=trnr_NoninterestBearingNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=trnr_NoninterestBearingNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=trnr_ClassBCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=trnr_ClassBCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=trnr_ClassACommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=trnr_ClassACommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047657955264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions - Schedule of Loan Payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable, Total</a></td>
<td class="nump">$ 6,266<span></span>
</td>
<td class="nump">$ 6,708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_FounderNotesMember', window );">Founder Notes | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_PrincipalStockholderPromissoryNotesMember', window );">Principal Stockholder Promissory Notes | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable, Total</a></td>
<td class="nump">5,404<span></span>
</td>
<td class="nump">5,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember', window );">Other Related Party Promissory Notes | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable, Total</a></td>
<td class="nump">$ 862<span></span>
</td>
<td class="nump">$ 1,126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_FounderNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_FounderNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_PrincipalStockholderPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_PrincipalStockholderPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=trnr_OtherRelatedPartyPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140047653556016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 10, 2023</div></th>
<th class="th"><div>Oct. 06, 2023</div></th>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Feb. 13, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of stock, amount issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance or sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from senior secured notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,030,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from senior secured notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_ContractTerminationMember', window );">Contract Termination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,072,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember', window );">Service Providers Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance or sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=trnr_RightsOfferingMember', window );">Rights Offering [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,749,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,072,515<span></span>
</td>
<td class="nump">8,676,924<span></span>
</td>
<td class="nump">8,676,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of stock, amount issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=trnr_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_AssetPurchaseAgreementTerms', window );">Asset purchase agreement terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The number of shares to be issued will be based on the volume weighted average price (&#8220;VWAP&#8221;) of the Company&#8217;s common stock based on the 10 consecutive trading days ending on (and including) the closing date of the Acquisition, on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;); provided, however, that such VWAP shall not exceed or be less than an amount equal to twenty-five percent (25%) of the VWAP for the common stock based on the 10 consecutive trading days ending on (and including) the date the Asset Purchase Agreement was executed (the &#8220;VWAP Collar&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from long-term lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  09,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Step-up interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_PercentageOfOriginalIssuanceDiscount', window );">Percentage of original issuance discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Class A Common Stock to Class B Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockConversionBasis', window );">Common stock, conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one to one basis<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Service Providers Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance or sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Rights Offering [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,749,439<span></span>
</td>
<td class="nump">8,677,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Asset Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected', window );">Purchase price under the Asset Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubordinatedDebt', window );">Subordinated debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_RetirementOfSeniorDebt', window );">Retirement of senior debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_MaximumNumberOfEarnOutShares', window );">Maximum number of earn-out shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,665,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from long-term lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,178,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,450,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of stock, amount issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of stock, amount issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Asset Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WeightedAverageThresholdConsecutiveTradingDays1', window );">Weighted Average Threshold Consecutive Trading Days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trnr_WeightedAverageThresholdConsecutiveTradingDays1', window );">Weighted Average Threshold Consecutive Trading Days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Subsequent Event [Member] | Asset Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected', window );">Purchase price under the Asset Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_AssetPurchaseAgreementTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset purchase agreement terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_AssetPurchaseAgreementTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_MaximumNumberOfEarnOutShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of earn-Out shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_MaximumNumberOfEarnOutShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_PercentageOfOriginalIssuanceDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of original issuance discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_PercentageOfOriginalIssuanceDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_RetirementOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Retirement of senior debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_RetirementOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trnr_WeightedAverageThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Threshold Consecutive Trading Days1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trnr_WeightedAverageThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trnr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of expected asset acquisition prior to consideration being transferred. Excludes business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionPriceOfAcquisitionExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockConversionBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of basis for conversion of convertible common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockConversionBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubordinatedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of subordinated debt (with initial maturities beyond one year or beyond the operating cycle if longer). Subordinated debt places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubordinatedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_ContractTerminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_ContractTerminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=trnr_ServiceProvidersStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=trnr_RightsOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=trnr_RightsOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=trnr_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=trnr_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ClassACommonStockToClassBCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=trnr_ClassACommonStockToClassBCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>d367939ds1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:trnr="http://formelife.com/20230930"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="trnr-20230930.xsd" xlink:type="simple"/>
    <context id="PAsOn12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="PAsOn12_23_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2022-12-23</instant>
        </period>
    </context>
    <context id="P01_01_2017To12_31_2017">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="P12_31_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To03_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P11_01_2022To11_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="PAsOn03_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn11_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="P09_30_2019To09_30_2019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="PAsOn01_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="PAsOn01_01_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="PAsOn08_16_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2022-08-16</instant>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="PAsOn07_23_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="P12_23_2022To12_23_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <startDate>2022-12-23</startDate>
            <endDate>2022-12-23</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">trnr:InternalUseSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:PreProductionToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MinimumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:PreProductionToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:CapitalizedContentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:CapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_PromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FounderNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:FounderNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CapitalizedContentCostsAndContentLicensesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:CapitalizedContentCostsAndContentLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:RightsOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ScenarioPreviouslyReportedMembersrtRestatementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:RightsOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trnr:AgreementAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ConvertibleDebtMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ForeignCountryMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesAStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesAOneMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesATwoMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesATwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedOneMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedFourMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedSixMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedEightMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedNineMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedNineOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedTenMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">trnr:ContentLicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CapitalizedStudioContentMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">trnr:CapitalizedStudioContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">trnr:InternalUseSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_MinimumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:PreProductionToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:PreProductionToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:CapitalizedContentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:CapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_OtherAssetsMemberusgaapBalanceSheetLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_PromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:RightsOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">trnr:NoninterestBearingNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMemberusgaapDeferredRevenueArrangementTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">trnr:RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMemberusgaapDeferredRevenueArrangementTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">trnr:RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">trnr:IdentifiableIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedNineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedTenConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:WarrantsToPurchaseSeriesClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:StockOptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedTwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedThreeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedFourConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedFiveConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedSixConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedSevenConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedEightConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To09_30_2022_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">trnr:IdentifiableIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2022To09_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeniorSecuredNotesStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">trnr:IdentifiableIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedNineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedTenConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:WarrantsToPurchaseSeriesClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:StockOptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedTwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedThreeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedFourConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedFiveConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedSixConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedSevenConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedEightConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trnr:VendorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_RestrictedStockMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_StockAppreciationRightsSARSMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trnr:VendorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMemberusgaapDeferredRevenueArrangementTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">trnr:RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMemberusgaapDeferredRevenueArrangementTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">trnr:RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">trnr:IdentifiableIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="P07_01_2023To09_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">trnr:InternalUseSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_PromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_OtherAssetsMemberusgaapBalanceSheetLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:CapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CapitalizedContentCostsAndContentLicensesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">trnr:CapitalizedContentCostsAndContentLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trnr:AgreementAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ConvertibleDebtMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedNineOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="P05_01_2023To05_31_2023_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="P05_01_2023To05_31_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="P05_01_2023To05_31_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="P05_01_2023To05_31_2023_BridgeNoteFinancingMemberusgaapCreditFacilityAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">trnr:BridgeNoteFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="P05_31_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-31</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="PAsOn05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedTwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedThreeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedFourConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedFiveConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedSixConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedSevenConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedEightConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedNineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedTenConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_WarrantsToPurchaseSeriesClassACommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:WarrantsToPurchaseSeriesClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:WarrantsToPurchaseSeriesClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:StockOptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trnr:VendorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trnr:VendorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">trnr:TwoIndividualMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:ClassACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ClassBCommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:ClassBCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:ClassACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:RightsOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ConversionOfPreferredStockToClassACommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">trnr:ConversionOfPreferredStockToClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ConversionOfPromissoryNotesToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">trnr:ConversionOfPromissoryNotesToConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ConversionOfAccountsPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">trnr:ConversionOfAccountsPayableToConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ConversionOfLoanPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">trnr:ConversionOfLoanPayableToConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">trnr:ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMemberusgaapConversionOfStockByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">trnr:ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ForeignCountryMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">trnr:ContentLicensingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">trnr:SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P11_01_2022To11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:November2022ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="P11_01_2022To11_30_2022_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="P11_01_2022To11_30_2022_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:November2022ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="PAsOn11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="PAsOn11_30_2022_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:November2022ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeniorSecuredNotesStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_LeadNoteholderMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:LeadNoteholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_OtherNoteholderMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:OtherNoteholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_SeniorNotesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2023To03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="PAsOn03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To03_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="P06_01_2023To06_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_01_2023To06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_01_2023To06_30_2023_TenPercentageSeniorSecuredNotesDueMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:TenPercentageSeniorSecuredNotesDueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="PAsOn06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-13</instant>
        </period>
    </context>
    <context id="PAsOn11_13_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-13</instant>
        </period>
    </context>
    <context id="PAsOn11_13_2022_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-13</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeed9PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeed9PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeed9PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeed9PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_Seed10MemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:Seed10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="PAsOn07_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P03_01_2023To03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="P01_01_2017To12_31_2017_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2017To12_31_2017_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn01_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:RightsOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:RightsOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:RightsOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="P01_01_2023To01_31_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-06</startDate>
            <endDate>2023-10-06</endDate>
        </period>
    </context>
    <context id="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_CommonStockMemberusgaapStatementEquityComponentsAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-06</startDate>
            <endDate>2023-10-06</endDate>
        </period>
    </context>
    <context id="P10_06_2023To10_06_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-06</startDate>
            <endDate>2023-10-06</endDate>
        </period>
    </context>
    <context id="P10_06_2023To10_06_2023_CommonStockMemberusgaapStatementEquityComponentsAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-06</startDate>
            <endDate>2023-10-06</endDate>
        </period>
    </context>
    <context id="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-06</startDate>
            <endDate>2023-10-06</endDate>
        </period>
    </context>
    <context id="PAsOn10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-06</instant>
        </period>
    </context>
    <context id="P12_31_2024To12_31_2024_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_ScenarioForecastMembersrtStatementScenarioAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">trnr:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-10</startDate>
            <endDate>2023-11-10</endDate>
        </period>
    </context>
    <context id="P11_10_2023To11_10_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-10</startDate>
            <endDate>2023-11-10</endDate>
        </period>
    </context>
    <context id="PAsOn11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-10</instant>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_IPOMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-17</startDate>
            <endDate>2019-05-17</endDate>
        </period>
    </context>
    <context id="PAsOn05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-17</instant>
        </period>
    </context>
    <context id="PAsOn08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-28</instant>
        </period>
    </context>
    <context id="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-28</startDate>
            <endDate>2019-08-28</endDate>
        </period>
    </context>
    <context id="PAsOn11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-28</instant>
        </period>
    </context>
    <context id="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-28</startDate>
            <endDate>2019-11-28</endDate>
        </period>
    </context>
    <context id="PAsOn03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-20</instant>
        </period>
    </context>
    <context id="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-20</startDate>
            <endDate>2020-03-20</endDate>
        </period>
    </context>
    <context id="PAsOn02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-12</instant>
        </period>
    </context>
    <context id="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PrincipalStockholderPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-12</startDate>
            <endDate>2021-02-12</endDate>
        </period>
    </context>
    <context id="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="PAsOn09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="PAsOn10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-21</instant>
        </period>
    </context>
    <context id="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-21</startDate>
            <endDate>2019-10-21</endDate>
        </period>
    </context>
    <context id="PAsOn02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-18</instant>
        </period>
    </context>
    <context id="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-18</startDate>
            <endDate>2020-02-18</endDate>
        </period>
    </context>
    <context id="PAsOn06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-09</instant>
        </period>
    </context>
    <context id="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-09</startDate>
            <endDate>2020-06-09</endDate>
        </period>
    </context>
    <context id="PAsOn06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-15</instant>
        </period>
    </context>
    <context id="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-15</startDate>
            <endDate>2020-06-15</endDate>
        </period>
    </context>
    <context id="PAsOn11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-02</instant>
        </period>
    </context>
    <context id="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-02</endDate>
        </period>
    </context>
    <context id="PAsOn01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-12</instant>
        </period>
    </context>
    <context id="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-12</startDate>
            <endDate>2021-01-12</endDate>
        </period>
    </context>
    <context id="PAsOn02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-22</instant>
        </period>
    </context>
    <context id="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-22</startDate>
            <endDate>2021-02-22</endDate>
        </period>
    </context>
    <context id="PAsOn10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-27</instant>
        </period>
    </context>
    <context id="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-27</startDate>
            <endDate>2022-10-27</endDate>
        </period>
    </context>
    <context id="P08_01_2023To08_31_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">trnr:NoninterestBearingNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="P02_27_2023To02_27_2023_ClassACommonStockToClassBCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">trnr:ClassACommonStockToClassBCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-27</startDate>
            <endDate>2023-02-27</endDate>
        </period>
    </context>
    <context id="P02_13_2022To02_13_2022_ContractTerminationMemberusgaapRestructuringCostAndReserveAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:ContractTerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-13</startDate>
            <endDate>2022-02-13</endDate>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trnr:AgreementAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="PAsOn07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesATwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_WarrantsToPurchaseSeriesClassACommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:WarrantsToPurchaseSeriesClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedTwoConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedThreeConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedFourConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedFiveConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedSixConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedSevenConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedEightConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedNineConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:SeriesSeedTenConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:WarrantsToPurchaseSeriesClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">trnr:StockOptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trnr:VendorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trnr:AgreementAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorOneMembersrtMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trnr:VendorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">trnr:NovemberTwoThousandTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:FuseprojectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">trnr:ClassACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:OtherRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">trnr:ApeironAdvisoryLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ConversionOfPreferredStockToClassACommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">trnr:ConversionOfPreferredStockToClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ConversionOfPromissoryNotesToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">trnr:ConversionOfPromissoryNotesToConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ConversionOfAccountsPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">trnr:ConversionOfAccountsPayableToConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ConversionOfLoanPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">trnr:ConversionOfLoanPayableToConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">trnr:ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMemberusgaapConversionOfStockByUniqueDescriptionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">trnr:ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ForwardContractIndexedToIssuersEquityTypeAxis">trnr:SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">trnr:TwoIndividualMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_MinimumMembersrtRangeAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_MaximumMembersrtRangeAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">trnr:TwoIndividualMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2020To12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandTwentyOneConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="P04_02_2021To04_02_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-02</startDate>
            <endDate>2021-04-02</endDate>
        </period>
    </context>
    <context id="P12_31_2020To12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandAndTwentySecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_SeriesSeedTwoTenMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedTwoTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:TwoThousandAndTwentySecuredConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_SeriesSeedAndSeriesAAgreementMemberusgaapTypeOfArrangementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">trnr:SeriesSeedAndSeriesAAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_SeriesAConvertibleNotesMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">trnr:SeriesAConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="P07_23_2021To07_23_2021_SimpleAgreementsForFutureEquityMemberusgaapTypeOfArrangementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="PAsOn08_25_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-25</instant>
        </period>
    </context>
    <context id="PAsOn08_25_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-25</instant>
        </period>
    </context>
    <context id="PAsOn08_25_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-25</instant>
        </period>
    </context>
    <context id="PAsOn08_25_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-25</instant>
        </period>
    </context>
    <context id="PAsOn08_25_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-25</instant>
        </period>
    </context>
    <context id="PAsOn08_25_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-25</instant>
        </period>
    </context>
    <context id="P08_25_2021To08_25_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-25</startDate>
            <endDate>2021-08-25</endDate>
        </period>
    </context>
    <context id="P08_14_2018To12_31_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-14</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn08_14_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-14</instant>
        </period>
    </context>
    <context id="PAsOn08_14_2018_SeriesSeedOneMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-14</instant>
        </period>
    </context>
    <context id="PAsOn08_14_2018_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-14</instant>
        </period>
    </context>
    <context id="PAsOn08_13_2021_SeriesAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-13</instant>
        </period>
    </context>
    <context id="PAsOn11_24_2021_MinimumMembersrtRangeAxis_SeriesAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-24</instant>
        </period>
    </context>
    <context id="PAsOn11_24_2021_MaximumMembersrtRangeAxis_SeriesAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-24</instant>
        </period>
    </context>
    <context id="PAsOn11_24_2021_SeriesAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-24</instant>
        </period>
    </context>
    <context id="PAsOn12_23_2022_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-23</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeniorSecuredNotesStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ServiceProvidersStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeniorSecuredNotesStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn09_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">trnr:TwoThousandTwentyPlanEarlyExerciseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesA2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:SeriesSeedZeroToTenPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trnr:AgreementAxis">trnr:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">trnr:ClassBCommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785056</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Year">
        <measure>utr:Year</measure>
    </unit>
    <unit id="Unit_Month">
        <measure>utr:Month</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Day">
        <measure>utr:Day</measure>
    </unit>
    <unit id="Unit_USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Customer">
        <measure>trnr:Customer</measure>
    </unit>
    <unit id="Unit_Vendor">
        <measure>trnr:Vendor</measure>
    </unit>
    <unit id="Unit_Y">
        <measure>utr:Y</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="P01_01_2023To09_30_2023">0001785056</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="P01_01_2023To09_30_2023">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="P01_01_2023To09_30_2023">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="P01_01_2023To09_30_2023">INTERACTIVE STRENGTH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="P01_01_2023To09_30_2023">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityPrimarySicNumber contextRef="P01_01_2023To09_30_2023">3600</dei:EntityPrimarySicNumber>
    <dei:EntityTaxIdentificationNumber contextRef="P01_01_2023To09_30_2023">82-1432916</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="P01_01_2023To09_30_2023">1005 Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="P01_01_2023To09_30_2023">Suite 925</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="P01_01_2023To09_30_2023">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P01_01_2023To09_30_2023">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P01_01_2023To09_30_2023">78701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_01_2023To09_30_2023">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_01_2023To09_30_2023">697-8655</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Trent A. Ward</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">1005 Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Suite 925</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">78701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_01_2023To09_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">697-8655</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="P01_01_2023To09_30_2023">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="P01_01_2023To09_30_2023">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="P01_01_2023To09_30_2023">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="P01_01_2023To09_30_2023">false</dei:EntityExTransitionPeriod>
    <us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration contextRef="PAsOn12_31_2022" id="hidden95757149">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet</us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration>
    <us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration contextRef="PAsOn09_30_2023" id="hidden95757150">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet</us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="PAsOn12_31_2022_MinimumMembersrtRangeAxis"
      id="hidden95757447">P2Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      id="hidden95758008"
      unitRef="Unit_USD">179000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="P01_01_2022To12_31_2022" id="hidden95757939">2029-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis"
      id="hidden95757488">2040-12-31</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate
      contextRef="P01_01_2022To12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis"
      id="hidden95757489">2035-12-31</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">226000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1697000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InventoryFinishedGoods
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4567000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2056000</us-gaap:InventoryFinishedGoods>
    <trnr:IncomeTaxesReceivables
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:IncomeTaxesReceivables>
    <trnr:IncomeTaxesReceivables
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-7000</trnr:IncomeTaxesReceivables>
    <us-gaap:DepositsAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3603000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3944000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1426000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1165000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">9822000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">8855000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1326000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2190000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">110000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3834000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2655000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredCosts
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2337000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredCosts>
    <us-gaap:OtherAssets
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7018000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">8366000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">24447000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">22066000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7743000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2114000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5304000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2420000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">106000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">29000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">15000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6708000</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">6927000</us-gaap:LoansPayableCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4270000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">24167000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">11476000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">9000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3004000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DerivativeLiabilities>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">520000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">27180000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">11996000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn12_31_2022"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn12_31_2021"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6462258</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6462258</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">42999</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">42999</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
      contextRef="PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
      contextRef="PAsOn12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">7594000</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">187673157</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">19696870</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn09_30_2023_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">96911</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">96911</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
      contextRef="PAsOn12_31_2022_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
      contextRef="PAsOn12_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">22139000</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">369950000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">86000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">2450922</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">2450922</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">213065</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">213065</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">112436000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">37806000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">365000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-159000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-115538000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-57313000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-2733000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-19663000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">24447000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">22066000</us-gaap:LiabilitiesAndStockholdersEquity>
    <trnr:FitnessProductRevenue1
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">530000</trnr:FitnessProductRevenue1>
    <trnr:FitnessProductRevenue1
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">319000</trnr:FitnessProductRevenue1>
    <trnr:MembershipRevenue1
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">74000</trnr:MembershipRevenue1>
    <trnr:MembershipRevenue1
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4000</trnr:MembershipRevenue1>
    <trnr:TrainingRevenue1
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">77000</trnr:TrainingRevenue1>
    <trnr:TrainingRevenue1
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:TrainingRevenue1>
    <trnr:CostOfFitnessProductRevenue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2402000</trnr:CostOfFitnessProductRevenue>
    <trnr:CostOfFitnessProductRevenue
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2652000</trnr:CostOfFitnessProductRevenue>
    <trnr:CostOfMembershipAndTraining
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7147000</trnr:CostOfMembershipAndTraining>
    <trnr:CostOfMembershipAndTraining
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2513000</trnr:CostOfMembershipAndTraining>
    <us-gaap:GrossProfit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-8868000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-4842000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">19960000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">16300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6219000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">6566000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">19298000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">9438000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">45477000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">32304000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-54345000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-37146000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-4036000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">303000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-952000</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-935000</us-gaap:InterestRevenueExpenseNet>
    <trnr:GainUponDebtForgiveness
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-523000</trnr:GainUponDebtForgiveness>
    <trnr:GainUponDebtForgiveness
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:GainUponDebtForgiveness>
    <trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity>
    <trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">251000</trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">107000</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">5193000</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-478000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-3880000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4310000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-58225000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32836000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-58225000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32840000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-119.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-119.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">-332.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">-332.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">487276</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">487276</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_shares">98823</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_shares">98823</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-58225000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32840000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">524000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">179000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-57701000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32661000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2020_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">9939</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2020_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2986000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">40474</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">14973</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">8041000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-24473000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_USD">-16411000</us-gaap:StockholdersEquity>
    <trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">106000</trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions>
    <trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">106000</trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">14906</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">4100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsShares
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">125982</trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsShares>
    <trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">2000</trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue>
    <trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">6992000</trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue>
    <trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">6994000</trnr:IssuanceOfClassACommonStockUponExerciseOfWarrantsValue>
    <trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares
      contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">879</trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares>
    <trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">237000</trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue>
    <trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">237000</trnr:IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue>
    <trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares
      contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">13852</trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares>
    <trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">5667000</trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue>
    <trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">5667000</trnr:IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">1999</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">35000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">35000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <trnr:IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">19519</trnr:IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2655000</trnr:IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues>
    <trnr:IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1666</trnr:IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">248</trnr:IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">140</trnr:IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">3414</trnr:IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">815</trnr:IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1716</trnr:IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">4410</trnr:IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">4939</trnr:IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">2171</trnr:IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">13405</trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">1933000</trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">136</trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock>
    <trnr:TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock
      contextRef="P01_01_2021To12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">20000</trnr:TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock>
    <trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">94000</trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock>
    <trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">94000</trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock
      contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">62127</trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock>
    <trnr:TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock
      contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">12113000</trnr:TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock>
    <trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">11370000</trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock>
    <trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">11370000</trnr:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock
      contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">24576</trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock>
    <trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock
      contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">7422000</trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.
      contextRef="P01_01_2021To12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">10208</trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.>
    <trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.
      contextRef="P01_01_2021To12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2604000</trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">1164000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1164000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2021To12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-179000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-32840000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32840000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">42999</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">7594000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">86703</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">19535000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">10208</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2604000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">181362</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">31703</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">37806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-57313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-19663000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">1339821</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">2625000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2626000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">124313</trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">5926000</trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">631292</trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">29996000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-86703000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-19535</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">86703000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">19535</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">19535</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-10208000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-2604</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">10208000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">2604</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">2604</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-755605</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-35922000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">755605</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">35922000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">35922000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-7546</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-2267000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">7546</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">2267000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2267000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-2393</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-719000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">2393</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">719000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">719000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-1666</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-160000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">1666</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">160000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">160000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-248</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-25000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">248</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">25000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">25000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-140</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-15000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">140</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">15000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">15000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-3414</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-425000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">3414</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">425000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">425000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-815</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-104000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">815</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">104000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">104000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-1716</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-235000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">1716</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">235000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">235000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-4410</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-659000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">4410</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">659000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">659000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-18481</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-2664000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">18481</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">2664000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2664000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-2170</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-321000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">2170</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">321000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue>
    <trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">321000</trnr:IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">2521</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">6347000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6347000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">524000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">524000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-58225000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-58225000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">2416698</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">34224</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">112436000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">365000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-115538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-2733000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-58225000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32840000</us-gaap:ProfitLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-422000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">54000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:Depreciation
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1143000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">747000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4999000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1444000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">590000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:InventoryWriteDown
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">904000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1371000</us-gaap:InventoryWriteDown>
    <us-gaap:ShareBasedCompensation
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6347000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1164000</us-gaap:ShareBasedCompensation>
    <trnr:FairValueOfWarrantsIssuedWithConvertibleNotes
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3482000</trnr:FairValueOfWarrantsIssuedWithConvertibleNotes>
    <trnr:FairValueOfWarrantsIssuedWithConvertibleNotes
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:FairValueOfWarrantsIssuedWithConvertibleNotes>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">523000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-181000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <trnr:NonCashInterestExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">952000</trnr:NonCashInterestExpense>
    <trnr:NonCashInterestExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">978000</trnr:NonCashInterestExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2275000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AssetImpairmentCharges>
    <trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity>
    <trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">251000</trnr:ChangeInFairValuesOfSimpleAgreementsForFutureEquity>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">107000</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">5193000</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-478000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2435000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3410000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">261000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-163000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-341000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3228000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-3000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-292000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3926000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-1181000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1490000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1225000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">14000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">15000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-585000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-35545000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38256000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">577000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2623000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2743000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1429000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4287000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">8307000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-7607000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-12359000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <trnr:ProceedsFromPPPLoan
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ProceedsFromPPPLoan>
    <trnr:ProceedsFromPPPLoan
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">520000</trnr:ProceedsFromPPPLoan>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">425000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1361000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-1324000</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-1887000</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <trnr:ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity>
    <trnr:ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3479000</trnr:ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">29996000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">30475000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">10106000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">14355000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2626000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">12000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">47000</us-gaap:ProceedsFromStockOptionsExercised>
    <trnr:RepaymentOfBouncebackLoans
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-69000</trnr:RepaymentOfBouncebackLoans>
    <trnr:RepaymentOfBouncebackLoans
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:RepaymentOfBouncebackLoans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">41772000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">52452000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-91000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-151000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-1471000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1686000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1697000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2020"
      decimals="-3"
      unitRef="Unit_USD">11000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">226000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1697000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <trnr:PropertyAndEquipmentInAccountsPayable
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">18000</trnr:PropertyAndEquipmentInAccountsPayable>
    <trnr:PropertyAndEquipmentInAccountsPayable
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">135000</trnr:PropertyAndEquipmentInAccountsPayable>
    <trnr:InventoriesInAccountsPayableAndAccrued
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-1007000</trnr:InventoriesInAccountsPayableAndAccrued>
    <trnr:InventoriesInAccountsPayableAndAccrued
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-27000</trnr:InventoriesInAccountsPayableAndAccrued>
    <trnr:CapitalizedSoftwareAndContentInAccountsPayable
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">75000</trnr:CapitalizedSoftwareAndContentInAccountsPayable>
    <trnr:CapitalizedSoftwareAndContentInAccountsPayable
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:CapitalizedSoftwareAndContentInAccountsPayable>
    <trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5926000</trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable>
    <trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable>
    <trnr:NoncashActivityDeferredCostsIncurred
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2337000</trnr:NoncashActivityDeferredCostsIncurred>
    <trnr:NoncashActivityDeferredCostsIncurred
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:NoncashActivityDeferredCostsIncurred>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">411000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <trnr:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">289000</trnr:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption>
    <trnr:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="P01_01_2022To12_31_2022_ConversionOfPreferredStockToClassACommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis"
      decimals="0"
      unitRef="Unit_shares">65655</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="P01_01_2021To12_31_2021_ConversionOfPreferredStockToClassACommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="P01_01_2022To12_31_2022_ConversionOfLoanPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">161000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="P01_01_2021To12_31_2021_ConversionOfLoanPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="P01_01_2022To12_31_2022_ConversionOfAccountsPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">36000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="P01_01_2021To12_31_2021_ConversionOfAccountsPayableToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">400000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="P01_01_2022To12_31_2022_ConversionOfPromissoryNotesToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="P01_01_2021To12_31_2021_ConversionOfPromissoryNotesToConvertibleNoteMemberusgaapDebtConversionByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">105000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <trnr:NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants>
    <trnr:NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">6605000</trnr:NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants>
    <trnr:NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA>
    <trnr:NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">388000</trnr:NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA>
    <us-gaap:NotesIssued1
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:NotesIssued1>
    <us-gaap:NotesIssued1
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1947000</us-gaap:NotesIssued1>
    <us-gaap:StockIssued1
      contextRef="P01_01_2022To12_31_2022_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMemberusgaapConversionOfStockByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="P01_01_2021To12_31_2021_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMemberusgaapConversionOfStockByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">2665000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="P01_01_2022To12_31_2022_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="P01_01_2021To12_31_2021_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis"
      decimals="-3"
      unitRef="Unit_USD">5667000</us-gaap:StockIssued1>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1. Description of Business and Basis of Presentation &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Description and Organization &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Interactive Strength Inc., together with its consolidated subsidiaries doing business as &#x201c;Forme&#x201d; (&#x201c;Forme&#x201d; or the &#x201c;Company&#x201d;), is an interactive home fitness platform that offers an immersive smart home gym with a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;life-size&lt;/div&gt; touchscreen mirror and accessories. Our Members are defined as any individual who has a Forme account through a paid connected fitness membership. The Company&#x2019;s interactive home fitness platform is known as the Studio, for which the Company continues to develop new accessories and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;add-ons&lt;/div&gt; to further customize a Member&#x2019;s experience (&#x201c;Connected Fitness Products&#x201d;). Through the Studio, Members can stream immersive, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;instructor-led&lt;/div&gt; boutique classes anytime, anywhere. The Company enables Members to get the most out of their wellness journey from their home. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basis of Presentation and Consolidation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements include the accounts of Interactive Strength Inc. and its subsidiaries in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liquidity and Going Concern &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Since its inception, the Company has sustained recurring losses and has relied on funding from private investors and other third-parties (collectively &#x201c;outside capital&#x201d;) to execute the Company&#x2019;s growth strategy. As a result, the Company incurred a net loss of $58.2 million during the year ended December 31, 2022 and had an accumulated deficit of $115.5 million as of December 31, 2022. The Company&#x2019;s long-term success is dependent upon its ability to successfully develop, market, and deliver its revenue-generating products and services in a profitable manner. While management believes the Company can be successful in executing its growth strategy, no assurance can be provided it will be able to do so in a timely or profitable manner. As a result, the Company anticipates it will continue to rely on outside capital to fund the Company&#x2019;s operations for the foreseeable future. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of the date the accompanying consolidated financial statements were issued (the &#x201c;issuance date&#x201d;), the Company&#x2019;s available liquidity was not sufficient to fund the Company&#x2019;s operations over the next twelve months or meet its obligations as they become due, absent the Company&#x2019;s ability to secure additional outside capital. While management plans to take action to address the Company&#x2019;s liquidity needs, such as cost mitigation initiatives to reduce unnecessary costs, securing additional outside capital, pursuing an initial public offering of the Company&#x2019;s common stock, and/or pursuing other strategic arrangements, no assurance can be provided that management&#x2019;s actions will be sufficient to fund the Company&#x2019;s operations over the next twelve months or meet its obligations as they become due. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In addition, as of December 31, 2022, the Company had loans outstanding from certain related parties (See Note&#160;22) with an aggregate principal and interest amount owed of approximately $6.7 million. Certain of these loans matured prior to December 31, 2022, but their repayment has been temporarily waived, and the remaining loans are scheduled to mature over the next twelve months beyond issuance date. However, absent additional outside capital, the Company will be unable to repay these loans upon their maturity and, as such, the aggregate amounts owed have been classified as current debt in the accompanying consolidated balance sheet as of December 31, 2022. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In the event that one or more of management&#x2019;s planned actions are not sufficient to fund the Company&#x2019;s operations over the next twelve months or meet its obligations as they become due, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment in the Company&#x2019;s operations, a sale of certain of the Company&#x2019;s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy. These uncertainties raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The accompanying consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties. &lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">-58200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">-115500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">6700000</us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2. Summary of Significant Accounting Policies &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Use of Estimates &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, simple agreement for future equity (&#x201c;SAFE&#x201d;) liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Segment Information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;at-home&lt;/div&gt; fitness technology platform. The Company&#x2019;s chief operating decision maker, its chief executive officer, manages the Company&#x2019;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of December&#160;31, 2022 and 2021, substantially all of the Company&#x2019;s long-lived assets are held in the United States. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Cash consists of cash on deposit in banks. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Concentration of Credit Risk and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Off-Balance&lt;/div&gt; Sheet Risk &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any credit losses on its cash or cash equivalents. The Company maintains its cash and cash equivalents at a high-quality financial institution. Management believes that such funds are not exposed to any significant credit or concentration risk. The Company has no financial instruments with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;off-balance-sheet&lt;/div&gt; risk of loss and has not experienced any losses on such accounts. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred Offering Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A &#x201c;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Expenses of Offering&#x201d;&lt;/div&gt;&lt;/div&gt;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. The Company has incurred and expensed offering costs amounting to $2.3&#160;million as of December&#160;31, 2022. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s material financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFEs and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these &lt;div style="display:inline;"&gt;instruments&lt;/div&gt;. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Inventories &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;written-off&lt;/div&gt; against the reserve. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Vendor Deposits &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#x2019;s inventory. In general, the Company&#x2019;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#x2019;s consolidated balance sheet. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Capitalized Studio Content &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Capitalized&#160;Studio content costs include certain expenditures to develop video and live content for the Company&#x2019;s customers. The Company capitalizes production costs for recorded&#160;content in accordance with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASC&#160;926-20,&#160;Entertainment-Films&lt;/div&gt; - Other&#160;Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;other&#160;non-current&#160;assets&lt;/div&gt; in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized&#160;content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#x201c;obsolescence&#x201d; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(3-year)&lt;/div&gt; amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $4.4&#160;million as of December&#160;31, 2022. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Identifiable Intangible Assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASC&#160;350-40,&#160;Internal-use&#160;Software&lt;/div&gt;&lt;/div&gt; and ASC 985, Software.&#160;These capitalized costs also relate to the Company&#x2019;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems.&#160;Capitalized software costs are amortized over the estimated useful life is three years.&#160;Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;probable the project will be completed, and the software will be used to perform the function intended.&#160;Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use.&#160;The Company expenses all costs incurred that relate to planning and post-implementation phases of development. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the years ended December&#160;31, 2022 and 2021, the Company capitalized $2.7&#160;million, and $1.4&#160;million, respectively, of internally developed software. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;Internal-use software&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;3 years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and Equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-production&lt;/div&gt; tooling which it owns under a supply arrangement. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pre-production&lt;/div&gt; tooling, including the related engineering costs the Company will not own or will not be used in producing products under long-term supply arrangements, are expensed as incurred. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="display:inline;"&gt;2 &lt;/div&gt;&#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 10 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;3 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="-sec-ix-hidden:hidden95757149"&gt;Lesser of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Content Licensing Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company entered into two agreements with a third-party content provider (&#x201c;Content Provider&#x201d;), a service agreement and a collaboration agreement. Per the service agreement, Forme is to provide content creation services for the Content Provider in which the Company is to produce workout content using the Content Provider&#x2019;s trainers and studios. Under the collaboration agreement, both the Company and the Content Provider agree to jointly market their partnership; in addition, the collaboration agreement provides the Company with a license to use the Content Provider&#x2019;s content on its Studio fitness ecosystem (i.e., the &#x201c;License&#x201d;). The license issued to the Company allows the Company to reproduce, modify, prepare derivative works based upon, distribute, publicly display, publicly perform the content and the modified content, to market, advertise or promote the Company, perform specified activities, and provide the Company&#x2019;s customers access to and use of the Content Provider&#x2019;s content, throughout the world on the Company&#x2019;s Studio devices and in any media, so long as such other media is associated or related to the use of the Company&#x2019;s Studio devices. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2022, the company determined that the Content Provider&#x2019;s content would no longer be used on Forme&#x2019;s platform, leading to a triggering event. Upon further analysis, it was determined that this content was abandoned in December 2022 with no remaining fair value. As such, Forme recorded an impairment loss of $2.3 million within general and administrative costs within the consolidated statement of operations and comprehensive loss as of December 31, 2022. As a result, there is no related unamortized costs of content as of December 31, 2022. Refer to Note 14 for further information on future minimum payments as of December 31, 2022. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The liability will be recorded and accreted at the gross amount for each tranche of content delivered to the Company for $0.5&#160;million per quarter and will be decreased when the payments per the payment schedule above are made. The liability for the license fee is approximately $2.3 million as of December 31, 2022. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Music&#160;Royalty Fees &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognizes&#160;music&#160;royalty fees&#160;as these fees are incurred in accordance with the terms of the relevant license agreement with the&#160;music&#160;rights holder. The incurrence of such royalties is primarily driven by&#160;the number of paid subscribers each month&#160;and it is classified as cost of membership and training within the Company&#x2019;s statement of operations. The Company&#x2019;s license agreements with&#160;music&#160;rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of December 31, 2022 and 2021, there were music guarantee-related prepaids of $0 million and $0.1 million, respectively. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Impairment of Long-Lived Assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. There was a $2.3 million impairment loss related to the impairment of the Content Provider&#x2019;s content for the year ended December 31, 2022. There was no charge to impairment for the year ended December&#160;31, 2021. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company adopted the Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Leases&lt;/div&gt;&lt;/div&gt; (Topic 842) (&#x201c;ASU 2016-02&#x201d; or &#x201c;ASC&#160;842&#x201d;) as of January 1, 2022, using the modified retrospective method and utilized the effective date as its date of initial application, with prior periods presented in accordance with previous guidance under Accounting Standards Codification (&#x201c;ASC&#x201d;) 840, Leases. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease liabilities, as applicable. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Prospectively, the Company will adjust the right-of-use assets for straight-line rent expense and remeasure the lease liability at the net present value using the same incremental borrowing rate that was in effect as of the lease commencement or transition date. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date: i) the Company did not reassess whether any expired or existing contracts are or contain leases, ii) the Company did not reassess the lease classification for any expired or existing leases, and iii) the Company did not reassess initial direct costs for any existing leases. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In accordance with ASC 842, components of a lease should be split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Entities may elect not to separate lease and non-lease components. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only. As a result of the adoption of ASC 842, the Company recognized right-of-use assets and lease liabilities of $0.3 million and $0.3 million, respectively, as of the January 1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. The Company recorded an immaterial amount of general and administrative expense in its consolidated statement of operations related to lease expense, including short-term lease expense during the year ended December 31, 2022. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#x2019; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#x2019; deficit. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#x2019;s hiring of certain employees from the third party (the &#x201c;acqui-hire transaction&#x201d;) that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x) the price per share of the next equity financing with total proceeds of at least $10.0 million or (y) the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.01 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In accordance with ASC 718, as the warrant contains a performance condition dependent on an initial public offering, there has been no impact recorded prior to December 31, 2022. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative Instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company measures derivative financial instruments at fair value and recognizes them as either assets or liabilities on the consolidated balance sheets. The Company evaluates its convertible instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives requiring separate recognition in the Company&#x2019;s financial statements in accordance with the criteria under ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-15.&lt;/div&gt; As of December&#160;31, 2022 and 2021, the Company did not have any material derivative contracts or contracts with material embedded derivative features requiring bifurcation. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Simple Agreements for Future Equity (&#x201c;SAFES&#x201d;) and Advance Subscription Agreements (&#x201c;ASAs&#x201d;) &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company has issued several SAFEs and ASAs in exchange for cash financing. The SAFEs were initially measured at fair value using a probability weighted expected return method (PWERM) and were subsequently remeasured at fair value at each reporting period, through the date of conversion. The ASAs were initially measured at fair value utilizing the&#160;fair value of the Company&#x2019;s common stock according to the ASC 718 valuation&#160;performed by an independent appraiser closest to the date of grant and were subsequently remeasured at fair value at each reporting period, through date of conversion. Pursuant to the SAFE agreement provisions, all outstanding SAFE instruments were converted to preferred stock in 2021, in connection with a Series A financing. All ASAs were converted to common stock on the respective ASA Longstop Dates &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(6-month&lt;/div&gt; anniversary of issuance). There were are no outstanding SAFEs or ASAs as of December&#160;31, 2022 or December 31, 2021. The remeasurements of the SAFEs and ASAs resulted in the recognition of a $0.3 million loss for the year ended December&#160;31, 2021 (see Note 4 to the consolidated financial statements for the accounting for significant inputs to the valuation of the SAFE and ASA instruments). &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Commitments and Contingencies &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. If a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the possible loss or states that such an estimate cannot be made. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Revenue Recognition &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On January&#160;1, 2020, the Company adopted Accounting Standards Update &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(&#x201c;ASU&#x201d;)&#160;2014-09,&#160;Revenue&lt;/div&gt; from Contracts with Customers (Topic 606) (&#x201c;ASC 606&#x201d;)&#160;and all subsequent amendments. As the Company had not recognized any revenue prior to the adoption of the new standard, there was no impact on the measurement or timing of revenue recognition as a result of the adoption. Revenue is recognized when control of the promised goods or services is transferred to the Company&#x2019;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Refer to Note 3 for additional information. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cost of Fitness Product Revenue &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Cost of fitness product revenue relates to the Fitness Product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management, facilities, and personnel-related expenses associated with supply chain logistics. Cost of fitness product revenue also contains valuation losses related to the Company&#x2019;s inventory lower of cost or market reserve. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cost of Membership and Training &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Membership costs include costs associated with the creation of content and training, including associated payroll, filming and production costs, other content specific costs, hosting fees, music royalties, amortization of capitalized software development costs, and warranty replacement and servicing costs associated with extended warranty contracts. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Advertising Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Advertising and other promotional costs to market the Company&#x2019;s products are expensed as incurred. Advertising expenses were $2.5&#160;million and $2.0&#160;million for the years ended December&#160;31, 2022 and 2021, respectively, and are included within sales and marketing expenses in the consolidated statements of operations and comprehensive loss. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and Development Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Research and development expenses consist primarily of personnel- and facilities-related expenses, consulting and contractor expenses, tooling and prototype materials software platform expenses, and depreciation of property and equipment. Substantially all of the Company&#x2019;s research and development expenses are related to developing new products and services and improving existing products and services. Research and development expenses are expensed as incurred. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock-Based Compensation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (&#x201c;the 2020 Plan&#x201d;). Stock-based awards are measured at the grant date based on the fair value of the award and are recognized as expense, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The determination of the grant date fair value of stock awards issued is affected by a number of variables, including the fair value of the Company&#x2019;s common stock, the expected common stock price volatility over the expected life of the awards, the expected term of the stock option, risk-free interest rates, and the expected dividend yield of the Company&#x2019;s common stock. The Company derives its volatility from the average historical stock volatilities of several peer public companies over a period equivalent to the expected term of the awards. The Company estimates the expected term based on the simplified method for employee stock options considered to be &#x201c;plain vanilla&#x201d; options, as the Company&#x2019;s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant. Expected dividend yield is 0.0% as the Company has not paid and does not currently anticipate paying dividends on its common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Stock-based compensation expense is classified in the accompanying consolidated statement of operations in the same manner in which the award recipient&#x2019;s payroll costs are classified or in which the award recipient&#x2019;s service payments are classified. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Foreign Currency Transactions &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The functional currency for the Company&#x2019;s wholly-owned foreign subsidiaries, Interactive Strength UK and Interactive Strength Taiwan, is the United States dollar. All foreign currency transaction gains and losses are recognized in the consolidated statements of operations and comprehensive loss through other income (expense). The Company has not recognized material currency transaction gains or losses during the years ended December&#160;31, 2022 and 2021. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Comprehensive Loss &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Comprehensive loss includes net loss as well as other changes in stockholders&#x2019; deficit that result from transactions and economic events other than those with stockholders. For the years ended December 31, 2022 and 2021, comprehensive loss included $0.5 million and $0.2 million of foreign currency transaction gains, respectively. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Loss Per Share &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company computes loss per share using the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;two-class&lt;/div&gt; method required for participating securities. The &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;two-class&lt;/div&gt; method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company&#x2019;s redeemable convertible preferred stock and common stock issued upon early exercise of stock options are participating securities. The Company considers any shares issued upon early exercise of stock options, subject to repurchase, to be participating securities because holders of such shares have &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-forfeitable&lt;/div&gt; dividend rights in the event a cash dividend is declared on common stock. These participating securities do not contractually require the holders of such shares to participate in the Company&#x2019;s losses. As such, net losses for the periods presented were not allocated to the Company&#x2019;s participating securities. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Basic loss per share is computed using the weighted-average number of outstanding shares of common stock during the period. Diluted earnings (loss) per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential shares of common stock outstanding during the period. Potential shares of common stock consist of incremental shares issuable upon the assumed exercise of stock options, employee stock purchase plan (&#x201c;ESPP&#x201d;) shares to be issued, and vesting of restricted stock awards. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Income Taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Recently Issued Accounting Pronouncements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial statements upon adoption. The Company qualifies as an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;) and has elected not to &#x201c;opt out&#x201d; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time private companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#x201c;opt out&#x201d; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Accounting Pronouncements Recently Adopted &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-02&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02, Leases (&#x201c;Topic 842&#x201d;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize an ROU asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January 1, 2022. Financial positions for reporting periods beginning on or after January 1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU 2016-13 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In June 2016, the FASB issued ASU 2016-03, Measurement of Credit Losses on Financial Instruments (&#x201c;CECL&#x201d;), which amends ASC 326 &#x201c;Financial Instruments - Credit Losses&#x201d; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#x201c;expected loss model&#x201d; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January 1, 2022 and the guidance did not have a material impact on our consolidated financial statements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2019, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/div&gt;&lt;/div&gt;, which amends ASC Topic 740, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances,&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU 2019-12 effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#x2019;s financial statements. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accounting Pronouncements Not Yet Adopted &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-04&lt;/div&gt; and ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2020, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-04,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial&lt;/div&gt;&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reporting&lt;/div&gt;&lt;/div&gt;. This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;ease entities&#x2019; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reference Rate Reform (Topic 848)&lt;/div&gt;&lt;/div&gt;, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01&lt;/div&gt; are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its consolidated financial statements. &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Use of Estimates &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, simple agreement for future equity (&#x201c;SAFE&#x201d;) liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. &lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Segment Information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;at-home&lt;/div&gt; fitness technology platform. The Company&#x2019;s chief operating decision maker, its chief executive officer, manages the Company&#x2019;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of December&#160;31, 2022 and 2021, substantially all of the Company&#x2019;s long-lived assets are held in the United States. &lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Cash consists of cash on deposit in banks. &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Concentration of Credit Risk and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Off-Balance&lt;/div&gt; Sheet Risk &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any credit losses on its cash or cash equivalents. The Company maintains its cash and cash equivalents at a high-quality financial institution. Management believes that such funds are not exposed to any significant credit or concentration risk. The Company has no financial instruments with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;off-balance-sheet&lt;/div&gt; risk of loss and has not experienced any losses on such accounts. &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <trnr:DeferredOfferingCostsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred Offering Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A &#x201c;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Expenses of Offering&#x201d;&lt;/div&gt;&lt;/div&gt;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. The Company has incurred and expensed offering costs amounting to $2.3&#160;million as of December&#160;31, 2022. &lt;/div&gt;</trnr:DeferredOfferingCostsPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts
      contextRef="PAsOn12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:DeferredOfferingCosts>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s material financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFEs and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these &lt;div style="display:inline;"&gt;instruments&lt;/div&gt;. &lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Inventories &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;written-off&lt;/div&gt; against the reserve. &lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <trnr:VendorDepositPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Vendor Deposits &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#x2019;s inventory. In general, the Company&#x2019;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#x2019;s consolidated balance sheet. &lt;/div&gt;</trnr:VendorDepositPolicyTextBlock>
    <trnr:CapitalizedStudioContentPolicytextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Capitalized Studio Content &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Capitalized&#160;Studio content costs include certain expenditures to develop video and live content for the Company&#x2019;s customers. The Company capitalizes production costs for recorded&#160;content in accordance with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASC&#160;926-20,&#160;Entertainment-Films&lt;/div&gt; - Other&#160;Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;other&#160;non-current&#160;assets&lt;/div&gt; in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized&#160;content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#x201c;obsolescence&#x201d; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(3-year)&lt;/div&gt; amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $4.4&#160;million as of December&#160;31, 2022. &lt;/div&gt;</trnr:CapitalizedStudioContentPolicytextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="PAsOn12_31_2022_CapitalizedStudioContentMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">P3Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:CooperativeAdvertisingAmount
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">4400000</us-gaap:CooperativeAdvertisingAmount>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Identifiable Intangible Assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASC&#160;350-40,&#160;Internal-use&#160;Software&lt;/div&gt;&lt;/div&gt; and ASC 985, Software.&#160;These capitalized costs also relate to the Company&#x2019;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems.&#160;Capitalized software costs are amortized over the estimated useful life is three years.&#160;Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;probable the project will be completed, and the software will be used to perform the function intended.&#160;Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use.&#160;The Company expenses all costs incurred that relate to planning and post-implementation phases of development. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the years ended December&#160;31, 2022 and 2021, the Company capitalized $2.7&#160;million, and $1.4&#160;million, respectively, of internally developed software. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;Internal-use software&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;3 years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
      contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-5"
      unitRef="Unit_USD">2700000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
      contextRef="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-5"
      unitRef="Unit_USD">1400000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;Internal-use software&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;3 years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P01_01_2022To12_31_2022">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and Equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-production&lt;/div&gt; tooling which it owns under a supply arrangement. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pre-production&lt;/div&gt; tooling, including the related engineering costs the Company will not own or will not be used in producing products under long-term supply arrangements, are expensed as incurred. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="display:inline;"&gt;2 &lt;/div&gt;&#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 10 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;3 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="-sec-ix-hidden:hidden95757149"&gt;Lesser of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="display:inline;"&gt;2 &lt;/div&gt;&#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 10 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;3 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="-sec-ix-hidden:hidden95757149"&gt;Lesser of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn12_31_2022_MinimumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn12_31_2022_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn12_31_2022_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn12_31_2022_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <trnr:ContentLicensingAgreementPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Content Licensing Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company entered into two agreements with a third-party content provider (&#x201c;Content Provider&#x201d;), a service agreement and a collaboration agreement. Per the service agreement, Forme is to provide content creation services for the Content Provider in which the Company is to produce workout content using the Content Provider&#x2019;s trainers and studios. Under the collaboration agreement, both the Company and the Content Provider agree to jointly market their partnership; in addition, the collaboration agreement provides the Company with a license to use the Content Provider&#x2019;s content on its Studio fitness ecosystem (i.e., the &#x201c;License&#x201d;). The license issued to the Company allows the Company to reproduce, modify, prepare derivative works based upon, distribute, publicly display, publicly perform the content and the modified content, to market, advertise or promote the Company, perform specified activities, and provide the Company&#x2019;s customers access to and use of the Content Provider&#x2019;s content, throughout the world on the Company&#x2019;s Studio devices and in any media, so long as such other media is associated or related to the use of the Company&#x2019;s Studio devices. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2022, the company determined that the Content Provider&#x2019;s content would no longer be used on Forme&#x2019;s platform, leading to a triggering event. Upon further analysis, it was determined that this content was abandoned in December 2022 with no remaining fair value. As such, Forme recorded an impairment loss of $2.3 million within general and administrative costs within the consolidated statement of operations and comprehensive loss as of December 31, 2022. As a result, there is no related unamortized costs of content as of December 31, 2022. Refer to Note 14 for further information on future minimum payments as of December 31, 2022. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The liability will be recorded and accreted at the gross amount for each tranche of content delivered to the Company for $0.5&#160;million per quarter and will be decreased when the payments per the payment schedule above are made. The liability for the license fee is approximately $2.3 million as of December 31, 2022. &lt;/div&gt;</trnr:ContentLicensingAgreementPolicyTextBlock>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="P01_01_2022To12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost
      contextRef="PAsOn12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost>
    <trnr:LicenseFeePayablePerQuarter
      contextRef="PAsOn12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</trnr:LicenseFeePayablePerQuarter>
    <us-gaap:EntertainmentLicenseAgreementForProgramMaterialLiability
      contextRef="PAsOn12_31_2022_ContentLicensingAgreementMemberusgaapTypeOfArrangementAxis"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:EntertainmentLicenseAgreementForProgramMaterialLiability>
    <trnr:MusicRoyaltyFeesPolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Music&#160;Royalty Fees &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognizes&#160;music&#160;royalty fees&#160;as these fees are incurred in accordance with the terms of the relevant license agreement with the&#160;music&#160;rights holder. The incurrence of such royalties is primarily driven by&#160;the number of paid subscribers each month&#160;and it is classified as cost of membership and training within the Company&#x2019;s statement of operations. The Company&#x2019;s license agreements with&#160;music&#160;rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of December 31, 2022 and 2021, there were music guarantee-related prepaids of $0 million and $0.1 million, respectively. &lt;/div&gt;</trnr:MusicRoyaltyFeesPolicyPolicyTextBlock>
    <trnr:MusicGuaranteesDeposits
      contextRef="PAsOn12_31_2022"
      decimals="-6"
      unitRef="Unit_USD">0</trnr:MusicGuaranteesDeposits>
    <trnr:MusicGuaranteesDeposits
      contextRef="PAsOn12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">100000</trnr:MusicGuaranteesDeposits>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Impairment of Long-Lived Assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. There was a $2.3 million impairment loss related to the impairment of the Content Provider&#x2019;s content for the year ended December 31, 2022. There was no charge to impairment for the year ended December&#160;31, 2021. &lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company adopted the Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Leases&lt;/div&gt;&lt;/div&gt; (Topic 842) (&#x201c;ASU 2016-02&#x201d; or &#x201c;ASC&#160;842&#x201d;) as of January 1, 2022, using the modified retrospective method and utilized the effective date as its date of initial application, with prior periods presented in accordance with previous guidance under Accounting Standards Codification (&#x201c;ASC&#x201d;) 840, Leases. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease liabilities, as applicable. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Prospectively, the Company will adjust the right-of-use assets for straight-line rent expense and remeasure the lease liability at the net present value using the same incremental borrowing rate that was in effect as of the lease commencement or transition date. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date: i) the Company did not reassess whether any expired or existing contracts are or contain leases, ii) the Company did not reassess the lease classification for any expired or existing leases, and iii) the Company did not reassess initial direct costs for any existing leases. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In accordance with ASC 842, components of a lease should be split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Entities may elect not to separate lease and non-lease components. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only. As a result of the adoption of ASC 842, the Company recognized right-of-use assets and lease liabilities of $0.3 million and $0.3 million, respectively, as of the January 1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. The Company recorded an immaterial amount of general and administrative expense in its consolidated statement of operations related to lease expense, including short-term lease expense during the year ended December 31, 2022. &lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn01_01_2022"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="PAsOn01_01_2022"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:OperatingLeaseLiability>
    <trnr:ConvertibleNotesPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#x2019; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. &lt;/div&gt;</trnr:ConvertibleNotesPolicyTextBlock>
    <trnr:WarrantsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#x2019; deficit. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#x2019;s hiring of certain employees from the third party (the &#x201c;acqui-hire transaction&#x201d;) that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x) the price per share of the next equity financing with total proceeds of at least $10.0 million or (y) the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.01 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In accordance with ASC 718, as the warrant contains a performance condition dependent on an initial public offering, there has been no impact recorded prior to December 31, 2022. &lt;/div&gt;</trnr:WarrantsPolicyTextBlock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="P11_01_2022To11_30_2022"
      decimals="-3"
      unitRef="Unit_USD">225000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="P11_01_2022To11_30_2022"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn11_30_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DerivativesPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative Instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company measures derivative financial instruments at fair value and recognizes them as either assets or liabilities on the consolidated balance sheets. The Company evaluates its convertible instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives requiring separate recognition in the Company&#x2019;s financial statements in accordance with the criteria under ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-15.&lt;/div&gt; As of December&#160;31, 2022 and 2021, the Company did not have any material derivative contracts or contracts with material embedded derivative features requiring bifurcation. &lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Simple Agreements for Future Equity (&#x201c;SAFES&#x201d;) and Advance Subscription Agreements (&#x201c;ASAs&#x201d;) &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company has issued several SAFEs and ASAs in exchange for cash financing. The SAFEs were initially measured at fair value using a probability weighted expected return method (PWERM) and were subsequently remeasured at fair value at each reporting period, through the date of conversion. The ASAs were initially measured at fair value utilizing the&#160;fair value of the Company&#x2019;s common stock according to the ASC 718 valuation&#160;performed by an independent appraiser closest to the date of grant and were subsequently remeasured at fair value at each reporting period, through date of conversion. Pursuant to the SAFE agreement provisions, all outstanding SAFE instruments were converted to preferred stock in 2021, in connection with a Series A financing. All ASAs were converted to common stock on the respective ASA Longstop Dates &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(6-month&lt;/div&gt; anniversary of issuance). There were are no outstanding SAFEs or ASAs as of December&#160;31, 2022 or December 31, 2021. The remeasurements of the SAFEs and ASAs resulted in the recognition of a $0.3 million loss for the year ended December&#160;31, 2021 (see Note 4 to the consolidated financial statements for the accounting for significant inputs to the valuation of the SAFE and ASA instruments). &lt;/div&gt;</trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock>
    <us-gaap:ForwardContractIndexedToIssuersEquityShares
      contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:ForwardContractIndexedToIssuersEquityShares>
    <us-gaap:ForwardContractIndexedToIssuersEquityShares
      contextRef="P01_01_2022To12_31_2022_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:ForwardContractIndexedToIssuersEquityShares>
    <trnr:RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements
      contextRef="P01_01_2022To12_31_2022_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMemberusgaapForwardContractIndexedToIssuersEquityTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</trnr:RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Commitments and Contingencies &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. If a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the possible loss or states that such an estimate cannot be made. &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Revenue Recognition &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On January&#160;1, 2020, the Company adopted Accounting Standards Update &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(&#x201c;ASU&#x201d;)&#160;2014-09,&#160;Revenue&lt;/div&gt; from Contracts with Customers (Topic 606) (&#x201c;ASC 606&#x201d;)&#160;and all subsequent amendments. As the Company had not recognized any revenue prior to the adoption of the new standard, there was no impact on the measurement or timing of revenue recognition as a result of the adoption. Revenue is recognized when control of the promised goods or services is transferred to the Company&#x2019;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Refer to Note 3 for additional information. &lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <trnr:CostOfFitnessProductRevenuePolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cost of Fitness Product Revenue &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Cost of fitness product revenue relates to the Fitness Product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management, facilities, and personnel-related expenses associated with supply chain logistics. Cost of fitness product revenue also contains valuation losses related to the Company&#x2019;s inventory lower of cost or market reserve. &lt;/div&gt;</trnr:CostOfFitnessProductRevenuePolicyTextBlock>
    <trnr:CostOfMembershipAndTrainingPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cost of Membership and Training &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Membership costs include costs associated with the creation of content and training, including associated payroll, filming and production costs, other content specific costs, hosting fees, music royalties, amortization of capitalized software development costs, and warranty replacement and servicing costs associated with extended warranty contracts. &lt;/div&gt;</trnr:CostOfMembershipAndTrainingPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Advertising Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Advertising and other promotional costs to market the Company&#x2019;s products are expensed as incurred. Advertising expenses were $2.5&#160;million and $2.0&#160;million for the years ended December&#160;31, 2022 and 2021, respectively, and are included within sales and marketing expenses in the consolidated statements of operations and comprehensive loss. &lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and Development Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Research and development expenses consist primarily of personnel- and facilities-related expenses, consulting and contractor expenses, tooling and prototype materials software platform expenses, and depreciation of property and equipment. Substantially all of the Company&#x2019;s research and development expenses are related to developing new products and services and improving existing products and services. Research and development expenses are expensed as incurred. &lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock-Based Compensation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (&#x201c;the 2020 Plan&#x201d;). Stock-based awards are measured at the grant date based on the fair value of the award and are recognized as expense, net of actual forfeitures, on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The determination of the grant date fair value of stock awards issued is affected by a number of variables, including the fair value of the Company&#x2019;s common stock, the expected common stock price volatility over the expected life of the awards, the expected term of the stock option, risk-free interest rates, and the expected dividend yield of the Company&#x2019;s common stock. The Company derives its volatility from the average historical stock volatilities of several peer public companies over a period equivalent to the expected term of the awards. The Company estimates the expected term based on the simplified method for employee stock options considered to be &#x201c;plain vanilla&#x201d; options, as the Company&#x2019;s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on the United States Treasury yield curve in effect at the time of grant. Expected dividend yield is 0.0% as the Company has not paid and does not currently anticipate paying dividends on its common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Stock-based compensation expense is classified in the accompanying consolidated statement of operations in the same manner in which the award recipient&#x2019;s payroll costs are classified or in which the award recipient&#x2019;s service payments are classified. &lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="P01_01_2022To12_31_2022"
      decimals="3"
      unitRef="Unit_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Foreign Currency Transactions &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The functional currency for the Company&#x2019;s wholly-owned foreign subsidiaries, Interactive Strength UK and Interactive Strength Taiwan, is the United States dollar. All foreign currency transaction gains and losses are recognized in the consolidated statements of operations and comprehensive loss through other income (expense). The Company has not recognized material currency transaction gains or losses during the years ended December&#160;31, 2022 and 2021. &lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="P01_01_2022To12_31_2022_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="P01_01_2021To12_31_2021_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Comprehensive Loss &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Comprehensive loss includes net loss as well as other changes in stockholders&#x2019; deficit that result from transactions and economic events other than those with stockholders. For the years ended December 31, 2022 and 2021, comprehensive loss included $0.5 million and $0.2 million of foreign currency transaction gains, respectively. &lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2022To12_31_2022_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2021To12_31_2021_ForeignCurrencyGainLossMemberusgaapIncomeStatementLocationAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Loss Per Share &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company computes loss per share using the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;two-class&lt;/div&gt; method required for participating securities. The &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;two-class&lt;/div&gt; method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company&#x2019;s redeemable convertible preferred stock and common stock issued upon early exercise of stock options are participating securities. The Company considers any shares issued upon early exercise of stock options, subject to repurchase, to be participating securities because holders of such shares have &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-forfeitable&lt;/div&gt; dividend rights in the event a cash dividend is declared on common stock. These participating securities do not contractually require the holders of such shares to participate in the Company&#x2019;s losses. As such, net losses for the periods presented were not allocated to the Company&#x2019;s participating securities. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Basic loss per share is computed using the weighted-average number of outstanding shares of common stock during the period. Diluted earnings (loss) per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential shares of common stock outstanding during the period. Potential shares of common stock consist of incremental shares issuable upon the assumed exercise of stock options, employee stock purchase plan (&#x201c;ESPP&#x201d;) shares to be issued, and vesting of restricted stock awards. &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Income Taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <trnr:PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions
      contextRef="PAsOn12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0.50</trnr:PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Recently Issued Accounting Pronouncements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial statements upon adoption. The Company qualifies as an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;) and has elected not to &#x201c;opt out&#x201d; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time private companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#x201c;opt out&#x201d; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Accounting Pronouncements Recently Adopted &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-02&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02, Leases (&#x201c;Topic 842&#x201d;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize an ROU asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January 1, 2022. Financial positions for reporting periods beginning on or after January 1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU 2016-13 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In June 2016, the FASB issued ASU 2016-03, Measurement of Credit Losses on Financial Instruments (&#x201c;CECL&#x201d;), which amends ASC 326 &#x201c;Financial Instruments - Credit Losses&#x201d; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#x201c;expected loss model&#x201d; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January 1, 2022 and the guidance did not have a material impact on our consolidated financial statements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2019, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/div&gt;&lt;/div&gt;, which amends ASC Topic 740, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances,&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU 2019-12 effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#x2019;s financial statements. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accounting Pronouncements Not Yet Adopted &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-04&lt;/div&gt; and ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2020, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-04,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial&lt;/div&gt;&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reporting&lt;/div&gt;&lt;/div&gt;. This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;ease entities&#x2019; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reference Rate Reform (Topic 848)&lt;/div&gt;&lt;/div&gt;, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01&lt;/div&gt; are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its consolidated financial statements. &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3. Revenue Recognition &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s primary source of revenue is solely derived from the United States from sales of its Connected Fitness Products and related accessories and associated recurring Membership revenue, as well as from sales of personal training services recorded within Training revenue. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company determines revenue recognition through the following steps: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Identification of the contract, or contracts, with a customer; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Identification of the performance obligations in the contract; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Determination of the transaction price; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Allocation of the transaction price to the performance obligations in the contract; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Recognition of revenue when, or as, the Company satisfies a performance obligation. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Revenue is recognized when control of the promised goods or services is transferred to the Company&#x2019;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company&#x2019;s revenue is reported net of sales returns, discounts and incentives as a reduction of the transaction price. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company applies the practical expedient as per ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;606-10-50-14&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company&#x2019;s consolidated statements of operations and comprehensive loss. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Connected Fitness Products &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Connected Fitness Products include the Company&#x2019;s portfolio of Connected Fitness Products and related accessories, delivery and installation services, and extended warranty agreements. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period. The Company allows customers to return products within thirty days of purchase, as stated in its return policy. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amounts paid for payment processing fees for credit card sales for Connected Fitness Products are included as a reduction to fitness product revenue in the Company&#x2019;s consolidated statements of operations and comprehensive loss. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Membership &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s memberships provide unlimited access to content in its library of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;on-demand&lt;/div&gt; fitness classes. The Company&#x2019;s memberships are offered on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;month-to-month&lt;/div&gt;&lt;/div&gt; basis. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amounts paid for membership fees are included within deferred revenue on the Company&#x2019;s consolidated balance sheets and recognized ratably over the membership term. The Company records payment processing fees for its monthly membership charges within cost of membership and training in the Company&#x2019;s consolidated statements of operations and comprehensive loss. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Training &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s training services are personal training services delivered through the Connected Fitness Products and third-party mobile devices. Training revenue is recognized at the time of delivery. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Standard Product Warranty &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company offers a standard product warranty that its Connected Fitness Products and related accessories will operate under normal, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-commercial&lt;/div&gt; use for a period of one year which covers the touchscreen, frame and all incorporated elements, and related accessories from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company also offers the option for customers in some markets to purchase a third-party extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of 24 to 48 months. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;For third-party extended warranty service sold along with the Company&#x2019;s Connected Fitness Products, the Company does not obtain control of the warranty before transferring it to the customers. Therefore, the Company accounts for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission it retains. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it can establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product. &lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <trnr:ExtendedProductWarrantyPeriod contextRef="P01_01_2022To12_31_2022_MinimumMembersrtRangeAxis">P24M</trnr:ExtendedProductWarrantyPeriod>
    <trnr:ExtendedProductWarrantyPeriod contextRef="P01_01_2022To12_31_2022_MaximumMembersrtRangeAxis">P48M</trnr:ExtendedProductWarrantyPeriod>
    <trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4. Simple Agreements for Future Equity and Advance Subscription Agreements &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;From 2017 to 2021, the Company issued Simple Agreements for Future Equity (&#x201c;SAFE&#x201d;) and Advance Subscription Agreements (&#x201c;ASA&#x201d;) to several investors. The SAFE and ASA agreements have no maturity date and bear no interest. The SAFE Agreements provide a right to the holder to (a)&#160;future equity in the Company in the form of SAFE Preferred Stock when it completes an Equity Financing (as defined in the SAFE agreements), or (b)&#160;future equity in the form of Common Stock or cash proceeds if there is a liquidity event or dissolution event. The ASA Agreements provide a right to the holder to future equity in the Company in the form of Common Stock when it completes an Equity Financing, in the event of a sale, on the date falling six months from the date of the Agreement, or at the option of the holder on the closing of a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-Qualifying&lt;/div&gt; Financing Round (as defined in the ASA agreements) or at any time prior to the occurrence of any of the events listed above. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The SAFE and ASA agreements will expire and terminate upon either (i)&#160;the issuance of shares to the investor pursuant to an equity financing event or (ii)&#160;the payment, or setting aside for payment, of amounts due to the investor pursuant to a liquidity or dissolution event. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On July&#160;23, 2021, in connection with a Series A financing, all outstanding SAFEs were converted through the issuance of 0.02&#160;million shares of SAFE Preferred Stock. There were no outstanding SAFEs as of December&#160;31, 2022 or 2021. &lt;/div&gt;</trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn07_23_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="-4"
      unitRef="Unit_shares">20000.00</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:InventoryDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5. Inventories, net &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Inventories consist of the following:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:75%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Finished products&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,567&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,056&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total inventories, net&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,567&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,056&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Inventories consist of the following:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:75%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Finished products&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,567&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,056&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total inventories, net&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,567&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,056&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4567000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2056000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4567000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2056000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6. Property and Equipment, net &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Property and equipment consisted of the following:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,775&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;243&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Software and technology development asset&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,370&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,156&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: Accumulated depreciation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,044)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(966)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total property and equipment, net&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,326&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,190&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Depreciation and amortization expense amounted to $1.2&#160;million and $0.7&#160;million for the years ended December&#160;31, 2022 and 2021, respectively. &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Property and equipment consisted of the following:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,775&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;243&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Software and technology development asset&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,370&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,156&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: Accumulated depreciation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,044)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(966)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total property and equipment, net&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,326&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,190&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <trnr:PreProductionTooling
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3094000</trnr:PreProductionTooling>
    <trnr:PreProductionTooling
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2775000</trnr:PreProductionTooling>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">125000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">243000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">113000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">113000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">13000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3370000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3156000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2044000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">966000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1326000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2190000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">1200000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="P01_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">700000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7. Intangible Assets, net &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Identifiable intangible assets, net consist of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:38%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;br/&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;br/&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;br/&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;br/&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internal-Use&lt;/div&gt; Software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;5,827&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(1,993)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;3,834&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;3,083&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(428)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;2,655&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total identifiable intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,827&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,993)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,834&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,083&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(428)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,655&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022, estimated annual amortization expense for each of the next five fiscal years is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:87%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fiscal Years Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,946&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,516&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;372&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Identifiable intangible assets, net consist of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:38%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;br/&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;br/&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;br/&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;br/&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internal-Use&lt;/div&gt; Software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;5,827&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(1,993)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;3,834&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;3,083&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(428)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;2,655&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total identifiable intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,827&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,993)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,834&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,083&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(428)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,655&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">5827000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">1993000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">3834000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">3083000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">428000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn12_31_2021_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">2655000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5827000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1993000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3834000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3083000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">428000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2655000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022, estimated annual amortization expense for each of the next five fiscal years is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:87%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fiscal Years Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,946&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,516&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;372&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1946000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1516000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">372000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8. Prepaid Expenses and Other Current Assets &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Prepaid expenses and other current assets consisted of the following:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Security deposit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;146&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;607&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Prepaid licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;45&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;202&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development tax credit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;750&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vendor deposits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;178&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other prepaid&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;307&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;356&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total prepaid expenses and other current assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,426&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,165&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Prepaid expenses and other current assets consisted of the following:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Security deposit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;146&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;607&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Prepaid licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;45&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;202&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development tax credit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;750&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vendor deposits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;178&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other prepaid&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;307&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;356&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total prepaid expenses and other current assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,426&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,165&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:SecurityDeposit
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">146000</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">607000</us-gaap:SecurityDeposit>
    <trnr:PrepaidLicenses
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">45000</trnr:PrepaidLicenses>
    <trnr:PrepaidLicenses
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">202000</trnr:PrepaidLicenses>
    <trnr:ResearchAndDevelopmentTaxCredit
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">750000</trnr:ResearchAndDevelopmentTaxCredit>
    <trnr:ResearchAndDevelopmentTaxCredit
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ResearchAndDevelopmentTaxCredit>
    <trnr:VendorDeposits
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">178000</trnr:VendorDeposits>
    <trnr:VendorDeposits
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:VendorDeposits>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="PAsOn12_31_2022_ScenarioPreviouslyReportedMembersrtRestatementAxis"
      decimals="-3"
      unitRef="Unit_USD">307000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">356000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1426000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1165000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9. Other Assets &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized content costs and content licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,404&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,099&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,605&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,258&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,018&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,366&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="P01_01_2022To12_31_2022">
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized content costs and content licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,404&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,099&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,605&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,258&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,018&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,366&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2022_CapitalizedContentCostsAndContentLicensesMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">4404000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2021_CapitalizedContentCostsAndContentLicensesMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">6099000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2605000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2021_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2258000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">9000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2021_OtherAssetsMemberusgaapBalanceSheetLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">9000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7018000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">8366000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10. Accrued Expenses and Other Current Liabilities &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Accrued expenses consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:72%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued bonus&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;145&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;223&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued payroll&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;193&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued PTO&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;188&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued offering costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,490&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued advertising&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;195&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued professional fees&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;31&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued engineering&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;93&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,250&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,050&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Sales tax payable&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued royalties&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;195&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other accrued expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;323&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;532&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total accrued expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,784&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,125&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;520&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;295&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total accrued expenses and other current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,304&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,420&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Accrued expenses consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:72%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued bonus&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;145&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;223&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued payroll&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;193&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued PTO&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;188&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued offering costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,490&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued advertising&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;195&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued professional fees&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;31&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued engineering&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;93&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,250&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,050&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Sales tax payable&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued royalties&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;195&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other accrued expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;323&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;532&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total accrued expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,784&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,125&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;520&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;295&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total accrued expenses and other current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,304&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,420&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedBonusesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">145000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">223000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">193000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AccruedPayrollTaxesCurrent>
    <trnr:PaidTimeOffAccrual
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">188000</trnr:PaidTimeOffAccrual>
    <trnr:PaidTimeOffAccrual
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:PaidTimeOffAccrual>
    <trnr:AccruedOfferingCosts
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1490000</trnr:AccruedOfferingCosts>
    <trnr:AccruedOfferingCosts
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:AccruedOfferingCosts>
    <us-gaap:AccruedAdvertisingCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AccruedAdvertisingCurrent>
    <us-gaap:AccruedAdvertisingCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">195000</us-gaap:AccruedAdvertisingCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">31000</us-gaap:AccruedProfessionalFeesCurrent>
    <trnr:AccruedEngineeringCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:AccruedEngineeringCurrent>
    <trnr:AccruedEngineeringCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">93000</trnr:AccruedEngineeringCurrent>
    <trnr:AccruedLicenses
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2250000</trnr:AccruedLicenses>
    <trnr:AccruedLicenses
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1050000</trnr:AccruedLicenses>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">195000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022_ScenarioPreviouslyReportedMembersrtRestatementAxis"
      decimals="-3"
      unitRef="Unit_USD">323000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">532000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4784000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2125000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">520000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">295000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5304000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2420000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11. Debt &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2020 Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the year ended December&#160;31, 2020 the Company issued convertible notes (the &#x201c;2020 Convertible Notes&#x201d;) with an aggregate principal amount of $6.2&#160;million, pursuant to a private placement offering. The 2020 Convertible Notes bore interest at 6% per annum and had a scheduled maturity date of 12 to 24 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2020 Convertible Notes under ASC Topic 825, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Financial Instruments&lt;/div&gt;&lt;/div&gt;, with changes in fair value recorded in earnings each reporting period. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The 2020 Convertible Notes did not include any financial covenants and were subject to acceleration upon the occurrence of specified events of default. The 2020 Convertible Notes were subject to the following conversion features: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $&lt;div style="display:inline;"&gt;3.0&lt;/div&gt;&#160;million prior to the maturity date of the 2020 Convertible Notes, all principal and accrued interest will automatically convert into preferred stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company did not complete a qualified financing prior to the maturity date of the 2020 Convertible Notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing. The conversion price with respect to an elective conversion at the time of maturity is equal to the fair market value of the Company divided by the Company&#x2019;s fully diluted capitalization table at the time of conversion. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Two individual 2020 Convertible Notes with an aggregate principal value of $1,250,000 were subject to the following conversion features: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $&lt;div style="display:inline;"&gt;10.0&lt;/div&gt;&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) $50.0&#160;million divided by the sum of the Company&#x2019;s then-outstanding common stock, outstanding option, and promised options (the &#x201c;Cap Price&#x201d;). The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In July 2021, the Company completed a qualified financing, and as a result the 2020 Convertible Notes were automatically converted into 13,373 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt; preferred stock and 3,279 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; preferred stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2021 Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;From January through July 2021, the Company issued convertible notes (the &#x201c;2021 Convertible Notes&#x201d;) with an aggregate principal amount of $14.8&#160;million, pursuant to a private placement offering. The 2021 Convertible Notes bore interest at 6% per annum and had a scheduled maturity date of 24 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2021 Convertible Notes under ASC Topic 825, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Financial Instruments&lt;/div&gt;&lt;/div&gt;, with changes in fair value recorded in earnings each reporting period. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The 2021 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2021 Convertible Notes were subject to the following conversion features: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#x201c;Cap Price&#x201d;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In July 2021, the Company completed a qualified financing, and as a result the 2021 Convertible Notes were automatically converted into 130 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt; preferred stock, &lt;div style="display:inline;"&gt;24,576 &lt;/div&gt;shares of Series A preferred stock, and 6,929 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; preferred stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2022 Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;From January through March 2022, the Company issued convertible notes (the &#x201c;2022 Convertible Notes&#x201d;) with an aggregate principal amount of $5.9&#160;million, pursuant to a private placement offering. The 2022 Convertible Notes bore interest at 6% per annum and had a scheduled maturity date of 24 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#x201c;Cap Price&#x201d;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March&#160;2022, the Company completed a qualified financing, and as a result the 2022 Convertible Notes were automatically converted into 124,313 shares of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Series&#160;A-2.&lt;/div&gt; &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In November 2022, the Company issued convertible notes (the &#x201c;November 2022 Convertible Notes&#x201d;) with an aggregate principal amount of $4.4&#160;million, pursuant to a private placement offering. The November 2022 Convertible Notes bore interest at 6% per annum and had a schedule maturing date of 12 months from issuance, at which time the principal and &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;accrued interest would be due and payable. The Company elected the fair value option for the November 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) the price per share in the Next Financing round, or ii) the Original Issue Price of the Company&#x2019;s Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt; Preferred Stock, which is $47.67. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognized gains equal to $0.1&#160;million and $5.2&#160;million for the years ended December&#160;31, 2022 and 2021, respectively, related to changes in fair value for the 2022 Convertible Notes, 2021 Convertible Notes, and 2020 Convertible Notes. The outstanding balance of convertible notes as of December&#160;31, 2022 and 2021 was $4.3&#160;million and $0&#160;million, respectively. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Paycheck Protection Program Loan &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On April&#160;2, 2021, the Company received loan proceeds of approximately $0.5&#160;million under the Paycheck Protection Program (&#x201c;PPP&#x201d;). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (&#x201c;CARES Act&#x201d;), provides for loans to qualifying businesses to help sustain its employee payroll costs, rent, and utilities due to the impact of the recent &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; pandemic. Loans obtained through the PPP are eligible to be forgiven as long as the proceeds are used for qualifying purposes, which include the payment of payroll costs, interest on covered mortgage obligations, rent obligations and utility payments. The receipt of these funds, and the forgiveness of the loan is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on its adherence to the forgiveness criteria. In June 2020, Congress passed the Payroll Protection Program Flexibility Act that made several significant changes to PPP loan provisions, including providing greater flexibility for loan forgiveness. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company used the proceeds from the PPP loan to fund payroll costs in accordance with the relevant terms and conditions of the CARES Act. The Company followed the government guidelines and tracking costs to ensure full forgiveness of the loan. To the extent it was not forgiven, the Company would have been required to repay that portion at an interest rate of 1% over a period of 5 years, beginning May 2022 with a final installment in April 2027. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The balance outstanding for the PPP loan was $0.5&#160;million at December&#160;31, 2021 and was forgiven in 2022, which resulted in a $0.5 million gain upon debt forgiveness. &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">6200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="P01_01_2020To12_31_2020_MinimumMembersrtRangeAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="P01_01_2020To12_31_2020_MaximumMembersrtRangeAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis">P24M</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2020To12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">3000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="P01_01_2020To12_31_2020_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.80</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">1250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2020To12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="P01_01_2022To12_31_2022_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.80</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature
      contextRef="P01_01_2020To12_31_2020_TwoIndividualMembersrtTitleOfIndividualAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">50000000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn07_31_2021_SeriesSeed9PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">13373</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn07_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">3279</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">14800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="P01_01_2021To07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis">P24M</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2021To07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="P01_01_2021To07_31_2021_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.80</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn07_31_2021_SeriesSeed9PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">130</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn07_31_2021_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">24576</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn07_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyOneConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">6929</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">5900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis">P24M</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.80</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">124313</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">4400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">47.67</us-gaap:SharesIssuedPricePerShare>
    <trnr:GainRecognizedOnFairValueChangesOfConvertibleNotes
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">100000</trnr:GainRecognizedOnFairValueChangesOfConvertibleNotes>
    <trnr:GainRecognizedOnFairValueChangesOfConvertibleNotes
      contextRef="P01_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">5200000</trnr:GainRecognizedOnFairValueChangesOfConvertibleNotes>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="PAsOn12_31_2022_ConvertibleDebtMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">4300000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="PAsOn12_31_2021_ConvertibleDebtMemberusgaapDebtInstrumentAxis"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="P04_02_2021To04_02_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <trnr:PercentageOfInterestRateOfDebtForgiveness
      contextRef="P04_02_2021To04_02_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.01</trnr:PercentageOfInterestRateOfDebtForgiveness>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="PAsOn12_31_2021_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="P01_01_2022To12_31_2022_PaycheckProtectionProgramLoanMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <trnr:WarrantsDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12. Warrants &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Class&#160;A Common Stock Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During July 2021 and August 2021 the Company issued an aggregate 125,982 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with its Series A financing rounds at that time. Additionally, on November 13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. Each warrant has a strike price of $0.01 per share and has a contractual term of ten years. The warrants are classified as other long-term liabilities within the consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The fair value of the warrants issued in 2021 at the time of issuance was recorded as a reduction to the carrying value of the related preferred stock that they were issued with. The fair value of the warrants issued in 2022 was recorded as a liability on the Balance Sheet and expensed to other (expense) income, net on the Statement of Operations and Comprehensive Loss, at the time of issuance. &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&#160;Common&lt;br/&gt;Stock Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2020&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125,982&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(125,982)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;92,296&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Class&#160;B Common Stock Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During July 2021, the Company issued an aggregate 6,632 warrants to purchase Class&#160;B Common Stock to various employees and nonemployees. Each warrant has a strike price of $0.01 and has a contractual term of seven years. The warrants are classified as permanent equity within the consolidated balance sheets. 4,000 of these warrants with an aggregate fair value of $0.2&#160;million were issued as compensation for services provided to the Company and are recorded within operating expenses, as described in Note 15. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&#160;Common&lt;br/&gt;Stock Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2020&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,632&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(879)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,753&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,753&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</trnr:WarrantsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn07_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">125982</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">92296</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="P01_01_2022To12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&#160;Common&lt;br/&gt;Stock Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2020&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125,982&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(125,982)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;92,296&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2020_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <trnr:ClassOfWarrantsIssued
      contextRef="P01_01_2021To12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">125982</trnr:ClassOfWarrantsIssued>
    <trnr:ClassOfWarrantsExercised
      contextRef="P01_01_2021To12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-125982</trnr:ClassOfWarrantsExercised>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2021_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <trnr:ClassOfWarrantsIssued
      contextRef="P01_01_2022To12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">92296</trnr:ClassOfWarrantsIssued>
    <trnr:ClassOfWarrantsExercised
      contextRef="P01_01_2022To12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:ClassOfWarrantsExercised>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">92296</trnr:WarrantOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">6632</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">4000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="P01_01_2022To12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2020 to December&#160;31, 2022: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&#160;Common&lt;br/&gt;Stock Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2020&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,632&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(879)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,753&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,753&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2020_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <trnr:ClassOfWarrantsIssued
      contextRef="P01_01_2021To12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">6632</trnr:ClassOfWarrantsIssued>
    <trnr:ClassOfWarrantsExercised
      contextRef="P01_01_2021To12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-879</trnr:ClassOfWarrantsExercised>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">5753</trnr:WarrantOutstanding>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">5753</trnr:WarrantOutstanding>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13. Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s financial instruments consist of its convertible notes, warrants, SAFEs, and ASAs. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;There were no assets measured at fair value on a recurring basis as of December 31, 2022 and 2021. Liabilities measured at fair value on a recurring basis as of December 31, 2022 were as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:72%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value measurements as of&lt;br/&gt;December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,274&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,274&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;There were no liabilities measured at fair value on a recurring basis as of December 31, 2021. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the year ended December&#160;31, 2022, there were no transfers between Level&#160;1 and Level&#160;2, nor into and out of Level&#160;3. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following tables summarize the activity for the Company&#x2019;s Level&#160;3 liabilities measured at fair value on a recurring basis: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands) &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;SAFE&#160;Liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2020&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,655&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of SAFEs and ASAs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,416&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;251&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of ASAs into common stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,667)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of SAFEs into series seed preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,655)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands) &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible&#160;Notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2020&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,546&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,620&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,193&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into Series Seed preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,947)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into Series A preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(10,026)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,303&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;107&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into Series A preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,926)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:13%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands) &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrant&#160;Liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,482&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(478)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SAFEs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As further described in Note 4, between 2017 and 2021, the Company entered into several SAFEs with certain investors. The Company recorded the liability related to the SAFEs at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the SAFEs was determined using a probability weighted expected return method (PWERM), in which the probability and timing of potential future events (such as a qualified equity financing or a dissolution) is considered in order to estimate the fair value of the SAFEs as of each valuation date. Management determined the fair value of the SAFEs using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;100% equity value of the business, (3)&#160;equity volatility, and (4)&#160;recovery rate. The Company recorded an unfavorable change in fair value adjustment of $0.3 million in the consolidated statement of operations for the year ended December 31, 2021. Upon the occurrence of a Series&#160;A financing in 2021, all outstanding SAFEs were converted through the issuance of 0.02&#160;million shares of SAFE Preferred Stock. There were no outstanding SAFEs as of December 31, 2022 or 2021. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As further described in Note 10, the Company entered into several convertible note arrangements with certain investors during 2020, 2021, and 2022. The Company recorded the liability related to the convertible notes at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the convertible notes was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the convertible notes as of each valuation date. For the outstanding notes as of December 31, 2022, management determined the fair value of the convertible notes using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;expected future equity value of the underlying shares at the time of conversion, and (3)&#160;a discount rate of 20.36%. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recorded a change in fair value adjustment of $0.1&#160;million and $5.2&#160;million in the consolidated statement of operations and comprehensive loss for the years ended December&#160;31, 2022 and 2021, respectively. Upon the occurrence of a Series Seed and Series A financing in 2021, $12.0&#160;million of convertible notes were converted through the issuance of 0.05&#160;million shares of Preferred Stock. Upon the occurrence of a Series A financing in 2022, $5.9 million of convertible notes were converted through the issuance of 0.1&#160;million shares of Preferred Stock. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As further described in Note 12, on November&#160;13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. The Company recorded the liability related to the warrants at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the warrants was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of December 31, 2022, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) a discount rate of 21.7%. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recorded a change in fair value adjustment of $0.5&#160;million and $0&#160;million in the consolidated statement of operations and comprehensive loss for the years ended December&#160;31, 2022 and 2021, respectively. &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="P01_01_2022To12_31_2022">Liabilities measured at fair value on a recurring basis as of December 31, 2022 were as follows:&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:72%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value measurements as of&lt;br/&gt;December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,274&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,274&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">4270000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">4270000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3004000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3004000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">7274000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">7274000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following tables summarize the activity for the Company&#x2019;s Level&#160;3 liabilities measured at fair value on a recurring basis: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands) &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;SAFE&#160;Liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2020&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,655&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of SAFEs and ASAs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,416&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;251&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of ASAs into common stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,667)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of SAFEs into series seed preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,655)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands) &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible&#160;Notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2020&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,546&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,620&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,193&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into Series Seed preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,947)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into Series A preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(10,026)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,303&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;107&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into Series A preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,926)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:13%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands) &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrant&#160;Liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,482&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(478)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2020_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="-3"
      unitRef="Unit_USD">4655000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="-3"
      unitRef="Unit_USD">3416000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments
      contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="-3"
      unitRef="Unit_USD">-251000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock
      contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="-3"
      unitRef="Unit_USD">-5667000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock
      contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="-3"
      unitRef="Unit_USD">-2655000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2020_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2546000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">14620000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments
      contextRef="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">5193000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock
      contextRef="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">-1947000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock
      contextRef="P01_01_2021To12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">-10026000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">10303000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments
      contextRef="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">-107000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock
      contextRef="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">-5926000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">4270000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3482000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments
      contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">478000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3004000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <trnr:EquityValuePercentage
      contextRef="PAsOn12_31_2022"
      decimals="2"
      unitRef="Unit_pure">1</trnr:EquityValuePercentage>
    <trnr:FairValueAdjustmentsOfSimpleAgreementsForFutureEquity
      contextRef="P01_01_2021To12_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</trnr:FairValueAdjustmentsOfSimpleAgreementsForFutureEquity>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn07_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis"
      decimals="-4"
      unitRef="Unit_shares">20000.00</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2021_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberusgaapFairValueByLiabilityClassAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <trnr:DebtInstrumentMeasurementDiscountRate
      contextRef="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="4"
      unitRef="Unit_pure">0.2036</trnr:DebtInstrumentMeasurementDiscountRate>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="P01_01_2022To12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="P01_01_2021To12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">5200000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:ConvertibleDebt
      contextRef="PAsOn12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">12000000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn12_31_2021_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-4"
      unitRef="Unit_shares">50000.00</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertibleDebt
      contextRef="PAsOn12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">5900000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn12_31_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_shares">100000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn11_13_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">92296</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <trnr:WarrantsMeasurementDiscountRate
      contextRef="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"
      decimals="3"
      unitRef="Unit_pure">0.217</trnr:WarrantsMeasurementDiscountRate>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14. Leases &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company adopted ASC 842 on January&#160;1, 2022, using the effective date transition method, which requires a cumulative-effect adjustment to the opening balance of retained earnings on the effective date. As a result of the adoption of ASC 842, the Company recognized &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets and lease liabilities of $0.3&#160;million and $0.3&#160;million, respectively, as of the January&#160;1, 2022, effective date. There was no impact to opening retained earnings from the adoption of ASC 842. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company has made certain assumptions and judgements when applying ASC 842 including the adoption of the package of practical expedients available for transition. The practical expedients allowed the Company to not reassess (i)&#160;whether expired or existing contracts contained leases, (ii)&#160;lease classification for expired or existing leases and (iii)&#160;previously capitalized initial direct costs. The Company also elected not to recognize &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets and lease liabilities for short-term leases (leases with a term of twelve months or less). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Operating lease arrangements primarily consist of office and warehouse leases expiring at various years through 2024. The facility leases have original lease terms of &lt;span style="-sec-ix-hidden:hidden95757447"&gt;two&lt;/span&gt; to seven years and contain options to extend the lease up to 5 years or terminate the lease. Options to extend are included in leased &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets and lease liabilities in the consolidated balance sheet when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of December&#160;31, 2022, the weighted average discount rate for operating leases was 7.98% and the weighted average remaining lease term for operating leases was 0.8 years, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company has entered into various short-term operating leases for office and warehouse space, with an initial term of twelve months or less. These short-term leases are not recorded on the Company&#x2019;s consolidated balance sheet and the related lease expense for these short-term leases was $0.1&#160;million and $0&#160;million for the years ended December&#160;31, 2022 and 2021 respectively. Total operating lease cost was $0.6&#160;million and $0&#160;million for the years ended December&#160;31, 2022 and 2021, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; assets of $0.4&#160;million were obtained in exchange for lease liabilities during the year ended December&#160;31, 2022. &lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn01_01_2022"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="PAsOn01_01_2022"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="PAsOn12_31_2022_MaximumMembersrtRangeAxis">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="P01_01_2022To12_31_2022">5 years</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="PAsOn12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.0798</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="PAsOn12_31_2022">P0Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:ShortTermLeaseCost
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="P01_01_2021To12_31_2021"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:ShortTermLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">600000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="P01_01_2021To12_31_2021"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseCost>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">400000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15. Commitments and Contingencies &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Lease Obligations &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following represents the Company&#x2019;s minimum annual rental payments under operating leases for each of the next five years and thereafter:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Future Minimum Payments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;160&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;169&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Commitments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company is subject to minimum payments on a content licensing agreement. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following represents the Company&#x2019;s minimum annual guarantee payments under license agreements for each of the next five years and thereafter:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Future Minimum Payments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,025&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,950&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,250&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,200&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,425&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Legal Proceedings &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company is involved in legal proceedings in the normal course of business. The Company currently believes that any ultimate liability arising out of such proceedings will not have a material adverse effect on the Company&#x2019;s financial position, results of operations or cash flows. &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following represents the Company&#x2019;s minimum annual rental payments under operating leases for each of the next five years and thereafter:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Future Minimum Payments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;160&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;169&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">160000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">9000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">169000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:OtherCommitmentsTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following represents the Company&#x2019;s minimum annual guarantee payments under license agreements for each of the next five years and thereafter:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Future Minimum Payments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,025&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,950&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,250&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,200&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,425&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCommitmentsTableTextBlock>
    <us-gaap:OtherCommitmentDueInNextTwelveMonths
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2025000</us-gaap:OtherCommitmentDueInNextTwelveMonths>
    <us-gaap:OtherCommitmentDueInSecondYear
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1950000</us-gaap:OtherCommitmentDueInSecondYear>
    <us-gaap:OtherCommitmentDueInThirdYear
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2250000</us-gaap:OtherCommitmentDueInThirdYear>
    <us-gaap:OtherCommitmentDueInFourthYear
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1200000</us-gaap:OtherCommitmentDueInFourthYear>
    <us-gaap:OtherCommitmentDueInFifthYear
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OtherCommitmentDueInFifthYear>
    <us-gaap:OtherCommitmentDueAfterFifthYear
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OtherCommitmentDueAfterFifthYear>
    <us-gaap:OtherCommitment
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7425000</us-gaap:OtherCommitment>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;16. Redeemable Convertible Preferred Stock and Stockholders&#x2019; Equity &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Common Stock &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s authorized common stock consisted of 369,950,000 shares and 86,000,000 shares at $0.0001 par value, as of December&#160;31, 2022 and 2021, respectively. The issued and outstanding common stock was 2,450,922 shares and 213,065 shares as of December&#160;31, 2022 and 2021, respectively. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Warrant Transactions &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On July&#160;23, 2021, the Company issued 6,632 common stock warrants in lieu of interest payments on the Company&#x2019;s convertible notes and as compensation for services provided to the Company in relation to agreements entered into with a third-party content provider. Refer to Note 2 for additional information regarding these agreements. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 7 years, risk-free rate of 1.30%, and volatility of 65%. The fair value of the warrants of $0.4 million was recorded as a long-term liability. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On July&#160;23, 2021, the Company issued 76,353 common stock warrants in connection with the issuance of preferred stock. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 10 years, risk-free rate of 1.30%, and volatility of 65%. The fair value of the warrants of $4.2&#160;million was recorded as a reduction in the value of the Series A Financing. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="line-height:normal;background-color:white;display: inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On August&#160;25, 2021, the Company issued 49,629 common stock warrants in connection with the issuance of preferred stock. The warrants were initially recorded at their fair value calculated using the Black-Scholes model, with the following weighted-average assumptions: exercise price of $0.01 per share, price of $55.50 per share, expected term of 9.9 years, risk-free rate of 1.35%, and volatility of 65%. The fair value of the warrants of $2.8&#160;million was recorded as a reduction in the value of the Series A Financing. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On November 13, 2022, the Company issued 92,296 common stock warrants in connection with the issuance of the November 2022 Convertible Notes. The fair value of the warrants was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of December&#160;31, 2022, management determined the fair value of the warrants using the following significant unobservable inputs: (1)&#160;probability and timing of events, (2)&#160;expected future equity value of the underlying shares at the time of conversion, and (3)&#160;a discount rate of 21.7%. The fair value of the warrants of $3.5 million was recorded as a long-term liability upon issuance. A change in the fair value of warrants of $0.5 million resulted in a long-term liability of $3.0 million as of December 31, 2022. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Preferred Stock &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On December 23, 2022, all outstanding shares of redeemable convertible preferred stock were converted into shares of common stock on a one-to-one basis. Accordingly, no shares of preferred stock were outstanding as of December 31, 2022. On December 23, 2022 the Company amended and restated its certificate of incorporation to provide for, among other things, the Company&#x2019;s authorized capital stock to consist of 369,950,000 shares of common stock, par value $0.0001 per share and 200,000,000 share of preferred stock, par value $0.0001 per share. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Series Seed Financing &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In August 2018, the company entered into a Series Seed Preferred Stock Purchase Agreement (the &#x201c;Series Seed Agreement&#x201d;) for the issuance of 7,546 shares of Series Seed and 2,393 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-1.&lt;/div&gt; The Company completed its initial Series Seed closing on August&#160;14, 2018, by issuing a total of 1,666 shares on this date at a purchase price of approximately $300.00 per share (the &#x201c;Series Seed Share Price&#x201d;). Between August 2018 and December 2018, the Company issued additional shares of Series Seed in a series of subsequent closings total of 5,880 shares and an additional 2,393 shares related from the conversion of the Company&#x2019;s SAFE (combined the &#x201c;Series Seed Financing&#x201d;). The aggregate gross proceeds from the Series Seed Financing were approximately $2.3&#160;million. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Series A Financing &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In July 2021 the Company amended its Certificate of Incorporation (&#x201c;COI&#x201d;) to authorize the issuance of 250,000 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-2,&lt;/div&gt; 37,313 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-3,&lt;/div&gt; 21,131 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-4,&lt;/div&gt; 512,425 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-5,&lt;/div&gt; 122,500 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-6,&lt;/div&gt; 257,797 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-7,&lt;/div&gt; 665,588 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-8,&lt;/div&gt; 2,775,210 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9,&lt;/div&gt; 327,218 shares of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-10,&lt;/div&gt; 18,165,136 shares of Series A, and 1,531,734 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1.&lt;/div&gt; &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On July&#160;23, 2021, the Company executed a Series Seed and Series A Preferred Stock Purchase Agreement (the &#x201c;Series Seed and Series A Agreement&#x201d;) for the purposes of raising capital in the aggregate amount of up to $33.0&#160;million by the means of issuance of Series A, Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; and Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-2,&lt;/div&gt; Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-3,&lt;/div&gt; Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-4,&lt;/div&gt; Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-5,&lt;/div&gt; Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-6,&lt;/div&gt; Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-7,&lt;/div&gt; Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-8,&lt;/div&gt; Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9,&lt;/div&gt; and Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-10&lt;/div&gt; (all Series Seed issuances noted herein are collectively referred to as &#x201c;Series Seed &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2-10&#x201d;).&lt;/div&gt; On this date, the Company cancelled $5.3&#160;million and $6.9&#160;million (including principal and interest) of Series A Convertible Notes and SAFEs, respectively, which converted into a total of 13,503 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt; and a total of 19,519 of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-2-10,&lt;/div&gt;&lt;/div&gt; respectively. On the date of the Series Seed and Series A Agreement, the Company also cancelled its 2020 Secured Convertible Notes, of which $12.1&#160;million (including principal and interest) converted into 24,576 shares of Series A and $4.0&#160;million (including principal and interest) converted into 10,208 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1(see&lt;/div&gt; Note 11). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On July&#160;23, 2021, the Company issued 14,182 shares of Series A at a purchase price of approximately $490.50 per share. On August&#160;13, 2021, the Company issued 25,189 shares of Series A at a purchase price of approximately $490.50 per share. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On November&#160;24, 2021, the Company amended its Amended and Restated Certificate of Incorporation to increase the number of Series A shares authorized from 9,592,788 to 18,165,136 total shares. As a result, on that date, the Company completed an additional closing of Series A and issued a total of 22,756 shares at a purchase price of approximately $490.50 per share. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The aggregate gross proceeds from the Series A Financing were approximately $30.5&#160;million. Proceeds from the issuances associated with the cancellation of the convertible notes were equal to the fair value of the convertible notes upon conversion. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividends &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The holders of common stock are entitled to receive dividends upon declaration by the Board of Directors. Such dividends &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;are&#160;non-cumulative.&lt;/div&gt; As of December&#160;31, 2022 and 2021, no dividends have been declared or distributed to any stockholders. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liquidation Preferences &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In the event of any voluntary or involuntary liquidation event, dissolution or winding up of the Company or deemed liquidation event, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to the stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Rights and Preferences &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;There are no preemptive, redemption or sinking fund provisions applicable to our common stock. The rights, preferences, and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate and issue in the future. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Voting &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The holder of each share of preferred stock is entitled to one vote for each share of common stock into which such preferred stock is convertible at the time of the vote. With respect to such vote, such holder has full voting rights and powers equal to the voting rights of the holders of common stock. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Redemption &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company has classified the preferred stock as temporary equity as the shares have certain&#160;redemption features&#160;that are not solely in the control of the Company. The preferred stock is not currently redeemable because the deemed liquidation provision is considered a substantive condition that is contingent on the event and it is not currently probable that it will become redeemable. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company classifies preferred stock in accordance with ASC 480,&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;Distinguishing Liabilities from Equity&lt;/div&gt;&lt;/div&gt;, which requires that contingently redeemable securities be classified outside of permanent stockholders&#x2019; equity. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Accordingly, the Company has classified all shares and classes of preferred stock as mezzanine equity in the accompanying financial statements as of December&#160;31, 2021. In 2022, the Company&#x2019;s preferred stock was converted to common stock on a one-to-one share basis. As a result, there is no mezzanine equity as of December 31, 2022. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Convertible redeemable preferred stock consisted of the following as of December&#160;31, 2022:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:28%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Redeemable&lt;br/&gt;Convertible&#160;Preferred&lt;br/&gt;Stock:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&#160;Authorized&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&#160;Outstanding&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Price&#160;per&#160;Share&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Carrying&#160;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liquidation&lt;br/&gt;Preference&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;13,006,028&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;490.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,531,734&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;173,135,395&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;47.67&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,133,701&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;300.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;359,375&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;210.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;250,000&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;60.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;37,313&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21,131&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;177.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;512,425&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;283.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-6&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;122,500&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;300.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;257,797&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;355.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;665,588&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;417.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,754,796&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20,414&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-10&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;327,218&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;490.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total redeemable convertible preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;194,135,415&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Convertible redeemable preferred stock consisted of the following as December&#160;31, 2021: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:26%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Redeemable&lt;br/&gt;Convertible Preferred&lt;br/&gt;Stock:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&#160;Authorized&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&#160;Outstanding&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Price&#160;per&#160;Share&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Carrying&#160;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liquidation&lt;br/&gt;Preference&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18,165,136&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;86,703&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;490.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19,535&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;53,162&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,531,734&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,208&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,604&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,013&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,133,701&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,546&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;300.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,267&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,267&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;359,375&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,393&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;210.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;719&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;503&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;250,000&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,666&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;60.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;160&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;37,313&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21,131&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;140&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;177.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;15&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;512,425&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,414&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;283.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;425&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;968&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-6&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;122,500&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;815&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;300.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;104&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;245&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;257,797&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,716&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;355.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;235&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;611&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;665,588&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,410&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;417.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;659&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,850&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,754,796&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18,344&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,644&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,218&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20,414&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;136&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;53&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-10&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;327,218&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,171&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;490.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;321&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,070&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total redeemable convertible preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;26,159,128&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;139,910&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;29,733&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;72,110&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">369950000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">86000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">2450922</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">2450922</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">213065</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">213065</us-gaap:CommonStockSharesIssued>
    <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
      contextRef="P07_23_2021To07_23_2021_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">6632</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_shares">0.01</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_shares">55.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_Y">7</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_pure">1.3</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_pure">65</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn07_23_2021_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">400000</us-gaap:DerivativeLiabilities>
    <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
      contextRef="P07_23_2021To07_23_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">76353</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_shares">0.01</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_shares">55.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_Y">10</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_pure">1.3</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn07_23_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_pure">65</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn07_23_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">4200000</us-gaap:DerivativeLiabilities>
    <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
      contextRef="P08_25_2021To08_25_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">49629</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn08_25_2021_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_shares">0.01</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn08_25_2021_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_shares">55.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn08_25_2021_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="1"
      unitRef="Unit_Y">9.9</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn08_25_2021_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_pure">1.35</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn08_25_2021_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_pure">65</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn08_25_2021_SeriesAFinancingMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">2800000</us-gaap:DerivativeLiabilities>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn11_13_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">92296</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <trnr:PercentageOfDiscountRateOnConvertibleNotes
      contextRef="P01_01_2022To12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="3"
      unitRef="Unit_pure">0.217</trnr:PercentageOfDiscountRateOnConvertibleNotes>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn11_13_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">3500000</us-gaap:DerivativeLiabilities>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">3000000</us-gaap:DerivativeLiabilities>
    <us-gaap:PreferredStockConversionBasis contextRef="P12_23_2022To12_23_2022">one-to-one</us-gaap:PreferredStockConversionBasis>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_23_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">369950000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_23_2022"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_23_2022"
      decimals="0"
      unitRef="Unit_shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_23_2022"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn08_14_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">7546</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn08_14_2018_SeriesSeedOneMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">2393</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn08_14_2018_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">1666</us-gaap:PreferredStockSharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn08_14_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">300</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P08_14_2018To12_31_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">5880</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P08_14_2018To12_31_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">2393</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="P08_14_2018To12_31_2018_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">250000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">37313</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">21131</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">512425</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">122500</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">257797</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">665588</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">2775210</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_Seed10MemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">327218</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">18165136</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn07_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1531734</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="P07_23_2021To07_23_2021_SeriesSeedAndSeriesAAgreementMemberusgaapTypeOfArrangementAxis"
      decimals="-5"
      unitRef="Unit_USD">33000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P07_23_2021To07_23_2021_SeriesAConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">5300000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P07_23_2021To07_23_2021_SimpleAgreementsForFutureEquityMemberusgaapTypeOfArrangementAxis"
      decimals="-5"
      unitRef="Unit_USD">6900000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P07_23_2021To07_23_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">13503</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P07_23_2021To07_23_2021_SeriesSeedTwoTenMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">19519</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P07_23_2021To07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">12100000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P07_23_2021To07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">24576</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P07_23_2021To07_23_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">4000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P07_23_2021To07_23_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis_TwoThousandAndTwentySecuredConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">10208</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">14182</us-gaap:PreferredStockSharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn07_23_2021_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">490.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn08_13_2021_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">25189</us-gaap:PreferredStockSharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn08_13_2021_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">490.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn11_24_2021_MinimumMembersrtRangeAxis_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">9592788</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn11_24_2021_MaximumMembersrtRangeAxis_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">18165136</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn11_24_2021_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">22756</us-gaap:PreferredStockSharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn11_24_2021_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">490.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="P01_01_2022To12_31_2022_SeriesAMemberusgaapStatementClassOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">30500000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:PaymentsOfDividends
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:PaymentsOfDividends>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:PreferredStockVotingRights contextRef="P01_01_2022To12_31_2022">one vote</us-gaap:PreferredStockVotingRights>
    <us-gaap:PreferredStockConversionBasis contextRef="P01_01_2022To12_31_2022">one-to-one</us-gaap:PreferredStockConversionBasis>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Convertible redeemable preferred stock consisted of the following as of December&#160;31, 2022:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:28%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Redeemable&lt;br/&gt;Convertible&#160;Preferred&lt;br/&gt;Stock:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&#160;Authorized&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&#160;Outstanding&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Price&#160;per&#160;Share&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Carrying&#160;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liquidation&lt;br/&gt;Preference&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;13,006,028&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;490.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,531,734&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;173,135,395&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;47.67&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,133,701&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;300.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;359,375&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;210.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;250,000&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;60.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;37,313&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21,131&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;177.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;512,425&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;283.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-6&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;122,500&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;300.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;257,797&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;355.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;665,588&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;417.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,754,796&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20,414&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-10&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;327,218&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;490.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total redeemable convertible preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;194,135,415&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Convertible redeemable preferred stock consisted of the following as December&#160;31, 2021: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:26%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Redeemable&lt;br/&gt;Convertible Preferred&lt;br/&gt;Stock:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&#160;Authorized&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&#160;Outstanding&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Price&#160;per&#160;Share&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Carrying&#160;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liquidation&lt;br/&gt;Preference&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18,165,136&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;86,703&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;490.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19,535&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;53,162&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,531,734&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,208&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,604&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,013&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,133,701&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,546&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;300.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,267&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,267&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;359,375&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,393&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;210.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;719&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;503&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;250,000&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,666&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;60.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;160&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;37,313&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21,131&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;140&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;177.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;15&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;512,425&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,414&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;283.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;425&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;968&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-6&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;122,500&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;815&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;300.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;104&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;245&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;257,797&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,716&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;355.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;235&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;611&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;665,588&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,410&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;417.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;659&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,850&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,754,796&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18,344&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,644&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,218&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20,414&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;136&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;393.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;53&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Seed-10&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;327,218&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,171&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;490.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;321&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,070&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total redeemable convertible preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;26,159,128&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;139,910&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;29,733&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;72,110&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesAStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">13006028</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesAStockMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">490.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesAOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1531734</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesAOneMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">393</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesATwoMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">173135395</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesATwoMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">47.67</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1133701</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">300</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">359375</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedOneMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">210</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">250000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">60</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">37313</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">100.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedFourMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">21131</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedFourMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">177</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">512425</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">283.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedSixMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">122500</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedSixMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">300</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">257797</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">355.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedEightMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">665588</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedEightMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">417</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">2754796</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">393</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">20414</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">393</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesSeedTenMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">327218</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2022_SeriesSeedTenMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">490.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_shares">194135415</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">18165136</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">86703</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">490.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">19535000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesAStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">53162000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1531734</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">10208</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">393</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2604000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesAOneMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">4013000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1133701</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">7546</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">300</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2267000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2267000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">359375</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">2393</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">210</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">719000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedOneMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">503000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">250000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1666</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">60</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">160000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedTwoMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">100000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">37313</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">248</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">100.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedThreeMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">21131</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">140</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">177</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">15000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedFourMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">512425</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">3414</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">283.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">425000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedFiveMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">968000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">122500</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">815</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">300</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">104000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedSixMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">245000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">257797</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1716</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">355.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">235000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedSevenMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">611000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">665588</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">4410</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">417</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">659000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedEightMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">1850000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">2754796</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">18344</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">393</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2644000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedNineMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">7218000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">20414</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">136</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">393</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">20000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedNineOneMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">53000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">327218</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">2171</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">490.5</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">321000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021_SeriesSeedTenMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">1070000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_shares">26159128</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_shares">139910</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">29733000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">72110000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17. Equity-Based Compensation &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020 Equity Incentive Plan &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2020, the Board of Directors approved the establishment of the 2020 Plan to provide stock award grants to employees, directors, and consultants of the Company. The Board of Directors, or at its sole discretion, a committee of the Board of Directors, is responsible for the administration of the 2020 Plan. As of December 2021, the Board of Directors has authorized the issuance of up to 3,000,000 shares of common stock for stock award grants, including incentive &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;and&#160;non-qualified&#160;stock&lt;/div&gt; options; restricted stock; or stock appreciation rights. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The 2020 Plan requires that the per share exercise price of each stock option shall not be less than 100% of the fair market value of the common stock subject to the stock option on the grant date. Stock option grants shall not be exercisable after the expiration of 10 years from the date of its grant or such shorter period as specified in a stock award agreement. The Board of Directors shall determine the terms of vesting. The 2020 Plan provides that the Board of Directors may, in its sole discretion, impose such limitations on transferability of stock options as the Board of Directors shall determine. In the absence of a determination by the Board of Directors to the contrary, stock options shall not be transferable except by will or by the laws of descent and distribution and domestic relations orders, unless specifically agreed to by the plan administrator. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Presented below is a summary of the compensation cost recognized in the consolidated statements of operations for the years ended December 31, 2022 and 2021. &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:56%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December 31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,765&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;112&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Sales and marketing&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;286&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;31&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;General and administrative&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,297&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,021&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,348&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,164&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock Options &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The 2020 Plan allows for the early exercise of stock options. Stock options exercised prior to vesting will continue to vest according to the respective option agreement. Shares purchased pursuant to the early exercise of stock options are subject to repurchase until those shares vest; therefore, cash received in exchange for unvested shares exercised is recorded as a liability on the accompanying consolidated balance sheets and are reclassified to common stock and additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital as the shares vest. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the fiscal year ended December&#160;31, 2022 and 2021, the Company granted options to purchase 439,786 and 45,394 shares under the 2020 Plan, respectively. The Company has not granted any restricted stock or stock appreciation rights. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2022, the Company enacted a restructuring cost savings initiative which resulted in employee terminations. In association with the restructuring, the Company accelerated the vesting of a number of individual option awards, resulting in the accelerated vesting of 42,934 shares on the date of modification. This was accounted for as an equity award modification under ASC Topic 718 which resulted in adjustment of the award value to reflect the fair value at the modification date and acceleration of the recognition schedule. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following summary sets forth the stock option activity under the 2020 Plan:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:41%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&lt;br/&gt;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;br/&gt;exercise price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;br/&gt;remaining&lt;br/&gt;contractual term&lt;br/&gt;(in years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Aggregate&lt;br/&gt;intrinsic&#160;value&lt;br/&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Balances at December&#160;31, 2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;51,149&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20.34&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.7&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,953&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options granted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;439,786&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1.66&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(7,784)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.75&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;271&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options cancelled&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(36,310)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;19.78&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Balances at December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;446,841&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.30&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.6&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,706&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Exercisable at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;145,713&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.53&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.6&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,638&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Unvested at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;266,993&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.07&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.6&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,058&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The aggregate intrinsic value of options outstanding, exercisable and unvested were calculated as the difference between the exercise price of the options and the estimated fair market value of the Company&#x2019;s common stock, as of December&#160;31, 2022 and 2021. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:69%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Early Option Exercises&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&lt;br/&gt;Options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Repurchase&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liability&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested common stock &#x2014; December&#160;31, 2021&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,134&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;88&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issued&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;6,057&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.48&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vested&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;(794)&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;7.17&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Repurchased&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;(2,574)&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested common stock &#x2014; December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;3,823&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;306&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;For the years ended December&#160;31, 2022 and 2021, the weighted-average grant date fair value per option was $27.17 and $0.21, respectively. The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:96%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average risk-free interest rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.3%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.2%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average expected term (in years)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.35&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.50&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average expected volatility&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;54.6%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;43.1%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;&lt;div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000"&gt;&#160;&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: justify; line-height: normal;"&gt;Based on U.S. Treasury&#160;seven-year&#160;constant maturity interest rate whose term is consistent with the expected term of the option. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: justify; line-height: normal;"&gt;Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#x2019;s stage of development. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="line-height:normal;background-color:white;display: inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;With respect to the 2020 Plan, the Company recognized stock compensation expense of $6.3 million and $1.2 for the fiscal years ended December&#160;31, 2022 and 2021, respectively. As of December 31, 2022 and 2021, the Company had $5.9 million and $0.9 million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of 1.6 years and 1.7 years, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Warrants Issued to Nonemployees &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On July&#160;23, 2021, the Company issued a total of 4,000 warrants to purchase Class&#160;B Common Stock to various nonemployees as compensation for services rendered. Each warrant has a strike price of $0.01 per share and has a seven-year term from the date of issuance. Each warrant had a grant date fair value of $55.50 for an aggregate fair value of $0.2&#160;million, which was recorded as a general and administrative expense within the Statement of Operations. Each warrant was fully vested at issuance and are subject to the guidance under ASC 718, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Compensation-Stock Compensation&lt;/div&gt;&lt;/div&gt;. The warrants meet the criteria for permanent equity classification. &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="P12_31_2020To12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_pure">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="P12_31_2020To12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Presented below is a summary of the compensation cost recognized in the consolidated statements of operations for the years ended December 31, 2022 and 2021. &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:56%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December 31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,765&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;112&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Sales and marketing&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;286&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;31&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;General and administrative&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,297&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,021&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,348&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,164&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">1765000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">112000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">286000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2021To12_31_2021_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">31000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">4297000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2021To12_31_2021_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">1021000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">6348000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">1164000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">439786</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P01_01_2021To12_31_2021_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">45394</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="P12_31_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">42934</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following summary sets forth the stock option activity under the 2020 Plan:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:41%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&lt;br/&gt;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;br/&gt;exercise price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;br/&gt;remaining&lt;br/&gt;contractual term&lt;br/&gt;(in years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Aggregate&lt;br/&gt;intrinsic&#160;value&lt;br/&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Balances at December&#160;31, 2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;51,149&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20.34&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.7&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,953&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options granted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;439,786&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1.66&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(7,784)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.75&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;271&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options cancelled&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(36,310)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;19.78&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Balances at December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;446,841&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.30&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.6&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,706&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Exercisable at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;145,713&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.53&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.6&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,638&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Unvested at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;266,993&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.07&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.6&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,058&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">51149</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">20.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P9Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="PAsOn12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">1953000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">439786</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">1.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">7784</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">2.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">271000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">36310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">19.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">446841</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">2.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P9Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">11706000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">145713</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">3.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P9Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">3638000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">266993</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">2.07</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <trnr:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P9Y7M6D</trnr:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">7058000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:69%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Early Option Exercises&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&lt;br/&gt;Options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Repurchase&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liability&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested common stock &#x2014; December&#160;31, 2021&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,134&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;88&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issued&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;6,057&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7.48&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vested&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;(794)&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;7.17&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Repurchased&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;(2,574)&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested common stock &#x2014; December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;3,823&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: right; line-height: normal;"&gt;306&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="PAsOn12_31_2021_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">1134</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="PAsOn12_31_2021_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_USD_per_Share">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability
      contextRef="PAsOn12_31_2021_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">88000</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">6057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">7.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">794</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">7.17</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">2574</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_USD_per_Share">0</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">3823</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability
      contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">306000</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">27.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="P01_01_2022To12_31_2022">The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:96%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average risk-free interest rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.3%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.2%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average expected term (in years)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.35&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.50&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average expected volatility&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;54.6%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;43.1%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;&lt;div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000"&gt;&#160;&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: justify; line-height: normal;"&gt;Based on U.S. Treasury&#160;seven-year&#160;constant maturity interest rate whose term is consistent with the expected term of the option. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: justify; line-height: normal;"&gt;Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#x2019;s stage of development. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="P01_01_2022To12_31_2022"
      decimals="3"
      unitRef="Unit_pure">0.033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="P01_01_2021To12_31_2021"
      decimals="3"
      unitRef="Unit_pure">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2022To12_31_2022">P5Y4M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2021To12_31_2021">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="P01_01_2022To12_31_2022"
      decimals="3"
      unitRef="Unit_pure">0.546</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="P01_01_2021To12_31_2021"
      decimals="3"
      unitRef="Unit_pure">0.431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">6300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">5900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="PAsOn12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2021To12_31_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <trnr:WarrantsIssuedDuringThePeriodShares
      contextRef="P07_23_2021To07_23_2021"
      decimals="0"
      unitRef="Unit_shares">4000</trnr:WarrantsIssuedDuringThePeriodShares>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn07_23_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <trnr:WarrantGrantDateFairValue
      contextRef="PAsOn07_23_2021"
      decimals="4"
      unitRef="Unit_pure">0.555</trnr:WarrantGrantDateFairValue>
    <trnr:FairValueOfWarrants
      contextRef="P07_23_2021To07_23_2021"
      decimals="-5"
      unitRef="Unit_USD">200000</trnr:FairValueOfWarrants>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18. Concentration of Credit Risk and Major Customers and Vendors &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company&#x2019;s cash and cash equivalents are maintained with high-quality financial institutions, the compositions and maturities of which are regularly monitored by management. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;For the years ended December&#160;31, 2022 and 2021, there were no customers representing greater than 10% of the Company&#x2019;s total revenue. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company had three vendors and one vendor representing greater than 10% of total finished goods purchases for the years ended December&#160;31, 2022 and 2021, respectively. &lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <trnr:NumberOfCustomer
      contextRef="P01_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="0"
      unitRef="Unit_Customer">0</trnr:NumberOfCustomer>
    <trnr:NumberOfCustomer
      contextRef="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="0"
      unitRef="Unit_Customer">0</trnr:NumberOfCustomer>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <trnr:NumberOfSignificantVendors
      contextRef="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis"
      decimals="0"
      unitRef="Unit_Vendor">3</trnr:NumberOfSignificantVendors>
    <trnr:NumberOfSignificantVendors
      contextRef="P01_01_2021To12_31_2021_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorOneMembersrtMajorCustomersAxis"
      decimals="0"
      unitRef="Unit_Vendor">1</trnr:NumberOfSignificantVendors>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2021To12_31_2021_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19. Benefit Plans &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company established a defined contribution savings plan under Section&#160;401(k) of the Internal Revenue Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;a&#160;pre-tax&#160;basis.&lt;/div&gt; Matching contributions to the plan may be made at the discretion of the Company&#x2019;s board of directors. During the years ended December&#160;31, 2022 and 2021, the Company made contributions of $0&#160;million and $0.6&#160;million, respectively, to the plan. &lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="P01_01_2022To12_31_2022"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="P01_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">600000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20. Income Taxes &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The components of loss before income taxes are as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands)&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;United States&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;$(56,817)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(31,746)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,408)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(1,090)&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Loss from operations before income taxes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(58,225)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(32,836)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The components of income tax (benefit) expense are as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:67%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands)&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Current:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Federal&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;State&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total current expense:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred expense:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Federal&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;State&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total deferred expense:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:73%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Federal statutory rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(12,228&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(6,879&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Effect of:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Nondeductible expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(78&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.13&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;192&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-0.60&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Nontaxable changes in fair value of convertible notes and SAFEs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(123&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.21&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,038&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.22&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development tax credits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,670&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.59&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(674&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.06&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;State taxes, net of federal benefit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,865&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.20&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,705&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.20&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign tax rate differential&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;28&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-0.05&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-0.03&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(190&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.33&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in valuation allowance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;15,567&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-26.73&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,093&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-30.81&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Disqualified debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;731&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-1.26&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Return to provision adjustements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,060&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.82&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Intangibles&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,281&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-2.20&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock based compensation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;615&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-1.06&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-0.01&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.04&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The primary differences from the U.S. statutory rate and the Company&#x2019;s effective tax rate for the year ended December&#160;31, 2022 are due to the change in valuation allowance, federal net operating loss true ups, and State taxes, net of Federal benefit. The primary differences from the U.S. statutory rate and the Company&#x2019;s effective tax rate for the year ended December&#160;31, 2021 were due to the change in valuation allowance, share based compensation including excess tax benefits, state and international taxes. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On August&#160;16, 2022, the Inflation Reduction Act was signed into law in the United States. Among other provisions, the Inflation Reduction Act includes a 15% minimum tax rate applied to corporations with profits in excess of $1&#160;billion and also includes an excise tax on the repurchase of corporate stock. The Company has reviewed the provisions of the law and does not believe that any of the provisions will have a material impact on the business. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On March&#160;11, 2021, the American Rescue Plan was enacted, which extends the period companies can claim an Employee Retention Credit, expands the IRC Section 162(m) limit on deductions for publicly traded companies, and repeals the election that allows US affiliate groups to allocate interest expense on a worldwide basis, among other provisions. The Company reviewed the provisions of the law and determined it had no material impact for the year ended December&#160;31, 2021. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On December&#160;21, 2020, Congress passed the Consolidated Appropriations Act, 2021. The act includes the Taxpayer Certainty and Disaster Tax Relief Act of 2020 and the COVID-related Tax Relief Act of 2020, both of which extend many credits and other COVID-19 relief, among other extensions. The Company evaluated the provisions of the Consolidated Appropriations Act, including but not limited to the Employee Retention Credit extension, the extension for the IRC Section 45S credit for paid family and medical leave, and the provision allowing a full deduction for certain business meals, and determined that there was no material impact for the year ended December&#160;31, 2022. &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022 and December&#160;31, 2021, the Company&#x2019;s deferred tax assets were primarily the result of U.S. federal and state net operating losses (&#x201c;NOLs&#x201d;). A valuation allowance was maintained and/or established in substantially all jurisdictions on the Company&#x2019;s gross deferred tax asset balances as of December&#160;31, 2022 and 2021. As of each reporting date, the Company&#x2019;s management considers new evidence, both positive and negative, that could impact management&#x2019;s view with regard to future realization of deferred tax assets. The realization of deferred tax assets was based on the evaluation of current and estimated future profitability of the operations, reversal of deferred tax liabilities and the likelihood of utilizing tax credit and/or loss carryforwards. As of December&#160;31, 2022 and December&#160;31, 2021, the Company continued to maintain that it is not at the more likely than not standard, wherein deferred taxes will be realized due to the recent history of losses and management&#x2019;s expectation of continued tax losses. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#x2019;s deferred tax assets (liabilities) are as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:65%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;(in thousands)&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred tax assets:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net operating loss carryforwards - Federal&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;16,776&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,760&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized research and development&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,768&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development tax credits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,593&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;923&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net operating loss carryforwards - State&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,752&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,260&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net operating loss carryforwards - Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,894&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,846&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,219&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fixed assets and intangibles&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(868)&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total deferred tax assets, gross:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,134&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,789&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Valuation allowance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(30,134)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(14,789)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total deferred tax liabilities:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred tax assets, net:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022, the Company had federal NOLs of approximately $79.9&#160;million, substantially all of which will be carried forward indefinitely. As of December&#160;31, 2022, the Company had state NOLs of approximately $75.8&#160;million, which will begin to expire in &lt;div style="display:inline;"&gt;&lt;span style="-sec-ix-hidden:hidden95757939"&gt;2029&lt;/span&gt;&lt;/div&gt;. As of December&#160;31, 2022, the Company had foreign NOLs of approximately $10.0&#160;million, generated primarily from its operations in the United Kingdom, which will be carried forward indefinitely. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022, the Company also has federal and state tax credits of $1.6&#160;million and $2.5&#160;million, respectively, which being to expire in &lt;div style="display:inline;"&gt;&lt;span style="-sec-ix-hidden:hidden95757488"&gt;2040&lt;/span&gt;&lt;/div&gt; for the federal tax credit and &lt;div style="display:inline;"&gt;&lt;span style="-sec-ix-hidden:hidden95757489"&gt;2035&lt;/span&gt;&lt;/div&gt; for the state tax credits. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022, the Company did not have material undistributed foreign earnings. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Tax Cuts and Jobs Act (TCJA) resulted in significant changes to the treatment of research and developmental (R&amp;amp;D) expenditures under Section&#160;174. For tax years beginning after December&#160;31, 2021, taxpayers are required to capitalize and amortize all R&amp;amp;D expenditures that are paid or incurred in connection with their trade or business. Specifically, costs for U.S.-based R&amp;amp;D activities must be amortized over five years and costs for foreign R&amp;amp;D activities must be amortized over 15 years&#x2014;both using a midyear convention. During the year ended December&#160;31, 2022, the Company capitalized $18.2&#160;million of domestic R&amp;amp;D expenses. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Section&#160;382 of the Internal Revenue Code and similar provisions under state law limit the utilization of federal NOL carryforwards, state NOL carryforwards, and Research and Development (R&amp;amp;D) credits following certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of &lt;div style="display:inline;"&gt;50&lt;/div&gt;%. Based on the Company&#x2019;s analysis under Section&#160;382, the Company believes that its federal NOL carryforwards, its state NOL carryforwards, and R&amp;amp;D credits are limited by Section&#160;382 and similar provisions under state law as of December&#160;31, 2022. The portion of federal NOL carryforwards, state NOL carryforwards, and R&amp;amp;D credits that were determined to be limited have been written off as of December&#160;31, 2022. The remaining unused carryforwards and credits remain available for future periods. Due the Company&#x2019;s full valuation allowance the write off of NOL carryforwards and R&amp;amp;D did not have any impact to the statements of operation and comprehensive loss. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;The Company is subject to taxation in the United States, various state and local jurisdictions, as well as foreign jurisdictions where the Company conducts business. Accordingly, on a continuing basis, the Company cooperates with taxing authorities for the various jurisdictions in which it conducts business to comply with audits and inquiries for tax periods that are open to examination. The tax years ended from December&#160;31, 2019 and 2018 and later remain open to examination by tax authorities in the United States and United Kingdom, respectively.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The components of loss before income taxes are as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands)&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;United States&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;$(56,817)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(31,746)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,408)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(1,090)&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Loss from operations before income taxes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(58,225)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(32,836)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-56817000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-31746000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-1408000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-1090000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-58225000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32836000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The components of income tax (benefit) expense are as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:67%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands)&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Current:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Federal&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;State&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total current expense:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred expense:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Federal&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;State&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total deferred expense:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="P01_01_2022To12_31_2022">
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:73%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Federal statutory rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(12,228&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(6,879&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Effect of:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Nondeductible expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(78&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.13&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;192&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-0.60&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Nontaxable changes in fair value of convertible notes and SAFEs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(123&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.21&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,038&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.22&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development tax credits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,670&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.59&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(674&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.06&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;State taxes, net of federal benefit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,865&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.20&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,705&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.20&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign tax rate differential&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;28&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-0.05&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-0.03&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(190&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.33&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in valuation allowance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;15,567&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-26.73&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,093&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-30.81&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Disqualified debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;731&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-1.26&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Return to provision adjustements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,060&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.82&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Intangibles&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,281&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-2.20&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock based compensation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;615&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-1.06&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;-0.01&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.04&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-12228000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-6879000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-78000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.0013</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">192000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <trnr:IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-123000</trnr:IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes>
    <trnr:EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.0021</trnr:EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent>
    <trnr:IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1038000</trnr:IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes>
    <trnr:EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0.0322</trnr:EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-2670000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.0459</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-674000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0.0206</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-1865000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1705000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0.052</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">28000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">-0.0005</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">11000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">-0.0003</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-190000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.0033</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">15567000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">-0.2673</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">10093000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">-0.3081</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <trnr:IncometaxreconciliationDisqualifiedDebt
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">731000</trnr:IncometaxreconciliationDisqualifiedDebt>
    <trnr:EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">-0.0126</trnr:EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent>
    <trnr:IncometaxreconciliationDisqualifiedDebt
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:IncometaxreconciliationDisqualifiedDebt>
    <trnr:EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0</trnr:EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-1060000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.0182</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <trnr:IncometaxreconciliationIntangibles
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1281000</trnr:IncometaxreconciliationIntangibles>
    <trnr:EffectiveIncomeTaxRateReconciliationIntangiblesPercent
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">-0.022</trnr:EffectiveIncomeTaxRateReconciliationIntangiblesPercent>
    <trnr:IncometaxreconciliationIntangibles
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:IncometaxreconciliationIntangibles>
    <trnr:EffectiveIncomeTaxRateReconciliationIntangiblesPercent
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0</trnr:EffectiveIncomeTaxRateReconciliationIntangiblesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">615000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">-0.0106</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="P01_01_2022To12_31_2022"
      decimals="4"
      unitRef="Unit_pure">-0.0001</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="P01_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0.0004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <trnr:MinimumTaxOnBookIncomeInflationReductionActPercent
      contextRef="PAsOn08_16_2022"
      decimals="2"
      unitRef="Unit_pure">0.15</trnr:MinimumTaxOnBookIncomeInflationReductionActPercent>
    <trnr:MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax
      contextRef="PAsOn08_16_2022"
      decimals="-9"
      unitRef="Unit_USD">1000000000</trnr:MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="P01_01_2022To12_31_2022">Significant components of the Company&#x2019;s deferred tax assets (liabilities) are as follows: &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:65%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;(in thousands)&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred tax assets:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net operating loss carryforwards - Federal&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;16,776&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,760&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized research and development&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,768&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development tax credits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,593&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;923&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net operating loss carryforwards - State&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,752&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,260&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net operating loss carryforwards - Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,894&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,846&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,219&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fixed assets and intangibles&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(868)&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total deferred tax assets, gross:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,134&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,789&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Valuation allowance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(30,134)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(14,789)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total deferred tax liabilities:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred tax assets, net:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">16776000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">9760000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <trnr:DeferredTaxAssetsCapitalizedResearchAndDevelopment
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3768000</trnr:DeferredTaxAssetsCapitalizedResearchAndDevelopment>
    <trnr:DeferredTaxAssetsCapitalizedResearchAndDevelopment
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:DeferredTaxAssetsCapitalizedResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3593000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">923000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3752000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2260000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1894000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1846000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1219000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredTaxAssetsOther>
    <trnr:DeferredTaxAssetsFixedAssetsAndIntangibles
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-868000</trnr:DeferredTaxAssetsFixedAssetsAndIntangibles>
    <trnr:DeferredTaxAssetsFixedAssetsAndIntangibles
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:DeferredTaxAssetsFixedAssetsAndIntangibles>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">30134000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">14789000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">30134000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">14789000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">79900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">75800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="PAsOn12_31_2022_ForeignCountryMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">1600000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">2500000</us-gaap:TaxCreditCarryforwardAmount>
    <trnr:AmortisationOfResearchAndDevelopmentalCost contextRef="P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis">P5Y</trnr:AmortisationOfResearchAndDevelopmentalCost>
    <trnr:AmortisationOfResearchAndDevelopmentalCost contextRef="P01_01_2022To12_31_2022_ForeignCountryMemberusgaapIncomeTaxAuthorityAxis">P15Y</trnr:AmortisationOfResearchAndDevelopmentalCost>
    <trnr:CapitalizedResearchAndDevelopmentExpenses
      contextRef="P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">18200000</trnr:CapitalizedResearchAndDevelopmentExpenses>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse contextRef="P01_01_2022To12_31_2022">Section&#160;382 of the Internal Revenue Code and similar provisions under state law limit the utilization of federal NOL carryforwards, state NOL carryforwards, and Research and Development (R&amp;D) credits following certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50%. Based on the Company&#x2019;s analysis under Section&#160;382, the Company believes that its federal NOL carryforwards, its state NOL carryforwards, and R&amp;D credits are limited by Section&#160;382 and similar provisions under state law as of December&#160;31, 2022. The portion of federal NOL carryforwards, state NOL carryforwards, and R&amp;D credits that were determined to be limited have been written off as of December&#160;31, 2022. The remaining unused carryforwards and credits remain available for future periods. Due the Company&#x2019;s full valuation allowance the write off of NOL carryforwards and R&amp;D did not have any impact to the statements of operation and comprehensive loss.</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <trnr:OperatingLossCarryForwardsPercentage
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0.50</trnr:OperatingLossCarryForwardsPercentage>
    <us-gaap:EarningsPerShareTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;21. Loss Per Share &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The computation of loss per share is as follows:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:58%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Numerator:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(58,225)&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(32,840)&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss attributable to common stockholders&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(58,225)&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(32,840)&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Denominator:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted average common stock outstanding - basic and diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;487,276&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;98,823&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss per share attributable to common stockholders - basic and diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(119.49)&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(332.31)&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:70%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series A convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;86,703&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,208&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt; convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,546&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 1 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,393&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 2 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,666&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 3 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 4 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;140&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 5 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,414&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 6 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;815&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 7 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,716&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 8 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,410&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 9 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18,480&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 10 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,171&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants to purchase series Class&#160;A common stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants to purchase series Class&#160;B common stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,753&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,753&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock options to purchase common stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;446,841&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;51,149&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;544,890&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;196,812&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The computation of loss per share is as follows:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:58%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Numerator:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(58,225)&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(32,840)&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss attributable to common stockholders&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(58,225)&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(32,840)&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Denominator:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.22em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted average common stock outstanding - basic and diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;487,276&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;98,823&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.44em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss per share attributable to common stockholders - basic and diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(119.49)&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(332.31)&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <trnr:NetLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-58225000</trnr:NetLoss>
    <trnr:NetLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32840000</trnr:NetLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-58225000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-32840000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">487276</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">487276</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_shares">98823</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_shares">98823</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-119.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-119.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">-332.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">-332.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:&lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:70%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series A convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;86,703&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,208&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt; convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,546&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 1 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,393&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 2 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,666&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 3 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 4 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;140&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 5 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,414&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 6 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;815&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 7 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,716&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 8 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,410&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 9 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18,480&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 10 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,171&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants to purchase series Class&#160;A common stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants to purchase series Class&#160;B common stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,753&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,753&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock options to purchase common stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;446,841&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;51,149&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;544,890&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;196,812&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">86703</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">10208</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">7546</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">2393</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">1666</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">248</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">140</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">3414</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">815</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">1716</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">4410</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">18480</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">2171</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_WarrantsToPurchaseSeriesClassACommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">92296</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_WarrantsToPurchaseSeriesClassACommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">5753</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">5753</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">446841</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">51149</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">544890</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_shares">196812</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22. Related Party Transactions &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In the ordinary course of business, we may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal stockholders (commonly referred to as &#x201c;related parties&#x201d;). &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Founder Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company has noninterest bearing promissory notes, of which $0.08 million was outstanding as of December&#160;31, 2022 and December 31, 2021. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Principal Stockholder Promissory Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During 2019, 2020, and 2021 the Company entered into the following promissory notes with a principal stockholder of the Company: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On May&#160;17, 2019, a $2.0&#160;million note with interest at the rate of 2.5% per annum and maturity date of May 17, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 7.5%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On August&#160;28, 2019, a $1.0&#160;million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5.0% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On November&#160;28, 2019, a $0.3 million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On March 20, 2020, a $0.3 million note with interest at the rate of 5.0% per annum and a maturity date of March 20, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On February&#160;12, 2021, a $0.6 million note with interest at the rate of 5.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022, all principal stockholder promissory notes were outstanding and included within the loan payable on the Consolidated Balance Sheet for a total of $5.5 million, including accrued interest and default interest of $1.4&#160;million. As the 2019, 2020, and 2021 notes were not paid upon maturity, these loans were in default as of year end. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the consolidated statement of operations was $0.8&#160;million during the twelve months ended December&#160;31, 2022. On September&#160;30, 2022, the principal officer and certain related parties waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#x2019;s assets. &lt;/div&gt;&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other Related Party Promissory Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During 2019, 2020, 2021, and 2022, the Company entered into the following promissory notes with other related parties: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On September 30, 2019, a $0.2 million note with interest at the rate of 12.0% per annum and a maturity date of September 30, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $0.2 million. This loan remains outstanding for interest in the amount of $.08 million. Upon default, on the September 30, 2019, loan the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#x2019;s assets. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On October&#160;21, 2019, a $0.2 million note with interest at the rate of 12.0% per annum and maturity date of October 21, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On February&#160;18, 2020, a $0.1 million note with interest at the rate of 12.0% per annum and a maturity date of February 18, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On June&#160;9, 2020, a $75,000 note was entered into by the Company from the president and co-founder of the Company. This note has interest at the rate of 5.0% per annum and a maturity date of June 9, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. The principal of this loan has been paid as of December 31, 2022. However, the loan remains outstanding for interest accrued throughout the term. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On June&#160;15, 2020, a $0.1&#160;million note with interest at the rate of 7.5% per annum and a maturity date of June 15, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $0.1&#160;million. The principal of this loan was paid as of December&#160;31, 2022 and remains outstanding for interest in the amount of $0.01&#160;million. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 12.5%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#x2019;s assets. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On November&#160;2, 2020, a $50,000 note was entered into by the Company from to the president and co-founder of the Company. This note has interest at the rate of 5.0% per annum and a maturity date of June 2, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. The principal of this loan has been paid as of December 31, 2022. However, the loan remains outstanding for interest accrued throughout the term. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On January&#160;12, 2021, a $0.3 million note with interest at the rate of 12.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On February&#160;22, 2021, a $40,000 note with interest at the rate of 12.0% per annum and a maturity date of June 22, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On October&#160;27, 2022, a $425,000 note with interest at the rate of 12.0% per annum and a maturity date of January 27, 2023. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest the Company&#x2019;s assets. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022, all other related party promissory notes were outstanding and included within the loan payable on the Consolidated Balance Sheet for a total of $1.2 million, including accrued interest and default interest of $0.4&#160;million. All notes, except the October&#160;27, 2022 note, were not paid upon maturity. These loans were in default as of period end due to outstanding interest. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the consolidated statement of operations was $0.2&#160;million during the twelve months ending December&#160;31, 2022. On September&#160;30, 2022, related parties waived their rights to remedy in the event of default, which in effect releases the Company from the obligation of the incremental interest and fees, as well as the lender from their lien on and security interest in the Company&#x2019;s assets. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During 2022, multiple of the loans above with maturity dates in 2022 remained unpaid as of the maturity date. On September&#160;30, 2022, those lenders waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#x2019;s assets. Currently, the Company is renegotiating the terms of the loans. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the twelve months ending December&#160;31, 2022 and 2021, the Company repaid $0.7&#160;million and $1.9&#160;million of its related party loans. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In 2016, the Company entered into an agreement with Fuseproject, a design firm that designed the Company&#x2019;s main product, its fitness mirror. As of December&#160;31, 2022 and 2021, the Company had incurred $0.2&#160;million and $0.8&#160;million, respectively, of expenses for design services provided by Fuseproject. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022, the principal stockholder associated with Fuseproject referenced above owned 7,499 of the Company&#x2019;s Class&#160;A common shares and 1,833 of the Company&#x2019;s Class&#160;B common warrants. As of December&#160;31, 2022, the principal stockholder also owned 28,666 shares of the Company&#x2019;s Class&#160;B common shares, with fully diluted ownership of 1.26% and 2.17 % as of December&#160;31, 2022 and 2021, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In 2022, the Company entered into an agreement with Apeiron Advisory Ltd for promotion of the Company, participation in industry conferences, and ongoing structural advice and consulting. As of December&#160;31, 2022 and 2021, the Company has incurred $0.9&#160;million and $ 0.0&#160;million, respectively, of expenses for such services provided by Apeiron Advisory Ltd. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of December&#160;31, 2022 and 2021, Apeiron Investment Group Ltd owned 447,318 and 11,520 shares of the Company&#x2019;s Class&#160;A common shares, 0 and 9,925 shares of the Company&#x2019;s Series A preferred shares, and 24,143 and 0 of the Company&#x2019;s Class&#160;A common warrants, respectively, with fully diluted ownership of 15.60% and 5.00%, respectively. &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn12_31_2021_PromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-4"
      unitRef="Unit_USD">80000.00</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn12_31_2022_PromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-4"
      unitRef="Unit_USD">80000.00</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">2000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-05-17</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.075</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">1000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-08-28</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-08-28</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-03-20</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">600000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-12</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:NotesAndLoansPayable
      contextRef="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">5500000</us-gaap:NotesAndLoansPayable>
    <trnr:AccruedInterestAndDefaultInterest
      contextRef="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">1400000</trnr:AccruedInterestAndDefaultInterest>
    <trnr:InterestExpenseAndDefaultInterest
      contextRef="P01_01_2022To12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">800000</trnr:InterestExpenseAndDefaultInterest>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-09-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <trnr:DefaultInterest
      contextRef="P09_30_2019To09_30_2019"
      decimals="-4"
      unitRef="Unit_USD">80000.00</trnr:DefaultInterest>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-10-21</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-02-18</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">75000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-09</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-06-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NotesAndLoansPayable
      contextRef="PAsOn06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-4"
      unitRef="Unit_USD">10000.00</us-gaap:NotesAndLoansPayable>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.125</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">50000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-02</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-12</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">40000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-22</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">425000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2023-01-27</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:NotesAndLoansPayable
      contextRef="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">1200000</us-gaap:NotesAndLoansPayable>
    <trnr:AccruedInterestAndDefaultInterest
      contextRef="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">400000</trnr:AccruedInterestAndDefaultInterest>
    <trnr:InterestExpenseAndDefaultInterest
      contextRef="P01_01_2022To12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</trnr:InterestExpenseAndDefaultInterest>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="P01_01_2022To12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">700000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="P01_01_2021To12_31_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">1900000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn12_31_2021_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">800000</us-gaap:OtherLiabilities>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">7499</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2022To12_31_2022_ClassBCommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">1833</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">28666</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="P01_01_2022To12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="4"
      unitRef="Unit_pure">0.0126</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="P01_01_2021To12_31_2021_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="4"
      unitRef="Unit_pure">0.0217</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">900000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">0</us-gaap:OtherLiabilities>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">447318</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">11520</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">9925</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">24143</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="4"
      unitRef="Unit_pure">0.156</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="P01_01_2021To12_31_2021_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="4"
      unitRef="Unit_pure">0.05</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:SubsequentEventsTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;23. Subsequent Events &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company has evaluated subsequent events through the financial statement issuance date, March&#160;29, 2023, pursuant to ASC 855-10 &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Subsequent Events.&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2022, January 2023 and February 2023, the Company issued 9,749,439 shares of Class&#160;A common stock (of which 1,072,438 were issued in December 2022 and 8,677,001 were issued in January and February&#160;2023) pursuant to a rights offering involving the sale of Class&#160;A common stock to all existing accredited investors as of December&#160;19, 2022 at a price equal to approximately $0.51 per share. Each accredited investor received the right to elect to purchase shares of Class A common stock in the rights offering up to their respective pro rata amount, which was equal to the product of (x)&#160;$5,000,000, multiplied by (y)&#160;the quotient obtained by dividing (a) the number of shares of the Company&#x2019;s capital stock held by the accredited investor as of December&#160;19, 2022 including any common stock issuable on the exercise of warrants or options held by such accredited investor as of December&#160;19, 2022, by (b) the Company&#x2019;s fully-diluted capitalization as of December&#160;19, 2022. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, the Company issued warrants to four accredited investors in consideration for services rendered, which warrants are exercisable for a total number of shares of the Company&#x2019;s common stock that is determined by dividing $400,000 by (x)&#160;the price per share of the Company&#x2019;s next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the offering price per share in the Company&#x2019;s contemplated initial public offering price, whichever event occurs first, for an exercise price of $0.01 per share, in whole or in part. The warrants may also be net exercised upon election. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On February&#160;27, 2023, the Company filed an Amended and Restated Certificate of Incorporation of Interactive Strength Inc., which converted all issued shares of Class A Common Stock and Class B Common Stock into shares of Common Stock on a one to one basis. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On March&#160;6, 2023, the Company entered into a Termination Agreement with a third-party content provider (&#x201c;Content Provider&#x201d;) to terminate a service agreement and collaboration agreement previously entered into in 2021. The Company made a payment of $0.1&#160;million to the Content Provider on February&#160;13, 2022 and has no further obligations to the Content Provider. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, the Company issued an aggregate of $2.0&#160;million of senior secured notes to three investors, including one related party, with associated warrants to purchase the Company&#x2019;s common stock at an exercise price of $0.0001, in lieu of future cash interest payments under the senior secured notes issued to such investors. &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">9749439</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">1072438</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">8677001</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.51</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">5000000000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">400000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">10000000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockConversionBasis contextRef="P02_27_2023To02_27_2023_ClassACommonStockToClassBCommonStockMemberusgaapConversionOfStockByUniqueDescriptionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">one to one basis</us-gaap:CommonStockConversionBasis>
    <us-gaap:PaymentsForRestructuring
      contextRef="P02_13_2022To02_13_2022_ContractTerminationMemberusgaapRestructuringCostAndReserveAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:PaymentsForRestructuring>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="P03_01_2023To03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">2000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">30000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">226000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryFinishedGoods
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1443000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4567000</us-gaap:InventoryFinishedGoods>
    <us-gaap:DepositsAssetsCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3280000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3603000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">962000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1426000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">5722000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">9822000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">583000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1326000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">296000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">110000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2866000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3834000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InventoryNoncurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3121000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InventoryNoncurrent>
    <us-gaap:DeferredCosts
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2337000</us-gaap:DeferredCosts>
    <us-gaap:OtherAssets
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">5683000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7018000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">18271000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">24447000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">8921000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7743000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1951000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5304000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">53000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">106000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">66000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">29000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">6266000</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6708000</us-gaap:LoansPayableCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1038000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:SecuredDebtCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4270000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">18302000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">24167000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">243000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">9000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3004000</us-gaap:DerivativeLiabilities>
    <us-gaap:Liabilities
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">18545000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">27180000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn09_30_2023"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn12_31_2022"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn09_30_2023"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn09_30_2023"
      decimals="INF"
      unitRef="Unit_shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">369950000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn09_30_2023"
      decimals="INF"
      unitRef="Unit_shares">14178514</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn09_30_2023"
      decimals="INF"
      unitRef="Unit_shares">14178514</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">2450922</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">2450922</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">154942000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">112436000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">286000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">365000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-155509000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-115538000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-274000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-2733000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">18271000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">24447000</us-gaap:LiabilitiesAndStockholdersEquity>
    <trnr:FitnessProductRevenue1
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">206000</trnr:FitnessProductRevenue1>
    <trnr:FitnessProductRevenue1
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">144000</trnr:FitnessProductRevenue1>
    <trnr:FitnessProductRevenue1
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">502000</trnr:FitnessProductRevenue1>
    <trnr:FitnessProductRevenue1
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">402000</trnr:FitnessProductRevenue1>
    <trnr:MembershipRevenue1
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">38000</trnr:MembershipRevenue1>
    <trnr:MembershipRevenue1
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">25000</trnr:MembershipRevenue1>
    <trnr:MembershipRevenue1
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">94000</trnr:MembershipRevenue1>
    <trnr:MembershipRevenue1
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">53000</trnr:MembershipRevenue1>
    <trnr:TrainingRevenue1
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">62000</trnr:TrainingRevenue1>
    <trnr:TrainingRevenue1
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">32000</trnr:TrainingRevenue1>
    <trnr:TrainingRevenue1
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">183000</trnr:TrainingRevenue1>
    <trnr:TrainingRevenue1
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">32000</trnr:TrainingRevenue1>
    <us-gaap:Revenues
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">306000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">201000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">779000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">487000</us-gaap:Revenues>
    <trnr:CostOfFitnessProductRevenue
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">360000</trnr:CostOfFitnessProductRevenue>
    <trnr:CostOfFitnessProductRevenue
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">764000</trnr:CostOfFitnessProductRevenue>
    <trnr:CostOfFitnessProductRevenue
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1529000</trnr:CostOfFitnessProductRevenue>
    <trnr:CostOfFitnessProductRevenue
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">2047000</trnr:CostOfFitnessProductRevenue>
    <trnr:CostOfMembership
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">960000</trnr:CostOfMembership>
    <trnr:CostOfMembership
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">1545000</trnr:CostOfMembership>
    <trnr:CostOfMembership
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2861000</trnr:CostOfMembership>
    <trnr:CostOfMembership
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">3537000</trnr:CostOfMembership>
    <trnr:CostOfTraining
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">109000</trnr:CostOfTraining>
    <trnr:CostOfTraining
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">387000</trnr:CostOfTraining>
    <trnr:CostOfTraining
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">300000</trnr:CostOfTraining>
    <trnr:CostOfTraining
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">1077000</trnr:CostOfTraining>
    <us-gaap:CostOfRevenue
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1429000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">2696000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">4690000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">6661000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-1123000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-2495000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-3911000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-6174000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2357000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">4854000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">7796000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">15284000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">282000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">1193000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1473000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">5194000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">6313000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">6131000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">30043000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">11774000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">8952000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">12178000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">39312000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">32252000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-10075000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-14673000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-43223000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-38426000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-179000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-417000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-740000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-154000</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-187000</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-1382000</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-748000</us-gaap:InterestRevenueExpenseNet>
    <trnr:GainUponDebtForgiveness
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:GainUponDebtForgiveness>
    <trnr:GainUponDebtForgiveness
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-523000</trnr:GainUponDebtForgiveness>
    <trnr:GainUponDebtForgiveness
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-2595000</trnr:GainUponDebtForgiveness>
    <trnr:GainUponDebtForgiveness
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-523000</trnr:GainUponDebtForgiveness>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-252000</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-24000</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-2266000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-333000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-81000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3252000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-989000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-10408000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-14754000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-39971000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-39415000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-10408000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-14754000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-39971000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-39415000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P07_01_2023To09_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P07_01_2023To09_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P07_01_2022To09_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-30.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P07_01_2022To09_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-30.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2023To09_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">-3.4</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2023To09_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">-3.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2022To09_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-93.1</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2022To09_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-93.1</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P07_01_2023To09_30_2023"
      decimals="0"
      unitRef="Unit_shares">14186222</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P07_01_2023To09_30_2023"
      decimals="0"
      unitRef="Unit_shares">14186222</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P07_01_2022To09_30_2022"
      decimals="0"
      unitRef="Unit_shares">489132</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P07_01_2022To09_30_2022"
      decimals="0"
      unitRef="Unit_shares">489132</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2023To09_30_2023"
      decimals="0"
      unitRef="Unit_shares">11750907</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2023To09_30_2023"
      decimals="0"
      unitRef="Unit_shares">11750907</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To09_30_2022"
      decimals="0"
      unitRef="Unit_shares">423362</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To09_30_2022"
      decimals="0"
      unitRef="Unit_shares">423362</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-10408000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-14754000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-39971000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-39415000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">172000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">441000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-79000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">931000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-10236000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-14313000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-40050000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-38484000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">42999</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2021_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">7594000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">86703</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2021_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">19535000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">10208</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2021_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2604000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">181362</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">31703</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">37806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-57313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-19663000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P01_01_2022To03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">267384</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2022To03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">2060000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2022To03_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2063000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">124313</trnr:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">5926000</trnr:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">66000</us-gaap:PaymentsOfStockIssuanceCosts>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">631292</trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2022To03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">30028000</trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P01_01_2022To03_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">501</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2022To03_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P01_01_2022To03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">97000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P01_01_2022To03_31_2022"
      decimals="-3"
      unitRef="Unit_USD">97000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2022To03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">167000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2022To03_31_2022"
      decimals="-3"
      unitRef="Unit_USD">167000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-12691000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To03_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-12691000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn03_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">42999</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn03_31_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">7594000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn03_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">86703</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn03_31_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">19535000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn03_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">10208</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn03_31_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2604000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">755605</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">35954000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">448746</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">6000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn03_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">32204</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">39971000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-70004000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-30019000</us-gaap:StockholdersEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P04_01_2022To06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">27000</us-gaap:PaymentsOfStockIssuanceCosts>
    <trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues
      contextRef="P04_01_2022To06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-27000</trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P04_01_2022To06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P04_01_2022To06_30_2022"
      decimals="-3"
      unitRef="Unit_USD">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P04_01_2022To06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P04_01_2022To06_30_2022"
      decimals="-3"
      unitRef="Unit_USD">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P04_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">323000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P04_01_2022To06_30_2022"
      decimals="-3"
      unitRef="Unit_USD">323000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-11970000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-11970000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn06_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">42999</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn06_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">7594000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn06_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">86703</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn06_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">19535000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn06_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">10208</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn06_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2604000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">755605</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn06_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">35927000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">448746</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">6000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn06_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">32204</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">40073000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">331000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-81974000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-41564000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P07_01_2022To09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">8</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P07_01_2022To09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:PaymentsOfStockIssuanceCosts>
    <trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1</trnr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues
      contextRef="P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-4000</trnr:TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P07_01_2022To09_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">57</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P07_01_2022To09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P07_01_2022To09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3754000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">3754000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P07_01_2022To09_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">441000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">441000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="P07_01_2022To09_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-14754000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P07_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-14754000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn09_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">42999</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn09_30_2022_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">7594000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">86703</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">19535000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn09_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">10208</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn09_30_2022_SeriesA1PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">2604000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">755606</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">35923000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">448754</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn09_30_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">32261</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">43830000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">772000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-96728000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-52122000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">2416698</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">34224</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">112436000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">365000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-115538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-2733000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">8676924</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">4449000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2023To03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">4452000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">2416698</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">4000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="P01_01_2023To03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">-2416698</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="P01_01_2023To03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-4000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="P01_01_2023To03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P01_01_2023To03_31_2023_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">646433</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">14000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2023To03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">14000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="P01_01_2023To03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">-680657</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="P01_01_2023To03_31_2023_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">680657</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">15057000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P01_01_2023To03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">15057000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <trnr:NetExerciseOfOptions
      contextRef="P01_01_2023To03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">323000</trnr:NetExerciseOfOptions>
    <trnr:NetExerciseOfOptions
      contextRef="P01_01_2023To03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">323000</trnr:NetExerciseOfOptions>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2023To03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-115000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P01_01_2023To03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">-115000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2023To03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-15961000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2023To03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">-15961000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">11774279</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">132279000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">250000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-131499000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">1037000</us-gaap:StockholdersEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P04_01_2023To06_30_2023_IPOMemberusgaapStatementClassOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">1200000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">10820000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P04_01_2023To06_30_2023_IPOMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">10820000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <trnr:InitialPublicOfferingCosts
      contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-4607000</trnr:InitialPublicOfferingCosts>
    <trnr:InitialPublicOfferingCosts
      contextRef="P04_01_2023To06_30_2023_IPOMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">-4607000</trnr:InitialPublicOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">565144</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">4521000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="P04_01_2023To06_30_2023"
      decimals="-3"
      unitRef="Unit_USD">4521000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <trnr:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="P04_01_2023To06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">339091</trnr:StockIssuedDuringPeriodSharesWarrantsExercised>
    <trnr:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">2468000</trnr:StockIssuedDuringPeriodValueWarrantsExercised>
    <trnr:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="P04_01_2023To06_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2468000</trnr:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">4510000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P04_01_2023To06_30_2023"
      decimals="-3"
      unitRef="Unit_USD">4510000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P04_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-136000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P04_01_2023To06_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-136000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-13602000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-13602000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">14178514</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">149991000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">114000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-145101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn06_30_2023"
      decimals="-3"
      unitRef="Unit_USD">5011000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P07_01_2023To09_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">4951000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">4951000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P07_01_2023To09_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">172000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">172000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="P07_01_2023To09_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-10408000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-10408000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">14178514</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">154942000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">286000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-155509000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-274000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-39971000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-39415000</us-gaap:ProfitLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-64000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-821000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:Depreciation
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">743000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">932000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">4188000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">3735000</us-gaap:AmortizationOfIntangibleAssets>
    <trnr:NonCashLeaseExpense
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">66000</trnr:NonCashLeaseExpense>
    <trnr:NonCashLeaseExpense
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:NonCashLeaseExpense>
    <us-gaap:InventoryWriteDown
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">261000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">1106000</us-gaap:InventoryWriteDown>
    <us-gaap:ShareBasedCompensation
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">23773000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">3951000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2595000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">523000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-77000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-746000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1305000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-252000</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <trnr:GainLossOnChangeInFairValueOfConvertibleNotes
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-24000</trnr:GainLossOnChangeInFairValueOfConvertibleNotes>
    <trnr:FairValueAdjustmentOfWarrantsIssuedToServiceProviders
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">442000</trnr:FairValueAdjustmentOfWarrantsIssuedToServiceProviders>
    <trnr:FairValueAdjustmentOfWarrantsIssuedToServiceProviders
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:FairValueAdjustmentOfWarrantsIssuedToServiceProviders>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-2266000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">442000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">2806000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-464000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">721000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-323000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-316000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDeferredCharges
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInDeferredCharges>
    <us-gaap:IncreaseDecreaseInDeferredCharges
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">1123000</us-gaap:IncreaseDecreaseInDeferredCharges>
    <trnr:IncreaseDecreaseInLongTermInventory
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:IncreaseDecreaseInLongTermInventory>
    <trnr:IncreaseDecreaseInLongTermInventory
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">313000</trnr:IncreaseDecreaseInLongTermInventory>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">10000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">1000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">585000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">1642000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-780000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">2141000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">37000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-4000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-70000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-13561000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-29492000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">501000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">349000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">2744000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">797000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">4958000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-1146000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-8203000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">465000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">14000</us-gaap:ProceedsFromRelatedPartyDebt>
    <trnr:RepaymentsOfRelatedPartyLoans
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">483000</trnr:RepaymentsOfRelatedPartyLoans>
    <trnr:RepaymentsOfRelatedPartyLoans
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">1178000</trnr:RepaymentsOfRelatedPartyLoans>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">10820000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1453000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3030000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <trnr:PaymentsOfSeniorSecuredNotes
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2000000</trnr:PaymentsOfSeniorSecuredNotes>
    <trnr:PaymentsOfSeniorSecuredNotes
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:PaymentsOfSeniorSecuredNotes>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">29997000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">5902000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">4247000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">2060000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">30000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">6000</us-gaap:ProceedsFromStockOptionsExercised>
    <trnr:RepaymentOfBouncebackLoans
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:RepaymentOfBouncebackLoans>
    <trnr:RepaymentOfBouncebackLoans
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-69000</trnr:RepaymentOfBouncebackLoans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">14656000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">36732000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-145000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-74000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-196000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-1037000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">226000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1697000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">30000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">660000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <trnr:PropertyAndEquipmentInAccountsPayable
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">18000</trnr:PropertyAndEquipmentInAccountsPayable>
    <trnr:PropertyAndEquipmentInAccountsPayable
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">175000</trnr:PropertyAndEquipmentInAccountsPayable>
    <trnr:InventoriesInAccountsPayableAndAccrued
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-815000</trnr:InventoriesInAccountsPayableAndAccrued>
    <trnr:InventoriesInAccountsPayableAndAccrued
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-783000</trnr:InventoriesInAccountsPayableAndAccrued>
    <trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable>
    <trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">5926000</trnr:IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable>
    <trnr:RecognitionOfDeferredAndAccruedOfferingCosts
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3155000</trnr:RecognitionOfDeferredAndAccruedOfferingCosts>
    <trnr:RecognitionOfDeferredAndAccruedOfferingCosts
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:RecognitionOfDeferredAndAccruedOfferingCosts>
    <trnr:ProceedsFromPaycheckProtectionProgramLoan
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2468000</trnr:ProceedsFromPaycheckProtectionProgramLoan>
    <trnr:ProceedsFromPaycheckProtectionProgramLoan
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ProceedsFromPaycheckProtectionProgramLoan>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">313000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">4521000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:ConversionOfStockAmountConverted1>
    <trnr:DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">61000</trnr:DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination>
    <trnr:DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination>
    <trnr:NonCashIssuanceOfCommonStockFromRightsOffering
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">202000</trnr:NonCashIssuanceOfCommonStockFromRightsOffering>
    <trnr:NonCashIssuanceOfCommonStockFromRightsOffering
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:NonCashIssuanceOfCommonStockFromRightsOffering>
    <trnr:NonCashExerciseOfOptions
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">323000</trnr:NonCashExerciseOfOptions>
    <trnr:NonCashExerciseOfOptions
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:NonCashExerciseOfOptions>
    <trnr:StockBasedCompensationCapitalizedInSoftware
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">745000</trnr:StockBasedCompensationCapitalizedInSoftware>
    <trnr:StockBasedCompensationCapitalizedInSoftware
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:StockBasedCompensationCapitalizedInSoftware>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1. Description of Business and Basis of Presentation &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Description and Organization &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Interactive Strength Inc., together with its consolidated subsidiaries doing business as &#x201c;Forme&#x201d; (&#x201c;Forme&#x201d; or the &#x201c;Company&#x201d;), is an interactive home fitness platform that offers an immersive smart home gym with a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;life-size&lt;/div&gt; touchscreen mirror and accessories. Our Members are defined as any individual who has a Forme account through a paid connected fitness membership. The Company&#x2019;s interactive home fitness platform is known as the Studio, for which the Company continues to develop new accessories and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;add-ons&lt;/div&gt; to further customize a Member&#x2019;s experience (&#x201c;Connected Fitness Products&#x201d;). Through the Studio, Members can stream immersive, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;instructor-led&lt;/div&gt; boutique classes anytime, anywhere. The Company enables Members to get the most out of their wellness journey from their home. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Initial Public Offering &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In May 2023, the Company closed its initial public offering (&#x201c;IPO&#x201d;) in which we issued and sold 1.5&#160;million shares of common stock at a public offering price of $8.00 per share and excluding shares sold in the IPO by certain of our existing stockholders. Total proceeds, after deducting underwriting commissions of $1.2&#160;million and other offering expenses of $4.6&#160;million, was $6.2&#160;million. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basis of Presentation and Consolidation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). The condensed consolidated financial statements include the accounts of Interactive Strength Inc. and its subsidiaries in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, cash flows, and the changes in equity for the interim period. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liquidity and Going Concern &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Since its inception, the Company has sustained recurring losses and has relied on funding from private investors and other third-parties (collectively &#x201c;outside capital&#x201d;) to execute the Company&#x2019;s growth strategy. As a result, the Company incurred a net loss of $40.0&#160;million during the nine months ended September&#160;30, 2023 and had an accumulated deficit of $155.5&#160;million as of September&#160;30, 2023. The Company&#x2019;s long-term success is dependent upon its ability to successfully develop, market, and deliver its revenue-generating products and services in a profitable manner. While management believes the Company can be successful in executing its growth strategy, no assurance can be provided it will be able to do so in a timely or profitable manner. As a result, the Company anticipates it will continue to rely on outside capital to fund the Company&#x2019;s operations for the foreseeable future. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of the date the accompanying condensed consolidated financial statements were issued (the &#x201c;issuance date&#x201d;), the Company&#x2019;s available liquidity was not sufficient to fund the Company&#x2019;s operations over the next twelve months or meet its obligations as they become due, absent the Company&#x2019;s ability to secure additional outside capital. While management plans to take action to address the Company&#x2019;s liquidity needs, such as cost mitigation initiatives to reduce unnecessary costs, securing additional outside capital, and/or pursuing other strategic arrangements, no assurance can be provided that management&#x2019;s actions will be sufficient to fund the Company&#x2019;s operations over the next twelve months or meet its obligations as they become due. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of September&#160;30, 2023, the Company had $1.0&#160;million of senior secured notes outstanding with THLWY, LLC (see Note 10). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In addition, as of September&#160;30, 2023, the Company had loans outstanding from certain related parties (See Note 19) with an aggregate principal and interest amount owed of approximately $6.3&#160;million. All of these loans matured prior to September&#160;30, 2023, but their repayment has been temporarily waived. However, absent additional outside capital, the Company will be unable to repay these loans upon their maturity and, as such, the aggregate amounts owed have been classified as current debt in the accompanying condensed consolidated balance sheet as of September&#160;30, 2023. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In the event that one or more of management&#x2019;s planned actions are not sufficient to fund the Company&#x2019;s operations over the next twelve months or meet its obligations as they become due, management will be required to seek other strategic &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;alternatives, which may include, among others, a significant curtailment in the Company&#x2019;s operations, a sale of certain of the Company&#x2019;s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy. These uncertainties raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying condensed consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties. &lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_shares">1500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">8</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
      contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">1200000</us-gaap:InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions>
    <us-gaap:DividendsCommonStockStock
      contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">4600000</us-gaap:DividendsCommonStockStock>
    <us-gaap:DividendsCommonStock
      contextRef="P05_31_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">6200000</us-gaap:DividendsCommonStock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2023To09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">-40000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">-155500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SecuredDebtCurrent
      contextRef="PAsOn09_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">1000000</us-gaap:SecuredDebtCurrent>
    <us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions
      contextRef="P01_01_2023To09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">6300000</us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2. Summary of Significant Accounting Policies &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unaudited Interim Financial Information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP, for interim financial reporting and as required by Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-X,&lt;/div&gt; Rule &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-01.&lt;/div&gt; The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated annual financial statements for the years ended December&#160;31, 2022 and 2021 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s condensed consolidated balance sheet as of September&#160;30, 2023, the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022, the condensed consolidated statement of redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) as of September&#160;30, 2023 and condensed consolidated statements of cash flows for the nine months ended September&#160;30, 2023 and 2022. The financial data and other information disclosed in these notes related to the nine months ended September&#160;30, 2023 and 2022 are unaudited. The results for the nine months ended September&#160;30, 2023, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2023, any other interim periods, or any future year or period. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Use of Estimates &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Segment Information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;at-home&lt;/div&gt; fitness technology platform. The Company&#x2019;s chief operating decision maker, its chief executive officer, manages the Company&#x2019;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of September&#160;30, 2023 and 2022, substantially all of the Company&#x2019;s long-lived assets are held in the United States. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Cash consists of cash on deposit in banks. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred Offering Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company complies with the requirements of ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;340-10-S99-1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; and SEC Staff Accounting Bulletin Topic 5A &#x201c;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Expenses of Offering&#x201d;&lt;/div&gt;&lt;/div&gt;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. As of September&#160;30, 2023, the Company incurred offering costs amounting to $4.6&#160;million through the IPO and subsequently classified the costs to additional paid in capital. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and Equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-production&lt;/div&gt; tooling which it owns under a supply arrangement. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pre-production&lt;/div&gt; tooling, including the related engineering costs the Company will not own or will not use in producing products under long-term supply arrangements, are expensed as incurred. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 10 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;3 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="-sec-ix-hidden:hidden95757150"&gt;Lesser of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Inventories, net &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;written-off&lt;/div&gt; against the reserve. Inventory not expected to be sold in the next twelve months is classified as long-term in the accompanying condensed, consolidated balance sheets. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Vendor Deposits &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#x2019;s inventory. In general, the Company&#x2019;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#x2019;s consolidated balance sheet. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Capitalized Studio Content &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Capitalized Studio content costs include certain expenditures to develop video and live content for the Company&#x2019;s customers. The Company capitalizes production costs for recorded content in accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;926-20,&lt;/div&gt; Entertainment-Films - Other Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; assets in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#x201c;obsolescence&#x201d; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(3-year)&lt;/div&gt; amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $2.9&#160;million and $4.4&#160;million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Identifiable Intangible Assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;350-40,&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internal-use&lt;/div&gt; Software and ASC 985, Software. These capitalized costs also relate to the Company&#x2019;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems. Capitalized software costs are amortized over the estimated useful life is three years. Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is probable the project will be completed, and the software will be used to perform the function intended. Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. The Company expenses all costs incurred that relate to planning and post-implementation phases of development. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment, and none were identified in the quarter ended September&#160;30, 2023. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the nine months ended September&#160;30, 2023 and the year ended December&#160;31, 2022, the Company capitalized $0.5&#160;million and $2.7&#160;million, respectively, of internal use software. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:41%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td style="width:56%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Internal-use&lt;/div&gt; software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;3 years&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Music Royalty Fees &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognizes music royalty fees as these fees are incurred in accordance with the terms of the relevant license agreement with the music rights holder. The incurrence of such royalties is primarily driven by the number of paid subscribers each month and it is classified as cost of membership and training within the Company&#x2019;s statement of operations. The Company&#x2019;s license agreements with music rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of September&#160;30, 2023 and December&#160;31, 2022 there were no music guarantee-related prepaids, respectively. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s material financial instruments consist primarily of cash and cash equivalents, accounts payable, accrued expenses, convertible notes, and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these instruments. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Impairment of Long-Lived Assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#x2019; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In May 2023, upon closing of the Company&#x2019;s IPO, the convertible notes were converted into an aggregate of 565,144 shares of common stock. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the condensed consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#x2019; deficit. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#x2019;s hiring of certain employees from the third party (the &#x201c;acqui-hire transaction&#x201d;) that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x)&#160;the price per share of the next equity financing with total proceeds of at least $10.0&#160;million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 28,124 shares of common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $400,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 49,996 shares of common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, we issued warrants to certain existing affiliate and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-affiliate&lt;/div&gt; stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with a note financing (the &#x201c;Bridge Note Financing&#x201d;). Such warrants are exercisable for a number of shares of our common stock that is determined by dividing: (A)&#160;(i) in the case of the warrants issued to the lead noteholder, 67% of the aggregate principal amount of notes issued to such lead noteholder and; (ii)&#160;in the case of all other noteholders in the Bridge Note Financing, 60% of the aggregate principal amount of notes issued to such other noteholders by (B)&#160;(i) the initial public offering price per share or (ii)&#160;if the initial public offering is not consummated, by either (x)&#160;the price per share offered in a change of control transaction or (y)&#160;if a change of control transaction does not occur, the fair market value of our common stock as determined by an independent appraiser. The warrants may also be net exercised upon election. The value of the warrants of $1.3&#160;million was recorded as debt discount on the senior notes of $2.0&#160;million. The debt discount was amortized into interest expense over life of the senior notes. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 163,121 shares of common stock. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Income Taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;estimates, assumptions, and judgments to determine the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Recently Issued Accounting Pronouncements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s condensed consolidated financial statements upon adoption. The Company qualifies as an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;) and has elected not to &#x201c;opt out&#x201d; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time public companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#x201c;opt out&#x201d; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Accounting Pronouncements Recently Adopted ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-02&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-02,&lt;/div&gt; Leases (&#x201c;Topic 842&#x201d;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January&#160;1, 2022. Financial positions for reporting periods beginning on or after January&#160;1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-13&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In June 2016, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-03,&lt;/div&gt; Measurement of Credit Losses on Financial Instruments (&#x201c;CECL&#x201d;), which amends ASC 326 &#x201c;Financial Instruments - Credit Losses&#x201d; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#x201c;expected loss model&#x201d; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January&#160;1, 2022 and the guidance did not have a material impact on our condensed consolidated financial statements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2019, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/div&gt;&lt;/div&gt;, which amends ASC Topic 740, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances, eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12&lt;/div&gt; effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#x2019;s condensed consolidated financial statements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Accounting Pronouncements Not Yet Adopted ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-04&lt;/div&gt; and ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2020, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-04,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/div&gt;&lt;/div&gt;. This guidance provides temporary optional expedients and exceptions to accounting &lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="line-height:normal;background-color:white;display: inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;guidance on contract modifications and hedge accounting to ease entities&#x2019; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reference Rate Reform (Topic 848)&lt;/div&gt;&lt;/div&gt;, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01&lt;/div&gt; are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its condensed consolidated financial statements. &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ComparabilityOfPriorYearFinancialData contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unaudited Interim Financial Information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP, for interim financial reporting and as required by Regulation &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S-X,&lt;/div&gt; Rule &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-01.&lt;/div&gt; The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated annual financial statements for the years ended December&#160;31, 2022 and 2021 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s condensed consolidated balance sheet as of September&#160;30, 2023, the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022, the condensed consolidated statement of redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) as of September&#160;30, 2023 and condensed consolidated statements of cash flows for the nine months ended September&#160;30, 2023 and 2022. The financial data and other information disclosed in these notes related to the nine months ended September&#160;30, 2023 and 2022 are unaudited. The results for the nine months ended September&#160;30, 2023, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2023, any other interim periods, or any future year or period. &lt;/div&gt;</us-gaap:ComparabilityOfPriorYearFinancialData>
    <us-gaap:UseOfEstimates contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Use of Estimates &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, valuation of the debt component of convertible notes, warrant liabilities, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. &lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Segment Information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;at-home&lt;/div&gt; fitness technology platform. The Company&#x2019;s chief operating decision maker, its chief executive officer, manages the Company&#x2019;s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of September&#160;30, 2023 and 2022, substantially all of the Company&#x2019;s long-lived assets are held in the United States. &lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Cash consists of cash on deposit in banks. &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <trnr:DeferredOfferingCostsPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred Offering Costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company complies with the requirements of ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;340-10-S99-1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; and SEC Staff Accounting Bulletin Topic 5A &#x201c;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Expenses of Offering&#x201d;&lt;/div&gt;&lt;/div&gt;. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. As of September&#160;30, 2023, the Company incurred offering costs amounting to $4.6&#160;million through the IPO and subsequently classified the costs to additional paid in capital. &lt;/div&gt;</trnr:DeferredOfferingCostsPolicyTextBlock>
    <us-gaap:GeneralPartnersOfferingCosts
      contextRef="PAsOn09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">4600000</us-gaap:GeneralPartnersOfferingCosts>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and Equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Property and equipment purchased by the Company are stated at cost less accumulated depreciation. Major updates and improvements are capitalized, while charges for repairs and maintenance which do not improve or extend the lives of the respective asset, are expensed as incurred. The Company capitalizes the cost of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-production&lt;/div&gt; tooling which it owns under a supply arrangement. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pre-production&lt;/div&gt; tooling, including the related engineering costs the Company will not own or will not use in producing products under long-term supply arrangements, are expensed as incurred. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 10 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;3 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="-sec-ix-hidden:hidden95757150"&gt;Lesser of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;2 &#x2013; 10 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;3 &#x2013; 5 years&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#160;&#160;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;white-space:nowrap"&gt;&lt;span style="-sec-ix-hidden:hidden95757150"&gt;Lesser of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn09_30_2023_MinimumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn09_30_2023_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn09_30_2023_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn09_30_2023_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn09_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="PAsOn09_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:InventoryPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Inventories, net &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Inventories, which are comprised of finished goods, are stated at the lower of cost or net realizable value, with cost determined using actual costs. The Company maintains inventory in a third-party warehouse. Reserves are established to reduce the cost of inventories to their estimated net realizable value and are reflected in cost of revenues in the consolidated statement of operations. The Company assessed the obsolescence reserve by evaluating factors such as inventory levels, historical sales, and the remaining life of its products. Inventory losses are &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;written-off&lt;/div&gt; against the reserve. Inventory not expected to be sold in the next twelve months is classified as long-term in the accompanying condensed, consolidated balance sheets. &lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <trnr:VendorDepositPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Vendor Deposits &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Vendor deposits represent prepayments made to the third-party manufacturers of the Company&#x2019;s inventory. In general, the Company&#x2019;s manufacturers require that the Company pay a portion of the costs for a manufacturing purchase order in advance, with the remaining cost being invoiced upon delivery of the products. Prior to receipt of the goods, any costs associated with the prepayments made by the Company are reflected as vendor deposits on the Company&#x2019;s consolidated balance sheet. &lt;/div&gt;</trnr:VendorDepositPolicyTextBlock>
    <trnr:CapitalizedStudioContentPolicytextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Capitalized Studio Content &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Capitalized Studio content costs include certain expenditures to develop video and live content for the Company&#x2019;s customers. The Company capitalizes production costs for recorded content in accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;926-20,&lt;/div&gt; Entertainment-Films - Other Assets - Film Costs. The Company recognizes capitalized content, net of accumulated amortization, within other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; assets in the consolidated balance sheets and recognizes the related amortization expense as a component of cost of revenue in the consolidated statements of operations and comprehensive (loss). Costs which qualify for capitalization include production costs, development costs, direct costs, labor costs, and production overhead. Expenditures for capitalized content are included within operating activities in the consolidated statements of cash flows. Based on certain factors, including historical and estimated user viewing patterns, the Company amortizes individual titles within the Studio content library on a straight-line basis over a three-year useful life. The Company reviews factors impacting the amortization of the capitalized Studio content on an ongoing basis. Estimates related to these factors require considerable management judgment. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company considered certain factors in determining the useful life of the content, including expected periods over which the content will be made available through the platform and related viewership, the lack of &#x201c;obsolescence&#x201d; of such content over such period given the nature of its videos (i.e., exercise classes which are not significantly impacted by changes in markets or customer preferences, and/or for which the content is expected to significantly change or evolve over time), and the expected significant growth of its subscriber base which will contribute to substantial increases in viewership over time given the recent launch of its product and membership offerings. Based on these factors, the Company has determined that a three-year &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(3-year)&lt;/div&gt; amortization period is reasonable for the content. The Company will continue to review factors impacting the amortization of the capitalized content on an ongoing basis. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s business model is membership based as opposed to generating revenues at a specific title level. Therefore, all content assets are monetized as part of a single asset group. The content is assessed at the group level when an event or change in circumstances indicates a change in the expected usefulness of the content or that fair value may be less than unamortized cost. Unamortized costs are assessed for impairment regardless of whether the produced content is completed. To date, the Company has recognized one impairment with regards to the carrying value of its content portfolio. If circumstances in the future suggest that an impairment may exist, these aggregated content assets will be stated at the lower of unamortized cost or fair value. In addition, unamortized costs for assets that have been, or are expected to be, abandoned are written off. The unamortized cost of content is approximately $2.9&#160;million and $4.4&#160;million as of September&#160;30, 2023 and December&#160;31, 2022, respectively. &lt;/div&gt;</trnr:CapitalizedStudioContentPolicytextBlock>
    <us-gaap:CooperativeAdvertisingAmount
      contextRef="P01_01_2023To09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">2900000</us-gaap:CooperativeAdvertisingAmount>
    <us-gaap:CooperativeAdvertisingAmount
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">4400000</us-gaap:CooperativeAdvertisingAmount>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Identifiable Intangible Assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company capitalizes certain eligible software development costs incurred in connection with its internal use software in accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;350-40,&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internal-use&lt;/div&gt; Software and ASC 985, Software. These capitalized costs also relate to the Company&#x2019;s Studio software that is accessed by its customers on a membership basis as well as certain costs associated with its information systems. Capitalized software costs are amortized over the estimated useful life is three years. Capitalization begins once the application development stage begins, management has authorized and committed to funding the project, it is probable the project will be completed, and the software will be used to perform the function intended. Internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. The Company expenses all costs incurred that relate to planning and post-implementation phases of development. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment, and none were identified in the quarter ended September&#160;30, 2023. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the nine months ended September&#160;30, 2023 and the year ended December&#160;31, 2022, the Company capitalized $0.5&#160;million and $2.7&#160;million, respectively, of internal use software. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:41%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td style="width:56%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Internal-use&lt;/div&gt; software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;3 years&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="P07_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
      contextRef="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
      contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-5"
      unitRef="Unit_USD">2700000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amortization is computed on a straight-line basis over the following estimated useful lives: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:41%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td style="width:56%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;Internal-use&lt;/div&gt; software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;3 years&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P01_01_2023To09_30_2023">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <trnr:MusicRoyaltyFeesPolicyPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Music Royalty Fees &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognizes music royalty fees as these fees are incurred in accordance with the terms of the relevant license agreement with the music rights holder. The incurrence of such royalties is primarily driven by the number of paid subscribers each month and it is classified as cost of membership and training within the Company&#x2019;s statement of operations. The Company&#x2019;s license agreements with music rights holders generally include provisions for advance royalties as well as minimum guarantees. When a minimum guarantee is paid in advance, the guarantee is recorded as a prepaid asset and amortized over the shorter of the period consumed or the term of the agreement. As of September&#160;30, 2023 and December&#160;31, 2022 there were no music guarantee-related prepaids, respectively. &lt;/div&gt;</trnr:MusicRoyaltyFeesPolicyPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;1 inputs are based on quoted prices in active markets for identical assets or liabilities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;2 inputs are based on observable inputs other than Level&#160;1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Level&#160;3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s material financial instruments consist primarily of cash and cash equivalents, accounts payable, accrued expenses, convertible notes, and warrants. The carrying amounts of current financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses, approximate their fair values due to the short-term nature of these instruments. &lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Impairment of Long-Lived Assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset (or asset group) to the future undiscounted cash flows expected to be generated by the &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;assets (or asset group). If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds their fair value. &lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <trnr:ConvertibleNotesPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As permitted under ASC Topic 825, Financial Instruments, the Company has elected the fair value option to account for its convertible notes. In accordance with ASC Topic 825, the Company records these convertible notes at fair value with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statement of operations and comprehensive loss. As a result of applying the fair value option, direct costs and fees related to the convertible notes were expensed as incurred and were not deferred. The Company concluded that it was appropriate to apply the fair value option as they are liabilities that are not, in whole or in part, classified as a component of members&#x2019; deficit. In addition, the convertible notes meet other applicable criteria for electing fair value option under ASC Topic 825. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In May 2023, upon closing of the Company&#x2019;s IPO, the convertible notes were converted into an aggregate of 565,144 shares of common stock. &lt;/div&gt;</trnr:ConvertibleNotesPolicyTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="P05_01_2023To05_31_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">565144</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <trnr:WarrantsPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company records its warrants as a liability as allowed in the exceptions for derivative accounting under ASC Topic 815, Derivatives and Hedging. Accordingly, as the Company has elected the fair value option to account for its convertible notes as permitted under ASC Topic 825, the Company also records the warrants issued in association with the convertible notes at fair value, with changes in fair value recorded as a component of other expense, net in the condensed consolidated statement of operations and comprehensive loss. The Company concluded that it was appropriate to apply the fair value option as the warrants are liabilities that are not, in whole or in part, classified as a component of members&#x2019; deficit. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#x2019;s hiring of certain employees from the third party (the &#x201c;acqui-hire transaction&#x201d;) that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x)&#160;the price per share of the next equity financing with total proceeds of at least $10.0&#160;million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 28,124 shares of common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $400,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 49,996 shares of common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, we issued warrants to certain existing affiliate and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-affiliate&lt;/div&gt; stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with a note financing (the &#x201c;Bridge Note Financing&#x201d;). Such warrants are exercisable for a number of shares of our common stock that is determined by dividing: (A)&#160;(i) in the case of the warrants issued to the lead noteholder, 67% of the aggregate principal amount of notes issued to such lead noteholder and; (ii)&#160;in the case of all other noteholders in the Bridge Note Financing, 60% of the aggregate principal amount of notes issued to such other noteholders by (B)&#160;(i) the initial public offering price per share or (ii)&#160;if the initial public offering is not consummated, by either (x)&#160;the price per share offered in a change of control transaction or (y)&#160;if a change of control transaction does not occur, the fair market value of our common stock as determined by an independent appraiser. The warrants may also be net exercised upon election. The value of the warrants of $1.3&#160;million was recorded as debt discount on the senior notes of $2.0&#160;million. The debt discount was amortized into interest expense over life of the senior notes. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 163,121 shares of common stock. &lt;/div&gt;</trnr:WarrantsPolicyTextBlock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="P11_01_2022To11_30_2022"
      decimals="-3"
      unitRef="Unit_USD">225000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="P11_01_2022To11_30_2022"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn11_30_2022"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <trnr:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="P11_01_2022To11_30_2022_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">28124</trnr:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="P01_01_2023To03_31_2023"
      decimals="-3"
      unitRef="Unit_USD">400000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="P01_01_2023To03_31_2023"
      decimals="0"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn03_31_2023"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <trnr:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">49996</trnr:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="P01_01_2023To03_31_2023_LeadNoteholderMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="2"
      unitRef="Unit_pure">0.67</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="P01_01_2023To03_31_2023_OtherNoteholderMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="2"
      unitRef="Unit_pure">0.60</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="PAsOn03_31_2023"
      decimals="-5"
      unitRef="Unit_USD">1300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="P01_01_2023To03_31_2023_SeniorNotesMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">2000000</us-gaap:AmortizationOfDebtDiscountPremium>
    <trnr:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="P05_01_2023To05_31_2023_BridgeNoteFinancingMemberusgaapCreditFacilityAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">163121</trnr:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Income Taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company utilizes the asset and liability method for computing its income tax provision. Deferred tax assets and liabilities reflect the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities as well as operating loss, capital loss, and tax credit carryforwards, using enacted tax rates. Management makes &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;estimates, assumptions, and judgments to determine the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits, which to date have not been material, are recognized within income tax expense. &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Recently Issued Accounting Pronouncements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s condensed consolidated financial statements upon adoption. The Company qualifies as an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;) and has elected not to &#x201c;opt out&#x201d; of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time public companies adopt the new or revised standard and will do so until such time that the Company either (i)&#160;irrevocably elects to &#x201c;opt out&#x201d; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Accounting Pronouncements Recently Adopted ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-02&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-02,&lt;/div&gt; Leases (&#x201c;Topic 842&#x201d;), and issued subsequent amendments to the initial guidance thereafter. This ASU requires an entity to recognize a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification of the underlying lease as either finance or operating. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted this accounting standard as of January&#160;1, 2022. Financial positions for reporting periods beginning on or after January&#160;1, 2022 are presented under the new guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-13&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In June 2016, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-03,&lt;/div&gt; Measurement of Credit Losses on Financial Instruments (&#x201c;CECL&#x201d;), which amends ASC 326 &#x201c;Financial Instruments - Credit Losses&#x201d; which introduces a new methodology for accounting for credit losses on financial instruments. The guidance establishes a new forward looking &#x201c;expected loss model&#x201d; that requires entities to estimate current expected credit losses on accounts receivable and financial instruments by using all practical and relevant information. The Company adopted the new standard effective January&#160;1, 2022 and the guidance did not have a material impact on our condensed consolidated financial statements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2019, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/div&gt;&lt;/div&gt;, which amends ASC Topic 740, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;. This ASU simplifies the accounting for income taxes by modifying the treatment of intraperiod tax allocation in certain circumstances, eliminating an exception to recognizing deferred tax liabilities for outside basis differences for foreign equity method investments and foreign subsidiaries when ownership or control changes, and modifying interim period tax calculations when a loss is forecasted. In addition, this ASU also requires that enacted changes in tax laws or rates be included in the annual effective rate determination in the period that includes the enactment date and clarifies the tax accounting of a step up in tax basis of goodwill. The Company adopted ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12&lt;/div&gt; effective January&#160;1, 2022, using the modified retrospective method. The adoption did not have a material impact on the Company&#x2019;s condensed consolidated financial statements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Accounting Pronouncements Not Yet Adopted ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-04&lt;/div&gt; and ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2020, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-04,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/div&gt;&lt;/div&gt;. This guidance provides temporary optional expedients and exceptions to accounting &lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="line-height:normal;background-color:white;display: inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;guidance on contract modifications and hedge accounting to ease entities&#x2019; financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Reference Rate Reform (Topic 848)&lt;/div&gt;&lt;/div&gt;, which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-01&lt;/div&gt; are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The Company plans to adopt this standard when LIBOR is discontinued. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its condensed consolidated financial statements. &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3. Revenue Recognition &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s primary source of revenue is solely derived from the United States from sales of its Connected Fitness Products and related accessories and associated recurring Membership revenue, as well as from sales of personal training services recorded within Training revenue. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company determines revenue recognition through the following steps: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Identification of the contract, or contracts, with a customer; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Identification of the performance obligations in the contract; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Determination of the transaction price; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Allocation of the transaction price to the performance obligations in the contract; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;Recognition of revenue when, or as, the Company satisfies a performance obligation. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Revenue is recognized when control of the promised goods or services is transferred to the Company&#x2019;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company&#x2019;s revenue is reported net of sales returns, discounts and incentives as a reduction of the transaction price. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company applies the practical expedient as per ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;606-10-50-14&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company&#x2019;s condensed consolidated statements of operations and comprehensive (loss). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Connected Fitness Products &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Connected Fitness Products include the Company&#x2019;s portfolio of Connected Fitness Products and related accessories, delivery and installation services, and extended warranty agreements. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period. The Company allows customers to return products within thirty days of purchase, as stated in its return policy. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amounts paid for payment processing fees for credit card sales for Connected Fitness Products are included as a reduction to fitness product revenue in the Company&#x2019;s condensed consolidated statements of operations and comprehensive (loss). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Membership &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s memberships provide unlimited access to content in its library of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;on-demand&lt;/div&gt; fitness classes. The Company&#x2019;s memberships are offered on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;month-to-month&lt;/div&gt;&lt;/div&gt; basis. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amounts paid for membership fees are included within deferred revenue on the Company&#x2019;s condensed consolidated balance sheets and recognized ratably over the membership term. The Company records payment processing fees for its monthly membership charges within cost of membership and training in the Company&#x2019;s condensed consolidated statements of operations and comprehensive (loss). &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Training &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s training services are personal training services delivered through the Connected Fitness Products and third-party mobile devices. Training revenue is recognized at the time of delivery. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Standard Product Warranty &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company offers a standard product warranty that its Connected Fitness Products and related accessories will operate under normal, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-commercial&lt;/div&gt; use for a period of one year which covers the touchscreen, frame and all incorporated elements, and related accessories from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company also offers the option for customers in some markets to purchase a third-party extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of 24 to 48 months. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;For third-party extended warranty service sold along with the Company&#x2019;s Connected Fitness Products, the Company does not obtain control of the warranty before transferring it to the customers. Therefore, the Company accounts for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission it retains. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it can establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product. &lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <trnr:ExtendedProductWarrantyPeriod contextRef="P01_01_2023To09_30_2023_MinimumMembersrtRangeAxis">P24M</trnr:ExtendedProductWarrantyPeriod>
    <trnr:ExtendedProductWarrantyPeriod contextRef="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis">P48M</trnr:ExtendedProductWarrantyPeriod>
    <us-gaap:InventoryDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4. Inventories, net &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Inventories consist of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:74%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Finished products&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,443&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,567&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Finished products - LT&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,121&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total inventories, net&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,564&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,567&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Finished products - LT represents inventory not expected to be sold in the next twelve months. &lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Inventories consist of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:74%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Finished products&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,443&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,567&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Finished products - LT&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,121&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total inventories, net&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,564&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,567&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Finished products - LT represents inventory not expected to be sold in the next twelve months. &lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1443000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4567000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNoncurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3121000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNet
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">4564000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4567000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5. Property and Equipment, net &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Property and equipment consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Software and technology development asset&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,370&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,370&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: Accumulated depreciation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,787)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,044)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total property and equipment, net&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;583&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,326&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Depreciation expense amounted to $0.2&#160;million and $0.3&#160;million for the three months ended September&#160;30, 2023 and 2022, respectively, and $0.7&#160;million and $1.0&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively. &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Property and equipment consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Pre-production&lt;/div&gt; tooling&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,094&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Machinery and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Leasehold improvements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Furniture and fixtures&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Software and technology development asset&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,370&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,370&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: Accumulated depreciation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,787)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,044)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total property and equipment, net&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;583&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,326&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <trnr:PreProductionTooling
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3094000</trnr:PreProductionTooling>
    <trnr:PreProductionTooling
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3094000</trnr:PreProductionTooling>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">125000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">125000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">113000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">113000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">13000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">13000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3370000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3370000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2787000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2044000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">583000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1326000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="P07_01_2023To09_30_2023_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P07_01_2022To09_30_2022_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P01_01_2023To09_30_2023_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P01_01_2022To09_30_2022_PropertyAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">1000000</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6. Intangible Assets, net &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Identifiable intangible assets, net consist of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:38%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internal-Use&lt;/div&gt; Software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;6,346&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(3,480)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;2,866&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;5,827&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(1,993)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;3,834&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total identifiable intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,346&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,480)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,866&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,827&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,993)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,834&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amortization expense amounted to $0.5&#160;million for each of the three months ended September&#160;30, 2023 and 2022, and $1.5&#160;million and $1.1&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively. Intangible assets are assessed for impairment when events or circumstances indicate the existence of a possible impairment. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of September&#160;30, 2023, estimated annual amortization expense for each of the next five fiscal years is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:87%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td colspan="4" style="vertical-align:bottom"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fiscal Years Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:6pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:6pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023 (remaining)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;530&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,689&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;554&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;93&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,866&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Identifiable intangible assets, net consist of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:38%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internal-Use&lt;/div&gt; Software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;6,346&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(3,480)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;2,866&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;5,827&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(1,993)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;3,834&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total identifiable intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,346&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,480)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,866&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,827&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,993)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,834&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">6346000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">3480000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn09_30_2023_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">2866000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">5827000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">1993000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn12_31_2022_InternalUseSoftwareMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-3"
      unitRef="Unit_USD">3834000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">6346000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">3480000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2866000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5827000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1993000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3834000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="P07_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="P07_01_2022To09_30_2022_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="P01_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-5"
      unitRef="Unit_USD">1500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="P01_01_2022To09_30_2022_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="-5"
      unitRef="Unit_USD">1100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of September&#160;30, 2023, estimated annual amortization expense for each of the next five fiscal years is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:87%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td colspan="4" style="vertical-align:bottom"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fiscal Years Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:6pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:6pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023 (remaining)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;530&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,689&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;554&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;93&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,866&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">530000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1689000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">554000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">93000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">2866000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7. Prepaid Expenses and Other Current Assets &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Prepaid expenses and other current assets consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:69%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;br/&gt; 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Security deposit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;66&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;146&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Prepaid licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;133&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;45&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development tax credit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;266&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;750&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other receivables&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;178&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;178&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Insurance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other prepaid&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;71&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;293&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total prepaid expenses and other current assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;962&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,426&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Prepaid expenses and other current assets consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:69%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;br/&gt; 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Security deposit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;66&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;146&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Prepaid licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;133&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;45&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development tax credit&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;266&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;750&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other receivables&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;178&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;178&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Insurance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other prepaid&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;71&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;293&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total prepaid expenses and other current assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;962&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,426&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:SecurityDeposit
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">66000</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">146000</us-gaap:SecurityDeposit>
    <trnr:PrepaidLicenses
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">133000</trnr:PrepaidLicenses>
    <trnr:PrepaidLicenses
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">45000</trnr:PrepaidLicenses>
    <trnr:ResearchAndDevelopmentTaxCredit
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">266000</trnr:ResearchAndDevelopmentTaxCredit>
    <trnr:ResearchAndDevelopmentTaxCredit
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">750000</trnr:ResearchAndDevelopmentTaxCredit>
    <us-gaap:OtherReceivables
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">178000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">178000</us-gaap:OtherReceivables>
    <us-gaap:PrepaidInsurance
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">248000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">14000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">71000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">293000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">962000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1426000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8. Other Assets, net &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Other assets consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:36%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized content costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,589&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(3,721)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;2,868&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,589&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(2,185)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;4,404&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,370&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,555)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,815&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,996&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,391)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,605&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total other assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;11,959&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(6,276)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,683&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;10,594&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,576)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,018&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Amortization expense amounted to $0.9&#160;million and $0.9&#160;million for the three months ended September&#160;30, 2023 and 2022, respectively, and $2.7&#160;million and $2.7&#160;million for each of the nine months ended September&#160;30, 2023 and 2022. &lt;/div&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Other assets consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:36%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net&#160;Book&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized content costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,589&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(3,721)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;2,868&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,589&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;(2,185)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;4,404&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Capitalized software&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,370&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,555)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,815&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,996&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,391)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,605&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total other assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;11,959&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(6,276)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,683&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;10,594&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,576)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,018&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:OtherDeferredCostsGross
      contextRef="PAsOn09_30_2023_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">6589000</us-gaap:OtherDeferredCostsGross>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts
      contextRef="PAsOn09_30_2023_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">3721000</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn09_30_2023_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2868000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsGross
      contextRef="PAsOn12_31_2022_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">6589000</us-gaap:OtherDeferredCostsGross>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts
      contextRef="PAsOn12_31_2022_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2185000</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2022_CapitalizedContentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">4404000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsGross
      contextRef="PAsOn09_30_2023_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">5370000</us-gaap:OtherDeferredCostsGross>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts
      contextRef="PAsOn09_30_2023_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2555000</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn09_30_2023_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2815000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsGross
      contextRef="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">3996000</us-gaap:OtherDeferredCostsGross>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts
      contextRef="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">1391000</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2022_CapitalizedSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2605000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsGross
      contextRef="PAsOn09_30_2023_OtherAssetsMemberusgaapBalanceSheetLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OtherDeferredCostsGross>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts
      contextRef="PAsOn09_30_2023_OtherAssetsMemberusgaapBalanceSheetLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn09_30_2023_OtherAssetsMemberusgaapBalanceSheetLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsGross
      contextRef="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">9000</us-gaap:OtherDeferredCostsGross>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts
      contextRef="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2022_OtherAssetsMemberusgaapBalanceSheetLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">9000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsGross
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">11959000</us-gaap:OtherDeferredCostsGross>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">6276000</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">5683000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">10594000</us-gaap:OtherDeferredCostsGross>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3576000</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7018000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="P07_01_2023To09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">900000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="P07_01_2022To09_30_2022"
      decimals="-5"
      unitRef="Unit_USD">900000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="P01_01_2023To09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">2700000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="P01_01_2022To09_30_2022"
      decimals="-5"
      unitRef="Unit_USD">2700000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9. Accrued Expenses and Other Current Liabilities &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Accrued expenses consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;br/&gt; 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued bonus&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;145&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued payroll&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;58&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;193&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued PTO&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;188&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued offering costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;500&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,490&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,250&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued royalties&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;204&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;195&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued professional fees&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;953&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer deposits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;52&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;517&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other accrued expenses and current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;138&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;326&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total accrued expenses and other current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,951&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,304&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Accrued expenses consisted of the following: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;br/&gt; 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued bonus&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;25&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;145&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued payroll&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;58&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;193&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued PTO&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;188&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued offering costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;500&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,490&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued licenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,250&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued royalties&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;204&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;195&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accrued professional fees&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;953&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer deposits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;52&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;517&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other accrued expenses and current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;138&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;326&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total accrued expenses and other current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,951&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,304&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedBonusesCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">25000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">145000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">58000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">193000</us-gaap:AccruedPayrollTaxesCurrent>
    <trnr:PaidTimeOffAccrual
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">21000</trnr:PaidTimeOffAccrual>
    <trnr:PaidTimeOffAccrual
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">188000</trnr:PaidTimeOffAccrual>
    <trnr:AccruedOfferingCosts
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">500000</trnr:AccruedOfferingCosts>
    <trnr:AccruedOfferingCosts
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1490000</trnr:AccruedOfferingCosts>
    <trnr:AccruedLicenses
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:AccruedLicenses>
    <trnr:AccruedLicenses
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2250000</trnr:AccruedLicenses>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">204000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">195000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">953000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AccruedProfessionalFeesCurrent>
    <trnr:CustomerDeposits
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">52000</trnr:CustomerDeposits>
    <trnr:CustomerDeposits
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">517000</trnr:CustomerDeposits>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">138000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">326000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">1951000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5304000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10. Debt &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2022 Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;From January through March 2022, the Company issued convertible notes (the &#x201c;2022 Convertible Notes&#x201d;) with an aggregate principal amount of $5.9&#160;million, pursuant to a private placement offering. The 2022 Convertible Notes bore interest at 6% per annum and had a scheduled maturity date of 24 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The 2022 Convertible Notes were subject to the following conversion features: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) 80% of the price per unit paid in cash by the other investors for preferred stock sold in a qualified financing, or ii) the &#x201c;Cap Price&#x201d;. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognized losses equal to $0.3&#160;million for the nine months ended September&#160;30, 2023 related to changes in fair value for the November 2022 Convertible Notes, and $0.02&#160;million for the nine months ended September&#160;30, 2022, related to changes in fair value for the 2022 Convertible Notes. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2022, the Company completed a qualified financing, and as a result the 2022 Convertible Notes were automatically converted into 124,313 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2.&lt;/div&gt; &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;November 2022 Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In November 2022, the Company issued convertible notes (the &#x201c;November 2022 Convertible Notes&#x201d;) with an aggregate principal amount of $4.4&#160;million, pursuant to a private placement offering. The November 2022 Convertible Notes bore interest at 6% per annum and had a schedule maturing date of 12 months from issuance, at which time the principal and accrued interest would be due and payable. The Company elected the fair value option for the November 2022 Convertible Notes under ASC Topic 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The November 2022 Convertible Notes did not include any financial covenants and are subject to acceleration upon the occurrence of specified events of default. The November 2022 Convertible Notes were subject to the following conversion features: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company completed a qualified financing, which is defined as the sale of preferred stock for gross proceeds of at least $10.0&#160;million prior to the maturity date of the related notes, all principal and accrued interest will automatically convert into preferred stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In the event the Company did not complete a qualified financing prior to the maturity date of the related notes, at the election of the note holder, all principal and accrued interest can be converted into common stock. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The conversion price with respect to an automatic conversion upon the occurrence of a qualified financing is equal to the lesser of i) the price per share in the Next Financing round, or ii) the Original Issue Price of the Company&#x2019;s Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt; Preferred Stock, which is $47.67. The conversion price with respect to an elective conversion at the time of maturity is equal to the Cap Price. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recognized losses equal to $0.3&#160;million for the nine months ended September&#160;30, 2023 related to changes in fair value for the November 2022 Convertible Notes, and $0.02&#160;million for the nine months ended September&#160;30, 2022, related to changes in fair value for the 2022 Convertible Notes. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In May 2023, upon closing of the Company&#x2019;s IPO, the November 2022 Convertible notes were converted into an aggregate of 565,144 shares of common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Senior Secured Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, the Company issued an aggregate of $2.0&#160;million of senior secured notes to three investors, including one related party, with associated warrants to purchase the Company&#x2019;s common stock at an exercise price of $0.0001, in lieu of future cash interest payments under the senior secured notes issued to such investors. In May 2023, the Company repaid the $2.0&#160;million in senior secured notes. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Note Purchase Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In June 2023, the Company entered into a note purchase agreement with THLWY, LLC (the &#x201c;June 2023 Notes&#x201d;) pursuant to which the Company agreed to issue up to $15.8&#160;million in aggregate principal amount of 10% senior secured notes due June 25, 2025 at their sole discretion. The June 2023 Notes are the senior secured obligations of the Company, bear interest at a rate of 10.0% per annum, and contain customary events of default. The June 2023 Notes will mature on June&#160;25, 2025, subject to earlier repurchase by the Company. The Company may redeem the June 2023 Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the June 2023 Notes to be redeemed, plus any accrued and unpaid interest to (including any additional interest), but excluding, the redemption date. As of September&#160;30, 2023, $1.0&#160;million of the senior secured notes have been issued. Additional senior secured notes may become available at the sole discretion of THLWY, LLC. As of September&#160;30, 2023, the Company defaulted on the payment of interest due on the June 2023 Notes. On November&#160;3, 2023, THLWY, LLC waived their rights to seek remedies resulting from an event of default. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was less than $0.1&#160;million for the nine months ended September&#160;30, 2023. &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">5900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis">P24M</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="P01_01_2022To03_31_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.80</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <trnr:LossDueToChangesInFairValueOfConvertibleNotes
      contextRef="PAsOn09_30_2023_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</trnr:LossDueToChangesInFairValueOfConvertibleNotes>
    <trnr:LossDueToChangesInFairValueOfConvertibleNotes
      contextRef="PAsOn09_30_2022_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-4"
      unitRef="Unit_USD">20000.00</trnr:LossDueToChangesInFairValueOfConvertibleNotes>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="PAsOn03_31_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis_TwoThousandTwentyTwoConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">124313</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">4400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="P11_01_2022To11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn11_30_2022_November2022ConvertibleNotesMemberusgaapDebtInstrumentAxis_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">47.67</us-gaap:SharesIssuedPricePerShare>
    <trnr:LossDueToChangesInFairValueOfConvertibleNotes
      contextRef="PAsOn09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">300000</trnr:LossDueToChangesInFairValueOfConvertibleNotes>
    <trnr:LossDueToChangesInFairValueOfConvertibleNotes
      contextRef="PAsOn09_30_2022"
      decimals="-4"
      unitRef="Unit_USD">20000.00</trnr:LossDueToChangesInFairValueOfConvertibleNotes>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="P05_01_2023To05_31_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">565144</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="P03_01_2023To03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">2000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="P03_01_2023To03_31_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">2000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="P06_01_2023To06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">15800000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P06_01_2023To06_30_2023_TenPercentageSeniorSecuredNotesDueMemberusgaapShortTermDebtTypeAxis">2025-06-25</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="P06_01_2023To06_30_2023_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis"
      decimals="2"
      unitRef="Unit_pure">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="P01_01_2023To09_30_2023_SeniorNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">1000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <trnr:InterestExpenseAndDefaultInterest
      contextRef="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis_NotePurchaseAgreementMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</trnr:InterestExpenseAndDefaultInterest>
    <trnr:WarrantsDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11. Warrants &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Class&#160;A Common Stock Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On November&#160;13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. Each warrant has a strike price of $0.01 per share and has a contractual term of ten years. The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings. The fair value of the warrants issued in 2022 was recorded as a liability on the Balance Sheet and expensed to other (expense) income, net on the Statement of Operations and Comprehensive Loss, at the time of issuance. The Company recognized a gain equal to $2.3&#160;million for the nine months ended September&#160;30, 2023, related to changes in fair value for the warrants issued in November 2022. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into shares of common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&#160;Common&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock&#160;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(92,296)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Class&#160;B Common Stock Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company issued warrants in 2021 to purchase Class&#160;B Common Stock to various employees and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-employees.&lt;/div&gt; Each warrant has a strike price of $0.01 and has a contractual term of seven years. The warrants are classified as permanent equity within the condensed consolidated balance sheets. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into shares of common stock. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:84%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&#160;Common&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock&#160;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,753&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,753)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Service Providers Stock Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In November 2022, the Company issued a warrant to an unrelated third party in consideration for the Company&#x2019;s hiring of certain employees from the third party that is exercisable for a number of shares of common stock that is determined by dividing $225,000 by (x)&#160;the price per share of the next equity financing with total proceeds of at least $10.0&#160;million or (y)&#160;the initial public offering price per share of a future initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrant may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 28,124 shares of common stock &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, we issued warrants to unrelated third-party service providers in consideration for certain marketing communications services, which warrants are exercisable for a total number of shares of our common stock that is determined by dividing $400,000 by (x)&#160;the price per share of our next bona fide equity financing with total proceeds of at least $10,000,000 or (y)&#160;the initial public offering price per share in our initial public offering, whichever event occurs first, for an exercise price of $0.0001 per share, in whole or in part. The warrants may also be net exercised upon election. The warrant vests associated with the services of certain employees and as such contains a substantive future requisite service condition. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 49,996 shares of common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Service&#160;Providers&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock&#160;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;78,120&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(78,120)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Senior Secured Notes Stock Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In March 2023, we issued warrants to certain existing affiliate and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-affiliate&lt;/div&gt; stockholders in lieu of future cash interest payments under our senior secured notes issued to such stockholders in connection with a note financing. The fair value of the warrants of $1.3&#160;million was recorded as debt discount on the senior secured notes of $2.0&#160;million. The debt discount was amortized into interest expense over life of the senior secured notes. In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into an aggregate of 163,121 shares of common stock. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:81%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Senior&#160;Secured&#160;Notes&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock&#160;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;163,121&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(163,121)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</trnr:WarrantsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">92296</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn11_13_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&#160;Common&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock&#160;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;92,296&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(92,296)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">92296</trnr:WarrantOutstanding>
    <trnr:ClassOfWarrantsIssued
      contextRef="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:ClassOfWarrantsIssued>
    <trnr:ClassOfWarrantsExercised
      contextRef="P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-92296</trnr:ClassOfWarrantsExercised>
    <trnr:WarrantOutstanding
      contextRef="PAsOn09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn07_31_2021_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapStatementEquityComponentsAxis">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="P01_01_2023To09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:84%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&#160;Common&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock&#160;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,753&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,753)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2022_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">5753</trnr:WarrantOutstanding>
    <trnr:ClassOfWarrantsIssued
      contextRef="P01_01_2023To09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:ClassOfWarrantsIssued>
    <trnr:ClassOfWarrantsExercised
      contextRef="P01_01_2023To09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-5753</trnr:ClassOfWarrantsExercised>
    <trnr:WarrantOutstanding
      contextRef="PAsOn09_30_2023_ClassBCommonStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="P11_01_2022To11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">225000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="P11_01_2022To11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn11_30_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <trnr:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="P11_01_2022To11_30_2022_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">28124</trnr:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      unitRef="Unit_USD">400000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="P03_01_2023To03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn03_31_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <trnr:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">49996</trnr:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="P01_01_2023To09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Service&#160;Providers&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock&#160;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;78,120&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(78,120)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2022_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <trnr:ClassOfWarrantsIssued
      contextRef="P01_01_2023To09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">78120</trnr:ClassOfWarrantsIssued>
    <trnr:ClassOfWarrantsExercised
      contextRef="P01_01_2023To09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-78120</trnr:ClassOfWarrantsExercised>
    <trnr:WarrantOutstanding
      contextRef="PAsOn09_30_2023_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <trnr:FairValueOfWarrants
      contextRef="P01_01_2023To03_31_2023"
      decimals="-5"
      unitRef="Unit_USD">1300000</trnr:FairValueOfWarrants>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="P01_01_2023To03_31_2023"
      decimals="-5"
      unitRef="Unit_USD">2000000</us-gaap:AmortizationOfDebtDiscountPremium>
    <trnr:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="P01_01_2023To03_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">163121</trnr:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="P01_01_2023To09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following is a schedule of changes in warrants issued and outstanding from December&#160;31, 2022 to September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:81%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Senior&#160;Secured&#160;Notes&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock&#160;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;163,121&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(163,121)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <trnr:WarrantOutstanding
      contextRef="PAsOn12_31_2022_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <trnr:ClassOfWarrantsIssued
      contextRef="P01_01_2023To09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">163121</trnr:ClassOfWarrantsIssued>
    <trnr:ClassOfWarrantsExercised
      contextRef="P01_01_2023To09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">-163121</trnr:ClassOfWarrantsExercised>
    <trnr:WarrantOutstanding
      contextRef="PAsOn09_30_2023_SeniorSecuredNotesStockWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</trnr:WarrantOutstanding>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12. Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s financial instruments consist of its convertible notes and warrants. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="line-height:normal;background-color:white;display: inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;There were no assets or liabilities measured at fair value on a recurring basis as of September&#160;30, 2023, and no assets measured at fair value on a recurring basis as of December&#160;31, 2022. Liabilities measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:72%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&#160;measurements&#160;as&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,274&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,274&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the nine months ended September&#160;30, 2023, there were no transfers between Level&#160;1 and Level&#160;2, nor into and out of Level&#160;3. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible&#160;Notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;252&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into common stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,521)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,266)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Exercise of stock warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(738)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2022: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:16%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible&#160;Notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,902&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;24&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into Series A preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,926)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at September&#160;30, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Convertible Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As further described in Note 10, the Company entered into several convertible note arrangements with certain investors during 2022. The Company recorded the liability related to the convertible notes at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recorded a change in fair value adjustment of $0.3&#160;million for the nine months ended September&#160;30, 2023 related to the November 2022 Convertible Notes, and $0.02&#160;million for the nine months ended September&#160;30, 2022 related to the 2022 Convertible Notes in the condensed consolidated statement of operations and comprehensive loss. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In May 2023, upon closing of the Company&#x2019;s IPO, the November 2022 Convertible notes were converted into an aggregate of 565,144 shares of common stock. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As further described in Note 11, on November&#160;13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class&#160;A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. The Company recorded the liability related to the warrants at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company recorded a change in fair value adjustment of $2.3&#160;million and $0&#160;million in the condensed consolidated statement of operations and comprehensive loss for the nine months ended September&#160;30, 2023 and 2022, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In May 2023, upon closing of the Company&#x2019;s IPO, the warrants were exercised and converted into shares of common stock. &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn09_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="P01_01_2023To09_30_2023">Liabilities measured at fair value on a recurring basis as of December&#160;31, 2022 were as follows: &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:72%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&#160;measurements&#160;as&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.89em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,274&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,274&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">4270000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">4270000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3004000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3004000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">7274000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="-3"
      unitRef="Unit_USD">7274000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
      contextRef="P01_01_2023To09_30_2023"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2023: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible&#160;Notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,270&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;252&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into common stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,521)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,004&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,266)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Exercise of stock warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(738)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following tables summarize the activity for the Company Level&#160;3 liabilities measured at fair value on a recurring basis for the nine months ended September&#160;30, 2022: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:16%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible&#160;Notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of convertible notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5,902&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in estimated fair value of financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;24&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Conversion of convertible notes into Series A preferred stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,926)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value at September&#160;30, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">4270000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2023To09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments
      contextRef="P01_01_2023To09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">-252000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock
      contextRef="P01_01_2023To09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">4521000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn09_30_2023_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3004000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments
      contextRef="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">2266000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants
      contextRef="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">738000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2022To09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">5902000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments
      contextRef="P01_01_2022To09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">-24000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments>
    <trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock
      contextRef="P01_01_2022To09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">5926000</trnr:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn09_30_2022_ConvertibleNotesPayableMemberusgaapShortTermDebtTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="P01_01_2023To09_30_2023_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="P01_01_2022To09_30_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="-4"
      unitRef="Unit_USD">20000.00</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="P05_01_2023To05_31_2023_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">565144</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn11_13_2022_NovemberTwoThousandTwentyTwoConvertibleNotesMemberusgaapShortTermDebtTypeAxis_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_shares">92296</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="P01_01_2023To09_30_2023_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="P01_01_2022To09_30_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13. Commitments and Contingencies &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lease Obligations &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following represents the Company&#x2019;s minimum annual rental payments under operating leases for each of the next five years and thereafter: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fiscal Year Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Future&#160;Minimum&#160;Payments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(in&#160;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023 (remaining)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;78&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;78&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;78&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;78&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;33&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;365&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay 3% of cumulative net sales up to $5.0&#160;million and 1% of cumulative net sales above $5.0&#160;million, up to a maximum total royalty of $1.0&#160;million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $0.2&#160;million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of September&#160;30, 2023. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Legal Proceedings &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company is involved in legal proceedings in the normal course of business. The Company currently believes that any ultimate liability arising out of such proceedings will not have a material adverse effect on the Company&#x2019;s financial position, results of operations or cash flows. &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following represents the Company&#x2019;s minimum annual rental payments under operating leases for each of the next five years and thereafter: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:80%;border:0"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fiscal Year Ending December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Future&#160;Minimum&#160;Payments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(in&#160;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023 (remaining)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;20&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;78&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;78&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;78&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;78&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;33&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;365&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">20000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">78000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">78000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">78000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">78000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <trnr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">33000</trnr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">365000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <trnr:PercentageOfCumulativeNetSales
      contextRef="P01_01_2017To12_31_2017_MaximumMembersrtRangeAxis"
      decimals="2"
      unitRef="Unit_pure">0.03</trnr:PercentageOfCumulativeNetSales>
    <trnr:CumulativeNetSales
      contextRef="P01_01_2017To12_31_2017_MaximumMembersrtRangeAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</trnr:CumulativeNetSales>
    <trnr:PercentageOfCumulativeNetSales
      contextRef="P01_01_2017To12_31_2017_MinimumMembersrtRangeAxis"
      decimals="2"
      unitRef="Unit_pure">0.01</trnr:PercentageOfCumulativeNetSales>
    <trnr:CumulativeNetSales
      contextRef="P01_01_2017To12_31_2017_MinimumMembersrtRangeAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</trnr:CumulativeNetSales>
    <us-gaap:RoyaltyExpense
      contextRef="P01_01_2017To12_31_2017"
      decimals="-5"
      unitRef="Unit_USD">1000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyGuaranteesCommitmentsAmount
      contextRef="PAsOn09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14. Stockholders&#x2019; Deficit &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Common Stock &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company&#x2019;s authorized common stock consisted of 900,000,000 and 369,950,000 shares at $0.0001 par value, as of September&#160;30, 2023 and December&#160;31, 2022, respectively. The issued and outstanding common stock was 14,178,514 shares and 2,450,922 shares as of September&#160;30, 2023 and December&#160;31, 2022, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In February 2023, the Company completed a rights offering involving the sale of Class&#160;A common stock to all existing accredited investors as of December&#160;19, 2022, at a price equal to approximately $0.51 per share. In connection with the rights offering, the Company issued a total of 9,749,439 shares of Class&#160;A common stock, of which 1,072,515 was issued in December 2022, and 8,676,924 was issued in January and February 2023. &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">369950000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">14178514</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn09_30_2023_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">14178514</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">2450922</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">2450922</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.51</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">9749439</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">1072515</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn02_28_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">8676924</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn01_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_RightsOfferingMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">8676924</us-gaap:CommonStockSharesIssued>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15. Equity-Based Compensation &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2023 and 2020 Equity Incentive Plan &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022. &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:43%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three&#160;Months&#160;Ended&#160;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Nine&#160;Months&#160;Ended&#160;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,347&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;383&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,803&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;478&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Sales and marketing&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;87&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;34&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;407&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;52&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;General and administrative&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,402&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,356&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18,563&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,421&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total stock-based compensation expense&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,836&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,773&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;23,773&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,951&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;For the three months ended September&#160;30, 2023 and 2022, $0.1&#160;million and $0.0&#160;million of stock-based compensation was capitalized as software costs, respectively. For the nine months ended September&#160;30, 2023 and 2022 $0.7&#160;million and $0.0&#160;million of stock-based compensation was capitalized as software costs, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During the nine months ended September&#160;30, 2023, the Company granted options to purchase 3,428,225 shares under the 2023 and 2020 Plan. The Company has not granted any restricted stock or stock appreciation rights. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In December 2022, the Company enacted a restructuring cost savings initiative which resulted in employee terminations in both December 2022 and January 2023. In association with January 2023 terminations, the Company accelerated the vesting of a number of individual option awards, resulting in the accelerated vesting of 5,938 shares on the date of modification. Also in January 2023, the Company repriced 301,537 option awards. Both the accelerated vesting and repricing were accounted for as an equity award modification under ASC Topic 718 which resulted in adjustment of the award value to reflect the fair value at the modification date and acceleration of the recognition schedule in the case of awards which were modified to have accelerated vesting. The adjustment resulted in additional expense of $0.5&#160;million. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In June 2023, the Company granted 1,294,998 options to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-employee&lt;/div&gt; directors, selected executives and other key employees where vesting is contingent on the Company&#x2019;s share price meeting certain targets. The fair value of each option granted was estimated on the date of grant using the Monte Carlo valuation model and assumes that share price targets are achieved. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following summary sets forth the stock option activity under the 2023 and 2020 Plan: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;Number&#160;of&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;exercise&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;remaining&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;contractual&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;term&#160;(in&#160;years)&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Aggregate&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;intrinsic&#160;value&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;446,839&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.30&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.6&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,706&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Granted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;3,428,225&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.38&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(677,350)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.53&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;12,690&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cancelled or forfeited&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(89,603)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;0.92&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,108,111&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.70&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.5&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,341&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options exercisable as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;178,310&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.97&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8.8&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options unvested as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,325,600&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.33&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.5&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;775&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The aggregate intrinsic value of options outstanding, exercisable and unvested were calculated as the difference between the exercise price of the options and the estimated fair market value of the Company&#x2019;s common stock, as of September&#160;30, 2023. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:92%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Early Option Exercises&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;average&#160;exercise&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;Repurchase&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;liability&#160;(in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested common stock as of December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,823&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;306&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,947&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.19&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vested&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(37)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Repurchased&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,655)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested common stock as of September&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;32,078&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;52&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;For the nine months ended September&#160;30, 2023 and 2022 the weighted-average grant date fair value per option was $12.67 and $0.18 respectively. The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:96%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average risk-free interest rate (1)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.7%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.3%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average expected term (in years)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.93&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.34&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average expected volatility (2)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;62.27%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;54.6%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: justify; line-height: normal;"&gt;Based on U.S. Treasury seven-year constant maturity interest rate whose term is consistent with the expected term of the option. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: justify; line-height: normal;"&gt;Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#x2019;s stage of development. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;With respect to the 2023 and 2020 Plan, the Company recognized stock compensation expense of $24.5&#160;million and $4.0&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively, of which $0.7&#160;million and $0.0&#160;million was capitalized as software costs for the nine months ended September&#160;30, 2023 and 2022, respectively. As of September&#160;30, 2023 and December&#160;31, 2022, the Company had $23.6&#160;million and $5.9&#160;million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of 1.9 years and 1.6 years, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;For financial reporting purposes for the awards granted in January 2023, we applied a straight-line calculation between the $30.00 per share determined in the contemporaneous third-party valuation as of December&#160;31, 2022 and the $6.08 per share determined in the contemporaneous third-party valuation as of March&#160;31, 2023 to determine the fair value of our common stock on the grant date. Using the benefit of hindsight, we determined that the straight-line calculation would provide the most appropriate conclusion for the valuation of our common stock on the interim dates between valuations because we did not identify any single event or series of events that occurred during this interim period that would have caused a material change in fair value. Based on this calculation, we assessed the fair value of our common stock for awards granted in January 2023 to be $19.27 per share. &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive (loss) for the three and nine months ended September&#160;30, 2023 and 2022. &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:43%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three&#160;Months&#160;Ended&#160;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Nine&#160;Months&#160;Ended&#160;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,347&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;383&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,803&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;478&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Sales and marketing&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;87&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;34&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;407&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;52&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;General and administrative&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,402&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,356&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18,563&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,421&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total stock-based compensation expense&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,836&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,773&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;23,773&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,951&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P07_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">1347000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P07_01_2022To09_30_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">383000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">4803000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To09_30_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">478000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P07_01_2023To09_30_2023_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">87000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P07_01_2022To09_30_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">34000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2023To09_30_2023_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">407000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To09_30_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">52000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P07_01_2023To09_30_2023_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">3402000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P07_01_2022To09_30_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">3356000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2023To09_30_2023_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">18563000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To09_30_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">3421000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P07_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">4836000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P07_01_2022To09_30_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">3773000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">23773000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To09_30_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">3951000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="P07_01_2023To09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="P07_01_2022To09_30_2022"
      decimals="-5"
      unitRef="Unit_USD">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="P01_01_2023To09_30_2023"
      decimals="-5"
      unitRef="Unit_USD">700000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="P01_01_2022To09_30_2022_MaximumMembersrtRangeAxis"
      decimals="-5"
      unitRef="Unit_USD">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P01_01_2023To09_30_2023_EmployeeStockOptionMemberusgaapAwardTypeAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">3428225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="P01_01_2023To09_30_2023_StockAppreciationRightsSARSMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="P01_01_2023To09_30_2023_RestrictedStockMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="P01_01_2023To01_31_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">5938</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber
      contextRef="P01_01_2023To01_31_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">301537</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber>
    <trnr:AdditionalExpense
      contextRef="P01_01_2023To01_31_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</trnr:AdditionalExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P06_01_2023To06_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">1294998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following summary sets forth the stock option activity under the 2023 and 2020 Plan: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:51%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;Number&#160;of&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;exercise&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;average&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;remaining&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;contractual&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;term&#160;(in&#160;years)&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Aggregate&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;intrinsic&#160;value&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding as of December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;446,839&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.30&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.6&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,706&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Granted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;3,428,225&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.38&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Exercised&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(677,350)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.53&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;12,690&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cancelled or forfeited&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(89,603)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;0.92&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding as of September&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,108,111&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2.70&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.5&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,341&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options exercisable as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;178,310&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.97&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8.8&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Options unvested as of September&#160;30, 2023&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,325,600&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.33&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.5&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;775&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">446839</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">2.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P9Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">11706000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">3428225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">2.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">677350</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">12690000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">89603</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">3108111</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">2.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P9Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">1341000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">178310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">5.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P8Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">50000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">2325600</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">3.33</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <trnr:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P9Y6M</trnr:Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="PAsOn09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">775000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;A summary of unvested common stock from early option exercises that are subject to repurchase by the Company under the 2020 Plan is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:92%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Early Option Exercises&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;average&#160;exercise&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;Repurchase&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;liability&#160;(in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested common stock as of December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,823&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;306&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issued&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,947&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.19&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vested&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(37)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Repurchased&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,655)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unvested common stock as of September&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;32,078&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;52&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">3823</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_USD_per_Share">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability
      contextRef="PAsOn12_31_2022_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">306000</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">30947</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">1.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">37</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_USD_per_Share">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">2655</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_USD_per_Share">0</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">0</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="PAsOn09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="0"
      unitRef="Unit_shares">32078</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability
      contextRef="PAsOn09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis"
      decimals="-3"
      unitRef="Unit_USD">52000</trnr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="P01_01_2023To09_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">12.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To09_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="P01_01_2023To09_30_2023">The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:96%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;September&#160;30,&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average risk-free interest rate (1)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.7%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.3%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average expected term (in years)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.93&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.34&#160;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average expected volatility (2)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;62.27%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;54.6%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: justify; line-height: normal;"&gt;Based on U.S. Treasury seven-year constant maturity interest rate whose term is consistent with the expected term of the option. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: justify; line-height: normal;"&gt;Expected volatility is based on an analysis of comparable public company volatilities and adjusted for the Company&#x2019;s stage of development. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="P01_01_2023To09_30_2023"
      decimals="3"
      unitRef="Unit_pure">0.037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="P01_01_2022To09_30_2022"
      decimals="3"
      unitRef="Unit_pure">0.033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2023To09_30_2023">P5Y11M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2022To09_30_2022">P5Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="P01_01_2023To09_30_2023"
      decimals="4"
      unitRef="Unit_pure">0.6227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="P01_01_2022To09_30_2022"
      decimals="3"
      unitRef="Unit_pure">0.546</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="P01_01_2023To09_30_2023"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="P01_01_2022To09_30_2022"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">24500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To09_30_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">700000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="P01_01_2022To09_30_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="PAsOn09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">23600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="PAsOn12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="-5"
      unitRef="Unit_USD">5900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2023To09_30_2023_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <trnr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue
      contextRef="PAsOn12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">30</trnr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue>
    <trnr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue
      contextRef="PAsOn03_31_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">6.08</trnr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="PAsOn01_31_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">19.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;16. Concentration of Credit Risk and Major Customers and Vendors &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company&#x2019;s cash and cash equivalents are maintained with high-quality financial institutions, the compositions and maturities of which are regularly monitored by management. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;For the nine months ended September&#160;30, 2023 and 2022, there were no customers representing greater than 10% of the Company&#x2019;s total revenue. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company had three vendors representing greater than 10% of total finished goods purchases for the nine months ended September&#160;30, 2023 and year ended December&#160;31, 2022, respectively. &lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <trnr:NumberOfCustomer
      contextRef="P01_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="0"
      unitRef="Unit_Customer">0</trnr:NumberOfCustomer>
    <trnr:NumberOfCustomer
      contextRef="P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="0"
      unitRef="Unit_Customer">0</trnr:NumberOfCustomer>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To09_30_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <trnr:NumberOfSignificantVendors
      contextRef="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis"
      decimals="0"
      unitRef="Unit_Vendor">3</trnr:NumberOfSignificantVendors>
    <trnr:NumberOfSignificantVendors
      contextRef="P01_01_2023To09_30_2023_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis"
      decimals="0"
      unitRef="Unit_Vendor">3</trnr:NumberOfSignificantVendors>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To09_30_2023_CostOfGoodsTotalMemberusgaapConcentrationRiskByBenchmarkAxis_MinimumMembersrtRangeAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_VendorThreeMembersrtMajorCustomersAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17. Benefit Plans &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company established a defined contribution savings plan under Section&#160;401(k) of the Internal Revenue Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;annual compensation on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-tax&lt;/div&gt; basis. Matching contributions to the plan may be made at the discretion of the Company&#x2019;s board of directors. During the nine months ended September&#160;30, 2023 and 2022, the Company did not make any contributions to the plan. &lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="P01_01_2022To09_30_2022"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="P01_01_2023To09_30_2023"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:EarningsPerShareTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18. Loss Per Share &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The computation of loss per share is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:94%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Nine&#160;months&#160;ended&#160;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(in thousands, except share and per share amounts)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Numerator:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(39,971)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(39,415)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss attributable to common stockholders&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(39,971)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(39,415)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Denominator:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted average common stock outstanding - basic and diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;11,750,907&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;423,362&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss per share attributable to common stockholders - basic and diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3.40)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(93.10)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:74%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series A convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;86,703&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,208&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt; convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;755,606&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,546&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 1 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,393&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 2 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,666&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 3 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 4 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;140&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 5 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,414&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 6 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;815&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 7 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,716&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 8 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,410&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 9 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18,480&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 10 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,171&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants to purchase series Class&#160;B common stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,753&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock options to purchase common stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,108,111&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;452,549&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,108,111&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,353,818&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The computation of loss per share is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:94%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Nine&#160;months&#160;ended&#160;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(in thousands, except share and per share amounts)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&#160;thousands,&#160;except&#160;share&#160;and&#160;per&#160;share&#160;amounts)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Numerator:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(39,971)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(39,415)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss attributable to common stockholders&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(39,971)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(39,415)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Denominator:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted average common stock outstanding - basic and diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;11,750,907&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;423,362&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss per share attributable to common stockholders - basic and diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3.40)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(93.10)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <trnr:NetLoss
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-39971000</trnr:NetLoss>
    <trnr:NetLoss
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-39415000</trnr:NetLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2023To09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">-39971000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2022To09_30_2022"
      decimals="-3"
      unitRef="Unit_USD">-39415000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2023To09_30_2023"
      decimals="0"
      unitRef="Unit_shares">11750907</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2023To09_30_2023"
      decimals="0"
      unitRef="Unit_shares">11750907</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To09_30_2022"
      decimals="0"
      unitRef="Unit_shares">423362</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To09_30_2022"
      decimals="0"
      unitRef="Unit_shares">423362</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2023To09_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">-3.4</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2023To09_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">-3.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2022To09_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-93.1</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2022To09_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-93.1</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:74%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;2023&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&#160;&#160;2022&#160;&#160;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series A convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;86,703&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,208&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt; convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;755,606&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,546&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 1 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,393&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 2 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,666&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 3 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 4 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;140&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 5 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,414&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 6 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;815&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 7 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,716&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 8 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,410&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 9 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18,480&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Series Seed 10 convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,171&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Warrants to purchase series Class&#160;B common stock (as converted to common stock)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,753&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock options to purchase common stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,108,111&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;452,549&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3,108,111&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,353,818&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesAConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">86703</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesAOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">10208</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesATwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">755606</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">7546</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedOneConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">2393</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedTwoConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">1666</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedThreeConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">248</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedFourConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">140</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedFiveConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">3414</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedSixConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">815</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedSevenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">1716</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedEightConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">4410</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedNineConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">18480</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_SeriesSeedTenConvertiblePreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">2171</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_WarrantsToPurchaseSeriesClassBCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">5753</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">3108111</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022_StockOptionsToPurchaseCommonStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="INF"
      unitRef="Unit_shares">452549</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To09_30_2023"
      decimals="0"
      unitRef="Unit_shares">3108111</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To09_30_2022"
      decimals="INF"
      unitRef="Unit_shares">1353818</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19. Related Party Transactions &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In the ordinary course of business, we may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal stockholders (commonly referred to as &#x201c;related parties&#x201d;). &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Founder Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company had &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-interest&lt;/div&gt; bearing promissory notes, of which $0.0&#160;million and $0.08&#160;million was outstanding as of September&#160;30, 2023 and December&#160;31, 2022, respectively. &lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Principal Stockholder Promissory Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During 2019, 2020, and 2021 the Company entered into the following promissory notes with a then-principal stockholder (the &#x201d;former principal stockholder&#x201d;) of the Company: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On May&#160;17, 2019, a $2.0&#160;million note with interest at the rate of 2.5% per annum and maturity date of May 17, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 7.5%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On August&#160;28, 2019, a $1.0&#160;million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5.0% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On November&#160;28, 2019, a $0.3&#160;million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On March&#160;20, 2020, a $0.3&#160;million note with interest at the rate of 5.0% per annum and a maturity date of March 20, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On February&#160;12, 2021, a $0.6&#160;million note with interest at the rate of 5.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of September&#160;30, 2023, all outstanding promissory notes with respect to the former principal stockholder are included within the loan payable on the condensed consolidated balance sheet for a total of $5.4&#160;million, including accrued interest and default interest of $1.4&#160;million. As the 2019, 2020, and 2021 notes were not paid upon maturity, these loans were in default as of September&#160;30, 2023, and on August&#160;4, 2023, the Company received a notice of default from the principal stockholder. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $0.3&#160;million for the nine months ended September&#160;30, 2023. On September&#160;30, 2022, the former principal stockholder and certain related parties waived their rights to seek remedies resulting from an event of default due to a failure to make payments of principal or interest at the stated maturity or due date, respectively. On October&#160;30, 2023, the Company entered into an agreement with the former principal stockholder regarding a mutually agreed upon repayment schedule with respect to the outstanding promissory notes issued to such former principal stockholder. &lt;/div&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other Related Party Promissory Notes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During 2019, 2020, 2021, and 2022, the Company entered into the following promissory notes with other related parties: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On September&#160;30, 2019, a $0.2&#160;million note with interest at the rate of 12.0% per annum and a maturity date of September 30, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Total payments made to this loan equate to $0.2&#160;million. This loan remains outstanding for interest in the amount of $0.1&#160;million. Upon default, on the September&#160;30, 2019, loan the Company shall pay a fee of 5% of the outstanding principal balance and accrued &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:8%"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;interest and from that point further interest shall accrue at an additional rate of 17.0%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#x2019;s assets. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On October&#160;21, 2019, a $0.2&#160;million note with interest at the rate of 12.0% per annum and maturity date of October 21, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. The principal and interest of this loan has been paid as of September&#160;30, 2023. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On February&#160;18, 2020, a $0.1&#160;million note with interest at the rate of 12.0% per annum and a maturity date of February 18, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On June&#160;9, 2020, a $75,000 note was entered into by the Company from the president and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;co-founder&lt;/div&gt; of the Company. This note has interest at the rate of 5.0% per annum and a maturity date of J&lt;div style="display:inline;"&gt;une 9, 2022&lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;/div&gt;. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. The principal and interest of this loan has been paid as of September&#160;30, 2023. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On June&#160;15, 2020, a $0.1&#160;million note with interest at the rate of 7.5% per annum and a maturity date of June 15, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. This loan was made from a company owned by the current CEO. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 12.5%. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#x2019;s assets. The principal and interest of this loan has been paid as of September&#160;30, 2023. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On November&#160;2, 2020, a $50,000 note was entered into by the Company from to the president and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;co-founder&lt;/div&gt; of the Company. This note has interest at the rate of 5.0% per annum and a maturity date of June 2, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. The principal and interest of this loan has been paid as of September&#160;30, 2023. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On January&#160;12, 2021, a $0.3&#160;million note with interest at the rate of 12.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On February&#160;22, 2021, a $40,000 note with interest at the rate of 12.0% per annum and a maturity date of June 22, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company&#x2019;s assets. The security interest will continue until all obligations under the note are satisfied. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;On October&#160;27, 2022, a $0.4&#160;million note with interest at the rate of 12.0% per annum and a maturity date of January 27, 2023. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 17.0%. The Company borrowed $0.3&#160;million in April 2023 and repaid $0.3&#160;million in May 2023 upon closing of the Company&#x2019;s IPO. This loan &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:8%"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;remains outstanding in the amount of $0.01&#160;million. The holder of this note waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#x2019;s assets. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 9pt; text-align: justify; line-height: normal;"&gt;In August 2023, the company borrowed $0.2&#160;million in a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-interest&lt;/div&gt; bearing note and repaid $0.1&#160;million. As of September&#160;30, 2023, this loan remains outstanding in the amount of $0.1&#160;million. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of September&#160;30, 2023, all other related party promissory notes were outstanding and included within the loan payable on the condensed consolidated balance sheet for a total of $0.8&#160;million, including accrued interest and default interest of $0.4&#160;million. All notes were not paid upon maturity. These loans were in default as of period end due to outstanding interest. The Company accrued for the default fee on the date of default and the additional default interest following that date. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $0.1&#160;million for the nine months ended September&#160;30, 2023. On September&#160;30, 2022, related parties waived their rights to remedy in the event of default, which in effect releases the Company from the obligation of the incremental interest and fees, as well as the lender from their lien on and security interest in the Company&#x2019;s assets. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;During 2022, multiple of the loans above with maturity dates in 2022 remained unpaid as of the maturity date. On September&#160;30, 2022, those lenders waived their rights to remedy in the event of default, which in effect releases the lender from their lien on and security interest in the Company&#x2019;s assets. Currently, the Company is renegotiating the terms of the loans. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Loan payable consisted of the following as of September&#160;30, 2023 and December&#160;31, 2022: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:70%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Founder Notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;79&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Principal stockholder promissory notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,404&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,503&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other related party promissory notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;862&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,126&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total Loan Payable&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,266&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,708&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other Related Party Transactions &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In 2016, the Company entered into an agreement with Fuseproject, a design firm that designed the Company&#x2019;s main product, its fitness mirror. As of September&#160;30, 2023 and 2022, the Company had incurred $0.1&#160;million and $0.0&#160;million, respectively, of expenses for design services provided by Fuseproject. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay 3% of cumulative net sales up to $5.0&#160;million and 1% of cumulative net sales above $5.0&#160;million, up to a maximum total royalty of $1.0&#160;million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $0.2&#160;million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of September&#160;30, 2023. As of September&#160;30, 2023 the Company has accrued $0.2&#160;million in royalty payments. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of September&#160;30, 2023, the principal stockholder associated with Fuseproject referenced above owned 226,217 of the Company&#x2019;s common stock., with fully diluted ownership of less than 5% as of September&#160;30, 2023 and December&#160;31, 2022, respectively. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;In 2022, the Company entered into an agreement with Apeiron Advisory Ltd for promotion of the Company, participation in industry conferences, and ongoing structural advice and consulting. The agreement was terminated and the Company is no longer receiving any advisory services from Apeiron Advisory Ltd. As of the nine months ended September&#160;30, 2023 and 2022, the Company has incurred $0.0&#160;million and $0.9&#160;million, respectively, of expenses for such services provided by Apeiron Advisory Ltd. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;As of September&#160;30, 2023, Apeiron Investment Group Ltd and certain of its affiliates (&#x201c;Apeiron&#x201d;) owned 1,490,524 shares of common stock. As of December&#160;31, 2022 Apeiron owned 447,318 shares of the Company&#x2019;s Class&#160;A common shares, and 24,143 of the Company&#x2019;s Class&#160;A common warrants. As of September&#160;30, 2023 and December&#160;31, 2022, Apeiron had fully diluted ownership of more than 5%, respectively. &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn09_30_2023_PromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn12_31_2022_PromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-4"
      unitRef="Unit_USD">80000.00</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">2000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-05-17</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P05_17_2019To05_17_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.075</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">1000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-08-28</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P08_28_2019To08_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-08-28</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P11_28_2019To11_28_2019_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-03-20</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P03_20_2020To03_20_2020_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">600000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-12</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P02_12_2021To02_12_2021_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:NotesAndLoansPayable
      contextRef="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">5400000</us-gaap:NotesAndLoansPayable>
    <trnr:AccruedInterestAndDefaultInterest
      contextRef="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">1400000</trnr:AccruedInterestAndDefaultInterest>
    <trnr:InterestExpenseAndDefaultInterest
      contextRef="P01_01_2023To09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</trnr:InterestExpenseAndDefaultInterest>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-09-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <trnr:DefaultInterest
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</trnr:DefaultInterest>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P09_30_2019To09_30_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-10-21</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P10_21_2019To10_21_2019_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-02-18</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P02_18_2020To02_18_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">75000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-09</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P06_09_2020To06_09_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2021-06-15</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P06_15_2020To06_15_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.125</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">50000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-02</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P11_02_2020To11_02_2020_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.10</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-12</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P01_12_2021To01_12_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">40000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2022-06-22</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P02_22_2021To02_22_2021_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">400000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis">2023-01-27</us-gaap:DebtInstrumentMaturityDate>
    <trnr:DebtInstrumentFeePercentage
      contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</trnr:DebtInstrumentFeePercentage>
    <trnr:DebtInstrumentInterestRateStatedPercentageAdditional
      contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.17</trnr:DebtInstrumentInterestRateStatedPercentageAdditional>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="P10_27_2022To10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NotesAndLoansPayable
      contextRef="PAsOn10_27_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-4"
      unitRef="Unit_USD">10000.00</us-gaap:NotesAndLoansPayable>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="P08_01_2023To08_31_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="P08_01_2023To08_31_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NotesAndLoansPayable
      contextRef="PAsOn09_30_2023_NoninterestBearingNoteMemberusgaapLongtermDebtTypeAxis_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:NotesAndLoansPayable>
    <us-gaap:NotesAndLoansPayable
      contextRef="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">800000</us-gaap:NotesAndLoansPayable>
    <trnr:AccruedInterestAndDefaultInterest
      contextRef="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">400000</trnr:AccruedInterestAndDefaultInterest>
    <trnr:InterestExpenseAndDefaultInterest
      contextRef="P01_01_2023To09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</trnr:InterestExpenseAndDefaultInterest>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;Loan payable consisted of the following as of September&#160;30, 2023 and December&#160;31, 2022: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:70%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;September&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Founder Notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;79&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Principal stockholder promissory notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,404&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,503&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other related party promissory notes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;862&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,126&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total Loan Payable&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,266&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,708&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:NotesPayable
      contextRef="PAsOn12_31_2022_FounderNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="-3"
      unitRef="Unit_USD">79000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="PAsOn09_30_2023_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="-3"
      unitRef="Unit_USD">5404000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="PAsOn12_31_2022_PrincipalStockholderPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="-3"
      unitRef="Unit_USD">5503000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="PAsOn09_30_2023_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="-3"
      unitRef="Unit_USD">862000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="PAsOn12_31_2022_OtherRelatedPartyPromissoryNotesMemberusgaapDebtInstrumentAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="-3"
      unitRef="Unit_USD">1126000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="PAsOn09_30_2023"
      decimals="-3"
      unitRef="Unit_USD">6266000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6708000</us-gaap:NotesPayable>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn09_30_2023_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn09_30_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">0</us-gaap:OtherLiabilities>
    <trnr:RoyaltyPaymentPercentage
      contextRef="PAsOn09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMemberusgaapDeferredRevenueArrangementTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.03</trnr:RoyaltyPaymentPercentage>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMemberusgaapDeferredRevenueArrangementTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</us-gaap:RoyaltyIncomeNonoperating>
    <trnr:RoyaltyPaymentPercentage
      contextRef="PAsOn09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMemberusgaapDeferredRevenueArrangementTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.01</trnr:RoyaltyPaymentPercentage>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMemberusgaapDeferredRevenueArrangementTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyExpense
      contextRef="P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">1000000</us-gaap:RoyaltyExpense>
    <trnr:GuaranteedRoyaltyPayment
      contextRef="P01_01_2023To09_30_2023_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</trnr:GuaranteedRoyaltyPayment>
    <trnr:ContingentRoyaltyObligation
      contextRef="P01_01_2023To09_30_2023_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</trnr:ContingentRoyaltyObligation>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2023To09_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">226217</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="P01_01_2023To09_30_2023_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="P01_01_2022To12_31_2022_FuseprojectMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MaximumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">0</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn09_30_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">900000</us-gaap:OtherLiabilities>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2023To09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">1490524</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_CommonClassAMemberusgaapStatementClassOfStockAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">447318</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ClassACommonWarrantsMemberusgaapClassOfWarrantOrRightAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_shares">24143</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="P01_01_2022To12_31_2022_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="P01_01_2023To09_30_2023_ApeironAdvisoryLtdMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_MinimumMembersrtRangeAxis_OtherRelatedPartyTransactionsMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:SubsequentEventsTextBlock contextRef="P01_01_2023To09_30_2023">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 9pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20. Subsequent Events &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Company has evaluated subsequent events through the financial statement issuance date, November&#160;14, 2023, pursuant to ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;855-10&lt;/div&gt; Subsequent Events. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On October&#160;6, 2023, the Company entered into an asset purchase agreement (the &#x201c;Asset Purchase Agreement&#x201d;) with CLMBR, Inc and CLMBR1, LLC (the &#x201c;Sellers&#x201d;) to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The purchase price enterprise value under the Asset Purchase Agreement is approximately $16.9&#160;million, of which $6.0&#160;million will be paid in the form of the Company&#x2019;s common stock, and the Company will assume $1.5&#160;million of subordinated debt and will retire $9.4&#160;million of senior debt. The number of shares to be issued will be based on the volume weighted average price (&#x201c;VWAP&#x201d;) of the Company&#x2019;s common stock based on the 10 consecutive trading days ending on (and including) the closing date of the Acquisition, on The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;); provided, however, that such VWAP shall not exceed or be less than an amount equal to twenty-five percent (25%) of the VWAP for the common stock based on the 10 consecutive trading days ending on (and including) the date the Asset Purchase Agreement was executed (the &#x201c;VWAP Collar&#x201d;). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Sellers shall also be entitled to receive a contingent payment in the form of the Company&#x2019;s common stock (collectively, the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x201c;Earn-Out&lt;/div&gt; Shares&#x201d;) calculated in the manner set forth in the Asset Purchase Agreement based on the 2024 Unit Sales (as defined in the Asset Purchase Agreement) and the VWAP for the Company&#x2019;s common stock based on the 10 consecutive trading days ending on (and including) December&#160;31, 2024, subject to the VWAP collar. In addition, in the event the 2024 Unit Sales include at least 2,400 Units sold in the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;business-to-business&lt;/div&gt;&lt;/div&gt; channel, the Sellers shall be entitled to an additional number of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Shares calculated in the manner set forth in the Asset Purchase Agreement subject to total maximum number of 22,665,681 &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Shares. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;The Asset Purchase Agreement contains customary representations and warranties and covenants for a transaction of this nature and customary indemnification provisions with respect to certain matters, including breaches of the Company&#x2019;s and Sellers&#x2019; representations and warranties. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On October&#160;30, 2023, the Company entered into an agreement with the former principal stockholder regarding a mutually agreed upon repayment schedule with respect to outstanding promissory notes previously issued to such former principal stockholder. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On November&#160;3, 2023, THLWY, LLC waived their rights to seek remedies resulting from an event of default on the June 2023 Notes. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;text-align:justify"&gt;On November&#160;10, 2023, the Company issued secured promissory notes in the aggregate principal amount of approximately $1.9&#160;million, of which approximately $0.8&#160;million was with a related party, with an original issuance discount of 15%, due November 9, 2024. Interest on the outstanding principal of the notes accrues initially at a rate of 3% per annum, with a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;step-up&lt;/div&gt; interest rate of 8% per annum after January&#160;31, 2024 until maturity. In addition, the Company issued warrants to purchase shares of common stock of the Company to the noteholders, which warrants expire five years from the date of issuance. &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:AssetAcquisitionPriceOfAcquisitionExpected
      contextRef="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">16900000</us-gaap:AssetAcquisitionPriceOfAcquisitionExpected>
    <us-gaap:AssetAcquisitionPriceOfAcquisitionExpected
      contextRef="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_CommonStockMemberusgaapStatementEquityComponentsAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">6000000</us-gaap:AssetAcquisitionPriceOfAcquisitionExpected>
    <us-gaap:SubordinatedDebt
      contextRef="PAsOn10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">1500000</us-gaap:SubordinatedDebt>
    <trnr:RetirementOfSeniorDebt
      contextRef="PAsOn10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">9400000</trnr:RetirementOfSeniorDebt>
    <trnr:AssetPurchaseAgreementTerms contextRef="P10_06_2023To10_06_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">The number of shares to be issued will be based on the volume weighted average price (&#x201c;VWAP&#x201d;) of the Company&#x2019;s common stock based on the 10 consecutive trading days ending on (and including) the closing date of the Acquisition, on The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;); provided, however, that such VWAP shall not exceed or be less than an amount equal to twenty-five percent (25%) of the VWAP for the common stock based on the 10 consecutive trading days ending on (and including) the date the Asset Purchase Agreement was executed (the &#x201c;VWAP Collar&#x201d;).</trnr:AssetPurchaseAgreementTerms>
    <trnr:WeightedAverageThresholdConsecutiveTradingDays1 contextRef="P10_06_2023To10_06_2023_CommonStockMemberusgaapStatementEquityComponentsAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">P10D</trnr:WeightedAverageThresholdConsecutiveTradingDays1>
    <trnr:WeightedAverageThresholdConsecutiveTradingDays1 contextRef="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">P10D</trnr:WeightedAverageThresholdConsecutiveTradingDays1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="P12_31_2024To12_31_2024_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_ScenarioForecastMembersrtStatementScenarioAxis"
      decimals="0"
      unitRef="Unit_shares">2400</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <trnr:MaximumNumberOfEarnOutShares
      contextRef="P10_06_2023To10_06_2023_AssetPurchaseAgreementMemberusgaapAssetAcquisitionAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="0"
      unitRef="Unit_shares">22665681</trnr:MaximumNumberOfEarnOutShares>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">1900000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="P11_10_2023To11_10_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">800000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <trnr:PercentageOfOriginalIssuanceDiscount
      contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.15</trnr:PercentageOfOriginalIssuanceDiscount>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">2024-11-09</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.08</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentTerm contextRef="P11_10_2023To11_10_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">P5Y</us-gaap:DebtInstrumentTerm>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>117
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M]Y/1@VQ8P[QT"?MG1U57S VS-.B=!E:G?[)RPRNY'>YYG<%K+- N2DFHKC)
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MO;4&R/\O"FG@VC=U [N'B:[_#U!+ P04    "  #,I97/QT?09T#  "I#
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M;S"WFWB7_B<U.730.C&J%:A6HII -8EJ%:K5J*9&[N4-.E6CFJ&T?NRTI>'
MWQJV#H\^VZ_.'"/]M;Z_7]_NW-D36>]*NES&CO A6Y K5,M1K4"U$M4$JLG
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M:@VJ:50SE-:/I+9LO?#6+/E(\AY,Q?;WY8>[JX9G<U S]#%S[*$7CJDY.K5
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MNP2F N3W-:7BX*@%BGZU]Q=02P,$%     @  S*65XGQS+NS$0  *8   !@
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6R]76USX[81_BL<MY-)9Z)8!,&W
MZYUG?"+=>.9R]D1)\Z'3#S0%V6PD4B$I^]Q?7X"2!1)8@&*ZER]G2?=P22R
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M5 %0&,$^))+;$SNWO]WN.&WIQM]+7;1L5JW7D/OL9J:Z#]5:0G1%04BH9K,
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MR=NDX\WR^$[N!^T6 +$J: [1R>C)HX%R\3W7^"786EX5G=D0;"D?EZ1S<KP
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M>S9EN*Q*:$J>9UZ*3^@#DE(Q"4F=\0LM,GT]F';%A+*IX,:0G+BFF_U@65_
M,N?A5 *63R\-D[=<=MY=Z5N[F(-)X0E</$(Z@]9,@P80I&5LU%\8,JAWM^\,
MP2&U<"M2]\:L!WMON:(I;SO;$\*YSYR'AW''&O>B*[/&V9*T#EM_!UC"W#Y=
M$GLPP[W;3=(5I.Q)EF,Y1YK"6"N(Q](1[S=JT@',7;^ZA#Z]6(3R_$57% B6
M:$#\T84U3.[LZW'(WS_D[Q_R]P_Y^X?\_4/^_B%__Y\^?_^N?/E[)O7#"&O^
M*5+[PU93A[93A[93A[93A[93A[93/[OMU"OXH@ X,#Y^G1=KJ[:%#:G2@:X;
MA[Y4A[Y4A[Y4A[Y4A[Y4YM"7ZA^K+]5N&ZJ=#BR_DPY3U_8E6O],A2#_X B&
MW61'S)Z9N]GL,]83IM$=I;A2(.;^S1D.@YU=0IJ?]0<O=X142ZVMY$PE\'5@
MPR;XA<VJ) ,H@B1O>LX-"[;*\#3;ND(U"U#"1E.X5];P5#89;0/3HB@#O%12
M DN;H4R,N1USU)-!EI2AE4U9#O9V$K;UD@96>UIU\;@^*6&P9U?4HHN;=IUX
MXKVC:1=Z2@E,$,C_!\V[W+;9+EZ'9N7_5,W*_W&;DUO3[2WW+\.:+EP:0\0I
M.*U9BT+:VVJGT5GLI'&26LNH?#1=;USI#9\#G+H:%Y](P1M%@Q5DLU0:^PSZ
MB%W99F3]%T<)/FHE@<'* N%M461XYYRWK64ZWK",H1L.%+E1V<.$[W)57>M&
M%R?7T&A._^7N<T;/4,.&<@,-+=/U[%GP*)E5;0R*E5 [@/-+ /.'*F>KQ::?
ML=,+FU2*OOV-^#3BXO7!Z2T>X_PHW7S;_P[Y[8VY>_E.D940O7H*%GG+VB[I
MB<VV:<W:FH.M3S46*K7VY@-A#'9J36%3#=)767/;C5Y^ EQ5O'TCR?K;CNQW
MA\):<_YXG!HD<..@&T*CAME(,WLA6_*&I.,VN!+J!4Z7M/%$SC+T2N9(4LRP
M.R,XE^"L9G\3\+VNVJB.9N2&]LGN')$)(@*6W._TE/"GDAK)&)2&*-X%=_>V
MC:SKH.I$#R8L%=D^3Y)N+HG?W&;&<.P;Y5E9GHZ0X,QI8;8@3OPI?%/-+>OU
M8MD3M9V(H+YKWDDOI]:6;6NV\HXI>R_RE1")3XVV>B%23L%]?,V3NE=&X,B9
MII$2OZQS,DY8.V*#D3@ 7(6+KF84I*0\;#G13XOC=X', V"0CNW,@KRW6CFE
M916X*D,#Y4)P;[FFC[I'!A.\PEQ@>3HY<Q:#1G+5,ZMU&O!E-9RK<F-]JT'$
M]Q?T$-AOH 1=37AK147F%0O)[-I=@56T=UA.@<5VH8E-<G*NJ7VR0V&^&6\<
M2VW;@],Y9O<.+LS+IH2$566*?8D0F<#F7-:,A;5K1,$M4!&FG:],N")U.._R
M0[P4-;_=2%8_=_-TE0<<@A5/4^;R/OR2-M89(!<2?$TSZ^ YF4'K8P]+FIG^
M$JV8M1Q[(>U'=QHEGWW9(#VTP3VTP?U]M,']@B5L.]]^J>VME+['+:VGDY-A
MZ_C0\NW0\HUG_A5;OGTOM,IG)^+A?16BI\3E$27>2_.R<N2NUN\A0*0&B <#
M<P;SW6.<DTGR5N(M4=A>JY[P\F %V4=VL#BK]^+ZHTLA=V5C.J[/B1=[/4K&
M%)LAEZ0G.L#H_H @2%AQ%E"']M(HMIZ7167/-C[OO.HRI9/KCJ\YD@V2!IPW
MP0HR+73F1'RN-)M+NKD\:<NJ6*KY+"6<8;@G6<*I1JL%!CT5;K?3@S9OL(Y2
M,H?K6APQM7HI[0'L+<SFNV@L7',A\\]&"J<2KBGMF_ES21WF.<0KQ(9Q"YG%
M!TK<0L$Y4OKM(57E:I.2:JVR?ZO]2US^'O PDEP7>XDVL*S6Q/-->9/75:DN
M#U(  R=G;(ES<>H/7:.52 -$PDEQD6^+0];J=5/?L<WO]&L)6K79TM6V1TS>
M[<$+O6N;."^;_7M:0QW4<%O:6:^-UAJR$/65J9+P'(FGL'&;<\UM0'NN$";+
M0S)8=YRFX=X4>9_./Z5+S?CAE-G,9JD9]J!(K8>-115R>FVI;PS@LR1_$.U-
MEF>6\J4NQ(;4U O/.<_L+-66*/[T<(YD;1O%Z+Q$*U^:(<"FJH)SW[]HW[1V
M=-8COSB%;=T3]8CTPT=C[FVZ^>3\=-0O^U' 2;O2[/V&]J,-LXQM0K%IGGF:
MT2'D^V"[5VUS&7]-"$D8@;@FQAI5F=O+KCHT;@)U[!,QP@0/+<_P$BZ>[X$C
M/5LUU&/0@5.<!^%>0$$&H,K,_MK<TOHW)LA9$5G"\4Y.$-5Z?%=$)2_M'R(\
M;%&GQ+@GXMW#T--+)?G&1]I[3PGQT"'CYHG2ES2H&7"E5GH.K7MM8'^&$<5-
M3G9:H#('U]8*MJ*%J3(D_D"1&I2^R%7:D=_2CNJLKY6?[8M9>3YHRW3=AVSZ
M+2TB[4;[3-"BR4 K)4U"&[*XZ@U7;#RPU-T>,M[_XQ)YO9"[P]MC)4E>VHC]
MEWT]P7$1%+HB37_(@GS7Z)DDB^.+^]7!0TOB7[,?Z*'_\*'_\*'?[^^WW^^A
MR^^AR^^AR^^]FHW^4_3X'=)-OCYY,NJ=T'"6H/6!'PSI2%#1)/P/!7/?CHCO
M&YR:V]]Y+=>QM(TMG1C0]KQ8"%6WN-I(W!Q-*&V&B]5B;4J<)&&;Q36PH%VX
M!DOUK'FWOZZBQSCC?BZA (C@<@V!O+L@ZL"9X^!5D3,.<IYPE4G90VAU]Y^4
M5E];Z13GA:Q4UDC#"C4@%1N:_3C(W/9UXQD*MCFEQ(M4$O7C$U(YKJ75RH4/
M+^%HOA8:?K7;:^4Z:DIWH?&D:PF>B8@)QO+NVHO&O=BW?FUC0# +6HXO)L1;
M[-.R;0@6MN^$8W:RR?(*ZZ#>8>M=\Q&Q:<F<IJQJI-C  #59Z*4E!-A:T^3X
MZJ^O/KQ[X#7=QK4'8,_PGJGH%T<2?0<KVX OK!7)M!&PT&3C6!6O_IYK8G_N
MD,X_G,L1B:/4JG56]U=.%)3<*N/1& ](TC,=Z!YIC@0Y=%?BU/ J6M>2V=BO
MCKHAM%V1A.F"$F#013_=JM$"?S@\NI9;Y'&D 8]&+3[B[W=P?IIM[R&((\J4
MH.) ?G6:7!LNB[P(:?6")O7;&@T>;<FN[XK>XI@BW=\D+YF/'3\>2XCZLM?D
MZ#)L<I2\#9@F.Y40,8KZ("6(U[&5 IV(M+M\+3V)3=.H?8[WEZE80^@LU,3-
M6$<!XW0M>^I 5^:$!PFC!ZGB7'#BC1@GF2++<C<:X"&SQ>VNJ]+6)V5RL"^5
MY7(HVCVRH4NYK1AFGQ;GX=1)+65("\71_K%CY54;BVD:GQO=CLKL.6Q6 [U'
M1\(D&H.5](X/VC/L0R  WI<]Y]6T9P;9CH$_/6YV/IX^';E)+S6GX;4F#EYI
M95/_ODTLM)5/<:,SYU/M#V/3])T+*BX,U=M9YP)U.\9UOK;<0!]&WL7&YM"3
MC,B*X*;$'T09U3YFX"=%JF$0?6S1%0O2A<-+MB(Z&(R-,U4'O:M9G"B![\2W
M"D 7MWG46( X6 ,V4;A4 U\MT%-$FXY-.!)["%!42SC^Y]QPZNX=8#W8:8R>
M@6O]<<_)L[<V>+<F79-=M8;: _(N3G_YWJ:_!-=[A:I[2V]=$G&81A:DU(24
M$[R_2;=U513@2\7:E5/TBE-'@5;'Z56VRDWODJ(F?AJ#S0H3G&3WPM1V;JO@
M:RCV%^!$'SN,28_3E-DL<"2V@Q/71=:-X#3)"10O3FOU/:;"*_[P2,8K@6W+
M9'QN[" )V#+J.TH'PHD< ;- ^^IT]Q/PWM ,<P/N4[32<^1KVX#<^C\TP8I+
M\K5TPGXYQ$%UI_>EN:?[!3T1N.DJ'G@9;++@/;H=TH"#8K SAV<&XH-UO&*'
M.8PD^ZEP7S.P9%#5P3-M514!]9/YO]T8US.D\63J2I/C+IEA48L4?PP5SDAC
M+%\C%82-^I14?Q$OHB$XCJ3/8!%H:>PIT9V5J+Y&-EHCHH,/3^ZQ-_O)_)H;
M7DKI[F78\+*7^*S"6#H<(_N,W>LH1 ]S6O"@-:?><.,Y$-@5V:M.-+O'<-4G
MY%\'C3=3_LB$9(,&>C/>%"V;97T4_]PU!GB0H V'B\*E3>R[A)M'.HL0O2R,
M-!48W:.<9]?U$3<>S\-,1;P ;XS7\8?JF0!SSZ!W'7AVEZE:M/J_?2+%"Y3<
MCZ_G\"<UUB-J>_%PZ;3,X=)HPI86 8:'9M.]L9[G1EO8VKPX[Q5$TU!H,Y$J
M]-/MME&<5A39#^)-NZD0[Y8DOITTI+ 70JK?+HD>"%,L0WR.N"':>(&<@2AC
MJ1FHU6>G)HK5MCG2!N^QK'B3I6N5^&R"Y?C(*UP&2Q/U:&%8W<,:-+;.A8TQ
M]6X'>49/:LG/MTGRGQD90(I@[2ZBC%^+CF4CC<3A0P^^JF/]C#T"WDE15(Y!
MK!P]"V@-19&ZEA'N.S+-(+)#5(DW=Z-]?-45&[2YS2HCG4%M!4P:-+#54\].
M5O>9#6?8[*Q?$+6'=G!>(OQ\1']B]#R1[M0U<[NMDA&QZ!L3)CL%7P>P#H<)
MM\ <(D*::CJ9_NM0!(N7RBG*D!=V\=J&!.*NE'Y>+2>C<8M;'=NW1XUH^?H+
M79-[>>6JK\ CPT!IWM*70T=A1AR9(&6_T$YX/@3\!GE;7MT3Y=EJH+4)H:GN
M.8AC\JX^(QIG@B(8DR_+Y%)S]6 F^"YXG#"DI=[04NU#^Z(ZB 84VW%UB\#)
M0H>&5RG/\E1Z<7&IL/;5NVYIN"7:DO\';^O@O>_3_#8EUJ;9AS'U94A2K,5[
M8^=S4(:=1I?BIT?BBN_W%+?^_*7JJ'-_#7_>>+BO;P""RSVY8P'J).+V:#^Q
MU'S"<WN0WP+DR]U5J!;?L)YAZY#<Y[?$5//15SY,6N/0"RPF6E3/R0\B%D+:
M8N75I7UJ!GWKVD**@UXL[F .IMB?9*L,;)0S5*+:(,U7.O7AM\4]:*I?:\!H
M1:WN-7/P.$#,5=>- .%C=EX):F^K,9_.X"_DEZF2QZR=U%Y"6&^(L*;;#V=]
MYV,KB[VF$_I7]\1" PH3Z3LA!;K@*5R>U3'@>/ ; Y*6K)ZB_2[F)T2/?%ON
M?2^%XPZLY.I+[UO+D#LK^/1>?1JJ).^&Z^/*C2;9-%19W==U1WT5PG5;VX2F
MQJOKJROG!M39M/B!U5?1Y*Q6SGWYI#FN\WU;Y>?P,<'#QP0/'Q,\?$PP7LSA
M8X*'CPFZ(^R<"/__/B9X^(3@[_03@OT1#]\0_-U]0U"+0>WS]AMKIT%_)!"C
M\A'_N8^4X,^<NM0&:9'N$W?86),N6NE 0(2.B=VWSN032U!QI0>Q" )<_O#^
M8Z@*]PH!;:6.UL%)7-1V26"!SS*/#CJG?323,$E@%+6[ER 0%Q,Z%[8/U3$1
M<_X.?ZPOKF73HQ^4"VD5DLO'$U;(^9A.MQ7F%Z!.4[.E9;2ELA^1F\/?&[R1
MY OYYH_\#C[/AJ87G62KLEY2<V+&6FJG=%][OJJT&83+9G+':Q3/O+/6TA:-
MY<3ALH,,ZZ@;R,A3D>X$PF1/17/>#!THE8R]LJ1)< J\NJ1=XJ),*!@K=,8Y
MVBYIO$R1_0$3:<_(M.!RZBV?LQ1MN]))_J<=WTI3J8 U[FOV!(2TS9\%'^<;
MR#S<@)W@&S%VFLG/_99G\)DBX$R_LO76?9=JL*K(=TA[=?G6GWIM?;QFIRUW
MMCQ];'GQ\#CC>$++J>V7"EKI>P7E%#@-/T_!1SK^1.C.-[4&$V2%E!S#B:T,
MS*(V(HU3?<+05K]PX9W*-@.VX*JC3)F4L46,H<_>]MOV0:4^L -?8I#P]6"6
M+ZF"FFU9%$'YL*3[:L>7H.7/OO,CM.K.C5?L=DA=PT\.;[:^=K_B5W7UEQ6]
MR3_8QV1_MQ^1_:4?2GU(Z@[]G_._7Z9M^OQ;*$+FTA0%]'G"V7=')T?!5;B,
MOCNZ.'EV<7KTD-[TCS__=I,N#2%J"9=X81;TZG3R]:,C*5:U/]IJ@R'11["M
MUOSGRJ3$8_$ W5]4I&[I#TS #?  WO/_!5!+ P04    "  #,I97=L0V0-$(
M  #N*@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6SM6EEO&T<2?M]?
MT6" 8!>02(J2C[4E ;*\1OQ@P+ VR4.P#\V9(J?7,]VSW3VBF5^_7U7/18FF
MXV0#+ P"MCA'=74=7UV-N=PX_S$41%%]JDH;KB9%C/6+V2QD!54Z3%U-%F]6
MSE<ZXM:O9Z'VI'-95)6SQ7S^=%9I8R?7E_+LO;^^=$TLC:7W7H6FJK3?OJ+2
M;:XF9Y/NP0>S+B(_F%U?UGI-=Q1_K-][W,UZ+KFIR ;CK/*TNIK<G+VXO6!Z
M(?C)T":,KA5KLG3N(]^\S:\F<Q:(2LHB<]#XN:=;*DMF!#'^T_*<]%ORPO%U
MQ_V-Z Y=ECK0K2M_-GDLKB;/)RJGE6[*^,%M?J!6GR?,+W-ED+]JDV@OGDU4
MUH3HJG8Q)*B,3;_Z4VN'T8+G\\\L6+0+%K]UP7F[X%P439*)6J]UU->7WFV4
M9VIPXPNQC:R&-L:R%^^BQUN#=?'Z ]V3;4A]H,RMK6'37LXB&//K6=8R>968
M+#[#Y._JG;.Q".H?-J=\S_K;P^O/%@<8S*!1K]:B4^O5XB#'.ZJGZGQ^HA;S
MQ?D^@0XO?TT9EI_)\L4!<<Y[*Y\+O_,O6'GE7:5NH:H'?.'I6*A;\3%Y]<O-
M,LCS?^US0.)_L9\_A_J+4.N,KB:(Y4#^GB;7WW]W]G3^<I_R_R-F.Z:XZ$UQ
M<8C[;P7<02;[13R?JCW,U3\+@LFK6MOM]]\]7YP]>QE4[0WG+!5<XS-2;H6$
ME%::@(<EE5OD H\$DR>?13#Y$0QQ?Q=UI) >!UWB$LM-#.Q7B^0$DC<F6@I!
MO?<N;S*\TC;'#J7FESK+\,YY0^FYQDUFY)6GK/'>V+5Z1]62?"A,W4EV D*U
M0;KCW]W-:U ZJTL%^!C+R]DB!MLP1^<14H(U V-T%"W7Z=@\4#F21Y*1A<D>
M?F3)6'C7K LQQLJ5* "R5Z0ZO/@+VW;Q]*5ZFY.-9F4R+6L@'I-G+>9/E//]
M33A)(:#;1$?^Y1?80%,I7):=MBS-6MX&9>S.+@.;UZU&.UQ 8X-.901(R&B@
MOX%6V6%B%=U7R<).[OF/@3E"W:8@*Z;1L$D<>22 :5@)5#ZSX0!Z$SIO_<H.
M!\LD!&I*9S[ Q@2\7#N7!]ZO!PH6BZ8K\AX$K8X/XZ;S$Z2$FAK_*M?8"%H=
MN:9S<0Z=^L$@A'2+G$$E^E0G*J>6I-C+L4P[@B5]R@IMUXPOCU4NT&-9IWM#
MVH^M4#O/\631!4'U%"B>8N,M),]-R%CJ%'X&YK3<2@0.+ TR#ME# -B-&0H1
MN80S N> TNBE*4W<B@)UBO]N:]D/AN'X%ZAP_Y$K\"T,[ K>$L-DH>]RVZ\&
M'FGM_!8VQY994HFTA#QV.DE9!+:[UV738Y<S"1130(2%US.A0M+[")O@46X2
M6E-FXB21_):\ ZDZ5[-;&Q -FCTP$QPWI"@0[G Q%F^@VE9Y[J<2YC-W3_X1
M'Y;9A3@*BZEZN^(^KX%9D@F%(L"#*^ T94'D_WOCFC X(D50B\S6B2/IQ0>P
M3:C9"D,J5-KC?_YOZ"V"=T%NG-QM"I,5:';Q)PGA,IAX%PNZKDN.U11KC!GV
M*!LC-^P+: R&ZN;N5CV=/ST]FY\^F9^>7>SB"=0V@$E";>8JA&R""XSTA3HC
M00]$-Q+$2\IT@PAJS>&C^37!H]5JXYHR5X6^)Y!B8<F\$,KPA26U)9W4"]1J
MS ;J"PI,<B<2#KAB8QJ[/W' UJR6X!\%UN12\ +74LP$4>H81A.O!UA"=3BW
MX(D!$OZU="'\;7I(^P.O8).RR6FO;)PL4,Z,8QF^OH@CH5!I$J(EGT"ILDR&
M[E)6B@SZ%,E*,=8>287!N/:4]-\%4I_'#RC5XW9?EI/]AD0GN&@K@*PM $7Q
M>2O[D/*[N#_A7$QUE$3V6/*A<G%8[)8>#F_AU5,GP#T(%FX@1B4E)1*)\KK'
M<^I:\,>#2ZZWJ=]!TP8%4DLD$!(X<FQT#.#.;#M5-U72O]8F3QE9;]G<O(-D
M82!V1=S-<5L"*QA.MSYOC<E/#P$"\= "*]^3%5<M??W 7W]ZB(R:QWV5LNI?
MBVSW*-.J08M=F0'9+#\W#VRKUK2E67KNF5D*>YI3)8'/8]MI=*=R\=C>PU[)
MSCLF:[V+H3LU'9V!W%<9:*E+:8ED!AX*6HM%6$LOT<WWF!Q)Q*WAX[CC2G@(
M)FP+T19<1\R 2+^F'K)=*1M12''L^N\_'01]I[\/ H\'!7;,@3EBE"9&0\ 7
MDB6';7Y::X[=RJ'^$OAT+=R#0>1!"M$Q]5ZFDNFLR[!3GKYLSA':9<&?NQPS
M]J/C_H #,G3D71#V*4E:UM\YMFT,QK#D!0X=M+G*<F=>GN#7GG+-)H^9KGR0
M\(+K)&/E7"V90E)/GP2!BX"KMJ)*'';I#NJ,+;JGFD#<UF/]^)'T3+3219,M
M.%R2")&RPDJ3$IJ:Z^")8N9MO2KU4J8U6%ZO*8F>,AT3=:T5-[&###O!?1@D
MHCG/$'EJ1B%%VYB \^*"5;]XGD(-@'DC \$A]3O5$380LG0 UTB(W0#XO--W
MYZ_<P5+60=EEU.;10-7OO20H0\,()2$>'];45.6]T.[N W2ES,DV&6;O!+V6
MBV0@R:SM@\/F:%.[YW2JI4F IPST6P[]!8OI;+D5=E8F@Z[=9/%13:'T@]ZD
MF^R0!9LRFAI1O0+0G&_;C.X0@7GC 3ASSFP-&'8M.,A?[W9J6 Q!FRBV[TI3
M="?]D,/VY6,7E&O+K3^2O E%V^.8=*8S:GA..EUV)I+P,<V9F#C-LJ1!"#SD
M#HD9I$$AF-%8ATS;B(<Y)]2QFRQV=YRJ?2=OQV.MX['6\5CK>*QU/-8Z'FL=
MC[6^A6.MWS6D\8QV/,HZ'F5]NT=9?R LOMWCJV_WT.H/N/MX4'4\J#H>5!T/
MJHX'5?\?!U7IJZ[9Z)-" &(M7UJR4>#\]'5A_[3_F/-&OF&<#>3I2]!WJ#&L
M4$DK+)U/GSV9I+&INXFNE@\4ERX"?7)9D(;GF #O5\[%[H8WZ#]QO?XO4$L#
M!!0    (  ,REE?@##Z!)@0  *0*   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;+56;6_C-@S^*X0/.+1 %R=.[UJT28"TUV ;<%MWV<N'81\4FXZ%
MRI)/DI/FWX^47Y+BTJ ';%\22R8?/GQ(R9QLC7UR!:*'YU)I-XT*[ZN;.'9I
M@:5P U.AIC>YL:7PM+3KV%4611:<2A4GP^''N!121[-)V'NTLXFIO9(:'RVX
MNBR%W=VA,MMI-(JZC2]R77C>B&>32JQQB?Z/ZM'2*NY1,EFB=M)HL)A/H_GH
MYNZ2[8/!GQ*W[N 9.).5,4^\^"F;1D,FA I3SPB"_C9XCTHQ$-'XVF)&?4AV
M/'SNT!<A=\IE)1S>&_67S'PQC:XCR# 7M?)?S/9';//YP'BI42[\PK:QO4HB
M2&OG3=DZ$X-2ZN9?/+<Z'#A<#U]Q2%J')/!N @66GX07LXDU6[!L36C\$%(-
MWD1.:B[*TEMZ*\G/SY:RK!3"?&T126OO@ H-B]K7%N'A:RW]#H3.8)YMA$X1
MEO7*I5960=*]UR3V1(8AX[0-?-<$3EX)/$K@L]&^</"@,\Q> L2419]*TJ5R
MEYQ$_(3I ,:C"TB&27(";]Q+,PYXXU?PVNS_GJ^<M]0]_QQ+LH&X/ [!)^K&
M52+%:41'QJ'=8#1[_V[T<7A[@N!E3_#R%/K_6;N3@8^G=3F _X@0+*PIJ8JC
M*_"&JTDU]07"O2DKH7<@G:LQ>U.TL_?OKI-D>+N<+Q["X^CV_$T4.L?Y<M[[
M$1F'&[1"@=0;I+-IW0!^)V8,W\ NYR#V*(78(&A#!Y9(,9],> R&*Q26WTCM
MD23T!S@'+"IK-C(C#[!\NS #%J(P*D/+JS-Q#GF3,3892_U2JV;)MS>8O GP
M2!<?6LL2>I,^P;9 #=)#:EA0CXX8=@(NI":=I%Y3*,?7';5"UJ$V:?=TSR^
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M0=D-N)Y+:?8#:Z#K5U?_ E!+ P04    "  #,I97\G+*GAX$   $#   &0
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MBBTXD+G68+1/?@4S"0QB6XV@Z'"N6YSX&9PQ^2"%J31Y)THH>^QO3MM'\0F
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M;0AMG@'5H<5Z01RN&*FLND5\-+A&HA7VCJZB1AEA(<L@3K/!UHY*Y*T=<9)
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M$3M$=@^#;J)%8^_6G=!X4]MAB6\ID&8!ZO="Z-/$.#B_SM;_ %!+ P04
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MI:%MZS[W=,M#91UH/I?2] ,;8+@WKOX&4$L#!!0    (  ,REE<QR($H! P
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M%OA0T98T1 YCG&4!5B9L#+(7\6QP W4K>L<;/3.9M;B314K%;!YB+E$2L?0
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MZ0:ZMB*T57JQP/AD' R/CQO$H1W#5RJE!+M2"$+(J/E"37M&G61A>YD'80.
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M$H!M4MPAD]#8%HSD^.N]1H1B'=JT<:W1IJEPW^K?>D9P>7G9?H. "X% -J'
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MOQ=3J2R&,:^@'P*$ =<SX."MGF&;2(U%<J#;:+=6>E;;OO82.;;N39UE%.'
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MCO:A__/^VPNWV]G1N"_VY_U' A.(G^9:+26SBQ?W!8G<:I <I$!7$8V5 UX
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M$I[VK2+#Q@8XAGSR7OR@?F2Y6.(8BDW*A>5'Y0-+S=">S.WC4[L%.I;-"%B
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MM,X#/1K=&Z8%B3L"IS;,YZ<V1@_ Y\DWWG@ >\'4UG:*75HU^GU7HT_F'2(
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M6UTM'_=Z_NR3MN$1FE7K]I@_:'0V#IQY.+[7[.P-9>K4#?BO&VFYGVP2=#P
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M3-Z^B?A>AM&R7Y!IPW2V,L0)")\U3^-HO0"?EX:K85AX ^-\O_@#4$L#!!0
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MF?O=MEWN?OW^71H$IL6LNL)6?S2?[@GC?E%V#T6^X5]QX65%GO+'M4*H&%J
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M?^)2HCLFT"*E@DTG"CCUS"1I\=<-GAS!Q^@3+U4JT<=RQ58'\#>G\9B<()A
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M%\#\FH,0M2_:0'<!.O\34$L#!!0    (  ,REE?\4E?-- X  #1V   9
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MT'.!E2<-PM_$#8LGT+8"0[?7[V#X4 SATP?A!RHA[/'=(H2X'P16AO$[ '8
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MEO,[H?*9W<\R'%AJ%V:?'JVJ/I;C06'"9B(%-V[T!327R5A5)-HCOY:-%VH
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MJ.?ZET!/ULW-[ZE^H'*&6<2(3:$K>)/AL?&\^9=4+/3/?$Y$FHI8?YPS"G8
M&\#[J8!PUW[! 8H?BGWS?U!+ P04    "  #,I97W<V/=J@)  "0&@  &0
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MSL=\.5<H-$L+\'QJX$#\0ALT/T+=_ =02P,$%     @  S*65W1QW;"W+0
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M)S(+9&^T#/G9B)D3^(*#D,$(R-"&#F&Q&CA[6AW"HKWEN'6PE0#NI^42:[K
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M?JX^M-DT)1J5B >ZO7<F[1:?VJ<UQO(^BC--]654]V@ZO0/5X;!$=0M3 @W
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MX]!9"B=BB#;U(4:ECC.N/I9<]@_GN$&U%<,9&RP2&((+,VEP(CLF:[,>_MC
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MRF*Y\\,2?TA .P'<+Y2RQXD[H/_%6?\+4$L#!!0    (  ,REE>#XJ>PQ0,
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M7*^,%X#W"ZU=N_$&NG\*DR]02P,$%     @  S*65Q>V;.BG!P  ;1@  !D
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M;"]W;W)K<VAE971S+W-H965T-#,N>&ULU5A;;^(X%'[G5UC,:$0E5!*'2R^
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MJFVH:X4L<Z"J#.,HFH45XR)8+=S8O5HM9&-*+O!>@6ZJBJF7:RSE;AF,@_W
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MWMN4X>!IZ;L4@W1_]\D8CNW?&&';,,6$0?S:"R5/J8I 8%N%Z"?^(S?$(_*
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MKA/B%W?"95%PN[/L=L$517'%,UEGHA2V4_?UP6$K_[N0FZ1J3.+:2/4 BOQ
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MX/E'-;>EYL/(E;VAS*7!^XY]7>(%DRL2P/\+B1M&^T$&NBOK[#]02P,$%
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M^MJP?M&BM#=O*Z&UR.UCRBA\*)D!T+\6L!$U+V:"]NYV\1=02P,$%     @
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M.NP QL$[@*@%1$YW<Y%3>4,-3:9*;HBRT<AF-RY5AT9Q3-A'61J%IPQQ)GD
M3@UD9$&5V9)'186FKEZ:G#S2%0=].O4-7F3#_;0EG3>DT3ND%^1>"E-H\E%D
MD+W%^RBP4QF]JIQ'!PF74)V10= G41 -#O -NJP'CF_P_UG_O%IIH]#ZM2_O
MAG:XG]8VT$17-(69AQVB03V#EQP?A7%P>4#TL!,]/,2>++$ALYH#D3GY+*E
M]5O[0OMT'F9RZ*I!DQ2S9MI6 WE- 227'%N5B36AVOJP^ ;*%:CN!0@5&;F!
MM/6&SAM->F\C=P-Z)TP@N:PU0O5IPV)!O5M9XT^BR!=I0),/Y/AH'(71)>[.
M+WH+Q43**LH)-D+Z5$AN0RLE2Z:U5%LB'&K4'P9#_(Z"0>\KIJ!P7#0/7+D'
M_@<PCB,2]L,H[CU*@^R[Y<2;XWX4QVX]#\;[7L[?:;@2U-J-%8VEK(5I>J_S
M=I/KJFG8O^'-V+NG:LWPO^.0(S0X.Q]Y1#6CI#&,K%S[KJ3!8>"V!4Y?4#8
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M]YOZXJU#!4E2_DZ&?+EWT-LW[] ;E.3H\Y*57 +YY5#()JO$PZAIWDW=//-
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M11#C(A%?Z.8OJ!L:*;Z0)KS\B3;ULYZ#PH(+FM9@.8.49-4GWM9"[ "&HSV
MH 8$AP*&-6!8-EK-K&SK!@L\'3.Z04P]+=G41:E-B9;=D$R]QH5@\ELB<6*Z
MJ%X?HC%:D%5&8A+B3*#W84B+3)!LA>8T(2$!COY "[F(HB(!]?2<R:7$Q.,
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M7RE9U+G1^,M\O1WRT>B,>[O'H:W%#1_;H."%B9WA_.=AC3JSHYUF;Z6A'/M
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MRH.)LB!H7GP7WU(AO[*+RS7@&)@*D/>7E(K'@FJ@/AV:_@902P,$%     @
M S*65QE?+K0E P  :0P  !D   !X;"]W;W)K<VAE971S+W-H965T-3<N>&UL
MM5==;]HP%/TK5E9-G52:[Q ZB$0;54/JIJJTV\.T!Y-<P&H2,]N!;K]^=D@S
M( :QBKV0V#GG^-Z#<^3T5Y0]\SF 0"]Y5O"!,1=B<66:/)E#CODE74 AGTPI
MR[&00S8S^8(!3BM2GIF.905FCDEA1/UJ[IY%?5J*C!1PSQ O\QRS7]>0T=7
ML(W7B0<RFPLU84;]!9[!&,33XI[)D=FHI"2'@A-:( ;3@3&TKV+;4H0*\97
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M7X)O<K-] '.YP:),3M,EN.4"2XM1!*9)DD$"IC%E O^#^5]WNY-[D"/0"Y"
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MUQ/)9\6)5W$CZ#X_ [JG0M TO]P!V0!3 /E^2ZEXNE''2M6YX^)_4$L#!!0
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M\'D_V^3[!]X^^,2?;?+](V_O/O/S^S_?W=]^-EZ/W[Y>+KXDR^WV&V_[Q6X
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MGF]E>/ZJ'A'.D<I%PFPDC")A#A+F(F$>"*8H]V*KW MM!_K%3^7]O]1K[9F
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M^9+K!7,Y,$_0J@>@\[\!4$L#!!0    (  ,REE<J7-B% @8  %$H   9
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M>'X\D=](MLFVTQ=,2I9DEVL@(?#40+U?,B;?;U('Y2'1Y%]02P,$%     @
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M]6M<2JZ>$J63P8RE*9'JO4B!,(W0C%%)Z!IH2$"@CVBIUDV4)X#8"EWF,N>
MK@@E:9ZB:R7""5K@QU*>TP@X^I8!QSH%^@JJO (=ST%BDH@3E>UV.4?'1R?H
M"!&*;F*6"S6GF)A2.=$\9EA17Y34S@'J)62GR+4^(,=RW!;YK%L^AU#)[4+N
M/)>;JGYU$9VZB$Z1SWU3$>=$A D3NG0_S^^$Y&KI_FKS7$XR:)]$[^<SD>$0
MIH;:L +X!HS@_3O;MSZU5> _)7M6#[>NA]N5/=!O!1UST,>(JL-)F]DR@U=D
MT&?-1JDFYJ9IH7.2-UH8U!8&?18&YH'5=5%*_0;[<+3#/MBSI\#JF&=(7HWD
M]2%Y&FG0AN3U(^V'C-N!_!K([P/R-9#7!N3W ^V''*C0L 8:]@$--9#?!C3L
M!]H/.0 TJH%&O4!M+)VJU^[TT4NIQS7UN)/Z)@;5$:PD\#;V3NUKV<<O9;>M
MOQ\TZQ_H*W%S1M?=60;=$[SQX+$;7V2[VP!3G]56=GOO4'%];Q=^/\CV=S>Z
MV6@8=+=VA?F:4($26"F5=3I4<EXV0.5 LJSH(>Z85!U)<1FKIA&X#E#/5XS)
MIX%N2^HV-/@#4$L#!!0    (  ,REE?58V=U<@(  ,@&   9    >&PO=V]R
M:W-H965T<R]S:&5E=#<R+GAM;(V546^;,!2%_XK%JJF5MD*<0)*.(+6)INUA
M6M6TV\.T!P<NP:JQF7V3=/]^-E"4*B392[#!YWSG$OL2[Y1^-@4 DI=22#/S
M"L3JQO=-6D#)S+6J0-HGN=(E0SO5:]]4&EA6BTKATR"(_))QZ25Q?>]>)[':
MH. 2[C4QF[)D^N\="+6;>0/O]<8#7Q?H;OA)7+$U+ &?JGMM9W[GDO$2I.%*
M$@WYS+L=W-Q-W?IZP0\..[,W)JZ2E5+/;O(UFWF!"P0"4G0.S%ZV, <AG)&-
M\:?U]#JD$^Z/7]T_U[7;6E;,P%R)GSS#8N9-/))!SC8"']3N"[3UA,XO5<+4
MOV37K@T\DFX,JK(5VP0EE\V5O;3O84] Z1$!;06TSMV ZI0+ABR)M=H1[59;
M-S>H2ZW5-AR7[D]9HK9/N=5A,E=ER=&^932$R8S,E40NUR!3#H9\)$N["[*-
M *+R-^/O6( F^^K+!2#CPER1"\(E>2S4QEA'$_MH<SJ:G[:9[II,]$BF!:37
M9#CX0&A *7E:+LCEQ=5;&]^6V=5*NUII[3L\XGN8^=?MRJ"V.^-W7\K&;=3O
MYD[+C:E8"C//'@<#>@M>\O[=( H^G<@Z[+(.3[DGMO1A7Z9&%=8J=^"V;F48
M^]L>UJACC<ZQ1GVL1A7ML0;3,.AGA1TK/,<*^UCA 8O28ZRH8T7G6%$?*SJL
MR_:P?M:X8XW/L<9]K/$!ZPAHTH$F)T&/=@\#RQ%T'V[RO[AIAYN>QBEDHH\T
M/=B(X]'!1O3W&I/K\=^87G-IB(#<RH+KL=7KIF\V$U15W:M6"FWGJX>%_=2
M=@OL\UPI?)VX]M=]O))_4$L#!!0    (  ,REE<&%XPB3@,  -8-   9
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M FDGF.=3(?1R8!TT1[GT+U!+ P04    "  #,I97/DZUG6@P  "$(P0 &0
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MWVYNEOL9;W$[$/=/$_=^_OM7J]PNEK>;?_OE_78W^MYX?WT8R7X:R7QAI.%
MKNZW7S8#^_ZFO.EXO:]__?BUUP?ZU\]?>[W4O]XP-<#[W9?]^6MO'K_V?S.U
MHE5>OQN8P[<#\\HT!_\R>#_8?%FLR\WA/QVG^%$/_O;P>0>.'T%C4"AK\*__
M\F]'],]U!VCI0?_A]OD,.\#:.7=]/^AM57Y]-QA>/=K#9_N<KX+SVDG?=\ O
M:JY>DXOU3C,.VHN*=_XG:[Y^3N+\<S)?5OPSOOV>%&/V^CD%E[J<X0]\Z;I^
M?,_^;&M7X)SSB\Z'C5YPK(>=\O?=#]_L\!4]!TQ>^<%8W)_SK9SJE6CU[=W
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MB_OKLKWL]K7UJ).7UMZT8_5.)5*S#EKCV<S#KL[Y-CJN@VHNJGFH)E#-1[4
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M!%4-$$Q] X2G=T'[@M2[NUW&/"62=OT-;7" :A:JV:CFH)J+:AZJ"53S42U
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M%-4R5%.HEJ-:06G-"*H:!DSU#0-^<%\&[1N :A:JV:CFH)J+:AZJ"53S42U
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MEDM9+F,YQ7(YRQ48UXJ@6LVZ.;[8^AA9W?F1Y2R6LUG.83F7Y3R6$RSGLUS
M<B'+29:+6"YFN83E4I;+6$ZQ7,YR!<:U@JE6:V_J:^V/>;1\N;Y2+_0/(+:J
M_L#5UQ<FDZ'9?IP8.JK#<B[+>2PG6,YGN8#E0I:3+!>Q7,QR"<NE+)>QG&*Y
MG.4*C&L%2ZV*W]17\3N+Y;%OR^YMS_>GF-GL>[ATAPQ;Q(]RUI$;UT)FU-$5
MR6;'=5C.93F/Y03+^2P7L%S(<K+K&W38U;<K8@>.62YAN;3SRS+N^+)D[,"*
MY7*6*S"N%0ZU.G]37^=?"X?%S7\^;+9WY7Y-[)R<8(O]4<YB.9OE')9S6<YC
M.<%R/LL%+!>RG#QR]6FS:]:,V'%CEDM8+F6YC.44R^4L5V!<*W%JG05,?6>!
M]CT NX#)EIL_!I_6Y2L/.-;#_1.';2B <C;+.2SGLIS'<H+E?)8+6"YD.<ER
M$<O%+)>P7,IR&<LIELM9KL"X9BX-:UT'AE>7NC%@R/840#F+Y6R6<UC.93F/
MY03+^2P7L%S(<I+E(I:+62YAN93E,I93+)>S7(%QK6"J=1X8ZCL/_/VX$G=7
M+C8/Z_)QA6YY__5AVQU&;'L!E+..W/[9GL\K&L:[87OW!AW583F7Y3R6$RSG
MLUS <B'+29:+6"YFN83E4I;+6$ZQ7,YR!<:U0L:LA8RV_K-K5>[?5[>+[?)V
MN?U3ORRGE_L'#MLV .5LEG-8SF4YC^4$R_DL%[!<R'*2Y2*6BUDN8;F4Y3*6
M4RR7LUR!<:U@JK4-& XOMBS'M@M .8OE;)9S6,YE.8_E!,OY+!>P7,ARDN4B
MEHM9+F&YE.4REE,LE[-<@7&M8*KU,MA]3"[+:;7^841RUI%KU.Z,3Q;ER#$=
MEG-9SF,YP7(^RP4L%[*<9+F(Y6*62U@N9;F,Y13+Y2Q78%PK8FJ]"H;:HM.N
M13E9"QNQ#YNW _L?Y?IZN2D'R7IY_<HM=/H!^Z<0V\( Y6R6<UC.93F/Y03+
M^2P7L%S(<I+E(I:+62YAN93E,I93+)>S7(%QK;RJM3 83BZV5L>V-D YB^5L
MEG-8SF4YC^4$R_DL%[!<R'*2Y2*6BUDN8;F4Y3*64RR7LUR!<:U@JK5 &.I;
M(/1=JV-;(*"<=>2,86VQ[NK=E7&R7,=V0$ YE^4\EA,LY[-<P'(ARTF6BU@N
M9KF$Y5*6RUA.L5S.<@7&M5*FUDMAJ.^E<-YRG=H_Z^"LM3JVP0+*62QGLYS#
M<B[+>2PG6,YGN8#E0I:3+!>Q7,QR"<NE+)>QG&*YG.4*C&N%5:T-PW!^L;4Z
MM@\#REDL9[.<PW(NRWDL)UC.9[F Y4*6DRP7L5S,<@G+I2R7L9QBN9SE"HQK
M!M.HUH=AI"VH[;M6I]=ZAQ'*64>N4>XZ'K\[N;4.'=9A.9?E/)83+.>S7,!R
M(<M)EHM8+F:YA.52ELM83K%<SG(%QK52IM9487164X57;ZW[6EYORYM!7J[O
M]*MU^O'ZYQ#;=@'E;)9S6,YE.8_E!,OY+!>P7,ARDN4BEHM9+F&YE.4REE,L
ME[-<@7&MN#)K<65>:K5NQ+9G0#F+Y6R6<UC.93F/Y03+^2P7L%S(<I+E(I:+
M62YAN93E,I93+)>S7(%QK6"JM6<8:>ML-:MUNW=4?ZZ[$XGMRX!RUI&KE\).
M3Y;KV&8+*.>RG,=R@N5\E@M8+F0YR7(1R\4LE[!<RG(9RRF6RUFNP+A6S-2:
M+>P^[KE<I\KULMP,?ALXR_O%_?7R_O,K"W3:$?JG#LE9+&>SG,-R+LMY+"=8
MSF>Y@.5"EI,L%[%<S'()RZ4LE[&<8KF<Y0J,:P54K57#:'RQ!3JV)P/*62QG
MLYS#<B[+>2PG6,YGN8#E0I:3+!>Q7,QR"<NE+)>QG&*YG.4*C&L%4ZTGPTA;
M7/O\SFFYV3R4-]T!Q/9>.'#U!;31?&+.FXMH5M=QT\EP?/(L"/3T')9S6<YC
M.<%R/LL%+!>RG&2YB.5BEDM8+F6YC.44R^4L5V!<*S)JW1)&^FX)M6>"G_,@
M<+W6/SY.GQ1OSCJ>>6QU'3DR.XZTV5-T6,YE.8_E!,OY+!>P7,ARDN4BEHM9
M+F&YE.4REE,LE[-<@7&M"*FU0ACU;H6@V:\Y_Q'@^F'[9PW;$P'E;)9S6,YE
M.8_E!,OY+!>P7,ARDN4BEHM9+F&YE.4REE,LE[-<@7&MU*KU1!A=K"?"B.V)
M@'(6R]DLY["<RW(>RPF6\UDN8+F0Y23+12P7LUS"<BG+92RG6"YGN0+CFL$T
MKO5$&*,]$?1:[S Z<(V&H\:[X;B]'C?N:';0\6QO].P<EG-9SF,YP7(^RP4L
M%[*<9+F(Y6*62U@N9;F,Y13+Y2Q78%PK/6J]#L:]>QWH%^/.??*W?MS^.</V
M/$ YF^4<EG-9SF,YP7(^RP4L%[*<9+F(Y6*62U@N9;F,Y13+Y2Q78%PKMLQ:
M;%VLY\&8[7F <A;+V2SGL)S+<A[+"9;S62Y@N9#E),M%+!>S7,)R*<ME+*=8
M+F>Y N-:P53K>3#^T9X'W6'$MCL8G_8G:#^JVSKG()L],8?E7);S6$ZPG,]R
M <N%+"=9+F*YF.42EDM9+F,YQ7(YRQ48UPJ.6A>#W<?H0MQ??-JW_G3Z)P_)
M62QGLYS#<B[+>2PG6,YGN8#E0I:3+!>Q7,QR"<NE+)>QG&*YG.4*C&NE6:WE
MP?AB+0_&;,L#E+-8SF8YA^5<EO-83K"<SW(!RX4L)UDN8KF8Y1*62UDN8SG%
M<CG+%1C7"J9:RX/Q62T/SEZ?8]L?'+A7'L]MG7F<S9Z>PW(NRWDL)UC.9[F
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M(Q]YK7:29'4!A86?CO/]8$3 14=Z6X*S+<M@5'$-S3T)O5])X 6A):#5[?3
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M<"V@OB\9D[L7/4%[PSC]"E!+ P04    "  #,I97D=B:4XP"  "[!P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6RM55MOVC 4_BM6-DVMM#57V,I"
M)"!,ZT,E5-3M8=J#20[$JF-GMH'NW\^7D+$NT#Z4!V(?G^\[-_N<=,_%@ZP
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M5]$E><^P2B5G6::4[JD$CECRY68A),?-]ZMN)53!>OI@U8$T$$44P\C $T<
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M!.C/EU*JMS>F@/TSP_-_ %!+ P04    "  #,I97]I.7"(<#  #S"P  &0
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M+O/=@]F09LA,D?E!]"QNG0/8=:"^@CM/D[O7##:S>T^CV3K*:NSRW8/1)1>
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MBTU'V#=L]D+QS+RD&G.E>&*^SH!&(/0"?#[A7"TOM('R/6?_?U!+ P04
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M[X#A;L"P[X#1;L"H[X#Q;L#X<,#DE0&3W8!)WQDN=@,N^LYPN1MPV7>&J]V
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M/%3S42U M1#5(E03J!;OM/T3>&?/%G36M.>L&3IK3FGMU&BJ'H?2DI9KO4]
MH/6-J*:CFH%J)JI9J&:CFH-J+JIYJ.:C6K#33GV;&Z*S1J@F4"U&M0354E3+
M4"VGM':,:$V,R"L7?[+SEUP_.V'0!ZBBFH%J)JI9J&:CFH-J+JIYJ.:C6H!J
M(:I%J"90+=YIDQ/)G*"SIAVS=BY<H;/FE-;.CJ:4<R@OY>S3^4OYIV(^KLN'
MU?(?Y4UWA*!/=44U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4(U@6HQJB6H
MEJ):AFHYI;7CJ*FFK5]N?+X/V ZF(HC4=%0S4,U$-0O5;%1S4,U%-0_5?%0+
M4"U$M0C5!*K%J):@6HIJ&:KEE-:.H*:R=RBO[-4?M\56^TDT[>Y^+(?.CART
MT!?5#%0S4<U"-1O5'%1S4<U#-1_5 E0+42U"-8%J,:HEJ)8.CQL>="^O'6_7
M==M:3NU=.R::XMRAO#CW_(6S^J=@NIC.'^?*WX-R_J5<=5_(H$_H134=U0Q4
M,U'-0C4;U1Q4<U'-0S4?U0)4"U$M0C6!:C&J):B6HEJ&:CFEM1.JJ4 >7KS5
M6AKZ!&)4TU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4$Z@6HUJ":BFJ9:B6
M4UH[@IK"[Z&\\#LM9MN>>.MJ>?/[+\K#2_'WYI?+[XMRM;Z?/BC%UZJ^EJJ:
MA.H,)?3QQJBFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@F4"U&M035TF%G
M@XF!JDT.E]NZ-]0.>RKDU/ZUHZ2IF!_**^9[KK=]>BBGJ_H2Y]/MM^GV#_SJ
MMC--T,<=HYJ.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H9I M1C5$E1+42U#
MM9S26KDT:BK_1X,W6F4;H:7_J*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%
MJ"90+4:U!-525,M0+:>T=@0U;01&)]H(]+YC30Z='3EH,P%4,U#-1#4+U6Q4
M<U#-134/U7Q4"U M1+4(U02JQ:B6H%HZ.FX0T=5I/.O8[O!F-6K'V@FA-0DA
M[Q#P$XMG/>]:D^_ V<F"-A% -0/53%2S4,U&-0?57%3S4,U'M0#50E2+4$V@
M6HQJ":JEJ):A6DYI[:AJ&A*,AF^UGH8V(4 U'=4,5#-1S4(U&]4<5'-1S4,U
M']4"5 M1+4(U@6HQJB6HEJ):AFHYI;4CJ&E"4+_\=]VU)I_J[% B-1W5#%0S
M4<U"-1O5'%1S4<U#-1_5 E0+42U"-8%J,:HEJ);NM,/'(HT/;UI[WD[^8+2<
MVKEVCC2=!$;R3@(]5]W"Y>+EL0%?RF*UZ=NYJ/^L,T[0E@.HIJ.:@6HFJEFH
M9J.:@VHNJGFHYJ-:@&HAJD6H)E M1K4$U5)4RU MI[1V-C7M"T:3MUIF0_L3
MH)J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H9I M1C5$E1+42U#M9S2VA'4
M]"<8R9^07E\*W93E[5KY6E\3*?5%T6.QN-FNL:UVX?2P#:?9L@ZGSB1"VQ2@
MFHYJ!JJ9J&:AFHUJ#JJYJ.:AFH]J :J%J!:AFMAII[J2Q>BL":JEJ):A6DYI
M[8QI&A",Y T(1/%C7BXJ95[<;N^1;B5+9Z:@709034<U ]5,5+-0S48U!]5<
M5/-0S4>U -5"5(M03>RT4P^6B]%9$U1+42U#M9S2VIG2="(8R3L1^/7UB%('
M2_%EUOT=#=I: -5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-4$JL4[[>3S
MU-!94U3+4"VGM%:$C)NF 6-I16C?.P,^SXKU6OFK\GDYGR\7RM^*U:I85#V>
MQR:?_MP(0C4=U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$M0C6!:C&J):B6HEJ&
M:CFEM8.J:2TP5M_H-H$QVFH U714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(
MU02JQ:B6H%J*:AFJY936CB"MB2!Y[X*#:IS%XZ8'P?87]T4]W_;&@3JAIHM3
MI3CR><Y.)+1% :H9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J M5B5$M0+=UI
MK37#R^'PH! 'G3.GM';2-*T'QM*ZTO-6Y3YUK,KU;3XMWX^SDPCM5(!J!JJ9
MJ&:AFHUJ#JJYJ.:AFH]J :J%J!:AFD"U&-425$M1+4.UG-+:B=5T*JA?OM'R
MW B-(%+34<U -1/5+%2S4<U!-1?5/%3S42U M1#5(E03J!:C6H)J*:IEJ)93
M6CN"FB8'8WF3 VYY#FUM@&HZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&H"
MU6)42U MW6G[RW/:2!T=K<\=;W;8FIK:KW9^-(T(QM(JTW]QT2U]"I?3-\*A
MS0I034<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(M03:!:C&H)JJ6HEJ%:3FGM
MF&J:%8POWFJE#>U2@&HZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&H"U6)4
M2U M1;4,U7)*:T=0T\M@+.]EP*VTH3T.4$U'-0/53%2S4,U&-0?57%3S4,U'
MM0#50E2+4$V@6HQJ":JE.VU_">UB='5UN-"&=CB@M';2-!T.QO(.!S^Y)M?[
M-CBT40*JZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&J"52+42U!M135,E3+
M*:V55Y.FG<)D\$:+<Q.T40*JZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&J
M"52+42U!M135,E3+*:T=04VCA(FT"I9;G)//<W8BH7T34,U -1/5+%2S4<U!
M-1?5/%3S42U M1#5(E03J!:C6H)JZ4[;7YP;C2Z&ZN7!\ES'=JHZU@[OA:-V
MKATB6A,B\E8'_UI;N+[WPLDG/SM9T/X'J&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@
M6HAJ$:H)5(M1+4&U%-4R5,LIK1U339^$R?"MEMO0Q@>HIJ.:@6HFJEFH9J.:
M@VHNJGFHYJ-:@&HAJD6H)E M1K4$U5)4RU MI[1V!#6-#^J7_Y[E-ND\9R<2
MJ>FH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1J@E4BU$M0;5TI[6J3B\GD\GA
M:ALY:4YI[:AI&AQ,Y T.>B[*I>5J6F[NAA.K\FNY6M7;GGU#G'Q/S@XCM 4"
MJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&H"U6)42U M1;4,U7)*:V=6TU1A
M,GFK%3JT80*JZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&J"52+42U!M135
M,E3+*:T=04W#A(FT&A9<H4/[)Z":CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H
M%J&:0+48U1)42W>:I.%;UK')U94V/KP5[BV:'4R:9@<3>;.#KE6WO>N8=6=2
MH'T-4$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4$V@6HQJ":JEJ):A6DYI
M[?!I^A],KMYJ^0QM:8!J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J M5B
M5$M0+46U#-5R2FM%T$73TN!"6J]Z_7FYJ*:+NW)1*<GR1S&K<RCZ,IO>%:\M
MD\F]<Y,'U714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(U02JQ3NM=;/88/._
M]DI3@LZ:HEJ&:CFEM3.EZ5%P(>]1<&I-3?FG$A1_3.>/<^7O0;GYOJ;S&D<^
MR]E)@W8H0#4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU!-H%J,:@FJI:B6H5I.
M:>T\TIH\TMYHF>T";66 :CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:@+5
M8E1+4"U%M0S5<DIK1U#3RN!"6J=Z_;RV9OSQ4"[696?6H#T+4$U'-0/53%2S
M4,U&-0?57%3S4,U'M0#50E2+4$V@6KS36LW,!ITK:V@[ E3+4"VGM':,-.T(
MZI<_N[(V79Q>69/.<G;4D)J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H9I
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M)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!936CO7FE*&R4FE#,<GLY$[O5,,+6)
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MVRM4 P  L!4   T   !X;"]S='EL97,N>&ULW5C1;MHP%/V5*%VG5IH:0M9
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MC3B".0 /&!)%YCVX\SX*UN^I8/,;[>@O4$L#!!0    (  ,REE>7BKL<P
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MW9;7E5SN_B2[^X/O^_\ 4$L#!!0    (  ,REE<<1N&VJP(  "LV   :
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M;%!+ 0(4 Q0    (  ,REE<& 18([0   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  ,REE>97)PC$ 8  )PG
M   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @  S*65\4:Z1*M!   [!0  !@              ("!# @  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  ,REE>AKK$3^0<  %<K
M   8              " @>\,  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q0
M2P$"% ,4    "  #,I97.#50FW@$  "'%P  &               @($>%0
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @  S*65W1EN6DY
M"0  6#0  !@              ("!S!D  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    (  ,REE<_'1]!G0,  *D,   8              "
M@3LC  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  #,I97
M1D)?4#8O  "J/@, &               @($.)P  >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @  S*65X<BD)L' P  NPH  !@
M     ("!>E8  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M  ,REE>)\<R[LQ$  "F    8              " @;=9  !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    "  #,I97#AU35H4*  !X+   &
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M970Q,RYX;6Q02P$"% ,4    "  #,I97DN(90;$#  "["@  &0
M    @('<L   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M  ,REE?R<LJ>'@0   0,   9              " @<2T  !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @  S*65V+\@SHG P  ] @  !D
M             ("!&;D  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    "  #,I97"N9.B<4#  "I"0  &0              @(%WO   >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (  ,REE?#-]&(F@,
M $,*   9              " @7/   !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @  S*65S'(@2@$#   HT,  !D              ("!
M1,0  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  #,I97
MQZ2$;><'  "='P  &0              @(%_T   >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    (  ,REE=YZPGT"PD   DK   9
M      " @9W8  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @  S*65Z6 IFOA!   L@X  !D              ("!W^$  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  #,I97]4Z92U $   5"@
M&0              @('WY@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    (  ,REE>P1K%S^0T  "$N   9              " @7[K  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @  S*65\G@[(,%
M#P  %#,  !D              ("!KOD  'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    "  #,I97G[ #C)X#  #K"P  &0
M@('J" $ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  ,R
MEE>T\5/*T@(   $(   9              " @;\, 0!X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @  S*65P74[L/Q"P  XA\  !D
M         ("!R \! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
M    "  #,I97M#*&W;<$   ,%0  &0              @('P&P$ >&PO=V]R
M:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (  ,REE?\4E?-- X  #1V
M   9              " @=X@ 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL
M4$L! A0#%     @  S*65]W-CW:H"0  D!H  !D              ("!22\!
M 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    "  #,I97=''=
ML+<M  "<V   &0              @($H.0$ >&PO=V]R:W-H965T<R]S:&5E
M=#,R+GAM;%!+ 0(4 Q0    (  ,REE=;!)SQ+0,   $*   9
M  " @19G 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
M S*65Y9+WH7B @  G0<  !D              ("!>FH! 'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    "  #,I972+:M7D4#  #N"   &0
M            @(&3;0$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    (  ,REE>#XJ>PQ0,  '<+   9              " @0]Q 0!X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @  S*65\QX&>\S P
MKP@  !D              ("!"W4! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    "  #,I97F$H\*',#  "8"   &0              @(%U
M> $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (  ,REE=+
M&8F^I ,  /,)   9              " @1]\ 0!X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @  S*65[ZO1/M:!   -0P  !D
M     ("!^G\! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  ,REE<DGB5SKP4  +X.   9              "
M@469 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @  S*6
M5\M#90??!   QQ4  !D              ("!*Y\! 'AL+W=O<FMS:&5E=',O
M<VAE970T-BYX;6Q02P$"% ,4    "  #,I9790?B/J\"  #;!0  &0
M        @(%!I $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0
M   (  ,REE<ENC: .@8  .$P   9              " @2>G 0!X;"]W;W)K
M<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @  S*65PBW?/=/$@  4!(!
M !D              ("!F*T! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q0
M2P$"% ,4    "  #,I97V6+5,^L#   /&   &0              @($>P $
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (  ,REE?ZF;$=
M; (  # &   9              " @4#$ 0!X;"]W;W)K<VAE971S+W-H965T
M-3$N>&UL4$L! A0#%     @  S*65UT(U-BM @  P@D  !D
M ("!X\8! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    "  #
M,I97A-X%.]P"  "W"P  &0              @(''R0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (  ,REE=3<M?HE0(  *@'   9
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M970U."YX;6Q02P$"% ,4    "  #,I975VX%3R$#  "_"P  &0
M    @('YW0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    (
M  ,REE>C(W^1>@,  !4-   9              " @5'A 0!X;"]W;W)K<VAE
M971S+W-H965T-C N>&UL4$L! A0#%     @  S*65WU*%SWT P  @Q0  !D
M             ("! N4! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"
M% ,4    "  #,I972B*V1;4"  #_!P  &0              @($MZ0$ >&PO
M=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (  ,REE<)RB%H3P0
M $,3   9              " @1GL 0!X;"]W;W)K<VAE971S+W-H965T-C,N
M>&UL4$L! A0#%     @  S*65S.@DIC@%@  L)\! !D              ("!
MG_ ! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    "  #,I97
MOT5E\(H,   /R   &0              @(&V!P( >&PO=V]R:W-H965T<R]S
M:&5E=#8U+GAM;%!+ 0(4 Q0    (  ,REE<5TWD?R@0  .,>   9
M      " @7<4 @!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%
M  @  S*65V"ICJ,&"   ZE(  !D              ("!>!D" 'AL+W=O<FMS
M:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    "  #,I97LJK<HB@$   ,'0
M&0              @(&U(0( >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+
M 0(4 Q0    (  ,REE<J7-B% @8  %$H   9              " @10F @!X
M;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @  S*65U:VZOJ*
M!   ,!H  !D              ("!32P" 'AL+W=O<FMS:&5E=',O<VAE970W
M,"YX;6Q02P$"% ,4    "  #,I97O_7(V 8#  "2"@  &0
M@($.,0( >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    (  ,R
MEE?58V=U<@(  ,@&   9              " @4LT @!X;"]W;W)K<VAE971S
M+W-H965T-S(N>&UL4$L! A0#%     @  S*65P87C"). P  U@T  !D
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M=#<W+GAM;%!+ 0(4 Q0    (  ,REE=.YSY44PD  /E4   9
M  " @<R+ @!X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @
M S*65T 'Q-$@!0  IQP  !D              ("!5I4" 'AL+W=O<FMS:&5E
M=',O<VAE970W.2YX;6Q02P$"% ,4    "  #,I97&]<-[5 #  !Y"P  &0
M            @(&MF@( >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4
M Q0    (  ,REE<^XY]@2P0  &T<   9              " @32> @!X;"]W
M;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @  S*65Y'8FE., @
MNP<  !D              ("!MJ(" 'AL+W=O<FMS:&5E=',O<VAE970X,BYX
M;6Q02P$"% ,4    "  #,I972>/$\I8#   I#@  &0              @(%Y
MI0( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    (  ,REE?B
MV[2P_0,  $4:   9              " @4:I @!X;"]W;W)K<VAE971S+W-H
M965T.#0N>&UL4$L! A0#%     @  S*65U*;%$1Z!P  /SP  !D
M     ("!>JT" 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  ,REE>%T_3.VB   ,^9 @ 9              "
M@2#, @!X;"]W;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @  S*6
M5^[+ZMT; P  @ T  !D              ("!,>T" 'AL+W=O<FMS:&5E=',O
M<VAE970Y,2YX;6Q02P$"% ,4    "  #,I97%2!$0F@6   '?@$ &0
M        @(&#\ ( >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4 Q0
M   (  ,REE=WAMLK5 ,  + 5   -              "  2(' P!X;"]S='EL
M97,N>&UL4$L! A0#%     @  S*65Y>*NQS     $P(   L
M ( !H0H# %]R96QS+RYR96QS4$L! A0#%     @  S*65TNCH)9P!@  9#P
M  \              ( !B@L# 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M  ,REE<<1N&VJP(  "LV   :              "  2<2 P!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  ,REE?-'F2\0 (  'HT   3
M              "  0H5 P!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !D
- &0 <QL  'L7 P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>652</ContextCount>
  <ElementCount>613</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>149</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2 (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2 (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - Description of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>Description of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure - Simple Agreements for Future Equity and Advance Subscription Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements</Role>
      <ShortName>Simple Agreements for Future Equity and Advance Subscription Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure - Inventories, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/InventoriesNet</Role>
      <ShortName>Inventories, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - Prepaid Expenses and Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssets</Role>
      <ShortName>Prepaid Expenses and Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - Other Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/OtherAssetsNet</Role>
      <ShortName>Other Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/StockholdersDeficit</Role>
      <ShortName>Stockholders' Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - Equity-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/EquityBasedCompensation</Role>
      <ShortName>Equity-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - Concentration of Credit Risk and Major Customers and Vendors</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendors</Role>
      <ShortName>Concentration of Credit Risk and Major Customers and Vendors</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/LossPerShare</Role>
      <ShortName>Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>1031 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>1032 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://formelife.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>1033 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>1034 - Disclosure - Inventories, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/InventoriesNetTables</Role>
      <ShortName>Inventories, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/InventoriesNet</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>1035 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>1036 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/IntangibleAssetsNet</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>1037 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsTables</Role>
      <ShortName>Prepaid Expenses and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssets</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>1038 - Disclosure - Other Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/OtherAssetsNetTables</Role>
      <ShortName>Other Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/OtherAssetsNet</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>1039 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>1040 - Disclosure - Stockholders' Deficit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/StockholdersDeficitTables</Role>
      <ShortName>Stockholders' Deficit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/StockholdersDeficit</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>1041 - Disclosure - Equity-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/EquityBasedCompensationTables</Role>
      <ShortName>Equity-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/EquityBasedCompensation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>1042 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/Warrants</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>1043 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/FairValueMeasurements</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>1044 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>1045 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/IncomeTaxes</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>1046 - Disclosure - Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/LossPerShareTables</Role>
      <ShortName>Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/LossPerShare</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>1047 - Disclosure - Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://formelife.com/role/RelatedPartyTransactions</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>1048 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails</Role>
      <ShortName>Description of Business and Basis of Presentation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>1049 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>1051 - Disclosure - Summary of Significant Accounting Policies - Schedule of Amortization Computed on a Straight-line Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Amortization Computed on a Straight-line Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>1052 - Disclosure - Revenue Recognition - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails</Role>
      <ShortName>Revenue Recognition - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>1053 - Disclosure - Simple Agreements for Future Equity and Advance Subscription Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails</Role>
      <ShortName>Simple Agreements for Future Equity and Advance Subscription Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>1054 - Disclosure - Inventories, Net - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails</Role>
      <ShortName>Inventories, Net - Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>1055 - Disclosure - Property and Equipment, Net - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property and Equipment, Net - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>1056 - Disclosure - Property and Equipment, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>1057 - Disclosure - Intangible Assets, Net - Schedule of Identifiable Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Identifiable Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>1058 - Disclosure - Intangible Assets, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails</Role>
      <ShortName>Intangible Assets, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>1059 - Disclosure - Intangible Assets, Net - Schedule of Estimated Annual Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Estimated Annual Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>1060 - Disclosure - Prepaid Expenses and Other Current Assets- Schedule of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails</Role>
      <ShortName>Prepaid Expenses and Other Current Assets- Schedule of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>1061 - Disclosure - Other Assets, Net - Schedule of Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails</Role>
      <ShortName>Other Assets, Net - Schedule of Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>1062 - Disclosure - Other Assets, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/OtherAssetsNetAdditionalInformationDetails</Role>
      <ShortName>Other Assets, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>1063 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>1064 - Disclosure - Debt - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/DebtAdditionalInformationDetails</Role>
      <ShortName>Debt - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>1065 - Disclosure - Warrants - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/WarrantsAdditionalInformationDetails</Role>
      <ShortName>Warrants - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>1066 - Disclosure - Warrants - Schedule of Changes in Warrants Issued and Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails</Role>
      <ShortName>Warrants - Schedule of Changes in Warrants Issued and Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>1067 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>1068 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>1069 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>1070 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>1071 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments under Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Rental Payments under Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>1072 - Disclosure - Commitments and Contingencies - Schedule of Schedule of Other Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Schedule of Other Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>1073 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>1074 - Disclosure - Stockholders' Deficit - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Deficit - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>1075 - Disclosure - Stockholders' Deficit - Disclosure of Temporary Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails</Role>
      <ShortName>Stockholders' Deficit - Disclosure of Temporary Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>1076 - Disclosure - Equity-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Equity-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>1077 - Disclosure - Equity-Based Compensation - Summary of Compensation Cost Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Compensation Cost Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>1078 - Disclosure - Equity-Based Compensation - Summary of Stock option activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Stock option activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>1079 - Disclosure - Equity-Based Compensation - Summary of Unvested Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Unvested Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>1080 - Disclosure - Equity-Based Compensation - Summary of Stock Option Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Stock Option Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>1081 - Disclosure - Concentration of Credit Risk and Major Customers and Vendors - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails</Role>
      <ShortName>Concentration of Credit Risk and Major Customers and Vendors - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>1082 - Disclosure - Benefit Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/BenefitPlansAdditionalInformationDetails</Role>
      <ShortName>Benefit Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>1083 - Disclosure - Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails</Role>
      <ShortName>Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>1084 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>1085 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>1086 - Disclosure - Income Taxes - Disclosure of the components of deferred tax assets (liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Disclosure of the components of deferred tax assets (liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>1087 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>1088 - Disclosure - Loss Per Share - Schedule of Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails</Role>
      <ShortName>Loss Per Share - Schedule of Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>1089 - Disclosure - Loss Per Share - Schedule of Potentially Dilutive Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails</Role>
      <ShortName>Loss Per Share - Schedule of Potentially Dilutive Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>1090 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>1091 - Disclosure - Related Party Transactions - Schedule of Loan Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails</Role>
      <ShortName>Related Party Transactions - Schedule of Loan Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="d367939ds1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>1092 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://formelife.com/role/SubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1" isDefinitelyFs="true" isUsgaap="true" original="d367939ds1.htm">d367939ds1.htm</File>
    <File>trnr-20230930.xsd</File>
    <File>trnr-20230930_cal.xml</File>
    <File>trnr-20230930_def.xml</File>
    <File>trnr-20230930_lab.xml</File>
    <File>trnr-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g367939g12q38.jpg</File>
    <File>g367939g26d49.jpg</File>
    <File>g367939g26m40.jpg</File>
    <File>g367939g38t23.jpg</File>
    <File>g367939g51z45.jpg</File>
    <File>g367939g56j56.jpg</File>
    <File>g367939g61d94.jpg</File>
    <File>g367939g72h71.jpg</File>
    <File>g367939g86x61.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1899">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>123
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d367939ds1.htm": {
   "nsprefix": "trnr",
   "nsuri": "http://formelife.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "d367939ds1.htm"
     ]
    },
    "schema": {
     "local": [
      "trnr-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "trnr-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "trnr-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "trnr-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "trnr-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 423,
   "keyCustom": 190,
   "axisStandard": 37,
   "axisCustom": 1,
   "memberStandard": 48,
   "memberCustom": 95,
   "hidden": {
    "total": 9,
    "http://fasb.org/us-gaap/2023": 7,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 652,
   "entityCount": 1,
   "segmentCount": 149,
   "elementCount": 935,
   "unitCount": 10,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1899,
    "http://xbrl.sec.gov/dei/2023": 26
   },
   "report": {
    "R1": {
     "role": "http://formelife.com/role/CoverPage",
     "longName": "1001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022_SeriesSeedConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "us-gaap:TemporaryEquityParOrStatedValuePerShare",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
     "longName": "1004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "trnr:FitnessProductRevenue1",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "trnr:FitnessProductRevenue1",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited",
     "longName": "1005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2 (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2 (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
     "longName": "1006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2020_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2020_SeriesSeedZeroToTenPreferredStockMemberusgaapStatementClassOfStockAxis",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical",
     "longName": "1007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_01_2022To09_30_2022_SeriesA2PreferredStockMemberusgaapStatementClassOfStockAxis",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
     "longName": "1008 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "longName": "1009 - Disclosure - Description of Business and Basis of Presentation",
     "shortName": "Description of Business and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://formelife.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "1010 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://formelife.com/role/RevenueRecognition",
     "longName": "1011 - Disclosure - Revenue Recognition",
     "shortName": "Revenue Recognition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements",
     "longName": "1012 - Disclosure - Simple Agreements for Future Equity and Advance Subscription Agreements",
     "shortName": "Simple Agreements for Future Equity and Advance Subscription Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://formelife.com/role/InventoriesNet",
     "longName": "1013 - Disclosure - Inventories, Net",
     "shortName": "Inventories, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://formelife.com/role/PropertyAndEquipmentNet",
     "longName": "1014 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://formelife.com/role/IntangibleAssetsNet",
     "longName": "1015 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssets",
     "longName": "1016 - Disclosure - Prepaid Expenses and Other Current Assets",
     "shortName": "Prepaid Expenses and Other Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://formelife.com/role/OtherAssetsNet",
     "longName": "1017 - Disclosure - Other Assets, Net",
     "shortName": "Other Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilities",
     "longName": "1018 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://formelife.com/role/Debt",
     "longName": "1019 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://formelife.com/role/Warrants",
     "longName": "1020 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "trnr:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "trnr:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://formelife.com/role/FairValueMeasurements",
     "longName": "1021 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://formelife.com/role/CommitmentsAndContingencies",
     "longName": "1022 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://formelife.com/role/Leases",
     "longName": "1023 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://formelife.com/role/StockholdersDeficit",
     "longName": "1024 - Disclosure - Stockholders' Deficit",
     "shortName": "Stockholders' Deficit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://formelife.com/role/EquityBasedCompensation",
     "longName": "1025 - Disclosure - Equity-Based Compensation",
     "shortName": "Equity-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendors",
     "longName": "1026 - Disclosure - Concentration of Credit Risk and Major Customers and Vendors",
     "shortName": "Concentration of Credit Risk and Major Customers and Vendors",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://formelife.com/role/BenefitPlans",
     "longName": "1027 - Disclosure - Benefit Plans",
     "shortName": "Benefit Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://formelife.com/role/IncomeTaxes",
     "longName": "1028 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://formelife.com/role/LossPerShare",
     "longName": "1029 - Disclosure - Loss Per Share",
     "shortName": "Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://formelife.com/role/RelatedPartyTransactions",
     "longName": "1030 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://formelife.com/role/SubsequentEvents",
     "longName": "1031 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "1032 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "32",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ComparabilityOfPriorYearFinancialData",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ComparabilityOfPriorYearFinancialData",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "1033 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://formelife.com/role/InventoriesNetTables",
     "longName": "1034 - Disclosure - Inventories, Net (Tables)",
     "shortName": "Inventories, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://formelife.com/role/PropertyAndEquipmentNetTables",
     "longName": "1035 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://formelife.com/role/IntangibleAssetsNetTables",
     "longName": "1036 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsTables",
     "longName": "1037 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)",
     "shortName": "Prepaid Expenses and Other Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://formelife.com/role/OtherAssetsNetTables",
     "longName": "1038 - Disclosure - Other Assets, Net (Tables)",
     "shortName": "Other Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables",
     "longName": "1039 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://formelife.com/role/StockholdersDeficitTables",
     "longName": "1040 - Disclosure - Stockholders' Deficit (Tables)",
     "shortName": "Stockholders' Deficit (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://formelife.com/role/EquityBasedCompensationTables",
     "longName": "1041 - Disclosure - Equity-Based Compensation (Tables)",
     "shortName": "Equity-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://formelife.com/role/WarrantsTables",
     "longName": "1042 - Disclosure - Warrants (Tables)",
     "shortName": "Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "trnr:WarrantsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "trnr:WarrantsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://formelife.com/role/FairValueMeasurementsTables",
     "longName": "1043 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://formelife.com/role/CommitmentsAndContingenciesTables",
     "longName": "1044 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://formelife.com/role/IncomeTaxesTables",
     "longName": "1045 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://formelife.com/role/LossPerShareTables",
     "longName": "1046 - Disclosure - Loss Per Share (Tables)",
     "shortName": "Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://formelife.com/role/RelatedPartyTransactionsTables",
     "longName": "1047 - Disclosure - Related Party Transactions (Tables)",
     "shortName": "Related Party Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
     "longName": "1048 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Details)",
     "shortName": "Description of Business and Basis of Presentation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
     "longName": "1049 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:GeneralPartnersOfferingCosts",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "trnr:DeferredOfferingCostsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:CooperativeAdvertisingAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "trnr:CapitalizedStudioContentPolicytextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails",
     "longName": "1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Plant and Equipment (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Property, Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023_MaximumMembersrtRangeAxis_PreProductionToolingMemberusgaapPropertyPlantAndEquipmentByTypeAxis",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "trnr:PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails",
     "longName": "1051 - Disclosure - Summary of Significant Accounting Policies - Schedule of Amortization Computed on a Straight-line Basis (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Amortization Computed on a Straight-line Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails",
     "longName": "1052 - Disclosure - Revenue Recognition - Additional Information (Details)",
     "shortName": "Revenue Recognition - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis",
      "name": "trnr:ExtendedProductWarrantyPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023_MaximumMembersrtRangeAxis",
      "name": "trnr:ExtendedProductWarrantyPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails",
     "longName": "1053 - Disclosure - Simple Agreements for Future Equity and Advance Subscription Agreements - Additional Information (Details)",
     "shortName": "Simple Agreements for Future Equity and Advance Subscription Agreements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn07_23_2021_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis",
      "name": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-4",
      "ancestors": [
       "div",
       "trnr:SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails",
     "longName": "1054 - Disclosure - Inventories, Net - Schedule of Inventories (Details)",
     "shortName": "Inventories, Net - Schedule of Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:InventoryNet",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails",
     "longName": "1055 - Disclosure - Property and Equipment, Net - Schedule of Property, Plant and Equipment (Details)",
     "shortName": "Property and Equipment, Net - Schedule of Property, Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "trnr:PreProductionTooling",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "trnr:PreProductionTooling",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails",
     "longName": "1056 - Disclosure - Property and Equipment, Net - Additional Information (Details)",
     "shortName": "Property and Equipment, Net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:Depreciation",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails",
     "longName": "1057 - Disclosure - Intangible Assets, Net - Schedule of Identifiable Intangible Assets, Net (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Identifiable Intangible Assets, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails",
     "longName": "1058 - Disclosure - Intangible Assets, Net - Additional Information (Details)",
     "shortName": "Intangible Assets, Net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_01_2023To09_30_2023_IdentifiableIntangibleAssetsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails",
     "longName": "1059 - Disclosure - Intangible Assets, Net - Schedule of Estimated Annual Amortization Expense (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Estimated Annual Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails",
     "longName": "1060 - Disclosure - Prepaid Expenses and Other Current Assets- Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "shortName": "Prepaid Expenses and Other Current Assets- Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:SecurityDeposit",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:SecurityDeposit",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "trnr:PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails",
     "longName": "1061 - Disclosure - Other Assets, Net - Schedule of Other Assets (Details)",
     "shortName": "Other Assets, Net - Schedule of Other Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:OtherDeferredCostsGross",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:OtherDeferredCostsGross",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://formelife.com/role/OtherAssetsNetAdditionalInformationDetails",
     "longName": "1062 - Disclosure - Other Assets, Net - Additional Information (Details)",
     "shortName": "Other Assets, Net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "us-gaap:OtherAmortizationOfDeferredCharges",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "us-gaap:OtherAmortizationOfDeferredCharges",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "longName": "1063 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:AccruedBonusesCurrent",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:AccruedBonusesCurrent",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://formelife.com/role/DebtAdditionalInformationDetails",
     "longName": "1064 - Disclosure - Debt - Additional Information (Details)",
     "shortName": "Debt - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "trnr:LossDueToChangesInFairValueOfConvertibleNotes",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://formelife.com/role/WarrantsAdditionalInformationDetails",
     "longName": "1065 - Disclosure - Warrants - Additional Information (Details)",
     "shortName": "Warrants - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "PAsOn07_23_2021",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P05_01_2023To05_31_2023_IPOMemberusgaapSubsidiarySaleOfStockAxis_ServiceProvidersStockWarrantsMemberusgaapStatementClassOfStockAxis",
      "name": "trnr:StockIssuedDuringPeriodSharesWarrantsExercised",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
     "longName": "1066 - Disclosure - Warrants - Schedule of Changes in Warrants Issued and Outstanding (Details)",
     "shortName": "Warrants - Schedule of Changes in Warrants Issued and Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis",
      "name": "trnr:WarrantOutstanding",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "trnr:WarrantsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2020_ClassACommonStockWarrantsMemberusgaapStatementClassOfStockAxis",
      "name": "trnr:WarrantOutstanding",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "longName": "1067 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails",
     "longName": "1068 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
     "longName": "1069 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2020_SimpleAgreementsForFutureEquityMemberTRNRAgreementAxis",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://formelife.com/role/LeasesAdditionalInformationDetails",
     "longName": "1070 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:LesseeOperatingLeaseOptionToExtend",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails",
     "longName": "1071 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments under Operating Leases (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Rental Payments under Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails",
     "longName": "1072 - Disclosure - Commitments and Contingencies - Schedule of Schedule of Other Commitments (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Schedule of Other Commitments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:OtherCommitmentDueInNextTwelveMonths",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OtherCommitmentsTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:OtherCommitmentDueInNextTwelveMonths",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OtherCommitmentsTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
     "longName": "1073 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "P01_01_2017To12_31_2017",
      "name": "us-gaap:RoyaltyExpense",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:RoyaltyGuaranteesCommitmentsAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
     "longName": "1074 - Disclosure - Stockholders' Deficit - Additional Information (Details)",
     "shortName": "Stockholders' Deficit - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_23_2022",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails",
     "longName": "1075 - Disclosure - Stockholders' Deficit - Disclosure of Temporary Equity (Details)",
     "shortName": "Stockholders' Deficit - Disclosure of Temporary Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
     "longName": "1076 - Disclosure - Equity-Based Compensation - Additional Information (Details)",
     "shortName": "Equity-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_01_2023To09_30_2023",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
     "longName": "1077 - Disclosure - Equity-Based Compensation - Summary of Compensation Cost Recognized (Details)",
     "shortName": "Equity-Based Compensation - Summary of Compensation Cost Recognized (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "P07_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_01_2023To09_30_2023_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails",
     "longName": "1078 - Disclosure - Equity-Based Compensation - Summary of Stock option activity (Details)",
     "shortName": "Equity-Based Compensation - Summary of Stock option activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails",
     "longName": "1079 - Disclosure - Equity-Based Compensation - Summary of Unvested Common Stock (Details)",
     "shortName": "Equity-Based Compensation - Summary of Unvested Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023_TwoThousandTwentyPlanEarlyExerciseMemberusgaapPlanNameAxis",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails",
     "longName": "1080 - Disclosure - Equity-Based Compensation - Summary of Stock Option Valuation Assumptions (Details)",
     "shortName": "Equity-Based Compensation - Summary of Stock Option Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails",
     "longName": "1081 - Disclosure - Concentration of Credit Risk and Major Customers and Vendors - Additional Information (Details)",
     "shortName": "Concentration of Credit Risk and Major Customers and Vendors - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis",
      "name": "trnr:NumberOfCustomer",
      "unitRef": "Unit_Customer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "trnr:NumberOfCustomer",
       "div",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis",
      "name": "trnr:NumberOfCustomer",
      "unitRef": "Unit_Customer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "trnr:NumberOfCustomer",
       "div",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://formelife.com/role/BenefitPlansAdditionalInformationDetails",
     "longName": "1082 - Disclosure - Benefit Plans - Additional Information (Details)",
     "shortName": "Benefit Plans - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails",
     "longName": "1083 - Disclosure - Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details)",
     "shortName": "Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails",
     "longName": "1084 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)",
     "shortName": "Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails",
     "longName": "1085 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "shortName": "Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To12_31_2022",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails",
     "longName": "1086 - Disclosure - Income Taxes - Disclosure of the components of deferred tax assets (liabilities) (Details)",
     "shortName": "Income Taxes - Disclosure of the components of deferred tax assets (liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails",
     "longName": "1087 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "PAsOn08_16_2022",
      "name": "trnr:MinimumTaxOnBookIncomeInflationReductionActPercent",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn08_16_2022",
      "name": "trnr:MinimumTaxOnBookIncomeInflationReductionActPercent",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails",
     "longName": "1088 - Disclosure - Loss Per Share - Schedule of Loss Per Share (Details)",
     "shortName": "Loss Per Share - Schedule of Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "trnr:NetLoss",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "trnr:NetLoss",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails",
     "longName": "1089 - Disclosure - Loss Per Share - Schedule of Potentially Dilutive Shares (Details)",
     "shortName": "Loss Per Share - Schedule of Potentially Dilutive Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
     "longName": "1090 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "P01_01_2023To09_30_2023",
      "name": "us-gaap:ProceedsFromRelatedPartyDebt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P09_30_2019To09_30_2019",
      "name": "trnr:DefaultInterest",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-4",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails",
     "longName": "1091 - Disclosure - Related Party Transactions - Schedule of Loan Payable (Details)",
     "shortName": "Related Party Transactions - Schedule of Loan Payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:NotesPayable",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:NotesPayable",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
     "longName": "1092 - Disclosure - Subsequent Events - Additional Information (Details)",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "PAsOn09_30_2023",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P02_13_2022To02_13_2022_ContractTerminationMemberusgaapRestructuringCostAndReserveAxis",
      "name": "us-gaap:PaymentsForRestructuring",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d367939ds1.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_OtherDeferredCostsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherDeferredCostsGross",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherDeferredCostsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Deferred Costs, Gross",
        "terseLabel": "Cost",
        "documentation": "Gross amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_DebtConversionNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionNameDomain",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Name [Domain]",
        "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r47"
     ]
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r245",
      "r360",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r376",
      "r383",
      "r384",
      "r386"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r340",
      "r748"
     ]
    },
    "trnr_SeriesA2PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesA2PreferredStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical",
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A-2 Preferred Stock [Member]",
        "terseLabel": "Series A-2 [Member]",
        "documentation": "Series A-2 preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Shares Conversion of Convertible Securities",
        "terseLabel": "Issuance of Series A-2 preferred stock upon conversion of convertible notes, shares",
        "documentation": "Temporary equity stock issued during period shares conversion of convertible securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-4 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r748"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedFourPreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-4 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Four Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-3 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r678"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherDeferredCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherDeferredCostsNet",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Deferred Costs, Net",
        "totalLabel": "Net Book Value",
        "documentation": "Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedThreePreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-3 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Three Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Long-Term Lines of Credit",
        "terseLabel": "Proceeds from long-term lines of credit",
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-1 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedOnePreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-1 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed One Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-2 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedTwoPreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-2 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Two Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r611",
      "r612",
      "r613",
      "r826",
      "r827",
      "r838",
      "r839",
      "r840"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Debt Instrument Carrying Amount",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r181",
      "r387"
     ]
    },
    "trnr_SeriesSeedZeroToTenPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedZeroToTenPreferredStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Zero To Ten Preferred Stock [Member]",
        "terseLabel": "Series Seed 0 - 10 [Member]",
        "documentation": "Series seed zero to ten preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities fair value disclosure",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleBeneficialConversionFeature",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Beneficial Conversion Feature",
        "terseLabel": "Debt Instrument, Convertible, Beneficial Conversion Feature",
        "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "trnr_InitialPublicOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "InitialPublicOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering Costs",
        "terseLabel": "Initial public offering costs",
        "documentation": "Initial public offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r871"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "trnr_SeriesAConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesAConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Convertible Preferred Stock [Member]",
        "terseLabel": "Series A Convertible Preferred Stock",
        "documentation": "Series A convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedFivePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Five preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-5 preferred stock upon conversion of SAFEs, shares",
        "documentation": "Issuance of Series Seed Five preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number",
        "terseLabel": "Number of accelerated vested shares",
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedSixPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Six preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-6 preferred stock upon conversion of SAFEs, shares",
        "documentation": "Issuance of Series Seed Six preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of Series A-2 preferred stock, net of issuance costs, shares",
        "documentation": "Temporary equity stock issued during period shares new issues."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Value Conversion of Convertible Securities",
        "terseLabel": "Issuance of Series A-2 preferred stock upon conversion of convertible notes",
        "documentation": "Temporary equity stock issued during period value conversion of convertible Securities."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-5 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityAdditionalStockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Additional Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of Series A-2 preferred stock, net of issuance costs",
        "documentation": "Temporary equity additional stock issued during period value new issues."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-6 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedFivePreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-5 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Five Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "trnr_IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedSevenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Seven preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-7 preferred stock upon conversion of SAFEs, shares",
        "documentation": "Issuance of Series Seed Seven preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 38.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Proceeds from issuance of related party loans",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_OtherCommitmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsTableTextBlock",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Table Text Block]",
        "terseLabel": "Schedule of Other Commitments",
        "documentation": "Tabular disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedEightPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Eight preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-8 preferred stock upon conversion of SAFEs, shares",
        "documentation": "Issuance of Series Seed Eight preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r120",
      "r180",
      "r859",
      "r977"
     ]
    },
    "trnr_IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedNinePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Nine preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-9 preferred stock upon conversion of SAFEs, shares",
        "documentation": "Issuance of Series Seed Nine preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-10 preferred stock upon conversion of SAFEs, shares",
        "documentation": "Issuance of Series Seed Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationComputedOnAStraightLineBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Internal-use software",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesSeriesSeedNinePreferredStock",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Shares New Issues Series Seed Nine Preferred Stock",
        "terseLabel": "Issuance of Series Seed-9 preferred stock, shares",
        "documentation": "Temporary Equity Stock Issued During Period Shares New Issues Series Seed Nine Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r361",
      "r579",
      "r826",
      "r827"
     ]
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssuesSeriesSeedNinePreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Value New Issues Series Seed Nine Preferred Stock",
        "terseLabel": "Issuance of Series Seed-9 preferred stock",
        "documentation": "Temporary Equity Stock Issued During Period Value New Issues Series Seed Nine Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssuesIssuanceOfSeriesAPreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Value New Issues Issuance of Series A Preferred Stock",
        "terseLabel": "Issuance of Series A preferred stock net of issuance costs",
        "documentation": "Temporary Equity Stock Issued During Period Value New Issues Issuance of Series A Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Risk free [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Product Information [Table]",
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r214",
      "r653"
     ]
    },
    "us-gaap_AssetAcquisitionPriceOfAcquisitionExpected": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionPriceOfAcquisitionExpected",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition, Price of Acquisition, Expected",
        "terseLabel": "Purchase price under the Asset Purchase Agreement",
        "documentation": "Purchase price of expected asset acquisition prior to consideration being transferred. Excludes business acquisition."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssuesIssuanceOfSeriesAPreferredStock",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Shares New Issues Issuance of Series A Preferred Stock",
        "terseLabel": "Issuance of Series A preferred stock net of issuance costs, shares",
        "documentation": "Temporary Equity Stock Issued During Period Shares New Issues Issuance of Series A Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A Preferred Stock",
        "terseLabel": "Issuance of Series A preferred stock upon conversion of convertible notes",
        "documentation": "Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAPreferredStock",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A Preferred Stock",
        "terseLabel": "Issuance of Series A preferred stock upon conversion of convertible notes, shares",
        "documentation": "Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r134",
      "r223",
      "r649",
      "r669",
      "r673"
     ]
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A One Preferred Stock.",
        "terseLabel": "Issuance of Series A-1 preferred stock upon conversion of convertible notes, shares",
        "documentation": "Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of Series A One Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesIssuanceOfSeriesAOnePreferredStock.",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A One Preferred Stock.",
        "terseLabel": "Issuance of Series A-1 preferred stock upon conversion of convertible notes",
        "documentation": "Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Issuance of Series A One Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesSeedNinePreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital Issuance of Series Seed Nine Preferred Stock",
        "terseLabel": "Issuance of Series Seed-9 preferred stock",
        "documentation": "Adjustments to Additional Paid in Capital Issuance of Series Seed Nine Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesAPreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital Issuance of Series A Preferred Stock",
        "terseLabel": "Issuance of Series A preferred stock net of issuance costs",
        "documentation": "Adjustments to Additional Paid in Capital Issuance of Series A Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Class A Common Stock Upon Conversion Of Series A Preferred Stock Value",
        "verboseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series A preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series A Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r65"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesAPreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series A Preferred Stock Shares",
        "verboseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series A preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series A Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Class A Common Stock Upon Conversion Of Series A1 Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series A-1 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series A1 Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedAmortizationOfOtherDeferredCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedAmortizationOfOtherDeferredCosts",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherDeferredCostsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Amortization of Other Deferred Costs",
        "negatedLabel": "Accumulated Amortization",
        "documentation": "Accumulated amortization of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs, deferred acquisition costs of insurance companies, or deferred leasing costs for real estate operations."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesA1PreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series A1 Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series A-1 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series A1 Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series A-2 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes Payable",
        "terseLabel": "Income tax payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r178",
      "r977"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesA2PreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series A-2 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series A2 Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedPreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Class A Common Stock Upon Conversion Of Series Seed Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets",
        "terseLabel": "Other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r216",
      "r644",
      "r862"
     ]
    },
    "trnr_IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedFourPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Four preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-4 preferred stock upon conversion of SAFE, shares",
        "documentation": "Issuance of Series Seed Four preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r89",
      "r90",
      "r91",
      "r94",
      "r252"
     ]
    },
    "trnr_IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedThreePreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Three preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-3 preferred stock upon conversion of SAFE, shares",
        "documentation": "Issuance of Series Seed Three preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, net",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r193",
      "r196",
      "r197"
     ]
    },
    "us-gaap_PreferredStockConversionBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockConversionBasis",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Conversion Basis",
        "terseLabel": "Preferred stock, conversion basis",
        "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r124"
     ]
    },
    "trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassBCommonStockUponExerciseOfWarrantsValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class B Common Stock Upon Exercise of Warrants Value",
        "terseLabel": "Issuance of Class B common stock upon exercise of warrants",
        "documentation": "Issuance of Class B Common Stock Upon Exercise of Warrants Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 33.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredCharges",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Deferred Charges",
        "negatedLabel": "Deferred offering costs",
        "documentation": "The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Value",
        "terseLabel": "Issuance of Class B common stock upon conversion of SAFEs",
        "documentation": "Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Endng balance",
        "terseLabel": "Temporary equity, carrying amount, attributable to parent",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r481",
      "r648"
     ]
    },
    "us-gaap_IncreaseDecreaseInDepositOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDepositOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Deposit Assets",
        "negatedLabel": "Vendor deposits",
        "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 45.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible notes",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r82"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from Issuance of Warrants",
        "verboseLabel": "Proceeds from issuance of warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Stock Option Valuation Assumptions",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Liabilities Measured on Recurring Basis",
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r174"
     ]
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Summary of Unvested Common Stock",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024 / 2023",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r849"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025 / 2024",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "trnr_IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedTwoPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Two preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-2 preferred stock upon conversion of SAFE, shares",
        "documentation": "Issuance of Series Seed Two preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ClassACommonStockToClassBCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ClassACommonStockToClassBCommonStockMember",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Stock to Class B Common Stock [Member]",
        "documentation": "Class A common stock to class B common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2026 / 2025",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "trnr_WeightedAverageThresholdConsecutiveTradingDays1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WeightedAverageThresholdConsecutiveTradingDays1",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Threshold Consecutive Trading Days1",
        "terseLabel": "Weighted Average Threshold Consecutive Trading Days",
        "documentation": "Weighted Average Threshold Consecutive Trading Days1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2027 / 2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponExerciseOfWarrantsValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock Upon Exercise of Warrants Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon exercise of warrants",
        "documentation": "Issuance of Class A Common Stock Upon Exercise of Warrants Value."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_AssetPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AssetPurchaseAgreementMember",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Purchase Agreement [Member]",
        "terseLabel": "Asset Purchase Agreement [Member]",
        "documentation": "Asset Purchase Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails",
      "http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "trnr_AssetPurchaseAgreementTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AssetPurchaseAgreementTerms",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Purchase Agreement Terms",
        "terseLabel": "Asset purchase agreement terms",
        "documentation": "Asset purchase agreement terms."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2023 (remaining)",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short term lease cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r848"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Amortization of operating lease assets",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_AccruedBonusesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedBonusesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Bonuses, Current",
        "terseLabel": "Accrued bonus",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r848"
     ]
    },
    "trnr_RetirementOfSeniorDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RetirementOfSeniorDebt",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Of Senior Debt",
        "terseLabel": "Retirement of senior debt",
        "documentation": "Retirement of senior debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r109",
      "r744",
      "r745",
      "r748"
     ]
    },
    "trnr_MaximumNumberOfEarnOutShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "MaximumNumberOfEarnOutShares",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Number of Earn-Out Shares",
        "terseLabel": "Maximum number of earn-out shares",
        "documentation": "Maximum number of earn-Out shares"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PercentageOfOriginalIssuanceDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PercentageOfOriginalIssuanceDiscount",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Original Issuance Discount",
        "terseLabel": "Percentage of original issuance discount",
        "documentation": "Percentage of original issuance discount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r601",
      "r602",
      "r604",
      "r607",
      "r684",
      "r685",
      "r686",
      "r746",
      "r747",
      "r748",
      "r768",
      "r770"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Measurement of Liabilities Using Unobservable Inputs Reconciliation",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r101"
     ]
    },
    "us-gaap_AccruedAdvertisingCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedAdvertisingCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Advertising, Current",
        "terseLabel": "Accrued advertising",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net Change In Cash and Cash Equivalents",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r146"
     ]
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireSoftware",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 34.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Software",
        "negatedLabel": "Acquisition of internal use software",
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r744",
      "r745",
      "r748"
     ]
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/InventoriesNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories, net",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 36.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rate on cash",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r454"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r849"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Tax Authority [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net",
        "terseLabel": "Fair value liabilities, measurements transfers between levels",
        "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 46.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from the issuance of common stock A",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodStartLabel": "Cash and restricted cash at beginning of year",
        "periodEndLabel": "Cash and restricted cash at end of year",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r146",
      "r243"
     ]
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedPayrollTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Payroll Taxes, Current",
        "terseLabel": "Accrued payroll",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of convertible preferred stock",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Cancelled or forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Changes in Warrants Issued and Outstanding",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Proceeds from Issuance or Sale of Equity",
        "verboseLabel": "Proceeds from issuance or sale of equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r678"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from issuance of common stock upon initial public offering, net of offering costs",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyGainLossMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Gain (Loss) [Member]",
        "documentation": "Primary financial statement caption encompassing foreign currency gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 52.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Other Long-Term Debt",
        "terseLabel": "Proceeds from issuance of loans",
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Total accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r484",
      "r976"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 44.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Preferred Stock and Preference Stock",
        "terseLabel": "Proceeds from issuance of Preferred Stock - Series A, net of issuance costs",
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r53",
      "r102",
      "r103",
      "r311",
      "r802"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r53",
      "r102",
      "r103",
      "r311",
      "r674",
      "r802"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Schedule of Loan Payable",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForwardContractIndexedToIssuersEquityTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForwardContractIndexedToIssuersEquityTypeAxis",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Contract Indexed to Issuer's Equity, Type [Axis]",
        "documentation": "Information by type of forward contract issued by the entity, that is indexed to, and potentially settled in an entity's own stock."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97",
      "r172"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Loss Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r385",
      "r579",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r894"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r953"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r56",
      "r190",
      "r191",
      "r194",
      "r195"
     ]
    },
    "us-gaap_RoyaltyGuaranteesCommitmentsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RoyaltyGuaranteesCommitmentsAmount",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Guarantees, Commitments, Amount",
        "terseLabel": "Guaranteed minimum payment of royalty",
        "documentation": "The amount the entity has committed to make for future royalty guarantees."
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r310",
      "r818"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Weighted-average expected term (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value, ending balance",
        "periodStartLabel": "Fair value, beginning balance",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r118",
      "r119",
      "r177",
      "r181",
      "r253",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r579",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r894"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfEstimatedAnnualAmortizationExpenseDetails",
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r621"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r76",
      "r77",
      "r104",
      "r105",
      "r106",
      "r113",
      "r162",
      "r164",
      "r253",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r385",
      "r579",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r894"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r625"
     ]
    },
    "us-gaap_ComparabilityOfPriorYearFinancialData": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComparabilityOfPriorYearFinancialData",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comparability of Prior Year Financial Data, Policy [Policy Text Block]",
        "terseLabel": "Unaudited Interim Financial Information",
        "documentation": "Disclosure of accounting policy for reporting any exceptions to the comparability of prior year financial data with data shown for the most recent accounting period."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedComputerSoftwareGross",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Computer Software, Gross",
        "terseLabel": "Software and technology development asset",
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r489",
      "r509"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign tax rate differential",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r953"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent, Total",
        "terseLabel": "Nondeductible expenses",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r953"
     ]
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "verboseLabel": "Sale of stock, number of shares issued in transaction",
        "terseLabel": "Sale of stock number of shares issued in transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "terseLabel": "Sale of stock, percentage of ownership after transaction",
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesIssued1",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Issued",
        "terseLabel": "Issuance of Series Seed preferred stock in connection with convertible notes payable",
        "documentation": "The fair value of notes issued in noncash investing and financing activities."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r701",
      "r703",
      "r704",
      "r705",
      "r708",
      "r772",
      "r774",
      "r776",
      "r779",
      "r780",
      "r788",
      "r789",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r853"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued",
        "terseLabel": "Issuance of connection with convertible SAFEs",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47"
     ]
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets Disclosure [Text Block]",
        "terseLabel": "Other Assets, Net",
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenues",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r891"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r953"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r966"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r219",
      "r220",
      "r221",
      "r247",
      "r277",
      "r278",
      "r281",
      "r283",
      "r289",
      "r290",
      "r316",
      "r351",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r389",
      "r390",
      "r392",
      "r395",
      "r402",
      "r559",
      "r678",
      "r679",
      "r680",
      "r681",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r719",
      "r741",
      "r764",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r867",
      "r893",
      "r902"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Return to provision adjustements",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r953"
     ]
    },
    "us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Software Development Costs for Software Sold to Customers",
        "terseLabel": "Capitalized software",
        "documentation": "Unamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r175"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before provision for income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r135",
      "r183",
      "r291",
      "r302",
      "r306",
      "r308",
      "r641",
      "r655",
      "r817"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State taxes, net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r953"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_EntertainmentLicenseAgreementForProgramMaterialLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EntertainmentLicenseAgreementForProgramMaterialLiability",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entertainment, License Agreement for Program Material, Liability",
        "terseLabel": "License fee liability",
        "documentation": "Amount of obligation incurred for right acquired by broadcaster under license agreement for program material."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      },
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Amotization Computed on a Straight-line Basis",
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r212",
      "r808"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets",
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "terseLabel": "Research and development tax credits",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r948",
      "r953"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share - basic",
        "verboseLabel": "Net loss per share attributable to common stockholders - basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r262",
      "r263",
      "r265",
      "r266",
      "r268",
      "r274",
      "r277",
      "r281",
      "r282",
      "r283",
      "r287",
      "r545",
      "r546",
      "r640",
      "r659",
      "r815"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 28.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on property and equipment disposal",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_DividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends, Common Stock",
        "totalLabel": "Dividends, Common Stock, Total",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r165"
     ]
    },
    "us-gaap_SeriesAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesAMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A [Member]",
        "documentation": "A classification of auction market preferred securities that may have different rights to other classifications of auction market preferred securities, for example Series B."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A convertible preferred stock [Member]",
        "verboseLabel": "Series A Preferred Shares",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r880",
      "r881",
      "r919"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Amortization period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r621"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "terseLabel": "Warrants [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r851",
      "r852",
      "r855",
      "r856",
      "r857",
      "r858"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/LeasesAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r419",
      "r439",
      "r468",
      "r469",
      "r470",
      "r614",
      "r615",
      "r661",
      "r709",
      "r710",
      "r773",
      "r775",
      "r777",
      "r778",
      "r790",
      "r805",
      "r806",
      "r819",
      "r830",
      "r842",
      "r850",
      "r853",
      "r912",
      "r918",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975"
     ]
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest expense",
        "documentation": "The net amount of operating interest income (expense)."
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r148",
      "r184",
      "r208",
      "r229",
      "r231",
      "r236",
      "r247",
      "r258",
      "r262",
      "r263",
      "r265",
      "r266",
      "r270",
      "r271",
      "r279",
      "r291",
      "r302",
      "r306",
      "r308",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r546",
      "r559",
      "r657",
      "r740",
      "r762",
      "r763",
      "r817",
      "r860",
      "r916"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical",
      "http://formelife.com/role/LeasesAdditionalInformationDetails",
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails",
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r288",
      "r620",
      "r676",
      "r699",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r719",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r728",
      "r729",
      "r730",
      "r731",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r742",
      "r743",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r764",
      "r854"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Gain upon debt forgiveness",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r69",
      "r70"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders",
        "terseLabel": "Net loss",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r262",
      "r263",
      "r265",
      "r266",
      "r274",
      "r275",
      "r280",
      "r283",
      "r291",
      "r302",
      "r306",
      "r308",
      "r817"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/LeasesAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r439",
      "r615",
      "r661",
      "r709",
      "r710",
      "r773",
      "r775",
      "r777",
      "r778",
      "r790",
      "r805",
      "r806",
      "r819",
      "r830",
      "r842",
      "r850",
      "r918",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/LeasesAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r419",
      "r439",
      "r468",
      "r469",
      "r470",
      "r614",
      "r615",
      "r661",
      "r709",
      "r710",
      "r773",
      "r775",
      "r777",
      "r778",
      "r790",
      "r805",
      "r806",
      "r819",
      "r830",
      "r842",
      "r850",
      "r853",
      "r912",
      "r918",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r743"
     ]
    },
    "us-gaap_GeneralPartnersOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralPartnersOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Partners' Offering Costs",
        "documentation": "The cumulative amount of offering costs allocated to the general partner."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding",
        "verboseLabel": "Value of warrants",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/LeasesAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r439",
      "r615",
      "r661",
      "r709",
      "r710",
      "r773",
      "r775",
      "r777",
      "r778",
      "r790",
      "r805",
      "r806",
      "r819",
      "r830",
      "r842",
      "r850",
      "r918",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsGross",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements",
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Debt discount on senior notes",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r104",
      "r143",
      "r382"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Outstanding",
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r311",
      "r833",
      "r920",
      "r979",
      "r980"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total stockholders' equity (deficit)",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r128",
      "r129",
      "r151",
      "r721",
      "r738",
      "r765",
      "r766",
      "r849",
      "r862",
      "r895",
      "r905",
      "r960",
      "r985"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary of Compensation Cost Recognized",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Description of Business and Basis of Presentation",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r149",
      "r150"
     ]
    },
    "trnr_DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DecreaseInRightOfUseAssetAndOperatingLeaseLiabilitiesDueToLeaseTermination",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in right-of-use asset and operating lease liabilities due to lease termination",
        "terseLabel": "Decrease in right-of-use asset and operating lease liabilities due to lease termination",
        "documentation": "Decrease in right-of-use asset and operating lease liabilities due to lease termination"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_StockBasedCompensationCapitalizedInSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "StockBasedCompensationCapitalizedInSoftware",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Based Compensation Capitalized in Software",
        "terseLabel": "Stock-based compensation capitalized in software",
        "documentation": "Stock based compensation capitalized in software."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NonCashIssuanceOfCommonStockFromRightsOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NonCashIssuanceOfCommonStockFromRightsOffering",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Issuance of Common Stock from Rights Offering",
        "terseLabel": "Issuance of Common Stock from Rights Offering",
        "documentation": "Non cash issuance of common stock from rights offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ProceedsFromPaycheckProtectionProgramLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ProceedsFromPaycheckProtectionProgramLoan",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Paycheck Protection Program Loan",
        "terseLabel": "Exercise of stock warrants",
        "documentation": "Proceeds from paycheck protection program loan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, Net",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "trnr_PropertyAndEquipmentInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PropertyAndEquipmentInAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment in Accounts Payable",
        "terseLabel": "Property &amp; equipment in AP",
        "documentation": "Property and equipment in accounts payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Conversion price as a percentage",
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_RepaymentsOfRelatedPartyLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RepaymentsOfRelatedPartyLoans",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 39.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments Of Related Party Loans",
        "negatedLabel": "Payments of related party loans",
        "documentation": "Repayments of related party loans."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueAdjustmentOfWarrantsIssuedToServiceProviders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueAdjustmentOfWarrantsIssuedToServiceProviders",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Adjustment Of Warrants Issued To Service Providers",
        "terseLabel": "Warrants issued to service providers",
        "documentation": "Fair value adjustment of warrants issued to service providers."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Number of options, unvested as of September 30, 2023",
        "periodEndLabel": "Ending balance of September 30, 2023",
        "periodStartLabel": "Beginning as of December 31, 2022",
        "documentation": "Number of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsNotSettleableInCashFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Not Settleable in Cash, Fair Value Disclosure",
        "terseLabel": "Warrants not settleable in cash",
        "documentation": "Fair value portion of warrants not settleable in cash classified as equity."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "negatedLabel": "Vested",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price",
        "verboseLabel": "Warrant strike price",
        "definitionGuidance": "Exercise price per share or per unit of warrants or rights outstanding",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "trnr_NonCashExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NonCashExerciseOfOptions",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non cash Exercise of Options",
        "terseLabel": "Net exercise of options",
        "documentation": "Non cash Exercise of Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedSixPreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-6 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Six Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCommonStockStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStockStock",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends, Common Stock, Stock",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in stock."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r334"
     ]
    },
    "us-gaap_OtherCommitmentDueInThirdYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentDueInThirdYear",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitment, to be Paid, Year Three",
        "terseLabel": "2025",
        "documentation": "Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-7 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "terseLabel": "Class B Common Stock",
        "verboseLabel": "Class B Common Shares",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance of September 30, 2023",
        "periodStartLabel": "Beginning as of December 31, 2022",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedSevenPreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-7 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Seven Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average exercise price, Vested",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-8 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Equity-Based Compensation",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r445",
      "r474",
      "r475",
      "r477",
      "r843"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedEightPreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-8 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Eight Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-9 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedNinePreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-9 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Nine Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsMember",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Member]",
        "terseLabel": "Other Member",
        "documentation": "Primary financial statement caption encompassing other assets."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r95"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Value",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-10 preferred stock",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r157"
     ]
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable",
        "totalLabel": "Notes Payable, Total",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r181",
      "r978"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponConversionOfSeriesSeedTenPreferredStockShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon conversion of Series Seed-10 preferred stock, shares",
        "documentation": "Issuance of Class A Common Stock upon Conversion of Series Seed Ten Preferred Stock Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://formelife.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "trnr_ConversionOfLoanPayableToConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ConversionOfLoanPayableToConvertibleNoteMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Loan Payable to Convertible Note [Member]",
        "documentation": "Conversion of Loan Payable to Convertible Note."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r647",
      "r849"
     ]
    },
    "trnr_ConversionOfAccountsPayableToConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ConversionOfAccountsPayableToConvertibleNoteMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Accounts Payable to Convertible Note [Member]",
        "documentation": "Conversion of Accounts Payable to Convertible Note."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ConversionOfPromissoryNotesToConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ConversionOfPromissoryNotesToConvertibleNoteMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Promissory Notes to Convertible Note [Member]",
        "documentation": "Conversion of Promissory Notes to Convertible Note."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NonCashLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NonCashLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash lease expense",
        "documentation": "Non-cash lease expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock shares authorized",
        "verboseLabel": "Common stock shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r719"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r125",
      "r719",
      "r738",
      "r985",
      "r986"
     ]
    },
    "trnr_RepaymentOfBouncebackLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RepaymentOfBouncebackLoans",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 48.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment of Bounceback Loans",
        "terseLabel": "Repayment Bounce Back Loan",
        "documentation": "Repayment of Bounceback Loans"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueOfWarrantsIssuedWithConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueOfWarrantsIssuedWithConvertibleNotes",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Of Warrants Issued With Convertible Notes",
        "terseLabel": "Fair value of warrants issued with convertible notes",
        "documentation": "Fair value of Warrants Issued with Convertible Notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "trnr_IncreaseDecreaseInLongTermInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IncreaseDecreaseInLongTermInventory",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) In Long-term Inventory",
        "negatedLabel": "Long-term inventories",
        "documentation": "Increase (decrease) in long-term inventory."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentDueInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentDueInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitment, to be Paid, Year One",
        "terseLabel": "2023",
        "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NonCashInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NonCashInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Interest Expense",
        "terseLabel": "Non-cash interest expense",
        "documentation": "Non Cash Interest Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentDueInFifthYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentDueInFifthYear",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitment, to be Paid, Year Five",
        "terseLabel": "2027",
        "documentation": "Amount of commitment classified as other to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PaymentsOfSeniorSecuredNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PaymentsOfSeniorSecuredNotes",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 43.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments Of Senior Secured Notes",
        "negatedLabel": "Payments of senior secured notes",
        "documentation": "Payments of senior secured notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93"
     ]
    },
    "us-gaap_OtherCommitmentDueInSecondYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentDueInSecondYear",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitment, to be Paid, Year Two",
        "terseLabel": "2024",
        "documentation": "Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentDueInFourthYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentDueInFourthYear",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitment, to be Paid, Year Four",
        "terseLabel": "2026",
        "documentation": "Amount of commitment classified as other to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ProceedsFromPPPLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ProceedsFromPPPLoan",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 49.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From PPP Loan",
        "terseLabel": "Proceeds from PPP loan",
        "documentation": "Proceeds from PPP loan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r53",
      "r102",
      "r103",
      "r311",
      "r802"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Dividends",
        "terseLabel": "Payments of dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "trnr_ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Simple Agreements for Future Equity",
        "terseLabel": "Proceeds from issuance of SAFEs",
        "documentation": "Proceeds from Issuance of Simple Agreements for Future Equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitment",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitment",
        "totalLabel": "Total",
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "trnr_RecognitionOfDeferredAndAccruedOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RecognitionOfDeferredAndAccruedOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognition Of Deferred And Accrued Offering Costs",
        "terseLabel": "Offering costs in AP and accrued",
        "documentation": "Recognition of deferred and accrued offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_InventoriesInAccountsPayableAndAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "InventoriesInAccountsPayableAndAccrued",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories in Accounts Payable and accrued",
        "negatedLabel": "Inventories in AP and accrued",
        "documentation": "Inventories in Accounts Payable and accrued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesAPreferredStockInConnectionWithConvertibleNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series A preferred stock in connection with convertible notes payable",
        "terseLabel": "Issuance of Series A preferred stock in connection with convertible notes payable",
        "documentation": "Issuance of Series A preferred stock in connection with convertible notes payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentDueAfterFifthYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentDueAfterFifthYear",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfScheduleOfOtherCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitment, to be Paid, after Year Five",
        "terseLabel": "Thereafter",
        "documentation": "Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesAConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesAConvertibleNotesMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r165",
      "r650",
      "r668",
      "r673",
      "r682",
      "r720",
      "r849"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities:",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r179",
      "r493"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_DeferredCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCosts",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Noncurrent",
        "terseLabel": "Deferred offering costs",
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r879"
     ]
    },
    "trnr_SeriesATwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesATwoMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Two [Member]",
        "terseLabel": "Series\u00a0A-2 [Member]",
        "documentation": "Series\u00a0A-2."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r226",
      "r247",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r518",
      "r522",
      "r559",
      "r849",
      "r916",
      "r917",
      "r968"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepaymentsOfOtherLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 53.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Repayments of) Other Long-Term Debt",
        "terseLabel": "Payments of loans",
        "documentation": "Amount of cash inflow (outflow) from other long-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "trnr_NumberOfCustomer": {
     "xbrltype": "integerItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NumberOfCustomer",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Customer",
        "terseLabel": "Number of customer",
        "documentation": "Number of customer."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_VendorOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "VendorOneMember",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendor One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_VendorThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "VendorThreeMember",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendor Three [Member]",
        "terseLabel": "Vendor Three [Member]",
        "documentation": "Vendor three."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardGrantsInPeriodStraightLineCalculationUsingThirdPartyValuationWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangements by Share Based Payment Award, Grants in Period, Straight-line Calculation using Third-Party Valuation, Weighted Average Grant Date Fair Value",
        "terseLabel": "Awards granted, straight-line using third-party valuation (in dollars per share)",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing by straight-line calculation using the contemporaneous third-party valuations methodology."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesAStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesAStockMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Stock [Member]",
        "definitionGuidance": "Series A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubordinatedDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubordinatedDebt",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subordinated Debt",
        "terseLabel": "Subordinated debt",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of subordinated debt (with initial maturities beyond one year or beyond the operating cycle if longer). Subordinated debt places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r118",
      "r181",
      "r978"
     ]
    },
    "trnr_SeriesSeedNineOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedNineOneMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Nine One [Member]",
        "terseLabel": "Series\u00a0Seed-9 [Member]",
        "documentation": "Series seed nine one."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical",
      "http://formelife.com/role/LeasesAdditionalInformationDetails",
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails",
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r288",
      "r620",
      "r676",
      "r699",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r719",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r728",
      "r729",
      "r730",
      "r731",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r742",
      "r743",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r764",
      "r854"
     ]
    },
    "trnr_SeriesSeedTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedTenMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Ten [Member]",
        "terseLabel": "Series\u00a0Seed-10 [Member]",
        "documentation": "Series\u00a0seed-10."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized amount of stock based compensation",
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "verboseLabel": "Recognized stock compensation expense",
        "terseLabel": "Compensation cost recognized",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r482"
     ]
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits Assets, Current",
        "terseLabel": "Vendor deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRePricedNumber",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options Re-priced Number",
        "terseLabel": "Number of repriced option awards",
        "documentation": "Number of options repriced."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAxis",
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "auth_ref": [
      "r206",
      "r254",
      "r255",
      "r256",
      "r258",
      "r259",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r287",
      "r321",
      "r322",
      "r503",
      "r540",
      "r544",
      "r545",
      "r546",
      "r583",
      "r598",
      "r599",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r675"
     ]
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and equipment",
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Stock price",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementDomain",
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "auth_ref": [
      "r206",
      "r254",
      "r255",
      "r256",
      "r258",
      "r259",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r287",
      "r321",
      "r322",
      "r503",
      "r540",
      "r544",
      "r545",
      "r546",
      "r583",
      "r598",
      "r599",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r675"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r609"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/LeasesAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r229",
      "r231",
      "r241",
      "r247",
      "r258",
      "r270",
      "r271",
      "r291",
      "r302",
      "r306",
      "r308",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r517",
      "r520",
      "r521",
      "r546",
      "r559",
      "r641",
      "r656",
      "r687",
      "r740",
      "r762",
      "r763",
      "r817",
      "r846",
      "r847",
      "r861",
      "r888",
      "r916"
     ]
    },
    "trnr_TwoThousandTwentyPlanEarlyExerciseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TwoThousandTwentyPlanEarlyExerciseMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Plan Early Exercise [Member]",
        "terseLabel": "2020 Plan Early Exercise",
        "documentation": "Two thousand twenty plan early exercise."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://formelife.com/role/LossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Loss Per Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r284",
      "r285",
      "r286"
     ]
    },
    "trnr_TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Three And Two Thousand Twenty Equity Incentive Plan Member",
        "terseLabel": "2023 and 2020 Equity Incentive Plan [Member]",
        "documentation": "Two thousand twenty three and two thousand twenty equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_AdditionalExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AdditionalExpense",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Expense",
        "documentation": "Additional expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_DeferredRevenueArrangementTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueArrangementTypeAxis",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue Arrangement Type [Axis]",
        "documentation": "Information by type of deferred revenue arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r609"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability, current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r609"
     ]
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_WarrantGrantDateFairValue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WarrantGrantDateFairValue",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Grant Date Fair Value",
        "terseLabel": "Warrant Grant Date Fair Value",
        "documentation": "Warrant grant date fair value."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r891"
     ]
    },
    "trnr_WarrantsIssuedDuringThePeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WarrantsIssuedDuringThePeriodShares",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Issued During The Period Shares",
        "terseLabel": "Warrants issued during the period shares",
        "documentation": "Warrants issued during the period shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedNumberOfSharesRepurchased",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Non Vested Number of Shares Repurchased",
        "negatedLabel": "Repurchased",
        "documentation": "Share based compensation arrangement by share based payment award options non vested number of shares repurchased."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r609"
     ]
    },
    "trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRepurchaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Vested Repurchase Liability",
        "terseLabel": "Repurchase liability, Vested",
        "documentation": "Share based compensation arrangement by share based payment award options vested repurchase liability."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r864",
      "r865"
     ]
    },
    "trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainingcontractualtermAbstract",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTerm [Abstract]",
        "documentation": "Share based compensation arrangement by share based payment award options weighted average remaining contractual term [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TwoThousandTwentyEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TwoThousandTwentyEquityIncentivePlanMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Equity Incentive Plan [ Member]",
        "terseLabel": "2020 Equity Incentive Plan [Member]",
        "documentation": "Two Thousand Twenty Equity Incentive Plan [ Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedRepurchaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Repurchased Repurchase Liability",
        "terseLabel": "Repurchase liability, Repurchased",
        "documentation": "Share based compensation arrangement by share based payment award options repurchased repurchase liability."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm",
        "terseLabel": "Options unvested",
        "documentation": "Share based compensation arrangement by share based payment award options non vested weighted average remaining contractual term."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating lease liability, net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SharebasedcompensationarrangementbysharebasedpaymentawardoptionsaggregateintrinsicvalueAbstract",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValue [Abstract]",
        "documentation": "Share based compensation arrangement by share based payment award options aggregate intrinsic value."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Repurchased Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average exercise price, Repurchased",
        "documentation": "Share based compensation arrangement by share based payment award options repurchased weighted average grant date fair value."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Repurchase Liability",
        "periodStartLabel": "Beginning Balance, Repurchase liability",
        "periodEndLabel": "Ending Balance, Repurchase liability",
        "documentation": "Share based compensation arrangement by share based payment award options repurchase liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r61"
     ]
    },
    "us-gaap_DeferredRevenueArrangementTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueArrangementTypeDomain",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue [Domain]",
        "documentation": "Category of obligation arising when an entity receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodRepurchaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Grants in Period Repurchase Liability",
        "terseLabel": "Repurchase liability, Issued",
        "documentation": "Share based compensation arrangement by share based payment award options grants in period repurchase liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r896"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "documentation": "Different names of stock transactions and the different attributes of each transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r244"
     ]
    },
    "us-gaap_CommonStockConversionBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockConversionBasis",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Conversion Basis",
        "terseLabel": "Common stock, conversion basis",
        "documentation": "Description of basis for conversion of convertible common stock."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount, Total",
        "terseLabel": "Nondeductible expenses",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r896",
      "r952"
     ]
    },
    "us-gaap_LoansPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans Payable, Current",
        "terseLabel": "Loan payable",
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r210",
      "r247",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r519",
      "r522",
      "r523",
      "r559",
      "r849",
      "r916",
      "r968",
      "r969"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation (loss) gain",
        "verboseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Total",
        "totalLabel": "Total current expense:",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r499",
      "r507",
      "r896"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Return to provision adjustements",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Term",
        "terseLabel": "Scheduled maturity date",
        "verboseLabel": "Debt instrument term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State taxes, net of federal benefit",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Current",
        "verboseLabel": "Deferred revenue",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r416"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "documentation": "Percentage of principal amount of debt redeemed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "terseLabel": "Research and development tax credits",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToDevelopSoftware",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 35.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Develop Software",
        "negatedLabel": "Acquisition of software and content",
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://formelife.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Option to Extend",
        "terseLabel": "lessee, Operating Lease, option to extend",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Options exercisable",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r896",
      "r952"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue",
        "negatedTotalLabel": "Total cost of revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r247",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r559",
      "r916"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Domain]",
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_WarrantOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WarrantOutstanding",
     "presentation": [
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Outstanding",
        "periodStartLabel": "Outstanding warrant, Beginning balance",
        "periodEndLabel": "Outstanding warrant, Ending balance",
        "documentation": "Warrant outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedFourMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Four [Member]",
        "terseLabel": "Series\u00a0Seed-4 [Member]",
        "documentation": "Series seed 4"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLimitationsOnUse",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards, Limitations on Use",
        "terseLabel": "Operating Loss Carryforwards, Limitations on Use",
        "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories, net",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r211",
      "r224",
      "r327",
      "r328",
      "r330",
      "r617",
      "r813"
     ]
    },
    "us-gaap_InterestRevenueExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRevenueExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Revenue (Expense), Net",
        "terseLabel": "Interest (expense)",
        "documentation": "Amount of interest revenue (income derived from investments in debt securities and on cash and cash equivalents) net of interest expense (cost of borrowed funds accounted for as interest)."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "trnr_SeriesSeedFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedFiveMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Five [Member]",
        "terseLabel": "Series\u00a0Seed-5 [Member]",
        "documentation": "Series\u00a0seed-5."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesAFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesAFinancingMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Financing [Member]",
        "documentation": "Series A financing."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_WarrantsMeasurementDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WarrantsMeasurementDiscountRate",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Measurement Discount Rate",
        "terseLabel": "Warrants measurement discount rate",
        "documentation": "Warrants measurement discount rate."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ClassOfWarrantsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ClassOfWarrantsIssued",
     "presentation": [
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrants Issued",
        "terseLabel": "Warrants issued",
        "documentation": "Class of warrants issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 51.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from the exercise of warrants",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r603",
      "r604",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r737",
      "r739",
      "r771",
      "r967"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Fair value of common stock for awards granted",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of total revenue",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r53",
      "r102",
      "r103",
      "r311"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Recently Issued Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Expense",
        "verboseLabel": "Maximum total royalty payments",
        "terseLabel": "Royalty Expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 37.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "trnr_ClassOfWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ClassOfWarrantsExercised",
     "presentation": [
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrants Exercised",
        "terseLabel": "Warrants exercised",
        "documentation": "Class of warrants exercised."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows From Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 32.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r621"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From Investing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r147",
      "r148"
     ]
    },
    "trnr_FairValueAdjustmentsOfSimpleAgreementsForFutureEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueAdjustmentsOfSimpleAgreementsForFutureEquity",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Adjustments Of Simple Agreements for Future Equity",
        "terseLabel": "Fair value adjustments of simple agreements for future equity",
        "documentation": "Fair value adjustments of simple agreements for future equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows From Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "totalLabel": "Total revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r247",
      "r292",
      "r293",
      "r301",
      "r304",
      "r305",
      "r309",
      "r310",
      "r311",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r559",
      "r641",
      "r916"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r302",
      "r306",
      "r308",
      "r817"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r335",
      "r621",
      "r625"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946"
     ]
    },
    "trnr_EquityValuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "EquityValuePercentage",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Value Percentage",
        "terseLabel": "Equity value, FV-NI",
        "documentation": "Equity value percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions",
        "totalLabel": "Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions, Total",
        "documentation": "Amount of fees and commissions from banking, advisory, brokerage, and securities underwriting activities. Activities include, but are not limited to, underwriting securities, private placements of securities, investment advisory and management services, merger and acquisition services, sale and servicing of mutual funds, and other related consulting fees."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Issuance of convertible notes",
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_RoyaltyIncomeNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RoyaltyIncomeNonoperating",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Income, Nonoperating",
        "terseLabel": "Licensing and royalty income",
        "documentation": "Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "terseLabel": "Class A Common Stock [Member]",
        "verboseLabel": "Class A Common Shares",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r62"
     ]
    },
    "trnr_DebtInstrumentMeasurementDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DebtInstrumentMeasurementDiscountRate",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Measurement Discount Rate",
        "terseLabel": "Debt instrument measurement discount rate",
        "documentation": "Debt instrument measurement discount rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansAndLeasesReceivableRelatedPartiesAdditions",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans and Leases Receivable, Related Parties, Additions",
        "terseLabel": "Loans outstanding from relate parties",
        "documentation": "Reflects the amount of new advances made to related parties in the form of loan and lease receivables."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r112"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471"
     ]
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Series A-2 preferred stock, net of issuance costs",
        "documentation": "Value of new stock classified as temporary equity issued during the period."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfConvertibleNotesInToPreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Conversion of Convertible Notes in to Preferred Stock",
        "negatedLabel": "Conversion of convertible notes into Series A preferred stock",
        "documentation": "Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, conversion of convertible notes in to preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesInToCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement with Unobservable Inputs Reconciliations Recurring Basis Liability Conversion of Convertible Notes in to Common Stock",
        "negatedLabel": "Conversion of convertible notes into common stock",
        "documentation": "Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of convertible notes into common stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CumulativeNetSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CumulativeNetSales",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Net Sales",
        "terseLabel": "Cumulative net sales",
        "documentation": "Cumulative Net Sales"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExerciseOfStockWarrants",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement with Unobservable Inputs Reconciliations Recurring Basis Liability Exercise of Stock Warrants",
        "negatedLabel": "Exercise of stock warrants",
        "documentation": "Fair value measurement with unobservable inputs reconciliations recurring basis liability exercise of stock warrants."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangesInEstimatedFairValueOfFinancialInstruments",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Changes in Estimated Fair Value of Financial Instruments",
        "negatedLabel": "Change in estimated fair value of financial instruments",
        "documentation": "Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, changes in estimated fair value of financial instruments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfAsasIntoCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Conversion Of ASAs Into Common Stock",
        "terseLabel": "Conversion of ASAs into common stock",
        "documentation": "Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of asas into common stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfSafesIntoSeriesSeedPreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Conversion Of SAFEs Into Series Seed Preferred Stock",
        "terseLabel": "Conversion of SAFEs into series seed preferred stock",
        "documentation": "Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of safes into series seed preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityConversionOfConvertibleNotesIntoSeriesAPreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Conversion Of Convertible Notes Into Series A Preferred Stock",
        "terseLabel": "Conversion of convertible notes into Series A preferred stock",
        "documentation": "Fair value measurement with unobservable inputs reconciliations recurring basis liability conversion of convertible notes into series a preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Operating Lease Liability To Be Paid After Year Four",
        "terseLabel": "Thereafter",
        "documentation": "Lessee operating lease liability to be paid after year four."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PercentageOfCumulativeNetSales": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PercentageOfCumulativeNetSales",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Cumulative Net Sales",
        "terseLabel": "Percentage of cumulative net sales",
        "documentation": "Percentage of cumulative net sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionByUniqueDescriptionAxis",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion Description [Axis]",
        "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r47"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and\u00a0Off-Balance\u00a0Sheet Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r192"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 32.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 13)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r111",
      "r646",
      "r718"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r609"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense), net:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Net operating loss carryforwards - Foreign",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r950"
     ]
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Redemption Price Per Share",
        "terseLabel": "Temporary equity, redemption price per share",
        "verboseLabel": "Price\u00a0per\u00a0Share",
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r71"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/LeasesAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use-assets",
        "definitionGuidance": "Operating lease, right-of-use asset",
        "terseLabel": "Right of use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedRoyaltiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued royalties",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r811"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Net operating loss carryforwards - Federal",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r950"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Net operating loss carryforwards - State",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r950"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r950"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r443"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RedeemableNoncontrollingInterestEquityPreferredCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 33.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount",
        "terseLabel": "Convertible preferred stock",
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r75"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization expenses",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r65"
     ]
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Conversion Description [Axis]",
        "documentation": "Information by description of stock conversions."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r361",
      "r362",
      "r372",
      "r373",
      "r374",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829"
     ]
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Aggregate Amount of Redemption Requirement",
        "verboseLabel": "Net\u00a0Carrying\u00a0Value",
        "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 28.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes Payable, Current",
        "terseLabel": "Convertible note payable",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Temporary equity, shares issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r950"
     ]
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r247",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r519",
      "r522",
      "r523",
      "r559",
      "r717",
      "r816",
      "r862",
      "r916",
      "r968",
      "r969"
     ]
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "verboseLabel": "Convertible Preferred Stock Shares Issued Upon Conversion",
        "terseLabel": "Convertible notes converted into preferred stock",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r76",
      "r124",
      "r163",
      "r398"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities, fair value disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r389"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock expressed as a percentage of its fair value",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]"
       }
      }
     },
     "auth_ref": [
      "r206",
      "r254",
      "r256",
      "r258",
      "r259",
      "r262",
      "r263",
      "r271",
      "r287",
      "r503",
      "r540",
      "r544",
      "r545",
      "r583",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r675",
      "r873",
      "r875",
      "r876",
      "r877",
      "r900",
      "r906",
      "r907",
      "r957",
      "r964",
      "r965"
     ]
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityLiquidationPreference",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Temporary equity, liquidation preference",
        "verboseLabel": "Liquidation Preference",
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r508"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityByClassOfStockTable",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, by Class of Stock [Table]",
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r71"
     ]
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, fair value disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://formelife.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Loss Per Share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Temporary equity, par or stated value per share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r71"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Temporary equity, shares authorized",
        "verboseLabel": "Shares\u00a0Authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsExpirationDate",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards, Expiration Date",
        "terseLabel": "Operating Loss Carryforwards, Expiration Date",
        "documentation": "Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r719"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "verboseLabel": "Preferred stock shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r719",
      "r738",
      "r985",
      "r986"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r508"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Outstanding",
        "terseLabel": "Temporary equity, shares outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares",
        "verboseLabel": "Shares\u00a0Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_PreferredStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockVotingRights",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Voting Rights",
        "terseLabel": "Preferred stock, voting rights",
        "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r124"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity (deficit)",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r182",
      "r651",
      "r849",
      "r895",
      "r905",
      "r960"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CooperativeAdvertisingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CooperativeAdvertisingAmount",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cooperative Advertising Amount",
        "terseLabel": "unamortized cost of content",
        "documentation": "Total amount received by an entity from a vendor under a cooperative advertising arrangement that has been offset against advertising expense."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r701",
      "r703",
      "r704",
      "r705",
      "r708",
      "r772",
      "r774",
      "r776",
      "r779",
      "r780",
      "r788",
      "r789",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r853"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r389"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent, Total",
        "terseLabel": "Total",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liability",
        "terseLabel": "Warrant liabilities",
        "verboseLabel": "Fair value of warrants",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r558",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r709",
      "r710",
      "r733",
      "r735",
      "r736",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r812",
      "r982"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://formelife.com/role/RevenueRecognition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r417"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "negatedLabel": "Foreign currency",
        "terseLabel": "Foreign currency transaction gains or losses",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r761"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Lines of Credit",
        "terseLabel": "Repayments of senior secured notes",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r894"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 22.0
      },
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Adjustment of Warrants",
        "negatedLabel": "Change in fair value of warrants",
        "terseLabel": "Change in fair value of warrants",
        "verboseLabel": "Fair value of warrants",
        "definitionGuidance": "Fair value adjustment of warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r9"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r362"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r62",
      "r621"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Identifiable Intangible Assets, Net",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r62"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r825",
      "r959"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Unvested, aggregate intrinsic value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r896",
      "r951",
      "r952"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IPOMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO [Member]",
        "terseLabel": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r896",
      "r951"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred expense:",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r171",
      "r198",
      "r506",
      "r507",
      "r896"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r253",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r372",
      "r373",
      "r374",
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r579",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r894"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r68"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Related Party Debt",
        "terseLabel": "Payment made to related party",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://formelife.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Potentially Dilutive Shares",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "trnr_LicenseFeePayablePerQuarter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "LicenseFeePayablePerQuarter",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License Fee Payable Per Quarter",
        "terseLabel": "Licence fee payable per quarter",
        "documentation": "License fee payable per quarter."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ClassACommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ClassACommonWarrantsMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Warrants [member]",
        "terseLabel": "Class A Common Warrants",
        "documentation": "Class A Common Warrants [member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RemeasurementLossOfSimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement Loss of Simple Agreements for Future Equity and Advance Subscription Agreements",
        "terseLabel": "Remeasurement loss of simple agreements for future equity and advance subscription agreements",
        "documentation": "Remeasurement loss of simple agreements for future equity and advance subscription agreements."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PromissoryNotesMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Notes [Member]",
        "terseLabel": "Promissory Notes",
        "documentation": "Promissory Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Step-up interest rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      },
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Finished Goods, Gross",
        "verboseLabel": "Inventories, net",
        "terseLabel": "Finished goods",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/BenefitPlansAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Benefit plans cost",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r435",
      "r840",
      "r841"
     ]
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityTableTextBlock",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Disclosure of Temporary Equity",
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r71"
     ]
    },
    "trnr_PropertyAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PropertyAndEquipmentMember",
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesGross",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures",
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "trnr_PrepaidLicenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PrepaidLicenses",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Licenses",
        "terseLabel": "Prepaid licenses",
        "documentation": "Prepaid licenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities",
        "terseLabel": "Due to Related Parties",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r643",
      "r713",
      "r714",
      "r862",
      "r983"
     ]
    },
    "trnr_DebtInstrumentInterestRateStatedPercentageAdditional": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DebtInstrumentInterestRateStatedPercentageAdditional",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Interest Rate Stated Percentage, Additional Accrued Rate",
        "terseLabel": "Additional Percentage",
        "documentation": "Debt Instrument Interest Rate Stated Percentage, Additional Accrued Rate"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NetExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NetExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Exercise of Options",
        "terseLabel": "Net exercise of options",
        "documentation": "Net exercise of options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r550",
      "r554"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Deposit",
        "terseLabel": "Security deposits",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "trnr_IdentifiableIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IdentifiableIntangibleAssetsMember",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Identifiable Intangible Assets [Member]",
        "terseLabel": "Identifiable Intangible Assets",
        "documentation": "Identifiable intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Adjustment",
        "terseLabel": "Change in fair value adjustment",
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_StockIssuedDuringPeriodValueWarrantsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period Value Warrants Exercised",
        "terseLabel": "Exercise of stock warrants",
        "documentation": "Stock issued during period value warrants exercised."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FounderNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FounderNotesMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Founder Notes [Member]",
        "terseLabel": "Founder Notes",
        "documentation": "Founder notes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_BridgeNoteFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "BridgeNoteFinancingMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bridge Note Financing [Member]",
        "documentation": "Bridge Note Financing."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_AccruedInterestAndDefaultInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AccruedInterestAndDefaultInterest",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Interest And Default Interest",
        "terseLabel": "Accrued interest and default interest",
        "documentation": "Accrued interest and default interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "trnr_DebtInstrumentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DebtInstrumentFeePercentage",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Fee Percentage",
        "terseLabel": "Fee Percentage",
        "documentation": "Debt Instrument Fee Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes [Member]",
        "verboseLabel": "Senior Secured Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CapitalizedStudioContentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CapitalizedStudioContentMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Studio Content [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ClassBCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ClassBCommonWarrantsMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Warrants [member]",
        "terseLabel": "Class B Common Warrants",
        "documentation": "Class B Common Warrants [member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IncomeTaxesReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IncomeTaxesReceivables",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes Receivables",
        "terseLabel": "Income tax receivable",
        "documentation": "Income taxes receivables."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplierConcentrationRiskMember",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk [Member]",
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "trnr_InternalUseSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "InternalUseSoftwareMember",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetScheduleOfIdentifiableIntangibleAssetsNetDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Internal Use Software [Member]",
        "terseLabel": "Internal-Use Software",
        "documentation": "Internal use software member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_OtherRelatedPartyPromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "OtherRelatedPartyPromissoryNotesMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Related Party Promissory Notes [Member]",
        "terseLabel": "Other Related Party Promissory Notes",
        "documentation": "Other related party promissory notes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Convertible Preferred Stock [Member]",
        "verboseLabel": "Series Seed convertible preferred stock [Member]",
        "terseLabel": "Series Seed Convertible Preferred Stock",
        "documentation": "Series Seed convertible preferred stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_MembershipRevenue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "MembershipRevenue1",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Membership revenue1",
        "terseLabel": "Membership revenue",
        "documentation": "Membership revenue."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CostOfTraining": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CostOfTraining",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Of Training",
        "negatedLabel": "Cost of training",
        "documentation": "Cost of training."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_GainUponDebtForgiveness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "GainUponDebtForgiveness",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain Upon Debt Forgiveness",
        "negatedLabel": "Gain upon debt forgiveness",
        "documentation": "Gain upon debt forgiveness"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ApeironAdvisoryLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ApeironAdvisoryLtdMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Apeiron Advisory Ltd [Member]",
        "terseLabel": "Apeiron Advisory Ltd",
        "documentation": "Apeiron Advisory Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_MusicGuaranteesDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "MusicGuaranteesDeposits",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Music Guarantees Deposits",
        "terseLabel": "Music guarantees deposits",
        "documentation": "Music guarantees deposits."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ChangeInFairValuesOfSimpleAgreementsForFutureEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ChangeInFairValuesOfSimpleAgreementsForFutureEquity",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 23.0
      },
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 31.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Values of Simple Agreements for Future Equity",
        "negatedLabel": "Change in fair value of SAFEs",
        "terseLabel": "Change in fair value of SAFEs",
        "documentation": "Change in fair values of simple agreements for future equity."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_OtherRelatedPartyTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "OtherRelatedPartyTransactionsMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Related Party Transactions [Member]",
        "terseLabel": "Other Related Party Transactions",
        "documentation": "Other related party transactions."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesA1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesA1PreferredStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A-1 preferred stock [Member]",
        "terseLabel": "Series A-1 [Member]",
        "documentation": "Series A-1 Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_GainLossOnChangeInFairValueOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "GainLossOnChangeInFairValueOfConvertibleNotes",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 21.0
      },
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain Loss On Change In Fair Value Of Convertible Notes",
        "terseLabel": "Change in fair value of convertible notes",
        "negatedLabel": "Change in fair value of convertible notes",
        "documentation": "Gain loss on change in fair value of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Intangible assets impairment",
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PrincipalStockholderPromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PrincipalStockholderPromissoryNotesMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal Stockholder Promissory Notes[Member]",
        "terseLabel": "Principal Stockholder Promissory Notes",
        "documentation": "Principal Stockholder Promissory Notes[Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FuseprojectMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FuseprojectMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fuseproject [Member]",
        "terseLabel": "Fuseproject",
        "documentation": "Fuseproject [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NoninterestBearingNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NoninterestBearingNoteMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noninterest Bearing Note [Member]",
        "terseLabel": "Noninterest bearing note",
        "documentation": "Noninterest bearing note."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "trnr_ExtendedProductWarrantyPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ExtendedProductWarrantyPeriod",
     "presentation": [
      "http://formelife.com/role/RevenueRecognitionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extended Product Warranty Period",
        "terseLabel": "Extended product warranty period",
        "documentation": "Extended product warranty period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net",
        "totalLabel": "Total inventories, net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r809",
      "r849"
     ]
    },
    "trnr_TrainingRevenue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TrainingRevenue1",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Training Revenue1",
        "terseLabel": "Training revenue",
        "documentation": "Training revenue."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SimpleAgreementsForFutureEquitySafesAndAdvanceSubscriptionAgreementMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Simple Agreements For Future Equity SAFES And Advance Subscription Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_FitnessProductRevenue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FitnessProductRevenue1",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fitness Product Revenue1",
        "terseLabel": "Fitness product revenue",
        "documentation": "Fitness product revenue."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "trnr_ContentLicensingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ContentLicensingAgreementMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Content Licensing Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PercentageOfRecognitionOfTaxBenefitsDuringIncomeTaxExaminationForUncertainTaxPositions",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Recognition of Tax Benefits During Income Tax Examination for Uncertain Tax Positions",
        "terseLabel": "Percentage of recognition of tax benefits during income tax examination for uncertain tax positions",
        "documentation": "Percentage of recognition of tax benefits during income tax examination for uncertain tax positions."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Arrangement, three Percentage of Cumulative Net Sales up to 5 Million [Member]",
        "documentation": "Royalty Arrangement, three Percentage of cumulative net sales up to 5 million."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://formelife.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Annual Amortization Expense",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r219",
      "r220",
      "r221",
      "r247",
      "r277",
      "r278",
      "r281",
      "r283",
      "r289",
      "r290",
      "r316",
      "r351",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r389",
      "r390",
      "r392",
      "r395",
      "r402",
      "r559",
      "r678",
      "r679",
      "r680",
      "r681",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r719",
      "r741",
      "r764",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r867",
      "r893",
      "r902"
     ]
    },
    "trnr_ContingentRoyaltyObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ContingentRoyaltyObligation",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Royalty Obligation",
        "terseLabel": "Contingent Royalty Obligation",
        "documentation": "Contingent royalty obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "trnr_CostOfFitnessProductRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CostOfFitnessProductRevenue",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Of Fitness Product Revenue",
        "negatedLabel": "Cost of fitness product revenue",
        "documentation": "Cost of fitness product revenue."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PreProductionToolingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PreProductionToolingMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Production Tooling [Member]",
        "terseLabel": "Pre - Production Tooling [Member]",
        "documentation": "Pre Production Tooling."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_DefaultInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DefaultInterest",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Default Interest",
        "terseLabel": "Default interest",
        "documentation": "Default interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r578",
      "r828",
      "r829",
      "r892"
     ]
    },
    "trnr_RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Arrangement, One Percentage of Cumulative Net Sales above 5 Million [Member]",
        "terseLabel": "Royalty Arrangement, One Percentage of Cumulative Net Sales above 5 Million",
        "documentation": "Royalty arrangement, one percentage of cumulative net sales above 5 Million."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_GuaranteedRoyaltyPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "GuaranteedRoyaltyPayment",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guaranteed Royalty Payment",
        "terseLabel": "Guaranteed Royalty payment",
        "documentation": "Guaranteed royalty payment."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTable",
     "presentation": [
      "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Simple Agreements for Future Equity and Advance Subscription Agreements [Table]",
        "documentation": "Simple agreements for future equity and advance subscription agreements."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_RoyaltyPaymentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RoyaltyPaymentPercentage",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Payment Percentage",
        "terseLabel": "Royalty Payment Percentage",
        "documentation": "Royalty payment percentage."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CostOfMembership": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CostOfMembership",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Of Membership",
        "negatedLabel": "Cost of membership",
        "documentation": "Cost of membership."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r550",
      "r554"
     ]
    },
    "trnr_AgreementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AgreementAxis",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreement [Axis]",
        "documentation": "Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsLineItems",
     "presentation": [
      "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Simple Agreements for Future Equity and Advance Subscription Agreements [Line Items]",
        "documentation": "Simple agreements for future equity and advance subscription agreements."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PreProductionTooling": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PreProductionTooling",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Production Tooling",
        "terseLabel": "Pre-production tooling",
        "documentation": "Pre-Production Tooling"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r339",
      "r341",
      "r342"
     ]
    },
    "trnr_CostOfMembershipAndTraining": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CostOfMembershipAndTraining",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Of Membership And Training",
        "negatedLabel": "Cost of membership and training",
        "documentation": "Cost of membership\u00a0and training."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_AgreementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AgreementDomain",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreement [Domain]",
        "documentation": "Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SimpleAgreementsForFutureEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SimpleAgreementsForFutureEquityMember",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Simple Agreements for Future Equity [Member]",
        "terseLabel": "Simple Agreements for Future Equity [Member]",
        "verboseLabel": "SAFE Liability [Member]",
        "documentation": "Simple agreements for future equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_LeadNoteholderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "LeadNoteholderMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "67 Lead Noteholder [Member]",
        "documentation": "67 Lead Noteholder ."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization",
        "verboseLabel": "Amortization expense",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r59",
      "r63"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "terseLabel": "Stock based compensation",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r870",
      "r948"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r265",
      "r272",
      "r287",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r337",
      "r478",
      "r479",
      "r480",
      "r500",
      "r501",
      "r502",
      "r503",
      "r513",
      "r514",
      "r515",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r556",
      "r557",
      "r560",
      "r561",
      "r562",
      "r563",
      "r576",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r622",
      "r623",
      "r624",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r675"
     ]
    },
    "trnr_NotePurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NotePurchaseAgreementMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Purchase Agreement [Member]",
        "terseLabel": "June 2023 Notes [Member]",
        "documentation": "Note purchase agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://formelife.com/role/InventoriesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r131",
      "r132",
      "r133"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r173"
     ]
    },
    "trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Simple Agreements for Future Equity and Advance Subscription Agreements [Policy Text Block]",
        "terseLabel": "Simple Agreements for Future Equity (\"SAFES\") and Advance Subscription Agreements (\"ASAs\")",
        "documentation": "Simple Agreements for Future Equity and Advance Subscription Agreements."
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r311",
      "r833",
      "r920",
      "r979",
      "r980"
     ]
    },
    "trnr_OtherNoteholderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "OtherNoteholderMember",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "60 Other Noteholder [Member]",
        "documentation": "60 Other noteholder."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r265",
      "r272",
      "r287",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r337",
      "r478",
      "r479",
      "r480",
      "r500",
      "r501",
      "r502",
      "r503",
      "r513",
      "r514",
      "r515",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r556",
      "r557",
      "r560",
      "r561",
      "r562",
      "r563",
      "r576",
      "r577",
      "r580",
      "r581",
      "r582",
      "r583",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r622",
      "r623",
      "r624",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r675"
     ]
    },
    "trnr_DeferredOfferingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DeferredOfferingCostsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Offering Costs [Policy Text Block]",
        "terseLabel": "Deferred Offering Costs",
        "documentation": "Disclosure of accounting policy for deferred offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NoncashActivityDeferredCostsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NoncashActivityDeferredCostsIncurred",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Activity Deferred Costs Incurred",
        "terseLabel": "Deferred offering\u00a0costs",
        "documentation": "Noncash Activity Deferred Costs Incurred."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CapitalizedSoftwareAndContentInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CapitalizedSoftwareAndContentInAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Software and Content in Accounts Payable",
        "terseLabel": "Capitalized software and content in AP",
        "documentation": "Capitalized Software and Content in Accounts Payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://formelife.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "weighted average discount rate for operating leases",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r593",
      "r848"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAmortizationOfDeferredCharges",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Other Deferred Charges",
        "terseLabel": "Amortization expense",
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r140"
     ]
    },
    "trnr_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAccountingStandardAdoption842Adoption",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability Upon Accounting Standard Adoption 842 Adoption",
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities upon ASC 842 adoption",
        "documentation": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability Upon Accounting Standard Adoption 842 Adoption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "terseLabel": "Stock based compensation",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r870",
      "r948"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
        "documentation": "Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value."
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "trnr_NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NoncashTransactionIssuanceOfCommonStockInConnectionWithExerciseOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Transaction Issuance of Common Stock in Connection with Exercise of Warrants",
        "terseLabel": "Issuance of common stock in connection with exercise of warrants",
        "documentation": "Noncash Transaction Issuance of Common Stock in Connection with Exercise of Warrants."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NoncashTransactionIssuanceOfWarrantsInConnectionWithSeriesA",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Transaction Issuance of Warrants in Connection with Series A",
        "terseLabel": "Issuance of warrants in connection with Series A",
        "documentation": "Noncash Transaction Issuance of Warrants in Connection with Series A."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ConversionOfConvertibleSimpleAgreementsForFutureEquityToSeriesSeedSharesMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Convertible Simple Agreements for Future Equity to Series Seed Shares [Member]",
        "documentation": "Conversion of Convertible Simple Agreements for Future Equity to Series Seed Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r550",
      "r611",
      "r612",
      "r613",
      "r826",
      "r827",
      "r838",
      "r839",
      "r840"
     ]
    },
    "trnr_ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ConversionOfConvertibleSimpleAgreementsForFutureEquityToCommonStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Convertible Simple Agreements for Future Equity to Common Stock [Member]",
        "documentation": "Conversion of Convertible Simple Agreements for Future Equity to Common Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ConversionOfPreferredStockToClassACommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ConversionOfPreferredStockToClassACommonStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Preferred Stock to Class A Common Stock [Member]",
        "documentation": "Conversion of Preferred Stock to Class A Common Stock."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreementsTextBlock",
     "presentation": [
      "http://formelife.com/role/SimpleAgreementsForFutureEquityAndAdvanceSubscriptionAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Simple Agreements for Future Equity and Advance Subscription Agreements [Text Block]",
        "terseLabel": "Simple Agreements for Future Equity and Advance Subscription Agreements",
        "documentation": "Simple agreements for future equity and advance subscription agreements."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses and Other Current Assets Disclosure [Abstract]",
        "documentation": "Prepaid expenses and other current assets disclosure abstract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "trnr_PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsDisclosureTextblock",
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses and Other Current Assets Disclosure [TextBlock]",
        "terseLabel": "Prepaid Expenses and Other Current Assets",
        "documentation": "Prepaid expenses and other current assets disclosure textBlock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "trnr_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Disclosure [Text Block]",
        "terseLabel": "Warrants",
        "documentation": "Disclosure of warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "trnr_VendorDepositPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "VendorDepositPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendor Deposit [Policy Text Block]",
        "terseLabel": "Vendor Deposits",
        "documentation": "Vendor Deposit policy ."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r550",
      "r552",
      "r553",
      "r555"
     ]
    },
    "trnr_CostOfFitnessProductRevenuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CostOfFitnessProductRevenuePolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Fitness Product Revenue [Policy Text Block]",
        "terseLabel": "Cost of Fitness Product Revenue",
        "documentation": "Cost of Fitness Product Revenue."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "terseLabel": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r251",
      "r603",
      "r604",
      "r605",
      "r606",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r737",
      "r739",
      "r771"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsScheduleOfLoanPayableDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r603",
      "r604",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r737",
      "r739",
      "r771"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Grants in period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024/2023",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "trnr_ContentLicensingAgreementPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ContentLicensingAgreementPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Content Licensing Agreement [Policy Text Block]",
        "terseLabel": "Content Licensing Agreement",
        "documentation": "Content Licensing Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CostOfMembershipAndTrainingPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CostOfMembershipAndTrainingPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Membership and Training [Policy Text Block]",
        "terseLabel": "Cost of Membership and Training",
        "documentation": "Cost of Membership and Training."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "trnr_WarrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WarrantsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Policy Text Block]",
        "terseLabel": "Warrants",
        "documentation": "Disclosure of accounting policy for warrants."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CapitalizedStudioContentPolicytextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CapitalizedStudioContentPolicytextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Studio Content [PolicyText Block]",
        "terseLabel": "Capitalized Studio Content",
        "documentation": "Capitalized studio content policy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "trnr_MusicRoyaltyFeesPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "MusicRoyaltyFeesPolicyPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Music Royalty Fees Policy [Policy Text Block]",
        "terseLabel": "Music Royalty Fees",
        "documentation": "Music royalty fees policy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027/2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "trnr_ConvertibleNotesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ConvertibleNotesPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes [Policy Text Block]",
        "terseLabel": "Convertible Notes",
        "documentation": "Disclosure of accounting policy for convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r851",
      "r852",
      "r853",
      "r855",
      "r856",
      "r857",
      "r858",
      "r897",
      "r898",
      "r956",
      "r981",
      "r985"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Disclosure of the components of deferred tax assets (liabilities)",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants contractual term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026/2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025/2024",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 (remaining)",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://formelife.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r610"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments under Operating Leases",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "trnr_ServiceProvidersStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ServiceProvidersStockWarrantsMember",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service Providers Stock Warrants [Member]",
        "terseLabel": "Service Providers Stock Warrants [Member]",
        "documentation": "Service providers stock warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r804"
     ]
    },
    "trnr_ClassBCommonStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ClassBCommonStockWarrantsMember",
     "presentation": [
      "http://formelife.com/role/WarrantsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Stock Warrants [Member]",
        "terseLabel": "Class B Common Stock Warrants [Member]",
        "documentation": "Class B common stock warrants."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLivesOfAssetsTableTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment Estimated Useful Lives Of Assets [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "documentation": "Property Plant And Equipment Estimated Useful Lives Of Assets [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for issuance under share-based payment arrangement",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "trnr_ClassACommonStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ClassACommonStockWarrantsMember",
     "presentation": [
      "http://formelife.com/role/WarrantsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Stock Warrants [Member]",
        "terseLabel": "Class A Common Stock Warrants [Member]",
        "documentation": "Class A common stock warrants."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeniorSecuredNotesStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeniorSecuredNotesStockWarrantsMember",
     "presentation": [
      "http://formelife.com/role/WarrantsAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsScheduleOfChangesInWarrantsIssuedAndOutstandingDetails",
      "http://formelife.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Secured Notes Stock Warrants [Member]",
        "terseLabel": "Senior Secured Notes Stock Warrants [Member]",
        "documentation": "Senior secured notes stock warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "verboseLabel": "Exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r849",
      "r984"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "verboseLabel": "Additional Paid In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r480",
      "r688",
      "r897",
      "r898",
      "r899",
      "r956",
      "r985"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of options, Cancelled or forfeited",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value per option",
        "verboseLabel": "Weighted average exercise price, Issued",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313"
     ]
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding, aggregate intrinsic value, outstanding",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodStartLabel": "Number of options, Outstanding as of December 31, 2022",
        "periodEndLabel": "Number of options, Outstanding as of September 30, 2023",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r450"
     ]
    },
    "us-gaap_TaxCreditCarryforwardExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardExpirationDate",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Expiration Date",
        "terseLabel": "Tax Credit Carryforward, Expiration Date",
        "documentation": "Expiration date of the tax credit carryforward, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodStartLabel": "Outstanding as of December 31, 2022",
        "periodEndLabel": "Outstanding as of September 30, 2023",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r450"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable as of September 30, 2023",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Options exercisable as of September 30, 2023",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Profit",
        "totalLabel": "Gross loss",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r247",
      "r291",
      "r302",
      "r306",
      "r308",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r559",
      "r817",
      "r916"
     ]
    },
    "us-gaap_ContractTerminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractTerminationMember",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Termination [Member]",
        "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": [
      "r821",
      "r822",
      "r823",
      "r824"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Expected dividend rate",
        "terseLabel": "Expected dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r339",
      "r341",
      "r342"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Weighted-average expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r485",
      "r490",
      "r491",
      "r497",
      "r504",
      "r510",
      "r511",
      "r512",
      "r683"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Identifiable Intangible Assets",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r57"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Weighted-average risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r470"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r742",
      "r807",
      "r814"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Insurance",
        "terseLabel": "Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r820",
      "r908"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred expense:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r217",
      "r247",
      "r291",
      "r303",
      "r307",
      "r316",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r518",
      "r522",
      "r559",
      "r645",
      "r732",
      "r849",
      "r862",
      "r916",
      "r917",
      "r968"
     ]
    },
    "us-gaap_OtherCommitmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfCompensationCostRecognizedDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r486",
      "r487",
      "r491",
      "r492",
      "r496",
      "r498",
      "r677"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r35",
      "r205",
      "r234",
      "r235",
      "r236",
      "r254",
      "r255",
      "r256",
      "r259",
      "r269",
      "r271",
      "r288",
      "r320",
      "r326",
      "r404",
      "r478",
      "r479",
      "r480",
      "r502",
      "r503",
      "r527",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r544",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r599",
      "r664",
      "r665",
      "r666",
      "r688",
      "r764"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 42.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from senior secured notes",
        "verboseLabel": "Senior secured notes issued",
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Accumulated Deficit",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r254",
      "r255",
      "r256",
      "r259",
      "r269",
      "r271",
      "r320",
      "r326",
      "r478",
      "r479",
      "r480",
      "r502",
      "r503",
      "r527",
      "r530",
      "r531",
      "r534",
      "r544",
      "r664",
      "r666",
      "r688",
      "r985"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss2Unaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive loss",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r230",
      "r232",
      "r238",
      "r639",
      "r658"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs",
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r53",
      "r102",
      "r103",
      "r311",
      "r802",
      "r872"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r205",
      "r234",
      "r235",
      "r236",
      "r254",
      "r255",
      "r256",
      "r259",
      "r269",
      "r271",
      "r288",
      "r320",
      "r326",
      "r404",
      "r478",
      "r479",
      "r480",
      "r502",
      "r503",
      "r527",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r544",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r599",
      "r664",
      "r665",
      "r666",
      "r688",
      "r764"
     ]
    },
    "us-gaap_CostOfGoodsTotalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsTotalMember",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Service Benchmark [Member]",
        "terseLabel": "Finished Goods Purchased [Member]",
        "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Income) Loss",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r13",
      "r37",
      "r529",
      "r532",
      "r599",
      "r664",
      "r665",
      "r886",
      "r887",
      "r888",
      "r897",
      "r898",
      "r899"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfUnvestedCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of options, Granted",
        "verboseLabel": "Issued",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 47.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from the exercise of common stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r19"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Federal statutory rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendors"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentration of Credit Risk and Major Customers and Vendors",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign tax rate differential",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 22.0
      },
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses and other current liabilities",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common stock outstanding - diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r283"
     ]
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Impairment loss",
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value."
       }
      }
     },
     "auth_ref": [
      "r892",
      "r911"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment write-off",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r64"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 41.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Stock Issuance Costs",
        "verboseLabel": "Issuance costs",
        "negatedLabel": "Payments of offering costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleNotesPayableMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes Payable [Member]",
        "verboseLabel": "Convertible Notes [Member]",
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r177"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of stock",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r124",
      "r125",
      "r165",
      "r688",
      "r764",
      "r797",
      "r861"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r555"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common stock outstanding - basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r283"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants issued",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Table]",
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r350",
      "r914",
      "r915"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of Class B common stock upon exercise of stock options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r35",
      "r165"
     ]
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Issuance of Common stock upon conversion of convertible notes",
        "verboseLabel": "Stock issued during period, value, conversion of convertible securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r35",
      "r165"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity (deficit)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of stock, shares",
        "verboseLabel": "Stock issued during period, shares, new issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r124",
      "r125",
      "r165",
      "r678",
      "r764",
      "r797"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share - diluted",
        "verboseLabel": "Net loss per share attributable to common stockholders - diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r262",
      "r263",
      "r265",
      "r266",
      "r268",
      "r277",
      "r281",
      "r282",
      "r283",
      "r287",
      "r545",
      "r546",
      "r640",
      "r659",
      "r815"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r350",
      "r914",
      "r915"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Common stock, warrant",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://formelife.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, operating lease, term of contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "Stockholders' Deficit",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r246",
      "r388",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r399",
      "r400",
      "r401",
      "r404",
      "r535",
      "r767",
      "r769",
      "r801"
     ]
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://formelife.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "weighted average remaining lease term for operating leases",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r848"
     ]
    },
    "trnr_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period Shares Warrants Exercised",
        "terseLabel": "Exercise of stock warrants (in shares)",
        "verboseLabel": "Stock issued upon exercise of warrants",
        "documentation": "Stock issued during period shares warrants exercised."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "trnr_AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AdjustmentsToAdditionalPaidInCapitalIssuanceOfPromissoryNotesInExchangeForStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital Issuance of Promissory Notes in Exchange for Stock Options",
        "terseLabel": "Issuance of promissory notes in exchange for stock options",
        "documentation": "Adjustments to Additional Paid in Capital Issuance of Promissory Notes in Exchange for Stock Options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, Plant and Equipment, Gross, Total",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r213",
      "r654"
     ]
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/EquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "verboseLabel": "Issuance of Class B common stock upon exercise of stock options, shares",
        "negatedLabel": "Number of options, Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r124",
      "r125",
      "r165",
      "r454"
     ]
    },
    "trnr_IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassBCommonStockUponExerciseOfWarrantsShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class B Common Stock Upon Exercise of Warrants Shares",
        "terseLabel": "Issuance of Class B common stock upon exercise of warrants, shares",
        "documentation": "Issuance of Class B Common Stock Upon Exercise of Warrants Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosure Of Cash Flow Information:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock upon conversion of convertible notes, shares",
        "verboseLabel": "Issuance of common stock upon conversion, shares",
        "definitionGuidance": "Stock issued during period, shares, conversion of convertible securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r34",
      "r76",
      "r165",
      "r377"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      },
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r642",
      "r654",
      "r849"
     ]
    },
    "trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValuesShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares",
        "terseLabel": "Issuance of Series Seed-2-10 preferred stock upon conversion of SAFEs, shares",
        "documentation": "Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values Shares."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfSeriesSeedTwoToTenPreferredStockUponConversionOfSimpleAgreementsForFutureEquityValues",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values",
        "terseLabel": "Issuance of Series Seed-2-10 preferred stock upon conversion of SAFEs",
        "documentation": "Issuance of Series Seed Two to Ten preferred stock upon conversion of Simple Agreements for Future Equity Values."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited",
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails",
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "totalLabel": "Total",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r199",
      "r270",
      "r271",
      "r294",
      "r488",
      "r505",
      "r660"
     ]
    },
    "trnr_IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassBCommonStockUponConversionOfSimpleAgreementsForFutureEquityShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Shares",
        "terseLabel": "Issuance of Class B common stock upon conversion of SAFEs, shares",
        "documentation": "Issuance of Class B Common Stock Upon Conversion of Simple Agreements for Future Equity Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "trnr_IssuanceOfClassACommonStockUponExerciseOfWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IssuanceOfClassACommonStockUponExerciseOfWarrantsShares",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Class A Common Stock Upon Exercise of Warrants Shares",
        "terseLabel": "Issuance of Class\u00a0A common stock upon exercise of warrants, shares",
        "documentation": "Issuance of Class A Common Stock Upon Exercise of Warrants Shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r193",
      "r196",
      "r652"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Write-down",
        "terseLabel": "Inventory valuation loss",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "us-gaap_PaymentsForRestructuring": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRestructuring",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Restructuring",
        "terseLabel": "Payments for restructuring",
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r890"
     ]
    },
    "trnr_SeriesSeedNineConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedNineConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Nine Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 9 Convertible Preferred Stock",
        "documentation": "Series seed nine convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_WarrantsToPurchaseSeriesClassACommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WarrantsToPurchaseSeriesClassACommonStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to Purchase Series Class A Common Stock [Member]",
        "terseLabel": "Warrants to Purchase Series Class A Common Stock",
        "documentation": "Warrants to purchase series class A common stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_StockOptionsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "StockOptionsToPurchaseCommonStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options to Purchase Common Stock [Member]",
        "terseLabel": "Stock Options to Purchase Common Stock",
        "documentation": "Stock options to purchase common stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_WarrantsToPurchaseSeriesClassBCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "WarrantsToPurchaseSeriesClassBCommonStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to Purchase Series Class B Common Stock [Member]",
        "terseLabel": "Warrants to Purchase Series Class B Common Stock",
        "documentation": "Warrants to purchase series class B common stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedTenConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedTenConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Ten Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 10 Convertible Preferred Stock",
        "documentation": "Series seed ten convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses and current liabilities",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "trnr_SeriesSeedEightConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedEightConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Eight Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 8 Convertible Preferred Stock",
        "documentation": "Series seed eight convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedSixConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedSixConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Six Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 6 Convertible Preferred Stock",
        "documentation": "Series seed six convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r896",
      "r951",
      "r952"
     ]
    },
    "trnr_SeriesSeedFourConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedFourConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Four Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 4 Convertible Preferred Stock",
        "documentation": "Series seed four convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entertainment, License Agreement for Program Material, Capitalized Cost",
        "terseLabel": "Content unamortized costs",
        "documentation": "Amount of capitalized cost for right acquired by broadcaster under license agreement for program material."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "trnr_SeriesAOneConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesAOneConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A One Convertible Preferred Stock [Member]",
        "terseLabel": "Series A-1 Convertible Preferred Stock",
        "documentation": "Series A one convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IncometaxreconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafes",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IncomeTaxReconciliation Nontaxable changes in fair value of convertible notes and SAFEs",
        "terseLabel": "Nontaxable changes in fair value of convertible notes and SAFEs",
        "documentation": "IncomeTaxReconciliation nontaxable changes in fair value of convertible notes and safes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NumberOfSignificantVendors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NumberOfSignificantVendors",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Significant Vendors",
        "terseLabel": "Number of vendors",
        "documentation": "Number of significant vendors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails",
      "http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://formelife.com/role/ConcentrationOfCreditRiskAndMajorCustomersAndVendorsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r311"
     ]
    },
    "us-gaap_ForwardContractIndexedToIssuersEquityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForwardContractIndexedToIssuersEquityShares",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Contract Indexed to Issuer's Equity, Shares",
        "terseLabel": "Maximum number of shares that could be issued to net share settle a contract",
        "documentation": "The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and Excise Tax Payable, Current",
        "terseLabel": "Sales tax payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_ForwardContractIndexedToIssuersEquityTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForwardContractIndexedToIssuersEquityTypeDomain",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Contract Indexed to Issuer's Equity, Type [Domain]",
        "documentation": "This element provides a description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock; specifically, the pertinent rights and privileges of the securities outstanding. Does not include forward purchase contracts which would be classified as liabilities under FAS 150."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "trnr_IncomeTaxDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IncomeTaxDisclosureLineItems",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period expected to be recognized",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "trnr_EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "EffectiveIncomeTaxRateReconciliationDisqualifiedDebtPercent",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Disqualified debt, Percent",
        "terseLabel": "Disqualified debt",
        "documentation": "Effective income tax rate reconciliation, disqualified debt, percent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://formelife.com/role/PropertyAndEquipmentNetAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r181",
      "r978"
     ]
    },
    "trnr_EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "EffectiveIncomeTaxRateReconciliationNontaxableChangesInFairValueOfConvertibleNotesAndSafesPercent",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nontaxable changes in fair value of convertible notes and SAFEs, Percent",
        "terseLabel": "Nontaxable changes in fair value of convertible notes and SAFEs",
        "documentation": "Effective income tax rate reconciliation, nontaxable changes in fair value of convertible notes and safes, percent."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NetLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NetLoss",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss",
        "terseLabel": "Net loss",
        "documentation": "Net loss."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_EffectiveIncomeTaxRateReconciliationIntangiblesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "EffectiveIncomeTaxRateReconciliationIntangiblesPercent",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Intangibles, Percent",
        "terseLabel": "Intangibles",
        "documentation": "Effective income tax rate reconciliation, intangibles, percent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r421",
      "r426",
      "r550",
      "r612",
      "r826",
      "r827",
      "r838",
      "r839",
      "r840"
     ]
    },
    "trnr_IncometaxreconciliationDisqualifiedDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IncometaxreconciliationDisqualifiedDebt",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IncomeTaxReconciliation Disqualified debt",
        "terseLabel": "Disqualified debt",
        "documentation": "IncomeTaxReconciliation disqualified debt."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_IncometaxreconciliationIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IncometaxreconciliationIntangibles",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IncomeTaxReconciliation Intangibles",
        "terseLabel": "Intangibles",
        "documentation": "IncomeTaxReconciliation intangibles."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r421",
      "r426",
      "r550",
      "r611",
      "r838",
      "r839",
      "r840"
     ]
    },
    "trnr_DeferredTaxAssetsCapitalizedResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopment",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Capitalized research and development",
        "terseLabel": "Capitalized research and development",
        "documentation": "Deferred tax assets, capitalized research and development."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_DeferredTaxAssetsFixedAssetsAndIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DeferredTaxAssetsFixedAssetsAndIntangibles",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Fixed Assets and Intangibles",
        "terseLabel": "Fixed assets and intangibles",
        "documentation": "Deferred tax assets, fixed assets and intangibles."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross, Total",
        "totalLabel": "Total deferred tax assets, gross:",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "trnr_IncomeTaxDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "IncomeTaxDisclosureTable",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r550",
      "r613",
      "r826",
      "r827",
      "r838",
      "r839",
      "r840"
     ]
    },
    "trnr_AmortisationOfResearchAndDevelopmentalCost": {
     "xbrltype": "durationItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AmortisationOfResearchAndDevelopmentalCost",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortisation Of Research And Developmental Cost",
        "terseLabel": "Amortisation Of Research And Developmental Cost",
        "documentation": "Amortisation of research and developmental cost."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedSevenConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedSevenConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Seven Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 7 Convertible Preferred Stock",
        "documentation": "Series seed seven convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_OperatingLossCarryForwardsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "OperatingLossCarryForwardsPercentage",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carry forwards Percentage",
        "terseLabel": "Operating Loss Carry forwards Percentage",
        "documentation": "Operating loss carry forwards percentage."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CapitalizedResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CapitalizedResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Research And Development Expenses",
        "terseLabel": "Capitalized Research And Development Expenses",
        "documentation": "Capitalized research and development expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/BenefitPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Text Block]",
        "verboseLabel": "Benefit Plans",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r419",
      "r420",
      "r426",
      "r428",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r840"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 31.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "PPP loan payable",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "trnr_MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "MinimumAdjustedFinancialStatementIncomeSubjectToInflationReductionActTax",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum Adjusted Financial Statement Income Subject to Inflation Reduction Act Tax",
        "terseLabel": "Minimum Adjusted Financial Statement Income Subject to Inflation Reduction Act Tax",
        "documentation": "Minimum adjusted financial statement income subject to inflation reduction act tax."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_MinimumTaxOnBookIncomeInflationReductionActPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "MinimumTaxOnBookIncomeInflationReductionActPercent",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum Tax on Book Income, Inflation Reduction Act, Percent",
        "terseLabel": "Minimum Tax on Book Income, Inflation Reduction Act, Percent",
        "documentation": "Minimum tax on book income, inflation reduction act, percent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/IncomeTaxesDisclosureOfTheComponentsOfDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net, Total",
        "totalLabel": "Deferred tax assets, net:",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "trnr_NumeratorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NumeratorAbstract",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Numerator [Abstract]",
        "terseLabel": "Numerator:",
        "documentation": "Numerator abstract"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedFiveConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedFiveConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Five Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 5 Convertible Preferred Stock",
        "documentation": "Series seed five convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://formelife.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r343",
      "r344",
      "r803",
      "r913"
     ]
    },
    "trnr_DenominatorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "DenominatorAbstract",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denominator [Abstract]",
        "terseLabel": "Denominator:",
        "documentation": "Denominator abstract"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedThreeConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedThreeConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Three Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 3 Convertible Preferred Stock",
        "documentation": "Series seed three convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedOneConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedOneConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed One Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 1 Convertible Preferred Stock",
        "documentation": "Series seed one convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesATwoConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesATwoConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Two Convertible Preferred Stock [Member]",
        "terseLabel": "Series A-2 Convertible Preferred Stock",
        "documentation": "Series A two convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedTwoConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedTwoConvertiblePreferredStockMember",
     "presentation": [
      "http://formelife.com/role/LossPerShareScheduleOfPotentiallyDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Two Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed 2 Convertible Preferred Stock",
        "documentation": "Series seed two convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockNameDomain",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Name [Domain]",
        "documentation": "The unique name of a noncash or part noncash stock conversion."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, estimated useful lives",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_ResearchAndDevelopmentTaxCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "ResearchAndDevelopmentTaxCredit",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Tax Credit",
        "terseLabel": "Research and development tax credit",
        "documentation": "Research and development tax credit."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "trnr_RightsOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "RightsOfferingMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Offering [Member]",
        "terseLabel": "Rights Offering [Member]",
        "documentation": "Rights offering member."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_VendorDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "VendorDeposits",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendor Deposits",
        "documentation": "Vendor deposits."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedAndSeriesAAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedAndSeriesAAgreementMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed and Series A Agreement [Member]",
        "documentation": "Series seed and series A agreement."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PercentageOfInterestRateOfDebtForgiveness": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PercentageOfInterestRateOfDebtForgiveness",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Interest Rate Of Debt Forgiveness",
        "terseLabel": "Percentage Of Interest Rate Of Debt Forgiveness",
        "documentation": "Percentage of interest rate of debt forgiveness."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TwoThousandAndTwentySecuredConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TwoThousandAndTwentySecuredConvertibleNotesMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand and Twenty Secured Convertible Notes [Member]",
        "terseLabel": "2020 Secured Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_PercentageOfDiscountRateOnConvertibleNotes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PercentageOfDiscountRateOnConvertibleNotes",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Discount Rate On Convertible Notes",
        "terseLabel": "Discount rate",
        "documentation": "Percentage of discount rate on convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://formelife.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "trnr_FairValueOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "FairValueOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/EquityBasedCompensationAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Of Warrants",
        "terseLabel": "Fair value of warrants",
        "documentation": "Fair value of warrants."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_NovemberTwoThousandTwentyTwoConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "NovemberTwoThousandTwentyTwoConvertibleNotesMember",
     "presentation": [
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "November Two Thousand Twenty Two Convertible Notes [Member]",
        "terseLabel": "November 2022 Convertible Notes [Member]",
        "documentation": "November two thousand twenty two convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedSixMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Six [Member]",
        "terseLabel": "Series\u00a0Seed-6 [Member]",
        "documentation": "Series\u00a0seed-6."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TwoIndividualMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TwoIndividualMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Individual [Member]",
        "documentation": "Two individual."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_InterestExpenseAndDefaultInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "InterestExpenseAndDefaultInterest",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense And Default Interest",
        "terseLabel": "Interest expense including default interest",
        "documentation": "Interest expense including default interest."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedSevenMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Seven [Member]",
        "terseLabel": "Series\u00a0Seed-7 [Member]",
        "documentation": "Series\u00a0seed-7."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_GainRecognizedOnFairValueChangesOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "GainRecognizedOnFairValueChangesOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain Recognized on Fair Value Changes of Convertible Notes",
        "documentation": "Gain recognized on fair value changes of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_AccruedOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AccruedOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Offering Costs",
        "terseLabel": "Accrued offering costs",
        "documentation": "Accrued offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Warrants measurement input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "trnr_CapitalizedSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CapitalizedSoftwareMember",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Software [Member]",
        "terseLabel": "Capitalized Software Member",
        "documentation": "Capitalized software."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedEightMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Eight [Member]",
        "terseLabel": "Series\u00a0Seed-8 [Member]",
        "documentation": "Series\u00a0seed-8."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesAndLoansPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesAndLoansPayable",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes and Loans Payable",
        "terseLabel": "Loan Payable",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r181",
      "r978"
     ]
    },
    "trnr_CapitalizedContentCostsAndContentLicensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CapitalizedContentCostsAndContentLicensesMember",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Content Costs And Content Licenses [Member]",
        "documentation": "Capitalized content costs and content licenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/InventoriesNetScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Noncurrent",
        "terseLabel": "Long-term inventories, net",
        "verboseLabel": "Finished products - LT",
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Converted",
        "negatedLabel": "Common stock converted, shares",
        "terseLabel": "Conversion of Common Stock, Shares",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47"
     ]
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueMeasurementOfLiabilitiesUsingUnobservableInputsReconciliationDetails",
      "http://formelife.com/role/FairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://formelife.com/role/WarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "trnr_SeriesSeedNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedNineMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Nine [Member]",
        "terseLabel": "Series\u00a0Seed-9 [Member]",
        "documentation": "Series\u00a0seed-9."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_CapitalizedContentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CapitalizedContentCostsMember",
     "presentation": [
      "http://formelife.com/role/OtherAssetsNetScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Content Costs [Member]",
        "terseLabel": "Capitalized Content Costs Member",
        "documentation": "Capitalized content costs."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r440",
      "r901"
     ]
    },
    "trnr_PaidTimeOffAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PaidTimeOffAccrual",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid Time Off Accrual",
        "terseLabel": "Accrued PTO",
        "documentation": "Paid time off accrual."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesAOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesAOneMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A One [Member]",
        "terseLabel": "Series\u00a0A-1 [Member]",
        "documentation": "Series\u00a0A-1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of convertible notes into common stock",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47"
     ]
    },
    "trnr_AccruedLicenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AccruedLicenses",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Licenses",
        "terseLabel": "Accrued licenses",
        "documentation": "Accrued licenses."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_Seed10Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "Seed10Member",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Seed 10 [Member]",
        "terseLabel": "Seed 10 [Member]",
        "documentation": "Seed-10."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Amount Issued",
        "terseLabel": "Issuance of Common stock upon conversion of Common Stock",
        "verboseLabel": "Conversion of stock, amount issued",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other prepaid",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r883",
      "r908"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r591",
      "r848"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Issuance of convertible note",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r47"
     ]
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r272",
      "r440",
      "r868",
      "r869",
      "r901"
     ]
    },
    "trnr_SeriesSeedOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedOneMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed One [Member]",
        "terseLabel": "Series\u00a0Seed-1 [Member]",
        "documentation": "Series\u00a0seed-1."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TwoThousandTwentyTwoConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TwoThousandTwentyTwoConvertibleNotesMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty-Two Convertible Notes [Member]",
        "terseLabel": "2022 Convertible Notes [Member]",
        "documentation": "Two thousand twenty-two convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedBalanceSheets",
      "http://formelife.com/role/DescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Secured Debt, Current",
        "terseLabel": "Senior secured notes",
        "verboseLabel": "Senior secured notes outstanding balance",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r177"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued",
        "terseLabel": "Warrant issued",
        "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r47"
     ]
    },
    "trnr_CustomerDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "CustomerDeposits",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Deposits",
        "terseLabel": "Customer deposits",
        "documentation": "Customer deposits"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedTwoTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedTwoTenMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Two Ten [Member]",
        "terseLabel": "Series\u00a0Seed-2-10 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://formelife.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://formelife.com/role/SubsequentEventsAdditionalInformationDetails",
      "http://formelife.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r272",
      "r440",
      "r868",
      "r901"
     ]
    },
    "trnr_AccruedEngineeringCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "AccruedEngineeringCurrent",
     "crdr": "credit",
     "calculation": {
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://formelife.com/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Engineering Current",
        "terseLabel": "Accrued engineering",
        "documentation": "Accrued engineering current."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed [Member]",
        "terseLabel": "Series Seed [Member]",
        "documentation": "Series seed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://formelife.com/role/CondensedConsolidatedStatementOfCashFlowsUnaudited",
      "http://formelife.com/role/CondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Issuance of Common stock upon conversion of Common Stock, shares",
        "verboseLabel": "Issuance of Class A common stock through conversion of preferred stock",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47"
     ]
    },
    "trnr_LossDueToChangesInFairValueOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "LossDueToChangesInFairValueOfConvertibleNotes",
     "crdr": "debit",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Due to Changes in Fair Value of Convertible Notes",
        "terseLabel": "Convertible Notes losses",
        "documentation": "Loss due to changes in fair value of convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedTwoMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Two [Member]",
        "terseLabel": "Series\u00a0Seed-2 [Member]",
        "documentation": "Series\u00a0seed-2."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TwoThousandTwentyConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TwoThousandTwentyConvertibleNotesMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Convertible Notes [Member]",
        "terseLabel": "2020 Convertible Notes [Member]",
        "documentation": "Two thousand twenty convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_November2022ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "November2022ConvertibleNotesMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "November 2022 Convertible Notes [Member]",
        "documentation": "November 2022 Convertible Notes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeedThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeedThreeMember",
     "presentation": [
      "http://formelife.com/role/StockholdersDeficitAdditionalInformationDetails",
      "http://formelife.com/role/StockholdersDeficitDisclosureOfTemporaryEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Three [Member]",
        "terseLabel": "Series\u00a0Seed-3 [Member]",
        "documentation": "Series\u00a0seed-3."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TwoThousandTwentyOneConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TwoThousandTwentyOneConvertibleNotesMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty One Convertible Notes [Member]",
        "terseLabel": "2021 Convertible Notes [Member]",
        "documentation": "Two thousand twenty one convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://formelife.com/role/PrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Receivables",
        "terseLabel": "Other receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r727"
     ]
    },
    "trnr_PaycheckProtectionProgramLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "PaycheckProtectionProgramLoanMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paycheck Protection Program Loan [Member]",
        "documentation": "Paycheck protection program loan."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_TenPercentageSeniorSecuredNotesDueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "TenPercentageSeniorSecuredNotesDueMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ten Percentage Senior secured Notes Due [Member]",
        "terseLabel": "10% senior secured notes due [Member]",
        "documentation": "10% senior secured notes."
       }
      }
     },
     "auth_ref": []
    },
    "trnr_SeriesSeed9PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://formelife.com/20230930",
     "localname": "SeriesSeed9PreferredStockMember",
     "presentation": [
      "http://formelife.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed 9 Preferred Stock [Member]",
        "documentation": "Series seed 9 preferred stock."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(27)",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483478/205-10-45-3"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Section": "S99",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-4"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.7(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-3"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.13(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483282/920-350-45-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483227/920-405-45-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483119/928-440-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "SubTopic": "740",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480341/340-10-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482190/360-10-35-3"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>124
<FILENAME>0001193125-23-301741-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-301741-xbrl.zip
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MLGTP:/=4@,P;*U_<:"EZQLLNP&W!S@;M>SCAZT=9_;!]KO;%Z6BD8G&L4O
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MN(#OO[5:.[5&H\&S_>.B5\,T<TGF3]14;TXA% 6QRRTKSANK<190^L0]@,"
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MG1=Z)S;IG,P)2MX)"H,4,E_G[+<AE;8T-L:GU:$_(OV!+@AE::?C3%NFB3M
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M)K'\/R_\4.BOQ']1PNZS]EK\_H/T"U\]T"\$()[V/N$B_S]7_P-02P,$%
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M]Q7[C?[PKU_1EC6__(*UJ"#%/>2BI:;28Q+/T@='6IU.&(Q#\E:S-=-@FX;
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M=H[:O5-/\><6W-=L?0*BJ-<.O0&R\X[^[1#(G'Y30SOLMLX)C>P9:'?>"QP
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M3P@, K^@X P((.,D"AMT-2*AB*_ R*.&& <@2*>P-5 @"/6W!@)0&D=3I"A
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M&L!",8*@#1G6<*$9IOPR(C$*IR&69+ I*J/;:-+;W);)#5ZL,2;0BNZ=[U^
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M4/+%KZYDOD@/%W(-6?4/%&<A%0$IHV&R\]:PLT+@-[U"=X.+%C84#:FU+ZT
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MB+WRR#A01+J'G^#B\>#T9/__ %!+ P04    "  #,I97TE0^D00)  "['0
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MW<%S-2>:!\_,U7@%/ N&YPXJ E<#GL*^EPBAPL0G@U18^1*!5!CZ%)!BG$/
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M,?;C:&&^8RG^QU$/\VW&I!*I(FDC]@*)R^;<)/:O")X.Y!%(A:'VU%?94,C
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MIP<3537=18(-B.):F@.W7[\KNJL2]<8RI[C"<ATJ_X\CKWO;$[%H&/=BGOR
MT@.JV'F'0PBK.=$D>/)EN3TTGUQP[V6;,#(MG$(2(-T*2-?D1Y.@RN57J-%2
MJ%&A0^/ ?#2(P&8IL+F:$\V#YX 05<"S#/#,P(EFPE,HT!(A5.C09)"*A7R)
M0"K6\BD@G5A$Z-+RP#0#.YH)U!O3M01.RX+3#-QH*$R!> *FI8'I:FXT$Z8#
M[5V@M"PH7<V,AH*4O!)#P+0T,,W CF8"]5H;3QP!U+( -0L[F@G4!TT$3LN#
MTPS<:"9,A\+LEP>EJYG1)) NS;I)*Z4M<+J;+*@M%\(N&53IM!]IU? 0>01$
MMZY*L_&A2="\=&W'G!(,(6/*MT6IBU5VPI!<^/%B[E=@N-<,;>KR&BBVY?1E
M8\R+W,DZL?NX5'7) W%6//""&,ID*EOE/XF98?#^@:4D$J3#:^40@+[G/H'A
M/?@YPH -GKUD>@D%(5;@IE$B9-K.X^A7TU1!J3BRO@[0EXF/.P/2;2"9O\-D
M38ON8_J/OY?_-"V/=^6W"=FPN()2&\I;(LFH.5D@</4D.TUQ)6.Z45*]J6$4
MYB]W\R=,U ?!?#V=Z>:<D) #'%ERO,F6Z@-7'(!<\P!D]B5.F,XAI*:RITD8
M#86V:$NZ)WDNP]]AI TFID4;*<6ZRY47<FDCCC8:2YETD[@OZK 558>MS%Q?
M."'I!1$C4E^[>DW)/0.C<V\<#"X:#(/TN3<*!J4.I#P:(HQ28!C%)Z\(HM1'
MHA_,5^:XQ5=9T4- "WVWZ^/H\\;7ZY*A22 1I56;Q.V>JFJH.F7]2=;46^-2
MGFDQ6U]_[B\E0I/0\.A,B-4G.CQ7?8*AS)\L<ZK9MFG-%XP":M9; _MNEWKY
M[_$X<;C4'&2;=)-@P)8_;$6<:<WWG)(\4P/5L:2^\R*9<G!HL^JL1J?)!$F8
M_TLL<V@.B9&>#%O32$5&&C0)%B&!O!!Z*XO>NA!Z:YL O7%M,K/,/XD265^%
MG8\AK$-L6:%)D1?S\"\KXFHU]MVRT\=3C@N$+GD82WBG:RQ99T2S3*.GOFI(
MA3M'%;)4I"RET5N(E!"IN$B%=U&3=@VY5\)_>K3Z>"*U[B*7.NFDO>>L^XW5
M$G@AE#L4RLU$RZO-VZ0%=JR#UWKK:B&90C*SFLNU ZTU-I,["[D*.:RH'&9*
MX&2R<"-KUN^R[I*+^9TFOV@ZQJ@HC,HN%JM&+E)9T]/7;7HV.6J^A^;2QBSA
M&^F/%_-OAO:72ZZ(K5C:+-0TK+R866,2; &R/K6:"Z:(TAW&,X;B!CBXMXI
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M. FV.+X*EZA\+E&!_!8NT9:38 O<UA9)L#DGHN:.MZV?\RX<:HU/@LTI$55
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M_/$#S[R2YRFCA%\^\#S@ZS/ Y'F K @]6=6P,ZW_$6]Z<*?$DAW3^C!(%I^
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M<SHEAD*P@39^ABMFIDU@K2WK!%XM.1,BS=P775/.TX"<UV9VL;._L<RIY(!
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M_/\M%(10$*57$+($*S!G/Y JD!I#98)$=4>B)E"6:0*A H0*$"J@[BI %2I
MJ "A C95 ;>&BNTKB/0RYU(#MWV'N1+:H0HA'&H*3J55A^>"D"H*T0F,!004
MQ=3"I/[$;TM[% A L1\:<+Z!-SY[&U "?P 19Z;EH!Y2S.E,-N9[$EOR@+I
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M-]& KJ/9HSG=X\6EBHOVYH5N0+&C.6\,**Z]S$>)&O0DVT,'H9J*BQ_0E"N
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M7%W?/]S>W%ZRI)B;Q[[$PQ6W8#G!3Y/N;GL7MW?TL\"@P&!V#!Y]^OK';]<
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ML:$!QZB.Y#1U#5H(F^IN@YZ<PC4HINIYO)?'8]0E#L6G@6<#=-QB=CF_.GO
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MZH[5)K2(KZ5T<W?M_U.D!3%>?'^A85%\;Z$ZYP=#Y!*^KG8B<QER/E#S@7J
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M?GSS-?@EA5NC@N<,[/_TVYW7PEYE@]WXJS1"OH8_]3MOQ%:HF[TY?+KX!'[
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M<_OQ!I?[R9.R:\#GQ2-[QGF9/"FI/W)_Y&!J=B/2M4K(+H8>C:+8\T7%-EZ
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M/0EK.H2*8J#RF*6)8-!8/^"XH;F E1X2M8*D:%HB,C-QQ12$(A$7)\U\?8:
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M#P>9"X=LX'@POL0.;<;2]?=Y#RQR^C%?5BH\E,XR-0Q[V'3;F3  OCJ>:J-
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M6,U,&-'8/1_!N]R[O]!'QVUY2W=HN&4:CE';5(DBI^'@CC$:457'RI-. DV
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M=D^NI5W&>HTUH($_.+@V1]!3G+KPT-.O2>M'WAZ@1P>6 EMAD4QTK-M2W,I
MIZ7WU/N(963PI;"IAIT@[Z(MYE3+K;<:RAP"!DF($1?[PXYJ/*.,"<90^KO<
M0XL'1G 8K.I/P[?R:M]L'*6H)6O$WLSYQ:S!&8$XO0C-Z&R ?) <D/PF?C.B
MX$Z>B@C(,@..<- &0IZ"EIDIEI-*F?P=**NQ+[]DT%O*)\C'$1EUIB36W(6+
MO3:2VQT?_Q5RC%&:\("RSR<V!@75=9IZ_2&+&4]7(>@7:RMJZ\9I+LIR$:BS
MWT[!#84]]L:'-U=\H:C>,V[%K &S9)[6I?MVR'-J#^8#JXIQQ4MI-R)\LU#A
MF.0@+UQ<ET#$,J5N;/-*QW?* V!Q\*B;->&G;Y#J.TH:"3YX5!/T%X8<;B$M
M+X'D!X4VR=D&6LD5=^WB7_/5[:CK:AV$AP\Y@Z*4@FGD(['C8I^I>P>O)4K1
MJ;?"\8WPTG># SO!UO,]EGHZIA4($-<@-&$L6A' SWI&[1 \ZQGB-Q*47M8A
MLIE!E\!/CRFFB??\X-SML2Z*H<&QFDA;@'#4"U'!R*!(^3HNR6$I^Q$)5H7P
M&%TW?NY0; G.;(#1,Q3"I&JW>"YH,J[=HXYJ3D[VJM(]?C-98^$DX_!:MJ"Q
M[!^H2P2=.AX'4R1X+VZH)B-+,#8$)\7A%#^KQ[$(B54MJ6RTDIR\P/4(Z!OT
M3O=$I<=EC933E&>Q:38'DDET)NBGAC0S-"]'EB+P@Y&V]3$ME1Y>ZOV3#J2D
MD"[T)3RGAYZ_-YY";HIF@KB>:>/O72O4/'LH#W2WY*T.^R2N%W^O0UO>6/M$
M3(TSMBTQRK$F)O@+9K.T'].D*DJIDDM0H(T0H*F:ZLZ.E$@X,<UN=!;A42"A
ME>$6**9TH#CK-=P<[5Q@"Z-6]BQ:@$0I(OG 6!L*Y #-@/E'7.)X^F0N<7SH
M)8Y1_ (\*OX2W+KCM+NN:@X^EM-)(IL(">DV.&QA;INI#]Z'P>%WD-C[F9/Z
MR$@SWC3EU=06>N+R*@ZRM1M ELY;@@;<;BJWY@K^$5--A"7#08MAIMM8B<@U
M-HV'R2.MFG;78$9"'RYLD7+<F$3&>/OX"!.;O[AE=.V\+7./Z#;]ZJT9!E=(
MAB%I4L;Q2F/VCH"3]LA=X269?1WMA3"W=?5=V38UE5,DK0^6MORG=T'E&E7_
MM@?W'$)M'J?@:M,=IX^+!@Q6OS6=$;(+3J<,0<A@*E8)XD<V7@AKD!UJS<PW
M#"W /G#9VBFD[YOHA:Q48ZZ(0U"E; K&UPM#<0_KJ1:4N'^ F\BY*YB]U2JA
M2;KL\A)R#)"20A>BZK'P0JV%R!BWA_*=W\Z\!<JJ@[3B)T?%5BZ9.*]#? E-
MA?($%=<0(SZT9NUO H*Q<NT2?P$#):@Y_%H5XH^8A<%EDN4VVSXVG*T=SXBD
MA3*V('>U<Z&C1 EV0 WC?/ :',S 4N_]NYQ\<DP_^37SK^N_'0_/Q 3LG)>\
MA\5';P?^P6* [.PTLXR!XS:OUGV]$O"'LOX%I)2@E6"/L8E(T.^$DA[B27D_
M8)@INZ3\36J0M2"@/I*"$4IWW55.4]!1*')T<X\@B<<I/=SP3*9F8]/%4!51
MZ_)[6ZP7#Z>0QT U!CHX&RI@9=G5812)9C\\XXJ.!(Y=.MOK8&;:&2-*FA0[
MKV[<^":DI'B8*8+?,FN3*8!E%GV%DV +H)[M9?F"'/C[@#W!"!+.4VB^>"0K
MQWR .#56)#!7FOW'N82++&9J$5%V,6%EI%BP+N.T":>TO3S^3^^?Z>F3IS>9
M]D/@G?\&P=+-GV^&HQ4FWZB_?LJ'GV[&EQC4S>$7S_L-Y KA-X-*/?S(WZ7N
M.+8G/JH2HW-1=87)/:/PA/R99%C,VX.=DC1U'",'^D9%IICJ PE?\=\H?ND-
MB7?D9)G-YN&3 A-XR4XEC.HX+T'9&/MN^B*$KI2^Y]ANXA)S%Y-MKE0(/GBB
M>V]'Z?69G4]C$#4*4)MQCC"F7 Y;@-LERDI*FZ:_PINM"JVA,Q-Z,-P)/A<1
M&J+.I600'HR:VK/&MI634@]=1_"VIF+/-"D[KQOO/$&,%/?/AA0]CLI$F3=*
M&.F6Q[4"/"5^=7$58;_;$H&V8#3]K73X//W\/P)G;U5=8>%"QYTI\J-$&7X"
M)0-B5=2,_\^$B)5C5HO\CZDG^M:MG ROTO'EQ\)WC9[KV9,+/!>+31.M$2",
M"9" '+G:,=^H7^-]L*-W3I@?D?H6OY /VGS&XQYC7_?@@BGAK1GGN=='5*S#
MZ!KF:#/J(6*%!;FI>/#)O>7G&CP+S9P-6SOPH'O; *86#F%M+&&HK=C7-"\T
M4C7*@OB&6EY4+Q)7WIPY:5;QWKFPPN+3;0EW#<TJRDYWZ/:.9VFEE[U987 C
M\#Q2:F1CSA5PM!YQ$4.50^!7%+]3S*"HB6 CE7N^=-Q!4A.(?NQKA=1H^H/;
MLL55BB<%]3(Y_J#G/ N\ UIF*^]1X9LL,P6!#BRCL,%&K@IYW]&*J-,8U^?3
MK*YQ*;GSGHL*,"%O-&U.%7HK8"H'^'1]V_7R;.+4AG2U;7S R@NCR6)LO7<;
M(OFN<Y[J2%;['NDI[Z%)!VJO[ M040>U_7T]Q1",\8%E\$--ZZ.Z>W20I4E5
M8/[&VR0XKMSB=BI(&.XP^]C^(O#"(^!J&@]K\.O>^@WH: V5G9??@@X<F$69
MYZWL9 '<Z^3TJKMB#T4G;+W#P][LJD%0#^Q?.H)4'G<L#KTM$[A*_&QA.J @
MX,_@2L<1<2XRRGIAB,EE2&8$ #V/L?JNP;$DI29;M24*RR"P"L=VH%'!S=KF
M;QQ$41@RZSG%9 <]!+N]D19-O5Y!!O%^P.TB+RE8]BH)]D"\/X$.."*#\+%X
MY%2R/RBG_2EOTI]E+7P 6MF$(YE%:=LJ/W3\+W+0R7,+NRS1$H^3$A2,@"=0
M!N)C+EG<S"6+#[UDX:3(%U"H,U/7-"X"Q@E%XZ@7SQHA.L*JA:Q?$T/BN;9!
M@&B;.2);%#J0ILM\)N /G6^I$>8T74"2>-@.F;\Z&B"14#,?*)@I_>A5Q+Z+
M@W],-P&=M:I)L/;0("%1EWP]+E*0<^'7#&"A]L?<BUV5$T /*B\<!>!?2V_D
M2Z,CI[(6>\@C\A/[]5^6M67>D"2(2E;P*) 5AI)C7BMJCGQHGN.V&EO![VOM
MF04_U/\'YBMNO2=.^E) V:GOAV=B@BNK@?(T@F?&87,W:-/C40GTN[P+ J"5
M7G!;?^K!$,*JUCW.+V*5+O(A308L6O'H(/W!ZGECF<*II"W[89W?Z+9IMOY)
MFKT/9B&LT1SMJ:ESFX557^/Q>N)YPWG:[4 Q&@!IX(Q1U-&H90*.I_#-]ARZ
MJRR;Z6@!Z O!L)S^U(&ELR7+B &-/T48P;-V\>O'X"2#']/7J)L]QX[;Q:'I
MR4MDL1[<#YI+^'8<61-OQ-[)0>'XN+M=K*OF?C1DQ\%[#J+BBWEE7V%Q/*/X
MAYNMMA -4EG+_Z#=7V$^ ;\YCD17NTVSAWI4BI-%T14\"$:5= UX*]2C_)]^
MW=P]%)[(BR;E@PVZ"+S%X%F6YQ?T95E;O8-M+-I'+-.YVA#7C(@0KL!82ZQM
M=%J0MX1K:%6IJ<#)1GB]+IM3:,!.V[WQBL[_T(5NKDZ3(UB#DX;;3IY*_& $
M7L%><17?];IS>TX0T)W%_GR(2FJTGTXWTF"SG%6CM_09%I_(%(TDH?*HQ8T?
MDCD=;JR#_X(XG6<5QHK[::/C>$XC#)]S'L/@9V6V"^"G!DX,_%S<GMAB\L.M
M_>=T$^T5("%D?(!$;V:/T+-.C8B9= ,2+*<F#8(("5P=E&3A&)WH9 0I.Y2N
MLKC:5G5B&1M<QGPE-:#.V8O@@0SZ*#>PAF-H)DGG;L/CUE6%B;(_IPLY4T?-
MU%&GJ:.\7^:XKQ_C6W'4LX4/U,J<CPC\<W'G?&1042J7@@1LT:*C/+-(SA)Y
M(6)4F2G%L!0P?M24DQ\MT]0TPH-E+_&SP9[EV-,#0CPMPS/[WBRP%Q/8D<IB
M\"D8>2R8<628$UDFH0RX4);&C2=;089T>B!?^9B">S3PRK\%)1\C;5$_!KC+
M)\LNK;N2+@6INZ3A,QYA_WXX(0I3JC5V?4KQ5#:9?38#+B6))7!P?92WA8($
M>UZT*\9#CMPO6QVW:(C#IRIK3>8!S6+114T815OJ.,89X=)E"#XD#,5$'@!@
M1NT2T2L$A#8S=A$W/')/8^'N*+*P(2L7R$U^(^HL@393",PYC!8 3@0(HEF;
M5:S""?X&QYQR+_\Y!#8061.Q#M7.)6;%+<*GYB;-/@56LV^J,YLQO%Z)*3L9
M;N*9L'_9(#?M><4NBC !&D6"DS>6J%XB \VF0+AH#18*(W=GA@BN'9V!U92E
M3#:?\2#PS&/7XMELPK,0Q&-T^>!Q*?;GU!2!K\936>/]@Q(S'WTL.<X+UEH!
MKEE2.=AI6N4KHEN#"2@J;@2HS],7IZT3 $/E"PKW"EKES%5,CHI)TB3=D;\2
M>S2"JOI(:XI/YYKBAUQ3?,\!XNF"'T#9"/3T$-IP>;#]*/[^/4(^MX)9A7:D
M<(CX: FUCF(@)>-7V,7#::W0I_Z(/<<!R!EZSW22PW;13"R@H,]$J_@N:Y8M
M7-LJ><NR1^S69G>+K25Y7"2DOK'P2*CN8,946V<"44=#R6/OJ@8>L-"X2P,?
M6(0 XC/[(GU-GI0KN&VI73OIO6($)1I("9PB_M3IFH'63Y<,YJY)0)0!!,W!
M@D%IFUH >Z&S)A P,^\-H[64;4'H'!&0EXB>D&>^<=.%3O]N7;Z&FBIQ0^?J
M+YD)%AIN ;XC!UT^/(J!Z4/I>Z+1$!GR)9RB7B'M;O-_(4HI-@-J,;5T0I"'
M7O!P$L3 &'.6=6-SFV+*_6_X@P#$9SG^3G5?L_,LRX:O()/)) F)L*"_8/C8
M3+_.'91E]$TRZ3&@<6>_T#2LY/7R=I+$)*I&"H \/:+\= +@"RH]5?7P#OI/
MV);'1[QNJ"J7TTJ2F"J%-[\3(#ARE^BZ? M/*4M++7VT\K)I8>!<^_4BF95A
ML*C870 IU !Q!>@KNEV+N!@PLX[M9"RY.M0ACT+.5#+VGO0%L/"G\T.F\B3A
MK,XQ$3XTSC^Q8--+ _Q50(S&(\U0(>DSI+3#5EZ#MD3(Q4WP[/SUH<..$#0K
MZ&/1KEYUO5F090<:%7FI-"%:",U> &:(7[PU/+?TGHS.AL3S!+G%1%2AIWC'
MQF)F'M9V[0>D'%$4T 518<?$#OKR@G\=OI\LV-"&#_N$&K^7V(@D_8]=U=P7
MS7U-*TN+S.748+Y/M8TFE*786VT]#29T(&!4N(Q23:O:@J_$Q$9DC71<1RK7
M!D>#M,2$VX$)A/#BU!:)S E'&J&RLQP4P,*BA(1%WL8(%58W QHP+3L&=#/I
M?HG88(\=0A1G_Q13:)L1/! ]>@61NLK]**;O]-3=,88=2\ECAF.IZ_:/@'WY
M.BPZ:1Q:=#U00?$V[8C>C:! 8'_BE"+Y;6+K&1$8&^# J\RLZCINM1,9BFGE
M2#,O<IBE[-!UD>-G$=*/*BV.K'FT7S#4NO":H1U8)*NLQ7!:/X"!V2@/=X<S
MS]3IY:TF(;5*<O0Q8H'S=W?<K(YL[WF6]K<7@03L4>*4*40VAF\LY$I1Y[8A
M94SHIWE*!:?&:'OIYTK6Q,-7ME6+X1EJ5K\C>D(-;<S8*O0>,FL]@/18",M[
MR!QU+KGA@^BNRV7O.6U'.<IJ[+A]#;V;#H=2)J-2=:]0D=.6J B" PQR2-W!
M-MSYI2\V2K8"#4<5<Z^@YV :]=&/['2Y*9?+P&ULF; G5LUR4!:H%7)@W1VC
M U\Z'KE@6&MPEDRQP?A*'>41"^69!HEHH<(!"5,BOV7DN$S#OPP;>LG<&NA*
MA ?8 _XFN/R (2YK9P57?6+3'*N);0[40SAG?#\3"JY!]B1ERXUB"8SR&LLM
M7FLB-@+M7A8G=(](![:KA/I4(*X,U2M1T;(3JC4,5SH?,?(2%=*%S\4(+Q.=
ML0^2E^GG,56B>\F'PV2Z@IC;S2]*X4(#S W\-Q<0FW9T2F^#.0F)GCJBPY%4
MC(][2A2@ ;S#0W4R/U+FC243X=2EE'2R"'GS]&KKKWLK%4AIIP]!:#V<5(*W
M'4QZ8W\8,@*WK>.Z4A(BTL%-]W^-)(/<7B^#"<!)M?#A2#C1FI/J.SQ\%44@
MH@\_YC+!IW.9X$,N$Q!:6C$0W,CNVHD7'KR=1 \_J67L?$Q5>F-98"YP4O5H
M/WJ'.%_)<PK$HW$9X+DQ51#2!@(7G;H&6N]+(ABRL1AK4*K1'/8L?89 [F72
MF*;] Z\5'/4D9<-)ZA',1/,3](V9XK+0G 8Z$I0_3;,40]H6+#\C+&:F.'8&
M5!U;4[ 7U8 _4DINFRN!Z66#]C %+:POBA3F]77)$%[LFPA8Y2"5?60 E-?+
M>W?8*(Z^VR\]C#ZGB\LX383S-<$V .L'$52:=!/82VXT.6"(=/I% JZFZ488
MBD&F7H9S-2*RWN:06O'2#J4?+!9 M0-$W0"EZ'+)XJ![CN,'E*6"+I (YS<7
M5/.)*UF9!OJ]YU77#,Y"$CX&MY7:$&(+^AMC)UZF+R=H%./_E>BZ(ZPKEOEZ
M"CVQI$5%1%P-FE$QQ(01,K8=(A_"NT6R*91-G8SX8TLE99WWC$D6 J3ODHN5
MG-KF>"( N?V]1G_I]9ZXL:&^0O1\U(>)]VJ1_ -_I40+%9X!_"H,,NX[!/U.
M+ZBU+&R,6&/V8/A@=WG+1 P(9-(R!3C^,U'HAH,)$S,[R%!:!)\0S=@[J_8>
MI1HTLXWAJ1"%@7Y#/F6&>"V9OH$2^Y7X;UBYM2O A66&0Z98E!C1WR'GE!FM
M[7B6C6P)@.[A<0EYMBER4QEACU0C#9>N0YD(*]H\@D\JE<;1A(R8Y[TXC83+
MY&^8MT6\*LIJ%H"?>)5\?-)RTY,N2NHX2+8[ IL/EPK*"FHA.1DRJU]\Q)Q7
M>X6UH"WM\EKRW7](I%8(6V2C4=(DL%=N65(<)L_#:LC*!*)6>9<MY$1X$2R-
M[J@'8OS"0:EJG'; TL4$^S0LH5MW+>0KF/#.F/2QDC1S#;9,C%=NR1&@/^]N
M#QVF;L%./E:(^[RJAI4FG*+7;4%#8GGZK'T8WT<L_7.#)L'@-?6&!C"#Q1@%
M+1F_GO V(A<#J"Y@%38D.;$0H=93:T9?7N9=V0'8.OR'<OV5[:K?$F-$E*-E
M =/T-OSYKJF\[L_;$CKR2)0P5>+?HFCS>U,>?G >2%M('SY)7DV)'S'L!8*D
M.!\8(PV'\G0T:<<SK]2=C.9-J%>.)9N@#NF$' (K#0+8V@5>0SF>_M6009'M
MYX W(XM1SK3B>.?5C;9ZD)K(]2H6O9Z>ENE!E,X9?:0XJ<:N94.FIR^3]GI@
MME3J4?G&XA.K7M+^8&G\K@]J FQ:&JKG/0 <=W^2+@8N4@1-@QL >&H$<LM:
M1.,+["_(H3,\5%7!T%"MYWUKH,=LCS0,!T6;- ^9!81)T;XV;$G8XX!Z@M+%
MA&#%F" CL:GWHUKO@_$@\0%SVZTRD8YHVR+6JV>J?=1-6F#&4Q!RR<HL@TH)
M5U6PMK!'+D2\4:@9A(F7AUNN"$P#,!-#C_22L]FB?#49WB+,L']QS--P:.E#
MY;JDWA;4G^6R#TO"6HT\#TZ,2^7L^<B62<W$UM[HS$=F]$%$Z8-S8V(\88J@
M(IH4SETPZF5"Q$AO:H0*:\:/C%<;,!WNF_:-^%5'8<+@77U(4T -]-; 9UF8
M67;B$F:/ <AX7#EV9Z6\7YX&,B-M;8;$,0V_V%3-G6)X,Y:AA*J),:3;G$SE
M^\7WGEVGPT1KG,(V??4$GMH)%FLI*70%TCT#E@W,(>+7-)A68]/,*<  ?)\$
M)HHBAZVWH_NTS?=[T_^RW?8U.M(0/8GWI1D  L$#VAGL2?+*SN_CR07R7LB5
M77!9J(^Y=/#97#KXT$L'#$@Z"#3 - (WP[8GMT/CCF59<U9\NRT5IN0\V$1-
M.(5JH#>6E6/R18L8B,F.%O>-G $FP,HK3K7<N8F[A89:K4:31^LWM5PC,[9C
M!&)M> ,EV#(%6#C+BL$<I@ :'*6K>(&X'V<\%7T"0E$P/ZX7/^+R$)SJF$TT
MM6.O'^]PM(][% TY, ^OP65.ZIJ37_ 6KKAJUE=;K\5NU<*20D+VS1;(Z:$_
MN86-"#'.NF&<I)K&LN+.0JK"QM1ET1O+@@]8S.X%*G[H&,34OA.T5A$XY*VK
M=I'*]ANS>H.4H;2WIHM;JM5F&I)1=B-7Q7@G 5M/>^/&86FEQ9*? @/D/1._
MF,S@Q#Q*,UA=R<B=!]KWF_5<R#DC'%M33T,O@YAH<'+CGNUM?&XPW*6!;),&
M"XQH%/-BZW@T2L(%,"\D>_3?V.&77(SD2QKRVG04-+1H.XZT"0Y:,J5ZBD>Y
MTOD5,7(,,[@$"CG\-LL#>;LH)M'A(&%7D.J15PZ9<'E,L[0&O'9\1$/?&=/9
M+H1L0K=X%UY?6YGU_1]YAFNT17UB<RA^*X42(!!>O[/7BDXJ3<5CC>5O3;=X
M7F\<CNE^X[?)WZX6^(IER,(1$43>-;4KQO8&W4I!&8 \D7\;//TP4M4K00P.
MX4@OEW;#! BB+O XY53WJ/>$0"8@<L0=(]2$BYB94 \?A*G:S/H:;("WN>;]
M@OT.50!,")JK0*H:Q1\]>>C&K_L.12TDN<KZMER6 W1!.6_&!4?=?G3/12+5
MU/PXX']X)YGQXB)TF;3L2D%WEO;Q@1045S7Y+FP.ZTB+&!$ T:(N1%8 /FPA
MZ_&/E]_*#R /TNW3]TEN:SE)HZ4Y*>XOZZMOL5M H;:U=HZ88*/J<MB401G
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MI;.C%88' Q18DI*'[Q))HF;>83S=$A%.)^^!-8. TF7 :?J[)L-62COW>6Q
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MC!!>[_W;$F@JYNLA)4@I<]#@/"ODBA!54Z[<\>KBM740G2Y\_=I'/I@]?^6
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ME#03H[MK1RHM;#N2!1PY08*H:P9:8WL\6K31*-B35#<1^O#,#.%HN$RJL9(
MQDDWPXBNA2VMWG$B/74)?!\*<U0E#R!/*?01J<1&<B'%/DBNCAG7:U-32;/A
M:5.9]$@EN)N9,S@;64%,%*N+\9*PPL%V;G"F^O.5BWP%LR)1.Y:W0MPLQT0U
MGI:!$D>1,7[N$YH[)#8W54IPE$U4_HMM00AH..TFI_)L9Q**SA@]\P7*80BA
MB!)L(N$!.IRD(#(W;46$CW32B4I]OLKNFG)KEE;%L)PH);PE'1K;'R+0-SLJ
M^[#]^FT9I9V*9326K-C9_DK9V7HL9E5 G4).C:"D;57 ,,H.S,7( 7C%E+W+
M@!33V\[Y"_3%Y!#?8IYHN)J$Y8<Q8PDJH%< =OQY:W8UD[AZA (-HZEE1F1;
M<X#6M25"YC"*RAWG0%Q8*B%"X#4@Q?ZX_&(>4#O#-#79JZT8+>O92M934WTX
M^;?E=6O6:3%[^$/RX/1E+,^!ZB1ZR2DK(Z]K:0FOT)PI.//%W';4;Q 4$E*E
MEC,0+S\\:2/Z#EV5@@RU@8\ W%@4#,!0T(=<E1K&I3<]PD'LR4L6,$XZ'LK=
MT)Y7UL@ X 8Z_\(2E87KW%P\YH8J6B!ENBF%"KONDR%O.^WUQD2EO<UJ[J5O
MF(=1".MS!X'M'Z^$Q/U X1Y#-U'Y8/RU=(;8W'+KBX[)9BE'F@2TS8S[/Q-U
MOXU##$=2N^P393,'N90HF3'_5GHU% &-;*>:,EN=$P&9S?H!CX>?2E IV@TA
M)6XV"!*'I*#!M!!A@8V>DF.?9)@87+_>"6&4!RE%0SP/5?F@Q,J?:,+Z^3%A
M_3$GK-\O-D.'M<&I4<;+:C&P9>(WI<FL8L5%20T4MO4@#89L4MK'8^,AWQ/N
MJB6RS/+7XN3:.<',$WH$E["E5Q#<DCY*]\;]^[SR3RK$4*X8$2$V'F5 =RXO
M7YIP"-,KN\8T![KAL[@50&Q-\E;P(*),@9]!D0'EDQ /<\^'R#D,"9EZIC40
MN8FVPI4&1T9#9GC 'D>4W$.=K/C@A*P"V)#"T'#",4]LN,W8A$./\$:,A2K9
MH:TN6SGTZ(T+R9LUJ@J1<7VD&/^P,4:J?@XC?)O@&0%K*QT,O:TF23U.TF$9
M&M B9?TU4V]LLG/*@Q0X)4\0+U6$^-[^S4?7MK)JO'3-V^53-:,40\_YO1Z1
MGREBT"$7,X%9E+%P6OV22$F)T"Y4&Y1R6QZKU:[+F%?97U46F.M%<*J2EB^+
M+:U;@>U'>2?^&H6GN/!'F,_BJKS7\ P#JVZ"!"8$6Q"IB2+B"]4 *;%5BRYI
M[7T/%^<95&64L,37Y@ORNHE\AKHQK8#0^:H;9YUQ[J6N9Z'=[Y]\;DL&1(9)
M4S7IJ.05U3 -O>Z16ZMI;7/"?-Q:3*-O?4^N\[-OGF6FC+E/-<C2>89#GSCQ
M2?7S)X.JHWN<EF#/88Y[*Q</2&>&4:O)@IG@[;FO=;_JVGVYTQXLN3RM.4\&
MTU7K-L1"X0$KTF/@VX(.I+^P,TZZ!8!FY,NTW7G9U/^\0\[YP>#)&C/2>C."
M8=LS=4,=?_0/]$ML]UI\-"T;:&R2="-MUW0T"I,$!34>IUC>-J0)#72@0ARI
ML"&7%^I3PK2N&<N\NMQW-:EF;PT<O:O.Z5P4XML?TQE >@!Y@F&H+J]8$!(+
M9G-=FL*U!"O2<MW>5)VQN9V-77@8/'G<I)S_@+T?)2N1!.F)$&.V)NAA-A5%
M[:!.#;%V") %X/5O%#WB1\HYC5?\Z9:=$.W#J-Z%"Z^43 9TVM?HW"#>"IRE
MDWO2*9<*4E*HRYJ4NK[Q3N%I+,(E6.007:RH=!G<N+ISR]3F5QM3K(&!B&;Z
M'4?"L8>-\!)GX>:59.ZD]0B0+)LDZT>ZL3T;DSC:=2A"SW&STL<7-FPQNV-)
M4^8&F(\M8'\R[,38O;AXE:7OK%H$YKHU_ A!?I:LR?#[!G[7UALWR ['#Z,)
MPV3;'5Y/<'VOVWHCN4W^!#D2PA68JKG"R[_"=J5AT"M)"3PX(30?I"!L,01?
M4 9;W:P=@6YH#E!4W56<PD)Q]&J/SY*4/"<6"DXQK2F]K>_BTHZX/LY5FATE
M U-@=5/A2^G,;8AM@"]$(2^=\\&36D.PP44V4^TW,FGT%TKWU)P/HKI]#1$"
M6,I]4@ B+QJ-AQ19!,L;3H!!K:906&=<??QH2<7DPZ^O5]3^5%T0;8TT"_&(
MT)[564@@CHHHGAO[$$Q@[S.!.D0L^'2$V!8%D6&?L;)MB!@B >9W#>_ -=/F
MAT&1%.3\(RA!.1OI^0.7OHSX#-<TKE;1;@L^3,VPX-EN:YAPUA.=>P 3 / /
M944:IB(E9_(L8K,E>O;WV;15S]SM?@HXXM(YH.4KIH89ONQQ='=-5C\W(8;W
M_4Q (WY17@?[T79/LA)(?%VQ?W-3&Z:1=E[;:"<1:<^M)[,,[YC;6OJ[6%">
M#M*4#D<=K;KIZ0:/@CM%HGFG#$&=:D(F7D;:Q40+:B=A8:^")+G3Q\6+[/YM
MY_HA\V<U8\I.(WHO-1:1:7X4SXZCIAVI/ZOV!BM*^6YRV%X\L$#_>>-,HAL:
MTH4<,=/ F)D64U@QBI_Q3.R\<7VCB#)K'VTHJIT_DB]!#8&Z6OQAZ5>*21/[
M]CTFDZ+"<-41.:A?;."+'N6+B\N5X[\JBQPYY1,'ED..^#!W:&QYJ/ SSH*/
M/O^UN7$^/R;K/^9D/=/#S.S1^VQ/;,XDR>'^2"&$$^BCHS0<<=\L$T=]%1?T
MXOK.=L;_PXWR<JD__?#CG[_]\>35#]]___+UFV^_T7\<7KSYJ)T!0/S-TV2Y
MK(,[>D4USN;\/W[WE'^F=(W\S,]B*]"MUAI<[M\@4I"/;=(%\N4?XDL-F]F/
M?/Z'%]?4O!G\"EE$88!^M\(__^-WM(B$T.RKY6L\F[W&S)W]5?42<]]T<YA9
MM-7RXKSC'&3;Y7?_&>Y-<<Q02;#_-A("$+E9M1&*!RQ;]G/V*ZLK&[9%Z6&Y
M>X%6[-A+IB,F.GWU)IX\DCJ.#C[+1=$=!U"FE C%H@^SA0(1%73EV<.N>('5
MC]$._^GH/[2 C_OAN!_NMQ\4J,WX<,H35"30U6N,5KV[VK7U8+T1'NM?>_5K
MCL'ZX\(\+LP'69B=2M"G*1I)2611'J<=DD2Z0'5[QY"YEQ*Y=7DRB9E%LYZN
M/C@<(WV3P+*:;)G&;5EX?ES\Q\7_,%Z*RYLPD;&#-3L0NF&73Q3JXLDN(EOR
M<6$>%^:#+TRMOG%13^N4R(,,#-<X+L'C$GSP)7C>E4QL*N>Q',Z<#*5:VDB4
M1]I_)51-EH&.N/HTB_>"L13')7I<HA_&2L8NHV;C#G,MX7@$RL$5^/"UQY3]
M:"Z31P@/Y7&D+N[+\3+69J4M-A7)0V)E\E$4U0@5LJXF++!:V>5T[&JHN8B'
M3NY):S)E1+@];\UN.EHO42U0"OR41?7E6DICN_T,D^)%74G9M1][O&4(B[=U
M(IL4"5^,HQ?,R-UP@'_ .J9\:Y/B)2/]C/$S.3 _ G 8*\D<"9,!H&[,19%(
M<C-&9JE6<F#V1+UJ)YDI,Y *?248*Z,&PB55&HCHC7Q_ @LQAWG=3=L20 -$
M=?F:"$@="7?P#B"1A/(6Y>+7I#5S<X'>&S;0,\\K3@;8I R]&0$GKOL[_//*
M(3RYK0A( '6?&>I9-]*4#YD</24TVS$9TBG'=BG$I_8^X,95;EK&+5T;;B[E
M1]4FO_21!/%1O5L3C>P=AL+3FHZ=K EK_LJ+4\3Y^<$Y2P3-<\BH*/;Q5@QC
MWY[0&JT,PRBR&]1N?8(N*X:\T)BJ<A%26[UTP/NLK6P)I9G$@O_,D4]H1WN&
M1GLB-HJY7ETW'?<HMGV5P ]8FQ+-6SM5WJDVYK0 OI"52\I+4E^"9 W!K+*_
MHC+$/:4M)(,(>>\>0]K?4(B>&Q<W( EQKJ>"MU)Q6H )2SL,/YF<WC/1Y%BV
M_O"4:SB06TGL%D &Z:V=NE,-P".A(<<A?/J?:0&]BF'P9]7I^6F1M(4E-'F7
M[:;:]4^D"[PF,->@V2$>[0BN= UH$5QU_R>6G:?\;W&;LTHP/:+FC:+-BESP
MCT*4.YVB2#<B] YF"6]:M?V<E:"I3CH-76=G=<F]VPS)8>81&N9;M_E55YWL
MRK%97^@^EV]S3_:\[V&'@1QR40)G;@T"U@[(TN^?/RV>/GU*\_G[9U_ROQ4>
MIY4?2"L60K5RS@(#@C /7[NG$<(6Y]#E'-A+^#1?GW[^^1] $8?37.M%3C/W
M]Y^?/O^21@*[;QU6=?@G 8M^_]7IET_S/Z _LF%K<44=\__F.*"49/=)A'OY
M232JD$T%-BYJ^^DT]6]ULL_B*K&F3!K0YZ=?_H&&Y?F7?WCBF.*7X-9X4OD,
M\^GB0X] H0)DE@ ZT#+IC!U<K/VR%7/8KK%/:B'LMRHR90M(%A@<<(:C07T=
MO,B9X+-(^FU<2U381Q6$VX*#*?Z--F$PYV*"_5$;(X,-([6 5CGSG;\?(2#H
M!_,M/;T +'FPPD3YQ2UQZGH#WV-TLX[.BZ'R_*7HPAL/E)!$B1^F7$I]WN%B
M J>/)!:<H(O!+MYQ YS;CM[]EF[YI#?;,Z4E1&+EU97:.4:>!Y<F0]I>M5?@
MLLA&F['D;21F)>H](BR?O8>B:Y.+T*;IY$KJ?$R^V94"]"@;/3#1YZ_J90(7
M4[7*08N5Z-S#+$?*LD\9^O3%$?KT<4.?9E<O3$ZV@R:F9\'"1)VDE\VFHZ8
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MO<9KV,,5:(P*1K34;@=E$D5R!9: R1X<$:Y2D4JHS2:W[>9.D%O76Q:\TZM
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MZE;O4!W<^"X!+KT:0M)*X2!4/E=\D/D6_%M/PVJE<^&--$G3HS-^7/D?P/=
MZX\#[$Z;<>Y'CV[5:4FMD.P5&+7S[K)?D5#QN1-+G*3IE0WAH.K^@G]?[0"+
M&BB]<J0U..Z@A]E!"L%@C;U^PL)][_BVX^;:R B2MK:TIH" HP'76W7MOMRE
M)+.QZ_8WD?B-A=2<R%R?4"&0PK\VK5Q9\A406^Z)9%NBTKM:(#8EWV*U&3E0
MXJ%S?Q! SGEXM XT<!DW_UTT'P2E*5XI=19MRF[3)[(UGANZR##%7*0T:%7:
M.7%X=<!?;M#,% < =4^C.2T\F H!(]L]#R])5&<9^ISE8^9TE6+A]'3UK7-K
M[@ L9]!GY%@2B1E-M-2-X5G3$(&'E#O-N<G"!P'Q@G.XD/<%O\N0,4=AHH@S
MB[%W$"-]!P.,>SA== 0]H-F]>8I5SJ'X#';;"N+*]!L';8I06/-NGQ2Z4[ Q
M^* O2:B(!$G*OJZZE2IL^\U)Y@4*T+JUEN!5Q:0P_-!-U[\M;!>]+JLWHC@2
MP;L_>[#%;PG?=386VW8*:;O)H5T3S929=NRT(S>178E-QTO0<(:N](S_C C$
MMC-_$#W9JF#.'P%T29]QH9UYPG)>W$6LQ8(G!<8+1*0FZ"<VH1"^D-Q[23C<
M7LX(AGO<@75 R FF^GO[K/.%0DPGU<-/IH_*]L+@D!Y9(^'EM)$\AH_,E=+(
MM#D!8[Z?45G(#9D^9D(A+^3OLF*X30M-PF1BZ&9*L@0G!SW)"%L%#1Q#:-G;
MC:C> [>VJ1:>TC\CQ]USCWBZLD;KFP44@'7: =B DX6R_V@\S++X52DB)ON(
M3,=7-9%Z4>:]$!/]H27-Q;0IAP8JWMPZ;!A7M>P721?$C,?C&Z#OVO5,<QD<
M$AGAL&U(:LY =7RZ'%A=K8-R8I?>J;U=CGZ*--87= CZDTT.K/Q*_B&\69F$
MH(N;SLZE'(0.HG:Y*_43;DR]3.9B.]/@;0)4[MR]\S,>7".+@)7$_5Y&SF2Q
MYB>)M_KW(][JX\9;_9#;O>+V%EG2##FY:&\*I]ISB\^@S1]#&TQ4X37?VMQ$
M%JP,Q\(+R7[E1HE"6V:#_:QQB0O@;T$JU9&9"<:J ]B7*KSA<:[)(#A@JGKD
MZC!XV5H<>UMBB@''%WLDDBJF,!Q5XWY ^E>^KO=?[\\XMN2;2S>0OMU(B/]^
M'WQ*XIB]NMCW3'%R$28_7L+@P-1AUQ)'E<O% =7+/!CR>80M) /;<7Y@'-).
MU3/MLJWTY)#CZ:)M6-XO]LT#F*H)B9A?X%&CTPQ<<P2%KYBCXY BW"D[TAK]
MSX;U2^?7XM&79/W0V'C@_#X-3OQ,YV8<S DC_7;&";A-U9.CFTJ@NPD">K >
MWD@H-BO<?%7BR;B[7B1[^C:E=#%9H-ADL=Q=)D?8K(O-3=RY/RP:2W1P5^AR
M\' )/=Z]AX^_,R%A<N+6POYODFS\Y:Q_]%;W#D^H?"I2:%3X,O_-!]S^_7!S
MI_%[+TE)>PCQ#%CHR\#D,891RB[A=5SL?[:6U=BX@L_>Q;LZ30-/6W)*LY$M
MU*Y*&3+D^I*,DG;Q#H%$S\[2YB#7!*ZXT^2];)VQT1_<&RP$3<ZJIOORMP[Z
M'=-=8B)^YH;NWS+<?V\2/J($FB'@"_MN1T;F_$*[#& O5%&;=JG1B2X9Q$4R
M *K<%.]!F<11V!I@+>MXPL_JKC,J)GUX!K^ VCJ<H5?80U3WN0PWEO;5_JW(
MUO=R>>D8D3VSC>V,UD$Y>7HS^#AD%K)N\^]VLTS5Z:RV]&6(=*Y-A=>I3SK.
M;JDHP)BBW3'K]K$2G3A'OFZMB<T9J6QM&9%>&'3S$G6*H^@T*VJP#:/<=2UD
M1\#^L=#V/J5J+J0)$!\%$]=P=P=RO"-HXK@2'V0EJEJTCW+@R%_5P;'>']?9
M<9T]C&*"+^?EX<J=<S$O-!=SQ+P<%^9#&4#A0ICA32L8WU (.6 4R6:9 XZN
M#=>@[?"_"4SE^Q!PCW46_9O'JA%_;%9WH7F7>-3W@I',T.DS1<TJ:V;W(NHL
M Z%-B"J^;J AU:78F%/4Z7VH!-*^5<4*EX)2?XJU#K*6?:[H5:R38@,1)>SK
MI7?D)(O[XL'(=)E<."J"Q#YX7Q>="3\*4ZN&.L/5#M*_VRU#?^C(+H7!X":J
M:I^!,F[-%Q5= "!B3!= J=&5WED\35=T=NFX H'JV!FG(_W,6NJB28[KD;A[
MU:F^7P_A84)+CET_)A'5W0%DA5<CWE1K"$APKERW7Z]X>@GS9(7,PH#N?-?(
MGQBF<K0@?SD]JS(I._!XE%D<?']QDN_Q2E#Z=/H;B.O=0")7J'Q[C WC:X1U
MJM-@I4.F\L&GFHK).!Z#3?QU2G^(U5#?3GTH!">U4H2$A6MCQ8HHR/<21!T"
M'TJBX49GBUP+>#$EV:#DE"OD9DNF .UB$B?.ES&"(&TA=?4V]M>%/=[NKIG;
M]!"X[A?)Y"BA6QG,4%>Q64O8/9)4D'X$[#*78Q/YM=0*[6I=UE[)A7*X B 6
MX'UR6"VO^W8.0A.A$_DKQ'KT[&,OAK-T>[)V7&)1Y1-C_\IC7]9\/K!([* E
MFJ,PU9O>.+88/+HWQ&@\QC1QSX4U[!QF#>OK,#F[*MA(.KG_7%G?&K]C6(NC
MZNG(I/F82=9J8=FI8!):/F-++305?,:>4R];K=@E*NI<L9,)V;LQ01WY1%:F
M#W"HY.XSR__2)?<OGAY+[A]SR?T]!'[8;0A^$#MQT>A&3Y1Z1).3<=E4W,0R
M+]<E8U5/2[/3-FBG=L:=&O0U8C7JZO7$JZ \.D[F^0< JLRRY,X[<)?0)V&S
M"@JOC#R4I*QFJ:D?2\KG;PFWR!Q'MFJ8SP^#3,)&!6Z3T9:#L.S<6>OIT[T6
M[L'+.Y!7%( 1+W'R"8,$CEQ>(23QK1F(MJE.*+ Q46E_P#0B9)<=/KYZG96
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MQE$FOJ)/3D-)XXZE\_V=L*R>[F&A^4-7K30):4-'<(3JH9!TAZ0Y6*2E(:(
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M9E4'S@]<BN##)IZW9(K5BQV;G?9WC,U0[S3+<>LYT%4GRFFI]G]0/FSBCTA
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M[]-V63U_Z=Y@]^/KB'E4TF 6OE!('48QYDI5Z"G#V7F\'O\]0O9P"G9V:%I
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M=$9^Z7^/N[V41)\#L$3B >_J2XY\GG_U!UW!%.Z?4!T[$C&?E:QOC:5(?^%
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M'8#<;DJ=)^SA.5'F@QKGFCT3TF!TF$\<(\(74(*>RXGQ@,UQ '?"SK@2,!9
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M%02PQV/\Z_!+X>T$U'R35QU0[H))[24D"Z>?I XA6@)%(T4PS?6$GZ.PE:%
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M[TR^5+#AU+HZR;HX='5>3(2-52U!;.556&T$#Q/WR @13E5M&-Z!@?V]"9R
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MF.$G&/#_Z%[0M?BE231N1H:&99#S+$Y@\617E@ ZS!%V2LJ*><+8^OIFA2D
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MT[=U5>1'2ZN@E^;5XS&=5GMX9ZD_+5V$G\PX_I)A YN6IO>M"YD&4D9-!#;
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M&NV50-W[M"J]00.513B>R0Y1.B1N#]Z&I+>$:@B_(WO U"_LFP1_MI2\$>Q
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MPM$G*;;YO1P.WP?=QM+[QYSU?[ED_9]ZUE]4O&9:*1)/O%U?"_V[:ZJ=N_K
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M+#_V/FG@_X<JZ9(S6#,=A+X8LFL4@? <2_@DY4RH?:P#0;3<4(31[[RKZ!A
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MF-L7,.>T/J")[,@>5PQ\H'.&T')M5Q<\$)6<-V^F=(()N@YG8S%39E^-8U3
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MVB?B7QE7]L+\QL*7P-BJE!9/>2HGDJ>_DOJ1[G:&G]X(C(ZZ5!A-]:/X*XE
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MN+8<@= ,Y'Q=6<#/97-LR2'Z"R+G:808245MU- P$E^!S2$KW%:X:Q'N3X3
M,_;\@&,?TYE(1='<][ L%/R(/)X*["A%A7_@LZ,K)4$-%ET1XWO ^AY>EF+)
ME[QM)/@))0KH(F1Q* 45OIF6JHDK?';7GGM6-#8M&B;H-#)Z%*H#*S^3\!8<
M6!2#LDY U=;X&KR%H;O#9((UT]<JQU!^.IQXX;7(*\.3.)OQ"90_X(?E@XJO
M!:UL6-G8O6S@9:*&:1MJ9RKP03!&:/EQ@<-,%37 ET,E!"4#41T3.3@;YEC+
M]C4(@B<!W"M0[.CN10+9A6:^P]PRNF7TVIP?@UDUNU&^1@"_XX2J$&;ISV13
ME3P1DOJ[Z!0<:H$B+V/P1BKVPL0C\(U=P':J0'*>:35R5:J@0F(KYN+)Q^!P
M0V@:>6SI&W,OSI,_S6/,O #!FH%,5G8P#LX\/UD)L(:'(;,13U($#/' R2-@
M3+Q*HY%]S&,UTL[R@Y>&"$@\\F(>O.()@FB8W[DA'J3&["P#<)869M1XT8X1
M"HK$ AK''FPOO 1M8:*FR@4>Y05A/#'.BV G-)%0%8L+U[A-?%>H[0S>&<S0
M8"M [=50PHWRU9)L<4%/N&4]*\FI$@X+Y4ZX3$H;D+F'A&1IFB(F3?1EK.E3
MJTNP@M\:92FBN]!,KR-<=U&/4RT6F2DFDQ #83C 59XX71GD9PNF*E8?+>95
M,:+G4.XF==M!9(=4]@I"-QOSR@B@AH!3<\2@$^?OT2VFF;HR;Q*'FL684I8J
M&!R/I2/3(J[ 2(FB@4S:6$8^JOZKG([TGRB'G,%T)49.Z>;=*P(<I2NWRPQ0
M2$C#8M*ZVGB'CA]3EBB7%J]L6."KY6D1O9908R78JWFL4XM*G8F#T$GQZ!C9
M?H[Y.AG>E[)N("B6",$,_6&B\EQBQK-2XG_B7.(5?P45\?4YZ"IEJ>;M8Q@?
M:XX!&C&=,0M$XS&B/U'*0/XD:1M.+,\_+(Y-J;&XU<RLN>AKDL(^<*\K5O.N
MQC2F7A_:U8W%+$LE-3\R2JPKL7$I_PS5;Z#0&U$'Z3,$R%LB'DK*';2CB'-Q
M*4B-*$9U'!7V#+0%9BK"$^J:+Z]SC24$EP)0XP,#ZU<)RTL^K].@8WG32 I)
M)C@KUQ\G0]>99:4USH(Q7;H7F#0Q 8H+@3?56<SHA3H24PI81$6=1SD?^/NB
M\N34*@5L::AHA=Y+INH-7U7J^$4L:!F89Y73E++ E*+B'FM2;)A8$JP'TU\Y
MXU1E[G&01$D"/Z9U*EK$/'FIG/Z%R*"^[*:F?,0Q#V;J'2]EM#)J'4:J:D&I
M275VAVJB]<(Q&#(L]')%%];@JVX84#=77+G,5O.+XC5U_F*ZQRT8VIA0'493
M!KB6P->H"\:!IS0B/,116\*AXO1Y5\%,RXC8383/!P1:K('/=;VK?H>"7BNF
M3Q'@F0&8'BH*_EQX!DT(G2YKF'XR=X!38CEA*4\$U*L!9:\!"0.)98L'J#(4
M$_-DX8LME%YY9V]$VO'-P#_FN>_J)G<JL2&-7)VHR)'&,)%L:?Y<*MW%,T0I
M/!6D*14K2,JS#4B9DQ)X.)=ZE\TR5PV5**MK.HW(%(F]V]RJ4PJ!VDV'.DE5
M)BH6F DQ=1-F(FTO^[(Z*U^(*&DL-LSN/3U?GEA<QHIB+\U ;N](==(IK)ZL
M22R+XC1G71(B>8V'U*#N.*+<222=1 @D=;-B9N6)Y7G*.2M%I?@7GB94OX-K
M_YU0P3C(L"3OI<IDFT2WH(C8FD)(Q7S[M2C*4T_/ _^-Z7<))I+P$;%^Y*UX
MS!QVW?# )J,<6-WP#]+XSOL<"B'9=+(E'*XY=@J#"&@ @=O8!_L[1&5/:1FI
M+K:7&.P:5-#LC2!36]7!20<9.N,2+Q6>_I\,E YVS'5^T#=H@N!=\MUE&^W6
M\?^HR@J%1(QG8S22<!O_E86BA+0Q\@DTN-#-5AV$HRH8>0FC+M?X63[P(P.V
M[/?ZK:.KET?MET=O7^H9R"=_IPQOYPNI977(R'%EH99'[V-$&EC$7*<!KR @
M9O^EZ._!'CUOE[$[V*\K0>0;DS*GSTYFDEU-<5^Q'D0E4V-&MCQ1P?97()UR
MB$*/XFMLV8* P FW7$D%YU6C[X,^#/[6&(:/"]G ^*.XBF'KY[P 3(&'#>HI
MY$ZSV^]B J\B'#PCIY6#W2?S*<B/0I_]^>/K#X4GJ\%&$":'^82+0]%EPT*/
MJK7O>7./?(LO11!(8T2[0N0Y<P]GVCA$ O9UT8CTM3P<6F/]8+<-95,IS\]G
M4\MXRW9[BD@/55HMBXU%./C)#MH]^HO(16=3\GG0G..HT/V:C.3H+-QDA):!
MOSZ07B.K>"B1& 6& JKN8R%;A:A&38K:>5,18(,0@^N!XTVQKH(HU'&!/&ZK
MU9)Q8=09>."A--)9=S0X:;UX"4K"!T)@(4JB*CEH# X$<34'6,$ZO2:AOD1Z
MD#,:9$;(QF$VS3=,]9@R181[I)QW>FYOT#(:$Y?A=M1"DP(4C6P4HKJ7P._:
M;;??/\5%KAS,Z+LI6SOI'E>:J.5IRQ;Q_S1:@F 5N9;-JLXQQ3J&>W5GH6GG
MX#M#;Y8H& G>\ECXX=+F*EV?)_\SORA9H[5*!4,NZ:Q"/R8-0.U5O-4-5AQ"
MEC:@IR16$*DXVK9]$=?5O5L>TX3FZ30.(C>05 C7.=@60IMM(;3-PC3$_?ZF
M/'6/895RI"6!(9)MN$LJ%JG(. 7+G$(07 MH^#EW-C<A]LED_\&\00QBB$2E
MA>:5,W*A9'!3):<H13SDA#@H99;L2(@]8RIHE@\]'77#BF[C(GP$)T#"$<K*
M(+R^[,B*7?OD%%T^QI45/^&E4NDS]Q'1S]%EQC_1">64X702C0@HQB%+BLM'
M20.,B_DERXA3+C<2U(MD4<,;>]]Y='9)*==C(1>DUNR3/(*2)Z+P/%^U=,Q"
MEM#$JI:FE.IQBBDEE,50_KZ4Q\$KE^_LJ!_Q3U;_;0?6?U.FR+WR?YQ[LP+%
M%>\QWQ690RN?7_S5,$(>#__Z[%3G%:E>7G) 9D<E+>V3%@9#2?\Y?VG1_\H)
M1NJ=BS@"!;W_?]AJZ@.&=]Y<Q<YO%PO]IC26P,,6N<[S.R3'SPD<P<X7!IDU
MR+*("[H.71K&M9VM;Q."^^Z2,7>RXO:36W'WR:UX+:XFM9(;*+6I%L[,]89_
M7L?8H^58WD -AT*,QW<HG4=EJYK71TA?O"*C*R:?*NQ>':L/'^1>_"3X[[]'
M8"ACZ"-QC@C=;20!(_UH]%)GH*ZE&)?>L2SCB_6'4*Q*+O&SB_:@MYD);6P!
M]=.@WWKR).AT3I\\#=IGW;HFM FSK=VZTV[;.Q7Z1:(H-UA_GI\_><&Q^O.B
MT^T\>1JTSVNCP:;T9P-LT[=AB,U%?^BN+S^XZF-'"O5YG4)TWG;;G8/3I[62
MH.OV6@>G3NND0.^TY_8Z_:=,@@YP0;]WMN_*](!TIFR$P+H3?C1:U)^4MJ)=
M_@9H4Z?MMCI/6I4XO>Z3/DS:[EFG-I?V, G0&=3& =8F7:I?OXK4>1\%@1>#
M-B70Z"AT?GCIKHS2VEV;KU\.38PL"381*U_/+'W1!"+4QP?6+D6]^1F[@QY1
M1A<8GUXX2G85&ZWSY#WJ#]S.FE[<RP.W/HZZ'7?06\\"/W@:M%MNKS5XXC3H
MN6?]]:Y97UI#]%Z./J6O@GO_X6^??KY_VT"]VFN[@]9Z3MW!RU.WZYZ=MY\X
M#=SNFM?5!T^"<RQJJU>KPCA;P)+[^H6*9-OMUUBQ90#^'C;0P;D%.C@PH(.[
M.L<9&7!;:Q2WI+NUT34N+SB;Y//S$RY0+37E4:@UI2YB"A:>LU2,8;  DRI=
ML"X_H?%N_%$FP?@PLI7J/F6(1,_=6*GNV8#8IYG*?M)[V!!09>5L9T\15B E
M.LL&[%Q2C!M&)5:%/:-2.<0)+;8\4CT&C+Y[5 S%6T6@Z30T;!F"[T7PV>TD
M(O@FSX''_\7-W:AXK]2LW76$S]!BJI6</T5,&V,[J2R2D0BQ?#T:^AYC+\"G
MR FR'$NST1YN^=L?/[:TW8P\Q,6]ZHHM]!B>:0PTHX;DY2VX%<Z-3WU_*;DA
M_Z5N+I'(1JH()XK<4Q9TZFB*-69IA!B0B6J$Q5T&N8A5\I=J73\1V#11?2HY
MZ,I+A,2+"X890O4Y2#L"#9E%?LCX?X0*->?&H[-@KLJ9\?$$#G0L"@GF,M5-
M@XNHM< /VYV]Y)'O?]^^GM?@-9Z\I(V-^U@M4FY>A@MG-W> !Y[ *;NL2I(4
M^[\JQI H$*5#1*&Y,DA&L8F\ DGD.E!?%3%*$,GAG_($PJVN9&(%3J;[/NCF
M]"5F B)'U.=!<@EPG*]+)5E1ZJ8QLB.MQ$RALXAAT):>@R.!R 3J_)*\'2!H
MS<B;\[_U@ R4ZB$FH@0"BF(E@OR$R_/UR^/BH,Q;^&^Y<6I!O$2D,X&6I50H
M!2/?#2O4.:8Q%+20FN7>2<K2^ZXM'JD&6T\1](U@8T "CG&?RNT &8YF0@)'
MYV"J?DY;N[P?D6S'HVRF8O^O:G;_">>N"&8([;*D!)KYVB=KRV,0W"CT4PDA
M"9::,V+BQIJX,35A+4C2TN=RR4(X<6!MG)XN^"^L@$&H)@1^-29H'J4--&01
M/A S@B<)/PT."IS_P')S'Q$#) ;5=_P7=FE%>969)31O^#(T)E\U$X0E]J8B
M5TA:?G6E-KY2O^N=_+3X-A-YA/MZJYZ[W"!#XY9B27C,."$D]RFHNQQ:C.>C
MID+2K#6)7KQ$5)&KHG<@("Q/0"3%%:JQ2 $Q>")J#WTJDI.7PUHB%/J]J8\_
M*N)C+8POC;0"*5DN8MGDF<"QX/\+&-)(_J":RK2G<IW,RQ@XG2%M[U1SL3@6
MX35HS)%2=(HT2BY,BEZ)H4<%^\91A1@ ZC-]_B ,&H)I15DJB9R PF$ #I0"
MN8F@2W*&Y!.% 6WHY*E>K3IQ^)DJ'J?S..8&@@R2NUP\%5Y;+ )QXZF]N,]A
MM'K<RE.J?#@M_7ERV$?6.P,>?TQ0;M\TX.</";&Y>:-.B=V*/I$2U(6@.&2+
M;XG8ZE9TJ6- #%A)0B@3RJE67[,8XMF%D,X2'!Q=!&HW(JX)Z^6* &\E:HT?
MTBE$VZXP96'VP"+T+)ZF\BPR#RR-RI&CJ!JH')="XD9UE,(&!<;HOO?"'U&*
M9.2((!'<J5RI B .X<ADW!/!@/<P5Y*W<J^FP1[:4$IQ;,=BNFLV[S17?I1<
M^5TBLF]G?LO?KR1)0O&1'-U3H"2^+N/->]2C+HH)35C#TC/(,[!B((\;V9,Z
M4<U-4@;TO&4DM'D.H91PVVH")H.C[WJ"/4CR)@4G>B$''-(^;]F0]CZ'M''P
MLISXA-@>78>4YBV-$4;Q'VN^=X&SAP(X;4R=0LI,KEND<L>"PHC:%-9/F\XT
MO<QHU;$XMFKZ#D<"-G&*3-]DU=D(7M(H(LM8M@ C^SW28*+Z!1+EE3I?@("2
M&^-K'+)BXYI8&MT(XS?DN.PXRKL\&[TJ"&]*(+P6QKH5".+*E:IV&ASN0,.+
M0ATN'KF*H'1DA<%<FW8(9><3T#C'>G"I)\Z[980QIIKC?IT.7A!5"K&4L=X=
MM.VD^\ S7H1LD;" J +/.G4,MO%XW[VC_FA<;>=,^[+8<]@\Q'2(0KMJ.JB@
MC/7%4S&W$$^<BO%-+FBW5VS<',&,>,,6<(QHOWCSUQFB??<,:V$MR:?U#+8'
M?/I3V?C;X=*?)9=BN:&UZ(4H8TF=*X8Q= _+K-#2*;K"NZF1N.$6:PNSNM>Q
M5O&[NB6BM9Y$K)Q?9]7@#Y:'TX.0AT=X3N^P21<LS7I0]_.@AI)>50)^F68C
M/R*&D7]^]L<2[SIWF+2U(5OCY!'68AL=^?4H2U4/%]FU"KNZ#,DJYRM,XV$\
M'6:J!\\$_A,87\Z\X9_>-2/<YL8I=9DS^RG+OE_F1_"XP&LA8S#J*2,8]#=O
MK45?FI:>$0VASD[>4"'1JSY"YB5XWF92]:'1_=1V?Y3LTN0I<YT.BC/!RR3D
MPR44@=Z*O&L3[.U4<8CD1+2/Y;9.(KZ 0>O<=::PY4,GCN9>D.H61]X4>>[?
M^EI4MEFCHR2)QNDMI[WH=B<\].[W;U>F0&U[MX>G1QX6_J#$>3\.D!]@!GCQ
MD"]EC-X[6YI>X?6F+,B]E(E!?C O'"#YWA>5Y?&B&.//,&%$2K*Z?XO,_FYI
M% 6&J(/U,I\)LV<:7><HD=5W/SF_T16IDFZM[JFM)'418 X&AL:+GA'W_%Q$
M63?7?Y\K+6H, :;Q<98(=16B9UF8,C<*H>!'I-+SQ$A&6JA9&MX@\I57?,>6
M4(3]!I.UR'.461+88V(KMS!WL_0EN0\X^R^Z2>5VN#E_\U2_63%RB7WU)4?^
MY%2,? ];3X38.)DZR& CN+QIF^RR&1,?TS<W>%43!&#. $M$T=0P%HP@=$ ]
M=&?>?*K:WM%?U.D:V\O)8^Q._E1=(^ZZ4"+6JR"%EMH%,3WH%.SSMHU7[W>\
M^BZ-\;ML*HGL^G8$5I]L,'&S+3?/G(!7G(#2']H:6BY%RPY#/GWRDU2UC16_
MQ#!C)<(7I*A-."!-SD\@KKT 3-ULRCV#S2[FGWZ"_Q,.90_7>\R_F*-"^F;,
MS<C'LL5ED$=V=#LE.O>GU&2+,DGEE#SP U,XM[U?RFF4DR[=I/EP]L?;:6OV
MAY!]N61[V:QP;7Q])X&2<LOT_-*;OIAE5P$U\*7>>:8WK <H-+DN-+/CNVD*
M^\,HUYYN*%$8U<_)IKN$$^N,J?6H)"6^6O9+H1?24+DM)6VHQ4T]<=[F"^3>
M,9)>*A?U/D2B=C"Z+SSZU%=@UF2ID/DEE,XC\]?9(&&Q6&ZP2/)R-RU*,=4N
M"*<XW9H[BPV'*;6%4[7TO'2:#PYWRRF ,BU YE*'HV*V\]9]E&]D/AQ)!^2E
M\RG$!KNN@WF5FTZ=Y%<+]6I?OIKOGG+#* MA7]E#YI2QX=S!!H6R'5*4[,:[
M^Z0ZL$G:;;[1CGQ?E?&HV\&5'6*9W44?<'P[B+P[>I1O*"UJXH77))T?/3]V
M_I<2O]G2H)I -#R^4K+.IF,+>/>J)S/&R=RHR9A][3ASR*1R6O@EW<,6?DTE
M#5F*+29''+PHCP9V]5#(XA9QXT=98JCAW66L+=D:V71OISMRJ^:PSD;H0?9Y
M%[[C)3U=M^/1RHK8^>G]VHY$S IO9UV,MI0I KFU2"K'>,2P,M [ 3M?9;O"
M(?S/#$PU;&JN^HGK A)L0([!?-662K;5DCGT'D;3 X=[>G%*<Q#=ZBZZ6),F
M1MHXX'>-L"2%;O_0#)1=7>GPG7@W]$*9WT<&AD_%;U-,T@C\/P4E/WC4WIF_
MYP",'%&.1L8&/G$E'#"4Z6#: ;?\R)NUZQ9P6V&4O"L;Y36"- E*54DGBRF6
M2SO**[N,&^XNF%K55X7*=-/7E+J-:/[&O+ME\9WPK6?TH[L2L(;";6FR\L:5
M)HKWIK(L-:9VX#I+@EP/LHQKR2]]Z+K4.D*LP+S/O:Q:3J=Z.5EH+&B$QD:-
M2_M#BB)L!A@DLH'N ]Y(*Y8IQ%2DH:NV*,G\OCN1=\1]Z+OE.G4+T6@&3@F%
MXT Q<-<^^0:S9W/(6C/$$)]95EGX 2F=6VG:8;Y6*# 81VX*I>33,2?96-\A
MT?FGYV@F(^>BR>@K6->B*<!MQF%[P&M#1 8MK<@3J.#4RU'AJV*^&WV^JJ<Y
MC*S;3Q<;(E*$,N]/2-D&_+-'\.S#IH6DQ"BV.3GU4LQ2C_,L"9Q7I=QW3U 0
M[XRYW_D :R[0P\?\EPX@<7R>/&TX(_-*R?5WI6KYA;TY[/!JQX97]SF\>F^#
M14DD]_!#=?$5%8+9S._N0^Q(J_"7MI\I]3/MV7ZFVQMX$RAP3ZJ?Z78:>#[R
M^1W294$5VKZF^]G7U/:\;/Z*[1X_0;6R\E<KCH:[J%M&0]TZ9^W_PM[8QK@/
M]*\H6OJJ5FC=9;ICIT_:V3Z!V1YJ2X)N;0C:'ZOK:QL G=UI'5R+XUI[(?4.
MKM%WG<OOMPZN06NM717K6W[CV@_4ISP7Z[V;T@"KNUX+CR8T/CJ\GJ2UD^#\
MX(Z0^GN=U]90T=J:93" IBC+TX,S->H_+RP)VH.#Z[VZQVQ0H2T-73/[=<\0
M[:9C5 ]5K#*23FDB&$;_50RCFYD!^S:)3<>#+2TM+2TM]X>6C?/[^_49LF;F
M>%.LV.[AQ4OK]_E;Z[49; (-SL[.GSP->H,S:\@^A4/.&@R6EOLR"4O+PS)D
M#R6-)T<0C6WVCIUM<V;;. ^UOJL6)?%+X/.;XK,>=6OL"'ZPWLK1V>EZ%[7-
MH$+;[7?6<UV;08>.V^JMY[Z^;(#U5+\NS7M1O$FRBMK/L_Z+UT[5,HXZF*.>
MS2X:HW;/K=IEA=-;+TFH&73HN(/3]>*FS:!#U^UW]U_Q-LBZ58U9&J-7VRUK
MP( <K1E];P@56O:,Q3.V=;91G6HO8_8F4&N#WI:6^S()2TM[&;/)Y*%2RZ'F
M6+!NSP;AR"<^/5\OGZH9=.@!':P=>W%TZI[6&".Q=NR^3<+:"Y:6EI9/AY8V
M.KN\I50<)0FU3&F05=ONK%?=UPPKIN/VSNV-%][TG+?MC1=:M>VS^E)/#C4V
M4%^B9MZL5[7WLKF:=K9-F*VUEQ[<B?JA64;MAF49==QNO[8RK(,]8WONH&]A
M>,[<LS7#J4V@0KOO=@:U,<.AFEOU:=Z*KNE/7ND.+)(/>/OG%LNG[?;.+!7Z
MP M[KW$;8 0O[^/^<(W<N'S[4[?;MJ)XZK:[%IZCVW);/<L,[;9[MF;HT=ZG
M'\A=F[VWM+3<ETE86A[6??KA6,"<%QHMW  UQ8@=N.=]&UMH=]SVF077[YZ#
M2V.YH=MQ._4)A;5B]VT2UEJPM+2T?#JT;%R M[[4IL^8%#J.HZDR<:.P,:;M
M4;OEMLYL8B00HN>>KGEKU Q"]+INQZ8,$YB#V^O45PEG;=Q]FX2U)2PM+2V?
M#BT/-5);8Y9^.A&Q<R0#M"\=/QQ&4^$ZH4AMNKZ=;1-FVSA'MKY[FJU)_T[]
MN#6;P#3#=^FU+1"=[8., -N]^C!,#M5^JD^#?@I3$8LDS95H<_3FFK4ZC= 8
M1VT+X$F@ =TUBRF:08>SWGKY#A84^7X9])X?.MDL"IV1N$H=&,\/KS,_F5 M
M:4,4[/_[RZ#3[KS>_ 0/2,#Z:]XS-($&';>_)C!)$ZA0(R=8*_7=Q NO!;CW
MSMCS8^?&"S*!B)W#**1)7P7"":.T.0F:5K=:FMS+H%LW9;$99FUG_X&/&F#5
M+M/"MUX<>V%JE6^#%8VE296AVSFU0"@;Y R;8+1OD[")'):6EI9/AY8V]"!+
M09<G&C3%ZCWJ=FV.],71P&()7W3KK(0\6"H<G0_J2[QI7%BAYFJD*S&.8N',
MXNC&3_PHA)_$4LLZJ?>K.9%=K$_JM>J[A3U<\6KWW#.;HH$'[[E[?F:/'2)$
MKUU?Z=ZA&J_UJ=9/6H&"@@W%V&]@GI>-3%J:6)KL'4UL[';?)F%C9):6EI9/
MAY8VY+#4+OXJTETVQ7MNXPDUT^ P0PFUTN! HPAUTV## 82&V;!=/EI&488I
MM+LZX!XRBWVV%BPU+34M-3=!3=+$\.EOJ0<_-&=@*.0.O*PXG]<+LS'?1:_!
M\=18?_OVX_V''\?OOGW^_/;[Y8=7ZH\'FL>TW%>MU[?^*)W 9ZT7SYRA"(*9
M-QKYX?5?G[7XWW@<R7_?STXOGS?\@MZ+\EF&EK8Z&M%REKVQ\OTUOZO36G^
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MU@=Q_D/<B# 3]4(:KYV%M8DG[6R?P&PW)>F'4S+_T4_IKFD61]@XW(E9P!L
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M:72O<=LGSL^)T&-CRYY83LU/G%%&R#D>OK%3?*/YB[&?A@(+J^-HE&$6A!?
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MS\R?C\0L%D.?'R,BF0>__!W\K%/BU^$0JVW(Q4"+P?MEOJ-5U)M7&? U6B=
M>3B%Z!?D5J5@?N&)Y"Y7P:V30>50P%VT>3C66""K?PKONXOX&(6D0GA=D$0@
M\L/H.B0SU<.E&L<,/.7'=&J6[%EER)9,8'*,CE'^Y\K5=+YC=Z*1B'<OCIS+
M>_1!-:7[E#>EVY(\?EO>%N\A@HAR\ORH]U)OE"EXYCER[T'+QP8P6W4+OR4'
M"E6?+6))D^>4))D7#H4TW;TDB5#B8"9DQ>,C%/$$?J%3 '_Z-4I1E.!5MP*E
M&PQT*E\E%R4+88Z2#55J)J9C[H'"_X1R+<"CE#RV);;2KU5*G1BD;?A1#V"N
M$B^=/Y:73(_9KYJ@-D:NX3D*I!CH2E=>0$R#SFKDD:)'IE)[?*#1PW,;/=SO
MZ.&=%AWH&><?,Y"&]^(JQ;CZ-4;OQ=:B:32!#"<PP@F,C0F0T)N6]:.%?AU1
MOUX^P?RFA$3:_$I&9Z5=0M!J9Z\3Y_OW[_3L[C4[PR?@ C^"2>3\KQ=D2B3*
MI]:R1R_??OP@8TS+'OG#BV,/#](MA6;U-,8XC1LUC:&QJ! 7]4B/MG_2KC11
M[LE:RZ9'A&2GZO+M@^;&(I+/Y;&VTK*9W:K]>_"<#+%=3Q:5H70K8K'H3 V7
M3!Q>@+Z@'\*A"ZX[/ ".8H:6_\:MJJKJY"@\_OWMV^_.1SVA+\!264S!S0V;
M4H7X.UX2<> 8=)> TPQ\: XAHP\8C\A&(3O6\ F!XC#I&<:'KMD!!^+#]V(F
MP\^XG?\(??S79>J1TH!-QA4#.PCG2@2^P #]!-WS(. +@% 1)=^EJ2(*WAQD
MB1AG 47J<%LY)HSSCW2$&/X ;IK2I/<ND/UV],\L09)\^-NGG^_?;DD%_@$2
MXP7##-U8ISP%D$STS([PDD([0)YZ"-A#_,*K1O%*.DO*NCWB1U^28_?:Z,B;
M/R';2[Y\?;\8Q.L[HQNO36]=?Q8+.&2]4([F.@GP58S[CU ,?@K:VD]F42)#
M1)$L=JWRT]!\C[-ARK>@,[#.D]<.G-XCX-Q$I&D@2%N\YBHYO'>B:"*'!U1T
MY+7SZ?NWBD_SES-U:1$@'],$A,!+'4R?$>0?^".6"Y ]$(-X#K/-8HZ6(*^K
M",GFK[#^((FK8AE/R25-JE+XU#U3_FU &\.JN;B0/TR% +1@57U/;4#QLQO8
MNBCF0PE>Z$<CH,,Q_R5/&\Q.2LI$E->4X'!C$RCEF5'\:IF&4;I2'5JY^D*;
M -[QJKPQ.=%/'PVH)X>J!S!/H^29GE$9HJ\$X7>_$H-RNB^_H/]B51D;/=)]
M44XVQC)95;F&_A(.,>AT3I>/T:X<H^+-YJA+$OD>5:3[D#TH>8:+AX./=\ C
M >=J)J^-<S:G6+ 8@J)*?;I'\((Y:C20!268'K.]X6E4RREJ/M ZP+S77DP:
MGY52DN'%8G*G4G;O&V%><7ZPQ["\QSMKA2&<K3>H#Y/L"D557L",XVBJUBJ;
MN]&?,"W!XDRN&KP=K$&I2L)K5\5Z':7SA7$Y/A5 %*(Y7[##22%2:7!ZPW]E
M/MBNKQV=C/GF3BA-*_A6\)<)/F:*P(- 5[(),KP'6E &Z#.%_\Q"-CK(7*DX
M%D$0V:^JL-[Y*,7S$0P;2HJ993$81C*Q1N:3(??S*#HS!(\_^$4&+\I5R%4V
MNB;!+1L#&5I7L:@X,)5PB?%88,Z.#HL4#F2ZO1/7<U<=S:6#.%^UH<78O++R
M:.5Q P?QC&_W,(,*" S?X&T,\AO;E=Z5'V#Z&0D9<NC,2])J-G6=,6PC/(V>
MV'W,U&I)<F5.AKS<-,8TA^#YT*$[$Q+@!]PD%/<IGH\8RZ'#C9+S?*"5%Z^T
MN>%L3;+9C+T@>9[2LW):)W<+X$:R[#+VC<K;-L',5EA62HHL(4T5LJE$_ 7K
MB0(FY3S*G 2LH&"$L4#>9Y!+O.M-M'+#.YXDDM@HH$;1-D)#Q$\S%3YD.\S7
MVY<34>O !/Z<@7D$\R2?@RAXXEQ&4R-(59AV+"AT@MLMXRKC#,T5<)E(_;+_
M8;T.J^P>I>P"-/^O)_>SXLGO1ATQ])()1EKC:]0GE$_*)O*50$6E!\.$BWPL
MP5IKXMW0%<D5YA>#-3+,0X;,VJY,)RH*]"B"I:%\QF(<(,0F3T*:\33#D4^2
M$0LRT2E:0X))SHQ\%W\*'^(75&=RQPA+#?W#O*$%N;-7M'5<T5HM^72T9$D5
MR:#X?:(C;&--Z.!'5@SFH/=$R"KNU@\"2C3SPTRIQ#RN"$:#$,1A6BV"H78=
M^F,@!F6F87)0.2MW(;SI498;*&#\#2:NY=:E,6'E=]FPAI69C<A,^?A^Y1RU
M)1AMGOE&IBZ=Z^4SW"66O8WB/Y'AU9D="C&" _JH(T<J9V'1>)2^O3!F".*8
M)!A/1,>&J^+R+"Z,D_ =)[IPWEQ:#7QS@6D?2K)C,<J&Z!SB"[P;#]PHF1F8
MP<1@F*.NG!M>CNF1***)QE",IE)"%5,\5BHS8:L'M,)IA7,+PFG>M$HSGPZ7
ML?\+37JR]?D(H[14OC\6R4N4$'7?NO@+R[Z6?;?#OLR5Y0O^Q;O\>\2L+$=:
MCJR!(W74Q,A*6]2="VF);IYPA]IV:6& 'L5RM.7H[7 TYSEY(_8T94I5F.<\
ML8T[BNA'_\I@[/$< ]9HA*?S4M&,95O+MMMAVPWG"UHVMFR\#3;66K94G_H6
M/2WG>Q:#VX;)F]>QX M;2K&*,'*.%Y*4Q910$KCE6<NSM? LUF84L U8>1I)
MSK="A<Y5$K#*3)>Y1F6VQPC9R!^/81C*\TM7O,)U_#%\-G?Y74ISRZP'&DJ]
MG,8JO^MV(N@2<BZOZ&6*0W4B$ZP$!G3+]Y;J!?QR(UCO@NF>)9FZ9J1:_[A
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M:]NQ;A9\B4"TPLR>QU[.33O\;1LT59P3Z&L8Y#CUB=.GV>P5S;TBGL&W,$]
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M\A:8I[5W[M-\,&@^V.GXQE!,D&XAU>U/&U=D'!T&$^PB"7-;U,48J[.IY8_
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M4OWY)S^-BU%>5\&O? 1^3\J/#^MC?4;T 784/IX%KXEM9[S446XCY/!'+O7
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MF2^MGO.0E [J!LM-FIIO3RS,=$&$V$'79:]SEI7<56A'C=:YK7,H-;SRSH/
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MY\9YFM:E:O@;#Q5>Q#F,@^["T=*>#-00!1T\!3GS2+3EH9-5..HBI79?,1.
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M35]$@0TPR_!C7/2.=^QB(2 ):@R%9;K72;6^.?=]A9\]I$4@W E2ZF*PE"(
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M^WM._$A@EX+")M^D35A KE<_PC>WK\C9ET/N?>:2JPI=&7-+H5?F[D)UZZU
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M$\%JH[&B;6]GSODZ!_=G%BO/9]\ MML&L]'D6GCX<#XDAS:WF93>')>OD8T
M,L>7Q-;:HGG@W@R+"N3@^-TV<Q39U&O5QH>,<\+I-6YC@VS#Q"%*G2(^D1T'
M3S_^3HW"07@"5X>T=,=>D./(M=DEAN!Q#,_WK:I5TTM3-D4@8L/+&*V$<5$G
ME5:P^Z@K A2EK:3-#]%]*68+9P"TVU,1<Q?=;D8=&1LIB-^@3WC]X0]/GZ A
M5ETG5>IY<15E@BK!_KEX;X.]\=OEZXM@[S=Y/]R\K%1)6EXK22)^_Z(L<]"/
M^./+,+AX??EKL(<W]@78+;AP\&G0=AS+O.3V&+_"/,:P"/3Y-\&>^6@-.B0E
MLN!/<3$&@83/_/;Z\JT9BOE08U2BAP2O\]L%#L1]Z6(<3>+YLF\0G<0K+-LM
M'#"^F>3PS$LB6E'47XSSW+8]J)@TC6TJS9T%)COSE@:_:;E'L/?AMY?M;Z"2
M<P4AYLF"[Y5\;M@TQ:YR ^FUD E2,OLW)(.V7ABI_^LYV(M1C5F%%FF.NY7:
ML;;F-83PS20O^)!P9LWBFVVBY8*(KDTR6BQ.2IT6,7&1X@4EMY$TS+1 "LS>
M\8ER;,1V!012?94WU9D_>*HD)ZP455'._>6'5BO<>33>)QTX/-X%#A]SX/ S
M[O\+!TV<UVF54*"[S2BKR;QH#(ZH()(0=)'%6Z-?;T4-M8$G6O%QVA/7HTE]
MWHQ\2C  PS?3?O6W8;38GNU],M6[Q5?$0=YP#VE*4Y_P:]$7CI"%:Y'F2S87
MR%=%'WHEXQ<GZ5RS;.Y3B=2.+H'IMLV2^.!08+3CCQBB6$3H>.0.YH/:L9KY
M2XO"L\A"2GXKAW>).YOR?70+Z#NJEL> =<Y+\OT9D[K!IK ;T&HRT\C*4&.-
M*D%V?6HBA*.NQ)7#5:?.(IZYG1[&E(6E-O%4(Y;;O3B;5^IGP&DD E:A[ D\
MMX_RJLF3>H)"8_(W2/VP9&+3&J*;Y,9DTAR-'04D8:TP: 2W%-SL%%=[A![#
MI5[A: 0*-$.O]_6W^O9T!4MJ6<(MC\YRY.V.]J!)1K%5LO$&J1")#Q9/8U_M
MW6YLKD%9J'%'CW/57#>^B@9%/>4]D9J"!OL#?X0M$E!<B[/6+G,KAH']'9(<
MY2W.F#2M4B?(=7*8@'<PCSL.D#?AW\ 9S/)/8? !CG6E79'??,HE1##%V!B'
M#F%J(N^(O(L7J?!I==1421EZY"^3^2F3I* A&^2$K2T4\TV*B&,+)L1)<+C$
MJT_*T70\'30G704: 4/$5INLY#9T%6%:GRTXB*T?2UQTS5=PNL* 5!X;LLX-
M=&LGGKN.Z27@ _ ,)@$AG2P=3&_-45J:MD.ZY=@)-_A[FH] //[4S[_+RBJI
M:LS(LJ]_Q1\H%7DJ@^B\0/J&'5*+LQ?'!\<@GN U,,?!5*Z09G#AQ=GQ83#B
M#]'7\"65)4CU 4<?7K3,GU8]<(A2N?#@BQ*\;!>XM_FB-/<FWN//PA/^.U[7
M<<4NR?^"2_D'<9+A?2/KX+O(PKN??[^\\%R'^&AJM:F ##V"^'VW:MS)GI<:
MHW&-!3H]YM?/98WP23Y;;?4H:M<71R=N-8FND-.ZM"^#<XS\BLG'&G].:0!-
M![,Y)';)WNN+O__^$A]R_!V]Y/2[)NDFZ-,$-=3@_/QL!7P2[T4#/#)Y0WD5
M&5?$NH .O%.=&^&/[JU*15);73R;SDJFX&Z\6QD;UB--F\2-32#H;<#/4(%K
ML4?I.@-X1,R1OU 2@!(6DZB*.*:,@O@C7)A1C9/X)1IASS.,\"/3-@L1B2[9
MG)K#%2,7KB4Y\"3*COVS(:9'PZ:8"C]W2W5I"J)98D"]25YM\OTU)3-$(')%
MO+K<!O-']4:2C.GF7'786[I;<$'$TP*%AQ= V3-[&MN+QJ'JIBY1;RD1ER,9
M_D=&,4E<9>&3IKS&G#)GW"2>U"_;_+?EX&MYLHR.KF^W-LZ;""F7>$](@8,6
M5.#16>M-*V%+ES&!0[G7)0'B+9X6=SY&+EEJE/3'Q:_]N71O:TGK/T5]7DM;
M.R2ZVL<G*<A<590XP::X1OY *I2[_JQ%UFZA',I>K0QQ @>E:#4SP#_ ^O@:
M<0%3#0Z;:H#R@#.0AK)U=_%MZ5L>Z4V')'.#5WI<0VH(X$R/I.P]G&SUXW"L
MIO>O[M^%L/N@4 M9BHRR;'RM4O-?&=GA87AX>(AEBU=4'<<@ O('B-E">ENY
MDB8]XJ8=+:H02J\2X *3(7*>>[ZDE()H5\'7\!68^F*H-X<+<&CD!!C-YK5S
MA4XE<O<IXS$&Q1EYH,@[AR7S #RW=(VHD,!A428Y.^O 0PXT1 =G-:*/EC!\
M=7CX'ZCB^ZYGRRJ7&8YV>5C(.":&';3QA_C]H\/]X\/O.)HO7Y7[KQ59OYO6
MIJY7<ZF?9EE[>%7]5 /Q)[M _!,+Q+_VL>.&&\]B&_P!6G-2/CI'_H]9W WJ
M8;BL1+R7\:LQ+,,=&T9+4PC4M+^P.K;']R;H+4%Q#K:?3G#5H^(@LG<;5>C=
M3ZCDC_M26%?;S\]#CGTCQ4P0=HJ*BR4;;2#(URZ([YJI1-KG-1G5<GNO6D=*
M,"?8\K%BCQ;FDM^T(A?BJO0ZT\;E[5KA<.G>X":V7.SOY!+#8F)T$-"E=:EA
M=)R#/9>SQ8>^?O_/=S_MPZ]A.\%_3<:26Y]1+P-E 90> RD'\I0?BK8+2\2E
MHH-0$W2!K)KZ);G9- P.J#.X4D)]R7P1495D_\C"0!KMTDNOEO.R'8<H6Y6.
M_,!8>J\6R?BCU)H5551T#DSH8.M1<'+V'?899> \7IF$1DO7[Q,MN U;2*P"
MU_K%H/7KX6$K=D.28'P]\G@QKI&D3-+X(4'[X1)FD&*W6F."VE'I8&;4EYK
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M!T0?=X04 =(<-%CV/2>"EF6WNBV+SY+;YWZZ 5:ABFBA@#H81-7]]6^O/>0
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M2:_J\;]$2@.\@:@=W[1H3DY!H]99,!!(]RK[@$BB=5= B><J <6HH(CUE*3
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MDUUXLV,J7LI-:)GVV*53'J*/V351NZ$8?)S^9BC^,*T<?8*OTG<IZ/!S>?0
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MJ+7==%"S++#7_!-'==Q"FTQ+D-4*5U%J.=>B@!D'Y"#89XT54KK*7O^>>WA
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M-#>WK S>!I1J5N$VS :W*\2"D5Q.EIN5'4N#G')P<\NXW0K>H?71;$A(&66
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MR)UIQL6#-H1E&&8I&!'170*.1P4&J1KPH5VOUO@HSJ:\+3LK?;?//V&?=[5
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M$30] #ZA*P$&GTLP2/T9\0BX&8_\!6SR<N.#GDX0\\A(T4"<PU 7YL[(7!B
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MM0W2FA&Y55!79N$LE#0P!S6Q&9 \!PT";N58)]C#+1FR; HO.G$AWZ;M<JW
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M/-#S@1*(:K?A0&L:,.ZX^ST/RJOY>1MYVJ+G\N7H*6K:,(0E)_8WDOH+- \
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M7R^5_^KG2VU%H3]EI2P..E-U:!+SAV&[864H0VKSKBOS09?+E%S@V 29"VW
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ML*3[,5:<Q+)#.?B@,SI\..[ZNN;&[A7I^S:,<)[E">V+DA:3#Z05'4CH6I]
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MZ?<XM6$4$D);4:\04-UL/N<Y=58$:=QAWFV;H:D7?--*BM&'S<4)W1- /XE
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M2Z$>DH08CR>W4:T+KUYCT-Z4BH[C$E93/6Y_FF;[?6AWI(8/H9&0WY;/XZC
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M,)B]<@X/.!OX@[/C93G H%@KN>V4][HDY(!;42-)PD(_AAK<JY?W!]4DNYN
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MJ(7/)S<1RJQR,6Z4/G^L-CQ_A@2MJC:G>=$[.//4+3&8+]"3ISI.H#[V]MA
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M-<U[#<9]XC-?7GO]5)N<NC+D\NO"+$4T45370TASM0%KIV %2,]K11 9I6#
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M*=FL$?W"R]_IP+BWAYU@I]1"$Q*M+W7N%T,!0'+9<-'R1!_70,/BV9'V6O(
M,290[&M "Q96RL1EK/(K3%78R2[S>*X*'@=E'K8G9HKTBG"SF+"#[(Q=!8]!
M("M?I!;,"U;G@Q@2A.^G\FKO\.#L3#,9J1<F3D[:N7L/!LM)JQ7K)97T!][K
M,I2I67$/T!04\+7Z[7<1619S0QW<,K.&AF@9"*DE[U40<PJ@!1#% P+4-(]M
M4XC(C[X_'$+?Q4.-_9$<7!W_LAX\P)O')>6 -%^?9,M: ,X["K0]Z75 VTT
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M!'!L2G :-YK',"]':K*!GS:$_"7Z\3N=SS_J\OG;GL_/@LB58"YL\"OY0"/
M3@H?,NR,MD/^9+$O)+CME$D0;B7\%D'K LJ+ZS("V*AEHO8.4&),5F]BS'\F
MM%+-F!X(OV)\@_<DX%K#+,<TBMJ7R42I9PP[HZYF!@["#6;FYD;L#T16')1/
M!M5 4G44 ;]T&>-S)E&NKLC4D]7D%-=1-MF'$AYED!4%0-DPSS"28!["$6!6
M<CA]9F&0"%8ZS*X@>E70>U!#8/CJ&R8]"HB("(X(  Q<M3#" ZB /#N'?N#B
M*"D9=@TS9[Z[DF2&RQNF]9J+CN#+LE"0F#K:Y*0D_56).ET_)0:FFZAS#FLM
M6O*+&N[* 0A67M*,WL3I)7N]+6GJ8YR('4R(Q\%<JYV,7&CPS8QL*7%EUBIJ
MPRRA,;0)7"H!U(I%#4M4R0B^M6T/ICNC0P6%A0]E6?%E.Z,I(^XLIH56-)N0
M)LY%63+(HA:857\*X=L0G( 8'7 :\G1LM48.G+.6ZA,2B5Z/]<F<+X.]M<"2
M0!@S.NK7!"@!0",9$\SHKF"E)ES2+$",:E14E0.9"+9* %$8H_'I$ZP0'MFJ
M0!#]3M<CULDMJ*A6??%>>BJX,5F$'[DF_(%-PO7KN8 *X]3O]]=A/+!GDXO;
MGV B_PPRP)N3.%Y8OL\'1#5MS<PF[H3=\K ?/EFKCK /Z0TQ[=&H;C6H0$:!
MID"9C:\Q ]V\\J#P;U.,FX23B,+Y &\"_:GN!1W$RALRXGSF4$5*M;S728+1
M,7%)NH<F\' O>+DW>&F"ELHD(4Z\\W$A0#0]]O#;/,+*8J5J%F&0Y>:M$W%.
M6462PM1WWH:9GHH&%>B@GBO)?0CUPK"PK+."I!/M;^:' T'!U96:!]23FH+1
M!*?<4L@7_8,S3ZUH3/@V/!8 Y,^)*CTN4H?TA/[1S\HJ*$.]X#2=9RB.AV#-
MJ&,,+2,:CPL?E!'QK-.W4)@,OB "9Q<"9P 6R7ABA]RK08?H?'."A?/]<@XQ
M='JGW'):O87K5/X9)&60+83GCL:LI$,YEE"Y!Q*PJ*P?%404#J4&W?!>&<-P
MO\\/EQKR<"$@*B7;H7,CXBI@V58&\S4>!N/VUV&RWSR1O+3&#JI("AMP&CC"
MJHRC!;\%42; F/_&4N9Z&H]GX@G4[F=[/W-MS /KV@L.OZZ"(*]S7HD(H5VA
M9E)--2*&P)A#Z&Q#A59=C=%G&^N48&Q5]*ISCW!1A'E +K6-T322XJH\1[^B
M5A+-PM@D;9)>06T0&.*C!;,R %:\S!U."\DN6;5B&,?!CU;.:_U+E8H-$S3K
MK  ACO861@EV):LA#4="-P#]%[>:E9X;HN*L?)7R5-3-RAN*KJX6T**)DMZ_
MI=G,N]P?.D.JH0>K*"]";4S5:L(GZ=JG!-('2JE""3I]NDPA#%_]Z>$/9':"
M(+F 5;MF(J%_H<2Z?$;-*U^4V 7X&G!SI014/$]<?2=589 NZE C_S7'  :Z
M5:3?JVH.)5$V%T03&*M%2O<NBR/B6 5XHH#Q<5T!,.! ]OJ,;G"A?0"D-(>[
MJ6ID@A.]K:)<SQZA)0:-CPOX(_$;<T2RZJKH2"==$5Q<7*O]M(\8%W!MHW3"
M>_1S&0/YP:$(]YMO7$F!!HH[E&L$RJJE!<0D!W:LN<;_0'VGZ6S3Y*^L7>SP
M1+79*!Y>\['P2"62]LG0[_O]D[Y_W#];4D;OUY/T9$. ;+H5%_920$Q%?2Y<
MN131?=?#B)/Y%1X990GM=,C[N MY;WO(&WB*FFT>,1E(^S<I^0/OW$:FHW)6
M5NOXVO8]3E:S71C'$]0R>(C@-$A-KU@-I*HA3@1H<F-0:;W=F+ WIR% ;R14
M<0DZ6%X$UK_S=;,RAU@V=G4PQICX8<:3TVJ></#D:!#")_=>#'OBPVVASOXD
M1_GC:NK&6C?KP*S)RK/2Y;#7:C0?),%2*XU5AEPF6;=J7!!]9*/$1( 1]6&$
M%IU%ZS&8UB@TLX7L,2A\@Y"Y=EE"RM"+NV >V.JGH#U++H)9S3#"7TP9-Y#>
M)A!5H)A%I@MX]*^FFG,)'[WP-!U/O9C"*(UERHLK?K3E*A1+329K8.&89ZUS
M#3J%M(=Y0J/FH:I7MY[5RFPHY0DY0O7(,L; EG(-0..XJP&<>7A5(T->VV+8
M#E'KS>H'L> =WZY6@=ET OCMS\U"($"":81[=9L1JTP%UCX4JQF%A?3ZJ@?F
M:1Q2GC)4UG^Z"$UM\CP.DA5B4MUX]D:K^+SPM3I]4?>P[/R4+D"RO#3RH&:4
MA$J:/2Z6+1W.<2=WB?!5+]["PP5\PFWR!H9'I_[1T>"9G"#+K;5E3OF!]P_+
M"I-*CD'OY]I>@?K#6?"55$^+.>:>0-:;HRE<!]L-@J5D?*U498XV:HQFK&^_
MV8/Y/EL./B!G=<56W1,:==44%\J51(X?WG(3<>14$NNB841C^6)779HT4Z"F
M/0%4.D38*&EB;Y6$">Q6ITA>#'RU"Y (E%?'+76J(O;K6]P0@VJJ4*E<Y<(O
MV8!.3JPB)M[9X- _/&UO65)P&@RR"Z$AO7C1/Q@<V92D7[ Z?=7<C-6((H1M
MN D@-_MS>J V,7Z"SMEPZL5)V9RHRRH9F%;^"1M:4*PU5"EZY4E$*="$8-<F
M^&H#' RNND%;W8%3LT$*A4Z33YTGV*[\;9\<(N*/*S L/E[QRJ*'UA :@,L\
MZ#:_5_"/!W>N#J/]+^K,0%U+0WTDS*M+/.;FDP>]H4@PT#]K#FV^2.FRH:'2
MKMUY)?%ZL,F9M#H0:*K^=!O]C/GG,+FBT#U&DOF-39:PN"-R'O&ELGO%@J#-
M(A<36(9CTOAM65B/D$O^&Q.59E? D'1&E#& D!(-D%O :WZSK[8]!*F[8NVN
M1N$>-0I.65J+7+9"+#7EF\4Y+V0-'%[ .UO\S*KXD^R3UVV\+_M(0GP N>TM
MVZ&KFNLVQD8V!N7SFT0,.74FQDD[/=+5HC9ZL6EW."6B5DUY=2> U0KHU8D/
MWHT47P"&G8&<Q*E$Z%=)K=<!,M;;]J#P!4 Y58"1.^3;Q.!>FK_^I7XZ7OO,
M.N"<=%FQKF>Y3,+9,CWYR H*IG4O8. $E$MPA<CM=4I4= [W41#G*81-E'\K
M7/A[(W.S#M'2KL< K3$^]5\!OXTD01#V8I)%-_3J@O"5USF%R@=&)-Y>AY0Q
ML-HL5RB[X,TZ9$8U(W3P![J"I!J._A5^U9WQW1F_@3,>0\B(+]6$;2R8T"<'
MVC;9X,"Z1=QDUS80EI'EC/O2%*)2+(H*VG$,$$Q5_YR%E)B"8]SI>D&\.@@A
M%% :C#*$: Z_*% ['ELGW82Z?88V4XZ/O<%_#+6ITFH#Z  >O&P-@^!N9<&;
MZ0!1C040_C9ORVF9E$WG)7>*XAZ* O+M5-K(/.IY&DN17I3<I/&-J5MT^Z^U
M[YO.4^V$<V/"";!U7V/EL7?@!"PFH>R?1+GR&R,YSOJ05^0R8#X/N)])@]-*
M#*,F^=!)<R?-#R?-EH=@LLH^01F=4'F;UL5DN$#P37VK,@#4,N5R!^)X$*H(
M,4]-@J0#CF@ZJ7>.8[4QT#[3==>UH,YJ&ZG;'=WN>,S=@7N  ND:F&22QJ:H
M2J36$6=NZM,6P]2U3LV"WO%G=<*^P1 \=MJ;%\O5JXBI( Y9A.,4@8?!Y"8@
M/H^K,D#, W)[H(64&Q.)"16 /YX>DQO:W=&"\E596EY=5W?$'7FQ-E4]SOEO
MOYX9U]YP6Y(,*7"@+26 U/#3=+)9&@?$"SC7X+3L']5LQ?;\04-"D$GQ:^^"
M8$5LL6NDNM%-;/I5X8_F=*T^Y F 7N=60^W/TE![&6@$KVR\BX D#XT.>Q6.
M@S(/:[6E3D2WK3>J7[\-_DO@Y6IC5+=;V-I<J1+_E6)0IR4J-D0T_1L^/D0C
M=$U^1W6(<>SN%6:41+3B*#2]Q1&^-2G53@%.9?6+EM#=DLC=@7>^*O GG7WX
M';P1JA0J]>2\[UU<!U'&FZWU,J$-O+B.PJGW!GLF@!1\I.3!PY?=GMOUJ-3&
M0ADL:T++WFM.*"P7'OSZ"C_PLLC*,3;BJ>#,(JIQR"::08^:@=]+HEKO'#%
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M!2MQ 5R_L$U_%U /*6)I%P^XL)R^1R\7@:V;<KU +2-VE#1&#2<$#Q^'"12
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M:!=@>1#2N>"NEB=5S'#6<Z9X;J1+M>T3SFZ77#<C&NIVHWIO\UR;3&B'XX_
MZ5CX4FRNU2CO6=Q]=2/"_E:9#*5'D1L\D5)V"WQH?:[L?=G7L\8)T%^.X!QK
M7 0QI<.TU2>[HZ6D1JV+1M&O@,\1)F$(!V-ULUB>&K0A!,L6^!2/*/G)E];6
MNNZ2^',8'UN=F':;X^&-JS]#7(4Z8'<*U#A.49OM,)C3-&\X3E%&H%S)NB!T
M/2MTNB2&+X7![D-@K;#QN#(^- &G;Q_DL!YS;*U,*QMPB]<$_$KA+JD=])PF
M9A=F JD![=A-EGC[S($4I[EA0++?BZX$<T<$MLDD^V$U_G892MHNYE-G=S +
M-?]6'5[T/18RZ0H:Z[(!"4N%:S8N,T MBW+=(?M:RS!+F:R3-?./LDO0GID'
MS);_#;X:V:'&V)>S4<9;23D$F#V=\I'B:,QVHV@,[ )WEQQX VDWT&3,"1;-
M1LK5#L'M$XS/-&3764D$_I&V+U0C%H@-5Y\<PR>7&3<3M8X9K']_G,#'GTQR
M5ODFI7_#60+TFVT":#/V,FT?-WL5YAOYJ_ <1,0 5CU.]>H)W^5JAQ*F9[2P
MM[']CI4\+LSQQ-0!^*% 50<GH16"Q+!?(L<,&>JYV3-TPN(V17)2%!Z]Y:WQ
M+#]&FZ:\-'-H?U?K]^A:4?AR=A!D\N4 MI7KM,P20OX0$],2-<,HAC&VV@#9
M+H5#NWI(/>Z4ODWR=!I@BQ"9-PDK3BUJC;7$@2TGAYV]M<146&:E 0@+O0\^
MH(FF!I.;* ^9<)V/AG0>)5;<!*P G,7J^".S^O-R%$=CXD-$#"NS<UM48NZG
MH.?+_!G@O/C5BNM'4">6?RM5/"G07&@]KV&0LNEUJ&^._+$SRN^^&!SU_%ZO
M]RB1_B:EU&)ZR\$A2FA9Y 6=-<*#-D$IZ%UUGZ#:ZB>2'@,,OY!*)1 "M9?5
M:ZX"HD?-K]-,T'KUH6LV3CRMU-_UH"!TQ@2=G!H(\KR<A>W*JS7C0T/ HR^,
MHQO:<[DS#M #:/JE)4I(E/%=>@P8X8/.2$AH1VTB*Q^#W.EUD);,"8P/AU9]
M^QJ?9"T; 5O,HGSO\F'D$NE^'!_ HLFQ/I%66BCUT;ZD*662H5I4>OG+496N
MXRJ)C-FK>N>748@7E\!-1+@GQQZ$%[4;0NDGH6= XVJ*1-+X?FOR'X%A[0\\
M,*R<JX5,K3)'M9(9&;>5-NFDS5.PW/U*6 ,<ZCR:E;'RE,.TA-X,9L,;8"^6
M30)U(,L.R*:<H7RB.<:4J&'[ T/BBP@Q 1VE$V1CHD9=./#/^I.]]SZ$5*D)
M 2F5V0Q86\4/K7YC UUSTQZ4L\!J(6@-T&T-49UNE]>L>:$*3?%EFX_N=QD%
M2R077(G*]JF$7G+M;30;JTNL*H?32WJ$B5^$S-EC92V("J^4&.LTJ:%5; ZM
M9>+*FW!9PU!H&A,V0D5E ]?+?-'T?DAB!G:& IGK,U<8I&Y7'Z,6?<YH48NN
MF[AZ_V30:J@]PI;_4[BNX4.^AN&\]OF4P 4]K6S7*"8/-LCBB.9R+V)&!11_
MTO(65UL]8(EDE4L]?9@A."<==QAC+>8/0*7-$8&;-"YG(7,K)TI;I]-]7 *4
M9=X%ZG4['?,?=#'_[8[Y_^W?H-T2G6S6[CX\]+78TH%G("#D76KBJ$9"2T$3
ML&/D1@S-HPSH2+]W633 #HGI>RPV+B$\S]3VEOW-C?\JF]IX@+BKE]D]Z<8'
M2(9MW8;01^K] 4?@VU>BNM:I3)B@"B9J/8Q2?;2N>[5A]%)MT*U IN^ +D7Y
M8Z.7FMB?>*O$"XL'ZLMW\T#MZH$Q_/_9>_/NQ)%D;_BKZ'BFGZ?J'-G%OMC=
M]1X*XV[N=1E?0W4]<__I(Z/$U@Q(C"2\S*=_,W*14DA@L!%((OK,N&R65.8O
M(R-C#[PPLGQAO*,R4*5$\?FC!S;WF\&HIXWN.C?#3G<OQ8$&MG9)QJS3'Z?H
MIJY52I4JLP*RV9*@:V92V!V_T*J6KEW?:I_$8:M:\J0)Q4R\GB 3)G_P!IKK
M]45U9EF(/'('<4'TF;-2/5"7DJ3.P,&L*QT'Z"=MBSEN&<,FS!3*@J>!3FUX
M/FN2$\BSHMA9I'(Z3#.8G?#M:L;# XBQ/E'B=,+8F+]7=/I\, 9*Y8SQV/#1
M#.O5C@,=G'7:DS%=$.WOI3,Z3IEGV<$W. YA2P3MV7!= 9A$(3I%^H1VI:;7
M6J55):+4]0*! C*CT'@15HD'CISP 6X>8SP[D=#X%Q]8N0U1-5*V50ANL(1A
MEU3VN?$::.O*LZ6AEF)-M7^*/>#.#+&C9&H63F)/">!RB0AX,J31DH-JD<"&
M_D1L0[C$5%*11!FA9J7.^8H3%<S!"*P8S)@KQ BF]HMRYKJ48,#G:KGCQ4Q4
MC]99]*O#3&UTPRMZJU'6*Z7&.I>4H/?P!F7SEHOX*4B)YY&04&>;6*[GB_"0
MF/(.9O G"%23/:>VG%-HXTC*L18"P%34)E#;ZAV@R\U(0K:'PH[L.6.Z);RW
M%&6?%AT3S)8,91D1 YBVSDJ_<"O*>.PNF.E<%.]F.;NN8 --^C%^,.>$]^Z;
M\5-"E1*6ORML ).0-"CG2CK2M0C/^"Z_?FF$S!(D:C$)<7)YP;F'A0%$1I0$
M?!@J,H8P$DQ%K&68P1G.2EHQ!%_EHC3E\2R@:#\1^'(J*FO_Q&K'.KQ^,"0
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MV/(,V1EVQ0W 0%M]LRF768\/2&]>-T*RZG.%6T@\&[IDA!R.^V2EIQ5>31:
M6%5_%E2M_=?")NJ;;?ZTZ$Q@L0K'"[4XP_PG_9U+FD$/>W'-VR:]J45^R7QJ
M,3G @ZMP+&)I0YZY"CBA)$$7V0,0UIUJX;WC#7M#?3)E4EL1<I2HLZLL(&)<
M,J)6:M%T. BQU]D]9ZXT5<F'1IF/2K!K(0KI]T>@_*[] K..A?&.+"C>D!Z
M%0'MS!L@Z3^:#<%%07EG5$OTYIX2N//X[1_R?E4%>V."HCTO!#FR4^9"5,L4
MN#$XLW@%L@E<M#R&B340S+5=O(9V\2S;Q6%PD2:][I1P[=,D8ZH3T,,5QBC(
M7H2]+@3RS%W*17Q>#35H[1.>$]Y]B5N/G(D..:#,?@1LA\D1MJ-!@K<HRW!%
M[MT%O26D!S/!C-&3$V&2G&K+N C:0.G:H^QGK4;+\B<"PW!Y#S3FSU/6$T27
MKH<FR,!FL19/%GGFVKGEL>4X]@,KAQ]<?K*]*?\L9[[Q940ZZ4RLB?^HJAZ*
MGA,/ Q%+\IQP53)PVN3V;]!4B!=\U5,:R@6"M>C9QCFOE/F7C)ET6/JPB6$Q
M!6I&"&_7X]Q3 H^%K;W!&-<+J=QM#PD=8<P_?8=?/Z8Q,QZ(ERSQBUY3SVI/
M;BM)STB2PZ-&UYRGL=:1$V>9$[_'0UD^^?J],^K=]3O7VH^;_JAWJ0U'](6A
M=M6[[-W15_LWW<'WGC;J_#^M.[@9]O[G1^^F2]]/E_XV6,K7T4"[&=R<_C@;
MGFE_#*[I=(?0@V7PXX[.]/OWP0U=RJ#[WWNQ<83L%&(MP#[+M!,ATD&Z@ O!
MQVRNLO49]'R##$SCA?7,M.!57^3DAJF%S+@#55,\V3?[V2:N]VC-=9F\)4/2
M5\1X<GYA.S:#BO\E>J$E&+1 ^V+*%E\!1-=X/"2'2>.1L1\)98F0(10T"H7F
MU;[V:8,2*&5ZR4I\^K+;^!UA[:+H436Y@M]N-5B KPRW5J]N^)"\K#]S+(*.
ML)9'541/4T*@-H1>";\!]64U=D(4B*BE+!6)E6\@AJ^$>:UZ-N_7KJ2H@CP#
M\V>!D$P'H7Q#1#CQS/(P--X5\3-C^M<%_50D\AU>2(QYAS?"X".7^#)&:#XU
MF(F1J<Y@T8R])X/IA3')>*'/FA#(#11V]#'S35UPI4_4B^6MF(6BQ!1$_CYD
MV_#X)N43/K0?NY"HPQ-XV).()G,?*"G]QQ#+@(0Q;^$RKZ$RM AEATV2*>6A
M.L]38GFU#9%8HC/;T@.8E$P]8FYEU@0J,IE3$G$^@TP@'Q/FLK,L@LC3PKL?
M:(RNC0N\3!2,1XD#-</\64>*Y<UFM :Y>*P_/?.B"9L)!-=37G8Z$^7=V6N\
M0!L,3(E,; LK!VC8W M#T1<?HI^@0E%4P S(./)MT9":KRIRE&OU\J?[STL+
ML67G87E.?-%!VI!)WH*-,;/-JA,R7[B4NX%SB(?!R<[>7 6P[,_*EK,'!>4,
MF+@:]8,GU$D@[I/HZR1%_3 */# G2TN7$/*X:^:">13"GIV\$@05"&>,\IFS
MTN9],BD?@>*#JQ:Y/)*@<U "%C[P)LZ_;,81AB(RD656^Z)&"RA#,M+F4C;4
M9!+/=#&[MXQ@#R@C Z\JCT]4]X--39W$)INRC+W%F>\:I@G?$-Q;9BCR$$AZ
MT]OJ\R]D_%#P^3F]6D0'4/;A!,:BQ!R)%1%*W!0-8S^N#N7:I+_>L]H7C(B2
M3[O.''U3T&JF/*^*CD!I&YR"X2W$UC$"Z\Z"!:V$>2*@*R^F#X;@!T'."(L\
M9KFS],2&_7*#SJ54";=$N2KFEF5)=R* V AFR#0]3EHL\4-V^J9J(;0-UD5\
MOU!=/4+^Q8F2/S.,\8G=[4-^YB)7>?]N&(VW4OR[S'$F+FJJS!%FO147O C"
MM>P@4HR'T(#>2W5G2!#D%T2@BM,GA;/V(8_%"%+Z>-:LP5/7WG@L$Y;XF1,>
MW& 4&-66=@#V/*8ZRA!A>L6Q<A4@:$&"(=4+'IWEC(LYW.*4&U$=G][JILZS
M\$QV:^MPZ!Z-.<B)] BQA"H"54B<H):6PLSI=T0.*_.A4-T]#'A2>N6&BNTZ
M04D!@F7F04P\WVA8R1(ZRY*D%,YDGU!.?+#-C.A6/%=7I#J0&G@XWG2:)+RI
M'8FI#$V>A-=;;?_+.DJ#7B$(W9+I373L)>M$1*24LV9Q*X0>)3"1P!RLV5P&
MPH5E0@+>)!8B/&&,8^O:U!D;4UVR,EU[L"90RTR\"Y\5'G=@"C/+MF:+6<)Z
MT^=I5XX;7L$RTTIL,Y.1 O;,=B\:^LDTH7MB4_6"\9TPG2NA>J2WT8USSF6
M0$8=TV/S'UZ[AVX.+\TAY7WUOER^8C]%$A:DH*)>B-O>A9]%RJS)ZPC)&]RR
M@RI"W)$D2K%^]$;G E;P\8#,)F'PJ<(#5DQ>)@JH85=P)5$.[XZ)N$>93 Z&
M.HOJ=67A28X.+\*-V"GW%G/@[YY01V5#=D4AC"R;-[97LHS95&69#G;G, 58
M\,C7H#Z#,^7521?W<%S]R+TF 6939^?I4T5,_%G<=M#VB-OM;*VS>*"?$T7S
M2CI5.ML-440%*.&)*DLF%[Q%B3]Q5\:23%9?U=SZ'9>X9&+EX<^QZ +-#W.2
MZ+;J5#-SQ,I#;8OR@V*]@@787(52=(#$ PFO@<OY0;@0WE D/F^F2<3IG:JW
MW(*K:ICP=*7D4'^2..-W3G5#E@)P>4MAXE(N"6T,CC(U+ML\T.UQF5?0I)*$
M;8:J#'",17! Y)>DFUO)S8Y^ N9\IG6"+SC+:"2JVU!;Q7W@ZC'<7$S  +\D
MZ)50?L1Q4[_#$KSJMW>#X6VO.^K_V=/Z-W_VAJ,!%=(Z=SWMQ]WOO4MM-&"6
MSA_7(VWT1Z]_QVR?G<L_^T/X''VKV[N[Z=_\#N_R38S:2G6MQVRHNM:YN=0&
M]%-W<?/IX$KK=/_G1_^.#J1K@Y\W[%_XPF5_>#L8POA)QLS^C7;=__V/$;S)
M9P=KZ5_UN_GV+330MY KWP(\;=@?_>A -M.04NY0^]F[OH9_X5C$Z+USUV<T
M_>.&'A5*Y__0Q!FY'G0[U_0$W''2DQ9]_A<,<]WY.60' [[$3U/DT 6?^42/
MW_6/R\23R4\D&^;W_M4H^-+ZA/UTHGHNE9(38%K7(#>RRQDGSWE,.;(G.H%E
M?3MZW<C Z?!*83<,LVB"29F$L5:;7;]"7J0$SBS+$ 4.V2:LS#//G(:[-+"C
MF:$=#6XI7GO4$T4_(-*5N2XV>3*]OZ*QB$:LUY]:<GKCN82.=O6RIVHVE/B!
MH:1K1-I+>&+-O4CUE35DS,68R[JAN,4"/6$)]X;'JG")PGSJ_DB/ ;='_(>X
M#E^G2V94$V6AG3S\GSW:A]J7T:E"'2^E.8+! \O#)ED38<%>BHI+6+1)O#%%
M,T@U^M6;&[:D84Z@\/LYH&&-@_ZD3(,L4\GR,NK)6CX50@#]]0L,^U6:&-*6
MG*-G15UM0/9!#>"@COIJ VAXH&)I#*N3I1(*SD2('8:2 AB3K=08V6KI%R:K
M\@)USC,$CK#>#F&7CZ -( NE434:Y1BQI;\&5GZ>V!?F/S*380!)F *OO @0
M!7$_TU=IC!<I9Z%+8Y7VP8X#A+0OQD+H9;X2ULQ;AF(GZ9CZLJX:*C[BV'"5
M@)DMA759N#T\+OBO\0)"$&Y8-6G3*0G/K40FR>09/7%O0J<"PXV=L8D84$Y7
MK9+ JOFOW6Z=/=GP^1$(O**!\DJ/"'#)H%-K$(G#DD8>9:+7&OR6]!4>5SR;
M^TJ2*"7@=>2N!\Z;,,H(,K.2*B%P(H3ZM1ZWI&XPN34'3\&+Z5?<""IWE=7N
MMTE@ ^1<G/FH'EBAX%5CN8Q$9#<;8T9$G1QFJA>!6'*&8/ VUAN_^(7 DRD2
M:4@\6JT$;B0Y97C"TF)=0-=262Q;C;&^!U/\8W!MPDJ#W!G)I3B#6D>2#)W/
M4G5/7E#B-2V+B8'A"T9^I9_BL04LA#R2(0ONF3-M!#4 #6LFG8!J 0Z5")>/
MK[$)W&_1W@S,;N'!$ 51108UV!CI+3$W7MD-SSHP0(2_0\\DU%Y[(>,%/ J\
M#U>..^,C_SQM4561_\[,%TJID<481!]A\^!9:XRKR.84&P1"!-80/32"W2E&
ML*#T66"9#S=5'&'A8V8Y.4*XDXF@O%F*:L22'Y%!C'(Y4%7U55P0"B=3V6U,
M=I%7-]OIP*3#7H!#+7>:69]%)HHEO)[\XV]>%-R6(ZUCHBOIJB*(LFRAV-DQ
M[X5J)\F']^31F$YTY:U@?6J.DP2896[/F4M4,QUZ=&4"?)!*R9XINBXM/4MI
M]2$ER:1G1-GO2HI-7WCK:'(K%.?#BE2/YT>'KLQ[E+4_Y;GGIDXA<' QW0R$
MJV7)2V;M1\*(.(6S\[S)*>;VYMC)_=:[D6$PP9M1$?OYD3+]4^B)2,YMY]DU
MYB=?^1=/>\&AE^+SZK,OMH_-R4L@@FB9(<E50_;(\XH#F#:2H*;6@R5SF.(H
MLPU<ACK2=-!.N"<BWCO(M0,N"@D=G <)LHW0*GCDF53LW+/+#:8R6=BFJ(AJ
M"C* :'.N*<KZT&QR1!3)"Q[%=I7/GEWK7"4,)#:ZBP*)F\38/!!58O93[K%4
M+:B*],K?9 QIJH3=,P*6D3M&R']CF!W&&+).Z4O;%#+<6#.X-\;0A$DA0WTM
M62\93 +O_R:2)%!8J)<;3"O7XXVKDV(_9>@9Z%_G:B(IO:G8D-8JH2E=)0P2
M9-^A?C"!>1OM0P.SA^@'PD,P5J_G\T4D-W8]CS+@+@GD;,H"2<03#=<'JY['
M2LHD0P#<#>I\L>0OZ? 4GU2ETD"'4_973^AFH*1W Z^8$9_Y;#^-I;.3YW$X
MKEKV/7#81Z;& C*Y_$A99^C-"63_]5V)6+QN)":PU6[2>7RJ<*=<KET3371-
M9-DU 8._:756JVPHZ<JLI'M88GA">>(I.X$BCSFY)D.$[;I)0KD\0&*8B9#T
MHJ;;^(&.62KHD:;:NV))20YO8VFK],*RR),(=0NSTD2@'DC[/([)%BV!2)#]
M#V$\6[*##2WND \EDKQ8N%0D ((_,=4#32_X#1>D\]L1/L<"=^!R6G,A,-O.
M6ZD76U[\'D_VH^B<AY$VZ^\E"+XPP[9D/'Y?M"@3!4""P'-XFQ)-6*@+J!TH
M="P,1['YPZ$!58]AJC!^Y=1$JA*]=7S4VPSNJ5?ENVL/D*AC(8-X$BJ<29O:
M])7+(R87HT+9 "+"U<K6$"VO'"U1<4QF1GB,1-_XNOY6O&DR04#XD@6!L)04
M^/-8MNO[%M"?A,(B_<(K;PH3DJ7E!9(%/>TL&5R<Q>V//.P!>T"0@91(-;R/
ML!<A+QV^&-I=C!>^/IY2JDPW%)JEC"$,GY&LG$B,F.BD&I98,I2Z[W1^K[$)
M!@&BH>5"2O7L',:M\;"704KJ'IJ]O*DPAZXV,,%.V;X&LGY0 $P>OKGA&@^N
M,7_<R-X=,<:KGA-IY2;,J,U(CO4$ ?^K--:KFQDD/W_8VKUNRMP KI"$+KU/
M;R@7TERE)"\O%>O:R.BY;"!?1@U,2''#=^BBR[8)O#]Y@V2XW5=1A!))\SY=
MTC2TR90B"@@J5/HFA:IM-.Y9LR=(7J0W/Z,F'@4;N.^GC@>")"0Q:!MYMD0V
MC S9!K%GO9]&<63)=(5U]F2Z;8I5:V5VD3 [Q9V,PB'L,4%M[W:?OE(7_XZP
MJ QF7S>U;]S0\E.Q]XWH,E(V!/UD61>.*QO1K$N:E8X,,,,F=09-\@<IW@=6
MU1:(-*X21)M^AM[U\-O,42$T&%8D;6)Y8[KA_"@SYFS(2H(B8\&1G7NHV&^%
M-62"!X0Q"2)C4%HS03Z:1H)DF&U<PA KEN0N.?]>52ZF&,Z S:I=$>3N1]4?
M^E5>U0.F9SM1CYNA5'"3@HTXW6IH$]EYR &WYL9,7J(R7'1^W(K]MIE+),JH
M),1Z? F^-(.'A?7[I1E7]CV4EP+KH1JIWBU#A=4,H["_FNV[3,P*RN.M83:<
M;WFB*HDBD\KZ'FLRG/7 9:;XX#@-2JT7"( W3Y)%8[?U- NC5MQ(&^01BAY)
M+#1!:2<%5_"GH!&!KE5JOWP^DSPH8NP-:L D6'8YL:I=GV5L7[SR\1OQ0<H=
ML&Y'9(-,;XTO:;6C ^Y\*-WL>TF/X$'BNG 'LE8\?%;<H;':0:7S/Y+>DBXH
MQ7NE.J7UX-U-+"(WC@];(_MR<]L-U6L?')Y%']L]WC>/;1)E)B(GX9DDHL:R
M/L8^R#+_LIUGUMA/YUXM0_3VAM?UX)+6%%%(%42U2%*L;.$1\N$D,E,^KE;T
MA!C A4\7[Y(I9R?F$],SQ8%9DF2XKPHD#M&E4W("V724N<>E!J4<HP3DV,+!
M"49"!SF/W;1\D37HB< Q*(2F%FP'UB-O&L7MK/(Y*Q!B6(,]*WP(>,?V+Y9<
MB:B7CHC_2EOLZ,H>N%'OID@%#=B*/!3^ZYR[KA5&:1*% <JHG>3.CI(9LH:&
M/,F?Y8CP^A^![.^).(S/<1-E$KM@_D9VMTQB[M3$>SYD_6'H8>R@PRG@YD\F
MUR^[?R/PB,7+ST2NDB!OB4E!K]% 36TM7B($1&'7P<?X2_+;,NQ%*)Z1\JWQ
M)^3:&=)"9TC6G2$J!;,S#0GI7G".37H!//#JWJSQI#R5:M&UC4ZH$D8)UMQ$
M3^K: R,O8L$T@(/X8<@&;_?.0NG"'$]VO7+[(TO0"Z0@IE:+J)4HUY$.?%%2
M.FFL+==[)AG.SP2&(_E-*"6"G]3C)0+"RS%1)@8AU$MR# 5\/V5O23AI66Y#
MR/(R[%2NP!)=7+B1).(=6(H]756Z@B?-6V'W&*U2*K=8F !/5Q1ZB:A/XP7]
M)(-8O(=@9T3$B\BDF+Y^AHBBF<5*U@=5)-7OQJZZP&84[5?#XR^ !D5>Q,JX
MBZ5>/E";D??!]<9435J(R?$;ZY[036*N\_\R;*4^)2M/69%&-\":$"Y5KKVF
M>-02A)>1L"DTZP84TP:7,Y2!PKD#< :>)T%LC[QH"!=?_9"',)5!G+,@0EZ3
M<4^28B/6>>$E/&6.*BUR_$6?'0H +U_+C"])YA3C'A*$N#(B'ZH2 Y,/H,J*
ME(E@^?R#@:WBF9?:&$ORX[4[+1%FSGKAO0:AO((N$N05E2<PKL>_&91& W,F
M[U*L\(ZDH$!V_$\?0&*V60CF5-FN>^(_$[(J;2!9J%#H07&BT9/[SX5K>2;O
M-23\16$5I8#9RM!-_S$JG]L$XMQ$211UL<K98?1G*?5:9>Q*U&S$-E"IWR22
M9I;#>Q*%N% 75;AE0G2^S!=8DA;/M#\$'7B/K-I)-)J.$F<844>6(^J@P,=4
M2+32F!:P#6%1M]QHS8\82\AYY<\V2GU9EOK>4_FS<O+UNO=[YUK[WAF-H'3F
M/LID,M.1,#_$DISD>0;10U;.$AUWZ?5R2]_U[N':^DF9YR,5(*"\^C-]W??I
M^-KU]:VNW1I3!YSZCJYUP;/N4/'06&=&J-0.@W[UY&OO_]WV[D;[P3V\)X*R
MTXR5L>)<O( 4O6*H^/E 67O?'I]IYKVA70WNOO=$2;!HA?ZJD%78A41_*7.A
M%7:+B=FR ,NSPQP3@=E9Q(7P6I[)0THGB.Q+1"^6VZ EL:Y&,BZXC8O2QB69
M.M"Z110Q,6;S"VWDT!N#<++@'DI6"@/XL]**5W1I5JH<3BQWQGRB#"G9',F2
M9FJ1&)$(*&]G'TZ>BJ*\.710?D-(.8Z0IN%9VH/%78KPC+#.#=1Z?(%8#&Y<
M"^?'/#NP=.9(R1YEUTZ^7O:'W>O!\,==#ZI40/F*_G (34^AK@7K?DK_U[^Y
M['V_@<(5K(0 $!L43?]Q1S\!]0*ZHPR4&+[N=[[UK_F,4H_ZL#UG8O"P!TJG
M,SN:9"%-MRPXB8IT$35FN1^WL -#C#2<"][EB 6&.2X(KA,ZM%"AI:0NZS&R
M<3T641B>-2X22L>TK'X^MVREK0^$[5L\=EZ(>M%%@"(CS-'BU,T=^E.2.K@J
M@^.VO![1LYK%6X' 0%=.8$IC E=\%H]!_>3KSS]Z] 3\8_!#ZW8H?5."U[X/
M[J#F###6SE[: ,O"C3Q$(- #E;U:ZM 2MB6@?X1>FN%I>36U):4OK\BRNB<\
M8GQ"7!F@'^DY+URA<X7CRRJ%LN!$6,-71!<E3%XI&B@8LEH*6E5P1%/6D/)6
MH2'3G!ZM>U: 0NKU7"EC]:D#[7/U.&> :=#!85W0P$)8X6*VA6<8F^+'0NK6
M/HS7E)-9?AZSY?!8)8X]&X99 H-^E"M6+YK.J BPUT(0WECU,+PEEQ"/[+;P
M2W+1D,OL,N.*U^8<^[*4HK#$B,7QM8AH/ND^D,JKQ3S_5(LC,ATM,MK22.#_
M8TR/GQD1",I7_1;>]!&L-Q\A8@US1=1=^<2@NG/XV#.MQ\R5P0XD8*56B5^[
MHJ2%6)Y2!APDC.E44I\G:Y?R[XEOI!_V^).(ADO,)J3#_"#,6(8RBXHL7(3B
MP5(OKQ'Q*S#3Q,Y5E.>=!6EF@@?R7#TNP(6!%K*RH1 1_:51 C/+,[GW+)\U
MRWQ^?C[SR/CLP7D2E0W9 5[Z!+!5<D8I\HLTAWC1D)CPB(ARXRQ!4]A6>.JP
M.JST&2N,<8F'2KL18X:>8K8,9B9BA1+(3$;X"34!KCY>'EXR#V@.<*;]@W(C
M$#OH!<]8F!&A_E5=@91FP*N1U45G(!X7P0O^[J=U9<*<N-W'@'8/HJF,< 8H
MW#7"7 ,'I.KVYOPV"G2PPF?"6^%(8RA/C^5^^Z@%4GC]F8.!BV83G@K"C/8R
MK5:-*^,?4&0"L$NR Q<H)_S>U\JET_]FMPW$MT-B)/1[9]5N79]GCX;KH:N!
MVT@NFT6GB>O)L!.YD4? 5LH:GR:>4"A9$45LU=W%JRNSYE*R%O\]67\4P O$
M2ADOK4)DSC NE"0K\4>!.0>^,6:&Z\6<I07Q84&8)B:18K)2/[)C*[QJ_1W(
MBV.&'@0.6(#?MDC(LM&LGX&<H1FKIK \BVBL!S?7;K6"$.1MUB!FZ_&X$U:9
M4Y"V(DWDV9;:+J$M-<NV5!$*O"1@A_U]0G&:,U_&2I73JHB."2SD?/G:"F?6
M".EV)1E'R)9BSKTF8JAO@[O+WMUI=W!]W;D=]L[E+^MI=!F;>\>E:MYY*4(4
M8S*=SB$@S7[X[:3$_X9"$^)O/I> SA2:M%CP^SGK?R$^9D;)H/Q+N"C?3/Q(
MY9<+Z($.#%>0"@7H1&.__G8"I"**R356CU%.'"/AR>JH<HBD;RI[J$6W35M-
M@AONP=*A./D*\NK_!.(PCY?WU)OZ?X+<#B$U>\+(&ASC1]^?GW_YHDBH7SKN
M^)&*=-X78CX8[A=ZCQE?SL[$_ZR7_X^2^F^)'RHW6_52O?&E1/]KUTOE9JE2
M+56:Y5KSB^_:[BET;RU5J^6S1W]V\O6[X<H4'F'DK0+S$"&?^YM@K5*KMY4)
M-JHE/L&P W&U%,Z/7>G[FUVCVJJ5E=FUY>R&9.ZK=G)EBA>,FS#JI3]<^ $,
M ?D+\I?M^4M7*-A+W$64<SC][S4V1%GT(>W34BZWJ^5*O5(M5RN-1O6+V:PU
M:G6S]2_):%ZURB$93*W94!D,I1@^L4B'@=8!9UBOM.N5<(;T\#7X# =CWPE8
M3%GETGMF@\U2J5E59E@I-?D,H]["<E7E@FR*R F1$WZ<$X+5AZ>PSE?6=8CH
MOGUZ.0N:%,8N_E>D6_$PV:O2.NUHGZ[ VG#CB&!ZRN1.:U20JG_6US+<K8]D
M$ALM5<JM>OV+66O42\VFV3+*E?LXQRISB:/"V4%H2F()?M+O(?1U,"#Q:4MY
M5-@8 !MF*@G*RBDHG[U]>E-)LH<@0D@($R41@C)T$.>XPIJG"TLYOR-#D[.B
M%I*XZ2-2K2[:!K7ZR:!;3?\9PS\UP+%<_V1&$Z9[LO07N-OFKB5K4X(YUF6!
MKH$CUO*X>XWA_&CPD)J(0>A--U""Q8SWVH%=4]<)]MZ5QK*P:[O22DZDHRL+
M()'.Y6]X]2 )BKRH!*C:[V0T."Q4A]2^1]D(/CQ)^M(T11@AR[?<&AM>8W #
MLZ.2?BYJ" G_BJB?Q:!5B2J .7T[MS3<@V49ZIH:=+(D]%TQ7YNH[ZWN/3>1
M@($7^KP+*HFX&Y_)RE.49#1<=1)-1_/H=M*O/[N6+U+2?#(E\T?'YM$*TCD3
M6FF$/R-F;MEU=YD$2]?JF*J]&QL[OF^?:]U'BTRTJR!B:<"C/_8_G3719E_N
MOQCL8B3[GQ85O.I@UGQ@'K .[U*Y]UD,%^"':U?J!R 3>M5#"\T1>3$\K=EJ
MELK[G\0GJHU\UAKMYFFK45\'PFZX7D^&,4@#KW !1VIVL3LGR/L.FAJ .!.$
M03#[K\S%%[5)R#I_U0I_B<U3*E@G6U89)7R;I<86P?517N/ZR*'?0_%I_%](
M"9H:K^>LQ?+__?JK]7+^2*"3-__5,DUBLU_I^S?T@G2M,:O4\=O)PCM],(SY
M^:VHO74[I7)BQS9[_UY8<]CT'QZ9+*;7UH1<AB+S8#*BDE\/O',L,*!GPZ!,
M#N*Q:/R1[7JSWBS7VB<\GN;%OX.EW7:\@5VN_%4M_P6"_<E7H4-,#._^S'$?
MOH@Y?0$5^V\K)W9#_%^_1)9TL!762PDK++7_JI9@A=5]K? :@AC)8,[F:3]<
M0S00K&(PZ8KPG-C4:[7FVLWYZSOO__J=63\\U[\#1:#S8E%2OZW\8\7TKES1
MK#XZOP&(Q%3XG;OD$6!](GV6WW?M>)Y(?>=FP/'K*.QX3Q%A?_'LO0ZK%270
MH9MDO"ROJ54JM9;65"K_56+K*8^<8&WE$\I3+?X)R'/ZZ\?P\H2U\9Q1>?RW
MDU.Z;^5FFVJL<I5R6>MW(<2?+JMKN.XK91#/AFMZO9>YQ4GHDC+FV%ZTJ\L'
M)9AW19DW/3#T9_NT7#FMEK>B#PI6E]5F4&?UQJ1JK95@1B;UUR7=2'J1C[N\
MM@LGF(4'#^:[3)_>D0'FG( JI5II;\O8#-N_F*V$DMPU-$G^+R5[;;,%5>LK
M%O0ERH>#"]G[^BN]^O]U#K&,,X-.37MA?T/.[6\G'F1_T=7PU_C-$'72O'@F
MW!YL?'70+\H5P"^[R ]Y.=%QR:FXDVQ09:>LBLV#2W?1/.57%ZOL?Q%<,98-
M7[J(.M53][FKHQT^?:EA4'WB9M2[Z_!&GL/17>_F]]$?T(.3]]$<_O@V[%_V
M.W<0O _9!O]/"_<A82%:PDJTI:5H\;5H_^??"\>_6%H2?_%"4Q:B\94L;5ML
MZ7*7@TT>#2!VO'/3[7>N>=/$[[T;EC<42E"Q$3GPE:T,W5P4$Y;N-^S0N[6$
MAW)8:!3G$STO!1$?BME;V9 2%>/XNTMFZ';CEQ-N4HR\N61@YCA<A ;R\!OK
M?F56RDTL\=I60)RLG2LSAF]-O)'#S:1I1I,62X4ZUT[92Q^@<)5_:8*!;4OB
M'9'*%=HHPGCQ")EOMIV2I!67PR9?2NF#<5I1-CVVYP+)!KRA/(?> ]"WY;>3
MVLG*3R)1OD64@6HWL6QQD91/OMX%27E])4GP+DP2O.41X)TP">_*<F=<$=PA
M6<;[]RP[TJ+CO'\$]7YE=SP%Y^JTLJ,I(1V^@PZI3D%51,^96B8S&7TSIBQU
M=/A(B.]MEH1;.(JL(D4>CB*K2Q0YC&2."QU;%HN*V!0TT+L#!_ _6 )X;TW*
M=W$)N(8$?#@"KJTEX#L"CENFZ]!/L:7#[[=!(N$PZ'7-?A.5A$0>$*7DB36&
M^D%(Y:=UI/+#47E]+95W#>]1NYHZS\B/@5*;2*F'H]3&R=<;Q^>YXA&235;[
M"T9ZK5V2G@R06T4-";6)8Z;,]E;[O*U)YX<MZ_/0K::DYO'?UF_Z!C;-[6)W
M"V;2K*-),ULLK<DNWR3R3M3?5Z3R\**GR7?QY\(QPNI..2%2['84VUI)L>_5
M[VWZ;&U&I_HH<PY7D;D0*RO%(^DVDO3A2+J](4GO6./?GNZU3PLI%16/K==*
M> 8.Z,8J;7@($@P"2,A10D8_V"$)N1RU$FRL.A::)'?J"'O#>+!E$/F:B*J4
MXLBO3LM10\&Z.6P?/RZ&VRY\_,L*<X5VUJK2QX43TNCA.6LTP]?XI,*75=.*
MQFPK)QO&I"^CL)^(0(C+4\,I<A19=]>['=R-H$8QA ?>]NB/FY%VU_N]/QSU
M[GJ7FCI<[-NW/[Y=][L<=JW3[0Y^W(SZ-[]K5_V[[RL-6=OEL<1,=&M.!P1E
M6Y-72AU* =;ECJ7?',,U622!+ :\:17P]:&32=W8]FQP',AJQ+R,ZU;F164I
M;W=U>]>FR#J\TBC*>N*IZ3YC]8*[%\8CCQN/UFZ1K&=GF9;A0N&T<,\^P5-$
M=<(N?Y0H1OAY*:!$2RCHSO-PIVQ"D=E%2\@[44/!.&(H@/;"T-8H4+S&BN(U
M#Q0O+U"\O 3%R^2*E^B+!/+K!.1777M?N7DMK#0OCX5<ILT$CT^4X4^#EK&1
MPK*L!'70:R^A!KS$EW42A\(!HDBV+I+,$JK&0^5K5A?1L%SH0"J*L<[H!US+
M"*NR+@^A=B 2.<USED7VYLZ&R^;=&T4C\:6=A)="M#\.ML7JFD*V-M2Q9!GC
M2EG[N6O19<VAMF;8A KJGL[#(OQ+S7#H1#HLMI]U>,@X>_H=6I/"A3TFKGU
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M=FB:%H!L3*DD;9D4 6ULS"W?F!X-;PHAN*4(].TN7_^^NGB5J1Q0Q4Y>^]W
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M$5[1:NC-4K4XI) *KU"'5G\>@(?LF'0^4 :JK=>K]>(03NYX"+9H0\ZQ%>?
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M$ U$ ]'("QII63"/+8IVM6E3UVSBPT<L^?&QX_D>O/+W=A-MFGA,$0U$ ]%
M--"F>0B;YI:A+!FQ73:J9;W2+E 9C'U&*VQAOCP<=7P@\*&MM]MHI\1+!]%
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M>#%;T#&(N6H:![#,UBM8YQ</5IX/5H[.0EK6QV.(BZ0TH4TI-:'UL7"L!=%
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M"!'H/M(=V+M%KJ)7FKO-+BPPRWK?SJ$P=H3"&*4)^X% ^N DXJD8=JYZ13+
MK;G;.01].S!A0UM&:S:?DLZ#2UAG*N_*<:\6_L(EB<V/=LS\#G2$BL8%=[VY
M*4EUE7K. DX*S_N*[)!=X8A@9R6TY<1.S6!R8(]LN;3;V)-B>"12W\VT\E3U
M<CL]#Q/*@KOEAS)JI?AL,,CPEB<EK,01QC4<+%5_Q^:?8K# %#82%>'B5@7C
M/,Y;JI?#$L*8;W9J&??6E-7.P=(Y>Y@IWM4?2^_9-9UF^EKNVV,7,MXN"?^W
M;RLP[-T@7:OFO=Q=7K8P)2VDJM?*>2M^5Q@&=NN2N4$7+WS__/9U_$?BBCIA
M?O'RM+<^&P*D2S(A%!)3N)T[MCD H Y2LZ+2V*VYLAA<;Y\;FW91T'(CM?I)
M*.V]CUG^26S3<>F^SAW/*A1+W/;@7'((4N5_&];.K6&PZ,=ON,WW,S4AL%))
MSZZ&0N!:OL:VO7ARWK:'@,$0%'4Y,%M#IK;/[4Q;F*NT4POT16'NG>7)QF.Z
M.M_3YL8K=*P[8L8GH;CE2.P]R[M=:2"[^[ ,M^$NIJZWZKO.WT));ANFYD)%
MBS7FO+1<:_EB>4PXX*7C_>L0D;U7R:YAV<6];V9J]7UVW7D)I;P=U/WGIEW-
M)4_$7ARSE <=TN&SK!3,PJ.C$E>>EI1#Z>-G!6LR'F8_T^)].6-\A>%O@Z6B
MVL64[K;6A:*EF5/D<IMV9<08E1V(>=MM:L'B1T/.49Z_K.=?[PQ"W#84<5L&
M*7IRLP_1-8AVW.[#_:>2KL'_/J_B<G)F6S&T@\]O5V))5M>7]?FA_K2;]LUO
MMC<]'DF#P@$%2&Y=YXE2C/GM]0>%1;F9PA;L!W,<UO5Z#:6- ^QLZEVB6WJE
MOEM'20$LZ_O*6%%GR<9ZYI^X=Z;F!100G!JOYY8-7X;\%F"95U/GV=.N7&>F
M072UQ[AF2$=!4VC,;\'\EHQ>_[<+=_P(=@5GLJ)XYO'<_;?&*ZM3,7(Z8[IZ
MET2*+'9L,\7"F>NM"TU,RC_ ;J95B$1OI%CV.:>W_/[\YW37/4NV+&2E,6UC
M"MH/54<G_K/A%LF%M.T9&0H(]I[DU]QQ,^GC9'%O;5]ZW5DKN^VOBV5&=L[J
M)'=CTATCC^.4[2[)$YDZ\P-QNII>::$PE_[VI<3I6GHUQ0)9Z!,JED\"?4)%
M] D51D"(N7ZLP(B)KI_ 01!8=@_O^FGJ#2S/>(B-33VEHJ)7ZZA!%<LE=&79
MACU&EU"Q7$*%N?TI.Z2GU?2T"1#K[>VM-G6,XO?Z9C5[Y=KAG-*57].%8ZGY
M FY>6F65*ZGE=!7MJCX,-X.VW_3N95YMX&I%TF+>,)0IAZ,O4!A,6/[<M6,_
MC(@[.T"?VUIZ>7-%8W$[VLC4/#W5'=>E0W/-QBQ.V,"+R-3>,O\KA^&.S 40
M>^%KF]9$J%9VF_%X%):9#^]K^K4N6BFZZU#8V[6P=T3MU)(%!&RHEB?VN*_M
M3:^P=W.W5FN4!C_. V]=61)CZ#OC?XF#."10^5WKZ)I-?!;Z*+\R=KPCJ@J9
M?*X"S!AD'=OD+Q#Z)GMEW_&0;;W=QI)I!]W:M'AFB3+-G!73.&:)LLA-*M6Y
M;?)S\^.G]#T\@+FQ7-++)62?V=OOM*R2-;U:SQE/+2CK]!_)$ON<S2CE>'#3
M:IT"\<[WB")=!L9!!$J]@25X][:)*;&Y&KW5T/&<>?9'7H@[MKST6OKF)^ K
M+Z=;=*KMB9W;=V'9G+4..)*S&Q%=G#GL2Y&4O\U/![OK!AP >43,?:MTJ9V1
M8^!O6^U@6M++;OVH*+I\F/T%'G?M&UTEU=>^T15KU\6* EX1@<!\; $ @PE'
M +8<UG^P#)]&>DD@1>-S[]Q!+!J;LA9RZ 30K,\/$X2S@W].]:/ZOA.$YR)U
M4KM_U29!6ELADX3?E4H:I/JEF2.\7KHNZ\TFZDA[W\[4,HST6GV/9B$4(_)\
MC:$8440QHO@&B-YD0L8L&)&\C!\-^X%HKN$3C?)I$#L*)%6\D0?!@1A,>@*&
M.XK"P(:K"?X/L;U/]-JP?>^.>+YKC7UBPAL=VXR^H'RR;X^G"Y/>89>6-W<\
M8_H[I:0Y_0;]&ZXRRUX04Q0_=PYG\&BGUTDTOT)+;JDE]72<.C:>S44M%- <
M/\G&3I\UV>J)_J*Q,BE0@Y+]HM!@"J51,GV,/W1@;XEK.6:\A98XQBIKX.SB
M<)F1M2;R^&T5TVS01FI)Y(U6:L%HJ-L62[="W19UVSS*2US,\;5[0I]M@[F<
MJKFOQ' +)."D>(=]3"'I> ,[I9NKG5H8"\HRZ=)!:8=TL,<:."B^Y/GZ1/&E
MB.)+X:048IL'ED_^?HQ7TBXSO/*>WW64!) 7V;3H8DF57CNFLX D_VS>BSN9
M8)8%D^/; ;2L[,,3-5S,YU-6+,N8:L"@IXZW<(DVF&A!P7ZM;W/62CDF5NC?
MWTQ1.'\K/9'W8_X_QFQ^$79DAE8]G=O"VQ%E&3R&@=JOMV]WQF/*X'SOUG@U
M*$/>=RYB*]^2=IZV,"T79#5GY6**?ZU#.R;;=UB50L;@6)"(,1Z[5)LZ#F:G
M0! [(/3T=#@6AXOD*.VX^UC1.=_']C/M8+I*SA*R"\/INL;<HMH('=!,[,I\
M3/*=@H5LZ4M/1I<#<6A!+[TZG85D=[O9RX(E:*/PMY'PI];P%Y6JM7E0R)K7
MX*%LD9*,33CA/5O^8[PZJS;GU'4<W%,I#,] ZT2+'??M;H#73PJ74J7S!L Z
M#%>MZ^V\^ZH*M<W(<(LK:EY*#NI,Z"\0A7@<U?[9L;EQ;$@C%$G<KQ*++B#0
MM\<+^&/O=5BK5=2A][6)R-F.4)2\@[]/G<GIPJ-:M><1Z)AW[QOTPR:(D$&J
M,=UCS:9C.CQ2@_+&*<M1FUK&O34]KKHF#+3!Y(='.H#80.#5MV6RT)7C#B1.
MUP#3M4 IY992"85.4HN]+1K_3'%SD;,65V;<)0/5%G-*CIUA5VO5*IIA\C*Z
MA6>KO#;A^X_=#XJ:,)?1]X:^89N&:W8$?!1*^>N^Q==6:NW>BL9\#TX"R**/
M4/A5[:C=*67>6B=:Q]Q_I,M_D(93#^B5?G3)TEIX_AR$@0<H#";,E#9\-%SB
M 8K$+&_$7/]2QXC:Y48.VX*.TC'D.YG=$W?AP=-C#__V2L_FOQ?DDGACUV*'
MN_-B><MGUV-S5(]O*3B]I;?J"]?U1GJ=DHK&PS]&)A$&G&DR*123+R0O7_9S
M"5^8PL*=A>^!D,#$<,>PC\81)@\I])T+SXKP@8"LY?GN F(..S,0IM[!U:&>
MN/"AT+,:=:ZH)S4Z@PV/Z0=B&!MH"=DSC:QFZ=F@D4(Q\N.2UM_F\$<0$I8^
M+U\*0LH2/Z]B4$1FV'F&R:26MQZ0A637<]>969[GN*\B[FS9,'Z<;>/28]RW
M > LINGXA"QDXMN;6;)",@D=ZC'_+,/</6(R3P@[3KW%;Q8/K!J.-:)+]OB[
MB9VQET-29=/)P42TVDVY/P[RZ!QM>4HYO@V]D3<N6TAF*AED$B.5N1[(/.4A
M63Y&(N(?V>41;W)*#++:2JV0!0JA.\N#&Q)B8BK<1MW\8-7;Q&X@O\S/QJ76
MBZ*=M\;TA6=V;S"W8>>J5WQM6YX-KEN]-R!-L7@-K=E\2CH/+F'5\+PKQ[U:
M^ N70%$F_W7D\"V '>#A3;L(0D*.FEVJ66TXS0W5).17-AHYT_F/2ZA]R[**
MC#Y]1K_C0%/D\=DEF-WP^$,13$+ID$8C76F=_@"=>15G!28:Y:OT%2TFH,M1
M&>M:/9(6&TH=J5Q:9K[+%XE",F.Z<<0]^7IUVM2B%8R5G\DO*/-3^;=@W[';
MB6$;U%G6@D++*];);I2E=<)+RM5Y3^BFTZMS^FR\>B=R;H_!+2MNQ3;[[T),
MKSI_N7BV3/^1XE3ZY>1+O"PTO\'.6M#-.IR01N^]LT8S?(U/*GQ9+2FML9K2
M=$J&]N@"_?Z-DOG)UQ&0"$NQX;6MZ"5E).'-?FJ_I@IU @VH;W.(6F=U*T(N
M( !<1(0!8^$[\A67+QY>$J-9)@75LJN-9KO:_JMQLI70H>Q&G*;7"Q3*E#6^
MO*T+@/=O1KV[3G?4_[.G#4=WO9O?1W]H_9ONF=:YN=2&/[X-^Y?]SEV_-]26
MST:.5GDS&-$%C 9:=W S'%SW+SNCWJ5VU;_IW'3[G6NZ<OK"]][-:&F5G)7>
M+&94C!\O73#?%AX=W/-4=FZ;WPS/\E@.BP=%U>'5$9W_MRF] #:TNM'QC#FS
MER_(:B&VL0'2[:V WA;4\IFFK!T.O(2$E6MD2,"K*A8;$='AEQ;GEO [Y3%0
MP&],)7GB4S)D5ZAE/\#L7BB=\@/P<A$?3\4)L!FX#X9M_2<!DG7 )."R!$L,
ME35WXC\7GF]-7J&T,%T+" M/5*GP76(_4$VC;X_/=+JD!^(_$I=K'Y;O 06S
M!E2&#];VQ3U5ZRR#&:=,!Y)K[@,2\#208BNE"RHPS0C[O7RA?4IZT7$U^A3Y
M>2I/S0W[5;SY6=<L("C*W\-I/CHSHDTLGSV)0NV#7$3','Q>RHE_838#^8M^
MW*.@^?Q+#Z\SOAA#BUP$BDBD"9EHZUV>6A/"]D%<;;ZS&#_2C2?$UF:6Z])E
MBJ+-!.*N*&AGVF#A:EQJI'-V"17\)JR2@ %+>*6+IB-9YL*8:L^/CO8(+VL,
M.Q@&(K^"G%6#"@V6*55&.H3$9\:'?[3F9]J(PJS@6VY>>!L 2S?@7Q04&V8%
M&S7T%Z;EZ"R2DR(W?F2OBG&U_Y^]=^UM&\G6A;^_P/L?B)YI( %DCR3?XO2<
M!A0GGITY2=LG=D_C? IHL61QFB8U)&5'\^O/NE6Q>-/%UMW<V.B);8FL6E6U
M:EV>]2S=Y <^&\%\'E4 =@4R(5@3)T$L?0%<SSLP>%)\^V <T_;MPUZ/'F!E
M0$HL;3-[]6.$,1ITP-^8#:A%>"F2N(XC;]Q/$[TG49 L=5L<>AW[+KKP8+P]
M9'NPM?S9^H0![*=1#$:*<("#239.T<EP^E@U28*>I* $6OB/)Y"%RFT"1X5H
MK25F[" T./(TK8<H2;%P#G4X_.S#6JL@('G\.QK'H9HX@SAZD+_ASCET7IMB
MK[[D<'-?&$6Y#3H>EQP5!BTZ$]U9>AQ4CAOV?5 R"<R W5S0-: /[E!WC6(U
M<F.3>D"5 (ZOJ%%#P@ ?\^$A(]Q-]RH$E1($$SKSHY2_BYL*75SXZ0;?0X+K
MD6WEFL/W^^'-H?./7N]:GS76F:,1K \Y%O$X$/T1J_MQP%W$9(\Z].T;U1_'
M3+""']-L$KCG$?&*ZZ'?=O/IPC[3:@ZY^-3?3-'K9/;T^MIKE :!=V?NN@1Y
ME%4GZW=4H'$4!"C4; BDIE62@F4>R$^RGLZ=&V $D:>;9M *>Q%5X#_ LV!:
MK^^4?@&-"(*'/8L"^@<9*G ^^RK>_,F\\?'J\7EC*3(16Z4]D<"GF6$HQKT=
M<QFSZ'>//A+# B.390B7'M<YDW*&0_GH4KW<(^R=*.8O1'0KID,_]@[@:--1
M>0->=:!H_\*YE?.!==,^;/8^DU>;,PG7A/H!0TF5/59SJ8*?_@2['^XG>/?]
M!+8L[FO8O>,@S<_.%Y)"^',(]PY."@_37V>DQ%4*)PMNG"_P^=ZCZP>Z#LF$
MXH:PL^!"0P7=7PK<X<3$X4[G[2%P\NZP6XK'@2D(1QNFY(UI'5$:V%D4NXR"
M'#ZJ/EW%SE&GY>"X9(4]-&E!WXP?4.?!!]%2[/OI'-+ZIGCS?')C;+6>]+*G
M?.2'O*@+YS,$T^F<')83448R+NV!DB2JS=<@"N\/0!T\P"DA Q/-54^-%&5M
MF&(+CY<P!^'6E0\.QGA#B87:PK/]ITI;)&\/3M,CO!J_&,,'P)P]X$M-KCJV
M!^FSB8H?_3ZK=!?_!/8SW51PY.$;A\X?0Y]_<N_I#@&%#&?U425YLQG6]TY9
M8^.B*3QD^$H<2>%8M<!T1 JR<4SY(WD #  \!KQQ4[BBX:J W]%PT!J'N4<\
M3C0*8?9@P5>,N/:XNG#5PQU/E[=^OK;W\04Q/3-T"GJ#;7&\G"H6,#*]0,FA
MP(]@Q#-1BL8TH&#[C$MK1<JY9PP+- C,E;^ %?4$=S9L2$Q#.&\L)]?763_\
M;N;J5LG'U?K-"<P]]@1')(Q2V"T#/,"XJ>84<?2H6,8AS-=)P:1_1%,_3(<)
M;H8'!5K8)TX[$(5\A]T^L#,4ZEQ07.A.W"7TUJH!6R<-KRL0F@>CAD>!; H[
MH^)TP-T=DB.2NG^BO$FCP8_PD!B/=]4K,\F$2GE)"X_1$,>-A,Z@5U*9"^Q]
M^+>+EUS"^Q7.L0(%!PX?/-N-)TP!W>*1XQK7C[WEC,9Q,J8/Z2<'\#N07#^C
ME)8-5!RQG>HEG?,W/(KZ>7Q!RT&'IQ$REN63S#CV% 7)Q)FMBIB$6B=L:NML
MYB1_#LU"MNKNEZ+=Y1%53)(CCR&C"@Q'O%%1V]')-R;4C5(.PO4XP]7MOA4G
M"5Y^?P_N"BH1<9-@IY!?(%:]XU(=GQ,]$1TY.CQQ] -NRQ0UZHP+'NDUDE[H
M$4=>\@WF!48?*(QO/+YK'EY/YK^<XJ+<K3^]TN2PG)345_VA<R&RY&."_)@D
M<WC<."9HKX]W0E2U6G?C5((/Z*!.2'F@*4S^#BC@412#KQ6@MH3S[O'-CDL<
MJP=XI>8"XL!;TA^"+@CP $7R]JD;_DY-(EP_6X\?.O\#ZP=?,NIQFO*P-YL^
ME.-07]4TI9Q(R)+A^=+XQ)^A[8SJCI^8;33>40EOJ<P1I,"0/_ YR$C6-PS4
M4W>I]M'KKSAQ-)UDB&>]UDS;T ''L:.MEDHD.%2DEJ*8LI$5*A%O&@JVBFK$
M?;#96]6Z!O66B+&S:<S[$FRB/\MW0P J).0[K25!A0=WH@,5+=P(^DJ!#[AD
MH\,&@(LCQ?6'XQ?HQJG3ITE?=CFYV\^=V[(-0,RX]A=H=<!2C+-=CS,RTP Q
MV<$.<5?-U>@&0?2D_27K 2(]'W<IK?W=!)[#L1/XVIT;_AF/1VE_0MY#@D=,
MADXJ.W:Q4!4C,RG:MO!J[&(->QL#J;.L&V/Y4MCF/I+S@G&%S1R"Y83Y6,V
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MHIBL3),YM.J&,6]BWQV67"QQ4(B."D3TLVQ/EM+E% 6+XPB. :>U)O8#Q/P
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M9C4])UVK(B$9NK&2DKZ'!R04@*W\I_FJ53Q[A_'^1Y^")C/B8M=Q1 BA2YC
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MD^7 W%CN$V5.J'^4A3C#;S(^C3(J.1ZM,I:.'F)N3SOWD.3+IA'NT4_'8#:
MHA@HZLZ-H0'B(,Q1!#+/H>&&+%=4:-@;,]WY=K,6PA&HQ$+'96US#'",QEQ
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MNJ?:GJQ^SD'^A=K:E"I4I*STQE1.3B>"H^11$-V+0L[38$O8.#!CK^RAQ(K
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MR-*.IUL#OJK)W+253VUN,/+G/F"@2Z.9!U(1*(3L2!#HBD]KE112Z$OS<E'
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M1DF#M%M<Y5\Q3^[\Q%@&I[,:IQ[6Y5UA#0/XJ>6,QG$R=D$8:>2X**)'$E4
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MRTD*[UNBAOT$=S\\&CZ7T ,2N-[Q4(QB:0(&DP:?B93H?1PE"9)!])7RZ.B
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MS[_U4VS<E_UE.3[_5/.G;0Y+>V9-?O>DW6JWRT>F\:P:6V:G;)G&L]HV-;2
M%]9I+\T-BU6 D7E.PZS7^ZHY,96ZSK%/P;NB[IORI.DW:Z=T$J=<K=RZC#>K
M^D&!O5\O#SKGM!+Z%V:VQ81OOGFMY&'9?O"]VESLE(1M;S12H6<^^KV3'UF-
M3 A"5I")HE9G1D_?*=A\H*>#)W>29"W^[&?_K3"%.>94'NX"<^L6YC8T]XO
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M(@['9D<%*&\<E#? ]FYB<@&]#X'>(P&]"T)OXZG^Q.A(4>6A2(DTC+V;X/Q
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M?TW-,P-X[IN\Y,J1CU:YYJA=UYSX Y[R+[K%LJY5F08+4:A#%':(B-)Z$:G
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M:?B<A!X*T$!_PA)Z7@:_6+ #<DB)1$'R@V;2TV7NBA"/;:/A0\#UL$LF.UL
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MSAI)KW1,*\]_%MV_MX,7QW#_NEHZA X_(( S/<D!@'7VU6<GQQ5AJ!##SC^
MF)^!EE\X*7\ )8\*M39^,H"(TGM7ZM[QT>FMEU]$T5B;16%G4'F"*"@]M3)1
M:,6IC [96<+'@$DX#$YZ;5@L\91;$MU![2K:^*:L?ZL9"I^EU.$LMX-GO^\8
MRC?J#4;;>8B,AQ.66\A6GJ?8(5NC?FVR);!XV3[BR39!E.*3!,Y A6L$7X$N
M_1'2L0DD/AKVTEOM HJW7!JJ N/#02^]LR/0>"V6-I  "58+I+!TZ<4@IBZ,
MZRGJ])'3LC33JN8J4_QH$R]+%X:U6Y)0R*RV0Q*2Q2HE;?<F\N\Q8Z7T^ONN
MI2(H3NX%A"=Z^$9 _KTZMT4=;DQ' T5?'>3B,G>G![]L,QR>/:X^Z)#PB+_R
M9J\5R/YE84]83NTKKV?*\WQ4CR4P __JW?:D.R"6"S$B8ZY+GHAUA0$C^QL4
M%T<<>[!:SW< )B6W!*3GE>T2EK\R<,8PT-SUP#Y$U1;))%=BGG$X7[@RS;HD
M*57/2TH_I0-?%+&'0'@U_*]FOH# H50M<*"R0WF]\1],8\'>L5ZBWQN$#=#6
M=+PUSL[FY7[;H[)!XA]I]9$.VF#:&W1X.V3UUZT2H3R"9LJK%"?G=)=GV+K2
M[O)'I;_-F!WUCVPCF,$$\G-A^CIY__E*G=$G"]X(GS_UM(G]W,-JIN8;P!EZ
M4#FEW ]W%8AM?YD76KW?LZ#"BQ@56<0X6$2.[^9RG$I84=01;HQ+T3YZC-0Y
M7*=AT!;7"=T:#ZW) P&9!FMB/FLO[JLXA<)KQU^O0HO$LVDS^I]W_!D&FY]Q
M&_;KCBMEE_KWI@-88/0($H1WO?$D>H\]1O1VO() HB4$\!":M'(0%O[-LQ>O
MWM-:1%3.:\24EN?^]JN6^:"_[I<1*61A>7R,72=+Q6(?,]).>R/#2EGE1$B,
MU7?!.PZC#2O(*R[CXUQSO]^F'%52_6_$ ;Q45?+LY*A[.6Y^X5L+^]&".Z'[
MPM/&BU@X0G&$Y5+.[RD+GINFO< :T>S YA.[T)$].S[]QP=/],5"AAI/!)_B
MV/,YHS"B&>\;$).Q?R\!"TR#.L*]A=*G4201IK6$(EG;V*$_7QIXE6)5_,EJ
MZCG%%,&/I)RJ_T!P5]I>#GQ:;TS[A9!;XCP9"Y+-A_!X+XVNW3O;T\SXY]>V
MZWVSO?\E0,) 50H>+FN$6:/>["3Q;81X;9'T_B[B@9#ZUK;=O&(8.=-Z>BO-
M0Q@=166V]$#BIM>&F$'2TB=:-O20!-YQY_YG9;QBAS0^VPY_"[]WV'[[B8S,
MW5!5HJV<8#^5VQR4Z0Y0J4S#OH-*DVPJI4ZP[(IX3C_PE74Z U^'(:=T<NDK
MNYX!;#(6Z:__6W/H>2.)C8-$S0,.$RX)KI011]5Z^.W&DO[IFSP/I [D#$=G
ML)5KL'9XR)@MR#I)'3PO>]R/O@-$O5L1)J'9DQ F]^J "V;TNLPN%$.YW^^G
MS>ESP!K@27!\6[HV-==EU/B %, N./2@%'[K28.G\%V0G1@'-3=I=!&/N$S#
M71!V "(.T7O2)SS3Q&\)V %^!TQVC+_ QH)V'()PZ=)NEIS"-\X/M-7!<?'O
M>)'P0Y=_ZFY; 71V^40NY=A:/[VY28] 4@Y2(\F?/DPZLB3ATH&8$.6.'NL"
M<J#<:6"'4K1#6<P^:IE/Q+AP'C2?.I]*VWL4PP*% /%RG"2$Q<S6XZ-#'HL]
M4O@($>^/TJ]3H$H:E#,%XGA%EB!LI@QT*>1P$)I3$7@D%L ,D^?GUH9E@$IH
MZ!I"Z((99<.B<G'K 6DP*X<TN0&1HOKF;HD'WF7IF^:+Q%M94>C#)(G="*30
M]1_^C(6FC[ZAT\]]U%9I?GLM392I+#7L.^)N_XH9H?A;<:?1D_ 496C1UH2P
M@Y(+QX 5&AH5,2 9N $D(*%.7EJ@13&6QD)+)N93>9-=J.;:IEB!<0.+G3]"
M(&;:+FC)28='<S/4&9[PQ QUT0,MRK0G)1Z;9J; S!N>A!2@<O:[]B?0_!H<
MK0UD8_#P#W 'MK/E]>L][&Y8(.D&*)UA@;+YJ$\N"Q V-F;6X"/0G5!!8C@
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M4"5RI_TLR7;O[1$X&,[:;.#5?D]B-)& *-L[NH?U9V2__T#+."/ZPO^ X5Z
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M75Q=^6=%72#3Y9]17">]?F!/]29L]2%*0 \K 9T4+@&=E5\">O@E+[2J3Y2
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MSC<;8NGA5^^5Y,IR:$*#_RV:X%NQ9,8# 7DA;S7S67MQ7[V//5!X[5^W'N&
M9THOM\"SJ5O/M@KC"KX%-J/_><<!%:"N=\^&[JV P?U?7OU:_NH+<6:0SYF8
M9^I-!\"(B%726TGIC2?1>XQ=T=MQ=R11?P3WT:25@T;A;^!OP6(C3$3]O$:[
M8WGN;[]J!S(TY6OH^.+WOVWK6QS(<AR;VJ&D,63HW:1,=YFE:/%YR92=T][(
M2.@D)KG>)1)>FN_9P3L.HPV^]>H()@^*,'EX1*3065SR/<1UMQ&NDR('UA+
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MPKNF."/@G8!WQ>'=:"^\4P6\.V)OUEFL)"P]X 4(I2?O!F!5L(*P#S%D^%K
MNH/R=A72JZNPKCIY.GQ7-J8RZH6BNKK46J"ZPDF[AC@C4)U =2)IUPY4]YD\
M.+[F!&5W*DM 5('NU'M%Y<>"H]?M0G?IEJ,M07<5TJNSZ*XR>3H4W?W3MXC$
M->9BP5U-6BW 76%PUQ!G!+@["MS%3[:IU1PBF>\XX"C31\H^"Y(^.0*$21Z=
MI$1F34.H]3*8W3)MD'PP.NSPEL6);]%N1M32?>"J=KLBA!DT3?*P 0^N= \
MH;(ZM_2O<!/W.[O)OG.IK<$:HXQZTP!KR)R6E+)9]B=P '&YSB$6M29S=I'
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M8H%TF05"M-"[D1[)TI!-;:U2W>PXB6$0Z(#',(C<S0^O+%F7NY*QE*D5O2I
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M.\UJK+_0M>.YZYB9Y_]B6ZIL:9B*\[*(,JM\NE;/=<1D(0H1%*VS$VDQ .Y
MT<SBWHB9P*<E83IMH&KMS&M0E2MR_MP2OY *>:!"06\WV?0<.,>@I=.%)5UI
M]0JV'TB;="DESE6S[P*)QW^1#QZD0AZH4#I#05:%>'9'_CG4)^X4 P!7H\<R
MMY+6L/EUUF1,I;U1$0VEI1%S?^F,Z6=Z$;JAS'KB6^")QO1JM(B6B'+IU*:N
M9)^$@3>A(NO@2(4\4 %O0MG5(=NB3IQ7]GOJ&L4VZVJST2R;5I$[TJ5B76UK
MU2MTKI[\M,C[_%"GR,/\T+IP1/35?&[YT/125HP :6HYC]0QH.S89XAF(=7Z
MEWP5:7HC%B=:4=<Q>_'U''_.OWC65\>R_^>3SP(*4UP[ ))?7'&@>^.<318Z
MO!ID<34888G!O,RWJ.=6:E'"\SF75Z(&ID86.B-/NAU0\M/;$LUU!%O?ZVS(
M1K[N4_-/^.@]9:.9SNBQDNW'@K(?ZI/+NT0CNDI4WKA*I#'AO:?81R=<N:Q4
M*IO%BC8>7).#ER9FXW4#?^8RSB/F44ORQ(?C:QG<?3]X-9U*1:O(_V^L0&A
M22YB-R-];!'U5D?K-'<L0@Y-]&AB1/? &SZB"Y_.)Y1) 5?GBC7 *Q9]0XWX
M2U7Q4DTC?* %-<",;[\>3=]AX'L^'YTK$1D2^,A)#CPOR)0!JPVMVK[2FM5-
M%T4B#+D?];0X,BG4TYI?36OP_=*I;08W[MQ EIBCK*.WQ#2AS71Y-C[<&.W%
M,889>J6@62H9+$4,-"E?1E[7-"U 7[=)?()QS(D"G=C4]RD33[EPA%F^\'NM
M7,/+]>8-<Z%;)L=:2C]BZ O+U^VSD85+9.\Y#@.G)]>?E?^IV= Z#0SOSX2
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M/1-E((S7S5@5J.:B\6/YR)66B-KB#4=RO9]<*2L!]0HJVFF0*S4UN]+.4@'
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M^.,4S4P/V9*XB*:-U,F:>INEHO5[*9^I8Y>J\JPSICM^F364T 08;8RN^>_
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M3:NT-CN1(S_@[D T<B$KDMWJ*:L%:3DASB%3->Z=2*_7BVH*0A9A^+ST>I"
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M.>W!%+^@CJ<#(=#67CI1@6@@&H@&HH%H(!J%00-M[<@]B :B@6@@&HC&.TQ
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M@6AU3K3JIK<=4\_?"ARJ+UZ(Z083F^8TLBF1">8YM PI@!1 "B %D )( :0
M4@ I<+84*$0J^IG3""F %$ *( 60 D@!I !2 "F %$ *( 60 AE28-,?AVW_
MUD <>%X B>7$G1(9PT[B4X^[08GR@Q*;^CZG&3RUG$>8_PN?K5S=R_5F[GKW
M0N6GDT48'<_'=XV_->)0'[[9"F=AN)[OP9.?]KN2[_57\/6'<6_A*GKP\?6Z
MYHU87?/6CWHE1P'[M6W=7TN0PU_<2#=$ ]% -! -1 /1R#,:.T+M?.:P]=3&
M97QTI"M1\R9@7'>[YTJ0:_ZIVP'E^J)X)6?JTV%Q?5OTJ%0",3'?L<1;"M%
M-! -1 /10#00#42CB&BD9?$^AX*L<5.XN+-(7+_Q^Q D5$N3-0D6_%?Z0IEA
M>>*M\K&[@%N'A]9;W*:(!J*!:" :B :B<2HTT%")W(-H(!J(!J*!:+RW)M$.
M5ZEX;2@O_'UE"3 /<YOFIU95;4ODV9ES!.X/1"-/TB+-S5X(JW.)C,N""RXF
M.J<]V),7U/%T( 0:C$LG*A -1 /10#00#42C,&B@P1BY!]% -! -1 /1>(<)
MJ&O^._!\D90\=G>8>47K#V$#Z,5,  _T/X'E\7F-*'NR#"IM1P_4<!\=,8HP
M(Q7-OERM5-#"C!L*T2B1>$E7.A3")'T.@=#?7<8?.<0(&*..\4I\ICN>+;B)
M/.H6&JW+)WT0#40#T4 T$ U$HS!HH-$:N0?10#00#40#T4 T/FACV]5,]M;U
M/&43Z2F3R!@L(G*0KF..E_:1I9WNCOK#Z5A_.=!PG\N>MO5:'8WXN*4*N:72
MW06%,%:7R";-24]LSC1H>BZ=!$$T$ U$ ]% -!"-PJ"!IF?D'D0#T4 T$ U$
M ]% -(Y"8T?[BM!L>$?]I9WP, /Z _5URZ%F7V>.Y3QZZ5C+#VM'4:UJG?9F
M@&LJ+2G.F^S%(]ZFK7=I+*TN7O:;;,/Q/LP&N\;]2/M&/GMU!<IG>\DDYI?4
M-LSK^O(^/\0?\4?\$7_$'_%'_!%_Q#\M?T1>$<C[_'"'(/Z(/^*/^"/^B#_B
MC_@C_H@_XH_X9X__IJ\-BP =FG 1GZ<8ZUF^8^+:YK5I>0M;?_UJ.?!A_NYO
MN@VM4SVB^^3_! Z51*AS^H&7-J11"5(W]CNPQW2^<)G.7F6@@2C(Y0T#W_-U
MQ[2<QS6?=M<;.K$0AA%E%O5&E)K_2YD[=L?4N6=T2AFCIN@?L#6F0;2J'4[%
M&[;%,WAB$G&O>"5RBE?>\(4W:EJGTTDW^>E,>*&G,_;*6: [YV+#[_H^LR:!
MKT]L.G;O.84<_Q3,\?ZDN+;6[#20,TXE);H]UQ'3X0QT8B%QU=+:E90S),^$
M%9(1$@GSQ@>J/':T9KV)G'$R(5$]L6BH5K1:Y0H9(#^B(0F.^$ ?,JU50:7A
M=/*@=F)YT&XV.0?@B9 C@9 $2WR@M$93Z]3:&?(#YFV6>/\@&H=+DR,/D)X[
MG[N.$ 3=@V2$^L1NH7)(+LZ';%>-*ZW=:.%9\^Z&MC/7-BGS)*'RR![O/W>0
M+3(6&M^*(33J-7YAQ1L*GJ^92]#\=&YJ5+1*&^VYV5 ]GV4_ZU4D_[LRF(^E
M?YZRUJ\@\7GS[,.L]61IG@+E&E6MV4J/<IMA-&5)6:\O7HCI!A.;YC0B*I$)
MYCDD#2F %$ *( 60 D@!I !2 "EPMA0H1 K[F=,(*8 40 H@!9 "2 &D %(
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MB#_BGY8_(J\(Y'U^N$,0?\0?\4?\$7_$'_%'_!%_Q!_Q1_RSQW_3UX:E@-9
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M-'IRA4Z\Y*WIZ)7JCXK0S^MCMU)7NGK]Y(;,*ZW5;FF=<M@R<\,*?^IV0$_
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MQ%WES51KK=UN:+5VIPSU?A/>,6]0&H@VXRHZ99XD4_JD?G_Q5VP:B.=#68%
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M<[L7*_\ISSL]N<W9U"K5E 7SIA>F+!E/]<4+,=U@8M.<.M02F6">/9I( :0
M4@ I@!1 "B %D )(@;.E0"$RH,Z<1D@!I !2 "F %$ *( 60 D@!I !2 "F
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M:V;)O]3QQ ]0OI&?J+=J&^&DGM#8W&3Z,NQ ^$J8R=J>T_A9!+D> 1,ARFJ
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MUR2$%2K:UG)*8<#-T4O3(IM6R.Q@O80L&4/<OB1%Y>#B9B*"6&4Z3&S[PI?
M]MFZ?>LB5R+"*![5XPE1#:]*954.!EZGU:"?=?O./C7E#ZB"T>?G&!BT#S5
MGZT^(N\1$5RY4#SD6:.'69![),^.\,,-S2(*G@Q/>F_]SCT'?RR-8(#-]N_
M?(Q=;/3I%(X57VPWT!_@>)M'P8VA=2!VC=/"0 LM"OW65("FBGV)VE!#YAI$
MRO)C25XRQ=&ZZA.@3[H=J#@%;SE731UI_%/K=A%_QB507.*H^42/X++(A(U%
M+@ONIJ$Q@*_)4DT+^;U1G'TP 2Y7J Y35H=DX%&([+"%UYE_!H)7Q%]F!$DT
M/_ (B^ZO,H<A:F$,?TW!>TW5)[F4T)U'<7"$@Z@ E;!U"9^2MZO<B0);(Q*P
M&!L)KP:\UW74<;51'EH+OV&5DNLW<G7P@!))'4/<8N-I8#"K-3J!YC2SP ($
M51[B>7+B!''X;+G,"SPE*,&;/I>U?!3_,1J&V9A*%D,92%=XB."6[P="E9'"
M&J[AI@69!]$UW(LQ^+LDZXB*_? 0:L_B"ODJ?W[HPGU& E=AF*O+7E0TE'A4
M2;RUU-EHRTA1YQ!AF.:7-(_&DE8]*;8E0X-L8U0$<2Y7:L4C?N"#=+E%)Z\J
M(-BBTUB57_#M0FCZ!4AHMLPI'=[\'L^F@[<)$3-SGT5 C<V9$>;"-X0;L##T
M6^1P>J!>B$GQW;>Z;\&9*_R"ZY!H2GZ(R+I(:(6&8-CHR6??^A>0!*HN<V$2
ML4^-F>/:[N-KE$^\/8IP%Y#BJ&.:S#X7[U$A>4+;XUHWO"@O5-OCD>)N34<&
MX\>O.7 E#'7#1< 6KE0Q%$%@)A%)1%C>>M@PP"\/6,$E$?YPGXONZ>KIBGE]
MA<U4I/K26/"FWK#*",H/#K%_T@+L;;4Z:/%'_P]?G.G.Y6$QUJUGW1$K?./^
M(N]7,7L]F#JB*(7MT:'Q U9LUAFUM]M%WB7IH:0<).)!93F..-^D@!!*^F.V
M+X!W<M$N)@&L;WFQ>S#<3ZE(UP"6 7_2<6RBRE#+"_U*>T%DD>/*F"B;2)3G
M+D \.=>L"$+^KPU^ G&1DM<$(80CTTIWU"M :X'$!ZPW*A?5RL6HT[FH;JG;
M!9)]U.^!%)Y.XXZ7;X'-OXKON[&[X#NJV0W#IG=QEZKO]:$5Q\93S+KQ]GXL
M.SGD1Z5AQ1=V2=8ZZ"KIL@PVM,7=$6+PJ4@J5.&'C#Y:PC4.)_24B@-5I='X
ML>(?JW92%:2NKC]KMK/!_?"-\W5'VHZ[N@)YBQ>.>/>M^,??I#<"XASY+]Z^
MWJH?2#_Y6*KU"IY0#$"HJER_X!M7ZC2QF#^I&WG2OA<+3Q3%;RQG&<N^XWPH
M:"A9/$3H^T6CL1*@LVNM[PHK:QP>O-0H5EA9XYBPLD;>PLH:QX25-8H95E:^
M<I)'$[E^#)$;G_;?B^Z5_?+>AJ@3Q^R')LPT]=Y#2D862^^]CYN!(PQ/KO;>
M;[=.+U26C!F:J*+40:Z2"/N!"26+1#:6+4KUK:2W+A@_N 6S7I+?]7^[C 0+
M,W(R6'/(DJ)+JUNL5K=P6=LB1YZ!,0:L*N :L51"]!P"J*@CU"5I@0L#M.2@
MX$CCRZ0J/#TRT4LEWEO(O&EI19".0&4Y%S:_4%M:LXM$T_,BU0'&3%R]YK!=
M*)N_%7;PXN]W11BD<N5##@LD0D )(0C+#!8+L)TL$],NDY_7_9YYQ5T=$F3)
M!-3AG$KC*N=&B""0#2H"@C$U_#N0;=ODMZTDZ<H5Q_.$UU?N[2/HGF"OL,WV
M=C$7^@G-/X37YQ8X:C@5S:<\<4RE(@%3VNXWL:TIC<-S\&O\-[(APM4W\&7,
MBR[">D5[.F $9>>,TCJF;AC+&[I8S!7/V-<ML;/+Z;>6VO).Y7E5689BXC+&
M@MKV M1VYU%4%H._%2^+O]5W?1L^W/0?+GK#V]ON_:C_-?SEX#X)@+ ZOBL_
M7T]<QAGP:^73:C>&V($$FV>ML8+\>+/Z\Z=#>PZH;ZQM_81\K=$.7TRA.40G
M'\TACCO<LVJ"'B]POT\H)MIE8@>;;%33?Z\>%\JUZ7H'@;7LV=\MQYH'<U7E
MD_D/('<A0?8'A^(^0F(L(8BGU>[\ZF^ORR3;V/W_PJ/&5S-@$!GSZ=?:^IU4
M&(^JU6N2\GKUEY.LM[FQ7A$MB!O^[0T?WTB_Z\:,OXFMJ;;EW)KA6N,?/I(C
M=^_O7.[-)!:\:X/O67"U@KLSB=WY/6".)<(?92#4"_R>;-NYO&S.:*G\P]_5
M0K/8F_43[<U$UON.K8GG9B([4U2YF(G2RC$[S:EV)O_3"3\&Y+ZP7BYFELG!
M^"K_ 3MFN]KDU[);RN_D3,1C1LW0A3EH\W8ZI?_\!4;^=4N/J0T'R!$Q)(,P
M>!1C HZK@"]A$U&G4%WPU%;1E0E)PYNP4T*JB>7)$C(0O.O-^.^/K@CJ7[6,
M"N.C^RSY41H,F5A:&'!L4QE:K,D@ _$6D_JB4;E@59&:(P-<A?ULU28I[*#\
M_]XR8%E5A(MJ14)%%L9W,N?Z2_*@HIZEA<P#7I>S7Q;-BILVK24 RO-LQ3?2
MMH5(<Y+P6(MDI##?S5,I,B(*V]L:FK:23+,,M5M=L0QC5-Y;=\(_S;>+B"56
M$=U@J@YC*R%M7#=$&<VP<M@2)QLB&CG%8I')$-08J]#**. KBG=R61%&.X:F
MR$LR6(ZEBGNR%!+;H$*\3YT+=SH- RP>@>1A0+Y8=7PR8$"-<E5DN'2\1OZ6
M.BQ@\5NIA;.TK^XMA*/M2?1Z1US5G]0Q778CX[-0=A[#)!(ZHK [?1R5FH\9
MSH?1L(#R(JH?!:'Z)@U#6N(2BX\:P,;E.B/S=D6#1CL9>#_,E=U>:W%U/!7%
MM5FQ ,I,Z42$^,?S;SR57J;'QA$^">4=(\(D+.2N^00;0(M'C(4B1(C "17E
M/QVN8QH@WA<B'E&4)WT-OW I7^[#JEP,BHTMHKS+\*AQ7L,P'L]SP9S/AXR^
M>0/G+2Z\I8SF>_YIC63N]@(BNW?\\1L^UL!4=CY2?GZY]WW<^P>&VRY['$L8
MPWB)DXN!+5,SU-0DYX8YR6$!&N&U,\6]<:7I%U33=,7!#)LE&B2,MM]@4M&E
M2W9YV>'"71KM8UN<;S38S&;T!98HV<R?25<S;*Y4@CX[M=9%K1)FR/<A@ 3P
M@.U[\=VRYQZY($.1'25=COQ/>"RC9E<7"6MX=,0:X]VOU8JD9@U9"3%7?=S]
M)X47U (27Y?X2KDDN% I!J$Z(U>T325<U2A4,&6TO+BC><6#J7R_1'5,6$EZ
M6U%$]^NAA^:97ZK@97E%^ _7U3GS"WZ*"!"6J97<OLY[VDIZ3?B(GU%&])>M
M3V \^0=,)#8&^&)G5#<O23^^?58F$.-ID/QJ)F9$["A91G2ID+5XW@9GF5M^
M241[:C@UPKVL5.]X:$!,UQ;F^/B=G/%-3H4C>:$#2SEK2:"*PF)>9MC*T+=\
M6T5HJ]FNB1G;FC!1#F:O(UN7)0(N1!)VS#ZPOK-@AEYTI[#X8]DJ2JC(<0X,
ME8?=\L_=3'J]C&4CKP;\0K*9^M)0>Q'!QUSO"&M]A\41P]S=T]6LBG5O%#,$
MUEME"9FV)F^Y(7PQU&.ISU)D+1DHNM>H+'I)OF6SE!#=L/B4T'R6B7?Q\."H
M)V4\+QD(+#M<2N:S=>-OF$[87R%VX8Q:CD[EY3(B+,Q(/)%S)(]<4JBKERBW
M&EXDQ9GFD<_6);V$/&G*#,@J#-LM+@T.HO#FLI81E"D0G"?CLF)]1&35>U%7
M,SP!5?D)F/"R_-IJM\WHK/-6KHVKWZ@:YHC$1:C-I@) .$M\65Z8HX_'B]*I
M0O=JT1",;3!K0IG(% Y[ 8;%Q_@KHDF%NU+%C=.?49E7[,1(M)Q##&/0E6'?
MZX%CS-;N[#)V+&IB&D7#QZ77RF[;;.T1,\[(X/RXY$C\L/Q<%P-_"4_*N(A1
MW&5YL63H2"%2-%V57ULJ_ .8[Y1G>P79B65/I A&9>+F+K]G 5@Q\LL$>DB\
M7"Q$P1+1LC1J#!$9JP29(6@06%H>.=)Z).!E(MY<9FE&1^PR/7'.=0]? ,:_
M"*ZW0ODB8-@+<_QABP2+J-M4N!DC4Y>ZIHIWR2_FVX8*V&517]CO<G^"K<UB
M7+.#O6.HL]*0,9>Q]ZQL5BEY!4JK@E=V4];]E1((.I3EE=&>_#4'ZK&H@]D4
MZLDE^6/MB<0A6HTH3/7_L_?EO6TC2=]?A<CN  D@:W1;GIEW ,>)]\DBB8W8
MLX/]*Z"EEL4=F=3RL*/]]&]5]<'F)8FR#E+JQ?-D$ELBNZNKZZY?/6$M)^DK
MA&CVQS/Q=MA7.!659?S2ZL8X+TR#2T2UF1[UR&2OJ+(0Q]11J[V+['?^0AG0
M!);V?8IJ\?T)@2%?B<& "1@_7M/Z-,F0EA? <?R6('I\9($ 6*:9T>JU2#.:
M0=D0TD4A4X_3'*/F >2'D-/$)IQ-=3@4"(D1V-,?%E$,_B):I@*YXF T/DO%
M#1&\&T2F1[WP\%L1BD2YV9086ZGU3!(<7 9?_<H31N@SNQQ3;@COR"5U*.T9
M3+W3O%ACQN4.]M.Y]]H=,=FQL\V^J=YK9O70;O/QR1I:.?5L<>2M4OW"5JGB
MWI/271NEFJ;Z]6J:ZI?9VZ!J35,E4-)[W\_KV#15[7ZF\S+T'ZZHY_F'YXU1
MV5ZZXT\*<HG'UDQ'4ZFL/5:D@&%,7!>34L8I#QV!+@K_JH S?)S6&WB3\(6#
M_Z1"<7'W-,=7<SG'<6N23X(DS/89M:VHY^PK=-SMM\YZ*G2\]<=_$IL[@\V)
M=]S)+:)=@'NZ&/8;ZJ<2FCWI*Y(;, L\$6F1UG?:7Q-!,D5$,E,=:BSCWL/#
M@MOG,L#/ WM)IXXCL[XPA$&-3SH_5<;/+P;0"18!F$#@P>JI"[4<S9U1=J_J
MA,FM,+((:QWA1ZD,37NNP'YBCP[!"8G2"S'6F"-I:IP(#L$C$Y].#$.AL<!1
M./5\[F0JM#9AQ<OQHL*C^@\P+R(@<:0@[T&$Q=3OE >B/*TXO*/(H&;T"*=9
M@$H)=\@=B6!W2 "<34NR$(_Y_A#_$+%L9R(CW7Q2TXCC:] <MF13H(50!;/D
M2IP@!1\DERVB>O:8!^+E-25$4"J%T06#&D_/??C$G2<.C)F6!N-(_.0Y?/3,
MP1?2DGE89FH+* GM^)JZ9-2" T5.,;GWY-OS8%ZN2R^\>/ KJ?Z%P@JPHH!>
M$C^,G]\*;(=";?A)/2>M!\\W\<&ZRF?I9FLXP6]Y 7D9,)?21"SCLXBYBT+C
MQ A7_XUL'[AJ.>#K88)2'S8=&*L#S!;"0R>#'_I=6>6<:IEW<9<^Q.Q*Z:QK
MSY>_N@-+XMZ[DC)W>>&OO.U_!$Q^7Z_[O2:T2^R?S!A>[Q?4)7R% ?#MCMQK
MK1Y6NX9#OV6:Q9Y^)6G6:9XOIUG2]V_P@L$<2VAIUZU"V!Q-V3B:L9O)Y8@C
MW:VYZ3KUW5Z:-MO=M]GVRK?9=I>TV?8']6NS7;\1(.UV:EQK";8]2%MMCM<A
MQ<DN>Q"J3.YETG,-F?DG/9"-+V'+P+:%;3Q%<C.GX489:UW98Y./&K65Y@HJ
M&/P2!<[HF[>P9^'BFK' X#"7OV9$0TL0T4(J5BI(H]5W/=%*?;%2 L[C$U<P
M0<]$O;T>G$G'6ZBNF/E/&O;+C#USA/,1KQ"3\Y_C+XBWXHD$%I_1P;U%\2;A
M:U&%!U\;U4JA.PUZF:9(C'TJ1Q 5MV!9/?#T'2'+Q140X ;8.-X/70+N_8;9
M4GR95M-"'.0>^**N6"M]2@=3UFFHT&:MIR@B<"]SR*%/)M)*VIX)9%ED&7DE
MM$8@+2+SQ-L8K4=PV^ P&$+U_DD)[>ROB+ "D$^55U,V7/^$JMNDBC\J?78$
M2+".;Z)':P(<\LV/A<(?O)H":Y9 [(PM.3F&NL?X1Q1EUH$V+ACG@\EMQMU8
MUQ.T53LY4U.N^0:"-;-KRS3#-7CO_\+D\)=X=H&1FN6E)M+1(D):&B4/+SJO
MX](,)Q 1(5'G ?)H)"*H+UXT&_.Y"3BV7 2<<&(Z71$<.X,7!H.RP(K!A$HB
MY12(A?46*TU^."%_Y#L9=HF'K-,P:9ROCC<4(Y4XS8%7HZF2)/6J^+D.+QU"
M4Q]$";U:>-X/+'S!X5OB&33V'5_EQHT)VC .*@3!T7\2Z%,OBM.*5]04QA@%
M79M&F1A#2=T1JHX$$P6VC_(VX+&Y$,=3>R-0"$)TI<L9"Z:&Z"48Z7?&!7_Z
M8&M^:$*ZZ:4XJ=B/*+8,2IP,["JN E1%8L0J\BQ4*(I_1<P<\9W@KP3]O9RI
M'7E'QQ^NT+V<D2HVXR31N(.:+N.N/92;6"T$;V[$3 KB,82GR'FV&/L&LCG\
M<RL"?NW.[HT9BN:+2O78@]=X8^J 'O5'TX5L,)UCSX\3JOIVQYU'"'LF(NV"
MZ/HC')=R*9ABX"V-1 <^AH47.(7L$;,#MLI:B?NK7LX;D62E$8'Y89$9!73F
M41AG850A+>'J:D6>(IV3S_5'$9N0$0F]R&"M:$ ^%MA/\9;RXPZ=GW[-.J>9
M7#L^9=CI# H?T\Y[3/&[UWIE-1WDS\BS?%]M>6UH<I"L[,57D''EB.H]FZ-
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MG"/GG60\?DAX@Z2S.<0M;BFT?\3H/4WK@RAZHI\7(%7(EC&><!=] M(! C.
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M?DQK:6@(ET99-ZEX@9!MX92/3TPK!6'P_=-V428(E$F.4M_4Y$+L,TY(R<@
M/5=J 9](2*C7/$=/ERGWJ40RP16JRTWJ;WDCR4J9,0Z#K%XBS45[C/(LSD.2
MCZ3@(G!I^7,@YJ@<$?A:ON8$M-_.!'.[6QV5]L_(9;HZ PVU!\W4E9KI2Q)\
MD2>;K<\>Q>G@/N2"1BA%=O7QZG.LPP0V*HJP@)H_NYV!-#;SGW.6?*$T127@
M7^A[XVA$L3B\83J@)(GZ6"10:I _:J;6G@LGR$6,4I_)B!^^1:34X#G>7_AH
MZ43))"$^GT/$RN6*^9I"Y9*^I2Y,3Z%/*H1#]93,8G, #3D<1"Y\(WB^/.&'
MZFY.F?B1F$ZJ!L1H,V&+Y"J77$J>QGYLOO030/J*>&-GO,+9Y:5):SNW1JAM
M>J<OSMH5LM/EZ!@4;!?[$VQ(A+PIT@<XYT2QQ5MN\)_W6N]^L>YPVBX02AI/
METDIIG]1/\,<\:J>VJC2;O5%:RY)P+<M1TFD9+>>FT+A!O)5(U&($7NIHE M
MV"(@07FBV<P3QB;6F<M1V3KD90-GI/.4!15FQ! +NEN$OTMDH/0J#5PD6-38
MS2;F6NJU(/A;3*##/9#-5*)FQ7&Q)T58].Y8?2J0-5M\; H#4?GBBN%85.;"
MZT$%D 'W#V.B4!F=\V1I9 #Q/XIFHHE.A,5(53FT/#:R@Y!/LDY Z8C3T9T-
M$5J3I20:E@(1Q7XA>%&J+B$,- EF(&QZVP75,=-T"7Y2)2IMW?R7RZ?\'W^,
M& "$[U9C<:1?X<?L0P<?LQ!U,\/^YE8TEPL5TT<GUJ.8#)VO!/<@D)>K55FZ
M@]NB$T9GS&=P_')NEN EX2&*R.\:RO>5D>834,:%\;6O0-A_LW#7X;5.ZZS5
MDV$-=W>O:9]A/UY5K /5)=7:FVE A*Z(:?"-";UA?4/A]@U+KYZDC3#L#<%&
M$-6^B7C21Y(B)-'RGY#PUK[),$>..E;VN^C5#K0*1RY<4'Z#IS)VE-[20(EB
M.""\.$=533C<0C5AR9K"=<& \:,;UA0.2E5(G;\1H+9%I05%VR]95H6[*;'U
MLFBR<C-EMCZ46]?X[E5XOONJS=Q>E635ZQ4WX<P31&H>EB]SY%=LKV6.2A%Y
M+O=XT'#E-K"$ Z$* H8-F9K.P<@:9E1DJ$T"E>65X3]$/AJ\$C--],[%N6T-
MT>LSV,:P$BKP>K#=OZP;T=M'6O;MYT_O;[[QF@:))BL_*)L N5.$"G)&P]^Y
M_Z.TM:C(QZ@O=P30"&KOSPA",[ N1E!>[,.G,A5^D,'(FY/(X%_!> A\+>4J
M!AA4P)A!J"=.4HDV\!?W8'=3F_I,.'14Q,0!_CP*X<9!8UZG^,QTW$<]\DL?
MP.E$U-,I2A')Q<8@!+^CE+:3;7CT#QE2P O&.UCI*G*L<M$%KYQ/.XE@G.1?
M_"<<5=*9AHT+PU"4M#A!'%6F8 1='NJUQV4)C9Q\",X-YV'RF9I]HC*,'JH%
MW;V="$^8/H!EO,D:M3@;]Q"%<2LMC[_S.(5TI&7-F%PO;*/8IQ;@EZ5]Z'64
MU;*:S6^((A,Q+,Z[$@?YIQ-.KT"4 H_[.Z[5[ VJ7*O9Q3P^D4?/YUN'\W'O
M<P(O?-#6 D12Y'.H'U^L&>^*-\,Z;#DF4&DD[-J$?]^%O$"-RJ#M&6\G0TZ\
MXJ@:\)%K)Z0:O5M*F0FG3=8DP[V WWF^JI^, 7)\!/&@'GC>44H!2+&RAMZ;
MEGSY'#Y);B)P(I\8K0!V5%^ *%N^EY\03SU\";UJF@C4&>BU">$4+,!'#AL4
M3SS&Z&)@Q@";\8N['[_XB2;XINN)I/Y.*/.@(>%T1D(3_+K63$+#M(9I]\&T
MH">H"(&<O =X4#Q)5^=IP[2&:0_!M!\264G!LSH&#_E*ACL-=QZ".R_CRH8B
MUI1EX6O+60(9--QLN'GOW*R[YIKWB]$A,FGM5(=5 "P<\*ZB O:NROCM;[$C
MKW?M8MA+UO%(<PB<:&IQPIH4*J-1;C-\F6ZWK#_R\LLWA)4?$(0N E=Q2#U1
M@CH1/5[3>%:A+7Q:K4F,8F!R4"]%'F?\C81+*D#I^&P,+V#9M2;"=FIIODX%
M4<B.('+85T9A Y^%D8\H!C(RR8,1CHM9$SZSA@<>,8"Q3.@EPX;QA'>,B"2;
M0>8\&B)?+8ON,1I"XE&UC$\=H*M/-;2A3P5V#POU;1R6_.CYBX86? R830$0
M>).$25 Q2[YT5?(++X13'_$2+IY^4)C!,DX3#\*)*X3%4>.Q1@DXI!29J(1-
M!FQ$B:YZ"M:?N;"UA44I)='8RL$/LN3&*73:Y:0AF+#AB#(J2$(QIX[7OO&8
MD.I,T$ K*+Z:F&"IK9[. &@3S#T"_5.<@R%RU1^1+!$CO&A, 0B(9EP$P2(>
M/II$C:0B*1%78JOR"3$8B1(4U6^ZVOH#!ZW!6;MUUF^=M7LY,W21&51P7O0O
M,;UR7<=5\-F3""46F3OC2%I$C@\2RX%C%V?!4;&H%XP#/'@NLQ;,QH]9V!)^
M>$92[65<7"*6GB/DE$@\+ GWDK91,R ?V,C&')&XAPIV4EZG%R^:C7F6@Z G
MJ">>>N,D64C&TC3.0+3XJ[@NW,4[6F$LT'A-:IF"0ZVA?=4 K;=8QOKN^*L1
MEYSNH8OVEBQ-U.WFXP\!YTW@R#U1VE$R5X$@13.'JRHR%(!I9KS$61L3PJO3
M1,^Z0/V$+SSZC&D-/SGP.84+4@HISWSA(DM9,'3OA&E'WT64 ;I38NVQ+2<5
M>D,4T_&9I)F5QX8Q-4$E;$I"2]7031?B0J=*FS%GH=F*7':2^IXK><&3,SC!
M!9XRMA<\K1/Y8/X%//-#5Y2N.X?CX0\@:)C#"$L.F0UL93L<#%)@T_,9)0%5
M4=/T7*T;;$00(G2 ^--E3.AKM>Q9$VLB/C]/\8@1>Z\4>UK>\=!B+L^M>5++
M"V2]K!6YV$X22RL:[, KU^1UF3D/O)YVLGVKSW//QF *N6-A1$G6I-;K(O=,
MWX>.6XZMAS4P3*EA'\[^C/Z2L"&IT:,B$BFF,I=$":$B9*[J,9(BI%RKQH,]
M([LWF#(6QOZCT! @3PCM16D*;45H_F:U(3J>RP0I<C,1?;;0'P9Z A'6Y*:D
MYZA]@GQ1F?P_K)BL?.VY7G=[?=:[2%2]%@%I;U)OWENW&!P_*NO-:X O*Y9;
M8F^="J'+B@656/T2Y-_*U&K7!TE6D717Y<\'M[)4%585;:QL$1D!K137F&F^
ME5:LM<+#U*=5/GD/B-$R9C*@G2I22_E=.HP;<+YT2X_?.)= 6LHU_E,ZGA7B
M(V[+!CH.H/32E)^L,(8W*)DDN"=NA A8)T'^QF[FM6'D#R>(V#-AX6(HCX\U
MDT!\DSA^R>,$%-(7O=%>-)H&X/]B8FWBVT^BWGPVHS9['SO]<(N,(]J*$$K>
MQE4=ZEA,1E$AU?@&Z.<P%4T6<4BV80FR\UIK F<6(%@^F]L4I<6_S6P.94;&
M,:^1%T?8M"ZURY=[/1N4?)%0*_$@.W7X.4',[-#[3.[CVAZ%GB_A/JG[,AE[
MB;>IHF!:'DFKG96I(,F5$]N9T3!)GBV1DR15M(NO5T5SR;R&OXTD^JK^$'%\
M<4 ( S2RT/=!0G>*Q 2K0)B;H ;$C25FX57X%+-1$2O8,O5N\/ R.=@R-H5#
M?S5)GA/Z<\?Z<$[>], A#>BSE,MD[I2@(5+HU$$TQZ!E@R:2"M+.[ >JN(2C
ML1]CQQGS.@B1*A)<F$J,UY#P^98K)TO,@I6H#(A8IFYY;D\ 32+Z*/8MGB+E
M,I]'M%87P/<OH/*>HB<1@/'#;YCXY7.#M$% 9P$;_3*.?/(!W_P>C["6?@@>
MSF[7:?\HO\[>,+-."?IW$%1E2J<O8UO)LN %H[#VU!CF'(.I6(DE:RCB$7(/
M'!4E68Z@WLW=L[@ @<_720>N>62)^G]8\CT*O(HC[,F:>I6YHU)Z#"A0H$3\
M8#DYY!QQ'J#"2#S%>6@NGX[80JCV',DJU')FN'R?T2#?I(Z2=1&!]13-0F>.
M$T.%H*=8OFP.H#'84\8;_20!@R0%X_7/D^D0ZKG"QB,^7(#'"D.OH;<U<23^
M$5=='(-,)!+$*&@MJ]"0>TGD\X._>)4&7 ?G8<;B1< /I2KF:?; T8HBF!O0
MZ#)2]?-0YN63;]P06OZ37-X'A47YJM:DPEJF]O#@;4<][.3DVZ5D%3)@.B93
M2*B[T92-(YS6IDAVQ:T$\J]W0K2=(7HH(O#;%2BEJ-IGCJ)Q)@[_Q-6&?)V_
MM$34(5%PJ'$B&ONYA8;GO9_>_+ZRSH^3X=>X-C'^QLJ_;O>15&:W3EFE58:T
M;Y8NU1)KM<1!Q_>]V9_S&LNUJB77?$[F:2,/6<KEHW'YD_GYRP>TFRV,)U/\
MVOI;B_Z7+NL4[\[$O5)BY]7^_%*1=0?RGJPHOL=NJY%TX[=#0',0*P]" B2*
M<VCO[APJ>6$/'-5Z2]DH+PK O0O>[8+T1\RZ:' 8J7$HTG=J)BBRD#I_ Z^#
M32;+)0@U093N8TADAB@K2>?ET-3S7ZPS^M'&_D%!7\,U^(H!&//*_5KS;/C*
M"[DV)Z@L8LIK/.?OFS](9W%*J*4NUCI_+I^#KAP>2;E_8(-!WNAWS<%9/LB\
MJX98=U<-L6[T>D7#WU]/?7/HKS[T=D<,1N]L[]![C?[@?+>'?@@SJ\Y"TCJS
M/M\?5%)N][:LR?U?/5<D@_8D[[J-=J=];/*N>D>W!:DU<7ZP\=G_F._QIM%V
MY]=]BRRMB&W^8[GLD<_;$@<4/;VL<!.&/0\1SW\(F]Y_?'C;:ECX?^^*)%2B
M]J\VZ]ON/:SJ+JN^/N-&O=Y"N/="FG&33*@<GR^UKK9A^[(0T#CN'9N%4+VC
M.QJ_YKB,A"Z(_[$782JQFOII*PNLOIEP>N=P0,"2?&\<ZS#Y;$N]S"1&S>6E
M/ ^B0DDT]+CP>"M\83,<4Y.LK\H;FZ#_>UEYQ*V/];;AXG9FN^&E._[XW\B9
M8[7J"=25])N6W#[5'ZJ]ERPQ*:1AG8I+$I1@<@>RSH2-3:7)NI4F@V'I2I/>
M]BM-UG]D)1/7)E5I*DWJ=1"FTL14FM24=4VEB:DT,2'2V*?<>K/AK<_.A OH
M>*YH-@P]X,YX;N#QA._*%C1LIP""FJ" T+>*SO><P'M+ +<N3'CW./AC%S'D
M/?"'J8U9*M:_V*,I_,)/Q3A.ICA&[5^/4?W#]X*]U01V^L<F("M[?KL083L_
M/V.P;B;9/N.4SBEE"YZPGY?C39R,8%/;_Z3M?J^"K7UTI<Z5/;^="+9=GY^Q
MS)97+4<^'" BM:!E-H$S0L"5DY%?:ON@V*_%YO<IOHQ9MJ_3VX7P,D99-87:
MG3<)7VPATPCY"+;YB%-1G]G,X^EUQ!$^'0?TRIY3_N9_;(PH,5'(?$FDO5IK
MQEC;[R'NQ&3;N\5V7/68I]8N8$ZA"J=@_*#5O1DG8PX4UDWNTQCH-KKG+6,/
M[/$4=Y-<V_DI&C=HT]AT$/QB78Y&T5/$<2K'6/X^<NRX%N(HKLG;Y?=$H\ '
MC0#P]QDCE'QW?*E-D"N\5ON*"37.A]F6IW=&)![XK'<206JT>MG2A&V=M?&D
MCLN&-Z=0A5,PGM0:7>[SW*:FDVQX+]0Q^VN [P^/+O!:_8/<2>RUT>T,3/CU
MX%W.E5]@]<V&TSN'WQ+M\.E>\;WV'.N^D9S*CF/4(U?TP/]]N2C4OY]NL3[/
MG7 BA:<N-_FXDRC 1Q8*U_>+^\5<S$)9+D;[2HP.5HC15K-3($2!@C/<+IHM
M6Z!!1Z-!IVHT*+()) UH\@9-,?&9A#ZP^ R3;.^KA:=,9,.M-F@J!Q]S-5LT
M7DO._*$Y%2-G$4S-EEBJ77V6:C>+(L%IEG)!A+Z&HPH1./*E:.6'XUZ?]5OK
MSQO<>!IMZ0&PN0@3^Y^YFOZ3AA+^_EN:1+IB%GHY$^0GFUCU"5JYS:-[F=RZ
M9,"0''=TB35*P:[Q8 J-H;W!P0QPS)":\<1WO?&P(43^"=EG$!/C-"7K-W<(
M S7.Q*&[X<0DLC42F7E$)5%BNN518KK;1XDQCSS$(P\1N]TS9(/V' 76T&[5
M':WA,D !5R_(G6,^B1/'W#&,4G]LFZ.E>MU@;0S^57E&K3W\TI47A'63#K4G
MNE8=E:#]@_\SCZGL:1E:!9;A@3WSP%<6\MV]][R_#LD%_[)G$3/';^3N\1/=
MR%W# R<B=TVS1D60+S\AA[M BC\"<=J6[!;>J *SHB5[^J,314S+D2.*DT2K
M6^"^2]("925)]9S[DH>_7WRQ_^/Y5S,["-;)O:]?&3AH='L[K@P\6EY9T5.R
MY#PUQ:XKU_JQ3[?1&V:+-_;?=%0SSMF8<5;5?E>223J-X<#(F(KHH[B\O)*\
MTF\,.SL>W':TO+(/?51Q]FDW+BZR]:E&'^U7'U6<2;J-87?OP-Z[[X:I3UMD
MU=>WK3M?U?U5?7V&_H;^AOZ&_H;^AOZ'J!VJ4?R?PR8X2PO^CRENO\/XO FJ
M[_,@]QL\-Q'OJM_/_:&:F'#T <3L+E!-3*RX&F)V-X@U)I"[/S&[&X17$V7=
MV(LZ/90;<P+F!,P)F!,P)V!.P)R P9LC(!/=\=@$;T[__LTD;0NOAT"G@ZFD
MG["C4H;UH;-VL?TD4EBEM]]J9D?IK0$EQNS15 +?;(12MP8F6SG:YR/559KV
M[1S:)TF],RK5B$/;S?;>L.T^I1,_%@TSA+_"_XWI1<[3W'9\FF3X,F4@4Y\1
M,\V"WXP<?Q0]!?"$$8AEQQV#G@H9K8P!14(&/\<[8UMS+PCH)?'#%*[>.EA;
MWC*LK>N(!G-J;/&1B_W:@7 50<_0&39@:2%P"*HQVW4C>X9J+:OKTM+*A1=9
M$R <_($<:"V8[<-QP5$' L,K, A>!0A>P_/2"%Z=0T)$#>,\M>IG[+TI84NF
MD\VO:1#<;7/A->?F?Q,W?W21Q59A!6V:TUX>-$Q7!@C[>8"_R.LOC<\C\\G=
M<L1AN*!B0"D;\$#&=\QI%=YZ L%TMVY6W4+FSEN?/=E@,;B/[[9SXEO+'!TD
M@Y-C&WTC H&21!A3%*0H1_<U(Z1;RS%^QW1%>N9:Y%Z+K_#X^Q<V>V9?R*W:
MU[3RQF!X4<<[<1+ZI&\N2^YE095Q_^+M2VOT]UX:8+1&\B(,S$4HO@@8%-[3
M5<@I<ZK!33@)77%NKDCA%;GVHAVY&!/G!QN?_8_Y'E)BV&EW?CV^,C+3,F1:
MA@[9,G0@R;8G/(.R?YJNA5.0@Z:4)UG*D_YW7O(V]%W_EUN?S6UG++1_<.F.
M;\(I\Z\BWP<YE3=NZF'KXZ;:PX//FSIO6H(2EB0%Y>*)&):@AIA#M?X(J@]L
MPN";8T38#:[L.>5!_L?&XE62V'L9ZK6C5+BD&M.IYA'51H)JHF!!3*5B8S.7
M:MVL]N"B=%:[M_U92NL_\A#6F1D&L4[:LZ8(R3G3G0@:N>J#9([X2+*E&_)$
MZC9DYOCC7'<,=+ 3+L MF7N!$YY,S$MN_ /?][ZP(2K3>GZ<9[:39N1=HWF8
MB-52$27]!["=R'\X>A&E>]V?Q:;W5;W0W7$^ZJ1/;!?2J5?4AU%IX73\AM4W
M%C#;'TTIVC%FSVSFS:GS(K1_6".?C4_ UJ)K(0EQZ8X_Q&2XMW]<$1'V%4 W
MEM<>3W 7@NZ\;TI-#RG0>)S;!]_>><;0Z?';8=+MH)U_BS>^+UOL?&A$UDY/
M;2?>XJY/S1ADF\FO3VX0^=C?>C)R2S@D:N/[,K5Z1F[M]M1V$^6JH]@Z&NG$
MK:LY/_N3D5"TZV1]B2BDV).L.B_"9S"B:MO'MPNAU=E_^?QQ%<6=6G&P.84J
MG()Q85XS[F&^;CW=0<T(_F=%*[XWJP1/:KID:>9^S9:+0>?8[!;#+SO%4^]U
M3/O X:OS*[_ ZMM*IW<.KV_C2/AK>VDEJ$+#QK I>C/XCAN6R\+U&S,D7N'-
M1*-:[6 (.0%,>\6F[17=0>GVBN[VVRO,(P_QR$JVJJRI:E_=A-!NU;T+H0B!
MM9Y-(<=R'BM@/;=X'.;ZUII=ZMN_=12TKUNGEND /=EV0VR=KZ>DJ#WIM2F1
MB1.@?L\]+D,#J3*<<!!.^,I"OKOWGO?7(7GA7_8L8H8)C"0^+=(;26PXX:0D
ML:DAV:R&1,.8XND+-X3_!L=8+;)&\6("?JMH>KTVDTVCWA4G'GU3'S1VZWMS
M6.'B=F:[X:4[_OC?R*&&N?>+^\6<K3-@K 2>1*._:[3Y(V&&HA*.MRM&U,5Z
M-3FM+LL^]>*<;N.\DRU^?F>89AVF*2M95@&%5HX[$&_TZ+IX*JUDXK*ORC&#
M43*55C(5YIQ.HSW,XI,8);-')5-A[N@U>BW3=5@59S#P)N&+[1^V/;K2*CK?
M7KL3=#O8->HWNN<[AD8Y$D8X@*]W<.[H-/I]HX*W+"'*^',5X(!A>\<@<2?*
M!N5\N8,S0K=Q<7%T*&CU4Q05Y8YVHWMA H)[4105Y8!.8] R:**5=-2(LXQG
MMH9GIG5KZ1?IO3U#,*6[*6/A9V]$\OI5MV?O<PI/XLBWYH(9-J@S&VS@<9D#
M/ZX#7\.WVM>19^$WS(D?6-(?@ O,Q:^(RW2LUS[K&QT7@LJIH9R94S"G8$[!
MG((Y!7,*YA2JL#Y3&502:M33X*..+_J\K<*[U5'I+6;IVHV+OHD_'#R)NY/A
ML(W.>38_;S*P.PT<;[,.;S \NNF9M12\.X'0;37Z%SNN5CZ2X]U3]<PV"Z/Z
M1O#N.XZ[Q2$NC59[[T/7CBLV>WJHRN8<S#F8<S#G4(4%FG.HQ@+-.51C@1G+
MZ[>BZ0=[!=/7O14Y?<FRG[S(14S]T+/^OH:-G'1YE,4\A=5F9A2WSO,G"BPW
MG/O*<!ZL,)Q;S:)((M!DAAO T5([VU5'V]5*=V";NX*OT_R#<.HS9CW!XJ:!
MQ=PQG&(6+]Q"FA,A<)D-RV?!G,%3G]ELT=@-@0H&26R+0)WF^2&.O;W;8U^]
M*SQV9H^F<OR%"R*IW.DWU?R0M>10[J0,2Y=#P_3DC"5/6B[1VJT2(HW#TKWY
M_?JLWTZ.1%FV"$HTI1;!"*U-)<X>&!"9_6+/7NQ%\$8^;JJ\9M&=<4'_^U6H
M ] 9VO".-S\7C"&QFL,NO"Y>D/6+U6X.SN.?\47%/]8QZBP"J8,EV1;<>F"W
MOX7>Z,WO--$%&4(@(@2__6SG4"&'=OJO^>J'S;Z3(#.F[.3:>/H.QY#(G_A\
M77PRR=)9-)>C$2J9X-9>X'+AGW[$QI\=^\&9.:'# CE;3/M1/.!'C!K;S9R?
M0J-@;V-^+IJ6((CU49^(R$??B,U;&F4VF0&4/@%WG#V$V@T'DF13@R3-@*""
M$%_Q@*#!L/2 H-[VA]JL_\A#E#T8]/V,BW@\<+,Y W8(9[:^\SMJ?R39&3OR
M1.HVU>/X&WNE#G[PW.@(2ZQ69H)Q\^]Q[VS/(Y0[1P>)4LFCVTDI1J^6* 5'
M)[/F]L('!^&@4NL /'_+MWUO_]BWS.H?'21O98]O)W+K8L?E@<8(>YU N[V_
M.7IA%OJN_\NM[8R10C>3">T=N'-/5E<68<I(L"V>V4[$UG#OQ77&W,J13MYD
MPGQPPRLPKF5O3"_V?B.VOL]NC'[KZ$!UJW9L.Y%6C=[%C@_.F%FO$V0S9T3Y
MII,289_%IG<CO4X G*9"![8+N=5I=/JUE%M')YY\;V'/,*%_]/(I%1GY)C>^
MYTC\KH> F,/;94RKEK'XTS&VYKXW84$ YV+/K D[/:EVJQ'@FNU;N%WTCZXE
MO-)GN 49MW=;VMAERX=410&L@/EP>',O<$XE]"6W_4'L>E]AKXZ15[L[L5V8
M8/UV4>-#I>73\9M@O +=3E=98W'Z2)2ES^+R\:.7:LG.H4SY_'[MLG;7U%+L
M\PQW MO2V?$TJZS@.R[4CU/#?#2G4(53,.[.&LB;N58#A^.LFNVP)W"X;?VY
M,N"0:O2KAKG2N.@?7>F489P].(>-[OYGK!^7E71ZF"OF'*IQ#K\MQ;Y)_WM9
M)_L']A#&B "O:E*GKS@N"+5+$#KXJ#LV8R17OE_TS_OG@\&PF)#MX<$! ]JM
MIH7TL-: O'A]Y_W!NYM1GR"Z!7$\\N97+TR#(.R6!+G@ ]>^]V3]TW8CVU\@
M$(\7/4ZM+[8_F@J<'<0?N/*>YK:[L)P@0&-XI.W"I5V\Q4]ADJ;3^C5_H_3+
M]J_OK!<GG((5;=F/CSY[M$-FS7W''3ESM+8)Q E1#U:@WB#??'(#N @XA/<:
M].0E?37/#.RJB57W+]Z]Z"^_?X'O+> 'VD)IG?HHJ^1;UAEBM3Y,3G\5.E+#
MFD=^$-E C]"S;*32,U%K!KO%]:A"Y*9U#]0OX"\0C,QRL/>9!:%EPVTK0=A/
MXGO?X,5W(2(%WS(?.ZG!4=PWJ8$:3*=U1Y'ZK+,*T#U#Z9^L.8:$7?@H>713
M>PPD#@3.R!CN61CY3KBPQDARX,>54CU>_#WSGY9A+FV72-K&SP(V^F4<^02E
M! *GEU9-$F1I@G<>[S(.:FL@4X#!"1<^!'E!]UV[D4 <Z0,K+GKQHMG8>F#6
M.&+TB3DWMCDC2F%!V@@!V1# Q'9\Z]F>P>>]>:AC?Q6P;02^O6]=WEU9]]X<
M"#[L]!O6M>/"BAU85DR%H,$ERFAJNX_P1<?57^:S$1H&N':+V;X+MR7@V%,^
MFR-FEON(G.!XXV8.LLKNI>^2BSMVQBA<8>6C631&.B^LB2+ R'MF\/>0!R1L
MN.-!]/ ?(#@)B]$(B.]S@+QH[KE$:6_$(Q8C8F@$3W,F#H8VGI&,^+,QF]C1
M+%PJ3UY8\ET)>!JA&0(Z8(9WB 5' 5FC<&HT?*RU8F>Y8#4($U/H^M$GNC^E
M'3Z@3@;2BM=%= :%CVGG/6;M:$/^*S=#H%HK$)<V/;676^+*%!GQGSB/$R\G
M3)81_!<L.X;R_;\1/(QX7EPD][$A1)\3(/?#H^%S 3T@L#D@V=P7<'JP:3#5
M27 ]XL #+.D:,3:FJP,R=,9LD(TK#)=;\1TTNSX)"7PSN97ON,-77+IC_@.\
MJ_23_:F3;9DW8-P755%+&$!0,J@#N C)*%S\H<]H.@&W,4%/S68K-1,\FR"D
MX'G(R;.%-%;Q,U[Z,&,<P;279Z2,D3(EI(Q4UE+:Y N;#5B>OT8Z]@HQ$WYK
M3<&K9OY:UV($_A:8:^(J\-]XN%@P"%?=A/T;1)H1 ?L"<X4,/('W2O:-&]]Q
M_=,%ID[^68#$9_AS>1PS%@1@<L+GG7>EG"1-Q-Y/895X+K&;=#,A"7Z+&[GW
MG<='YA]*FK_"@QIFA?E/DAGY&:$_A:\#7\ A<WMD!U/K8<'/@Q)F#BP>F,T/
M2(>F]6H 9,/O%:AI^(8#!Z/%&:[LN45D%:$%;K:NPSS\.CTG/BQN&KE L#%U
M.=-LHMYZ.(=!"AUT;AY=>-38FH$]PK25%E@A5![W&3[[(6+WWA5WF3ZYU^ P
M_0O]I9M)FL.6YM4J97&TFD45WFFXZ?7QAJ4T1F&9ZU_*1WX%=PR_7^ U+<6G
MWNZA[,,,[)4XE%91'>NFIT+0WVL>2_YI'.;F@NU0%%9=Z:.04@=7'^48..C+
M B?DG^=:P%+M+]=MVA.37LG=U(:W?Z((\!^@:*^4[%P>";QC/B(C=Y)/TQF0
M(HND26=V$ B%B7RX U8.:!<Z-[<4,[=6^32=7J/;SDH9BS\4U0;?K)7 I-9R
MN99(YI;.-5R>=9J<:7?-NP?/DZP0I0=/F, ]3BQQ@PS)BBT>+%72;BLE(I>(
M_SB41N\UBRHF-DR1K&*M?>9*=D+K/>9(A(4,CM1V4B1MS0O:$FV*4R/M3AU2
M(ZO8]81R)*M(<>ADR:KUF:R)B6?6*9YYC%F3'6@8DRTQV1(C74RV9&6VI/(3
MR%#^LA]D/.$T,FX?RQ\435M+S6\2!:G<DG+&A46I2RI7+^=SYH[51[^WDRO;
M]D T?9/T#WT+:^PIN]P2>^ND]E9Z.MNV5]\IL_IN\<D<<%3<"I)D0D<4J?O]
MM_1]T^69$&>9+GF*ZZGPE94;[MK+N+IRA]PMU!:K)4N=,[K)3"5%;"V'/_LK
MK%KZS? 8.N1$PO$&:.X@;A-%OWGZ3RH7H=,(H.;\UV"7$6#!LLKLM<C*U6SQ
M%5:T'L&G/=PRGWZVJ_#4:V+_.<;U=SBY[V+!>3&N5?'[WCG(F(R9;=+&^TX;
MFYSOMG.^)F&[JX3M@IBBP141MFVAAB@0_9]N;QHK.,.-HX$I]R*1YHFCZ4NS
MM &->]:RLU?RF>UTC5%?ZRCKB]QL]WN:R433;$) 3SV?XO4HWN\7<[9>5O73
MU^NUY7)_T&^T>]E<CY97S76^CC8%>L=<]'SO&-@\P!^5R7NJ^H5N;M(SS<(;
M!?7$II';TCS<U7BXJWB8$RMCC:S%MZ^9<KXJ8(=I WZ.@3A'?OG)(,!Y]ZH<
MKB'2%B1:W#BJ,;?]<"%2-V <>2.'?OQB^SXE,S!"%\&)V '+E4?ZI4%#!4V8
M'\P?.8$TA5<?DC#+_N3OO/&_H??Q43R%#!KURT#\-D@+GT1!R*L/+-\*[*TM
M;4##M5I9# <\!&OFL B),HDP"<-+&%58:&XO*)DF\FX4[<X[8'$;X'2"".UR
M><Q-*Z%1PH1)1E63^*,5Y_&-R67<3#Z#M(#_7,&KG9I?%J!]'BV/7]3C45BW
M\A9?@O3DA0L5D/;_C%R6PZL4QU!6"P^N*C%DJPV0U+K_O\]__KMA??Y\E:A_
M44].U;OHU1PB[:Z]F)Y-]XIN&)AD2UR6C97,0+LW U7HBNN4IZ0.:8\WJ-UO
M%N'D:5=H>9W0+AM_MTVI5Q2RM/-*U7,%-99HE"A:^2)\^P] CO6XYIZY,=FX
MZ!6<1WP/OM\:A-$WB[F/,W*Y<*%G8WMQMF"V?\9 D/%+U2>7JY\I;^%Q"O"W
M @_<$!!#(Y\A;7CT(W4AJ40B1[]Y#R D*,X8I'R@AO4 ZTC43MF6OY8K4VW&
MZY9AO!PUIQ51\8  ;L'&]@@"J470A8*2DO294+*6XDM 5"Z=N0"09][0"TS@
M-,"8\=&RD+)9]&*($TL6)#W9:(2,@6CTF=2[R39ZF2+G8%34)<NT(0X9OO7$
MZY:X3:F"266._9MZB@Q,YI_Y3L7SJX3.\@:9C##.H3+2[(&)8V#CAC6?10%5
M,LD,)?)/Y(H&&W'3X$MO8_>!/CT&<Y#/&9"?>@?W,PHMGAFA^@V>/55'AX*E
M:5V*&N;<P%ACZZHV%^7F0"9J>QU_KM#DG]K/<+\8<X7Q#Z2,#R'W&WCA'AAX
M:& S/=O.C'):(IB<$M'XYMB06GE*B40[%R@HNGFJ0S@/E!.1'(1J4/PZQ9%-
MZR8N=A;OD:_13+L7VWGFQ8R@7R@]1;P<,/87\!BP,B9$>.<"\BB56*(O^BQ6
MHL2>%/X2;5%WC,6'U+(;B;K%D(?PQ_@MDK$$E$GN<B S#/@J;RXJ_4">V@%E
MB."[L)AE<5JYK(]\59<N<#,M1OYB/<;^8O]PGJ(GSM2!#RK.?20N/KAUV6H6
M81IN'$9OZC4#F;QTQN(B.LLXPMX LLY;U0;(:C<M29,3 <FB<!/GI$N48AB_
MHOAV 2$.X!EG1&*[*],<JV*B&X3:X)K BX0:Y;B5]FS&QN\7Z:A;?A*WW>5)
M7'KX):<H$51^?;U&++GCL@U9N8+KNWAW[JL__C<"'PNIZ+EH%V\_W7#1:70N
MLNT.^7'58H:$3SW;O@/$@'-W_/$9A6NU)F<T\CWW/Y'+#YL"(L@ALKN E#"\
M;D4>L6E]Q%I\L3HP-; /$.QFYZ_]1W&/E:&V4%P SE]6B6JU)KR#!L\.J8H?
M(#<)=K*R=T92%@P/?C0W40A6C8MV44XGS7$=5$X3SPN8?0&&/$(PN#'^$:3#
M'=RY51<:Z3_"C?&*(3@%#D@P\]S',SH"#<.;+NIRD_+!GM$%#J:,:4TE(W@?
M/3_44MNE6V_XVO6N(.YXJ-T(S0)?(8&!=JQZ#C&8W,Q"FO7OQ7KO<+VT7&%@
M4S25T^*M^-$[M+G!+6E8+GQ6/.!.MZ%O8AL:'X4'YK,I?!=+8["FH9&NBI$2
M+QEST.I0;.L18R*KZE#DA5!E$I=C5,NXL%A^K6>,O_)6;$'@;)Q+V7K)2XGZ
MC!PF3*BO5(ZK5-6$>C:51\A,Y5A&S?1BB16% <N$Z9WH7Q2GR<O" WYF*,32
M:K"<"_)*ODIY, <H$HN;TIQ [_9$4L><D68#&HH0*R7NXG]@(YW9VMQ*1AXK
MX,.CZ'F+2[3C!A6^SE]:HFBW *.=/*C<WI1A]Z>UD=GE A+?6/;70XP!L<1:
M+7$JL8/=[,_#7]?NAEGS.9FGC3P\?Y?;=_S) D!</*#=;&&#!A^W\K<6_6_U
M! 1>XYWR>E_M,2^-$>C^"?\/EST)__C!__EW:W]K(G'&%R.E7])IW\ZIFIEX
MKYF)ITEKFS1IOK@^HFEXNYY+4FY>B1[QU YCZ3B25UL7>PBC['BD22U&5+6:
MPXM=7-H_DV;7$=W-9=-<$[$KT;ZR'V-\8^BH(QE=?3@UN/,;I-S+([I$;]>_
M13+V6\6+%,">_M^;L\W4SSLS3,L,NS3#+E_O#A3$:(Y(7+[6+C>&QA'*13/<
M+@GQ<0J5)N\K6FERGRTGB0/OE/UK%]4JO"^L56!/\YFW8&*2\=9A"H!WSM0K
M)&1M=0H86N<BEM+F,OO](3. NRDYV&^AP2$)NJPT(,#JT@V+ ^!8X$IBMIO1
M>TM7!%0C"WH<2%3=G2%1G;?6QCLZ;]4*B8J66V)OU4*BH@656'TMD:@J#!(5
MD_2@110;:Y(UBRAV"'=EBBBJ6$31,T44IHAB51'%>U-$4?_LD2FB,$44*XHH
M7F%=;!7ZJG'>+ZKGK71JN/X98%-#L1=;O,ZIC7IK05-#4;T:BGU=I/5J*/*U
MCRFA,"44IH3"E% <H(3B1.V,XY*+IH3B1$HH[IC_C.G[6]][=C !4+4"BK5&
MM=JJ,H&C<$>NZH9%6 =+PCI0PA>W:2>&-*83N? =D>8= >M25[.JN*"(/C5&
M:T\.IW9(XP*X.4FQ=GRX;;F$_4% PKF97O75,</T/HUA>\#I2G :N(:-\+H*
MVJ@+AJ<)%E <\'K)G>Z,C@'XNJLZHSO]1BL'APUI\O;'.WY?\\: R#%1. 9$
M9/SCH2(<ML.#*["]R77^G8VY,YXOJPJAMSJM#OCW[4(CN0-OQ$F<<Y"ZSDB-
MY<T["ENB+Q=\1\P[8: 9)(08SH:!V^7X" M&=^> 2->[/K0=X5_'AY"+]I@H
MFB'T.G@MX14B3$1<ID*U+C*MG/P2XN($"2!SB8@3<#H%^5*3X#4"#J8MT#,I
MJQH]H&5) UD$Q_AX>P,PR>03J5S'X4O92TG.>E,<R$"F,^:1N \T2/F69NSR
M00ZK8@P%4@*6G& K(!&H MM?<($3%UMMGS-+6-Q9R3ULM#MKSW\XW#"0>/K!
M"\M49,+IITP'@0@E>7&NS*1<8T(R/JS]+Q;RL<!/3T#DD0!;D;=$#GQ*5+!E
MK0>NL_)L""_R#V9'%.+25\>.Z+5:&]L12%JR(QX\%Q09[.7P%L6A2+[^_6\3
MP?.)OJDE 3<)#Z.F1L2NSZD"1D1@K(A#6Q$%4Z%J:D7T+AH7>;B.U06+V@;]
M#&"4J74T@%&FUG'MND(N<_@.E>0QE8[UK/$PE8Z5S6UJ%8<'M9,JD-^L19V
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M/]+BK I5Z8@"KN?GV>;+;1JUOY6;9)<+S6OIAN,P#=6[Y$G+\8O;K;0)N@3
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MVAE;K@<*'I-C(. L-%1QKS-F8=01]@GG H]C1%WZD9A,ZXU&D>]CRBOR.7'
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M@?N*U%#=N2^CB3J-[H5)1AU>X72,PJFHPJE[G,,HG#IP7Y'"J3OW9=-'C<'
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M,,4!IT!I>+CUE@<'9PM+54S $NW PH1"I_6K+^@^![K#@^FG[5_?-:VE]*X
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MF+5#O_FOW$PJK)722,L/[>66N 1%,98;U_IB+_C&VN<-<4?L548U7/$18^,
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M":<D@-$M;0],:$S27Q<\<XT]L)S<-)Y+-+ELSXP$^YD=> =7L1K'Q4&41-2
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M2ZN]-]S?&R0=(' /<G,AU>JGQ(#)LA(2..  ?L<Z-08#)XAZF<M9?TF(5CY
MOR3M83$44A80<53R!9V]&+5*BZFX#N_!]T2$579C^P%.T% &U+!6#A\\<4"$
M.O1[S)5\H;:UA/?Q)M7Z[YGK^[SGGZOC7/T7A[F6&L9*@E=Z]D ^<)8+K-4S
M\?.F&S^@]V/&_BN[I/-CWG!$.U[9H6B7RP8+_>HUK-(U2IZLK[I,+\(B.,AE
M3[S[1:\+I51JCB*3.%8L 5@#]9?40N<!> NSW14; $MX8N)$G )4',3=$&1#
MD L1)-I$*(95/!_%;E;EHN/-QF\???>1T@GPK.)> 0^8T<":*-4]_^%QRL:C
MX[O),0C'94.O#;TNA5YC#Z@)]5MM1N;80?7#&Y.:"^HB6,Y*+0A$4LF3M!=[
MCS\TY-B0XQ+(,54F4\4QL1Y JZ1)N:X<8%E/<SV<3YL;-7]FJO?2WQ!**S]M
M9W%H_)98-(L96F9)(MN0W9NI%1&DEA4FN:%E.U:#SF@KDC$7J(ZI+D6;562S
M@CJT\_,#2^V_R4G>QIQD7'R&VY(\5G*NL/0*3,@;*),Q-:M7M9L=/N<XA3N3
MC(4+ID% HL21_F!V%43V'^1*9/<X^LD%+#A)'&XEK&)R SXX2"FE-<G]]-5F
MQ^BW@L?PUK"YA^S2,$3G$4\=S+AB2Q["$PBC3+NIH>8L$27O:J(ACC,+\?]I
M8>T5L>$(]>=!I[H3I/=OPD\RZ&8])#)*8R(P,<56!C!@VZ%9<'U04,9Q79[2
M@RY*<0=$#9!"3QBY#KF$C7 \1^W1K^'\95WUR:A%Z!<&%-P+=ZQ\*LFX.]GP
MXM XR>T3^T\Z]#KV,*1>._>"W8C)8^6]%&A2^Q^SAS+$6U"\LVL0"$G0-CAC
M('6N "K1\XUHUGS=\OZDBXYZ4*3:2<IV0+3VT/?_"%47)UP(B#2.TM9(#T)@
MUE_R]]"W@S&#,W'4:;O,>*M'\OC!4_L!V]XP.W 1.E_)P$E@)_M;$@\XHZ09
MK ZS</5$>Z)[J35V,?-"AN:GZ.V5\D[-I->2["^BM)]9GDXD>\FL148OXQ-?
M<R[/6%@YF\O&<[!;A4B,NMGG@X$.'G VUGA1?"+@2:OZHW25HMQ9BV(-B/S>
M&3H2KH!4"L*$16^P!CC)?V&,RSO,[L/ MTDV,I[*G,D5FE,*#BIJ4-O7G9:.
MR#0+"X3S,(R#,(G(%/0KDZ"&UZ9NZ!OL@,3 /1E%FCJGCW4)"Q0EQ7\BK#/N
MXNP[XI9S/<XR(:TR6%)/V;1-H+J=SMYQ'*B .3=?GTXIIJ UU22]?>3:S@,]
M/?\@)$M!(%A+!"(0% U"JJ+.;!APDA%W ]%XE]@,&=T"W3)*UZVFDPQE<RMA
M#+*GY$-DSGQ3$N5*$.@'J2Q)N]P7,<[I"3*VI&4:5+X((0IY@QN)<9BO$C?K
M#@D512.Z9[TP#DBMF_JN,WKF=\!>@&B'1)7,6=79KX)A=<$VCS$SD;Z90%IY
M:D_OT+@^.SV[O#5N3BZXH.RWR^NS7\]O;L^P^.WF[/2WZ_/;\[.U)/:DY61:
M(9GC<1L46<FDV@*BMNMIE5]A"F+J$5O4S@$G0 69/C34AL8Z9A&6/CW[R GV
MJPZYXVPXM;WJE#LPA^9=8!W T@=6K_7WG_#27^3_P6.0((74"\,ID)(A)A,:
M"H*F0JY1,??!:Q>;$:OKY*1)!!-LW#O0VTBE_7*PH ZU3E#7*:/!]\A;@Y^G
M29"9MT0:H[Q L5=VH=*QI]R)!\6$];.%7:N=I.T.+Q9*X<4G$,$:#VH!J&"T
ME$%&SEM7M\,&2K>; + D_P%['U+#:35D#L5;&OE1FZ3#2[K5Q]A4BSLK@M 0
M =Z29EC!,SZ)88#$13T*X?B=R@"_O$BK8I2MNHQI/ 2AE"PW%V%+0=8,W,PH
M#?Q.7:S=^2[67@T7ZYZUOS9'Z>)N+-XC=FS,"1JK1X*FA2>@HF[^I7VD6G$^
M">,.!6Q"??XTL?VTL7Y:_TV@P3:.R3:[O7ZU$/F0)50;E7H1C!PU"0L4'MN[
M2YJ9_M Z[%GXS!] +O9:U(",UJ8L&=ER&I]L'25Y>R"+L&D\J#*VJOA--8#T
M^"8(?'%MT&BN)E*?EB^)RC3/JZP"3QDT!D<]L]7ISGKW3$^<>QO4P*$ :UZ!
M@ N/1W9(<A2)./'NYIJ=IBU.?^C#D=#J6N5[ZO;-H_Z1VE+Z1'C.1#BD28Y0
MCP+[:FRR@CHE;5.E5'$Q=K)!5CS+GF29_6/ ?R]Y?W87Z:T.FUCD^B13>T<D
M4UD'01),_XQ=I<_QMQ8))=DR$*F0-,*""#HRCSJ=VO('FU>U6M1L$[O8TK&*
MJ= ^QS/*\BNS*DJNBZYE'7;+!FJ%H\"9%FQH]$JJ24H':I*2MCX/54(F[QSW
M#WN#5/PUK+0^5NKL"BLE'-.6'$-CDN.[.(PD)[47X"2K:QZW9ISD)P5."M&W
M4\Y+Y:2>&X*)A-X>= ^/.RFAFYSWEVRLY' L<F'WT,HP826W[&Q<LMW$)9<1
MEVP$G2[HNKLGZ#JIH,O:..J76J)NS]DW^FW3:@]RXNX&#'AT[]4UT5\@JSI@
MX60U!I*5):*Q>]S*F$ F[!LV#A97;Y"7TXMNO):N\X/5S@G6TJ$+^G-D+_.(
MY\P5]9K2=X*7LEIFNW54_E)SW7$G!U;J@:OU^D ^),A>H0C^T#D\7BYL.L=8
M8IJ%S>.^\G'V^Q4XGPN>&P%'<'MQ"/F>*(-/7=II494SZ<,.>LYT31CY9A+3
ME![IOZL&2[^5A\HC,L%+B86@T5DW--J]Y0 #H)KGGT=DGV[K->#H[BPX!H,"
M<: XZ9A=*^^860@BO<4A8K5?(TV.!TMBE_91IT@A"),CJ_<:B/07AP@&(TNI
MI"Y0VMTET4FG51 BSC=@&W-@O4JJ#A8'"K7\?P5,^M:2"*73Z^4)!4#2!<YY
ME2PY6APDG64Z9/*G\JOAU+4*,N:;@X Z'E2HC_4 =?P"$6,M#U#M)8.I1'OY
M1II=Q^RU\@ZZ50.J<[0\0/56K>6AF8*P0MW>M ;6:V!EM5Y 5;UELI^U;/;+
M60R-)W1]#H+>3CL(=$]HNU=T#Y2.(2IX13MMLU_0):O=HLC,U>&'BG ?J;+F
M$6ANV*;GRBMYH5I^C:/!\2*1D(55$146I.43\"'O>KFP+KT2Z%R6%L&MXRSY
MX>AP<'QH$%9OQ#32H]B:DSLW4+*_B)L;2.'XJ+V0G]OYMFU@0FHY/AP<U:AA
M:J3ADJ1A?T>DX6<;9)GJ+\$I9DC%VM<J\ZR48>#2;H6>6>9';?<'9N>X/C_5
MC@SU#X_["[)%7L7-*2/2@=KO6&;[^*4JZ<G"KK1*_^[@L#]XW1MV6H57)&V2
M?:KMKMFQUO>>2[#X\ZKWLEVL.9 WTG-]TG.P(](SIUIT4@&:_:5]7)2A15*$
MV]K5MNC" ZV[^6P3.115S=Y,!BR5OD7'U(?/ATH720K38AKN=MP&Z9CWBA5$
MN/?F0NR=)L3>A-@5$(Y+I5Y=J?77O\Q5\RGIO^Q K$@J)\X=VB$7$LRZ,'WB
M4<[1E)ZWNHCB*E) ']9*C*@!6"[IO <JWG$F.ELP>7'I1*Z4K(@*!"SGB2B7
M_'J,8?AVQ=)X/C=G\^K/YJ/M/YN!6Y*QZ_EC=[%P)'6X_3-V#NZI3E;K$V8K
M$I9]F(HGI&UX,6TAZ7%3PX$@U](*^8?/7%..[/I#6P9#X<N];S+<C^S$?)R:
M!_)!'D#&&/J>C5WU1+'\A04)Y<G+FC\N;8\,5]AAA"%D?!S'D )C[UE[9%&&
MS"QSH>(:+.Q119Y8MHTM%X(PDGE\-1P>5/'T=.^[0O8;QK;(FQ*/+Y)AG;;9
M.K)FR+#&QEB/'#O>"3F6J^Z3&?&DH!,99PK0=#EW; ZZQV:WHSMYJ^7.GJ]&
MYUEF:]"&^XZ8JN5J^3I#>O:1V1\,0#98^4O5+@L;W*?*G#(#9PK"(+:YG42Q
MYBXMITZF!<Y\'5S$=8'SG)"&294[J @FN>HG::A)/PRQ/TA-$ VX9-:^HNJC
M5.3N,?S2+Z1A1DW,Q_^-PXA/'UGRN)75I?N'QIE-K36*IZ-LFC'66KQC9IPK
MJZ43GU4=<M,;Q6MH9IN2&T'(0FR,.@#4C<".; E15:A)W4\4;O@0]+GGX82R
M$W[HJ;/+-!ZP3PX @<_3S#GV9^Q'#IU(0RSWSIVX>[9V:=5Y/K*G#IZA_'+4
MPD46(Y<!<B;=:5V9L4-Y!FC 7VS >9G(029P@(7FL@!+[4,V2UEL(]2S:&\H
M7QY?DAKB'(P=-Z9^8_S*SO]+^N57+M4<:FNL.6WMQ*E&X87"D:7'6"=(<C-\
MPYJG>Y(VB\'"0JSAQ%I$)2141"T0"VCH"RGE7:DA;Y]2GCZ;BBTKU7.^O%'2
ME9+>&^2*=1LE?4/R; >*Z&O)LS1G)*U+MX[Z9K>=3[0M\9Z7<UPKDPDP-Z &
MRD^,M\I<*@H9JI$:JH&=*H''?83"<TBR@@A )B'_7^I$(:TB><!.<;?5[YA6
M!NX->V^(O7>@$CWG3*SD\.BIPK0M-XYTDBLH*]QH@7.NGH6-1S"&&VD@@>KP
MB]: -Y*3I;)\D%KBI2PI[U0V2I V3$(]2/([J![8?=X'RSV)3F9Y_D5!R4+*
MM7*S^F ,4OO59'MC[&(O5[%Z/YK&.!:Y6"5;&-T<#% <4G=33=W#J=(NR&GR
M0W1-V1TRF?/PS,WHA@+04M03Z;W+5,6,K,[8HH6./@78I,U&<J"6+403&_)W
MZ6?FQB"?;#".X;SY \3:OVTWY@:)8D)JJ<2(A(29XKRP^<28I ZVNBFI/U)%
M:]3?7T@8(WS#>/A?-4J+G!L\;2S4VO[)S<A[&[&Z1K&Z UT)<K[-C%BUE?(1
M>TH<Y4.1/,.M*HPS7RS]T#8!SNP<2KJ#D5,+- R,=QM[H&_\N)^52YI0HKE[
M7JI!!5(N<Y^#9)$!+8):B^T!$\IY?6GL2#L;5$9%U^P>M2J5D]O2N*P=9+_E
M7HB -)"\\0-)4,OL]?ID-,Y?FC*A<*=YP5! 0RZ>FY<-) K!:$X:^WY1;WNB
M,OSUGHK4^I=FZ="D-O_)@[W<.U-07A^<R&:_%B4?LE&KCHJ1/07),Q4C[EU-
M'4(=KU+D[&S:2;=).]GNCO.WR@<3FA2F8&I5=)IP@=:Z<BRP_<^0#^^I'=AW
M@3V]-_8LZ=6A:7^LUDF#1C;8_H:=PUDO5!H<Z7F5/4@=;&WI.MSPWC.N8T#*
M &Q(1\Y_(UY-(]Q2E^3EL)^A@%\B5%+DM"MCZMJ2';&Q=X!=L_$)-H5<L(&J
MNDEZB)-YDKRFVH!J^@@BVB$;U)?=\34H<7/'M(=;IF]NZDO36[OY^::[<HR%
M%L70'A#/FH,A77383=3CB 2^^:%Q@KHMG"XH^EUQ1UW?V1"=3)QO(AEIJ3TG
M5<VYJ9P.<!E\D1O/ 41;HNQ>FE9JCU$'C<@'($*M4QU#CJ7M$#NYPZ])3UJ)
M,U@$)*WJ])VV0P4"C*,<9!AERR#TT-AK)_Y+WBRJ+\;*R#XS*J"[9^_#\]5N
M<W?B&Q&1]EI]4M)C]TZ;.0W@B.4XK8^9G],&U=2_6<<2C4AA(@CD5*^D473>
M]5'*%QDR$"FYY,F!LE:"(IU/DH'.W&?<D_,]<2\R/_31 7F&:3(!&S\VZ1,E
MJ3'H P?X.\,X[<N-%A]J.%O$&7**=)FJ2, ((R>*Y>2TLHOP;1TUM]6FZ07P
M6$D8%E 0_:D30R4M(FC6S*B7/F_G";8A> YVTMRV M:;;$_=!U3_YQ_G'\YO
M7])_FC0"[$GN16!,+7AV(R;/OM'@@#5,?[@1/'=!/M$XAUU_RPRPF.)9E:C%
M(:@Y-GEN46W#"1R"PF08Q7*=4(X,X-W#88A#7?#(M8.(V8:ZQ6ORDJ8Y21DP
M/P_A$U 98^CFP#+Y$SE/5+Y![C5H:H&<0 4[87V<YSV <!/DMWH!A%^'W^&^
M\8FC;,#I-\G[WXSNQ1BX>1TC/UQ7LG*H'JKU7?75+! A!XV36UQO3)Z.:\!1
M%8FG1=H[29/_Z13.$5:Z>0#U/5A2RBY&'<EWG3$A9I+ (Z$'.:_/I=_)NMRL
M1!@<&K]=?CR[OCWYU_GEKVN7"K?W4@=&!A1CW5N*4 >25F.01%@8/UQC<[K1
M@IM['8E;^\:M3^R/[M) Y9%,0:'PQQR6=>@@1<W-D*<[NP^XF>\#'$TFZB)^
M&!UPPA 5_N(DN <Y[F>&,'DM!(Y?#0&'(" GWO'+!SZE$L79Z52YV=JH"794
MNDN9.OA^\Z_&[Z82R"0_:Z^';SLA,\R7$?QT- 4[O"EO*,&JBB7H48#<X; G
MYZ@_^.CC$N34JJ8-U@#WF<K0L4.N;)XB7^*9,W$<EIRJ A8<,!*NA='1T;WM
MW0EU@RX$"_[E\HVCXA.AYI8XX",:^ !7^]QVWR.##N</D9@<"_D9E@7U*'X0
M.>62>$9@O20#C,.X8]]U[<!X)$]\^0U/?NR.94 "LSG8VDYSV-*1%OO2JXBQ
MRT?'3N=1X_-<_XE&;SFH)M+$)<9FR /@QIJS3X9. X*A'&R43EJ0<$.0XB(:
M_;#:D 0-L"&Y'$"LIV>BYBO-IW8W21%S)F8)?NG (5R&&F#Q+3FNF^+?\X'&
M:!85ZNI&N_5CC@C4Z^E%Q9D8<8$R:,AIZ_VI[8[B=.[Q)\?%>SX)0;];P)4V
MNTQSW%%.6.]I]YL7!44YAU00X%&NLTM^J U)#-<F2&2L-YZ;!63GQZ%+EMW(
M]<.47*J4QR#[;(FS-%B8;F7F0N]W?!9HK_',KMTSFU>=%F*AC,G#=^+GGRFK
M%4"CG)6F <HSIL29AK1U2'SK#BS0'*Q]4#S,Y*/#DCSYTU$.K;&?:.C/ACQ(
M9JCXDKV)"6?H9!0H]C$_*-V5DXQ;Y-M!TH)LS,AX:JP4>$YXGSID-)T'W^#L
MFV1H[2PHI@WHIT-6K>K@0[)?]?;&90ZWY$DGG,%M'7>Z?%)R^J)F3>IFY&RI
M8DH#* ,)N_KHRQ]S!I]P209H:DY7ZQV;-@':<## =CE=D\1]#)#C$)[*8%5V
M03KCL\IE9;*3D80YT9]11H#)F-R,K]8V/-A7Q<&A!PIRGD"E.$FS-IUGEQSX
M)1$"6Q;B\7S0TOWH:69IS"!95&JOF\=@1ZKY#R@QBIYN('_T0W)2<+50T 8/
M:F!B*T^;HL9ZJ)S'$GO<!BE* K>.EQEUF?JF-PVD;DTRGT_BG$KPG 3B@\UK
M=_OL[YXKGW0U/+%>RXE_ONB211Q)DAD9"?S8=!]/E&U$ZZH5*?"C'52SE+SM
MT)V+X,V=NS6@W<;C'OZ_IWP& ?TY4&';]+"PJ^!=$I"5C^BT/F0$).GK4DRA
MAZ9J:W"X:LH(=C=.-Z<J$TKXA74=9227ZB.E#I,9WI(*$;PXS6A4*>S =3B+
M+2%2.@9*SG-'5BT8,=HP[/Q(I*2*JNCYE$SM>(<*9M,I(TL-"T&F%!^9N&;6
M(7-HG&A1;R>/8I9=J8"2&$G>5X8)E4]@*H+0]Q)=1!UX] )JX#Q'>4PY^)T
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M\/%<\5P!@/TYZI*;-G 4'&D#=V01XN,'B%]55"$D!. 2=7R%@M5?1<!I1GP
M /?+B'\3</RFK8,#TAR-</W&P'[8@C*,#P\^&"]>9D1L8[@8&4][6 <^K)LX
MJ,>]\ Y+I(X(6QA*#8UR1*-PQ6,'M)M(E*8Y'.YPV$(1AK*TA*&A/_('G[(.
MB(/RR4->35N7@Q97;5$'/'_)M$2HFD$MM:[I:?T$^\9P$P&'6VE:HM".:N9V
M$!R9#' 3@ # <3]6 !: )L 2@ *@ 8Z'+"<<?[;^(>:J PKV72,R<[2M \H6
M=B@25SY^V%I615_YFS4D#MKC\_ZMQ]2_]%C-$64+AR%QU#.'_7)$P7YT M=)
M<\3/@H8U4N6O&@1,]J\"#/57X88Y;BQ^%%2M49B?A6M0![F?!9P=_Q)]%6)O
M_=T0WQ0$:"A<E<5]$!SF+5A8+.!H\\OPSX ?20$!^P?MJL,_VUU%6&AIPU#R
M%S0<4(!?TE4'"Y;?T360#JA#^DT7A\LPO=>7OY%/8"PA*#A"S@QE]M,K;EK?
M1/[PBH/\]T_90R-86J%^)UX+Y]B_HVM"'+[1;R(@E_5_DBDA"+BCKHTE;G!Q
MXV4+L_YA,8J#"@V<3E?A*!0<Z@"'67]G(?M1<Z#"+W3R'W0-6VN;7RM(?U3@
M=/M)/O <@KEO.A!4[HG@IAK>C\]#K[IX6$?Q5P]D;G_C(B0_+![,4H/#,OW/
M,O.AU.7#\O$??'B'7!R4W\S\8_B_H1"L'N:O X!65K@:!]P[T7>F;Y3G4=$_
M*8*'[P:X]Q\4D<-WWK\HAS(W#O.XF;3_VT3PY:#Z?[_NT!8DWRQZJ!< __*W
MU_<ZYI]V^E8^>Y CD/VI_6'"A^%HQ;@,,< "@,3U0@#7;S& .>#GQ/E;^H5V
MP'7 _<<&/]-?RP0 AG8X<#?\ R7,X6B8!?)?9BD$)?!#Z0/7_L6M /_B?X"K
M/_WTFQH:/]WPL$-$2 =;B"52Q^'&P43"^QO.L<,Z7(;ZH.>'!46Y7V036R/@
M:,>_D8C@"%MKVY]KY#7- R:U0QJN3&Z&1L$5+&&6"#.4I<6A]JZ./Y;X$]\:
M'U .:A2AUBS_!_I/@$8X_&VC.#3^WRDJ2.N_;R9$9@XH+3/KO]$H()8X/DL7
ME"+RNI;*C1_+%<D/\M\:'[>!(]RN.-A:_[#4R6^=O_Z#?&!="TLK,_3A>G4<
M8XE _::YS@_RWYN3FEO+PAW@B%^,2_6-X:K"SXH#-53AL(//XRBX(VY30EK^
M:K@3#CA#_H-*9GZX\/V#3HHX6-[^A7PXGRY]XSMP9YE%P%]TJL,LWK=UB/#4
M8>E@0 D.RP?M 23ZWPV6@'O9X+*? 8#J [H4@ Z M]^S/P<@NV(!-[<TE54!
MX._/ R@.2P"+VP=\^_V >P R$A*2XR1DQX^349&>(*4Z?9*,[.1I.AJ:TS0T
M=%1DA^G[Q^\3'CDI*3D%.24%!>4I"@J*4P=O%*>^L5#])P+VWP*H2'#*)Q#@
ML0+PJ7XW\8_243I*1^DH':6C=)2.TG^>]D>D/6Q0*$<P$ A#\ID=A']\$#@4
MZ&+F"!3@XP<")&5<',T@]I8H%G-+W"%$BG6AM)*5Q=9"BE571(5?Q5'6TL;V
MNAO"4M--50OB9@\!6;#*2)^0= &[0!VAEB@S%A>H PP)=I%B/10.QN4/R$!6
MEL,F*'LIUL.@DT5/Y2:++!QAR2+*Q\\+X><79!$#\0F("@N+B_.P"/(+\@/Y
MQ8 "_+R"@F!^4;"($,OWQ"I] O<NB;"P FO(R7^'PY6D6+_WR]G9F<]9B ^.
ML 8*@$ @(+\@4%"0%]>"%^D*0YFY\,*0%[X)^2%'SA()0=@>WB^Q')3-<&<H
ME!0KZPF67]+W?D$=?P+]UH"_8W+\1;N_,>$J<$Q"OV6R@/SD<<2=N0[[8P$!
M6CI80BUA*"2.3^"W?#@-553^O8Y0Z&\YD:AK&-2_YT0>G(2 &I9(.!H!L;R&
MP6ERX?>B-"S_T.??B\(U_ZT@QQ_WK'\PX(_J;[:7_DN"),X.8%F$)>[@+(=[
M2>,\2HA70)!74$!+@!\L+ 86$N'F%P$+\4L"_Z7E[V3@CH"X\ZFTBBT$ 4?"
MK5#O<EATX0@+G)\*B/XBX'NS?Y&@ K>PM7+]AQ8"8 %1L(#8KUK\TO)?9>#F
MD(49RNP_DO)KVU_DX+P-?!,!MT!#+!%_ZLK?VOS":P$!0[[U4/IOHW0X?S0M
MG?Y._5'A8"O]\\Y;$OB=\G=^X#\%2 )_BW:@@Q4< 35#2=M"S:PM@9:.2*O#
MMM^I?S>9B@I8$89$F<$.+F&D<00^6UL+,+^9@*B0E9 HK["8D"6OA84PA-=<
M6 S":R8H#K&R$#"W$K4R.[3BW]G_(5H.#D$?S$-<W;=US@(.P8G_Z8]@?@LS
M08@%3C*_L(4@KYF(L" .2$"85UP88F%A:6%F92E@_@/H%V'_ /IV%V3F\$N;
M@[Y8X,"$186MK$#F(KQ"8B+\O%8BPF:\(#$+"*^8N8BXI8BY&,A*0.P'Q&_$
M_ /JNBT29W'7_]H 'RZ8CF8(Y.%%E!3KCPG-^@^& Y[#)09L!CE8:J619AA+
M"TG@WVA_9K+]YV#^9P;X!_N?,9QM+&'_G%W\@C]FUR^M_BSD8%(YFR$LKUCC
M["S];;/[Z^LB04$^?I9+NK8P"[@SDO.'R+_S_%DVQ,8,9FUI(0W\P?B#\(_1
M^>UL^[]CV,0A%J+" D(6O!"(N2@O1$18@-?<"@3"S4:0I;D%"")H+B;XOS!L
M?RV*1\.&&R((''9P*_I?&#H<CADN=K-$(*6M$' HBYFCHX,MQ.R "XB!67S?
MAG\N>2PH.,NO"_,_A/P?[*R%)<+VO^*EOVCYTTXL_Z]U^G\\,?^SS?%H8OX+
M]5^CES_MIC]"AV^^*7_@7?_98$L>AM/_DZ7T7]A_)]WBOQM@_(/]=]+A_],P
MYH]B_FGY7PS\M_#W9VQV^)T.+M:VE!:6!/Z._.-P"/R7T^&WHR?P^]D3=^P%
M_CSW_L[)_O?3$<@1R!'($<@1R!'($<@1R!'($<@1R!'($<@1R!'($<@1R!'(
M$<@1R!'($<@1R!'($<@1R!'($<@1R!'($<@1R!'($<@1R!'($<@1R!'($<@1
MR!'($<@1R!'($<C_,LB)O_Z2W!)F(<7JS"HCO=\/D 7@_0_3@9#_J0R\;_]F
M: W/E0"/ZN#?#!%0X>W7 )@!> !\? )<_<\_F,<CP3].<(R(D/@$KOX6)0 /
M_Q@^ >$Q0M(3),?)<=4$.';"8^>)!(BOJ)-0FSG1G#I]YRFMX/-7Q\^P7F!C
M%Q;10HS(:>B&AE>UMG4N<@B)7=/6L?QZ4?2JO*:Y57 8G2P$B<;<O7<_)"7O
M-0Z!%N]7\&\:X./H/#@8?#P" D*<<@""PR9X5.<%KJ@OFCG=>?K\557KR%=\
M:E;!JQIW]_L 9 2X?E#A5),![.VQ$ )N4^(#+I/@ 7Z7)?BJRKUV?X2#</K%
MBI%BIS=')M ?J'V=[96=81^JL$_[4VI6N4EX>Y=]YEFW:D5UC;NGQ?JWNDK!
MI+RL=ET?%&^M8Z44*-UE%[WOKTMQ6'7UM06W.G6E1S>0@W7Z!\?5'$YKG;JX
MC4S/,\PY5>*NJFR,+/K4DKYZ8JV!)2<G*6EU'Z!O(O<AJ,XKCK=C#_'(\-RY
M#?7T&>Y+/"6O2.\;TV:?95)"94?TGC;4.!L01Y?\_*F] =+(9B(KS\2VLZS_
MO?;3T[RZE-FUZO+%H>R#7A#O[N:3O5<<285N&R8MW4'<^+==___))I=GN\#K
MABYU39$+5,=@?(H7,U.UNT8[H_<!67Q;$NHS)PS<,M'0$BGNSC1E._;6UH)4
M[4R1:TS"'=KKH1-7.[@^%0%->2\_%B*?TNL6+>K8B7B-M=CC6?,IG7K/^]#6
M$T\N+GBF6DK1L3UZ7:=W7H21/[MTJF'Z%#J\ 1IJN,HK'"::F?&D7=N^+[EH
MP"+QA=)>]C&5CWW/Q*BDMKC6N[C?,P?XQ3T1X=EZL)OQ1LS89F2W+>)35K)V
MT=""3HIUAUC-/.GTKKU+1DI*YJI;+Y_(!Q7HJ];G(H4Y=SWUE=4%9?6-"9N1
M"][X)N<7DC%JP+,SJ*B7F<)=2L%A7&&>4E=17U)+!EN!J09R*6':[DG46]<(
MV]?E"5Z3#FS]-XQYF"6X4WP;F_'82VU8>1_@XGT#L%"_/>6]<'+J-M.4MR>P
MQOO&<<X-K RD\OP^( Q8<SFI'+B0LO%XZ@X[8G.CC&8H=$XX;8B%W6.;:CAD
MO6U'CA0,NQZMH:?"*85'^#:DV;I*9GA['^"Q=$?NOZ$?_FM,9.E@M@ZY*%07
MO&W1>>;AO6Z-84--N<1@9;B)K46\&YHFVE;N\PWVV"CWM[2.9 K-[JBHBQ4T
MV@;;H3,3F,SZ3=V,P@]B,Q$AE%S.XG B)#5$9[[?SE-8F_RJG_NIQV%]61P3
M.FD20J8YD O$1"G%Y+V;YL>G//DL)72GPZ:>(A-+P[KAZ3L$66C=K<Y,L)=G
M<>% Y7'RNZ2;=P7?9G, )1H'+*?F.\A494[/KVR\8YF>T]PKL/,8WY,NAK#O
M ]"W*.F69?"/+P@)T)2GKRH9L2^QV>WJWD6;I$'KQF:>T-/M=K0$]\>;4#%G
MBW5R= ZQR]N+^V:]ZUJ<EV&L)]"9SM[3MGOJV[0U?GP8D\DX/%V%R1]6]$V=
MFNN4F^B\W^NF%J%KV&ASO;,O:]>N YMDFG.[F$D*WO06@%A^G&3K;-"X6H!8
MS$ED:/\8"Y$<F)V-KM0.:$J.T\RP=@\CX6SQ*&YB6XH.3>;,X,@6KF_B%&SB
M)*17),-CF](Q;,Y>F1,Z=RDL4EFWW32E!LJJL?11=?*FEU^*X'_'T[2].H8C
M4;E!\\G>&],/]CPHZUY8[R*75N^-FCW3\! %8<5K%23)?(88'[F&D,+..LW=
MY\Z-C')[7GN=858Y?QS6% RH*==;8;MSHE]%NSKF7C[?V84W9$T17YM[,9A)
M2<9Q"O53(E.*-:-34Q)S+V29]P%YQ\6W0,L?Z#8J8RCGM.?TAZDZTX*L$D<-
M_6[WQT(8 I7%;CA\7FUN(O]:FIKWVCD\7*J'38#=;]#OR\YM>F"\^T(;J4+R
M4':3:L-9\7U A,CE<VG50W.?('6\)%GO;@YQ%\$C?"- 1OVPYGJQL1@U-=M/
M$(>M-CF\(A[*A0B.ISSS>\]562>@?!=./*X$#?0;)0B:=D9,4SVS_,_MQLS@
M[W'UY6*6K)TTR[23OLCC&S?==A&8E6,JB+;F$N%TS;8+8'\.J6O7M*^2L$^%
M7Z&WNGDCKYZ=9UJ)>&* 8(X[<5N6";*DU)G.JS'%$"Q<I3PM?#S-Z[5.MF-:
MP;2RY-K6UJ95@?'I MTF!5ZSE.SX<"6[W@S+U.Q4]<L\6M]4.&U:(#-)SKT/
M*)Q&B!'T-@1OWRHR=?+;*(H.*E=$,@EV6G>7V1:^CO-Y!>)M>DE7N%.+82]>
M\F^M"]/.:N[DA<::N!+>\I1R>G+\BW3PS@/SK(R<9LQ]SH*SSGH.%D3\BM:.
M52TNQ9+U?,1/87>!^FMK;0QAQXOG8R[7(!GR(3R "XP^( :)B//1')&]\]&Q
M7,ZJN?0 ,AAH3(*63'&8F;=8<FAR*<6L.])]J"!J'S 1!(QV&F5Y,K (J&6
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MQJDTRSI\$-U6#X0G;0I8MZZY*;_G"7_HK\WGMN15HR4QK":U#TC]8$&HS/V
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MJ/K5(W>;<_1O)4(BF*1Y%-[0,C26@>^?R%OJ<Z;0,OZ MTE9M56Z+$ZQ?1<
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M:Y-;J:71I*:17NC.53+HE9->D':I))J;7..,4JYV>/BCQ'C<3+S\.'1GC$+
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M:Z>$4@_IU+AD7S:F?#]S4*I4CB;!Y^+)> <&WGPL8U6SZP//Q#TW,Y&O3DI
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MD5,V^"W_Y)4/V%B!1<^=8KF70W9]P]=;WT.!NL=VEV-LB/"6Z:68RDCCBG@
MYHA;0XP#&@N9<;F*339@;]>FX^R#/1%>E>(@#T /@4,$,^6J>JJ[KO]]<BC%
M%8;\L<%%!$.D,P6BAE)/;G(K>\0>-2F&IFR_LAS!],!C'6:X.J[:6^URS20O
M92:,.E0U2$Y.YIBKFSS8U&U]F\/C)8%D'D&A:IWCP&;",2/1F 551EVHP''4
M>?*@A,G@$3]DXTLZ ,VZ?BV_HJJ6/762Z"[<1M72)S]O=-FFUC--MMAL4TEE
MT>MV7.2=8[$SRN_@0^LQ7;5]X]^_-/\1LB<M97/L S+>D%?./.N=QB8\66S9
MLI7M<V(2VZK(4E>O)ENV6OXZ<UL4&5\6I4ZN"J=>  \-QN'+M[RL=89[$5=2
M]$S61?I2,7#OZ-H&OC,_AQAD>N!(<H[LI+=4-;= :/]>:HR2NPN!PQF01. 8
MIAJ_CO<)GH<D\U)^+[BS):FBF8T8>)=!?-"'V0NV;?&$;I1>/<E.@$K(7_45
M Y<^@=G82SI&GZ !3SDS'QKJQ3$WC2'_[GU <W/\6_RYEY*^5P4^/ 9854D&
M$-WC>?<@'S&1_G'0K!R>7;V*E60>?@!?JVV]M@_ GBY--<D6;.KF48L0I4(%
MI+>^%Z&*2&MPO0%D=@?MHOTZ^F[8_/G*);]@E2IWMO_]1WV>;ONES"E+?-%^
MIG<YG<@X5WN;CK07:6\^&<)65\R[ROR-:4WN]AH;LDN=K0V/MRR]1[+GVKC&
MS=$SV5VFWZ43SWGSJ\&<=ZD1:J)?[5,B_ R3LG-PMZ'(,:V(@#.O12Z&MWUL
M<BKH;-]C8&<]W3%S7E/6E-<NN$N9Y^YR[(JH\?=@2@>W1U/:WGR[!\Y8WAFH
M\!QF7+DHM!>3WKFL[3DU5LS3./9NI332R>5N*(2W-6\<)M;#./9EB$T$MC0Q
M"5%$)DL_U2><5>VW;H%YU XM>&AO&6B4!EZKY8J_0@Q\G)*_DO!%AB23HW,M
MX71??([590RH]O/($B8B?-;4V<IADC-H,C\Q/AO4);9T3NGD*-8:$@B[O&B%
M5ZMG36E;@T[QUU<685@A-*LGO.OVX$,_,8@)3 N)5-,^#9VP'[:I,TIF$Z^+
M'Q@<F.M<<^RG:I!9F=L'"#[78?0RR," FBJ#,>$WAJ ,E:^_@"SV:/U!S13R
M PDQM4.Z:2KM"YQLJA[+&]#,[W%+4D+(H1,[]<7MVBLN;3=5R^S86.?L"JW4
MN!K*)L"]>[BD-[]LPK.+0U;F(>(&W)VV4%7'R0L"V@*>*,/R$C>7\\U$AHV^
MQ(02: ?RI1J8@WU4Z.I\V#M59K3]*ZF7='%+@MOS5PABL$)(QEASMCFGK$Z[
M3LL;5TN*W^(583P?F2(VZ0D1= X;UQ[%I5T;U3DOESR6]52<>;V*#1LC2I"_
M7<+XP;_.0%DA*EHQ2U.; (1=F/4)[X]Q8,A@.NYXSHK\].CRE_A7\VUJHGV6
MQFD)##O/5X-'!F_W'XO)U4 6@;B<=?JGHV> G':IY]5/.E7S>_64<!:>?=CW
M><DM>4]B96"SRM"7*=2F'9HMK&I-(82&%6Z:]@S\VZN5P+7[[7WM.HN&?GWV
MOL[1O#+90 -8JH^:<8Y8=).4K+)1B3]15H5A1A8?;:9;*'Y'9M<GS>@.-J,6
M^421\R(AR-B5"Y/2:\TK.GSUL7QSW.^@AAES??VJB\VM[U0N!S%Y%G:F;E37
MY+ 9"[]?"K\KQZU5J)*[\E$DH&WZX3N^,X#LW;-NQT.>M+5RY75R90BDF'!)
M(E9Z$D?=UK,7F,GOO/_^%(AA@>PV@1+_/D"JHW*/L?*19'\4W]D+K7/]?.$)
M]NG=[;,I%RYP2)"YA$S6W>H7$Q)%TO:[:*I+NQMT&EW2,@R"]-PE78$\C67D
M7\<BD WDM$*%^9J191]3@,HZE^=\BB019L5 WW6?8#I)Q=[4+9.U[ )U[K,\
MCY!AQ<!+S<Z$XHX7O6Y+\Q.@(_/?VX[8):X8"R0704>3*)!Q0^](I D\@IJK
MS_L(-.1O6FFJ"^T#E,3\-OTSX[8DD=YL$D0.9&;%$[$@XB0+O*)+(DX1L17=
M2>\ZE>\' "B5QZE)+<C?#H>H% EN2([H1JY]?%=FG:-A3Y"7!P#JW&WT3+M,
M1#2:P6-=[4U>I_3:.*UT%RL_9'6GL/Y[G'+Y1YSB;=#F@%UT#YA[7,'B7;P\
M;BZ>D9//Y,E<F:'IM0]0#M4RWY:X)>,;LLQB^8A?X+6E=FF?B+KX@EB<L:)K
MLQ[YR.=Y>?U"*>7/V%N@:AE;N1>UT[8\Z0TO0%_OM. UQ*YZN;:LDQ&93+GT
M067;1.>$3NBQD(6$L[F6@@;R:6NO# @](7NCWFDT'ZP:\<X3R8K T'LNCK&5
M/AG(?]#;[Y)I-5QNJSY16[1GY4@B4:C?0]4R7QQH'1'.U*S5*8<NT*Y4<NKB
M0<9N"8D35O+-+ 37B!+?)%UR^LB>TF=J,]W?3IGH9IG=(KT/D([O?@!=>]_*
M$=4A.EC5,L*);S3OV!^Q6'/>2%[+ED+;KBW"7B5*-UO&8D]8-(3ASV=0T;GJ
MFO?")X\MZ+P6%O$QX<WF[2[5ZIK31;Q2GWIXEAN=;5A0.^/YO-P.RIHR/0Q/
M2M5)L??,V98U4M+@YKTJJ"P\TK+ DM"X@U[A:NGIN)JXJ9BQT,7,^]5NP2Y_
M0.=YQ]DS>C,4C/92@.@(.[EIW@^+>[W)W64FPL>.W;=S34Y*+9Z.&32NC;-+
MMN_,%M3L:+N; )Y;34NY,5.X<>K;=UBY?7'E=U*,#YQ^1RKNYMSHL()/C5?H
M0HY CB?DV3"=\:8I.Y?7Y88/UF27Q\<A&"N'_%NU9N)+!05BO+!L]  ?I#;:
M?3OR@8RX:--@#\2<:&#X%J;^;5&J?T9WFL*D)(<YAOWVX*8$+0MYH6=5U20K
MQ$-$KS<=61@\6/@,F9 G.&N$ALW/]Q!0.#)(6 ;XO2H %4<89@P;0<!WA9Y6
MX#58WN& [+2LRJ&Z+O"/7'VA9C6C55:RL[VTW$,4]2I8D4^BF02ZY3L CW]J
MJQ-">MJ^LZD9 6H>QWILBHKR.)(*66!SZ"*#1I_+I1U$8<(C:><B-2_/SB9O
M6[7U[%C#U[THP\^-$JFZ?HXL;7QCWSOGYQ=M4!XIVOG]"52;PR=0-1]U$BQF
M<_CLL8YZ"(!E%"<2>IFU:B"EGJ#TX6C6).IMBF07"?&9]HAW[+F/[5ZH+K8U
M>.)M;5".(00EFW?\%Q]@E)7?:7/ASG<WA;CSQ6NKJA"NQ"W2B931@^@HZ(WD
M6(5';QA7L6K/W"Q]7C5CSC%6J'J0G*3.AG&A@D; K5QJ5(Y[J]WC#@IU#F\D
M5%K7:YT?9MG>-^AN?MD?B";,?]GP^9$U,EAQ<;!86NSND%U_O_S7.+3C]F4R
MK\2WP8R^O0./LQCX??R6H;5AW+A]@_=Y,U)SP+%A)]$F>Q\P=KK@9?52<D*,
M!$#5M 5X]D'!&X,"H&Z:HEI)JK;D[)[6;HQ"T),_/J3R8NU=9U>05)7*-;/T
M3N<@WHPW=]CZ9&4](O/MYJYDP<$/4T[#N'I7)M*N?!I (PJT10T].[JZ>J94
MC!.[V:'=;4GLC!^5+LQ)MW;DG(-XWVA)@WH87?6$8"K5E--Y1-UBB#)-'P;;
MQ\EHP@JRP-HE)0WO7]N*$,6_L6. :I>\,(2NY.MIQ4<GCCB\, 9/!:<%? V\
M]+&=>??\\3>3"2%6KY2^S43=.;48HK /WM".0K4MT>>+8G5S-0IK%>X0G:5G
MT1O8EC&-4'%H9"!9+((0+ZZ\.H:D(98M5Z(BJ(9#"JW>E>/D +HEA,*0J1*Y
M/2WU;684,IJ<OBB@,U4SUIB.-QR_1\'0\F1CC-X%RC4A1GK&2>WL^YGT;$X>
MQ#Z D)ALN*G8ZTX=;VR%6:H9D-P\,1BZH"BN5=?CI1)K/;,7EU SR17C1#_8
MW)'6*$,%P/M07$7,A+>X45D9%5BJ'76_S1PK8+?4'\$5$GM7OX@\_^G*=O/V
MW.=6[2%;NUR1>]EONHWX,1CYM::T"\MQ  F:30V]EANN( 3(V"RC6*WE47F8
M;&?_U_=+/V.83X=/KJ;N9LIPM7EZ'JL![5KP2Y=7>9;4N+E#BI21%3Y>,RUZ
MX[Q*3WTGB>-W'AE:.U_PO&T=^ *B>X9&2(G)2(<6$>"=,+!<3_R<I:)9%3&P
MF0]_LW$%I!K=*N(^>/5%H7\S\I5$!=&0Z3EWM&24SS7,J/&*.X1R<K"B_RX8
MVW!NOFIC=?@X[#2V-H==.@CLU,U#.M)#J2Q-L _ 3#LR??#G8C>)*>WJ:'.B
M34E>Y2J7PJW)N5/4\C5"KF/'%AM5&=A?S1\#5M"H&,_T&ILPSC]G<$'*M+4T
MY#3VPQPRXD0#8J);Q>.GC8R*F]7GQ2UDWO$]A#YX7N3N^R*Q)19KQ0SU4V7P
MA[HDW+BX4_ZP8';+9A]0_,ZN*5G^SQ?F1AMS;W<5WAMB3Z Q :/&"F0BOL=S
MMX+7+<LX4K+!)>&%QNK)\VY7)Q3T[4NS57TQANBN3#=TNXZVAH$9?_5=1BS/
MI@O3VSCM:B:SFGD6^PHN+2=EW:]@X_,JCKDQUWM7H*=+?.0-9Z!K']WLH?&)
M*>QA.DJKV(Q,XZO)@QW)3Y1Y?,O83!*&L?J+^C;?U^[LO@1:)BY7=]CS?<#B
M]"/3=I\G'D)[H6-BV#3KK+8[2HJ+XF:O;BG/7ND)'.>O9R+4;_9_;PQLY$1L
M<\*0@>A:1B&))<?QA)2O^8Q787QCGB7BCYJC71-WO7H\"P=BT:$OS2(&J'>J
M>EZ?YEOWNCC*^C)5"ZR78'I.#O 9KX.H67 DKWFB6:]P?I2ZP#<L*RIU<=2>
M)C1#H!EVF4X*66ET@^(<P\H%0"PE=;Z!AFZFGM=C8\$[3XY5/[KE4RF*@962
M[>B]GU[1OA^?0UM\/S\6=\ !B"_1UY):.\.R&ZNNV;1URL^<-6EV3&:*>[J;
M;_N!%_F,8NZQ@7(N;X 0V9D^RI#[!ENZ:Q--G0*%Q7\+5&+6TM_KA&+7 WS$
M9IZYNE+%)TE!HM2[]?J3O.(50"UYR1:5994ZN[Y-U4^(S)7*:3^M*1?(MEV@
MB*QKOLX$J&;6!\;?PDH3$]>\G\X=;A/(6;CN=S(6F^YYIX4WJO@NQ5B,F&B]
M56"E&+TZTDVN6+%(U8U?F=:J^:28%4.@D(S_$E;+S.!F2 LJX;[I31+R48+9
MZU]ZV;R:7=EK8%W"0^<QCMG6<K&9FM[:%0,S<EC/.QL^;_@P7V8W@(UR@PX%
M";LZC\Z6>IX-<&6IOOTY:'/<J\X:WI\]&O=.S6A :PZ6IDA<-!)U\!06Y\#)
M4-&N^I816_>B^GX,&=D[#KV$G;"*KXA)K=>I3O>#<],>M73"H*RB?WR&Y2!+
M7#=W@LS'\#H)&Z6=.B&EWEVRSX%O3]KT[P-4D_8$?5<_$[^&[@/2U/<!]+);
MBP1]HON ]O1]0.#S71?\[+6DS&2#JI3=T]K@N(;.&^WK9Y0PS,W&@6]5]?"K
MR[PF6M U-03,<;LO%Y309T;ERY9G3.[S+5PGP9/3KYQJ&\#)<@[\+$"''>H'
MBXZRUX84-,K99T8'Y@<6M[=Q2W7*6+L*\F>>S-^R<"W2!N=/+/6\]3'0$LWX
M$EK$9!KQ8A8+VN2HB#?6DG<FO?"8\=+LQCC>1@#<NE!H$H547 _T6TA+J'@>
M4IFJP.XKO>E4&FLQ_U;.MRBPUHHZ2\V]D_N6<\@^(%FA9LOB3OVM!1D?:.'.
M<Z'L9AI5Q(Q51T-:X'7/S;DFQ84/ E,W/<;:68EJQ%K>4N^ B>\)I\B+ZC7)
M70S7R-($BYKD[+J.^PC"P]0]*R\IO@K<[>YN?XHD?'76($Q"QK#U2_6P=WUO
MK]8-$^A%]"> 43I930<;X3-M]B$^Z_&Z\KLD5C#,7/K#^^IG*P*T<[;.?VQA
M+F6X%3P&%U2ZYDG/U)J@KY V4^M7*0'_U/"K]4^YRP]OH<]]#97)!4@EP7?!
MCS<^GNN^S;E@!WYH.?TZ2BDUZC+E&__ ,))PJ96SNC1/.2^P,/44W?-J1:S,
MW:G4+5+909D@-6_4QQY3)T:<J+\%05B__;('<FG0F](4H#E[(].ID%WN&E:@
MH&P]3Z)^29ML'K]>QL=S,9PE&/%Y!0OC'44KV@4[AKY7%?H<!X\3P[>HE_&0
M\]D'I%['/O7:H ,U"^Z,2+R.:W?*-5RF7$A2.TFSV=[S% S3UY+9KG^"#6F2
M'CR7)(!E0":6(\*-7/Q]DR?>4 W=N)7I[^']6"'2>QCK5$K>_]1'I>,:5C#,
MI2&]=##PI"(+1I^F-5QE6(J#S]5L<WZ46^FU4C:/04-%G%4!)*Y@;BVZ79\F
M59!6(?SJAUT9C*@XWP;DTRE,M49GS0((,=&.? BI-.U*8'IL6VT9K.;G=JDQ
M#_]*.K2=?E?0XKAEABK"2FH- #":12CPLT,?)+*N%8ST%[5>%[TSQ^ ]U>%=
M>W.OS.$_FQ\$<>RM)IJ"7*DOGA6Y<DYHZ))=__\Z.=.H)+1VCU-9J:5U'.ID
M)RL#!YS*T),X9"HJ*"((>L#03JD)3CDKIIEE)67'$##)608!T5)Q0*UL,J=2
M0#UJZJD<<<HIR_*<VWWO7>M^>=>]:]U/^UGK^;3W_JV]G_]ZUO])4E'_Y52B
M>DS/Q+__9S3=39YV'M=T/ZY'"@:DJRL?^2O]^)G6M--0[VOO@#Y)?;X9S=9H
MF$$>3,O;F90W59@TN8BR7>D..XFTE6E"9!YPUOGQG/O;]M0.*)].+SQXY6AM
MV^>S@&_(2]>^&+VO7S[H<27HZ7\E*_\[N:4K5[D![>DA_V[Q?LWVQ0E6D<N,
M7/]HZP4+GQD5]2WG\4]MTAP"OT1 ;:[5L3IQD@EV0X(3,95/N-OMZGM!1N_S
M)4LHN%F!D:C<U%V/(59&R\RQ D@K3(,'A_&8V''6N6-O:O(;JD[,NA;6@@;'
MO(Z2^(]Z/E&74*E-HQ7[8/.Q0XY_98VN\]0HE/3><!^&9:"H8=! _&ZB">W=
MQ8%)0E/.52 /\/LU5(RK\.&.;_6-2Z8G>_,/,Q>RTL.//>]-\K^:7&KU_+SL
M0XM?G,5K&=;7 *YXG(=P]BT_LUT0E,UF"?7R5S+E-(Q9 [_K3>&8KDQY^HTZ
MEFA<$3+C><@XJ0Z#'GAG2L+'?LA5!1^\OF;AA>OK=?<@DV:$^F5"9EX<YAYH
MDNN/Y>5S3L=:CYZV"1]?ZLO5[<)J]L-_JU*:":X?SAI](NLN]5HS=F-S*PNG
M?+ +&RU*=!P]+J9/..+FC9.9Z+-@LI,G<9/VW]3T=1^,BD6>1\.F%^?J4K<I
M8$%.*'RB7S+>_7)NDJ9XN%9$R1GJ*\<P;.C5TM**T5(. B%KQ[0:,3UC)QXT
M*ZL]DA[S'$;U7_,M,/MX:AAES"XLF@]Z[AJ9#06-_$FZK3O7MK[_S+VEM(S;
M:S$K4(U$XG,XQZ+[^;PFI&:;B;2;4Y&CPGF@Y*&FHO13^JX;4;6[?F%>/DRJ
MW!O^F?^^)O:K&A?Z9,.\\O)?*O\"!_P_X(PI7_D!SC^ ?Y'CYF?NX/SNE_<
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M(L3XM)_-.$;9XP3,,:.!Y5BW[,IRX@D?,881XUG[&B>KBQXQE[_SW&_:MUY
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M640":DID#$'4M 6"4BR!DR4+4:7^,)'@>[ENA\_.\6< =7S$&W#2U/*81\:
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MMYAC4FLTEE1"48J#K9.GS$I.R@9C6J=5I@AIXU$71Z]#8Y2DQ(.2,RF5I#*
M3)=< [KI7HLP1D8^H8A"8I3C3*U,0&'Y-)ZX+QB#N$D:R96H0"1(N2 @IK%"
M01<&(BJ>+$XSF&"ZR,WC!,1:"2T#:.,!(1TMX )#UA DH&F2,L##!G")7&-6
MA)2*D,4O,!)F4":ER.PF(R:*XI0D3TE^2QAH6@F@5KH@[FVB9BTVD+3:206C
M0D:IW0A0U'8G %EM&HJ4#.+ &#.,L[2P#4BDV<F5QA/D8@AU:$*G3CLL14P9
M ^1JF%2U-#NSM.'#=E(R14K2<("J$(7(%19IHB&R96X$H)D3UB@9*'FL$2W
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M4$4+BD-QA8,N8GJ\N,>>53T!@R=F2M5,*4LBLB1$%+L+-,$QB@7W2ZBAF"K
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MC(*!E<Q?)1!SD;\RYM"_,M*ZL+KXD9$U@-K\S(B9F8K^S,#B^)=J8:")P?=
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M)Z66-L @";X;#/C5)'B$Z[ B?ICE,'CXFQ<VP2-<@X<585PC8WTHOP&O8XF
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MUF6;<V?=X G@.<#@;4W,6?719R?[VO>*ZXGG@,RWM0S;6ZV=LL#&F&.Q6N>
M4YGK.[M[)XW-MWYJ0%E<K@4G?@<XZQ0.NE G5^-QEN9:X\UW(O&-=?,<('5W
MP\ZE,1$\/3@G>/-@V\6P=+T !I'(G%9^:']Z4 4#?;KYPO'N49P0NMOX_E?^
M"\+^EW- 7U=$L\,9=YH>]G;U$\+:(QAI:$%^NN/T[3=$._&S1P?;=J?DXRZ+
MP.FU?2&?A_:?QL"SAW5Q'@'<^?/8![4"MV =HS?M]5[AO), D\@/;^+=-K9'
MQD7_\C>1.?WIFC-K&TQNS^?%\=V(L_6-%W=0G*M.JIU_M]EAEN=0TR/@_MX;
M&-NQ $KUZJ^.^W1N^L_8_>3?.I/J8D[/GT[/BX@$A<X7IWB^T<W:3UA$=;'F
M419;2\90#5O\Q"QK/_^068:]3IM9(5_8[V*(=C-'JV_'969KO.LK:;,2I(7_
M'&0:(UZ]90"XM>/9-=[,X-DML!9V3V!*[-KM%0*2AH*/)49>Y6?K1VB&V:R6
MX;/;S'4<P<:,8K*3]:'R_3S4XB6/DH[HM>E[*.$;0Q?:_5]+2"/ARC&4QFNM
M@BCGN4KBG)7L;H^V^E2NNN'$2\A3>R\,A0^7?,I[$GC+^_G:'B7)0G1/E/;=
MLH8,U'TR=*9%3];J%JZNE2*[W8\[^[) Q72L9D'1[>W#'=H[?_I"#;-ZE4AY
M'<*9*ZLYNV5,$YUU%"1@7(TU^)8W?IFS>3^X11_G?3CDWN8]MN8;G../&/Q5
M$():DJ-\5VM3WVV:02CO36!V4D'MH66MP\^]2O"DU=ZY:X2_,[;8L)NJSH\O
MMMQDW!L)%?N\?>_IQX!7U=W33Z,WY.?@_?O U_)'"0EWW3AR3>XGZ8OX1/;$
MS^54ON-%(IN:L&T_V.UIQC..[U(+H:E/'B4\;D]NFB.VF%8Q1^ :5.F(5;6]
M@1G#ZJT>:3W4=K9,@5BQ4J@GT&X(K.X0[:()8#P\_IPCLT#AV6:$(!X(7FHL
M<&QSL-\:I/D(81; P9%WEDHT<%SV6H:MK9 SXI1=F$/:H5B(82W[T:A$13IJ
MU_GC6D8!!S)1 0I-Q,95X!ZUO  :[A;43P.ZW?U9'FKNIE6OI94LZ196M)(P
M1,'I3!7@> Q'1I+6]J;59-#QF.5=OEHOVI"%39Y7##+OZSK&MWS#["8]Q6?P
MY$=G568)A-*^H(U69''>&W\2*!K.TK]I5]S)40ZI\7A8X ?4:"#GS!4UT?#Z
M1$X33$XC*KI'(X-&3_F>^O_M>]$_7=@V;-KH",U $Y*#35]]CGAF]WE4<P>*
M$XS(ZH[8RCJ,NV.S&O5:T6CK\)K/>5=KGG+IF=#A9.C985 A>+I1H$I43P5F
MJ99C^-H3^KMWHCWY8-)2%Y61Y6>V[)^\75O[QFCAQY1NX3,7>W3F8O[R-6?F
MS$!ZDV<TO*2-QUE]D4OCG>SE<T"Q-/O:@D18&LB!'VWLT)$#Y7JW%>&/Y<.U
M+)KH)*=J#L1WHV@CGTL6R1H**4=RW(=:Z%"9\3R/1UO)@ON5+(P-D_)]O[IA
M:#.U&)$IJ2+E<?JY/BA^].K^P69(+]S8Z"T(H@W05L;L/6Z2INX^:VH7:(=&
MXD#.S]YG]#7:F(ZXDOQ^RJ?GMS90L'L \F%?36ODG2):DTZD5BX"A2[//^@'
M9UQ6G=KXEJ1C;[@PNH8=9S[.1)#1Z4$QAFIP<[@\@M.^JO]V;YC8=!S"="M6
MS 0-Q2JVKD260!IM 3,M/-T"5<C3D+5WP&KQ#>!GK,\.:-7161E/Q\5L0Z_[
MFTD][X[D"M>I*MW,[('N[*J=ZB%K/%Y05N:T?(A84U'#DB3B@<G2]2" D$?C
M(X(P(85: R>AUTPT!F5I?+54N!MC2>@NM_565IX)_:H)#4+0W*"ZL!\?:MFL
M\;NW89B/6I#@Z(GG;HL1?1'G;7=4SLI(X@P0.(CFK8ZU) 0ZJ(S-$.3U-QF7
M?T3'"&S" 8S.TP?=\=#B6KY%&IV5]7+?ZY5Q=BP7ZY*_(1C<1/FBAR<1X\V[
MD?;1[+O(C7(!P)(HD\AQ3XIH0*&I5HO42%^PQ"U"[Y135-* 9'B._+5W:K7K
M0G!4>^%-81*(R29[+:QV<V;M?G,S3\5D8_=IE^$]E&_']6N[+N^CI8@>W#!0
M18RL8@L@.M9]3W[J5]*DUC_Z;&JTK;(J(4:Y5ZUNI,K,7MN56F62U7CU%E'?
MP%/MIP18;NK,$-O09P=$)AB?-DTQHP6%O!0>)&?YIU  /R%S-O#&IH0PZ7ED
M4LG&W<N:EHKCV**68H]5IV'5G,\@$/\_6: :WD*2V%'KH<S&]B*^SN>7?WMT
M!XMX5Y>_\[9:GOA& "LB==:6,*MGW@/.5?195:U@!ZY"IX<J*H\+HR$U9#WL
M.E&;,XT\0/QT?Y?;XCOZDK?OL+[D?3!XTW"_FKLOI'5RUK6AM.N=F0UL0[PN
M4_K*+;ZMAQ8>-HWR%6P0O@S=]KV%%;N?W*V%EU3LF >VQZOLAY(HUN:+0 WE
MOR^T6-J.*<.\IMF9$A$P02^[/A)RN(9,2G*4"_NR\ 2)D 8%YI%S@@*9 S"R
M%MGDA6F2XDJKOZ))TML5VGSP(Z\D]C*B$UTIN3G],OA3JC.YG!E[EP*@F10M
MBKXE6(]?#%5+;-Q*@HU7@V::<6)$QFPD*B2!Y8N\=G-NF#RUN7:)$76)&J4$
M/]8;6TL )JLZ VO;O)O$J&45AF^'!+:,X6B?H;^.+-LT0ZQX="Y[1( <3;!#
M!8V<OGOUH^^CQ2T"3'AL4?[7+*0H),*1^8:?60MP.NUO[IJH#13CM,S3D9/3
M;7]B!EA)YPZTE"H8+7#="4(2S@LBF78PGZH1IWB<9.SUZ6/6\$+JJ(D" <[K
M!$(])\'JL4/,W)76.[147F5;[O,W:_=,GU4.\UO!J=MX+Y8S&9GZ'9%W;BFF
MAJN^F,LJ?Q,DT 9\KB*NO/8A*0N;3J,[B0V;S(F&AP(G_!GC8NO7K(X]G^NC
M-&)1]D_>-M'+=Z2T+E(_3FPS1,V=3$MKSFHF&;Y+(NKMX80DLGX-JLX:_^ V
M.4O)?M<@.M>1V>-7Z(WK'9BN\DU!^-9V9RM/X.0S*/@P'7#IXQL-%E)S%*:X
M,;XT5C"@NC\<!MSP&)RV"V,>/YF30$M;&:S&-9[+=Y?T&#XQE=52)A@_(A\U
MGBX@J3$LZ&^3K6ZTOR<GT=V>G!Z>>K\4[WWH[E1,T0LAM4'R)#R^"3Z-"+36
MQCL;DVKZ4YSR&(X=HGQT^0S&9VXM)''.MM.O-$[H72#%1(757Y(_DF'X*?:L
M"K+4R=Z@R_J:9A3+-[1-XE6'"XMC6+YQ5LEM+3^;U_M:<D*^;$S6SV+WDHB_
M/M/J:ADE]D69P)4J+\6->65QC7DA3NLD7MF53IS7X8@3@2Y#9HM8A48&&0QW
M4X<( >.=,)'&1U\S<59?8W).7Z \X4 Q!D:NZ+?4A;7P?] I?[V0M&: FKM;
M)LJM_5C)\LH.64GVY/G*781Y 59+6_3V2@A941@?*#.L[M)N4(IM7K\=4L4$
M;&$CX8@>8$AKPY] DU_QGTKT;LB)K2EU.^*0_/3"L@ZUH*_D88M-VEDI"SH2
MR$>NV,]/W7%FF+I>$NC)HW^[FNP#$<E7%L_N AS-AFQY#"S7?LIL$Y;4A?6L
M6*4#F0Z*?<%N+)I1UW- E&&-=N_>O?CB77)' 1=RM+ORT+_V-J[+W7R')RY,
M+WL$$H_,3,<QA%2(5,\!QXJHVLP1(IPZ*1UW3[5E4LQ,EI%VE4JXE*$]A00;
MB>'2&CQL9&(QQO+<-5_D*=4?>0 4]"QR4.9:_ ANYF[ZD^W'=T,VQD)/HE^7
MOE<9S7FI,H?)N%=XL.3[6* S/<PS:$YL+? )TRRMY?V!@A;?G1Q'LA+W^7SK
M0N(J"%-5:3DWU"A(_Z:$%RG; \OWB?P0CH\LX['O7]_KKW,DCM.8*Y=7#!-;
MJ$#2"..#>\MYYE)NES;RP8^>-%I"KI#M<V*C"9"PDZK9E&<VK&R74M1I6=)_
M-FONY0M4G:RF2,/-2!$6R9XS$TVSUA%%611SJV?S@?3/%I&G(PG?=JH7<O;>
M(%5\E+(IP0T%Z_"V-:6\TXY*HU+2F7IN^7@$,DN%3?$)C430?S.B5HK!/]H#
MG?_F6X_;% B&GYX#X%!U;S^@WA?%N&GVO(&,];8N$>$ FI\)H:=G-';F?[90
M(K2UW[?AZ@!V0R1#TZN])7,"J+$)=*X'P[7TV6<GA;E:A[ZB#UKS_(Q,2J@H
M^"!:D(1Z'[Q2:S;PM;%S\YZZHDFS9K-">AWT"8&9JWM^'#E*,R'T07'P-$YW
M_S2[L.!2]N>==59E8>NY#3OZW3H2FX8&LW5?EX&6O;.@F).$#?LS=&%[ 1;'
MS;H!DH/&4]/\*OUS ,WL"[TN6?R)D%V2@P883?7$';PIL>MP#KC!AS2SW;JN
M6?W<<?KN;F'-9@QL(S<ER)R03HBT/'/H?* EK-:HO0IRVKA0<U+M *.>E7;]
M8%Z9[^P^.*AYAK#U0D[I7:,096,-Z]$)@6;ZON_$S(G3,%(=T=:81PW&:7"U
MRQ9!M="AR]?Y!Q,T,S"V<\!3^G6"VKJOEF_C:^2&*6$J\S^&]1XW@(_1:[E>
M.TR$')5Z[C<(+8.<ISF%7)%Z'](GA+SHM?SFK.4"^PNA=1>?C;37#LNLO>O=
M 4X4V[/TLSL$53"OJL\!S%JOS=XLHML>OKH4@*G=A'\HX)30M/])2.X-?7Y^
ME_[F&7AI?M.(*/34-<^9K+.4_#)@M1<!>]=55*;GO.EW-*1M)WM06WTF]*$"
MTUZ@<S +!7@'0YF(]L4C=M5\+:&9LQJ..[.=B&O)Z&G%:6/1E;Z!=B/&\ZXI
MDB<R)FY,A#GD!)X-P<S>@X'Q?J1Z6-H3J('8J$8G%%5D@]U")H?-YJ_*B21M
MF>8\<*O>Q@0]S*TP,LE**NU-]C465BNMP,_8*^HYH'PO-MD@2B:O%;?KHCV0
MQ!K'SUXBD^ID7<H<%^?GVS5369BROG%RK3_SP_BN&#3_3:OX8!:-M6($+Z&?
M;%9&!6W-73][LQOA/+-\ JBU[X@3W]",:AUAR.^\]XR__1@T6Y2C;/^@8"EV
M>RYSL"]["?Q"I\S?_%8*KZ#HD@,]_3V@U4R]?SX\Y8<"^=MY=@VLV:*X01V.
M"6.Z%)'C^\@*KH^FB@.CF@]:!CNGZGW@VYBV)$;1]T*MF=QX*3Y"06&D;&Z'
ME9K[49.&PWEJ9SP5R=JXHKK<X;?!I&";19]!2M,XY(NQ#)$Y<N9KW>9AQ!9Y
MN!6Y(#LF/AH^&TA0.DCB.7E.DJM8J 0.$:&09R-QRT>*F'%5#I)]%Z LT?MG
M1'23:HT-$*3\R,.F)M8XC47/>VWPTQBYE-U>Z^'!TTFOD*;J(5*2C+HB?,75
M:Y]KF<&%/M"MI=%Y78\098YD-U#$ZIO7M#<'FO$\*M7LE R Q#,8PSEBI-V=
M#\N5X^:3'5LH/G;>7TC,G#L2YZ%(PVH6"NB<[^KYZ*3S]6G.$EU>8GC-5,GU
M'/AT:)>I[C53$6XW613"1RV8-,BUR;J'"X\:'3?>B(44^=/*W1L@ @;.W1=@
MF;7TN76M_*&NOF/0_19IY"/.<8([,Q#Z3O*LX#S3B,HJ>[VU-+?-O2.ZLXCC
M(;3L=9O3&N.D$\29IY8^T@8DG_@2=]P@.[*YI">#Z<$+4JV]Y*&A<1G)!74!
M94]IG@]21/;*C1!W8 =1!,FGJCX<G6]@)9Q=MWOAC5'I"F:<KWIY4KHY%=<K
M+O-R%<><RH";L>9]1.P:8UDTD>;4B:YZFV><NE3  TP'1$9_"4CV&SE9TG>S
MJFU% GZOI!@G22+US/HN)MU)# P,K&8,/G*G86S__V2N13<>/SVD[A^=[K-X
M*$%M5I; T&P8I1ZJ8](Y2IC&ZZ?YNHK9#[W!?B4'=*L[<4#F'MW*"??;SZV=
MX4<'<3A:1IBD=?SOW/F3Q>'TKO&[11#3D Y/>6+&XG<$XPIH=C^"6M!&^I&[
M&J]-(8LKX2L^,6)CL'^$R?%)$HX@FH*5V/?>L'@YODKRJ!^%/(GG/#DS<L4U
MPP+R3R@4(KXW@SY[OT;082$CI ]K>7-[>( 5IR5/R40>1UFU\R&*\+\<-7(@
M9,U,VBEI"3RJ?B%$M7BBY0 OW0LZ[#OY8!UL.!Q9F:IV?4 NIR _,O?F+#F$
M][J3O@3&M,>'T.GLM(;01F^^\J6"SSL?3W-WV8R?GN8S;AI:+ILR1#%(R!EE
M+:7V"4[Q(NSN-^?[$"PS@'4(,QGC.K:U!NURQ<2ZU)?C:P(:NB=?;7,7R0DI
MJ=AY>B9TY7Z2Y:^=I5KL]??J#?B8231X5%WN\::EXXCDF6_$$6BL$]QS-M'.
M9Q$\&'#L,I%=R[(U+F=;ZDN04'[0)YT P<$0RGFO:9%]_*(>+Z'9;FO74'&A
MQCFF:[6$(,2@7%(6U18S+<X98E@P1O?@JZJ;'-E# F]_WDH_;509)=5*]ZW8
MK=?WM1U[6]F55VX8Q>6MTJJZ@$O8\BA%&](;<M]+10<KQ06#Q'?>VNF2H4SY
M?9QU7%CS[A<37<A"L5MV4B$T2:%XNW/O\J1!!:=XKSO\3BQ^."OQ9EAWNCAJ
MV1JIEBO6*-:[-ZJ>?D:(LV#[ !/-?@ERIC>.)[AS4U]&B+G9W./\L7PWL^E)
MB]46Z4"!<W3PX67+U,)A[4J6V'.JV54*MF]>G /TTR<6@G3,1)LVIMWO8;&/
MW'B;[*E#R#^2[X&=OX:68V"7YNBI2FX;O\^[ILJKK"2QM]V]?O^YWVJB"O*_
M[__".L1I[%L_09>W\@G]&FJ0'YA$KV54[8@=5T-EK3=EKID]N?S5$Y^9FT:M
M8V.RF2U)25 MO*S-Y>.,C,P4YR-)+%E<M.+'LNTED\+UK30Z^+M*)N6[A\S(
M\7W*LCAX?9G=3KVARXE6)AR3Z?H)XG+?]VX_+\$7>[ =RO;]=@O'*F/V5D5M
MC>?\_97V\&REH ,#_N(@N7NE_1)YZ9&\!J:]DC>J<_$E,4&N:@,AA/*"1RXO
MPG?7Z2)BP\+60V_4!R]8]FUZOA26X';M(]4*TFOS#< J!P9BIGCAX"!"2CTR
M&(1J@R<3_RT4J)J'::R$[4:=8&(5F=";YMX[= *4CU3>RZC:.7\&QN\AU:_;
M2;-_P:M.@7 ^J,LN.5L@>+!%2W#+'4X/5P6V$BX,QXXLHA] M0Q*"\Z@)9W_
M3-^-3($QYX!JG/B@5BA@&3U%ZB/0;SZ>[5WGO4\-9&+#$K>:;+7,NT6SJG!6
MZ.FCDSIYDDJ*MVCQ;9M5>(.U*>K()5Q>SU_'45:L\9U_R]MB&: )3E.WEKAE
M>FU[A)YY?N5LOC1=5IXA;4%3)7XA9:4O=L^G4Y"OND[TT)FT-N*XF.;F<B\:
M(Y]=W0 _\8+]'OMRL/G$H5"9G&J6PN:2')/=<E)G9X=]L2U3=SMVNT#G1+_@
MC,LKPQJYWCVAX*7U%R^7.H9<-/+. 2[!)]FGQ-J5A_;V;_VD(49'"8+.#;/S
M"./6VIRM!>L[K,[:;^:Z>FTV'5\XO>MD+AJ^?1%.%&H1YUN$.=8YF\V4*E+Y
MGCO>S/BYSJ$'NQ\<BJHFVJ+(GX1VSF^SVD[455;WPS_K&'>"E!#IRV0W"3>V
M-3_G,'HZC=%38'-G^QH'G-0T[E-@R'C7FWJ.8AV,-Z(8.$ER\6=FRX.WQTZB
MLUF&$)HRI8/I32&K[YQTDR/S5'QLWFWD>P[PCA-@U&D=:(^Q/&MJ:\#(,X9_
M;WW@,M3=/!-GOSB_>O"MQ_YV!LR?3$A7O:I+3I=5W@2;+6:5E95YY/P<:/+E
MN+L?D?84+'@W<H[N@E%:> 4R,COO53&3],MRQN_3554S)PC+!KG7^K+4LG?C
MQ6?F7ASJV=LOH#'&#,FT,^.9% S=0%5]B5F*? 87:I[ZEIM9VIP_,:F, %']
M3HHWMX2C?F]OS;-L;$PI)8.=5%O,W*':C=0<,W]>&AZ.K;Y9Q?4*(]74\;3H
M,U9!;DNIWNYN;G!AU75=(E/P7;I(-"6F<5"(?FN&76_%.@I)D]?B(/YBD/V#
MUT_S:(?[=YX/UA'Z=E<P<2.F*O,[:/8%)U58IN,H952UV&7G&?"5*?<JXU@L
M6:17R]*68MB%AFTYS37/1)XM*:I]8;_3I"/S<6N0Q=_\?DB&+B$$2<V-$<V'
MY'&5-SO.0CZC:#D5/#8X_.:"#D5Y_\>\L/%$N@.S]UEI^E:RD19SIN-X*G4N
MM<+9E9K=L,W=O<<'(C%MBSPQO*E$W5F#%$'CC^/D':SF8M-S!5Y40V25XE+Y
M"6C][ZU8HC[T-#.)GP];)<+(D=T.TUPC]/3J;\F"W1R,2\)&)(U7@A2RLC*3
MHHWS*F(596@KLAPH"YS\'M+;D<M%4!==2W[7N4(1UMU.'9B$RXLH0I),FE,8
M!33C&<<D+Q$UI"YX=ZU8XY&,0W'>ENK(O6I^0N-I2ZJ\%3Y%%<G]I!PMKP39
MA)Z#4(6#N%*?NA4.FKO%#0&[?L+&68[T6=%CZ%'0OJ7')=$R8KMG4E.)&JL3
MHV1U9M%E%ERUUYP#*;_0?.).1.UO*F^0)\,Z$QK?5'QP[VF;=T'#3@!>/DK1
MGK\ LU>]7*7$-K07.\M(LB2F(:.PN=^1$G26^.4^IB9)_8>TFKZ1=9N.7F5^
MC:ELE^*A,8$.>$7:_8,\#S0EJ/7-*>_XXG=OHPO)'_HV]6]1'#%XRG^A?H\1
M<+=J%TF80YS_\:P*[WWOJF+K$;%@E:='FX)6YEE9>>F<2B.9GZ7+ZQB;;;O>
M_.W7"F_;# <%?DH9/ORRIDI/%'*7#RB#RR5GZR=XP);L3[\,T/"%'/''T""D
M[Q<PH:D_Q>\D:]*M)GP-7P*T6O@*ZR+R:+!/:Z<U[ZR&9[^V<1*YU4RLH>BL
M[/Z:X\^SNK^N:UK'6.VK<E2GF/;,P8='IQKPR)6=FT<HUW,**=\V[RBT$043
MC%^K]_T8;AH4]<:*&/DK3B&- -ZKZR3)PF5B)@BQ#G*QI[B9%.TS>@-,KNI!
MM ^%"*!*;(.X' =&3'P3E%!Y!U'Y$B+?03+-0S;4 'F>:X:1&T>V1EO[C01N
MUMR,I3Q<(@8A%:-6R8VOEQUHO<F>CC;RB619M>@]6B'0==![G0TX4^Z.TW+U
MYP*D,42XG6J''U5V9.HIL"!;C?,=;*_&,0ZPKHS>:,-*HDVZ#H=-ARGAD/,H
M<YS#<&E7S][5J2N;ZGY]%T\'KYSWP-XV+WGV>ZY)J=4'JUFTQC6NJI0%F0]2
MK01X"Y(522PB>AU/SP$8Z)3*MM:$N<K&I4ET".K:+\",#M'W3?'\1P9/\NFB
MXK\FY=.V9*$/\6HSX3A %QOO12,DBK-.>KS9*#KD+[G.LQH183T?<]JI?0YH
MEED<'$JN_Z#&%/,A9:6WL1\OWE%@>939BT^2.W\XOI:)Y_#]!,N&,\'LE]9=
MJ<H7G:FGM:5[/=N'Y,[CG'@3E1-=CB=;"_KQ\^M+"1"A#Z%"\WO::X<52Z%+
MX["Y(.T<X/14.\SQ12..@#9S\PD?QFR_\WK/1D)GOF5MPEN9^?G.A<J[\UGY
M^]@U_<_0PYZG$UA!3T%59';:%"MK[I?3[-NB[/PR]P/<('@N A),3-[A/*($
MXK; &UGDZ9\PW-D*[ ^8@9IQ\AS7<P[<V:D^6BX^Q^L>5;V>#Z_9P'\6G$;.
M.EKZF:XM/(7FSC[#&[IR)?^91QN+9NLB\NNI,F;47<WY&6]P*VX6R>3938FB
MP!$;/QNJDP8]=Q\HR(*MBK0P^+*<-&ZXFU--.Y&LNJL134E';B0'2Q>Y<UB4
MUAAA(G]PE9;%T!(.:@,2QNY:C?;)::2][GK_W@D+83*8FH17_'E8QF:HG!'B
M7GY(Y!Y]](RVB;*B<'QL>C&?_>Y6%_Z<9,0TOI-*>_.Z\4)24!-+=(>IG1=I
M2Q4'AH8NZU8*KP,;OTU@I[*H"8ZJ2K1)7JH,=D5,[S.*%_K&>=&6SKCZE<\&
MBZH4BL ;J,FT0)R6$<<G1<@-XWV3+O>']!CNA$4XXP5&Q_NW$ U^#7^$0;RS
M='"G81#/.]-H/(9;-JO;;=/9HI;[<^YX/)$)]2J?'1[RLXE&JB_BC5O/U;[:
MR[<$>8B$O[1>%I2[.5?H/4,5\C#P?5-MY'&GP;V.^;('UT0>(>KGH5F.)YE,
MIJ5[/7XO*)^;Q@'2U'!L\:[UP$@[]LLL877\5.F+2SUH$M3<PIR)HS@0>Q0F
M(+7)5+[^0D)3BO/T5)!=E6YNKP='0)-#XG&"X"/RAFOWD^5G _?8JR3HU5B3
M0]THHEDYUZW4"J/MJAX?Q]+=Q<QV(;2LG>RXE1B=I42;U>RP;MJWTLI]PX+$
M[R-I&IEO5M9]SI:L<2EZC&P'//S/*3E6/'0S7U7LL;ZZ9M1P&)=O*BD@+:Q9
M'&COWUWK]T[DD0OM6<UC#Z=!MHO5HI*JE$KR'7OL3&[0LF?7K) VP7<CBQ^?
M:U)8EYG$]_! ;/O+N)TRP2!I*FL_UB2-CR8FQHM;R>S)P.RB@6'9/*)/=[<4
MI^;8GK$:R.T;5=FNAS)5-H:$2K<OI.>1-[9;GM3!W5?U2"!/<O(6.QNLXH^Y
MPSC.-\=[BN]:A!K@VD]IF;3E-K0,.;#.8PK-2+@G(X3GNF7G]&+9GXK9/3A"
M\1Q U)$[@:[V"7TTUH=Z_8;9N\.!5\H/TU3#$PLTU?UM!7I$B"-GFI@UO.J"
M^G?)\^GH.$O:71@ECZ4\S@&.GB'G@'J1S*<W;H<=EFUP+>?63HI%%\NAEWW=
M'";;R2MN06XF2@P?TGL#AN8VW--R4D6%T\C50D&N6K:R\^H/,#MM6Z 4%?8N
MI A[FGV\TS/\=4,9UZH^^[11(6'S<<TNLNEQ2U1Q=%7GL'5*61@W="I\L2+6
M.+UBG$D%+Z:,#JW@*21/X<$;%V&QZ8H3$XXVRUG"I/1/A$I:GTUP,# R_(PY
ML9*XL[;S=_G-#)>/-6G/ 4<O[(-L7F!^5+5E/NV@&J^=I=UY'3>B:OVLM6!U
M>HQ0/VF#IRA]FA=J[C_I2V;%KWO672?Z__#Q%D!Q!=^;Z,1Q=PT6-%AP30@N
M@PXN@<%]<"?!?7 (&AP&F> ."39(<!G<88*[V\O^WMNJ_?_W[5:=6[>JJ_KT
MZ>Y[3W]?]SF]1EQ11SDM?-@>!S(RA31I-:\[LZXKN=PM*CJ>1;$7O==0?&_Q
MRD]DWC:.7ZLP0T'S\^%<D:>2(U-@<JN2:RR'46];%Z-<Z5*?5!@AZ:_*18KQ
M6PE::U1"02S-7A\K=:1A6EM$0@E5/>]R9Q;'H@X''5M)J+[[\9Y6SRAZLPV'
M;6JFC6V&N@"$J>B$U2YL!QZU6P/+L&CIO)V8T,QB4<5:KP)>FM4PB@@P'#6L
M*DF[DG 2&BZ4_I$LJ^$B2JAN4@$2^Y[!S6)U0NP643Q5-RM[7ABP%*YHA%L3
M+ <7MWW)QDB9'>5=6[?J'R4I?]#>V[LQ+F>VII7T,#+74Q"R]@08S!D-D"3)
MY%]>F]@!#@\$6V;_> ])?P8/F'/DLV_9F:#;<#]"?-E4VQH@%#UE'E)F0S&D
MB_BD[];:CXRC#PKPOC7:J2EXV2[D7YRQW7(G:+]V;/T$>'=MTSC!!%2WVPNN
M?TPCFFBB+7M,0, C.L-]8WM7^0-OG*^GCO<*5+<GHE<GU7XU4CH<MZ3*UG?4
MAUMP?CJH45J$4[4BB@R-5:7][H1CJZO"?ET7RB*BL<M6M3]A6>-G](]+1V;<
M.6' FMPAMAO.H)TU];ZU*]$HZB*U8J(G0 I0W_& PN0V\,*8%GNJ51"W3F3I
M@X[I@7A2@Z9F6:F-LZB.]?IG[XD,O7J5X6GHH<2;%'+PQO<X85\Z/$<WV]:,
MG<2^$!T&/^OQ0HF/?LWW8\IKA#GM[I/A?6L0BW$C?D\S_6CE(A3A).'0O"3P
MX"$!YJMC?D#U>M+NRLM=D]6H;EZARZ:I2ZE!)@K\W=]WST4D0I#;\#(E/_U=
MVB^AFT^*$<"02 X,V(\T\O5$4C^ZE"J@^]_\EM+R=AF=!E<EZ".GS9[=MA?[
MVG@/,&,'>)6EN5O5=AR<=6I-O\ :O\==.3I*[LMGJQC;*KIV:*9;#U7+(Z=D
M,N6E&/Q-[$>O=,M55!(V R/:D&ULS9%TRL](7#_.I8S\-TK.+,51>S.DV!I%
MK"Z3ZNR$</,']CH(.+)K77/.]SWI!J15!B1!BI.6"6M8\7T"$%7L'<X53R*,
MH!ZA S-4L5.PGIH*-ZD3G6?=\ H>*P5>XA5<QA13"FG#!'U!;')E2L46@>_P
M\\;Y@F=T6;FXM9<]3P (Y%JK.&,-R<>XH#<V#9)JTYK7^P=)V.X",<]'%PO.
M<P@/0"*!T%WQXBB; ZT3NJN_:\?,#Y*XH:0%44V!K9H.(BD%ME)]5Z1O8V8Y
M_"W'P5ADOR@JK);O8MI_@-5SXA9>]$GP0P6[M^(<S"F#GW6^IHY0[%-$PM+F
MKL7G09C1(#;B]_6*>8%1M<"2BJ6AMFX3YLB> ^K\DM[U$W8_Q2FD"?[5GGOC
M>\]=QZK=3(U<C]SKPNS+U^P-UP%O"Q-4U7)N!\ :_A<QW[5OB(,*XJ-WKAK"
M4FS>PXSE@_C27D%=4X+-V(IK30A@)S6#&8%12G)+D:@/P@,97EILV9#[W;X2
M3^'6PR7EHR%=D?\MO;[KH3[:%'.'W<I0_V\HB9\^<C33,UU-1,10-IJ,7J$I
M^5J5\</ %Q,!ZF#S.'TY-(9OH]YN[[Q7#\1YD;DY<LZ]#YPX7J@N*_%ID)/X
M%"I<-(W-=;,*Y'+3# +I?/QI0GG[-\:58_C$G@2MXG0HO<Y]6S HR;)\C@BX
M9KBN(*J[UALG4,*4Q-05QWF&OV67T^,,O)JT5?SC]*Y@"/;)&ZI*G&*8EF6:
M2N2JORXCS"!/F2[[L^!M''/L!CO9)<S=,?3["G0@X'_MD$U-1TF)\W<;, %F
M7#?>^T33R#YS"-XID8IK0L^QE&!\=H_QACIQH/24.G.@7X7I]P#->)U>^,]>
MN]^>SRW\=@KCW_:G;__0P%P7PHK;YBY[:Q5?@3G(3+XNR_?;%B_6K>->>EGP
M@.;*^?1]6O&BG:*M$H4D0;%AAF#&<EY,A6;45%B9*$/,#+9+WAOJAH0$,O7(
M;)10E :'"_K-<JM?B/OR[=E[Y)UWJOD!7&QH5HT)2E4:+C[V(,25X$:N;JGW
M_3#F(_;%D;/Q;$+?+W:,"[KXF$\QIGX3,S?BW!>\.[I59#7C5QSA]/-:UO@Q
M.S,OI8;M!5K$=$38BWCBI JBZ+',#K-#^5SX@MEGC_6\'9U2ZI,4#DEMTF=Q
M#J8<#*KU2'#K/"1Z&I5>HYFYGZ=@L/6IB8_*[RSYE$0MWUZ-XTM@_-4T<<RU
M;N_N]GP,=F +A8I2_?S90Z_H!]MY7:UM/(3&+.1B(/09/-_%5<#V33UJ2J<N
MVQO_CY"34'=VY<->7DDC*6/_IP5%;#4GQQ=ZYZHAH78R%CPINPP:FFU=;@*9
MX\D6WL:G@EV'[:,^S<*@K<X?>2M4IM>]C=_,?]S>I@CM?J]'L)]N:!*+!]*$
MOEL@?JR\#P_YVUR\=G[Q#PC,,]<.^T=.YF00[!B5(;D"];;[[4F1::E/@'!/
MT;E+12>:3JNA>Q&GP'2RBJH6^"!+*]\#1 ]US>[<^=!9C+EU'TA*$4U4W<7O
M>+9!2[=Z^V&HNF0WTV-RIM7?Z12RHQ@YNK5WG03ROSM=;J1P"<3V^U[2?-FV
MN9 P&<=JW6%<NZ]SR"5VWW9_<!3()-+:8&(\V'J?LP0?U$1>BN4,HQ,@3=K]
MO6DEQ/L.);Y>?=?,(7V/2(,C%(VP_]GN'C D&7./6SM/_A]V..WJ;@3][9Y2
MEDM#:?XY:KU&+))M4C45C4==CDR6C?_4'#V.V;6;T+"0/5V@^> -^'ENVX*W
MGA'.?-?)B1U*8B!ADZ!A-%2Q0(2OAC@VHA M];,!C;#B#*]"U.MGQL5FG+Y3
M>W\?(\7:F)3U_4I<3.\67 WB]Q>JV!@96^9N'&<HJ(JK]\WC'_B/M_FZI?BK
MU E;X(0II5"*^IUCPZR_T.*6^9'+I5/+J^S7U%G">,R]L2)$U4($^<J PMY$
MTA)<K @4N,=47%@N)L:5*JJTK*LJ2>-12^+ #J,JXT0-^<[&XN3D@:+YCKJ.
M18[BW;,XC2&7]I[,&*0_QK#O8NFZN!78^$(10K6=7YYE)>YO6]K&!9H7E2I.
M,<&?9O7,;'78X+H1<K3<(_-N[*IZ\VH:9#0+,U+I,=%3 -(()8?-97R"\^OE
M[(S7@_#E2"&GWW\<NE]C6WX6V2J0/K6-U-UVCIJ6L77V\Z0=C+)5PC02L[3P
M.=_UH]!_Y.?WK3NB\#\;U^T$WUE]!1/ZGT>JTSB<QA9PJL93R,HE45FWE0XD
M+)/X_X/'=Z/RWU+)P/2P**')D"E8RW6<85,7$6/S)YN"\&[@CLI"V>1]B6@S
MY'6/5'A+%+*VI6S(M\VY;.O8ZV_'2 8*5Z7"+ZY]UU3B-#PX!<<Y:-S_LTRR
M=D[FV[*JUHJ,D<T(DI_/3-$VMHCUU13QI<J.O8%WWEOX^E%MMK"F9'X=C$89
MA?6Z8:]R%R:M<9V32L]FL/NP]=J-"__GADF.GD6I@U0G3CYMP6_K>K^VM[SZ
M,V*EK>V*)?SLX[)C]U;KM%U7^\!J#!7J7@ZT)DLED;3-4NZ!6TI:C2F+C,N"
MWJUSC*Y^(I,97@G*HOS<E6'I%@X$T4NL#0WT*M!X*R3OAS^)/(9>[VJC^J>(
M>(E%8<HF%#9%/16"[J"8:K%H]LY7NZ3Z[#2R+:!>9R1.SF[Q9=]9K*Z/OACJ
M0&/CBBWC9^J::&FM7V5>VN;W2\H(.:J8<+J*<IO^,6GTV.4TOL._0M/'@)!,
M4Y8L-@P.LE-&8OU2'M&60[$VH"!FZ!/ I45S@!56P5N<O.O($RJ4^[GFDA.Y
M8/7 _+R#UV1+WVB9F-1S'6+K=GQM4S?ACE1TYZNV_JWC=Z+W2DU;_9 _+R.J
M\MR_=F0](J(4-FU>KD_Q-PH)&10VAW25&)-F0_QK@V.)3JZA_-VK,[GO5@BB
M-'41[NU&4'^3'Y?S(*[HGGTQ\B? C:^5I8,I;^FZ]I1E\FG2L*?BH:[\3P%?
MEPI*9-A@%6*73/:LZ[R^,V[SAD9"YUQI?]PC*O/(^5J\K'PI8(ETF/$ZLDI/
M)GOX"3!^QQ;EM5+YF*+B7?18$I'4RWE!G=-B<(* B9,WWWRF*&>WN*)AH\]W
MD<PCCUHQRY<=) 81K@/+)G/?6SWHX#\!KHVJK$BN,=*$.Z\,H%B&?8Q/@,)+
M0]8'S_.&8W55>YW-%2M%X5:[/#;'_6])S>SV5[*B.CDT^V8<><U##S 1IC\Y
MPKMM!2!\?'\C[2< K"K=#SC05R23X0;"51(DR40%?7@"R.;>!98'?.\Y'*H,
M.'"389N\OW93F:])\PY+@A)8&80ZT4F$"00LD2\=%L69^GZ.EC8[OFKL0(/V
M5V5D"<,J'0RREF\]$X3V) -C>SM?U$JE'YWL:OEHOB\?M-,N^*!TOC(II""!
MO$6^:$OYNR\.C5X0BGP";-QE*;9*XJ1%_0/LR5?%.\_ K4-.ZQ0(CC[NDWY7
M&MM[QSA+%2$<3TWLQANBV]EWLG TP2H:B5W^0.DJ&94K455\_IYU]2ZW)T#T
M&N=Y6T8V#[ H(PLKX.JOX6LD;G5 WFVP LSN(+LA9U3*Y:[^"5"\>GP=J;&T
M\N8J0\&3V-&W9Z]:M[)I^OM^M-$?C7N&%Z*)HC!F8<(25SQU7!*S^L$J?%HM
MS?"P LQCRIZ"ZHFF9(A7EJ,@9:2,8M%*F2?SO\&,@-AT:?59B3P!= X4XY@Q
MJ\>['R1#>XK&-?:GKKSBTJQ4_4MTW->//+;UG2N_]?)6YMMA?NM.2ET#'/YL
MPL=ZM@@^(4R66],FB.)1#*5<;?QK//\QH__^;MB"G"&N1F<LAY8 !JMD8R\K
MK2)08/)64')8:NTD7&OQ.E<Q:>T]('68["EOU^9-P:XG6AI,"ZWCS>Y .%B,
M9C<UAQ"'IICS?*?!YI&?+*:.K3]@U >D4%U6[#B25=0PA*IIO*?^VZ4C]0V;
M8AU$--FMHE76.VFAV7Y$2+#NM^RSY@ES;"EU$\GTGYFT/2&HY&1", Z7JD7\
M.<2/=?4&1O4UBW !XV2 XF6(-)$M]/7"H_>!L<"T)&V[PD\AYI3@QAL#]>^<
M^)'&]5";UPU-#\I7?+'&9S2]*7A5Y&3G<CP;KH;3:_J;&X9>63BXI*UW69RT
MA"TPI4[5ZZM\,)4OS,*\6MR09F7AFE\5L_[DVN$S,(=)!Z%7,SEB;PJ=_0.4
MC$K6.*-2LX45O'Z?:3X='P++"K!04R(G^F/K)FTFI9[/CU\A2R]HJ /.D[PL
M7_>PAMZ!^*6&KVQL.0^G&'==QL]U]A[:2QZ+<[IOHVTFG@"[M,67.)-:GY4>
M#IE?G61QK</<A_D*RT(2]5*I&Z\?R;K?FVO0^*'0&AI30_SC/D'>QVC?@NI[
M\@G,N_@E ++KC-9!AX@P@.R7GN5%B='?:\L9@3F<)1[+V.6*CH;+/#&JF?.^
MGC8'(#F"TM5RYR8J_J6UXZ1PC.2[,CU6):8XO<-6&M/_;1OYG[Q I=G[_0P9
M%?!$"TZ6Q&A0^CV/:/:PTHL( K\G,*>7$@%F Q!1:/4NB[Y"FS4.%B$M7CM0
M0^6ZL(20+&_?N06OW$\;]'7/9;1<"@C3Z M:A_8"O?'Q![>N%3>EC]C.NES[
M0F4[%XU^(AJEF$ !*O1+[+;[XB?ZNS?#T:_'(JG&YS'31Y_U@O&L/:F>L6N.
M%\>)AUB]=I.O>4YY>7O'.5N,_3E\#($HE_9V!N<8PDEFR\#<I\7]')$$C/(?
M\.7EQ&!]GOI]:.^_A,W4MQ"('!4_8'UC8YN\RWYS]#$0[R&@';/]$<UW7.=2
M!)=F5!JZM?_O7SZ]L!9LO\7U87M$?+J;D+R3-(%_E%O.Z*P>"SA_8Y)V)HZ^
M_B 1X3L.^E>ITNM<_K%NXU)R:'.L0V+%F#8SX2J_?-^>MOW9_K]2RZ\IMC #
ME,DS8G\[ A'7:?$ VKNV1W'T#1K9]RGS:F;Q8-VA0@5(H3RC9P<16I'N7Y8/
MS*R*_';RE\+Q_23<[UFU"FE_'3(LCJ78K=^C M'JP@J(%O<=J_I3MH+Q^G*.
M^\"OR [8/YLJ<(J-_P"%6KDEZEH7VX7(V.EJMT=LB["O^%Z2"Z.N6$^1"?!&
M4;=+5.V#!SO(7P%L3GX"):DW_1S*G0_5_696$33$(O07\A-,P*X_4R ['EL:
M*5L]2K4$'T*[$"ZIASOL/@X[+I!J';RWM*&$G.SHX0V /3B\4G[V72L06;-,
MD=J\+;9/$XHX??:ZP$Y]1,9UGFQ^C]D]>L0XBFMTZ)/'XD%"2ZMXO#UR8HRL
ME\G2OY%8+SL+DR.@XV]7DBU$/.$5=]>+>:%5P:]7$:8G=Z4R=OB@%A*J<PA-
M1G<'V8,%=;$%T<)*(TKFHX\#R1N6[MC^SQM*R9/?]=^QZT^Y+K8+[>;XG?S@
M;,_[BN_1V//Q;>0W/;(WVRI@??XC(##@A3IE5[EF\L79:/_R67^T1"=:6D"!
M'*[='ZW/:/.D1@X(O_=@?:;M+C9A6 _P"$?:V,=]*^"+AVK!S2523$'P'9^'
MQWPP\3="A@?B-6RU'[/CY29RBBAZ;,+FXQ0OS]][@W=NZ(.Y3M#12 R6U4!'
M.3EGV1^&,TMBQ)1:1C,;252QAVSL0D?T7)ZM"'$O5,I8X8(5C>B=_2;^U&=G
MB1A/]%)B2B+KF:C)L!_7VLXKC-+ G"H^QJZ)$^\90127D#V']>9!9&J?U\M5
MIL-M9V9L&)_LK+)L/D]_Y5II1$26M49TK;TS:9V$!SV:$Z'MU8L6P>HJ,W;&
M%(-NPZC(Q371=B&G,A%;,'[P<M:%\::74!\5@8<0&FZ28TLZ STNH%&[?M]N
MOM>^"G_8+L&W?-PO06R:,&1#)V A%ZM["-Z]HFMI,HO#82,LL($C_X*N3$EZ
MNV[=5)VJM@+?2ZZ^/YLB>A1]6NATIP3ENZT)\S5#(M_4C#SBJ>7'!"]0Y0W[
M,L0XVA82.)=6@G6&B?'][J^-A<?2^4ZB18$\T *_FBZA-XL0 'KP$;DQ?EO>
M4"F1C"M%H95/\L 052=Z:2F*60:HKI,KCBU&,/Y'E5W?>62O(.F )N0_-&;<
M6\$D03L5-F;.QT#"&L%#=9)3&,[R@:$9FRSH@Y_P6WP)S'&JBL-F8ECI#U/I
M>3&B,*+PR>LBHN^3^%N97V3<RADRI+OQ:9GZ=<BV-;DBXF2)U)=[[#9"Y4*E
M5 NRO/\8.[]^UM:T),!<^[HP+XAMMVFN:BX9;^/J'E]"^V"=0'51KOG0SAB,
MOS1EO*?^/\*.2R-K)'78QULY>$<YA@\@#C1Q#1:%?=3C7[X!S6-IE <P!!XC
M7Y"\-5>(E]["ST?+D8/E\W?4(0A:O-Q:8+_-JZV,:7$Z! GB2'&;5]:URHQN
M=];&2D3*8:Q%X&A=5]GL=Q9-<^"</\PX'J( N)U<@B.Z^+,P?*%#A6^1O^FX
M(I>V!K>7*I_Y]O=\R4**MF[Y 9&(HL=1;&=6UT<4\;MY#Y!&60OD/KG)8^H6
M7AV0/;MX^;BD0PE5,1H]-PJ=[*WGY]LMKS,)*G/BYV0J'-\_R)+X.$X*J:5L
M&^OO/6'K,]M(C\]I<YF]/N#Y6$.115_7Z$%*H-]^A%5@-QUILV]3>'T?($E1
ME 3+L-Y;TEK/X_3JW'+E"X#W[%?")UL%+?8'V4PZ>U;'YT4-BDLSC/RDK]U*
M"/G&8"I2SG.[F;CA;]J/["N*HY.E91!G8@U%%+&[$4%0UU4VUVGU+E>0NK ,
M,&-B/UF3+:HIN1AUOV"SNJ'$Y:U'S?8$F*(M/6&X0GXYX%'U?'@"3/I2:T_H
MH$LD[B\$3PO4,H8A&S(]:Z]C[+Q>VFFO>U-I<V%VQ:=ZM2Q\%VOMWPLX+1%'
M5H.(&?87;3)\K:Q+^)7<6K0CWQ73S_Y1%.Z<%J+Z!UNG'A-NG0AUNM:0<PO'
M:S-EZEY:A3]K?I5<)?G;IHR^-OEJ06<%><FN;(RB3J[4<0;>PS(S/Y:GM%-4
MALS0P^#A"&SYTH.!KHUC:LG[)I!GI5?RFE(#J3ZUI.<30!7"$M@\%ZB^OZ@3
M?NLHB!G=I3']#YKZ'@DIS"TUI6H5&[34VVO/.LA79>6^HHW83@[SO58-0LD.
M4L;\4!\:=$X"KI5T:</H838GK8KU1BE-BFP%D<J@U:-K.RH@5TU @M%U8#E$
MR*;S^( Z*6I/GTGG-:PL(-T-&'J>V9S9WM/4!E_PX>4K.P)R?VL?C)I>HQ@@
MY[O>4]>]D''%F!^,++)EN^6/Z)^A+I&CC?6!&7)2/@&"-'O4K?C_F!"C%^98
M=OJ>=_2G[1_K[!J:5_8>8%316CA:B'@1JI+,%!<9Z81-9Y^VJ=KQ4(GMB-3\
ME&UD]F9:F:-0:?C$0]5CE_ENM[_&ZGLT0H(R)DA5(+:-F:*@YEA(9^UX)V]+
MBZU<,_J(GW6]A<9X^A;J<)![=7TPB7_GQ\:R?T^6R?QKE4T(2"<Z'I7B_J[G
M.",;GS!41H[^N"W_YK9I;_!L-*>5<>H?N#]/ATIGWZ<J(J++1,EF!%NFI('E
M7?3T[M=)^7;2"DSH4GJ$UAIR/,0B_&VW*9I;%\>=S-6$'U]/V[)Q496G^$ 0
MQN(1R^WBN=%23.1,DRNN4[G_2<_\OPI5\/RHL^";Y\&-([\X*O>@_@D4'=.L
M)];D')$\'W?G6/C<OY,3O FGKE7T%*^BV\LT^WE=C<7G_/TZ,)!66-50%N3F
MW P"&0JPI^A7@%SRV3M>M#3")5^!O$ZWU(75=+F:+[::Q.O^9W@-R9V2/-]8
M+-B"KMKTFVSHA_DK_BBSGR^V7B,[UXABG%BFI8]<VNC9_F)I3+(D2?PXX^ZA
M+AQ<S,C/GV%]KDT$:;^JPOX[&^9G&27M4V:1*OS*IX]L80?GA&QY-U*@_H!]
M4&NG;4C%C2.3IW>5E"G,3__QG8PIT[B?-I<+%F8FR_2P"U*WGRA,H4R^T#=5
M,>Q3VH0^'?_O3Z]. VQ0OJ83O UIQ42+!M;'@Q'-EPHZ&!UBX5+A O.?5JBQ
M9.+59(BBGRM\?UL04T@+90R)UZ83T^#R5O]M3^\D;)!S%$/EOB#*9V;:JF/3
MV(QN-C8_U!])HRW(]]-4A<@9^=-V.N2X+@;=A*YT&D@&8I8.%,&RU-F<IB[=
M4LQM$,]^IQ)OHU%H6L07^<8W"DQ\PM;:0T<#NVH?FAX!@4Q,1#+ %TC77<W$
MARE'#5J+#I&3>K9.B&W;0T<]2HM=6.F-.#@@C/8P@5E@*4WXS"BT!U\'^01@
MO-AM'2%K/Q^;4NIPYYM)=W 3U:E+N[1>D"#6O-5;Z.B\Z$50>VWY^P<89X09
ME=P^QD#K5)'>$4^ "8\+8O'.W!L4-'HH5U(G+3WCHC&1^H=$&Y;J_8=&6N:+
M$<&U2[_;-\$G*+@)QT^Q1JZ]]:]9@2O&V)-0KK_8M)7B6<PT 3V7?PD:]9"&
MM8M#/:%OD!.=&^VCY?\^\V*?AX! S]STC@=RA8;NO95^<;]MWW\\=Z%N#(KE
MY]DA+8#N?9"2QD6[M#1R>;X^:!M@'!"P)#A51&I9E9U_-BWSN.5("A\]&TB#
MIZG^+D9Y,OP^]P*O>GM\>- X1)4%I%T^ 5!*7>>7%T8OAB0SQ22%%5(O7V/T
M=RP!^$<),FF+"1692P<%"1PRQ3XE2!#2]!J?&2^7;LK(7+/^$I,H0>#HN@J&
MV^Q[OBW>'YAGDVDOWV?HGUL06IH8],L7<1,Q!21*%\92GW0] =#]U/%JT=]N
MNB6S@(Y,*9>? %B3*!LC"PF86__&$:3UXDW;/_KN(7[R!( H(58WKENLG1XE
M'T?G G!K6_[?/<XH_QB*ICW./D,O]?CJWQL#[  N&CT$!;>?E'#%":,\RU<2
MUP$,6>S2*A?Z;U\X/<-"Y%TVSX-?1%J^2[E4IQ D2.M(W9=C51>=CA(LO(1C
MXNMW2(;G,</3X,HM&8@ ^[=S!U21/QG###]OB^I_2WQ3]Y79TX-[K%E7EJU^
MV(9BNSP!) P4WO*:!!Q6CC@,;-X@C,/.7 L2HI!XBDAFK:/: 9%;Y'1)D+]6
M-#\.A8>/R:&V#XV]N7H)EE=&[IN!KG\+J!8JV=BO#0EC_NNUTYNZ?ZRMQ#3.
MSL+$IZEZ7;7G56]Y(QBM^F:@7360R*0&%Y[6[63276JKW03N]\I_B ]L==H8
MPR4SJ8%>.=S[/,=09X.LQXIU-EJ5;X'&7K[5S,'@0\UN,YLXJ9H,E5$M+3YR
M_\*3"X5M2>&NL;ED7QYG"_W-.LXZ&1T:J<IJ=)%9R'+9P5!H,PT8E%QJ//FK
MOAY]^>GQH!/Z4>Q_%KV)X9J3NVMX% ><R-RQ/ $\5A _:+@[+6@/%Z[/7_22
M[@<_+ 32?/W?;7OV3Y?Z?],5Q73Z%OG8&D@3I-'[ZW_1Q_+_IR_Y_Z0/&!65
ME7\:O5FVV?)<Y+_R6J$7C<].!E(-Z#X[N%,4VYWN47XI+_#=81DKP.C *DW8
MI0V,X]X#[W2$[?S(?#>"2;P?;,3*U'_<[>67?48)E</U;%\ZGELZ8AA?=,[R
MC,]JIT9DB/OVMU,CL]%^]GGO_B<FZWF<V[C.[S2Q2AX9'.'">$C/6?8^VJ(<
M'QT%>[\</RS&C)G3$WV0F2W(;26\.:J1ZVJ!MK.N+R]5:S?B2$WZY\N(X93W
MT]P'&[$QA IO"_B\?]E1D<"CC&69V4%%DQX,?AL#%WW<G<G+%!Q??PZ<W@?R
MAE.;*'U!U]BS+L%@"E7P4T,0SEI<]4+II.:RCRMF][^8H]/\L(*\-HN"3_ ;
M;N^<_VE6F]#M:'@4,$;AD9"<#M'P.-#RT95OLI-7)E>B2ZVSM('183QH(Z[@
MF,_21V$8]\4!^V"]0Z>(?4=:</I@I 781.!2U(+W9=AHNB_F,P&AI?7AY)DZ
MNI=TD04G"<_IL,S,^/%;,+T6EAY5*%L>"AS0?VK=P1N@_#P'M0"U L<OW<G.
M7SE:[(M+Q13P;UC+N]92X#I\0&TX#FA5\]-1@Y5O$W6: ()]@!$#-)QJP#")
M@]8=0<_A,2\'CG\N#:8*)E17SR;V=CD9+$Z0V-861!%.NS602S0!FY8ELC-;
M!9D?7T,>4YRVNB[N12BX_(LEJ^4L5Z(Q/&^*=.XNF._J?/N%59=D46-WG(&)
M*:B4'11H<J$+LJ\:*3R-20ME_0V4>&# O9+OK&I/(RR1E#?\O&DRD1M\>D-V
MQI]?^ZA:K%M).S??7I@6^W<!*-81YG&4:T7S-FDH#I]T@!2:5")#[M5)8X+\
MG7 9:;+;UN/7?)[=_@20--'P6SD\P[="KCEVU[U!?HL*#&O8@#XR48YN #L]
MM\;$V/X^0-__6?.%?-J9YFVC?'BE<&_HKLHIX8!6I'&A&9#DMWUU3?=I='JB
M8[3 -^Z?(]R<&M79VKT)BVQ _'/ZZGY(OD6@UQZRNQZU=;:#+$D-^>TV,VMW
MM?&R]=7%EL5RX=6=ZZ/YU: 3_/K^YFRO $%U8[)2&:;?-)F:?OU);JY,$L8N
M=O$$D+K"'7U,--$XSNGD)-RXSF\3.]'I'J+)^\_15:YRIL=#>2.2)L"0L7YC
M*I<>=C^$E#F]0MTT3<*[Z>8P&3+#)RZ#ALJ[*:3W#1P8-]5^\Z#]+4E1('@<
M%#*OXR)/%<8FKV!#"Z:/!)%=BJXQ=!O=WB7/>$'M_?L/E.8R&XBH3M,(RBR9
MZEPMD(3DX3;$?5>#XA'* S9@!S.H]+EIZ90U*0_QTN$5Z_ [.Z$^AS@ODWGO
M M8K2F06H?>#TKD!E M]7U_CI/@!ONZP6HF;+"T5;I%KX)5KY<;[GY0BR61P
M=0T,/#&4PHD'].+55J:5/L]+[7#S!;#,V.LEC!.=R(8</1M1+T^(HYRF&>-?
M\]"D3J%2MW?DQ>2.<]B_NC4H':M1C6^PLS=X)VTKCV)!2U(7P\4O\/D<$OZ9
MCU,*_7K1E>ODLA''\>5#?1W<0R8"CRG&]L_72/'BJ)V.'+(M'VZV@A"/2--F
MT>(W!:&/[#&CQ#)\_-L3'O)]^Y@@[RAP2FW0;)3\J6I\K/X _'B]O4HO!_^E
M9CE#GNP5=B(:M_@P^SP"G4O)%7'R8.K5NM&*.^?+KL#^*7ALEE%6FC&9'-ZS
M6N.\+#]XF?,E+?%MU+2TC',_/5I$%_;PQ[T'![^EU-:EO/V46%5QBT/FV)F1
MF-E>;@OY?O)%K 98F%SD3I2@W!:>>3Q"B.Y##Z&8!3M%=5TU>9<NEW7HYI7+
M!G3?Q"*FL 3[-7FL7@:'KBMCE-A0/<<75<:?O=Y]-W^<M8J_<<L+YN,714$2
M8EP)VY*/;6+$Q1W.#>"7X37&[_GJ;UXSQVHIH85XQIEGA5C/]GT6KO'32L[3
MW3^FW2 O4I?S="_QRKED*$5P\:^=;8PU@0W(Y\!<YU,([@J?<;L<'N!'^0[;
M7E;UW;'OV'S^DXW=OHHT6M]\#;OJXX!\K)_B'=Z85^B[[M5@J5+ DGE>'ID/
M"*Z#/WHHL&,5ZT418\K@*&!I)^A1?W/)[M[*7FW]+9CZX)?#U$T]VS$D;+"%
M2=-5O<?[\5/%]G.9,R/\3=?Y7_TVEK'2;MJ2'6_HB0SI$V*/!.-]))DOMK;5
MS"G%Y[A(<N87@PGZ=HN%/HE@&$:?U/^.K\$S-VWGD;K,EQ$=W$Y0>T&8$X@-
MB\H'IG4C-W*-<'VPD_?+DY7<*,3>1;D51M1.O0^0YC^7_<X@M+2A1(;LCN]
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MZ'"-QS?W88W8TJNDU)W,CXU"E40ON8:N4'C.)+HWT#@Z_'4G(E/?R^O]AN>
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M>>:8B'*LT&30"5U,7(M5U/&4Q?X@Z+"EF9O2%DI2#K\K-7Q^2"'FA"Y3<)\
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M2<@2&<+T_S_(RK^W?!YS9/I+,>;3UY\E79IV!ZBU"*99.WQ,Z&N,1 K^_*[
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M  '0<LQIC4Q:_*VBTV5J1G]G%U5/AO\#4$L#!!0    (  0REE>!EA.F]H@
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M1I_J_&D3AM0#N\-,U,U-?H']4#! (A .QC"TEX>^O0ODA$T$,  @ 8B3/P<
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MN]$1KK[XHF.%1]S/)>\*))?HI1I5B]VFEC+ F;5Z+C/E'135'^[8VMK"8A#
M#W[%DWT,J ^Z.2=>J)WLV%PO*UOYHK^K,T .8!',^$'8Z<+B&*;^TV=5S7P,
MHR7TJ"10J1^X![0G&O/477[J45-!@V3[361D:FN;\W6J3B.JVV%F><'Q3-JA
MLLCZ.9[%.:$PD=H8-SDYY:C5FG)_NYJXL-06V>GFR)Y=K^$WOHXAOI>E)CPN
M7 NJ72#]P+QSI9?M,0E;X8I#!2OC/<UJ>@01TB6%FX>:/MF'RVBYMG=TK5??
M.$=+.PJ9V4#$+7OGT%E;V[C;R(\JGG]#-6Q@3PZ%99?JMM69[IJS^MT.DT*Y
M$F P:.3VL'WRB'$*1X*&8SXT.J2Q,U6_U\/M/8U,K"<K=,G2+.JERR!=AL7=
M#OSP C&'E\*6[KPW)\DQHP3JXZ>=C,8*J,JMRUDMK@(Y/T#R(%6>EL,Q8T3V
M7/U@[%HR9^[7C7P6F9G(K'1?.$K8>@U<T^712+;Y,F,Q("D=$-F0<O&Q(?F1
M*S86F3(VIVWK3&$78DYRW>U:&*"C!8=>]2&(Q;!>V(67&\L%SW*BY1566'V4
M9K!27D,(.>M'*]KOZ6QPH9H"AH)C0+Q%EF775\?D\JKUNL+6-3>T>:6M!DBD
M@.5!HV;T5Y?&\7@ET$UB[K0* _?<B@\3Y6=O+#W7QHLJ\$K&[F^L9C@3DUR&
MCLQ\2GDL3P/2DUN>>6D1KJL5/Z25]OY=XYL$ 3O2 T,+O^%)7#(-6C8=QB"Y
MX#9)LIQY6ZJ/KY^&\FFPCGN5BG:1@IAU%4#)UL6<]Q0Q2Q_J:R-T(F^.@25L
M.*"8XQ15G$1?JW="*J(QOYGX6]7OC/F62;*;(I3%-B7$A=[S.A@6FA8+CKWA
M6/*MR5RM'?D2?<E]K.NYL75,*)F2;>?'^'4Q[D9($TG4PE- <64)NV/N4A&V
MZ<WPC%X3WF^PUPL=V5D@'=Y927$3+XQ'"D_,B]M#TBQZ]^1?]Y3>>7E=MM1?
MY&'4C.A&"NM+GWUU_@=OLO*:"_"&<D;77BK/LHXXVO-Z]52'4"*E8J=PE>?!
MP>6HO^U->?7+6C]SY[EIX-F^L0XV4'IWX[WLM64@;$47,6_B'%Z7P.PYCWU?
MGX'OTJ*C07R% <4H(+8L0"K1V^R[^^"WIY]:VI4I.*,UDN;L/]O84(6T.FME
M.1J6S>%+FFT1CU*$8O@U*&$>Z/L'K6UZ")+"<QR&?"P713,]XDGCAU]?M^)/
MDTC4V?^B3W+(^R3YM8#HHG94S1-VV7Z%MGYJME5;I]#J1;/LP6HIBCRE%ZUX
M'[J 2[*JEFO?N@  $'?_Q0W/8X"3$T-'9Z"$/DO^(<C:LK-:UF\0$,+Y/N$9
M%>?+"$ 28^#+ -/%9]J\5%'/O@1E?M@B-$0*&E^/5]B_62RH$2K,MDXZG/H%
M,S';.$:"ZPEI!X_GLP(N'P1C[?A.5_L%WW2&RS0DH%J;)]C3EP="(X.B/QS<
M%259%<3CCS'#O:D;P+SGY$IM(SBP.$?0Q2CG7@2,<V!K;6]OZVJ=;^MHPQYH
M\W1=M@>P3< I@)S5@*KPCGER&:9KY2O6+^*?L/8/C+)$TC>($CEW%QK;6F@[
MW0POZ@PK8LS@^BC+1=1E2>4']%/.K]HX]&G+D8Y\#(%L00AA%W0%+T#A$#(>
MV3O CG( +4TMH.3IAQO:BPC@,4 (TW%23W#HT^(3(CF6K##KI6<4D]B=X'(<
MZ_5 MW(&<9A899J)P>/\[%&HC6IR<@YTYA)GCH';E03 UJ,JWY"9M7>'=^!L
M;0'O=UB#R(BA\SQE?;/7CW@6RF?;.EK:4(P>0>VMLVR'_HL!A02U>R3DG<DU
M<J\I6_PVHQF2J2:LIQ;7"K_[!ZVLQ>W9=0BVVOE,JW(.Q8,:V!O3^AN-<7W(
MN]#;N  KZJA.8U45B+)6/W=Z(J.1BMY;0UF&J0/%>'E_KXM,8:^N=+N1.5TB
M6D7<O?HH<T4B$H=H!F89(D-/2<F$NJ9^Q]XHZ U*>=ONEG)BUK6Z.=2 [J>)
M^;QI^&&UXXQ5[^<E/MU]S)"!9"EB6<8E42E^6JS;T<6!N$8:F&!4PP= ;GP+
M3>'S63U>L>=%Y9FD29>JJQV>CH7UWI)>]7N<Q!5EG+ I7M;$+L =]56_0"?^
M2>H#7NO'$\XI$5N5=0Q6%?;O6/8WG^DO-1@6Q\GC*Y;(F[V\(;6+&R^5-=1X
MKU2:>E)@&"5.0&PA-G6?75PK:[N\6*#.RNBN=CENYLU"6)=G]P>*UT8F^#S4
M- D>2MWQ:I\+JS>U^H\!&'6F/B 847DVCZB3Q3.A(9 X#40/Q)UF7=3Q4-FO
MSLI8F^".2%$6MH91N(P1C1"ZF POE(^T\?)7<BG+4;%1OBFMJ,Y0QTCE\?SN
MGD<9TM)&8Q7^^CV)%)8B.9Y:HC=?Z3B:4>71Q&MP"8A(CJGI[([X-YOK] DW
MY0?T]KU/'Z5/=8'H3Z=/H]_MJCK<3T?G/"&JQV3Q;XWGO)*O07Q;YB%,O5B@
M>@UD6-#C(=!LIFT7Y<(]W)UY-64/D)(B0'?PBAXD[9#[J%JN*6-Q5<+A!:;,
M.F0EPW9=SRM]6Z=X12LK]G%10>,7DQFG47H_%?KX_"2'0:TG.))VW31)N=GE
M);%F8+%;43<QQLUCY NG<E-*DZ[I2\X(FM 7.ER.,DK<L,X;N<I<\ BK6&+I
M]42 I(P)V9<AC$@U)E(")/.JZ'(%SN)X?>4&G%]@/"#++IKT^0P5]@[(W(N3
M[%61\RV1^@G93/:Z\;R+N0WO99DV VS\C^P%3!T8$Y4HA>&R X+5Q2/C;,)I
M)<,I.RG<QDJ$GP1D?"KKO[&/L>[//Y>^Q>B?^4TB@0C%(*CH</"U'6&@268W
MEI=.F+]C3=,T$;2&KM68"TJZ[)DM1N9;<E VBLS2^+1!;?C%1J/LH>B$7V?J
M[6I-K _E%S,<$5$+=N8A8'ATBP+C9.W6G6\Q;J F03O_(&"S>(%J1&2:1ID)
M8^G:85V[E7=O=7:N8R>Q ^--8#,=5N^=(TZ"(4ZUS&*W +8:=F*V*3/GXAI#
M_9@/5AEL)02I)F\.&;E"\;9KY;BPN4:X-/BTWBU2/[__G&1G_L/+3EEMCTB
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M)K;QT@Y$?F/=I6G6@'"%(-I6ISW[;77R;BWKP/@<8\>C,/^RVNCIMO:V+WV
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MY/UK\:'OD5]G&[EQ*T,R"\WXRU7K:*([-.*^I,@HBFIJSQ%LM:YXX%[/D4?
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M#1IU99+-G\_85<4C.E(8QV.J+"V3EK@C_<%'T &U@^XN5-T*]+\!W)2%WP#
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MLK.C3ASM9W(OQJMM)2VHI?N[K.JZP[_@.$!,6$2Q3K+A;143CZ8V<6QCRRD
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MD#_RQB<-V@$SK^1E_:GYK-?;]J(?^SYZA-6*]6<FK&P_LI50!Z_^<L=M[<P
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MEE>R)I#8 &<  /6R   1    9S,V-SDS.6<U,7HT-2YJ<&?LO =4DUVS/QI
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M'@X3 )<<!X\<YW 4ZRCQ81..+-;*TSC'[4<8\0 XN*=.XQ,0$A&3X/SK( X
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M<*[23$S$C+^U'W[9._X"^F, _R3D^)MU?Q/"#F"%!/\H! '_DG'$GOF._8&
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M=M4*+#A6G$&ZQ$A0H(I:?<_FL'YX<;//K0>.4'P L]!E6$81MW;'^#!XI&I
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MBKII(9N^:Q[J]$_O:^LZ$\7=#*AJ8["GIHRHZK9X2+O<N=!A[5[=>_\K_O(
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M)U.AI6QJOT+*PW-%3@<S,#+7-" =XVU17K,J0O;LB1M, ZQH>#J2J_NS2'X
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M$I$<."N3\$ZEC&S(V[/!YF(9O3?AB+\M;X-6TFAM0Y7GM[DT?/-&*G^NH0#
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MCYI] C-^9SZ-:AE3:]@ZQ5G3<:V#ULOQ+][UP[F%5#(';6SW7X^39O!>J.$
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M=]$7XD?\+P&"HE](\D?T0) D^C]]P1 4@Q'PC_P+>OB)('_"J"^?/S_\[=^
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MTBV@9 E<M+]MYZ#YI/F&>H#)!S >F  KN-(!/VYF^RP3>AX]Y:S1B5HKBA#
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M4P-!BRUJ+4$+2L8QW.)U;U[XF5=8DDB0E+]3,!S93H*=AF<6U>[O5!%G0>?
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MW..CHS>(Y^CQ(QA6=5Z:2^/)Q3(BK62\+HF1YMF8'.1867_X4#,+(VZCBY.
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M7QY.>6!2HU%7A:IZ)B^<\2*%E:@K>"CV""-E6Z%]097-'90IC@;/XYQF054
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MV\+3C V2)I'1% -@P("C %)FI\USR20\;\7#U:3H LEM>]2DQ ()F!I@P'X
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MRS60!ZD;3B#I:#CR)L#XU8F;+V]XOTTO\_'TM<2IU)(5_73R^^;. 7'-G_=
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M&6@5'/"A%"^*I]HB3?"XVI,&\MRYX9>0TH1H):I7!$6.L&58 >5#WB)"K?!
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M("^:C?E%#FL>3ZN+6O\!@?[H>^ZH7;I*=4\'&PP6DH4MEV\6P@S(Y<*K#&]
M:@+("2Z_O1#F*(JD'9TZSNAMH:G:$B*AQY1UJFH-13^PC6#JUM&((Z3R8GI&
M!9FW48(6",ET8=.5N+[>*)ZRF6W5" ),ZP.=YN=E*/A;TP$ ZG X14RBL3\=
M_C4Z;)VZ0N/Q.W5+Y^9/W,RR/^JXJ>IVM%@K]R/?*=WF,P&!/P=E^F83<MYD
MI4K4PD7D8_UBKZ@=]*83,GN$-WT+VI9-RX&$<=#S#"H>?@8@ P3#29\1C+^J
M*S24'38)/9YS5@*;+I0ET^*!)!YM*XG4^WW?U ;<N*=OP2S&&WX4EX,E\;BR
M*#*#@TW\<:*&D): PS-)G%*O/]&6&:$/5.>IT#^/'_TW?1E9N'J#2RRST431
M_,PEKIZ1"^=JDX7:'&N%6>.BGM,J%]ZB:3&<!4-G7+ [7#GSJQ?LG5\[K1I2
M]=.?@[1[Q6?W3Q'RQX;'E:2.I$&N/V%+#!&&0+3\@ [F%%?88^BOZ78]6US.
MJ_*\/JS18AY #1IA3"F:#GKS8/[@"1I%*^_5V+XYZA-'H(PXE'E*+/1,H59*
M$U@E]=UD0'NY;,\7L*@,&?$K\1RZ'C D4%$,'?&4) \J!O3%V4'(!8H#NZ=/
M,>_4D;"4HL-KI4.*@<PTQF:<^)41]*/.9HQUH6+5FD/1)?,C[-!8)); J=9%
ML5+?.%_*KM3X)#1TL+>MKZX""D[A%4;+A"<U*#/A+21C1CCPE,L73Q7&U#;=
MINTI7E/7J7I"1\BBH1$6;J7"Q?,20T;"=(5IK?<"9R&V9HY\8EN'DGZ=_+ Y
M?]*! AKK37;F!+@2;P\O(-4BY.'!L1C:!WH6%&C"6;4-]0I%> $S%^?\S](<
M;0]57*+1?1:;?5 =W8:96QF SYB&+6.2WR:?Y#90_B9R=CBHX9>?Z@>)BM;A
M1$7'O9. @E<6HJP);O0Z9XK#&-SM+T#Z[&C7RT.N-4O6;MMB=_I?M;N)>OV?
MM8DJSR<=S1*FDL!-<8C\9?-3->BJC&8G:I(E.]HM1;78[(S81'*^^^J>$5:K
M62Q(:OUHF0S\_%$-FK&C,LB'K$ZY AAL6AP.J@ZA+[8  *ZP]2/=%_,YRGU?
M,/I$USY]?- J4F4TC.K4,]6UJW@6> A21]?AH93ZP^@',,M,GWDS=]OIG0V5
MAA[SN:>(#P9V31I.VU0XR+N8"*\$Q.(VV="7\?M5;]IDY$J41O1=.*X ,LO5
M$K3I 8YE3<#R\OM$8J<.,_%%\"0\LPH]BH%GJ!#-6)R \K2XY1"=14"\K7NL
M!)UU:@R8.0)\X>W<F6+X$R(D@_X)=0R<^R=L<L\?W@(T'# J^GY* ?]%*7Y^
M2E%P]34<++JH9TP9B)]O#-!%<\2#$YF,?NF/*F#8B:/5L]/3J_NRIX5GC?4&
M@C,JGHB2DWDB'VDWC1Z\%5I\!DXF3YX3<T6#EIFB+6M5+\4\NHF)W(\Z&0E$
M]IEQ^0NO$YV2]G4O,>>R4B/P 3LE)6G4>"\7*RG.70(\-66FLA[B9? KL*94
M".M<R26;2(TN!N?%%E<<H[W@JZY82J7XX!8,#T83*Y?LS\A-+J4O*VU*J7VX
MR1@;_WCYV^MIR6MSOCSLPD\G"&S*3P#7E=@-:+(2[X-.22F3F95&XS\&53T*
MOQ#5T"<F G,@#81D5 8Q'%>:\"UHP;Z6$-2^AC4'+R0^3&XL$IW@F\S^D,,Y
MUNG9BQ*W!'T@9;QHJ/RK8^CTC+A6CHX78(_:CC3D=2@: B<3B[/+,W!C.S6@
M8SA7=?+U"^)_F>!?)OBG-<'>&-83]$72ZZ$/ZWRYYHU6ZA:\=$_>V0)TOS+:
M GA=WP)<7%RL(_3H:=0W;-'#8ID3\Z1O.T"C#ZG/8SX3<VE3W<*&@U O+8<\
M2T'$K%MWG!%L;VN3:J7XK(;'6_-.]&Q.CHKO]$*!133Q661-.1C"5U_?_NK9
M]2]7^!ZKBI$$\SD@E/9JOZ;$9FR?ZU"(W$H%8)A5M_VPM*M'E/'Z$ET/I6-X
M0$;^?3Y"D39;;=OC=#"&EQ(7')7[@S<?]MXJZ.D+CY F"QT([)T:/R&_?F2I
M]ZG@LT+$R<B2)<MX>J2I96 J8X_'8PJSF++YH),$'2ZO+CP<X\9I33:-U+TF
M$Y!$12[ $?$P,EM](EPMX0X5/DW6YBA((=;]2&HG82%G86S^_9?"K_04Y++;
MTK6PSPC3]?!9CU?>)7BV,1AX/0KZ] K7T!6C5"=->JH31.6>$H/Y.B&LB*B'
M*4EK-WE0E1G']./+S?P;A;@44Z^_E<:7\"W.IBV0\@Z98']W^T3M";?E*VG*
M#:7W"!XKX<",LDU39H[T3/8%CQBDB1:%W)/ LM%MSX>^! T5>/BWL[M75\8:
MJ5 >!X;28YEE:#JYBVA)#,G%$6\,D@Q1F%:S/,%(?B*W6(MBSL$T^0+QX(?'
M6S@)"4;C"Y@I:6# HS;M!P#PVT#AL)XB"8+ .P3^[),C1;;6DZ_J70OOJ^]$
M2,H3CAR],OC1P.A=V38@S7^/C?K+9E);ZTUQXE$WCB*\9LRA(@ '2F4@*(3G
M&8$_77D+'>ZK\@)J_5=U2_>LW48(:\^V+UCL]'1X?_;T9A''?&@5D1N0G3K.
MOQ%H&"?!2,<HX1\8(I0I(][(JBXIIYG0'6]<@($3P2A.7_=_[9UW5)-=NN@#
M E("A!ZJ$$()O7>EEX0BO8/T#DH1I".]]]X$I H1B( @(#5T5'H'Z2)(4ZHB
M5V>^;V;NN;/NO>><66N^F>,_[UI9*RM[O^^3Y/GMO?;S>^*AXR.XRE;<CU8+
MWQ3@60X&F-VA=<JO5WDPMQ?W]+"4IGT**R*5QD1]D(Q&\;Q]6Z)-40HW&2MU
MP"HPGMU*\\FAAK7O(-IJ7T=G]7[(U9AQVUF%"[PJVCG@%F]_/H/Q[";P<W1U
M@Y\13_]G0X6U.Q2V]2/O<S !7ZGSNC>Y;9K%H!HG-,$NQB)G5)2-.(7S:RV0
M4$S9RBM,:<9)BK&="8U9P;O "9P1KN7F38\=CZB1'*%T&_%"\T%!WVXL]MDW
M)LG'WLII:O:IRN69&W@T9,S!R54W,"& Q?F$=NZ.MPK0@FM D>1NLU%;C7J)
M=<G>S51!D(YM $NB1Z)989/&9P*%,('^,;CY=E&X0K&Z!@]_E51SSRP%-5Y<
M;]Z$B%!3 Y-V#H<]+9.PTPFG7NJ$[,.PA&!;F\] QW+?2 NRFC$II@4!&SH"
MKAZ O5=6-M6.-T9R6^H57]+3L/,C>,%Z''UJ>O&03$+XYDXG1NF++MP18;%!
M'8U+_8Z4;_-UYY1Y#3X13[[,);RO;];E,:A0X9&WFP@ MTQTY%CS&<VY5@G(
M96;OEI:I-@PR=^9HQGQ4A,*AACGN;#4$N;9#,PQ%&:Q-TTT9]RN+?SD>?SD>
M>5I6/5B;H@S8V !"HJ*B/*;MDUVIAK0D4#6G"(T;_++V;%RXT5QH"/4FC8J+
M7J^C-78X;8HO6AK3*E!@^_LPWA8YNOGR\J'/R"BWJ]\U(%S]J0Y2QZG\7F4^
M=:J*I<O;<J'.^E7>V5T>U0T6C;(</& MV^/1J5#V^M=D6(X4TXV4ZA %B[1[
MEWF 8JP4G3;M]+KQIH*A7:=;#1I6PV&3')83RY5"<U(#U-110'1Y2\_-9404
M S15L+T=X9E2;\IW#<@V&# ZZG5-Z-T2H=C1G#=)I>JVBNW,>+QT=)++V1K8
M?N<CEL@9"-M%\AOG54F7)/'F;(H2>'*+%RT 7RSNH'-6UJI6]1EP$:>@*U[F
MYQ\DO5%"*DZ7Q*AL.#FP.:XPXL:#ZNZU1+&^](R$Z5ASO(0ZOB6^Q4#QHD0)
M=ZSV2OGL,7Y3S^H<D66U^53?;)3]=+YPP.-^/2WO,NUONZG%H/'9C.IQR@)$
M&UQ5+0JX,5-V%$+JSC,TV5@-9<4;\[#Y%/R1W8D<D?9K.?_'7^3^SUK.SVQ8
M8(10VP%8*2T4;A" 7?B -QJ[&8&0'Y=HT?9PVOG3]EI_\YG&#[&1ZQIOZ6DL
M7=*P,^77!+"2DB/&C8@H^E%MZ]E;S1UD8BTLVK&:G\/J3-<ATE;?W$H;M"G8
MW5#8!(YMKNT;?=-:+T1Y2740\PJQ!@<655]S=;\CVCGS0<)EPIZYDPD#,=^X
M/-!#<)7TZFP+!$]?I:; $.\I#1\E\8#WMQ&P#,,1_G2+GE)V[HU8_DN\',,,
M6FV1B]<JN;:PZ-Q[TP-X'@,MA.^T\>)6^[F]'EX#, YXE)<<YM]E)U11Q->[
MC@Y,!+%HD<N,\8]YWQBDCH:A7I/VBROSO#5A\XTHD<VQ_E!:Z_E.#J)97D$%
MGBPTM=S#CP]'KZGOY-&8&(.JU#($$Y)S&_TRG@VY"E$9BLV<ZM_EZ\NUS[;#
MD!@EZZ9_P2K;B1KAP_&!^SX.RK*@)ACDG<"]%)-.(L]9%JN?@R'H2G%G-<SS
M 32J4J#X'IWX#*&#,N>+6Z/5Q(\=6Y4?&5T#U+.7"6@CY#;]O$(W1%Q%N^(*
M)"\R!;$+,N?3H##'Q%<(W5:U5"F\#-S"4FV%5,68+%*_SI9R4Z3[1SQM9U=G
M1_W+6"J2+@O:=S6F%E@6).7B*IU$NT!+:#V8\4>B0U[@_R71R3IBGF"](WOP
M+#'P]V29$?@SI5;]<7/X_]='14">&V/A4M3R85([DN97VH:>?NO] 3I9/T!G
M5CIC[W?0:?SY #S^M-=A_N^UUY'N% ?9-3=+Y7O1>H<7E5=LYVJZUS204O7
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MYYS@6H2CR=46Y8%\8>1:"K8* (!NJGH(AK8/[\N=>GGB23":7 YLZ;V()E?
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MY7LA!K[(AW@M#B@'8+H *HNETKC-8K6#Q68Y>"P-BRUBL;@ 7<4*Z03.B%W
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MSH#%BX6L!C!BHJA)=I^="AD#=%A((L 4!<]IL@@1D5>"4.-REY_ <8,:O2<
MF;SF(H%!JT],AGR@Q!60&+P!&A((!L,AU$*+^-7X^N+3%W'9*APN*A./@P/"
MFEPS)X_+YO T,AV/KU/+G2*'.>8P\^)% OU6890O$ZJI&CF'KQ<CM@@O(>:J
MN0ZG1:.+&Q 37<IA4Y0:.23F.6)VG3OJ*)JRV&7F"Q"[V\[741A!12(:=P2*
M!!()RH13K'%C,JT.5*H]=I-!'[ :^23(2%)[S%Z[WV((H%8!*6PE_]'TBP02
MN!ZQP> !$;,W$+;YS#38'52X Q:++RCQ!H.T.(8&"1' @@.-FT0$+PDQ+H-%
MBQ&LX3#@!4%#2!I)<$&[ISATD@E$#9GE#DL5%K*;$(KB]BP#1!J&6<\FB+R(
MFQNRZ&-ZJAV(LKDFV.L$(JA627!#6B"((EY?P$@0P00;!A "IF*!"<!MMN"0
M-YL1-,)0 0S0"K"4NI#%#,1E&$R()_@Z @.A)8"$6VN#+*A F(#]>I>98#0P
MC32F+:JT>M465=@4%A7G!Z#'"NDD<H]"$C&$=&(U&&20+6Q03X2L>J8M3,*D
M$JG5;2?;$T2-7!U."+Q1@23"1GV 3P0D0#!"(EJ$! /!(4T4"72C45_820M1
M6':SD&4VF?1\/*V(,ADZ8AR2QHU E 5*C3(-18\SAZP:.H&(!?A6M9P79JI0
MF=2F!ZC\2""FBOD,10)Q!C*<( -2"\/A8M#Q&&E)!-P!:B#(DQ"\(:=0)Y9S
M@B*73D@V(BC=%( PV!-AL+P44,L #"XLH$-5%B>+12(5P\834YO=0JU;PG,2
M40(Q0B3&5 DCWR"#("K>631ABB4@38#.MH9%&@%$(G'D9!Z%#+%<;C6)P]-9
MZ2J_Q673Q?2,8J48C8!"1P%#!BPAM5#D6("HC['H:JU:;M6P/79NS*Q1ZFD.
M%U\N(Q.Y"5QA#)9"I_1R-5*K02YB1&AF&\T.28P82"AV#CQ8K(KI?"ZQW4^E
MZ)AJ)$B@ S(ZX!.C:I,@+-<QO(80$Q/J T;$Z?:8)&P@3J?P/"P%!BDD?DK<
M#"0\+M!"DE"+!+I"@(SLBUND$I *&$5D&3,21[746,R@D<$J2B)F\.&EE(W,
M3%AC^ 1$(5)$YG<[O2Z16:AVZ@UZ9TBE1ISXE*F^8DNQ4GQ:!BTB<DMI,:LR
M8/!#1I^7*3>KK1I4SDZ(\8\>&<91DB&+#R7SU0C*4DJ, (OKL8-A.,$WQ2 3
M52ID<A*:(H&H$-*HU$JA6.#R^H(LK]K)$.H0GY8O5P8#!CV)*U'%0Y)@E,)F
MTWA"/A>2A&-ZT$F A6#(J 1A&MOLTY"<'E)$5^R^PG),J.#0I%QA1"J*!^-N
MIEX'*\DQO0,&98"/#H(,*@%&E2J[P17RA,S4 ,46587QQ?0C-*(I+E/X&3*=
M6^F/\+G%I@<S6')70DBP^CQ!DH_DBT=,-'W0X"2'C$&C3L:P1TF@@,\WBR5B
M*<\E8D>PL$P/"6$FUPY[M0!+;J"H<5RZU?;BJ,?$;<X"N=6034FPH6(3T>-B
M>&DRG5T5]Y%,,1U/+\3%ZHTP-02 \2A <R?4$8*:" .0*J97*"5"KQ0W0B^-
M$2^V%)W0ZXI' AZG7^:226ET#.19]'R.3"]Q&$,Q D4%FW K5ROE,HL&,MB-
M+AO;#<7#?+.6*))I62X^ET&S&;1,B<T@+1(8TML15"L+!@TFAX2M<]-9+%.0
M(% F@H LS& P"%8Z8A9[ 94=H:LL6BO)'PD$+0*3@^?R2-2&B%-E#^F<3!7L
MEA<#V^A!024#(5LC/#:J0-4!.PTG9)AD",-/M1!X&DSC8Y"TE)B**8KII4I9
MQ)/01&1>I]&+6%">&!4P73(;0M?K?/0G]1,>];@,C2^&6Z.((F+$8$\")(1%
MJ(8JPPL7H1T3N.,D3EP2((M9"IHFH/)HR0JIF!F'U!&Y/0"&& &:&71BZFBQ
M/P2<W+A:C])L07= *C0"(K?.Q4=\84G$86502'HXH680G2J6DNBQ"1QDBM3M
M!F DSJ71 )$6B.N4G@C@8HMQ1U)L*:#,(%4R]+ $AT_" X-\(D5C-Q/I"7F
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M"6JOWZ@'E&""@9(31JD6$*("GUIB<(,.*X6G<=&-(MBJLY((Q98"!?P!M@K
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M&!ANHT&K7( KA^JT $R]3*\6^ BP4D0.&-UV3X#BE6JE<897S)-C5HHG(I6
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M(4 AR%=Z\/""1MXBXJ]&! =?T;> ^$,!_X)DL@@.;$^X%%46;PJ'-T\B_O&
MD!6O2.G!Q%M$/$?QUR*B$PE,DW7"%RG-U(E)3)/@'TL/,DC@_Q@:S#<M0?_F
MX"#BV& FH<$ <6B4(F2\F<\HJ=;7Q@4#_$?[C"0L&$4>XU\%"\8;NXM_/BS
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M*:7NM5[_ZZ^G_-/?ZU7T8!;\]R&CY"&NM\!XJ<_XU[V7_(W?S_,/?R]YR?<
MEB)@E/;7 /[=H?'D92RE\+OS;_PREK??G2\QL.> 02NMN"AY'OA_ 0L*Z4U@
M0?FK"OW_BZKN=_^Z]BO^@';' ,ZB1/WVL U"G_PA=R67G^9!K*@%C:>1Z%G)
M&3]'5>6WW7&AD U% ACB+U9E<:N:R\^I@O>=C??NA?Y 1W_9];:3MYV\[>1M
M)V\[>=O)VT[^5IU4Z=@Y%L 3)@A+@WSV3NG1],XYCT^F<%)2W_!*"GE3&:F/
M-Z?4JI22E7*^;&JME#*U4LO62GV\-:592DJ9LD7W4YY<E:ND5*I:L4*Y\F7Q
MVY*:*2D5RJ26*5NF4L5WJI3%;^.?RY6O4+%2Y91:56K7J=NR7OUT!C,:6]V@
M(4N%K3C6N!4)I&4;C)'\E6L:M7ZW'=44'//1JM"$Y;BPAG@G99_U4W3API*C
M8. C2DTM7ZY2V8KEGQ"DEJE5MB6)%:RMLBPEH_\9,_WS+[^O0SF?WHK=?^R6
M6VJ-U;9LQN,3*>_@ G'*6BF=4WH^<E(:O-L8&9S5)#JW,-K >"NSUE9R(:'&
MF>_W:A?.F-AM7+Q9ZJV-"X,(];2$VI6Y>E^]J8/RAWA;UFI\:^]N2@W;Q<DK
M71V6*\<5CMUP[KI\Q^536?()H<_W\7^\,2?[R.1.L2/&;B/&C?"#?25I%X[5
M/%+_<\E,$UIN]99#RO;F-EV''UQIJMNP5X<F9\TBO1.XL>^(Z40-<J&I\'-=
M@6; H[*[?LZYQ>LG[]VC'V:_>?PF>]WQ[Z8.*>A<\4R[Q=\<&''SN]PI]YM=
M)=C6]6T^_?+GLE"=#N"(PAL=\K-MV;29QVKM0=?\2!^FFD4N$QRYQQE5RUD#
MNUXP'!M?,8.7?RK4(.7@KOX+59W1E(6'%GVD.[3FJU97#IANUKQ>O^U:1]/K
M\<$[C%L&-40D;3[Q\E+K5H(JG9[<JX)WW/ML&.U^;2[_\\U;5_8"P':7%V V
MNJ)IZV'_:7NZWK?#G2<_>9\=!X\/6??55MI&K3-03=/]A^V1_=^6^0(P%<RX
MNK#,XQ07/'9Q.\:%UM<[:,W'NO,ONYN>.#<BQFTJG+= S/[:T9"_W+>VS<>G
MI_1JWV7"THLC/EH;8RNZQO>NY%V:_6%%\7;MBI]JMF@JV!GO?;'Y.,5@PLS,
MYE5^DBZK8FBYWYY;L6.[8>7KE:--?[A2OF+^V1\J;(]?YDSLVY0LDU?\<%WU
M]%,;HFMW-<]>.I5T*H.QV[QYIK51^$+7_;IS%S)6SI_/6#:_[96)_NUMJ.>H
MF.MTP:FNC1KEE<MKZ=SX17#\>UD+?3O"H8WYT9[D52/]B]:@3085PON"J]M3
M:D_ZAM<MH\[0E@WZ;+]K2ZM>=\$9PJYUL5H''K8D+^BQ+-HJE7%X3J^R0-N#
MGQIGK.5M^W*Q8%NOPVL%92M+R],_W*(J,W5)D]V6U!1Z7I_MMT=;;N2<__9X
MHE:=U1]]UR4^_L+8PE&SE/O6E"5;.FR>=3];=^J7'[;,MP]:>G3GYZ=FB\^7
MF;(*&M;L'6RF8,FX,<NL)_I4.+2]8S?RESM<TS;N)T[1R,"UGQU]G.*=/&[D
M1OZ]NY?3 >+NZ]O57^[>;91]VVSD['?6LI8=ZR:<WY=]]$+3(X]3AN>[=U<?
MYQ'W'F/GBYPST\/'!U@_RQ@Q<?G9C1>7C\QK+!,=T7]]G?W(=#I6L/2^@!)<
ML.;NOB&CI=]5U2TH._=K]-%'E3?D+QO_*6-*BDK9+N^#A?T9TK:W?]E&'&*I
ML;;?T<\VSG9MSFGW65O&W@/ADWD+Y>..WE]?[@1X?=#)9BM6]&J6(0IP=ZU;
M>?X^<B7SV^NP:UWM64MTBPSO C.ZK>I3^?WQ\/G/\H=TS]<?;K-B=<=^GU1K
MN>:;U1F?< N.WLR3- 4W3@@.S%UVQ L65CAT4-^P\OAAG8=_-'0</&-A#\$F
M>)W<O);%F3-/7'=;BW[LR:2<7J=XBQ+3.]<0K*G]'V_?K3N[G,I;M&35ISWZ
M76N+G25T'1?8E[NE)WM*FT9K(L<_39]#:B!B?W@YM0F3=*7SI/<IJX;[NZ%M
MN<>ZSN?-']/@1O3#EM]W=8XW+(CWC&<VJ9<]J]7'K2Z?@YKLV2S_7+9E[B,>
MC?S]S=3<R;.LN?8I(VL.FGS1#([3[>WXH.KM^=9+Q[HMN@:#KGT1295N99JD
MD^8+>E=LT$FVLNS:CKTBHP=2=FS<\O$RRI1YNZ:=#M?N,%LGJE-K7DC6I*X!
MJ39,U?.(X=/U Y8?7# EI=R].Y==Q[;[-EV<\S-O7_?N8_9%*>39JU;PQO8E
M;^KR:;T%(W\Y\4O=;JM;S6QW_L?([+HC9LZ9--]XJ?6DR=>[9$QE[VG7?G6W
MVK=B\3S!%[?V]KV*TI<7CJY[8]8J1C_UK'..M56J94"55ZKN=7#:,S*]8+-.
M;%;A9$JE/>6&\>9^.+M>[O S?;])J92_H%6Y@JYG/-Y%@]*#MV_N5-!Z:TW?
MJ,=.?,^TO'KUW:.OS'2:,H#4-0O$RZ8,%C78/X^>6#YB_6[E5YR&EQ;/:"Z0
M[]E^8)DC_7*;AMG6V^"2=34'7C\DL\XK./[-@:V7)GMO!P\XVHMA[H\G[LT$
ME_>\;;MS\G%*54SB#32O( 0/+NF<4DW?]GN@_)HOV_:M>_=<[MV N7/AH*\7
M7"P4.*HRU)]%C^85[M&N'M3B GUXG5_L%P[<7YS5=_>ZFO<7W^UWZ2[CNPD7
MI)PTE6%7H7]DQ8^.-!EIZ39P_^(F^2(X+)![AWT[<OZ<:.ZDE1VN?9^:EL>:
MO,YSJO4[I_2!X3VA*C7.J[ZZH)]@@/-WKR_[..7@@D;=]GU0H]YGIT^E]#M]
MXKN<QRG]UC>9D=;YQ]24F@^V-/NESO)O=F@Z/TZI7N.KS+DM'G1-?62\0^\6
MV]&CK7/5U4ZJ@L7=R76FO=O%P;LP_NS\MH&3E[#M!=F7FS+G.[D+'2/@2^=;
M>/;K8VWOU*E#;B/<)KJJ<E-4AX]C3>>$+;!NP_",8=!^[O:/&ZJ\'=]OVN#8
MV,:4+W;,/O*M^&*TYHEZ@WPG,[SEJ/I^NRA#?.Q='4>N(3?X>=GZ\/X>+G'6
MZE'OLQ?DJ>=5Z7 C-'[U-^G]#WTW-'V^R2O[SI"UM]=Q+%$O[W%*GY7U\]?_
MDC\I_,F-?<,'[@0KU]9<>3]=4Z#8><OYB:#%J8F$2^1]QQ87GMRQ#JNV=^*L
M] KB1I^/VB(ZD3%JNSP3G#"Z^E=@]891^-8.0\N?OSG\PX"?F_K[K2-M/ME,
MFU@[=E0FBFXV?W]@]\HZP\N-WS8^_.%*,#&Q_&WIQ4^G-\GB1RJWGEPM,D8S
M2-]>#YSY\?*:(YNFYRI;-*3O\ZLV;EK8(^I?U\"(3=7=$;3Z/M"O]=K41U^Z
M%3_#Z/6)&QHPFZW>GIUC6Q@^])\V'7M^5/O#,W54JUS9F;E]67TZ1;8<+=!?
MG?7QR4Y0NSFK,Q)J<=UIT51U[S/'A3^^DX.V0=#A@[,1,"/]?H7K;?())Q9]
M,=+_98.*6TQ3OF/6X:-WFZX0KL\?OMFTE)_7YI.,&=-KJ';^>/=HV'5CZX4T
M?H?,?9F:@K;-?SBR/.NC"'?HAP/&[VI_!)[WH,_]M?/6U1U:]<+D;:M[G]QU
M9=&%O<'JO:I=^.K3+X<=[=GDWH95$7'G=H["L5\(:LYB+":TRU,=WPK>4*\;
M%RA<>H0[OTK!'?J,.S]032)^;7^Y8R-K-EZC/MLF=O]L;M=QCLO:T5\4IO;\
MHK"P7CU2HU:CLT8?;UU_@FCHL"['?]E]M,J-L'#LZ+JY \</<[6I#&U^V&'%
MJ,/-?TS\M*WQ]M;S)+,F[9P[:>>"B?5$VE&ZVKHV52K*N(?3AE6?N#/-VG1&
M&Q+W'57-FLT'D]O-<,X)ZYBU1>F->'65V]*1.>QAHT*3MY1O64E9I^'VFNW%
M9=+34@\V2J"%$X!34QVG"\]DKQ@^W+5QNO#B.ZG#6TMY^E&3<Y>\W^,8H?Q
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MU^X.\-:7"2.2](?N+W &+BKXN,TPI[2.J-$+YZG*T\'A-[)A:GH B*P7?LF
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M"P8L676N';*0>XTML::CK0N^JC)=F.O75?6J7%J]7BY5WS!9I_!!9-SW*R;
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MT;&^%KXZ%_[R]E/, P;%,(Z'V)S+I:&Y=L\/UMX0D2NVZ@%?@MS$(GOH,^=
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M(\16BQY69A7Z(E& TD>?MT+=0.-K#96A]3" J!C?G5E$LB[-TUS2.7@?O02
MF ^*S^?;D+UF($RY+\L&B2!Z&(D#"Q=\1%25R%K_- M@>Z-P43*8"$;7J/$*
M&QK>B9-6R+4WW\K6[BBO?."W\_+Q>J$[Z6C+QZWW3=![T"+QINO0^,3A@3@Q
M@.<K8;Q,Z\,HFN:O7Y604&K0XO/1ALWEBRU?,4DM(F@[4Z(#JEO%V8EXW729
M;FUN<X3I[9T+A:1UM8(S)2,2^C^'' %D6*TI9-F@^M'%;3;T0/!H8K@70 1]
M4.L;\<+(^\H1D!.H"HI[[_D]5S7.P-/TX<Y,)IX&M=B\@$P;J9 Q:Y812FOW
M90%Q^4U;O/<PHH&1Y*CM3A>D$69@_A(S7Z9OP>M&V!%@,T#8\>:E8'R'&6&6
M'Z&<S3.[MO6,1]UT5,67=B=)7VR-,G3(E!A/Y2'V]*$: 8HM, R]N8G( YOT
MA $'@9$@K,/4Q"R:!9=%B:UUT,A<HIIJ(KM*JZRD*H1FO2L6MO;.;V,A@RY4
M<E]E&I1BIZ?U<NHQ%3@,>PH,$XU1D9P6A2:+QNG#0K_'U[&;:LH\,P^#ZZ=X
M3=%G?^/-W?[*'[UKM?=H:GZ-4[# KK\VS+K)-JV#7;O_*QX5A1)0FV6]*!A1
MN/\>9^\5176ZX+,N14)N/Z^+3.U$'U[A1J6[0M)].AZ)J_+YC0S8>K;?T<6F
MNY[?*F5WIV)I8LZON*$[LW+^@9CKP.93M91BH0.&U8\&OOG<-3F)!B8?B\P\
M1>&;->I1D+"JR"1 N;*$UP!_)W8G@&.AI"*981L=)E_,7EK-]^:R'3C>PBZY
M[JZ(^-BG_/?#T\]KRT2,$Q_(;G0:?N;+>7SG<MGF>\.!*GSY@6KXD_XY0XQ1
M-W!=O2[+H!SC IO\ Z6L@7PYN*RY'$XAUIL%VRB58<_ +WY/YOJ+EHIE+_)D
MT:M7@HA(2,CYK?TQC 9T_!7@V1<\-8WL&)045QL_NA%Q5JH8]WK*<G+E'HQ9
ML"GAP=-5\2_J8+\U8+,(L?PBV]]28+HJ6M*>!4QP8I@9.0BB&9=&IK.U;8SN
MC@V4P3IIKVUFK^#!1$RQK>+WV04!1D'68O7<Q-S$AOOUJ[??,35[A,&@YY=F
M,0[%$995$2%16#2O(_9EPWL N8ZNEMVA]CG0#9/>2M.YS5#RPE<R7)GY.!HY
MS9E&+1/!^J_R^B,A<64."'!$B-2\07QGZS-7!.M;\7DV?5^NQ[3)6K5C-;UO
M)MX%.4^.BWIK5'/4T99CVJ/>9SE#FOF-M>.;/=8F&',!PK=*5_<2W0>VHBZ^
MYM;D:[%:\\+1T@J@PR@K4NT-;)+=[APP7#7WH*JV82JDG]&@)[\X ,U/[YDG
M;S6='3=?ZDB<4E.Y]71@,U\=!3X OEHSW)>7F0/[*R\L?;!](#$<2.3YU+AH
MK_**P9721Y>+G]Y12UG?3,W)1MZE>_1X06TOJ>_INEFQ+?IVO'QR(H&#B>92
M]T.M?/O'A1F0W**+L KPBXY!V18C?"5:C/M[5:5#1X"K203:I(=P^&Z<EFC[
MTZM,O.CJ,GAV59G]1=UI 6N5S$P,\7ZR5CAY)YZ\W8T0#!\X@6*]G?=YKULO
MP&@0.$E\L%8_@ZU"REQ ;N7X.?KKT)[Z_"[QJK?$QYC/GB6EO>(%RD9;M&W.
M1;Y#1=^&4[0,3;XZ&U"JFA933BTZU0N,F3KF7#ROI%4=DA^6U/4VF[)/C30Q
M@>.&G$@J1N#5*;D+EHM\ZM5E9$[Y7!^^9;^3(W?5$LT$@^AGAT)W.D13@ ];
ME=41S^Z23?6I#RQ$S.)IQ'>RVPBPRW"N9!I/9Q&5Q+VXOS+J_W$:[\"SC2VI
M*[3.$AJE(BHCV!5D[GXWFO# JF6@KD_$R;7Q^E#49$*Q1$^K')Y GKGB;BJX
MRR^V7$.5FXABP;I-U/?60'.FA$42O F/5"ZQ4"YM)OAXQ6,M4/5X'1!#C>:V
MYITP<2HH(,+_/IJ(%C,B539OH5Z/?8/9HZR#(YU7GUQ5>[DMC@!S5(8Z1N;<
MW"J"26Y_5G"A7PCW[OV/90]AOF.C(5KDCI(U&X%^TS,,;7$48%)?%K&-M>F"
M[5NAX4H]4;Y\"5F>WFYOZF]GCC :?IG2S_6-!T?&X3"ZN_7N[NXN/9,&P0!R
MAHY9X]:@%<;,0HJ=?08)AMC0=KVZ[S+IEDFE-\;L6M5"N;DA5*IX6^ZRJ:$0
M>G/$*[)9.X[#M;?@A-;2,N;O^\72&UR0$&>7PN6.O"_RVA5IAJIN]Z] "(@I
M?$(K*T>PUSD.G&I83.%9:0+&3G .L6US0G-J*9@&V6*>-5,C1>%V?MN++='"
M'.TG!G+0&^]!O)+,46Q=;).W63ZP(%\<OL<%M]XCAW;=@,QV9 )R8_/6C;3Y
MF34&+5BO*<3CER_>\@(+JB?X- ].2;>7?.'690.>IG[OG[I +E\G>Y$YDI"0
M#V]N(G2,]B$=Z/$ M$M.>K5/F?_X^>4=38]I5QVLN_06@#8V:57]8JTB[=.>
MP=O/I4U":E/IVJ8N^$!B!-O$'.P-/P( H('YNURHD1J^;"?K=.JD@+5-0?YX
M<2%$[B[&'*%7W4JS?K"G7#G6DD9%]5*W1?B4O[*H5MU0I")PI8:I-8AB>>F3
M*^Z$2K[@P(#UDW'=229'3=T05>[69D>T(LI]8FOR^=TKW%O43%//N*_P;Y<E
M=K)('C(2F\>WOWZ=3'-;O%P6%E\V_9SKG1N5;' .08L;=@]=6ZS1"UV?JUY-
MAN 26R6S"=RU^L4=3$#ME9$H2T!&MM%A8?E.A+.+>W <I$VH.MQ0]@C8;"%<
MQ ._W.09@B;W0Z42!_*\"J[G*9(*[2A/\=]E:HCSH7BJ$DJ6-O])4U%''SW<
MN1=31D1=DCIYH$E.C:F11':8PW/E.>^C*#J@:N"K'#2)#!WW,"H]%K:Q,:.(
M$FPOX%E<=R/9MWMS7J^U9=O*O74)0LGKB)?*ST'?04[8KEU0H!TQT'WE'DV9
MB]DV22,SS,Y\QTDF_F8\GZ55Q$1X5#LJ<MN &YPP6=8AYB@_>P?/F;E<].7%
MX6L*4ET#BVGPE'R:JRIL(D(8 2N-TODVJ9A%G/OZ[1@O&1W[.KZ-+A%C?;3G
MO#WE]?[5^?/<C]H:,!O[W&?*.(I?1&[1/&.0\#]WFQ9F6F8F8_T>'X=6)86N
MA)L3 ^^2:HB/0';<1:[L870$C%2]!4-]\?$NJ7:C4.^RJ+X]1A [,P^(70Z/
MIWM28CI3"B=OKL&IV)\[N':$6_]>7]/5#]3/[6O*,WW?#^WNW?14ITT?I75+
M,N3DYGZH9*JVL$>O:7%)_G)8J11C;S?MA@>^R9!:DA)(.6? 6.S@#A1$C"D<
M1>BG_55"F.&^'H^=+DT,)9DN9='-]ZB;*VP6D@8\<1H1CDYZ2INSQVM5F?_H
MTS=L%6_Z'[WOU3.X'R@^<./]XY'JUPKW*<L#C+D$%N+H#WLWDT*KI6+>7G,1
M$OS8KZ.7;UO:!]-5(Y=UU?D6!XL-NWJKGY[GXP'V%;/,>"4AVD\'($_R&TFE
MY,SVJE.0I^'D<CQ;;<3MMO?9HQ]?OU18YN5GM"R>O&:D;J;@C+Q34,8CWH9:
M[Q9/7-[BEM"8A_=1+<G!]+49>#I*KO.C\TR>I#\I*DRBXE3#=]571\M6WJ=^
MYBZ5K?6_ #% SK]=&?J4LNR$)""*8 "4NAR0E( #F[#6;-C,KV9W0[W6K=OX
MCH^]*D8!!O6GP!/KS/  R3UT:GRD[/Y''(H![B'-[0V\<L;,*10 2"2D+2(C
M ) B? /K)G^G5/$R@Q+ -H!9@[,+; ,(O.)!N-ICSB>3^OGY3,<="KY3W>8P
MO5K=.X]/K@<U3N33Z5$J5[S7=F$ Y2-[>W&9$IQ@9\R,T<S:@U_U%,1<@F1I
M!%Q(.H:<&C]P=S<#;06VOH=G.'5.2K7>LQ.$::M9,D_W:P1D\@))Y,B<1U9'
M_KF=%PBFD-#)+6#0)EA-WU.&K_\ NW_UPY;D_/NUP-T<+T9VWVG\>H[>GZCW
MU;&( C((&!SYZHK)]Q3'[O>HDM=Q)+G6"8&NIQ:@*+@<127+ EN'Q.K@W>^-
M(_VWO:RT]R;6%U#*W;UIO35PN%K]VR*BHJ5N-4TTM*T7FBM\OL4Z@A*7RI+B
MX:"CO'%[2[8SW9>>HFB$LH*2J>%"PH .2&"CM!(8XV'LYV1E.U,I6&8924CB
M! "EH*79 #$I!+@D"'',GC"UEVTU/8;D\P_;:P-[P$33O!25J0"IIQ("E(6B
M2$)4 2(\G&TR':].OET5:[A92'*26T,.6;<:&#C,Y_LE>7S52E2*> *(2%\(
M4P.QN=VQT5_Z-E[/E_K^_G=7OM7[**TZ&T&=',4KB4JJJNY:SKZ2H*TH7);9
MIZ6R*)=2A)4M7NMP!<2H,YG$UZB:5$N 05$,2Q_U\)=K,XM]*1HKH)J)K( ,
M<*B  7#_  EF.K\)N#9B,=FJT[R"=PR"8)&)D3.8C,^(CSBF>(J9U$/8.P8;
M GE-KXC !0X:U[[$SX@1L<,W4!(*0-P,F5#=SD'U SY(GD<9E@1)LY=^%S(>
MP^]C>(V].3YXCU^(_O<B//Z8^N/E@].6<'86U EB6.D6D7VPL,G4J)63E)3
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M54MQ2GG5I05N'WKFU(4 #N)$DE)(*22J<QUK"B$I# )!  #,]VY1C.49*RY
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MUZ]>.&M87F-7PR6A<JA*(P8@<P"?F9\9X.")Z6%N]G/ASO8N#LV@PV6VI8Q
M$^ # CB)_E^7,=+#X14D *!))(^$Q Y\Q\O^7CHD?,._R.&F('-C]9;7T<(A
MER!^'@?YYZFPF&P\!C".F<4B\4*$I"D** 3P "VX 2<Q.T')S/7FO:##VM0"
M6(RH<$;J:7BSM^7QO<@1_P!G9T<0<YB X<F+"':;#%A!PINU*C:=JDMD[9*?
MB%0F3\P$?(#Y=2YX'_N7(F90GI=,#3P_&*>1#^RF;N6J*)Y09Y2U^5W P0MK
M4F[T8&$*8^)7 28JQ),1RE(,YD@ \=0U3P^VF2)/"/=D$F 9JQS-BWTW.@I/
M_9>=!*2??I9)(=PFB+.#?7SPA3K".YEJ)22%6^J2F <A5#4GT@@>[!$3S/ S
MM$1G0_P@DL\;P-/#RQB@%?IZA8LYTLS26_N-=<%E 0CN>N2 'K)5I!. 2IRW
MJ$1(_A5!QD&.#U.C_P#,*DNP4^P/NU<H:VG/%DA\O3:Y+FTV)>Y)O;8VQ)V5
M2F^X-]3*056I!YGBL;.!B<'GP",9Z9!;-&6B9;47\?KB*LWZ9G8N-1M#B6VT
M<&PPQTTLIOFMT).7!1*/H-IN85 \S&1P,@]%2(XLPQ#%YY[=;V@>4=5BG+/9
MAM,P^A'VYXJVZO3H/6C8F?\ 6)'CXS:*$X'\1F?.8'RBHKB&4J%R_$H]-=P8
M^PC$MLT-V#>>D1]#:XQ?OLE/>\[<ZN"N54M>F!&2*5Z"51G\0\$'$=6\B?\
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M\'G$LPD[""% ) R!Y)@^F.!]8B".D6 ?Q]>K84[#74]VGKG@)UXHA[0^W_\
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M831IXS^/7(LF;88!@8DX]>.,R!G\IP(Z,%CIT,^/CY;X8W_D;;^ML(&WF3\
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M3=)5*54L):;6VXVH?=_?I9=*DNK3_;M+(F4[5)"NKYRE4U0OAX&+I3?A8N0
M27:SD..D8Y?'3"#3$@W$N2!>XG=FWU8&3':^^.W9J_*TLM-X9IUTK-P=>0EU
MNG<"4NM)"J@-G>E "H050 9G/5A676I::AIA"G)X^)4&VIX3M:')?7#*6G@*
M4AK;V!)U)Z]>L$E/VLU NO5=FK%0T]U=9#+U<MVF15.,'8HMJ=;*EE!+;:E)
M)"24)4J2D'JV,J.(5"#QD-Q.1H(;BX6C8.]YQ#54I20E1ARX8;OL"X//$S3]
MGM3)<?J::EL])456Q-0\EX>^>VJ*@'7&V'%+V%2BDK61\2@#"B"!R_"5<((*
MP>*Y<%]R[ER[6Q$5%7""7"/E@!@/OU?OPLKL#JBJ:>0DVA@/%1<#2'%!Q2P
M5+2EAMM6\8.9Y!]>DGLXI0>%+(/QF5$O!W)>9MK:#@SF9#EU)9H D<@&@MR-
MS@^[9=IJ_M];]0T574TSAJFJFM0BD9+*$MBE*-J4DJF2D[B(!5R 3/3(HFBE
M0#A*BY#6/4DFYT-C+X%5853H29C5KPP$<F\\>D4Q62%)P<P,?0>#X\'$SF)Z
M+UX8$*(L6?IAQ]S _AF./A_*(GT]9^IF>D7.O]MO5ML/QJW^@_&&E9;DK;7"
M2-V(B02<>3Q/\LQT24NI(@N0")M<_CKXXFV)@M:_IOOCG4^W9[+:_P!=]HNV
M[6A=)WG5EQ9[CI4Y16&A<KJAME=CNJE.NMH']FTE2!*R0-QVC<<=7<@D U D
M:JB8^(7>=AM>+8JK4$K<EH(\# ^C7Z\^81OV'_:LN:T&D[):N9#I3L16M6^W
MJ"E1YK*UJ29!C:(')$9Z18$/4X'T8$$%KN#$-%[2XQ$M0@IA@0=?B<EY-P.9
M-B;8-[7]G%[85PV)1VN-&%)!3]_U+I=@$3X0FZK<DC.WW:51DD& 1*J8+&N"
MHWAB(AX VMX 8)*_A$^6YV<?=GN<'=O^RE]L*X;"K2^F*/=!W/:E2]M@ D*1
M06ZM48)*=R$+ (5X@],JOE0"/>@P=];DRP/K9GXZFM(@:L5!P;:[C</W8LVS
M?8Z^U]6*3_8Z+9"N2FHU74$\3M(TFVT8G,+(YR..H??Y03[\ \@#]R>5F;G<
MDE1,T^#GQ CBB'YB7>XWQN2^R.^S5[\>RQ[1%\[M=S[GI@Z<J.V=^TFU16P7
M!->Y=;M>-.U]*M*:ZEIR:=MBTU?OE0"%+9"0=RB*>9S% C@00HE+\0#$!S#0
MG39W+/;$Z)'?TVVQTHMU;*! 6.! $28$&))CQSQUSBH@ .78NX&HC1OH.Z#@
MH+.SW_EC(PX:N%.W(WI45$844@<CR3@&/EP8]2@6$7@0[W,M8N]GO]$X>XV\
MS^<6)IY\5%O+E.M* IU840AMS@)QN6E7$G'S'RZL.  0 YNX!MR+@7N&^P1
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MF2"02IY>HDGA4Q(+\1.]H!N6Z?0QK6DAP1Y6!U@>N1Q7=7[)-];V)H*70#4
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MFK)2(5Z'=6ZB96G=. 4B,_#B>HRR5%S+7:"[G2_. 7&"X5&P BS\]'[M=;R
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M)#%0N7!5:=IVZD(]Y3*?6H'87DLJ*B,H(?2B">0$#/B1GJS6SN7H!?O5A'
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M.S>0$ZL"=2-6=K8F&U[%;O=J*1(*MR0!Q^+& ?KT 44S$/Q$.P%Y[OJVXPB
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MP1  $1XGT,3D_*<]/$NQU>1)_%[#KH6^5CKY6B";_3JS>2$J2$E(49/J/A
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MZ?C#UEY1@[OB4)42?Q#C  ,&09&8XXZ36Y^O(@]^*$=\!_M]8(U.NCM#BE*
M*@8Y.!C$>/J#C'&.D>3Z,\1ZM_,(,>_83/)QO]<.6W./BV;MNX1B=W, GY?+
MSB!TV%J?+UZ=^@?!W*?BE,\DG&,&,'\^.?4]3IL.F)TV'0>6%P\(">,0)/SG
M,G/I,<<])5BP?#^O7HX70_M $IP"#\Y^I_QGZ]1<*M1/5_74L,+:3SMZ\L*A
M]*AD'=X \ # @\\'YG]1TQ#%F;U>Y \6?"UY3XW_ #UPL'DJ$$&> 29.1&?T
MY_J#APDW:&?N^OKNPPM+:6MZ>V/H5L()F3(^$C''CT]?EQ'22SR1'(S^.IP^
M.5;[=/V?JFW]SK/W6MM($6GN/IY%-5OM-@)5JO2\)6RXN0E#E3:ET;J"6RX\
M$/)3(05*F2M,@W@"'=CO8N-]9NV$=K_@L]]-_P"<<S5<HLDMEA*%MDI5\ !W
M$R0J1$C@X!_/J1F+DRSL'F&T9B[GH^+--R@!A<@$[O-]&V$PSX'GG!\2BB%
M@@D\Q]#F(XQ@'J(I))<,+'H2Y?KI.I-XP:0 1)()V(!;>'M=GO-IR*]CSL%3
M>TU[3/:'LK<[NJR6?7>ITT=XN+.W[Q36FVT=9>KFFD*PI":ZHH+=4,496"!4
M.M2.B26,ZP(#LP=I\_!L'6+I)$L01&C1H\'Q)<-CIO\ :=^RQ^SSH%:3LK%H
MUWV:=T_16X5NJ-(4FL+[8M2V>DBDJZ?45VK:._6EG4%0Z6U5%:P:*L:#S;[[
M=4VZE(D#$ABW?)Y'EXVAI>F*JDV:Q<M:YT8B&/,WTQ27M*V#V2-$=E]+Z#T]
MVJMW<^S=I]'V]S2CM30WK5>I-VM6G+II^FMB'"AE+=\HV**Z72H^ZO*=-8RP
MVU2%ATKR'M%G<W1/Z3(/3SE<O2S(2HIHLD \0 ?1PQ;1S;&J]G.SLMF%5,]G
M:J*>5I?YN74I(->9(?E'Q <6NF-2NI?:"[V^SGI6BUQ3]@]0]K['7+2BQ7*]
M:,KM.::8?6-E+*5TE.BN<"U;VDUI4AYQ(^%T*@XBIV/FC4%3,YO-UU)4_"M/
MP'DK5A&A+[X]7H=L]D!!1E,KD:(((!1605@W^&6>XANKXUF]P^^7='N[J>X:
MIOUPN>HKS=7UO5=VNCY#9WDR&B\AA++(2 4-T[?NTI$);($#LY7L/,5@.$*2
M#=18!G#7^*"P9F(..)7[>R672H+X>)*R GB!)+$"$P-AOKBNSIF]7=WWEZO:
MFD+3\;% D@@ #X0XZC:E62%*2UGQ $]=NA[,HI$5%50L"33 (+BY))OIM! &
M,[GO:FK6!&7HLKA^%8(B=G$:WA[/B>H]%Z7;!0_;GJWX2%N5M74/J6"(G:7$
MLA0R1M;2 .(/763V7D^$?T6+6C3F"QD".8OC/CM;M>J2*F8X4A^$$$L(8!NF
M_C)Q.VZPV&TK+ELM5)2. 1O2TE;WQ2,.KWN)(Y("O X&!<H9:A1'$E'"H/PE
MP"QO,:$LQ8/I&*M>MG<P>*O7XQJ@"^VPB#O%\36U"TN)]W,[=VX&(S/!_P"7
MCJ9?Q!+>B"-(>1L.[%8A3"+6([M^=V[XNQ73I;4'$*0-HR#)2$Y$C$@C.9.1
M,'PZ(#$AW@&=((DO'.=P8P@E6@,.1X$;F[/W%B&P/WRE:K6BV7 M&U4@*4%I
M) !(*=JI'G'(!.#T;/NS,[C7QT#@F9.&X5-(/*1W:Z2.\[31E]I'+-4AZF>)
M;"Y6G>5$' A0)_%)W#!\2(QTXHI(<GQ&TGNWYB\/B)*6+D%K<G>SZ\K1S+BM
M+KI[0EQK'KG7-76BJGLNLVYVG12.N$P7X>#A:<6,N-H(0O:(2"3 %**3A[N=
M?V]($M#C!QIZVL_+;[X>LVFVN4#5+9Z1U=+3)62*A*7'05%2BM;B=Q6I9).(
M$8"1 ZF1\2 4Q)!)<&YU!\W?#L]@#OO<Z.XAK/UOB-=<J;2D+I6%MO)$D"=D
M B#"@8GR 1.9@=0JH $EV,G5R;D/].]GV0N#S>3L=+/]R[;":H.XE:MA-'4T
M;-0F(EULJ6))/PG:0!\7@"#_ ! XZ9*5 R&AC/CX-!N^TXE%1(N2=->[0VTY
MS@PT9[1_M+]E;E2UW93N/J'1%%3+==8MEK30*H4.OK]]4J=HZVDJJ:H0^Z"X
MXAUM:%*.9@#H^$W9B8M<MI]&F=A? +(+-J)^FI U!Z<L9$ZR]M?V@?:=H]*'
MO^_9K]>M"4UPMMDU-06*@L5SK[9=5TK[U%=Z>UHIK=6&FJ:,OTU6W1L/35/-
M+44! $*T$$EB!ON S@,7> "6?!)*0-!,@P==')^KF-H:45^:>:A *( *A\0(
M)D08(WD1(CYP#U'PD"T7=I)%VL= ;P8D6F1<#5YBT$-Y%NNV))NO?#C;U.^\
MPZVH+0ZTZMIQ*T*!2M"TJ"TK2H I((4DPI)"@D]&E_BT@-;<";LP:7T=Q.)"
M 6<^BX:>NF\'&PSV;?M6/;&]F--+;=,]T:_5^D&5MI.B>XB#JNRI81 4S0U-
M:1=[1N;W("K;=*9 )2IQIS8@)<@DP9MRO$.S3HVS[U54RLND.T.6&KW?2Y:"
M/#&][V=_M_\ LOW 70V+OU8:WL]?*A+++NHZ&GJM2Z+6^LI0I;JJ&G=O5J:)
ME:G%4E4PA)&]]/X@P!)9O7/;R$7TK*RQ4HD@W<@$==S \M=<;F= ]Y])=X]/
MLZK[5Z^TQKS3U4A*DW+35VI*]I.Y.]+=0AE2GZ1P)4G^QJD,NA7]FIM*P1TY
M!$MX]WJ>F(RD@3;J!<MH>?WO."GW]_.=SN<X4T1^1)DCZYZ;K^/IIA!@ &$=
M?SBP*:J6V0$J"B$\+!,Y!,?EP">?IT_KI:>3XH*00"8(VUZ;'Z8E45+:BDE6
MR8E))@8]))@SB( CY@!==[M/.?L^!P\%1(W0-H*0#,#!$?.)\D\\ CI#U#^C
MM]L*#=G9G>>C]T,UL/4U#9VB8GG,^/UYQ&>#CST86  &,08;UWMORQ(%@1,1
MI^<+)<2HP%&)F1QCZ?,2/)QXZ(+<@,=;Z-Z[L$%@E@"\_0.\'3"N])(@3$20
M>#ZXY]3,F/'GIRH)^V'4H)9Q)&A#0&T-]?MNX2Z,?$DSB1,D9C_C]>)GJ,@K
M+B(U?OEFN2,#QC8X5WI$^\6!$%$&) /CQF! Y/GHN( -+B.\=[]^#T!WD84"
MCE0((@Q,QXQD9,8]9D_6.-._?8CIZ.%Z]>ITQ@5]I-V7'>SV5->45';TUFH]
M#L(UWIXI;*ZD/6!"W+FS3PDJ/WBR.7%HHE6XP$H4H( 0^8=?5N[OO@%04DC\
M>7WT//'"!W0TPY8=1UC32 *:KBJ:(24I07)]ZV"J%**5CX@0,D$#:>K:A+V
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MDI:T+V+[2:5]P4I:=LO;[2U%5 ("2DJK&K6*M:P<E;CREE1)*B22:Q)XU)>
M[ 0UK-@2I6YN-3J1BWVZ:FHZ<MT=.Q2MIVA+=,RVPVD3'PH:2E(^H /494H$
M@& 2! _&)ZEE#0'[C'CWB_[ZC\R9/YDY)^9STW&K?Z#\8@Q__]E02P,$%
M  @ !#*65]+-A)$F^0  "5 ! !$   !G,S8W.3,Y9S@V>#8Q+FIP9^R\!UA3
M6],&NA-"[Q"JH*$3I'<0$0BAUQ Z(A!"+R$)33U*[R"]HW1"0)1B 2P@18J
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MO;_H_+N'ZXGY,5I<*#Y@IS(],7+8 &P@-HA(H(Q8X:\C]L1H8KZE4OLO[G:
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MJ-A!7WN!O0  HJ(&_?RW1FEHZ4!@"#4]%0.EWY,- *C!$# UA):=GH4&1 V
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M^W&'&ML[-:LHL!H;<'6K4":M^%DUIRTQ2DJ9PP]@6!&P12U^1B>37 #CEI9
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M\N_=ZB(\/:6('F3$I[VBS:(1&"./6YM[U024KYH)9O.K27QPJ,\*$)D8GOO
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MH?$8XP8;F\TPK/"J2LE%NFN^AA-Y6JET6VKCOIK60\8<8JVA]P_:*N:A&I$
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MQ6&^%Z;$*CYVNIL)SX-68L2,.'P>/\!W8>]EJ9@QD, G3\-O1GA$&1]B C0
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M<=&$$G<34J,&,+.%S"NU0@.8T9]VOBXKD;"TD<ZY,79HK.@A'IV]Y$H8IDS
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MS_H'&V$Y>VG;E+\E2=K_K0"M^#?U&]]]GI%GWBG? MX'[+>+'(C53W_G;7T
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M-93MQ6@.D-5)X>ER6?+0"2T0O^A -$IO%3LO_]HU,*2\09"<;TK0'%AV7'J
M66B^NT7VO4PFWR.\+):8EU'LGJM8?CU,+D862UQFB\2QHF$%R=]RL/P'#4^Z
MRS[JP!^R<B!1U%\X/5$(I>'W!U"AHSXLJWKK0\XFAFZYV1^ADD1IK=$TYWQQ
M<)JX,)]\I+:/&40F28\F/J_"1*<W4!JG;/:=OEE?NMWT#DW;=.:H(U95=Q0X
MV,='4-'5^#W$KE<RMGEKU&8-E-:"2 )4HW.O?7#;%+5[BK^"\4%>V7* X*WV
M;$4=$)S(0TO='+@ %%C$$Y(=\;G0,)\+AUR!M-?/C#Y_DM.]9H)LM!C;&*_J
M_4,%\P(^@$_P'\"[GV#)2MK(!K(&WEI+:Z3TP<\Z,!;Q\G*H.:<_/:G=;<4Z
M=,3T!YQOF!8W>6;BI\<8>" DQEH2&__03ICM=6#G!_CLRF]Q 75-!H^0/LLL
M'MZ6*.'VO-H+>2P[(E6^G+Q<N4)*]_F9EDJSL_&GZDDO5$I.->Z$:$.FX@'4
M;#!&O+3&3W:; T5AX]W6U'9)KFBFB3),E*S)FJMWQ?-">^7@RFS2-FE94:U]
M*5&3NOKR>R'53%/;5GR+1;GV)3A;Y>8J7TW14E/<SDRMM9_530],5[_'D:-S
MJJ &QBR;1A55!E9]<LFSIF-2%J\(I\0?E@VD0=#:;,;_;BK[N?,H0A$'_-1P
MQAP!.\%\ 9FE+N#G8_8\1U&GV0_S)N_J8E,9)&J,S$J$&\8I>O' 7S!-PNR!
M<CSJ&#NU[E^7A+'VVU1^GE%E>@U?\TC"8V4Z^%,C-4ACMKLQZ 1C>Z"9A<H6
M<*K  JE. X2AYO;C,Y(4):5.)IRTY5\2FFO<<DR/K748^9)5D]--*?R+QHZ*
MN[0WVWG@X&3:U*O":G5PJJ3A-47:P&IA(_;I"RN]&7F,/13QL5N@8&;\-"U/
M%"A=U4#Y_L.3F4U.@ADHX#Q82?0PW83T)!0F*AH^,5SQ"P?D-"/E%?U3P8=#
M <61"3C\UB[Q82$.QD'$A;&5T<KR%6NE]5&-!T>ET?HD,$_FL&&.%LX,G,V?
MPH3O5:B/&?1E-W$2ASCJ$4S11-S98I.GZ/2&17)L6;;5.VOV=$;*YQ?38)B:
MT 2@G2BQQ>35-)T2IQ8\] O(>-P"(Q-82.XKG<L7'.K;1;U;0A_LD[GL,[@I
M[4]K.\D/2>-XXX]:LZS,J,J%WK'[=&0%J?U>.-WK5Z$'5TH+8IX^7\&&(4_^
MZK.QBXE#?0O].NF$?67&QOJH.:D5]][@]4B>-Y8'(;59]Q @^W;Y7M]#4G^(
M:CSW 5C<TO_N8)YR]"/VJ\)DOSG),ZDT_699JMXH:-OXMXFHJK"$(&9+*.LZ
M@86*E"KZ46^"QN)*1B_% _8&5S7&2Q6>7L9V,02$,M&5QU"WM=L=V47E&L0>
ML7>#Z^0T9D1*?,4*#VP1U$!-Q,B\.TRD3X[S4@G<XV.*B/XV=LP*:K1=XW/8
M'L%,H[/.3[>4\M5H?>N1Q21.GQY_5,5F=:IE9MU1J3,MI3Z 2O8B>\MDF<DD
MB0IC8_#.IN>C+U680L+-=XTANFZ(=QE65U?N+.&]!)>B0+N>O-Z>N$:!0631
M%?2TROMUVI3RLR UR25;G)Z*O586F>1='3=W>XLW3<6I,2PUT?M>A8U>/?9H
M8+(8)J4#11@RF=UEP=$L\$'#XG'Y"M]L8J&5MW$-2[U.$DL*%)GT=40/0L8D
M1Q1,:CYI/!ZA8&B$)T!*"3U[P,2:JB-8$N5Y[)%H1<W9E=Q1^;_>AE2V*64R
MU<!53;AUC8&GR)87F=$'52)CFB\_PP2=8FRTD[1Z9);CJ,D-"+'$RRGCI^EB
M](JB-VVT>T<>7%U=G?)[(1DVH=)LK-?P^R'?.CCANR.1(F<0%-7',#]^SKTL
MR9/\LSN%<%)J;G&+9$7;P=.1.%SO$.U,LU X= &W.YY!14.2&;02$3?B%-$G
M)@3U \';CUC/.%Z8":8LG3<[ A<[+![LX8E/W#53RF%H>,>$^S"ON$_.$-1=
M4]M&9 Y:$O/TM_$1L(\#04.C(ZBJ2T:%/$5MR@H9-<^6?;-VCI)#%6;$55PV
M<AMC'QS(YKA:A3&\C#8%_80Z]7="T@?%+>R%#N;S,DHE.>->]MBJXU5RJN$D
MZMDYMOQGM9/8/N5DTR7MSM/>;_&L7^[/^]9G7[O_$;Z&\=8=+PKUW%CZ?P#7
M]"_,<5E_%%\Y/H"V?>;,^R?2X=B13<ROLL,7):.YRMD#V'-"X';?K&S=D1&9
M6P5UXZ$R8<D03Y0&9ZD?/P"[0MIZ"NB35F/1VV6M?$>J BGCTH)%'E1]0&F(
M)UFH# Q'*!0-QC] C($/PP6UY5MZ:TB @VPHY)0]!*]KNF= ;K]8YWB<-,_9
M/AQ?8N61A=4)QH6")ZR9U9EXM@UN@%W!;NQ=88:Z]QYD>" L&YU\>&/50U%U
MH55M@ONU!!&HF/@\X#8<P 8&/QU*?]+$JZS,UB"!HV,45SHF;T."L6E4+#PO
MZ9""\A:I=)%YK9;N\L$QCA['U)VC$:\L!'-:4,"-,BK/K2V@1O%<E\4HE.]+
M11!AF46)EAB@@-VKI#.IYF@'IV=4#06&0+.8F+@942P +A,WE$K%LO!"1M,H
MV7IJB2EN0K_<&F3D&C78\CA>N6GGW5%6*;4A?8<\*]8?&]P$5655N/P>+L5[
MJ>(W'C5E[S#4EJ><M>;5[S!P#E;&LLNJGW:A4.;PM;U@:9\+=-6N*BS+7+--
MM+XE]/%I2 <Q >*HT#8)#5,B3!<<J0YC,3\<$O288.F<*> )8+U-L(_! F7Y
M9WIJ#MW))H4C]I%@8EXV3YWC:4UM14,/;"R)8AY QY]6Z@^HBJ#9^J:T@WE2
MT?1R7BP[KKXC?W)6I)+#\>ZEPUH9EP[]_O/PDQLAM,YMJV"8?WFW6NK,($]2
MJC*R4]<[]^F@H7&FP0>0G4?VI_#!BC:NO.?;/V4<['?BCE?N!R"AN?/L-$*/
M+"[Z :C^.HN*-1(> &#"8ZX<GUJ0]I#V?B\20\=6VE3#I%&$$<2EJD[[! K*
M\9+!KYN>N)U[T0?G4_7DD]?K]^&'N9_"(W<15!)8A"_I!8/UL?=#X+./9\PE
M%D.!:8EG'UU]7;W5A$H# ?BG-=6$'P CN,]%S*(V6*:O"@24^]=-1%LC9P@Z
M2\A)=&3>^Z ,1I8?+.4DQ..@:V)O:!]HY1V%2_>3/@(PZ^PXA*@F4_G2TT&(
M0]X;+ZD9-C5:(7]0=S"O_\Z*#^,Y8BWA0SP-6;YL%#^+HWI ?6K7)#4@T)G:
M&GAC##/+Z;$JJI)Z8/MI[\[&UXV8$!JO^GK!BB) C:>M@A6!R+"#X0L""QTF
MB"-1^\4JU=:].<00.Q@"$+/C7N)>>.S-=T4F=,RTV@.+'X+G=?>@8$<9 @<G
MY_L9*:^NIHL&/LC.CV1KK)!1X@/U>>#%VRL/Y=,-?>E@N\%*7=GB'CF.)<ZV
MX7!1[GE:1#3:VO?VY4U90C;(T(E_0&SB_P5B21M\4,F=>M<AF1^_OPP\P2/)
MUR08SSW>O)NY>V[G]1[25+U'JY,^&ATQ/LKURH6RU-T8*].F7C.'\$YX>J2/
MIU0&:\O(E]Z!@L!#<!*7\8-J1O)+?PADR^( F*PJX 8Y?F[X?<P/,;F30@F6
M\M1"9^8R3%S-.:Z8BNR1E6!($J +6H&N38I@P\*.1>7/=-.?*W ZI<X(8O%F
M)$=XI8;WT B-&6 O\XJ=B"8ING7&F7L,?4D4S&0(CF8D<'E&L#0T<G,SHA(\
MOFO.DD9.J4:0PJ2I%05^=PC8K#XR"\\R_]JO24>EJ> !PHK":1BOS!1B5@:;
M=0)G<7)& ._.^[0 @ECRL"JUYH.ER/5_QIA:]&'[N1Y9&%FV4F8M!7F(R6ZV
M*<N(%(2%E-6=8'X7JQ<T^!<"R,=9\Q?/F$^ _>26>RM7B%=5PG0@+N\QQ,DK
M;M&8SDB5!_[<&4=60)_Z[XV%032O6@X-.#:%B-#KW;EJLV.,5V3838DF"_49
MY\:4RPG31CE%R.'Y^X?#:(GL<@]?]3S39DV]N,09>T*2.:C_US5/*>@X!"9,
MXENZD.W=>V*;;Y,E\$>W^],3;9[>/G-1CP]3CP^"X%.XO8_+[R51O1J;[9=8
MN-H4%WKD/Y\KP5:Z57*[/P#9",/+>BO?]U?$L'T_E!=&ZXKQR]DT?1_BC5W%
M>^OMO#'?V%(182.T\#.^3>9\+5M[J<<G#Y/1J+<I1%]YCFVGZ8CIVW/)E3@C
M!\)QLF\"3M L0F#VB[V&1N^/''\B6%]D!"/]EI@SVWC6_WG]>!3!'?K9]E-Z
MO\E)W[SY0/?<+7[^DO=_Q?K:F+4^.#N067=[/H7B:SO;ML7;_E?6J1.OXZ]6
M;M8";FL9\G014D4EBT*!CM+VQE!JAS3IHDHTNA+K4$%QT-=X-CS@H;%<Y8+K
MWV*51K#]$)7+,%"D&!VVZQH8G)3%K''HWS(C5CK%\T.&P/4PZ\/\=;F/;/[L
MA40/OD >;) _IFYKME;+"9+1#W,LF?8Q2'L'ZW_U03W!0+S/C&K;P?K1EJ^^
MTN[UK(,<%@U##A&:CC#XP[!_I2 /'2+T:>A[$&#K<8MK 0FN)*3K8;[_EGJP
ML0Z\[M8\ U //P8K_)TUPX8J.QN0PZ@J>PKO>3,"I?!"<;G.\'[#Y!-H[MKA
ML&*[@1N_?9WH<1!R"%ML;T#=+"*9 T]YT+2!]&<@K:FQ.9"$QXA%]Q=RL$*'
MX,>FS@UT#JP;'D!CC0X5"+?A9D16TKIYX_5Z=J(1LW6 Q2JZ^O.J\ TJR-:=
M (J(1<!EMT4=@'W.;@GI,[$;R/9@'+R.$DSU.F)<WE?0]!Q4U+7EQL%>Y?<2
M0O*9=&J_:>V$"K"V'.7NBS<*:/[I_!!X&=B%0HYSZ(1LX4[0,2E:A:@D%" 9
MZ,8 X8;^V1)4[XSI0G2EZ<NCJ<!3'N=O1QI3Y\Z=9I$%XZH?6>P1BBOVBK"C
M'W$Q]IS>UH*1*4^!RZ\S+HY*[FZ[PH.!30,[5%%NM+>_!^^O8_/TQ@P:.OK=
MKOBL3K9_>[(<4I07_9D*(S,WTRS_3Y&LBY&36MGHDCZ$892BDD]PZNOFXZ#"
M5)V@ <D(JV!D!Z95^_&G)4)%Q_:87S;G[5K\]X<$H=MX)K<G9W4D4NZ][-]%
M65.QX'_YA1*^YP!IJ7<7R^^]7GTNQT0YS$\7\=J#4LV\'H@ISY^5FL$#\#KX
MY )WO(M97;Q[#(IZ%TM)(8]!9(1Y@LISGYJ_0.!+ ^/(]4T9MT9\E:N?^-V1
M]NH*UQ\W%!5H$?',9W S)@FBME[&6,=SQ'.*4;2<(;3"U'IRMJ,>8S-C:GI6
M_GB@[6(9PPN,?(_]8D<".(&C;'PJ4G)B6V1!R/0.RQ-\?82L.0AN/B;:BT(=
M;S4Q1X9%>FV)"H.2W$0QFW&R/W@:'=DG?(6N<L0? 7L3Q6X:.C$6-9W_!CM!
M?+KP0&(.I9K!%6(+;<^_ZUK_L&^U\PMC\1KY)\$W;^K'T_G3K?10Y)-G;@$!
MS0=%045/NRLC([:&1\WQ_Q?("7O]SY98O'B4Z%O>5-W W0? *FY<D2?\^(9.
MOBC>.=/(YXH1^;N$HUN0B6BT=AQZ7AZ>)+X]R1IY[;.\*SX*3T@C#7S*P)#0
M(4OZT4$4-0+T9Q[(H-:CO-9QEWS>B;6P*2J;_"@>CU/=90MI@<JC\IO,3!4F
MA5H<#2>@,V8K8^,S^;#H,&XY67FZEW"_F"9MN H,0^;316O\^M=ZW]IB1$Y[
M>3958K;&R(QI2JME.DET2IDL?7FWJ:(C C;#)[-T(LYY,[SB3SI]Y.)8\@U3
MD-IU^KM*ZNP,1@-#J!!2O($,$C&-UFRDX6.Q"C]\!^QS7%0GW)MU^' W:-U9
MY7*D/M,/FQ-EZEGA<@][7]QF$+%JFTTYL-&"^E3%.T(HQ@!N&"'*J;QGX7+K
MH2!'>!+.= 1_ '0Q==+9RYE>0*AY9Q=CJ2Q?[&L<Q36$CK,O<4%3,82J&'Z,
MGCE>"HF.,X):?PT3'K[K>[#45KB0R%/^/^=Z$A<0T2]4MGMD*8;2DC27'V[5
MYOV+?/')D=,ITFN:M^'73-1@G!S#[81F\%C+FI+J9#D ,ZRP,.^8*BI]!<)
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MM$@]#/#EOLR2K*/#[Z1W7 >K+H^'W;GPKZ6?1WLM5"D_C=['KC\]WB[T"7X
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MA' RZ?FJ?#'^N]#,+Y,RDJ=^^]Q[9:%TQ_WZ(/1>]_DX0S2S*6(8,N)OKDD
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M"7]\4J<P-[,[M@%I5DI/6;\[27>^HTBA7W=]BDH&G]R7G@N![F>$,2\K=,Q
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M@D#5QTN6DX7*O=E%X6@J6>KB$ J!@ZF51GD"[6HPX25?%.WG76+E"\Z46V6
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MRR/.9.*LYE9%+=G3*=/'(F';F# KG*V@+P@NV6ZS[XD)445]J2&\!1M/0N=
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M'Z.D!<OAO+2KBP@D7O"#A>OFQRCU9'>;%W/NF4"N!<<VJ7:,8BS=%N=E6E5
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M[[K"!]7C5A9DB#VPRP M,#W&P(4Y3M';+7;P'#089:D?.::[PO!X^(:2,"Z
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M4<+ TL-=Z2!#NSX3V5M8M/)03KI!L"+G>_ [.V-'%/:DU1W:!ZF-X0T<*_X
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M8: OP5(U_0;N% Y(=!_'>!Y=]ZWH/(3$G%I NL5W[<(WEWB%_O+_4$L#!!0
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M8OYK&(LYW&#Y=;&],?H:DMS>?W,\44SP2Y1:KU3D$D&3940GY^WOKB=X@J>
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M$>_= ,7Z3J*5\H6:5KY6+2(%:<X<#Q.0 # 7R0VL:?&='$Y9_0\CE $":%9
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MX:WIV?VJ<&?;[+V\8[CML+;=E<*=;]*_Z?OW6G6Z#J_;.W5W<+U:]Y90S]C
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M&1T4!5AD\+[U=W(-JU )WQ-.\)P'=; 9>8]YK)TYT^ZS\]AC+U$27[Z]H(&
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MA;F\:"!9E18DN94W!J0]_#Y5<1$,NO5M[$+46N5&>T>>C_;;,$3A(!AQZX%
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M3I]T7*^[7DK/^RE-&OCBAW".5(V0>@6\F.<@&EB:258;G=_8C^HOXGE;H3W
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MA94]1+>Z@>]) )>@U41&J97/:?ATELUA1GZ,QG^J>>-V6HP.OH3H(._DBB-
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M+0!33UUT0D $28Z](^N[\1=S3+I8%P:JI?W&?E1_$D< J70 B#TG=6CM2=/
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M7KGOI>5K=!"X"*P6'=Y(3&!I2\#0+UOXE+"%%9&&X*AH>K^'3]O2"KY0<4,
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M7/?C9Q;/T>Y9Y29<_JE><0=IW!AP'^B.EY'ZE<O>A?,4\22($+3YO,=WV5-
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M&-2B]5W/A6;493!HWT0ELU4"/N+(:?>AT=[>Z<<*KC_>\3B3J W$<,J(($\
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MYXJ4AH70C3")8D]W&U)0!%^.ZTOR]T2UN-_8C^I/+3:36QT@9+]5+TSO&OD
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M*(22'UVU!>IY8DDY!Z0V"P+2;P,;I9^)^KU-7J020SCB[5FLXHF=J<YZK*+
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MZWY7[9OCG(SHP#,0X"&F:)BR;BS).P D7F\0="5*%:'%VIFU( \_LFY<R3L
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MKV*J3#[+6.V/!KJ.V853%K+%O%/'\]R)TY3(:8KE-.VK:2JJ:4K9-"6#TQ3
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M-^E0U3J@-<?.?V_-J9<9H1\,P64PVJ$!D5X9- @*;(\TR]XHT#W1/'NA^3=
M61EMY]L ::1<<RD/4C#VOUJN2"M7F!N?Z1N>$!3OEJV'T5S!"6-G^(IHEM53
M(9O.3B XX2=X/S@Q)&F(P0D'*#OJJ@..@>YA_?U0E-6J_9'RX4FVE#$M<_/Y
M_8.';#ZM7N9SH+>^%ADO]895\QGNW#8?(MQDR$^1;_G'OA-QZ7!LB/.-,XQA
MS)MA3-DP;ME'^&_3OL.0-6,6A6&-EE12]4+<<AH*E,^U9_.<#)X7=3*/VLU
M\[8Z_*FY6L<_XZSPF PZF@\/%@G]LJ=I@1J['8*DFMFFXA'& ]AE>9G\4WSX
M=G.=EFPD^0GGJBBH\0*&C1!R5;;)H"P,+0(>>CF2$$F#=*=TBAQH:_FDP0]
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MDKH[+(=NJKMC<GK-G_JNL%O9'Z4U<.4?E=N!TC2RQG-S@1NE.I4WT[*>3A+
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M(1A0N]R^,USW.#2[=26)P$RD_R"T!?[<$KAO$'4"!V$$'3'O;/8@ 3_9T.$
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M6B7F*SGJD?!P0&;K&;3"[M11T#[!(KH\:[\T=4:J;L]:VA^:ES(S/M0*M[.
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M,PA*/]/XC+<&9W4DN/V9NL9I<*8"8+B.8:!5FAZB[># A&!%YE0MG7F94Z^
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M$I,F:=],TE+*G299?D_7AYS&HGRJEWH[$<,IN)LLZEAS.E(15L6%0])R>+$
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MN)K*(WA)*6;#69MMA("*:Y6A#\[J/NZ1(ACE\Q9%K1K0HL;4(3=@]=7%#57
M,;QWFPWE^<JT>9_L8U32W@+MGPT\IEN42-XH^8T5J^H.R?&E.L+[#-7E#F L
MP@CDC5<%?2QOO!X VX&Z4A#C4)8S6:43:X9X]HBB_;Y2F\#>5.3B(*^J]O"
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ML.3[854QHKY(GI5#9_L83CW1^<;*6%FS]1ER_ ZI/T0XA$GK4\,F)4#[ 32
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MRA'RE7*$?+^Z>G=/5M:#9'Q/8G;T='R.V:$#8NAEV*-YG.J&?X2S9/9%C%2
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M$1L@MGZ])-FAV+Y^9/:%/^&IO2#E1@:$"0?^!QS]JBFIVZ+6(O*9AC987.<
MQ-.^B+;B>>AG2LL;_@5>+&MXP;"3 'K9!K[[N*F:$M&6U(T1%Q+7L>\[K+:!
M1P.,=MUQ(4(&C79%TL$&<3URGP,7Z,RU4OGNZRWW> UMH7?QEEN4[4P&I)NY
M_NS*/Z/OU$UW;:T(@*Z1W$XUNMT(MMY6SPCS2C.FQ=*K%YQ*QP[2N1;]X-Z[
MA%G= Q%=!%"H>$8I ZE"[(I*0Z%A5TC"+0Z=SYMKF&C:0R\2 QP/6]ZN2B#6
M*7%EFQ?AO,BR7\E?H^T!]=#""(W!94.'"R0DV\K':2E0T:PKKS:,9\02<>ZL
M8U>&LT##CF7O.G": XK6NRWU>RWFTCH& JAC"Q//IA>$F@=X$,OG3.8=SW%W
MPTOG4 8&+$[G,V,'OJ@:SY7[UWDH*2T9VT*?5VG]SSH?T5D-W;I!4$Y'^<R/
M?@D:N;80UDGSF[H;_#KT(V=4IRC@T^FK/C-,Z[J:Q+685IZX5_]F[E1;#=^C
ME"L051JA.&$L>!.%"&?ETR/)1:D#4V%_A45*I^U&*1IO^#G*G^P)MA9B\)"R
M118E!F6)KDE"S*#S%(&JEX70-V1."!L.3[O "RI>G1]H?)&E![:,VM,E->UA
M8]"#' _$87D[4C5$3H_TY?J1-T0.&>N!,1 <UJ,"$L=WT2L3<OL0??$ \R 1
M/**'>=<!I&I-1/,PP.TGP%ZV#@#C!M!H@&Y S)1KKU$2/R0[>KO9B.]$RI@W
M%R8'6H)=?AWB4LFZXHGIO!5AS4C5#N,2K NSC4H]W.)=@=7.??<6[+(3[W81
MUAD )0= Q@ 0R79S[=*K"6,,T#Q)GW2GZ8:V4,JBX52'P+K=W.??SOKBR6]6
M\[L>XA=,>4QXZ*C/XF!P4J!)@SRS#MEJ+"C-@#7'<-V^'A_$&@ON3*+76-#,
M]Y!ZX-58\!]/^.!2Q<''[#7:EHG'-D.E@-]C#'"M&^&F:1B;"P_.\[II 'L+
M'4PT&PL=1D#WT'FVH<7_5]Z[]D:.(VO"?X7 XEW, %E 5_=<3N\""V2YRKWU
MPFT;=DXW#NK#@9QBVIK.E'(DI:M\?OV2U/U",BA1#*KF6U6:I"*"SQ,,WH+\
M6DUPO*8F\VA9182YM%0':?#?JD%X%3]@;Z[(N:W(@7K! @VD9+-L-9[F;/-=
MLCPY4>U-VV$Y9YMY0PD'&RYE$>E]6P<!D(F8F"G-E+W>W85;LLMA&V\S;>IP
MBZT*UX*GZ!C!@B%=1>=;:PH=)%<WZGE'7<6'W OFB@2E(N5^6GFRHDRM>6S:
MP=]HT^%L?)--!S*70=4V?*5I'F5\O@^-I\;JN ^E1B67!1^MPG[$3T;2!TUA
M#X(F.60D\9(<+_/7B3[%SU%,B_4J*7YU%1RO'8W*+.O[5F$<X$Z6G#:%L5>7
MY"@96V=:&"(F*TY3#5X-E^Z7H1Z#(^7G*3]]VT<9W07?[H,WGA%./[IH:[K,
MW*S58I AF=<0D4I11Z0$+6LA#SE3E>&9)\]%4=1TSS!$#=(_P^#D,M@RFI#X
M,1<QB=[]FX"82"^>+Q_,/3R(M^#3"S]F%F*28S[W]F'2;3!)]0?DII+[.),V
MG$(C(_PC?<H_QUF>7HJLSFQ44:![M+1#9(]+.QCR]R\TO!SYN1ARD\3/[W8T
M/1%>ES25,_)%U$?-%Z.P?A\L"M,C $63B6JL,!I,)-FG>GCP(.V4W,1J,#A/
M-=7]_&UPHMI$4_(J:+CHR*U!QX;PTE[DF-(97XV5H>5G+%SMOB:[E^22L:GB
M[BMK_(W]<)7$8HF,^:?;)-==FC5IP=72EI%6@]#[:T*JVJ2H_H[_UFJ B!8P
M;P#.TI#!X$<#=9RMCYF#L;-@AH1$T K:;$3F%2+S I$Y^VW?ZL*8MV#KV.-M
M\BIDX4 Q\P:0FJZ\ $B+06*>LA+QE23PONF0PW''@$BQ1 >Y7V-NB< ':FWR
M14EYAT&43.)A0I_&N"*:P@0_R-S]R$EI:YMAT\R8"=M5PO4!1$N>1THF8=(/
M/HX AN!3QTB^C 7S$-B+CI:+C 9BWL5T)O<5+:#17Z45Q .P^IY[ 1,-&0S>
MK\(1:,&H]@5ND#C-'9@BLN\1$H;(Q;S"??"V?Z'[/^Y3UNJ>Z\7^]9P&IYLD
MB-7N %35W:UEB![#6ZQ%+=)4(V4]PBOB$\6@?WH7B=UV#O!F\:Q..C>=="X[
MZ<@J6AL@:7Q/F=I,B6?Z2.,H2<73US04G/UXT:3"A-=W-CC"-1HX(AJ3IBXI
M*I.LJ%V.(JP^ZL X7;OW/_Q_3)>.2L*KDE"ADKO!T1"(W:$1 X6P@=%^?]FB
M_B--(YH]4AK^?)^6V9H>\V3_AYKQVFJNB*Z7?[!-+6H07H7\3.I*1-3"IP"P
M0SK(=]D;(,!/[I6LZ)5SW2L9K^5^?;"[>W<3Q?1S3D_PO?=6#;2-UK;4VEUX
M7IB(TA[ML@[LKMYD'1@=XR@/34]@E!2%\0[R%+)J]^!Y.9R#:2!YJW-'(3D%
M^26-V,0Q#'+[SUZS:>A38DEF8>.HX5\^8F+$$U$M$&L.1+40C,"VUNK"CGT@
M>TF.81-IW1W$F'.?1GNZ2Z/G9^46S^R6T7@\Q0I:TK<:91Z@:K8],TH.9<PD
MFB9EVSXX"AL&*=K(BBDWUR_(2$#.=2O^L'4R"=34GLP -Y>$7@(FT^<L$]D4
MF!!,-/&;@N&*.BXO!BDD'PQMHBPI"F]*HK'R1/P!Z2Z0B?S"/PC^H-[_T8%E
M</-'AY09,^Z;).,S_EUR]<),Q;X27P=1*IZ4NCOTE\ME\V_#1ES-QDUUZ^.%
MUQ>+:WE"RB98E$1X(\6C6WS0&6SJ(*S S55TN#%U9"TB)E&;A,K.(@0>)$%+
M$E:@&1;0W#?0/'!HOE;0'&Q6(2]</-"0GL[%=D/AQ<KA&QP'*UI BW=56FGC
MVJ9R,9QN6B&M/S&=MN/4L9NVUQ"P^&LY.?_(YN9@^'4KH2&N)[L69%5Y\G&)
MA8@),R*- DIY\5@P!ADU\,?P@H#UZV!/MZ?DHKRS*J^"AO..W%J4\]*D*.X#
MQJT)CP?X(6[4<!^"!@'LGV/6633+'QCG'G/^C/*$.$/="!HA-+II45;5)[R!
M#2F:4$0<&+PQU+%6*?5JK("@4$TF" 2=T.L^3?:4AMDU4YFO003,''<'?J6:
M+[=SH16T@E1V2">0+H-S3V4EPCN=5-6&]\HQT0?OI#[JX#TT8Y7IER"*'^@^
M>8[YLW5WS62WG/["EYJFM.1JO6F2EGVT\49(TPI).@M.U3(49.')V6K-]-[M
M+-D@=RUHW<9>%Z>=+FXMW.R;+IY_VGBV]W^@Y^!-I,I@3B&*A88I#2.5TU?4
M<>CK59+W>Z0I*]PZ+RTH)LKC1$73Q1\[H(<Y-FDAU!^2M/B9,1)58=6G(A_6
M-@X_TD-P.=;QEFS@ 51T-<Y =)#&R64E\6AW6:V>%R!L7<S2I4QJ1J)X?[R$
M/$UD6&H4231R-B:"<=89 MV"##3B+=Q!V(<IKX(T?6."&:Z/]:OAG;;IRS_<
M*6K/43;DES3)D%XD-I2\?RJTJN#=.MDXAC3G648!-.<"6>LP3'OM@#][_)1?
M,TVC5\K&4NG,RJ !9Y?)#'0:S-J;HV%WA^[*%_]!@*O5 L:;F7C:N;LV9XK*
M[N4Y%$C"KM#9Z3P6KD?M%4S^0\@[[]"T@#Y$-K/0#TR@0[2/@F-S(/&:\ETN
M^-HZM#D?#K"J]34[M=JT15JG.<O6O!B0/=#;BW.K )2##ZL"(#Z=TEF:M^C,
M_M=0F?WGOW91?A3N*8Q>H_ 2'"4).Q5E'9!0)>G@-BPOQWUD4Q(Q9:?6QA5*
MM 9V!X'?H_SE@1[%V):]1.==\BG.^1$%6>[.2:U@P4:K'0A0B/D]9_29$FRP
M#IN7U:;YFC9]S;"HPSPU(W*.I?]H(P+[&J["NOU\+(N:%IIX!6CBJ"YF.^WD
M_*2T4UIRG99R5DK0.@OB6/8E[[+5VE79]\R<,]/8(F/7*'.GG0[-1_(UV<EO
M.WLR_7N0ID&<\Z=['J+GESR[N^19SN2,BB,6BHFSOJK#23) CW[W5%7$,U)%
M)=*JA7F7>XXV#%1Y&NQS'AI@7Y6&HJL_885"RTW^VV.097>'4J:[5$AT>^',
MOCN(W#3%TRC!\4C##V^5[&5!51Z,V2V[S*D[VPJ#>UV\13Z[*<N2)"UHN"%%
MN^+6=-TR*9HF3V^DQGI5 VG+: &;)*=3$A>97#;D:U$!-1NQ'? /\A;;0;[3
M(9(-]H\T9U-7_K#-Y_@JR%[J U8?HVQ_3#+U2K-I0PC#)UA'Z?##6B!-$_S:
M'V]DTSXFV#2$.[K.5Y8%;23K*+MGC?@PXIJ!53;^FB%UQLRX=;^T^K9LZCM:
MU-7<=ES./CY:6+^KAS>,35P#<>M[N5\EXCJ;9BJPT)E'+@T$T$1QCH41GG(8
M&W9;L;5IK-JIBAV,=O4PB#9;%3V*(]7JU$-0)!)O>!<BCH *% ..(&K&L%*U
MK42XM*2K06542DF'+PK6,TVC)'S,@S17#BL@@5M_K3P>WVY_CN*8__04'/EE
MGH5T^!2'"VGPJ?B_1'QG@Z0<V9TQ<F%8@X9((W@G32E;NRY=/U-F*I+Y 4EA
M5ZY )JMN-*OR7B'$F%"1/1BQ]'#HD&=Y+(#X8XR)KUU++\2C3]]HNH\R,)5:
MY9'8U)983ZBZ-#ZG5(+7\E*9O%C,&@!$1:YET#&%7R"4?!U8W?UDKIYZ;K.,
MBKV2UD/MO]* +\V$=_Q"Z"5-^6'^.+Q-XK3Z[X<@BS+=:^H6O^%P>FC3,O*U
M'9X?JZPAMA#;3?CP<KMU?/0G<-;!X80VI6!%%HOS)=^Q;VG>BI=7<0AJA=R#
M%%5-42+*$E[8@^?C=;;O(TQG>#3 :!^35U5"!HWTN*D,-AZ\**_O PATS,^3
M6@</WS7A=^KX;1SM2[J0RHA@&M5%"ZH-J>H5%\)\>',7WDLZF,F[R&U,^.&M
M&HO?1-"J&>$T]3!B-XD&@QO$52%2!.?X@QRH#Z2QE*H#W$)('<R)Z.T?<?*4
MT?2UV!YF\.?99^(]JR5F7'U=M*.F@V]C0'E!2RJVGI_>R( <'@SESO EI=C2
MX%K-[/\&\%:7Y>^L;!7@1O$N6'LEH/B$6 9H?8147^%)M!2+!>)3WKPKM@BR
MEE@[&,#*S1F*YM"^)KWDH*3+$Q(#*57/*F GB)38='!B8-R@;OUM*^+G]Q8'
M(T76'2H>>I MAXU=&L39@:;9+55!:-&O8OCB1:RG\LSM^>=7]D72_F0Q(\U(
M]Z/MA5WQW4T32&U(_>T-85_'.3"$8,[B]-JQ<=(;<FH^GI&\:H,\T?PKI3$Y
MTE=Z1,WMYX"STG%M.<(Z<7>MT;@9JL-_7K*<:Z3P6+J*#IV.5@?96H) =VLF
MU53"H;NQ(D6^U]Z;.X%4"Y><A &K3RL8JFP<0&]:S>X.C]'I?*3;YY067NXZ
M2:\O/#O*IW]=&#ME)Q\F-N;\$+NAKHJUAE9+_,A[T19I&N,9HTC1'"G:PSP-
M;T/O/J>*Y+:%WD%7[T.A-QW5V_VQ^BD('S]XCP9OLZ/YF-UMZ_!5(9U01_EB
MB*JP*_\BD[5OV*)<Z4&PWOF8(O%K,;6X_NW=[6<T/BL1T>'K\G  \7&*D5N/
M"-MB4G7.JQ6@MS?M9)S25G-\6T AO_2(8'LNW-F$1:#<##5:\TX25FI@O;!C
M@JFQH_E. &5R3M]JC]@B;>_E.C/J BN[(C!4%UW&:9_8/$NGJ-')/VH;(:]#
M</>P ]%\\:YR?Q)Z;'4 E)%!5Q%YL4J9A$"V6(6=76&>(JWUJE"J"/9ZE3Z!
M @Q83LA1;+":\4)1QR$E5)+W0524]8H(4\3W#OY:]/21KX6.ZW.0K1'N.J7_
MNM!X_P8_#2FOC7,F4J&-ZN1M7=:O\Y&ZOE&<DM1U#-JA@%H:^&E'56WD3?JA
M-D"8^7324-\[D&U<2=>@ 2VK]XRU%PE@U9&A-J(/[/(=3N)?IZI@TT:&-0AO
M9$!S'0C4__R_$4V935[>;O@)%7@LH&P )QQ0ZZ38L*W+%Z=1M[_Y%1@ ^DH1
M&P Z"L]K#X6;%"@HVL'VXPH-S1#I:0RA[4*05]3UGUN$%F?2!$W>P\.)L5H8
MZ!N57C7B%A4V1%0A[WT)(4!ZZ&1&H8<</U(RR,&#!OT?)T'_1T^@_^,$Z/_H
M(?3E>NADQH;^C^;0_]$3Z/\T"?H_>0+]GR9 _R</H2_70R<S-O1_,H?^3QC0
MC^(@Y@\>3MXS!+?@DA)@K0;TJ&IV[BUZM(MB0[76K17_=E@,$3D@EAD<UY9"
MX,;DBK+5SZTS4< -\,*R_I9R>?-M>%VN=UO.OWO+"Z!NP5P" \C9N,5B>/LL
MDUP_:UX%OCOTGSW['.^2XKF:1_Y:S0@_\45R?J,&Q>Z*1;4)MU^SO@]H9Q%I
MGLA.#B-/%$8QR?G3C.(1(R&>O:#AYZ(?8OH<Y%2=W=NO[N@:;?#F'S-:SI\"
M;!Y^PK\BA.<^QB\:K=QWF%U7\@*TK4M/I[X/N;1]2%3XD+3G0YKD)D_"AQQK
M'[(WI8.M,^26KV;K['O/9*$IBP<6&1XM">7[ &G+]DXS1,!&R5K&%0Z42W4+
M:*A\I"F?M6S)N;;@.H=-JX[%RL#IGU=9=.ATX5TFC)Z;_NBY:8;/#6#\Y-ZE
MQPW$[/26PAG1EN$9"0O?6T&.))W%'(Y]1;/NWW1",6%Y"YPJ'X2RI+OR32Y,
M[9]T#WIA']:QYG-L97H".1R/U@"K]U#N#F*X S_/NO3G?9^ZF-O3W3I>)8-X
M89U+L< CM8CK=7 3MPTA B6/GK]UP]]%%]Q<D!=E<<V0Q(LLI%$I=M<3[4O,
M*]ZX VWYVOW>"J)]G<6<KG3QK_*@S_';YJYM6*DY.N%>8\ +HMW"J4V[G/-H
M75_DSLP^QY^R/#KQV*7^P-VA/FW39-"P'@G;D\OW$-EB#[A=X"\$Y$MMM8CM
M,W/,332'SUIRKBJX7K!SFO2TM#9?ZUP>,]^A-E\D-Y_W(;EM#[/H&C^J>T%9
MYK?E9EZ76NEOW(P13[ WS"$G$K99P"R?8Y\@&Q7#]V%SNGV!*TR_6STI=G<@
MV\=M1K@X"YT-,T\!C6;R[A:W,,R_QP$P!>.='?I:FN[H![T,:._@<%? I/'O
M/!?$CH_!@0I#%H=-'BD-ESW/94FH[V'H@M@>:R![W%Y_*D>R\A@2%V^YLUQ>
M#&Q3.J0[S!5F$YX@*\R6<;.M_0"754_B;!!TZT;0A\3)[L3! )EQV;2\6,.
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M4QC0JH=,@+8&4_"/M]5KJ@WVCBX(/Q#\#\"#!G^^3)V_3,!_NR(R 3HZ3&
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MSB8^ 61[_GK#J/PYIR?5X2EY%;RY:EMNW0R5?.&EB2CNTYQT8'O-3'1@> S
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M$IU<N.Q$"/].2$]J\?U<KE];AQ8.JUC*Y\-EUNF*PORY,/]9F/^U^ACY$^O
M,#D>@S1KWJ1"N4_DN\TG["U_#S[/SBZU/U39O5#RM;^Q(XCSKK\'UMH3+YE%
MPDM:<(F'5^<D%<^$EN%7D)%]*3,KR;QG<#X?WZKB893MCTG6G+W@>TC\CZQ@
MEZ[[@>?D]1E[\B*+44R32S9.YXR<:/Z2,$(GSV\KVK^O.VR;99<B$5/VJ=QL
M$^<7EMBJ!WQT#;OR$-LML '?#,VD]6&^ 53ND8IOKVR7?8HMKSL.8Y^<3LR.
MQ1X2GZX&G:%YE7O%8'9:VQ8&4]-OMU:<K2HS967;"W/-J69;9X%OK<&)*2RU
M@.]JSKP5WR/-!U?FL SLUBA='!XG05U:.*KZ1;U+'%83@7*WYUR:+V@$6J4C
MT_'1FO_2D='O:S#W#.,O0>EI^5.#?$@3V1I8E+ZGRJ2Q2WYT#1=C(+9;P*-5
MGRT?SA8O@(I I'Q4M_SXRF[+3#%F;8ES98E.2$:_G9F>W()LNA;PJ1MOA\\!
M6<DHSUKS/W07MRAWK5VS 1/7;Z?WZ=LY2D5AV-UG.]]8@TL;L<P2MY?KK^#?
M2U[(2EH55^%A9$2QYE!D+)FQF_:[B%SS\BWSCV(1;_="RT5'$:3)-K9 55WM
M,<'T&.P7E[7*\^JDJ$?X2FBYKUY41=ACF:E05"C46I4MUV*S486<;6,8X*VS
MH^ :;*#%_67[R-;31.7WX#O6B@J.Z0R[C%*4]69W=#'979,4N-GG!BXFA#0R
M_>@M+_<[1*!S..4)?_8O_C)']Z0-/X.3707G* ^._-?B)/;< WY3ONC;2;Y)
M5C,^LE<^A]-JR^-#>%9,TBI#@OHQH&(U87@8WONC=M/)->E,W71F.?%'559]
MS;,@W6(.F=^3;[#8Q?Y'^-\]>!-DS)1]R(S9T6D_:]_R0'R%0_M^1JNWBS)>
M]+?Z\8OISU9(XOS=UV3WDERR( YW7]F0]+9CQ?D#&8,_5"G*^!ID]$JY).HG
M2ZTT[6KN8,<.@]-17Q-2U29%=2(:)EOQP_"O==;!LGDB4%I\ &%:LHQ9. P)
M5YK]XP>)RN@/L5ID1F?FXQLM0'.DY>B15P3("P+D@A[%#\._T@(K48V5,VO0
MUIK' B[/1\\VUX%)^$KPGGN>ZXS6XX-FNAJ?/8I#6+IZ 8FROGYA3O(C?:7'
MY,QM4EXCA;R'I*_M]G4D@#8CCPZ)6L*?M^I5%Y#QWTZ:JU38U$-^40D*MI'W
ME:!(<W/D@!Y9<\],G%^#] _*KP1 2:.OZO* @%Z/P7)A444 JZ[D"5>FJ!,<
M^;E(ILRIJH*Z10\$UF#G'8@J)^SXA<8T#8Y,F&UXBN*(WW7AHQV4(L#Z#GD"
MU6B0=[ZH)_#5K>D)8VPH%G1J8K+'"'A]"AFASN]+"&6*O;M+GN6LAY@S>$B.
MQ^LDY7_4G7);X(-KN(Z@L]F2"4U;'R5?^&=)^=UUOGD&@I_M?))J[*V-K[!'
M*.Q^:YTL=9 QOD/0Q5ZA.)?7H8,TU\:Y#LPW\BI:VTT%&?_31[H7PR+YZ?V&
M+Y3_N)!5/L7A:FSRR%QK:90?A%%^^DZ<..#-CB4<TBI<=WE3-7@ZTL5=]\BW
M5N2ZQRRUI.MN?<^#!X06-ESUQ EMRGZ77DE*-]M>2<HUOV\VE=+7V<VZEU-U
MOFF)+Z[AUI/6:DOZJ?JKP[OJ*[L696S&D;#J4F6)A'HOQX&F$[M\*L+*I^ H
M+NF[M -\&N+$$A_H<Q3'!O..55RK@WEI:Y?L8"YZ%>'V=9(>:)1?F-Q+/ERL
M^MJ*0NYQ:RTYF+6^N,2KPS\7=HOI,\^[MG3@#3/?R"!VQ=WV\<CSOZ4\WPIO
M9:7YH/2\LQUY*TBW"A?56L_HY2SL9+7B:]4'EQLS8&%6Y. FV=K9>O$@VVTW
M7Q[YLGWB>XW[_'O9[3'$^X(KB89@_YX<"[XW^1Y=B$=^ WWFAV+M?Y<]J-EF
M^;X6? V='M*0XM<X(DW W5W;IK)'.*T-)Y8%\6E4L6WC*8-+9K@51M5/)R\\
MRMAZ"GAIRU=_]WN^O@C'C;WG(@3WPXG"]P>1@G&P!#ZY36M6=79R8*UN<C%+
M_QL>-<"(/ WIO:YC"5.>'L,08HV'%R8_$F;#>W:.,^"L8[C<R9]BZW^;S?TI
MQOGWV.\W?H(,S_?Y$8SKYAG=E\6PEC-,I/ I*+=JW447,H8/4:XU/%_4YJ+R
MRA<PS"EM??7"G,_K\)8C)RRP7*:Q*&ORF^9V7M1YCI[-^GX]Z'SKK_ 8UT+4
MM^Y:)_)^[B/K(BYNI_!MO7+V]);51<I'T,1[CN6IONH=V?(9V93R')=LHL+?
M:N5G>"[!,:?IJ3K2,^(T<<1P^B2Z4_N..LL9*VX] #Y4$EPU$NR8!,C'MC#!
M/'P1>Z5(AC]TC8_HD<3C[<<9Q9O2K7+U^XU<DOI-Z\$KV+4TI"4.R>7X7L4"
ML_RXAHS-/RZXTCQ)FA4M.4^S-MXQNEHJTA*+<+G6>='.COT_% O1Z&$M#NUM
MK[#.X/PJ/*Q\6U*FW_L%/>PD:5;D8:=9&^]LQ/?F8>W8?^3$Q)J][0P78-O;
MSN _XE)"7.W" 6<(2ZTEF,NQEL6$"1:VO9H@VVJ5 1,A,[T'5JY<8Y7V8;4K
M*E,Y;75)!9703M94;!';RJ(*$X:4V4H,UE=L/0@RUY3!\W,J[M%'3+XHSJ*]
M>"=RZ05L[6?7,L;H[6=[2-E67_Q<?5$<U?D>%J2!8+3J+5TBT8ESG(A(*[ZP
M_C:I/X[U[JRED]?-SN0NR8-CEW/+W^O0?-ZG<Q!V[.E@U:)[\*&68*%WM=W>
MY# U[SJNN5FDZD(7-$ \787?:RU=.W-VBF^NR,.I+.=LNVMI=^8DUZV))3O:
M2^./#4F:<FOV=5IZ+IC[ -NKV5DB[FKA:%]J\-%U;C\-;>=LE\FG.,V5,;_?
M+2,)"1?<&9(P<!4QV6]B>7$;A_PQJCW[YR[A/[5<LV11:,&8;89,*XKIYEA^
M2=?X6YD>.PY))1G)$_%S+R"LY?L^0D.;'?*/^HZR-&Y$=[>87L-V*#G;9<S=
M)YDA^P,],SZ\\+].25N ((/3'11WEAU?O 9Z53+B52NG2EJ"#,\T"5D(%X9P
M:3!<J _6_KV_PTFK:V)G?D-GTS8B[C:48ZX/]Z362'3X!A4VX6WL5J4MP@^V
M[I\%X4-.^ ,G_+1MK,5'HYLH>(J.4?ZV_*#3^M3ZQI:VG5P,(:3^($86%X?&
M:W*UE%<(VF, .2YL!46:'X<V*)/Y&!E@A:/AP-<L-.@MXV@<CVUZAV-W"&N0
MYLL@U4V<X7#( GQX+0,8Q(;+#6?]1#MNQK?E)T%3K#KFTS?D<Y9=5CS3 5/4
MJJ=WRT\G?G\Z3VV, L\U3XNHR.MAH5@%=#@<*#ZXEF% 9;/EW'^YR?"=.'T3
M&XX[^]\\N)RR)/&L.GDWK'/BW,W99\.IEW=*?';EK94\E!6I=3MUK?7<;'5\
M)^[=V)KC/OX[V[]POWCS?;C\B=RTO2MAQ?FC'[[\3?&\]0+'+L<_MZ(#EQ)[
M+7^>:$.:9XR+SZ(^VKR\"?$B>A?<LGV:4D4LQ"CT-HG')&NY\*4B4<B7UQ*-
M@JRX7$3*/E^M-_1]D"HF6]H?X9GV>PA$X<RT&HPZIJ63@'0&/6T$I:TD%W%-
MSZR@9RM@76MLBOD2%5B"U46PJ&]0M8):'P]SXEM:>Y3S>PF.T=Y9,F3VC!!Z
M]S79O227+(C#W5<FQ=L]Z^I/07I\J^ZG_RH>T)(%PO#ZKL)9 XWZP&952567
M%)4)KTU$]>9ABR]%"X-T.0X6.V=HQSK_AS%UT()$4^QU0CT4X($"MID S"L
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MV0@T1!HD(^.B,)N3:W$&W 9;=][D133<I#-J!7^P=[<5Y^'8_1ULODT +7!
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MS0CG&1_3/"KNK]X=QH\T!\>K))->/C!IP56H;Z15'U?MRN3N4!_>):P^Z31
M> L(6\28ZCF;Y)@CLS/E08(E:-?87O\E!^GE =9_>]:"\9ZQQ%%H+SZ4:12D
MBP &#;AR$R8ZJ6[HR"A4I9; .$:"IILS!V&,R(Y_P($CR#W8ZCJ99R"TK&_+
M-PSGOM?EW+=,\QT\2Y>&875=>02@)I!5#E(?RFVJ(O@!QQHY8[\)YCK$=PXX
M$.=G=U-S&+SIIG-=U?W),?EZV$UTB@IC9'?Q/[)I:[W#1KQ8[1W1S6Q%M-4
M8?$=:\*W)5\'*OJQ[BO#*7SE5P929 ).(IPG!#-$FV_DF2F^'\0P)X*%A:I?
MHS@Z74[%ZPDTO([B(-Y'P5%<V>/#:[''^7AY^B?=Y[OD<WPX"NH]T/"R%T?D
MV,_!-UD<:J]]5[&J18OT,5DV3:JV2=TXJ5NO<BN6[?,DP?472/T)PK[!]] 1
M(M]5V\=9'&V;5YU8VTM2@>)Q!^ )*O <:O!D-7C*1QFS!CQ1#9ZT!D^P%RD8
M;,WC2\F8V'?QAR3YH]!Q5#7- [!36G+L-\VTE'4BWX1B'<';*0F_D=$<\]E7
M[W1V[=\F8'K,DV$!VL1GV>GDO.CD)][)4=G)$A>$^"IL?;!M>\E?DC3*W[;?
M(M C%;T*&.]1]&56G$"LBY(OO#!JWEFUS:5O+(P:' DD'Y-3$*DR:,BKH *E
MEAL&E:*X9V#IVEX/EZ[AG0"FDP;F_[^D419&PMO]2D]/R@0/VIH.X:/78ICV
MO9/MB+0KD2]%-50T 3NF#RI@KSC!5IFGY(H?@TO?M( :+^X011)Y!XD'BF)]
M#^0!9E0&[P-%96TWM\C*]+)0>$C*N[PQ)I%X<,&J+.<A0I1&'URN4EE\QMS[
MEL7W*2^M2&<O*^AJYCPFXR!%554&+1&]N:@HE_S4O=Z9?"[;Y:"YI5G7!V4A
M2^M2MS2_&4\[TOVS,Q[4\HPE:+M9Y"JX'O%*H8XC0KE#>;?_NMA>H/-@B-;:
MR]:RZD<:)Z<HACCWT:+N4FN-R3F\*5V7PG7QQN+BN7D% GJIKI;M?F!.*U,8
M3'7W\R?J^Q<:7H[T[K"-\RB,CA?^<-<CW;,Y'K_M_NG;_G@):7C-NH,_R7+)
MRS/7GX(TCN)G?KA*O.4EN[V^U(=<+@/8MM%@U:#\ #^,WOX$:;Y!JH\03@S2
M^@RO5'V([Q443^]AWK9?%EN#I8E%@.6$?#,%OE%D#;#_"8>$LVB7P=T/6_2Z
MP<UBL!2$^NRRC9\U\$I[O=M2^^MAE/2^M24ZX5XQ7ZEQ5N1FU-?<K=)I#0[F
MP]MX YJ=]T6_NAYGI+$>E(7XQP <H,@RU2 00B3@;7"BVH,)^JKH5.CH <3S
MAO!:7IQ8@'8.#)S#GIFQD/A(4P[7NYA>)?$K37.>%?P^+=/]B4?;I3N&I@VX
M6G0TT6FP\B#JDBUAM4FK.JGKD^(E>]DNHX-52AOZO7NOT@YM5=,8CIVU3APL
M@E9 K6 R89C<MWKM7/=:)C!Y$BW8VF,H1=Y]3>:Y!D@#CET#2"=I-[#:GKN&
M6?J]^]%GUP"'XYAK<(Q%$]<P#Y,YPZ1KU_!(:3@W<("VX=9!@#63] >O[W\$
M845+G^,(,X".^ L$=!JXC+G]E_'^PX@IN.!SPPIH&^X=QQQ'+BCE?7QA14N?
MHPPS@$H<A[^QQMS^$XX#*^+8L7+S8PY8*PC. Z:=TGWP)E;@0.9K^I/O+L0
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MLD"DH,\^O'7^ DY$:-0>2KY!,XU5:07+\D14(.VV-N3IK?=GKW('3NAU>8K
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M(<E7_4%RG\1O8?%X@);&G2H@ 3_/'2HX!*'6UICV";V/TRR8_8_P5;NGE54
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MD(0:,#M ;D,Z=SH5&+:&\O%G/U$+(Z$#+;E5NM(!JZG M#F4D#^W5_5 $FK
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MVVYZKWQ-'RRR- NB<1A-%4SJJH)\O+!@V^$A^+:V2K_FB]-5-&;G_")(D@_
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M>:I=K\/=CI@,#;(.])[9UU M5_F0T,#Q=S@LSXGW09)]E)*&M7I((KI@E$-
M775X\JE=QT&J0W;KBD4K@)#9Y<^, _FPL@;J[T##R&SQ[P6T=_76LA/'[J>-
M'J.55P$6VMV9[7;$R,!/U8'>LR>'4\F5,.6KX?@\)$P20QU @JB33^UF<<.#
M=) L'ZK!K&)AG/R7"))URK++( LT%A-M?4#%[#>HDSCI=&$*KJFAU8X6?,<D
MP%=I%LYAC96E7)87!.C,&_1JO,I0R GT)97MHYBBR>I!O,;)6AH?Q?\W6@=-
MZH.@F"_'JM%M 4ZN!;YDP<4<LN@=AF^(_'L1O@4SW 28:X%1_>%)K[NY_E23
MN3DXN19PO[M5?'GK850]M<9U 3GSZ=".5DM@<DI;>O>JN<0RYF/;M D0%_/U
M:K7A;8=/K@XMO8/E+C^7.?U4%1 'LXMT-;K5>(@WPEDG\,*EY!(V(6EH,&ZU
M=0 ILX6BPH2M!T0\=\1*72G+P&.V&(<Q^M^OIY9,QZ)A=<#/?*M>@5 K;,3+
M!)[,NNOT2M%X-WN2^3QLW@B(C-FEN-K,;(N0L)SP/E_U;9&&HX?X(YAE']=B
M:5DT6&[-*P-XKVQBML@(6GVQB,FB:6V-*L9M@,2\M*-9 B14PA<;V\W\%? B
MQD%R&::PA0EF@\EM'$UOPS<QMET)JC0'<O32 E<=*Z$S+5GDJ/U@\20C+FSY
M4UJ&ZX*FVO#DR"O#FCDF@D1>@]HJ%80A>41Q .B?V4R)A2#+%U/9VB/1QC8B
MKP+R\-(4IL9#\.N+[>M._"A))8DC^.>H2'9BNS^S;0KDYZ6MK!I.0D^LC6AL
M[T[O1=ML0KZ4#@UDK6'OY,3+([D>$T$VL]FM,"7=AB,,TXBFZU=*S/=;1O51
M!EZ=OZJ@(QCVQ?A6I'PH,CV8S_"*6B@6+\]2>DR$*TM+%C4'R1J3\ VX>+-A
MFJX$0NGPXX0*HK60")YYGVFO^?Z4X=3N]BLH3_].<8W(@- I7VQTBC19%FY0
MQHV@T+P\(EI#)/3"%\^X_0=0S=5!6Q=%Y-7-K2TR@GQ>^QWZ>N'3VAD^D0VG
MVO%BE"T!&9\/3%M .?AW6V>-C^"Y)=.?DN=O8OX,K;Z$KS!?/25!&*T=>0UY
M-FD!Y>#C2= 2'\&S+R9 V-;@E4-J[@5K6!/%X^69T P707M+;G$.UO!4@##1
MB?L29K%9G+MW+I\S*1 K5W%M;1#3%R]/BN;8"!5HR<[G-,M/.6V9U=[>I 44
MEU<GPFKX"'7PQ2@()UX13J/B49?1=DAYO@9&Z2R7A(6"5&X31>KE6; N8B)F
MRA=S(XZ81+R@$?U-%%>GMA>)IDV P$Z]/"A: B0TPA??O]T,+N:*H*F)XO'J
M&&F'BZ"]ONVP*_D%GO('RWS.+G!DE8.;?"B6"+5:A52/OZ=BLIBA;U\ZF!3>
M?;GLM$=U!TT#R Y?TA_MI>%VB]OO/ 2/HQ<Q7LP$(!R!!*"WUV$49B+W$MV-
M)CC_*-+VSH+4+-=+[<9!Q!V>OO=5RS7RIG(DM)'NL@@7!('=B:SU>7P=K6B9
M]Y*L!7RT^S+61H76O5J]I:F;V&V;&)X<,UMAM(+7#3,3@/XF8UHM5N5UBF-4
MD8NFR1/"NKI 4KN9F,@>U8KN+RL=\]IE*'+YV#(%Z.^HVEV'>=:IO3Y<O8]F
MBS%L.-9QG28+EWDS0%N[;]%M9FG%)JC"HF;<&B!F=B.WYT>WX%F"/XQ32JR"
M7;AB]>>8<NH_.<'+^QAKU7+Q&1 [>X9QMSKG3BK^GFKN$_$:A.,EMG3UC,%R
MTUD:?A9K"&GST7_*Z'!3HS6@J]U#SRJ]5'Z#5LITL>S^JMN[_37S5Z[7]/#D
MA.F05)M ^;AV(Q!_MW\E=!P[OXKB-WF:KE[+P"O7_K#4KPK[0;(V(&+>_SFA
M1+<EU.#W=Z3V1Z-D(:BY[S8L\@5S7!?=!Q_Y)]'U'SL9S$SNBQ2U@*J6'VTM
M6:IS2W>Z[-VJ<Z 6.P*V-?W;-CMD#_K4$J2W^E<#[>\8E3RAW/IH7(;A&+S>
MLU40O6K:?5GN2<Q?XR1(/HJ.&(\J93V$P>SK(I6K?*R80/%W-! /'[>_R>SH
M\\>;\.^V5[ER9[&7UW&R]P1O'Y.U3(N@O?XL[U&(+]AN"NZVDI[G=O(*RV.+
M_1FRQU^[T!K=TMNZ0 _#M$J!S]?UP6OAG#K*PC>;]:I^XT/V4/(V=+:>=#Q_
M2&,MA3O,;):"3(N7_ZHKFTE#0_8 ]#84RUP2?K_#(1M*J[G^1Y",RT,)\V<6
M7*?I8E[\5FM&J_ZA(7LP>[NS6UU)-?5,2/,'@E4"P-9/ *L/XYO=X?0E2S%I
MI)4YV;"%X2:0MQUDN;_D8++LWB#).Y?+5Q4X0E8:LL>?60E:/NAT\!SM56?M
M3_# 1KY?7R+,9X_^>ZAZ.HVL,V2/&]/Q1$RI:D".]H'MDUN&<QG/@S#2C^!2
M84#/;"_6$*,<JWM '.W$K&FDLD%@-_N8OF9Y(EE-4T7Z \KA0%-MR![W3XE_
MFRQS+%U\PBSO^'DU[NAJ("?FZU1;[G186-\JH]*ZB>0M'(G[)'X+\5+%@C^#
MJD/VNP(+#HWQL#XR1O(8A7'R*$:PA1OG&=NMF#2H#-B9'<VMN#1&Q/JF6#/'
M$SA'BAO8*JBVK>J*P\U=I5=[5Q-4CEXB8SB=;&P=I6OPXA(0=7REW4O8EL&3
MEFT.V7/JF'"M-1I5 =W4<V?-VX=D#_NT;RQ:]V)C=3"Y#%95 V+:=2%>=Z;D
M:K,4ZG@0/>#"@P_7G@=I:#0.*[4W/#EE'H-Z3N0CL 9<OR]";8!_C^+G%#:E
M.#YOHM=%A@D]HQ'4*MP\'*N5Z>> !F839AM:9R<-?V--%!F#6U\8%'VQNDNP
M:@<(/&YU"B@2_0]>!;[;$4WSC/\KA?SX%F2+Q.8^ND)K@)A[<V]/D'Q$5T;O
M]RI2.*9OA&BL+>J*PU[OA/O*PI5F&"'U=]I>OP7&,$VOOVV9]82L->P=]]I-
MRE!.Z8'=.A<@8['I(OQ/FH4C4,%E%L5*V5 JM(RB8#:SZ8G2G:KK(/=[8MYV
M$(TCG'E6\@ 9+&.+SD4D)F&5##O6K:)4F3.?U]>GJJ@/Q67Q:C(1Z%2W&4P/
M029V#B3VRF3?+,J5^4*UOC95AGTHSHNK,%% 7L1QPI1<+_K.JD60)O>#R/65
MJ IB?_T*;^-TG2.V_7B[G22U)I%W1)7AR>=V0_!*L\Y.E]#(A'NARW"VR%"/
M[*=OFQ:'[$\9J3G13MKV8 ]E)]F',_ 88<*2E=]HYS-,D61'C*]!T+@_6F3+
MZ*)=25G&43OZ&%# ["U73]_<RL%?.\/20_\^2+*M%P1:7P6HCABL!KJJPY-3
M+NN#4KQV(]>LJ2%[IGHS-G3CTP:MOP'>EV+]P.=@<KY(0WSQ#5:]_(9J,+DO
M,S@>AP7"FPA;RG^\%%D0SMH<IH-D&D3+W&P7P$<\"\=%_Z)QN;MY:L$ #ES!
M;.W6;#*6G;0/:M%REN7%<PK+";Y$D!1N)M]$]A*/;XJX.?$8K)U1SC_V"Z^*
MZ<).7'YF>'+&?$GDD&IB-G$N+G\#7];H2J!U@2]4'9 %LX. >V9U&B05@;>A
M,B4T=\$<_EE:8K6A,_K*(!UFUWX-<03;AL"X0FOJ7^S=#TA'\;TR@)4['LJ0
M#SF;.T <&><8QNI+G&1/(IE?BN?L"3ZDF[9EY4$&S,>"UJ9L&KZC^)P.J(!^
MCI;7 #DP6^85]!CR64;B*%+'59 C^I;?+Y+12Y"*_C01^595'9JCJ (0F4VZ
M2MEOTV4&QN]8'.FFXM8@%D==$43#?.?*NIW>D8.WT3MW(BNN'?$RK?\6A+/<
M5!67@D:7@2CYW89"72Q; KDQ._69\"K7B$I0FXK/:<O0G<$<*L:K*X7^:+28
M+W)KYS+CJ=+4K:L,(F+V!ZJN#:;H"#.,]<O%;R)YCEE6DB)P%9?59?IIU>JQ
M5WAX\I5[&U>98PH-P:FU;8V-T]LXR!_>SGW4TP<Q$F$>7%*ZR<!G'Y=F?-5V
MP;(ED%]GS'&VVE )*J$JOOC]E=:V_"XYO4G3Q>;.B(AWD=0 :7B[\"LA$01[
M8&'+ 150+A<8:W8ODC N\B:F=^)'_B=UMBF3!D!,732PFBT %@@)1?# :E><
MB?#\>QY$?P#*_O@M3./DXSR)_Q!),,5L_M\CP/,#74^BZ;40143,?!ZFJ6:%
M<- Z")CY_J^Z"CF#3^B7?<J>. MF[:\DER%FLHG&:7DVS30/6%%U0"+<YJ;*
M"J$!1=#<O)VP$88MR041=,;T[X+7 @]!J;TI<7?DMO#&R6(^1^O9Y#&<1B$<
M:_%EW+WWX>\P1PEZ)[;OXT,_5J]0/=4+]U_;]<:!342I-TD<P3]'A=O((+EX
MP9S]-U&Y1!B-PM>9UOVF5KO#SY^8IU<=0Y2%KC9HOQVU%<^5GG]\"_X5)T5B
M1_6MK$4KP\\]YLV] \[ERF0M!6\];!1(-SC1JT%[E6O9$LB-V6W#FF1K7:%Q
M=RSK+71<)-"3[ZEXC"?9#Y"?^CJ8K "CBMFL7XD/R26Q!F(G$^!NGMI\S!;C
M,,:\%=JK?76M8>\SMZ>^*T:-@'KK?$-%(IQ_E/^B6?[-&P$I,WL#-+;ZVPJ!
MR[O'J<IHU_?]PB##CL;P4$SI^2XC<^0%Y&J1OA5!GD*X<#10S^FRL@"*>;].
M"5HR5], N!QO"%;R_$ZFM$@+@VHR;YDL>%$@<.3NXGO0R><CYEONQM9%#697
MWBZ'%V;RN==%-Y@-<P3=AL!<><1T/<[D<X_;B\&0$.(R<AN(*^>4#D095 HT
M^7QTJ,9+!5Z/'5:<A99\_L0]&=/\&!):1N*OZ\D%OM::9&C,R5]&N0\^4+6U
M,[*R'DQNW$Z&*K;D!!L@<N4!PD S="W,KH-1G@M9,U?O%X:!P7P?V=A$38'U
MUPUD&Y'^<4-)<5!W[J>Z"%I,2"QC<.7ZX<I2<9Z$XVD^P2SS5$13M;6"K !*
MS?V<(2EUB<U"@X/@R8-0KMLXFF;F&V%9<5!M9AMN8],K#9=@W -3U2XF[10K
MKP!#A=FIEB;'C,PR#L+YP@?#4_X\8+[GTVY[]\J"[G>,Q#(IQ%%&#H)@D,N$
ME"99B3WXKPUS\!^;]X\?1R(*DC FYEVR+"CZH=V=:K 2!'-9FW0$+_O_/4I?
MQ2B<A&),3K3*\B I)B<G#1\2\M08" (]L!SAQ#28]/$EQ6DN#<TN25I^V/O,
M_<QD8_LD%6""=@^L2R4\&%)S!P VOY1]!;0+KV5+*#EF$Y2*4;D.5,-(:$?S
M1BG*_ZWPY[H-82Y+,=S*++>-IAJ"9;[YJ4:/Y"AL!I7@U0,#U'6<_ B2_+TN
M#!BXB<;B78R?XCQ8<_6TKL%1V:H=]!QD]N!HSA.^@B (]6G>\-6>^NB]X>U:
M0LDQ'PFJ,%U39[:P$UK#YMCU&,YA@*PGR!1072^R12**_C\&DSQ6MS]^"V"H
MH8?%*D6VX;+C[ ,@0.YT>=4HERQ0KH5":)4'IKXBW]3Z#'>+'T&8ZH5+40LE
MPKR/:6R9TL,F(FX\,!(2V+1+D+(>2H79 4;/F1776[@(MCWP25N^25GDG!I]
M_ :8,.><]I2JK(=28;85F[!&;B>TR B^??!F6TFD6. V3TSJO-I4]5 JAV9A
MM@%.J(,'ULH=4-I)7EH>I,">>,^ )3F_*D0$KQZ8(W_/#3;TB4!:#E$SFQ)5
M;,CYDR$@>+//7\236J'J7'9KD'.Y=MO#S\>'&G#B2#:$]EF;,YFT[S<1B228
M8706_",=3*#+@/8B3C.58JFJ#3]S/^[NB%JYWNBA$RKA@8GR(HY?19%QJ3_.
MO89S._X<!:5TFJ:K#3]SOX/<J#;HH1/:8&UZY$K46LIKL,Q4<2G>Q"Q^10GF
M6@]GJ-6?'N/9^"F^6*09G,<2I3-VG79!LIX:F\R4JKYL"*WS)3_\;W$\_A'.
M9OUH-RO'S?PU"!.4@VIY,J@.<F*V6C2[3!F+@$@V8VV\9%(5$-Q(B'&*SQ7C
MC0":[@>3Y4%!-0.I*X)LF%-(-:H>)N )Q?# SBE%EQ0AKL6ATU8OMBJ#>#R]
MDJ^N&Q(!$/KA30IZS.RTUOE!\A!.7[*K=Y&,PE2 Q,H#8OG7M*?:T51I#W@X
MZ.UQ=9D0VN6!F14]UF^B-$L6*,4',1;S'$:.]QZP(\M3@4];Y[(,9L5Y 4N"
MX%6/(-1M&D1[R!MG-^(A-,\?0S Z,11C:;#(4MC\C4&2>KNPM!J(Q--<!D8:
MHX=.:(.U>9GM31Y0\21;/C$^F. 0N0S37%KWB9B'B[G*/5E7%V1TR*<H0_R$
MCOAB!%:^1E+D#TAS 91R">1/6(7X,)'R'KE.PR!;3Z/SC73+A7 (Q;,V-5>=
MG"CW1A6TU92[V@;*]CL56@&!'.*!O;(D"-6PMCNSK5N7RUZ:WDE)RP][GS][
MZJQBN..E01,:X(L-.,\&N6.Q!'$E4^62HZB% 2B'O)?50R?R3_MBZKW"K.GX
M.NI\'6:T\>:^CA,0Z#0)YM\"*!8&L](U"@X+E:-3K891N(>\"78B'4+U6GH
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M('V)9Z5=S?)"*E_AGI)P.E7>L-5L&:3;J3"("G-+1<R$1OF2E:J$>GL$/;Z
MV%,<7V+\_36.BH*8R=#,Q=>T-9 B^\M1UII3&2>A+;XDMBK#6VV=\]]4=_=4
M'9"(?P<)#1J"7UYOJ-LX14?8I_CB!6^1TIOH.@B3?P:S!4QKNS[LE#W7JA$0
M1J?R0BBIK0J/X-J7=%>;J6FYMA6JO<0JQCWM/*^H"Q+RSV1HB(I().&+[5"^
M?5XZS:/4K$\9I;H@H4Z%3]8X4.RA(GBW-A#R!6X5?FJ_!TD21-D@>0BG+]G5
M.^QQPU3DB]GZC^GRKZER%JC2'LC2/YM2#:2$UOB2S_U!O 8?*"> CZ*"_[F
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MP<#3ME[#P[-UK%A+GIJC%S%>Y(ERL5/[=)6>-CS_V)19=KS_(TC&.O]=9]\
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MI-0<L5Y:V+.EGL-%5;1Y2KT<]GWJX+-_CDYBS9=D;\%]4.8I^7*TGOT_AIV
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M*4T;9(;9':SEORF9+1Q?!<<C2Y8]BL7O:P+!5DJ\G70><V%_8PHX,RFBT,^
MPE=E\6$UO,IR,4D*>D:E'\9%'9-+P48/6D$EC!#+BQLTW-WFHZ?.QC./)R>?
MPCH+U4^9JL$'5A3<5B+M!+GW%/+!=%A"L:[1IC%FM@+?W8^WYDE1C)__3+!J
M5CG.[^3LQ73SB&P#K'&5PVF]S3.!\54%/!!IC1L^32MDA'G79U++0>,&)K:Z
MW51B)!PA#!E^6J8S0_T_Q;,(B]GK;29=L>G38/%5?IOK_'FSZE[S4IVOVP8
M[;=!2KBK^+4._B' ^*KFS3;15H!LY]?:PXB?VSEJT$8[K1Y"\57MFRO:IP)V
M:AGN4W\8\3,?-Y.B$!I2&-BJ<A-?Q'N1O\F)N,VS-PE#*2J ZX^+X1J@15,
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ML2U2%-.ZRQ48;]GKSMK;5W/7&(%])T@:MX.KC34X(^2MG.W9+'XD>/I2?EP
M5&LSJ#="4F):QULCXBW![5GFLZ20Q3T,/)F.TS^27**?$&U<M=AW[0()B]$5
MYH@O\OK=3;3XS;.6'A]&$F+:S1F1^*K>K2@^UV5AWBBRF,N9Q+2_L+=(THFX
MD,4D6]*U96W:(OJP8G@L%NH.P"*O[5TOMXF>>4!>[4?LMMV-)ACK'-8=7><M
MM@I/Y 6]:^&&=<>!-HY'V0+IB&G';0>'M\:W_Z#JTP7.32N(NK66OB&2$].D
M[83*5W7PMA]BKTZ6S5=I>TM3%U>@;XCTQ.@BM4+EJZ!X6*+GJV_7*D&TJ_"-
MQA@'&>/'VQJ9KP+A; :@O(Q]^0XK55F(=53%QNC7_ZH\6NO4'Y(9Y2*@ UA?
M5</Y%X"[SV/E?+!; ^XU0E)B=,(;$1$RQ^)_NTT^T.%07&5Y(\Q=]U4@FB A
M,;I>#'@(@6/QIZF7.?=BLLR-D6;&MAAE&^.\;@N,T+Y[+)JR.M=_X5B?DD+\
M]_\#4$L! A0#%     @  S*65YR'I(JJ$   [DH  !$              ( !
M     &0S-C<Y,SED97@Q,#DN:'1M4$L! A0#%     @  S*65WR-&!(N @
M"@4  !$              ( !V1   &0S-C<Y,SED97@R,S$N:'1M4$L! A0#
M%     @  S*65UT_A#Z/*@  #]\  !               ( !-A,  &0S-C<Y
M,SED97@T-BYH=&U02P$"% ,4    "  #,I97TE0^D00)  "['0  $
M        @ 'S/0  9#,V-SDS.61E>#4Q+FAT;5!+ 0(4 Q0    (  ,REE=5
MH?"L<P<  &Q"   8              "  25'  !D,S8W.3,Y9&5X9FEL:6YG
M9F5E<RYH=&U02P$"% ,4    "  #,I97O50"[Q!*!@#_O4< #@
M    @ '.3@  9#,V-SDS.61S,2YH=&U02P$"% ,4    "  $,I97W)4NI59?
M  #LJP  $0              @ $*F08 9S,V-SDS.6<Q,G$S."YJ<&=02P$"
M% ,4    "  $,I97?'SB7- W  #,R   $0              @ &/^ 8 9S,V
M-SDS.6<R-F0T.2YJ<&=02P$"% ,4    "  $,I97S0$4NEV8  !RY0  $0
M            @ &., < 9S,V-SDS.6<R-FTT,"YJ<&=02P$"% ,4    "  $
M,I97@983IO:(  !FU   $0              @ $:R0< 9S,V-SDS.6<S.'0R
M,RYJ<&=02P$"% ,4    "  $,I97LB:0V !G  #UL@  $0
M@ $_4@@ 9S,V-SDS.6<U,7HT-2YJ<&=02P$"% ,4    "  $,I97.,;C3 "K
M  #8K@$ $0              @ %NN0@ 9S,V-SDS.6<U-FHU-BYJ<&=02P$"
M% ,4    "  $,I97!A8L.)<^   =T0  $0              @ &=9 D 9S,V
M-SDS.6<V,60Y-"YJ<&=02P$"% ,4    "  $,I97ENHUQZBV  #! 0$ $0
M            @ %CHPD 9S,V-SDS.6<W,F@W,2YJ<&=02P$"% ,4    "  $
M,I97TLV$D2;Y   )4 $ $0              @ $Z6@H 9S,V-SDS.6<X-G@V
M,2YJ<&=02P$"% ,4    "  $,I97>B!N&N<B   $V0$ $0
M@ &/4PL =')N<BTR,#(S,#DS,"YX<V102P$"% ,4    "  $,I97>H6_M= 2
M   9%0$ %0              @ &E=@L =')N<BTR,#(S,#DS,%]C86PN>&UL
M4$L! A0#%     @ !#*65YL$X'#K?@  $ \( !4              ( !J(D+
M '1R;G(M,C R,S Y,S!?9&5F+GAM;%!+ 0(4 Q0    (  0REE=;-@KP,<X
M  T3#0 5              "  <8(# !T<FYR+3(P,C,P.3,P7VQA8BYX;6Q0
M2P$"% ,4    "  $,I97=P,TD6^=   DL@H %0              @ $JUPP
K=')N<BTR,#(S,#DS,%]P<F4N>&UL4$L%!@     4 !0 _@0  ,QT#0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
